Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases

FIELD OF THE INVENTION

This application is in the field of chronic inflammatory diseases. In particular, this invention relates to methods and compositions for diagnosing or monitoring chronic inflammatory diseases.

BACKGROUND OF THE INVENTION

Many of the current shortcomings in diagnosis, prognosis, risk stratification and treatment of disease can be approached through the identification of the molecular mechanisms underlying a disease and through the discovery of nucleotide sequences (or sets of nucleotide sequences) whose expression patterns predict the occurrence or progression of disease states, or predict a patient's response to a particular therapeutic intervention. In particular, identification of nucleotide sequences and sets of nucleotide sequences with such predictive value from cells and tissues that are readily accessible would be extremely valuable. For example, peripheral blood is attainable from all patients and can easily be obtained at multiple time points at low cost. This is a desirable contrast to most other cell and tissue types, which are less readily accessible, or accessible only through invasive and aversive procedures. In addition, the various cell types present in circulating blood are ideal for expression profiling experiments as the many cell types in the blood specimen can be easily separated if desired prior to analysis of gene expression. While blood provides a very attractive substrate for the study of diseases using expression profiling techniques, and for the development of diagnostic technologies and the identification of therapeutic targets, the value of expression profiling in blood samples rests on the degree to which changes in gene expression in these cell types are associated with a predisposition to, and pathogenesis and progression of a disease.

There is an extensive literature supporting the role of leukocytes, e.g., T-and B-lymphocytes, monocytes and granulocytes, including neutrophils, in a wide range of disease processes, including such broad classes as cardiovascular diseases, inflammatory, autoimmune and rheumatic diseases, infectious diseases, transplant rejection, cancer and malignancy, and endocrine diseases.

Of particular interest is the role of leukocytes and leukocyte gene expression in chronic inflammatory diseases such as Systemic Lupus Erythematosis and Rheumatoid Arthritis. Systemic lupus erythematosis (SLE) and Rheumatoid Arthritis (RA) are chonic autoimmune and inflammatory disorders characterized by dysregulation of the immune system, which causes damage to a variety of organs. These diseases clearly involve differential expression of genes in leukocytes. Diagnostic and disease monitoring tools are severly lacking for these patients and their physicians. Leukocyte expression profiling can be applied to discover expression markers for SLE and RA and apply them as patient management tools in the clinical setting. In addition, osteoarthirtis is a degenerative joint disease that can be confused with RA. This disease also involves leukocytes and expression profiling of leukocytes associated with osteoarthritis may lead to the discovery of new diagnostic and therapeutic approaches to the disease.

The accuracy of technologies based on expression profiling for the diagnosis, prognosis, and monitoring of disease would be dramatically increased if numerous differentially expressed nucleotide sequences, each with a measure of sensitivity and specificity for a disease in question, could be identified and assayed in a concerted manner. Using the expression of multiple genes (gene sets) for diagnostic applications helps overcome assay and population variability. In order to achieve this improved accuracy, the appropriate sets of nucleotide sequences need to be identified and validated against numerous samples in combination with relevant clinical data.

SUMMARY OF THE INVENTION

In order to meet these needs, the present invention identifies genes and gene sets that have clinical utility as diagnostic tools for the management of transplant recipients, lupus patients and patients with a variety of chronic inflammatory and autoimmune diseases. The present invention is thus directed to a method of diagnosing or monitoring chronic autoimmune or inflammatory disease in a patient. The method of the invention involves detecting in a patient expression of one or more genes such as those genes depicted in Table 8 and Table 10A and surrogates derived therefrom. Exemplary surrogates are provided in Table 10C. The present invention is further directed to a method of diagnosing or monitoring an autoimmune or chronic inflammatory disease in a patient by detecting the expression level of one or more genes or surrogates derived therefrom in said patient to diagnose or monitor the autoimmune or chronic inflammatory disease in the patient wherein said genes include a nucleotide sequence selected from SEQ ID NO: 41; SEQ ID NO:328; SEQ ID NO:668; SEQ ID NO:855; SEQ ID NO:981; SEQ ID NO:1001; SEQ ID NO:1003; SEQ ID NO:1025; SEQ ID NO:1035; SEQ ID NO:1227; SEQ ID NO:1341; SEQ ID NO:1390; SEQ ID NO:1436; SEQ ID NO: 1535; SEQ ID NO: 1750; SEQ ID NO:2102; SEQ ID NO:2331; SEQ ID NO:2386; SEQ ID NO:2412; SEQ ID NO:2560; SEQ ID NO:2648; SEQ ID NO:2895, SEQ ID NO:3249; SEQ ID NO:3305; SEQ ID NO:3541; SEQ ID NO:3692; SEQ ID NO:3701; SEQ ID NO:3741; SEQ ID NO:3825; SEQ ID NO:3827; SEQ ID NO:3832; SEQ ID NO:4149; SEQ ID NO:4400; SEQ ID NO:4601; SEQ ID NO:4604; SEQ ID NO:4631; SEQ ID NO:4637; SEQ ID NO:5067; SEQ ID NO:5074; SEQ ID NO:5468; SEQ ID NO:5531; SEQ ID NO:5607; SEQ ID NO:6382; SEQ ID NO:6956; SEQ ID NO:7238; SEQ ID NO:7330; SEQ ID NO:7641; SEQ ID NO:8015 and SEQ ID NO:8095.

In the method of the invention, the chronic inflammatory disease or autoimmune disease may be systemic lupus erythematosis (SLE).

In one format, expression is detecting by measuring RNA levels or protein levels from the genes.

In the method of the invention, RNA may be isolated from the patient prior to detecting expression of a gene such as those depicted in Table 10A. RNA levels may be detected by PCR, hybridization such as hybridization to an oligonucleotide. The nucleotide sequence may include comprises DNA, cDNA, PNA, genomic DNA, or synthetic oligonucleotides.

In the methods of the invention, the RNA may be detected by hybridization to an oligonucleotide having a nucleotide sequence selected from SEQ ID NO: 41; SEQ ID NO:328; SEQ ID NO:668; SEQ ID NO:855; SEQ ID NO:981; SEQ ID NO:1001; SEQ ID NO:1003; SEQ ID NO:1025; SEQ ID NO:1035; SEQ ID NO:1227; SEQ ID NO:1341; SEQ II) NO:1390; SEQ ID NO: 1436; SEQ ID NO:1535; SEQ ID NO:1750; SEQ ID NO:2102; SEQ ID NO:2331; SEQ ID NO:2386; SEQ ID NO:2412; SEQ ID NO:2560; SEQ ID NO:2648; SEQ ID NO:2895, SEQ ID NO:3249; SEQ ID NO:3305; SEQ ID NO:3541; SEQ ID NO:3692; SEQ ID NO:3701; SEQ ID NO:3741; SEQ ID NO:3825; SEQ ID NO:3827; SEQ ID NO:3832; SEQ ID NO:4149; SEQ ID NO:4400; SEQ ID NO:4601; SEQ ID NO:4604; SEQ ID NO:4631; SEQ ID NO:4637; SEQ ID NO:5067; SEQ ID NO:5074; SEQ ID NO:5468; SEQ ID NO:5531; SEQ ID NO:5607; SEQ ID NO:6382; SEQ ID NO:6956; SEQ ID NO:7238; SEQ ID NO:7330; SEQ ID NO:7641; SEQ ID NO:8015 and SEQ ID NO:8095.

The present invention is further directed to a diagnostic oligonucleotide for detecting chronic or inflammatory disease wherein the oligonucleotide has a nucleotide sequence selected from SEQ ID NO: 4637. The diagnostic oligonucleotide of may include DNA, cDNA, PNA, genomic DNA, or synthetic oligonucleotides.

The present invention is further directed to a system or kit for diagnosing or monitoring chronic inflammatory or autoimmune disease in a patient comprising an isolated DNA molecule wherein the isolated DNA molecule detects expression of a gene listed in Table 10A. In the system of the invention, the DNA molecules may be synthetic DNA, genomic DNA, PNA or cDNA. The isolated DNA molecule may be immobilized on an array. Such arrays may include a chip array, a plate array, a bead array, a pin array, a membrane array, a solid surface array, a liquid array, an oligonucleotide array, polynucleotide array or a cDNA array, a microtiter plate, a membrane and a chip.

The present invention is further directed to a system or detecting differential gene expression. In one format, the system has one or more isolated DNA molecules wherein each isolated DNA molecule detects expression of a gene selected from the group of genes corresponding to the oligonucleotides depicted in the Sequence Listing. It is understood that the DNA sequences and oligonucleotides of the invention may have slightly different sequences than those identified herein. Such sequence variations are understood to those of ordinary skill in the art to be variations in the sequence which do not significantly affect the ability of the sequences to detect gene expression.

The sequences encompassed by the invention have at least 40-50, 50-60, 70-80, 80-85, 85-90, 90-95 or 95-100% sequence identity to the sequences disclosed herein. In some embodiments, DNA molecules are less than about any of the following lengths (in bases or base pairs): 10,000; 5,000; 2500; 2000; 1500; 1250; 1000; 750; 500; 300; 250; 200; 175; 150; 125; 100; 75; 50; 25; 10. In some embodiments, DNA molecule is greater than about any of the following lengths (in bases or base pairs): 10; 15; 20; 25; 30; 40; 50; 60; 75; 100; 125; 150; 175; 200; 250; 300; 350; 400; 500; 750; 1000; 2000; 5000; 7500; 10000; 20000; 50000. Alternately, a DNA molecule can be any of a range of sizes having an upper limit of 10,000; 5,000; 2500; 2000; 1500; 1250; 1000; 750; 500; 300; 250; 200; 175; 150; 125; 100; 75; 50; 25; or 10 and an independently selected lower limit of 10; 15; 20; 25; 30; 40; 50; 60; 75; 100; 125; 150; 175; 200; 250; 300; 350; 400; 500; 750; 1000; 2000; 5000; 7500 wherein the lower limit is less than the upper limit.

The gene expression system may be a candidate library, a diagnostic agent, a diagnostic oligonucleotide set or a diagnostic probe set. The DNA molecules may be genomic DNA, protein nucleic acid (PNA), cDNA or synthetic oligonucleotides.

In one format, the gene expression system is immobilized on an array. The array may be a chip array, a plate array, a bead array, a pin array, a membrane array, a solid surface array, a liquid array, an oligonucleotide array, a polynucleotide array, a cDNA array, a microfilter plate, a membrane or a chip.

BRIEF DESCRIPTION OF THE SEQUENCE LISTING

A brief description of the sequence listing is given below. There are 9090 entries. The Sequence Listing presents 50mer oligonucleotide sequences derived from human leukocyte, plant and viral genes. These are listed as SEQ IDs 1-8143. The 50mer sequences and their sources are also displayed in Table 8. Most of these 50mers were designed from sequences of genes in Tables 2, 3A, B and C and the Sequence listing.

SEQ IDs 8144-8766 are the cDNA sequences derived from human leukocytes that were not homologous to UniGene sequences or sequences found in dbEST at the time they were searched. So me of these sequences match human genomic sequences and are listed in Tables 3B and C. The remaining clones are putative cDNA sequences that contained less than 50% masked nucleotides when submitted to RepeatMasker, were longer than 147 nucleotides, and did not have significant similarity to the UniGene Unique database, dbEST, the NR nucleotide database of Genbank or the assembled human genome of Genbank.

SEQ IDs 8767-8770, 8828-8830 and 8832 are sequences that appear in the specification (primer, masked sequences, exemplary sequences, etc.).

SEQ IDs 8845-8893 are the full length gene sequences for the genes identified by an accession number in Table 10A.

SEQ IDs 8894-9085 are the primer sequences for lupus genes identified in Table 10B.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1: FIG. 1 is a schematic flow chart illustrating an instruction set for characterization of the nucleotide sequence and/or the predicted protein sequence of novel nucleotide sequences.

FIG. 2: FIG. 2 shows PCR Primer efficiency testing. A standard curve of Ct versus log of the starting RNA amount is shown for 2 g enes.

FIG. 3: FIG. 3 depicts a graph comparing the median background subtracted expression signals for various leukocyte reference RNAs.

FIG. 4: FIG. 4 depicts Diagnostic genes, gene sets and diagnostic algorithms for Systemic Lupus Erythematosis are identified. FIG. 4A shows the relative expression level of oligonucleotide and SEQ ID # 4637 (Sialyltransferase 4A) between Lupus and control samples is shown. The gene is identified as having a false detection rate for differential expression from the SAM algorithm of 0.5%. FIG. 4B shows the scaled ratios (non log) for Sialyltransferase (SEQ ID # 4637) are given for the samples in the analysis. The average ratio of each group along with the standard deviation of the ratio is shown. The average fold change from control to Lupus is 1.48. FIG. 4C shows CART gene expression models for diagnosis of SLE. For each model, the number of genes used, the relative cost with 10 fold cross validation, the SEQ ID, Locus accession number, the name and the position and values in the CART model are given. The CART values given are the expression level thresholds for classification of the sample as SLE after the node. For example, in the single gene model II, the first node of the decision tree asks if expression of gene 5067 is >0.103. If yes, the sample is placed in the lupus class. FIG. 4D shows the sensitivity and specificity of Model 1. The sensitivity and specificity are given for both the 2 and 3 gene models and both the training set and on cross validation. The relative cost is given for cross-validation. FIG. 4E shows the CART Model I, 2 genes. The model uses 2 genes in a single node to classify samples as Lupus (Class 1) or non-Lupus (Class 2). FIG. 4F shows CART Model 1, 3 genes. The model uses a second node to classify all samples correctly as lupus (class 1) or non-lupus (class 2) for the training set.

FIG. 5: FIG. 5 shows endpoint testing of PCR primers. Electrophoresis and microfluidics are used to assess the product of gene specific PCR primers. FIG. 5A is a β-GUS gel image. Lane 3 is the image for primers F178 and R242. Lanes 2 and 1 correspond to the no-template control and −RT control, respectively. FIG. 5B shows the electropherogram of β-GUS primers F178 and R242, a graphical representation of Lane 3 from the gel image. FIG. 5C shows a β-Actin gel image. Lane 3 is the image for primers F75 and R178. Lanes 2 and 1 correspond to the no-template control and −RT control, respectively. FIG. 5D shows the electropherogram of β-Actin primers F75 and R178, a graphical representation of Lave 3 from the gel image.

FIG. 6: FIG. 6 shows the validation of differential expression of a gene discovered using microarrays using Real-time PCR. FIG. 6A shows the Ct for each patient sample on multiple assays is shown along with the Ct in the R50 control RNA. Triangles represent −RT (reverse transcriptase) controls. FIG. 6B shows the fold difference between the expression of Granzyme B and an Actin reference is shown for 3 samples from patients with and without CMV disease.

BRIEF DESCRIPTION OF THE TABLES

Table 1: Table 1 lists some of the diseases or conditions amenable to study by leukocyte profiling.

Table 2: Table 2 describes genes and other nucleotide sequences identified using data mining of publically available publication databases and nucleotide sequence databases. Corresponding Unigene (build 133) cluster numbers are listed with each gene or other nucleotide sequence.

Table 3A: Table 3A describes differentially expressed nucleotide sequences useful for the prediction of clinical outcomes. This table contains 4517 identified cDNAs and cDNA regions of genes that are members of a leukocyte candidate library, for use in measuring the expression of nucleotide sequences that could subsequently be correlated with human clinical conditions. The regions of similarity were found by searching three different databases for pair wise similarity using blastn. The three databases were UniGene Unique build Mar. 30, 2001, file Hs.seq.uniq.Z; the downloadable database located at the website ftp.ncbi.nlm.nih.com/blast/db/est human.Z with date Apr. 8, 2001 which is a section of Genbank version 122; and the non-redundant section of Genbank ver 123. The Hs.XXXXX numbers represent UniGene accession numbers from the Hs.seq.uniq.Z file of Mar. 30, 2001. The clone sequences are not in the sequence listing.

Table 3B: Table 3B describes Identified Genomic Regions that code for novel mRNAs. The table contains 591 identified genomic regions that are highly similar to the cDNA clones. Those regions that are within ˜100 to 200 Kb of each other on the same contig are likely to represent exons of the same gene. The indicated clone is exemplary of the cDNA clones that match the indicated genomic region. The “number clones” column indicates how many clones were isolated from the libraries that are similar to the indicated region of the chromosome. The probability number is the likelihood that region of similarity would occur by chance on a random sequence. The Accession numbers are from the Mar. 15, 2001 build of the human genome. The file date for the downloaded data was Apr. 17, 2001. These sequences may prove useful for the prediction of clinical outcomes.

Table 3C: Table 3C describes 48 clones whose sequences align to two or more non-contiguous sequences on the same assembled human contig of genomic sequence. The Accession numbers are from the Mar. 15, 2001 build of the human genome. The file date for the downloaded data was Apr. 17, 2001. The alignments of the clone and the contig are indicated in the table. The start and stop offset of each matching region is indicated in the table. The sequence of the clones themselves is included in the sequence listing. The alignments of these clones strongly suggest that they are novel nucleotide sequences. Furthermore, no EST or mRNA aligning to the clone was found in the database. These sequences may prove useful for the prediction of clinical outcomes.

Table 4: Database mining. The Library Browser at the NCBI UniGene web site was used to identify genes that are specifically expressed in leukocyte cell populations. The table lists the library name and type, the number of sequences in each library and the number used for the array.

Table 5: Table 5 describes the nucleotide sequence databases used in the sequence analysis described herein.

Table 6: Table 6 describes the algorithms and software packages used for exon and polypeptide prediction used in the sequence analysis described herein.

Table 7: Table 7 describes the databases and algorithms used for the protein sequence analysis described herein.

Table 8: Table 8 provides a listing of all oligonucleotides designed for the arrays and their associated genes. In this table, the sequence ID is given which corresponds to the sequence listing. The origin of the sequence for inclusion on the array is noted as coming from one of the cDNA libraries described in example 1, mining from databases as described in examples 2 and 11 or identification from the published literature. The unigene number, genebank accession and GI number are also given for each sequence when known. These data were obtained from the Unigene unique database, build 137. The name of the gene associated with the accession number is noted. The sequence of these genes as available from the databases are hereby incorporated by reference in their entirety. The strand is noted as −1 or 1, meaning that the probe was designed from the complement of the sequence (−1) or directly from the sequence (1). The nucleotide sequence of each probe is also given in the Sequence Listing.

Table 9: Table 9 shows viral genes for arrays. Viral genomes were used to design oligonucleotides for the microarrays. The accession numbers for the viral genomes used are given, along with the gene name and location of the region used for oligonucleotide design.

Table 10A. Table 10A shows Lupus gene expression markers. This table lists the oligonucleotides and associated genes identified as having value for the diagnosis and monitoring of lupus. The first column gives the SEQ ID that corresponds to the oligonuclotide in the sequence listing. The origin of the sequence for inclusion on the array is noted as coming from one of the cDNA libraries described in example 1, mining from databases as described in examples 2 and 11 or identification from the published literature. The unigene number, genebank accession and GI number are also given for each sequence when known. The SEQ ID for the sequence listing for the full-length genes corresponding to the accession numbers in the table are also given (SEQ ID ACC). These data were obtained from the Unigene unique database, build ###. The name of the gene associated with the accession number is noted. The strand is noted as −1 or 1, meaning that the probe was designed from the complement of the sequence (−1) or directly from the sequence (1). Next, the nucleotide sequence of each probe is also given. For each gene, the false detection rate (FDR) from the significance analsysis described in example 10 is given if applicable. Also, those genes that were identified by CART as a diagnostic gene are noted with the model and position in the model (see example 10 and FIG. 5).

Table 10B. Table 10B shows primers for PCR. For each of the lupus gene expression markers identified in Table 10A, 2 sets of PCR primer pairs are shown that were derived by the methods described in example 15. The melting temperature (Tm) for each primer is shown, as is the corresponding SEQ ID number for the primer in the sequence listing.

Table 10C. Table 10C shows surrogates for the lupus gene expression markers disclosed herein. For some of the lupus marker genes identified in Table 10A, genes are identified by the SEQ ID number as surrogates. The surrogates are identified as such by the CART algorithm or by hierarchical clustering as detailed below.

Table 11: Table 11 describes kits useful for the practice of the invention. Table 11A describes the contents of a kit useful for the discovery of diagnostic nucleotide sets using microarrays. Table 11B describes the contents of a kit useful for the application of diagnostic nucleotide sets using microarrays. Table 11C describes contents of a kit useful for the application of diagnostic nucleotide sets using real-time PCR.

DETAILED DESCRIPTION OF THE INVENTION

Definitions

Unless defined otherwise, all scientific and technical terms are understood to have the same meaning as commonly used in the art to which they pertain. For the purpose of the present invention, the following terms are defined below.

In the context of the invention, the term “gene expression system” refers to any system, device or means to detect gene expression and includes diagnostic agents, candidate libraries oligonucleotide, oligonucleotide sets or probe sets.

The terms “diagnostic oligonucleotide” or “diagnostic oligonucleotide set” generally refers to an oligonucleotide or to a set of two or more oligonucleotides that, when evaluated for differential expression their corresponding diagnostic genes, collectively yields predictive data. Such predictive data typically relates to diagnosis, prognosis, monitoring of therapeutic outcomes, and the like. In general, the components of a diagnostic oligonucleotide or a diagnostic oligonucleotide set are distinguished from oligonucleotide sequences that are evaluated by analysis of the DNA to directly determine the genotype of an individual as it correlates with a specified trait or phenotype, such as a disease, in that it is the pattern of expression of the components of the diagnostic oligonucleotide set, rather than mutation or polymorphism of the DNA sequence that provides predictive value. It will be understood that a particular component (or member) of a diagnostic oligonucleotide set can, in some cases, also present one or more mutations, or polymorphisms that are amenable to direct genotyping by any of a variety of well known analysis methods, e.g., Southern blotting, RFLP, AFLP, SSCP, SNP, and the like.

A “diagnostic gene” is a gene whose expression is detected by a diagnostic oligonucleotide or diagnostic oligonucleotide set.

A “disease specific target oligonucleotide sequence” is a gene or other oligonucleotide that encodes a polypeptide, most typically a protein, or a subunit of a multi-subunit protein that is a therapeutic target for a disease, or group of diseases.

A “candidate library” or a “candidate oligonucleotide library” refers to a collection of oligonucleotide sequences (or gene sequences) that by one or more criteria have an increased probability of being associated with a particular disease or group of diseases. The criteria can be, for example, a differential expression pattern in a disease state or in activated or resting leukocytes in vitro as reported in the scientific or technical literature, tissue specific expression as reported in a sequence database, differential expression in a tissue or cell type of interest, or the like. Typically, a candidate library has at least 2 members or components; more typically, the library has in excess of about 10, or about 100, or about 1000, or even more, members or components.

The term “disease criterion” is used herein to designate an indicator of a disease, such as a diagnostic factor, a prognostic factor, a factor indicated by a medical or family history, a genetic factor, or a symptom, as well as an overt or confirmed diagnosis of a disease associated with several indicators such as those selected from the above list. A disease criterion includes data describing a patient's health status, including retrospective or prospective health data, e.g. in the form of the patient's medical history, laboratory test results, diagnostic test result, clinical events, medications, lists, response(s) to treatment and risk factors, etc.

An autoimmune disorder is defined as a disease state in which a patient's immune system recognizes an antigen in that patient's organs or tissues as foreign and becomes activated. The activated immune cells can then cause damage to the inciting organ or tissue or can damage other organs or tissues. In some cases, the disorder may be caused by a dysregulation of the immune system cells, rather than by the recognition as a self-antigen as foreign. Dysregulated immune cells can secrete inflammatory cytokines that cause systemic inflammation or they can recognize self-antigens as foreign.

Examples of autoimmune diseases include: Autoimmune hepatitis, Multiple Sclerosis, Myasthenia Gravis, Type I diabetes, Rheumatoid Arthritis, Psoriasis, Systemic Lupus Erythematosis, Hashimoto's Thyroiditis, Grave's disease, Ankylosing Spondylitis Sjogrens Disease, CREST syndrome, Scleroderma and many more.

Most of the autoimmune diseases are also chronic inflammatory diseases. This is defined as a disease process associated with long-term (>6 months) activation of inflammatory cells (leukocytes). The chronic inflammation leads to damage of patient organs or tissues. Many diseases are chronic inflammatory disorders, but are not know to have an autoimmune basis. For example, Atherosclerosis, Congestive Heart Failure, Crohn's disease, Ulcerative Colitis, Polyarteritis nodosa, Whipple's Disease, Primary Sclerosing Cholangitis and many more.

The terms “molecular signature” or “expression profile” refers to the collection of expression values for a plurality (e.g., at least 2, but frequently about 10, about 100, about 1000, or more) of members of a candidate library. In many cases, the molecular signature represents the expression pattern for all of the nucleotide sequences in a library or array of candidate or diagnostic nucleotide sequences or genes. Alternatively, the molecular signature represents the expression pattern for one or more subsets of the candidate library. The term “oligonucleotide” refers to two or more nucleotides. Nucleotides may be DNA or RNA, naturally occurring or synthetic.

The term “healthy individual,” as used herein, is relative to a specified disease or disease criterion. That is, the individual does not exhibit the specified disease criterion or is not diagnosed with the specified disease. It will be understood, that the individual in question, can, of course, exhibit symptoms, or possess various indicator factors for another disease.

Similarly, an “individual diagnosed with a disease” refers to an individual diagnosed with a specified disease (or disease criterion). Such an individual may, or may not, also exhibit a disease criterion associated with, or be diagnosed with another (related or unrelated) disease.

The term “monitoring” is used herein to describe the use of gene sets to provide useful information about an individual or an individual's health or disease status. “Monitoring” can include, determination of prognosis, risk-stratification, selection of drug therapy, assessment of ongoing drug therapy, prediction of outcomes, determining response to therapy, diagnosis of a disease or disease complication, following progression of a disease or providing any information relating to a patients health status.

An “array” is a spatially or logically organized collection, e.g., of oligonucleotide sequences or nucleotide sequence products such as RNA or proteins encoded by an oligonucleotide sequence. In some embodiments, an array includes antibodies or other binding reagents specific for products of a candidate library.

When referring to a pattern of expression, a “qualitative” difference in gene expression refers to a difference that is not assigned a relative value. That is, such a difference is designated by an “all or nothing” valuation. Such an all or nothing variation can be, for example, expression above or below a threshold of detection (an on/off pattern of expression). Alternatively, a qualitative difference can refer to expression of different types of expression products, e.g., different alleles e.g., a mutant or polymorphic allele), variants (including sequence variants as well as post-translationally modified variants), etc.

In contrast, a “quantitative” difference, when referring to a pattern of gene expression, refers to a difference in expression that can be assigned a value on a graduated scale, (e.g., a 0-5 or 1-10 scale, a +−+++scale, a grade 1-grade 5 scale, or the like; it will be understood that the numbers selected for illustration are entirely arbitrary and in no-way are meant to be interpreted to limit the invention).

Gene Expression Systems and Methods of Detecting Gene Expression

The invention is directed to methods of detecting gene expression with a gene expression system having one or more DNA molecules wherein the one or more DNA molecules has a nucleotide sequence which detects expression of a gene corresponding to the oligonucleotides depicted in the Sequence Listing. In one format, the oligonucleotide detects expression of a gene that is differentially expressed in leukocytes. The gene expression system may be a candidate library, a diagnostic agent, a diagnostic oligonucleotide set or a diagnostic probe set. The DNA molecules may be genomic DNA, RNA, protein nucleic acid (PNA), cDNA or synthetic oligonucleotides. Following the procedures taught herein, one can identity sequences of interest for analyzing gene expression in leukocytes. Such sequences may be predictive of a disease state.

Diagnostic Oligonucleotides of the Invention

The invention relates to diagnostic oligonucleotides and diagnostic oligonucleotide set(s) comprising members of the leukocyte candidate library listed in Table 2, Table 3 and Tables 8-10 in the Sequence Listing, for which a correlation exists between the health status of an individual, and the individual's expression of RNA or protein products corresponding to the nucleotide sequence. In some instances, only one oligonucleotide is necessary for such detection. Members of a diagnostic oligonucleotide set may be identified by any means capable of detecting expression of RNA or protein products, including but not limited to differential expression screening, PCR, RT-PCR, SAGE analysis, high-throughput sequencing, microarrays, liquid or other arrays, protein-based methods (e.g., western blotting, proteomics, and other methods described herein), and data mining methods, as further described herein.

In one embodiment, a diagnostic oligonucleotide set comprises at least two oligonucleotide sequences listed in Table 2, Table 3 and Tables 8-10 or the Sequence Listing which are differentially expressed in leukocytes in an individual with at least one disease criterion for at least one leukocyte-implicated disease relative to the expression in individual without the at least one disease criterion, wherein expression of the two or more nucleotide sequences is correlated with at least one disease criterion, as described below.

In another embodiment, a diagnostic oligonucleotide set comprises at least one oligonucleotide having an oligonucleotide sequence listed in Table 2, 3 and Tables 8-10, or the Sequence Listing which is differentially expressed, and further wherein the differential expression/correlation has not previously been described. In some embodiments, the diagnostic oligonucleotide set is immobilized on an array.

In another embodiment, diagnostic oligonucleotides (or oligonucleotide sets) are related to the members of the leukocyte candidate library listed in Table 2, Table 3, Tables 8-10 and in the Sequence Listing, for which a correlation exists between the health status (or disease criterion) of an individual. The diagnostic oligonucleotides are partially or totally contained in (or derived from) full-length gene sequences (or predicted full-length gene sequences) for the members of the candidate library listed in Table 2, 3 and the Sequence Listing. This includes sequences from accession numbers and unigene numbers from Table 8. Table 8 shows the accession and unigene number (when known) for each oligonucleotide used on the 8134 gene leukocyte array described in examples 11-13. In some cases, oligonucleotide sequences are designed from EST or Chromosomal sequences from a public database. In these cases the full-length gene sequences may not be known. Full-length sequences in these cases can be predicted using gene prediction algorithms (Examples 4-6). Alternatively the full-length can be determined by cloning and sequencing the full-length gene or genes that contain the sequence of interest using standard molecular biology approaches described here. The same is true for olignonucleotides designed from our sequencing of cDNA libraries (see Examples 1-4) where the cDNA does not match any sequence in the public databases.

The diagnostic oligonucleotides may also be derived from other genes that are coexpressed with the correlated sequence or full-length gene. Genes may share expression patterns because they are regulated in the same molecular pathway. Because of the similarity of expression, behavior genes are identified as surrogates in that they can substitute for a diagnostic gene in a diagnostic gene set. Example 10 demonstrates the discovery of surrogates from the data and Table 10C and the sequence listing identify and give the sequence for surrogates for lupus diagnostic genes. Surrogate oligonucleotide and surrogate oligonucleotide sets can be utilized to detect expression of surrogate genes and thereby diagnose or monitor patients with a disease.

As used herein the term “gene cluster” or “cluster” refers to a group of genes related by expression pattern. In other words, a cluster of genes is a group of genes with similar regulation across different conditions, such as a patient having a chronic autoimmune or inflammatory disease or a patient without chronic autoimmune or inflammatory disease. The expression profile for each gene in a cluster should be correlated with the expression profile of at least one other gene in that cluster. Correlation may be evaluated using a variety of statistical methods. As used herein the term “surrogate” refers to a gene with an expression profile such that it can substitute for a diagnostic gene in a diagnostic assay. Such genes are often members of the same gene cluster as the diagnostic gene. For each member of a diagnostic gene set, a set of potential surrogates can be identified through identification of genes with similar expression patterns as described below.

Many statistical analyses produce a correlation coefficient to describe the relatedness between two gene expression patterns. Patterns may be considered correlated if the correlation coefficient is greater than or equal to 0.8. In preferred embodiments, the correlation coefficient should be greater than 0.85, 0.9 or 0.95. Other statistical methods produce a measure of mutual information to describe the relatedness between two gene expression patterns. Patterns may be considered correlated if the normalized mutual information value is greater than or equal to 0.7. In preferred embodiments, the normalized mutual information value should be greater than 0.8, 0.9 or 0.95. Patterns may also be considered similar if they cluster closely upon hierarchical clustering of gene expression data (Eisen et al. 1998). Similar patterns may be those genes that are among the 1, 2, 5, 10, 20, 50 or 100 nearest neighbors in a hierarchical clustering or have a similarity score (Eisen et al. 1998) of >0.5, 0.7, 0.8, 0.9, 0.95 or 0.99. Similar patterns may also be identified as those genes found to be surrogates in a classification tree by CART (Breiman et al. 1994). Often, but not always, members of a gene cluster have similar biological functions in addition to similar gene expression patterns.

Correlated genes, clusters and surrogates are identified for the diagnostic genes of the invention. These surrogates may be used as diagnostic genes in an assay instead of, or in addition to, the diagnostic genes for which they are surrogates.

The invention also provides diagnostic probe sets. It is understood that a probe includes any reagent capable of specifically identifying a nucleotide sequence of the diagnostic nucleotide set, including but not limited to amplified DNA, amplified RNA, cDNA, synthetic oligonucleotide, partial or full-length nucleic acid sequences. In addition, the probe may identify the protein product of a diagnostic nucleotide sequence, including, for example, antibodies and other affinity reagents.

It is also understood that each probe can correspond to one gene, or multiple probes can correspond to one gene, or both, or one probe can correspond to more than one gene.

Homologs and variants of the disclosed nucleic acid molecules may be used in the present invention. Homologs and variants of these nucleic acid molecules will possess a relatively high degree of sequence identity when aligned using standard methods. The sequences encompassed by the invention have at least 40-50, 50-60, 70-80, 80-85, 85-90, 90-95 or 95-100% sequence identity to the sequences disclosed herein.

It is understood that for expression profiling, variations in the disclosed sequences will still permit detection of gene expression. The degree of sequence identity required to detect gene expression varies depending on the length of the oligomer. For a 60 mer, (an oligonucleotide with 60 nucleotides) 6-8 random mutations or 6-8 random deletions in a 60 mer do not affect gene expression detection. Hughes, T R, et al. “Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nature Biotechnology, 19:343-347(2001). As the length of the DNA sequence is increased, the number of mutations or deletions permitted while still allowing gene expression detection is increased.

As will be appreciated by those skilled in the art, the sequences of the present invention may contain sequencing errors. That is, there may be incorrect nucleotides, frameshifts, unknown nucleotides, or other types of sequencing errors in any of the sequences; however, the correct sequences will fall within the homology and stringency definitions herein.

The minimum length of an oligonucleotide probe necessary for specific hybridization in the human genome can be estimated using two approaches. The first method uses a statistical argument that the probe will be unique in the human genome by chance. Briefly, the number of independent perfect matches (Po) expected for an oligonucleotide of length L in a genome of complexity C can be calculated from the equation (Laird CD, Chromosoma 32:378 (1971):

Po=(1/4)^L*2C

In the case of mammalian genomes, 2C=˜3.6×10⁹, and an oligonucleotide of 14-15 nucleotides is expected to be represented only once in the genome. However, the distribution of nucleotides in the coding sequence of mammalian genomes is nonrandom (Lathe, R. J. Mol. Biol. 183:1 (1985) and longer oligonucleotides may be preferred in order to in increase the specificity of hybridization. In practical terms, this works out to probes that are 19-40 nucleotides long (Sambrook J et al., infra). The second method for estimating the length of a specific probe is to use a probe long enough to hybridize under the chosen conditions and use a computer to search for that sequence or close matches to the sequence in the human genome and choose a unique match. Probe sequences are chosen based on the desired hybridization properties as described in Chapter 11 of Sambrook et al, infra. The PRIMER3 program is useful for designing these probes (S. Rozen and H. Skaletsky 1996,1997; Primer3 code available at genome.wi.mit.edu/genome_softwarelother/primer3.html, the website). The sequences of these probes are then compared pair wise against a database of the human genome sequences using a program such as BLAST or MEGABLAST (Madden, T. L et al.(1996) Meth. Enzymol. 266:131-141). Since most of the human genome is now contained in the database, the number of matches will be determined. Probe sequences are chosen that are unique to the desired target sequence.

In some embodiments, a diagnostic oligonucleotide or oligonucleotide probe set is immobilized on an array. The array is optionally comprises one or more of: a chip array, a plate array, a bead array, a pin array, a membrane array, a solid surface array, a liquid array, an oligonucleotide array, a polynucleotide array or a cDNA array, a microtiter plate, a pin array, a bead array, a membrane or a chip.

In some embodiments, the leukocyte-implicated disease is selected from the diseases listed in Table 1. In other embodiments, the disease is atherosclerosis or cardiac allograft rejection. In other embodiments, the disease is congestive heart failure, angina, myocardial infarction, chronic autoimmune and inflammatory diseases, systemic lupus erythematosis (SLE) and rheumatoid arthritis.

In some embodiments, diagnostic oligonucleotides of the invention are used as a diagnostic gene set in combination with genes that are know to be associated with a disease state (“known markers”). The use of the diagnostic oligonucleotides in combination with the known markers can provide information that is not obtainable through the known markers alone. The known markers include those identified by the prior art listing provided.

General Molecular Biology References

In the context of the invention, nucleic acids and/or proteins are manipulated according to well known molecular biology techniques. Detailed protocols for numerous such procedures are described in, e.g., in Ausubel et al. Current Protocols in Molecular Biology (supplemented through 2000) John Wiley & Sons, New York (“Ausubel”); Sambrook et al. Molecular Cloning-A Laboratory Manual (2nd Ed.), Vol. 1-3, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1989 (“Sambrook”), and Berger and Kimmel Guide to Molecular Cloning Techniques, Methods in Enzymology volume 152 Academic Press, Inc., San Diego, Calif. (“Berger”).

In addition to the above references, protocols for in vitro amplification techniques, such as the polymerase chain reaction (PCR), the ligase chain reaction (LCR), Q-replicase amplification, and other RNA polymerase mediated techniques (e.g., NASBA), useful e.g., for amplifying cDNA probes of the invention, are found in Mullis et al. (1987) U.S. Pat. No. 4,683,202; PCR Protocols A Guide to Methods and Applications (Innis et al. eds) Academic Press Inc. San Diego, Calif. (1990) (“Innis”); Amheim and Levinson (1990) C&EN 36; The Journal Of NIH Research (1991) 3:81; Kwoh et al. (1989) Proc Natl Acad Sci USA 86, 1173; Guatelli et al. (1990) Proc Natl Acad Sci USA 87:1874; Lomell et al. (1989) J Clin Chem 35:1826; Landegren et al. (1988) Science 241:1077; Van Brunt (1990) Biotechnology 8:291; Wu and Wallace (1989) Gene 4: 560; Barringer et al. (1990) Gene 89:117, and Sooknanan and Malek (1995) Biotechnology 13:563. Additional methods, useful for cloning nucleic acids in the context of the present invention, include Wallace et al. U.S. Pat. No. 5,426,039. Improved methods of amplifying large nucleic acids by PCR are summarized in Cheng et al. (1994) Nature 369:684 and the references therein.

Certain polynucleotides of the invention, e.g., oligonucleotides can be synthesized utilizing various solid-phase strategies involving mononucleotide- and/or trinucleotide-based phosphoramidite coupling chemistry. For example, nucleic acid sequences can be synthesized by the sequential addition of activated monomers and/or trimers to an elongating polynucleotide chain. See e.g., Caruthers, M. H. et al. (1992) Meth Enzymol 211:3.

In lieu of synthesizing the desired sequences, essentially any nucleic acid can be custom ordered from any of a variety of commercial sources, such as The Midland Certified Reagent Company (mcrc@oligos.com), The Great American Gene Company (genco.com), ExpressGen, Inc. (expressgen.com), Operon Technologies, Inc. (operon.com), and many others.

Similarly, commercial sources for nucleic acid and protein micro arrays are avaiable, and include, e.g., Agilent Technologies, Palo Alto, Calif. and Affymetrix, Santa Clara, Calif.

Candidate Library

Libraries of candidate genes that are differentially expressed in leukocytes are substrates for the identification and evaluation of diagnostic oligonucleotides and oligonucleotide sets and disease specific target nucleotide sequences.

The term leukocyte is used generically to refer to any nucleated blood cell that is not a nucleated erythrocyte. More specifically, leukocytes can be subdivided into two broad classes. The first class includes granulocytes, including, most prevalently, neutrophils, as well as eosinophils and basophils at low frequency. The second class, the non-granular or mononuclear leukocytes, includes monocytes and lymphocytes (e.g., T cells and B cells). There is an extensive literature in the art implicating leukocytes, e.g., neutrophils, monocytes and lymphocytes in a wide variety of disease processes, including inflammatory and rheumatic diseases, neurodegenerative diseases (such as Alzheimer's dementia), cardiovascular disease, endocrine diseases, transplant rejection, malignancy and infectious diseases, and other diseases listed in Table 1. Mononuclear cells are involved in the chronic immune response, while granulocytes, which make up approximately 60% of the leukocytes, have a non-specific and stereotyped response to acute inflammatory stimuli and often have a life span of only 24 hours.

In addition to their widespread involvement and/or implication in numerous disease related processes, leukocytes are particularly attractive substrates for clinical and experimental evaluation for a variety of reasons. Most importantly, they are readily accessible at low cost from essentially every potential subject. Collection is minimally invasive and associated with little pain, disability or recovery time. Collection can be performed by minimally trained personnel (e.g., phlebotomists, medical technicians, etc.) in a variety of clinical and non-clinical settings without significant technological expenditure. Additionally, leukocytes are renewable, and thus available at multiple time points for a single subject.

Assembly of Candidate Libraries

At least two conceptually distinct approaches to the assembly of candidate libraries exist. Either, or both, or other, approaches can be favorably employed. The method of assembling, or identifying, candidate libraries is secondary to the criteria utilized for selecting appropriate library members. Most importantly, library members are assembled based on differential expression of RNA or protein products in leukocyte populations. More specifically, candidate nucleotide sequences are induced or suppressed, or expressed at increased or decreased levels in leukocytes from a subject with one or more disease or disease state (a disease criterion) relative to leukocytes from a subject lacking the specified disease criterion. Alternatively, or in addition, library members can be assembled from among nucleotide sequences that are differentially expressed in activated or resting leukocytes relative to other cell types.

Firstly, publication and sequence databases can be “mined” using a variety of search strategies. For example, currently available scientific and medical publication databases such as Medline, Current Contents, OMIM (online Mendelian inheritance in man) various Biological and Chemical Abstracts, Journal indexes, and the like can be searched using term or key-word searches, or by author, title, or other relevant search parameters. Many such databases are publicly available, and one of skill is well versed in strategies and procedures for identifying publications and their contents, e.g., genes, other nucleotide sequences, descriptions, indications, expression pattern, etc. Numerous databases are available through the internet for free or by subscription, see, e.g., the websites, ncbi.nlm.nih.gov/PubMed/; 3.infotrieve.com/; isinet.com/; sciencemag.org/. Additional or alternative publication or citation databases are also available that provide identical or similar types of information, any of which are favorably employed in the context of the invention. These databases can be searched for publications describing differential gene expression in leukocytes between patients with and without diseases or conditions listed in Table 1. We identified the nucleotide sequences listed in Table 2 and some of the sequences used to design oligonucleotides for microarrays (sequence listing), using data mining methods.

Alternatively, a variety of publicly available and proprietary sequence databases (including GenBank, dbEST, UniGene, and TIGR and SAGE databases) including sequences corresponding to expressed nucleotide sequences, such as expressed sequence tags (ESTs) are available. For example, the Genbank™ website located at ncbi.nlm.nih.gov/Genbank/among others, can be readily accessed and searched via the internet. These and other sequence and clone database resources are currently available; however, any number of additional or alternative databases comprising nucleotide sequence sequences, EST sequences, clone repositories, PCR primer sequences, and the like corresponding to individual nucleotide sequence sequences are also suitable for the purposes of the invention. Nucleotide sequences can be identified that are only found in libraries derived from leukocytes or sub-populations of leukocytes, for example see Table 2 and Example 2.

Alternatively, the representation, or relative frequency, of a nucleotide sequence may be determined in a leukocyte-derived nucleic acid library and compared to the representation of the sequence in non-leukocyte derived libraries. The representation of a nucleotide sequence correlates with the relative expression level of the nucleotide sequence in leukocytes and non-leukocytes. An oligonucleotide sequence that has increased or decreased representation in a leukocyte-derived nucleic acid library relative to a non-leukocyte-derived libraries is a candidate for a leukocyte-specific gene.

Nucleotide sequences identified as having specificity to activated or resting leukocytes or to leukocytes from patients or patient samples with a variety of disease types can be isolated for use in a candidate library for leukocyte expression profiling through a variety of mechanisms. These include, but are not limited to, the amplification of the nucleotide sequence from RNA or DNA using nucleotide sequence specific primers for PCR or RT-PCR, isolation of the nucleotide sequence using conventional cloning methods, the purchase of an IMAGE consortium cDNA clone (EST) with complimentary sequence or from the same expressed nucleotide sequence, design of oligonucleotides, preparation of synthetic nucleic acid sequence, or any other nucleic-acid based method. In addition, the protein product of the nucleotide sequence can be isolated or prepared, and represented in a candidate library, using standard methods in the art, as described further below.

While the above discussion related primarily to “genomics” approaches, it is appreciated that numerous, analogous “proteomics” approaches are suitable to the present invention. For example, a differentially expressed protein product can, for example, be detected using western analysis, two-dimensional gel analysis, chromatographic separation, mass spectrometric detection, protein-fusion reporter constructs, colorometric assays, binding to a protein array, or by characterization of polysomal mRNA. The protein is further characterized and the nucleotide sequence encoding the protein is identified using standard techniques, e.g. by screening a cDNA library using a probe based on protein sequence information.

The second approach involves the construction of a differential expression library by any of a variety of means. Any one or more of differential screening, differential display or subtractive hybridization procedures, or other techniques that preferentially identify, isolate or amplify differentially expressed nucleotide sequences can be employed to produce a library of differentially expressed candidate nucleotide sequences, a subset of such a library, a partial library, or the like. Such methods are well known in the art. For example, peripheral blood leukocytes, (i.e., a mixed population including lymphocytes, monocytes and neutrophils), from multiple donor samples are pooled to prevent bias due to a single-donor's unique genotype. The pooled leukocytes are cultured in standard medium and stimulated with individual cytokines or growth factors e.g., with IL-2, IL-1, MCPI, TNFα, and/or IL8 according to well known procedures (see, e.g., Tough et al. (1999); Winston et al. (1999); Hansson et al. (1989)). Typically, leukocytes are recovered from Buffy coat preparations produced by centrifugation of whole blood. Alternatively, mononuclear cells (monocytes and lymphocytes) can be obtained by density gradient centrifugation of whole blood, or specific cell types (such as a T lymphocyte) can be isolated using affinity reagents to cell specific surface markers. When affinity reagents are used to isolate specific cell types, it is desirable to isolate the cells using negative selection to avoid activation of the desired cell type by binding of the antibody. Leukocytes may also be stimulated by incubation with ionomycin, and phorbol myristate acetate (PMA). This stimulation protocol is intended to non-specifically mimic “activation” of numerous pathways due to variety of disease conditions rather than to simulate any single disease condition or paradigm.

Using well-known subtractive hybridization procedures (as described in, e.g., U.S. Pat. Nos. 5,958,738; 5589,339; 5,827,658; 5,712,127; 5,643,761) each of which are hereby incorporated by reference, a library is produced that is enriched for RNA species (messages) that are differentially expressed between test and control leukocyte populations. In some embodiments, the test population of leukocytes are simply stimulated as described above to emulate non-specific activation events, while in other embodiments the test population can be selected from subjects (or patients) with a specified disease or class of diseases. Typically, the control leukocyte population lacks the defining test condition, e.g., stimulation, disease state, diagnosis, genotype, etc. Alternatively, the total RNA from control and test leukocyte populations are prepared by established techniques, treated with DNAseI, and selected for messenger RNA with an intact 3′ end (i.e., polyA(+) messenger RNA) e.g., using commercially available kits according to the manufacturer's instructions e.g. Clontech. Double stranded cDNA is synthesized utilizing reverse transcriptase. Double stranded cDNA is then cut with a first restriction enzyme (e.g., NlaIII, that cuts at the recognition site: CATG, and cuts the cDNA sequence at approximately 256 bp intervals) that cuts the cDNA molecules into conveniently sized fragments.

The cDNAs prepared from the test population of leukocytes are divided into (typically 2) “tester” pools, while cDNAs prepared from the control population of leukocytes are designated the “driver” pool. Typically, pooled populations of cells from multiple individual donors are utilized and in the case of stimulated versus unstimulated cells, the corresponding tester and driver pools for any single subtraction reaction are derived from the same donor pool.

A unique double-stranded adapter is ligated to each of the tester cDNA populations using unphosphorylated primers so that only the sense strand is covalently linked to the adapter. An initial hybridization is performed consisting of each of the tester pools of cDNA (each with its corresponding adapter) and an excess of the driver cDNA. Typically, an excess of about 10-100 fold driver relative to tester is employed, although significantly lower or higher ratios can be empirically determined to provide more favorable results. The initial hybridization results in an initial normalization of the cDNAs such that high and low abundance messages become more equally represented following hybridization due to a failure of driver/tester hybrids to amplify.

A second hybridization involves pooling un-hybridized sequences from initial hybridizations together with the addition of supplemental driver cDNA. In this step, the expressed sequences enriched in the two tester pools following the initial hybridization can hybridize. Hybrids resulting from the hybridization between members of each of the two tester pools are then recovered by amplification in a polymerase chain reaction (PCR) using primers specific for the unique adapters. Again, sequences originating in a tester pool that form hybrids with components of the driver pool are not amplified. Hybrids resulting between members of the same tester pool are eliminated by the formation of “panhandles” between their common 5′ and 3′ ends. For additional details, see, e.g., Lukyanov et al. (1997) Biochem Biophys Res Commun 230:285-8.

Typically, the tester and driver pools are designated in the alternative, such that the hybridization is performed in both directions to ensure recovery of messenger RNAs that are differentially expressed in either a positive or negative manner (i.e., that are turned on or turned off, up-regulated or down-regulated). Accordingly, it will be understood that the designation of test and control populations is to some extent arbitrary, and that a test population can just as easily be compared to leukocytes derived from a patient with the same of another disease of interest.

If so desired, the efficacy of the process can be assessed by such techniques as semi-quantitative PCR of known (i.e., control) nucleotide sequences, of varying abundance such as β-actin. The resulting PCR products representing partial cDNAs of differentially expressed nucleotide sequences are then cloned (i.e., ligated) into an appropriate vector (e.g., a commercially available TA cloning vector, such as pGEM from Promega) and, optionally, transformed into competent bacteria for selection and screening.

Either of the above approaches, or both in combination, or indeed, any procedure, which permits the assembly of a collection of nucleotide sequences that are expressed in leukocytes, is favorably employed to produce the libraries of candidates useful for the identification of diagnostic nucleotide sets and disease specific target nucleotides of the invention. Additionally, any method that permits the assembly of a collection of nucleotides that are expressed in leukocytes and preferentially associated with one or more disease or condition, whether or not the nucleotide sequences are differentially expressed, is favorably employed in the context of the invention. Typically, libraries of about 2,000-10,000 members are produced (although libraries in excess of 10,000 are not uncommon). Following additional evaluation procedures, as described below, the proportion of unique clones in the candidate library can approximate 100%.

A candidate oligonucleotide sequence may be represented in a candidate library by a full-length or partial nucleic acid sequence, deoxyribonucleic acid (DNA) sequence, cDNA sequence, RNA sequence, synthetic oligonucleotides, etc. The nucleic acid sequence can be at least 19 nucleotides in length, at least 25 nucleotides, at least 40 nucleotides, at least 100 nucleotides, or larger. Alternatively, the protein product of a candidate nucleotide sequence may be represented in a candidate library using standard methods, as further described below.

Characterization of Candidate Oliponucleotide Sequences

The sequence of individual members (e.g., clones, partial sequence listing in a database such as an EST, etc.) of the candidate oligonucleotide libraries is then determined by conventional sequencing methods well known in the art, e.g., by the dideoxy-chain termination method of Sanger et al. (1977) Proc Natl Acad Sci USA 74:5463-7; by chemical procedures, e.g., Maxam and Gilbert (1977) Proc Natl Acad Sci USA 74:560-4; or by polymerase chain reaction cycle sequencing methods, e.g., Olsen and Eckstein (1989) Nuc Acid Res 17:9613-20, DNA chip based sequencing techniques or variations, including automated variations (e.g., as described in Hunkapiller et al. (1991) Science 254:59-67; Pease et al. (1994) Proc Natl Acad Sci USA 91:5022-6), thereof. Numerous kits for performing the above procedures are commercially available and well known to those of skill in the art. Character strings corresponding to the resulting nucleotide sequences are then recorded (i.e., stored) in a database. Most commonly the character strings are recorded on a computer readable medium for processing by a computational device.

Generally, to facilitate subsequent analysis, a custom algorithm is employed to query existing databases in an ongoing fashion, to determine the identity, expression pattern and potential function of the particular members of a candidate library. The sequence is first processed, by removing low quality sequence. Next the vector sequences are identified and removed and sequence repeats are identified and masked. The remaining sequence is then used in a Blast algorithm against multiple publicly available, and/or proprietary databases, e.g., NCBI nucleotide, EST and protein databases, Unigene, and Human Genome Sequence. Sequences are also compared to all previously sequenced members of the candidate libraries to detect redundancy.

In some cases, sequences are of high quality, but do not match any sequence in the NCBI nr, human EST or Unigene databases. In this case the sequence is queried against the human genomic sequence. If a single chromosomal site is matched with a high degree of confidence, that region of genomic DNA is identified and subjected to further analysis with a gene prediction program such as GRAIL. This analysis may lead to the identification of a new gene in the genomic sequence. This sequence can then be translated to identify the protein sequence that is encoded and that sequence can be further analyzed using tools such as Pfam, Blast P, or other protein structure prediction programs, as illustrated in Table 7. Typically, the above analysis is directed towards the identification of putative coding regions, e.g., previously unidentified open reading frames, confirming the presence of known coding sequences, and determining structural motifs or sequence similarities of the predicted protein (i.e., the conceptual translation product) in relation to known sequences. In addition, it has become increasingly possible to assemble “virtual cDNAs” containing large portions of coding region, simply through the assembly of available expressed sequence tags (ESTs). In turn, these extended nucleic acid and amino acid sequences allow the rapid expansion of substrate sequences for homology searches and structural and functional motif characterization. The results of these analysis permits the categorization of sequences according to structural characteristics, e.g., as structural proteins, proteins involved in signal transduction, cell surface or secreted proteins etc.

It is understood that full-length nucleotide sequences may also be identified using conventional methods, for example, library screening, RT-PCR, chromosome walking, etc., as described in Sambrook and Ausubel, infra.

Candidate Nucleotide Library of the Invention

We identified members of a candidate nucleotide library that are differentially expressed in activated leukocytes and resting leukocytes. Accordingly, the invention provides the candidate leukocyte nucleotide library comprising the nucleotide sequences listed in Table 2, Table 3, Tables 8-10 and in the Sequence Listing. In another embodiment, the invention provides a candidate library comprising at least two nucleotide sequences listed in Table 2, Table 3, Tables 8-10 and the Sequence Listing. In another embodiment, at least two nucleotide sequences are 18 nucleotides in length, at least 35 nucleotides, at least 40 nucleotides or at least 100 nucleotides. In some embodiments, the nucleotide sequences comprises deoxyribonucleic acid (DNA) sequence, ribonucleic acid (RNA) sequence, synthetic oligonucleotide sequence, or genomic DNA sequence. It is understood that the nucleotide sequences may each correspond to one gene, or that several nucleotide sequences may correspond to one gene, or that a single nucleotide sequence may correspond to multiple genes.

The invention also provides probes to the candidate nucleotide library. In one embodiment of the invention, the probes comprise at least two nucleotide sequences listed in Table 2, Table 3, Tables 8-10, or the Sequence Listing which are differentially expressed in leukocytes in an individual with a least one disease criterion for at least one leukocyte-related disease and in leukocytes in an individual without the at least one disease criterion, wherein expression of the two or more nucleotide sequences is correlated with at least one disease criterion. It is understood that a probe may detect either the RNA expression or protein product expression of the candidate nucleotide library. Alternatively, or in addition, a probe can detect a genotype associated with a candidate nucleotide sequence, as further described below. In another embodiment, the probes for the candidate nucleotide library are immobilized on an array.

The candidate nucleotide library of the invention is useful in identifying diagnostic nucleotide sets of the invention, as described below. The candidate nucleotide sequences may be further characterized, and may be identified as a disease target nucleotide sequence and/or a novel nucleotide sequence, as described below. The candidate nucleotide sequences may also be suitable for use as imaging reagents, as described below.

Generation of Expression Patterns

RNA, DNA or Protein Sample Procurement

Following identification or assembly of a library of differentially expressed candidate nucleotide sequences, leukocyte expression profiles corresponding to multiple members of the candidate library are obtained. Leukocyte samples from one or more subjects are obtained by standard methods. Most typically, these methods involve trans-cutaneous venous sampling of peripheral blood. While sampling of circulating leukocytes from whole blood from the peripheral vasculature is generally the simplest, least invasive, and lowest cost alternative, it will be appreciated that numerous alternative sampling procedures exist, and are favorably employed in some circumstances. No pertinent distinction exists, in fact, between leukocytes sampled from the peripheral vasculature, and those obtained, e.g., from a central line, from a central artery, or indeed from a cardiac catheter, or during a surgical procedure which accesses the central vasculature. In addition, other body fluids and tissues that are, at least in part, composed of leukocytes are also desirable leukocyte samples. For example, fluid samples obtained from the lung during bronchoscopy may be rich in leukocytes, and amenable to expression profiling in the context of the invention, e.g., for the diagnosis, prognosis, or monitoring of lung transplant rejection, inflammatory lung diseases or infectious lung disease. Fluid samples from other tissues, e.g., obtained by endoscopy of the colon, sinuses, esophagus, stomach, small bowel, pancreatic duct, biliary tree, bladder, ureter, vagina, cervix or uterus, etc., are also suitable. Samples may also be obtained other sources containing leukocytes, e.g., from urine, bile, cerebrospinal fluid, feces, gastric or intestinal secretions, semen, or solid organ or joint biopsies.

Most frequently, mixed populations of leukocytes, such as are found in whole blood are utilized in the methods of the present invention. A crude separation, e.g., of mixed leukocytes from red blood cells, and/or concentration, e.g., over a sucrose, percoll or ficoll gradient, or by other methods known in the art, can be employed to facilitate the recovery of RNA or protein expression products at sufficient concentrations, and to reduce non-specific background. In some instances, it can be desirable to purify sub-populations of leukocytes, and methods for doing so, such as density or affinity gradients, flow cytometry, Fluorescence Activated Cell Sorting (FACS), immuno-magnetic separation, “panning,” and the like, are described in the available literature and below.

Obtaining DNA, RNA and Protein Samples for Expression Profiling

A variety of techniques are available for the isolation of RNA from whole blood. Any technique that allows isolation of mRNA from cells (in the presence or absence of rRNA and tRNA) can be utilized. In brief, one method that allows reliable isolation of total RNA suitable for subsequent gene expression analysis is described as follows. Peripheral blood (either venous or arterial) is drawn from a subject, into one or more sterile, endotoxin free, tubes containing an anticoagulant (e.g., EDTA, citrate, heparin, etc.). Typically, the sample is divided into at least two portions. One portion, e.g., of 5-8 ml of whole blood is frozen and stored for future analysis, e.g., of DNA or protein. A second portion, e.g., of approximately 8 ml whole blood is processed for isolation of total RNA by any of a variety of techniques as described in, e.g, Sambook, Ausubel, below, as well as U.S. Pat. Nos: 5,728,822 and 4,843,155.

Typically, a subject sample of mononuclear leukocytes obtained from about 8 ml of whole blood, a quantity readily available from an adult human subject under most circumstances, yields 5-20 μg of total RNA. This amount is ample, e.g., for labeling and hybridization to at least two probe arrays. Labeled probes for analysis of expression patterns of nucleotides of the candidate libraries are prepared from the subject's sample of RNA using standard methods. In many cases, cDNA is synthesized from total RNA using a polyT primer and labeled, e.g., radioactive or fluorescent, nucleotides. The resulting labeled cDNA is then hybridized to probes corresponding to members of the candidate nucleotide library, and expression data is obtained for each nucleotide sequence in the library. RNA isolated from subject samples (e.g., peripheral blood leukocytes, or leukocytes obtained from other biological fluids and samples) is next used for analysis of expression patterns of nucleotides of the candidate libraries.

In some cases, however, the amount of RNA that is extracted from the leukocyte sample is limiting, and amplification of the RNA is desirable. Amplification may be accomplished by increasing the efficiency of probe labeling, or by amplifying the RNA sample prior to labeling. It is appreciated that care must be taken to select an amplification procedure that does not introduce any bias (with respect to gene expression levels) during the amplification process.

Several methods are available that increase the signal from limiting amounts of RNA, e.g. use of the Clontech (Glass Fluorescent Labeling Kit) or Stratagene (Fairplay Microarray Labeling Kit), or the Micromax kit (New England Nuclear, Inc.). Alternatively, cDNA is synthesized from RNA using a T7-polyT primer, in the absence of label, and DNA dendrimers from Genisphere (3DNA Submicro) are hybridized to the poly T sequence on the primer, or to a different “capture sequence” which is complementary to a fluorescently labeled sequence. Each 3DNA molecule has 250 fluorescent molecules and therefore can strongly label each cDNA.

Alternatively, the RNA sample is amplified prior to labeling. For example, linear amplification may be performed, as described in U.S. Pat. No. 6,132,997. A T7-polyT primer is used to generate the cDNA copy of the RNA. A second DNA strand is then made to complete the substrate for amplification. The T7 promoter incorporated into the primer is used by a T7 polymerase to produce numerous antisense copies of the original RNA. Fluorescent dye labeled nucleotides are directly incorporated into the RNA. Alternatively, amino allyl labeled nucleotides are incorporated into the RNA, and then fluorescent dyes are chemically coupled to the amino allyl groups, as described in Hughes et al. 2001. Other exemplary methods for amplification are described below.

It is appreciated that the RNA isolated must contain RNA derived from leukocytes, but may also contain RNA from other cell types to a variable degree. Additionally, the isolated RNA may come from subsets of leukocytes, e.g. monocytes and/or T-lymphocytes, as described above. Such consideration of cell type used for the derivation of RNA depends on the method of expression profiling used.

DNA samples may be obtained for analysis of the presence of DNA mutations, single nucleotide polymorphisms (SNPs), or other polymorphisms. DNA is isolated using standard techniques, e.g. Maniatus, supra.

Expression of products of candidate nucleotides may also be assessed using proteomics. Protein(s) are detected in samples of patient serum or from leukocyte cellular protein. Serum is prepared by centrifugation of whole blood, using standard methods. Proteins present in the serum may have been produced from any of a variety of leukocytes and non-leukocyte cells, and may include secreted proteins from leukocytes. Alternatively, leukocytes or a desired sub-population of leukocytes are prepared as described above. Cellular protein is prepared from leukocyte samples using methods well known in the art, e.g., Trizol (Invitrogen Life Technologies, cat # 15596108; Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156; Simms, D., Cizdziel, P. E., and Chomczynski, P. (1993) Focus® 15, 99; Chomczynski, P., Bowers-Finn, R., and Sabatini, L. (1987) J. of NIH Res. 6, 83; Chomczynski, P. (1993) Bio/Techniques 15, 532; Bracete, A. M., Fox, D. K., and Simms, D. (1998) Focus 20, 82; Sewall, A. and McRae, S. (1998) Focus 20, 36; Anal Biochem 1984 April;138(1):141-3, A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids; Wessel D, Flugge Ul. (1984) Anal Biochem. 1984 April;138(1):141-143.

Obtaining Expression Patterns

Expression patterns, or profiles, of a plurality of nucleotides corresponding to members of the candidate library are then evaluated in one or more samples of leukocytes. Typically, the leukocytes are derived from patient peripheral blood samples, although, as indicated above, many other sample sources are also suitable. These expression patterns constitute a set of relative or absolute expression values for some number of RNAs or protein products corresponding to the plurality of nucleotide sequences evaluated, which is referred to herein as the subject's “expression profile” for those nucleotide sequences. While expression patterns for as few as one independent member of the candidate library can be obtained, it is generally preferable to obtain expression patterns corresponding to a larger number of nucleotide sequences, e.g., about 2, about 5, about 10, about 20, about 50, about 100, about 200, about 500, or about 1000, or more. The expression pattern for each differentially expressed component member of the library provides a finite specificity and sensitivity with respect to predictive value, e.g., for diagnosis, prognosis, monitoring, and the like.

Clinical Studies, Data and Patient Groups

For the purpose of discussion, the term subject, or subject sample of leukocytes, refers to an individual regardless of health and/or disease status. A subject can be a patient, a study participant, a control subject, a screening subject, or any other class of individual from whom a leukocyte sample is obtained and assessed in the context of the invention. Accordingly, a subject can be diagnosed with a disease, can present with one or more symptom of a disease, or a predisposing factor, such as a family (genetic) or medical history (medical) factor, for a disease, or the like. Alternatively, a subject can be healthy with respect to any of the aforementioned factors or criteria. It will be appreciated that the term “healthy” as used herein, is relative to a specified disease, or disease factor, or disease criterion, as the term “healthy” cannot be defined to correspond to any absolute evaluation or status. Thus, an individual defined as healthy with reference to any specified disease or disease criterion, can in fact be diagnosed with any other one or more disease, or exhibit any other one or more disease criterion.

Furthermore, while the discussion of the invention focuses, and is exemplified using human sequences and samples, the invention is equally applicable, through construction or selection of appropriate candidate libraries, to non-human animals, such as laboratory animals, e.g., mice, rats, guinea pigs, rabbits; domesticated livestock, e.g., cows, horses, goats, sheep, chicken, etc.; and companion animals, e.g., dogs, cats, etc.

Methods for Obtaining Expression Data

Numerous methods for obtaining expression data are known, and any one or more of these techniques, singly or in combination, are suitable for determining expression profiles in the context of the present invention. For example, expression patterns can be evaluated by northern analysis, PCR, RT-PCR, Taq Man analysis, FRET detection, monitoring one or more molecular beacon, hybridization to an oligonucleotide array, hybridization to a cDNA array, hybridization to a polynucleotide array, hybridization to a liquid microarray, hybridization to a microelectric array, molecular beacons, cDNA sequencing, clone hybridization, cDNA fragment fingerprinting, serial analysis of gene expression (SAGE), subtractive hybridization, differential display and/or differential screening (see, e.g., Lockhart and Winzeler (2000) Nature 405:827-836, and references cited therein).

For example, specific PCR primers are designed to a member(s) of a candidate nucleotide library. cDNA is prepared from subject sample RNA by reverse transcription from a poly-dT oligonucleotide primer, and subjected to PCR. Double stranded cDNA may be prepared using primers suitable for reverse transcription of the PCR product, followed by amplification of the cDNA using in vitro transcription. The product of in vitro transcription is a sense-RNA corresponding to the original member(s) of the candidate library. PCR product may be also be evaluated in a number of ways known in the art, including real-time assessment using detection of labeled primers, e.g. TaqMan or molecular beacon probes. Technology platforms suitable for analysis of PCR products include the ABI 7700, 5700, or 7000 Sequence Detection Systems (Applied Biosystems, Foster City, Calif.), the MJ Research Opticon (MJ Research, Waltham, Mass.), the Roche Light Cycler (Roche Diagnositics, Indianapolis, Ind.), the Stratagene MX4000 (Stratagene, La Jolla, Calif.), and the Bio-Rad iCycler (Bio-Rad Laboratories, Hercules, Calif.). Alternatively, molecular beacons are used to detect presence of a nucleic acid sequence in an unamplified RNA or cDNA sample, or following amplification of the sequence using any method, e.g. IVT (In Vitro transcription) or NASBA (nucleic acid sequence based amplification). Molecular beacons are designed with sequences complementary to member(s) of a candidate nucleotide library, and are linked to fluorescent labels. Each probe has a different fluorescent label with non-overlapping emission wavelengths. For example, expression of ten genes may be assessed using ten different sequence-specific molecular beacons.

Alternatively, or in addition, molecular beacons are used to assess expression of multiple nucleotide sequences at once. Molecular beacons with sequence complimentary to the members of a diagnostic nucleotide set are designed and linked to fluorescent labels. Each fluorescent label used must have a non-overlapping emission wavelength. For example, 10 nucleotide sequences can be assessed by hybridizing 10 sequence specific molecular beacons (each labeled with a different fluorescent molecule) to an amplified or un-amplified RNA or cDNA sample. Such an assay bypasses the need for sample labeling procedures.

Alternatively, or in addition bead arrays can be used to assess expression of multiple sequences at once (See, e.g, LabMAP 100, Luminex Corp, Austin, Tex.). Alternatively, or in addition electric arrays are used to assess expression of multiple sequences, as exemplified by the e-Sensor technology of Motorola (Chicago, Ill.) or Nanochip technology of Nanogen (San Diego, Calif.)

Of course, the particular method elected will be dependent on such factors as quantity of RNA recovered, practitioner preference, available reagents and equipment, detectors, and the like. Typically, however, the elected method(s) will be appropriate for processing the number of samples and probes of interest. Methods for high-throughput expression analysis are discussed below.

Alternatively, expression at the level of protein products of gene expression is performed. For example, protein expression, in a sample of leukocytes, can be evaluated by one or more method selected from among: western analysis, two-dimensional gel analysis, chromatographic separation, mass spectrometric detection, protein-fusion reporter constructs, calorimetric assays, binding to a protein array and characterization of polysomal mRNA. One particularly favorable approach involves binding of labeled protein expression products to an array of antibodies specific for members of the candidate library. Methods for producing and evaluating antibodies are widespread in the art, see, e.g., Coligan, supra; and Harlow and Lane (1989) Antibodies: A Laboratory Manual, Cold Spring Harbor Press, NY (“Harlow and Lane”). Additional details regarding a variety of immunological and immunoassay procedures adaptable to the present invention by selection of antibody reagents specific for the products of candidate nucleotide sequences can be found in, e.g., Stites and Terr (eds.)(1991) Basic and Clinical Immunology, 7^thed., and Paul, supra. Another approach uses systems for performing desorption spectrometry. Commercially available systems, e.g., from Ciphergen Biosystems, Inc. (Fremont, Calif.) are particularly well suited to quantitative analysis of protein expression. Indeed, Protein Chip(arrays (see, e.g., the website, ciphergen.com) used in desorption spectrometry approaches provide arrays for detection of protein expression. Alternatively, affinity reagents, (e.g., antibodies, small molecules, etc.) are developed that recognize epitopes of the protein product. Affinity assays are used in protein array assays, e.g. to detect the presence or absence of particular proteins. Alternatively, affinity reagents are used to detect expression using the methods described above. In the case of a protein that is expressed on the cell surface of leukocytes, labeled affinity reagents are bound to populations of leukocytes, and leukocytes expressing the protein are identified and counted using fluorescent activated cell sorting (FACS).

It is appreciated that the methods of expression evaluation discussed herein, although discussed in the context of discovery of diagnostic nucleotide sets, are also applicable for expression evaluation when using diagnostic nucleotide sets for, e.g. diagnosis of diseases, as further discussed below.

High Throughput Expression Assays

A number of suitable high throughput formats exist for evaluating gene expression. Typically, the term high throughput refers to a format that performs at least about 100 assays, or at least about 500 assays, or at least about 1000 assays, or at least about 5000 assays, or at least about 10,000 assays, or more per day. When enumerating assays, either the number of samples or the number of candidate nucleotide sequences evaluated can be considered. For example, a northern analysis of, e.g., about 100 samples performed in a gridded array, e.g., a dot blot, using a single probe corresponding to a candidate nucleotide sequence can be considered a high throughput assay. More typically, however, such an assay is performed as a series of duplicate blots, each evaluated with a distinct probe corresponding to a different member of the candidate library. Alternatively, methods that simultaneously evaluate expression of about 100 or more candidate nucleotide sequences in one or more samples, or in multiple samples, are considered high throughput.

Numerous technological platforms for performing high throughput expression analysis are known. Generally, such methods involve a logical or physical array of either the subject samples, or the candidate library, or both. Common array formats include both liquid and solid phase arrays. For example, assays employing liquid phase arrays, e.g., for hybridization of nucleic acids, binding of antibodies or other receptors to ligand, etc., can be performed in multiwell, or microtiter, plates. Microtiter plates with 96, 384 or 1536 wells are widely available, and even higher numbers of wells, e.g, 3456 and 9600 can be used. In general, the choice of microtiter plates is determined by the methods and equipment, e.g., robotic handling and loading systems, used for sample preparation and analysis. Exemplary systems include, e.g., the ORCA™ system from Beckman-Coulter, Inc. (Fullerton, Calif.) and the Zymate systems from Zymark Corporation (Hopkinton, Mass.).

Alternatively, a variety of solid phase arrays can favorably be employed in to determine expression patterns in the context of the invention. Exemplary formats include membrane or filter arrays (e.g, nitrocellulose, nylon), pin arrays, and bead arrays (e.g., in a liquid “slurry”). Typically, probes corresponding to nucleic acid or protein reagents that specifically interact with (e.g., hybridize to or bind to) an expression product corresponding to a member of the candidate library are immobilized, for example by direct or indirect cross-linking, to the solid support. Essentially any solid support capable of withstanding the reagents and conditions necessary for performing the particular expression assay can be utilized. For example, functionalized glass, silicon, silicon dioxide, modified silicon, any of a variety of polymers, such as (poly)tetrafluoroethylene, (poly)vinylidenedifluoride, polystyrene, polycarbonate, or combinations thereof can all serve as the substrate for a solid phase array.

In a preferred embodiment, the array is a “chip” composed, e.g., of one of the above-specified materials. Polynucleotide probes, e.g., RNA or DNA, such as cDNA, synthetic oligonucleotides, and the like, or binding proteins such as antibodies, that specifically interact with expression products of individual components of the candidate library are affixed to the chip in a logically ordered manner, i.e., in an array. In addition, any molecule with a specific affinity for either the sense or anti-sense sequence of the marker nucleotide sequence (depending on the design of the sample labeling), can be fixed to the array surface without loss of specific affinity for the marker and can be obtained and produced for array production, for example, proteins that specifically recognize the specific nucleic acid sequence of the marker, ribozymes, peptide nucleic acids (PNA), or other chemicals or molecules with specific affinity.

Detailed discussion of methods for linking nucleic acids and proteins to a chip substrate, are found in, e.g., U.S. Pat. No. 5,143,854 “Large Scale Photolithographic Solid Phase Synthesis Of Polypeptides And Receptor Binding Screening Thereof” to Pirrung et al., issued, Sep. 1, 1992; U.S. Pat. No. 5,837,832 “Arrays Of Nucleic Acid Probes On Biological Chips” to Chee et al., issued Nov. 17, 1998; U.S. Pat. No. 6,087,112 “Arrays With Modified Oligonucleotide And Polynucleotide Compositions” to Dale, issued Jul. 11, 2000; U.S. Pat. No. 5,215,882 “Method Of Immobilizing Nucleic Acid On A Solid Substrate For Use In Nucleic Acid Hybridization Assays” to Bahl et al., issued Jun. 1, 1993; U.S. Pat. No. 5,707,807 “Molecular Indexing For Expressed Gene Analysis” to Kato, issued Jan. 13, 1998; U.S. Pat. No. 5,807,522 “Methods For Fabricating Microarrays Of Biological Samples” to Brown et al., issued Sep. 15, 1998; U.S. Pat. No. 5,958,342 “Jet Droplet Device” to Gamble et al., issued Sep. 28, 1999; U.S. Pat. No. 5,994,076 “Methods Of Assaying Differential Expression” to Chenchik et al., issued Nov. 30, 1999; U.S. Pat. No. 6,004,755 “Quantitative Microarray Hybridization Assays” to Wang, issued Dec. 21, 1999; U.S. Pat. No. 6,048,695 “Chemically Modified Nucleic Acids And Method For Coupling Nucleic Acids To Solid Support” to Bradley et al., issued Apr. 11, 2000; U.S. Pat. No. 6,060,240 “Methods For Measuring Relative Amounts Of Nucleic Acids In A Complex Mixture And Retrieval Of Specific Sequences Therefrom” to Kamb et al., issued May 9, 2000; U.S. Pat. No. 6,090,556 “Method For Quantitatively Determining The Expression Of A Gene” to Kato, issued Jul. 18, 2000; and U.S. Pat. No. 6,040,138 “Expression Monitoring By Hybridization To High Density Oligonucleotide Arrays” to Lockhart et al., issued Mar. 21, 2000 each of which are hereby incorporated by reference in their entirety.

For example, cDNA inserts corresponding to candidate nucleotide sequences, in a standard TA cloning vector are amplified by a polymerase chain reaction for approximately 30-40 cycles. The amplified PCR products are then arrayed onto a glass support by any of a variety of well-known techniques, e.g., the VSLIPS™ technology described in U.S. Pat. No. 5,143,854. RNA, or cDNA corresponding to RNA, isolated from a subject sample of leukocytes is labeled, e.g., with a fluorescent tag, and a solution containing the RNA (or cDNA) is incubated under conditions favorable for hybridization, with the “probe” chip. Following incubation, and washing to eliminate non-specific hybridization, the labeled nucleic acid bound to the chip is detected qualitatively or quantitatively, and the resulting expression profile for the corresponding candidate nucleotide sequences is recorded. It is appreciated that the probe used for diagnostic purposes may be identical to the probe used during diagnostic nucleotide sequence discovery and validation. Alternatively, the probe sequence may be different than the sequence used in diagnostic nucleotide sequence discovery and validation. Multiple cDNAs from a nucleotide sequence that are non-overlapping or partially overlapping may also be used.

In another approach, oligonucleotides corresponding to members of a candidate nucleotide library are synthesized and spotted onto an array. Alternatively, oligonucleotides are synthesized onto the array using methods known in the art, e.g. Hughes, et al. supra. The oligonucleotide is designed to be complementary to any portion of the candidate nucleotide sequence. In addition, in the context of expression analysis for, e.g. diagnostic use of diagnostic nucleotide sets, an oligonucleotide can be designed to exhibit particular hybridization characteristics, or to exhibit a particular specificity and/or sensitivity, as further described below.

Oligonucleotide probes are also prepared using the DNA sequence information for the candidate genes identified by differential hybridization screening (listed in Tables 3, 8-10 and the Sequence Listing) and/or the sequence information for the genes identified by database mining (listed in Table 2) is used to design complimentary oligonucleotide probes. Oligo probes are designed on a contract basis by various companies (for example, Compugen, Mergen, Affymetrix, Telechem), or designed from the candidate sequences using a variety of parameters and algorithms as indicated at the website genome.wi.mit.edu/cgi-bin/primer/primer3.cgi. Briefly, the length of the oligonucleotide to be synthesized is determined, preferably at least 16 nucleotides, generally 18-24 nucleotides, 24-70 nucleotides and, in some circumstances, more than 70 nucleotides. The sequence analysis algorithms and tools described above are applied to the sequences to mask repetitive elements, vector sequences and low complexity sequences. Oligonucleotides are selected that are specific to the candidate nucleotide sequence (based on a Blast n search of the oligonucleotide sequence in question against gene sequences databases, such as the Human Genome Sequence, UniGene, dbEST or the non-redundant database at NCBI), and have <50% G content and 25-70% G+C content. Desired oligonucleotides are synthesized using well-known methods and apparatus, or ordered from a company (for example Sigma). Oligonucleotides are spotted onto microarrays. Alternatively, oligonucleotides are synthesized directly on the array surface, using a variety of techniques (Hughes et al. 2001, Yershov et al. 1996, Lockhart et al 1996).

Hybridization signal may be amplified using methods known in the art, and as described herein, for example use of the Clontech kit (Glass Fluorescent Labeling Kit), Stratagene kit (Fairplay Microarray Labeling Kit), the Micromax kit (New England Nuclear, Inc.), the Genisphere kit (3DNA Submicro), linear amplification, e.g. as described in U.S. Pat. No. 6,132,997 or described in Hughes, T R, et al., Nature Biotechnology, 19:343-347 (2001) and/or Westin et al. Nat Biotech. 18:199-204. In some cases, amplification techniques do not increase signal intensity, but allow assays to be done with small amounts of RNA.

Alternatively, fluorescently labeled cDNA are hybridized directly to the microarray using methods known in the art. For example, labeled cDNA are generated by reverse transcription using Cy3- and Cy5-conjugated deoxynucleotides, and the reaction products purified using standard methods. It is appreciated that the methods for signal amplification of expression data useful for identifying diagnostic nucleotide sets are also useful for amplification of expression data for diagnostic purposes.

Microarray expression may be detected by scanning the microarray with a variety of laser or CCD-based scanners, and extracting features with numerous software packages, for example, Imagene (Biodiscovery), Feature Extraction Software (Agilent), Scanalyze (Eisen, M. 1999. SCANALYZE User Manual; Stanford Univ., Stanford, Calif. Ver 2.32.), GenePix (Axon Instruments).

In another approach, hybridization to microelectric arrays is performed, e.g. as described in Umek et al (2001) J Mol Diagn. 3:74-84. An affinity probe, e.g. DNA, is deposited on a metal surface. The metal surface underlying each probe is connected to a metal wire and electrical signal detection system. Unlabelled RNA or cDNA is hybridized to the array, or alternatively, RNA or cDNA sample is amplified before hybridization, e.g. by PCR. Specific hybridization of sample RNA or cDNA results in generation of an electrical signal, which is transmitted to a detector. See Westin (2000) Nat Biotech. 18:199-204 (describing anchored multiplex amplification of a microelectronic chip array); Edman (1997) NAR 25:4907-14; Vignali (2000) J Immunol Methods 243:243-55.

In another approach, a microfluidics chip is used for RNA sample preparation and analysis. This approach increases efficiency because sample preparation and analysis are streamlined. Briefly, microfluidics may be used to sort specific leukocyte sub-populations prior to RNA preparation and analysis. Microfluidics chips are also useful for, e.g., RNA preparation, and reactions involving RNA (reverse transcription, RT-PCR). Briefly, a small volume of whole, anti-coagulated blood is loaded onto a microfluidics chip, for example chips available from Caliper (Mountain View, Calif.) or Nanogen (San Diego, Calif.) A microfluidics chip may contain channels and reservoirs in which cells are moved and reactions are performed. Mechanical, electrical, magnetic, gravitational, centrifugal or other forces are used to move the cells and to expose them to reagents. For example, cells of whole blood are moved into a chamber containing hypotonic saline, which results in selective lysis of red blood cells after a 20-minute incubation. Next, the remaining cells (leukocytes) are moved into a wash chamber and finally, moved into a chamber containing a lysis buffer such as guanidine isothyocyanate. The leukocyte cell lysate is further processed for RNA isolation in the chip, or is then removed for further processing, for example, RNA extraction by standard methods. Alternatively, the microfluidics chip is a circular disk containing ficoll or another density reagent. The blood sample is injected into the center of the disc, the disc is rotated at a speed that generates a centrifugal force appropriate for density gradient separation of mononuclear cells, and the separated mononuclear cells are then harvested for further analysis or processing.

It is understood that the methods of expression evaluation, above, although discussed in the context of discovery of diagnostic nucleotide sots, are also applicable for expression evaluation when using diagnostic nucleotide sets for, e.g. diagnosis of diseases, as further discussed below.

Evaluation of Expression Patterns

Expression patterns can be evaluated by qualitative and/or quantitative measures. Certain of the above described techniques for evaluating gene expression (as RNA or protein products) yield data that are predominantly qualitative in nature. That is, the methods detect differences in expression that classify expression into distinct modes without providing significant information regarding quantitative aspects of expression. For example, a technique can be described as a qualitative technique if it detects the presence or absence of expression of a candidate nucleotide sequence, i.e., an on/off pattern of expression. Alternatively, a qualitative technique measures the presence (and/or absence) of different alleles, or variants, of a gene product.

In contrast, some methods provide data that characterize expression in a quantitative manner. That is, the methods relate expression on a numerical scale, e.g., a scale of 0-5, a scale of 1-10, a scale of +−+++, from grade 1 to grade 5, a grade from a to z, or the like. It will be understood that the numerical, and symbolic examples provided are arbitrary, and that any graduated scale (or any symbolic representation of a graduated scale) can be employed in the context of the present invention to describe quantitative differences in nucleotide sequence expression. Typically, such methods yield information corresponding to a relative increase or decrease in expression.

Any method that yields either quantitative or qualitative expression data is suitable for evaluating expression of candidate nucleotide sequence in a subject sample of leukocytes. In some cases, e.g., when multiple methods are employed to determine expression patterns for a plurality of candidate nucleotide sequences, the recovered data, e.g., the expression profile, for the nucleotide sequences is a combination of quantitative and qualitative data.

In some applications, expression of the plurality of candidate nucleotide sequences is evaluated sequentially. This is typically the case for methods that can be characterized as low- to moderate-throughput. In contrast, as the throughput of the elected assay increases, expression for the plurality of candidate nucleotide sequences in a sample or multiple samples of leukocytes, is assayed simultaneously. Again, the methods (and throughput) are largely determined by the individual practitioner, although, typically, it is preferable to employ methods that permit rapid, e.g. automated or partially automated, preparation and detection, on a scale that is time-efficient and cost-effective.

It is understood that the preceding discussion, while directed at the assessment of expression of the members of candidate libraries, is also applies to the assessment of the expression of members of diagnostic nucleotide sets, as further discussed below.

Genotyping

In addition to, or in conjunction with the correlation of expression profiles and clinical data, it is often desirable to correlate expression patterns with the subject's genotype at one or more genetic loci or to correlate both expression profiles and genetic loci data with clinical data The selected loci can be, for example, chromosomal loci corresponding to one or more member of the candidate library, polymorphic alleles for marker loci, or alternative disease related loci (not contributing to the candidate library) known to be, or putatively associated with, a disease (or disease criterion). Indeed, it will be appreciated, that where a (polymorphic) allele at a locus is linked to a disease (or to a predisposition to a disease), the presence of the allele can itself be a disease criterion.

Numerous well known methods exist for evaluating the genotype of an individual, including southern analysis, restriction fragment length polymorphism (RFLP) analysis, polymerase chain reaction (PCR), amplification length polymorphism (AFLP) analysis, single stranded conformation polymorphism (SSCP) analysis, single nucleotide polymorphism (SNP) analysis (e.g., via PCR, Taqman or molecular beacons), among many other useful methods. Many such procedures are readily adaptable to high throughput and/or automated (or semi-automated) sample preparation and analysis methods. Most, can be performed on nucleic acid samples recovered via simple procedures from the same sample of leukocytes as yielded the material for expression profiling. Exemplary techniques are described in, e.g., Sambrook, and Ausubel, supra.

Identification of the Diagnostic Oligonucleotides and Oligonucleotide Sets of the Invention

Identification of diagnostic nucleotides and nucleotide sets and disease specific target nucleotide sequence proceeds by correlating the leukocyte expression profiles with data regarding the subject's health status to produce a data set designated a “molecular signature.” Examples of data regarding a patient's health status, also termed “disease criteria(ion)”, is described below and in the Section titled “selected diseases,” below. Methods useful for correlation analysis are further described elsewhere in the specification.

Generally, relevant data regarding the subject's health status includes retrospective or prospective health data, e.g., in the form of the subject's medical history, as provided by the subject, physician or third party, such as, medical diagnoses, laboratory test results, diagnostic test results, clinical events, or medication lists, as further described below. Such data may include information regarding a patient's response to treatment and/or a particular medication and data regarding the presence of previously characterized “risk factors.” For example, cigarette smoking and obesity are previously identified risk factors for heart disease. Further examples of health status information, including diseases and disease criteria, is described in the section titled Selected diseases, below.

Typically, the data describes prior events and evaluations (i.e., retrospective data). However, it is envisioned that data collected subsequent to the sampling (i.e., prospective data) can also be correlated with the expression profile. The tissue sampled, e.g., peripheral blood, bronchial lavage, etc., can be obtained at one or more multiple time points and subject data is considered retrospective or prospective with respect to the time of sample procurement.

Data collected at multiple time points, called “longitudinal data”, is often useful, and thus, the invention encompasses the analysis of patient data collected from the same patient at different time points. Analysis of paired samples, such as samples from a patient at different times, allows identification of differences that are specifically related to the disease state since the genetic variability specific to the patient is controlled for by the comparison; Additionally, other variables that exist between patients may be controlled for in this way, for example, the presence or absence of inflammatory diseases (e.g., rheumatoid arthritis) the use of medications that may effect leukocyte gene expression, the presence or absence of co-morbid conditions, etc. Methods for analysis of paired samples are further described below. Moreover, the analysis of a pattern of expression profiles (generated by collecting multiple expression profiles) provides information relating to changes in expression level over time, and may permit the determination of a rate of change, a trajectory, or an expression curve. Two longitudinal samples may provide information on the change in expression of a gene over time, while three longitudinal samples may be necessary to determine the “trajectory” of expression of a gene. Such information may be relevant to the diagnosis of a disease. For example, the expression of a gene may vary from individual to individual, but a clinical event, for example, a heart attack, may cause the level of expression to double in each patient. In this example, clinically interesting information is gleaned from the change in expression level, as opposed to the absolute level of expression in each individual.

When a single patient sample is obtained, it may still be desirable to compare the expression profile of that sample to some reference expression profile. In this case, one can determine the change of expression between the patient's sample and a reference expression profile that is appropriate for that patient and the medical condition in question. For example, a reference expression profile can be determined for all patients without the disease criterion in question who have similar characteristics, such as age, sex, race, diagnoses etc.

Generally, small sample sizes of 1040 samples from 10-20 individuals are used to identify a diagnostic nucleotide set. Larger sample sizes are generally necessary to validate the diagnostic nucleotide set for use in large and varied patient populations, as further described below. For example, extension of gene expression correlations to varied ethnic groups, demographic groups, nations, peoples or races may require expression correlation experiments on the population of interest.

Expression Reference Standards

Expression profiles derived from a patient (i.e., subjects diagnosed with, or exhibiting symptoms of, or exhibiting a disease criterion, or under a doctor's care for a disease) sample are compared to a control or standard expression RNA to facilitate comparison of expression profiles (e.g. of a set of candidate nucleotide sequences) from a group of patients relative to each other (i.e., from one patient in the group to other patients in the group, or to patients in another group).

The reference RNA used should have desirable features of low cost and simplicity of production on a large scale. Additionally, the reference RNA should contain measurable amounts of as many of the genes of the candidate library as possible.

For example, in one approach to identifying diagnostic nucleotide sets, expression profiles derived from patient samples are compared to a expression reference “standard.” Standard expression reference can be, for example, RNA derived from resting cultured leukocytes or commercially available reference RNA, such as Universal reference RNA from Stratagene. See Nature, V406, 8-17-00, p. 747-752. Use of an expression reference standard is particularly useful when the expression of large numbers of nucleotide sequences is assayed, e.g. in an array, and in certain other applications, e.g. qualitative PCR, RT-PCR, etc., where it is desirable to compare a sample profile to a standard profile, and/or when large numbers of expression profiles, e.g. a patient population, are to be compared. Generally, an expression reference standard should be available in large quantities, should be a good substrate for amplification and labeling reactions, and should be capable of detecting a large percentage of candidate nucleic acids using suitable expression profiling technology.

Alternatively, or in addition, the expression profile derived from a patient sample is compared with the expression of an internal reference control gene, for example, β-actin or CD4. The relative expression of the profiled genes and the internal reference control gene (from the same individual) is obtained. An internal reference control may also be used with a reference RNA. For example, an expression profile for “gene 1” and the gene encoding CD4 can be determined in a patient sample and in a reference RNA. The expression of each gene can be expressed as the “relative” ratio of expression the gene in the patient sample compared with expression of the gene in the reference RNA. The expression ratio (sample/reference) for gene 1 may be divided by the expression ration for CD4 (sample/reference) and thus the relative expression of gene 1 to CD4 is obtained.

The invention also provides a buffy coat control RNA useful for expression profiling, and a method of using control RNA produced from a population of buffy coat cells, the white blood cell layer derived from the centrifugation of whole blood. Buffy coat contains all white blood cells, including granulocytes, mononuclear cells and platelets. The invention also provides a method of preparing control RNA from buffy coat cells for use in expression profile analysis of leukocytes. Buffy coat fractions are obtained, e.g. from a blood bank or directly from individuals, preferably from a large number of individuals such that bias from individual samples is avoided and so that the RNA sample represents an average expression of a healthy population. Buffy coat fractions from about 50 or about 100, or more individuals are preferred: 10 ml buffy coat from each individual is used. Buffy coat samples are treated with an erthythrocyte lysis buffer, so that erthythrocytes are selectively removed. The leukocytes of the buffy coat layer are collected by centrifugation. Alternatively, the buffy cell sample can be further enriched for a particular leukocyte sub-populations, e.g. mononuclear cells, T-lymphocytes, etc. To enrich for mononuclear cells, the buffy cell pellet, above, is diluted in PBS (phosphate buffered saline) and loaded onto a non-polystyrene tube containing a polysucrose and sodium diatrizoate solution adjusted to a density of 1.077+/−0.001 g/ml. To enrich for T-lymphocytes, 45 ml of whole blood is treated with RosetteSep (Stem Cell Technologies), and incubated at room temperature for 20 minutes. The mixture is diluted with an equal volume of PBS plus 2% FBS and mixed by inversion. 30 ml of diluted mixture is layered on top of 15 ml DML medium (Stem Cell Technologies). The tube is centrifuged at 1200×g, and the enriched cell layer at the plasma:medium interface is removed, washed with PBS+2% FBS, and cells collected by centrifugation at 1200×g. The cell pellet is treated with 5 ml of erythrocyte lysis buffer (EL buffer, Qiagen) for 10 minutes on ice, and enriched T-lymphocytes are collected by centrifugation.

In addition or alternatively, the buffy cells (whole buffy coat or sub-population, e.g. mononuclear fraction) can be cultured in vitro and subjected to stimulation with cytokines or activating chemicals such as phorbol esters or ionomycin. Such stimuli may increase expression of nucleotide sequences that are expressed in activated immune cells and might be of interest for leukocyte expression profiling experiments.

Following sub-population selection and/or further treatment, e.g. stimulation as described above, RNA is prepared using standard methods. For example, cells are pelleted and lysed with a phenol/guanidinium thiocyanate and RNA is prepared. RNA can also be isolated using a silica gel-based purification column or the column method can be used on RNA isolated by the phenol/guanidinium thiocyanate method. RNA from individual buffy coat samples can be pooled during this process, so that the resulting reference RNA represents the RNA of many individuals and individual bias is minimized or eliminated. In addition, a new batch of buffy coat reference RNA can be directly compared to the last batch to ensure similar expression pattern from one batch to another, using methods of collecting and comparing expression profiles described above/below. One or more expression reference controls are used in an experiment. For example, RNA derived from one or more of the following sources can be used as controls for an experiment: stimulated or unstimulated whole buffy coat, stimulated or unstimulated peripheral mononuclear cells, or stimulated or unstimulated T-lymphocytes.

Alternatively, the expression reference standard can be derived from any subject or class of subjects including healthy subjects or subjects diagnosed with the same or a different disease or disease criterion. Expression profiles from subjects in two or more distinct classes are compared to determine which subset of nucleotide sequences in the candidate library can best distinguish between the subject classes, as further discussed below. It will be appreciated that in the present context, the term “distinct classes” is relevant to at least one distinguishable criterion relevant to a disease of interest, a “disease criterion.” The classes can, of course, demonstrate significant overlap (or identity) with respect to other disease criteria, or with respect to disease diagnoses, prognoses, or the like. The mode of discovery involves, e.g., comparing the molecular signature of different subject classes to each other (such as patient to control, patients with a first diagnosis to patients with a second diagnosis, etc.) or by comparing the molecular signatures of a single individual taken at different time points. The invention can be applied to a broad range of diseases, disease criteria, conditions and other clinical and/or epidemiological questions, as further discussed above/below.

It is appreciated that while the present discussion pertains to the use of expression reference controls while identifying diagnostic nucleotide sets, expression reference controls are also useful during use of diagnostic nucleotide sets, e.g. use of a diagnostic nucleotide set for diagnosis of a disease, as further described below.

Analysis of Expression Profiles

In order to facilitate ready access, e.g., for comparison, review, recovery, and/or modification, the molecular signatures/expression profiles are typically recorded in a database. Most typically, the database is a relational database accessible by a computational device, although other formats, e.g., manually accessible indexed files of expression profiles as photographs, analogue or digital imaging readouts, spreadsheets, etc. can be used. Further details regarding preferred embodiments are provided below. Regardless of whether the expression patterns initially recorded are analog or digital in nature and/or whether they represent quantitative or qualitative differences in expression, the expression patterns, expression profiles (collective expression patterns), and molecular signatures (correlated expression patterns) are stored digitally and accessed via a database. Typically, the database is compiled and maintained at a central facility, with access being available locally and/or remotely.

As additional samples are obtained, and their expression profiles determined and correlated with relevant subject data, the ensuing molecular signatures are likewise recorded in the database. However, rather than each subsequent addition being added in an essentially passive manner in which the data from one sample has little relation to data from a second (prior or subsequent) sample, the algorithms optionally additionally query additional samples against the existing database to further refine the association between a molecular signature and disease criterion. Furthermore, the data set comprising the one (or more) molecular signatures is optionally queried against an expanding set of additional or other disease criteria. The use of the database in integrated systems and web embodiments is further described below.

Analysis of Expression Profile Data from Arrays

Expression data is analyzed using methods well known in the art, including the software packages Imagene (Biodiscovery, Marina del Rey, Calif.), Feature Extraction Software (Agilent, Palo Alto, Calif.), and Scanalyze (Stanford University). In the discussion that follows, a “feature” refers to an individual spot of DNA on an array. Each gene may be represented by more than one feature. For example, hybridized microarrays are scanned and analyzed on an Axon Instruments scanner using GenePix 3.0 software (Axon Instruments, Union City, Calif.). The data extracted by GenePix is used for all downstream quality control and expression evaluation. The data is derived as follows. The data for all features flagged as “not found” by the software is removed from the dataset for individual hybridizations. The “not found” flag by GenePix indicates that the software was unable to discriminate the feature from the background. Each feature is examined to determine the value of its signal. The median pixel intensity of the background (B_n) is subtracted from the median pixel intensity of the feature (F_n) to produce the background-subtracted signal (hereinafter, “BGSS”). The BGSS is divided by the standard deviation of the background pixels to provide the signal-to-noise ratio (hereinafter, “S/N”). Features with a SIN of three or greater in both the Cy3 channel (corresponding to the sample RNA) and Cy5 channel (corresponding to the reference RNA) are used for further analysis (hereinafter denoted “useable features”). Alternatively, different SINs are used for selecting expression data for an analysis. For example, only expression data with signal to noise ratios >3 might be used in an analysis. Alternatively, features with S/N values <3 may be flagged as such and included in the analysis. Such flagged data sets include more values and may allow one to discover expression markers that would be missed otherwise. However, such data sets may have a higher variablilty than filtered data, which may decrease significance of findings or performance of correlation statistics.

For each usable feature (i), the expression level (e) is expressed as the logarithm of the ratio (R) of the Background Subtracted Signal (hereinafter “BGSS”) for the Cy3 (sample RNA) channel divided by the BGSS for the Cy5 channel (reference RNA). This “log ratio” value is used for comparison to other experiments.
$\begin{matrix} R_{i} = \frac{{BGSS}_{sample}}{{BGSS}_{reference}} & (0.1) \end{matrix}$
e_i=log r_i (0.2)

Variation in signal across hybridizations may be caused by a number of factors affecting hybridization, DNA spotting, wash conditions, and labeling efficiency.

A single reference RNA may be used with all of the experimental RNAs, permitting multiple comparisons in addition to individual comparisons. By comparing sample RNAs to the same reference, the gene expression levels from each sample are compared across arrays, permitting the use of a consistent denominator for our experimental ratios.

Scaling

The data may be scaled (normalized) to control for labeling and hybridization variability within the experiment, using methods known in the art. Scaling is desirable because it facilitates the comparison of data between different experiments, patients, etc. Generally the BGSS are scaled to a factor such as the median, the mean, the trimmed mean, and percentile. Additional methods of scaling include: to scale between 0 and 1, to subtract the mean, or to subtract the median.

Scaling is also performed by comparison to expression patterns obtained using a common reference RNA, as described in greater detail above. As with other scaling methods, the reference RNA facilitates multiple comparisons of the expression data, e.g., between patients, between samples, etc. Use of a reference RNA provides a consistent denominator for experimental ratios.

In addition to the use of a reference RNA, individual expression levels may be adjusted to correct for differences in labeling efficiency between different hybridization experiments, allowing direct comparison between experiments with different overall signal intensities, for example. A scaling factor (α) may be used to adjust individual expression levels as follows. The median of the scaling factor (α), for example, BGSS, is determined for the set of all features with a S/N greater than three. Next, the BGSS_i(the BGSS for each feature “i”) is divided by the median for all features (α), generating a scaled ratio. The scaled ration is used to determine the expression value for the feature (e_i), or the log ratio.
$\begin{matrix} S_{i} = \frac{{BGSS}_{i}}{a} & (0.3) \\ e_{i} = \log (\frac{{Cy3S}_{i}}{C_{y} 5 S_{i}}) & (0.4) \end{matrix}$

In addition, or alternatively, control features are used to normalize the data for labeling and hybridization variability within the experiment. Control feature may be cDNA for genes from the plant, Arabidopsis thaliana, that are included when spotting the mini-array. Equal amounts of RNA complementary to control cDNAs are added to each of the samples before they were labeled. Using the signal from these control genes, a normalization constant (L) is determined according to the following formula:
$L_{j} = \frac{\frac{\sum_{i = 1}^{N} {BGSS}_{j, i}}{N}}{\frac{\sum_{j = 1}^{K} \frac{\sum_{i = 1}^{N} {BGSS}_{j, i}}{N}}{K}}$

where BGSS_iis the signal for a specific feature, N is the number of A. thaliana control features, K is the number of hybridizations, and L_jis the normalization constant for each individual hybridization.

Using the formula above, the mean for all control features of a particular hybridization and dye (e.g., Cy3) is calculated. The control feature means for all Cy3 hybridizations are averaged, and the control feature mean in one hybridization divided by the average of all hybridizations to generate a normalization constant for that particular Cy3 hybridization (L_j), which is used as a in equation (0.3). The same normalization steps may be performed for Cy3 and Cy5 values.

Many additional methods for normalization exist and can be applied to the data. In one method, the average ratio of Cy3 BGSS/Cy5 BGSS is determined for all features on an array. This ratio is then scaled to some arbitrary number, such as 1 or some other number. The ratio for each probe is then multiplied by the scaling factor required to bring the average ratio to the chosen level. This is performed for each array in an analysis. Alternatively, the ratios are normalized to the average ratio across all arrays in an analysis.

If multiple features are used per gene sequence or oligonucleotide, these repeats can be used to derive an average expression value for each gene. If some of the replicate features are of poor qualitay and don't meet requirements for analysis, the remaining features can be used to represent the gene or gene sequence.

Correlation Analysis

Correlation analysis is performed to determine which array probes have expression behavior that best distinguishes or serves as markers for relevant groups of samples representing a particular clinical condition. Correlation analysis, or comparison among samples representing different disease criteria (e.g., clinical conditions), is performed using standard statistical methods. Numerous algorithms are useful for correlation analysis of expression data, and the selection of algorithms depends in part on the data analysis to be performed. For example, algorithms can be used to identify the single most informative gene with expression behavior that reliably classifies samples, or to identify all the genes useful to classify samples. Alternatively, algorithms can be applied that determine which set of 2 or more genes have collective expression behavior that accurately classifies samples. The use of multiple expression markers for diagnostics may overcome the variability in expression of a gene between individuals, or overcome the variability intrinsic to the assay. Multiple expression markers may include redundant markers (surrogates), in that two or more genes or probes may provide the same information with respect to diagnosis. This may occur, for example, when two or more genes or gene probes are coordinately expressed. For diagnostic application, it may be appropriate to utilize a gene and one or more of its surrogates in the assay. This redundancy may overcome failures (technical or biological) of a single marker to distinguish samples. Alternatively, one or more surrogates may have properties that make them more suitable for assay development, such as a higher baseline level of expression, better cell specificity, a higher fold change between sample groups or more specific sequence for the design of PCR primers or complimentary probes. It will be appreciated that while the discussion above pertains to the analysis of RNA expression profiles the discussion is equally applicable to the analysis of profiles of proteins or other molecular markers.

Prior to analysis, expression profile data may be formatted or prepared for analysis using methods known in the art. For example, often the log ratio of scaled expression data for every array probe is calculated using the following formula:

log (Cy3 BGSS/Cy5 BGSS), where Cy3 signal corresponds to the expression of the gene in the clinical sample, and Cy5 signal corresponds to expression of the gene in the reference RNA.

Data may be further filtered depending on the specific analysis to be done as noted below. For example, filtering may be aimed at selecting only samples with expression above a certain level, or probes with variability above a certain level between sample sets.

The following non-limiting discussion consider several statistical methods known in the art. Briefly, the t-test and ANOVA are used to identify single genes with expression differences between or among populations, respectively. Multivariate methods are used to identify a set of two or more genes for which expression discriminates between two disease states more specifically than expression of any single gene.

t-test

The simplest measure of a difference between two groups is the Student's t test. See, e.g., Welsh et al. (2001) Proc Natl Acad Sci USA 98:1176-81 (demonstrating the use of an unpaired Student's t-test for the discovery of differential gene expression in ovarian cancer samples and control tissue samples). The t-test assumes equal variance and normally distributed data. This test identifies the probability that there is a difference in expression of a single gene between two groups of samples. The number of samples within each group that is required to achieve statistical significance is dependent upon the variation among the samples within each group. The standard formula for a t-test is:
$\begin{matrix} t (e_{i}) = \frac{{\overline{e}}_{i, c} - {\overline{e}}_{i, t}}{\sqrt{(s_{i, c}^{2} / n_{c}) + (s_{i, t}^{2} / n_{t})}}, & (0.5) \end{matrix}$

where ē_iis the difference between the mean expression level of gene i in groups c and t, s_i,cis the variance of gene x in group c and s_i,tis the variance of gene x in group t. n_cand n_tare the numbers of samples in groups c and t.

The combination of the t statistic and the degrees of freedom [min(n_t, n_c)−1] provides a p value, the probability of rejecting the null hypothesis. A p-value of ≦0.01, signifying a 99 percent probability the mean expression levels are different between the two groups (a 1% chance that the mean expression levels are in fact not different and that the observed difference occurred by statistical chance), is often considered acceptable.

When performing tests on a large scale, for example, on a large dataset of about 8000 genes, a correction factor must be included to adjust for the number of individual tests being performed. The most common and simplest correction is the Bonferroni correction for multiple tests, which divides the p-value by the number of tests run. Using this test on an 8000 member dataset indicates that a p value of ≦0.00000125 is required to identify genes that are likely to be truly different between the two test conditions.

Significance Analysis for Microarrays (SAM)

Significance analysis for microarrays (SAM) (Tusher 2001) is a method through which genes with a correlation between their expression values and the response vector are statistically discovered and assigned a statistical significance. The ratio of false significant to significant genes is the False Discovery Rate (FDR). This means that for each threshold there are a set of genes which are called significant, and the FDR gives a confidence level for this claim. If a gene is called differentially expressed between 2 classes by SAM, with a FDR of 5%, there is a 95% chance that the gene is actually differentially expressed between the classes. SAM takes intoaccount the variability and large number of variables of microarrays. SAM will identiy genes that are most globally differentially expressed between the classes. Thus, important genes for identifying and classifying outlier samples or patients may not be identified by SAM.

Wilcoxon's Signed Ranks Test

This method is non-parametric and is utilized for paired comparisons. See e.g., Sokal and Rohlf (1987) Introduction to Biostatistics 2^ndedition, WH Freeman, New York. At least 6 pairs are necessary to apply this statistic. This test is useful for analysis of paired expression data (for example, a set of patients who have had samples taken before and after administration of a pharmacologic agent).

ANOVA

Differences in gene expression across multiple related groups may be assessed using an Analysis of Variance (ANOVA), a method well known in the art (Michelson and Schofield, 1996).

Multivariate Analysis

Many algorithms suitable for multivariate analysis are known in the art (Katz 1999). Generally, a set of two or more genes for which expression discriminates between two disease states more specifically than expression of any single gene is identified by searching through the possible combinations of genes using a criterion for discrimination, for example the expression of gene X must increase from normal 300 percent, while the expression of genes Y and Z must decrease from normal by 75 percent. Ordinarily, the search starts with a single gene, then adds the next best fit at each step of the search. Alternatively, the search starts with all of the genes and genes that do not aid in the discrimination are eliminated step-wise.

Paired Samples

Paired samples, or samples collected at different time-points from the same patient, are often useful, as described above. For example, use of paired samples permits the reduction of variation due to genetic variation among individuals. In addition, the use of paired samples has a statistical significance in that data derived from paired samples can be calculated in a different manner that recognizes the reduced variability. For example, the formula for a t-test for paired samples is:
$\begin{matrix} t (e_{x}) = \frac{{\overline{D}}_{{\overline{e}}_{x}}}{\sqrt{\frac{\sum D^{2} - {(\sum D)}^{2} / b}{b - 1}}} & (0.5) \end{matrix}$

where D is the difference between each set of paired samples and b is the number of sample pairs. {overscore (D)} is the mean of the differences between the members of the pairs. In this test, only the differences between the paired samples are considered, then grouped together (as opposed to taking all possible differences between groups, as would be the case with an ordinary t-test). Additional statistical tests useful with paired data, e.g., ANOVA and Wilcoxon's signed rank test, are discussed above.

Diagnostic Classification

Once a discriminating set of genes is identified, the diagnostic classifier (a mathematical function that assigns samples to diagnostic categories based on expression data) is applied to unknown sample expression levels.

Methods that can be used for this analysis include the following non-limiting list:

CLEAVER is an algorithm used for classification of useful expression profile data See Raychaudhuri et al. (2001) Trends Biotechnol 19:189-193. CLEAVER uses positive training samples (e.g., expression profiles from samples known to be derived from a particular patient or sample diagnostic category, disease or disease criteria), negative training samples (e.g., expression profiles from samples known not to be derived from a particular patient or sample diagnostic category, disease or disease criteria) and test samples (e.g., expression profiles obtained from a patient), and determines whether the test sample correlates with the particular disease or disease criteria, or does not correlate with a particular disease or disease criteria. CLEAVER also generates a list of the 20 most predictive genes for classification.

Artificial neural networks (hereinafter, “ANN”) can be used to recognize patterns in complex data sets and can discover expression criteria that classify samples into more than 2 groups. The use of artificial neural networks for discovery of gene expression diagnostics for cancers using expression data generated by oligonucleotide expression microarrays is demonstrated by Khan et al. (2001) Nature Med. 7:673-9. Khan found that 96 genes provided 0% error rate in classification of the tumors. The most important of these genes for classification was then determined by measuring the sensitivity of the classification to a change in expression of each gene. Hierarchical clustering using the 96 genes results in correct grouping of the cancers into diagnostic categories.

Golub uses cDNA microarrays and a distinction calculation to identify genes with expression behavior that distinguishes myeloid and lymphoid leukemias. See Golub et al. (1999) Science 286:531-7. Self organizing maps were used for new class discovery. Cross validation was done with a “leave one out” analysis. 50 genes were identified as useful markers. This was reduced to as few as 10 genes with equivalent diagnostic accuracy.

Hierarchical and non-hierarchical clustering methods are also useful for identifying groups of genes that correlate with a subset of clinical samples such as those with and without Lupus. Alizadeh used hierarchical clustering as the primary tool to distinguish different types of diffuse B-cell lymphomas based on gene expression profile data. See Alizadeh et al. (2000) Nature 403:503-11. Alizadeh used hierarchical clustering as the primary tool to distinguish different types of diffuse B-cell lymphomas based on gene expression profile data. A cDNA array carrying 17856 probes was used for these experiments, 96 samples were assessed on 128 arrays, and a set of 380 genes was identified as being useful for sample classification.

Perou demonstrates the use of hierarchical clustering for the molecular classification of breast tumor samples based on expression profile data. See Perou et al. (2000) Nature 406:747-52. In this work, a cDNA array carrying 8102 gene probes was used. 1753 of these genes were found to have high variation between breast tumors and were used for the analysis.

Hastie describes the use of gene shaving for discovery of expression markers. Hastie et al. (2000) Genome Biol. 1(2):RESEARCH 0003.1-0003.21. The gene shaving algorithm identifies sets of genes with similar or coherent expression patterns, but large variation across conditions (RNA samples, sample classes, patient classes). In this manner, genes with a tight expression pattern within a diagnostic group, but also with high variability across the diagnoses are grouped together. The algorithm takes advantage of both characteristics in one grouping step. For example, gene shaving can identify useful marker genes with co-regulated expression. Sets of useful marker genes can be reduced to a smaller set, with each gene providing some non-redundant value in classification. This algorithm was used on the data set described in Alizadeh et al., supra, and the set of 380 informative gene markers was reduced to 234.

Supervised harvesting of expression trees (Hastie 2001) identifies genes or clusters that best distinguish one class from all the others on the data set. The method is used to identify the genes/clusters that can best separate one class versus all the others for datasets that include two or more classes or all classes from each other. This algorithm can be used for discovery or testing of a diagnostic gene set.

Clinical data are gathered for every patient sample used for expression analysis. Clinical variables can be quantitative or non-quantitative. A clinical variable that is quantitiative can be used as a variable for significance or classification analysis. Non-quantitative clinical variables, such as the sex of the patient, can also be used in a significance analysis or classification analysis with some statistical tool. It is appreciated that the most useful diagnostic gene set for a condition may be optimal when considered along with one or more predictive clinical variables. Clinical data can also be used as supervising vectors for a correlation analysis. That is to say that the clinical data associated with each sample can be used to divide the samples into meaningful diagnostic categories for analysis. For example, samples can be divided into 2 or more groups based on the presence or absence of some diagnostic criterion (a). In addition, clinical data can be utilized to select patients for a correlation analysis or to exclude them based on some undesirable characteristic, such as an ongoing infection, a medicine or some other issue. Clincial data can also be used to assess the pre-test probability of an outcome. For example, patients who a re female a re much more likely to be diagnosed as having systemic lupus erythematosis than patients who are male.

Once a set of genes are identified that classify samples with acceptable accuracy. These genes are validated as a set using new samples that were not used to discover the ge ne set. These samples can be taken from frozen archieves from the discovery clinical study or can be taken from new patients prospectively. Validation using a “test set” of samples can be done using expression profiling of the gene set with microarrays or using real-time PCR for each gene on the test set samples. Alternatively, a different expression profiling technology can be used.

Validation and Accuracy of Diagnostic Nucleoside Sets

Prior to widespread application of the diagnostic probe sets of the invention the predictive value of the probe set is validated. When the diagnostic probe set is discovered by microarray based expression analysis, the differential expression of the member genes may be validated by a less variable and more quantitive and accurate technology such as real time PCR. In this type of experiment the amplification product is measured during the PCR reaction. This enables the researcher to observe the amplification before any reagent becomes rate limiting for amplification. In kinetic PCR the measurement is of C_T(threshold cycle) or C_P(crossing point). This measure ment (C_T=C_p) is the point at which an amplification curve crosses a threshold fluorescence value. The threshold is set to a point within the area where all of the reactions were in their linear phase of amplification. When measuring C_T, a lower C_Tvalue is indicative of a higher amount of starting material since an earlier cycle number means the threshold was crossed more quickly.

Several fluorescence methodologies are available to measure amplification product in real-time PCR. Taqman (Applied BioSystems, Foster City, Calif.) uses fluorescence resonance energy transfer (FRET) to inhibit signal from a probe until the probe is degraded by the sequence specific binding and Taq 3′exonuclease activity. Molecular Beacons (Stratagene, La Jolla, Calif.) also use FRET technology, whereby the fluorescence is measured when a hairpin structure is relaxed by the specific probe binding to the amplified DNA. The third commonly used chemistry is Sybr Green, a DNA-binding dye (Molecular Probes, Eugene, Oreg.). The more amplified product that is produced, the higher the signal. The Sybr Green method is sensitive to non-specific amplification products, increasing the importance of primer design and selection. Other detection chemistries can also been used, such as ethedium bromide or other DNA-binding dyes and many modifications of the fluorescent dye/quencher dye Taqman chemistry, for example scorpions.

Real-time PCR validation can be done as described in Example 15.

Typically, the oligonucleotide sequence of each probe is confirmed, e.g. by DNA sequencing using an oligonucleotide-specific primer. Partial sequence obtained is generally sufficient to confirm the identity of the oligonucleotide probe. Alternatively, a complementary polynucleotide is fluorescently labeled and hybridized to the array, or to a different array containing a resynthesized version of the oligo nucleotide probe, and detection of the correct probe is confirmed.

Typically, validation is performed by statistically evaluating the accuracy of the correspondence between the molecular signature for a diagnostic probe set and a selected indicator. For example, the expression differential for a nucleotide sequence between two subject classes can be expressed as a simple ratio of relative expression. The expression of the nucleotide sequence in subjects with selected indicator can be compared to the expression of that nucleotide sequence in subjects without the indicator, as described in the following equations.

ΣE_xai/N=E_xA

the average expression of nucleotide sequence x in the members of group A;

ΣE_xbi/M=E_xB

the average expression of nucleotide sequence x in the members of group B;

E_xA/E×B=ΔE_xAB

the average differential expression of nucleotide sequence x between groups A and B:

where Σ indicates a sum; Ex is the expression of nucleotide sequence x relative to a standard; ai are the individual members of group A, group A has N members; bi are the individual members of group B, group B has M members.

Individual components of a diagnostic probe set each have a defined sensitivity and specificity for distinguishing between subject groups. Such individual nucleotide sequences can be employed in concert as a diagnostic probe set to increase the sensitivity and specificity of the evaluation. The database of molecular signatures is queried by algorithms to identify the set of nucleotide sequences (i.e., corresponding to members of the probe set) with the highest average differential expression between subject groups. Typically, as the number of nucleotide sequences in the diagnostic probe set increases, so does the predictive value, that is, the sensitivity and specificity of the probe set. When the probe sets are defined they may be used for diagnosis and patient monitoring as discussed below. The diagnostic sensitivity and specificity of the probe sets for the defined use can be determined for a given probe set with specified expression levels as demonstrated above. By altering the expression threshold required for the use of each nucleotide sequence as a diagnostic, the sensitivity and specificity of the probe set can be altered by the practitioner. For example, by lowering the magnitude of the expression differential threshold for each nucleotide sequence in the set, the sensitivity of the test will increase, but the specificity will decrease. As is apparent from the foregoing discussion, sensitivity and specificity are inversely related and the predictive accuracy of the probe set is continuous and dependent on the expression threshold set for each nucleotide sequence. Although sensitivity and specificity tend to have an inverse relationship when expression thresholds are altered, both parameters calf be increased as nucleotide sequences with predictive value are added to the diagnostic nucleotide set. In addition a single or a few markers may not be reliable expression markers across a population of patients. This is because of the variability in expression and measurement of expression that exists between measurements, individuals and individuals over time. Inclusion of a large number of candidate nucleotide sequences or large numbers of nucleotide sequences in a diagnostic nucleotide set allows for this variability as not all nucleotide sequences need to meet a threshold for diagnosis. Generally, more markers are better than a single marker. If many markers are used to make a diagnosis, the likelihood that all expression markers will not meet some thresholds based upon random variability is low and thus the test will give fewer false negatives. Surrogate markers are useful for these purposes. These are markers or genes that are coordinately expressed. Surrogate markers essential provide redundant infomation, but this redundancy can improve accuracy by decreasing errors due to assay variability.

It is appreciated that the desired diagnostic sensitivity and specificity of the diagnostic nucleotide set may vary depending on the intended use of the set. For example, in certain uses, high specificity and high sensitivity are desired. For example, a diagnostic nucleotide set for predicting which patient population may experience side effects may require high sensitivity so as to avoid treating such patients. In other settings, high sensitivity is desired, while reduced specificity may be tolerated. For example, in the case of a beneficial treatment with few side effects, it may be important to identify as many patients as possible (high sensitivity) who will respond to the drug, and treatment of some patients who will not respond is tolerated. In other settings, high specificity is desired and reduced sensitivity may be tolerated. For example, when identifying patients for an early-phase clinical trial, it is important to identify patients who may respond to the particular treatment. Lower sensitivity is tolerated in this setting as it merely results in reduced patients who enroll in the study or requires that more patients are screened for enrollment.

To discover and validate a gene set that can be applied to accurately diagnose or classify patients across the country or around the world, it is necessary to ensure that the gene set was developed and validated using samples that represent the types of patients that will be encountered in the clinical setting. For example, diverse ethnicity, drug usage and clinical practice patterns must all be represented in the discovery and validation to ensure that the test works on this variety of patients.

Selected Diseases

In principle, individual oligonucleotides and diagnostic oligonucleotide sets of the invention may be developed and applied to essentially any disease, or disease criterion, as long as at least one subset of oligonucleotide sequences is differentially expressed in samples derived from one or more individuals with a disease criteria or disease and one or more individuals without the disease criteria or disease, wherein the individual may be the same individual sampled at different points in time, or the individuals may be different individuals (or populations of individuals). For example, the subset of oligonucleotide sequences may be differentially expressed in the sampled tissues of subjects with the disease or disease criterion (e.g., a patient with a disease or disease criteria) as compared to subjects without the disease or disease criterion (e.g., patients without a disease (control patients)). Alternatively, or in addition, the subset of oligonucleotide sequence(s) may be differentially expressed in different samples taken from the same patient, e.g at different points in time, at different disease stages, before and after a treatment, in the presence or absence of a risk factor, etc.

Expression profiles corresponding to oligonucleotides and sets of oligonucleotide sequences that correlate not with a diagnosis, but rather with a particular aspect of a disease can also be used to identify the diagnostic oligonucleotide sets and disease specific target oligonucleotide sequences of the invention. For example, such an aspect, or disease criterion, can relate to a subject's medical or family history, e.g., occurance of an autoimmune disease, childhood illness, cause of death of a parent or other relative, prior surgery or other intervention, medications, laboratory values and results of diagnostic testing (radiology, pathology, etc.), symptoms (including onset and/or duration of symptoms), etc. Alternatively, the disease criterion can relate to a diagnosis, e.g., chronic inflammatory disease such as lupus, rheumatoid arthritis, osteoarthritis, or prognosis (e.g., prediction of future diagnoses, events or complications), e.g., renal failure from lupus, joint replacement surgery for rheumatoid arthritis, rheumatoid arthritis or systemic lupus erythematosis disease activity or the like. In other cases, the disease criterion corresponds to a therapeutic outcome, e.g., response to a medication, response to a surgery or physical therapy for a joint. Alternatively, the disease criteria correspond with previously identified or classic risk factors and may correspond to prognosis or future disease diagnosis. As indicated above, a disease criterion can also correspond to genotype for one or more loci. Disease criteria (including patient data) may be collected (and compared) from the same patient at different points in time, from different patients, between patients with a disease (criterion) and patients respresenting a control population, etc. Longitudinal data, i.e., data collected at different time points from an individual (or group of individuals) may be used for comparisons of samples obtained from an individual (group of individuals) at different points in time, to permit identification of differences specifically related to the disease state, and to obtain information relating to the change in expression over time, including a rate of change or trajectory of expression over time. The usefulness of longitudinal data is further discussed in the section titled “Identification of diagnostic nucleotide sets of the invention”.

It is further understood that diagnostic oligonucleotides and oligonucleotide sets may be developed for use in diagnosing conditions for which there is no present means of diagnosis. For example, in rheumatoid arthritis, joint destruction is often well under way before a patient experience symptoms of the condition. A diagnostic nucleotide or nucleotide set may be developed that diagnoses rheumatic joint destruction at an earlier stage than would be possible using present means of diagnosis, which rely in part on the presentation of symptoms by a patient. Diagnostic nucleotide sets may also be developed to replace or augment current diagnostic procedures. For example, the use of a diagnostic nucleotide or nucleotide set to diagnose lupus may replace or supplement the current diagnostic tests and strategies.

It is understood that the following discussion of diseases is exemplary and non-limiting, and further that the general criteria discussed above, e.g. use of family medical history, are generally applicable to the specific diseases discussed below.

In addition to leukocytes, as described throughout, the general method is applicable to oligonucleotide sequences that are differentially expressed in any subject tissue or cell type, by the collection and assessment of samples of that tissue or cell type. However, in many cases, collection of such samples presents significant technical or medical problems given the current state of the art.

Systemic Lupus Erythematosis (SLE)

SLE is a chronic, systemic inflammatory disease characterized by dysregulation of the immune system, which affects up to 2 million patients in the US. Symptoms of SLE include rashes, joint pain, abnormal blood counts, renal dysfunction and damage, infections, CNS disorders, arthralgias and autoimmunity. Patients may also have early onset atherosclerosis. The diagnosis of SLE is difficult to make with certainty using current diagnostic tests and algorithms. Antibody tests can be specific for the disease, but often lack sensitivity. Clinical diagnosis may lack both high sensitivity and specificity. SLE is a disease that clearly involves differential gene expression in leukocytes compared to patients without the disease.

Diagnostic oligonucleotides and oligonucleotide sets are identified and validated for use in diagnosis and monitoring of SLE activity and progression. Disease criteria correspond to clinical data, e.g. symptom rash, joint pain, malaise, rashes, blood counts (white and red), tests of renal function e.g. creatinine, blood urea nitrogen (hereinafter, “bun”) creative clearance, data obtained from laboratory tests, including complete blood counts with differentials, CRP, ESR, ANA, Serum IL6, Soluble CD40 ligand, LDL, HDL, Anti-DNA antibodies, rheumatoid factor, C3, C4, serum creatinine and any medication levels, the need for pain medications, cumulative doses or immunosuppressive therapy, symptoms or any manifestation of carotid atherosclerosis (e.g. ultrasound diagnosis or any other manifestations of the disease), data from surgical procedures such as gross operative findings and pathological evaluation of resected tissues and biopsies (e.g., renal, CNS), information on pharmacological therapy and treatment changes, clinical diagnoses of disease “flare”, hospitalizations, death, response to medications, quantitative joint exams, results from health assessment questionnaires (HAQs), and other clinical measures of patient symptoms and disability. In addition, disease criteria correspond to the clinical score known as SLEDAI (Bombadier C, Gladman D D, Urowitz M B, Caron D, Chang C H and the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI for Lupus Patients. Arthritis Rheum 35:630-640, 1992.). Diagnostic nucleotide sets may be useful for diagnosis of SLE, monitoring disease progression including progressive renal dysfunction, carotid atherosclerosis and CNS dysfunction, and predicting occurrence of side-effects, for example.

Rheumatoid Arthritis

Rheumatoid arthritis (RA) effects about two million patients in the US and is a chronic and debilitating inflammatory arthritis, particularly involving pain and destruction of the joints. RA often goes undiagnosed because patients may have no pain, but the disease is actively destroying the joint. Other patients are known to have RA, and are treated to alleviate symptoms, but the rate of progression of joint destruction can't easily be monitored. Drug therapy is available, but the most effective medicines are toxic (e.g., steroids, methotrexate) and thus need to be used with caution. A new class of medications (TNF blockers) is very effective, but the drugs are expensive, have side effects, and not all patients respond. Side-effects are common and include immune suppression, toxicity to organ systems, allergy and metabolic disturbances.

Diagnostic oligonucleotides and oligonucleotide sets of the invention are developed and validated for use in diagnosis and treatment of RA. Disease criteria correspond to disease symptoms (e.g., joint pain, joint swelling and joint stiffness and any of the American College for Rheumatology criteria for the diagnosis of RA, see Arnett et al (1988) Arthr. Rheum. 31:315-24), progression of joint destruction (e.g. as measured by serial hand radiographs, assessment of joint function and mobility), surgery, need for medication, additional diagnoses of inflammatory and non-inflammatory conditions, and clinical laboratory measurements including complete blood counts with differentials, CRP, ESR, ANA, Serum IL6, Soluble CD40 ligand, LDL, HDL, Anti-DNA antibodies, rheumatoid factor, C3, C4, serum creatinine, death, hospitalization and disability due to joint destruction. In addition, or alternatively, disease criteria correspond to response to drug therapy and presence or absence of side-effects or measures of improvement exemplified by the American College of Rheumatology “20%” and “50%” response/improvement rates. See Felson et al (1995) Arthr Rheum 38:531-37. Diagnostic nucleotide sets are identified that monitor and predict disease progression including flaring (acute worsening of disease accompanied by joint pain or other symptoms), response to drug treatment and likelihood of side-effects.

In addition to peripheral leukocytes, surgical specimens of rheumatoid joints can be used for leukocyte expression profiling experiments. Members of diagnostic nucleotide sets are candidates for leukocyte target nucleotide sequences, e.g. as a candidate drug target for rheumatoid arthritis. Synovial specimens can be used for expression profiling or cells derived and sorted from that tissue (such as subsets of leukocytes) can be used. Cells can be separated by fluorescence activated cell sorting or magnetic affinity reagent techniques or some other technique. Synovial specimens and blood can be obtained from the same patient and gene expression can be compared between these 2 sample types.

Osteoarthritis

20-40 million patients in the US have osteoarthritis. Patient groups are heterogeneous, with a subset of patients having earlier onset, more aggressive joint damage, involving more inflammation (leukocyte infiltration). Leukocyte diagnostics can be used to distinguish osteoarthritis from rheumatoid arthritis and other differntial diagnoses, define likelihood and degree of response to NSAID therapy (non-steroidal anti-inflammatory drugs) or other anti-inflammatory therapies. Rate of progression of joint damage can also be assessed. Diagnostic nucleotide sets may be developed for use in selection and titration of treatment therapies. Disease criteria correspond to response to therapy, and disease progression using certain therapies, response to medications, need for joint surgery, joint pain and disability.

In addition to peripheral leukocytes, surgical specimens of osteoarthritic joints can be used for leukocyte expression profiling experiments. Diagnostic oligonucleotides and diagnostic oligonucleotide sets are candidates for leukocyte target nucleotide sequences, e.g. as a candidate drug target for osteoarthritis. Synovial specimens can be used for expression profiling or cells derived and sorted from that tissue (such as subsets of leukocytes) can be used. Cells can be separated by fluorescence activated cell sorting or magnetic affinity reagent techniques or some other technique. Synovial specimens and blood can be obtained from the same patient and gene expression can be compared between these 2 sample types.

In another example, diagnostic nucleotide sets ate developed and validated for use in diagnosis and therapy of peri-prosthetic osteolysis. In this disease, a prosthetic joint such as a knee or hip is found to loosen over time and requires repeat surgery. Loosening may occur in some patients due to an inflammatory response incited by the foreign material of the prosthesis. Disease criteria include joint loosening, radiographic evidence of peri-prosthetic osteolysis, need for repeat surgery, response to pharmacological therapy, and/or histological (from biopsy or surgery) or biochemical (markers of bone metabolism such as alkaline phosphatase) evidence of osteolysis. Tissues used for expression profiling can include peripheral leukocytes or leukocyte subsets, periprosthetic tissue, or synovial fluid. In addition, gene sets can be discovered using an in vitromodel of the disease in which immune cells are exposed to prosthesis materials such as cement or titanium.

Pharmacogenomics

Pharmocogenomics is the study of the individual propensity to respond to a particular drug therapy (combination of therapies). In this context, response can mean whether a particular drug will work on a particular patient, e.g. some patients respond to one drug but not to another drug. Response can also refer to the likelihood of successful treatment or the assessment of progress in treatment. Titration of drug therapy to a particular patient is also included in this description, e.g. different patients can respond to different doses of a given medication. This aspect may be important when drugs with side-effects or interactions with other drug therapies are contemplated.

Diagnostic oligonucleotides and oligonucleotide sets are developed and validated for use in assessing whether a patient will respond to a particular therapy and/or monitoring response of a patient to drug therapy(therapies). Disease criteria correspond to presence or absence of clinical symptoms or clinical endpoints, presence of side-effects or interaction with other drug(s). The diagnostic nucleotide set may further comprise nucleotide sequences that are targets of drug treatment or markers of active disease.

Diagnostic oligonucleotides and oligonucleotide sets are developed and validated for use in assessing whether a patient has a particular drug toxicity or toxicity due to an environmental, work-related or other agent. Such exposures of the patient may also be related to biological or biochemical agents used in warfare. Diagnostic oligonucleotides and oligonucleotide sets may allow early diagnosis of a toxicity or exposure or may monitor the severity and course of toxic responses.

Methods of Using Diagnostic Oligonucleotides and Oligonucleotide Sets.

The invention also provide methods of using the diagnostic oligonucleotides and oligonucleotide sets to: diagnose or monitor disease; assess severity of disease; predict future occurrence of disease; predict future complications of disease; determine disease prognosis; evaluate the patient's risk, or “stratify” a group of patients; assess response to current drug therapy; assess response to current non-pharmacological therapy; determine the most appropriate medication or treatment for the patient; predict whether a patient is likely to respond to a particular drug; and determine most appropriate additional diagnostic testing for the patient, among other clinically and epidemiologically relevant applications.

The oligonucleotides and oligonucleotide sets of the invention can be utilized for a variety of purposes by physicians, healthcare workers, hospitals, laboratories, patients, companies and other institutions. As indicated previously, essentially any disease, condition, or status for which at least one nucleotide sequence is differentially expressed in leukocyte populations (or sub-populations) can be evaluated, e.g., diagnosed, monitored, etc. using the diagnostic nucleotide sets and methods of the invention. In addition to assessing health status at an individual level, the diagnostic nucleotide sets of the present invention are suitable for evaluating subjects at a “population level,” e.g., for epidemiological studies, or for population screening for a condition or disease.

Collection and Preparation of Sample

RNA, protein and/or DNA are prepared using methods well-known in the art, as further described herein. It is appreciated that subject samples collected for use in the methods of the invention are generally collected in a clinical setting, where delays may be introduced before RNA samples are prepared from the subject samples of whole blood, e.g. the blood sample may not be promptly delivered to the clinical lab for further processing. Further delay may be introduced in the clinical lab setting where multiple samples are generally being processed at any given time. For this reason, methods that feature lengthy incubations of intact leukocytes at room temperature are not preferred, because the expression profile of the leukocytes may change during this extended time period. For example, RNA can be isolated from whole blood using a phenol/guanidine isothiocyanate reagent or another direct whole-blood lysis method, as described in, e.g., U.S. Pat. Nos. 5,346,994 and 4,843,155. This method may be less preferred under certain circumstances because the large majority of the RNA recovered from whole blood RNA extraction comes from erythrocytes since these cells outnumber leukocytes 1000:1. Care must be taken to ensure that the presence of erythrocyte RNA and protein does not introduce bias in the RNA expression profile data or lead to inadequate sensitivity or specificity of probes.

Alternatively, intact leukocytes may be collected from whole blood using a lysis buffer that selectively lyses erythrocytes, but not leukocytes, as described, e.g., in (U.S. Pat. Nos. 5,973,137, and 6,020,186). Intact leukocytes are then collected by centrifugation, and leukocyte RNA is isolated using standard protocols, as described herein. However, this method does not allow isolation of sub-populations of leukocytes, e.g. mononuclear cells, which may be desired. In addition, the expression profile may change during the lengthy incubation in lysis buffer, especially in a busy clinical lab where large numbers of samples are being prepared at any given time.

Alternatively, specific leukocyte cell types can be separated using density gradient reagents (Boyum, A, 1968.). For example, mononuclear cells may be separated from whole blood using density gradient centrifugation, as described, e.g., in U.S. Pat. Nos. 4,190,535, 4,350,593, 4751001, 4818418, and 5053134. Blood is drawn directly into a tube containing an anticoagulant and a density reagent (such as Ficoll or Percoll). Centrifugation of this tube results in separation of blood into an erythrocyte and granulocyte layer, a mononuclear cell suspension, and a plasma layer. The mononuclear cell layer is easily removed and the cells can be collected by centrifugation, lysed, and frozen. Frozen samples are stable until RNA can be isolated. Density centrifugation, however, must be conducted at room temperature, and if processing is unduly lengthy, such as in a busy clinical lab, the expression profile may change.

The quality and quantity of each clinical RNA sample is desirably checked before amplification and labeling for array hybridization, using methods known in the art. For example, one microliter of each sample may be analyzed on a Bioanalyzer (Agilent 2100 Palo Alto, Calif. USA) using an RNA 6000 nano LabChip (Caliper, Mountain View, Calif. USA). Degraded RNA is identified by the reduction of the 28S to 18S ribosomal RNA ratio and/or the presence of large quantities of RNA in the 25-100 nucleotide range.

It is appreciated that the RNA sample for use with a diagnostic oligonucleotide or oligonucleotide set may be produced from the same or a different cell population, sub-population and/or cell type as used to identify the diagnostic nucleotide set. For example, a diagnostic oligonucleotide or oligonucleotide set identified using RNA extracted from mononuclear cells may be suitable for analysis of RNA extracted from whole blood or mononuclear cells, depending on the particular characteristics of the members of the diagnostic nucleotide set. Generally, diagnostic oligonucleotides or oligonucleotide sets must be tested and validated when used with RNA derived from a different cell population, sub-population or cell type than that used when obtaining the diagnostic gene set. Factors such as the cell-specific gene expression of diagnostic nucleotide set members, redundancy of the information provided by members of the diagnostic nucleotide set, expression level of the member of the diagnostic nucleotide set, and cell-specific alteration of expression of a member of the diagnostic nucleotide set will contribute to the usefullness of a different RNA source than that used when identifying the members of the diagnostic nucleotide set. It is appreciated that it may be desirable to assay RNA derived from whole blood, obviating the need to isolate particular cell types from the blood.

Assessing Expression for Diagnostics

Expression profiles for the oligonucleotides or the set of diagnostic oligonucleotide sequences in a subject sample can be evaluated by any technique that determines the expression of each component oligonucleotide sequence. Methods suitable for expression analysis are known in the art, and numerous examples are discussed in the Sections titled “Methods of obtaining expression data” and “high throughput expression Assays”, above.

In many cases, evaluation of expression profiles is most efficiently, and cost effectively, performed by analyzing RNA expression. Alternatively, the proteins encoded by each component of the diagnostic nucleotide set are detected for diagnostic purposes by any technique capable of determining protein expression, e.g., as described above. Expression profiles can be assessed in subject leukocyte sample using the same or different techniques as those used to identify and validate the diagnostic oligonucleotide or oligonucleotide set. For example, a diagnostic nucleotide set identified as a subset of sequences on a cDNA microarray can be utilized for diagnostic (or prognostic, or monitoring, etc.) purposes on the same array from which they were identified. Alternatively, the diagnostic nucleotide sets for a given disease or condition can be organized onto a dedicated sub-array for the indicated purpose. It is important to note that if diagnostic nucleotide sets are discovered using one technology, e.g. RNA expression profiling, but applied as a diagnostic using another technology, e.g. protein expression profiling, the nucleotide (or gene, or protein) sets must generally be validated for diagnostic purposes with the new technology. In addition, it is appreciated that diagnostic nucleotide sets that are developed for one use, e.g. to diagnose a particular disease, may later be found to be useful for a different application, e.g. to predict the likelihood that the particular disease will occur. Generally, the diagnostic nucleotide set will need to be validated for use in the second circumstance. As discussed herein, the sequence of diagnostic nucleotide set members may be amplified from RNA or cDNA using methods known in the art providing specific amplification of the nucleotide sequences.

Identification of Novel Nucleotide Sequences that are Differentially Expressed in Leukocytes

Novel nucleotide sequences that are differentially expressed in leukocytes are also part of the invention. Previously unidentified open reading frames maybe identified in a library of differentially expressed candidate nucleotide sequences, as described above, and the DNA and predicted protein sequence may be identified and characterized as noted above. We identified unnamed (not previously described as corresponding to a gene, or an expressed gene) nucleotide sequences in our candidate nucleotide library, depicted in Table 3A, 3B AND 3C and the sequence listing. Accordingly, further embodiments of the invention are the isolated nucleic acids described in Tables 3A and 3B AND 3C and in the sequence listing. The novel differentially expressed nucleotide sequences of the invention are useful in the diagnostic nucleotide set of the invention described above, and are further useful as members of a diagnostic nucleotide set immobilized on an array. The novel partial nucleotide sequences may be further characterized using sequence tools and publically or privately accessible sequence databases, as is well known in the art: Novel differentially expressed nucleotide sequences may be identified as disease target nucleotide sequences, described below. Novel nucleotide sequences may also be used as imaging reagent, as further described below.

As used herein, “novel nucleotide sequence” refers to (a) a nucleotide sequence containing at least one of the DNA sequences disclosed herein (as shown in FIGS. Table 3A, 3B a nd the sequence listing); (b) a any DNA sequence that encodes the amino acid sequence encoded by the DNA sequences disclosed herein; (c) any DNA sequence that hybridizes to the complement of the coding sequences disclosed herein, contained within the coding region of the nucleotide sequence to which the DNA sequences disclosed herein (as shown in Table 3A, 3B AND 3C and the sequence listing) belong, under highly stringent conditions, e.g., hybridization to filter-bound DNA in 0.5 M NaHPO₄, 7% sodium dodecyl sulfate (SDS), 1 mM EDTA at 65° C., and washing in 0.1×SSC/0.1% SDS at 68° C. (Ausubel F. M. et al., eds., 1989, Current Protocols in Molecular Biology, Vol. I, Green Publishing Associates, Inc., and John Wiley & sons, Inc., New York, at p. 2.10.3), (d) any DNA sequence that hybridizes to the complement of the coding sequences disclosed herein, (as shown in Table 3A, 3B AND 3C and the sequence listing) contained within the coding region of the nucleotide sequence to which DNA sequences disclosed herein (as shown in TABLES 3A, 3B and the sequence listing) belong, under less stringent conditions, such as moderately stringent conditions, e.g., washing in 0.2×SSC/0.1% SDS at 42° C. (Ausubel et al., 1989, supra), yet which still encodes a functionally equivalent gene product; and/or (e) any DNA sequence that is at least 90% identical, at least 80% identical or at least 70% identical to the coding sequences disclosed herein (as shown in TABLES 3A, 3B AND 3C and the sequence listing), wherein % identity is determined using standard algorithms known in the art.

The invention also includes nucleic acid molecules, preferably DNA molecules, that hybridize to, and are therefore the complements of, the DNA sequences (a) through (c), in the preceding paragraph. Such hybridization conditions may be highly stringent or less highly stringent, as described above. In instances wherein the nucleic acid molecules are deoxyoligonucleotides (“oligos”), highly stringent conditions may refer, e.g., to washing in 6×SSC/0.05% sodium pyrophosphate at 37° C. (for 14-base oligos), 48° C. (for 17-base oligos), 55° C. (for 20-base oligos), and 60° C. (for 23-base oligos). These nucleic acid molecules may act as target nucleotide sequence antisense molecules, useful, for example, in target nucleotide sequence regulation and/or as antisense primers in amplification reactions of target nucleotide sequence nucleic acid sequences. Further, such sequences may be used as part of ribozyme and/or triple helix sequences, also useful for target nucleotide sequence regulation. Still further, such molecules may be used as components of diagnostic methods whereby the presence of a disease-causing allele, may be detected.

The Invention Also Encompasses Nucleic Acid Molecules Contained in Full-Length Gene Sequences That Are Related to Or Derived From Sequences In Tables 2, 3, 8-10 and the Sequence Listing. One Sequence May Map to More Than One Full-Length Gene.

The invention also encompasses (a) DNA vectors that contain any of the foregoing coding sequences and/or their complements (i.e., antisense); (b) DNA expression vectors that contain any of the foregoing coding sequences operatively associated with a regulatory element that directs the expression of the coding sequences; and (c) genetically engineered host cells that contain any of the foregoing coding sequences operatively associated with a regulatory element that directs the expression of the coding sequences in the host cell. As used herein, regulatory elements include but are not limited to inducible and non-inducible promoters, enhancers, operators and other elements known to those skilled in the art that drive and regulate expression. The invention includes fragments of any of the DNA sequences disclosed herein. Fragments of the DNA sequences may be at least 5, at least 10, at least 15, at least 19 nucleotides, at least 25 nucleotides, at least 50 nucleotides, at least 100 nucleotides, at least 200, at least 500, or larger.

In addition to the oligonucleotide sequences described above, homologues and orthologs of such sequences, as may, for example be present in other species, may be identified and may be readily isolated, without undue experimentation, by molecular biological techniques well known in the art, as well as use of gene analysis tools described above, and e.g., in Example 4. Further, there may exist nucleotide sequences at other genetic loci within the genome that encode proteins, which have extensive homology to one or more domains of such gene products. These nucleotide sequences may also be identified via similar techniques.

For example, the isolated differentially expressed nucleotide sequence may be labeled and used to screen a cDNA library constructed from mRNA obtained from the organism of interest. Hybridization conditions will be of a lower stringency when the cDNA library was derived from an organism different from the type of organism from which the labeled sequence was derived. Alternatively, the labeled fragment may be used to screen a genomic library derived from the organism of interest, again, using appropriately stringent conditions. Such low stringency conditions will be well known to those of skill in the art, and will vary predictably depending on the specific organisms from which the library and the labeled sequences are derived. For guidance regarding such conditions see, for example, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, Cold Springs Harbor Press, N.Y.; and Ausubel et al., 1989, Current Protocols in Molecular Biology, Green Publishing Associates and Wiley Interscience, N.Y.

Protein Products

Novel nucleotide products include those proteins encoded by the novel nucleotide sequences described, above. Specifically, novel gene products may include polypeptides encoded by the novel nucleotide sequences contained in the coding regions of the nucleotide sequences to which DNA sequences disclosed herein (in TABLES 3A, 3B and the sequence listing).

In addition, novel protein products of novel nucleotide sequences may include proteins that represent functionally equivalent gene products. Such an equivalent novel gene product may contain deletions, additions or substitutions of amino acid residues within the amino acid sequence encoded by the novel nucleotide sequences described, above, but which result in a silent change, thus producing a functionally equivalent novel nucleotide sequence product. Amino acid substitutions may be made on the basis of similarity in polarity, charge, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature of the residues involved.

For example, nonpolar (hydrophobic) amino acids include alanine, leucine, isoleucine, valine, proline, phenylalanine, tryptophan, and methionine; polar neutral amino acids include glycine, serine, threonine, cysteine, tyrosine, asparagine, and glutamine; positively charged (basic) amino acids include arginine, lysine, and histidine; and negatively charged (acidic) amino acids include aspartic acid and glutamic acid. “Functionally equivalent”, as utilized herein, refers to a protein capable of exhibiting a substantially similar in vivo activity as the endogenous novel gene products encoded by the novel nucleotide described, above.

The novel gene products (protein products of the novel nucleotide sequences) may be produced by recombinant DNA technology using techniques well known in the art. Methods which are well known to those skilled in the art can be used to construct expression vectors containing novel nucleotide sequence protein coding sequences and appropriate transcriptional/translational control signals. These methods include, for example, in vitro recombinant DNA techniques, synthetic techniques and in vivo recombination/genetic recombination. See, for example, the techniques described in Sambrook et al., 1989, supra, and Ausubel et al., 1989, supra. Alternatively, RNA capable of encoding novel nucleotide sequence protein sequences may be chemically synthesized using, for example, synthesizers. See, for example, the techniques described in “Oligonucleotide Synthesis”, 1984, Gait, M. J. ed., IRL Press, Oxford, which is incorporated by reference herein in its entirety. A variety of host-expression vector systems may be utilized to express the novel nucleotide sequence coding sequences of the invention. (Ruther et al., 1983, EMBO J. 2:1791; Inouyc & Inouye, 1985, Nucleic Acids Res. 13:3101-3109; Van Heeke & Schuster, 1989, J. Biol. Chem. 264:5503; Smith et al., 1983, J. Virol. 46: 584; Smith, U.S. Pat. No. 4,215,051; Logan & Shenk, 1984, Proc. Natl. Acad. Sci. USA 81:3655-3659; Bittner et al., 1987, Methods in Enzymol. 153:516-544; Wigler, et al., 1977, Cell 11:223; Szybalska & Szybalski, 1962, Proc. Natl. Acad. Sci. USA 48:2026; Lowy, et al., 1980, Cell 22:817; Wigler, et al., 1980, Natl. Acad. Sci. USA 77:3567; O'Hare, et al., 1981, Proc. Natl. Acad. Sci. USA 78:1527; Mulligan & Berg, 1981, Proc. Natl. Acad. Sci. USA 78:2072; Colberre-Garapin, et al., 1981, J. Mol. Biol. 150:1; Santerre, et al., 1984, Gene 30:147; Janknecht, et al., 1991, Proc. Natl. Acad. Sci. USA 88: 8972-8976

Where recombinant DNA technology is used to produce the protein encoded by the novel nucleotide sequence for such assay systems, it may be advantageous to engineer fusion proteins that can facilitate labeling, immobilization and/or detection.

Indirect labeling involves the use of a protein, such as a labeled antibody, which specifically binds to the protein encoded by the novel nucleotide sequence. Such antibodies include but are not limited to polyclonal, monoclonal, chimeric, single chain, Fab fragments and fragments produced by an Fab expression library.

Antibodies

The invention also provides for antibodies to the protein encoded by the novel nucleotide sequences. Described herein are methods for the production of antibodies capable of specifically recognizing one or more novel nucleotide sequence epitopes. Such antibodies may include, but are not limited to polyclonal antibodies, monoclonal antibodies (mAbs), humanized or chimeric antibodies, single chain antibodies, Fab fragments, F(ab′)2 fragments, fragments produced by a Fab expression library, anti-idiotypic (anti-Id) antibodies, and epitope-binding fragments of any of the above. Such antibodies may be used, for example, in the detection of a novel nucleotide sequence in a biological sample, or, alternatively, as a method for the inhibition of abnormal gene activity, for example, the inhibition of a disease target nucleotide sequence, as further described below. Thus, such antibodies may be utilized as part of cardiovascular or other disease treatment method, and/or may be used as part of diagnostic techniques whereby patients may be tested for abnormal levels of novel nucleotide sequence encoded proteins, or for the presence of abnormal forms of the such proteins.

For the production of antibodies to a novel nucleotide sequence, various host animals may be immunized by injection with a novel protein encoded by the novel nucleotide sequence, or a portion thereof. Such host animals may include but are not limited to rabbits, mice, and rats, to name but a few. Various adjuvants may be used to increase the immunological response, depending on the host species, including but not limited to Freund's (complete and incomplete), mineral gels such as aluminum hydroxide, surface active substances such as lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, keyhole limpet hemocyanin, dinitrophenol, and potentially useful human adjuvants such as BCG (bacille Calmette-Guerin) and Corynebacterium parvum.

Polyclonal antibodies are heterogeneous populations of antibody molecules derived from the sera of animals immunized with an antigen, such as novel gene product, or an antigenic functional derivative thereof. For the production of polyclonal antibodies, host animals such as those described above, may be immunized by injection with novel gene product supplemented with adjuvants as also described above.

Monoclonal antibodies, which are homogeneous populations of antibodies to a particular antigen, may be obtained by any technique which provides for the production of antibody molecules by continuous cell lines in culture. These include, but are not limited to the hybridoma technique of Kohler and Milstein, (1975, Nature 256:495-497; and U.S. Pat. No. 4,376,110), the human B-cell hybridoma technique (Kosbor et al., 1983, Immunology Today 4:72; Cole et al., 1983, Proc. Natl. Acad. Sci. USA 80:2026-2030), and the EBV-hybridoma technique (Cole et al., 1985, Monoclonal Antibodies And Cancer Therapy, Alan R. Liss, Inc., pp. 77-96). Such antibodies may be of any immunoglobulin class including IgG, IgM, IgE, IgA, IgD and any subclass thereof. The hybridoma producing the mAb of this invention may be cultivated in vitro or in vivo.

In addition, techniques developed for the production of “chimeric antibodies” (Morrison et al., 1984, Proc. Natl. Acad. Sci., 81:6851-6855; Neuberger et al., 1984, Nature, 312:604-608; Takeda et al., 1985, Nature, 314:452-454) by splicing the genes from a mouse antibody molecule of appropriate antigen specificity together with genes from a human antibody molecule of appropriate biological activity can be used. A chimeric antibody is a molecule in which different portions are derived from different animal species, such as those having a variable region derived from a murine mAb and a human immunoglobulin constant region.

Alternatively, techniques described for the production of single chain antibodies (U.S. Pat. No. 4,946,778; Bird, 1988, Science 242:423-426; Huston et al., 1988, Proc. Natl. Acad. Sci. USA 85:5879-5883; and Ward et al., 1989, Nature 334:544-546) can be adapted to produce novel nucleotide sequence-single chain antibodies. Single chain antibodies are formed by linking the heavy and light chain fragments of the Fv region via an amino acid bridge, resulting in a single chain polypeptide.

Antibody fragments which recognize specific epitopes may be generated by known techniques For example, such fragments include but are not limited to: the F(ab′)2 fragments which can be produced by pepsin digestion of the antibody molecule and the Fab fragments which can be generated by reducing the disulfide bridges of the F(ab′)2 fragments. Alternatively, Fab expression libraries may be constructed (Huse et al., 1989, Science, 246:1275-1281) to allow rapid and easy identification of monoclonal Fab fragments with the desired specificity.

Disease Specific Target Oligonucleotide Sequences

The invention also provides disease specific target oligonucleotide sequences, and sets of disease specific target oligonucleotide sequences. The diagnostic oligonucleotide sets, subsets thereof, novel oligonucleotide sequences, and individual members of the diagnostic oligonucleotide sets identified as described above are also disease specific target oligonucleotide sequences. In particular, individual oligonucleotide sequences that are differentially regulated or have predictive value that is strongly correlated with a disease or disease criterion are especially favorable as disease specific target oligonucleotide sequences. Sets of genes that are co-regulated may also be identified as disease specific target oligonucleotide sets. Such oligonucleotide sequences and/or oligonucleotide sequence products are targets for modulation by a variety of agents and techniques. For example, disease specific target oligonucleotide sequences (or the products of such oligonucleotide sequences, or sets of disease specific target oligonucleotide sequences) can be inhibited or activated by, e.g., target specific monoclonal antibodies or small molecule inhibitors, or delivery of the oligonucleotide sequence or gene product of the oligonucleotide sequence to patients. Also, sets of genes can be inhibited or activated by a variety of agents and techniques. The specific usefulness of the target oligonucleotide sequence(s) depends on the subject groups from which they were discovered, and the disease or disease criterion with which they correlate.

Kits

The present invention is optionally provided to a user as a kit. Typically, a kit contains one or more diagnostic nucleotide sets of the invention. Alternatively, the kit contains the candidate nucleotide library of the invention. Most often, the kit contains a diagnostic nucleotide probe set, or other subset of a candidate library, (e.g., as a cDNA, oligonucleotide or antibody microarray or reagents for performing an assay on a diagnostic gene set using any expression profiling technology), packaged in a suitable container. The kit may further comprise, one or more additional reagents, e.g., substrates, labels, primers, for labeling expression products, tubes and/or other accessories, reagents for collecting blood samples, buffers, e.g., erythrocyte lysis buffer, leukocyte lysis buffer, hybridization chambers, cover slips, etc., as well as a software package, e.g., including the statistical methods of the invention, e.g., as described above, and a password and/or account number for accessing the compiled database. The kit optionally further comprises an instruction set or user manual detailing preferred methods of using the diagnostic nucleotide sets in the methods of the invention.

This invention will be better understood by reference to the following non-limiting Examples:

Examples

Example 1: Generation of subtracted leukocyte candidate nucleotide library

Example 2: Identification of nucleotide sequences for candidate library using data mining techniques

Example 3: DNA Sequencing and Processing of raw sequence data

Example 4: Further sequence analysis of novel nucleotide sequences identified by subtractive hybridization screening

Example 5: Further sequence analysis of novel Clone 596H6

Example 6: Further sequence analysis of novel Clone 486E11

Example 7: Preparation of RNA from mononuclear cells for expression profiling

Example 8: Preparation of Universal Control RNA for use in leukocyte expression profiling

Example 9: Identification of diagnostic oligonucleotide sets for use in diagnosis of rheumatoid arthritis

Example 10: Identification of diagnostic oligonucleotide sets for diagnosis of Systemic Lupus Erythematosis

Example 11: Probe selection for a 24,000 feature Array.

Example 12: Design of oligonucleotide probes

Example 13: Production of an array of 8,000 spotted 50 mer oligonucleotides.

Example 14: Amplification, labeling and hybridization of total RNA to an oligonucleotide microarray

Example 15: Real-time PCR validation of array expression results

Example 16: Correlation and classification analysis

EXAMPLES
Example 1
Generation of Subtracted Leukocyte Candidate Nucleotide Library

To produce a candidate nucleotide library with representatives from the spectrum of nucleotide sequences that are differentially expressed in leukocytes, subtracted hybridization libraries were produced from the following cell types and conditions:

- 1. Buffy Coat leukocyte fractions—stimulated with ionomycin and PMA
- 2. Buffy Coat leukocyte fractions—un-stimulated
- 3. Peripheral blood mononuclear cells stimulated with ionomycin and PMA
- 4. Peripheral blood mononuclear cells—un-stimulated
- 5. T lymphocytes—stimulated with PMA and ionomycin
- 6. T lymphocytes—resting

Cells were obtained from multiple individuals to avoid introduction of bias by using only one person as a cell source.

Buffy coats (platelets and leukocytes that are isolated from whole blood) were purchased from Stanford Medical School Blood Center. Four buffy coats were used, each of which was derived from about 350 ml of whole blood from one donor individual 10 ml of buffy coat sample was drawn from the sample bag using a needle and syringe. 40 ml of Buffer EL (Qiagen) was added per 10 ml of buffy coat to lyse red blood cells. The sample was placed on ice for 15 minutes, and cells were collected by centrifugation at 2000 rpm for 10 minutes. The supernatant was decanted and the cell pellet was re-suspended in leukocyte growth media supplemented with DNase (LGM-3 from Clonetics supplemented with Dnase at a final concentration of 30 U/ml). Cell density was determined using a hemocytometer. Cells were plated in media at a density of 1×10⁶cells/ml in a total volume of 30 ml in a T-75 flask (Corning). Half of the cells were stimulated with ionomycin and phorbol myristate acetate (PMA) at a final concentration of 1 μg/ml and 62 ng/ml, respectively. Cells were incubated at 37° C. and at 5% CO₂for 3 hours, then cells were scraped off the flask and collected into 50 ml tubes. Stimulated and resting cell populations were kept separate. Cells were centrifuged at 2000 rpm for 10 minutes and the supernatant was removed. Cells were lysed in 6 ml of phenol/guanidine isothyocyanate (Trizol reagent, GibcoBRL), homogenized using a rotary homogenizer, and frozen at 80°. Total RNA and mRNA were isolated as described below.

Two frozen vials of 5×10⁶pooled human peripheral blood mononuclear cells (PBMCs) were purchased from Clonetics (catalog number cc-2702). The cells were rapidly thawed in a 37° C. water bath and transferred to a 15 ml tube containing 10 ml of leukocyte growth media supplemented with DNase (prepared as described above). Cells were centrifuged at 200 μg for 10 minutes. The supernatant was removed and the cell pellet was resuspended in LGM-3 media supplemented with DNase. Cell density was determined using a hemocytometer. Cells were plated at a density of 1×10⁶cells/ml in a total volume of 30 ml in a T-75 flask (Corning). Half of the cells were stimulated with ionomycin and PMA at a final concentration of 1 μg/ml and 62 ng/ml, respectively. Cells were incubated at 37° C. and at 5% CO₂for 3 hours, then cells were scraped off the flask and collected into 50 ml tubes. Stimulated and resting cell populations were kept separate. Cells were centrifuged at 2000 rpm and the supernatant was removed. Cells were lysed in 6 ml of phenol/guanidine isothyocyanate solution (TRIZOL reagent, GibcoBRL)), homogenized using a rotary homogenizer, and frozen at 80°. Total RNA and mRNA were isolated from these samples using the protocol described below.

45 ml of whole blood was drawn from a peripheral vein of four healthy human subjects into tubes containing anticoagulant. 50 μl RosetteSep (Stem Cell Technologies) T-cell isolation cocktail per ml of blood was added, mixed well, and incubated for 20 minutes at room temperature. The mixture was diluted with an equal volume of PBS+2% fetal bovine serum (FBS) and mixed by inversion. 30 ml of diluted mixture sample was layered on top of 15 ml DML medium (Stem Cell Technologies). The sample tube was centrifuged for 20 minutes at 1200×g at room temperature. The enriched T-lymphocyte cell layer at the plasma: medium interface was removed. Enriched cells were washed with PBS+2% FBS and centrifuged at 1200×g. The cell pellet was treated with 5 ml of erythrocyte lysis buffer (EL buffer, Qiagen) for 10 minutes on ice. The sample was centrifuged for 5 min at 1200 g. Cells were plated at a density of 1×10⁶cells/ml in a total volume of 30 ml in a T-75 flask (Corning). Half of the cells were stimulated with ionomycin and PMA at a final concentration of 1 μg/ml and 62 ng/ml, respectively. Cells were incubated at 37° C. and at 5% CO₂for 3 hours, then cells were scraped off the flask and collected into 50 ml tubes. Stimulated and resting cell populations were kept separate. Cells were centrifuged at 2000 rpm and the supernatant was removed. Cells were lysed in 6 ml of phenol/guanidine isothyocyanate solution (TRIZOL reagent, GibcoBRL), homogenized using a rotary homogenizer, and frozen at 80°. Total RNA and mRNA were isolated as described below.

Total RNA and mRNA were isolated using the following procedure: the homogenized samples were thawed and mixed by vortexing. Samples were lysed in a 1:0.2 mixture of Trizol and chloroform, respectively. For some samples, 6 ml of Trizol-chloroform was added. Variable amounts of Trizol-chloroform was added to other samples. Following lysis, samples were centrifuged at 3000 g for 15 min at 4° C. The aqueous layer was removed into a clean tube and 4 volumes of Buffer RLT Qiagen) was added for every volume of aqueous layer. The samples were mixed thoroughly and total RNA was prepared from the sample by following the Qiagen Rneasy midi protocol for RNA cleanup (October 1999 protocol, Qiagen). For the final step, the RNA was eluted from the column twice with 250 μl Rnase-free water. Total RNA was quantified using a spectrophotometer. Isolation of mRNA from total RNA sample was done using The Oligotex mRNA isolation protocol (Qiagen) was used to isolate mRNA from total RNA, according to the manufacturer's instructions (Qiagen, 7/99 version). mRNA was quantified by spectrophotometry.

Subtracted cDNA libraries were prepared using Clontech's PCR-Select cDNA Subtraction Kit (protocol number PT-1117-1) as described in the manufacturer's protocol. The protocol calls for two sources of RNA per library, designated “Driver” and “Tester.” The following 6 libraries were made:

Library
Driver RNA
Tester RNA

Buffy Coat
Un-stimulated Buffy
Stimulated Buffy Coat

Stimulated
Coat

Buffy Coat Resting
Stimulated Buffy Coat
Un-stimulated Buffy Coat

PBMC Stimulated
Un-stimulated PBMCs
Stimulated PBMCs

PBMC Resting
Stimulated PBMCs
Un-stimulated PBMCs

T-cell Stimulated
Un-stimulated T-cells
Stimulated T-cells

T-cell Resting
Stimulated T-cells
Un-stimulated T-cells

The Clontech protocol results in the PCR amplification of cDNA products. The PCR products of the subtraction protocol were ligated to the pGEM T-easy bacterial vector as described by the vector manufacturer (Promega 6/99 version). Ligated vector was transformed into competent bacteria using well-known techniques, plated, and individual clones are picked, grown and stored as a glycerol stock at −80C. Plasmid DNA was isolated from these bacteria by standard techniques and used for sequence analysis of the insert. Unique cDNA sequences were searched in the Unigene database (build 133), and Unigene cluster numbers were identified that corresponded to the DNA sequence of the cDNA. Unigene cluster numbers were recorded in an Excel spreadsheet.

Example 2
Identification of Nucleotide Sequences for Candidate Library Using Data Mining Techniques

Existing and publicly available gene sequence databases were used to identify candidate nucleotide sequences for leukocyte expression profiling. Genes and nucleotide sequences with specific expression in leukocytes, for example, lineage specific markers, or known differential expression in resting or activated leukocytes were identified. Such nucleotide sequences are used in a leukocyte candidate nucleotide library, alone or in combination with nucleotide sequences isolated through cDNA library construction, as described above.

Leukocyte candidate nucleotide sequences were identified using three primary methods. First, the publically accessible publication database PubMed was searched to identify nucleotide sequences with known specific or differential expression in leukocytes. Nucleotide sequences were identified that have been demonstrated to have differential expression in peripheral blood leukocytes between subjects with and without particular disease(s) selected from Table 1. Additionally, genes and gene sequences that were known to be specific or selective for leukocytes or sub-populations of leukocytes were identified in this way.

Next, two publicly available databases of DNA sequences, Unigene located on the website at ncbi.nlm.nih.gov/UniGene and BodyMap located on the website at bodymap.ims.u-tokyo.ac.jp, were searched for sequenced DNA clones that showed specificity to leukocyte lineages, or subsets of leukocytes, or resting or activated leukocytes.

The human Unigene database (build 133) was used to identify leukocyte candidate nucleotide sequences that were likely to be highly or exclusively expressed in leukocytes. We used the Library Differential Display utility of Unigene located on the website at ncbi.nlm.nih.gov/UniGene/info/ddd.html, which uses statistical methods (The Fisher Exact Test) to identify nucleotide sequences that have relative specificity for a chosen library or group of libraries relative to each other. We compared the following human libraries from Unigene release 133:

- 546 NCI_CGAP_HSCI (399)
- 848 Human_mRNA_from_cd34+_stem_cells (122)
- 105 CD34+DIRECTIONAL (150)
- 3587 KRIBB_Human_CD4_intrathymic_T-cell-cDNA_library (134)
- 3586 KRIBB_Human_DP_intrathymic_T-cell_cDNA_library (179)
- 3585 KRIBB_Human_TN_intrathymic-T-cell_cDNA_library (127) 3586 323 Activated_T-cells_I (740)
- 376 Activated_T-cells_XX (1727)
- 327 Monocytes,_stimulated_II (110)
- Proliferating_Erythroid_Cells_(LCB:ad_library) (665)
- 825 429 Macrophage_II (105)
- 387 Macrophage_I (137)
- 669 NCI_CGAP_CLL1 (11626)
- 129 Human_White_blood_cells (922)
- 1400 NIH_MGC_—2 (422)
- 55 Human_promyelocyte (1220)
- 1010 NCI_CGAP_CML1 (2541)
- 2217 NCI_CGAP_Sub7 (218)
- 1395 NCI_CGAP_Sub6 (2764)
- 4874 NIH_MGC_—48 (2524)

Sequences from these libraries were compared to sequences from non-leukocyte derived libraries in the Unigene database to identify genes that had some specificity for the leukocyte-derived libraries.

BodyMap, like Unigene, contains cell-specific libraries that contain potentially useful information about genes that may serve as lineage-specific or leukocyte specific markers (Okubo et al. 1992). We compared three leukocyte specific libraries, Granulocyte, CD4 T cell, and CD8 T cell, with the other libraries. Nucleotide sequences that were found in one or more of the leukocyte-specific libraries, but absent in the others, were identified. Clones that were found exclusively in one of the three leukocyte libraries were also included in a list of nucleotide sequences that could serve as lineage-specific markers.

Next, the sequence of the nucleotide sequences identified in PubMed or BodyMap were searched in Unigene (version 133), and a human Unigene cluster number was identified for each nucleotide sequence. The cluster number was recorded in a Microsoft Excel™ spreadsheet, and a non-redundant list of these clones was made by sorting the clones by UniGene number, and removing all redundant clones using Microsoft Excel™ tools. The non-redundant list of UniGene cluster numbers was then compared to the UniGene cluster numbers of the cDNAs identified using subtractive cDNA hybridization, as described above in Example 1 (listed in Table 3 and the sequence listing). Only UniGene clusters that were not contained in the cDNA libraries were retained. Unigene clusters corresponding to 1911 candidate nucleotide sequences for leukocyte expression profiling were identified in this way and are listed in Table 3 and the sequence listing.

DNA clones corresponding to each UniGene cluster number are obtained in a variety of ways. First, a cDNA clone with identical sequence to part of, or all of the identified UniGene cluster is bought from a commercial vendor or obtained from the IMAGE consortium located on the web at image.llnl.gov/, the Integrated Molecular Analysis of Genomes and their Expression. Alternatively, PCR primers are designed to amplify and clone any portion of the nucleotide sequence from cDNA or genomic DNA using well-known techniques. Alternatively, the sequences of the identified UniGene clusters are used to design and synthesize oligonucleotide probes for use in oligonucleotide microarray based expression profiling.

Example 3
DNA Sequencing and Processing of Raw Sequence Data

Clones of differentially expressed cDNAs (identified by subtractive hybridization, described above) were sequenced on an MJ Research BaseStation™ slab gel based fluorescent detection system, using BigDye™ (Applied Biosystems, Foster City, Calif.) terminator chemistry was used (Heiner et al., Genome Res 1998 May;8(5):557-61).

The fluorescent profiles were analyzed using the Phred sequence analysis program (Ewing et al, (1998), Genome Research 8: 175-185). Analysis of each clone results in a one pass nucleotide sequence and a quality file containing a number for each base pair with a score based on the probability that the determined base is correct. Each of the sequence files and its respective quality files were initially combined into single fasta format (Pearson, W R. Methods Mol. Biol. 2000;132:185-219), multi-sequence file with the appropriate labels for each clone in the headers for subsequent automated analysis.

Initially, known sequences were analyzed by pair wise similarity searching using the blastn option of the blastall program obtained from the National Center for Biological Information, National Library of Medicine, National Institutes of Health (NCBI) to determine the quality score that produced accurate matching (Altschul SF,et al. J. Mol. Biol. 1990 Oct. 5;215(3):403-10.). Empirically, it was determined that a raw score of 8 was the minimum that contained useful information. Using a sliding window average for 16 base pairs, an average score was determined. The sequence was removed (trimmed) when the average score fell below 8. Maximum reads were 950 nucleotides long.

Next, the sequences were compared by similarity matching against a database file containing the flanking vector sequences used to clone the cDNA, using the blastall program with the blastn option. All regions of vector similarity were removed, or “trimmed” from the sequences of the clones using scripts in the GAWK programming language, a variation of AWK (Aho AV et al, The Awk Programming Language (Addison-Wesley, Reading Mass., 1988); Robbins, AD, “Effective AWK Programming” (Free Software Foundation, Boston Mass., 1997). It was found that the first 45 base pairs of all the sequences were related to vector; these sequences were also trimmed and thus removed from consideration. The remaining sequences were then compared against the NCBI vector database (Kitts, P. A. et al. National Center for Biological Information, National Library of Medicine, National Institutes of Health, Manuscript in preparation (2001) using blastall with the blastn option. Any vector sequences that were found were removed from the sequences.

Messenger RNA contains repetitive elements that are found in genomic DNA. These repetitive elements lead to false positive results in similarity searches of query mRNA sequences versus known mRNA and EST databases. Additionally, regions of low information content (long runs of the same nucleotide, for example) also result in false positive results. These regions were masked using the program RepeatMasker2 found on the website at repeatmasker.genome.washington.edu (Smit, AFA & Green, P “RepeatMasker” at the website at genome.washington.edu/RM/RepeatMasker.html. The trimmed and masked files were then subjected to further sequence analysis.

Example 4
Further Sequence Analysis of Novel Nucleotide Sequences Identified by Subtractive Hybridization Screening

cDNA sequences were further characterized using BLAST analysis. The BLASTN program was used to compare the sequence of the fragment to the UniGene, dbEST, and nr databases at NCBI (GenBank release 123.0; see Table 5). In the BLAST algorithm, the expect value for an alignment is used as the measure of its significance. First, the cDNA sequences were compared to sequences in Unigene on the web at ncbi.nlm.nih.gov/UniGene. If no alignments were found with an expect value less than 10⁻²⁵, the sequence was compared to the sequences in the dbEST database using BLASTN. If no alignments were found with an expect value less than 10⁻²⁵, the sequence was compared to sequences in the nr database.

The BLAST analysis produced the following categories of results: a) a significant match to a known or predicted human gene, b) a significant match to a nonhuman DNA sequence, such as vector DNA or E. coli DNA, c) a significant match to an unidentified GenBank entry (a sequence not previously identified or predicted to be an expressed sequence or a gene), such as a cDNA clone, mRNA, or cosmid, or d) no significant alignments. If a match to a known or predicted human gene was found, analysis of the known or predicted protein product was performed as described below. If a match to an unidentified GenBank entry was found, or if no significant alignments were found, the sequence was searched against all known sequences in the human genome database located on the web at ncbi.nlmm.nih.gov/genome/seq/page.cgi?F=HsBlast.html&&ORG=Hs, see Table 5.

If many unknown sequences were to be analyzed with BLASTN, the clustering algorithm CAP2 (Contig Assembly Program, version 2) was used to cluster them into longer, contiguous sequences before performing a BLAST search of the human genome. Sequences that can be grouped into contigs are likely to be cDNA from expressed genes rather than vector DNA, E. coli DNA or human chromosomal DNA from a noncoding region, any of which could have been incorporated into the library. Clustered sequences provide a longer query sequence for database comparisons with BLASTN, increasing the probability of finding a significant match to a known gene. When a significant alignment was found, further analysis of the putative gene was performed, as described below. Otherwise, the sequence of the original cDNA fragment or the CAP2 contig is used to design a probe for expression analysis and further approaches are taken to identify the gene or predicted gene that corresponds to the cDNA sequence, including similarity searches of other databases, molecular cloning, and Rapid Amplification of cDNA Ends (RACE).

In some cases, the process of analyzing many unknown sequences with BLASTN was automated by using the BLAST network-client program blastcl3, which was downloaded from ftp://ncbi.nlm.nih.gov/blast/network/netblast.

When a cDNA sequence aligned to the sequence of one or more chromosomes, a large piece of the genomic region around the loci was used to predict the gene containing the cDNA. To do this, the contig corresponding to the mapped locus, as assembled by the RefSeq project at NCBI, was downloaded and cropped to include the region of alignment plus 100,000 bases preceding it and 100,000 bases following it on the chromosome. The result was a segment 200 kb in length, plus the length of the alignment. This segment, designated a putative gene, was analyzed using an exon prediction algorithm to determine whether the alignment area of the unknown sequence was contained within a region predicted to be transcribed (see Table 6).

This putative gene was characterized as follows: all of the exons comprising the putative gene and the introns between them were taken as a unit by noting the residue numbers on the 200 kb+ segment that correspond to the first base of the first exon and the last base of the last exon, as given in the data returned by the exon prediction algorithm. The truncated sequence was compared to the UniGene, dbEST, and nr databases to search for alignments missed by searching with the initial fragment.

The predicted amino acid sequence of the gene was also analyzed. The peptide sequence of the gene predicted from the exons was used in conjunction with numerous software tools for protein analysis (see Table 7). These were used to classify or identify the peptide based on similarities to known proteins, as well as to predict physical, chemical, and biological properties of the peptides, including secondary and tertiary structure, flexibility, hydrophobicity, antigenicity (hydrophilicity), common domains and motifs, and localization within the cell or tissues. The peptide sequence was compared to protein databases, including SWISS-PROT, TrEMBL, GenPept, PDB, PIR, PROSITE, ProDom, PROSITE, Blocks, PRINTS, and Pfam, using BLASTP and other algorithms to detemine similarities to known proteins or protein subunits.

Example 5
Further Sequence Analysis of Novel Clone 596H6

The sequence of clone 596H6 is provided below

ACTATATTTA GGCACCACTG CCATAAACTA CCAAAAAAAA AATGTAATTC
50
(SEQ ID NO:8767)

CTAGAAGCTG TGAAGAATAG TAGTGTAGCT AAGCACGGTG TGTGGACAGT
100

GGGACATCTG CCACCTGCAG TAGGTCTCTG CACTCCCAAA AGCAAATTAC
150

ATTGGCTTGA ACTTCAGTAT GCCCGGTTCC ACCCTCCAGA AACTTTTGTG
200

TTCTTTGTAT AGAATTTAGG AACTTCTGAG GGCCACAAAT ACACACATTA
250

AAAAAGGTAG AATTTTTGAA GATAAGATTC TTCTAAAAAA GCTTCCCAAT
300

GCTTGAGTAG AAAGTATCAG TAGAGGTATC AAGGGAGGAG AGACTAGGTG
350

ACCACTAAAC TCCTTCAGAC TCTTAAAATT ACGATTCTTT TCTCAAAGGG
400

GAAGAACGTC AGTGCAGCGA TCCCTTCACC TTTAGCTAAA GAATTGGACT
450

GTGCTGCTCA AAATAAAGAT CAGTTGGAGG TANGATGTCC AAGACTGAAG
500

GTAAAGGACT AGTGCAAACT GAAAGTGATG GGGAAACAGA CCTACGTATG
550

GAAGCCATGT AGTGTTCTTC ACAGGCTGCT GTTGACTGAA ATTCCTATCC
600

TCAAATTACT CTAGACTGAA GCTGCTTCCC TTCAGTGAGC AGCCTCTCCT
650

TCCAAGATTC TGGAAAGCAC ACCTGACTCC AAACAAAGAC TTAGAGCCCT
700

GTGTCAGTGC TGCTGCTGCT TTTACCAGAT TCTCTAACCT TCCGGGTAGA
750

AGAG

This sequence was used as input for a series of BLASTN searches. First, it was used to search the UniGene database, build 132 located on the web at ncbi.nlm.nih.gov/BLAST. No alignments were found with an expect value less than the threshold value of 10⁻²⁵. A BLASTN search of the database dbEST, release 041001, was then performed on the sequence and 21 alignments were found (http://www.ncbi.nlm.nih.gov/BLAST/). Ten of these had expect values less than 10⁻²⁵, but all were matches to unidentified cDNA clones. Next, the sequence was used to run a BLASTN search of the nr database, release 123.0. No significant alignment to any sequence in nr was found. Finally, a BLASTN search of the human genome was performed on the sequence located on the web at ncbi.nlm.nih.gov/genome/seq/page.cgi?F=HsBlast.html&&ORG=Hs.

A single alignment to the genome was found on contig NT_—004698.3 (e=0.0). The region of alignment on the contig was from base 1,821,298 to base 1,822,054, and this region was found to be mapped to chromosome 1, from base 105,552,694 to base 105,553,450. The sequence containing the aligned region, plus 100 kilobases on each side of the aligned region, was downloaded. Specifically, the sequence of chromosome 1 from base 105,452,694 to 105,653,450 was downloaded from the website at ncbi.nlm.nih.gov/cgi-bin/Entrez/seq_reg.cgi?chr=1&from=105452694&to =105653450.

This 200,757 bp segment of the chromosome was used to predict exons and their peptide products as follows. The sequence was used as input for the Genscan algorithm located on the web at genes.mit.edu/GENSCAN.html, using the following Genscan settings:

- Organism: vertebrate
- Suboptimal exon cutoff: 10.00 (no suboptimal exons)
- Print options: Predicted CDS and peptides

The region matching the sequence of clone 596H6 was known to span base numbers 100,001 to 100,757 of the input sequence. An exon was predicted by the algorithm, with a probability of 0.695, covering bases 100,601 to 101,094 (designated exon 4.14 of the fourth predicted gene). This exon was part of a predicted cistron that is 24,195 bp in length. The sequence corresponding to the cistron was noted and saved separately from the 200,757 bp segment. BLASTN searches of the Unigene, dbEST, and nr databases were performed on it.

At least 100 significant alignments to various regions of the sequence were found in the dbEST database, although most appeared to be redundant representations of a few exons. All matches were to unnamed cDNAs and mRNAs (unnamed cDNAs and mRNAs are cDNAs and mRNAs not previously identified, or shown to correspond to a known or predicted human gene) from various tissue types. Most aligned to a single region on the sequence and spanned 500 bp or less, but several consisted of five or six regions separated by gaps, suggesting the locations of exons in the gene. Several significant matches to entries in the UniGene database were found, as well, even after masking low-complexity regions and short repeats in the sequence. All matches were to unnamed cDNA clones.

At least 100 significant alignments were found in the nr database, as well. A similarity to hypothetical protein FLJ22457 (UniGene cluster Hs.238707) was found (e=0.0). The cDNA of this predicted protein has been isolated from B lymphocytes located on the web at ncbi.nlm.nih.gov/entrez/viewer.cgi?save=0&cmd=&cfm=on&f=1 &view=gp&txt=0&val=13637988.

Other significant alignments were to unnamed cDNAs and mRNAs.

Using Genscan, the following 730 residue peptide sequence was predicted from the putative gene:

MDGLGRRLRA SLRLKRGHGG HWRLNEMPYM KHEFDGGPPQ DNSGEALKEP
50
SEQ ID NO:8768

ERAQEHSLPN FAGGQHFFEY LLVVSLKKKR SEDDYEPIIT YQFPKRENLL
100

RGQQEEEERL LKAIPLFCFP DGNEWASLTE YPSLSCKTPG LLAALVVEKA
150

QPRTCCHASA PSAAPQARGP DAPSPAAGQA LPAGPGPRLP KVYCIISCIG
200

CFGLFSKILD EVEKRHQISM AVIYPFMQGL REAAFPAPGK TVTLKSFIPD
250

SGTEFISLTR PLDSHLEHVD FSSLLHCLSF EQILQIFASA VLERKIIFLA
300

EGLREEEKDV RDSTEVRGAG ECHGFQRKGN LGKQWGLCVE DSVKMGDNQR
350

GTSCSTLSQC IHAAAALLYP FSWAHTYIPV VPESLLATVC CPTPFMVGVQ
400

MRFQQEVMDS PMEEIQPQAE IKTVNPLGVY EERGPEKASL CLFQVLLVNL
450

CEGTFLMSVG DEKDILPPKL QDDILDSLGQ GINELKTAEQ INEHVSGPFV
500

QFFVKIVGHY ASYIKREANG QGHFQERSFC KALTSKTNRR FVKKFVKTQL
550

FSLFIQEAEK SKNPPAEVTQ VGNSSTCVVD TWLEAAATAL SHHYNIFNTE
600

HTLWSKGSAS LHEVCGHVRT RVKRKILFLY VSLAFTMGKS IFLVENKAMN
650

MTIKWTTSGR PGHGDMFGVI ESWGAAALLL LTGRVRDTGK SSSSTGHRAS
700

KSLVWSQVCF PESWEERLLT EGKQLQSRVI

Multiple analyses were performed using this prediction. First, a pairwise comparison of the sequence above and the sequence of FLJ22457, the hypothetical protein mentioned above, using BLASTP version 2.1.2 located on the web at ncbi.nlm.nih.gov/BLAST, resulted in a match with an expect value of 0.0. The peptide sequence predicted from clone 596H6 was longer and 19% of the region of alignment between the two resulted from gaps in hypothetical protein FLJ22457. The cause of the discrepancy might be alternative mRNA splicing, alternative post-translational processing, or differences in the peptide-predicting algorithms used to create the two sequences, but the homology between the two is significant.

BLASTP and TBLASTN were also used to search for sequence similarities in the SWISS-PROT, TrEMBL, GenBank Translated, and PDB databases. Matches to several proteins were found, among them a tumor cell suppression protein, HTS1. No matches aligned to the full length of the peptide sequence, however, suggesting that similarity is limited to a few regions of the peptide.

TBLASTN produced matches to several proteins—both identified and theoretical—but again, no matches aligned to the full length of the peptide sequence. The best alignment was to the same hypothetical protein found in GenBank before (FLJ22457).

To discover similarities to protein families, comparisons of the domains (described above) were carried out using the Pfam and Blocks databases. A search of the Pfam database identified two regions of the peptide domains as belonging the DENN protein family (e=2.1×10⁻³³). The human DENN protein possesses an RGD cellular adhesion motif and a leucine-zipper-like motif associated with protein dimerization, and shows partial homology to the receptor binding domain of tumor necrosis factor alpha DENN is virtually identical to MADD, a human MAP kinase-activating death domain protein that interacts with type I tumor necrosis factor receptor located on the web at srs.ebi.ac.uk/srs6bin/cgi-bin/wgetz?-id+fS5n1GQsHf+−e+[INTERPRO:‘IPR001194’]. The search of the Blocks database also revealed similarities between regions of the peptide sequence and known protein groups, but none with a satisfactory degree of confidence. In the Blocks scoring system, scores over 1,100 are likely to be relevant. The highest score of any match to the predicted peptide was 1,058.

The Prosite, ProDom, PRINTS databases (all publicly available) were used to conduct further domain and motif analysis. The Prosite search generated many recognized protein domains. A BLASTP search was performed to identify areas of similarity between the protein query sequence and PRINTS, a protein database of protein fingerprints, groups of motifs that together form a characteristic signature of a protein family. In this case, no groups were found to align closely to any section of the submitted sequence. The same was true when the ProDom database was searched with BLASTP.

A prediction of protein structure was done by performing a BLAST search of the sequence against PDB, a database in which every member has tertiary structure information. No significant alignments were found by this method. Secondary and super-secondary structure was examined using the Gamier algorithm. Although it is only considered to be 60-65% accurate, the algorithm provided information on the locations and lengths of alpha-helices, beta-sheets, turns and coils.

The antigenicity of the predicted peptide was modeled by graphing hydrophilicity vs. amino acid number. This produced a visual representation of trends in hydrophilicity along the sequence. Many locations in the sequence showed antigenicity and five sites had antigenicity greater than 2. This information can be used in the design of affinity reagents to the protein.

Membrane-spanning regions were predicted by graphing hydrophobicity vs. amino acid number. Thirteen regions were found to be somewhat hydrophobic. The algorithm TMpred predicted a model with 6 strong transmembrane helices located on the web at ch.embnet.orglsoftware/TMPRED_form.html.

NNPSL is a neural network algorithm developed by the Sanger Center. It uses amino acid composition and sequence to predict cellular location. For the peptide sequence submitted, its first choice was mitochondrial (51.1% expected accuracy). Its second choice was cytoplasmic (91.4% expected accuracy).

Example 6
Further Sequence Analysis of Novel Clone 486E11

The sequence of clone 486E11 is provided below

TAAAAGCAGG CTGTGCACTA GGGACCTAGT GACCTTACTA GAAAAAACTC
50
SEQ ID NO:8769

AAATTCTCTG AGCCACAAGT CCTCATGGGC AAAATGTAGA TACCACCACC
100

TAACCCTGCC AATTTCCTAT CATTGTGACT ATCAAATTAA ACCACAGGCA
150

GGAAGTTGCC TTGAAAACTT TTTATAGTGT ATATTACTGT TCACATAGAT
200

NAGCAATTAA CTTTACATAT ACCCGTTTTT AAAAGATCAG TCCTGTGATT
250

AAAAGTCTGG CTGCCCTAAT TCACTTCGAT TATACATTAG GTTAAAGCCA
300

TATAAAAGAG GCACTACGTC TTCGGAGAGA TGAATGGATA TTACAAGCAG
350

TAATGTTGGC TTTGGAATAT ACACATAATG TCCACTTGAC CTCATCTATT
400

TGACACAAAA TGTAAACTAA ATTATGAGCA TCATTAGATA CCTTGGCCTT
450

TTCAAATCAC ACAGGGTCCT AGATCTNNNN NNNNNNNNNN NNNNNNNNNN
500

NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNAC TTTGGGATTC
550

CTATATCTTT GTCAGCTGTC AACTTCAGTG TTTTCAGGTT AAATTCTATC
600

CATAGTCATC CCAATATACC TGCTTTAGAT GATACAACCT TCAAAAGATC
650

CGCTCTTCCT CGTAAAAAGT GGAG

The BLASTN program was used to compare the sequence to the UniGene and dbEST databases. No significant alignments were found in either. It was then searched against the nr database and only alignments to unnamed genomic DNA clones were found.

CAP2 was used to cluster a group of unknowns, including clone 486E11. The sequence for 486E11 was found to overlap others. These formed a contig of 1,010 residues, which is shown below:

CGGACAGGTA CCTAAAAGCA GGCTGTGCAC TAGGGACCTA GTGACCTTAC
50
SEQ ID NO:8832

TAGAAAAAAC TCAAATTCTC TGAGCCACAA GTCCTCATGG GCAAAATGTA
100

GATACCACCA CCTAACCCTG CCAATTTCCT ATCATTGTGA CTATCAAATT
150

AAACCACAGG CAGGAAGTTG CCTTGAAAAC TTTTTATAGT GTATATTACT
200

GTTCACATAG ATNAGCAATT AACTTTACAT ATACCCGTTT TTAAAAGATC
250

AGTCCTGTGA TTAAAAGTCT GGCTGCCCTA ATTCACTTCG ATTATACATT
300

AGGTTAAAGC CATATAAAAG AGGCACTACG TCTTCGGAGA GATGAATGGA
350

TATTACAAGC AGTAATTTTG GCTTTGGAAT ATACACATAA TGTCCACTTG
400

ACCTCATCTA TTTGACACAA AATGTAAACT AAATTATGAG CATCATTAGA
450

TACCTTGGGC CTTTTCAAAT CACACAGGGT CCTAGATCTG NNNNNNNNNN
500

NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN
550

NACTTTGGAT TCTTATATCT TTGTCAGCTG TCAACTTCAG TGTTTTCAGG
600

NTAAATTCTA TCCATAGTCA TCCCAATATA CCTGCTTTAG ATGATACAAA
650

CTTCAAAAGA TCCGGCTCTC CCTCGTAAAA CGTGGAGGAC AGACATCAAG
700

GGGGTTTTCT GAGTAAAGAA AGGCAACCGC TCGGCAAAAA CTCACCCTGG
750

CACAACAGGA NCGAATATAT ACAGACGCTG ATTGAGCGTT TTGCTCCATC
800

TTCACTTCTG TTAAATGAAG ACATTGATAT CTAAAATGCT ATGAGTCTAA
850

CTTTGTAAAA TTAAAATAGA TTTGTAGTTA TTTTTCAAAA TGAAATCGAA
900

AAGATACAAG TTTTGAAGGC AGTCTCTTTT TCCACCCTGC CCCTCTAGTG
950

TGTTTTACAC ACTTCTCTGG CCACTCCAAC AGGGAAGCTG GTCCAGGGCC
1000

ATTATACAGG

The sequence of the CAP2 contig was used in a BLAST search of the human genome. 934 out of 1,010 residues aligned to a region of chromosome 21. A gap of 61 residues divided the aligned region into two smaller fragments. The sequence of this region, plus 100 kilobases on each side of it, was downloaded and analyzed using the Genscan site at MIT located on the web at genes.mit.edu/GENSCAN.html, with the following settings:

- Organism: vertebrate
- Suboptimal exon cutoff: 1.00 (no suboptimal exons)
- Print options; Predicted CDS and peptides

The fragment was found to fall within one of several predicted genes in the chromosome region. The bases corresponding to the predicted gene, including its predicted introns, were saved as a separate file and used to search GenBank again with BLASTN to find any ESTs or UniGene clusters identified by portions of the sequence not included in the original unknown fragment. The nr database contained no significant matches. At least 100 significant matches to various parts of the predicted gene were found in the dbEST database, but all of them were to unnamed cDNA clones. Comparison to UniGene produced fewer significant matches, but all matches were to unnamed cDNAs.

The peptide sequence predicted by Genscan was also saved. Multiple types of analyses were performed on it using the resources mentioned in Table 3. BLASTP and TBLASTN were used to search the TrEMBL protein database located on the web at expasy.ch/sprot/) and the GenBank nr database located on the web at ncbi.nlm.hih.gov/BLAST, which includes data from the SwissProt, PIR, PRF, and PDB databases. No significant matches were found in any of these, so no gene identity or tertiary structure was discovered.

The peptide sequence was also searched for similarity to known domains and motifs using BLASTP with the Prositc, Blocks, Pfam, and ProDom databases. The searches produced no significant alignments to known domains. BLASTP comparison to the PRINTS database produced an alignment to the P450 protein family, but with a low probability of accuracy (e=6.9).

Two methods were used to predict secondary structure—the Gamier/Osguthorpe/Robson model and the Chou-Fasman model. The two methods differed somewhat in their results, but both produced representations of the peptide sequence with helical and sheet regions and locations of turns.

Antigenicity was plotted as a graph with amino acid number in the sequence on the x-axis and hydrophilicity on the y-axis. Several areas of antigenicity were observed, but only one with antigenicity greater than 2. Hydrophobicity was plotted in the same way. Only one region, from approximately residue 135 to residue 150, had notable hydrophobicity. TMpreα, accessed through ExPASy, was used to predict transmembrane helices. No regions of the peptide sequence were predicted with reasonable confidence to be membrane-spanning helices.

NNPSL predicted that the putative protein would be found either in the nucleus (expected prediction accuracy=51.1%) or secreted from the cell (expected prediction accuracy=91.4%).

Example 7
Preparation of RNA from Mononuclear Cells for Expression Profiling

Blood was isolated from the subject for leukocyte expression profiling using the following methods:

Two tubes were drawn per patient. Blood was drawn from either a standard peripheral venous blood draw or directly from a large-bore intra-arterial or intravenous catheter inserted in the femoral artery, femoral vein, subclavian vein or internal jugular vein. Care was taken to avoid sample contamination with heparin from the intravascular catheters, as heparin can interfere with subsequent RNA reactions.

For each tube, 8 ml of whole blood was drawn into a tube (CPT, Becton-Dickinson order #362753) containing the anticoagulant Citrate, 25° C. density gradient solution (e.g. Ficoll, Percoll) and a polyester gel barrier that upon centrifugation was permeable to RBCs and granulocytes but not to mononuclear cells. The tube was inverted several times to mix the blood with the anticoagulant. The tubes were centrifuged at 1750×g in a swing-out rotor at room temperature for 20 minutes. The tubes were removed from the centrifuge and inverted 5-10 times to mix the plasma with the mononuclear cells, while trapping the RBCs and the granulocytes beneath the gel barrier. The plasma/mononuclear cell mix was decanted into a 15 ml tube and 5 ml of phosphate-buffered saline (PBS) is added. The 15 ml tubes were spun for 5 minutes at 1750×g to pellet the cells. The supernatant was discarded and 1.8 ml of RLT lysis buffer is added to the mononuclear cell pellet. The buffer and cells were pipetted up and down to ensure complete lysis of the pellet. The cell lysate was frozen and stored until it is convenient to proceed with isolation of total RNA.

Total RNA was purified from the lysed mononuclear cells using the Qiagen Rneasy Miniprep kit, as directed by the manufacturer (10/99 version) for total RNA isolation, including homogenization (Qiashredder columns) and on-column DNase treatment. The purified RNA was eluted in SOul of water.

Some samples were prepared by a different protocol, as follows:

Two 8 ml blood samples were drawn from a peripheral vein into a tube (CPT, Becton-Dickinson order #362753) containing anticoagulant (Citrate), 25° C. density gradient solution (Ficoll) and a polyester gel barrier that upon centrifugation is permeable to RBCs and granulocytes but not to mononuclear cells. The mononuclear cells and plasma remained above the barrier while the RBCs and granulocytes were trapped below. The tube was inverted several times to mix the blood with the anticoagulant, and the tubes were subjected to centrifugation at 1750×g in a swing-out rotor at room temperature for 20 min. The tubes were removed from the centrifuge, and the clear plasma layer above the cloudy mononuclear cell layer was aspirated and discarded. The cloudy mononuclear cell layer was aspirated, with care taken to rinse all of the mononuclear cells from the surface of the gel barrier with PBS (phosphate buffered saline). Approximately 2 mls of mononuclear cell suspension was transferred to a 2 ml microcentrifuge tube, and centrifuged for 3 min. at 16,000 rpm in a microcentrifuge to pellet the cells. The supernatant was discarded and 1.8 ml of RLT lysis buffer (Qiagen) were added to the mononuclear cell pellet, which lysed the cells and inactivated Rnases. The cells and lysis buffer were pipetted up and down to ensure complete lysis of the pellet. Cell lysate was frozen and stored until it was convenient to proceed with isolation of total RNA.

RNA samples were isolated from 8 mL of whole blood. Yields ranged from 2 ug to 20ug total RNA for 8 mL blood. A260/A280 spectrophotometric ratios were between 1.6 and 2.0, indicating purity of sample. 2 ul of each sample were run on an agarose gel in the presence of ethidium bromide. No degradation of the RNA sample and no DNA contamination were visible.

In some cases, specific subsets of mononuclear cells were isolated from peripheral blood of human subjects. When this was done, the StemSep cell separation kits (manual version 6.0.0) were used from StemCell Technologies (Vancouver, Canada). This same protocol can be applied to the isolation of T cells, CD4 T cells, CD8 T cells, B cells, monocytes, NK cells and other cells. Isolation of cell types using negative selection with antibodies may be desirable to avoid activation of target cells by antibodies.

Example 8
Preparation of Universal Control RNA for Use in Leukocyte Expression Profiling

Control RNA was prepared using total RNA from Buffy coats and/or total RNA from enriched mononuclear cells isolated from Buffy coats, both with and without stimulation with ionomycin and PMA. The following control RNAs were prepared:

Control 1: Buffy Coat Total RNA
Control 2: Mononuclear cell Total RNA
Control 3: Stimulated buffy coat Total RNA
Control 4: Stimulated mononuclear Total RNA
Control 5: 50% Buffy coat Total RNA/50% Stimulated buffy coat Total RNA
Control 6: 50% Mononuclear cell Total RNA/50% Stimulated Mononuclear Total RNA.

Some samples were prepared using the following protocol: Buffy coats from 38 individuals were obtained from Stanford Blood Center. Each buffy coat is derived from ˜350 mL whole blood from one individual. 10 ml buffy coat was removed from the bag, and placed into a 50 ml tube. 40 ml of Buffer EL (Qiagen) was added, the tube was mixed and placed on ice for 15 minutes, then cells were pelleted by centrifugation at 2000×g for 10 minutes at 4° C. The supernatant was decanted and the cell pellet was re-suspended in 10 ml of Qiagen Buffer EL. The tube was then centrifuged at 2000×g for 10 minutes at 4° C. The cell pellet was then re-suspended in 20 ml TRIZOL (GibcoBRL) per Buffy coat sample, the mixture was shredded using a rotary homogenizer, and the lysate was then frozen at −80° C. prior to proceeding to RNA isolation.

Other control RNAs were prepared from enriched mononuclear cells prepared from Buffy coats. Buffy coats from Stanford Blood Center were obtained, as described above. 10 ml buffy coat was added to a 50 ml polypropylene tube, and 10 ml of phosphate buffer saline (PBS) was added to each tube. A polysucrose (5.7 g/dL) and sodium diatrizoate (9.0 g/dL) solution at a 1.077+/−0.0001 g/ml density solution of equal volume to diluted sample was prepared (Histopaque 1077, Sigma cat. no 1077-1). This and all subsequent steps were performed at room temperature. 15 ml of diluted buffy coat/PBS was layered on top of 15 ml of the histopaque solution in a 50 ml tube. The tube was centrifuged at 400×g for 30 minutes at room temperature. After centrifugation, the upper layer of the solution to within 0.5 cm of the opaque interface containing the mononuclear cells was discarded. The opaque interface was transferred into a clean centrifuge tube. An equal volume of PBS was added to each tube and centrifiged at 350×g for 10 minutes at room temperature. The supernatant was discarded. 5 ml of Buffer EL (Qiagen) was used to resuspend the remaining cell pellet and the tube was centrifuged at 2000×g for 10 minutes at room temperature. The supernatant was discarded. The pellet was resuspended in 20 ml of TRIZOL (GibcoBRL) for each individual buffy coat that was processed. The sample was homogenized using a rotary homogenizer and frozen at −80C until RNA was isolated.

RNA was isolated from frozen lysed Buffy coat samples as follows: frozen samples were thawed, and 4 ml of chloroform was added to each buffy coat sample. The sample was mixed by vortexing and centrifuged at 2000×g for 5 minutes. The aqueous layer was moved to new tube and then repurified by using the RNeasy Maxi RNA clean up kit, according to the manufacturer's instruction (Qiagen, PN 75162). The yield, purity and integrity were assessed by spectrophotometer and gel electrophoresis.

Some samples were prepared by a different protocol, as follows. The further use of RNA prepared using this protocol is described in Example 14.

50 whole blood samples were randomly selected from consented blood donors at the Stanford Medical School Blood Center. Each buffy coat sample was produced from ˜350 mL of an individual's donated blood. The whole blood sample was centrifuged at ˜4,400×g for 8 minutes at room temperature, resulting in three distinct layers: a top layer of plasma, a second layer of buffy coat, and a third layer of red blood cells. 25 ml of the buffy coat fraction was obtained and diluted with an equal volume of PBS (phosphate buffered saline). 30 ml of diluted buffy coat was layered onto 15 ml of sodium diatrizoate solution adjusted to a density of 1.077+/−0.001 g/ml (Histopaque 1077, Sigma) in a 50 mL plastic tube. The tube was spun at 800 g for 10 minutes at room temperature. The plasma layer was removed to the 30 ml mark on the tube, and the mononuclear cell layer removed into a new tube and washed with an equal volume of PBS, and collected by centrifugation at 2000 g for 10 minutes at room temperature. The cell pellet was resuspended in 10 ml of Buffer EL (Qiagen) by vortexing and incubated on ice for 10 minutes to remove any remaining erthythrocytes. The mononuclear cells were spun at 2000 g for 10 minutes at 4 degrees Celsius. The cell pellet was lysed in 25 ml of a phenol/guanidinium thiocyanate solution (TRIZOL Reagent, Invitrogen). The sample was homogenized using a PowerGene 5 rotary homogenizer (Fisher Scientific) and Omini disposable generator probes (Fisher Scientific). The Trizol lysate was frozen at −80 degrees C. until the next step.

The samples were thawed out and incubated at room temperature for 5 minutes. 5 ml chloroform was added to each sample, mixed by vortexing, and incubated at room temperature for 3 minutes. The aqueous layers were transferred to new 50 ml tubes. The aqueous layer containing total RNA was further purified using the Qiagen RNeasy Maxi kit (PN 75162), per the manufacturer's protocol (October 1999). The columns were eluted twice with 1 ml Rnase-free water, with a minute incubation before each spin. Quantity and quality of RNA was assessed using standard methods. Generally, RNA was isolated from batches of 10 buffy coats at a time, with an average yield per buffy coat of 870 μg, and an estimated total yield of 43.5 mg total RNA with a 260/280 ratio of 1.56 and a 28S/18S ratio of 1.78.

Quality of the RNA was tested using the Agilent 2100 Bioanalyzer using RNA 6000 microfluidics chips. Analysis of the electrophorgrams from the Bioanalyzer for five different batches demonstrated the reproducibility in quality between the batches.

Total RNA from all five batches were combined and mixed in a 50 ml tube, then aliquoted as follows: 2×10 ml aliquots in 15 ml tubes, and the rest in 100 μl aliquots in 1.5 ml microcentrifuge tubes. The aliquots gave highly reproducible results with respect to RNA purity, size and integrity. The RNA was stored at −80° C.

Test Hybridization of Reference RNA.

When compared with BC38 and Stimulated mononuclear reference samples, the R50 performed as well, if not better than the other reference samples as shown in FIG. 3.

In an analysis of hybridizations, where the R50 targets were fluorescently labeled with Cy-5 using methods described herein and the amplified and labeled aRNA was hybridized (as in example 14) to the olignoucleotide array described in example 13. The R50 detected 97.3% of probes with a Signal to Noise ratio (S/N) of greater than three and 99.9% of probes with S/N greater one.

Example 9
Identification of Diagnostic Oligonucleotides and Oligonucleotide Sets for Use in Monitoring Treatment and/or Progression of Rheumatoid Arthritis

Rheumatoid arthritis (hereinafter, “RA”) is a chronic and debilitating inflammatory arthritis. The diagnosis of RA is made by clinical criteria and radiographs. A new class of medication, TNF blockers, are effective, but the drugs are expensive, have side effects and not all patients respond to treatment. In addition, relief of disease symptoms does not always correlate with inhibition of joint destruction. For these reasons, an alternative mechanism for the titration of therapy is needed.

An observational study was conducted in which a cohort of patients meeting American College of Rheumatology (hereinafter “ARC”) criteria for the diagnosis of RA was identified. Arnett et al. (1988) Arthritis Rheum 31:315-24. Patients gave informed consent and a peripheral blood mononuclear cell RNA sample was obtained by the methods as described herein. When available, RNA samples were also obtained from surgical specimens of bone or synovium from effected joints, and synovial fluid. Also, T-cells were isolated from the peripheral blood for some patients for expression analysis. This was done using the protocol given in Example 7.

From each patient, the following clinical information was obtained if available: Demographic information; information relating to the ACR criteria for RA; presence or absence of additional diagnoses of inflammatory and non-inflammatory conditions; data from laboratory test, including complete blood counts with differentials, CRP, ESR, ANA, Serum IL6, Soluble CD40 ligand, LDL, HDL, Anti-DNA antibodies, rheumatoid factor, C3, C4, serum creatinine and any medication levels; data from surgical procedures such as gross operative findings and pathological evaluation of resected tissues and biopsies; information on pharmacological therapy and treatment changes; clinical diagnoses of disease “flare”; hospitalizations; quantitative joint exams; results from health assessment questionnaires (HAQs); other clinical measures of patient symptoms and disability; physical examination results and radiographic data assessing joint involvement, synovial thickening, bone loss and erosion and joint space narrowing and deformity. In some cases, data includes pathological evaluation of synovial memebranes and joint tissues from RA and control patients. Pathology scoring systems were used to determine disease category, inflammation, type of inflammatory infiltrate, cellular and makeup of the synovial inflammation.

For some specimens of synovium, mononuclear cells or subsets of mononuclear cells (such as T cells) can be isolated for expression profiling. The relative number of lyphocyte subsets for some specimens can be determined by fluorescence activated cell sorting. Examples are determination of the CD4/CD8 T-cell ratio for a specimen. This information can be used as a variable to correlate to other outcomes or as an outcome for correlation analysis.

From these data, measures of improvement in RA are derived as exemplified by the ACR 20% and 50% response/improvement rates (Felson et al. 1996). Measures of disease activity over some period of time is derived from these data as are measures of disease progression. Serial radiography of effected joints is used for objective determination of progression (e.g., joint space narrowing, peri-articular osteoporosis, synovial thickening). Disease activity is determined from the clinical scores, medical history, physical exam, lab studies, surgical and pathological findings.

Samples from patients during a clinically diagnosed RA flare versus samples from these same or different patients while they are asymptomatic.

Samples from patients who subsequently have high measures of disease activity versus samples from those same or different patients who have low subsequent disease activity.

Samples from patients who subsequently have high measures of disease progression versus samples from those same or different patients who have low subsequent disease progression.

Samples from patients who subsequently respond to a given medication or treatment regimen versus samples from those same or different patients who subsequently do not respond to a given medication or treatment regimen (for example, TNF pathway blocking medications).

Samples from patients with a diagnosis of osteoarthritis versus patients with rheumatoid arthritis.

Samples from patients with tissue biopsy results showing a high degree of inflammation versus samples from patients with lesser degrees of histological evidence of inflammation on biopsy.

Expression profiles correlating with progression of RA are identified. Subsets of the candidate library (or a previously identified diagnostic nucleotide set) are identified, according to the above procedures, that have predictive value for the progression of RA.

Diagnostic nucleotide set(s) are identified which predict respond to TNF blockade. Patients are profiled before and during treatment with these medications. Patients are followed for relief of symptoms, side effects and progression of joint destruction, e.g., as measured by hand radiographs. Expression profiles correlating with response to TNF blockade are identified. Subsets of the candidate library (or a previously identified diagnostic nucleotide set) are identified, according to the above procedures that have predictive value for response to TNF blockade.

Example 10
Identification of Diagnostic Oligonucleotide and Oligonucleotide Sets for Diagnosis of Systemic Lupus Erythematosis

SLE is a chronic, systemic inflammatory disease characterized by dysregulation of the immune system. Clinical manifestations affect every organ system and include skin rash, renal dysfunction, CNS disorders, arthralgias and hematologic abnormalities. SLE clinical manifestations tend to both recur intermittently (or “flare”) and progress over time, leading to permanent end-organ damage.

An observational study was conducted in which a cohort of patients meeting American College of Rheumatology (hereinafter “ACR”) criteria for the diagnosis of SLE were identified. See Tan et al. (1982) Arthritis Rheum 25:1271-7. Patients gave informed consent and a peripheral blood mononuclear cell RNA sample or a peripheral T cell sample was obtained by the methods as described in example 7.

From each patient, the following clinical information was obtained if available: Demographic information, ACR criteria for SLE, additional diagnoses of inflammatory and non-inflammatory conditions, data from laboratory testing including complete blood counts with differentials, CRP, ESR, ANA, Serum IL6, Soluble CD40 ligand, LDL, HDL, Anti-DNA antibodies, rheumatoid factor, C3, C4, serum creatinine (and other measures of renal dysfunction), medication levels, data from surgical procedures such as gross operative findings and pathological evaluation of resected tissues and biopsies (e.g., renal, CNS), information on pharmacological therapy and treatment changes, clinical diagnoses of disease “flare”, hospitalizations, quantitative joint exams, results from health assessment questionnaires (HAQs), SLEDAls (a clinical score for SLE activity that assess many clinical variables; Bombadier C, Gladman DD, Urowitz MB, Caron D, Chang CH and the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI for Lupus Patients. Arthritis Rheum 35:630-640, 1992), other clinical measures of patient symptoms and disability, physical examination results and carotid ultrasonography.

The collected clinical data (disease criteria) is used to define patient or sample groups for correlation of expression data. Patient groups are identified for comparison, for example, a patient group that possesses a useful or interesting clinical distinction, verses a patient group that does not possess the distinction. Measures of disease activity in SLE are derived from the clinical data described above to divide patients (and patient samples) into groups with higher and lower disease activity over some period of time or at any one point in time. Such data are SLEDAI scores and other clinical scores, levels of inflammatory markers or complement, number of hospitalizations, medication use and changes, biopsy results and data measuring progression of end-organ damage or end-organ damage, including progressive renal failure, carotid atherosclerosis, and CNS dysfunction.

Expression profiles correlating with progression of SLE are identified, including expression profiles corresponding to end-organ damage and progression of end-organ damage. Expression profiles are identified predicting disease progression or disease “flare”, response to treatment or likelihood of response to treatment, predict likelihood of “low” or “high” disease measures-(optionally described using the SLEDAI score), and presence or likelihood of developing premature carotid atherosclerosis. Subsets of the candidate library (or a previously identified diagnostic nucleotide set) are identified, according to the above procedures that have predictive value for the progression of SLE.

Further examples of useful and interesting patient distinctions that can be made on the basis of collected clinical data are listed here. Samples can be grouped and groups are compared to discover diagnostic gene sets:

- 1. Samples from patients during a clinically diagnosed SLE flare versus samples from these same or different patients while they are asymptomatic or while they have a documented infection.
- 2. Samples from patients who subsequently have high measures of disease activity versus samples from those same or different patients who have low subsequent disease activity.
- 3. Samples from patients who subsequently have high measures of disease progression versus samples from those same or different patients who have low subsequent disease progression.
- 4. Samples from patients who subsequently respond to a given medication or treatment regimen versus samples from those same or different patients who subsequently do not respond to a given medication or treatment regimen.
- 5. Samples from patients with premature carotid atherosclerosis on ultrasonography versus patients with SLE without premature atherosclerosis.

Identification of a Diagnostic Oligonucleotide or Oligonucleotide Set for Diagnosis of Lupus

Mononuclear RNA samples were collected from patients with SLE and patients with Rheumatoid or Osteoarthritis (RA and OA) or controls using the protocol described in example 7. The patient diagnoses were determined using standard diagnostic algorithms such as those that are employed by the American College of Rheumatology (see example See Tan et al. (1982) Arthritis Rheum 25:1271-7; Arnett et al. (1988) Arthritis Rheum 31:315-24).

32 samples were included in the anaysis. 15 samples were derived from patients with a clinical diagnosis of SLE and the remainder were derived from patients with RA (9), OA (4) and subjects without known disease (4) who served as controls. Samples from patients with SLE or RA were classified as “Active” or “Controlled” (with respect to disease activity) by the patient's physician based on objective and subjective criteria, such as patient history, physical exam and lab studies. An attempt was made to match SLE patients and controls with respect to important variables such as medication use, sex, age and secondary diagnoses.

After preparation of RNA (example 7), amplification, labeling, hybridization, scanning, feature extraction and data processing were done as described in Example 14 using the oligonucleotide microarrays described in Example 13. The resulting log ratio of expression of Cy3 (patient sample)/Cy5 (R50 reference RNA) was used for analysis.

Initially, significance analysis for microarrays (SAM, Tusher 2001, Example 16) was used to discover that were differentially expressed between 7 of the Lupus samples and 17 control samples. 1 gene was identified that was expressed at a higher level in the lupus patients than in all controls. This gene had a 0.5% false detection rate using SAM. This means that there is statistically, a 99.5% chance that the gene is truly differentially expressed between the Lupus and control samples. This gene was oligonucleotide and SEQ ID #4637. The oligonucleotide: GCCTCTTGCTTGGCGTGATAACCCTGTCATCTTCCCAAAGCTCATTTATG detects a specific human gene: sialyltransferase (SIAT4A), Unigene:Hs.301698 Locus: NM_—003033, GI: 4506950. Expression ratios for the gene are given for each sample in FIGS. 4A-B. The average fold change in expression between SLE and controls was 1.48.

When a larger data set was used, 15 SLE samples were compared to 17 controls. Using SAM, genes were identified as significantly differentially expressed between Lupus and controls. These genes and their FDRs are given in Table 10A. Supervised harvesting classification (X-Mine, Brisbane, Calif.) and CARTF (Salford Systems, San Diego Calif.) were also used on the same data to determine which set of genes best distinguish SLE from control samples (Example 16).

CART was used to build a decision tree for classification of samples as lupus or not lupus using the gene expression data from the arrays. The analysis identitifies sets of genes that can be used together to accurately identify samples derived from lupus patients. The set of genes and the identified threshold expression levels for the decision tree are referred to as “models”. Multiple models for diagnosis of Lupus were derived by using different settings and parameters for the CART algorithm and using different sets of genes in the analysis. When using CART, it may be desirable to limit the number of independent variables. In the case of the genes on the arrays, a subset of ˜8000 can be selected for analysis in CART based on significant differential expression discovered by using SAM or some other algorithm.

Model I was based on a data set consisting of thirty-two samples (fifteen SLE and seventeen non-SLE). These samples were used to derive the model and are referred to a the “training set”. Model I used the expression values for twenty-nine genes, which were found to be most significant in differentiating SLE and non-SLE samples in the analysis using SAM described above. SLE samples were designated as Class 1 and non-SLE samples were designated as Class 2. For this analysis, the following settings were used in the MODEL SETUP (CART, Salford Systems, San Diego, Calif.). In the Model settings, the tree type selected for the analysis was classification. In the Categorical settings, the default values were used. In the Testing settings, V-fold cross-validation was selected with a value of 10. In the Select Cases settings, the default values were used. In the Best Tree settings, the default values were used. In the Combine settings, the default values were used. In the Method settings, Symmetric Gini was selected as the type of classification tree and Linear combinations for splitting was also selected. The default values were used for the linear combinations. In the Advance Settings, the default values were used. In the Costs settings, the default values were used. In the Priors settings, Equal was selected as the priors for Class. In the penalty settings, the default values were used.

From this analysis, CART built two models, a two-gene model and a three-gene model (FIGS. 4C-E). The sensitivity and specificity for the identification of lupus in the training set samples of the two genes model were 100% and 94%, respectively. The sensitivity and specificity for the 10-fold cross validation set of the two-gene model were 100% and 88%, respectively, with a relative cost of 0.118. The sensitivity and specificity for the training set of the three genes model were 100% and 100%, respectively. The sensitivity and specificity for the 10-fold cross validation set of the three genes model were 93% and 94%, respectively, with a relative cost of 0.125.

Model II was based on a data set consisted of thirty-two samples, fifteen SLE and seventeen non-SLE (training set) and six thousand forty-four genes with expression values for at least 80% of the samples. The MODEL SETUP for the analysis of this data set was the same as for the analysis above, except for the following correction. In the Method settings, Linear combination for splitting was unchecked after the analysis yielded no classification tree. The change in the linear combination setting resulted in the following.

The sensitivity and specificity for the training set of the one gene model were 87% and 82%, respectively. The sensitivity and specificity for the 10-fold cross validation set of the one gene model were 80% and 59%, respectively, with a relative cost of 0.612. The sensitivity and specificity for the training set of the three genes model were 100% and 88%, respectively. The sensitivity and specificity for the 10-fold cross validation set of the three genes model were 67% and 65%, respectively, with a relative cost of 0.686. The sensitivity and specificity for the training set of the five genes model were 100% and 94%, respectively. The sensitivity and specificity for the 10-fold cross validation set of the five genes model were 67% and 59%, respectively, with a relative cost of 0.745. Results and models are summarized in FIGS. 4C and F.

Those genes that were found to be useful for classification are noted in Table 10A.

These genes can be used alone or in association with other genes or variables to build a diagnostic gene set or a classification algorithm. These genes can be used in association with known gene markers for lupus (such as those identified in the prior art) to provide a diagnostic algorithm.

Primers for real-time PCR validation were designed for each of the genes as described in Example 15 and are listed in Table 10B.

Surrogates for some of the most useful genes were identified and are listed in Table 10C. Surrogates can be used in addition to or in place of a diagnostic gene in a method of detecting lupus or in diagnostic gene set. For genes that were splitters in CART, surrogates were identified and reported by the software. In these cases, the best available surrogates are listed. For other genes, hierarchical clustering of the data was performed with default settings (x-miner, X-mine, Brisbane, Calif.) and members of gene expression clusters were noted. A cluster was selected that included the gene of interest and the members of that cluster were recorded in Table 10C.

Example 11
Probe Selection for a 24,000 Feature Array

This Example describes the compilation of almost 8,000 unique genes and ESTs using sequences identified from the sources described below. The sequences of these genes and ESTs were used to design probes, as described in the following Example.

Tables 3A, 3B and 3C list the sequences identified in the subtracted leukocyte expression libraries. All sequences that were identified as corresponding to a known RNA transcript were represented at least once, and all unidentified sequences were represented twice—once by the sequence on file and again by the complementary sequence—to ensure that the sense (or coding) strand of the gene sequence was included.

Table 3A. Table 3A contained all those sequences in the subtracted libraries of example 1 that matched sequences in GenBank's nr, EST_Human, and UniGene databases with an acceptable level of confidence. All the entries in the table representing the sense strand of their genes were grouped together and all those representing the antisense strand were grouped. A third group contained those entries whose strand could not be determined. Two complementary probes were designed for each member of this third group.

Table 3B and 3C. Table 3B and 3C contained all those sequences in the leukocyte expression subtracted libraries of example 1 that did not match sequences in GenBank's nr, EST_Human, and UniGene databases with an acceptable level of confidence, but which had a high probability of representing real mRNA sequences. Sequences in Table 3B did not match anything in the databases above but matched regions of the human genome draft and were spatially clustered along it, suggesting that they were exons, rather than genomic DNA included in the library by chance. Sequences in Table 3C also aligned well to regions of the human genome draft, but the aligned regions were interrupted by genomic DNA, meaning they were likely to be spliced transcripts of multiple exon genes.

Table 3B lists 510 clones and Table 3C lists 48 clones that originally had no similarity with any sequence in the public databases. Blastn searches conducted after the initial filing have identified sequences in the public database with high similarity (E values less than 1e-40) to the sequences determined for these clones. Table 3B contained 272 clones and Table 3C contained 25 clones that were found to have high similarity to sequences in dbEST. The sequences of the similar dbEST-clones were used to design probes. Sequences from clones that contained no similar regions to any sequence in the database were used to design a pair of complementary probes.

Probes were designed from database sequences that had the highest similarity to each of the sequenced clones in Tables 3A, 3B, and 3C. Based on BLASTn searches the most similar database sequence was identified by locus number and the locus number was submitted to GenBank using batch Entrez (located at the website ncbi.nlm.nih.gov/entrez/batchentrez.cgi?db=Nucleotide) to obtain the sequence for that locus. The GenBank entry sequence was used because in most cases it was more complete or was derived from multi-pass sequencing and thus would likely have fewer errors than the single pass cDNA library sequences. When only UniGene cluster IDs were available for genes of interest, the respective scquences were extracted from the UniGene_unique database, build 137, downloaded from NCBI (ftp://ncbi.nlm.nih.gov/repository/UniGene/). This database contains one representative sequence for each cluster in UniGene.

Summary of library clones used in array probe design

Table
Sense Strand
Antisnese Strand
Strand Undetermined

3A
3621
763
124

3B
142
130
238

3C
19
6
23

Totals
3782
899
385

Literature Searches

Example 2 describes searches of literature databases. We also searched for research articles discussing genes expressed only in leukocytes or involved in inflammation and particular disease conditions, including genes that were specifically expressed or down-regulated in a disease state. Searches included, but were not limited to, the following terms and various combinations of theses terms: inflammation, atherosclerosis, rheumatoid arthritis, osteoarthritis, lupus, SLE, allograft, transplant, rejection, leukocyte, monocyte, lymphocyte, mononuclear, macrophage, neutrophil, eosinophil, basophil, platelet, congestive heart failure, expression, profiling, microarray, inflammatory bowel disease, asthma, RNA expression, gene expression, granulocyte.

A UniGene cluster ID or GenBank accession number was found for each gene in the list. The strand of the corresponding sequence was determined, if possible, and the genes were divided into the three groups: sense (coding) strand, anti-sense strand, or strand unknown. The rest of the probe design process was carried out as described above for the sequences from the leukocyte subtracted expression library.

Database Mining

Database mining was performed as described in Example 2. In addition, the Library Browser at the NCBI UniGene web site (located on the web at ncbi.nlmn.nih.gov/UniGene/lbrowse.cgi?ORG=Hs&DISPLAY=ALL) was used to identify genes that are specifically expressed in leukocyte cell populations. All expression libraries available at the time were examined and those derived from leukocytes were viewed individually. Each library viewed through the Library Browser at the UniGene web site contains a section titled “Shown below are UniGene clusters of special interest only” that lists genes that are either highly represented or found only in that library. Only the genes in this section were downloaded from each library. Alternatively, every sequence in each library is downloaded and then redundancy between libraries is reduced by discarding all UniGene cluster IDs that are represented more than once. A total of 439 libraries were downloaded, containing 35,819 genes, although many were found in more than one library. The most important libraries from the remaining set were separated and 3,914 genes remained. After eliminating all redundancy between these libraries and comparing the remaining genes to those listed in Tables 3A, 3B and 3C, the set was reduced to 2,573 genes in 35 libraries as shown in Table 4. From these, all genes in first 30 libraries were used to design probes. A random subset of genes was used from Library Lib.376, “Activated_T_cells_XX”. From the last four libraries, a random subset of sequences listed as “ESTs, found only in this library” was used.

Angiozenesis Markers

215 sequences derived from an angiogenic endothelial cell subtracted cDNA library obtained from Stanford University were used for probe design. Briefly, using well known subtractive hybridization procedures, (as described in, e.g., U.S. Pat. Nos. 5,958,738; 5,589,339; 5,827,658; 5,712,127; 5,643,761; 5,565,340) modified to normalize expression by suppressing over-representation of abundant RNA species while increasing representation of rare RNA species, a library was produced that is enriched for RNA species (messages) that are differentially expressed between test (stimulated) and control (resting) HUVEC populations. The subtraction/suppression protocol was performed as described by the kit manufacturer (Clontech, PCR-select cDNA Subtraction Kit).

Pooled primary HUVECs (Clonetics) were cultured in 15% FCS, M199 (GibcoBRL) with standard concentrations of Heparin, Penicillin, Streptomycin, Glutamine and Endothelial Cell Growth Supplement. The cells were cultured on 1% gelatin coated 10 cm dishes. Confluent HUVECs were photographed under phase contrast microscopy. The cells formed a monolayer of flat cells without gaps. Passage 2-5 cells were used for all experiments. Confluent HUVECs were treated with trypsin/EDTA and seeded onto collagen gels. Collagen gels were made according to the protocol of the Collagen manufacturer (Becton Dickinson Labware). Collagen gels were prepared with the following ingredients: Rat tail collagen type I (Collaborative Biomedical) 1.5 mg/mL, mouse laminin (Collaborative Biomedical) 0.5 mg/mL, 10% 10X media 199 (Gibco BRL). 1N NaOH, 10 X PBS and sterile water were added in amounts recommended in the protocol. Cell density was measured by microscopy. 1.2×10⁶cells were seeded onto gels in 6-well, 35 mm dishes, in 5% FCS M199 media. The cells were incubated for 2 hrs at 37 C with 5% CO₂. The media was then changed to the same media with the addition of VEGF (Sigma) at 30 ng/mL media. Cells were cultured for 36 hrs. At 12, 24 and 36 hrs, the cells were observed with phase contrast microscopy. At 36 hours, the cells were observed elongating, adhering to each other and forming lumen structures. At 12 and 24 hrs media was aspirated and refreshed. At 36 hrs, the media was aspirated, the cells were rinsed with PBS and then treated with Collagenase (Sigma) 2.5 mg/mL PBS for 5 min with active agitation until the collagen gels were liquefied. The cells were then centrifuged at 4C, 2000 g for 10 min. The supernatant was removed and the cells were lysed with 1 mL Trizol Reagent (Gibco) per 5×10⁶cells. Total RNA was prepared as specified in the Trizol instructions for use. mRNA was then isolated as described in the micro-fast track mRNA isolation protocol from Invitrogen. This RNA was used as the tester RNA for the subtraction procedure.

Ten plates of resting, confluent, p4 HUVECs, were cultured with 15% FCS in the M199 media described above. The media was aspirated and the cells were lysed with 1 mL Trizol and total RNA was prepared according to the Trizol protocol. mRNA was then isolated according to the micro-fast track mRNA isolation protocol from Invitrogen. This RNA served as the control RNA for the subtraction procedure.

The entire subtraction cloning procedure was carried out as per the user manual for the Clontech PCR Select Subtraction Kit. The cDNAs prepared from the test population of HUVECs were divided into “tester” pools, while cDNAs prepared from the control population of HUVECs were designated the “driver” pool. cDNA was synthesized from the tester and control RNA samples described above. Resulting cDNAs were digested with the restriction enzyme Rsal. Unique double-stranded adapters were ligated to the tester cDNA. An initial hybridization was performed consisting of the tester pools of cDNA (with its corresponding adapter) and an excess of the driver cDNA. The initial hybridization results in a partial normalization of the cDNAs such that high and low abundance messages become more equally represented following hybridization due to a failure of driver/tester hybrids to amplify.

A second hybridization involved pooling unhybridized sequences from the first hybridization together with the addition of supplemental driver cDNA. In this step, the expressed sequences enriched in the two tester pools following the initial hybridization can hybridize. Hybrids resulting from the hybridization between members of each of the two tester pools are then recovered by amplification in a polymerase chain reaction (PCR) using primers specific for the unique adapters. Again, sequences originating in a tester pool that form hybrids with components of the driver pool are not amplified. Hybrids resulting between members of the same tester pool are eliminated by the formation of “panhandles” between their common 5′ and 3′ ends. The subtraction was done in both directions, producing two libraries, one with clones that are upregulated in tube-formation and one with clones that are down-regulated in the process.

The resulting PCR products representing partial cDNAs of differentially expressed genes were then cloned (i.e., ligated) into an appropriate vector according to the manufacturer's protocol (pGEM-Teasy from Promega) and transformed into competent bacteria for selection and screening. Colonies (2180) were picked and cultured in LB broth with 50 ug/mL ampicillin at 37C overnight. Stocks of saturated LB+50 ug/mL ampicillin and 15% glycerol in 96-well plates were stored at −80C. Plasmid was prepared from 1.4 mL saturated LB broth containing 50 ug/mL ampicillin. This was done in a 96 well format using commercially available kits according to the manufacturer's recommendations (Qiagen 96-turbo prep).

2 probes to represent 22 of these sequences required, therefore, a total of 237 probes were derived from this library.

Viral Genes

Several viruses may play a role in a host of disease including inflammatory disorders, atherosclerosis, and transplant rejection. Table 12 lists the viral genes represented by oligonucleotide probes on the microarray. Low-complexity regions in the sequences were masked using RepeatMasker before using them to design probes.

Strand Selection

It was necessary to design sense oligonucleotide probes because the labeling and hybridization protocol to be used with the microarray results in fluorescently-labeled antisense cRNA. All of the sequences we selected to design probes could be divided into three categories:

(1) Sequences known to represent the sense strand
(2) Sequences known to represent the antisense strand
(3) Sequences whose strand could not be easily determined from their descriptions

It was not known whether the sequences from the leukocyte subtracted expression library were from the sense or antisense strand. GenBank sequences are reported with sequence given 5′ to 3′, and the majority of the sequences we used to design probes came from accession numbers with descriptions that made it clear whether they represented sense or antisense sequence. For example, all sequences containing “mRNA” in their descriptions were understood to be the sequences of the sense mRNA, unless otherwise noted in the description, and all IMAGE Consortium clones are directionally cloned and so the direction (or sense) of the reported sequence can be determined from the annotation in the GenBank record.

For accession numbers representing the sense strand, the sequence was downloaded and masked and a probe was designed directly from the sequence. These probes were selected as close to the 3′ end as possible. For accession numbers representing the antisense strand, the sequence was downloaded and masked, and a probe was designed complementary to this sequence. These probes were designed as close to the 5′ end as possible (i.e., complementary to the 3′ end of the sense strand).

Minimizing Probe Redundancy.

Multiple copies of certain genes or segments of genes were included in the sequences from each category described above, either by accident or by design. Reducing redundancy within each of the gene sets was necessary to maximize the number of unique genes and ESTs that could be represented on the microarray.

Three methods were used to reduce redundancy of genes, depending on what information was available. First, in gene sets with multiple occurrences of one or more UniGene numbers, only one occurrence of each UniGene number was kept. Next, each gene set was searched by GenBank accession numbers and only one occurrence of each accession number was conserved. Finally, the gene name, description, or gene symbol were searched for redundant genes with no UniGene number or different accession numbers. In reducing the redundancy of the gene sets, every effort was made to conserve the most information about each gene.

We note, however, that the UniGene system for clustering submissions to GenBank is frequently updated and UniGene cluster IDs can change. Two or more clusters may be combined under a new cluster ID or a cluster may be split into several new clusters and the original cluster ID retired. Since the lists of genes in each of the gene sets discussed were assembled at different times, the same sequence may appear in several different sets with a different UniGene ID in each.

Sequences from Table 3A were treated differently. In some cases, two or more of the leukocyte subtracted expression library sequences aligned to different regions of the same GenBank entry, indicating that these sequences were likely to be from different exons in the same gene transcript. In these cases, one representative library sequence corresponding to each presumptive exon was individually listed in Table 3A.

Compilation.

After redundancy within a gene set was sufficiently reduced, a table of approximately 8,000 unique genes and ESTs was compiled in the following manner. All of the entries in Table 3A were transferred to the new table. The list of genes produced by literature and database searches was added, eliminating any genes already contained in Table 3A. Next, each of the remaining sets of genes was compared to the table and any genes already contained in the table were deleted from the gene sets before appending them to the table.

Probes

Subtracted Leukocyte Expression Library

Table 3A
4,872

Table 3B
796

Table 3C
85

Literature Search Results
494

Database Mining
1,607

Viral genes

a. CMV
14

b. EBV
6

c. HHV 6
14

d. Adenovirus
8

Angiogenesis markers: 215, 22 of which needed two probes
237

Arabidopsis thaliana genes
10

Total sequences used to design probes
8,143

Example 12
Design of Oligonucleotide Probes

By way of example, this section describes the design of four oligonucleotide probes using Array Designer Ver 1.1 (Premier Biosoft International, Palo Alto, Calif.). The major steps in the process are given first.

1) Obtain best possible sequence of mRNA from GenBank. If a full-length sequence reference sequence is not available, a partial sequence is used, with preference for the 3′ end over the 5′ end. When the sequence is known to represent the antisense strand, the reverse complement of the sequence is used for probe design. For sequences represented in the subtracted leukocyte expression library that have no significant match in GenBank at the time of probe design, our sequence is used.

2) Mask low complexity regions and repetitive elements in the sequence using an algorithm such as RepeatMasker.

3) Use probe design software, such as Array Designer, version 1.1, to select a sequence of 50 residues with specified physical and chemical properties. The 50 residues nearest the 3′ end constitute a search frame. The residues it contains are tested for suitability. If they don't meet the specified criteria, the search frame is moved one residue closer to the 5′ end, and the 50 residues it now contains are tested. The process is repeated until a suitable 50-mer is found.

4) If no such 50-mer occurs in the sequence, the physical and chemical criteria are adjusted until a suitable 50-mer is found.

5) Compare the probe to dbEST, the UniGene cluster set, and the assembled human genome using the BLASTn search tool at NCBI to obtain the pertinent identifying information and to verify that the probe does not have significant similarity to more than one known gene.

Clone 40H12

Clone 40H12 was sequenced and compared to the nr, dbEST, and UniGene databases at NCBI using the BLAST search tool. The sequence matched accession number NM_—002310, a ‘curated RefSeq project’ sequence, see Pruitt et al. (2000) Trends Genet. 16:44-47, encoding leukemia inhibitory factor receptor (LIFR) mRNA with a reported E value of zero. An E value of zero indicates there is, for all practical purposes, no chance that the similarity was random based on the length of the sequence and the composition and size of the database. This sequence, cataloged by accession number NM_—002310, is much longer than the sequence of clone 40H 12 and has a poly-A tail. This indicated that the sequence cataloged by accession number NM_—002310 is the sense strand and a more complete representation of the mRNA than the sequence of clone 40H 12, especially at the 3′ end. Accession number “NM_—002310” was included in a text file of accession numbers representing sense strand mRNAs, and sequences for the sense strand mRNAs were obtained by uploading a text file containing desired accession numbers as an Entrez search query using the Batch Entrez web interface and saving the results locally as a FASTA file. The following sequence was obtained, and the region of alignment of clone 40H12 is outlined:
embedded image

The FASTA file, including the sequence of NM_—002310, was masked using the RepeatMasker web interface (Smit, AFA & Green, P RepeatMasker at genome.washington.edu/RM/RepeatMasker.html, Smit and Green). Specifically, during masking, the following types of sequences were replaced with “N's”: SINE/MIR & LINE/L2, LINE/L1, LTR/MaLR, LTR/Retroviral, Alu, and other low informational content sequences such as simple repeats. Below is the sequence following masking:
embedded image

The length of this sequence was determined using batch, automated computational methods and the sequence, as sense strand, its length, and the desired location of the probe sequence near the 3′ end of the mRNA was submitted to Array Designer Ver 1.1 (Premier Biosoft International, Palo Alto, Calif.). Search quality was set at 100%, number of best probes set at 1, length range set at 50 base pairs, Target Tm set at 75 C. degrees plus or minus 5 degrees, Hairpin max deltaG at 6.0-kcal/mol., Self dimmer max deltaG at 6.0-kcal/mol, Run/repeat (dinucleotide) max length set at 5, and Probe site minimum overlap set at 1. When none of the 49 possible probes met the criteria, the probe site would be moved 50 base pairs closer to the 5′ end of the sequence and resubmitted to Array Designer for analysis. When no possible probes met the criteria, the variation on melting temperature was raised to plus and minus 8 degrees and the number of identical basepairs in a run increased to 6 so that a probe sequence was produced.

In the sequence above, using the criteria noted above, Array Designer Ver 1.1 designed a probe corresponding to oligonucleotide number 2280 in Table 8 and is indicated by underlining in the sequence above. It has a melting temperature of 68.4 degrees Celsius and a max run of 6 nucleotides and represents one of the cases where the criteria for probe design in Array Designer Ver 1.1 were relaxed in order to obtain an oligonucleotide near the 3′ end of the mRNA (Low melting temperature was allowed).

Clone 463D12

Clone 463D12 was sequenced and compared to the nr, dbEST, and UniGene databases at NCBI using the BLAST search tool. The sequence matched accession number A 184553, an EST sequence with the definition line “qd60a05.x1 Soares_testis_NHT Homo sapiens cDNA clone IMAGE:1733840 3′ similar to gb:M29550 PROTEIN PHOSPHATASE 2B CATALYTIC SUBUNIT 1 (HUMAN); mRNA sequence.” The E value of the alignment was 1.00×10⁻¹¹⁸. The GenBank sequence begins with a poly-T region, suggesting that it is the antisense strand, read 5′ to 3′. The beginning of this sequence is complementary to the 3′ end of the mRNA sense strand. The accession number for this sequence was included in a text file of accession numbers representing antisense sequences. Sequences for antisense strand mRNAs were obtained by uploading a text file containing desired accession numbers as an Entrez search query using the Batch Entrez web interface and saving the results locally as a FASTA file. The following sequence was obtained, and the region of alignment of clone 463D12 is outlined:
embedded image

The FASTA file, including the sequence of AA184553, was then masked using the RepeatMasker web interface, as shown below. The region of alignment of clone 463D12 is outlined.
embedded image

The sequence was submitted to Array Designer as described above, however, the desired location of the probe was indicated at base pair 50 and if no probe met the criteria, moved in the 3′ direction. The complementary sequence from Array Designer was used, because the original sequence was antisense. The oligonucleotide designed by Array Designer corresponds to oligonucleotide number 4342 in Table 8 and is complementary to the underlined sequence above. The probe has a melting temperature of 72.7 degrees centigrade and a max run of 4 nucleotides.

Clone 72D4

Clone 72D4 was sequenced and compared to the nr, dbEST, and UniGene databases at NCBI using the BLAST search tool. No significant matches were found in any of these databases. When compared to the human genome draft, significant alignments were found to three consecutive regions of the reference sequence NT_—008060, as depicted below, suggesting that the insert contains three spliced exons of an unidentified gene.

Residue Numbers on Matching Residue

clone 72D4 sequence numbers on NT_008060

1-198
478646-478843

197-489
479876-480168

491-585
489271-489365

Because the reference sequence contains introns and may represent either the coding or noncoding strand for this gene, BioCardia's own sequence file was used to design the oligonucleotide. Two complementary probes were designed to ensure that the sense strand was represented. The sequence of the insert in clone 72D4 is shown below, with the three putative exons outlined.
embedded image

The sequence was submitted to RepeatMasker, but no repetitive sequences were found. The sequence shown above was used to design the two 50-mer probes using Array Designer as described above. The probes are shown in bold typeface in the sequence depicted below. The probe in the sequence is oligonucleotide number 6415 (SEQ ID NO: 6415) in Table 8 and the complementary probe is oligonucleotide number 6805 (SEQ ID NO:6805).

CAGGTCACACAGCACATCAGTGGCTACATGTGAGCTCAGACCTGGGTCTGCTGCTGTCTGTCTTCCC

AATATCCATGACCTTGACTGATGCAGGTGTCTAGGGATACGTCCATCCCCGTCCTGCTGGAGCCCAG

AGCACGGAAGCCTGGCCCTCCGAGGAGACAGAAGGGAGTGTCGGACACCATGACGAGAGCTTGGCAG

AATAAATAACTTCTTTAAACAATTTTACGGCATGAAGAAATCTGGACCAGTTTATTAAATGGGATTT

CTGCCACAAACCTTGGAAGAATCACATCATCTTANNCCCAAGTGAAAACTGTGTTGCGTAACAAAGA

ACATGACTGCGCTCCACACATACATCATTGCCCGGCGAGGCGGGACACAAGTCAACGACGGAACACT

TGAGACAGGCCTACAACTGTGCACGGGTCAGAAGCAAGTTTAAGCCATACTTGCTGCAGTGAGACTA

CATTTCTGTCTATAGAAGATACCTGACTTGATCTGTTTTTCAGCTCCAGTTCCCAGATGTGC--->

<----3′-GTCAAGGGTCTACAC

GTGTTGTGGTCCCCAAGTATCACCTTCCAATTTCTGGGAG--->

CACAACACCAGGGGTTCATAGTGGAAGGTTAAAG-5′(SEQ ID NO:6805))

CAGTGCTCTGGCCGGATCCTTGCCGCGCGGATAAAAACT---->(end of SEQ ID:8545)

Confirmation of Probe Sequence

Following probe design, each probe sequence was confirmed by comparing the sequence against dbEST, the UniGene cluster set, and the assembled human genome using BLASTn at NCBI. Alignments, accession numbers, gi numbers, UniGene cluster numbers and names were examined and the most common sequence used for the probe. The final probe set was compiled into Table 8. In this table, the sequence ID is given which corresponds to the sequence listing. The origin of the sequence for inclusion on the array is noted as coming from one of the cDNA libraries described in example 1, mining from databases as described in examples 2 and 11 or identification from the published literature. The unigene number, genebank accession and GI number are also given for each sequence when known. The name of the gene associated with the accession number is noted. The strand is noted as −1 or 1, meaning that the probe was designed from the complement of the sequence (−1) or directly from the sequence (1). Finally, the nucleotide sequence of each probe is also given.

Example 13
Production of an Array of 8000 Spotted 50mer Oligonucleotides

We produced an array of 8000 spotted 50mer oligonucleotides. Examples 11 and 12 exemplify the design and selection of probes for this array.

Sigma-Genosys (The Woodlands, Tex.) synthesized un-modified 50-mer oligonucleotides using standard phosphoramidite chemistry, with a starting scale of synthesis of 0.05 μmole (see, e.g., R. Meyers, ed. (1995) Molecular Biology and Biotechnology: A Comprehensive Desk Reference). Briefly, to begin synthesis, a 3′ hydroxyl nucleoside with a dimethoxytrityl (DMT) group at the 5′ end was attached to a solid support. The DMT group was removed with trichloroacetic acid (TCA) in order to free the 5′-hydroxyl for the coupling reaction. Next, tetrazole and a phosphoramidite derivative of the next nucleotide were added. The tetrazole protonates the nitrogen of the phosphoramidite, making it susceptible to nucleophilic attack. The DMT group at the 5′-end of the hydroxyl group blocks further addition of nucleotides in excess. Next, the inter-nucleotide linkage was converted to a phosphotriester bond in an oxidation step using an oxidizing agent and water as the oxygen donor. Excess nucleotides were filtered out and the cycle for the next nucleotide was started by the removal of the DMT protecting group. Following the synthesis, the oligo was cleaved from the solid support. The oligonucleotides were desalted, resuspended in water at a concentration of 100 or 200 μM, and placed in 96-deep well format. The oligonucleotides were re-arrayed into Whatman Uniplate 384-well polyproylene V bottom plates. The oligonucleotides were diluted to a final concentration 30 μM in 1X Micro Spotting Solution Plus (Telechem/arrayit.com, Sunnyvale, Calif.) in a total volume of 15)μl. In total, 8,031 oligonucleotides were arrayed into twenty-one 384-well plates.

Arrays were produced on Telechem/arrayit.com Super amine glass substrates (Telechem/arrayit.com), which were manufactured in 0.1 mm filtered clean room with exact dimensions of 25×76×0.96 mm. The arrays were printed using the Virtek Chipwriter with a Telechem 48 pin Micro Spotting Printhead. The Printhead was loaded with 48 Stealth SMP3B TeleChem Micro Spotting Pins, which were used to print oligonucleotides onto the slide with the spot size being 110-115 microns in diameter.

Example 14
Amplification, Labeling, and Hybridization of Total RNA to an Oligonucleotide Microarray

Amplification, Labeling, Hybridization and Scanning

Samples consisting of at least 2 μg of intact total RNA were further processed for array hybridization. Amplification and labeling of total RNA samples was performed in three successive enzymatic reactions. First, a single-stranded DNA copy of the RNA was made (hereinafter, “ss-cDNA”). Second, the ss-cDNA was used as a template for the complementary DNA strand, producing double-stranded cDNA (hereinafter, “ds-cDNA, or cDNA”). Third, linear amplification was performed by in vitro transcription from a bacterial T₇promoter. During this step, fluorescent-conjugated nucleotides were incorporated into the amplified RNA (hereinafter, “aRNA”).

The first strand cDNA was produced using the Invitrogen kit (Superscript II). The first strand cDNA was produced in a reaction composed of 50 mM Tris-HCl (pH 8.3), 75 mM KCl, and 3 mM MgCl₂(1×First Strand Buffer, Invitrogen), 0.5 mM dGTP, 0.5 mM DATP, 0.5 mM dTTP, 0.5 mM dCTP, 10 mM DTT, 10 U reverse transcriptase (Superscript II, Invitrogen, #18064014), 15 U RNase inhibitor (RNAGuard, Amersham Pharmacia, #27-0815-01), 5 μM T7T24 primer (5′-GGCCAGTGAATIGTAATACGACTCACTATAGGGAGGCCGGTTTTTTTTTTT TTTTTTTTTTTT-3′), (SEQ ID NO:8831) and 2 μg of selected sample total RNA. Several purified, recombinant control mRNAs from the plant Arabidopsis thaliana were added to the reaction mixture: 2-20 pg of the following genes CAB, RCA, LTP4, NAC1, RCP1,XCP2, RBCL, LTP6, TIM, and PRKase (Stratagene, #252201, #252202, #252204, #252208, #252207, #252206, #252203, #252205, #252209, #252210 respectively). The control RNAs allow the estimate of copy numbers for individual mRNAs in the clinical sample because corresponding sense oligonucleotide probes for each of these plant genes are present on the microarray. The final reaction volume of 20 μl was incubated at 42° C. for 60 min.

For synthesis of the second cDNA strand, DNA polymerase and RNase were added to the previous reaction, bringing the final volume to 150 μl. The previous contents were diluted and new substrates were added to a final concentration of 20 mM Tris-HCl (pH 7.0) (Fisher Scientific, Pittsburgh, Pa. #BP1756-100), 90 mMKCl (Teknova, Half Moon Bay, Calif., #0313-500), 4.6 mM MgCl₂(Tcknova, Half Moon Bay, Calif., #0304-500), 10 mM(NH₄)₂SO₄(Fisher Scientific #A702-500)(1×Second Strand buffer, Invitrogen), 0.266 mM dGTP, 0.266 mM dATP, 0.266 mM dTTP, 0.266 mM dCTP, 40 U E. coli DNA polymerase (Invitrogen, #18010-025), and 2 U RNaseH (Invitrogen, #18021-014). The second strand synthesis took place at 16° C. for 120 minutes.

Following second-strand synthesis, the ds-cDNA was purified from the enzymes, dNTPs, and buffers before proceeding to amplification, using phenol-chloroform extraction followed by ethanol precipitation of the cDNA in the presence of glycogen.

Alternatively, a silica-gel column is used to purify the cDNA (e.g. Qiaquick PCR cleanup from Qiagen, #28104). The cDNA was collected by centrifugation at >10,000×g for 30 minutes, the supernatant is aspirated, and 150 μl of 70% ethanol, 30% water was added to wash the DNA pellet. Following centrifugation, the supernatant was removed, and residual ethanol was evaporated at room temperature.

Linear amplification of the cDNA was performed by in vitro transcription of the cDNA. The cDNA pellet from the step described above was resuspended in 7.4 μl of water, and in vitro transcription reaction buffer was added to a final volume of 20 μl containing 7.5 mM GTP, 7.5 mM ATP, 7.5 mM TTP, 2.25 mM CTP, 1.025 mM Cy3-conjugated CTP (Perkin Elmer; Boston, Mass., #NEL-580), 1x reaction buffer (Ambion, Megascript Kit, Austin, Tex. and #1334) and 1% T₇polymerase enzyme mix (Ambion, Megascript Kit, Ausfin, Tex. and #1334). This reaction was incubated at 37° C. overnight. Following in vitro transcription, the RNA was purified from the enzyme, buffers, and excess NTPs using the RNeasy kit from Qiagen (Valencia, Calif.; # 74106) as described in the vendor's protocol. A second elution step was performed and the two eluates were combined for a final-volume of 60 μl. RNA is quantified using an Agilent 2100 bioanalyzer with the RNA 6000 nano LabChip.

Reference RNA was prepared as described above, except Cy5-CTP was incorporated instead of Cy3CTP. Reference RNA from five reactions, each reaction started with 2 ug total RNA, was pooled together and quantitated as described above.

Hybridization to an Array

RNA was prepared for hybridization as follows: for an 18 mm×55 mm array, 20 μg of amplified RNA (aRNA) was combined with 20 μg of reference aRNA. The combined sample and reference aRNA was concentrated by evaporating the water to 10 μl in a vacuum evaporator. The sample was fragmented by heating the sample at 95° C. for 30 minutes to fragment the RNA into 50-200 bp pieces. Alternatively, the combined sample and reference aRNA was concentrated by evaporating the water to 5 μl in a vacuum evaporator. Five μl of 20 mM zinc acetate was added to the aRNA and the mix incubated at 60° C. for 10 minutes. Following fragmentation, 40 μl of hybridization buffer was added to achieve final concentrations of 5×SSC and 0.20% SDS with 0.1 μg/μl of Cot-1 DNA (Invitrogen) as a competitor DNA. The final hybridization mix was heated to 98° C., and then reduced to 50° C. at 0.1° C. per second.

Alternatively, formamide is included in the hybridization mixture to lower the hybridization temperature.

The hybridization mixture was applied to a pre-heated 65° C. microarray, surface, covered with a glass coverslip (Corning, #2935-246), and placed on a pre-heated 65° C. hybridization chamber (Telechem, AHC-10). 15 ul of 5×SSC was placed in each of the reservoir in the hybridization chamber and the chamber was scaled and placed in a water bath at 62° C. for overnight (16-20 hrs). Following incubation, the slides were washed in 2×SSC, 0.1% SDS for five minutes at 30° C., then in 2×SSC for five minutes at 30° C., then in 2×SSC for another five minutes at 30° C., then in 0.2×SSC for two minutes at room temperature. The arrays were spun at 1000×g for 2 minutes to dry them. The dry microarrays are then scanned by methods described above.

The microarrays were imaged on the Agilent (Palo Alto, Calif.) scanner G2565AA. The scan settings using the Agilent software were as follows: for the PMT Sensitivity (100% Red and 100% Green); Scan Resolution (10 microns); red and green dye channels; used the default scan region for all slides in the carousel; using the largest scan region; scan date for Instrument ID; and barcode for Slide ID. The full image produced by the Agilent scanner was flipped, rotated, and split into two images (one for each signal channel) using TIFFSplitter (Agilent, Palo Alto, Calif.). The two channels are the output at 532 nm (Cy3-labeled sample) and 633 nm (Cy5-labeled R50). The individual images were loaded into GenePix 3.0 (Axon Instruments, Union City, Calif.) for feature extraction, each image was assigned an excitation wavelength corresponding the file opened; Red equals 633 nm and Green equals 532 mm. The setting file (gal) was opened and the grid was laid onto the image so that each spot in the grid overlaped with >50% of the feature. Then the GenePix software was used to find the features without setting minimum threshold value for a feature. For features with low signal intensity, GenePix reports “not found”. For all features, the diameter setting was adjusted to include only the feature if necessary.

The GenePix software determined the median pixel intensity for each feature (F_i) and the median pixel intensity of the local background for each feature (B_i) in both channels. The standard deviation (SDF_{i and}and SDB_i) for each is also determined. Features for which GenePix could not discriminate the feature from the background were “flagged” as described below.

Following feature extraction into a .gpr file, the header information of the .gpr file was changed to carry accurate information into the database. An Excel macro was written to change the headers. The steps in that macro were:

- 1. Open .gpr file.
- 2. Check the value in the first row, first column. If it is “ATF”, then the header has likely already been reformatted. The file is skipped and the user is alerted. Otherwise, proceed through the following steps.
- 3. Store the following values in variables.
  - a. Name of .tif image file: parsed from row 11.
  - b. SlideD: parsed from name of .tif image file.
  - c. Version of the feature extraction software: parsed from row 25
  - d. GenePix Array List file: parsed from row 6
  - e. GenePix Settings file: parsed from row 5
- 4. Delete rows 1-8, 10-12, 20, 22, and 25.
- 5. Arrange remaining values in rows 15-29.
- 6. Fill in rows 1-14 with the following:
  - Row 1: ScanID (date image file was last modified, formatted as yyyy.mm.dd-hh.mm.ss)
  - Row 2: SlideID, from stored value
  - Row 3: Name of person who scanned the slide, from user input
  - Row 4: Image file name, from stored value
  - Row 5: Green PMT setting, from user input
  - Row 6: Red PMT setting, from user input
  - Row 7: ExtractID (date .gpr file was created, formatted as yyyy.mm.dd-hh.mm.ss)
  - Row 8: Name of person who performed the feature extraction, from user input
  - Row 9: Feature extraction software used, from stored value
  - Row 10: Results file name (same as the .gpr file name)
  - Row 11: GenePix Array List file, from stored value
  - Row 12: GenePix Settings file, from stored value
  - Row 13: StorageCD, currently left blank
  - Row 14: Extraction comments, from user input (anything about the scanning or feature extraction of the image the user feels might be relevant when selecting which hybridizations to include in an analysis)
    
    Pre-Processing with Excel Templates

Following analysis of the image and extraction of the data, the data from each hybridization was pre-processed to extract data that was entered into the database and subsequently used for analysis. The complete GPR file produced by the feature extraction in GenePix was imported into an excel file pre-processing template. The same excel template was used to process each GPR file. The template performs a series of calculations on the data to differentiate poor features from others and to combine triplicate feature data into a single data point for each probe.

Each GPR file contained 31 rows of header information, followed by rows of data for 24093 features. The last of these rows was retained with the data. Rows 31 through the end of the file were imported into the excel template. Each row contained 43 columns of data. The only columns used in the pre-processing were: Oligo ID, F633 Median (median value from all the pixels in the feature for the Cy5 dye), B633 Median (the median value of all the pixels in the local background of the selected feature for Cy5), B633 SD (the standard deviation of the values for the pixels in the local background of the selected feature for Cy5), F532 Median (median value from all the pixels in the feature for the Cy3 dye), B532 Median (the median value of all the pixels in the local background of the selected feature for Cy3), B532 SD (the standard deviation of the values for the pixels in the local background of the selected feature for Cy3), and Flags. The GenePix Flags column contains the flags set during feature extraction. “−75” indicates there were no features printed on the array in that position, “−50” indicates that GenePix could not differentiate the feature signal from the local background, and “−100” indicates that the user marked the feature as bad.

Once imported, the rows with −75 flags were deleted. Then the median of B633 SD and B532 SD were calculated over all features with a flag value of “0”. The minimum values of B633 Median and B532 Median were identified, considering only those values associated with a flag value of “0”. For each feature, the signal to noise ratio (S/N) was calculated for both dyes by taking the fluorescence signal minus the local background (BGSS) and dividing it by the standard deviation of the local background:
$S / N = \frac{F_{i} - B_{i}}{{SDB}_{i}}$

If the S/N was less than 3, then an adjusted background-subtracted signal was calculated as the fluorescence minus the minimum local background on the slide. An adjusted SIN was then calculated as the adjusted background subtracted signal divided by the median noise over all features for that channel. If the adjusted S/N was greater than three and the original S/N were less than three, a flag of 25 was set for the Cy5 channel, a flag of 23 was set for the Cy3 channel, and if both met these criteria, then a flag of 20 was set. If both the adjusted S/N and the original S/N were less than three, then a flag of 65 was set for Cy5, 63 set for Cy3, and 60 set if both dye channels had an adjusted S/N less than three. All signal to noise calculations, adjusted background-subtracted signal, and adjusted S/N were calculated for each dye channel. If the BGSS value was greater than or equal to 64000, a flag was set to indicate saturation; 55 for Cy5, 53 for Cy3, 50 for both.

The BGSS used for further calculations was the original BGSS if the original S/N was greater than or equal to three. If the original S/N ratio was less than three and the adjusted S/N ratio was greater than or equal to three, then the adjusted BGSS was used. If the adjusted S/N ratio was less than three, then the adjusted BGSS was used, but with knowledge of the flag status.

To facilitate comparison among arrays, the Cy3 and Cy5 data were scaled to have a median of 1. For each dye channel, the median value of all features with flags=0,20,23, or 25 was calculated. The BGSS for each dye in each feature was then divided by this median value. The Cy3/Cy5 ratio was calculated for each feature using the scaled
$R_{n} = \frac{{Cy3S}_{i}}{{Cy5S}_{i}}$

The flag setting for each feature was used to determine the expression ratio for each probe, a combination of three features. If all three features had flag settings in the same category (categories=negatives, 0 to 25, 50-55, and 60-65), then the average and CV of the three feature ratios was calculated. If the CV of all three features was less than 15, the average was used. If the CV was greater than 15, then the CV of each combination of two of the features was calculated and the two features with the lowest CV were averaged. If none of the combinations of two features had a CV less than 15, then the median ratio of the three features was used as the probe feature.

If the three features do not have flags in the same category, then the features with the best quality flags were used (0>25>23>20>55>53>50>65>63>60). Features with negative flags were never used. When the best flags were two features in the samc category, the average was used. If a single feature had a better flag category than the other two then that feature was used.

Once the probe expression ratio was calculated from the three features, the log of the ratio was taken as described below and stored for use in analyzing the data. Whichever features were used to calculate the probe value, the worst of the flags from those features was carried forward and stored as the flag value for that probe. 2 different data sets can be used for analysis. Flagged data uses all values, including those with flags. Filtered data sets are created by removing flagged data from the set before analysis.

Example 15
Real-Time PCR Validation of Array Expression Results

In example 10, leukocyte gene expression was used to discover expression markers and diagnostic gene sets for clinical outcomes. It is desirable to validate the gene expression results for each gene using a more sensitive and quantitative technology such as real-time PCR. Further, it is possible for the diagnostic nucleotide sets to be implemented as a diagnostic test as a real-time PCR panel. Alternatively, the quantitative information provided by real-time PCR validation can be used to design a diagnostic test using any alternative quantitative or semi-quantitative gene expression technology.

To validate the results of the microarray experiments we used real-time, or kinetic, PCR. In this type of experiment the amplification product is measured during the PCR reaction. This enables the researcher to observe the amplification before any reagent becomes rate limiting for amplification. In kinetic PCR the measurement is of C_T(threshold cycle) or C_P(crossing point). This measurement (C_T=C_P) is the point at which an amplification curve crosses a threshold fluorescence value. The threshold is set to a point within the area where all of the reactions were in their linear phase of amplification. When measuring C_T, a lower C_Tvalue is indicative of a higher amount of starting material since an earlier cycle number means the threshold was crossed more quickly.

Several fluorescence methodologies are available to measure amplification product in real-time PCR. Taqman (Applied BioSystems, Foster City, Calif.) uses fluorescence resonance energy transfer (FRET) to inhibit signal from a probe until the probe is degraded by the sequence specific binding and Taq 3′ exonuclease activity. Molecular Beacons (Stratagene, La Jolla, Calif.) also use FRET technology, whereby the fluorescence is measured when a hairpin structure is relaxed by the specific probe binding to the amplified DNA. The third commonly used chemistry is Sybr Green, a DNA-binding dye (Molecular Probes, Eugene, Oreg.). The more amplified product that is produced, the higher the signal. The Sybr Green method is sensitive to non-specific amplification products, increasing the importance of primer design and selection. Other detection chemistries can also been used, such as ethedium bromide or other DNA-binding dyes and many modifications of the fluorescent dye/quencher dye Taqman chemistry, for example scorpions.

Initially, samples are chosen for validation, which have already been used for microarray based expression analysis. They are also chosen to represent important disease classes or disease criteria. For the first steps of this example (primer design, primer endpoint testing, and primer efficiency testing) we examined β-actin and β-GUS. These genes are considered “housekeeping” genes because they are required for maintenance in all cells. They are commonly used as a reference that is expected to not change with experimental treatment. We chose these two particular genes as references because they varied the least in expression across 5 mRNA samples examined by real-time PCR.

The inputs for real time PCR reaction are gene-specific primers, cDNA from specific patient samples, and the standard reagents. The cDNA was produced from mononuclear RNA (prepared as in example 7) by reverse transcription using OligodT primers (Invitrogen, 18418-012) and random hexamers (Invitrogen, 48190-011) at a final concentration of 0.5 ng/lp and 3 ng/μl respectively. For the first strand reaction mix, 1.45 μg/μl of total RNA (R50, universal leukocyte reference RNA as described in Example 8) and 1 μl of the Oligo dT/Random Hexamer Mix, were added to water to a final volume of 11.5 s. The sample mix was then placed at 70° C. for 10 minutes. Following the 70° C. incubation, the samples were chilled on ice, spun down, and 88.5 μl of first strand buffer mix dispensed into the reaction tube. The final first strand buffer mix produced final concentrations of 1X first strand buffer (Invitrogen, Y00146, Carlsbad, Calif.), 0.01 mM DTT (Invitrogen, Y00147), 0.1 mM dATP (NEB, N0440S, Beverly, Mass.), 0.1 mM dGTP (NEB, N0442S), 0.1 mM dATP (NEB, N0443S), 0.1 mM dCTP (NEB, N0441S), 2U of reverse transcriptase (Superscript II, Invitrogen, 18064-014), and 0.18U of RNase inhibitor (RNAGaurd Amersham Pharmacia, 27-0815-01, Piscataway, N.J.). The reaction was incubated at 42° C. for 1 hour. After incubation the enzyme was heat inactivated at 70° C. for 15 minutes, 1 μl of RNAse H added to the reaction tube, and incubated at 37° C. for 20 minutes.

Primer Design

Two methods were used to design primers. The first was to use the software, Primer Express™ and recommendations for primer design that are provided with the GeneAmp® 7700 Sequence Detection System supplied by Applied BioSystems (Foster City, Calif.). The second method used to design primers was the PRIMER3 ver 0.9 program that is available from the Whitehead Research Institute, Cambridge, Mass. The program can also be accessed on the World Wide Web at: genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi. Primers and Taqman/hybridization probes were designed as described below using both programs.

The Primer Express literature explains that primers should be designed with a melting temperature between 58 and 60 degrees C. while the Taqman probes should have a melting temperature of 68 to 70 under the salt conditions of the supplied reagents. The salt concentration is fixed in the software. Primers should be between 15 and 30 basepairs long. The primers should produce and ampricon in size between 50 and 150 base pairs, have a C-G content between 20% and 80%, have no more than 4 identical base pairs next to one another, and no more than 2 C's and G's in the last 5 bases of the 3′ end. The probe cannot have a G on the 5′ end and the strand with the fewest G's should be used for the probe.

Primer3 has a large number of parameters. The defaults were used for all except for melting temperature and the optimal size of the amplicon was set at 100 bases. One of the most critical is salt concentration as it affects the melting temperature of the probes and primers. In order to produce primers and probes with melting temperatures equivalent to Primer Express, a number of primers and probes designed by Primer Express were examined using PRIMER3. Using a salt concentration of 50 mM these primers had an average melting temperature of 3.7 degrees higher than predicted by Primer Express. In order to design primers and probes with equivalent melting temperatures as Primer Express using PRIMER3, a melting temperature of 62.7 plus/minus 1.0 degree was used in PRIMER3 for primers and 72.7 plus/minus 1.0 degrees for probes with a salt concentration of 50 mM.

The C source code for Primer3 was downloaded and complied on a Sun Enterprise 250 server using the GCC complier. The program was then used from the command line using a input file that contained the sequence for which we wanted to design primers and probes along with the input parameters as described by help files that accompany the software. Using scripting it was possible to input a number of sequences and automatically generate a number of possible probes and primers.

Primers for β-Actin (Beta Actin, Genbank Locus: NM_—0010) and β-GUS: glucuronidase, beta, (GUSB, Genbank Locus: NM_—000181), two reference genes, were designed using both methods and are shown here as examples.

The first step was to mask out repetitive sequences found in the mRNA sequences using RepeatMasker program that can be accessed at the web site located at repeatmasker.genome.washington.edu/cgi-bin/RepeatMasker (Smit, AFA & Green, P “RepeatMasker” at the web site located at

ftp.genome.washington.edu/RM/RepeatMasker.html).

The last 500 basepairs on the last 3′ end of masked sequence was then submitted to PRIMER3 using the following exemplary input file:

PRIMER_SEQUENCE_ID=>ACTB Beta Actin

PRIMER_EXPLAIN_FLAG=1

PRIMER_MISPRIMING_LIBRARY=

SEQUENCE=TTGGCTTGACTCAGGATTTAAAAACTGGAACGGTGAAGGTGACAGCAGTCGGTTGGACGAGC

ATCCCCCAAAGTTCACAATGTGGCCGAGGACTTTGATTGCACATTGTTGTTTTTTAATAGTCATTCCAAAT

ATGAGATGCATTGTTACAGGAAGTCCCTTGCCATCCTAAAAGCACCCCACTTCTCTCTAAGGAGAATGGCC

CAGTCCTCTCCCAAGTCCACACAGGGGAGGGATAGCATTGCTTTCGTGTAAATTATGTAATGCAAAATTTT

TTTAATCTTCGCCTTAATCTTTTTTATTTTGTTTTATTTTGAATGATGAGCCTTCGTGCCCCCCCTTCCCC

CTTTTTTCCCCCAACTTGAGATGTATGAAGGCTTTTGGTCTCCCTGGGAGTGGGTGGAGGCAGCCGGGCTT

ACCTGTACACTGACTTGAGACCAGTTGAATAAAAGTGCACACCTTA (SEQ ID NO: 8833)

PRIMER_PRODUCT_OPT_SIZE=100

PRIMER_NUM_RETURN=100

PRIMER_MAX_END_STABILITY=9.0

PRIMER_MAX_MISPRIMING=12.00

PRIMER_PAIR_MAX_MISPRIMING=24.00

PRIMER_MIN_SIZE=18

PRIMER_OPT_SIZE=20

PRIMER_MAX_SIZE=32

PRIMER_MIN_TM=61.7

PRIMER_OPT_TM=62.7

PRIMER_MAX_TM=63.7

PRIMER_MAX_DIFF_TM=100.0

PRIMER_MIN_GC=20.0

PRIMER_MAX_GC=80.0

PRIMER_SELF_ANY=8.00

PRIMER_SELF_END=3.00

PRIMER_NUM_NS_ACCEPTED=0

PRIMER_MAX_POLY_X=4

PRIMER_OUTSIDE_PENALTY=0

PRIMER_GC_CLAMP=0

PRIMER_SALT_CONC=50.0

PRIMER_DNA_CONC=50.0

PRIMER_LIBERAL_BASE=1

PRIMER_MIN_QUALITY=0

PRIMER_MIN_END_QUALITY=0

PRIMER_QUALITY_RANGE_MIN=0

PRIMER_QUALITY_RANGE_MAX=100

PRIMER_WT_TM_LT=1.0

PRIMER_WT_TM_GT=1.0

PRIMER_WT_SIZE_LT=1.0

PRIMER_WT_SIZE_GT=1.0

PRIMER_WT_GC_PERCENT_LT=0.0

PRIMER_WT_GC_PERCENT_GT=0.0

PRIMER_WT_COMPL_ANY=0.0

PRIMER_WT_COMPL_END=0.0

PRIMER_WT_NUM_NS=0.0

PRIMER_WT_REP_SIM=0.0

PRIMER_WT_SEQ_QUAL=0.0

PRIMER_WT_END_QUAL=0.0

PRIMER_WT_POS_PENALTY=0.0

PRIMER_WT_END_STABILITY=0.0

PRIMER_PAIR_WT_PRODUCT_SIZE_LT=0.05

PRIMER_PAIR_WT_PRODUCT_SIZE_GT=0.05

PRIMER_PAIR_WT_PRODUCT_TM_LT=0.0

PRIMER_PAIR_WT_PRODUCT_TM_GT=0.0

PRIMER_PAIR_WT_DIFF_TM=0.0

PRIMER_PAIR_WT_COMPL_ANY=0.0

PRIMER_PAIR_WT_COMPL_END=0.0

PRIMER_PAIR_WT_REP_SIM=0.0

PRIMER_PAIR_WT_PR_PENALTY=1.0

PRIMER_PAIR_WT_IO_PENALTY=0.0

PRIMER_INTERNAL_OLIGO_MIN_SIZE=18

PRIMER_INTERNAL_OLIGO_OPT_SIZE=20

PRIMER_INTERNAL_OLIGO_MAX_SIZE=35

PRIMER_INTERNAL_OLIGO_MIN_TM=71.7

PRIMER_INTERNAL_OLIGO_OPT_TM=72.7

PRIMER_INTERNAL_OLIGO_MAX_TM=73.7

PRIMER_INTERNAL_OLIGO_MIN_GC=20.0

PRIMER_INTERNAL_OLIGO_MAX_GC=80.0

PRIMER_INTERNAL_OLIGO_SELF_ANY=12.00

PRIMER_INTERNAL_OLIGO_SELF_END=12.00

PRIMER_INTERNAL_OLIGO_NUM_NS=0

PRIMER_INTERNAL_OLIGO_MAX_POLY_X=5

PRIMER_INTERNAL_OLIGO_MISHYB_LIBRARY=

PRIMER_INTERNAL_OLIGO_MAX_MISHYB=12.00

PRIMER_INTERNAL_OLIGO_MIN_QUALITY=0

PRIMER_INTERNAL_OLIGO_SALT_CONC=50.0

PRIMER_INTERNAL_OLIGO_DNA_CONC=50.0

PRIMER_IO_WT_TM_LT=1.0

PRIMER_IO_WT_TM_GT=1.0

PRIMER_IO_WT_SIZE_LT=1.0

PRIMER_IO_WT_SIZE_GT=1.0

PRIMER_IO_WT_GC_PERCENT_LT=0.0

PRIMER_IO_WT_GC_PERCENT_GT=0.0

PRIMER_IO_WT_COMPL_ANY=0.0

PRIMER_IO_WT_NUM_NS=0.0

PRIMER_IO_WT_REP_SIM=0.0

PRIMER_IO_WT_SEQ_QUAL=0.0

PRIMER_TASK=pick_pcr_primers_and_hyb_probe

PRIMER_PRODUCT_SIZE_RANGE=50-150

PRIMER_FIRST_BASE_INDEX=1

PRIMER_PICK_ANYWAY=1

=

PRIMER_SEQUENCE_ID=>GUSB

PRIMER_EXPLAIN_FLAG=1

PRIMER_MISPRIMING_LIBRARY=

SEQUENCE=GAAGAGTACCAGAAAAGTCTGCTAGAGCAGTACCATCTGGGTCTGGATCAAAAACGCAGAAA

ATATGTGGTTGGAGAGCTCATTTGGAATTTTGCCGATTTCATGACTGAACAGTCACCGACGAGAGTGCTGG

GGAATAAAAAGGGGATCTTCACTCGGCAGAGACAACCAAAAAGTGCAGCGTTCCTTTTGCGAGAGAGATAC

TGGAAGATTGCCAATGAAACCAGGTATCCCCACTCAGTAGCCAAGTCACAATGTTTGGAAAACAGCCCGTT

TACTTGAGCAAGACTGATACCACCTGCGTGTCCCTTCCTCCCCGAGTCAGGGCGACTTCCACAGCAGCAGA

ACAAGTGCCTCCTGGACTGTTCACGGCAGACCAGAACGTTTCTGGCCTGGGTTTTGTGGTCATCTATTCTA

GCAGGGAACACTAAAGGTGGAAATAAAAGATTTTCTATTATGGAAATAAAGAGTTGGCATGAAAGTCGCTA

CTG (SEQ ID NO: 8834)

PRIMER_PRODUCT_OPT_SIZE=100

PRIMER_NUM_RETURN=100

PRIMER_MAX_END_STABILITY=9.0

PRIMER_MAX_MISPRIMING=12.00

PRIMER_PAIR_MAX_MISPRIMING=24.00

PRIMER_MIN_SIZE=18

PRIMER_OPT_SIZE=20

PRIMER_MAX_SIZE=32

PRIMER_MIN_TM=61.7

PRIMER_OPT_TM=62.7

PRIMER_MAX_TM=63.7

PRIMER_MAX_DIFF_TM=100.0

PRIMER_MIN_GC=20.0

PRIMER_MAX_GC=80.0

PRIMER_SELF_ANY=8.00

PRIMER_SELF_END=3.00

PRIMER_NUM_NS_ACCEPTED=0

PRIMER_MAX_POLY_X=4

PRIMER_OUTSIDE_PENALTY=0

PRIMER_GC_CLAMP=0

PRIMER_SALT_CONC=50.0

PRIMER_DNA_CONC=50.0

PRIMER_LIBERAL_BASE=1

PRIMER_MIN_QUALITY=0

PRIMER_MIN_END_QUALITY=0

PRIMER_QUALITY_RANGE_MIN=0

PRIMER_QUALITY_RANGE_MAX=100

PRIMER_WT_TM_LT=1.0

PRIMER_WT_TM_GT=1.0

PRIMER_WT_SIZE_LT=1.0

PRIMER_WT_SIZE_GT=1.0

PRIMER_WT_GC_PERCENT_LT=0.0

PRIMER_WT_GC_PERCENT_GT=0.0

PRIMER_WT_COMPL_ANY=0.0

PRIMER_WT_COMPL_END=0.0

PRIMER_WT_NUM_NS=0.0

PRIMER_WT_REP_SIM=0.0

PRIMER_WT_SEQ_QUAL=0.0

PRIMER_WT_END_QUAL=0.0

PRIMER_WT_POS_PENALTY=0.0

PRIMER_WT_END_STABILITY=0.0

PRIMER_PAIR_WT_PRODUCT_SIZE_LT=0.05

PRIMER_PAIR_WT_PRODUCT_SIZE_GT=0.05

PRIMER_PAIR_WT_PRODUCT_TM_LT=0.0

PRIMER_PAIR_WT_PRODUCT_TM_GT=0.0

PRIMER_PAIR_WT_DIFF_TM=0.0

PRIMER_PAIR_WT_COMPL_ANY=0.0

PRIMER_PAIR_WT_COMPL_END=0.0

PRIMER_PAIR_WT_REP_SIM=0.0

PRIMER_PAIR_WT_PR_PENALTY=1.0

PRIMER_PAIR_WT_IO_PENALTY=0.0

PRIMER_INTERNAL_OLIGO_MIN_SIZE=18

PRIMER_INTERNAL_OLIGO_OPT_SIZE=20

PRIMER_INTERNAL_OLIGO_MAX_SIZE=35

PRIMER_INTERNAL_OLIGO_MIN_TM=71.7

PRIMER_INTERNAL_OLIGO_OPT_TM=72.7

PRIMER_INTERNAL_OLIGO_MAX_TM=73.7

PRIMER_INTERNAL_OLIGO_MIN_GC=20.0

PRIMER_INTERNAL_OLIGO_MAX_GC=80.0

PRIMER_INTERNAL_OLIGO_SELF_ANY=12.00

PRIMER_INTERNAL_OLIGO_SELF_END=12.00

PRIMER_INTERNAL_OLIGO_NUM_NS=0

PRIMER_INTERNAL_OLIGO_MAX_POLY_X=5

PRIMER_INTERNAL_OLIGO_MISHYB_LIBRARY=

PRIMER_INTERNAL_OLIGO_MAX_MISHYB=12.00

PRIMER_INTERNAL_OLIGO_MIN_QUALITY=0

PRIMER_INTERNAL_OLIGO_SALT_CONC=50.0

PRIMER_INTERNAL_OLIGO_DNA_CONC=50.0

PRIMER_IO_WT_TM_LT=1.0

PRIMER_IO_WT_TM_GT=1.0

PRIMER_IO_WT_SIZE_LT=1.0

PRIMER_IO_WT_SIZE_GT=1.0

PRIMER_IO_WT_GC_PERCENT_LT=0.0

PRIMER_IO_WT_GC_PERCENT_GT=0.0

PRIMER_IO_WT_COMPL_ANY=0.0

PRIMER_IO_WT_NUM_NS=0.0

PRIMER_IO_WT_REP_SIM=0.0

PRIMER_IO_WT_SEQ_QUAL=0.0

PRIMER_TASK=pick_pcr_primers_and_hyb_probe

PRIMER_PRODUCT_SIZE_RANGE=50-150

PRIMER_FIRST_BASE_INDEX=1

PRIMER_PICK_ANYWAY=1

=

After running PRIMER3, 100 sets of primers and probes were generated for ACTB and GUSB. From this set, nested primers were chosen based on whether both left primers could be paired with both right primers and a single Taqman probe could be used on an insert of the correct size. With more experience we have decided not use the mix and match approach to primer selection and just use several of the top pairs of predicted primers.

For ACTB this turned out to be:

Forward
75
CACAATGTGGCCGAGGACTT,
(SEQ ID NO: 8835)

Forward
80
TGTGGCCGAGGACTTTGATT,
(SEQ ID NO: 8836)

Reverse
178
TGGCTTTTAGGATGGCAAGG,
(SEQ ID NO: 8837)

and

Reverse
168
GGGGGCTTAGTTTGCTTCCT.
(SEQ ID NO: 8838)

Upon testing, the F75 and R178 pair worked best.

For GUSB the following primers were chosen:

Forward
59
AAGTGCAGCGTTCCTTTTGC,
(SEQ ID NO: 8839)

Forward
65
AGCGTTCCTTTTGCGAGAGA,
(SEQ ID NO: 8840)

Reverse
158
CGGGCTGTTTTCCAAACATT
(SEQ ID NO: 8841)

and

Reverse
197
GAAGGGACACGCAGGTGGTA.
(SEQ ID NO: 8842)

No combination of these GUSB pairs worked well.

In addition to the primer pairs above, Primer Express predicted the following primers for GUSB: Forward 178 TACCACCTGCGTGTCCCTTC (SEQ ID NO: 8843) and Reverse 242 GAGGCACTTGTTCTGCTGCTG (SEQ ID NO: 8844). This pair of primers worked to amplify the GUSB mRNA.

The parameters used to predict these primers in Primer Express were:

Primer Tm: min 58, Max=60, opt 59, max difference=2 degrees
Primer GC: min=20% Max=80% no 3′ G/C clamp
Primer: Length: min=9 max=40 opt=20
Amplicon: min T_m=0 max T_m=85
- min=50 bp max=150 bp
Probe: Tm 10 degrees>primers, do not begin with a G on 5′ end
Other: max base pair repeat=3
- max number of ambiguous residues=0
- secondary structure: max consec bp=4, max total bp=8
- Uniqueness: max consec match=9
  - max % match=75
  - max 3′ consecutive match=7

Using this approach, multiple primers were designed for genes that were shown to have expression patterns that correlated with clinical data in example 10. These primer pairs are shown in Table 10B and are added to the sequence listing. Primers can be designed from any region of a target gene using this approach.

Granzyme B is an important marker of CMV infection and transplant rejection. For Granzyme B the following sequence (NM_—004131) was used as input for Primer3:

(SEQ ID No: 9086)

GGGGACTCTGGAGGCCCTCTTGTGTGTAACAAGGTGGCCCAGGGCATTGT

CTCCTATGGACGAAACAATGGCATGCCTCCACGAGCCTGCACCAAAGTCT

CAAGCTTTGTACACTGGATAAAGAAAACCATGAAACGCTACTAACTACAG

GAAGCAAACTAAGCCCCCGCTGTAATGAAACACCTTCTCTGGAGCCAAGT

CCAGATTTACACTGGGAGAGGTGCCAGCAACTGAATAAATACCTCTCCCA

GTGTAAATCTGGAGCCAAGTCCAGATTTACACTGGGAGAGGTGCCAGCAA

CTGAATAAATACCTCTTAGCTGAGTGG

For Granzyme B the following primers were chosen for testing:

Forward
81
ACGAGCCTGCACCAAAGTCT
(SEQ ID No: 9087)

Forward
63
AAACAATGGCATGCCTCCAC
(SEQ ID No: 9088)

Reverse
178
TCATTACAGCGGGGGCTTAG
(SEQ ID No: 9089)

Reverse
168
GGGGGCTTAGTTTGCTTCCT
(SEQ ID No: 9090)

Testing demonstrated that F81 and R178 worked well in amplifying a product.

Primer Endpoint Testing

Primers were first tested to examine whether they would produce the correct size product without non-specific amplification. The standard real-time PCR protocol was used with out the Rox and Sybr green dyes. Each primer pair was tested on cDNA made from universal mononuclear leukocyte reference R NA that was produced from 50 individuals as described in Example 8 (R50).

The PCR reaction consisted of 1X RealTime PCR Buffer (Ambion, Austin, Tex.), 3 mM MgC12 (Applied BioSystems, B02953), 0.2 mM dATP (NEB), 0.2 mM dTTP (NEB), 0.2 mM dCTP (NEB), 0.2 mM dGTP (NEB), 1.25U AmpliTaq Gold (Applied BioSystems, Foster City, Calif.), 0.3 μM of each primer to be used (Sigma Genosys, The Woodlands, Tex.), 5 μl of the R50 reverse-transcription reaction and water to a final volume of 19 μl.

Following 40 cycles of PCR, one microliter of the product was examined by agarose gel electrophoresis and on an Agilent Bioanalyzer, DNA1000 chip (Palo Alto, Calif.). Results for 2 genes are shown in FIG. 5. From the primer design and the sequence of the target gene, one can calculate the expected size of the amplified DNA product. Only primer pairs with amplification of the desired product and minimal amplification of contaminants were used for real-time PCR. Primers that produced multiple products of different sizes are likely not specific for the gene of interest and may amplify multiple genes or chromosomal loci.

Primer Op Tjm!Za Tion/Efficiency

Once primers passed the end-point PCR, the primers were tested to determine the efficiency of the re action in a real-time PCR reaction. cDNA was synthesized from starting total RNA as described above. A set of 5 serial dilutions of the R50 reverse-transcribed cDNA (as described above) were made in water: 1:10, 1:20, 1:40, 1:80, and 1:160.

The Sybr Green real-time PCR reaction was performed using the Taqman PCR Reagent kit (Applied BioSystcms, Foster City, Calif., N808-0228). A master mix was made that consisted of all reagents except the primes and template. The final concentration of all ingredients in the reaction was 1×Taqman Buffer A (Applied BioSystems), 2 mM MgCl2 (Applied BioSystems), 200 μM dATP (Applied BioSystems), 200 μM dCTP (Applied BioSystems), 200 μM dGTP (Applied BioSystems), 400 μM dUTP (Applied BioSystems), 1:400,000 diluted Sybr Green dye (Molecular Probes), 1.25U AmpliTaq Gold (Applied BioSystems). The master mix for 92 reactions was made to a final volume of 2112 μl. 1012 μl of PCR master mix was dispensed into two, light-tight tubes. Each β-Actin primer F75 and R178 (Genosys), was added to one tube of PCR master mix and Each β-GUS primer F178 and R242 (Genosys), was added to the other tube of PCR master mix to a final primer concentration of 300 nM, and a final volume of 1035 μl per reaction tube. 45 μl of the β-Actin master mix was dispensed into 23 wells, in a 96well plate (Applied BioSystems). 45 μl of the β-GUS master mix was dispensed into 23 wells, in a 96well plate (Applied BioSystems). 5 μl of the template dilution series was dispensed into triplicate wells for each primer. The reaction was run on an ABI 7700 Sequence Detector (Applied BioSystems).

The Sequence Detector v1.7 software was used to analyze the fluorescent signal from each well. A threshold value was selected that allowed most of the amplification curves to cross the threshold during the linear phase of amplification. The cycle number at which each amplification curve crossed the threshold (CT) was recorded and the file transferred to MS Excel for further analysis. The C_Tvalues for triplicate wells were averaged. The data were plotted as a function of the log₁₀of the calculated starting concentration of RNA. The starting RNA concentration for each cDNA dilution was determined based on the original amount of RNA used in the RT reaction, the dilution of the RT reaction, and the amount used (5 μl) in the real-time PCR reaction. For each gene, a linear regression line was plotted through all of the dilutions series points. The slope of the line was used to calculate the efficiency of the reaction for each primer set using the equation:
$E = 10^{(\frac{- 1}{slope})}$

Using this equation (Pfaffl 2001), the efficiency for these β-actin primers is 2.28 and the efficiency for these P-GUS primers is 2.14 (FIG. 2). This efficiency was used when comparing the expression levels among multiple genes and multiple samples. This same method was used to calculate reaction efficiency for primer pairs for each gene we studied.

Assay and Results

Once primers were designed and tested and efficiency analysis was completed, primers were used examine expression of a single gene among many clinical samples. The basic design was to examine expression of both the experimental gene and a reference gene in each sample and, at the same time, in a control sample. The control sample we used was the universal mononuclear leukocyte reference RNA described in example 8 (R50).

In this example, three patient samples from patients with known CMV infection were compared to three patient samples from patients with no diagnosis of CMV infection based on standard diagnostic algorithms for active CMV infection (including viral PCR assays, serologies, culture and other tests). cDNA was made from all six RNA samples and the R50 control as described above. The cDNA was diluted 1:10 in water and 5 μl of this dilution was used in the 50 μl PCR reaction. Each 96-well plate consisted of 32 reactions, each done in triplicate. There were 17 templates and 3 primer sets. The three primer sets were β-GUS, β-Actin, and Granzyme B AS described above. Each of the three primer sets was used to measure template levels in 8 templates: the six experimental samples, R50, and water (no-template control). The β-GUS primers were also used to measure template levels a set of 8 templates identical except for the absence of the reverse transcriptase enzyme in the cDNA synthesis reaction (−RT). The real-time PCR reactions were performed as described above in “primer optimization/efficiency”.

The β-GUS amplification with +RT and −RT cDNA synthesis reaction templates were compared to measure the amount of genomic DNA contamination of the patient RNA sample (FIG. 6A). The only source of amplifiable material in the −RT cDNA synthesis reaction is contaminating genomic DNA. Separation by at least four C_Tbetween the −RT and +RT for each sample was required to consider the sample useful for analysis of RNA levels. Since a C_Tdecrease of one is a two-fold increase in template, a difference of four C_Twould indicate that genomic DNA contamination level in the +RT samples was 6.25% of the total signal. Since we used these reactions to measure 30% or greater differences, a 6% contamination would not change the result.

For samples with sufficiently low genomic DNA contamination the data were used to identify differences in gene expression by measuring RNA levels. C_Tvalues from the triplicate wells for each reaction were averaged and the coefficient of variation (CV) determined. Samples with high CV (>2%) were examined and outlier reaction wells were discarded from further analysis. The average of the wells for each sample was taken as the C_Tvalue for each sample. For each gene, the ΔC_Twas the R50 control C_Tminus the sample C_T. The equation below was then used to identify an expression ratio compared to a reference gene (β-Actin) and control sample (R50) for Granzyme B expression in each experimental sample (Pfaffl, M. W. 2001). E is the amplification efficiency determined above.
$ratio = \frac{{(E_{target})}^{Δ C_{T} target (control - sample)}}{{(E_{ref})}^{Δ C_{T} ref (control - sample)}}$

The complete experiment was performed in duplicate and the average of the two ratios taken for each gene. When β-Actin was used as the reference gene, the data show that Granzyme B is expressed at 25-fold higher levels in mononuclear cell RNA from patients with CMV than from patients without CMV (FIG. 6B). In this graph, each circle represents a patient sample and the black bars are the average of the three samples in each category.

Example 16
Correlation and Classification Analysis

After generation and processing of expression data sets from microarrays as described in Example 14, a log ratio value is used for most subsequent analysis. This is the logarithm of the expression ratio for each gene between sample and universal reference. The processing algorithm assigns a number of flags to data that are of low signal to noise or are in some other way of uncertain quality. Correlation analysis can proceed with all the data (including the flagged data) or can be done on filtered data sets where the flagged data is removed from the set. Filtered data should have less variability and may result in more significant results. Flagged data contains all information available and may allow discovery of genes that are missed with the filtered data set.

In addition to expression data, clinical data are included in the analysis. Continuous variables, such as the ejection fraction of the heart measured by echocardiography or the white blood cell count can be used for correlation analysis. In some cases, it may be desirable to take the logarithm of the values before analysis. These variables can be included in an analysis along with gene expression values, in which case they are treated as another “gene”. Sets of markers can be discovered that work to diagnose a patient condition and these can include both genes and clinical parameters. Categorical variables such as male or female can also be used as variables for correlation analysis. For example, the sex of a patient may be an important splitter for a classification tree.

Clinical data are used as supervising vectors for the significance or classification analysis. In this case, clinical data associated with the samples are used to divide samples in to clinically meaningful diagnostic categories for correlation or classification analsysis. For example, pathologic specimens from kidney biopsies can be used to divide lupus patients into groups with and without kidney disease. A third or more categories can also be included (for example “unknown” or “not reported”). After generation of expression data and definition of using supervising vectors, correlation, significance and classification analysis is used to determine which set of genes are most appropriate for diagnosis and classification of patients and patient samples.

Significance Analysis for Microarrays (SAM)

Significance analysis for microarrays (SAM) (Tusher 2001) is a method through which genes with a correlation between their expression values and the response vector are statistically discovered and assigned a statistical significance. The ratio of false significant to significant genes is the False Discovery Rate (FDR). This means that for each threshold there are a set of genes which are called significant, and the FDR gives a confidence level for this claim. If a gene is called differentially expressed between 2 classes by SAM, with a FDR of 5%, there is a 95% chance that the gene is actually differentially expressed between the classes. SAM takes into account the variability and large number of variables of microarrays. SAM will identify genes that are most globally differentially expressed between the classes. Thus, important genes for identifying and classifying outlier samples or patients may not be identified by SAM.

After generation of data from patient samples and definition of categories using clinical data as supervising vectors, SAM is used to detect genes that are likely to be differentially expressed between the groupings. Those genes with the highest significance can be validated by real-time PCR (Example 15) or can be used to build a classification algorithm as described here.

Classification

Supervised harvesting of expression trees (Hastie 2001) identifies genes or clusters that best distinguish one class from all the others on the data set. The method is used to identify the genes/clusters that can best separate one class versus all the others for datasets that include two or more classes from each other. This algorithm can be used to identify genes that are used to create a diagnostic algorithm. Genes that are identified can be used to build a classification tree with algorithms such as CART.

CART is a decision tree classification algorithm (Breiman 1984). From gene expression and or other data, CART can develop a decision tree for the classification of samples. Each node on the decision tree involves a query about the expression level of one or more genes or variables. Samples that are above the threshold go down one branch of the decision tree and samples that are not go down the other branch. Genes from expression data sets can be selected for classification building using CART by significant differential expression in SAM analysis or other significance test), identification by supervised tree-harvesting analysis, high fold change between sample groups, or known relevance to classification of the target diseases. In addition, clinical data can also be used as variables for CART that are of know importance to the clinical question or are found to be significant predictors by multivariate analysis or some other technique. CART identifies surrogates for each splitter (genes that are the next best substitute for a useful gene in classification). Analysis is performed in CART by weighting misclassification costs to optimize desired performance of the assay. For example, it may be most important the sensitivity of a test for a given diagnosis be near 100% while specificity is less important.

Once a set of genes and expression criteria for those genes have been established for classification, cross validation is done. There are many approaches, including a 10 fold cross validation analysis in which 10% of the training samples are left out of the analysis and the classification algorithm is built with the remaining 90%. The 10% are then used as a test set for the algorithm. The process is repeated 10 times with 10% of the samples being left out as a test set each time. Through this analysis, one can derive a cross validation error which helps estimate the robustness of the algorithm for use on prospective (test) samples. When a gene set is established for a diagnosis with a low cross validation error, this set of genes is tested using samples that were not included in the initial analysis (test samples). These samples may be taken from archives generated during the clinical study. Alternatively, a new prospective clinical study can be initiated, where samples are obtained and the gene set is used to predict patient diagnoses.

TABLE 1

Disease Classification
Disease/Patient Group

Cardiovascular Disease
Atherosclerosis

Unstable angina

Myocardial Infarction

Restenosis after angioplasty

Congestive Heart Failure

Myocarditis

Endocarditis

Endothelial Dysfunction

Cardiomyopathy

Cardiovascular drug use

Endocrine Disease
Diabetes Mellitus I and II

Thyroiditis

Addisson's Disease

Infectious Disease
Hepatitis A, B, C, D, E, G

Malaria

Tuberculosis

HIV

Pneumocystis Carinii

Giardia

Toxoplasmosis

Lyme Disease

Rocky Mountain Spotted Fever

Cytomegalovirus

Epstein Barr Virus

Herpes Simplex Virus

Clostridium Dificile Colitis

Meningitis (all organisms)

Pneumonia (all organisms)

Urinary Tract Infection (all organisms)

Infectious Diarrhea (all organisms)

Anti-infectious drug use

Anglogenesis
Pathologic angiogenesis

Physiologic angiogenesis

Treatment induced angiogenesis

Pro or anti-angiogenic drug use

Inflammatory/Rheumatic
Rheumatoid Arthritis

Systemic Lupus Erythematosis

Sjogrens Disease

CREST syndrome

Scleroderma

Ankylosing Spondylitis

Crohn's

Ulcerative Colitis

Primary Sclerosing Cholangitis

Appendicitis

Diverticulitis

Primary Biliary Sclerosis

Wegener's Granulomatosis

Polyarteritis nodosa

Whipple's Disease

Psoriasis

Microscopic Polyanngiitis

Takayasu's Disease

Kawasaki's Disease

Autoimmune hepatitis

Asthma

Churg-Strauss Disease

Beurger's Disease

Raynaud's Disease

Cholecystitis

Sarcoidosis

Asbestosis

Pneumoconioses

Antinflammatory drug use

Transplant Rejection
Heart

Lung

Liver

Pancreas

Bowel

Bone Marrow

Stem Cell

Graft versus host disease

Transplant vasculopathy

Skin

Cornea

Immunosupressive drug use

Malignant Disorders
Leukemia

Lymphoma

Carcinoma

Sarcoma

Neurological Disease
Alzheimer's Dementia

Pick's Disease

Multiple Sclerosis

Guillain Barre Syndrome

Peripheral Neuropathy

TABLE 2

Candidate genes, Database mining

Unigene clusters are listed.

Cluster numbers are defined as in Unigene build #133 uploaded on: Fri Apr 20 2001

CD50

Hs.99995

Homo sapiens cAMP responsive element
Hs.79194

binding protein 1 (CREB1) mRNA.

CD70 = CD27L

Hs.99899

Nucleolin (NCL)
Hs.79110

MDC

Hs.97203

MAPK14
Hs.79107

CD3z
Hs.97087
CD100

Hs.79089

CD19

Hs.96023

OX-2
Hs.79015

Hs.95388
PCNA

Hs.78996

CD3d
Hs.95327

Hs.78909

Hs.9456
GRO-a

Hs.789

interleukin 6
Hs.93913
CDw32A

Hs.78864

phospholipaseA2

Hs.93304

H. sapiens mRNA for herpesvirus associated
Hs.78683

ubiquitin-specific protease (HAUSP).

Human mRNA for KIAA0128 gene, partial
Hs.90998
CD41b = LIBS1

Hs.785

cds.

CD48

Hs.901

ANXA1 (LPC1)
Hs.78225

heat shock 70 kD protein 1A

Hs.8997

CD31

Hs.78146

TxA2 receptor

Hs.89887

Homo sapiens TERF1 (TRF1)-interacting
Hs.7797

nuclear factor 2 (TINF2), mRNA.

fragile X mental retardation protein (FMR-
Hs.89764
major histocompatibility complex, class I, B

Hs.77961

1)

CD20

Hs.89751

LOX1

Hs.77729

ENA-78

Hs.89714

major histocompatibility complex, class II,

Hs.77522

DM alpha

IL-2

Hs.89679

CD64

Hs.77424

CD79b

Hs.89575

CD71

Hs.77356

CD2

Hs.89476

Hs.77054

SDF-1 = CXCR4

Hs.89414

HLA-DRA

Hs.76807

CD61

Hs.87149

CD105

Hs.76753

IFN-g

Hs.856

Hs.76691

CD34

Hs.85289

TNF-alpha
Hs.76507

CD104

Hs.85266

LCP1
Hs.76506

CD8

Hs.85258

TMSB4X
Hs.75968

IGF-1

Hs.85112

PAI2
Hs.75716

CD103

Hs.851

MIP-1b

Hs.75703

IL-13

Hs.845

CD58

Hs.75626

RPA1
Hs.84318
CD36

Hs.75613

CD74

Hs.84298

hnRNP A2/hnRNP B1
Hs.75598

CD132

Hs.84

CD124

Hs.75545

CD18

Hs.83968

MIP-3a

Hs.75498

Cathepsin K
Hs.83942
beta-2-microglobulin
Hs.75415

CD80

Hs.838

FPR1
Hs.753

CD46

Hs.83532

Topo2B
Hs.75248

NFKB1
Hs.83428
interleukin enhancer binding factor 2, 45 kD

Hs.75117

IL-18

Hs.83077

chloride intracellular channel 1

Hs.74276

interleukin 14

Hs.83004

EGR3
Hs.74088

L-selectin = CD62L

Hs.82848

MIP-1a

Hs.73817

CD107b

Hs.8262

CD62P = p-selectin

Hs.73800

CD69

Hs.82401

CD21

Hs.73792

CD95

Hs.82359

APE
Hs.73722

CD53

Hs.82212

IL12Rb2

Hs.73165

Human lymphocyte specific interferon
Hs.82132
NFKB2
Hs.73090

regulatory factor/interferon regulatory factor

4 (LSIRF/IRF4) mRNA, complete cds.

IL-16

Hs.82127

I-309

Hs.72918

DUT
Hs.82113
immunoglobulin superfamily, member 4

Hs.70337

CDw121a

Hs.82112

IL-3

Hs.694

PAI-1

Hs.82085

Hs.6895

TGF-bR2

Hs.82028

NTH1
Hs.66196

CD117

Hs.81665

CD40L

Hs.652

HLA-DPB1

Hs.814

IL-11R

Hs.64310

NFKBIA
Hs.81328

Homo sapiens toll-like receptor 2 (TLR2)
Hs.63668

mRNA.

CD6

Hs.81226

ferritin H chain
Hs.62954

IL-1 RA

Hs.81134

IL8

Hs.624

UBE2B (RAD6B)
Hs.811
Tissue Factor

Hs.62192

Lyn
Hs.80887
F-box only protein 7

Hs.5912

STAT4

Hs.80642

CD5

Hs.58685

UBE2A (RAD6A)
Hs.80612
guanine nucleotide binding protein (G

Hs.5662

protein), beta polypeptide 2-like 1

Fractalkine

Hs.80420

SCYA11
Hs.54460

IK cytokine, down-regulator of HLA II

Hs.8024

IK1
Hs.54452

Hs.79933
CCR1

Hs.516

CD79a

Hs.79630

Homo sapiens TRAIL receptor 2 mRNA,
Hs.51233

complete cds.

Hs.7942
CD11c

Hs.51077

nuclear factor, interleukin 3 regulated

Hs.79334

CD66a

Hs.50964

CD83

Hs.79197

JAK1
Hs.50651

DC-CK1

Hs.16530

Homo sapiens programmed cell death 4
Hs.100407

(PDCD4), mRNA.

CCR7
Hs.1652
SCYB13 (CXCL13)
Hs.100431

TLR4
Hs.159239
SMAD7
Hs.100602

EST
Hs.158975
RAD51L1 (RAD51B)
Hs.100669

EST
Hs.158966
PPARG
Hs.100724

EST
Hs.158965
transcription factor 3 (E2A immunoglobulin

Hs.101047

enhancer binding factors E12/E47)

EST
Hs.158943
major histocompatibility complex, class I-

Hs.101840

like sequence

EST
Hs.158894
immunoglobulin superfamily containing

Hs.102171

leucine-rich repeat

EST
Hs.158877
CD166

Hs.10247

EST
Hs.157815
fibroblast tropomyosin TM30 (pl)
Hs.102824

EST
Hs.157813
interleukin 1 receptor-like 2

Hs.102865

ESTs
Hs.157569
GTF2H4
Hs.102910

immunoglobulin kappa constant

Hs.156110

Hs.10326

INPP5D
Hs.155939
Human ITAC (IBICK)
Hs.103982

C3AR1
Hs.155935
novel protein with MAM domain

Hs.104311

PRKDC
Hs.155637
ESTs, Weakly similar to interleukin

Hs.105125

enhancer binding factor 2 [H. sapiens]

MHC class II HLA-DRw53-associated

Hs.155122

Homo sapiens clone 24686 mRNA
Hs.105509

glycoprotein

sequence.

CD73

Hs.153952

Hs.105532

CD37

Hs.153053

Homo sapiens granulysin (GNLY),
Hs.105806

transcript variant 519, mRNA.

IFNAR1

Hs.1513

CD77
Hs.105956

Homo sapiens solute carrier family 21
Hs.14805
RD RNA-binding protein

Hs.106061

(organic anion transporter), member 11

(SLC21A11), mRNA.

EST
Hs.146627

Hs.106673

SET translocation (myeloid leukemia-

Hs.145279

Hs.10669

associated)

EST
Hs.144119

Homo sapiens clone 24818 mRNA
Hs.106823

sequence.

ESTs
Hs.143534

Hs.106826

STAT3
Hs.142258

Hs.10712

CD96

Hs.142023

Hs.107149

CD23

Hs.1416

hypothetical protein

Hs.10729

EGR2
Hs.1395
Tachykinin Receptor 1
Hs.1080

CDw84

Hs.137548

glycophorin A
Hs.108694

CD55

Hs.1369

Histone H1x
Hs.109804

EST
Hs.135339
CD66d
Hs.11

GM-CSF

Hs.1349

interleukin 17
Hs.110040

EST
Hs.133175

Hs.110131

CD1a

Hs.1309

major histocompatibility complex, class I, F

Hs.110309

CD10

Hs.1298

REV1
Hs.110347

HVEM

Hs.129708

HCR
Hs.110746

C9

Hs.1290

VWF
Hs.110802

C6

Hs.1282

high affinity immunoglobulin epsilon

Hs.11090

receptor beta subunit

C1R

Hs.1279

interleukin 22 receptor

Hs.110915

IL-1b

Hs.126256

Hs.110978

CD9

Hs.1244

Homo sapiens ubiquitin specific protease 6
Hs.111065

(Tre-2 oncogene) (USP6), mRNA.

Hs.12305

Hs.111128

Homo sapiens Vanin 2 (VNN2) mRNA.
Hs.121102
MMP2
Hs.111301

Hsp10
Hs.1197
major histocompatibility complex, class II,

Hs.11135

DN alpha

CD59

Hs.119663

LTBR

Hs.1116

CD51

Hs.118512

ESTs, Weakly similar to A41285

Hs.111941

interleukin enhancer-binding factor ILE-1

[H. sapiens]

CD49a

Hs.116774

Homo sapiens STRIN protein (STRIN),
Hs.112144

mRNA.

CD72

Hs.116481

MSH5
Hs.112193

HLA-DMB

Hs.1162

TCRg
Hs.112259

MCP-4

Hs.11383

Hs.11307

Hs.111554
CMKRL2
Hs.113207

ferritin L chain
Hs.111334
CCR8

Hs.113222

TGF-b

Hs.1103

LILRA3
Hs.113277

Homo sapiens ras homolog gene family,
Hs.109918
Human CXCR-5 (BLR-1)
Hs.113916

member H (ARHH), mRNA.

lysosomal alpha-mannosidase (MANB)
Hs.108969
RAD51C
Hs.11393

Hs.108327
myosin, heavy polypeptide 8, skeletal

Hs.113973

muscle, perinatal

granzyme B

Hs.1051

CD42a
Hs.1144

HCC-4

Hs.10458

TNFRSF11A
Hs.114676

Hs.10362

Hs.114931

Hs.102630
MSH4
Hs.115246

Hs.101382

Homo sapiens dendritic cell
Hs.115515

immunoreceptor (DCIR), mRNA.

C4BPA

Hs.1012

REV3L (POLZ)
Hs.115521

CD125

Hs.100001

JAK2
Hs.115541

TERF2
Hs.100030
OPG ligand
Hs.115770

LIG3
Hs.100299
PCDH12
Hs.115897

Hs.157489

Hs.166235

EST
Hs.157560
POLE1
Hs.166846

EST
Hs.157808
regulatory factor X, 5 (influences HLA class

Hs.166891

II expression)

EST
Hs.157811
PIG-F (phosphatidyl-inositol-glycan class
Hs.166982

F)

Hs.158127
ESTs, Moderately similar to

Hs.167154

ILF1_HUMAN INTERLEUKIN

ENHANCER-BINDING FACTOR 1

[H. sapiens]

interleukin 18 receptor accessory protein

Hs.158315

HLA-DRB6

Hs.167385

CCR3

Hs.158324

ret finger protein-like 3

Hs.167751

Human DNA sequence from clone CTA-

Hs.158352

CD56

Hs.167988

390C10 on chromosome 22q11.21-12.1

Contains an Immunoglobulin-like gene and

a pseudogene similar to Beta Crystallin,

ESTs, STSs, GSSs and taga and tat repeat

polymorphisms

ESTs
Hs.158576
RBT1
Hs.169138

Hs.158874
APOE
Hs.169401

EST
Hs.158875

Hs.16944

EST
Hs.158876

Hs.169470

EST
Hs.158878
MMP12
Hs.1695

EST
Hs.158956
CD161
Hs.169824

EST
Hs.158967
tenascin XB

Hs.169886

EST
Hs.158969

Hs.170027

EST
Hs.158971

Hs.170150

EST
Hs.158988
C4A

Hs.170250

CD120a = TNFR-1

Hs.159

TP53BP1
Hs.170263

EST
Hs.159000
ESTs
Hs.170274

Hs.159013
ESTs, Weakly similar to ALU1_HUMAN
Hs.170338

ALU SUBFAMILY J SEQUENCE

CONTAMINATION WARNING

ENTRY□ [H. sapiens]

EST
Hs.159025
ESTs
Hs.170578

EST
Hs.159059
EST
Hs.170579

IL18R1

Hs.159301

ESTs
Hs.170580

ftp-3
Hs.159494
EST
Hs.170581

CASP8
Hs.159651
ESTs
Hs.170583

EST
Hs.159655
EST
Hs.170586

EST
Hs.159660
EST
Hs.170588

EST
Hs.159678
EST
Hs.170589

kallikrein 12 (KLK12)
Hs.159679

Hs.170772

EST
Hs.159682
ESTs
Hs.170786

EST
Hs.159683
EST
Hs.170909

EST
Hs.159693
EST
Hs.170912

EST
Hs.159706
EST
Hs.170933

EST
Hs.159718
ESTs
Hs.171004

SPO11
Hs.159737
EST
Hs.171095

EST
Hs.159754
EST
Hs.171098

EST
Hs.160401
ESTs
Hs.171101

EST
Hs.160405
EST
Hs.171108

EST
Hs.160408
ESTs
Hs.171110

EST
Hs.160410
ESTs
Hs.171113

EST
Hs.160423
ESTs
Hs.171117

RPA3
Hs.1608
EST
Hs.171119

ESTs
Hs.160946
ESTs
Hs.171120

EST
Hs.160956
EST
Hs.171122

ESTs
Hs.160978
EST
Hs.171123

EST
Hs.160980
EST
Hs.171124

EST
Hs.160981
EST
Hs.171140

EST
Hs.160982
EST
Hs.171216

EST
Hs.160983
EST
Hs.171260

Tachykinin Receptor 2
Hs.161305
ESTs
Hs.171264

RAD17 (RAD24)
Hs.16184
RIP
Hs.171545

Human phosphatidylinositol 3-kinase
Hs.162808
ESTs, Weakly similar to immunoglobulin

Hs.171697

catalytic subunit p110delta mRNA,

superfamily member [D. melanogaster]

complete cds.

Human alpha-1 Ig germline C-region

Hs.163271

CD22

Hs.171763

membrane-coding region, 3′ end

GCP-2

Hs.164021

Hs.171776

Hs.164284
sema domain, immunoglobulin domain (Ig),

Hs.171921

short basic domain, secreted, (semaphorin)

3C

EST
Hs.164331
interleukin 11

Hs.1721

Hs.164427

CD11b

Hs.172631

Hs.165568
EST, Highly similar to APS [H. sapiens]
Hs.172656

ER
Hs.1657
ALK1
Hs.172670

EST, Highly similar to JM26 [H. sapiens]
Hs.165701

Hs.172674

EST
Hs.165702
CD123

Hs.172689

EST
Hs.165704
ESTs
Hs.172822

EST
Hs.165732
CollaI
Hs.172928

regulatory factor X, 3 (influences HLA class

Hs.166019

Hs.172998

II expression)

LIG4
Hs.166091

Hs.173081

TNFSF18
Hs.248197
myosin, heavy polypeptide 3, skeletal

Hs.173084

muscle, embryonic

EST
Hs.248228

Hs.173201

H. sapiens rearranged gene for kappa

Hs.248756

Mediterranean fever (MEFV)
Hs.173730

immunoglobulin subgroup V kappa IV

caspase 1, apoptosis-related cysteine

Hs.2490

Hs.173749

protease (interleukin 1, beta, convertase)

EST
Hs.249031
interleukin 1 receptor accessory protein

Hs.173880

TNFRSF10A
Hs.249190
EST, Weakly similar to RL13_HUMAN
Hs.174231

60S RIBOSOMAL PROTEIN L13

[H. sapiens]

immunoglobulin lambda variable 3-10

Hs.249208

EST
Hs.174242

Homo sapiens mRNA for single-chain

Hs.249245

EST
Hs.174300

antibody, complete cds

EST
Hs.250473
EST
Hs.174634

ESTs
Hs.250591
EST
Hs.174635

ESTs
Hs.250605
EST
Hs.174650

Hs.25063
EST
Hs.174673

Human DNA sequence from clone RP1-

Hs.250675

EST
Hs.174716

149A16 on chromosome 22 Contains an

IGLC (Immunoglobulin Lambda Chain C)

pseudogene, the RFPL3 gene for Ret finger

protein-like 3, the RFPL3S gene for Ret

finger protein-like 3 antisense, the gene for

a novel Immunoglobulin Lambda Chain V

family protein, the gene for a novel protein

similar to mouse RGDS (RALGDS,

RALGEF, Guanine Nucleotide Dissociation

Stimulator A) and rabbit oncogene RSC, the

gene for a novel protein (ortholog of worm

F16A11.2 and bacterial and archea-bacterial

predicted proteins), the gene for a novel

protein similar to BPI (Bacterial

Permeability-Increasing Protein) and rabbit

LBP (Liposaccharide-Binding Protein) and

the 5′ part of a novel gene. Contains ESTs,

STSs, GSSs and three putative CpG islands

ACE

Hs.250711

EST
Hs.174740

TREX2
Hs.251398
EST
Hs.174778

Human DNA sequence from clone 1170K4

Hs.251417

EST
Hs.174779

on chromosome 22q12.2-13.1. Contains

three novel genes, one of which codes for a

Trypsin family protein with class A LDL

receptor domains, and the IL2RB gene for

Interleukin 2 Receptor, Beta (IL-2 Receptor,

CD122 antigen). Contains a putative CpG

island, ESTs, and GSSs

EST
Hs.251539
EST, Weakly similar to RL13_HUMAN
Hs.174780

60S RIBOSOMAL PROTEIN L13

[H. sapiens]

EST
Hs.251540
(KIAA0033) for ORF, partial cds.
Hs.174905

C3

Hs.251972

Hs.175270

EST
Hs.252273
EST
Hs.175281

EST
Hs.252359
EST
Hs.175300

ESTs, Moderately similar to
Hs.252867
EST
Hs.175336

T2DT_HUMAN TRANSCRIPTION

INITIATION FACTOR TFIID 105 KDA

SUBUNIT [H. sapiens]

EST, Moderately similar to RS2_HUMAN
Hs.253150
EST
Hs.175388

40S RIBOSOMAL PROTEIN S2

[H. sapiens]

EST
Hs.253151

Hs.175437

EST
Hs.253154
EST, Weakly similar to salivary proline-rich
Hs.175777

protein precursor [H. sapiens]

EST
Hs.253165
EST
Hs.175803

EST
Hs.253166
ESTs
Hs.176337

EST
Hs.253167
EST
Hs.176374

EST
Hs.253168
EST
Hs.176380

EST
Hs.253169
EST
Hs.176404

interleukin 1 receptor, type II

Hs.25333

EST
Hs.176406

Hs.25361
LCK
Hs.1765

EST
Hs.253742
LIG1
Hs.1770

EST
Hs.253743
EST
Hs.177012

EST, Weakly similar to AF161429_1
Hs.253744
PERB11 family member in MHC class I

Hs.17704

HSPC311 [H. sapiens]

region

EST
Hs.253747
EST
Hs.177146

EST
Hs.253748
EST
Hs.177209

EST
Hs.253753

Hs.177376

EST, Moderately similar to
Hs.254108

Hs.177461

ALU5_HUMAN ALU SUBFAMILY SC

SEQUENCE CONTAMINATION

WARNING ENTRY□ [H. sapiens]

ESTs
Hs.254948
CD99

Hs.177543

ESTs
Hs.255011
PMS2
Hs.177548

EST
Hs.255118
human calmodulin
Hs.177656

EST
Hs.255119

Hs.177712

EST
Hs.255123

Homo sapiens immunoglobulin lambda

Hs.178665

gene locus DNA, clone:288A10

EST
Hs.255129

Hs.178743

EST
Hs.255134
EST
Hs.179008

EST
Hs.255135
EST
Hs.179070

EST
Hs.255139
EST
Hs.179130

EST
Hs.255140
EST
Hs.179132

ESTs
Hs.255142

Hs.179149

EST
Hs.255150
EST
Hs.179490

EST
Hs.255152
EST
Hs.179492

ESTs
Hs.255153
promyelocytic leukemia cell mRNA, clones
Hs.179735

pHH58 and pHH81.

ESTs
Hs.255157

Hs.179817

ESTs
Hs.255171
major histocompatibility complex, class II,

Hs.1802

DO beta

EST
Hs.255172
HLA-DRB1

Hs.180255

EST, Moderately similar to
Hs.255174
TNFRSF12
Hs.180338

PGTA_HUMAN RAB

GERANYLGERANYLTRANSFERASE

ALPHA SUBUNIT [H. sapiens]

EST
Hs.255177
RAD23A (HR23A)
Hs.180455

EST
Hs.255178
MKK3
Hs.180533

EST
Hs.255245
EST
Hs.180637

EST
Hs.255246
CD27

Hs.180841

EST
Hs.255249
STAT6
Hs.181015

EST
Hs.255251
TNFSF4
Hs.181097

EST
Hs.255253
immunoglobulin lambda locus

Hs.181125

EST
Hs.255254

Hs.181368

EST
Hs.255255

CD3

Hs.181392

ESTs
Hs.255256
EST
Hs.255745

EST
Hs.255330
EST
Hs.255746

EST, Weakly similar to putative G protein-
Hs.255333
EST
Hs.255747

coupled Receptor [H. sapiens]

EST
Hs.255336
EST
Hs.255749

EST
Hs.255337
EST
Hs.255754

EST
Hs.255339
ESTs, Moderately similar to KIAA1271
Hs.255759

protein [H. sapiens]

EST
Hs.255340
EST
Hs.255762

EST
Hs.255341
EST
Hs.255763

ESTs
Hs.255343
EST
Hs.255764

EST
Hs.255347
EST
Hs.255766

EST
Hs.255349
EST
Hs.255767

EST
Hs.255350
EST
Hs.255768

EST
Hs.255354
EST
Hs.255769

ESTs
Hs.255359
EST
Hs.255770

ESTs
Hs.255387
EST
Hs.255772

EST
Hs.255388
EST
Hs.255777

EST
Hs.255389
EST
Hs.255778

ESTs
Hs.255390
EST
Hs.255779

EST
Hs.255392
EST
Hs.255782

EST
Hs.255444
EST
Hs.255783

EST
Hs.255446
EST
Hs.255784

EST
Hs.255448
EST
Hs.255785

ESTs
Hs.255449
EST, Weakly similar to Con1 [H. sapiens]
Hs.255788

EST
Hs.255454
EST
Hs.255791

EST
Hs.255455
EST
Hs.255794

EST
Hs.255457
EST
Hs.255796

EST
Hs.255459
EST
Hs.255797

EST
Hs.255462
EST
Hs.255799

EST
Hs.255464
ESTs
Hs.255877

EST
Hs.255492
EST
Hs.255880

EST
Hs.255494
EST
Hs.255920

EST
Hs.255495
EST
Hs.255927

EST
Hs.255497
CD40

Hs.25648

EST
Hs.255498
interleukin enhancer binding factor 3, 90 kD

Hs.256583

EST
Hs.255499
ESTs
Hs.256810

EST
Hs.255501
EST
Hs.256956

EST
Hs.255502
EST
Hs.256957

EST
Hs.255505
EST
Hs.256959

EST
Hs.255541
EST
Hs.256961

EST
Hs.255543
EST
Hs.256970

ESTs
Hs.255544
EST
Hs.256971

EST
Hs.255546
ESTs
Hs.256979

EST
Hs.255549
ESTs
Hs.257572

EST
Hs.255552
EST
Hs.257579

EST
Hs.255554
EST
Hs.257581

EST
Hs.255556
EST
Hs.257582

EST
Hs.255558
EST
Hs.257630

EST
Hs.255559
EST
Hs.257632

EST
Hs.255560
EST
Hs.257633

EST
Hs.255561
EST
Hs.257636

EST
Hs.255569
EST
Hs.257640

EST
Hs.255572
ESTs
Hs.257641

EST
Hs.255573
EST
Hs.257644

EST
Hs.255575
EST
Hs.257645

EST
Hs.255577
EST
Hs.257646

EST
Hs.255578
EST
Hs.257647

EST
Hs.255579
EST
Hs.257667

EST
Hs.255580
EST
Hs.257668

EST
Hs.255590
EST
Hs.257677

EST
Hs.255591
EST
Hs.257679

EST
Hs.255598
EST
Hs.257680

TNFRSF17
Hs.2556
ESTs
Hs.257682

EST
Hs.255600
ESTs
Hs.257684

EST
Hs.255601
EST
Hs.257687

ESTs, Highly similar to KIAA1039 protein
Hs.255603
EST
Hs.257688

[H. sapiens]

EST
Hs.255614
EST
Hs.257690

EST
Hs.255615
EST
Hs.257695

ESTs
Hs.255617
EST
Hs.257697

EST
Hs.255618
EST
Hs.257705

EST
Hs.255621
EST
Hs.257706

EST
Hs.255622
EST
Hs.257709

ESTs
Hs.255625
ESTs, Moderately similar to
Hs.257711

ALU8_HUMAN ALU SUBFAMILY SX

SEQUENCE CONTAMINATION

WARNING ENTRY□ [H. sapiens]

EST
Hs.255626
EST
Hs.257713

ESTs
Hs.255627
EST
Hs.257716

ESTs
Hs.255630
EST
Hs.257719

EST
Hs.255632
EST
Hs.257720

EST
Hs.255633
EST
Hs.257727

EST
Hs.255634
EST
Hs.257730

EST
Hs.255635
EST
Hs.257738

EST
Hs.255637
EST
Hs.257743

ESTs
Hs.255639
ESTs
Hs.258513

EST
Hs.255641
EST
Hs.258820

EST
Hs.255644
EST
Hs.258864

EST
Hs.255645
sema domain, immunoglobulin domain (Ig),

Hs.25887

transmembrane domain (TM) and short

cytoplasmic domain, (semaphorin) 4F

EST
Hs.255646
EST
Hs.258898

EST
Hs.255647
EST
Hs.258933

EST
Hs.255648
interleukin 13 receptor, alpha 2

Hs.25954

EST
Hs.255649

Homo sapiens HSPC101 mRNA, partial cds
Hs.259683

EST
Hs.255650
EST
Hs.263695

EST
Hs.255653
ESTs
Hs.263784

EST
Hs.255657
TNFSF12
Hs.26401

EST
Hs.255661
EST
Hs.264154

ESTs
Hs.255664
EST
Hs.264654

EST
Hs.255665
CDw116b

Hs.265262

EST
Hs.255666
MHC binding factor, beta

Hs.2654

EST
Hs.255668
EST
Hs.265634

EST
Hs.255671
EST
Hs.266387

EST
Hs.255672
ESTs
Hs.268027

EST
Hs.255673
ATHS (LDLR?)
Hs.268571

EST
Hs.255674
ESTs, Highly similar to AAD18086 BAT2

Hs.270193

[H. sapiens]

EST
Hs.255675
ESTs
Hs.270198

EST
Hs.255677
ESTs
Hs.270294

EST
Hs.255679
ESTs, Weakly similar to alternatively
Hs.270542

spliced product using exon 13A [H. sapiens]

EST
Hs.255681
ESTs, Moderately similar to
Hs.270561

ALU2_HUMAN ALU SUBFAMILY SB

SEQUENCE CONTAMINATION

WARNING ENTRY□ [H. sapiens]

EST
Hs.255682
ESTs, Weakly similar to pro alpha 1(I)
Hs.270564

collagen [H. sapiens]

EST
Hs.255686
ESTs, Weakly similar to ALU1_HUMAN
Hs.270578

ALU SUBFAMILY J SEQUENCE

CONTAMINATION WARNING

ENTRY□ [H. sapiens]

ESTs
Hs.255687
ESTs, Moderately similar to brain-derived

Hs.270588

immunoglobulin superfamily molecule

[M. musculus]

EST
Hs.255688
TALL1
Hs.270737

ESTs
Hs.255689
ESTs
Hs.271206

EST
Hs.255691
MYH
Hs.271353

EST
Hs.255692
POLI (RAD30B)
Hs.271699

ESTs
Hs.255693
ADPRTL3
Hs.271742

EST
Hs.255695
ESTs, Moderately similar to
Hs.272075

ALU8_HUMAN ALU SUBFAMILY SX

SEQUENCE CONTAMINATION

WARNING ENTRY□ [H. sapiens]

EST, Highly similar to transmembrane
Hs.255697
Human DNA sequence from clone RP5-

Hs.272271

chloride conductor protein [H. sapiens]

1170K4 on chromosome 22q12.2-13.1

Contains three novel genes, one of which

codes for a Trypsin family protein with

class A LDL receptor domains, and the

IL2RB gene for Interleukin 2 Receptor,

Beta (IL-2 Receptor, CD122 antigen), a

putative CpG island, ESTs, and GSSs

EST
Hs.255698
interleukin 1 receptor accessory protein-like 2

Hs.272354

EST
Hs.255699

Homo sapiens partial IGVH3 V3-20 gene

Hs.272355

for immunoglobulin heavy chain V region,

case 1, clone 2

EST
Hs.255705

Homo sapiens partial IGVH3 gene for

Hs.272356

immunoglobulin heavy chain V region, case

1, clone 16

EST
Hs.255706

Homo sapiens partial IGVH3 gene for

Hs.272357

immunoglobulin heavy chain V region, case

1, clone 19

EST
Hs.255708

Homo sapiens partial IGVH3 gene for

Hs.272358

immunoglobulin heavy chain V region, case

1, cell Mo IV 72

EST
Hs.255710

Homo sapiens partial IGVH1 gene for

Hs.272359

immunoglobulin heavy chain V region, case

1, cell Mo V 94

EST
Hs.255713

Homo sapiens partial IGVL2 gene for

Hs.272360

immunoglobulin lambda light chain V

region, case 1, cell Mo V 94

EST
Hs.255717

Homo sapiens partial IGVH3 gene for

Hs.272361

immunoglobulin heavy chain V region, case

1, cell Mo VI 7

EST
Hs.255718

Homo sapiens partial IGVL1 gene for

Hs.272362

immunoglobulin lambda light chain V

region, case 1, cell Mo VI 65

EST
Hs.255721

Homo sapiens partial IGVH3 gene for

Hs.272363

immunoglobulin heavy chain V region, case

1, cell Mo VI 162

ESTs
Hs.255723

Homo sapiens partial IGVH3 DP29 gene

Hs.272364

for immunoglobulin heavy chain V region,

case 1, cell Mo VII 116

EST
Hs.255725

Homo sapiens partial IGVH4 gene for

Hs.272365

immunoglobulin heavy chain V region, case

2, cell D 56

EST
Hs.255726

Homo sapiens partial IGVH3 gene for

Hs.272366

immunoglobulin heavy chain V region, case

2, cell E 172

EST
Hs.255727
interleukin 20

Hs.272373

EST
Hs.255736
Human DNA sequence from clone RP1-

Hs.272521

149A16 on chromosome 22 Contains an

IGLC (Immunoglobulin Lambda Chain C)

pseudogene, the RFPL3 gene for Ret finger

protein-like 3, the RFPL3S gene for Ret

finger protein-like 3 antisense, the gene for

a novel Immunoglobulin Lambda Chain V

family protein, the gene for a novel protein

similar to mouse RGDS (RALGDS,

RALGEF, Guanine Nucleotide Dissociation

Stimulator A) and rabbit oncogene RSC, the

gene for a novel protein (ortholog of worm

F16A11.2 and bacterial and archea-bacterial

predicted proteins), the gene for a novel

protein similar to BPI (Bacterial

Permeability-Increasing Protein) and rabbit

LBP (Liposaccharide-Binding Protein) and

the 5′ part of a novel gene. Contains ESTs,

STSs, GSSs and three putative CpG islands

EST
Hs.255740
TdT
Hs.272537

EST
Hs.255742
ret finger protein-like 3 antisense

Hs.274285

EST
Hs.255743
PRKR
Hs.274382

EST
Hs.7569

H. sapiens immunoglobulin epsilon chain

Hs.274600

SMAD4
Hs.75862
EST, Weakly similar to HLA-DQ alpha

Hs.275720

chain [H. sapiens]

Homo sapiens splicing factor,
Hs.76122
EST, Weakly similar to RL13_HUMAN
Hs.276279

arginine/serine-rich 4 (SFRS4) mRNA.

60S RIBOSOMAL PROTEIN L13

[H. sapiens]

thymosin beta-10
Hs.76293
EST
Hs.276341

CD63

Hs.76294

EST
Hs.276342

AIF1
Hs.76364
EST, Weakly similar to RL13_HUMAN
Hs.276353

60S RIBOSOMAL PROTEIN L13

[H. sapiens]

phospholipase A2, group IIA (platelets,
Hs.76422
EST
Hs.276774

synovial fluid),

CES1
Hs.76688
EST
Hs.276819

ubiquitin conjugating enzyme
Hs.76932
EST
Hs.276871

Homo sapiens KIAA0963 protein
Hs.7724
EST, Weakly similar to FBRL_HUMAN
Hs.276872

(KIAA0963), mRNA.

FIBRILLARIN [H. sapiens]

Homo sapiens fragile histidine triad gene
Hs.77252
EST
Hs.276887

(FHIT) mRNA.

PAF-AH

Hs.77318

EST
Hs.276902

Mig

Hs.77367

EST
Hs.276917

DDB2
Hs.77602
EST
Hs.276918

ATR
Hs.77613
EST, Weakly similar to RL13_HUMAN
Hs.276938

60S RIBOSOMAL PROTEIN L13

[H. sapiens]

XPB (ERCC3)
Hs.77929
EST
Hs.277051

PNKP
Hs.78016
EST
Hs.277052

C7

Hs.78065

EST, Moderately similar to RL13_HUMAN
Hs.277236

60S RIBOSOMAL PROTEIN L13

[H. sapiens]

Homo sapiens small nuclear RNA activating
Hs.78403
EST, Moderately similar to DEAD Box
Hs.277237

complex, polypeptide 2, 45 kD (SNAPC2)

Protein 5 [H. sapiens]

mRNA.

Hs.78465
EST
Hs.277238

sphingolipid activator protein/cerebroside
Hs.78575
EST
Hs.277286

sulfate activator protein

Homo sapiens aminolevulinate, delta-,
Hs.78712
major histocompatibility complex, class I, C

Hs.277477

synthase 1 (ALAS1), nuclear gene encoding

mitochondrial protein, mRNA.

tyrosine kinase with immunoglobulin and

Hs.78824

EST, Weakly similar to AF150959 1

Hs.277591

epidermal growth factor homology domains

immunoglobulin G1 Fc fragment

[H. sapiens]

Hsp72
Hs.78846
EST
Hs.277714

UNG
Hs.78853
EST
Hs.277715

CX3CR1

Hs.78913

EST
Hs.277716

MSH2
Hs.78934
EST
Hs.277717

CRHR1
Hs.79117
EST
Hs.277718

BCL2
Hs.79241
EST, Weakly similar to BAT3_HUMAN

Hs.277774

LARGE PROLINE-RICH PROTEIN BAT3

[H. sapiens]

P-selectin
Hs.79283
EST
Hs.277975

UBE2VE (MMS2)
Hs.79300
EST
Hs.278060

retinoid X receptor, beta

Hs.79372

cytochrome P450, subfamily XXIA (steroid

Hs.278430

21-hydroxylase, congenital adrenal

hyperplasia), polypeptide 2

MPG
Hs.79396
KIAA0015 gene product

Hs.278441

RPA2
Hs.79411
CD32B

Hs.278443

heat shock 70 kD protein-like 1

Hs.80288

KIR2DL1
Hs.278453

FANCG (XRCC9)
Hs.8047
CD158a
Hs.278455

CD43

Hs.80738

CD24

Hs.278667

POLG
Hs.80961
HLA class II region expressed gene KE4

Hs.278721

Human CB-4 transcript of unrearranged

Hs.81220

IL-17C

Hs.278911

immunoglobulin V(H)5 gene

Human L2-9 transcript of unrearranged

Hs.81221

HSPC048 protein (HSPC048)
Hs.278944

immunoglobulin V(H)5 pseudogene

immunoglobulin superfamily, member 3

Hs.81234

HSPC054 protein (HSPC054)
Hs.278946

UBL1
Hs.81424
HSPC073 protein (HSPC073)
Hs.278948

PF4

Hs.81564

ESTs
Hs.279066

palmitoyl-protein thioesterase 2

Hs.81737

ESTs
Hs.279067

natural killer cell receptor, immunoglobulin

Hs.81743

ESTs
Hs.279068

superfamily member

TNFRSF11B
Hs.81791
ESTs
Hs.279069

interleukin 6 signal transducer (gp130,

Hs.82065

ESTs
Hs.279070

oncostatin M receptor)

CD138
Hs.82109
ESTs
Hs.279071

Human monocytic leukaemia zinc finger
Hs.82210
ESTs
Hs.279072

protein (MOZ) mRNA, complete cds.

sema domain, immunoglobulin domain (Ig),

Hs.82222

ESTs, Weakly similar to KIAA0052 protein
Hs.279073

short basic domain, secreted, (semaphorin)

[H. sapiens]

3B

HPRT
Hs.82314
ESTs
Hs.279074

Human RNA binding protein Etr-3 mRNA,
Hs.82321
ESTs
Hs.279075

complete cds.

MNAT1
Hs.82380
ESTs
Hs.279076

SMAD2
Hs.82483
ESTs
Hs.279077

CD47

Hs.82685

EST
Hs.279078

CETN2
Hs.82794
EST
Hs.279079

protein phosphatase 1, regulatory (inhibitor)

Hs.82887

ESTs
Hs.279080

subunit 11

MMP1
Hs.83169
EST
Hs.279081

D3-type cyclin (CCND3)
Hs.83173
ESTs
Hs.279082

MMP3
Hs.83326
ESTs
Hs.279083

TNFSF10
Hs.83429
ESTs
Hs.279084

CD33

Hs.83731

ESTs
Hs.279085

CD102

Hs.83733

ESTs
Hs.279086

Hs.84153
ESTs, Weakly similar to AF201422_1
Hs.279087

splicing coactivator subunit SRm300

[H. sapiens]

interleukin 8 receptor, beta

Hs.846

ESTs
Hs.279088

titin immunoglobulin domain protein

Hs.84665

ESTs
Hs.279089

(myotilin)

KU80 (XRCC5)
Hs.84981

Hs.86437

Raf-1
Hs.85181

Hs.86761

major histocompatibility complex, class I, J

Hs.85242

CD118 = IFNAR-2

Hs.86958

(pseudogene)

RELB
Hs.858

Hs.87113

Hs.85923
PGHS-1

Hs.88474

ERK1
Hs.861

Hs.8882

FADD
Hs.86131
LT-b

Hs.890

MHC class I polypeptide-related sequence A

Hs.90598

EST
Hs.92440

TNF receptor-associated factor 6

Hs.90957

Hs.92460

Topo3A
Hs.91175
myosin-binding protein H

Hs.927

PARG
Hs.91390
IFN-b

Hs.93177

HLA-DPA1

Hs.914

C8A

Hs.93210

SEEK1
Hs.91600
pre-B-cell leukemia transcription factor 2

Hs.93728

POLD1
Hs.99890
Tachykinin Receptor 3
Hs.942

ALK4
Hs.99954

Homo sapiens cDNA FLJ12242 fis, clone

Hs.94810

MAMMA1001292

XPD (ERCC2)
Hs.99987
CD29
Hs.287797

SCYA25 (CCL25)
Hs.50404
LIF

Hs.2250

SCYA19 (CCL19)
Hs.50002
Human IP-10
Hs.2248

TCIRG1
Hs.46465
IL-5

Hs.2247

PAF-Receptor

Hs.46

G-CSF

Hs.2233

CD26

Hs.44926

TGF-bR
Hs.220

Hs.44865
G-CSFR

Hs.2175

REL
Hs.44313
CD15

Hs.2173

IL-17

Hs.41724

STAT1
Hs.21486

CD49d

Hs.40034

CD85

Hs.204040

CCR2

Hs.395

HCC-1

Hs.20144

Hs.3688
Fas ligand

Hs.2007

TNF-b

Hs.36

CD28

Hs.1987

lactoferrin

Hs.347

HLA-DQA1

Hs.198253

MCP-1

Hs.340

Ku70 (G22P1)
Hs.197345

CD150
Hs.32970
PGHS-2

Hs.196384

IL-10Ra

Hs.327

CDw128

Hs.194778

EGR1
Hs.326035
IL-10

Hs.193717

SCYC1 (XCL1)
Hs.3195
CD126

Hs.193400

HLA-DR
Hs.318720

Hs.1880

Topo I (TOP1)
Hs.317
CD98

Hs.184601

SCYA2 (MCP1)
Hs.303649

Hs.184542

HuRNPD
Hs.303627
MHC class I region ORF

Hs.1845

Human C mu gene for IgM heavy chain

Hs.302063

CDw116a

Hs.182378

exons CH1-4, secretory

P1
Hs.297681
HLA-DRB5

Hs.181366

immunoglobulin lambda joining 3

Hs.289110

major histocompatibility complex, class I, A

Hs.181244

major histocompatibility complex, class II,

Hs.289095

elongation factor 1-alpha (clone CEF4)
Hs.181165

DQ alpha 2

HSPCA
Hs.289088
CD119

Hs.180866

interleukin 22

Hs.287369

Hs.180804

ribosomal protein L4
Hs.286

Hs.180532

IgM
Hs.285823
POLB
Hs.180107

EST
Hs.283267
CD1d

Hs.1799

TREM1
Hs.283022
CD87

Hs.179657

HLA-DRB3

Hs.279930

minichromosome maintenance deficient (S.

Hs.179565

cerevisiae) 3

LIFR

Hs.2798

RAD23B (HR23B)
Hs.178658

C4B

Hs.278625

Hs.178391

EST
Hs.276907

Hs.177781

CDw52

Hs.276770

ADPRT
Hs.177766

CD16b

Hs.274467

IFNGR2

Hs.177559

heat shock 70 kD protein 1B

Hs.274402

CD16a

Hs.176663

Th1
Hs.273385

CD4

Hs.17483

MIP-5/HCC-2

Hs.272493

SCYC2 (XCL2)
Hs.174228

TBX21
Hs.272409
CD115
Hs.174142

Homo sapiens mRNA; cDNA
Hs.272307

CD11a

Hs.174103

DKFZp434O2417 (from clone

DKFZp434O2417); partial cds

Human DNA sequence from clone RP1-

Hs.272295

IL-10Rb

Hs.173936

108C2 on chromosome 6p12.1-21.1.

Contains the MCM3 gene for

minichromosome maintenance deficient (S.

cerevisiae) 3 (DNA replication licensing

factor, DNA polymerase alpha holoenzyme-

associated protein P1, RLF beta subunit), a

CACT (carnitine/acylcarnitine translocase)

pseudogene, part of the gene for a

PUTATIVE novel protein similar to IL17

(interleukin 17 (cytotoxic T-lymphocyte-

associated serine esterase 8)) (cytotoxic T

lymphocyte-associated antigen 8, CTLA8),

ESTs, STSs, GSSs and a putative CpG

island

CD49b

Hs.271986

MSCF

Hs.173894

MCP-2

Hs.271387

TDG
Hs.173824

CD49c

Hs.265829

RAC1
Hs.173737

NBS1
Hs.25812
integrin cytoplasmic domain-associated

Hs.173274

protein 1

CD120b = TNFRSF1B

Hs.256278

IL2R
Hs.1724

CDw75

Hs.2554

IL-1a

Hs.1722

CD82

Hs.25409

Hs.171872

MCP-3

Hs.251526

Hs.171118

xanthine oxidase

Hs.250

EST
Hs.171009

Human Ig rearranged lambda-chain mRNA,

Hs.247947

EST
Hs.170934

subgroup VL3, V-J region, partial cds

Eotaxin-2/MPIF-2

Hs.247838

EST
Hs.170587

CTLA-4

Hs.247824

IL-9R

Hs.1702

immunoglobulin kappa variable 1-9

Hs.247792

CD45

Hs.170121

CD68

Hs.246381

TGF-a

Hs.170009

OSMR

Hs.238648

CD44

Hs.169610

CDw127

Hs.237868

Fyn
Hs.169370

transcription factor 8 (represses interleukin

Hs.232068

MPIF-1

Hs.169191

2 expression)

CD8b

Hs.2299

ICAM-1
Hs.168383

EST
Hs.229374
IL-15

Hs.168132

TRF4-1
Hs.225951
STAT5A
Hs.167503

CD3g
Hs.2259
ESTs
Hs.167208

C2

Hs.2253

ESTs
Hs.165693

Hs.116834

Hs.135750

Hs.117741
DINB1 (POLK)
Hs.135756

Human MHC Class I region proline rich

Hs.118354

Human DNA sequence from clone RP1-

Hs.136141

protein mRNA, complete cds

238O23 on chromosome 6. Contains part of

the gene for a novel protein similar to PIGR

(polymeric immunoglobulin receptor), part

of the gene for a novel protein similar to rat

SAC (soluble adenylyl cyclase), ESTs,

STSs and GSS

ESTs, Weakly similar to FCE2 MOUSE

Hs.118392

Hs.136254

LOW AFFINITY IMMUNOGLOBULIN

EPSILON FC RECEPTOR [M. musculus]

MKK6
Hs.118825

Hs.13646

Hs.118895

Hs.136537

H. sapiens mRNA for ITBA4 gene.
Hs.119018
Histone H1 (F3)
Hs.136857

Hs.119057
MGMT
Hs.1384

TNFRSF10c
Hs.119684

Hs.138563

Hs.12064
IgG
Hs.140

Hs.120907

Hs.140478

acid phosphatase 5, tartrate resistant
Hs.1211

Hs.14070

Hs.121297

Hs.141153

Human immunoglobulin (mAb59) light

Hs.121508

Hs.143954

chain V region mRNA, partial sequence

IL12Rb1

Hs.121544

ESTs, Moderately similar to

Hs.144814

I1BC_HUMAN INTERLEUKIN-1 BETA

CONVERTASE PRECURSOR [H. sapiens]

Human MHC class II DO-alpha mRNA,

Hs.123041

CHK2 (Rad53)
Hs.146329

partial cds

Histone H4 (H4F2)
Hs.123053
EST
Hs.146591

TSHR
Hs.123078

Hs.147040

Hs.123445
CD42b
Hs.1472

regulatory factor X, 1 (influences HLA class

Hs.123638

Hs.149235

II expression)

CD13

Hs.1239

AICD
Hs.149342

IL-15R

Hs.12503

Homo sapiens putative tumor suppressor
Hs.149443

protein (101F6) mRNA, complete cds.

RAD51L3 (RAD51D)
Hs.125244
CD49e

Hs.149609

CDw90

Hs.125359

heparan sulfate proteoglycan (HSPG) core
Hs.1501

protein

LYPLA1
Hs.12540
CD107a

Hs.150101

ESTs, Weakly similar to AF201951 1 high

Hs.126580

ESTs, Weakly similar to 157587 MHC HLA

Hs.150175

affinity immunoglobulin epsilon receptor

SX-alpha [H. sapiens]

beta subunit [H. sapiens]

Hs.127128
ALK2
Hs.150402

Hs.127444
WRN
Hs.150477

C5

Hs.1281

EST
Hs.150708

C8G

Hs.1285

XRCC4
Hs.150930

RAD54B
Hs.128501
IFN-a

Hs.1510

Hs.129020
MAPK
Hs.151051

Hs.129268

Hs.15200

Hs.129332
immunoglobulin mu binding protein 2

Hs.1521

XRCC2
Hs.129727
4-1BBL
Hs.1524

potassium voltage-gated channel, Shaw-
Hs.129738

Hs.152818

related subfamily, member 3 (KCNC3)

interleukin 17 receptor

Hs.129751

HUS1
Hs.152983

CD134
Hs.129780
SWAP70
Hs.153026

TNFRSF10d
Hs.129844
DOM-3 (C. elegans) homolog Z

Hs.153299

POLL
Hs.129903

Hs.153551

GADD153 = growth arrest and DNA-damage
Hs.129913

Hs.15370

inducible gene/fus-chop fusion protein

solute carrier family 5 (neutral amino acid

Hs.130101

SMAD6
Hs.153863

transporters, system A), member 4

Hs.130232
APEXL2
Hs.154149

Hs.13034

Hs.154198

CD30L

Hs.1313

Hs.154366

SCYA26 (CCL26)
Hs.131342
BCL6
Hs.155024

CD30

Hs.1314

Hs.155150

Hs.131885

Hs.155402

Hs.131887
RAIDD
Hs.155566

Hs.13256
POLH
Hs.155573

ESTs
Hs.132775

Hs.15589

Homo sapiens (clone 3.8-1) MHC class I

Hs.132807

Homo sapiens mRNA for KIAA0695
Hs.155976

mRNA fragment

protein complete cds.

Hs.13288
SNM1 (P502)
Hs.1560

Hs.132943
Topo2A
Hs.156346

EST
Hs.133261
ESTs, Highly similar to MHC class II

Hs.156811

antigen [H. sapiens]

Hs.133388
Histamine H1 receptor

Hs.1570

EST
Hs.133393

Hs.157118

EST
Hs.133930

Hs.157267

ESTs
Hs.133947
EST
Hs.157279

ESTs
Hs.133949
EST
Hs.157280

EST
Hs.134017
EST
Hs.157308

EST
Hs.134018
EST
Hs.157309

EST
Hs.134590
EST
Hs.157310

Hs.135135
EST
Hs.157311

immunoglobulin superfamily, member 6

Hs.135194

ESTs
Hs.157344

Hs.135570
ret finger protein-like 2

Hs.157427

Homo sapiens arrestin, beta 2 (ARRB2)
Hs.18142

Hs.214956

mRNA.

myeloperoxidase
Hs.1817
WASP
Hs.2157

APO-1
Hs.182359
CD88

Hs.2161

TRAP1
Hs.182366

Hs.21618

Hs.182594
ring finger protein 5

Hs.216354

TNFRSF16
Hs.1827
class II cytokine receptor ZCYTOR7

Hs.21814

Hs.182817

Hs.219149

regulatory factor X, 4 (influences HLA class

Hs.183009

cyclophilin-related protein
Hs.219153

II expression)

Homo sapiens killer cell lectin-like receptor
Hs.183125

Homo sapiens mannosyl (alpha-1,6-)-
Hs.219479

F1 (KLRF1), mRNA.

glycoprotein beta-1,2-N-

acetylglucosaminyltransferase (MGAT2)

mRNA.

Hs.183171
perforin

Hs.2200

EST
Hs.183386

Hs.220154

Hs.183656
ESTs, Weakly similar to FCE2 MOUSE

Hs.220649

LOW AFFINITY IMMUNOGLOBULIN

EPSILON FC RECEPTOR [M. musculus]

Hs.18368

Hs.220868

advanced glycosylation end product-specific

Hs.184

Hs.220960

receptor

CDK7
Hs.184298
immunoglobulin superfamily, member 1

Hs.22111

Hs.184376

Hs.221539

CCR4

Hs.184926

ESTs
Hs.221694

EST, Weakly similar to A27307 proline-
Hs.185463

Hs.222921

rich phosphoprotein [H. sapiens]

EST
Hs.185498

Hs.222942

EST, Weakly similar to B39066 proline-
Hs.186243
EST
Hs.223520

rich protein 15 - rat [R. norvegicus]

EST, Weakly similar to salivary proline-rich
Hs.186265
EST
Hs.223935

protein [R. norvegicus]

EST
Hs.187200
EST, Moderately similar to SMO_HUMAN
Hs.224178

SMOOTHENED HOMOLOG

PRECURSOR [H. sapiens]

Hs.188048
Blk
Hs.2243

EST
Hs.188075
EST
Hs.224344

EST
Hs.188194
EST
Hs.224408

EST
Hs.188300
EST
Hs.224409

Hs.190251
CPN1
Hs.2246

Hs.19056
MMP7
Hs.2256

EST
Hs.190831
MMP10
Hs.2258

MAPK8
Hs.190913
CCR9

Hs.225946

EST
Hs.190921
toll-like receptor 6 (TLR6)
Hs.227105

EST, Weakly similar to S39206
Hs.190924
XPR1
Hs.227656

hypothetical protein 1 - rat□ [R. norvegicus]

GTF2H2
Hs.191356
CD49f

Hs.227730

Hs.191367

Hs.22790

Hs.191914
EST
Hs.228337

ESTs, Weakly similar to immunoglobulin

Hs.192078

EST, Highly similar to 1409218A elastase
Hs.228525

superfamily member [D. melanogaster]

[H. sapiens]

XPA
Hs.192803
EST
Hs.228528

CD89

Hs.193122

EST, Moderately similar to
Hs.228874

R37A_HUMAN 60S RIBOSOMAL

PROTEIN L37A□ [H. sapiens]

DFFRY
Hs.193145
EST
Hs.228891

CD35

Hs.193716

EST
Hs.228926

REV7 (MAD2L2)
Hs.19400
EST
Hs.229071

Hs.194082
EST
Hs.229405

Hs.194110
EST
Hs.229494

BRCA1
Hs.194143
EST, Weakly similar to ALU1_HUMAN
Hs.229560

ALU SUBFAMILY J SEQUENCE

CONTAMINATION WARNING

ENTRY□ [H. sapiens]

ESTs, Moderately similar to MHC Class I

Hs.194249

EST, Moderately similar to AAD18086
Hs.229901

region proline rich protein [H. sapiens]

BAT2 [H. sapiens]

Hs.194534
EST
Hs.229902

Topo3B
Hs.194685
EST, Highly similar to 1409218A elastase
Hs.230053

[H. sapiens]

Human DNA sequence from clone 1170K4

Hs.194750

RAD51
Hs.23044

on chromosome 22q12.2-13.1. Contains

three novel genes, one of which codes for a

Trypsin family protein with class A LDL

receptor domains, and the IL2RB gene for

Interleukin 2 Receptor, Beta (IL-2 Receptor,

CD122 antigen). Contains a putative CpG

island, ESTs, and GSSs

major histocompatibility complex, class II,

Hs.194764

EST, Moderately similar to A54746 adhalin
Hs.230485

DP alpha 2 (pseudogene)

precursor - human□ [H. sapiens]

Human DNA sequence from clone RP11-

Hs.194976

EST
Hs.230691

367J7 on chromosome 1. Contains (part of)

two or more genes for novel

Immunoglobulin domains containing

proteins, a SON DNA binding protein

(SON) pseudogene, a voltage-dependent

anion channel 1 (VDAC1) (plasmalemmal

porin) pseudogene, ESTs, STSs and GSSs

Hs.195447
EST
Hs.230775

PDGF-B

Hs.1976

EST
Hs.230805

CXCR3

Hs.198252

EST
Hs.230848

Hs.198694
EST
Hs.230862

Hs.198738
EST
Hs.230874

MAR/SAR DNA binding protein (SATB1)
Hs.198822
EST
Hs.230931

CHUK
Hs.198998
EST
Hs.231031

hemochromatosis

Hs.20019

EST
Hs.231261

T-cell receptor active beta-chain
Hs.2003
EST
Hs.231284

APO-1
Hs.2007,
EST
Hs.231285

RXRA
Hs.20084
EST
Hs.231292

EST
Hs.200876
EST, Weakly similar to putative
Hs.231512

mitochondrial outer membrane protein

import receptor [H. sapiens]

Hs.201194

Homo sapiens mRNA for KIAA0529
Hs.23168

protein, partial cds.

TCRd
Hs.2014
EST
Hs.235042

ESTs, Highly similar to TNF-alpha
Hs.202407
EST
Hs.235826

converting enzyme [H. sapiens]

Hs.202608
TREX1 (Dnase III)
Hs.23595

Integrin b1 = CD29

Hs.202661

EST
Hs.237126

thrombomodulin

Hs.2030

Hs.23860

Hs.203064
RAD9
Hs.240457

Hs.203184
1-acylglycerol-3-phosphate O-

Hs.240534

acyltransferase 1 (lysophosphatidic acid

acyltransferase, alpha)

Hs.203584
EST
Hs.240635

EST
Hs.204477
EST, Weakly similar to ALU8_HUMAN
Hs.241136

ALU SUBFAMILY SX SEQUENCE

CONTAMINATION WARNING

ENTRY□ [H. sapiens]

EST
Hs.204480
TNFSF15
Hs.241382

EST, Weakly similar to CA13_HUMAN
Hs.204483
interleukin 1 receptor accessory protein-like 1

Hs.241385

COLLAGEN ALPHA 1(III) CHAIN

PRECURSOR□ [H. sapiens]

ESTs
Hs.204588
RANTES

Hs.241392

EST, Weakly similar to salivary proline-rich
Hs.204598
sema domain, immunoglobulin domain (Ig),

Hs.2414

protein 1 [H. sapiens]

short basic domain, secreted, (semaphorin)

3A

EST
Hs.204610
POLQ
Hs.241517

ESTs
Hs.204703
TNF-a

Hs.241570

ESTs
Hs.204751

Homo sapiens genes encoding RNCC

Hs.241586

protein, DDAH protein, Ly6-C protein, Ly6-

D protein and immunoglobulin receptor

EST
Hs.204760
megakaryocyte-enhanced gene transcript 1

Hs.241587

protein

EST
Hs.204771
EST, Moderately similar to 1409218A
Hs.241981

elastase [H. sapiens]

ESTs
Hs.204873
EST
Hs.241982

ESTs
Hs.204932
EST
Hs.241983

EST
Hs.204954
EST
Hs.242605

EST
Hs.205158
ADPRT2
Hs.24284

ESTs
Hs.205159
EST
Hs.243284

ESTs
Hs.205327
EST
Hs.243286

CD39

Hs.205353

ESTs
Hs.243288

ESTs
Hs.205435
SCYB14
Hs.24395

EST
Hs.205438
EST
Hs.244046

EST, Highly similar to elastic titin
Hs.205452
EST
Hs.244048

[H. sapiens]

EST
Hs.205456
EST
Hs.244049

MRE11A
Hs.20555
EST
Hs.244050

HLA class II region expressed gene KE2

Hs.205736

RFXAP
Hs.24422

EST
Hs.205788

Hs.24435

ESTs
Hs.205789
STAT5B
Hs.244613

EST
Hs.205803
EST
Hs.244666

EST
Hs.205815
EST
Hs.245586

ESTs
Hs.206160
CDw108

Hs.24640

Hs.206654
ESTs
Hs.246796

EST
Hs.207060
dimethylarginine dimethylaminohydrolase 2

Hs.247362

EST
Hs.207062

Homo sapiens clone mcg53-54

Hs.247721

immunoglobulin lambda light chain variable

region 4a mRNA, partial cds

EST
Hs.207063

Homo sapiens ELK1 pseudogene (ELK2)

Hs.247775

and immunoglobulin heavy chain gamma

pseudogene (IGHGP)

EST
Hs.207473
immunoglobulin kappa variable 1/OR2-108

Hs.247804

ESTs
Hs.207474
butyrophilin-like 2 (MHC class II

Hs.247808

associated)

ESTs
Hs.207971

Homo sapiens genes encoding RNCC

Hs.247879

protein, DDAH protein, Ly6-C protein, Ly6-

D protein and immunoglobulin receptor

EST
Hs.207993
Histamine H2 receptor

Hs.247885

EST
Hs.208153
Human anti-streptococcal/anti-myosin

Hs.247898

immunoglobulin lambda light chain variable

region mRNA, partial cds

EST, Weakly similar to S10889 proline-rich
Hs.208667

Homo sapiens isolate donor Z clone Z55K

Hs.247907

protein - human□ [H. sapiens]

immunoglobulin kappa light chain variable

region mRNA, partial cds

ESTs
Hs.209142

Homo sapiens isolate donor D clone D103L

Hs.247908

immunoglobulin lambda light chain variable

region mRNA, partial cds

EST
Hs.209261

Homo sapiens isolate 459 immunoglobulin

Hs.247909

lambda light chain variable region (IGL)

gene, partial cds

ESTs
Hs.209306

Homo sapiens isolate donor N clone N88K

Hs.247910

immunoglobulin kappa light chain variable

region mRNA, partial cds

Hs.209362

Homo sapiens isolate donor N clone N8K

Hs.247911

immunoglobulin kappa light chain variable

region mRNA, partial cds

EST, Weakly similar to FCEB MOUSE

Hs.209540

Human Ig rearranged mu-chain V-region

Hs.247923

HIGH AFFINITY IMMUNOGLOBULIN

gene, subgroup VH-III, exon 1 and 2

EPSILON RECEPTOR BETA-SUBUNIT

[M. musculus]

EST
Hs.209913
Epsilon, IgE = membrane-bound IgE,

Hs.247930

epsilon m/s isoform {alternative splicing}

[human, mRNA Partial, 216 nt]

EST
Hs.209989

H. sapiens (T1.1) mRNA for IG lambda light

Hs.247949

chain

EST
Hs.210049

H. sapiens mRNA for Ig light chain, variable

Hs.247950

region (ID:CLL001VL)

EST, Moderately similar to probable
Hs.210276
Human interleukin 2 gene, clone pATtacIL-

Hs.247956

sodium potassium ATPase gamma chain

2C/2TT, complete cds, clone pATtacIL-

[H. sapiens]

2C/2TT

EST, Weakly similar to N-WASP
Hs.210306
pre-B lymphocyte gene 1

Hs.247979

[H. sapiens]

EST
Hs.210307
Human immunoglobulin heavy chain

Hs.247987

variable region (V4-31) gene, partial cds

EST
Hs.210385
Human immunoglobulin heavy chain

Hs.247989

variable region (V4-30.2) gene, partial cds

interleukin 21 receptor

Hs.210546

Human DNA sequence from phage LAW2

Hs.247991

from a contig from the tip of the short arm

of chromosome 16, spanning 2Mb of

16p13.3 Contains Interleukin 9 receptor

pseudogene

EST
Hs.210727

Homo sapiens HLA class III region

Hs.247993

containing NOTCH4 gene, partial sequence,

homeobox PBX2 (HPBX) gene, receptor

for advanced glycosylation end products

(RAGE) gene, complete cds, and 6

unidentified cds

Hs.211266

Homo sapiens immunoglobulin lambda

Hs.248010

gene locus DNA, clone: 61D6

SMAD3
Hs.211578
immunoglobulin lambda variable 9-49

Hs.248011

MHC class I polypeptide-related sequence B

Hs.211580

immunoglobulin lambda variable 4-3

Hs.248012

ESTs, Weakly similar to CA1B_MOUSE
Hs.211744

H. sapiens mRNA for IgG lambda light

Hs.248030

COLLAGEN ALPHA 1(XI) CHAIN

chain V-J-C region (clone Tgl11)

PRECURSOR□ [M. musculus]

sema domain, immunoglobulin domain (Ig),

Hs.212414

Human immunoglobulin (mAb56) light

Hs.248043

short basic domain, secreted, (semaphorin)

chain V region mRNA, partial sequence

3E

TNFRSF18
Hs.212680

Homo sapiens lymphocyte-predominant

Hs.248077

Hodgkin's disease case #4 immunoglobulin

heavy chain gene, variable region, partial

cds

Homo sapiens general transcription factor 2-
Hs.212939

Homo sapiens lymphocyte-predominant

Hs.248078

I pseudogene 1 (GTF2IP1) mRNA.

Hodgkin's disease case #7 immunoglobulin

heavy chain gene, variable region, partial

cds

RAD 18
Hs.21320

Homo sapiens clone ASMneg1-b3

Hs.248083

immunoglobulin lambda chain VJ region,

(IGL) mRNA, partial cds

Hs.213226
OSM

Hs.248156

ESTs
Hs.279090

Hs.29128

ESTs
Hs.279091

Homo sapiens clone 24659 mRNA
Hs.29206

sequence.

ESTs
Hs.279092
EST
Hs.292235

EST
Hs.279093
EST
Hs.292450

ESTs
Hs.279094
EST, Moderately similar to Ewing sarcoma
Hs.292455

breakpoint region 1, isoform EWS

[H. sapiens]

ESTs
Hs.279095
EST
Hs.292461

ESTs, Weakly similar to AF279265_1
Hs.279096
ESTs
Hs.292501

putative anion transporter 1 [H. sapiens]

ESTs
Hs.279097
EST
Hs.292516

EST
Hs.279098
EST
Hs.292517

ESTs
Hs.279099
EST
Hs.292520

ESTs
Hs.279100
EST, Moderately similar to RL13_HUMAN
Hs.292540

60S RIBOSOMAL PROTEIN L13

[H. sapiens]

ESTs
Hs.279101
EST
Hs.292545

ESTs
Hs.279102
EST, Weakly similar to ORFII [H. sapiens]
Hs.292704

ESTs
Hs.279103
EST
Hs.292761

ESTs
Hs.279104
ESTs
Hs.292803

ESTs
Hs.279105
ESTs
Hs.293183

ESTs
Hs.279106
ESTs
Hs.293280

EST
Hs.279107
ESTs
Hs.293281

ESTs
Hs.279108
ESTs, Moderately similar to 0501254A

Hs.293441

protein Tro alpha1 H,myeloma [H. sapiens]

EST
Hs.279109
MMP13
Hs.2936

ESTs
Hs.279110
major histocompatibility complex, class II,

Hs.293934

DR beta 4

ESTs
Hs.279111
Human MHC class III serum complement

Hs.294163

factor B, mRNA

ESTs
Hs.279112
EST
Hs.294315

EST
Hs.279113
EST
Hs.294316

ESTs
Hs.279114
EST, Highly similar to Y196_HUMAN
Hs.295582

HYPOTHETICAL PROTEIN KIAA0196□

[H. sapiens]

ESTs
Hs.279115
EST
Hs.295583

ESTs
Hs.279116
EST, Highly similar to ZN07_HUMAN
Hs.295584

ZINC FINGER PROTEIN 7 [H. sapiens]

ESTs
Hs.279117
EST
Hs.295585

ESTs
Hs.279118
EST
Hs.295586

ESTs
Hs.279119
EST, Moderately similar to angiotensin
Hs.295595

converting enzyme [H. sapiens]

ESTs
Hs.279120
EST
Hs.295621

ESTs
Hs.279121
EST
Hs.295622

ESTs
Hs.279122
EST, Moderately similar to RL13_HUMAN
Hs.295629

60S RIBOSOMAL PROTEIN L13

[H. sapiens]

ESTs
Hs.279123
EST
Hs.295724

ESTs
Hs.279124
EST
Hs.296064

ESTs
Hs.279125
EST, Moderately similar to IDS_HUMAN
Hs.296070

IDURONATE 2-SULFATASE

PRECURSOR□ [H. sapiens]

ESTs
Hs.279126
EST
Hs.296073

ESTs
Hs.279127
interleukin enhancer binding factor 1

Hs.296281

EST
Hs.279128
similar to rat integral membrane

Hs.296429

glycoprotein POM121

ESTs, Weakly similar to aconitase
Hs.279129
Human histocompatibility antigen mrna

Hs.296476

[H. sapiens]

clone phla-1

ESTs
Hs.279130
immunoglobulin lambda-like polypeptide 3

Hs.296552

ESTs
Hs.279131
RFXANK
Hs.296776

ESTs
Hs.279132

Hs.29826

ESTs
Hs.279133

Hs.29871

ESTs, Weakly similar to PYRG_HUMAN
Hs.279134
MEKK1
Hs.298727

CTP SYNTHASE [H. sapiens]

ESTs, Weakly similar to RIR1_HUMAN
Hs.279135

Hs.30029

RIBONUCLEOSIDE-DIPHOSPHATE

REDUCTASE M1 CHAIN [H. sapiens]

ESTs
Hs.279136
CD3e
Hs.3003

ESTs
Hs.279137
ESTs, Weakly similar to CA13_HUMAN

Hs.300697

COLLAGEN ALPHA 1(III) CHAIN

PRECURSOR [H. sapiens]

ESTs
Hs.279138

Homo sapiens clone BCSynL38

Hs.300865

immunoglobulin lambda light chain variable

region mRNA, partial cds

ESTs
Hs.279139
FCGR3A
Hs.300983

ESTs
Hs.279140

Homo sapiens DP47 gene for

Hs.301365

immunoglobulin heavy chain, partial cds

ESTs
Hs.279141
PMS2L9
Hs.301862

EST
Hs.279142
CCR1
Hs.301921

ESTs
Hs.279143
FANCE
Hs.302003

ESTs
Hs.279144
interleukin 21

Hs.302014

ESTs
Hs.279145
interleukin 17E

Hs.302036

ESTs
Hs.279146

Hs.30446

EST
Hs.279147
EST
Hs.30709

ESTs
Hs.279148
EST
Hs.30731

ESTs
Hs.279149
MHC class II transactivator

Hs.3076

ESTs
Hs.279150
EST
Hs.30766

ESTs, Weakly similar to PUR2_HUMAN
Hs.279151
EST
Hs.30793

TRIFUNCTIONAL PURINE

BIOSYNTHETIC PROTEIN ADENOSINE

3 [H. sapiens]

ESTs
Hs.279152

Hs.30818

ESTs
Hs.279153
CD97

Hs.3107

ESTs
Hs.279154
RAR-beta2
Hs.31408

ESTs
Hs.279155
RECQL4
Hs.31442

ESTs
Hs.279156
XPC
Hs.320

ESTs
Hs.279157
ERK2
Hs.324473

ESTs
Hs.279158

Hs.32456

ESTs
Hs.279159
MSH6
Hs.3248

ESTs
Hs.279160
ribosomal protein L23-related
Hs.3254

ESTs, Weakly similar to IDHA_HUMAN
Hs.279161
PI3CG
Hs.32942

ISOCITRATE DEHYDROGENASE

[H. sapiens]

ESTs
Hs.279162
CSA (CKN1)
Hs.32967

ESTs
Hs.279163
sema domain, immunoglobulin domain (Ig),

Hs.32981

short basic domain, secreted, (semaphorin)

3F

ESTs
Hs.279164
BRCA2
Hs.34012

ESTs
Hs.279165
MEK1
Hs.3446

ESTs
Hs.279166
STRL33 (CXCR6)
Hs.34526

ESTs
Hs.279167
MBD4
Hs.35947

ESTs
Hs.279168
immunoglobulin (CD79A) binding protein 1

Hs.3631

EST
Hs.279169

CD7

Hs.36972

ESTs
Hs.279170
IFNA1
Hs.37026

ESTs
Hs.279171
PDGF-A

Hs.37040

EST
Hs.279172
immunoglobulin kappa variable 1-13

Hs.37089

ESTs
Hs.279174
DMC1
Hs.37181

ESTs
Hs.279175

Hs.37892

CD86

Hs.27954

Homo sapiens suppressor of variegation 3-9
Hs.37936

(Drosophila) homolog (SUV39H) mRNA,

and translated products.

CGI-81 protein

Hs.279583

C8B

Hs.38069

ESTs
Hs.279821
MTH1 (NUDT1)
Hs.388

ESTs
Hs.279823
Adrenomedullin
Hs.394

ESTs, Weakly similar to IRE1_HUMAN
Hs.279824

Hs.39441

IRON-RESPONSIVE ELEMENT

BINDING PROTEIN 1 [H. sapiens]

ESTs
Hs.279825
CD66b

Hs.41

ESTs
Hs.279826
RAD50
Hs.41587

MLH3
Hs.279843
CD94

Hs.41682

TNFRSF14
Hs.279899
HLJ1
Hs.41693

RPA4
Hs.283018
ESM1
Hs.41716

EST
Hs.283165
MSH3
Hs.42674

EST
Hs.283166
cAMP responsive element binding protein-

Hs.42853

like 1

EST
Hs.283167
IKBKG
Hs.43505

EST
Hs.283168

Homo sapiens suppressor of white apricot
Hs.43543

homolog 2 (SWAP2), mRNA.

ESTs
Hs.283169
LEU2
Hs.43628

EST
Hs.283245

Homo sapiens immunoglobulin lambda

Hs.43834

gene locus DNA, clone:288A10

EST
Hs.283247
SIRT2
Hs.44017

ESTs
Hs.283248

Hs.44087

EST
Hs.283249
TREM2
Hs.44234

EST
Hs.283250
serine/threonine kinase 19

Hs.444

EST
Hs.283251

Hs.44512

EST
Hs.283252

Hs.44628

EST
Hs.283253

Hs.45063

EST
Hs.283254
LTC4 synthase

Hs.456

EST
Hs.283255
FUT2
Hs.46328

EST
Hs.283256
CCR6

Hs.46468

EST
Hs.283257
POLM
Hs.46964

EST
Hs.283258
EXO1 (HEX1)
Hs.47504

ESTs
Hs.283259
FEN1 (Dnase IV)
Hs.4756

EST
Hs.283261

Hs.4863

EST
Hs.283262
golgin-165
Hs.4953

EST
Hs.283263

Hs.50102

EST
Hs.283264
ATP-binding cassette, sub-family B

Hs.502

(MDR/TAP), member 3

EST
Hs.283266

Hs.5057

ESTs
Hs.283268
corneodesmosin

Hs.507

EST
Hs.283269
Histone H2 (H2AFP)
Hs.51011

EST, Weakly similar to AF189011_1
Hs.283270
CCNH
Hs.514

ribonuclease III [H. sapiens]

EST
Hs.283271
EST
Hs.5146

EST
Hs.283272
SMUG1
Hs.5212

EST
Hs.283274
ABH (ALKB)
Hs.54418

EST
Hs.283275
CCR5

Hs.54443

EST
Hs.283276
CD81

Hs.54457

ESTs, Weakly similar to S32605 collagen
Hs.283392
TNFSF13
Hs.54673

alpha 3(VI) chain - mouse [M. musculus]

ESTs
Hs.283433
PRPS1
Hs.56

ESTs
Hs.283434

Hs.56156

ESTs
Hs.283438

Hs.56265

ESTs
Hs.283442
killer cell immunoglobulin-like receptor,

Hs.56328

three domains, long cytoplasmic tail, 2

ESTs
Hs.283443
EST
Hs.5656

ESTs
Hs.283456

Hs.56845

ESTs
Hs.283457
MLH1
Hs.57301

ESTs, Weakly similar to similar to collagen
Hs.283458
testis specific basic protein

Hs.57692

[C. elegans]

ESTs
Hs.283459
ESTs

Hs.57841

ESTs
Hs.283460
Human 6Ckine
Hs.57907

ESTs
Hs.283462
EST
Hs.5816

ESTs
Hs.283463

Homo sapiens cell growth regulatory with
Hs.59106

ring finger domain (CGR19) mRNA.

ESTs
Hs.283496
ERCC1
Hs.59544

ESTs
Hs.283497

Hs.61558

ESTs
Hs.283499

Homo sapiens GPI transamidase mRNA,
Hs.62187

complete cds.

ESTs
Hs.283500

Hs.62699

ESTs, Weakly similar to ORF YDL014w
Hs.283504

Hs.63913

[S. cerevisiae]

ESTs, Weakly similar to S09646 collagen
Hs.283505

Homo sapiens chloride intracellular channel
Hs.64746

alpha 2(VI) chain precursor, medium splice

3 (CLIC3), mRNA.

form - human□ [H. sapiens]

ESTs
Hs.283608
FANCF
Hs.65328

CD42c
Hs.283743

Hs.6544

tenascin XA

Hs.283750

interleukin 1 receptor-like 1

Hs.66

immunoglobulin kappa variable 1D-8

Hs.283770

CD38

Hs.66052

protocadherin gamma subfamily A, 2
Hs.283801

Hs.6607

(PCDHGA2)

Homo sapiens mRNA; cDNA
Hs.283849
RAD54L
Hs.66718

DKFZp762F0616 (from clone

DKFZp762F0616)

Homo sapiens clone bsmneg3-t7

Hs.283876

SCYA17 (CCL17)
Hs.66742

immunoglobulin lambda light chain VJ

region, (IGL) mRNA, partial cds

Homo sapiens transgenic-JHD mouse #2357

Hs.283878

IL-12

Hs.673

immunoglobulin heavy chain variable

region (IgG VH251) mRNA, partial cds

Homo sapiens clone N97 immunoglobulin

Hs.283882

Human IL-12 p40
Hs.674

heavy chain variable region mRNA, partial

cds

Homo sapiens clone case06H1

Hs.283924

LILRB4
Hs.67846

immunoglobulin heavy chain variable

region gene, partial cds

Homo sapiens HSPC077 mRNA, partial cds
Hs.283929
interleukin 5 receptor, alpha

Hs.68876

Homo sapiens HSPC088 mRNA, partial cds
Hs.283931

Hs.6891

Homo sapiens HSPC097 mRNA, partial cds
Hs.283933

Hs.69233

Homo sapiens HSPC102 mRNA, partial cds
Hs.283934
FUT1
Hs.69747

Homo sapiens HSPC107 mRNA, partial cds
Hs.283935
B-factor, properdin

Hs.69771

CMKRL1
Hs.28408

Hs.70333

FANCA
Hs.284153

Hs.71618

Homo sapiens immunoglobulin mu chain

Hs.284277

RAD1

Hs.7179

antibody MO30 (IgM) mRNA, complete

cds

gamma-glutamyltransferase 1

Hs.284380

interleukin 19

Hs.71979

putative human HLA class II associated

Hs.285013

MEK2
Hs.72241

protein I

interleukin 13 receptor, alpha 1

Hs.285115

IL-7

Hs.72927

CDw131
Hs.285401
STAT2
Hs.72988

Homo sapiens VH2-D3.10-JH5b gene for

Hs.287403

CD42d
Hs.73734

immunoglobulin heavy chain variable

region

Homo sapiens cDNA: FLJ22546 fis, clone
Hs.287697
MIF

Hs.73798

HSI00290

Homo sapiens cDNA: FLJ23140 fis, clone
Hs.287728
ECP

Hs.73839

LNG09065

H. sapiens mRNA for HLA-C alpha chain

Hs.287811

CPN2
Hs.73858

(Cw*1701)

Homo sapiens clone ASMneg1-b1

Hs.287815

MMP8
Hs.73862

immunoglobulin lambda chain VJ region,

(IGL) mRNA, partial cds

Homo sapiens clone CPRF1-T2

Hs.287816

HLA-G histocompatibility antigen, class I, G

Hs.73885

immunoglobulin lambda chain VJ region,

(IGL) mRNA, partial cds

EST
Hs.287817
TNFRSF9
Hs.73895

myelin protein zero-like 1

Hs.287832

IL-4

Hs.73917

immunoglobulin lambda-like polypeptide 1

Hs.288168

HLA-DQB1

Hs.73931

cathepsinB
Hs.288181
RAG1
Hs.73958

G18.2 protein

Hs.288316

LAG-3

Hs.74011

ESTs
Hs.288403

Hs.7402

EST
Hs.288431
CD163
Hs.74076

Homo sapiens partial IGVH2 gene for

Hs.288553

immunoglobulin superfamily, member 2

Hs.74115

immunoglobulin heavy chain V region, case

2, cell B 45

polymeric immunoglobulin receptor

Hs.288579

CD158b
Hs.74134

Human immunoglobulin heavy chain

Hs.288711

Hs.7434

variable region (V4-4) gene, partial cds

Human immunoglobulin heavy chain

Hs.289036

TCRa
Hs.74647

variable region (V4-4b) gene, partial cds

Hs.28921
human immunodeficiency virus type I

Hs.75063

enhancer-binding protein 2

EST
Hs.289577
MLN50
Hs.75080

EST
Hs.289836
lysyl hydroxylase (PLOD)
Hs.75093

EST
Hs.289878
TAK1
Hs.7510

GSN
Hs.290070

Homo sapiens transcription factor 6-like 1
Hs.75133

(mitochondrial transcription factor 1-like)

(TCF6L1) mRNA.

EST, Weakly similar to unnamed protein
Hs.290133
UBE2N (UBC13, BTG1)
HS.75355

product [H. sapiens]

EST
Hs.290227

Hs.75450

ESTs
Hs.290315
HSPA2
Hs.75452

EST
Hs.290339
CD151
Hs.75564

EST
Hs.290340
RELA
Hs.75569

Hs.29055
CD122

Hs.75596

EST
Hs.291125
CD14-UZ

Hs.75627

EST
Hs.291126
nuclear factor erythroid 2 isoform f = basic
Hs.75643

leucine zipper protein {alternatively spliced

CD91 = LRP

Hs.89137

C1QB

Hs.8986

XPF (ERCC4)
Hs.89296
superkiller viralicidic activity 2 (S.

Hs.89864

cerevisiae homolog)-like

Carbonic anhydrase IV
Hs.89485
EST
Hs.90165

CETP
Hs.89538
EST
Hs.90171

RAD52
Hs.89571
GTF2H3
Hs.90304

GTF2H1
Hs.89578
protein tyrosine kinase related sequence
Hs.90314

Fc fragment of IgE, high affinity I, receptor

Hs.897

Hs.90463

for; alpha polypeptide

transcript ch138
Hs.94881
SGRF protein, Interleukin 23 p19 subunit

Hs.98309

Hs.9578
XRCC1
Hs.98493

IL-9

Hs.960

Homo sapiens mRNA for KIAA0543
Hs.98507

protein, partial cds.

NFATC1
Hs.96149

Hs.9893

OGG1
Hs.96398
DIR1 protein

Hs.99134

Hs.96499
XRCC3
Hs.99742

NFKBIB
Hs.9731
Elastase(leukocyte)

Hs.99863

XAB2 (HCNP)
Hs.9822
JAK3
Hs.99877

CD40
Hs.652

TABLE 3A

Candidate nucleotide sequences identified using differential cDNA

hybridization analysis

Offset

Example
on Acc
Accession

Number

Clone
Start
End
Number
UniGene
Signif
Clones
Genbank Description

56D1
1521
1685
D00022
Hs.25
1.00E−84
1
for F1 beta subunit, complete

586E3
1227
1448
NM_001686
Hs.25
1.00E−89
1
ATP synthase, H+ transporting, mitochondrial

459F4
1484
2522
NM_002832
Hs.35
0
3
protein tyrosine phosphatase, non-receptor t

41A11
885
1128
D12614
Hs.36
1.00E−125
1
lymphotoxin (TNF-beta), complete

41G12
442
1149
D10202
Hs.46
0
1
for platelet-activating factor receptor,

98E12
1928
2652
NM_002835
Hs.62
0
1
protein tyrosine phosphatase, non-receptor t

170E1
473
1071
U13044
Hs.78
0
1
nuclear respiratory factor-2 subunit alpha mRNA, com

40C6
939
1357
D11086
Hs.84
0
1
interleukin 2 receptor gamma chain

521F9
283
1176
NM_000206
Hs.84
0
8
interleukin 2 receptor, gamma (severe combined

60A11
989
1399
L08069
Hs.94
0
2
heat shock protein, E. coli DnaJ homologue complete

cd

520B9
545
1438
NM_001539
Hs.94
0
3
heat shock protein, DNAJ-like 2 (HSJ2), mRNA/

460H9
626
1104
NM_021127
Hs.96
0
1
phorbol-12-myristate-13-acetate-induced p

127G12
651
1223
NM_004906
Hs.119
0
2
Wilms' tumor 1-associating protein (KIAA0105

586A7
438
808
NM_000971
Hs.153
0
3
ribosomal protein L7 (RPL7), mRNA/cds = (10,756

99H12
2447
4044
NM_002600
Hs.188
0
2
phosphodiesterase 4B, cAMP-specific (dunce (

464D4
2317
2910
NM_002344
Hs.210
0
1
leukocyte tyrosine kinase (LTK), mRNA/cds = (17

464B3
10
385
NM_002515
Hs.214
1.00E−164
1
neuro-oncological ventral antigen 1 (NOVA1),

40A12
296
1153
L11695
Hs.220
0
1
activin receptor-like kinase (ALK-5) mRNA, complete

129A2
4138
4413
NM_000379
Hs.250
1.00E−155
1
xanthene dehydrogenase (XDH), mRNA

36B10
80
1475
AF068836
Hs.270
0
3
cytohesin binding protein HE mRNA, complete cd

45C11
58
1759
NM_004288
Hs.270
0
2
pleckstrin homology, Sec7 and coiled/coil dom

128C12
2555
3215
NM_000153
Hs.273
0
4
galactosylceramidase (Krabbe disease) (GALC)

67H2
259
1418
D23660
Hs.286
0
8
ribosomal protein, complete cds

151E6
624
1170
AF052124
Hs.313
0
1
clone 23810 osteopontin mRNA, complete cds/c

45A7
4
262
NM_000582
Hs.313
1.00E−136
1
secreted phosphoprotein 1 (osteopontin, bone

44C10
2288
2737
J03250
Hs.317
0
1
topoisomerase I mRNA, complete cds/

cds = (211,2508)/

99H9
2867
3246
NM_001558
Hs.327
0
2
interleukin 10 receptor, alpha (IL10RA), mRNA

41B4
2867
3315
U00672
Hs.327
0
6
interleukin-10 receptor mRNA, complete

144E1
283
989
M26683
Hs.340
0
36
interferon gamma treatment inducible/cds = (14,1

41A12
1854
2590
X53961
Hs.347
0
1
lactoferrin/cds = (294,2429)/gb = X53961/gi =

40F1
1377
1734
U95626
Hs.395
0
1
ccr2b (ccr2), ccr2a (ccr2), ccr5 (ccr5) and cc

463H4
55
434
NM_001459
Hs.428
0
1
fms-related tyrosine kinase 3 ligand (FLT3LG)

127E1
552
1048
NM_005180
Hs.431
0
1
murine leukemia viral (bmi-1) oncogene homolo

73G12
189
1963
NM_004024
Hs.460
0
17
activating transcription factor 3 (ATF3), ATF

524A4
1361
2136
NM_004168
Hs.469
0
2
succinate dehydrogenase complex, subunit A,

41C7
1554
2097
D10925
Hs.516
0
1
HM145/cds = (22,1089)/gb = D10925/gi = 219862

588A2
48
163
NM_001032
Hs.539
1.00E−59
1
ribosomal protein S29 (RPS29), mRNA/cds = (30,2

177B4
1
1674
AF076465
Hs.550
2.00E−37
2
PhLOP2 mRNA, complete cds/cds = (5,358)/gb = AF

68G5
2
1454
M26383
Hs.624
0
17
monocyte-derived neutrophil-activating protein (M

45F10
1
1454
NM_000584
Hs.624
0
11
interleukin 8 (IL8), mRNA/cds = (74,373)/gb = N

59F11
59
1822
X68550
Hs.652
0
14
TRAP mRNA for ligand of CD40/cds = (56,841)/gb = X6

471C9
3115
3776
NM_000492
Hs.663
0
1
cystic fibrosis transmembrane conductance re

68D1
228
866
M20137
Hs.694
0
3
interleukin 3 (IL-3) mRNA, complete cds, clone pcD-

SR

49H3
42
665
NM_000588
Hs.694
0
1
interleukin 3 (colony-stimulating factor, mu

147H3
110
340
BF690338
Hs.695
1.00E−102
1
602186730T1 cDNA, 3′ end/clone = IMAGE: 4299006

483E4
310
846
NM_000942
Hs.699
0
1
peptidylprolyl isomerase B (cyclophilin B) (

522B12
349
755
NM_000788
Hs.709
0
2
deoxycytidine kinase (DCK), mRNA/cds = (159,94

331E5
1293
1470
J03634
Hs.727
9.00E−75
1
erythroid differentiation protein mRNA (EDF), comple

514D12
1164
1579
NM_004907
Hs.737
1.00E−169
3
immediate early protein (ETR101), mRNA/cds = (

73H7
1953
3017
AJ243425
Hs.738
0
8
EGR1 gene for early growth response protein 1/

592A8
10
454
NM_003973
Hs.738
0
5
ribosomal protein L14 (RPL14), mRNA

519A1
116
1527
NM_000801
Hs.752
1.00E−163
2
FK506-binding protein 1A (12 kD) (FKBP1A), mRN

109H11
1
1206
M60626
Hs.753
0
10
N-formylpeptide receptor (fMLP-R98) mRNA, complete

99C5
1
1175
NM_002029
Hs.753
0
25
formyl peptide receptor 1 (FPR1), mRNA

103C1
2285
2890
NM_002890
Hs.758
0
1
RAS p21 protein activator (GTPase activating p

41H4
3142
3332
NM_000419
Hs.785
1.00E−84
1
integrin, alpha 2b (platelet glycoprotein IIb

171D2
198
748
X54489
Hs.789
1.00E−132
2
melanoma growth stimulatory activity (MGSA)

458H7
2165
2818
NM_001656
Hs.792
0
1
ADP-ribosylation factor domain protein 1, 64

62B3
833
1241
M60278
Hs.799
0
2
heparin-binding EGF-like growth factor mRNA,

complet

53G4
1299
2166
AK001364
Hs.808
0
6
FLJ10502 fis, clone NT2RP2000414, highly

597F3
1136
1797
NM_004966
Hs.808
0
2
heterogeneous nuclear ribonucleoprotein F (

143F7
575
985
M74525
Hs.811
0
3
HHR6B (yeast RAD 6 homologue) mRNA, complete

518H8
580
974
NM_003337
Hs.811
0
1
ubiquitin-conjugating enzyme E2B (RAD6 homol

45G8
277
833
NM_002121
Hs.814
0
1
major histocompatibility complex, class II,

41H11
719
1534
NM_005191
Hs.838
0
1
CD80 antigen (CD28 antigen ligand 1, B7-1 antig

41G1
117
557
U31120
Hs.845
0
1
interleukin-13 (IL-13) precursor gene, complete cds

75E1
693
862
J05272
Hs.850
2.00E−58
4
IMP dehydrogenase type 1 mRNA complete

129B11
3361
3883
L25851
Hs.851
0
1
integrin alpha E precursor, mRNA, complete cds

481E9
3361
3742
NM_002208
Hs.851
1.00E−173
1
integrin, alpha E (antigen CD103, human mucosa

71G7
1
1193
NM_000619
Hs.856
0
111
interferon, gamma (IFNG), mRNA/cds = (108,608)

75H5
1
1193
X13274
Hs.856
0
314
interferon IFN-gamma/cds = (108,608)/gb = X13

525B12
672
894
NM_002341
Hs.890
1.00E−121
1
lymphotoxin beta (TNF superfamily, member 3)

40E8
75
999
AL121985
Hs.901
0
6
DNA sequence RP11-404F10 on chromosome 1q2

48H4
680
933
NM_001778
Hs.901
1.00E−130
2
CD48 antigen (B-cell membrane protein) (CD48)

179G8
1652
2181
AL163285
Hs.926
0
1
chromosome 21 segment HS21C085

48G11
1049
2092
NM_002463
Hs.926
0
3
myxovirus (influenza) resistance 2, homolog o

110B12
209
1734
M32011
Hs.949
0
8
neutrophil oxidase factor (p67-phox) mRNA, complete

99C9
207
1733
NM_000433
Hs.949
0
11
neutrophil cytosolic factor 2 (65 kD, chronic g

125D2
958
1645
NM_004645
Hs.966
0
1
coilin (COIL), mRNA/cds = (22,1752)/gb = NM_004

458C1
1649
2285
NM_006025
Hs.997
0
1
protease, serine, 22 (P11), mRNA/cds = (154,126

40H11
621
864
L26953
Hs.1010
1.00E−135
1
chromosomal protein mRNA, complete cds/cds = (7

116D10
513
858
NM_002932
Hs.1010
0
1
regulator of mitotic spindle assembly 1 (RMSA

40G11
1565
2151
M31452
Hs.1012
0
1
proline-rich protein (PRP) mRNA, complete

192A6
321
908
NM_000284
Hs.1023
0
1
pyruvate dehydrogenase (lipoamide) alpha 1 (

460H11
2158
2402
NM_004762
Hs.1050
2.00E−91
1
pleckstrin homology, Sec7 and coiled/coil dom

41F12
291
565
M57888
Hs.1051
1.00E−112
1
(clone lambda B34) cytotoxic T-lymphocyte-associate

41A5
1311
1852
M55654
Hs.1100
0
1
TATA-binding protein mRNA, complete

461D7
999
1277
NM_002698
Hs.1101
1.00E−92
1
POU domain, class 2, transcription factor 2 (P

597H9
1083
1224
NM_000660
Hs.1103
3.00E−75
1
transforming growth factor, beta 1 (TGFB1), mR

40B5
1433
2010
X02812
Hs.1103
0
1
transforming growth factor-beta (TGF-beta)

106A10
1977
2294
M73047
Hs.1117
1.00E−176
1
tripeptidyl peptidase II mRNA, complete cds/c

165E8
4273
4582
NM_003291
Hs.1117
1.00E−173
1
tripeptidyl peptidase II (TPP2), mRNA/cds = (23

63G12
1114
2339
D49728
Hs.1119
0
7
NAK1 mRNA for DNA binding protein, complete

45B10
1317
1857
NM_002135
Hs.1119
0
1
nuclear receptor subfamily 4, group A, member

37H3
568
783
M24069
Hs.1139
1.00E−119
1
DNA-binding protein A (dbpA) gene, 3′ end

476F9
209
608
NM_000174
Hs.1144
0
1
glycoprotein IX (platelet) (GP9), mRNA/cds = (

43A10
1105
1357
U15085
Hs.1162
3.00E−41
1
HLA-DMB mRNA, complete cds

139D6
1345
1680
L11329
Hs.1183
1.00E−102
1
protein tyrosine phosphatase (PAC-1) mRNA, co

134B12
1233
1675
NM_004418
Hs.1183
0
1
dual specificity phosphatase 2 (DUSP2), mRNA

58F1
17
341
NM_002157
Hs.1197
0
1
heat shock 10 kD protein 1 (chaperonin 10) (HSP

158G5
20
341
U07550
Hs.1197
1.00E−180
2
chaperonin 10 mRNA, complete cds

167C8
813
1453
NM_000022
Hs.1217
0
4
adenosine deaminase (ADA), mRNA/cds = (95,1186

179H1
730
1452
X02994
Hs.1217
0
6
adenosine deaminase (adenosine aminohydrola

40E10
594
792
M38690
Hs.1244
1.00E−109
1
CD9 antigen mRNA, complete cds

41C5
1280
1438
AK024951
Hs.1279
2.00E−80
1
FLJ21298 fis, clone COL02040, highly sim

40E3
1002
1735
NM_000065
Hs.1282
0
1
complement component 6 (C6) mRNA/cd

40A11
1638
1821
K02766
Hs.1290
3.00E−98
1
complement component C9 mRNA, complete

40B12
4639
5215
NM_007289
Hs.1298
0
1
membrane metallo-endopeptidase (neutral end

41G2
1576
1870
M28825
Hs.1309
1.00E−115
1
thymocyte antigen CD1a mRNA, complete cds

41F8
1171
1551
AX023365
Hs.1349
0
1
Sequence 36 from Patent WO0006605

40E1
673
1147
M30142
Hs.1369
0
1
decay-accelerating factor mRNA, complete cds

118B12
1129
1719
NM_000574
Hs.1369
0
1
decay accelerating factor for complement (CD5

75F8
830
2979
NM_000399
Hs.1395
0
48
early growth response 2 (Krox-20 (Drosophila)

41F11
973
1428
M15059
Hs.1416
0
1
Fc-epsilon receptor (IgE receptor) mRNA, complete cd

110G12
1931
2071
AL031729
Hs.1422
2.00E−70
1
DNA seq RP1-159A19 on chromosome 1p36

113D10
1718
2066
NM_005248
Hs.1422
6.00E−76
2
Gardner-Rasheed feline sarcoma viral (v-fgr)

477C2
3292
3842
NM_000152
Hs.1437
0
1
glucosidase, alpha; acid (Pompe disease, glyc

124D1
795
1127
NM_000167
Hs.1466
0
1
glycerol kinase (GK), mRNA/cds = (66,1640)/gb

41B9
2231
2447
J03171
Hs.1513
1.00E−108
1
interferon-alpha receptor (HuIFN-alpha-Rec) mRNA,

99F7
927
1889
NM_014882
Hs.1528
0
2
KIAA0053 gene product (KIAA0053), mRNA/cds = (

469G9
1220
1507
NM_005082
Hs.1579
1.00E−117
1
zinc finger protein 147 (estrogen-responsive

195B7
190
1801
BC002971
Hs.1600
0
3
clone IMAGE: 3543711, mRNA, partial cds/cds =

195F10
3676
3856
NM_000110
Hs.1602
1.00E−85
1
dihydropyrimidine dehydrogenase (DPYD), mRN

129E7
648
1827
L08176
Hs.1652
0
2
Epstein-Barr virus induced G-protein coupled recepto

478H5
1839
2050
NM_002056
Hs.1674
7.00E−79
1
glutamine-fructose-6-phosphate transaminas

39H1
436
865
L35249
Hs.1697
0
1
vacuolar H+-ATPase Mr 56,000 subunit (HO57) mR

183H8
972
1183
NM_001693
Hs.1697
1.00E−106
1
ATPase, H+ transporting, lysosomal (vacuolar

481A4
1594
1785
NM_001420
Hs.1701
2.00E−79
1
ELAV (embryonic lethal, abnormal vision, Dros

40B3
3846
4009
L39064
Hs.1702
4.00E−70
1
interleukin 9 receptor precursor (IL9R) gene,

176G8
1033
1400
NM_006084
Hs.1706
0
1
interferon-stimulated transcription factor

589C11
1
1347
NM_005998
Hs.1708
0
2
chaperonin containing TCP1, subunit 3 (gamma)

70H5
1
494
X74801
Hs.1708
0
1
Cctg mRNA for chaperonin/cds = (0,1634)/gb = X7480

460C12
3310
3809
NM_012089
Hs.1710
0
1
ATP-binding cassette, sub-family B (MDR/TAP),

41D5
484
1862
M28983
Hs.1722
0
3
interleukin 1 alpha (IL 1) mRNA, complete cds/

119E8
493
904
NM_000575
Hs.1722
1.00E−151
2
interleukin 1, alpha (IL1A), mRNA/cds = (36,851

479E11
5
268
NM_000417
Hs.1724
1.00E−145
1
interleukin 2 receptor, alpha (IL2RA), mRNA/

62C8
85
1887
X01057
Hs.1724
0
2
interleukin-2 receptor/cds = (180,998)/gb = X

466A3
2166
2675
NM_000889
Hs.1741
0
1
integrin, beta 7 (ITGB7), mRNA/cds = (151,2547)

107A4
4960
5610
L33075
Hs.1742
0
1
ras GTPase-activating-like protein (IQGAP1)

189A5
4318
7450
NM_003870
Hs.1742
0
3
IQ motif containing GTPase activating protein

597D1
1230
1737
NM_005356
Hs.1765
1.00E−127
5
lymphocyte-specific protein tyrosine kinase

41C10
1057
1602
J04142
Hs.1799
0
1
(lambda-gt11ht-5) MHC class I antigen-like gl

104H1
1854
2023
L06175
Hs.1845
4.00E−54
1
P5-1 mRNA, complete cds/cds = (304,735)/gb = L06

98F7
34
2041
NM_006674
Hs.1845
4.00E−63
5
MHC class I region ORF (P5-1),/cds = (304,735)/

104F1
1390
1756
NM_002436
Hs.1861
0
2
membrane protein, palmitoylated 1 (55 kD) (MPP

171F7
1760
2192
M55284
Hs.1880
0
1
protein kinase C-L (PRKCL) mRNA, complete cds

134B2
123
1182
NM_002727
Hs.1908
0
10
proteoglycan 1, secretory granule (PRG1), mRN

61C11
126
902
X17042
Hs.1908
0
11
hematopoetic proteoglycan core protein/cds

458G1
1
475
NM_001885
Hs.1940
0
1
crystallin, alpha B (CRYAB), mRNA

520E10
71
343
NM_001024
Hs.1948
1.00E−142
3
ribosomal protein S21 (RPS21), mRNA

459D6
2435
3055
NM_001761
Hs.1973
0
1
cyclin F (CCNF), mRNA/cds = (43,2403)

41H3
184
1620
NM_006139
Hs.1987
0
2
CD28 antigen (Tp44) (CD28), mRNA/cds = (222,884

71C5
721
1329
NM_000639
Hs.2007
0
2
tumor necrosis factor (ligand) superfamily, m

73C1
721
1603
X89102
Hs.2007
0
8
fasligand/cds = (157,1002)

135G3
940
1352
NM_002852
Hs.2050
6.00E−96
1
pentaxin-related gene, rapidly induced by IL

44A10
1562
1748
M58028
Hs.2055
7.00E−69
1
ubiquitin-activating enzyme E1 (UBE1) mRNA,

complete

155G5
973
2207
AL133415
Hs.2064
0
7
DNA sequence from clone RP11-124N14 on

chromosome 10.

599H7
48
3022
AK025306
Hs.2083
0
12
cDNA: FLJ21653 fis, clone COL08586,

71H1
1598
2163
NM_004419
Hs.2128
0
5
dual specificity phosphatase 5 (DUSP5), mRNA

69H7
1595
2161
U15932
Hs.2128
0
11
dual-specificity protein phosphatase mRNA, complete

458C4
1928
2356
NM_005658
Hs.2134
0
1
TNF receptor-associated factor 1 (TRAF1), mRN

192E11
6
414
NM_002704
Hs.2164
0
1
pro-platelet basic protein (includes platele

40D12
1935
2645
M58597
Hs.2173
0
2
ELAM-1 ligand fucosyltransferase (ELFT) mRNA,

comple

40E5
2834
3024
M59820
Hs.2175
1.00E−104
1
granulocyte colony-stimulating factor receptor (CSF

482D8
2521
2943
NM_000760
Hs.2175
0
2
colony stimulating factor 3 receptor (granuloc

60H6
918
1723
AF119850
Hs.2186
0
6
PRO1608 mRNA, complete cds/cds = (1221,2174)/

597F11
99
1267
NM_001404
Hs.2186
0
29
eukaryotic translation elongation factor 1 g

595G4
6
570
L40410
Hs.2210
0
1
thyroid receptor interactor (TRIP3) mRNA, 3′

41H12
970
1353
X03656
Hs.2233
0
1
granulocyte colony-stimulating factor (G-C

461A9
287
730
Z29067
Hs.2236
0
1

H. sapiens nek3 mRNA for protein kinase

493E11
212
608
NM_000879
Hs.2247
1.00E−141
2
interleukin 5 (colony-stimulating factor, eo

150B5
363
815
X04688
Hs.2247
0
1
T-cell replacing factor (interleukin-5)/cd

461E12
255
342
NM_001565
Hs.2248
8.00E−34
1
small inducible cytokine subfamily B (Cys-X-C

129A8
1790
1970
NM_002309
Hs.2250
2.00E−94
1
leukemia inhibitory factor (cholinergic diff

40G10
2152
2560
X04481
Hs.2253
0
1
complement component C2/cds = (36,2294)/gb = X

479A2
95
610
NM_000073
Hs.2259
0
2
CD3G antigen, gamma polypeptide (TiT3 complex

592G6
783
1163
NM_002950
Hs.2280
0
2
ribophorin I (RPN1), mRNA/cds = (137,1960)/gb

459G11
673
1316
NM_004931
Hs.2299
0
1
CD8 antigen, beta polypeptide 1 (p37) (CD8B1),

129B8
1159
1316
X13444
Hs.2299
1.00E−74
1
CD8 beta-chain glycoprotein (CD8 beta. 1)/cd

467F12
2928
3239
NM_000346
Hs.2316
3.00E−85
1
SRY (sex determining region Y)-box 9 (campomeli

44A6
1506
1629
U23028
Hs.2437
7.00E−62
1
eukaryotic initiation factor 2B-epsilon mRNA, partia

127B8
1814
2405
NM_003816
Hs.2442
0
1
a disintegrin and metalloproteinase domain 9

36G6
1361
2019
D13645
Hs.2471
0
2
KIAA0020 gene, complete cds/cds = (418,1944)

458D6
396
961
NM_021966
Hs.2484
0
1
T-cell leukemia/lymphoma 1A (TCL1A), mRNA/c

124G1
966
1473
NM_005565
Hs.2488
0
1
lymphocyte cytosolic protein 2 (SH2 domain-con

107A6
1962
2031
U20158
Hs.2488
2.00E−22
1
76 kDa tyrosine phosphoprotein SLP-76 mRNA,

complete

592E12
2175
2458
NM_002741
Hs.2499
1.00E−158
1
protein kinase C-like 1 (PRKCL1), mRNA/cds = (8

106A11
1455
2219
U34252
Hs.2533
0
2
gamma-aminobutyraldehyde dehydrogenase mRNA,

compl

40F8
2201
2694
NM_003032
Hs.2554
0
1
sialyltransferase 1 (beta-galactoside alpha-

460G6
565
2052
NM_002094
Hs.2707
0
2
G1 to S phase transition 1 mRNA

60G5
35
184
X92518
Hs.2726
7.00E−27
2
HMGI-C protein/cds = UNKNOWN

461F10
1034
1520
NM_002145
Hs.2733
0
2
homeo box B2 (HOXB2), mRNA

69G2
408
1369
AK026515
Hs.2795
0
4
FLJ22862 fis, clone KAT01966, highly sim

71D8
13
541
NM_005566
Hs.2795
0
1
lactate dehydrogenase A (LDHA), mRNA/cds = (97

40H12
4119
4807
NM_002310
Hs.2798
0
1
leukemia inhibitory factor receptor (LIFR) mR

189C12
696
1287
NM_006196
Hs.2853
0
2
poly(rC)-binding protein 1 (PCBP1), mRNA/cds

111E8
1298
1938
NM_003566
Hs.2864
0
1
early endosome antigen 1, 162 kD (EEA1), mRNA/

127F12
34
248
NM_001033
Hs.2934
1.00E−109
1
ribonucleotide reductase M1 polypeptide (RRM

74G6
11
241
AK023088
Hs.2953
1.00E−128
38
FLJ13026 fis, clone NT2RP3000968, modera

128D8
178
518
NM_000117
Hs.2985
1.00E−173
1
emerin (Emery-Dreifuss muscular dystrophy) (

169G7
2406
3112
AL136593
Hs.3059
0
1
DKFZp761K102 (from clone DKFZp761K1

193A3
2405
3017
NM_016451
Hs.3059
0
5
coatomer protein complex, subunit beta (COPB)

53F12
486
1007
L11066
Hs.3069
0
3
sequence/cds = UNKNOWN/gb = L11066/gi = 307322/u

71E8
1623
2131
NM_004134
Hs.3069
0
2
heat shock 70 kD protein 9B (mortalin-2) (HSPA9

458A5
2236
2874
NM_014877
Hs.3085
0
1
KIAA0054 gene product; Helicase (KIAA0054), m

69E8
1752
1916
D31884
Hs.3094
7.00E−68
1
KIAA0063 gene, complete cds/cds = (279,887)/

66B3
251
1590
D32053
Hs.3100
0
2
for Lysyl tRNA Synthetase, complete cds/

458E1
1645
1964
NM_001666
Hs.3109
1.00E−178
1
Rho GTPase activating protein 4 (ARHGAP4), mRN

331D8
2882
3585
U26710
Hs.3144
0
1
cbl-b mRNA, complete cds/cds = (322,3270)/

gb = U26710

73D9
1
613
AL031736
Hs.3195
0
18
DNA sequence clone 738P11 on chromosome 1q24.1-2

58B1
1
607
NM_002995
Hs.3195
0
17
small inducible cytokine subfamily C, member

98F11
145
588
NM_003172
Hs.3196
0
1
surfeit 1 (SURF1), mRNA/cds = (14,916)/gb = NM_—

124E9
1258
2414
NM_007318
Hs.3260
0
2
presenilin 1 (Alzheimer disease 3) (PSEN1), tr

64G7
1040
1569
NM_002155
Hs.3268
0
1
heat shock 70 kD protein 6 (HSP70B') (HSPA6), mR

36D4
1116
1917
X51757
Hs.3268
0
4
heat-shock protein HSP70B' gene/cds = (0,1931)/

gb = X5

39H11
1
507
BE895166
Hs.3297
1.00E−152
4
601436095F1 cDNA, 5′ end/clone = IMAGE: 3921239

103G4
16
540
NM_002954
Hs.3297
0
4
ribosomal protein S27a (RPS27A), mRNA/cds = (3

127H7
1391
1806
AB037752
Hs.3355
0
1
mRNA for KIAA1331 protein, partial cds/cds = (0

107D3
1932
2517
AK027064
Hs.3382
0
1
FLJ23411 fis, clone HEP20452, highly sim

121B3
1270
3667
NM_005134
Hs.3382
0
4
protein phosphatase 4, regulatory subunit 1 (

58H1
104
573
NM_001122
Hs.3416
0
6
adipose differentiation-related protein (AD

75G1
104
1314
X97324
Hs.3416
0
16
adipophilin/cds = (0,1313)/gb = X97324/

182A4
147
334
NM_001867
Hs.3462
1.00E−102
1
cytochrome c oxidase subunit VIIc (COX7C), mRN

134D7
36
270
NM_001025
Hs.3463
1.00E−127
3
ribosomal protein S23 (RPS23), mRNA/cds = (13,4

192B10
129
1135
AL357536
Hs.3576
0
3
mRNA full length insert cDNA clone EUROIMAGE 37

112G12
56
687
NM_003001
Hs.3577
0
1
succinate dehydrogenase complex, subunit C,

526H6
143
537
BF666961
Hs.3585
0
1
602121608F1 cDNA, 5′ end/clone = IMAGE: 4278768

599F10
2098
2351
NM_004834
Hs.3628
1.00E−118
2
mitogen-activated protein kinase kinase kina

594F1
239
1321
NM_001551
Hs.3631
0
4
immunoglobulin (CD79A) binding protein 1 (IG

463E7
911
1033
AL359940
Hs.3640
1.00E−63
1
mRNA; cDNA DKFZp762P1915 (from clone

DKFZp762P

182A9
657
1179
AL050268
Hs.3642
0
2
mRNA; cDNA DKFZp564B163 (from clone

DKFZp564B1

38B4
257
568
AB034205
Hs.3688
1.00E−151
3
for cisplatin resistance-associated ove

185H6
769
995
NM_006003
Hs.3712
2.00E−88
1
ubiquinol-cytochrome c reductase, Rieske iro

587A1
716
1609
NM_006007
Hs.3776
0
2
zinc finger protein 216 (ZNF216), mRNA/cds = (2

473B5
46
531
NM_021633
Hs.3826
0
1
kelch-like protein C3IP1 (C3IP1), mRNA/cds = (

194G5
2456
2984
AB002366
Hs.3852
0
1
mRNA for KIAA0368 gene, partial cds/cds = (0,4327)/

gb

589B4
526
1337
NM_000310
Hs.3873
0
3
palmitoyl-protein thioesterase 1 (ceroid-lip

515A10
1618
2130
NM_002267
Hs.3886
0
1
karyopherin alpha 3 (importin alpha 4) (KPNA3)

186A8
1160
1632
NM_002807
Hs.3887
0
1
proteasome (prosome, macropain) 26S subunit,

102F7
4226
4531
AB023163
Hs.4014
1.00E−158
1
for KIAA0946 protein, partial cds/cds = (0

50B8
1
166
AL117595
Hs.4055
3.00E−89
2
cDNA DKFZp564C2063 (from clone DKFZp564

473A10
1064
1709
NM_006582
Hs.4069
0
1
glucocorticoid modulatory element binding pr

524A12
2863
3386
AL136105
Hs.4082
0
1
DNA sequence from clone RP4-670F13 on

chromosome 1q42

525E1
521
974
BC002435
Hs.4096
0
1
clone IMAGE: 3346451, mRNA, partial cds/cds = t-complex

163G12
1130
1630
X52882
Hs.4112
0
6
polypeptide 1 gene/cds = (21,1691)/

gb = X528

176A7
515
892
BC000687
Hs.4147
0
1
translocating chain-associating membrane p

185B5
3480
3707
AB023216
Hs.4278
1.00E−86
1
mRNA for KIAA0999 protein, partial cds/cds = (0

154E12
1731
2531
AF079566
Hs.4311
0
2
ubiquitin-like protein activating enzyme (UB

331C9
1595
1966
AF067008
Hs.4747
0
1
dyskerin (DKC1) mRNA, complete cds/cds = (60,16

182C8
1676
1966
NM_001363
Hs.4747
1.00E−148
2
dyskeratosis congenita 1, dyskerin (DKC1), mR

178C4
1623
2162
AL136610
Hs.4750
0
3
mRNA; cDNA DKFZp564K0822 (from clone

DKFZp564K

107F9
3857
4266
AB032976
Hs.4779
0
1
for KIAA1150 protein, partial cds/cds = (0

191C11
1945
2618
AF240468
Hs.4788
0
3
nicastrin mRNA, complete cds/cds = (142,2271)

143G11
869
2076
AK022974
Hs.4859
0
2
FLJ12912 fis, clone NT2RP2004476, highly

127H11
977
1666
NM_020307
Hs.4859
0
1
cyclin L ania-6a (LOC57018), mRNA/cds = (54,163

479A11
215
544
AK001942
Hs.4863
1.00E−173
1
cDNA FLJ11080 fis, clone PLACE1005181/cds = UN

73C5
2314
2851
AF105366
Hs.4876
0
1
K-CI cotransporter KCC3a mRNA, alternatively

525F9
1059
1764
NM_006513
Hs.4888
0
3
seryl-tRNA synthetase (SARS), mRNA/cds = (75,1

114D8
931
1061
Z24724
Hs.4934
4.00E−52
1

H. sapiens polyA site DNA/cds = UNKNOWN/

gb = Z24724/gi = 50503

587C10
1104
1343
NM_006787
Hs.4943
3.00E−94
1
hepatocellular carcinoma associated protein;

174F12
1749
2291
NM_018107
Hs.4997
0
3
hypothetical protein FLJ10482 (FLJ10482), mR

514C11
899
1489
AK021776
Hs.5019
0
1
cDNA FLJ11714 fis, clone HEMBA1005219, weakly

126H9
25
397
BE379724
Hs.5027
1.00E−118
1
601159415T1 cDNA, 3′ end/clone = IMAGE: 3511107

599B5
801
970
NM_017840
Hs.5080
5.00E−73
1
hypothetical protein FLJ20484 (FLJ20484), mR

47E5
4
720
AL034553
Hs.5085
0
2
DNA sequence from clone 914P20 on chromosome

20q13.13

122C11
492
860
NM_003859
Hs.5085
0
1
dolichyl-phosphate mannosyltransferase pol

116H6
1644
2902
NM_014868
Hs.5094
1.00E−102
2
ring finger protein 10 (RNF10), mRNA/cds = (698,

187G7
700
1268
NM_004710
Hs.5097
0
1
synaptogyrin 2 (SYNGR2), mRNA/cds = (29,703)/

174G3
240
500
NM_003746
Hs.5120
1.00E−144
4
dynein, cytoplasmic, light polypeptide (PIN)

145B6
199
695
BE539096
Hs.5122
1.00E−165
2
601061641F1 cDNA, 5′ end/clone = IMAGE: 3447850

486C1
1
529
BG028906
Hs.5122
0
2
602293015F1 cDNA, 5′ end/clone = IMAGE: 4387778

69F6
62
455
BF307213
Hs.5174
0
1
601891365F1 cDNA, 5′ end/clone = IMAGE: 4136752

583F4
82
477
NM_001021
Hs.5174
0
1
ribosomal protein S17 (RPS17), mRNA/cds = (25,4

74C4
1955
2373
AK025367
Hs.5181
1.00E−179
1
FLJ21714 fis, clone COL10256, highly sim

73E12
702
987
AL109840
Hs.5184
1.00E−161
1
DNA sequence from clone RP4-543J19 on

chromosome 20 C

180G4
26
639
NM_002212
Hs.5215
0
2
integrin beta 4 binding protein (ITGB4BP), mRN

98F1
17
636
NM_014165
Hs.5232
0
5
HSPC125 protein (HSPC125), mRNA/cds = (79,606)

525A8
479
992
NM_006698
Hs.5300
0
1
bladder cancer associated protein (BLCAP), mR

99C1
19
507
NM_003333
Hs.5308
0
3
ubiquitin A-52 residue ribosomal protein fusi

172D11
714
1805
NM_005721
Hs.5321
0
3
ARP3 (actin-related protein 3, yeast) homolog

591F6
475
970
NM_015702
Hs.5324
0
1
hypothetical protein (CL25022), mRNA/cds = (1

68H8
724
1190
NM_014106
Hs.5327
0
2
PRO1914 protein (PRO1914), mRNA/cds = (1222,14

194D12
2128
2499
AB018305
Hs.5378
0
1
mRNA for KIAA0762 protein, partial cds/cds = (0

501G11
823
1322
NM_020122
Hs.5392
0
3
potassium channel modulatory factor (DKFZP434

74B4
502
1257
AF008442
Hs.5409
0
7
RNA polymerase I subunit hRPA39 mRNA, complete

134H7
543
916
NM_004875
Hs.5409
0
1
RNA polymerase I subunit (RPA40), mRNA/cds = (2

168A3
1909
2379
AF090891
Hs.5437
0
1
clone HQ0105 PRO0105 mRNA, complete cds/cds = (

145C10
2375
2564
AF016270
Hs.5464
1.00E−104
2
thyroid hormone receptor coactivating protein

587H7
1857
2563
NM_006696
Hs.5464
0
4
thyroid hormone receptor coactivating protein

183D10
1199
1347
NM_006495
Hs.5509
9.00E−40
1
ecotropic viral integration site 2B (EVI2B), m

181D7
1385
1752
AK002173
Hs.5518
0
1
cDNA FLJ11311 fis, clone PLACE1010102/cds = UNK

173B1
1
642
NM_003315
Hs.5542
0
2
tetratricopeptide repeat domain 2 (TTC2), mRN

120F8
1782
2430
AF157323
Hs.5548
0
2
p45SKP2-like protein mRNA, complete cds/cds = ribosomal

464H2
46
357
NM_000998
Hs.5566
1.00E−163
2
protein L37a (RPL37A), mRNA/cds = (1

75F5
1252
2194
AK027192
Hs.5615
0
9
FLJ23539 fis, clone LNG08101, highly sim

56E8
27
205
AI570531
Hs.5637
2.00E−95
1
tm77g04.x1 cDNA, 3′ end/clone = IMAGE: 2164182

524G2
2
926
NM_006098
Hs.5662
0
9
guanine nucleotide binding protein (G protein

39F6
2311
2902
AB014579
Hs.5734
0
1
for KIAA0679 protein, partial cds/cds = (0

587G2
2883
4606
NM_012215
Hs.5734
0
11
meningioma expressed antigen 5 (hyaluronidase

469E5
5041
5393
NM_014864
Hs.5737
3.00E−75
2
KIAA0475 gene product (KIAA0475), mRNA/cds = (

120H3
1022
1553
NM_016230
Hs.5741
0
1
flavohemoprotein b5+b5R (LOC51167), mRNA/cd

63H8
1049
1507
AK025729
Hs.5798
0
1
FLJ22076 fis, clone HEP12479, highly sim

590D9
1015
1470
NM_015946
Hs.5798
0
1
pelota (Drosophila) homolog (PELO), mRNA/cds

102E3
665
1027
AK000474
Hs.5811
0
1
FLJ20467 fis, clone KAT06638/cds = (360,77

187E5
665
1028
NM_017835
Hs.5811
0
1
chromosome 21 open reading frame 59 (C21ORF59),

39F9
1402
1728
AK025773
Hs.5822
0
3
FLJ22120 fis, clone HEP18874/cds = UNKNOW

39E12
1064
1843
AF208844
Hs.5862
0
1
BM-002 mRNA, complete cds/cds = (39,296)/gb = A

173H9
906
1684
NM_016090
Hs.5887
0
2
RNA binding motif protein 7 (LOC51120), mRNA/

120E8
1702
2055
NM_012179
Hs.5912
1.00E−146
1
F-box only protein 7 (FBXO7), mRNA/cds = (205,17

195D1
1309
2656
AK025620
Hs.5985
0
8
cDNA: FLJ21967 fis, clone HEP05652, highly sim

116A6
1451
2073
AK024941
Hs.6019
0
1
cDNA: FLJ21288 fis, clone COL01927/cds = UNKNOW

113F9
1232
1598
NM_002896
Hs.6106
1.00E−126
1
RNA binding motif protein 4 (RBM4), mRNA/cds = (

520H1
563
1007
NM_018285
Hs.6118
0
2
hypothetical protein FLJ10968 (FLJ10968), mR

180H12
5224
5568
AF315591
Hs.6151
1.00E−135
1
Pumilio 2 (PUMH2) mRNA, complete cds/cds = (23,3

185A7
612
1558
NM_016001
Hs.6153
0
6
CGI-48 protein (LOC51096), mRNA/cds = (107,167

595G2
3207
4752
Z97056
Hs.6179
0
10
DNA seq from clone RP3-434P1 on chromosome 22

592B11
234
4611
AI745230
Hs.6187
1.00E−130
6
wg10e05.x1 cDNA, 3′ end/clone = IMAGE: 2364704

590F2
994
1625
NM_004517
Hs.6196
0
3
integrin-linked kinase (ILK), mRNA/cds = (156,

188A3
1550
2929
M61906
Hs.6241
0
3
P13-kinase associated p85 mRNA sequence

103C12
502
1129
AF246238
Hs.6289
0
1
HT027 mRNA, complete cds/cds = (260,784)/gb = A

100C2
804
1111
AK024539
Hs.6289
1.00E−122
1
FLJ20886 fis, clone ADKA03257/cds = (359,

480A11
1149
1242
AB032977
Hs.6298
1.00E−46
1
mRNA for KIAA1151 protein, partial cds/cds = (0

473C8
3944
4149
NM_014859
Hs.6336
1.00E−106
1
KIAA0672 gene product (KIAA0672), mRNA/cds = (

125A10
1293
1766
NM_006791
Hs.6353
0
1
MORF-related gene 15 (MRG15), mRNA/cds = (131,1

182F5
143
2118
NM_018471
Hs.6375
0
3
uncharacterized hypothalamus protein HT010

587E8
398
2287
NM_016289
Hs.6406
0
7
MO25 protein (LOC51719), mRNA/cds = (53,1078)

135C3
2519
3084
AF130110
Hs.6456
0
2
clone FLB6303 PRO1633 mRNA, complete cds/cds = DNA

178B5
1744
2425
AL117352
Hs.6523
0
2
seq from clone RP5-876B10 on chromosome

1q42

522F10
2392
2591
NM_001183
Hs.6551
1.00E−110
2
ATPase, H+ transporting, lysosomal (vacuolar

595C4
1676
2197
NM_021008
Hs.6574
0
4
suppressin (nuclear deformed epidermal autor

481F3
745
904
AL117565
Hs.6607
9.00E−82
1
mRNA; cDNA DKFZp566F164 (from clone

DKFZp566F1

124A3
1046
1575
NM_017792
Hs.6631
0
1
hypothetical protein FLJ20373 (FLJ20373), mR

177F11
1966
2281
AB046844
Hs.6639
1.00E−152
1
for KIAA1624 protein, partial cds/cds = (0

521G7
4600
5210
NM_014856
Hs.6684
0
2
KIAA0476 gene product (KIAA0476), mRNA/cds = (

54C6
265
756
AB037801
Hs.6685
0
1
for KIAA1380 protein, partial cds/cds = (0

75F7
95
3507
AB014560
Hs.6727
0
4
for KIAA0660 protein, complete cds/cds = (

477H12
2
457
BF976590
Hs.6749
0
1
602244267F1 cDNA, 5′ end/clone = IMAGE: 4335353

60A1
1028
1307
AB026908
Hs.6790
1.00E−155
1
for microvascular endothelial differenti

100G9
341
454
BE875609
Hs.6820
2.00E−58
1
601487048F1 cDNA, 5′ end/clone = IMAGE: 3889762

184F7
1259
1633
AF056717
Hs.6856
0
5
ash2l2 (ASH2L2) mRNA, complete cds/cds = (295,1

195E7
1250
1711
NM_004674
Hs.6856
0
3
ash2 (absent, small, or homeotic, Drosophila,

135F11
328
600
NM_020188
Hs.6879
1.00E−151
1
DC13 protein (DC13), mRNA/cds = (175,414)/gb = DKFZP434D156

172G2
1477
1782
NM_015530
Hs.6880
1.00E−169
1
protein (DKFZP434D156), mRNA/c

483G5
3712
3947
AL031681
Hs.6891
3.00E−72
1
DNA sequence from clone 862K6 on chromosome

20q12-13.1

184B1
1
622
AF006086
Hs.6895
0
3
Arp2/3 protein complex subunit p21-Arc (ARC21

599C12
1
622
NM_005719
Hs.6895
0
24
actin related protein 2/3 complex, subunit 3 (

43A1
2111
2312
AF037204
Hs.6900
9.00E−78
1
RING zinc finger protein (RZF) mRNA, complete c

105F6
638
1209
AK026850
Hs.6906
0
1
FLJ23197 fis, clone REC00917/cds = UNKNOW

178G10
5939
6469
AJ238403
Hs.6947
0
1
mRNA for huntingtin interacting protein 1/cd

72A2
178
2992
AF001542
Hs.6975
0
9
AF001542/clone = alpha_est218/52C1/gb = FLJ12506

37F2
1757
2397
AK022568
Hs.7010
0
1
fis, clone NT2RM2001700, weakly

598D3
1153
1299
NM_004637
Hs.7016
8.00E−56
1
RAB7, member RAS oncogene family (RAB7), mRNA

524C11
5542
5678
AB033034
Hs.7041
3.00E−72
1
mRNA for KIAA1208 protein, partial cds/cds = (2

109E10
452
1093
AF104921
Hs.7043
0
1
succinyl-CoA synthetase alpha subunit (SUCLA1

595F7
449
1150
NM_003849
Hs.7043
0
2
succinate-CoA ligase, GDP-forming, alpha sub

104H2
644
992
NM_020194
Hs.7045
1.00E−156
1
GL004 protein (GL004), mRNA/cds = (72,728)/gb

155C1
3322
3779
AK024478
Hs.7049
0
2
FLJ00071 protein, partial cds/cds = (3

473B1
3029
3439
AB051492
Hs.7076
1.00E−152
1
mRNA for KIAA1705 protein, partial cds/cds = (1

125E3
3612
3948
AL390127
Hs.7104
0
1
mRNA; cDNA DKFZp761P06121 (from clone

DKFZp761

499B11
1451
1852
NM_021188
Hs.7137
0
2
clones 23667 and 23775 zinc finger protein (LOC

52B12
1850
2178
U90919
Hs.7137
1.00E−174
1
clones 23667 and 23775 zinc finger protein mRNA,

compl

486A11
855
1186
NM_003904
Hs.7165
1.00E−132
1
zinc finger protein 259 (ZNF259), mRNA/cds = (2

460B6
2514
3182
NM_021931
Hs.7174
0
1
hypothetical protein FLJ22759 (FLJ22759), mR

592H8
3999
4524
AB051544
Hs.7187
0
2
mRNA for KIAA1757 protein, partial cds/cds = (3

180A10
102
468
AL117502
Hs.7200
1.00E−141
3
mRNA; cDNA DKFZp434D0935 (from clone

DKFZp434

127A12
1503
2688
AL035661
Hs.7218
0
2
DNA sequence from clone RP4-568C11 on

chromosome 20p1

592G9
12
263
NM_015953
Hs.7236
1.00E−138
2
CGI-25 protein (LOC51070), mRNA/cds = (44,949)

127E3
2624
4554
AB028980
Hs.7243
0
3
mRNA for KIAA1057 protein, partial cds/cds = (0

135F2
5029
5175
AB033050
Hs.7252
3.00E−78
1
mRNA for KIAA1224 protein, partial cds/cds = (0

57G1
2299
2723
NM_014319
Hs.7256
0
1
integral inner nuclear membrane protein (MAN1

122D11
2920
3123
AB014558
Hs.7278
5.00E−74
1
mRNA for KIAA0658 protein, partial cds/cds = (0

471H6
1
449
AV702692
Hs.7312
0
1
AV702692 cDNA 5′ end/clone = ADBBQC12/clone_—

104G12
4314
4797
AF084555
Hs.7351
0
2
okadaic acid-inducible and cAMP-regulated ph

590G7
771
1259
NM_005662
Hs.7381
0
5
voltage-dependent anion channel 3 (VDAC3), mR

159H2
355
1252
AL137423
Hs.7392
0
3
mRNA; cDNA DKFZp761E0323 (from clone

DKFZp761E

161F3
1708
2371
NM_024045
Hs.7392
0
1
hypothetical protein MGC3199 (MGC3199), mRNA

195E1
1107
1362
NM_022736
Hs.7503
1.00E−129
1
hypothetical protein FLJ14153 (FLJ14153), mR

137F5
59
666
NM_018491
Hs.7535
0
2
COBW-like protein (LOC55871), mRNA/cds = (64,9

597E1
2302
2893
AF126028
Hs.7540
0
2
unknown mRNA/cds = (0,1261)/gb = AF126028/gi = cDNA:

473B6
3006
3302
AK025615
Hs.7567
1.00E−158
1
FLJ21962 fis, clone HEP05564/cds = UNKNOW

519H1
232
720
BG112505
Hs.7589
0
2
602282107F1 cDNA, 5′ end/clone = IMAGE: 4369729

73A9
106
3912
M20681
Hs.7594
0
8
glucose transporter-like protein-III (GLUT3), compl

51D3
106
3200
NM_006931
Hs.7594
0
2
solute carrier family 2 (facilitated glucose t

596E8
1512
1748
M94046
Hs.7647
1.00E−129
2
zinc finger protein (MAZ) mRNA/cds = UNKNOWN/

gb = M9404

472A8
1575
1983
NM_004576
Hs.7688
0
1
protein phosphatase 2 (formerly 2A), regulator

191A10
386
889
NM_007278
Hs.7719
0
3
GABA(A) receptor-associated protein (GABARAP

459C4
5636
5897
AB002323
Hs.7720
2.00E−87
1
mRNA for KIAA0325 gene, partial cds/cds = (0,6265)/

gb

99A12
606
1253
NM_018453
Hs.7731
0
1
uncharacterized bone marrow protein BM036 (BM

72G8
5806
6409
AB007938
Hs.7764
0
5
for KIAA0469 protein, complete cds/cds = (

45G2
6168
6404
NM_014851
Hs.7764
1.00E−132
1
KIAA0469 gene product (KIAA0469), mRNA/cds = (

172A4
371
588
NM_007273
Hs.7771
1.00E−107
1
B-cell associated protein (REA), mRNA/cds = (9

177B8
2055
2431
AK023166
Hs.7797
0
1
FLJ13104 fis, clone NT2RP3002343/cds = (28

99B6
865
1244
NM_012461
Hs.7797
0
1
TERF1 (TRF1)-interacting nuclear factor 2 (T

160G8
727
860
U94855
Hs.7811
5.00E−66
1
translation initiation factor 3 47 kDa subunit

54G6
1
1007
AK001319
Hs.7837
1.00E−148
3
FLJ10457 fis, clone NT2RP1001424/cds = UN

594A7
1295
1793
NM_013446
Hs.7838
0
4
makorin, ring finger protein, 1 (MKRN1), mRNA

188A12
1
2013
NM_017761
Hs.7862
0
3
hypothetical protein FLJ20312 (FLJ20312), mR

594A2
3060
3588
AK023813
Hs.7871
0
2
cDNA FLJ13751 fis, clone PLACE3000339, weakly

124C12
472
1251
NM_001550
Hs.7879
0
1
interferon-related developmental regulator

147A8
1381
1711
Y10313
Hs.7879
1.00E−134
1
for PC4 protein (IFRD1 gene)/cds = (219,158

74H3
4430
4978
AF302505
Hs.7886
0
2
pellino 1 (PELI1) mRNA, complete cds/cds = (4038

71G3
473
1112
NM_016224
Hs.7905
0
2
SH3 and PX domain-containing protein SH3PX1 (S

52C7
1637
2231
AB029551
Hs.7910
0
1
YEAF1 mRNA for YY1 and E4TF1 associated factor

177H5
5411
6045
AB002321
Hs.7911
0
1
KIAA0323 gene, partial cds/cds = (0,2175)/gb

114C8
1678
3078
NM_017657
Hs.7942
1.00E−149
2
hypothetical protein FLJ20080 (FLJ20080), mR

169D8
1453
2158
AK001437
Hs.7943
0
1
FLJ10575 fis, clone NT2RP2003295, highly

599G8
618
1204
NM_003796
Hs.7943
0
1
RPB5-mediating protein (RMP), mRNA/cds = (465,

127E11
107
796
NM_016099
Hs.7953
0
3
HSPC041 protein (LOC51125), mRNA/cds = (141,45

98D6
4769
6506
NM_001111
Hs.7957
0
20
adenosine deaminase, RNA-specific (ADAR), tr

37H10
2479
6594
X79448
Hs.7957
0
8
IFI-4 mRNA for type I protein/cds = (1165,3960)/g

178G4
4209
5132
AB028981
Hs.8021
0
4
mRNA for KIAA1058 protein, partial cds/cds = (0

118E9
630
1688
NM_006083
Hs.8024
0
2
IK cytokine, down-regulator of HLA II (IK), mRN

171A8
1658
1973
AK002026
Hs.8033
1.00E−151
1
FLJ11164 fis, clone PLACE1007226, weakly

103G5
1504
1977
NM_018346
Hs.8033
0
1
hypothetical protein FLJ11164 (FLJ11164), mR

179G7
2860
3032
AK022497
Hs.8068
6.00E−46
1
FLJ12435 fis, clone NT2RM1000059/cds = (88

594A11
2327
2658
NM_018210
Hs.8083
1.00E−167
1
hypothetical protein FLJ10769 (FLJ10769), mR

103B5
1968
2448
AF267856
Hs.8084
0
1
HT033 mRNA, complete cds/cds = (203,931)/gb = A

98E4
1367
1808
AF113008
Hs.8102
0
7
clone FLB0708 mRNA sequence/cds = UNKNOWN/

gb = erbb2-interacting

191H10
4581
5819
NM_018695
Hs.8117
0
3
protein ERBIN (LOC55914),

99F1
550
2672
AB014550
Hs.8118
0
4
mRNA for KIAA0650 protein, partial cds/cds = (0

165H11
488
663
NM_024408
Hs.8121
3.00E−93
1
Notch (Drosophila) homolog 2 (NOTCH2), mRNA/

515C7
2188
2514
AL050371
Hs.8128
1.00E−114
1
mRNA; cDNA DKFZp566G2246 (from clone

DKFZp566G

166A12
234
1196
AF131856
Hs.8148
1.00E−155
2
clone 24856 mRNA sequence, complete cds/cds = (

520H8
512
712
NM_016275
Hs.8148
1.00E−110
1
selenoprotein T (LOC51714), mRNA/cds = (138,62

592D4
1
735
NM_014886
Hs.8170
1.00E−152
3
hypothetical protein (YR-29), mRNA/cds = (82,8

105F12
349
760
AK001665
Hs.8173
0
1
FLJ10803 fis, clone NT2RP4000833/cds = (1

75A7
737
1458
AF000652
Hs.8180
0
1
syntenin (sycl) mRNA, complete cds/cds = (148,1

64H5
105
618
NM_005625
Hs.8180
0
3
syndecan binding protein (syntenin) (SDCBP),

61G9
3147
3660
AB018339
Hs.8182
0
2
for KIAA0796 protein, partial cds/cds = (0

39G2
255
1675
AF042284
Hs.8185
0
4
unknown mRNA/cds = (76,1428)/gb = AF042284/gi

192G5
1054
1580
NM_021199
Hs.8185
0
8
CGI-44 protein; sulfide dehydrogenase like (y

109D3
1463
2503
AF269150
Hs.8203
0
2
transmembrane protein TM9SF3 (TM9SF3) mRNA, c

115H4
1251
3187
NM_020123
Hs.8203
0
12
endomembrane protein emp70 precursor isolog (

113F12
2349
3576
AL355476
Hs.8217
4.00E−35
2
DNA sequence from clone RP11-517O1 on

chromosome X Co

125D5
582
1050
NM_005006
Hs.8248
0
1
NADH dehydrogenase (ubiquinone) Fe-S protein

460D3
4851
5043
AF035947
Hs.8257
7.00E−76
1
cytokine-inducible inhibitor of signalling t

111E7
729
3182
NM_013995
Hs.8262
0
2
lysosomal-associated membrane protein 2 (LAM

590F10
3012
4133
AK022790
Hs.8309
0
6
cDNA FLJ12728 fis, clone NT2RP2000040, highly

109B1
138
476
AW973507
Hs.8360
1.00E−161
1
EST385607/gb = AW973507/gi = 8164686/ug = for

61A3
1137
1649
AB033017
Hs.8594
0
1
KIAA1191 protein, partial cds/cds = (0

523E12
905
2998
NM_007271
Hs.8724
0
4
serine threonine protein kinase (NDR), mRNA/

590G2
3618
3932
NM_018031
Hs.8737
1.00E−166
3
WD repeat domain 6 (WDR6), mRNA/cds = (39,3404)

464C3
2299
2494
NM_018255
Hs.8739
1.00E−107
1
hypothetical protein FLJ10879 (FLJ10879), mR

128H8
1580
1711
NM_018450
Hs.8740
2.00E−64
1
uncharacterized bone marrow protein BM029 (BM

179D3
921
1457
AF083255
Hs.8765
0
1
RNA helicase-related protein complete c

195H11
1247
1481
NM_007269
Hs.8813
1.00E−100
1
syntaxin binding protein 3 (STXBP3), mRNA/cds

460F1
68
308
AA454036
Hs.8832
1.00E−105
1
zx48b04.r1 cDNA, 5′ end/clone = IMAGE: 795439/

110E10
3672
5371
AB032252
Hs.8858
0
3
BAZ1A mRNA for bromodomain adjacent to zinc fi

113D1
4814
5890
NM_013448
Hs.8858
0
2
bromodomain adjacent to zinc finger domain, 1A

120H7
373
633
NM_017748
Hs.8928
1.00E−143
1
hypothetical protein FLJ20291 (FLJ20291), mR

470F10
1670
2260
NM_003917
Hs.8991
0
2
adaptor-related protein complex 1, gamma 2 su

72H11
1785
2418
M11717
Hs.8997
1.00E−147
23
heat shock protein (hsp 70) gene, complete cds/

cds = (2

49H4
1769
2243
NM_005345
Hs.8997
1.00E−145
12
heat shock 70 kD protein 1A (HSPA1A), mRNA/cds = VAMP

519E7
270
729
NM_003574
Hs.9006
0
1
(vesicle-associated membrane protein)-a

142E2
1265
1518
AK022215
Hs.9043
1.00E−107
1
FLJ12153 fis, clone MAMMA1000458/cds = UNK

108B9
1160
1823
AJ002030
Hs.9071
0
1
for putative progesterone binding protein

47C7
452
795
AB011420
Hs.9075
0
1
for DRAK1, complete cds/cds = (117,1361)/

590A4
791
1377
NM_004760
Hs.9075
0
4
serine/threonine kinase 17a (apoptosis-induc

168D11
1000
1641
NM_017426
Hs.9082
0
1
nucleoporin p54 (NUP54), mRNA/cds = (25,1542)

63H9
799
1163
Y17829
Hs.9192
0
1
for Homer-related protein Syn47/cds = (75,

167B11
1466
1863
NM_006251
Hs.9247
0
1
protein kinase, AMP-activated, alpha 1 cataly

196D5
1021
1492
AK024327
Hs.9343
0
1
cDNA FLJ14265 fis, clone PLACE1002256/cds = UNK

192F3
245
790
NM_017983
Hs.9398
0
1
hypothetical protein FLJ10055 (FLJ10055), mR

121C3
3381
3567
AF217190
Hs.9414
3.00E−90
1
MLEL1 protein (MLEL1) mRNA, complete cds/cds = SWI/SNF

196B6
959
1551
NM_003601
Hs.9456
0
1
related, matrix associated, actin dep

331B5
2624
2950
AF027302
Hs.9573
1.00E−179
1
TNF-alpha stimulated ABC protein (ABC50) mRNA

592E11
1
479
NM_002520
Hs.9614
1.00E−139
7
nucleophosmin (nucleolar phosphoprotein B23

515D6
1739
2091
AB037796
Hs.9663
1.00E−160
1
mRNA for KIAA1375 protein, partial cds/cds = (0

124A5
1387
1762
NM_012068
Hs.9754
0
2
activating transcription factor 5 (ATF5), mRN

122A7
1484
1928
AB028963
Hs. 9846
1.00E−154
1
mRNA for KIAA1040 protein, partial cds/cds = (0

591E2
1626
2194
AF123073
Hs. 9851
0
5
C/EBP-induced protein mRNA, complete cds/cds

111G2
4208
5361
AB033076
Hs. 9873
0
2
mRNA for KIAA1250 protein, partial cds/cds = (0

469D5
932
3551
AK022758
Hs. 9908
1.00E−178
6
cDNA FLJ12696 fis, clone NT2RP1000513, highly

590D5
172
742
NM_001425
Hs. 9999
2.00E−94
2
epithelial membrane protein 3 (EMP3), mRNA/c

112E7
1065
1753
NM_001814
Hs. 10029
0
1
cathepsin C (CTSC), mRNA/cds = (33,1424)/gb = N

106C7
1066
1641
X87212
Hs. 10029
0
1
cathepsin C/cds = (33,1424)/gb = X87212/

127B1
1003
1429
NM_014959
Hs. 10031
0
1
KIAA0955 protein (KIAA0955), mRNA/cds = (313,1

462E5
332
487
AW293461
Hs. 10041
3.00E−46
1
UI-H-BI2-ahm-e-02-0-UI.s1 cDNA, 3′ end/clon

190E3
101
356
NM_016551
Hs. 10071
6.00E−98
1
seven transmembrane protein TM7SF3 (TM7SF3),

61B6
2571
2764
AL163249
Hs. 10175
7.00E−94
1
chromosome 21 segment HS21C049/cds = (128,2599

110F6
5310
5808
D87432
Hs. 10315
0
1
KIAA0245 gene, complete cds/cds = (261,1808)

196E10
5312
5753
NM_003983
Hs. 10315
0
1
solute carrier family 7 (cationic amino acid t

49D8
315
2207
AK024597
Hs. 10362
0
3
cDNA: FLJ20944 fis, clone ADSE01780/cds = UNKNO

129C7
1000
1364
AB018249
Hs. 10458
0
1
CC chemokine LEC, complete cds/cds = (1

62F11
1239
2034
AL031685
Hs. 10590
0
2
DNA sequence from clone RP5-963K23 on

chromosome 20q1

460D5
86
815
AL357374
Hs. 10600
0
4
DNA sequence from clone RP11-353C18 on

chromosome 20

179C12
3765
4300
AK000005
Hs. 10647
0
2
FLJ00005 protein, partial cds/cds = (0

482D12
1753
2359
NM_004848
Hs. 10649
0
1
basement membrane-induced gene (ICB-1), mRNA

184F4
2686
3194
AL137721
Hs. 10702
0
1
mRNA; cDNA DKFZp761H221 (from clone

DKFZp761H2

186F10
2688
3084
NM_017601
Hs. 10702
1.00E−137
2
hypothetical protein DKFZp761H221 (DKFZp761H

461E3
593
1110
NM_021821
Hs. 10724
0
1
MDS023 protein (MDS023), mRNA/cds = (335,1018)

598D5
660
1191
NM_014306
Hs. 10729
0
2
hypothetical protein (HSPC117), mRNA/cds = (75

125D9
104
397
NM_002495
Hs. 10758
1.00E−165
1
NADH dehydrogenase (ubiquinone) Fe-S protein

36A7
172
1114
NM_006325
Hs. 10842
0
11
RAN, member RAS oncogene familyRAN, member

RAS

54H1
240
1467
NM_012257
Hs. 10882
0
2
HMG-box containing protein 1 (HBP1), mRNA/cds

596B8
1186
1895
AK025212
Hs. 10888
0
17
cDNA: FLJ21559 fis, clone COL06406/cds = UNKNOW

458G7
989
1492
Z78330
Hs. 10927
0
1
HSZ78330 cDNA/clone = 2.49-(CEPH)/gb = Z78330

115D2
308
638
BF793378
Hs. 10957
1.00E−102
1
602254823F1 cDNA, 5′ end/clone = IMAGE: 4347076

148H9
226
863
AF021819
Hs. 10958
0
1
RNA-binding protein regulatory subunit mRNA,

173D5
356
816
NM_007262
Hs. 10958
0
1
RNA-binding protein regulatory subunit (DJ-1

39B7
1553
2256
AF063605
Hs. 11000
0
1
brain my047 protein mRNA, complete cds/cds = (8

592H5
1553
2257
NM_015344
Hs. 11000
0
3
MY047 protein (MY047), mRNA/cds = (84,479)/gb

112G3
2591
3180
AB046813
Hs. 11123
0
1
mRNA for KIAA1593 protein, partial cds/cds = (4

592E8
251
725
NM_014041
Hs. 11125
0
2
HSPC033 protein (HSPC033), mRNA/cds = (168,443

477A2
1610
1697
NM_003100
Hs. 11183
8.00E−43
2
sorting nexin 2 (SNX2), mRNA/cds = (29,1588)/g

41G4
6498
6751
AB014522
Hs. 11238
1.00E−142
1
for KIAA0622 protein, partial cds/cds = (0

519A3
759
987
NM_018371
Hs. 11260
1.00E−127
1
hypothetical protein FLJ11264 (FLJ11264), mR

175B4
404
688
BE788546
Hs. 11355
4.00E−75
1
601476186F1 cDNA, 5′ end/clone = IMAGE: 3878948

114F11
245
401
BF665055
Hs. 11356
4.00E−55
1
602119656F1 cDNA, 5′ end/clone = IMAGE: 4276860

40D2
96
824
U59808
Hs. 11383
0
1
monocyte chemotactic protein-4 precursor (MCP-4)

mR

109C3
767
2345
M74002
Hs. 11482
0
2
arginine-rich nuclear protein mRNA, complete cds/cds

117G9
408
2345
NM_004768
Hs. 11482
0
8
splicing factor, arginine/serine-rich 11 (SF

458G6
2053
2164
AK022628
Hs. 11556
1.00E−54
1
cDNA FLJ12566 fis, clone NT2RM4000852/cds = UNK

181E7
644
1004
AK021632
Hs. 11571
1.00E−167
1
cDNA FLJ11570 fis, clone HEMBA1003309/cds = UNK

458B3
85
522
R12665
Hs. 11594
1.00E−137
1
yf40a04.s1 cDNA, 3′ end/clone = IMAGE: 129294/

146B6
498
677
BE794595
Hs. 11607
5.00E−82
1
601590368F1 5′ end/clone = IMAGE: 3944489

516F12
388
711
BG288429
Hs. 11637
1.00E−132
1
602388093F1 cDNA, 5′ end/clone = IMAGE: 4517086

60B1
1291
1882
NM_005121
Hs. 11861
0
1
thyroid hormone receptor-associated protein,

44C6
2613
2834
NM_000859
Hs. 11899
9.00E−72
1
3-hydroxy-3-methylglutaryl-Coenzyme A reduc

39F10
1
221
BF668230
Hs. 12035
1.00E−120
2
602122419F1 cDNA, 5′ end/clone = IMAGE: 4279300

596D8
234
849
U72514
Hs. 12045
0
2
C2f mRNA, complete cds

481E7
1902
2190
AB028986
Hs. 12064
1.00E−151
1
mRNA for KIAA1063 protein, partial cds/cds = (0

465D9
2529
2699
NM_004003
Hs. 12068
8.00E−91
1
carnitine acetyltransferase (CRAT), nuclear

116H8
283
738
NM_003321
Hs. 12084
0
1
Tu translation elongation factor, mitochondri

44A4
319
836
S75463
Hs. 12084
0
1
P43 = mitochondrial elongation factor homolog [human,

live

114F7
4254
4495
AL137753
Hs. 12144
1.00E−115
1
mRNA; cDNA DKFZp434K1412 (from clone

DKFZp434K

123F12
1
219
NM_021203
Hs. 12152
1.00E−114
1
APMCF1 protein (APMCF1), mRNA/cds = (82,225)/

519H7
166
753
AK025775
Hs. 12245
0
1
cDNA: FLJ22122 fis, clone HEP19214/cds = UNKNOW

70E3
953
4720
AB014530
Hs. 12259
0
3
for KIAA0630 protein, partial cds/cds = (0

107H1
680
1078
AK024756
Hs. 12293
0
1
FLJ21103 fis, clone CAS04883/cds = (107,1

71E5
4750
5283
NM_003170
Hs. 12303
0
1
suppressor of Ty (S. cerevisiae) 6 homolog (SUP

106F3
977
1490
AL050272
Hs. 12305
0
1
cDNA DKFZp566B183 (from clone DKFZp566B1

481F4
1859
2403
NM_015509
Hs. 12305
0
1
DKFZP566B183 protein (DKFZP566B183), mRNA/c

114D3
1271
1520
AF038202
Hs. 12311
1.00E−118
1
clone 23570 mRNA sequence/cds = UNKNOWN/

gb = AF0

463B9
1006
1224
AK021670
Hs. 12315
1.00E−121
1
cDNA FLJ11608 fis, clone HEMBA1003976/cds = (56

167A8
71
723
BG034192
Hs. 12396
0
2
602302446F1 cDNA, 5′ end/clone = IMAGE: 4403866

460E9
3808
4166
D83776
Hs. 12413
1.00E−176
1
mRNA for KIAA0191 gene, partial cds/cds = (0,4552)/

gb

157E1
1887
3154
NM_020403
Hs. 12450
0
3
cadherin superfamily protein VR4-11 (LOC57123

69F11
2715
3447
AK001676
Hs. 12457
0
1
FLJ10814 fis, clone NT2RP4000984/cds = (92

118B8
5781
6374
AB032973
Hs. 12461
0
1
mRNA for KIAA1147 protein, partial cds/cds = (0

193G12
2069
2368
NM_005993
Hs. 12570
1.00E−169
1
tubulin-specific chaperone d (TBCD), mRNA/cd

459D11
2828
3122
NM_021151
Hs. 12743
1.00E−147
1
carnitine octanoyltransferase (COT), mRNA/c

196H4
1
5439
AB046785
Hs. 12772
0
2
mRNA for KIAA1565 protein, partial cds/cds = (0

56G11
458
1088
AL080156
Hs. 12813
0
1
cDNA DKFZp434J214 (from clone DKFZp434J2

476E6
1221
1638
NM_006590
Hs. 12820
0
1
SnRNP assembly defective 1 homolog (SAD1), mRN

109E7
1
180
AF208855
Hs. 12830
3.00E−79
1
BM-013 mRNA, complete cds/cds = (67,459)/gb = A

458A2
1818
2276
AK026747
Hs. 12969
0
1
cDNA: FLJ23094 fis, clone LNG07379, highly sim

466D10
1469
1745
AK001822
Hs. 12999
9.00E−39
1
cDNA FLJ10960 fis, clone PLACE1000564/cds = UNK

187A11
1866
2555
NM_003330
Hs. 13046
0
2
thioredoxin reductase 1 (TXNRD1), mRNA/cds = (

60D9
1757
3508
X91247
Hs. 13046
0
3
thioredoxin reductase/cds = (439,1932)

75D7
2071
2550
AF055581
Hs. 13131
0
1
adaptor protein Lnk mRNA, complete cds/cds = (3

196C2
190
845
AK026239
Hs. 13179
0
2
cDNA: FLJ22586 fis, clone HSI02774/cds = UNKNOW

480G6
11
380
AL570416
Hs. 13256
1.00E−161
1
AL570416 cDNA/clone = CS0DI020YK05-(3-prime)

196H3
2814
3382
AB020663
Hs. 13264
0
1
mRNA for KIAA0856 protein, partial cds/cds = (0

460H3
127
431
BF029796
Hs. 13268
1.00E−151
1
601556721F1 cDNA, 5′ end/clone = IMAGE: 3826637

170B2
1487
1635
AB011164
Hs. 13273
1.00E−69
1
for KIAA0592 protein, partial cds/cds = (0,

115E6
2153
2376
AK025707
Hs. 13277
1.00E−124
1
cDNA: FLJ22054 fis, clone HEP09634/cds = (144,9

110F10
119
648
BE537908
Hs. 13328
0
1
601067373F1 cDNA, 5′ end/clone = IMAGE: 3453594

36C2
427
4137
AF054284
Hs. 13453
0
5
spliceosomal protein SAP 155 mRNA, complete cd

594C3
5
4229
NM_012433
Hs. 13453
0
10
splicing factor 3b, subunit 1, 155 kD (SF3B1), m

110C6
4
1853
AF131753
Hs. 13472
0
5
clone 24859 mRNA sequence/cds = UNKNOWN/

gb = AF

173B6
1156
1672
NM_013236
Hs. 13493
0
1
like mouse brain protein E46 (E46L), mRNA/cds =

462C4
794
1093
BC001909
Hs. 13580
1.00E−115
1
clone IMAGE: 3537447, mRNA, partial cds/cds =

597H11
412
936
NM_014174
Hs. 13645
0
1
HSPC144 protein (HSPC144), mRNA/cds = (446,112

107F8
429
821
AK025767
Hs. 13755
0
1
FLJ22114 fis, clone HEP18441/cds = UNKNOW

102D12
3153
4764
AF000993
Hs. 13980
0
2
ubiquitous TPR motif, X isoform (UTX) mRNA, alt

515G12
1710
2120
AK025425
Hs. 14040
0
2
cDNA: FLJ21772 fis, clone COLF7808/

cds = UNKNOW

480H5
1945
2259
AK024228
Hs. 14070
1.00E−119
1
cDNA FLJ14166 fis, clone NT2RP1000796/cds = (20

61D1
73
499
NM_014245
Hs. 14084
0
1
ring finger protein 7 (RNF7), mRNA/cds = (53,394

122E4
2162
2685
NM_014454
Hs. 14125
0
1
p53 regulated PA26 nuclear protein (PA26), mRN

123D9
22
722
NM_001161
Hs. 14142
0
1
nudix (nucleoside diphosphate linked moiety

460F11
1084
1322
NM_017827
Hs. 14220
4.00E−74
1
hypothetical protein FLJ20450 (FLJ20450), mR

458D2
127
536
NM_018648
Hs. 14317
0
1
nucleolar protein family A, member 3 (H/ACA sm

167G1
30
198
AK022939
Hs. 14347
3.00E−91
1
cDNA FLJ12877 fis, clone NT2RP2003825/cds = (3

117H10
975
1721
NM_003022
Hs. 14368
0
1
SH3 domain binding glutamic acid-rich protein

591B12
1082
1801
NM_001614
Hs. 14376
0
9
actin, gamma 1 (ACTG1), mRNA/cds = (74,1201)/g

179H3
1160
1791
X04098
Hs. 14376
1.00E−178
5
cytoskeletal gamma-actin/cds = (73,1200)/g

116D9
5818
6073
NM_012199
Hs. 14520
5.00E−84
1
eukaryotic translation initiation factor 2C,

64D11
1901
2506
NM_003592
Hs. 14541
0
1
cullin 1 (CUL1), mRNA/cds = (124,2382)/gb = NM_0

516F4
750
1331
AK025166
Hs. 14555
0
1
cDNA: FLJ21513 fis, clone COL05778/cds = UNKNOW

459G5
1
260
AK025269
Hs. 14562
5.00E−88
1
cDNA: FLJ21616 fis, clone COL07477/cds = (119,1

521B7
7
1825
NM_005335
Hs. 14601
0
8
hematopoietic cell-specific Lyn substrate 1

110D7
7
1295
X16663
Hs. 14601
0
3
HS1 gene for heamatopoietic lineage cell specific pro

114D11
1460
1559
NM_003584
Hs. 14611
1.00E−45
1
dual specificity phosphatase 11 (RNA/RNP comp

589A3
1665
2197
NM_016293
Hs. 14770
0
2
bridging integrator 2 (BIN2), mRNA/cds = (38,17

104C8
2113
2380
AB031050
Hs. 14805
1.00E−135
2
for organic anion transporter OATP-D, com

481D10
2466
2694
NM_013272
Hs. 14805
1.00E−68
1
solute carrier family 21 (organic anion transp

125B2
2704
3183
NM_001455
Hs. 14845
0
1
forkhead box O3A (FOXO3A), mRNA/cds = (924,2945

500D7
2174
2379
AL050021
Hs. 14846
1.00E−100
1
mRNA; cDNA DKFZp564D016 (from clone

DKFZp564D0

123B5
1793
2195
NM_016598
Hs. 14896
0
1
DHHC1 protein (LOC51304), mRNA/cds = (214,1197

499E2
1266
1549
AB020644
Hs. 14945
1.00E−155
3
mRNA for KIAA0837 protein, partial cds/cds = (0

123H6
2980
3652
NM_007192
Hs. 14963
0
3
chromatin-specific transcription elongation

61G10
264
528
D13627
Hs. 15071
1.00E−144
1
KIAA0002 gene, complete cds/cds = (28,1674)/

460D10
2162
4305
NM_014837
Hs. 15087
0
4
KIAA0250 gene product (KIAA0250), mRNA/cds = (

176E12
9289
9739
NM_022473
Hs. 15220
0
1
zinc finger protein 106 (ZFP106), mRNA/cds = (3

487E11
1561
1989
NM_006170
Hs. 15243
0
1
nucleolar protein 1 (120 kD) (NOL1), mRNA/cds =

75E11
1628
2201
AF127139
Hs. 15259
0
20
Bcl-2-binding protein BIS (BIS) mRNA, complete

71H9
1656
2532
NM_004281
Hs. 15259
0
12
BCL2-associated athanogene 3 (BAG3), mRNA/cd

484G9
465
1006
NM_005826
Hs. 15265
0
1
heterogeneous nuclear ribonucleoprotein R (

480H8
2013
2635
AB037828
Hs. 15370
0
1
mRNA for KIAA1407 protein, partial cds/cds = (0

587G9
2436
2769
AK024088
Hs. 15423
1.00E−167
1
cDNA FLJ14026 fis, clone HEMBA1003679, weakly

483D6
5239
5810
NM_004774
Hs. 15589
0
1
PPAR binding protein (PPARBP), mRNA/cds = (235,

514A7
673
942
NM_006833
Hs. 15591
1.00E−151
1
COP9 subunit 6 (MOV34 homolog, 34 kD) (MOV34-34

125A2
522
746
NM_024348
Hs. 15961
1.00E−112
1
dynactin 3 (p22) (DCTN3), transcript variant

591A5
295
704
NM_005005
Hs. 15977
0
3
NADH dehydrogenase (ubiquinone) 1 beta subcom

39H12
1641
1993
X74262
Hs. 16003
1.00E−180
1
RbAp48 mRNA encoding retinoblastoma binding prot

113A9
1328
1891
NM_016334
Hs. 16085
0
1
putative G-protein coupled receptor (SH120),

45C2
765
1674
NM_006461
Hs. 16244
0
2
mitotic spindle coiled-coil related protein (

494H10
113
2576
NM_016312
Hs. 16420
0
3
Npw38-binding protein NpwBP (LOC51729), mRNA

40D8
52
246
Y13710
Hs. 16530
1.00E−107
1
for alternative activated macrophage spe

597E7
244
524
AL523085
Hs. 16648
1.00E−147
1
AL523085 cDNA/clone = CS0DC001YF21-(5-prime)

458D11
232
319
AY007106
Hs. 16773
1.00E−42
1
clone TCCCIA00427 mRNA sequence/

cds = UNKNOWN

70F2
824
991
AL021786
Hs. 17109
2.00E−90
2
DNA sequence from PAC 696H22 on chromosome

Xq21.1-21.2

167C5
5768
5905
D86964
Hs. 17211
3.00E−62
1
mRNA for KIAA0209 gene, partial cds/cds = (0,5530)/

gb

460H2
3424
3624
AL162070
Hs. 17377
1.00E−103
1
mRNA; cDNA DKFZp762H186 (from clone

DKFZp762H1

70G11
1384
1885
AK023680
Hs. 17448
0
2
FLJ13618 fis, clone PLACE1010925/cds = UNK

129C11
2458
3044
U47924
Hs. 17483
0
2
chromosome 12p13 sequence/cds = (194,1570)/

gb = U4792

467H3
4713
4908
NM_014521
Hs. 17667
1.00E−61
1
SH3-domain binding protein 4 (SH3BP4), mRNA/

71A11
100
370
BG035218
Hs. 17719
1.00E−142
1
602324727F1 cDNA, 5′ end/clone = IMAGE: 4412910

598C7
513
902
NM_021622
Hs. 17757
1.00E−178
1
pleckstrin homology domain-containing, fami

595A7
3296
5680
AB046774
Hs. 17767
0
5
mRNA for KIAA1554 protein, partial cds/cds = (0

58D12
5225
5857
AB007861
Hs. 17803
0
1
KIAA0401 mRNA, partial cds/cds = (0,1036)/gb =

524G8
357
809
NM_014350
Hs. 17839
0
1
TNF-induced protein (GG2-1), mRNA/cds = (197,7

521B10
1008
1476
NM_002707
Hs. 17883
0
2
protein phosphatase 1G (formerly 2C), magnesiu

69B12
1014
1490
Y13936
Hs. 17883
0
1
for protein phosphatase 2C gamma/cds = (24,

178E6
1903
4365
NM_014827
Hs. 17969
0
3
KIAA0663 gene product (KIAA0663), mRNA/cds = (

173H3
481
2362
AK001630
Hs. 18063
0
4
cDNA FLJ10768 fis, clone NT2RP4000150/cds = UN

113A8
1285
1393
NM_005606
Hs. 18069
5.00E−48
1
protease, cysteine, 1 (legumain) (PRSC1), mRN

118H9
3709
3950
AB020677
Hs. 18166
1.00E−125
1
mRNA for KIAA0870 protein, partial cds/cds = (0

513H7
2204
2757
NM_005839
Hs. 18192
1.00E−112
3
Ser/Arg-related nuclear matrix protein (plen

523G9
507
768
AB044661
Hs. 18259
1.00E−147
1
XAB1 mRNA for XPA binding protein 1, complete c

105B9
695
1115
AJ010842
Hs. 18259
0
1
for putative ATP(GTP)-binding protein, p

589D12
335
715
NM_016565
Hs. 18552
0
2
E2IG2 protein (LOC51287), mRNA/cds = (131,421)

170C8
414
737
AF072860
Hs. 18571
0
2
protein activator of the interferon-induced p

189A12
414
736
NM_003690
Hs. 18571
0
1
protein kinase, interferon-inducible double

134B9
2751
3057
AB046808
Hs. 18587
1.00E−165
1
mRNA for KIAA1588 protein, partial cds/cds = (2

519G5
1291
1581
NM_012332
Hs. 18625
1.00E−157
2
Mitochondrial Acyl-CoA Thioesterase (MT-ACT4

526H2
827
1205
NM_004208
Hs. 18720
0
1
programmed cell death 8 (apoptosis-inducing f

462F12
409
556
NM_017899
Hs. 18791
2.00E−78
1
hypothetical protein FLJ20607 (FLJ20607), mR

138B2
388
995
AF003938
Hs. 18792
0
1
thioredoxin-like protein complete cds

36G12
935
1272
AJ250014
Hs. 18827
0
2
for Familial Cylindromatosis cyld gene/

194D3
924
2123
NM_018253
Hs. 18851
0
2
hypothetical protein FLJ10875 (FLJ10875), mR

523E1
3653
4056
NM_012290
Hs. 18895
0
1
tousled-like kinase 1 (TLK1), mRNA/cds = (212,2

587G5
1
350
NM_016302
Hs. 18925
1.00E−166
1
protein × 0001 (LOC51185), mRNA/cds = (33,1043)

595C10
161
1281
AC006042
Hs. 18987
0
4
BAC clone RP11-505D17 from 7p22-p21/cds = (0,12

125G10
54
752
NM_002492
Hs. 19236
0
3
NADH dehydrogenase (ubiquinone) 1 beta subcom

478G7
1
193
NM_021603
Hs. 19520
9.00E−51
1
FXYD domain-containing ion transport regulat

595F11
3623
3736
AB051481
Hs. 19597
3.00E−49
1
mRNA for KIAA1694 protein, partial cds/cds = (0

177C6
284
671
AF161339
Hs. 19807
0
2
HSPC076 mRNA, partial cds/cds = (0,301)/gb = AF

37E12
3485
3919
AB018298
Hs. 19822
0
1
for KIAA0755 protein, complete cds/cds = (

64G8
962
1311
NM_001902
Hs. 19904
0
1
cystathionase (cystathionine gamma-lyase) (

499D5
2829
3183
AB011169
Hs. 20141
0
1
mRNA for KIAA0597 protein, partial cds/cds = (0,

40D11
62
684
NM_004166
Hs. 20144
0
1
small inducible cytokine subfamily A (Cys-Cys

66C10
1240
2240
U76248
Hs. 20191
0
12
hSIAH2 mRNA, complete cds/cds = (526,1500)/

gb = U76248

586B12
1686
4288
AB040922
Hs. 20237
0
2
mRNA for KIAA1489 protein, partial cds/cds = (1

173G8
2578
3197
AL096776
Hs. 20252
0
1
DNA sequence from clone RP4-646B12 on

chromosome 1q42

98C6
3303
4699
AB051487
Hs. 20281
0
6
mRNA for KIAA1700 protein, partial cds/cds = (1

107H11
781
1380
AK022103
Hs. 20281
0
1
FLJ12041 fis, clone HEMBB1001945/cds = UNK

121B8
778
1264
NM_001548
Hs. 20315
0
1
interferon-induced protein with tetratricope

110C4
1050
1431
AF244137
Hs. 20597
0
1
hepatocellular carcinoma-associated antigen

99H6
899
1412
NM_014315
Hs. 20597
0
2
host cell factor homolog (LCP), mRNA/cds = (316,

152B12
69
424
AK025446
Hs. 20760
0
1
FLJ21793 fis, clone HEP00466/cds = UNKNOW

459A8
1858
2143
AL021366
Hs. 20830
1.00E−155
1
DNA sequence from cosmid ICK0721Q on

chromosome

587A11
720
1080
AL137576
Hs. 21015
0
1
mRNA; cDNA DKFZp564L0864 (from clone

DKFZp564L

191E12
1688
2235
AK025019
Hs. 21056
0
2
cDNA: FLJ21366 fis, clone COL03012, highly sim

52G3
225
1652
NM_005880
Hs. 21189
0
6
HIRA interacting protein 4 (dnaJ-like) (HIRIP

181B7
3176
3316
AB018325
Hs. 21264
3.00E−72
1
mRNA for KIAA0782 protein, partial cds/cds = (0

45E11
1378
1518
NM_003115
Hs. 21293
1.00E−72
1
UDP-N-acteylglucosamine pyrophosphorylase

109G1
2989
3487
AB032948
Hs. 21356
0
1
for KIAA1122 protein, partial cds/cds = (0

116D4
5522
5741
NM_016936
Hs. 21479
1.00E−107
1
ubinuclein 1 (UBN1), mRNA/cds = (114,3518)/gb

37G10
294
3960
M97935
Hs. 21486
0
4
transcription factor ISGF-3 mRNA, complete cd

599E8
329
3568
NM_007315
Hs. 21486
0
6
signal transducer and activator of transcripti

592D10
2223
3204
NM_002709
Hs. 21537
0
3
protein phosphatase 1, catalytic subunit, bet

68A7
1327
1612
AB028958
Hs. 21542
1.00E−161
1
for KIAA1035 protein, partial cds/cds = (0

72B3
2519
2862
L03426
Hs. 21595
1.00E−179
1
XE7 mRNA, complete alternate coding regions/

cds = (166

592E6
2520
2854
NM_005088
Hs. 21595
1.00E−161
1
DNA segment on chromosome X and (unique) 155 ex

589G6
190
522
AL573787
Hs. 21732
1.00E−141
1
AL573787 cDNA/clone = CS0DI055YM17-(3-prime)

593H1
452
899
NM_005875
Hs. 21756
0
2
translation factor sui1 homolog (GC20), mRNA

59B8
2893
3273
NM_012406
Hs. 21807
0
1
PR domain containing 4 (PRDM4), mRNA/cds = (122,

196A9
12
543
AL562895
Hs. 21812
0
1
AL562895 cDNA/clone = CS0DC021YO20-(3-prime)

67D8
62
631
AW512498
Hs. 21879
1.00E−150
3
xx75e03.x1 cDNA, 3′ end/clone = IMAGE: 2849500

477B6
1969
2520
D84454
Hs. 21899
0
1
mRNA for UDP-galactose translocator, complete cds/c

515D1
2232
2647
NM_007067
Hs. 21907
0
2
histone acetyltransferase (HBOA), mRNA/cds =

100F8
1082
1508
AK022554
Hs. 21938
0
1
FLJ12492 fis, clone NT2RM2001632, weakly

470E4
1135
1244
NM_020239
Hs. 22065
4.00E−45
2
small protein effector 1 of Cdc42 (SPEC1), mRNA

68G4
1391
2013
AK022057
Hs. 22265
0
2
FLJ11995 fis, clone HEMBB1001443, highly

193H6
922
1328
NM_022494
Hs. 22353
1.00E−178
1
hypothetical protein FLJ21952 (FLJ21952), mR

151D2
1492
1694
AL049951
Hs.22370
4.00E−88
1
cDNA DKFZp564O0122 (from clone DKFZp564O

497E8
1581
4794
D83781
Hs.22559
0
3
mRNA for KIAA0197 gene, partial cds/cds = (0,3945)/gb

182D10
999
1830
AL117513
Hs.22583
0
5
mRNA; cDNA DKFZp434K2235 (from clone

DKFZp434K

75B5
1775
2380
AF006513
Hs.22670
0
1
CHD1 mRNA, complete cds/cds = (163,5292)/gb = A

126H8
1776
2377
NM_001270
Hs.22670
0
1
chromodomain helicase DNA binding protein 1 (

73D5
1599
1696
AK025485
Hs.22678
2.00E−42
1
FLJ21832 fis, clone HEP01571/cds = (32,15

481D11
128
562
BF968270
Hs.22790
1.00E−172
1
602269653F1 cDNA, 5′ end/clone = lMAGE: 4357740

74E4
724
1195
NM_012124
Hs.22857
0
1
chord domain-containing protein 1 (CHP1), mRN

459C6
813
1472
NM_012244
Hs.22891
0
1
solute carrier family 7 (cationic amino acid t

462G7
2972
3144
AB037784
Hs.22941
2.00E−93
1
mRNA for KIAA1363 protein, partial cds/cds = (0

70F12
37
846
AB020623
Hs.22960
0
3
DAM1 mRNA, complete cds/cds = (48,725)/gb = AB0

585H10
91
748
NM_005872
Hs.22960
0
1
breast carcinoma amplified sequence 2 (BCAS2)

142C8
1359
1597
AK024023
Hs.23170
1.00E−103
1
FLJ13961 fis, clone Y79AA1001236, highly

164F2
1220
1474
NM_012280
Hs.23170
1.00E−135
1
homolog of yeast SPB1 (JM23), mRNA/cds = (300,12

127F11
682
806
AL046016
Hs.23247
2.00E−58
1
DKFZp434P246_r1 cDNA, 5′ end/clone = DKFZp434P

98G7
760
1368
NM_022496
Hs.23259
0
1
hypothetical protein FLJ13433 (FLJ13433), mR

470C9
2
538
AL574514
Hs.23294
0
2
AL574514 cDNA/clone = CS0DI056YA07-(3-prime)

458F12
4293
4917
AB002365
Hs.23311
0
1
mRNA for KIAA0367 gene, partial cds/cds = (0,2150)/gb

57D8
460
566
BF439063
Hs.23349
3.00E−54
1
nab70e03.x1 cDNA/clone = IMAGE/gb = BF439063/

599G12
352
983
NM_014814
Hs.23488
0
2
KIAA0107 gene product (KIAA0107), mRNA/cds = (

112B3
2400
2715
NM_014887
Hs.23518
1.00E−172
1
hypothetical protein from BCRA2 region (CG005

167C10
1771
2107
NM_004380
Hs.23598
1.00E−175
1
CREB binding protein (Rubinstein-Taybi syndr

196G9
114
307
BF970427
Hs.23703
1.00E−101
1
602272760F1 cDNA, 5′ end/clone = IMAGE: 4360767

184B3
2488
2882
AK026983
Hs.23803
0
1
FLJ23330 fis, clone HEP12654/cds = (69,13

480H4
4871
5467
AB023227
Hs.23860
0
1
mRNA for KIAA1010 protein, partial cds/cds = (0

479C12
4
190
NM_005556
Hs.23881
4.00E−91
1
keratin 7 (KRT7), mRNA/cds = (56,1465)/gb = NM_—

36E7
742
1126
AL360135
Hs.23964
0
1
full length insert cDNA clone EUROIMAGE 12

598B5
544
1271
NM_005870
Hs.23964
0
12
sin3-associated polypeptide, 18 kD (SAP18), m

462D8
1205
1653
NM_004790
Hs.23965
0
1
solute carrier family 22 (organic anion transp

479A5
1817
2164
NM_002967
Hs.23978
0
1
scaffold attachment factor B (SAFB), mRNA/cds

188E2
1762
2160
NM_014950
Hs.24083
0
1
KIAA0997 protein (KIAA0997), mRNA/cds = (262,2

67D2
1304
1856
AK024240
Hs.24115
0
2
FLJ14178 fis, clone NT2RP2003339/cds = UNK

177D8
4674
5185
AF251039
Hs.24125
0
1
putative zinc finger protein mRNA, complete cd

190E1
5222
5394
NM_016604
Hs.24125
8.00E−73
1
putative zinc finger protein (LOC51780), mRNA

192A5
1517
1985
NM_003387
Hs.24143
1.00E−135
2
Wiskott-Aldrich syndrome protein interacting

170A4
1666
3280
X86019
Hs.24143
4.00E−23
1
PRPL-2 protein/cds = (204,1688)/gb = X860

480B6
1517
1937
NM_012155
Hs.24178
1.00E−133
1
microtubule-associated protein like echinode

143H11
177
656
BE877357
Hs.24181
0
2
601485590F1 cDNA, 5′ end/clone = IMAGE: 3887951

473D10
146
491
AW960486
Hs.24252
0
1
EST372557 cDNA/gb = AW960486/gi = 8150170/ug =

98H1
23
562
NM_003945
Hs.24322
0
1
ATPase, H+ transporting, lysosomal (vacuolar

169G2
391
638
BE612847
Hs.24349
4.00E−75
2
601452239F1 5′ end/clone = IMAGE: 3856304

479B12
1132
1599
AY007126
Hs.24435
0
1
clone CDABP0028 mRNA sequence/cds = UNKNOWN/g

480H9
4716
5012
NM_006048
Hs.24594
1.00E−145
1
ubiquitination factor E4B (homologous to yeas

110B10
520
1171
AL163206
Hs.24633
0
1
chromosome 21 segment HS21C006/cds = (82,1203)

99A3
519
1000
NM_022136
Hs.24633
0
2
SAM domain, SH3 domain and nuclear localisation

109G7
2024
2350
AB037797
Hs.24684
1.00E−141
1
for KIAA1376 protein, partial cds/cds = (1

61B7
485
1656
AK024029
Hs.24719
0
4
FLJ13967 fis, clone Y79AA1001402, weakly

166C11
1216
1509
AF006516
Hs.24752
1.00E−165
1
eps8 binding protein e3B1 mRNA, complete cds/

464D12
166
764
NM_002882
Hs.24763
0
1
RAN binding protein 1 (RANBP1), mRNA/cds = (149

98C12
6523
8023
AB051512
Hs.25127
0
3
mRNA for KIAA1725 protein, partial cds/cds = (0

63F7
2164
2802
AL133611
Hs.25362
0
1
cDNA DKFZp434O1317 (from clone DKFZp434O

41D11
45
463
X53795
Hs.25409
0
1
R2 mRNA for an inducible membrane protein/

cds = (156,95

62G6
1452
1827
V01512
Hs.25647
0
3
cellular oncogene c-fos (complete sequence)/cds = (15

593D12
1135
2111
NM_015832
Hs.25674
0
8
methyl-CpG binding domain protein 2 (MBD2), tr

172G9
2014
2371
NM_021211
Hs.25726
0
1
transposon-derived Buster1 transposase-like

106D6
432
1878
AF058696
Hs.25812
0
2
cell cycle regulatory protein p95 (NBS1) mRNA,

98A4
533
3758
NM_002485
Hs.25812
0
2
Nijmegen breakage syndrome 1 (nibrin) (NBS1),

477H5
6320
6599
NM_004638
Hs.25911
1.00E−111
3
HLA-B associated transcript-2 (D6S51E), mRNA

71F11
2070
2931
NM_019555
Hs.25951
0
3
Rho guanine nucleotide exchange factor (GEF)

164B9
2163
2502
AK023999
Hs.26039
1.00E−159
1
cDNA FLJ13937 fis, clone Y79AA1000805/cds = UNK

100A3
2043
2620
M34668
Hs.26045
0
1
protein tyrosine phosphatase (PTPase-alpha) mRNA/c

123A5
2046
2638
NM_002836
Hs.26045
0
1
protein tyrosine phosphatase, receptor type,

466E5
7817
8241
NM_014112
Hs.26102
0
2
trichorhinophalangeal syndrome I gene (TRPS1)

588A1
361
857
AF070582
Hs.26118
0
1
clone 24766 mRNA sequence/cds = UNKNOWN/

gb = AF

526H12
176
1809
NM_018384
Hs.26194
0
5
hypothetical protein FLJ11296 (FLJ11296), mR

149G7
96
1123
AK027016
Hs.26198
0
3
FLJ23363 fis, clone HEP15507/cds = (206,1

122A4
1196
1332
AL050166
Hs.26295
3.00E−72
1
mRNA; cDNA DKFZp586D1122 (from clone

DKFZp586D

122D5
1936
2435
AB029006
Hs.26334
0
1
mRNA for KIAA1083 protein, complete cds/cds = (

137G5
137
452
AK025778
Hs.26367
1.00E−145
1
FLJ22125 fis, clone HEP19410/cds = (119,5

595D2
1
372
NM_022488
Hs.26367
3.00E−89
3
PC3-96 protein (PC3-96), mRNA/cds = (119,586)

64D12
1024
1135
NM_017746
Hs.26369
2.00E−57
1
hypothetical protein FLJ20287 (FLJ20287), mR

39E4
2132
2750
AK000367
Hs.26434
0
1
FLJ20360 fis, clone HEP16677/cds = (79,230

473C10
4318
4623
AF051782
Hs.26584
1.00E−154
1
diaphanous 1 (HDIA1) mRNA, complete cds/cds = (

590C4
1740
2198
AL050205
Hs.26613
0
1
mRNA; cDNA DKFZp586F1323 (from clone

DKFZp586F

523F3
454
792
AC002073
Hs.26670
1.00E−164
1
PAC clone RP3-515N1 from 22q11.2-q22/cds = (0,791)/g

587E11
1226
1876
NM_004779
Hs.26703
0
2
CCR4-NOT transcription complex, subunit 8 (C

110G4
191
685
BE868389
Hs.26731
0
1
601444360F1 cDNA, 5′ end/clone = IMAGE: 3848487

110E11
1001
3955
AL117448
Hs.26797
0
2
cDNA DKFZp586B14I7 (from clone DKFZp586B

152A8
12
112
AI760224
Hs.26873
2.00E−48
1
wh62g06.x1 cDNA, 3′ end/clone = IMAGE: 2385370

467G11
528
858
NM_016106
Hs.27023
1.00E−174
1
vesicle transport-related protein (KIAA0917)

465E11
634
1065
AL136656
Hs.27181
3.00E−83
1
mRNA; cDNA DKFZp564C1664 (from clone

DKFZp564C

58E11
1
551
AJ238243
Hs.27182
0
1
mRNA for phospholipase A2 activating protein

590H2
398
1016
NM_014412
Hs.27258
0
1
calcyclin binding protein (CACYBP), mRNA/cds

179E9
1039
1905
AK025586
Hs.27268
0
4
FLJ21933 fis, clone HEP04337/cds = UNKNOW

459D7
1293
1936
AL050061
Hs.27371
0
1
mRNA; cDNA DKFZp566J123 (from clone

DKFZp566J1

54A11
709
1542
AK022811
Hs.27475
0
1
FLJ12749 fis, clone NT2RP2001149/cds = UNK

111A5
42
686
NM_022485
Hs.27556
0
1
hypothetical protein FLJ22405 (FLJ22405), mR

123D4
879
1005
NM_016059
Hs.27693
3.00E−49
1
peptidylprolyl isomerase (cyclophilin)-like

518E11
1245
2235
AF332469
Hs.27721
0
5
putative protein WHSC1L1 (WHSG1L1) mRNA, comp

103B11
631
1343
NM_014805
Hs.28020
0
1
KIAA0766 gene product (KIAA0766), mRNA/cds = (

479H3
4
100
AB007928
Hs.28169
7.00E−37
1
mRNA for KIAA0459 protein, partial cds/cds = (0

526B3
1901
1995
NM_007218
Hs.28285
4.00E−47
1
patched related protein translocated in renal

480E4
4088
4596
AB046766
Hs.28338
0
1
mRNA for KIAA1546 protein, partial cds/cds = (0

164D10
651
970
NM_002970
Hs.28491
1.00E−163
2
spermidine/spermine N1-acetyltransferase (

69E10
729
1588
AB007888
Hs.28578
0
2
KIAA0428 mRNA, complete cds/cds = (1414,2526)

49B1
632
4266
NM_021038
Hs.28578
0
4
muscleblind (Drosophila)-like (MBNL), mRNA/

173A10
2105
2391
AL034548
Hs.28608
1.00E−161
2
DNA sequence from clone RP5-1103G7 on

chromosome 20p1

156H8
467
585
AV691642
Hs.28739
8.00E−43
1
AV691642 5′ end/clone = GKCDJG11/clone_—

588D3
444
909
NM_004800
Hs.28757
1.00E−123
1
transmembrane 9 superfamily member 2 (TM9SF2)

493B12
500
930
NM_003512
Hs.28777
0
1
H2A histone family, member L (H2AFL), mRNA/cd

115C5
63
661
BF341640
Hs.28788
0
1
602016073F1 cDNA, 5′ end/clone = IMAGE: 4151706

524C10
37
412
NM_007217
Hs.28866
1.00E−179
1
programmed cell death 10 (PDCD10), mRNA/cds = (

39A8
1380
1873
AK000196
Hs.29052
0
1
FLJ20189 fis, clone COLF0657/cds = (122,84

477H7
690
1047
NM_005859
Hs.29117
1.00E−163
1
purine-rich element binding protein A (PURA),

134C8
2462
2789
NM_002894
Hs.29287
1.00E−173
1
retinoblastoma-binding protein 8 (RBBP8), mR

108A11
182
992
M31165
Hs.29352
0
9
tumor necrosis factor-inducible (TSG-6) mRNA fragme

99E8
179
992
NM_007115
Hs.29352
0
7
tumor necrosis factor, alpha-induced protein

169B3
2219
2683
AF039942
Hs.29417
0
1
HCF-binding transcription factor Zhangfei (Z

526A7
2219
2670
NM_021212
Hs.29417
0
1
HCF-binding transcription factor Zhangfei (Z

184H12
2380
4852
AB033042
Hs.29679
0
2
KIAA1216 protein, partial cds/cds = (0

125G9
1169
1814
AB037791
Hs.29716
0
1
mRNA for KIAA1370 protein, partial cds/cds = (4

68F3
1011
1892
AK027197
Hs.29797
0
5
FLJ23544 fis, clone LNG08336/cds = (125,5

72H12
2103
2564
L27071
Hs.29877
0
2
tyrosine kinase (TXK) mRNA, complete cds/

cds = (86,166

588D5
793
1321
NM_003328
Hs.29877
0
1
TXK tyrosine kinase (TXK), mRNA/cds = (86,1669)

127C3
1
1424
AK024961
Hs.29977
0
4
cDNA: FLJ21308 fis, clone COL02131/cds = (287,1

128H7
351
977
NM_014188
Hs.30026
0
1
HSPC182 protein (HSPC182), mRNA/cds = (65,649)

521G4
502
1260
NM_004593
Hs.30035
0
4
splicing factor, arginine/serine-rich (trans

47A2
503
1265
U61267
Hs.30035
0
4
putative splice factor transformer2-beta mRN

37G9
1287
1763
M16967
Hs.30054
0
2
coagulation factor V mRNA, complete cds/

cds = (90,6764

459E1
43
536
NM_015919
Hs.30303
0
1
Kruppel-associated box protein (LOC51595), m

465F6
256
573
NM_005710
Hs.30570
7.00E−75
1
polyglutamine binding protein 1 (PQBP1), mRNA

120H1
5305
5634
NM_012296
Hs.30687
1.00E−172
2
GRB2-associated binding protein 2 (GAB2), mRN

189G2
1
147
BG260954
Hs.30724
2.00E−68
1
602372562F1 cDNA, 5′ end/clone = IMAGE: 4480647

482E6
3086
3254
AK023743
Hs.30818
4.00E−91
1
cDNA FLJ13681 fis, clone PLACE2000014, weakly

179H5
20
1232
AK001972
Hs.30822
0
2
FLJ11110 fis, clone PLACE1005921, weakly

598B6
1
1169
NM_018326
Hs.30822
0
19
hypothetical protein FLJ11110 (FLJ11110), mR

126G10
1309
2463
AK000689
Hs.30882
0
18
cDNA FLJ20682 fis, clone KAIA3543, highly simi

126G7
5221
5904
NM_019081
Hs.30909
1.00E−163
2
KIAA0430 gene product (KIAA0430), mRNA/cds = (

483D1
1481
2098
NM_003098
Hs.31121
0
1
syntrophin, alpha 1(dystrophin-associated p

464C9
1188
1755
NM_003273
Hs.31130
0
1
transmembrane 7 superfamily member 2 (TM7SF2),

478A6
3024
3837
NM_012238
Hs.31176
1.00E−176
2
sir2-like 1 (SIRT1), mRNA/cds = (53,2296)/gb =

122E5
1060
1294
NM_002893
Hs.31314
1.00E−113
1
retinoblastoma-binding protein 7 (RBBP7), mR

117B1
2056
2489
AF153419
Hs.31323
0
1
IkappaBkinase complex-associated protein (I

462E10
337
569
AV752358
Hs.31409
1.00E−108
1
AV752358 cDNA, 5′ end/clone = NPDBHG03/clone_—

126E7
1962
2748
AB014548
Hs.31921
0
2
mRNA for KIAA0648 protein, partial cds/cds = (0

186G11
729
954
BC000152
Hs.31989
1.00E−125
1
Similar to DKFZP586G1722 protein, clone MGC:

67H7
1705
2336
AJ400877
Hs.32017
0
2
ASCL3 gene, CEGP1 gene, C11orf14 gene, C11orf1

102B11
175
874
AK026455
Hs.32148
0
1
FLJ22802 fis, clone KAIA2682, highly sim

458D4
46
449
H14103
Hs.32149
1.00E−167
1
ym62a02.r1 cDNA, 5′ end/clone = IMAGE: 163466/

99A2
3991
4532
AB007902
Hs.32168
0
1
KIAA0442 mRNA, partial cds/cds = (0,3519)/gb =

458G5
27
540
N30152
Hs.32250
0
1
yx81f03.s1 cDNA, 3′ end/clone = IMAGE: 268157/

112D11
4399
5040
NM_005922
Hs.32353
0
1
mitogen-activated protein kinase kinase kina

48C8
3278
3988
AB002377
Hs.32556
0
2
mRNA for KIAA0379 protein, partial cds/cds = (0,

515F9
761
989
NM_003193
Hs.32675
1.00E−116
1
tubulin-specific chaperone e (TBCE), mRNA/c

158C12
342
809
NM_016063
Hs.32826
0
1
CGI-130 protein (LOC51020),/cds = (63,575

585E6
128
512
NM_005594
Hs.32916
0
3
nascent-polypeptide-associated complex alp

459B5
1271
1972
NM_017632
Hs.32922
0
1
hypothetical protein FLJ20036 (FLJ20036), mR

469G12
2711
2978
NM_001566
Hs.32944
1.00E−136
1
inositol polyphosphate-4-phosphatase, type

71B7
483
1787
NM_003037
Hs.32970
0
29
signaling lymphocytic activation molecule (S

74G1
1
1780
U33017
Hs.32970
0
33
signaling lymphocytic activation molecule (SLAM) mR

473B11
2993
3361
NM_006784
Hs.33085
1 .00E−111
1
WD repeat domain 3 (WDR3), mRNA/cds = (47,2878)

56B5
23
578
AB019571
Hs.33190
0
1
expressed only in placental villi, clone

469D12
187
394
AL359654
Hs.33756
1.00E−110
1
mRNA full length insert cDNA clone EUROIMAGE 19

98H8
371
618
AI114652
Hs.33757
3.00E−98
1
HA1247 cDNA/gb = AI114652/gi = 6359997/ug = Hs.

594E7
2134
2320
NM_012123
Hs.33979
5.00E−93
1
CGI-02 protein (CGI-02), mRNA/cds = (268,2124)

110D1
1158
1349
NM_018579
Hs.34401
1.00E−105
1
hypothetical protein PRO1278 (PRO1278), mRNA

596A6
1950
2144
NM_022766
Hs.34516
1.00E−102
2
hypothetical protein FLJ23239 (FLJ23239), mR

37B10
237
563
AI123826
Hs.34549
1.00E−145
1
ow61c10.x1 cDNA, 3′ end/clone = IMAGE: 1651314

458H4
3656
4415
AB040929
Hs.35089
0
1
mRNA for KIAA1496 protein, partial cds/cds = (0

100D1
3563
3777
D25215
Hs.35804
1.00E−105
1
KIAA0032 gene, complete cds/cds = (166,3318)

519A12
402
623
AW960004
Hs.36475
3.00E−48
1
EST372075 cDNA/gb = AW960004/gi = 8149688/ug =

498H2
11143
11490
NM_000081
Hs.36508
0
1
Chediak-Higashi syndrome 1 (CHS1), mRNA/cds = (

521D6
304
791
NM_002712
Hs.36587
0
2
protein phosphatase 1, regulatory subunit 7 (

460E1
1200
1542
AF319476
Hs.36752
0
2
GKAP42 (FKSG21) mRNA, complete cds/cds = (174,1

184G9
498
1191
AF082569
Hs.36794
0
2
D-type cyclin-interacting protein 1 (DIP1) mR

462D3
493
1517
NM_012142
Hs.36794
0
3
D-type cyclin-interacting protein 1 (DIP1), m

74E12
659
3054
D86956
Hs.36927
0
23
KIAA0201 gene, complete cds/cds = (347,2923)

58G5
1268
2888
NM_006644
Hs.36927
0
12
heat shock 105 kD (HSP105B), mRNA/cds = (313,275

52C10
1479
2588
AK022546
Hs.37747
0
2
FLJ12484 fis, clone NT2RM1001102, weakly

479F9
2066
2322
AL136932
Hs.37892
1.00E−119
1
mRNA; cDNA DKFZp586H1322 (from clone

DKFZp586H

483C2
2222
2723
NM_003173
Hs.37936
0
1
suppressor of variegation 3-9 (Drosophila) ho

593G6
673
1213
NM_004510
Hs.38125
0
1
interferon-induced protein 75, 52 kD (IFI75),

101G12
118
436
N39230
Hs.38218
1.00E−173
1
yy50c03.s1 cDNA, 3′ end/clone = IMAGE: 276964/

107E5
238
525
AW188135
Hs.38664
1.00E−158
1
xj92g04.x1 cDNA, 3′ end/clone = IMAGE: 2664726

596F2
9
504
BF892532
Hs.38664
0
9
IL0-MT0152-061100-501-e04 cDNA/gb = BF892532

469D7
47
474
NM_014343
Hs.38738
0
1
claudin 15 (CLDN15), mRNA/cds = (254,940)/gb =

166H8
1
81
BF103848
Hs.39457
9.00E−34
1
601647352F1 cDNA, 5′ end/clone = IMAGE: 3931452

465F3
157
296
NM_017859
Hs.39850
2.00E−47
1
hypothetical protein FLJ20517 (FLJ20517), mR

195C12
2684
2944
NM_000885
Hs.4C034
1.00E−146
1
integrin, alpha 4 (antigen CD49D, alpha 4 subu

151F11
1393
1661
AL031427
Hs.40094
6.00E−81
1
DNA sequence from clone 167A19 on chromosome

1p32.1-33

134C12
4532
4802
NM_004973
Hs.40154
1.00E−114
1
jumonji (mouse) homolog (JMJ), mRNA/cds = (244,

115C9
5279
5614
AB033085
Hs.40193
1.00E−157
1
mRNA for KIAA1259 protein, partial cds/cds = (1

119A8
862
2087
NM_006152
Hs.40202
0
3
lymphoid-restricted membrane protein (LRMP),

104D4
924
1398
U10485
Hs.40202
0
2
lymphoid-restricted membrane protein (Jaw1) mRNA, c

155G3
226
530
AF047472
Hs.40323
1.00E−114
1
spleen mitotic checkpoint BUB3 (BUB3) mRNA, c

521C2
233
710
NM_004725
Hs.40323
0
1
BUB3 (budding uninhibited by benzimidazoles 3

107B8
187
545
AI927454
Hs.40328
0
1
wo90a02.x1 cDNA, 3′ end/clone = IMAGE: 2462570

458F10
1
436
BE782824
Hs.40334
0
1
601472323F1 cDNA, 5′ end/clone = IMAGE: 3875501

463G6
16
496
AI266255
Hs.40411
0
1
qx69f01.x1 cDNA, 3′ end/clone = IMAGE: 2006617

162F1
2711
2895
D87468
Hs.40888
4.00E−96
1
KIAA0278 gene, partial cds/cds = (0,1383)/gb

463E1
70
272
AL137067
Hs.40919
1.00E−109
1
DNA sequence from clone RP11-13B9 on

chromosome 9q22.

458E7
107
774
AK024474
Hs.41045
0
1
mRNA for FLJ00067 protein, partial cds/cds = (1

185G12
1051
2315
AL050141
Hs.41569
1.00E−140
11
mRNA; cDNA DKFZp586O031 (from clone

DKFZp586O0

593F5
2106
2490
NM_006190
Hs.41694
0
1
origin recognition complex, subunit 2 (yeast h

513H4
739
1249
NM_002190
Hs.41724
0
6
interleukin 17 (cytotoxic T-lymphocyte-assoc

155F4
739
1247
U32659
Hs.41724
0
1
IL-17 mRNA, complete cds/cds = (53,520)/gb = U32659/g

108H12
892
1227
L40377
Hs.41726
1.00E−170
1
cytoplasmic antiproteinase 2 (CAP2) mRNA, com

477E7
249
404
BG033294
Hs.41989
6.00E−75
1
602298548F1 cDNA, 5′ end/clone = IMAGE: 4393186

143E2
5775
6018
A8033112
Hs.42179
1.00E−136
2
for KIAA1286 protein, partial cds/cds = (1

586B10
720
1225
NM_001952
Hs.42287
0
1
E2F transcription factor 6 (E2F6), mRNA/cds = (

583A10
346
883
NM_012097
Hs.42500
0
1
ADP-ribosylation factor-like 5 (ARL5), mRNA

459A7
152
251
BC003525
Hs.42712
2.00E−50
1
Similar to Max, clone MGC: 10775, mRNA, comple

37B7
43
2687
AF006082
Hs.42915
1.00E−130
2
actin-related protein Arp2 (ARP2) mRNA, compl

120E3
512
2426
NM_005722
Hs.42915
0
3
ARP2 (actin-related protein 2, yeast) homolog

99D1
3298
3761
NM_014939
Hs.42959
0
1
KIAA1012 protein (KIAA1012), mRNA/cds = (57,43

473B2
3025
3425
AK023647
Hs.43047
1.00E−164
1
cDNA FLJ13585 fis, clone PLACE1009150/cds = UNK

460E6
2988
3184
AB033093
Hs.43141
1.00E−105
1
mRNA for KIAA1267 protein, partial cds/cds = (9

471F7
232
575
AW993524
Hs.43148
0
1
RC3-BN0034-120200-011-h06 cDNA/gb = AW993524

460B10
402
706
BE781009
Hs.43273
1.00E−78
1
601469768F1 cDNA, 5′ end/clone = IMAGE: 3872704

36F6
2815
3403
AK024439
Hs.43616
0
1
for FLJ00029 protein, partial cds/cds = (0

471G3
43
454
NM_006021
Hs.43628
1.00E−165
1
deleted in lymphocytic leukemia, 2 (DLEU2), mR

184H3
1819
2128
D14043
Hs.43910
1.00E−168
2
MGC-24, complete cds/cds = (79,648)/gb = D1404

195F4
511
2370
NM_006016
Hs.43910
0
7
CD164 antigen, sialomucin (CD164), mRNA/cds =

188H9
1573
2277
NM_006346
Hs.43913
0
3
PIBF1 gene product (PIBE1), mRNA/cds = (0,2276)

177H6
1575
2272
Y09631
Hs.43913
0
2
PIBF1 protein, complete/cds = (0,2276)/

481E6
2529
2873
AB032952
Hs.44087
1.00E−159
1
mRNA for KIAA1126 protein, partial cds/cds = (0

112F5
1105
1701
AF197569
Hs.44143
0
1
BAF180 (BAF180) mRNA, complete cds/cds = (96,48

146F5
2620
3147
AL117452
Hs.44155
0
1
DKFZp586G1517 (from clone DKFZp586G

514C5
166
431
NM_018838
Hs.44163
1.00E−149
3
13 kDa differentiation-associated protein (L

71D9
1117
1800
AF263613
Hs.44198
0
2
membrane-associated calcium-independent ph

68E1
289
527
AA576946
Hs.44242
4.00E−83
1
nm82b03.s1 cDNA, 3′ end/clone = IMAGE: 1074701

53H12
1925
2112
X75042
Hs.44313
4.00E−84
1
rel proto-oncogene mRNA/cds = (177,2036)/gb = X75

595D4
21
402
NM_017867
Hs.44344
0
1
hypothetical protein FLJ20534 (FLJ20534), mR

165B10
250
658
BC000758
Hs.44468
0
1
clone MGC: 2698, mRNA, complete cds/cds = (168,

592E9
37
2422
NM_002687
Hs.44499
0
5
pinin, desmosome associated protein (PNN), mR

69F10
14
1152
Y09703
Hs.44499
0
3
MEMA protein/cds = (406,2166)/gb = Y09703

458H6
1
352
NM_015697
Hs.44563
0
1
hypothetical protein (CL640), mRNA/cds = (0,39

182C11
690
1324
AB046861
Hs.44566
0
4
mRNA for KIAA1641 protein, partial cds/cds = (6

115G3
318
731
BG288837
Hs.44577
0
1
602388170F1 cDNA, 5′ end/clone = IMAGE: 4517129

70B11
1879
4363
U58334
Hs.44585
0
3
Bcl2, p53 binding protein Bbp/53BP2 (BBP/53BP2)

mRNA

165F10
265
496
AV726117
Hs.44656
6.00E−66
1
AV726117 cDNA, 5′ end/clone = HTCAXB05/clone_—

36F1
444
1176
AK001332
Hs.44672
0
1
FLJ10470 fis, clone NT2RP2000032, weakly

596H1
1073
2711
AF288571
Hs.44865
0
14
lymphoid enhancer factor-1 (LEF1) mRNA, compl

41C4
2876
3407
X60708
Hs.44926
0
1
pcHDP7 mRNA for liver dipeptidyl peptidase IV/

cds = (75

588A7
7564
7849
AL031667
Hs.45207
1.00E−158
1
DNA sequence from clone RP4-620E11 on

chromosome 20q1

183G6
3967
4942
AB020630
Hs.45719
0
5
mRNA for KIAA0823 protein, partial cds/cds = (0

465C9
700
1325
BC002796
Hs.46446
0
1
lymphoblastic leukemia derived sequence 1,

464B1
1519
1997
NM_006019
Hs.46465
0
1
T-cell, immune regulator 1 (TCIRG1), mRNA/cds

466F10
455
518
AW974756
Hs.46476
6.00E−26
1
EST386846 cDNA/gb = AW974756/gi = 8165944/ug =

110E7
620
1153
AF223469
Hs.46847
0
1
AD022 protein (AD022) mRNA, complete cds/cds =

112D5
618
1197
NM_016614
Hs.46847
0
4
TRAF and TNF receptor-associated protein (AD0

172G6
4157
4527
NM_003954
Hs.47007
0
1
mitogen-activated protein kinase kinase kina

177C8
4217
4469
Y10256
Hs.47007
1.00E−96
1
serine/threonine protein kinase, NIK/c

458H9
18
457
AW291458
Hs.47325
0
1
UI-H-BI2-agh-c-02-0-UI.s1 cDNA, 3′ end/clon

62B6
562
697
BE872760
Hs.47334
7.00E−54
1
601450902F1 cDNA, 5′ end/clone = IMAGE: 3854544

178F12
169
2413
AF307339
Hs.47783
0
2
B aggressive lymphoma short isoform (BAL) mRNA

460G4
598
1081
NM_005985
Hs.48029
0
1
snail 1 (drosophila homolog), zinc finger prot

70D12
1
2038
AK027070
Hs.48320
0
13
FLJ23417 fis, clone HEP20868/cds = (59,12

41G5
6587
7128
NM_014345
Hs.48433
0
1
endocrine regulator (HRIHFB2436), mRNA/cds =

516H2
1
212
NM_017948
Hs.48712
2.00E−90
2
hypothetical protein FLJ20736 (FLJ20736), mR

517G9
665
1649
NM_004462
Hs.48876
0
2
farnesyl-diphosphate farnesyltransferase 1

146A2
88
440
X76770
Hs.49007
0
1
PAP/cds = UNKNOWN/gb = X76770/gi = 556782/ug

174H4
2612
3200
AF189011
Hs.49163
0
1
ribonuclease III (RN3) mRNA, complete cds/cds

121G3
463
829
NM_017917
Hs.49376
0
1
hypothetical protein FLJ20644 (FLJ20644), mR

170B9
2260
2948
AK023825
Hs.49391
0
1
FLJ13763 fis, clone PLACE4000089/cds = (56

65E2
629
1798
AF062075
Hs.49587
0
4
leupaxin mRNA, complete cds/cds = (93,1253)/g

518B2
26
1798
NM_004811
Hs.49587
0
12
leupaxin (LPXN), mRNA/cds = (93,1253)/gb = NM_0

472E8
1182
1516
AL390132
Hs.49822
0
1
mRNA; cDNA DKFZp547E107 (from clone

DKFZp547E1

41B12
57
576
AB000887
Hs.50002
0
1
for EBI1-ligand chemokine, complete cds

41D1
1
310
U86358
Hs.50404
1.00E−135
1
chemokine (TECK) mRNA, complete cds/cds = (0,452)/gb

107C9
2861
3541
M64174
Hs.50651
0
3
protein-tyrosine kinase (JAK1) mRNA, complete cds/c

599H12
202
3541
NM_002227
Hs.50651
0
11
Janus kinase 1 (a protein tyrosine kinase) (JAK

105E3
621
1101
AF047442
Hs.50785
0
1
vesicle trafficking protein sec22b mRNA, comp

129B5
2489
2919
X16354
Hs.50964
0
2
transmembrane carcinoembryonic antigen BGPa

587H2
748
1673
NM_000521
Hs.51043
0
2
hexosaminidase B (beta polypeptide) (HEXB), m

458H12
4043
4561
NM_000887
Hs.51077
0
1
integrin, alpha X (antigen CD11C (p150), alpha

129C9
4055
4567
Y00093
Hs.51077
0
1
leukocyte adhesion glycoprotein p150,95

125D8
2502
3966
AF016266
Hs.51233
0
3
TRAIL receptor 2 mRNA, complete cds/cds = (117,1

179E1
17
343
M22538
Hs.51299
1.00E−179
1
nuclear-encoded mitochondrial NADH-ubiquinone redu

165D7
35
754
NM_021074
Hs.51299
0
4
NADH dehydrogenase (ubiquinone) flavoprotein

107F10
2632
2993
Y11251
Hs.51957
0
2
novel member of serine-arginine domain p

195B12
1344
1590
NM_017903
Hs.52184
3.00E−96
1
hypothetical protein FLJ20618 (FLJ20618), mR

69D7
3046
3568
AB014569
Hs.52526
0
4
for KIAA0669 protein, complete cds/cds = (

55D1
2607
2847
NM_014779
Hs.52526
1.00E−130
1
KIAA0669 gene product (KIAA0669), mRNA/cds = (

480B8
1943
2062
AL080213
Hs.52792
8.00E−44
1
mRNA; cDNA DKFZp586I1823 (from clone

DKFZp586I

72G7
1236
1348
NM_018607
Hs.52891
2.00E−55
1
hypothetical protein PRO1853 (PRO1853), mRNA

526D1
1
256
NM_004597
Hs.53125
1.00E−114
1
small nuclear ribonucleoprotein D2 polypeptid

458E8
1182
1701
NM_002621
Hs.53155
0
1
properdin P factor, complement (PFC), mRNA/cd

458G2
2171
2836
NM_001204
Hs.53250
0
1
bone morphogenetic protein receptor, type II

458F7
30
650
NM_002200
Hs.54434
0
1
interferon regulatory factor 5 (IRF5), mRNA/

459F12
2023
3325
NM_006060
Hs.54452
0
2
zinc finger protein, subfamily 1A, 1 (lkaros) (

41A6
498
755
U46573
Hs.54460
1.00E−140
1
eotaxin precursor mRNA, complete cds/cds = (53,346)/

590A10
243
659
NM_004688
Hs.54483
0
2
N-myc (and STAT) interactor (NMI), mRNA/cds = (

461C11
872
1415
NM_014291
Hs.54609
0
1
glycine C-acetyltransferase (2-amino-3-keto

170H5
412
1630
AJ243721
Hs.54642
0
3
for dTDP-4-keto-6-deoxy-D-glucose 4-re

521F5
270
1491
NM_013283
Hs.54642
0
8
methionine adenosyltransferase II, beta (MAT

189H5
737
1049
X76302
Hs.54649
1.00E−131
2

H. sapiens RY-1 mRNA for putative nucleic acid

binding protei

599D10
2614
3035
AB029015
Hs.54886
0
5
mRNA for KIAA1092 protein, partial cds/cds = (0

458D5
1026
1676
AK027243
Hs.54890
0
1
cDNA: FLJ23590 fis, clone LNG14491/cds = (709,1

37A10
1633
2040
AK026024
Hs.55024
0
1
FLJ22371 fis, clone HRC06680/cds = (77,12

121A8
799
1217
NM_018053
Hs.55024
1.00E−160
1
hypothetical protein FLJ10307 (FLJ10307), mR

460B1
11195
11326
AF231023
Hs.55173
1.00E−45
1
protocadherin Flamingo 1 (FMI1) mRNA, complete

57F1
1450
2070
NM_003447
Hs.55481
0
2
zinc finger protein 165 (ZNF165), mRNA/cds = (5

68D10
979
2070
U78722
Hs.55481
0
4
zinc finger protein 165 (Zpf165) mRNA, complete

584G7
268
1674
NM_003753
Hs.55682
0
4
eukaryotic translation initiation factor 3,

161C8
63
394
NM_017897
Hs.55781
1.00E−177
1
hypothetical protein FLJ20604 (FLJ20604), mR

588F6
1
387
NM_016497
Hs.55847
0
1
hypothetical protein (LOC51258), mRNA/cds = (

597E10
334
2073
NM_004446
Hs.55921
0
5
glutamyl-prolyl-tRNA synthetase (EPRS), mRN

138H10
3603
4112
X54326
Hs.55921
0
1
glutaminyl-tRNA synthetase/cds = (58,43

121D5
3959
4192
AB018348
Hs.55947
1.00E−130
1
mRNA for KIAA0805 protein, partial cds/cds = (0

473D12
1428
1866
AJ245539
Hs.55968
0
2
partial mRNA for GaINAc-T5 (GALNT5 gene)/cds =

71E3
843
1724
NM_005542
Hs.56205
0
30
insulin induced gene 1 (INSIG1), mRNA/cds = (414

73F4
843
2495
U96876
Hs.56205
0
32
insulin induced protein 1 (INSIG1) gene, compl

75C8
180
2439
AJ277832
Hs.56247
0
13
for inducible T-cell co-stimulator (ICOS

187A6
2073
2255
AF195530
Hs.56542
2.00E−99
1
soluble aminopeptidase P (XPNPEP1) mRNA, comp

584H5
1496
1889
NM_001494
Hs.56845
1.00E−151
1
GDP dissociation inhibitor 2 (GDI2), mRNA/cds

460C5
2395
2860
AK022936
Hs.56847
0
1
cDNA FLJ12874 fis, clone NT2RP2003769/cds = UNK

460B5
164
741
BC003581
Hs.56851
0
1
Similar to RIKEN cDNA 2900073H19 gene, clone

54G4
1359
1761
AK027232
Hs.57209
0
2
FLJ23579 fis, clone LNG13017/cds = UNKNOW

192D8
1576
2872
AL136703
Hs.57209
0
3
mRNA; cDNA DKFZp566J091 (from clone

DKFZp566J0

66F9
618
1056
U41654
Hs.57304
0
1
adenovirus protein E3-14.7k interacting protein 1 (

183A1
2093
2334
NM_003751
Hs.57783
1.00E−132
1
eukaryotic translation initiation factor 3,

117B3
6933
7225
NM_022898
Hs.57987
1.00E−154
3
B-cell lymphoma/leukaemia 11B (BCL11B), mRNA

74C11
273
359
BE739287
Hs.58066
7.00E−21
1
601556492F1 cDNA, 5′ end/clone = IMAGE: 3826247

174H2
5591
5977
AJ131693
Hs.58103
0
1
mRNA for AKAP450 protein/cds = (222,11948)/gb

599H8
26
993
NM_003756
Hs.58189
0
3
eukaryotic translation initiation factor 3,

168F12
295
593
U54559
Hs.58189
1.00E−166
1
translation initiation factor elF3 p40 subuni

68B11
1
297
BE867841
Hs.58297
1.00E−146
1
601443614F1 cDNA, 5′ end/clone = IMAGE: 3847827

104A6
376
2578
AF001862
Hs.58435
0
3
FYN binding protein mRNA, complete cds/cds = (67

192E3
230
648
NM_001465
Hs.58435
0
4
FYN-binding protein (FYB-120/130) (FYB), mRN

73B4
1287
1763
AK022834
Hs.58488
0
1
FLJ12772 fis, clone NT2RP2001634, highly

100G3
1568
1786
NM_004850
Hs.58617
1.00E−108
1
Rho-associated, coiled-coil containing prot

116G9
1997
2464
NM_013352
Hs.58636
0
1
squamous cell carcinoma antigen recognized by

178C6
5
710
AV760147
Hs.58643
1.00E−111
5
AV760147 cDNA, 5′ end/clone = MDSEPB12/clone_—

519B1
2203
2320
NM_014207
Hs.58685
1.00E−56
1
CD5 antigen (p56-62) (CD5), mRNA/cds = (72,1559

40B6
1655
2283
X04391
Hs.58685
0
1
lymphocyte glycoprotein T1/Leu-1/cds = (72,1

466B9
262
534
AI684437
Hs.58774
1.00E−107
1
wa82a04.x1 cDNA, 3′ end/clone = IMAGE: 2302638

480H7
86
234
NM_006568
Hs.59106
1.00E−54
1
cell growth regulatory with ring finger domain

44A7
2229
2703
X17094
Hs.59242
0
1
fur mRNA for furin/cds = (216,2600)/gb = X17094/

gi = 314

106D12
21
380
M96982
Hs.59271
0
2
U2 snRNP auxiliary factor small subunit, compl

39C5
1821
2653
AB011098
Hs.59403
0
1
for KIAA0526 protein, complete cds/cds = (

185H7
1826
2352
NM_004863
Hs.59403
0
1
serine palmitoyltransferase, long chain base

459C5
126
443
AA889552
Hs.59459
1.00E−158
1
ak20d12.s1 cDNA, 3′ end/clone = IMAGE: 1406519

108B8
2760
3079
AJ132592
Hs.59757
1.00E−138
1
for zinc finger protein, 3115/cds = (107,27

194F7
2074
2461
NM_018227
Hs.59838
0
1
hypothetical protein FLJ10808 (FLJ10808), mR

465D4
2
132
AI440512
Hs.59844
7.00E−67
1
tc83f09.x1 cDNA, 3′ end/clone = IMAGE: 2072777

161H10
1
381
AA004799
Hs.60088
1.00E−169
1
zh96b05.s1 cDNA, 3′ end/clone IMAGE: 429105/

465B6
228
383
NM_018986
Hs.61053
1.00E−66
1
hypothetical protein (FLJ20356), mRNA/cds = (

102G9
359
725
D11094
Hs.61153
0
1
MSS1, complete cds/cds = (66,1367)/gb = D11094

193C6
359
725
NM_002803
Hs.61153
1.00E−174
2
proteasome (prosome, macropain) 26S subunit,

99E7
1768
2339
AL023653
Hs.61469
0
10
DNA sequence from clone 753P9 on chromosome

Xq25-26.1.

462B9
5
411
BE779284
Hs.61472
1.00E−152
1
601464557F1 cDNA, 5′ end/clone = IMAGE: 3867566

594F11
220
569
NM_003905
Hs.61828
1.00E−159
2
amyloid beta precursor protein-binding prote

102E7
1216
1921
AF046001
Hs.62112
0
3
zinc finger transcription factor (ZNF207) mRN

192B4
754
934
NM_003457
Hs.62112
2.00E−98
2
zinc finger protein 207 (ZNF207), mRNA/cds = (2

41G9
1664
2096
J02931
Hs.62192
0
1
placental tissue factor (two forms) mRNA, complete cd

482E12
1857
2149
NM_001993
Hs.62192
5.00E−87
1
coagulation factor III (thromboplastin, tiss

459C10
1548
1845
AB011114
Hs.62209
1.00E−166
1
mRNA for KIAA0542 protein, partial cds/cds = (39

114D6
2251
2712
NM_002053
Hs.62661
0
1
guanylate binding protein 1, interferon-induc

590C9
83
760
NM_002032
Hs.62954
0
43
ferritin, heavy polypeptide 1 (FTH1), mRNA/c

458C5
1798
2407
AB033118
Hs.63128
0
1
mRNA for KIAA1292 protein, partial cds/cds = (0

109E5
4661
5114
AB002369
Hs.63302
0
1
KIAA0371 gene, complete cds/cds = (247,3843)

589G9
250
5650
NM_021090
Hs.63302
0
6
myotubularin related protein 3 (MTMR3), mRNA

182E4
1751
2144
NM_002831
Hs.63489
0
1
protein tyrosine phosphatase, non-receptor t

589C8
1787
2222
AK023529
Hs.63525
0
2
cDNA FLJ13467 fis, clone PLACE1003519, highly

458D7
1595
1912
NM_022727
Hs.63609
1.00E−180
1
Hpall tiny fragments locus 9C (HTF9C), mRNA/c

193A2
144
2588
NM_003264
Hs.63668
0
5
toll-like receptor 2 (TLR2), mRNA/cds = (129,24

117C3
1504
2366
AF131762
Hs.64001
0
3
clone 25218 mRNA sequence/cds = UNKNOWN/

gb = AF

109F1
568
2157
AL031602
Hs.64239
0
3
DNA sequence from clone RP5-1174N9 on

chromosome 1p34

40D5
698
1192
U32324
Hs.64310
0
1
interleukin-11 receptor alpha chain mRNA, complete c

522F4
12
504
NM_006356
Hs.64593
0
1
ATP synthase, H+ transporting, mitochondrial

462E9
215
891
NM_015423
Hs.64595
0
1
aminoadipate-semialdehyde dehydrogenase-ph

164G10
37
889
NM_006851
Hs.64639
0
2
glioma pathogenesis-related protein (RTVP1),

155G10
1
601
U16307
Hs.64639
0
1
glioma pathogenesis-related protein (GliPR) mRNA, c

110D11
341
712
S60099
Hs.64797
0
1
APPH = amyloid precursor protein homolog [human,

placenta,

513E8
3411
3986
AF148537
Hs.65450
0
7
reticulon 4a mRNA, complete cds/cds = (141,3719

460F4
1415
1749
NM_018174
Hs.66048
1.00E−163
1
hypothetical protein FLJ10669 (FLJ10669), mR

478H8
486
1037
NM_001775
Hs.66052
0
1
CD38 antigen (p45) (CD38), mRNA/cds = (69,971)

461A6
2977
3516
AB051540
Hs.66053
0
1
mRNA for KIAA1753 protein, partial cds/cds = (0

191E7
1
494
AL157438
Hs.66151
0
6
mRNA; cDNA DKFZp434A115 (from clone

DKFZp434A1

464B6
76
623
NM_002528
Hs.66196
0
1
nth (E. coli endonuclease III)-like 1 (NTHL1),

473C6
149
517
BE673759
Hs.66357
0
1
7d69d02.x1 cDNA, 3′ end/clone = IMAGE: 3278211

171G11
1001
1385
Z98884
Hs.66708
0
1
DNA sequence from clone RP3-467L1 on

chromosome 1p36.

169H3
15
1800
X82200
Hs.68054
0
4
Staf50/cds = (122,1450)/gb = X82200/gi = 8992

167G9
747
1104
NM_005932
Hs.68583
1.00E−101
1
mitochondrial intermediate peptidase (MIPEP)

170H3
747
1104
U80034
Hs.68583
6.00E−99
1
mitochondrial intermediate peptidase precurs

69F9
321
1348
U78027
Hs.69089
0
5
Bruton's tyrosine kinase (BTK), alpha-D-galac

586D6
16
676
NM_006360
Hs.69469
1.00E−173
2
dendritic cell protein (GA17), mRNA/cds = (51,1

591E3
74
189
NM_002385
Hs.69547
2.00E−59
1
myelin basic protein (MBP), mRNA/cds = (10,570)

597H2
482
2702
NM_007158
Hs.69855
0
8
NRAS-related gene (D15155E), mRNA/cds = (420,2

515C5
3257
3421
NM_003169
Hs.70186
8.00E−45
1
suppressor of Ty (S.cerevisiae) 5 homolog (SUP

461B9
44
425
H06786
Hs.70258
0
1
yl83g05.r1 cDNA, 5′ end/clone = IMAGE: 44737/c

525H4
2834
2978
NM_014933
Hs.70266
4.00E−77
1
yeast Sec31p homolog (KIAA0905), mRNA/cds = (53

521C3
1
1165
NM_016628
Hs.70333
1.00E−176
2
hypothetical protein (LOC51322), mRNA/cds = (

460E5
414
994
AF138903
Hs.70337
0
1
immunoglobulin superfamily protein beta-like

190C7
1406
1788
D50926
Hs.70359
0
1
mRNA for KIAA0136 gene, partial cds/cds = (0,2854)/gb

497F10
653
1096
NM_014210
Hs.70499
0
3
ecotropic viral integration site 2A (EVI2A), m

37C11
820
1523
AB002368
Hs.70500
0
4
KIAA0370 gene, partial cds/cds = (0,2406)/gb

464B2
496
721
BG283002
Hs.71243
3.00E−99
1
602406192F1 cDNA, 5′ end/clone = IMAGE: 4518214

69G4
1292
2708
AL161991
Hs.71252
0
4
cDNA DKFZp761C169 (from clone DKFZp761C1

485E4
176
485
AA131524
Hs.71433
1.00E−151
1
zl31h02.s1 cDNA, 3′ end/clone = IMAGE: 503571/

161G2
1338
1877
NM_003129
Hs.71465
0
1
squalene epoxidase (SQLE), mRNA/cds(214,193

188D6
328
597
NM_016630
Hs.71475
1.00E−129
1
hypothetical protein (LOC51324), mRNA/cds = (

483B5
12
384
NM_021128
Hs.71618
0
1
polymerase (RNA) II (DNA directed) polypeptide

161F6
675
1114
U79277
Hs.71848
0
1
clone 23548 mRNA sequence/cds = UNKNOWN/

gb = U79277/g

473F8
377
729
BE889075
Hs.71941
1.00E−146
1
601513514F1 cDNA, 5′ end/clone = IMAGE: 3915003

102A6
1129
1560
AK023183
Hs.72782
0
1
FLJ13121 fis, clone NT2RP3002687/cds = (39

41E2
56
539
M57506
Hs.72918
0
1
secreted protein (I-309) gene, complete cds/cds = (72,

476E12
1790
2311
S76638
Hs.73090
0
2
p50-NF-kappa B homolog [human, peripheral blood T

cells, mR

41G7
3116
3469
U64198
Hs.73165
1.00E−173
1
II-12 receptor beta2 mRNA, complete cds/

cds = (640,322

51C9
1721
2339
NM_005263
Hs.73172
0
4
growth factor independent 1 (GFI1), mRNA/cds =

67H6
1723
2342
U67369
Hs.73172
0
1
growth factor independence-1 (Gfi-1) mRNA, complete

179E7
211
610
M92444
Hs.73722
0
1
apurinic/apyrimidinic endonuclease (HAP1) g

585G3
174
589
NM_001641
Hs.73722
0
8
APEX nuclease (multifunctional DNA repair enz

138A11
1360
1717
M72709
Hs.73737
1.00E−151
1
alternative splicing factor mRNA, complete cds/cds =

49C8
1628
2276
AK001313
Hs.73742
0
4
cDNA FLJ10451 fis, clone NT2RP1000959, highly

41D7
2760
3563
J03565
Hs.73792
0
1
Epstein-Barr virus complement receptor type ll(cr2)

121F8
2470
2815
AL136131
Hs.73793
1.00E−123
1
DNA sequence from clone RP1-261G23 on

chromosome 6p12

482C7
2864
3199
NM_003005
Hs.73800
1.00E−165
3
selectin P (granule membrane protein 140 kD, an

153E12
160
778
D90144
Hs.73817
0
22
gene for LD78 alpha precursor, complete cds/c

489E12
161
776
NM_002983
Hs.73817
0
6
small inducible cytokine A3 (homologous to mo

177D7
112
388
BF673951
Hs.73818
1.00E−143
1
602137331F1 cDNA, 5′ end/clone = IMAGE: 4274094

587E10
5
387
NM_006004
Hs.73818
1.00E−155
6
ubiquinol-cytochrome c reductase hinge prote

142H11
119
436
AL110183
Hs.73851
1.00E−148
1
cDNA DKFZp566A221 (from clone DKFZp566A2

190G11
1
375
NM_001685
Hs.73851
0
6
ATP synthase, H+ transporting, mitochondrial

119D10
675
1700
BC001267
Hs.73957
0
4
RAB5A, member RAS oncogene family, clone MGC:

135H12
1244
1772
NM_003016
Hs.73965
0
2
splicing factor, arginine/serine-rich 2 (SFR

160E6
1811
2196
X75755
Hs.73965
0
5
PR264 gene/cds = (98,763)/gb = X75755/gi = 455418

175F9
791
1446
L29218
Hs.73986
0
2
clk2 mRNA, complete cds/cds = (129,1628)/gb = L2

516D9
782
1144
NM_003992
Hs.73987
0
1
CDC-like kinase 3 (CLK3), transcript variant p

469F3
1778
1956
NM_002286
Hs.74011
4.00E−78
1
lymphocyte-activation gene 3 (LAG3), mRNA/cd

481D6
1323
1805
Z22970
Hs.74076
1.00E−173
1

H. sapiens mRNA for M130 antigen cytoplasmic variant

2/cds = (

193H9
813
1569
NM_007360
Hs.74085
1.00E−127
3
DNA segment on chromosome 12 (unique) 2489 expr

39D9
810
994
X54870
Hs.74085
1.00E−100
1
NKG2-D gene/cds = (338,988)/gb = X54870/gi = 3

71F3
3014
3858
NM_004430
Hs.74088
1.00E−114
4
early growth response 3 (EGR3), mRNA/cds = (357,

74B12
3651
4214
S40832
Hs.74088
1.00E−114
7
EGR3 = EGR3 protein mRNA,

105E11
2
142
AL050391
Hs.74122
6.00E−72
2
cDNA DKFZp586A181 (from clone DKFZp586A1

174A12
141
1072
NM_001225
Hs.74122
0
9
caspase 4, apoptosis-related cysteine protea

599E9
351
1864
AF279903
Hs.74267
0
6
60S ribosomal protein L15 (EC45) mRNA, complet

74F7
126
1867
AF283772
Hs.74267
0
8
clone TCBAP0781 mRNA sequence/cds = (40,654)/

156G12
554
831
AF034607
Hs.74276
1.00E−156
1
chloride channel ABP mRNA, complete cds/cds = (

118F4
1
148
BG112085
Hs.74313
7.00E−65
2
602283260F1 cDNA, 5′ end/clone = IMAGE: 4370727

70G10
1
2177
M16660
Hs.74335
0
26
90-kDa heat-shock protein gene, cDNA, complete cds/c

64D1
330
2219
NM_007355
Hs.74335
0
26
heat shock 90 kD protein 1, beta (HSPCB), mRNA/

121E12
700
1033
NM_006826
Hs.74405
0
1
tyrosine 3-monooxygenase/tryptophan 5-monoo

177D3
480
1645
X57347
Hs.74405
0
2
HS1 protein/cds = (100,837)/gb = X57347/

155A5
680
1176
U86602
Hs.74407
0
1
nucleolar protein p40 mRNA, complete cds/

cds = (142,10

181G10
1802
2302
NM_012381
Hs.74420
0
2
origin recognition complex, subunit 3 (yeast h

66D8
927
1490
X86691
Hs.74441
0
1
218 kD Mi-2 protein/cds = (89,5827)/gb = X

189D10
383
1102
NM_001749
Hs.74451
0
7
calpain 4, small subunit (30 K) (CAPN4), mRNA/

171A3
721
1092
X04106
Hs.74451
1.00E−174
1
calcium dependent protease (small subunit)/

173F3
1069
1468
NM_004559
Hs.74497
0
1
nuclease sensitive element binding protein 1

176B7
1592
1990
NM_001178
Hs.74515
0
1
aryl hydrocarbon receptor nuclear translocato

481A11
2012
2210
NM_000947
Hs.74519
2.00E−61
1
primase, polypeptide 2A (58 kD) (PRIM2A), mRNA

116G8
689
1417
NM_002537
Hs.74563
0
4
ornithine decarboxylase antizyme 2 (OAZ2), mR

526F6
185
1088
NM_003145
Hs.74564
0
3
signal sequence receptor, beta (translocon-as

104D3
713
1127
X79353
Hs.74576
0
1
XAP-4 mRNA for GDP-dissociation inhibitor/cds = (

518G1
2725
2993
NM_001357
Hs.74578
1.00E−134
1
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide

459H1
3093
3268
NM_014767
Hs.74583
3.00E−67
1
KIAA0275 gene product (KIAA0275), mRNA/cds = (

69C5
2304
2781
M97287
Hs.74592
0
3
MAR/SAR DNA binding protein (SATB1) mRNA

587F12
930
2777
NM_002971
Hs.74592
0
6
special AT-rich sequence binding protein 1 (b

124H10
1240
1812
NM_002808
Hs.74619
0
2
proteasome (prosome, macropain) 26S subunit,

57F10
700
2310
NM_000311
Hs.74621
0
60
prion protein (p27-30) (Creutzfeld-Jakob dis

74A10
870
2252
U29185
Hs.74621
0
34
prion protein (PrP) gene, complete cds/cds = (24

176H10
465
923
NM_000108
Hs.74635
0
1
dihydrolipoamide dehydrogenase (E3 component

98F4
870
2566
NM_003217
Hs.74637
0
7
testis enhanced gene transcript (TEGT), mRNA

179H8
1
1210
X75861
Hs.74637
0
3
TEGT gene/cds = (40,753)/gb = X75861/gi = 456258/

125C4
417
1425
NM_014280
Hs.74711
0
2
splicing factor similar to dnaJ (SPF31), mRNA

74C5
21
177
BE549137
Hs.74861
4.00E−65
1
601076443F1 cDNA, 5′ end/clone = IMAGE: 3462154

497B12
124
384
NM_006713
Hs.74861
1.00E−123
2
activated RNA polymerase II transcription cof

191E10
497
859
NM_022451
Hs.74899
0
1
hypothetical protein FLJ12820 (FLJ12820), mR

114A3
1032
1446
AY007131
Hs.75061
0
1
clone CDABP0045 mRNA sequence

117G3
279
799
NM_004622
Hs.75066
0
1
translin (TSN), mRNA/cds = (81,767)/gb = NM_004

483G2
3293
3639
NM_006148
Hs.75080
1.00E−180
1
LIM and SH3 protein 1 (LASP1),/cds = (75,860)/g

181E11
8314
8804
NM_000038
Hs.75081
0
1
adenomatosis polyposis coli (APC), mRNA/cds =

597G6
374
2361
NM_003406
Hs.75103
0
6
tyrosine 3-monooxygenase/tryptophan 5-monoo

596F11
684
1088
NM_002097
Hs.75113
0
1
general transcription factor IIIA (GTF3A), mR

69C9
995
1564
AF113702
Hs.75117
0
4
clone FLC1353 PRO3063 mRNA, complete cds/cds =

46E7
128
1519
NM_004515
Hs.75117
1.00E−164
2
interleukin enhancer binding factor 2, 45 kD (

481B10
66
515
NM_003201
Hs.75133
0
1
transcription factor 6-like 1 (mitochondrial

469C5
368
969
NM_006708
Hs.75207
0
1
glyoxalase I (GLO1), mRNA/cds = (87,641)/gb = N

71B4
939
2049
NM_002539
Hs.75212
0
24
ornithine decarboxylase 1 (ODC1) mRNA/cds = (33

75E10
173
1991
X16277
Hs.75212
0
51
ornithine decarboxylase ODC (EC 4.1.1.17)/c

166G9
2077
2632
L36870
Hs.75217
0
1
MAP kinase kinase 4 (MKK4) mRNA, complete cds/

167A12
2074
2619
NM_003010
Hs.75217
0
1
mitogen-activated protein kinase kinase 4 (M

105B12
3030
5207
D67029
Hs.75232
0
3
SEC14L mRNA, complete cds

125D1
4782
5209
NM_003003
Hs.75232
0
1
SEC14 (S. cerevisiae)-like 1 (SEC14L1), mRNA

184E4
2075
3174
D42040
Hs.75243
0
5
KIAA9001 gene, complete cds/cds = (1701,4106)

191E5
2071
3174
NM_005104
Hs.75243
0
2
bromodomain-containing 2 (BRD2), mRNA/cds = (1

186C12
4159
4866
NM_001068
Hs.75248
0
6
topoisomerase (DNA) II beta (180 kD) (TOP2B), m

177C9
4473
4866
X68060
Hs.75248
0
1
topIIb mRNA for topoisomerase IIb/cds = (0,4865)

39D8
743
1980
D31885
Hs.75249
0
6
KIAA0069 gene, partial cds/cds = (0,680)/gb =

127G2
1363
1769
NM_016166
Hs.75251
0
1
DEAD/H (Asp-Glu-Ala-Asp/His) box binding pro

64E5
4
1214
NM_002922
Hs.75256
0
6
regulator of G-protein signalling 1 (RGS1), mR

69G5
276
914
S59049
Hs.75256
0
6
BL34 = B cell activation gene [human, mRNA, 1398 nt]

101F6
315
758
AF054174
Hs.75258
0
1
histone macroH2A1.2 mRNA, complete cds/cds = (

596E10
320
1667
NM_004893
Hs.75258
0
5
H2A histone family, member Y (H2AFY), mRNA/cds

587G10
639
953
NM_001628
Hs.75313
1.00E−147
1
aldo-keto reductase family 1, member B1 (aldo

128F7
181
933
X06956
Hs.75318
0
4
HALPHA44 gene for alpha-tubulin, exons 1-3

74A1
321
3290
D21262
Hs.75337
0
10
KIAA0035 gene, partial cds/cds = (0,2125)/gb

50D8
2
667
BF303895
Hs.75344
0
4
601886515F2 cDNA, 5′ end/clone = IMAGE: 4120514

179F7
379
720
L07633
Hs.75348
1.00E−179
4
(clone 1950.2) interferon-gamma IEF SSP 5111 m

191F3
158
872
NM_006263
Hs.75348
0
18
proteasome (prosome, macropain) activator su

463G4
1849
2394
NM_001873
Hs.75360
0
1
carboxypeptidase E (CPE), mRNA/cds = (290,1720

117D6
224
671
AB023200
Hs.75361
0
1
mRNA for KIAA0983 protein, complete cds/cds = (

73E8
1
2339
D89077
Hs.75367
0
8
for Src-like adapter protein, complete cd

49H5
1
2388
NM_006748
Hs.75367
0
4
Src-like-adapter (SLA), mRNA/cds = (41,871)/

134A3
550
1126
NM_005917
Hs.75375
0
1
malate dehydrogenase 1, NAD (soluble) (MDH1),

462F2
73
361
NM_004172
Hs.75379
1.00E−158
1
solute carrier family 1 (glial high affinity gl

477G6
769
2043
NM_004300
Hs.75393
0
3
acid phosphatase 1, soluble (ACP1), transcript

62A10
1028
2528
X87949
Hs.75410
0
7
BiP protein/cds = (222,2183)/gb = X87949

125H4
510
807
NM_006010
Hs.75412
1.00E−130
2
Arginine-rich protein (ARP), mRNA/cds = (132,8

70H1
29
2349
AK026463
Hs.75415
0
30
FLJ22810 fis, clone KAIA2933, highly sim

60D3
160
1666
D31767
Hs.75416
0
6
KIAA0058 gene, complete cds/cds = (69,575)/g

98D5
103
1233
NM_014764
Hs.75416
0
10
DAZ associated protein 2 (DAZAP2), mRNA/cds = (

55H1
1183
1390
NM_016525
Hs.75425
2.00E−81
1
ubiquitin associated protein (UBAP), mRNA/cd

44B12
51
480
BF131654
Hs.75428
0
3
601820480F1 cDNA, 5′ end/clone = IMAGE: 4052586

64E11
1
177
NM_000454
Hs.75428
7.00E−94
1
superoxide dismutase 1, soluble (amyotrophic

65D3
387
969
L33842
Hs.75432
0
4
(clone FFE-7) type II inosine monophosphate de

58F9
379
672
NM_000884
Hs.75432
1.00E−149
1
IMP (inosine monophosphate) dehydrogenase 2

73B1
87
291
BE790474
Hs.75458
5.00E−71
2
601476059F1 cDNA, 5′ end/clone = IMAGE: 3878799

585G5
1
302
NM_000979
Hs.75458
1.00E−170
8
ribosomal protein L18 (RPL18), mRNA/cds = (15,5

173A1
1893
2653
NM_006763
Hs.75462
0
2
BTG family, member 2 (BTG2), mRNA/cds = (71,547)

166A10
601
1147
AB00015
Hs.75470
0
1
mRNA expressed in osteoblast, complete cds/cd

180D10
601
1045
NM_006820
Hs.75470
0
1
hypothetical protein, expressed in osteoblast

122D9
3322
5191
AB023173
Hs.75478
0
2
mRNA for KIAA0956 protein, partial cds/cds = (0

461E5
2484
2804
AL133074
Hs.75497
1.00E−144
1
mRNA; cDNA DKFZp434M1317 (from clone

DKFZp434M

512D6
69
799
NM_004591
Hs.75498
0
12
small inducible cytokine subfamily A (Cys-Cys

146B12
54
783
U64197
Hs.75498
0
4
chemokine exodus-1 mRNA, complete cds/cds = (4

596H5
685
1952
NM_001157
Hs.75510
0
5
annexin A11 (ANXA11), mRNA/cds = (178,1695)/g

179D6
215
603
D23662
Hs.75512
1.00E−168
2
ubiquitin-like protein, complete cds

522G12
52
603
NM_006156
Hs.75512
0
2
neural precursor cell expressed, developmenta

46B6
1108
1418
NM_000270
Hs.75514
1.00E−166
1
nucleoside phosphorylase (NP), mRNA/cds = (109

73H11
83
1418
X00737
Hs.75514
1.00E−104
3
purine nucleoside phosphorylase (PNP; EC 2.

154F7
1279
2056
L05425
Hs.75528
0
3
nucleolar GTPase mRNA, complete cds/cds = (79,2

164C10
1268
1910
NM_013285
Hs.75528
0
2
nucleolar GTPase (HUMAUANTIG), mRNA/cds = (79,

106C8
76
322
Z25749
Hs.75538
1.00E−130
3
gene for ribosomal protein S7/cds = (81,665)/gb =

98E5
474
1188
NM_003405
Hs.75544
0
1
tyrosine 3-monooxygenase/tryptophan 5-monoo

459G10
2160
2717
NM_000418
Hs.75545
0
1
interleukin 4 receptor (IL4R), mRNA/cds = (175,

44B2
71
692
U03851
Hs.75546
0
1
capping protein alpha mRNA, partial cds/

cds = (16,870)

483F2
1207
1392
NM_004357
Hs.75564
1.00E−80
1
CD151 antigen (CD151), mRNA/cds = (84,845)/gb

596D6
1968
2392
NM_021975
Hs.75569
0
1
v-rel avian reticuloendotheliosis viral onco

466G10
679
896
NM_014763
Hs.75574
1.00E−120
2
mitochondrial ribosomal protein L19 (MRPL19),

524B3
6194
6477
NM_001759
Hs.75586
1.00E−147
1
cyclin D2 (CCND2), mRNA/cds = (269,1138)/gb = N

481B4
3423
3804
NM_000878
Hs.75596
1.00E−160
2
interleukin 2 receptor, beta (IL2RB), mRNA/cd

162B5
753
1694
M29064
Hs.75598
0
6
hnRNP B1 protein mRNA/cds = (149,1210)/

gb = M29064/gi

176F5
730
922
NM_002137
Hs.75598
1.00E−106
1
heterogeneous nuclear ribonucleoprotein A2/

106C2
1654
2589
D10522
Hs.75607
0
8
for 80K-L protein, complete cds/cds = (369,

98C5
1538
2589
NM_002356
Hs.75607
0
20
myristoylated alanine-rich protein kinase C

192E5
1007
1416
NM_006819
Hs.75612
0
1
stress-induced-phosphoprotein 1 (Hsp70/Hsp9

40E12
836
1765
M98399
Hs.75613
0
2
antigen CD36 (clone 21) mRNA, complete cds/

cds(254,1

107C6
1491
1595
AF113676
Hs.75621
3.00E−51
1
clone FLB2803 PRO0684 mRNA, complete cds/cds =

117E9
149
1033
NM_001779
Hs.75626
0
2
CD58 antigen, (lymphocyte function-associate

482H10
740
1367
NM_000591
Hs.75627
0
1
CD14 antigen (CD14), mRNA/cds = (119,1246)/gb

482D4
1342
1659
NM_006163
Hs.75643
3.00E−82
1
nuclear factor (erythroid-derived 2), 45 kD (N

73F8
2864
3657
L49169
Hs.75678
0
20
G0S3 mRNA, complete cds/cds = (593,1609)/

gb = L49169/

58G3
3222
3657
NM_006732
Hs.75678
0
6
FBJ murine osteosarcoma viral oncogene homolo

53A7
30
836
J04130
Hs.75703
0
138
activation (Act-2) mRNA, complete cds/cds = (108,386)

500E11
41
688
NM_002984
Hs.75703
0
128
small inducible cytokine A4 (homologous to mo

170E9
415
2376
M16985
Hs.75709
0
6
cation-dependent mannose 6-phosphate-specific rece

591E8
1759
2401
NM_002355
Hs.75709
0
3
mannose-6-phosphate receptor (cation depende

191A11
20
1900
NM_002575
Hs.75716
0
13
serine (or cysteine) proteinase inhibitor, cl

184F5
18
1900
Y00630
Hs.75716
0
8
Arg-Serpin (plasminogen activator-inhibito

593G8
238
747
NM_005022
Hs.75721
1.00E−110
2
profilin 1 (PFN1), mRNA/cds = (127,549)/gb = NM

178G9
504
2101
NM_002951
Hs.75722
0
2
ribophorin II (RPN2), mRNA/cds = (288,2183)/g

138F12
2341
2488
Y00282
Hs.75722
4.00E−60
1
ribophorin II/cds = (288,2183)/gb = Y00282/g

37F7
1328
1863
AK023290
Hs.75748
0
3
FLJ13228 fis, clone OVARC1000085, highly

119C7
3736
4103
NM_003137
Hs.75761
1.00E−172
1
SFRS protein kinase 1 (SRPK1), mRNA/cds = (108,2

52E8
574
1106
M36820
Hs.75765
0
2
cytokine (GRO-beta) mRNA, complete cds/

cds = (74,397)

74C8
2055
3026
M10901
Hs.75772
0
4
glucocorticoid receptor alpha mRNA, complete cds/cd

196C5
2600
4591
NM_000176
Hs.75772
0
5
nuclear receptor subfamily 3, group C, member

68E7
2194
2597
D87953
Hs.75789
0
1
RTP, complete cds/cds = (122,1306)/gb = D87953

116E3
289
621
NM_016470
Hs.75798
0
1
hypothetical protein (HSPC207), mRNA/cds = (0

107C10
650
1165
AK025732
Hs.75811
0
1
FLJ22079 fis, clone HEP13180, highly sim

123C12
459
969
NM_004315
Hs.75811
0
1
N-acylsphingosine amidohydrolase (acid cera

99E11
1007
2346
NM_014761
Hs.75824
0
2
KIAA0174 gene product (KIAA0174), mRNA/cds = (

128C11
377
906
NM_006817
Hs.75841
0
2
endoplasmic reticulum lumenal protein (ERP28

175F5
455
843
X94910
Hs.75841
1.00E−173
1
ERp28 protein/cds = (11,796)/gb = X9491

182F12
4263
4842
D86550
Hs.75842
0
1
mRNA for serine/threonine protein kinase, complete c

175E3
3255
3787
AL110132
Hs.75875
0
1
mRNA; cDNA DKFZp564H192 (from clone

DKFZp564H1

195G3
1435
2132
NM_003349
Hs.75875
0
2
ubiquitin-conjugating enzyme E2 variant 1 (U

184B12
17
282
BF698920
Hs.75879
1.00E−138
8
602126495F1 cDNA, 5′ end/clone = IMAGE: 4283350

67G6
1218
1605
AK000639
Hs.75884
1.00E−173
1
FLJ20632 fis, clone KAT03756, highly simi

516A11
721
1109
NM_015416
Hs.75884
0
2
DKFZP586A011 protein (DKFZP586A011), mRNA/c

44B1
1066
4914
NM_004371
Hs.75887
0
4
coatomer protein complex, subunit alpha (COPA

594D3
3971
4158
NM_003791
Hs.75890
1.00E−73
1
site-1 protease (subtilisin-like, sterol-reg

459H8
5291
5688
D87446
Hs.75912
1.00E−160
1
mRNA for KIAA0257 gene, partial cds/cds = (0,5418)/gb

113F6
2281
2807
NM_006842
Hs.75916
0
1
splicing factor 3b, subunit 2, 145 kD (SF382), m

104F9
2334
2804
U41371
Hs.75916
0
1
spliceosome associated protein (SAP 145) mRNA,

compl

100F12
656
825
AK024890
Hs.75932
6.00E−83
1
FLJ21237 fis, clone COL01114/cds = UNKNOW

39E1
40
526
BF217687
Hs.75968
1.00E−124
2
601882510F1 cDNA, 5′ end/clone = IMAGE: 4094907

111G8
41
547
NM_021109
Hs.75968
1.00E−166
19
thymosin, beta 4, X chromosome (TMSB4X), mRNA

478A7
1335
1653
NM_006813
Hs.75969
1.00E−119
1
proline-rich protein with nuclear targeting s

70E9
652
1065
U03105
Hs.75969
0
1
B4-2 protein mRNA, complete cds/cds = (113,1096)/

gb = U

596B9
508
1461
NM_003133
Hs.75975
0
2
signal recognition particle 9 kD (SRP9), mRNA

513F12
1359
2169
NM_005151
Hs.75981
0
3
ubiquitin specific protease 14 (tRNA-guanine

74B3
1361
2166
U30888
Hs.75981
0
2
tRNA-guanine transglycosylase mRNA, complete cds/c

67B6
81
1457
X17025
Hs.76038
0
4
homolog of yeast IPP isomerase/cds = (50,736)/

gb = X170

586F2
1471
2197
NM_004396
Hs.76053
0
13
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide

70B3
762
2211
X52104
Hs.76053
0
12
p68 protein/cds = (175,2019)/gb = X52104/gi = 3

73B2
32
494
BF214146
Hs.76064
0
1
601847762F1 cDNA, 5′ end/clone = IMAGE: 4078622

523E6
10
441
NM_000990
Hs.76064
0
2
ribosomal protein L27a (RPL27A), mRNA/cds = (1

38F7
6
372
Z23090
Hs.76067
0
2
28 kDa heat shock protein/cds = (491,1108)

59B6
916
1274
AF071596
Hs.76095
1.00E−174
1
apoptosis inhibitor (IEX-1L) gene, complete c

493B3
540
1206
NM_003897
Hs.76095
0
3
immediate early response 3 (IER3), mRNA/cds = (

483D7
1399
2063
NM_005626
Hs.76122
0
1
splicing factor, arginine/serine-rich 4 (SFR

591C12
13412
13873
NM_003922
Hs.76127
0
3
hect (homologous to the E6-AP (UBE3A) carboxyl

65H7
12209
12580
U50078
Hs.76127
0
1
guanine nucleotide exchange factor p532 mRNA,

complet

160B6
79
535
X77584
Hs.76136
1.00E−140
1
ATL-derived factor/thiredoxin/cds = (80

596A9
1
124
NM_001009
Hs.76194
3.00E−62
1
ribosomal protein S5 (RPS5), mRNA/cds = (37,651

51H5
2834
3174
AK025353
Hs.76230
1.00E−180
1
cDNA: FLJ21700 fis, clone COL09849, highly sim

115C8
1589
2005
NM_001748
Hs.76288
0
1
calpain 2, (m/II) large subunit (CAPN2), mRNA

588C5
4
336
NM_004492
Hs.76362
0
2
general transcription factor IIA, 2 (12 kD subu

111D9
732
1077
NM_004930
Hs.76368
1.00E−161
2
capping protein (actin filament) muscle Z-lin

192A11
1589
1995
NM_002462
Hs.76391
0
3
myxovirus (influenza) resistance 1, homolog o

39F5
8481
8730
Y00285
Hs.76473
1.00E−111
1
insuline-like growth factor II receptor/cds

98C4
487
3719
NM_002298
Hs.76506
0
38
lymphocyte cytosolic protein 1 (L-plastin) (L

124H12
611
1747
NM_004862
Hs.76507
0
5
LPS-induced TNF-alpha factor (PIG7), mRNA/cd

37A6
920
1524
U77396
Hs.76507
1.00E−162
2
LPS-Induced TNF-Alpha Factor (LITAF) mRNA, co

71E9
759
3362
D00099
Hs.76549
0
4
mRNA for Na,K-ATPase alpha-subunit, complete

73F5
951
1277
AK001361
Hs.76556
1.00E−168
1
FLJ10499 fis, clone NT2RP2000346, weakly

48H6
1097
1603
NM_014330
Hs.76556
0
2
growth arrest and DNA-damage-inducible 34 (G

160C8
74
181
BE730376
Hs.76572
2.00E−40
1
601563816F1 5′ end/clone = IMAGE: 3833690

589D11
86
455
NM_001697
Hs.76572
0
2
ATP synthase, H+ transporting, mitochondrial

38B1
227
886
NM_014059
Hs.76640
0
9
RGC32 protein (RGC32), mRNA/cds = (146,499)/g

174B12
3024
4628
D80005
Hs.76666
1.00E−136
4
mRNA for KIAA0183 gene, partial cds/cds = (0,3190)/gb

37A11
1788
3255
AF070673
Hs.76691
0
5
stannin mRNA, complete cds/cds = (175,441)/gb

58H11
1706
2088
AL136807
Hs.76698
0
2
mRNA; cDNA DKFZp434L1621 (from clone

DKFZp434L

477F9
6930
7298
AB002299
Hs.76730
0
2
mRNA for KIAA0301 gene, partial cds/cds = (0,6144)/gb

40G7
293
819
NM_000118
Hs.76753
0
1
endoglin (Osler-Rendu-Weber syndrome 1) (EN

75C11
10
1113
J00194
Hs.76807
0
5
human hla-dr antigen alpha-chain mrna & ivs

fragments/cds =

99F4
10
969
NM_019111
Hs.76807
0
6
major histocompatibility complex, class II,

61G12
1870
2511
AL133096
Hs.76853
0
1
cDNA DKFZp434N1728 (from clone DKFZp434N

599C2
41
346
NM_002790
Hs.76913
1.00E−124
1
proteasome (prosome, macropain) subunit, alp

155C2
508
870
X61970
Hs.76913
0
1
for macropain subunit zeta/cds = (21,746)/g

70C5
3398
3754
AF002020
Hs.76918
0
1
Niemann-Pick C disease protein (NPC1) mRNA, co

57A11
2173
2764
NM_000271
Hs.76918
0
1
Niemann-Pick disease, type C1 (NPC1), mRNA/cd

158C9
314
1233
NM_001679
Hs.76941
0
3
ATPase, Na+/K+ transporting, beta 3 polypeptid

520E1
4175
4502
NM_014757
Hs.76986
1.00E−158
1
mastermind (Drosophila), homolog of (MAML1),

587D8
22
869
NM_001006
Hs.77039
0
5
ribosomal protein S3A (RPS3A), mRNA/cds = (36,8

481F2
440
1488
NM_001731
Hs.77054
0
3
B-cell translocation gene 1, anti-proliferati

53G11
340
1490
X61123
Hs.77054
0
3
BTG1 mRNA/cds = (308,823)/gb = X61123/gi = 29508/

ug = Hs

521A6
147
1325
D55716
Hs.77152
0
2
mRNA for P1cdc47, complete cds/cds = (116,2275)/

gb = D

37H9
2109
2530
X07109
Hs.77202
0
1
protein kinase C (PKC) type/cds = (136,2157)/

167H5
3915
4508
NM_006437
Hs.77225
0
1
ADP-ribosyltransferase (NAD+; poly (ADP-ribo

139G5
2183
2389
U61145
Hs.77256
1.00E−111
1
enhancer of zeste homolog 2 (EZH2) mRNA, complete

cds

109H2
2502
2893
D38549
Hs.77257
0
1
KIAA0068 gene, partial cds/cds = (0,3816)/gb

184B7
619
1111
L25080
Hs.77273
0
1
GTP-binding protein (rhoA) mRNA, complete cds

587H1
614
1371
NM_001664
Hs.77273
0
9
ras homolog gene family, member A (ARHA), mRNA

99G10
1387
2219
NM_002658
Hs.77274
0
1
plasminogen activator, urokinase (PLAU), mRN

143C12
2403
2905
AL049332
Hs.77311
0
2
cDNA DKFZp564L176 (from clone DKFZp564L1

519B11
5248
5555
NM_000430
Hs.77318
1.00E−160
1
platelet-activating factor acetylhydrolase,

52F10
3249
3459
AF095901
Hs.77324
1.00E−114
2
eRF1 gene, complete cds/cds = (136,1449)/gb = A

494G1
3255
3453
NM_004730
Hs.77324
1.00E−109
2
eukaryotic translation termination factor 1

517E4
305
973
NM_014754
Hs.77329
0
2
phosphatidylserine synthase 1 (PTDSS1), mRNA

72F9
1934
4605
AF187320
Hs.77356
0
10
transferrin receptor (TFRC) gene, complete cd

46D6
241
4902
NM_003234
Hs.77356
0
2
transferrin receptor (p90, CD71) (TFRC), mRNA

113A12
1028
1290
NM_024033
Hs.77365
1.00E−145
1
hypothetical protein MGC5242 (MGC5242), mRNA

173A7
1142
1649
AK026164
Hs.77385
0
2
cDNA: FLJ22511 fis, clone HRC11837, highly sim

189E7
466
798
NM_002004
Hs.77393
0
1
farnesyl diphosphate synthase (farnesyl pyro

479B1
306
482
NM_000566
Hs.77424
8.00E−55
1
Fc fragment of IgG, high affinity Ia, receptor

41E12
351
898
X14356
Hs.77424
0
1
high affinity Fc receptor (FcRI)/cds = (36,116

122D3
562
855
NM_002664
Hs.77436
1.00E−145
1
pleckstrin (PLEK), mRNA/cds = (60,1112)/gb = N

59C11
1
2745
X07743
Hs.77436
0
5
pleckstrin (P47)/cds = (60,1112)/gb = X07743

590B1
5185
5274
NM_001379
Hs.77462
1.00E−44
1
DNA (cytosine-5-)-methyltransferase 1 (DNMT1

522D1
572
956
NM_001929
Hs.77494
0
1
deoxyguanosine kinase (DGUOK), mRNA/cds = (11,

109E12
723
2474
D87684
Hs.77495
1.00E−163
5
for KIAA0242 protein, partial cds/cds = (0,

148E2
61
271
BE737246
Hs.77496
1.00E−81
1
601305556F1 5′ end/clone = IMAGE: 3640165

586D4
1887
2362
NM_003363
Hs.77500
0
1
ubiquitin specific protease 4 (proto-oncogene

57E8
29
2808
BC001854
Hs.77502
0
30
methionine adenosyltransferase II, alpha, c

70H9
87
1283
X68836
Hs.77502
0
14
S-adenosylmethionine synthetase/cds = (

69B2
778
3033
M20867
Hs.77508
0
2
glutamate dehydrogenase (GDH) mRNA, complete

cds/cd

513F9
2694
2929
NM_005271
Hs.77508
1.00E−105
1
glutamate dehydrogenase 1 (GLUD1), mRNA/cds =

75A3
190
701
X62744
Hs.77522
0
1
RING6 mRNA for HLA class II alpha product/

cds = (45,830

105E10
72
597
BE673364
Hs.77542
0
3
7d34a03.x1 cDNA, 3′ end/clone = IMAGE: 3249100

124B2
85
683
BF508702
Hs.77542
0
8
UI-H-BI4-aop-g-05-0-UI.s1 cDNA, 3′ end/clon

524C9
829
1233
AK021563
Hs.77558
0
3
cDNA FLJ11501 fis, clone HEMBA1002100/cds = UNK

523B12
7580
8153
NM_004652
Hs.77578
0
2
ubiquitin specific protease 9, X chromosome (D

166F3
169
340
AL021546
Hs.77608
7.00E−63
1
DNA sequence from BAC 15E1 on chromosome 12.

Contains

195A11
164
451
NM_003769
Hs.77608
1.00E−162
1
splicing factor, arginine/serine-rich 9 (SF

595E1
618
1461
AF056322
Hs.77617
0
7
SP100-HMG nuclear autoantigen (SP100) mRNA, c

115A6
2954
3541
AL137938
Hs.77646
0
2
mRNA; cDNA DKFZp761M0223 (from clone

DKFZp761M

592H6
261
951
NM_014752
Hs.77665
0
3
KIAA0102 gene product (KIAA0102), mRNA/cds = (

461F3
4657
4980
NM_014749
Hs.77724
1.00E−174
1
KIAA0586 gene product (KIAA0586), mRNA/cds = (

98C8
27
1961
NM_002543
Hs.77729
0
4
oxidised low density lipoprotein (lectin-like

598A12
101
1396
NM_006759
Hs.77837
0
4
UDP-glucose pyrophosphorylase 2 (UGP2), mRNA

594H8
1
872
NM_006802
Hs.77897
1.00E−144
2
splicing factor 3a, subunit 3, 60 kD (SF3A3), mR

171E4
1140
1394
X81789
Hs.77897
1.00E−110
1
for splicing factor SF3a60/cds = (565,2070)

500F1
2185
2496
AK025736
Hs.77910
1.00E−160
1
cDNA: FLJ22083 fis, clone HEP14459, highly sim

525B10
1696
2060
NM_000122
Hs.77929
0
1
excision repair cross-complementing rodent r

53E1
877
1539
AK026595
Hs.77961
0
7
FLJ22942 fis, clone KAT08170, highly sim

521C6
631
1089
NM_005514
Hs.77961
1.00E−115
4
major histocompatibility complex, class I, B

588C3
300
653
NM_004792
Hs.77965
0
1
Clk-associating RS-cyclophilin (CYP), mRNA

523C6
277
582
NM_001912
Hs.78056
1.00E−143
1
cathepsin L (CTSL), mRNA/cds = (288,1289)/gb =

140D10
292
1549
X12451
Hs.78056
0
3
pro-cathepsin L (major excreted protein MEP)

463E5
129
552
NM_005969
Hs.78103
0
1
nucleosome assembly protein 1-like 4 (NAP1L4)

166H3
540
895
U77456
Hs.78103
0
1
nucleosome assembly protein 2 mRNA, complete cds/cd

40B10
2433
2543
M28526
Hs.78146
5.00E−29
1
platelet endothelial cell adhesion molecule (PECAM-1

114E5
1671
2029
NM_000442
Hs.78146
1.00E−162
1
platelet/endothelial cell adhesion molecule

513D11
28
1399
NM_000700
Hs.78225
0
5
annexin A1 (ANXA1), mRNA/cds = (74,1114)/gb = N

331B3
219
1370
X05908
Hs.78225
0
3
lipocortin/cds = (74,1114)/gb = X05908/gi = 34

56A12
1383
2379
X94232
Hs.78335
0
4
novel T-cell activation protein/cds = (14

465H1
386
904
NM_002812
Hs.78466
0
2
proteasome (prosome, macropain) 26S subunit,

108H7
2067
2486
L42572
Hs.78504
0
1
p87/89 gene, complete cds/cds = (92,2368)/gb =

187E9
729
1494
NM_006839
Hs.78504
0
2
inner membrane protein, mitochondrial (mitofi

102F2
672
2947
L14561
Hs.78546
0
2
plasma membrane calcium ATPase isoform 1 (ATP

591H12
42
1949
NM_004034
Hs.78637
0
3
annexin A7 (ANXA7), transcript variant 2, mRN

595H3
2775
3030
NM_003470
Hs.78683
3.00E−96
1
ubiquitin specific protease 7 (herpes virus-as

62F5
2775
3838
Z72499
Hs.78683
0
2
herpesvirus associated ubiquitin-speci

46G4
2632
3238
NM_003580
Hs.78687
0
1
neutral sphingomyelinase (N-SMase) activatio

513A11
342
1258
NM_002635
Hs.78713
0
10
solute carrier family 25 (mitochondrial carri

472A4
3018
3286
NM_024298
Hs.78768
1.00E−132
1
malignant cell expression-enhanced gene/tumo

177A3
377
1186
AL049589
Hs.78771
0
3
DNA sequence from clone 570L12 on chromosome

Xq13.1-2

71E6
303
1767
NM_000291
Hs.78771
0
12
phosphoglycerate kinase 1 (PGK1), mRNA/cds = (

181D8
2104
3677
NM_018834
Hs.78825
0
4
matrin 3 (MATR3), mRNA/cds = (254,2800)/gb = NM

126G6
2498
2959
AL162049
Hs.78829
0
1
mRNA; cDNA DKFZp762E1712 (from clone

DKFZp762E

41C3
1743
2340
M31932
Hs.78864
0
2
IgG low affinity Fc fragment receptor (FcRIIa) mRNA, c

166D11
1696
2156
M81601
Hs.78869
0
1
transcription elongation factor (SII) mRNA, complete

517B3
565
1392
D42039
Hs.78871
0
3
mRNA for KIAA0081 gene, partial cds/cds = (0,702)/

gb =

180G11
59
517
NM_020548
Hs.78888
0
1
diazepam binding inhibitor (GABA receptor mod

99B7
2356
3329
U07802
Hs.78909
0
45
Tis11d gene, complete cds/cds = (291,1739)/

gb = U07802

54C4
557
1101
U13045
Hs.78915
0
1
nuclear respiratory factor-2 subunit beta 1 mRNA, com

44A5
634
1128
U29607
Hs.78935
0
2
methionine aminopeptidase mRNA, complete cds/

cds = (2

63A2
964
1050
X92106
Hs.78943
7.00E−31
1
bleomycin hydrolase/cds = (78,1445)/gb

163G9
228
877
L13463
Hs.78944
0
3
helix-loop-helix basic phosphoprotein (G0S8) mRNA,

119H6
472
877
NM_002923
Hs.78944
0
1
regulator of G-protein signalling 2,24 kD (RG

166E2
5629
5764
U51903
Hs.78993
2.00E−69
1
RasGAP-related protein (IQGAP2) mRNA, complete

cds

40F9
66
603
M15796
Hs.78996
0
1
cyclin protein gene, complete cds/cds = (118,903)/gb

593E5
156
854
NM_012245
Hs.79008
0
5
SKI-INTERACTING PROTEIN (SNW1), mRNA/

cds = (2

485B7
276
599
AF063591
Hs.79015
1.00E−136
1
brain my033 protein mRNA, complete cds/cds = (5

61B4
125
732
X05323
Hs.79015
0
2
MRC OX-2 gene signal sequence/cds = (0,824)/

gb = X05323

71C8
330
1958
NM_005261
Hs.79022
0
24
GTP-binding protein overexpressed in skeletal

75G8
330
1957
U10550
Hs.79022
0
63
Gem GTPase (gem) mRNA, complete cds/

cds = (213,1103)/

584G1
4424
5153
AF226044
Hs.79025
0
2
HSNFRK (HSNFRK) mRNA, complete cds/

cds = (641,2

117C5
358
933
NM_012413
Hs.79033
0
1
glutaminyl-peptide cyclotransferase (glutam

72B2
910
2015
AJ250915
Hs.79037
0
9
p10 gene for chaperonin 10 (Hsp10 protein) and

71G11
880
1981
NM_002156
Hs.79037
0
5
heat shock 60 kD protein 1 (chaperonin) (HSPD1)

193H12
1859
2474
NM_003243
Hs.79059
0
5
transforming growth factor, beta receptor III

460B4
846
1325
NM_001930
Hs.79064
0
1
deoxyhypusine synthase (DHPS), transcript va

75C4
1166
2087
K02276
Hs.79070
0
85
(Daudi) translocated t(8;14) c-myc oncogene mRNA,

co

71G10
1274
2121
NM_002467
Hs.79070
0
12
v-myc avian myelocytomatosis viral oncogene h

183D8
385
741
NM_002710
Hs.79081
0
1
protein phosphatase 1, catalytic subunit, gam

170A12
741
1203
X74008
Hs.79081
0
1
protein phosphatase 1 gamma/cds = (154,11

121D9
2920
3385
NM_006378
Hs.79089
0
1
sema domain, immunoglobulin domain (Ig), tran

40C12
2933
4108
U60800
Hs.79089
0
4
semaphorin (CD100) mRNA, complete cds/

cds = (87,2675)

104E1
1708
1932
L35263
Hs.79107
1.00E−101
1
CSaids binding protein (CSBP1) mRNA, complete cds/cd

70B2
913
2497
AK000221
Hs.79110
0
9
FLJ20214 fis, clone COLF2014, highly simi

123B12
1929
2644
D42043
Hs.79123
0
3
mRNA for KIAA0084 gene, partial cds/cds = (0,1946)/gb

193G7
802
1425
NM_004379
Hs.79194
0
2
cAMP responsive element binding protein 1 (CR

75D5
158
2139
NM_004233
Hs.79197
0
16
CD83 antigen (activated B lymphocytes, immuno

74H2
98
1357
NM_001154
Hs.79274
0
2
annexin A5 (ANXA5), mRNA/cds = (192,1154)/gb =

519G7
5358
5496
D86985
Hs.79276
2.00E−69
1
mRNA for KIAA0232 protein, partial cds/cds = (0,

462C2
1477
2031
NM_003006
Hs.79283
0
1
selectin P ligand (SELPLG), mRNA/cds = (59,1267

65C6
23
1609
M15353
Hs.79306
0
6
cap-binding protein mRNA, complete cds/cds = (1

64H8
326
1610
NM_001968
Hs.79306
0
3
eukaryotic translation initiation factor 4E

52C3
1333
1904
X64318
Hs.79334
0
1
E4BP4 gene/cds = (213,1601)/gb = X64318/gi = 30955

39F7
1179
1740
AF109733
Hs.79335
0
1
SWI/SNF-related, matrix-associated, actin-d

194A7
1512
1803
NM_003076
Hs.79335
1.00E−118
1
SWI/SNF related, matrix associated, actin dep

463E12
4326
4831
NM_015148
Hs.79337
0
1
KIAA0135 protein (KIAA0135), mRNA/cds = (1803,

526B5
1420
1867
NM_002958
Hs.79350
0
2
RYK receptor-like tyrosine kinase (RYK), mRNA

460F3
1755
2242
NM_006285
Hs.79358
0
2
testis-specific kinase 1 (TESK1), mRNA/cds = (

98B11
2076
4834
X76061
Hs.79362
0
11

H. sapiens p130 mRNA for 130K protein/

cds = (69,3488)/gb = X76

45F3
2286
2666
NM_001423
Hs.79368
0
1
epithelial membrane protein 1 (EMP1), mRNA/cd

50C10
2016
2666
Y07909
Hs.79368
0
2
Progression Associated Protein/cds = (21

118E3
549
1078
NM_012198
Hs.79381
0
1
grancalcin (GCL), mRNA/cds = (119,772)/gb = NM_—

181F4
657
1271
NM_002805
Hs.79387
0
2
proteasome (prosome, macropain) 26S subunit,

105H3
1114
1538
D83018
Hs.79389
0
1
for nel-related protein 2, complete cds/

173B2
429
3009
NM_006159
Hs.79389
0
5
nel (chicken)-like 2 (NELL2), mRNA/cds = (96,25

177B3
662
991
AC004382
Hs.79402
0
1
Chromosome 16 BAC clone CIT987SK-A-152E5/cds

590H3
663
1002
NM_002694
Hs.79402
0
1
polymerase (RNA) II (DNA directed) polypeptide

523B7
223
582
NM_002946
Hs.79411
0
1
replication protein A2 (32 kD) (RPA2), mRNA/c

182B10
472
1024
U02019
Hs.79625
1.00E−121
2
AU-rich element RNA-binding protein AUF1 mRNA,

comple

479F3
100
301
NM_001783
Hs.79630
2.00E−86
1
CD79A antigen (immunoglobulin-associated al

40H9
582
1107
U05259
Hs.79630
0
1
MB-1 gene, complete cds/cds = (36,716)/gb = U05259/gi

116A2
1003
1368
NM_006224
Hs.79709
1.00E−176
1
phosphotidylinositol transfer protein (PITPN

74G8
252
1297
D21853
Hs.79768
0
5
KIAA0111 gene, complete cds/cds = (214,1449)

525G2
830
1297
NM_014740
Hs.79768
0
2
KIAA0111 gene product (KIAA0111), mRNA/cds = (

125G3
2757
3339
AF072928
Hs.79877
0
1
myotubularin related protein 6 mRNA, partial c

184A2
532
1102
AF135162
Hs.79933
0
1
cyclin I (CYC1) mRNA, complete cds/cds = (199,13

514C6
329
1256
NM_006835
Hs.79933
0
6
cyclin I (CCNI), mRNA/cds = (0,1133)/gb = NM_006

116G5
824
1058
NM_006875
Hs.80205
1.00E−121
1
pim-2 oncogene (PIM2), mRNA/cds = (185,1189)/

106C11
1700
1995
U77735
Hs.80205
1.00E−125
1
pim-2 protooncogene homolog pim-2 h mRNA,

complete cd

110E3
276
653
AL136139
Hs.80261
0
1
DNA sequence from clone RP4-76112 on chromosome

6 Con

478D1
1067
2761
NM_006403
Hs.80261
2.00E−70
2
enhancer of filamentation 1 (cas-like docking;

178C8
880
1226
AL050192
Hs.80285
0
1
mRNA; cDNA DKFZp586C1723 (from clone

DKFZp586C

494F11
477
5535
NM_014739
Hs.80338
0
8
KIAA0164 gene product (KIAA0164), mRNA/cds = (

190A1
1165
1540
NM_004156
Hs.80350
1.00E−166
2
protein phosphatase 2 (formerly 2A), catalytic

461A1
4639
4913
NM_004653
Hs.80358
1.00E−140
1
SMC (mouse) homolog, Y chromosome (SMCY),

mRNA

158A8
2656
3229
L24498
Hs.80409
0
1
gadd45 gene, complete cds/cds = (2327,2824)/

gb = L2449

41E6
2385
2992
U84487
Hs.80420
0
2
CX3C chemokine precursor, mRNA, alternatively

splice

40H4
2830
3605
NM_000129
Hs.80424
0
1
coagulation factor XIII, A1 polypeptide (F13A

464D3
214
835
NM_004899
Hs.80426
0
2
brain and reproductive organ-expressed (TNFR

75H8
1180
4930
U12767
Hs.80561
0
60
mitogen induced nuclear orphan receptor (MINOR)

mRNA

593E10
1
510
NM_004552
Hs.80595
1.00E−158
5
NADH dehydrogenase (ubiquinone) Fe-S protein

113C5
1182
1583
NM_003336
Hs.80612
0
1
ubiquitin-conjugating enzyme E2A (RAD6 homol

515B7
268
538
NM_001020
Hs.80617
2.00E−91
3
ribosomal protein S16 (RPS16), mRNA/cds = (37,4

477F12
460
606
NM_018996
Hs.80618
1.00E−47
1
hypothetical protein (FLJ20015), mRNA/cds = (

41A8
1331
1788
L78440
Hs.80642
0
1
STAT4 mRNA, complete cds/cds = (81,2327)/gb = L

594C1
1594
2586
NM_003151
Hs.80642
0
4
signal transducer and activator of transcripti

112C8
1802
1932
NM_002198
Hs.80645
2.00E−35
1
interferon regulatory factor 1 (IRF1), mRNA/

522H8
1130
1533
NM_003355
Hs.80658
1.00E−135
4
uncoupling protein 2 (mitochondrial, proton c

123E4
259
757
NM_002129
Hs.80684
0
4
high-mobility group (nonhistone chromosomal)

109H1
263
754
X62534
Hs.80684
0
1
HMG-2 mRNA/cds = (214,843)/gb = X62534/gi = 32332

149G9
1020
1607
J05032
Hs.80758
0
2
aspartyl-tRNA synthetase alpha-2 subunit mRNA,

compl

461F12
1702
2246
AL031600
Hs.80768
0
1
DNA sequence from clone 390E6 on chromosome 16.

Contai

102B2
1486
2008
M16038
Hs.80887
0
1
lyn mRNA encoding a tyrosine kinase/cds = (297,1835)/

125B11
1260
2013
NM_002350
Hs.80887
0
5
v-yes-1 Yamaguchi sarcoma viral related oncog

37C9
2901
5260
D79990
Hs.80905
0
8
KIAA0168 gene, complete cds/cds = (196,1176)

196D6
2949
5261
NM_014737
Hs.80905
0
9
Ras association (RalGDS/AF-6) domain family 2

584H1
4072
4296
NM_002693
Hs.80961
3.00E−91
1
polymerase (DNA directed), gamma (POLG), nucl

584F9
31
568
AF174605
Hs.81001
0
5
F-box protein Fbx25 (FBX25) mRNA, partial cds

102D11
1037
1632
J03459
Hs.81118
0
1
leukotriene A-4 hydrolase mRNA, complete cds/

cds = (68

193F8
1037
1643
NM_000895
Hs.81118
0
2
leukotriene A4 hydrolase (LTA4H), mRNA/cds = (

118H7
354
1148
U65590
Hs.81134
0
5
IL-1 receptor antagonist IL-1Ra (IL-1RN) gene

41H1
2549
2936
X60992
Hs.81226
0
1
CD6 mRNA for T cell glycoprotein CD6/cds = (120,152

171B9
2070
2479
AF248648
Hs.81248
0
1
RNA-binding protein BRUNOL2 (BRUNOL2) mRNA, c

590A6
291
512
NM_002961
Hs.81256
3.00E−66
1
S100 calcium-binding protein A4 (calcium prot

73H2
389
1481
M69043
Hs.81328
0
14
MAD-3 mRNA encoding IkB-like activity, complet

513G1
637
1481
NM_020529
Hs.81328
0
13
nuclear factor of kappa light polypeptide gene

488F2
1065
1417
NM_004499
Hs.81361
1.00E−180
4
heterogeneous nuclear ribonucleoprotein A/B

151C8
1260
1423
U76713
Hs.81361
1.00E−61
1
apobec-1 binding protein 1 mRNA, complete cds/

cds = (15

593B9
41
954
NM_001688
Hs.81634
0
3
ATP synthase, H+ transporting, mitochondrial

104H12
352
912
X60221
Hs.81634
0
1
H+-ATP synthase subunit b/cds = (32,802)

141G8
1132
1642
AK001883
Hs.81648
0
1
FLJ11021 fis, clone PLACE1003704, weakly

41A1
4214
4395
X06182
Hs.81665
5.00E−67
1
c-kit proto-oncogene mRNA/cds = (21,2951)/

gb = X06182

102F5
3037
3646
D38551
Hs.81848
0
1
KIAA0078 gene, complete cds/cds = (184,2079)

111E11
1375
1752
NM_006265
Hs.81848
0
1
RAD21 (S. pombe) homolog (RAD21), mRNA/cds = (1

592F8
38
720
NM_014736
Hs.81892
0
1
KIAA0101 gene product (KIAA0101), mRNA/cds = (

194F1
6886
7115
AF241785
Hs.81897
1.00E−117
1
NPD012 (NPD012) mRNA, complete cds/cds = (552,2

525C6
1
615
NM_005563
Hs.81915
0
4
leukemia-associated phosphoprotein p18 (sta

101D12
3249
3508
D38555
Hs.81964
1.00E−143
1
KIAA0079 gene, complete cds/cds = (114,3491)

176D11
2996
3168
NM_004922
Hs.81964
9.00E−94
2
SEC24 (S. cerevisiae) related gene family, mem

129B7
5068
5759
D50683
Hs.82028
0
4
for TGF-betallR alpha, complete cds/cds =

195H6
946
1208
NM_006023
Hs.82043
6.00E−74
1
D123 gene product (D123), mRNA/cds = (280,1290)

481D9
2709
3085
NM_002184
Hs.82065
1.00E−134
1
interleukin 6 signal transducer (gp130, oncos

129A5
1338
1802
M14083
Hs.82085
0
1
beta-migrating plasminogen activator inhibitor I mR

57G9
500
1561
AF220656
Hs.82101
1.00E−145
3
apoptosis-associated nuclear protein PHLDA1

40C11
3748
4497
M27492
Hs.82112
0
1
interleukin 1 receptor mRNA, complete cds/

cds = (82,17

481B6
3164
3609
NM_000877
Hs.82112
0
1
interleukin 1 receptor, type I (IL1R1), mRNA/

40H6
161
557
AB049113
Hs.82113
0
1
DUT mRNA for dUTP pyrophosphatase, complete cd

592B7
184
568
NM_001948
Hs.82113
1.00E−111
2
dUTP pyrophosphatase (DUT), mRNA/cds = (29,523

114F1
465
720
U70451
Hs.82116
1.00E−135
1
myleoid differentiation primary response protein My

71H5
194
3415
NM_006186
Hs.82120
0
36
nuclear receptor subfamily 4, group A, member

75C1
1264
3422
X75918
Hs.82120
0
84
NOT/cds = (317,2113)/gb = X75918/gi = 4158

40D1
1621
2080
M90391
Hs.82127
0
1
putative IL-16 protein precursor, mRNA, comple

71C4
678
5065
NM_002460
Hs.82132
0
88
interferon regulatory factor 4 (IRF4), mRNA/

75G12
3219
5316
U52682
Hs.82132
0
27
lymphocyte specific interferon regulatory factor/in

193G6
1118
2682
NM_006874
Hs.82143
1.00E−178
3
E74-like factor 2 (ets domain transcription fa

147F6
1484
1951
AK025643
Hs.82148
0
1
FLJ21990 fis, clone HEP06386/cds = (22,49

155E4
853
1264
M64992
Hs.82159
0
1
prosomal protein P30-33K (pros-30) mRNA, complete

cd

595F1
30
614
NM_002786
Hs.82159
0
3
proteasome (prosome, macropain) subunit, alp

58A4
473
1715
NM_005655
Hs.82173
0
3
TGFB inducible early growth response (TIEG), m

67E6
784
2109
S81439
Hs.82173
0
7
EGR alpha = early growth response gene alpha

[human, prostate

593H2
132
722
NM_000985
Hs.82202
0
2
ribosomal protein L17 (RPL17), mRNA/cds = (138,

40H5
283
1442
M37033
Hs.82212
0
12
CD53 glycoprotein mRNA, complete cds/

cds = (93,752)/

592C4
1
1442
NM_000560
Hs.82212
0
11
CD53 antigen (CD53), mRNA/cds = (93,752)/gb = N

460D4
1519
1845
NM_002510
Hs.82226
1.00E−160
1
glycoprotein (transmembrane) nmb (GPNMB), mR

61A8
507
736
AF045229
Hs.82280
1.00E−116
1
regulator of G protein signaling 10 mRNA, compl

45F7
418
651
NM_002925
Hs.82280
1.00E−119
1
regulator of G-protein signalling 10 (RGS10),

49C2
416
1323
NM_006417
Hs.82316
0
7
interferon-induced, hepatitis C-associated

41C11
847
1716
X63717
Hs.82359
0
2
APO-1 cell surface antigen/cds = (220,122

71H4
15
1627
NM_001781
Hs.82401
0
21
CD69 antigen (p60, early T-cell activation ant

75B10
9
1627
Z22576
Hs.82401
0
33
CD69 gene/cds = (81,680)/gb = Z22576/gi = 397938/

117B7
1441
1515
NM_022059
Hs.82407
7.00E−28
1
CXC chemokine ligand 16 (CXCL16), mRNA/cds = (4

110D6
1219
1721
AF006088
Hs.82425
0
1
Arp2/3 protein complex subunit p16-Arc (ARC16)

598F10
39
1497
NM_005717
Hs.82425
0
5
actin related protein 2/3 complex, subunit 5 (

99A9
621
1214
D26018
Hs.82502
0
1
mRNA for KIAA0039 gene, partial cds/cds = (0,1475)/gb

183F6
222
2235
NM_001637
Hs.82542
0
2
acyloxyacyl hydrolase (neutrophil) (AOAH), m

459G4
5196
5801
NM_003682
Hs.82548
0
1
MAP-kinase activating death domain (MADD), mR

75A6
301
2231
D85429
Hs.82646
0
44
heat shock protein 40, complete cds/c

64A5
300
2008
NM_006145
Hs.82646
0
17
heat shock 40 kD protein 1 (HSPF1), mRNA/cds = (4

50E5
628
2399
AK025459
Hs.82689
0
2
FLJ21806 fis, clone HEP00829, highly sim

115C6
23
589
NM_005087
Hs.82712
0
1
fragile X mental retardation, autosomal homol

105H10
1017
1429
M61199
Hs.82767
0
1
cleavage signal 1 protein mRNA, complete cds/

cds = (97,

461A11
204
748
NM_006296
Hs.82771
0
1
vaccinia related kinase 2 (VRK2), mRNA/cds = (1

39B4
1049
1203
M25393
Hs.82829
8.00E−83
1
protein tyrosine phosphatase (PTPase) mRNA,

complete

590F5
123
436
NM_002828
Hs.82829
1.00E−178
1
protein tyrosine phosphatase, non-receptor t

517F10
1038
2618
AK025583
Hs.82845
0
9
cDNA: FLJ21930 fis, clone HEP04301, highly sim

40B7
972
1933
M25280
Hs.82848
0
6
lymph node homing receptor mRNA, complete cds/

cds = (11

515B1
1
2322
NM_000655
Hs.82848
0
12
selectin L (lymphocyte adhesion molecule 1) (

587A10
190
685
NM_001344
Hs.82890
0
1
defender against cell death 1 (DAD1), mRNA/cd

113G9
1
2812
AF208850
Hs.82911
0
7
BM-008 mRNA, complete cds/cds = (341,844)/gb =

127H6
1828
2501
NM_003591
Hs.82919
0
2
cullin 2 (CUL2), mRNA/cds = (146,2383)/gb = NM_0

477E3
931
1777
NM_006416
Hs.82921
0
2
solute carrier family 35 (CMP-sialic acid tran

184D2
1355
1773
AL049795
Hs.83004
1.00E−164
1
DNA sequence from clone RP4-622L5 on

chromosome 1p34.

41F10
507
774
D49950
Hs.83077
1.00E−150
1
for interferon-gamma inducing factor(IGI

482E7
499
774
NM_001562
Hs.83077
5.00E−97
1
interleukin 18 (interferon-gamma-inducing f

515C6
111
1162
L38935
Hs.83086
1.00E−107
2
GT212 mRNA/cds = UNKNOWN/gb = L38935/

gi = 100884

479D3
1775
2028
NM_001760
Hs.83173
1.00E−122
1
cyclin D3 (CCND3), mRNA/cds = (165,1043)/gb = N

583H12
945
1655
NM_012151
Hs.83363
0
9
coagulation factor VIII-associated (intronic

47B3
2140
3625
M58603
Hs.83428
0
13
nuclear factor kappa-B DNA binding subunit (NF-

kappa-

58G1
2538
3625
NM_003998
Hs.83428
0
4
nuclear factor of kappa light polypeptide gene

477C6
1628
2131
Z49995
Hs.83465
0
1

H. sapiens mRNA (non-coding; clone h2A)/

cds = UNKNOWN/gb = Z4

587D10
1576
1900
AF064839
Hs.83530
0
2
map 3p21; 3.15 cR from WI-9324 region, complete

516B9
1662
3296
X59405
Hs.83532
0
4

H. sapiens, gene for Membrane cofactor protein/

cds = UNKNOWN

459A5
120
298
NM_017459
Hs.83551
7.00E−42
1
microfibrillar-associated protein 2 (MFAP2),

591A12
321
1116
NM_005731
Hs.83583
0
17
actin related protein 2/3 complex, subunit 2 (

102C1
554
1127
AK025198
Hs.83623
0
1
FLJ21545 fis, clone COL06195/cds = UNKNOW

458C8
1022
1831
NM_001619
Hs.83636
0
1
adrenergic, beta, receptor kinase 1 (ADRBK1),

107G1
303
1008
L20688
Hs.83656
0
4
GDP-dissociation inhibitor protein (Ly-GDI) mRNA, c

597F8
293
1180
NM_001175
Hs.83656
0
55
Rho GDP dissociation inhibitor (GDI) beta (AR

591G5
1
216
NM_003142
Hs.83715
1.00E−108
3
Sjogren syndrome antigen B (autoantigen La) (

184H9
240
392
X69804
Hs.83715
4.00E−77
2
for La/SS-B protein/cds = UNKNOWN/gb = X69804

193C10
1
1605
BC000957
Hs.83724
1.00E−154
4
Similar to hypothetical protein MNCb-2146, c

40A2
1101
1294
U90904
Hs.83724
1.00E−72
1
clone 23773 mRNA sequence/cds = UNKNOWN/

gb = U90904/g

57H2
191
422
NM_001827
Hs.83758
1.00E−126
1
CDC28 protein kinase 2 (CKS2), mRNA/cds = (95,33

60E10
191
422
X54942
Hs.83758
1.00E−129
1
ckshs2 mRNA for Cks1 protein homologue/cds = (95,3

164F5
1896
2293
NM_016325
Hs.83761
0
1
zinc finger protein 274 (ZNF274), mRNA/cds = (4

463E6
555
1128
NM_000791
Hs.83765
0
1
dihydrofolate reductase (DHFR), mRNA/cds = (47

194F8
1806
2223
NM_002199
Hs.83795
1.00E−161
1
interferon regulatory factor 2 (IRF2), mRNA/

520D11
180
1229
NM_000365
Hs.83848
0
5
triosephosphate isomerase 1 (TPI1), mRNA/cds

168B6
530
891
U47924
Hs.83848
0
1
chromosome 12p13 sequence/cds = (373,1122)/

gb = U4792

331E11
2591
3485
NM_000480
Hs.83918
0
8
adenosine monophosphate deaminase (isoform E

458A11
125
409
NM_000396
Hs.83942
1.00E−108
1
cathepsin K (pycnodysostosis) (CTSK), mRNA/

185H2
2501
2690
NM_000195
Hs.83951
3.00E−85
1
Hermansky-Pudlak syndrome (HPS), mRNA/cds = (2

99D2
977
1191
NM_019006
Hs.83954
1.00E−97
1
protein associated with PRK1 (AWP1), mRNA/cds

167D5
2275
2755
NM_000211
Hs.83968
0
4
integrin, beta 2 (antigen CD18 (p95), lymphocyt

524B2
262
575
BF028896
Hs.83992
1.00E−155
1
601765270F1 cDNA, 5′ end/clone = lMAGE: 3997576

523B2
688
1065
NM_015937
Hs.84038
0
1
CGI-06 protein (LOC51604), mRNA/cds = (6,1730)

102F1
951
1416
M63180
Hs.84131
0
1
threonyl-tRNA synthetase mRNA, complete cds/

cds = (13

589D5
863
1700
NM_006400
Hs.84153
0
3
dynactin 2 (p50) (DCTN2), mRNA/cds = (136,1356)

108F6
448
704
U70439
Hs.84264
1.00E−117
1
silver-stainable protein SSP29 mRNA, complete cds/

146D6
1022
1253
K01144
Hs.84298
6.00E−95
2
major histocompatibility class II antigen gamma chain

188B10
823
1302
NM_004355
Hs.84298
0
1
CD74 antigen (invariant polypeptide of major

175D2
1060
1479
M63488
Hs.84318
1.00E−158
1
replication protein A 70 kDa subunit mRNA complete

cds

115F4
2305
2393
NM_002945
Hs.84318
2.00E−43
1
replication protein A1 (70 kD) (RPA1), mRNA/cd

595H4
5400
5649
NM_004239
Hs.85092
1.00E−131
1
thyroid hormone receptor interactor 11 (TRIP1

106F1
493
1371
NM_017491
Hs.85100
0
3
WD repeat domain 1 (WDR1), transcript variant 1

40C10
438
880
X57025
Hs.85112
0
1
IGF-I mRNA for insulin-like growth factor I/cds = (166,

44C5
2247
2430
AF017257
Hs.85146
5.00E−89
1
chromosome 21 derived BAC containing erythrobl

45D4
1962
3324
X79067
Hs.85155
0
6

H. sapiens ERF-1 mRNA 3′ end/cds = UNKNOWN/

gb = X79067/gi = 483

591B9
2378
2603
NM_002880
Hs.85181
1.00E−109
1
v-raf-1 murine leukemia viral oncogene homolo

39E2
67
2493
X76488
Hs.85226
0
3
lysosomal acid lipase/cds = (145,1344)/

62H12
1249
1975
M12824
Hs.85258
0
3
T-cell differentiation antigen Leu-2/T8 mRNA, partia

40C8
4505
4856
X53587
Hs.85266
0
1
integrin beta 4/cds = UNKNOWN/gb = X53587/gi =

40E11
1983
2633
S53911
Hs.85289
0
1
CD34 = glycoprotein expressed in lymphohematopoietic

proge

135A2
121
695
BC001646
Hs.85301
0
2
clone MGC: 2392, mRNA, complete cds/cds = (964,

459H4
33
244
AK027067
Hs.85567
2.00E−90
1
cDNA: FLJ23414 fis, clone HEP20704/cds = (37,10

479A4
5556
5974
AB040974
Hs.85752
1.00E−171
1
mRNA for KIAA1541 protein, partial cds/cds = (9

146C3
1610
2062
AL049796
Hs.85769
0
1
DNA sequence from clone RP4-561L24 on

chromosome 1p22

463H11
871
1153
NM_006546
Hs.86088
5.00E−83
1
IGF-II mRNA-binding protein 1 (IMP-1), mRNA/

480A12
2
165
NM_004876
Hs.86371
7.00E−84
1
zinc finger protein 254 (ZNF254), mRNA/cds = (1

192F7
2854
3462
AF198614
Hs.86386
0
3
McI-1 (MCL-1) and McI-1 delta S/TM (MCL-1) gene

459G3
12
577
AL049340
Hs.86405
0
1
mRNA; cDNA DKFZp564P056 (from clone

DKFZp564P0

460E4
2361
2787
NM_000161
Hs.86724
0
2
GTP cyclohydrolase 1 (dopa-responsive dystoni

62F9
834
1282
M60724
Hs.86858
0
1
p70 ribosomal S6 kinase alpha-1 mRNA, complete cds/cd

187E7
84
766
NM_001695
Hs.86905
0
1
ATPase, H+ transporting, lysosomal (vacuolar

159D4
315
559
J03798
Hs.86948
1.00E−113
1
autoantigen small nuclear ribonucleoprotein Sm-D mR

459F9
1557
1619
NM_006938
Hs.86948
2.00E−25
1
small nuclear ribonucleoprotein D1 polypeptid

480G11
87
603
BG168139
Hs.87113
0
1
602341526F1 cDNA, 5′ end/clone = IMAGE: 4449343

41D6
2208
2320
M35999
Hs.87149
4.00E−39
1
platelet glycoprotein lll a (GPllla) mRNA, complete c

462H11
387
648
NM_003806
Hs.87247
1.00E−133
1
harakiri, BCL2-interacting protein (contains

99D7
614
5517
NM_003246
Hs.87409
0
62
thrombospondin 1 (THBS1), mRNA/cds = (111,3623

39B8
2130
5517
X14787
Hs.87409
0
33
thrombospondin/cds = (111,3623)/gb = X14787

525A2
329
560
NM_007047
Hs.87497
1.00E−129
2
butyrophilin, subfamily 3, member A2 (BTN3A2)

583F2
3303
3622
D63876
Hs.87726
1.00E−155
1
mRNA for KIAA0154 gene, partial cds/cds = (0,2080)/gb

184D7
2211
2556
M34181
Hs.87773
1.00E−165
1
testis-specific cAMP-dependent protein kinase catal

460A4
499
1074
AL117637
Hs.87794
0
1
mRNA; cDNA DKFZp4341225 (from clone

DKFZp43412

459G2
258
452
AW967701
Hs.87912
8.00E−88
1
EST379776 cDNA/gb = AW967701/gi = 8157540/ug =

74H7
1660
2397
AK026960
Hs.88044
0
9
FLJ23307 fis, clone HEP11549, highly sim

463D12
351
568
AI184553
Hs.88130
1.00E−118
1
qd60a05.x1 cDNA, 3′ end/clone = IMAGE: 1733840

595B1
309
986
NM_003454
Hs.88219
0
1
zinc finger protein 200 (ZNF200), mRNA/cds = (2

458D3
1018
1285
NM_000487
Hs.88251
6.00E−74
1
arylsulfatase A (ARSA), mRNA/cds = (375,1898)

462F4
4272
4846
AJ271878
Hs.88414
0
1
mRNA for putative transcription factor (BACH2

460B12
1267
2022
NM_006800
Hs.88764
0
3
male-specific lethal-3 (Drosophila)-like 1

461A4
2039
2421
AL161659
Hs.88820
0
1
DNA sequence from clone RP11-526K24 on

chromosome 20

460F9
3413
3654
NM_000397
Hs.88974
1.00E−133
1
cytochrome b-245, beta polypeptide (chronic g

459G9
790
1160
NM_006228
Hs.89040
1.00E−145
1
prepronociceptin (PNOC), mRNA/cds = (211,741)

70H12
1
661
AV716500
Hs.89104
0
274
AV716500 cDNA, 5′ end/clone = DCBAKA08/clone_—

469H5
1620
2142
AB040961
Hs.89135
0
1
mRNA for KIAA1528 protein, partial cds/cds = (4

175G6
2069
2501
D83243
Hs.89385
0
1
NPAT mRNA, complete cds/cds = (66,4349)/

gb = D83243/g

592B10
3703
3936
NM_002519
Hs.89385
1.00E−130
1
nuclear protein, ataxia-telangiectasia locu

120B7
337
630
NM_005176
Hs.89399
1.00E−114
1
ATP synthase, H+ transporting, mitochondrial

39D2
370
1892
AF147204
Hs.89414
0
68
chemokine receptor CXCR4-Lo (CXCR4) mRNA, alt

99H4
7
1625
NM_003467
Hs.89414
0
137
chemokine (C-X-C motif), receptor 4 (fusin) (C

106D2
2
266
U03644
Hs.89421
1.00E−143
1
recepin mRNA, complete cds/cds = (32,1387)/

gb = U03644

41F5
1203
1522
M16336
Hs.89476
1.00E−170
1
T-cell surface antigen CD2 (T11) mRNA, complete

cds, c

463A3
876
1025
NM_000698
Hs.89499
1.00E−79
1
arachidonate 5-lipoxygenase (ALOX5), mRNA/c

47D12
1198
4887
AB028969
Hs.89519
0
2
for KIAA1046 protein, complete cds/cds = (

498G2
4420
5265
NM_014928
Hs.89519
0
2
KIAA1046 protein (KIAA1046), mRNA/cds = (577,1

589G3
598
689
NM_002796
Hs.89545
4.00E−45
2
proteasome (prosome, macropain) subunit, bet

331B1
699
788
S71381
Hs.89545
1.00E−41
1
prosome beta-subunit = multicatalytic proteinase

complex

110A2
1403
1739
AK026432
Hs.89555
1.00E−177
1
FLJ22779 fis, clone KAIA1741/cds = (234,1

118E4
780
1672
NM_002110
Hs.89555
0
5
hemopoietic cell kinase (HCK), mRNA/cds = (168,

41B8
570
1166
M89957
Hs.89575
0
1
immunoglobulin superfamily member B cell receptor

co

44A11
2567
2808
L20814
Hs.89582
1.00E−115
1
glutamate receptor 2 (HBGR2) mRNA, complete cds/

cds = (

191G11
309
596
NM_006284
Hs.89657
1.00E−162
11
TATA box binding protein (TBP)-associated fac

72G5
1172
1575
AX023367
Hs.89679
0
38
Sequence 38 from Patent WO0006605

71B12
40
559
NM_000586
Hs.89679
0
13
interleukin 2 (IL2), mRNA/cds = (47,517)/gb = N

179G12
158
737
M36821
Hs.89690
0
1
cytokine (GRO-gamma) mRNA, complete cds

193B5
680
1146
NM_002994
Hs.89714
0
17
small inducible cytokine subfamily B (Cys-X-Cy

182G10
681
1146
X78686
Hs.89714
0
7
ENA-78 mRNA/cds = (106,450)/gb = X78686/gi = 47124

191C6
617
1597
NM_021950
Hs.89751
0
2
membrane-spanning 4-domains, subfamily A, m

40H3
1347
1597
X07203
Hs.89751
3.00E−71
1
CD20 receptor (S7)/cds = (90,983)/gb = X07203

458H2
3524
4331
NM_002024
Hs.89764
0
2
fragile X mental retardation 1 (FMR1), mRNA/c

40F6
1665
2210
D38081
Hs.89887
0
1
thromboxane A2 receptor, complete cds/cds = (9

473E1
578
956
AL515381
Hs.89986
1.00E−172
1
AL515381 cDNA/clone = CLOBB017ZH06-(3-prime)

126A12
770
982
AL558028
Hs.90035
1.00E−102
1
AL558028 cDNA/clone = CS0DJ002YF02-(5-prime)

183E12
2203
2814
NM_001316
Hs.90073
0
1
chromosome segregation 1 (yeast homolog)-like

145H12
1602
1811
AK026766
Hs.90077
1.00E−113
2
FLJ23113 fis, clone LNG07875, highly sim

62C2
1472
2610
AB023420
Hs.90093
0
2
for heat shock protein apg-2, complete cds

46H6
3172
3411
D26488
Hs.90315
6.00E−86
1
mRNA for KIAA0007 gene, partial cds/cds = (0,2062)/gb

116E2
1637
2016
AK025800
Hs.90421
1.00E−118
1
cDNA: FLJ22147 fis, clone HEP22163, highly sim

525H3
6
1231
NM_004261
Hs.90606
0
2
15 kDa selenoprotein (SEP15), mRNA/cds = (4,492

184D8
287
387
BE888304
Hs.90654
1.00E−46
2
601514033F1 cDNA, 5′ end/clone = IMAGE: 3915177

99D4
1948
4309
D50918
Hs.90998
0
5
mRNA for KIAA0128 gene, partial cds/cds = (0,1276)/gb

72B9
571
1312
AK026954
Hs.91065
0
1
FLJ23301 fis, clone HEP11120/cds = (2,188

586H8
189
478
NM_000987
Hs.91379
2.00E−83
1
ribosomal protein L26 (RPL26), mRNA/cds = (6,44

160A12
1
132
X69392
Hs.91379
4.00E−69
5
ribosomal protein L26/cds = (6,443)/gb =

331H4
1632
2166
AK027210
Hs.91448
0
1
FLJ23557 fis, clone LNG09686, highly sim

473E6
915
1390
NM_004556
Hs.91640
0
2
nuclear factor of kappa light polypeptide gene

69E4
673
1328
A8007956
Hs.92381
1.00E−122
2
mRNA, chromosome 1 specific transcript KIAA04

182F10
117
781
AF070523
Hs.92384
0
1
JWA protein mRNA, complete cds/cds = (115,681)

585F10
77
1890
NM_006407
Hs.92384
0
13
vitamin A responsive; cytoskeleton related (J

469G3
2061
2293
AK025683
Hs.92414
1.00E−110
1
cDNA: FLJ22030 fis, clone HEP08669/cds = UNKNOW

472H4
247
671
AW978555
Hs.92448
0
1
EST390664 cDNA/gb = AW978555/gi = 8169822/ug =

193F11
2051
4721
NM_003103
Hs.92909
0
3
SON DNA binding protein (SON), mRNA/cds = (414,4

37E7
1287
1805
AK002059
Hs.92918
0
1
FLJ11197 fis, clone PLACE1007690/cds = (37

111D7
244
596
NM_016623
Hs.92918
1.00E−166
1
hypothetical protein (BM-009), mRNA/cds = (385

41B10
1216
1530
U24577
Hs.93304
1.00E−173
1
LDL-phospholipase A2 mRNA, complete cds/

cds = (216,15

48B4
76
723
NM_001417
Hs.93379
0
5
eukaryotic translation initiation factor 4B

39F8
76
876
X55733
Hs.93379
0
1
initiation factor 4B cDNA/cds = (0,1835)/gb = X557

471B10
660
886
NM_007020
Hs.93502
1.00E−125
1
U1-snRNP binding protein homolog (70 kD) (U1SN

467A3
1189
1284
X91348
Hs.93522
3.00E−36
1

H. sapiens predicted non coding cDNA (DGCR5)/

cds = UNKNOWN/

461B5
652
874
NM_003367
Hs.93649
1.00E−104
1
upstream transcription factor 2, c-fos intera

62B8
1386
1739
J05016
Hs.93659
1.00E−170
1
(clone pA3) protein disulfide isomerase related prote

461E7
1931
2086
NM_004911
Hs.93659
1.00E−65
1
protein disulfide isomerase related protein (

458G11
2423
3161
AB040959
Hs.93836
0
1
mRNA for KIAA1526 protein, partial cds/cds =

104E3
516
981
AK000967
Hs.93872
0
1
FLJ10105 fis, clone HEMBA 1002542/cds = UN

41B6
87
846
X04430
Hs.93913
0
2
IFN-beta 2a mRNA for interferon-beta-2/cds = (86,724)

179H7
1610
1682
AF009746
Hs.94395
9.00E−34
1
peroxisomal membrane protein 69 (PMP69) mRNA,

470G3
74
493
NM_007221
Hs.94446
0
1
polyamine-modulated factor 1 (PMF1), mRNA/c

472A5
2325
2429
AK022267
Hs.94576
2.00E−48
1
cDNA FLJ12205 fis, clone MAMMA1000931/

cds = UNK

459C9
5356
6120
NM_006421
Hs.94631
0
3
brefeldin A-inhibited guanine nucleotide-exc

465F8
3580
4049
NM_015125
Hs.94970
0
1
KIAA0306 protein (KIAA0306), mRNA/cds = (0,436

57B9
4145
4379
NM_005109
Hs.95220
1.00E−126
1
oxidative-stress responsive 1 (OSR1), mRNA/c

160D6
30
480
X01451
Hs.95327
0
2
gene for 20 K T3 glycoprotein (T3-delta-chain) of T-c

512G1
1
415
BF107010
Hs.95388
1.00E−175
2
601824367F1 cDNA, 5′ end/clone = IMAGE: 4043920

593E11
24
273
BG291649
Hs.95835
1.00E−79
10
602385778F1 cDNA, 5′ end/clone = IMAGE: 4514827

41H2
1011
1306
M28170
Hs.96023
1.00E−114
1
cell surface protein CD19 (CD19) gene, complete cds/c

149G8
213
435
BF222826
Hs.96487
1.00E−119
2
7q23f06.x1/clone = IMAGE/gb = BF222826/g

101G7
2266
3173
AL133227
Hs.96560
0
2
DNA sequence from clone RP11-394O2 on

chromosome 20 C

103E6
2840
3451
BC000143
Hs.96560
0
1
Similar to hypothetical protein FLJ11656, cl

107G5
226
2349
BF673956
Hs.96566
7.00E−24
1
602137338F1 cDNA, 5′ end/clone = IMAGE: 4274048

461A12
3602
4135
AB014555
Hs.96731
0
2
mRNA for KIAA0655 protein, partial cds/cds = (0

595A8
82
1571
NM_000734
Hs.97087
1.00E−147
10
CD3Z antigen, zeta polypeptide (TiT3 complex)

479H8
883
1378
NM_014373
Hs.97101
0
3
putative G protein-coupled receptor (GPCR150)

466D12
2001
5732
NM_012072
Hs.97199
0
2
complement component C1q receptor (C1QR), mRN

194B3
1835
2898
NM_002990
Hs.97203
0
2
small inducible cytokine subfamily A (Cys-Cys)

109E9
2880
3536
AF083322
Hs.97437
0
1
centriole associated protein CEP110 mRNA, com

459H5
9
230
BF438062
Hs.97896
1.00E−116
1
7q66e08.x1 cDNA/clone = IMAGE/gb = BF438062/g

473A4
871
1327
NM_007015
Hs.97932
0
1
chondromodulin I precursor (CHM-I), mRNA/cds

466E9
1408
1808
AL442083
Hs.98026
1.00E−172
2
mRNA; cDNA DKFZp547D144 (from clone

DKFZp547D1

460E3
1290
1687
AF038564
Hs.98074
0
1
atrophin-1 interacting protein 4 (AIP4) mRNA,

462E6
103
642
NM_016440
Hs.98289
0
1
VRK3 for vaccinia related kinase 3 (LOC51231),

460B8
114
546
AA418743
Hs.98306
1.00E−178
1
zv98f06.s1 cDNA, 3′ end/clone = IMAGE: 767843/

124A8
1
157
NM_019044
Hs.98324
2.00E−69
1
hypothetical protein (FLJ10996), mRNA/cds = (

71B10
79
520
AI761058
Hs.98531
1.00E−112
34
wi69b03.x1 cDNA, 3′ end/clone = IMAGE: 2398541

49F1
36
435
AA913840
Hs.98903
0
1
oI39d11.s1 cDNA, 3′ end/clone = IMAGE: 1525845

462F6
61
201
AC006276
Hs.99093
2.00E−74
1
chromosome.19, cosmid R28379/cds = (0,633)/gb

473A2
47
475
BE326857
Hs.99237
0
1
hr65h06.x1 cDNA, 3′ end/clone = IMAGE: 3133403

599D8
1468
1748
NM_005825
Hs.99491
1.00E−132
1
RAS guanyl releasing protein 2 (calcium and DA

459F8
300
541
AW444899
Hs.99665
1.00E−123
1
UI-H-BI3-ajz-d-07-0-UI.s1 cDNA, 3′ end/clon

163H9
8
141
AL049319
Hs.99821
2.00E−58
1
cDNA DKFZp564C046 (from clone DKFZp564C0

165H8
1176
1930
NM_015400
Hs.99843
0
2
DKFZP586N0721 protein (DKFZP586N0721), mRNA

188C9
543
998
NM_001436
Hs.99853
0
2
fibrillarin (FBL), mRNA/cds = (59,1024)/gb = N

37H2
759
2017
AC018755
Hs.99855
0
4
chromosome 19, BAC BC330783 (CIT-HSPC_470E3),

127H3
758
2183
NM_001462
Hs.99855
0
5
formyl peptide receptor-like 1 (FPRL1), mRNA

62F2
1
642
BF315159
Hs.99858
0
6
601899519F1 cDNA, 5′ end/clone = IMAGE: 4128749

599A7
26
838
NM_000972
Hs.99858
0
11
ribosomal protein L7a (RPL7A), mRNA/cds = (31,8

167B3
1994
2101
AB032251
Hs.99872
2.00E−37
1
BPTF mRNA for bromodomain PHD finger transcript

41G8
461
751
L08096
Hs.99899
1.00E−161
1
CD27 ligand mRNA, complete cds/cds = (150,731)/

gb = L08

479C10
327
738
NM_001252
Hs.99899
0
1
tumor necrosis factor (ligand) superfamily, m

36D8
1180
2315
AL162047
Hs.99908
0
7
cDNA DKFZp762E1112 (from clone DKFZp762E

593E2
62
435
NM_000983
Hs.99914
1.00E−145
1
ribosomal protein L22 (RPL22), mRNA/cds = (51,4

478C8
48
311
NM_000023
Hs.99931
1.00E−112
1
sarcoglycan, alpha (50 kD dystrophin-associat

61A1
827
1053
S62140
Hs.99969
1.00E−126
1
TLS = translocated in liposarcoma [human, mRNA,

1824 nt]/cd

40C7
971
1724
X69819
Hs.99995
0
1
ICAM-3 mRNA/cds = (8,1651)/gb = X69819/gi = 32627

116F8
109
376
NM_002964
Hs.100000
1.00E−123
5
S100 calcium-binding protein A8 (calgranulin

121F4
30
540
NM_001629
Hs.100194
1.00E−118
7
arachidonate 5-lipoxygenase-activating pro

46G10
5175
5624
NM_003605
Hs.100293
0
2
O-linked N-acetylglucosamine (GlcNAc) transf

49E4
1279
2585
NM_006773
Hs.100555
0
4
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide

61E1
1279
1767
X98743
Hs.100555
0
2
RNA helicase (Myc-regulated dead box pro

460A10
824
1321
NM_018099
Hs.100895
0
1
hypothetical protein FLJ10462 (FLJ10462), mR

458F1
1
303
R18757
Hs.100896
1.00E−157
1
yg17e04.r1 cDNA, 5′ end/clone = IMAGE: 32522/c

64B8
2062
2711
AB007859
Hs.100955
0
1
mRNA for KIAA0399 protein, partial cds/cds = (0,

515H6
131
201
NM_001207
Hs.101025
6.00E−33
1
basic transcription factor 3 (BTF3), mRNA/cd

472H12
10
358
AW968686
Hs.101340
0
1
EST380762 cDNA/gb = AW968686/gi = 8158527/ug =

99G6
2427
4860
AB002384
Hs.101359
0
9
mRNA for KIAA0386 gene, complete cds/

cds = (177,3383)

62E12
193
573
AI936516
Hs.101370
1.00E−100
6
wd28h07.x1 cDNA, 3′ end/clone = IMAGE: 2329501

493B9
3
638
AL583391
Hs.101370
0
8
AL583391 cDNA/clone = CS0DL012YA12-(3-prime)

117D4
2812
2966
NM_006291
Hs.101382
7.00E−79
1
tumor necrosis factor, alpha-induced protein

462A9
382
620
BC000764
Hs.101514
1.00E−133
1
hypothetical protein FLJ10342, clone MGC: 27

193G3
3368
3659
AL139349
Hs.102178
3.00E−88
1
DNA sequence from clone RP11-261P9 on

chromosome 20.

62H6
3035
4257
AF193339
Hs.102506
0
5
eukaryotic translation initiation factor 2 a

46E2
3223
4023
NM_004836
Hs.102506
0
2
eukaryotic translation initiation factor 2-a

460C4
151
635
AW978361
Hs.102630
0
2
EST390470 cDNA/gb = AW978361/gi = 8169626/ug =

58E4
1
321
BF970875
Hs.102647
1.00E−177
2
602271536F1 cDNA, 5′ end/clone = IMAGE: 4359609

189G9
5473
6137
NM_018489
Hs.102652
0
2
hypothetical protein ASH1 (ASH1), mRNA/cds = (

111H5
3043
3331
AK000354
Hs.102669
1.00E−125
1
cDNA FLJ20347 fis, clone HEP13790/cds = (708,14

465B8
27
348
AI707589
Hs.102793
1.00E−164
1
as30b05.x1 cDNA, 3′ end/clone = IMAGE: 2318673

126G11
1069
1431
NM_016128
Hs.102950
0
2
coat protein gamma-cop (LOC51137), mRNA/cds =

165H5
326
564
BF698884
Hs.103180
4.00E−71
1
602126455F1 cDNA, 5′ end/clone = IMAGE: 4283340

108H6
2135
2505
AB023187
Hs.103329
1.00E−59
1
for KIAA0970 protein, complete cds/cds = (

521C9
1440
1962
AL136885
Hs.103378
0
2
mRNA; cDNA DKFZp434P116 (from clone

DKFZp434P1

458C9
3876
4415
AF254411
Hs.103521
0
1
ser/arg-rich pre-mRNA splicing factor SR-A1 (

99F6
349
767
NM_018623
Hs.103657
0
5
hypothetical protein PRO2219 (PRO2219), mRNA

162G11
1745
2161
AF117829
Hs.103755
1.00E−151
1
8q21.3: RICK gene/cds = (224,1846)/gb = AF11782

188G1
1757
2566
NM_004501
Hs.103804
0
2
heterogeneous nuclear ribonucleoprotein U (

470F7
56
302
NM_024056
Hs.103834
1.00E−137
1
hypothetical protein MGC5576 (MGC5576), mRNA

460A11
225
288
BG033732
Hs.103902
3.00E−29
1
602301101F1 cDNA, 5′ end/clone = IMAGE: 4402465

522H7
2157
2397
NM_006342
Hs.104019
1.00E−132
1
transforming, acidic coiled-coil containing

39E5
1007
2535
L12168
Hs.104125
0
10
adenylyl cyclase-associated protein (CAP) mRN

98C11
1023
2558
NM_006367
Hs.104125
0
29
adenylyl cyclase-associated protein (CAP), m

461B2
88
221
AW968823
Hs.104157
1.00E−38
1
EST380899 cDNA/gb = AW968823/gi = 8158664/ug =

110A4
4010
4306
AB023143
Hs.104305
1.00E−125
1
for KIAA0926 protein, complete cds/cds = (

122H5
4634
5232
NM_014922
Hs.104305
0
2
KIAA0926 protein (KIAA0926), mRNA/cds = (522,4

105C2
1817
2174
AB020669
Hs.104315
0
1
for KIAA0862 protein, complete cds/cds = (

37G4
1321
2886
AF016495
Hs.104624
0
46
small solute channel 1 (SSC1) mRNA, complete cd

98D4
1578
2946
NM_020980
Hs.104624
0
71
aquaporin 9 (AQP9), mRNA/cds = (286,1173)/gb =

458E6
1007
1399
NM_015898
Hs.104640
0
1
HIV-1 inducer of short transcripts binding pro

462C11
1037
1532
NM_018492
Hs.104741
0
1
PDZ-binding kinase; T-cell originated protein

118G4
1940
2513
BC002538
Hs.104879
0
2
serine (or cysteine) proteinase inhibitor, c

496A7
1
618
BG035120
Hs.104893
0
4
602324815F1 cDNA, 5′ end/clone = IMAGE: 4413099

112G4
3421
3933
NM_003633
Hs.104925
0
2
ectodermal-neural cortex (with BTB-like doma

460E2
16
460
AI479075
Hs.104985
0
1
tm30h01.x1 cDNA, 3′ end/clone = IMAGE: 2158129

461H4
1500
1781
NM_020979
Hs.105052
1.00E−148
1
adaptor protein with pleckstrin homology and

469C7
231
380
NM_018331
Hs.105216
1.00E−77
1
hypothetical protein FLJ11125 (FLJ11125), mR

461B6
84
489
AA489227
Hs.105230
0
1
aa57f07.s1 cDNA, 3′ end/clone = IMAGE: 825061/

462D5
1735
2129
NM_015393
Hs.105460
0
1
DKFZP564O0823 protein (DKFZP564O0823), mRNA

465H7
1
624
NM_017780
Hs.105461
0
1
hypothetical protein FLJ20357 (FLJ20357), mR

471F3
819
1126
AY007243
Hs.105484
1.00E−160
1
regenerating gene type IV mRNA, complete cds/

473C1
42
479
AW970759
Hs.105621
0
1
EST382842 cDNA/gb = AW970759/gi = 8160604/ug =

102A9
1
331
AK025947
Hs.105664
0
1
FLJ22294 fis, clone HRC04426/cds = (240,6

465G9
193
524
AI475680
Hs.105676
0
1
tc93d12.x1 cDNA, 3′ end/clone = IMAGE: 2073719

469G2
1528
1625
AK022481
Hs.105779
8.00E−38
1
cDNA FLJ12419 fis, clone MAMMA1003047, highly

482A9
289
839
NM_012483
Hs.105806
0
3
granulysin (GNLY), transcript variant 519, m

595B11
918
1300
NM_002343
Hs.105938
0
1
lactotransferrin (LTF), mRNA/cds = (294,2429)

69B3
3649
4226
Y13247
Hs.106019
0
1
fb19 mRNA/cds = (539,3361)/gb = Y13247/gi = 2117

459E8
106
563
NM_013322
Hs.106260
0
1
sorting nexin 10 (SNX10), mRNA/cds = (128,733)

459E2
1939
2361
NM_003171
Hs.106469
0
1
suppressor of var1 ( S. cerevisiae) 3-like 1 (S

98H12
658
1040
BC002748
Hs.106650
0
2
Similar to hypothetical protein FLJ20533, cl

594H5
1418
1501
NM_001568
Hs.106673
6.00E−36
1
eukaryotic translation initiation factor 3,

194H12
751
1233
NM_021626
Hs.106747
0
1
serine carboxypeptidase 1 precursor protein (

138G6
2749
3214
AF189723
Hs.106778
0
3
calcium transport ATPase ATP2C1 (ATP2C1A) mRN

56A5
1
1089
AL355722
Hs.106875
0
2
EST from clone 35214, full insert/cds = UNKNOWN

67H8
844
1102
X71490
Hs.106876
1.00E−103
1
vacuolar proton ATPase, subunit D/cds = (2

463G10
538
725
AF035306
Hs.106890
1.00E−102
1
clone 23771 mRNA sequence/cds = UNKNOWN/

gb = AF

121H2
14
394
NM_016619
Hs.107139
0
1
hypothetical protein (LOC51316), mRNA/cds = (

185D12
118
884
NM_001564
Hs.107153
0
3
inhibitor of growth family, member 1-like (ING

186D6
1140
1507
NM_017892
Hs.107213
0
1
hypothetical protein FLJ20585 (FLJ20585), mR

462B10
192
541
AI707896
Hs.107369
1.00E−168
1
as34a10.x1 cDNA, 3′ end/clone = IMAGE: 2319066

59A10
1694
2335
AJ270952
Hs.107393
0
3
for putative membrane protein (GENX-3745

499G1
2987
4266
AL035683
Hs.107526
1.00E−104
2
DNA sequence from clone RP5-1063B2 on

chromosome 20q1

466F11
327
493
AI391443
Hs.107622
9.00E−90
1
tf96e06.x1 cDNA, 3′ end/clone = IMAGE: 2107138

182F9
153
649
AF265439
Hs.107707
0
1
DC37 mRNA, complete cds/cds = (5,856)/gb = AF26

481F9
1216
1609
NM_016270
Hs.107740
0
2
Kruppel-like factor (LOC51713), mRNA/cds = (84

184H4
189
576
AF081282
Hs.107979
0
1
small membrane protein 1 (SMP1) mRNA, complete

103E11
1006
2137
NM_014313
Hs.107979
0
4
small membrane protein 1 (SMP1), mRNA/cds = (99,

596H7
1265
1771
NM_004078
Hs.108080
0
3
cysteine and glycine-rich protein 1 (CSRP1), m

46H8
777
914
AF070640
Hs.108112
2.00E−47
1
clone 24781 mRNA sequence/cds = UNKNOWN/

gb = AF

53B4
1552
1967
U32986
Hs.108327
0
2
xeroderma pigmentosum group E UV-damaged DNA

binding

124A10
1089
1733
AK001428
Hs.108332
0
3
cDNA FLJ10566 fis, clone NT2RP2002959, highly

127F8
428
746
AL136941
Hs.108338
0
1
mRNA; cDNA DKFZp586C1924 (from clone

DKFZp586

191G10
518
883
AL136640
Hs.108548
0
2
mRNA; cDNA DKFZp564F163 (from clone

DKFZp564F1

458G8
2374
5101
NM_016227
Hs.108636
0
2
membrane protein CH1 (CH1), mRNA/cds = (124,434

58F11
735
798
NM_006963
Hs.108642
2.00E−28
1
zinc finger protein 22 (KOX 15) (ZNF22), mRNA/

118B5
2715
2797
AK022874
Hs.108779
2.00E−38
1
cDNA FLJ12812 fis, clone NT2RP2002498/cds = (3,

110H2
18
661
AF026292
Hs.108809
0
1
chaperonin containing t-complex polypeptide

181G4
1008
1142
NM_006429
Hs.108809
2.00E−71
1
chaperonin containing TCP1, subunit 7 (eta) (C

189F11
415
615
AK024569
Hs.108854
2.00E−79
1
cDNA: FLJ20916 fis, clone ADSE00738, highly s

596F8
5958
6097
AB011087
Hs.108945
8.00E−48
1
mRNA for KIAA0515 protein, partial cds/cds = (0,

157D8
399
830
NM_016145
Hs.108969
0
1
PTD008 protein (PTD008),/cds = (233,553)

175E7
712
1849
AL133111
Hs.109150
0
2
mRNA; cDNA DKFZp434H068 (from clone

DKFZp434H0

514E1
66
613
NM_012417
Hs.109219
0
4
retinal degeneration B beta (RDGBB), mRNA/cd

106A4
1864
2220
AJ011895
Hs.109281
1.00E−111
1
for HIV-1, Nef-associated factor 1 alpha

169E1
938
1331
AK024297
Hs.109441
0
2
FLJ14235 fis, clone NT2RP4000167/cds = (82

100B8
1
191
NM_012456
Hs.109571
3.00E−85
1
translocase of inner mitochondrial membrane 1

115B7
983
1193
NM_007074
Hs.109606
1.00E−116
1
coronin, actin-binding protein, 1A (CORO1A),

62H11
1
626
BF245892
Hs.109641
1.00E−154
10
601864070F1 cDNA, 5′ end/clone = lMAGE: 4082465

595B2
4976
5286
AB040884
Hs.109694
1.00E−142
1
mRNA for KIAA1451 protein, partial cds/cds = (0

75H11
227
482
BF244603
Hs.109697
1.00E−129
1
601862620F1 cDNA, 5′ end/clone = IMAGE: 4080412

118G3
219
392
NM_024292
Hs.109701
2.00E−66
1
ubiquitin-like 5 (UBL5), mRNA/cds = (65,286)/

105A5
3271
3532
AL117407
Hs.109727
1.00E−147
2
cDNA DKFZp434D2050 (from clone DKFZp434D

481B7
1101
1201
NM_006026
Hs.109804
9.00E−42
1
H1 histone family, member X (H1FX), mRNA/cds = (

476H12
1018
1429
NM_004310
Hs.109918
0
3
ras homolog gene family, member H (ARHH), mRNA

144C8
1252
1429
Z35227
Hs.109918
7.00E−92
1
TTF for small G protein/cds = (579,1154)/gb =

141E10
630
1269
AK001779
Hs.110445
0
4
FLJ10917 fis, clone OVARC1000321/cds = (18

494D8
4102
4476
NM_014918
Hs.110488
0
1
KIAA0990 protein (KIAA0990), mRNA/cds = (494,2

47C3
2298
2431
D86974
Hs.110613
1.00E−60
1
KIAA0220 gene, partial cds/cds = (0,1661)/gb

194C10
1210
1704
AL157477
Hs.110702
0
1
mRNA; cDNA DKFZp761E212 (from clone

DKFZp761E2

192F1
3254
3686
NM_015726
Hs.110707
1.00E−150
2
H326 (H326), mRNA/cds = (176,1969)/gb = NM_0157

595B8
1148
1414
NM_003472
Hs.110713
1.00E−147
1
DEK oncogene (DNA binding) (DEK), mRNA/cds = (3

459F3
3337
3915
NM_001046
Hs.110736
0
1
solute carrier family 12 (sodium/potassium/ch

195F5
1051
1482
AK025557
Hs.110771
0
2
cDNA: FLJ21904 fis, clone HEP03585/cds = UNKNOW

53B10
163
742
NM_020150
Hs.110796
0
1
SAR1 protein (SAR1), mRNA/cds = (100,696)/gb =

164B11
122
932
NM_016039
Hs.110803
0
5
CGI-99 protein (LOC51637), mRNA/cds = (161,895

594H4
982
1454
AK026528
Hs.111222
6.00E−95
3
cDNA: FLJ22875 fis, clone KAT02879/cds = (30,51

50A10
1688
2095
AF119897
Hs.111334
0
2
PRO2760 mRNA, complete cds/cds = UNKNOWN/

gb = A

102H11
175
498
AI436587
Hs.111377
1.00E−148
1
ti03d11.x1 cDNA, 3′ end/clone = IMAGE: 2129397

109G11
1324
1388
AB016811
Hs.111554
2.00E−29
1
for ADP ribosylation factor-like protein,

144E10
77
304
BF219474
Hs.111611
1.00E−122
2
601884269F1 5′ end/clone = IMAGE: 4102769

583C9
4
272
NM_000988
Hs.111611
1.00E−148
10
ribosomal protein L27 (RPL27), mRNA/cds = (17,4

111F4
31
380
NM_014463
Hs.111632
0
1
Lsm3 protein (LSM3), mRNA/cds = (29,337)/gb = N

106E6
2646
2892
AL096723
Hs.111801
1.00E−135
1
cDNA DKFZp564H2023 (from clone DKFZp564H

169A2
773
1015
D14696
Hs.111894
1.00E−135
2
KIAA0108 gene, complete cds/cds = (146,847)/

182D6
264
748
NM_014713
Hs.111894
0
1
lysosomal-associated protein transmembrane

460D11
205
452
AI557431
Hs.111973
4.00E−60
1
PT2.1_7_C05.r cDNA, 3′ end/clone_end = 3′ /gb =

121A7
355
589
NM_020382
Hs.111988
1.00E−128
1
PR/SET domain containing protein 07 (SET07), m

476C12
254
463
AA442585
Hs.112071
1.00E−111
1
zv57f09.r1 cDNA, 5′ end/clone = IMAGE: 757769/

172E7
469
736
AF228422
Hs.112242
1.00E−143
1
normal mucosa of esophagus specific 1 (NMES1)

108E10
4800
4901
AF071076
Hs.112255
6.00E−48
1
cell-line HeLa Nup98-Nup96 precursor, mRNA, c

47G12
1
301
BF237710
Hs.112318
1.00E−165
5
601842210F1 cDNA, 5′ end/clone = IMAGE: 4079930

599G7
38
455
NM_019059
Hs.112318
0
32
6.2 kd protein (LOC54543), mRNA/cds = (93,260)

469F9
226
546
NM_002638
Hs.112341
1.00E−107
1
protease inhibitor 3, skin-derived (SKALP) (P

589G11
482
1336
AK026396
Hs.112497
0
2
cDNA: FLJ22743 fis, clone HUV00901/

cds = UNKNOW

464F10
1686
1917
NM_002978
Hs.112842
1.00E−119
1
sodium channel, nonvoltage-gated 1, delta (SC

54B11
1
423
BF025727
Hs.113029
0
26
601670406F1 cDNA, 5′ end/clone = IMAGE: 3953425

591C5
31
469
NM_001028
Hs.113029
0
10
ribosomal protein S25 (RPS25), mRNA/cds = (71,4

585F4
1882
3918
AK027136
Hs.113205
1.00E−130
3
cDNA: FLJ23483 fis, clone KAIA04052/cds = UNKNO

61B12
1168
2386
AF105253
Hs.113368
0
5
neuroendocrine secretory protein 55 mRNA, com

163D9
3470
4109
Y08890
Hs.113503
0
1
mRNA for Ran_GTP binding protein 5

466C4
276
946
AL359916
Hs.113872
0
1
DNA sequence from clone RP11-550O8 on

chromosome 20 C

592C12
2506
2696
AF323540
Hs.114309
2.00E−80
1
apolipoprotein L-I mRNA, splice variant B, co

476A11
121
528
AA702108
Hs.114931
0
1
zi85e01.s1 cDNA, 3′ end/clone = IMAGE: 447576/

109F4
3123
3521
D30783
Hs.115263
0
1
for epiregulin, complete cds/cds = (166,67

123D1
3123
3526
NM_001432
Hs.115263
0
1
epiregulin (EREG), mRNA/cds = (166,675)/gb = N

465D7
1
175
BG288391
Hs.115467
1.00E−94
1
602388053F1 cDNA, 5′ end/clone = IMAGE: 4517076

74H9
346
602
AK027114
Hs.115659
1.00E−108
1
FLJ23461 fis, clone HSI07757/cds = UNKNOW

585E4
384
1146
NM_024061
Hs.115659
0
3
hypothetical protein MGC5521 (MGC5521), mRNA

462C1
945
1222
NM_024036
Hs.115960
1.00E−152
1
hypothetical protein MGC3103 (MGC3103), mRNA

464E4
1276
1635
AK023633
Hs.116278
1.00E−138
1
cDNA FLJ13571 fis, clone PLACE1008405/cds = UNK

43B10
1601
1798
AF283777
Hs.116481
9.00E−47
1
clone TCBAP0702 mRNA sequence/cds = UNKNOWN/g

465G1
374
654
NM_001782
Hs.116481
5.00E−85
2
CD72 antigen (CD72), mRNA/cds = (108,1187)/gb

51G8
29
203
BF341330
Hs.116567
6.00E−26
1
602013274F1 cDNA, 5′ end/clone = IMAGE: 4149066

40D10
2694
3430
X68742
Hs.116774
0
1
integrin, alpha subunit/cds = UNKNOWN/g

107D1
1778
1943
U71383
Hs.117005
1.00E−84
1
OB binding protein-2 (OB-BP2) mRNA, complete cds/

cds

459D4
2882
3522
AK025364
Hs.117268
0
1
cDNA: FLJ21711 fis, clone COL10156/cds = UNKNOW

473E8
2104
2233
AB029016
Hs.117333
2.00E−65
3
mRNA for KIAA1093 protein, partial cds/cds = (0

458E2
88
627
AI825645
Hs.117906
0
2
wb75b09.x1 cDNA, 3′ end/clone = IMAGE: 2311481

163A7
1160
1420
X53793
Hs.117950
1.00E−109
1
ADE2H1 mRNA showing homologies to SAICAR

syntheta

123B8
18
740
NM_002799
Hs.118065
0
1
proteasome (prosome, macropain) subunit, bet

583G3
924
1199
AB011182
Hs.118087
1.00E−155
4
mRNA for KIAA0610 protein, partial cds/cds = (0,

127A1
263
557
NM_006441
Hs.118131
1.00E−141
1
5,10-methenyltetrahydrofolate synthetase (

459A10
188
817
AL522477
Hs.118142
0
1
AL522477 cDNA/clone = CS0DB008YK14-(3-prime)

584A10
8484
8875
NM_003316
Hs.118174
0
1
tetratricopeptide repeat domain 3 (TTC3), mRN

52D4
1287
1752
AK026486
Hs.118183
0
1
FLJ22833 fis, clone KAIA4266/cds = (479,8

470B6
68
532
BF030930
Hs.118303
0
1
601558648F1 cDNA, 5′ end/clone = IMAGE: 3828706

41B3
5041
5669
M14648
Hs.118512
0
1
cell adhesion protein (vitronectin) receptor alpha s

125B8
999
1573
NM_003733
Hs.118633
0
1
2′-5′oligoadenylate synthetase-like (OASL),

459D3
3
427
AI052447
Hs.118659
0
1
oz07g04.x1 cDNA, 3′ end/clone = IMAGE: 1674678

112F11
191
387
NM_006923
Hs.118684
1.00E−103
1
stromal cell-derived factor 2 (SDF2), mRNA/c

129E4
1727
1891
AL050404
Hs.118695
2.00E−86
1
DNA sequence from clone 955M13 on chromosome

20. Conta

126H2
1512
2209
NM_000358
Hs.118787
0
2
transforming growth factor, beta-induced, 68

598D9
817
1106
NM_001155
Hs.118796
1.00E−108
1
annexin A6 (ANXA6), transcript variant 1, mRN

331E6
89
475
BE311727
Hs.118857
0
1
601143334F1 cDNA, 5′ end/clone = IMAGE: 3507009

521C1
700
1180
NM_006292
Hs.118910
0
2
tumor susceptibility gene 101 (TSG101), mRNA

139E8
463
1198
AJ012506
Hs.118958
0
1
activated in tumor suppression, clone TSA

69H2
578
1117
U05040
Hs.118962
0
1
FUSE binding protein mRNA, complete cds/

cds = (26,1960

461F1
1241
1715
AK024119
Hs.118990
0
1
cDNA FLJ14057 fis, clone HEMBB1000337/cds = UNK

481E1
1682
1969
NM_017544
Hs.119018
1.00E−129
1
transcription factor NRF (NRF), mRNA/cds = (653

479B4
45
203
AL109806
Hs.119057
5.00E−43
1
DNA sequence from clone RP5-1153D9 on

chromosome 20 C

520F1
177
672
NM_012423
Hs.119122
1.00E−148
8
ribosomal protein L13a (RPL13A), mRNA/cds = (1

477E4
46
1565
AL109786
Hs.119155
0
3
mRNA full length insert cDNA clone EUROIMAGE 81

166F10
304
814
M37583
Hs.119192
0
3
histone (H2A.Z) mRNA, complete cds/cds = (106,492)/g

592E5
302
814
NM_002106
Hs.119192
0
7
H2A histone family, member Z (H2AFZ), mRNA/cd

54B1
47
1144
AJ400717
Hs.119252
0
9
TPT1 gene for translationally controlled tumo

594H9
609
1013
NM_000520
Hs.119403
0
1
hexosaminidase A (alpha polypeptide) (HEXA),

492D9
30
272
NM_001004
Hs.119500
1.00E−135
2
ribosomal protein, large P2 (RPLP2), mRNA/cd

59H8
14
1890
NM_016091
Hs.119503
0
12
HSPC025 (HSPC025), mRNA/cds = (33,1727)/gb = N

525E8
12
446
NM_006432
Hs.119529
0
2
epididymal secretory protein (19.5 kD) (HE1),

166G7
1323
2293
M88108
Hs.119537
0
3
p62 mRNA, complete cds/cds = (106,1437)/

gb = M88108/g

112D10
1054
1722
NM_006559
Hs.119537
0
1
GAP-associated tyrosine phosphoprotein p62

158E9
847
1273
AL022326
Hs.119598
0
1
DNA sequence from clone 333H23 on chromosome

22q12.1-1

161H7
738
1272
NM_000967
Hs.119598
0
1
ribosomal protein L3 (RPL3), mRNA/cds = (6,1217

168F8
284
778
M34671
Hs.119663
0
1
lymphocytic antigen CD59/MEM43 mRNA, complete

cds/c

585C9
285
783
NM_000611
Hs.119663
0
1
CD59 antigen p18-20 (antigen identified by mo

143G12
753
1329
AK023975
Hs.119908
0
4
FLJ13913 fis, clone Y79AA1000231, highly

55D12
1107
1365
NM_015934
Hs.119908
1.00E−119
1
nucleolar protein NOP5/NOP58 (NOP5/NOP58), m

467E7
37
419
AI492066
Hs.119923
0
1
tg12b03.x1 cDNA, 3′ end/clone = IMAGE: 2108525

462C10
2669
3025
NM_012318
Hs.120165
0
1
leucine zipper-EF-hand containing transmembr

473F11
396
1006
AK025068
Hs.120170
0
1
cDNA: FLJ21415 fis, clone COL04030/cds = (138,7

98E11
211
458
AW081455
Hs.120219
1.00E−114
2
xc31c07.x1 cDNA, 3′ end/clone = IMAGE: 2585868

471C8
60
301
NM_014487
Hs.120766
1.00E−120
1
nucleolar cysteine-rich protein (HSA6591), m

134C4
284
529
AK000470
Hs.120769
9.00E−98
1
cDNA FLJ20463 fis, clone KAT06143/

cds = UNKNOWN

469C10
1
441
AA677952
Hs.120891
0
1
zi14a06.s1 cDNA, 3′ end/clone = IMAGE: 430738/

60C9
1022
1615
AB011421
Hs.120996
0
1
for DRAK2, complete cds/cds = (261,1379)/

461A7
738
1274
NM_014205
Hs.121025
0
1
chromosome 11 open reading frame 5 (C11ORF5), m

104A4
557
1942
D89974
Hs.121102
0
4
for glycosylphosphatidyl inositol-ancho

196C9
557
1463
NM_004665
Hs.121102
0
9
vanin 2 (VNN2), mRNA/cds = (11,1573)/gb = NM_004

467F4
4
328
AW972196
Hs.121210
1.00E−162
1
EST384285 cDNA/gb = AW972196/gi = 8162042/ug =

587A12
224
367
AW975541
Hs.121572
1.00E−62
1
EST387650 cDNA/gb = AW975541/gi = 8166755/ug =

36G5
13
604
AL008729
Hs.121591
0
1
DNA sequence from PAC 257A7 on chromosome

6p24. Contai

464C1
120
413
AA772692
Hs.121709
1.00E−120
1
ai35b09.s1 cDNA, 3′ end/clone = 1358969/clone

36E2
411
821
AK025556
Hs.121849
0
1
FLJ21903 fis, clone HEP03579/cds = (84,46

196A6
411
1113
NM_022818
Hs.121849
0
1
Microtubule-associated proteins 1A and 1B, I

471G2
176
333
AW469546
Hs.122116
2.00E−64
1
hd19e09.x1 cDNA, 3′ end/clone = IMAGE: 2909992

462F5
218
611
BF677944
Hs.122406
1.00E−166
1
602084766F1 cDNA, 5′ end/clone = IMAGE: 4248905

465A6
376
478
AV762642
Hs.122431
2.00E−28
1
AV762642 cDNA, 5′ end/clone = MDSEMB08/clone_—

467G10
603
803
AL040371
Hs.122487
9.00E−96
1
DKFZp434P0213_r1 cDNA, 5′ end/clone = DKFZp434

465C12
66
260
AI804629
Hs.122848
3.00E−83
1
tc81g03.x1 cDNA, 3′ end/clone = IMAGE: 2072596

98H6
442
591
AI081246
Hs.122983
5.00E−78
1
oy67b06.x1 cDNA, 3′ end/clone = IMAGE: 1670867

52B4
123
236
BE676541
Hs.123254
8.00E−46
1
7f31g03.x1 cDNA, 3′ end/clone = IMAGE: 3296308

128C7
4875
5186
AB020631
Hs.123654
1.00E−131
1
mRNA for KIAA0824 protein, partial cds/cds = (0

184B5
594
1187
AL109865
Hs.124186
0
1
DNA sequence from clone GS1-120K12 on

chromosome 1q25

106A6
1135
1456
AK026776
Hs.124292
9.00E−99
1
FLJ23123 fis, clone LNG08039/cds = UNKNOW

525G12
314
503
BF996704
Hs.124344
1.00E−72
1
MR1-GN0173-071100-009-g10 cDNA/gb = BF996704

466C3
120
496
AA831838
Hs.124391
1.00E−172
1
oc85h06.s1 cDNA, 3′ end/clone = IMAGE: 1356539

48G4
1
568
AA203497
Hs.124601
0
1
zx58g05.r1 cDNA, 5′ end/clone = IMAGE: 446744/

517G2
577
756
AA858297
Hs.124675
3.00E−61
1
ob13b08.s1 cDNA, 3′ end/clone = IMAGE: 1323543

107H3
913
1220
AK023013
Hs.124762
1.00E−174
1
FLJ12951 fis, clone NT2RP2005457, highly

473A7
729
929
NM_019062
Hs.124835
4.00E−82
1
hypothetical protein (FLJ20225), mRNA/cds = (

108D12
3225
3531
AF023142
Hs.125134
1.00E−142
2
pre-mRNA splicing SR protein rA4 mRNA, partial

463E11
158
519
AI380443
Hs.125608
0
1
tg02f04.x1 cDNA, 3′ end/clone = IMAGE: 2107615

104F6
1581
2028
NM_019853
Hs.125682
0
1
protein phosphatase 4 regulatory subunit 2 (P

462A5
5
282
AW975851
Hs.125815
1.00E−149
1
EST387960 cDNA/gb = AW975851/gi = 8167072/ug =

462B1
534
702
AI378032
Hs.125892
1.00E−69
1
te67g08.x1 cDNA, 3′ end/clone = IMAGE: 2091806

121A6
3074
3494
AB028978
Hs.126084
1.00E−174
1
mRNA for KIAA1055 protein, partial cds/cds = (0

171G12
94
1240
M15330
Hs.126256
0
7
interleukin 1-beta (IL1B) mRNA, complete cds/

cds = (86

183D12
100
1275
NM_000576
Hs.126256
0
9
interleukin 1, beta (IL1B), mRNA/cds = (86,895)

458B2
6
415
AI393205
Hs.126265
0
1
tg14b07.x1 cDNA, 3′ end/clone = IMAGE: 2108725

102G6
885
1906
AJ271684
Hs.126355
1.00E−171
2
for myeloid DAP12-associating lectin (MD

463E4
847
1015
NM_013252
Hs.126355
2.00E−89
1
C-type (calcium dependent, carbohydrate-reco

167B2
2468
2721
AF195514
Hs.126550
1.00E−142
1
VPS4-2 ATPase (VPS42) mRNA, complete cds/cds =

473D8
19
397
BF445163
Hs.126594
0
1
nad21d12.x1 cDNA, 3′ end/clone = IMAGE: 3366191

143C9
333
551
BE250027
Hs.126701
1.00E−121
1
600943030F1 cDNA, 5′ end/clone = IMAGE: 2959639

471E10
806
945
AK021519
Hs.126707
2.00E−71
1
cDNA FLJ11457 fis, clone HEMBA1001522/cds = (1

462B4
159
572
NM_017762
Hs.126721
0
1
hypothetical protein FLJ20313 (FLJ20313), mR

41D8
1
2519
AK023275
Hs.126925
0
5
FLJ13213 fis, clone NT2RP4001126, weakly

463F5
2
563
NM_014464
Hs.127011
0
1
tubulointerstitial nephritis antigen (TIN-A

597C8
2662
2905
AB046765
Hs.127270
1.00E−136
1
mRNA for KIAA1545 protein, partial cds/cds = (0

458F11
15
212
BF508731
Hs.127311
8.00E−81
1
UI-H-BI4-aoq-b-08-0-UI.s1 cDNA, 3′ end/clon

462B3
76
389
AW978753
Hs.127327
1.00E−133
1
EST390862 cDNA/gb = AW978753/gi = 8170027/ug =

463E2
176
787
AI028267
Hs.127514
0
1
ow01d06.x1 cDNA, 3′ end/clone = IMAGE: 1645547

465G5
181
372
AA953396
Hs.127557
6.00E−78
1
on63h10.s1 cDNA, 3′ end/clone = IMAGE: 1561411

125B8
999
1573
NM_003733
Hs.118633
0
1
2′-5′oligoadenylate synthetase-like (OASL),

459D3
3
427
AI052447
Hs.118659
0
1
oz07g04.x1 cDNA, 3′ end/clone = IMAGE: 1674678

112F11
191
387
NM_006923
Hs.118684
1.00E−103
1
stromal cell-derived factor 2 (SDF2), mRNA/c

129E4
1727
1891
AL050404
Hs.118695
2.00E−86
1
DNA sequence from clone 955M13 on chromosome

20. Conta

126H2
1512
2209
NM_000358
Hs.118787
0
2
transforming growth factor, beta-induced, 68

598D9
817
1106
NM_001155
Hs.118796
1.00E−108
1
annexin A6 (ANXA6), transcript variant 1, mRN

331E6
89
475
BE311727
Hs.118857
0
1
601143334F1 cDNA, 5′ end/clone = IMAGE: 3507009

521C1
700
1180
NM_006292
Hs.118910
0
2
tumor susceptibility gene 101 (TSG101), mRNA

139E8
463
1198
AJ012506
Hs.118958
0
1
activated in tumor suppression, clone TSA

69H2
578
1117
U05040
Hs.118962
0
1
FUSE binding protein mRNA, complete cds/

cds = (26,1960

461F1
1241
1715
AK024119
Hs.118990
0
1
cDNA FLJ14057 fis, clone HEMBB1000337/cds = UNK

481E1
1682
1969
NM_017544
Hs.119018
1.00E−129
1
transcription factor NRF (NRF), mRNA/cds = (653

479B4
45
203
AL109806
Hs.119057
5.00E−43
1
DNA sequence from clone RP5-1153D9 on

chromosome 20 C

520F1
177
672
NM_012423
Hs.119122
1.00E−148
8
ribosomal protein L13a (RPL13A), mRNA/cds = (1

477E4
46
1565
AL109786
Hs.119155
0
3
mRNA full length insert cDNA clone EUROIMAGE 81

166F10
304
814
M37583
Hs.119192
0
3
histone (H2A.Z) mRNA, complete cds/cds = (106,492)/g

592E5
302
814
NM_002106
Hs.119192
0
7
H2A histone family, member Z (H2AFZ), mRNA/cd

54B1
47
1144
AJ400717
Hs.119252
0
9
TPT1 gene for translationally controlled tumo

594H9
609
1013
NM_000520
Hs.119403
0
1
hexosaminidase A (alpha polypeptide) (HEXA),

492D9
30
272
NM_001004
Hs.119500
1.00E−135
2
ribosomal protein, large P2 (RPLP2), mRNA/cd

59H8
14
1890
NM_016091
Hs.119503
0
12
HSPC025 (HSPC025), mRNA/cds = (33,1727)/gb = N

525E8
12
446
NM_006432
Hs.119529
0
2
epididymal secretory protein (19.5 kD) (HE1),

166G7
1323
2293
M88108
Hs.119537
0
3
p62 mRNA, complete cds/cds = (106,1437)/

gb = M88108/g

112D10
1054
1722
NM_006559
Hs.119537
0
1
GAP-associated tyrosine phosphoprotein p62

158E9
847
1273
AL022326
Hs.119598
0
1
DNA sequence from clone 333H23 on chromosome

22q12.1-1

161H7
738
1272
NM_000967
Hs.119598
0
1
ribosomal protein L3 (RPL3), mRNA/cds = (6,1217

168F8
284
778
M34671
Hs.119663
0
1
lymphocytic antigen CD59/MEM43 mRNA, complete

cds/c

585C9
285
783
NM_000611
Hs.119663
0
1
CD59 antigen p18-20 (antigen identified by mo

143G12
753
1329
AK023975
Hs.119908
0
4
FLJ13913 fis, clone Y79AA1000231, highly

55D12
1107
1365
NM_015934
Hs.119908
1.00E−119
1
nucleolar protein NOP5/NOP58 (NOP5/NOP58), m

467E7
37
419
AI492066
Hs.119923
0
1
tg12b03.x1 cDNA, 3′ end/clone = IMAGE: 2108525

462C10
2669
3025
NM_012318
Hs.120165
0
1
leucine zipper-EF-hand containing transmembr

473F11
396
1006
AK025068
Hs.120170
0
1
cDNA: FLJ21415 fis, clone COL04030/cds = (138,7

98E11
211
458
AW081455
Hs.120219
1.00E−114
2
xc31c07.x1 cDNA, 3′ end/clone = IMAGE: 2585868

471C8
60
301
NM_014487
Hs.120766
1.00E−120
1
nucleolar cysteine-rich protein (HSA6591), m

134C4
284
529
AK000470
Hs.120769
9.00E−98
1
cDNA FLJ20463 fis, clone KAT06143/

cds = UNKNOWN

469C10
1
441
AA677952
Hs.120891
0
1
zi14a06.s1 cDNA, 3′ end/clone = IMAGE: 430738/

60C9
1022
1615
AB011421
Hs.120996
0
1
for DRAK2, complete cds/cds = (261,1379)/

461A7
738
1274
NM_014205
Hs.121025
0
1
chromosome 11 open reading frame 5 (C11ORF5), m

104A4
557
1942
D89974
Hs.121102
0
4
for glycosylphosphatidyl inositol-ancho

196C9
557
1463
NM_004665
Hs.121102
0
9
vanin 2 (VNN2), mRNA/cds = (11,1573)/gb = NM_004

467F4
4
328
AW972196
Hs.121210
1.00E−162
1
EST384285 cDNA/gb = AW972196/gi = 8162042/ug =

587A12
224
367
AW975541
Hs.121572
1.00E−62
1
EST387650 cDNA/gb = AW975541/gi = 8166755/ug =

36G5
13
604
AL008729
Hs.121591
0
1
DNA sequence from PAC 257A7 on chromosome

6p24. Contai

464C1
120
413
AA772692
Hs.121709
1.00E−120
1
ai35b09.s1 cDNA, 3′ end/clone = 1358969/clone

36E2
411
821
AK025556
Hs.121849
0
1
FLJ21903 fis, clone HEP03579/cds = (84,46

196A6
411
1113
NM_022818
Hs.121849
0
1
Microtubule-associated proteins 1A and 1B, I

471G2
176
333
AW469546
Hs.122116
2.00E−64
1
hd19e09.x1 cDNA, 3′ end/clone = IMAGE: 2909992

462F5
218
611
BF677944
Hs.122406
1.00E−166
1
602084766F1 cDNA, 5′ end/clone = IMAGE: 4248905

465A6
376
478
AV762642
Hs.122431
2.00E−28
1
AV762642 cDNA, 5′ end/clone = MDSEMB08/clone_—

467G10
603
803
AL040371
Hs.122487
9.00E−96
1
DKFZp434P0213_r1 cDNA, 5′ end/clone = DKFZp434

465C12
66
260
AI804629
Hs.122848
3.00E−83
1
tc81g03.x1 cDNA, 3′ end/clone = IMAGE: 2072596

98H6
442
591
AI081246
Hs.122983
5.00E−78
1
oy67b06.x1 cDNA, 3′ end/clone = IMAGE: 1670867

52B4
123
236
BE676541
Hs.123254
8.00E−46
1
7f31g03.x1 cDNA, 3′ end/clone = IMAGE: 3296308

128C7
4875
5186
AB020631
Hs.123654
1.00E−131
1
mRNA for KIAA0824 protein, partial cds/cds = (0

184B5
594
1187
AL109865
Hs.124186
0
1
DNA sequence from clone GS1-120K12 on

chromosome 1q25

106A6
1135
1456
AK026776
Hs.124292
9.00E−99
1
FLJ23123 fis, clone LNG08039/cds = UNKNOW

525G12
314
503
BF996704
Hs.124344
1.00E−72
1
MR1-GN0173-071100-009-g10 cDNA/gb = BF996704

466C3
120
496
AA831838
Hs.124391
1.00E−172
1
oc85h06.s1 cDNA, 3′ end/clone = IMAGE: 1356539

48G4
1
568
AA203497
Hs.124601
0
1
zx58g05.r1 cDNA, 5′ end/clone = IMAGE: 446744/

517G2
577
756
AA858297
Hs.124675
3.00E−61
1
ob13b08.s1 cDNA, 3′ end/clone = IMAGE: 1323543

107H3
913
1220
AK023013
Hs.124762
1.00E−174
1
FLJ12951 fis, clone NT2RP2005457, highly

473A7
729
929
NM_019062
Hs.124835
4.00E−82
1
hypothetical protein (FLJ20225), mRNA/cds = (

108D12
3225
3531
AF023142
Hs.125134
1.00E−142
2
pre-mRNA splicing SR protein rA4 mRNA, partial

463E11
158
519
AI380443
Hs.125608
0
1
tg02f04.x1 cDNA, 3′ end/clone = IMAGE: 2107615

104F6
1581
2028
NM_019853
Hs.125682
0
1
protein phosphatase 4 regulatory subunit 2 (P

462A5
5
282
AW975851
Hs.125815
1.00E−149
1
EST387960 cDNA/gb = AW975851/gi = 8167072/ug =

462B1
534
702
AI378032
Hs.125892
1.00E−69
1
te67g08.x1 cDNA, 3′ end/clone = IMAGE: 2091806

121A6
3074
3494
AB028978
Hs.126084
1.00E−174
1
mRNA for KIAA1055 protein, partial cds/cds = (0

171G12
94
1240
M15330
Hs.126256
0
7
interleukin 1-beta (IL1B) mRNA, complete cds/

cds = (86

183D12
100
1275
NM_000576
Hs.126256
0
9
interleukin 1, beta (IL1B), mRNA/cds = (86,895)

458B2
6
415
AI393205
Hs.126265
0
1
tg14b07.x1 cDNA, 3′ end/clone = IMAGE: 2108725

102G6
885
1906
AJ271684
Hs.126355
1.00E−171
2
for myeloid DAP12-associating lectin (MD

463E4
847
1015
NM_013252
Hs.126355
2.00E−89
1
C-type (calcium dependent, carbohydrate-reco

167B2
2468
2721
AF195514
Hs.126550
1.00E−142
1
VPS4-2 ATPase (VPS42) mRNA, complete cds/cds =

473D8
19
397
BF445163
Hs.126594
0
1
nad21d12.x1 cDNA, 3′ end/clone = IMAGE: 3366191

143C9
333
551
BE250027
Hs.126701
1.00E−121
1
600943030F1 cDNA, 5′ end/clone = IMAGE: 2959639

471E10
806
945
AK021519
Hs.126707
2.00E−71
1
cDNA FLJ11457 fis, clone HEMBA1001522/cds = (1

462B4
159
572
NM_017762
Hs.126721
0
1
hypothetical protein FLJ20313 (FLJ20313), mR

41D8
1
2519
AK023275
Hs.126925
0
5
FLJ13213 fis, clone NT2RP4001126, weakly

463F5
2
563
NM_014464
Hs.127011
0
1
tubulointerstitial nephritis antigen (TIN-A

597C8
2662
2905
AB046765
Hs.127270
1.00E−136
1
mRNA for KIAA1545 protein, partial cds/cds = (0

458F11
15
212
BF508731
Hs.127311
8.00E−81
1
UI-H-BI4-aoq-b-08-0-UI.s1 cDNA, 3′ end/clon

462B3
76
389
AW978753
Hs.127327
1.00E−133
1
EST390862 cDNA/gb = AW978753/gi = 8170027/ug =

463E2
176
787
AI028267
Hs.127514
0
1
ow01d06.x1 cDNA, 3′ end/clone = IMAGE: 1645547

465G5
181
372
AA953396
Hs.127557
6.00E−78
1
on63h10.s1 cDNA, 3′ end/clone = IMAGE: 1561411

463E10
11190
11634
NM_016239
Hs.127561
0
1
unconventional myosin-15 (LOC51168), mRNA/c

476A9
27
216
AW384918
Hs.127574
1.00E−101
1
PM1-HT0422-291299-002-d01 cDNA/gb = AW384918

111B10
1825
2463
NM_014007
Hs.127649
0
1
KIAA0414 protein (KIAA0414), mRNA/cds = (1132,

499A7
2134
5198
AF070674
Hs.127799
0
8
inhibitor of apoptosis protein-1 (MIHC) mRNA,

331F5
4
460
BF342439
Hs.127863
0
1
602013944F1 cDNA, 5′ end/clone = IMAGE: 4149562

176A12
796
1351
NM_022900
Hs.128003
0
1
hypothetical protein FLJ21213 (FLJ21213), mR

462B5
1766
1949
NM_014406
Hs.128342
5.00E−82
1
potassium large conductance calcium-activate

467D5
157
279
AI222805
Hs.128630
6.00E−62
1
qp39c07.x1 cDNA, 3′ end/clone = IMAGE: 1925388

465G3
1
529
BE222032
Hs.128675
0
1
hr61g11.x1 cDNA, 3′ end/clone = IMAGE: 3133028

467C7
1172
1726
AF118274
Hs.128740
0
1
DNb-5 mRNA, partial cds/cds = (0,1601)/gb = AF11

175G11
358
724
AL110151
Hs.128797
0
1
mRNA; cDNA DKFZp586D0824 (from clone

DKFZp586

472A12
402
782
BE745645
Hs.129135
1.00E−153
1
601578727F1 cDNA, 5′ end/clone = IMAGE: 3927535

473C7
46
217
BE670584
Hs.129192
3.00E−37
1
7e36h08.x1 cDNA, 3′ end/clone = IMAGE: 3284607

463G11
7
397
AA746320
Hs.129572
0
1
ob08f01.s1 cDNA, 3′ end/clone = IMAGE: 1323097

63D8
18
1167
D13748
Hs.129673
0
4
eukaryotic initiation factor 4AI/cds = (16,12

57F3
19
1279
NM_001416
Hs.129673
0
4
eukaryotic translation initiation factor 4A,

144G5
1071
1192
AF064090
Hs.129708
3.00E−62
3
ligand for herpesvirus entry mediator (HVEM-L)

118A9
2684
3198
AB046805
Hs.129750
0
1
mRNA for KIAA1585 protein, partial cds/cds = (2

50G5
1119
1440
AK024068
Hs.129872
1.00E−172
1
FLJ14006 fis, clone Y79AA1002399, highly

469D6
376
603
D43968
Hs.129914
1.00E−126
1
AML1 mRNA for AML1b protein (alternatively spliced

pr

590G11
823
1571
NM_003563
Hs.129951
0
3
speckle-type POZ protein (SPOP), mRNA/cds = (15

591C7
68
571
NM_005243
Hs.129953
0
1
Ewing sarcoma breakpoint region 1 (EWSR1), tra

459F5
579
768
AI763262
Hs.130059
1.00E−35
1
wi66c04.x1 cDNA, 3′ end/clone = IMAGE: 2398278

479A10
259
448
AI089359
Hs.130232
1.00E−103
1
qb05h03.x1 cDNA, 3′ end/clone = IMAGE: 1695413

461G5
193
347
AW898615
Hs.130729
2.00E−68
1
RC1-NN0073-090500-012-f02 cDNA/gb = AW898615

466B1
373
569
AI347054
Hs.130879
1.00E−76
1
qp60a04.x1 cDNA, 3′ end/clone = IMAGE: 1927374

463G3
3212
5430
AJ404611
Hs.130881
0
2
mRNA for B-cell lymphoma/leukaemia 11A extra

462C3
48
468
AI421806
Hs.131067
0
1
tf44h11.x1 cDNA, 3′ end/clone = IMAGE: 2099109

596G10
39
491
NM_006294
Hs.131255
0
3
ubiquinol-cytochrome c reductase binding pro

469G10
189
361
AI024984
Hs.131580
1.00E−81
1
ov39d11.x1 cDNA, 3′ end/clone = IMAGE: 1639701

458B7
169
659
AW978870
Hs.131828
0
1
EST390979 cDNA/gb = AW978870/gi = 8170147/ug =

63D1
185
500
AF176706
Hs.131859
1.00E−133
1
F-box protein FBX11 mRNA, partial cds/cds = (0,

58C10
4188
4313
NM_014913
Hs.131915
2.00E−65
1
KIAA0863 protein (KIAA0863), mRNA/cds = (185,3

117H2
282
569
NM_003608
Hs.131924
1.00E−143
1
G protein-coupled receptor 65 (GPR65), mRNA/

462D11
441
683
AW976422
Hs.132064
1.00E−118
1
EST388531 cDNA/gb = AW976422/gi = 8167649/ug =

586F11
161
1094
NM_017830
Hs.132071
0
2
hypothetical protein FLJ20455 (FLJ20455), mR

466A8
118
224
AI042377
Hs.132156
2.00E−44
1
ox62c03.x1 cDNA, 3′ end/clone = IMAGE: 1660900

472F6
979
1431
AK022463
Hs.132221
0
1
cDNA FLJ12401 fis, clone MAMMA 1002796/cds = (3,

462E4
19
567
AI031656
Hs.132237
0
1
ow48e06.x1 cDNA, 3′ end/clone = IMAGE: 1650082

462E2
4
539
AI829569
Hs.132238
0
1
wf28e02.x1 cDNA, 3′ end/clone = IMAGE: 2356922

461H9
453
618
BG037042
Hs.132555
4.00E−57
1
602288311F1 cDNA, 5′ end/clone = IMAGE: 4374122

467D10
4518
4689
AK024449
Hs.132569
2.00E−55
1
mRNA for FLJ00041 protein, partial cds/cds = (0

463H7
162
438
AI346336
Hs.132594
1.00E−132
1
qp50b04.x1 cDNA, 3′ end/clone = IMAGE: 1926415

592B8
2415
2957
NM_005337
Hs.132834
0
1
hematopoietic protein 1 (HEM1), mRNA/cds = (158

70H2
6370
6718
AF047033
Hs.132904
1.00E−175
1
sodium bicarbonate cotransporter 3 (SLC4A7) m

50G10
1167
2041
AL121985
Hs.132906
0
4
DNA sequence from clone RP11-404F10 on

chromosome 1q2

123C10
1323
1570
NM_015071
Hs.132942
1.00E−136
1
GTPase regulator associated with the focal adh

121B10
92
503
AA504269
Hs.133032
0
1
aa61c09.s1 cDNA, 3′ end/clone = IMAGE: 825424/

171A12
696
909
AL050035
Hs.133130
6.00E−83
1
mRNA; cDNA DKFZp566H0124 (from clone

DKFZp566

463B5
123
449
AI051673
Hs.133175
1.00E−176
1
oy77g06.x1 cDNA, 3′ end/clone = IMAGE: 1671898

463B7
966
1103
AL044498
Hs.133262
3.00E−46
1
DKFZp4341082_s1 cDNA, 3′ end/clone = DKFZp4341

463B8
1
322
AV661783
Hs.133333
1.00E−176
1
AV661783 cDNA, 3′ end/clone = GLCGXE12/clone_—

463A10
431
694
AW966876
Hs.133543
1.00E−110
1
EST378950 cDNA/gb = AW966876/gi = 8156712/ug =

464B10
63
547
BF965766
Hs.133864
0
1
602276890F1 cDNA, 5′ end/clone = IMAGE: 4364495

460C6
454
653
AW009671
Hs.134272
8.00E−70
1
ws85g09.x1 cDNA, 3′ end/clone = IMAGE: 2504800

459C12
3337
3745
AJ278245
Hs.134342
1.00E−121
1
mRNA for LanC-like protein 2 (lancl2 gene)/cds

462G1
33
454
AI074016
Hs.134473
0
1
oy66g02.x1 cDNA, 3′ end/clone = IMAGE: 1670834

462G6
260
597
BE676210
Hs.134648
1.00E−156
1
7f25c05.x1 cDNA, 3′ end/clone = IMAGE: 3295688

466H12
505
662
AV706481
Hs.134829
3.00E−65
1
AV706481 cDNA, 5′ end/clone = ADBBYF02

148H11
16
474
BE786820
Hs.135056
0
1
601477630F1 5′ end/clone = IMAGE: 3880471

462E1
139
487
BF109873
Hs.135106
0
1
7170e11.x1 cDNA, 3′ end/clone = IMAGE: 3526772

147E6
11
364
AV712376
Hs.135167
0
2
AV712376 cDNA, 5′ end/clone = DCAAND12/clone_—

465B4
1993
2237
AJ271326
Hs.135187
1.00E−92
1
mRNA for unc-93 related protein (UNC93 gene)/

463B4
185
352
AI051664
Hs.135339
4.00E−48
1
oy77f06.x1 cDNA, 3′ end/clone = IMAGE: 1671875

478H4
2126
2458
AK024921
Hs.135570
1.00E−170
1
cDNA: FLJ21268 fis, clone COL01718/cds = UNKNOW

148B6
119
444
AI004582
Hs.135764
3.00E−82
8
ou04a11.x1 3′ end/clone = IMAGE: 1625276

598E9
1948
2184
NM_022117
Hs.136164
3.00E−93
1
cutaneous T-cell lymphoma-associated tumor a

514C10
398
840
AL049597
Hs.136309
0
2
DNA sequence from clone RP4-612B15 on

chromosome 1p22

461C6
18
219
BF513274
Hs.136375
1.00E−101
1
UI-H-BW1-amo-d-11-0-UI.s1 cDNA, 3′ end/clon

482E4
291
699
BF526066
Hs.136537
1.00E−142
1
602071176F1 cDNA, 5′ end/clone = IMAGE: 4214059

461G7
43
466
NM_013378
Hs.136713
0
1
pre-B lymphocyte gene 3 (VPREB3), mRNA/cds = (4

119B10
10
677
NM_013269
Hs.136748
0
2
lectin-like NK cell receptor (LLT1), mRNA/cd

462A10
1233
1727
AK024426
Hs.137354
0
1
mRNA for FLJ00015 protein, partial cds/cds = (3

41F2
2684
3000
AJ223324
Hs.137548
1.00E−156
1
for MAX.3 cell surface antigen/cds = (44,10

74E8
16
2000
D10923
Hs.137555
0
15
HM74/cds = (60,1223)/gb = D10923/gi = 219866/

58D10
8
2000
NM_006018
Hs.137555
0
9
putative chemokine receptor; GTP-binding pro

120E2
210
814
NM_002027
Hs.138381
0
1
farnesyltransferase, CAAX box, alpha (FNTA),

168E12
1953
2522
D38524
Hs.138593
0
1
5′-nucleotidase/cds = (83,1768)/gb = D38524

178F7
573
824
NM_006413
Hs.139120
1.00E−115
1
ribonuclease P (30 kD) (RPP30), mRNA/cds = (27,8

473D1
1635
1767
AL049942
Hs.139240
6.00E−50
1
mRNA; cDNA DKFZp564F1422 (from clone

DKFZp564F

188A8
924
1038
NM_017523
Hs.139262
1.00E−56
2
XIAP associated factor-1 (HSXIAPAF1), mRNA/c

168F7
933
1038
X99699
Hs.139262
1.00E−53
1
for XIAP associated factor-1/cds = (0,953)/

181B10
1556
2517
NM_005816
Hs.142023
0
3
T cell activation, increased late expression (

514E7
2052
2339
NM_003150
Hs.142258
1.00E−114
1
signal transducer and activator of transcripti

196C7
355
524
NM_016123
Hs.142295
9.00E−92
1
putative protein kinase NY-REN-64 antigen (LO

585B10
3261
3465
AK023129
Hs.142442
1.00E−100
1
cDNA FLJ13067 fis, clone NT2RP3001712, highly

458F2
283
413
BE293343
Hs.142737
3.00E−68
1
601143756F1 cDNA, 5′ end/clone = IMAGE: 3051493

134C6
289
572
BE886127
Hs.142838
1.00E−160
1
601509912F1 cDNA, 5′ end/clone = IMAGE: 3911451

110A11
345
584
AI126688
Hs.143049
1.00E−102
1
qb94a06.x1 cDNA, 3′ end/clone = IMAGE: 1707730

472G7
127
452
AW976331
Hs.143254
0
1
EST388440 cDNA/gb = AW976331/gi = 8167557/ug =

464G11
425
547
AI357640
Hs.143314
1.00E−56
1
qy15b06.x1 cDNA, 3′ end/clone = IMAGE: 2012051

463F11
257
640
BF446017
Hs.143389
0
1
7p18a11.x1 cDNA, 3′ end/clone = IMAGE: 3646004

463H2
107
443
AA825245
Hs.143410
1.00E−151
1
oe59g09.s1 cDNA, 3′ end/clone = IMAGE: 1415968

48B7
1
3366
NM_005813
Hs.143460
0
2
protein kinase C, nu (PRKCN), mRNA/cds = (555,32

463C9
290
405
AW173163
Hs.143525
5.00E−41
1
xj84b08.x1 cDNA, 3′ end/clone = IMAGE: 2663895

463C8
330
473
AI095189
Hs.143534
5.00E−57
2
oy83b06.s1 cDNA, 3′ end/clone = IMAGE: 1672403

464G5
94
189
BG033028
Hs.143554
1.00E−38
1
602300135F1 cDNA, 5′ end/clone = IMAGE: 4401776

463D7
120
563
NM_006777
Hs.143604
0
1
Kaiso (ZNF-kaiso), mRNA/cds = (0,2018)/gb = NM

471A10
132
586
AK026372
Hs.143631
0
1
cDNA: FLJ22719 fis, clone HSI14307/cds = UNKNOW

74G2
5129
5285
AF073310
Hs.143648
2.00E−79
2
insulin receptor substrate-2 (IRS2) mRNA, com

471G11
7
320
AI568622
Hs.143951
1.00E−154
2
tn41e10.x1 cDNA, 3′ end/clone = IMAGE: 2170218

478H12
963
1532
NM_018270
Hs.143954
0
1
hypothetical protein FLJ10914 (FLJ10914), mR

462G3
100
529
AI074020
Hs.144114
0
1
oy66g06.x1 cDNA, 3′ end/clone = IMAGE: 1670842

463C1
52
151
AI090305
Hs.144119
1.00E−42
1
oy81b01.s1 cDNA, 3′ end/clone = IMAGE: 1672201

472H8
157
485
BF509758
Hs.144265
1.00E−178
1
UI-H-B14-apg-d-04-0-UI.s1 cDNA, 3′ end/clon

166E1
23
443
D63874
Hs.144321
0
1
HMG-1, complete cds/cds = (76,723)/gb = D63874

145G8
125
1606
NM_018548
Hs.144477
0
2
hypothetical protein PRO2975 (PRO2975), mRNA

191H8
46
624
BF036686
Hs.144559
0
1
601459771F1 cDNA, 5′ end/clone = IMAGE: 3863248

151B1
1983
2561
M93651
Hs.145279
0
2
set gene, complete cds/cds = (3,836)/gb = M93651/

gi = 33

514B2
115
1583
NM_003011
Hs.145279
0
4
SET translocation (myeloid leukemia-associat

596D4
89
734
AA631938
Hs.145668
0
8
fmfc5 cDNA/clone = CR6-21/gb = AA631938/gi = 25

492B3
512
2226
NM_004902
Hs.145696
0
2
splicing factor (CC1.3) (CC1.3), mRNA/cds = (14

192E4
1483
1837
AF246126
Hs.145956
0
1
zinc finger protein mRNA, complete cds/cds = (1

480B9
1094
1426
AL136874
Hs.146037
1.00E−111
1
mRNA; cDNA DKFZp434C135 (from clone

DKFZp434C1

49H1
1761
2182
NM_022894
Hs.146123
0
1
hypothetical protein FLJ12972 (FLJ12972), mR

129C6
517
603
BE220959
Hs.146215
6.00E−21
1
hu02b06.x1 cDNA, 3′ end/clone = IMAGE: 3165395

583D9
249
646
NM_003641
Hs.146360
0
1
interferon induced transmembrane protein 1 (

589D9
125
1866
NM_002139
Hs.146381
0
5
RNA binding motif protein, X chromosome (RBMX)

68H11
122
1567
Z23064
Hs.146381
0
2
mRNA gene for hnRNP G protein/cds = (11,1186)/gb =

174A8
461
1008
NM_004757
Hs.146401
0
1
small inducible cytokine subfamily E, member 1

171A6
461
686
U10117
Hs.146401
1.00E−100
1
endothelial-monocyte activating polypeptide II mRN

465C4
53
342
AI141004
Hs.146627
3.00E−89
1
oy68f02.x1 cDNA, 3′ end/clone = IMAGE: 1671003

190H7
1306
3107
AB033079
Hs.146668
0
3
mRNA for KIAA1253 protein, partial cds/cds = (0

102E9
412
1022
AF054187
Hs.146763
0
3
alpha NAC mRNA, complete cds/cds = (309,956)/g

179B1
364
843
D16481
Hs.146812
0
1
mitochondrial 3-ketoacyl-CoA thiolas

126H12
1
358
NM_000183
Hs.146812
0
1
hydroxyacyl-Coenzyme A dehydrogenase/3-keto

476C9
20
249
AI187423
Hs.147040
1.00E−128
2
qf31d04.x1 cDNA, 3′ end/clone = IMAGE: 1751623

70H11
47
1593
AF272148
Hs.147644
0
7
KRAB zinc finger protein (RITA) mRNA, complete

51F1
635
1039
NM_018555
Hs.147644
0
3
C2H2-like zinc finger protein (ZNF361), mRNA

72H1
948
5026
AF000982
Hs.147916
0
7
dead box, X isoform (DBX) mRNA, alternative tra

37F10
3128
3652
X63563
Hs.148027
0
1
RNA polymerase II 140 kDa/cds = (43,3567)

64C11
163
279
AA908367
Hs.148288
6.00E−29
1
og76c11.s1 cDNA, 3′ end/clone = IMAGE: 1454228

463G2
52
473
AI335004
Hs.148558
0
1
tb21e09.x1 cDNA, 3′ end/clone = IMAGE: 2055016

471F8
17
463
AI471866
Hs.149095
0
1
ti67d04.x1 cDNA, 3′ end/clone = IMAGE: 2137063

169C12
449
1711
L06132
Hs.149155
0
2
voltage-dependent anion channel isoform 1 (VDAC)

mRN

189G6
1353
1711
NM_003374
Hs.149155
0
5
voltage-dependent anion channel 1 (VDAC1), mR

481E3
501
669
NM_007022
Hs.149443
5.00E−84
1
putative tumor suppressor (101F6), mRNA/cds =

472B3
93
182
BF029894
Hs.149595
6.00E−44
1
601557056F1 cDNA, 5′ end/clone = IMAGE: 3827172

173D1
3719
3877
AB037901
Hs.149918
3.00E−83
1
GASC-1 mRNA, complete cds/cds = (150,3320)/gb

153G12
1429
1787
M31627
Hs.149923
0
2
X box binding protein-1 (XBP-1) mRNA, complete cds/cd

116B10
1435
1787
NM_005080
Hs.149923
1.00E−180
1
X-box binding protein 1 (XBP1), mRNA/cds = (12,7

111G4
480
1891
L12052
Hs.150395
0
2
cAMP phosphodiesterase PDE7 (PDE7A1) mRNA, co

461D6
1407
1904
NM_000790
Hs.150403
0
1
dopa decarboxylase (aromatic L-amino acid dec

73B3
896
1779
AL050005
Hs.150580
0
23
cDNA DKFZp564A153 (from clone DKFZp564A1

465G12
1
549
AJ272212
Hs.150601
0
1
mRNA for protein serine kinase (PSKH1 gene)/c

140G12
2
195
BF028489
Hs.150675
1.00E−100
1
601763692F1 cDNA, 5′ end/clone = IMAGE: 3995950

496E10
17
1686
BC000167
Hs.151001
0
5
clone IMAGE: 2900671, mRNA, partial cds/cds =

597G7
623
1488
NM_005015
Hs.151134
0
2
oxidase (cytochrome c) assembly 1-like (OXA1L

50C9
1051
1467
X80695
Hs.151134
0
1
OXA1Hs mRNA/cds = (6,1313)/gb = X80695/

gi = 619490

125H7
3154
3957
NM_001421
Hs.151139
0
3
E74-like factor 4 (ets domain transcription fa

111F2
306
638
BG286500
Hs.151239
1.00E−149
1
602382992F1 cDNA, 5′ end/clone = IMAGE: 4500527

177A4
9686
10035
AF075587
Hs.151411
0
1
protein associated with Myc mRNA, complete cds

185C7
6934
13968
NM_015057
Hs.151411
0
3
KIAA0916 protein (KIAA0916), mRNA/cds = (146,1

115E7
3406
4005
NM_004124
Hs.151413
0
1
glia maturation factor, beta (GMFB), mRNA/cds

182H7
234
833
AF099032
Hs.151461
0
1
embryonic ectoderm development protein short

169C10
4247
4727
U38847
Hs.151518
0
1
TAR RNA loop binding protein (TRP-185) mRNA,

complete

167D6
1013
1197
NM_002870
Hs.151536
6.00E−83
1
RAB13, member RAS oncogene family (RAB13), mRN

588G11
1249
1898
AK023362
Hs.151604
1.00E−157
9
cDNA FLJ13300 fis, clone OVARC1001342, highly

479G10
1
277
NM_007210
Hs.151678
1.00E−103
1
UDP-N-acetyl-alpha-D-galactosamine: polype

178B7
2664
3033
NM_004247
Hs.151787
0
4
U5 snRNP-specific protein, 116 kD (U5-116 KD),

59A6
382
860
D42054
Hs.151791
0
1
KIAA0092 gene, complete cds/cds = (53,1477)/

521B6
2017
2205
NM_014679
Hs.151791
2.00E−93
1
KIAA0092 gene product (KIAA0092), mRNA/cds = (

59C10
37
697
AF070525
Hs.151903
0
5
clone 24706 mRNA sequence/cds = UNKNOWN/

gb = AF

519A7
165
686
NM_005792
Hs.152720
0
1
M-phase phosphoprotein 6 (MPHOSPH6), mRNA/c

481E11
3990
4280
NM_005154
Hs.152818
1.00E−135
1
ubiquitin specific protease 8 (USP8), mRNA/cd

110F2
1210
1841
L25931
Hs.152931
0
2
lamin B receptor (LBR) mRNA, complete cds/

cds = (75,192

516F8
1217
1708
NM_002296
Hs.152931
0
1
lamin B receptor (LBR), mRNA/cds = (75,1922)/g

462B2
93
2385
AF244129
Hs.153042
0
2
cell-surface molecule Ly-9 mRNA, complete cds

41F4
617
905
X14046
Hs.153053
1.00E−162
1
leukocyte antigen CD37/cds = (63,908)/gb = X14

462G8
2312
2843
AF311312
Hs.153057
0
1
infertility-related sperm protein mRNA, comp

142H5
17
221
M94856
Hs.153179
1.00E−92
1
fatty acid binding protein homologue (PA-FABP)

mRNA,

486G9
3
431
NM_001444
Hs.153179
0
1
fatty acid binding protein 5 (psoriasis-associ

40A1
2158
2716
X79201
Hs.153221
0
1
SYT/cds = (3,1178)/gb = X79201/gi = 531105

101D9
1524
2060
AB014601
Hs.153293
0
1
for KIAA0701 protein, partial cds/cds = (0

460F10
1457
6107
AB032972
Hs.153489
0
2
mRNA for KIAA1146 protein, partial cds/cds = (0

106A5
445
547
AI761622
Hs.153523
2.00E−37
1
wg66f05.x1 cDNA, 3′ end/clone = IMAGE: 2370081

482A6
49
369
AI859076
Hs.153551
1.00E−106
1
wl33b04.x1 cDNA, 3′ end/clone = IMAGE: 2426671

589B2
1054
1556
AF261091
Hs.153612
0
1
iron inhibited ABC transporter 2 mRNA, complet

57A3
1586
1757
NM_004073
Hs.153640
9.00E−87
1
cytokine-inducible kinase (CNK), mRNA/cds = (3

466H3
2
257
NM_003866
Hs.153687
1.00E−133
1
inositol polyphosphate-4-phosphatase, type

483B6
3337
3544
NM_002526
Hs.153952
2.00E−72
1
5′ nucleotidase (CD73) (NT5), mRNA/cds = (49,17

41F1
2749
3371
X55740
Hs.153952
0
1
placental cDNA coding for 5′ nucleotidase (EC 3.1.3.5)

44C3
1319
1574
X82206
Hs.153961
1.00E−130
1
alpha-centractin/cds = (66,1196)/gb = X8

64F12
2578
2713
NM_022790
Hs.154057
1.00E−26
1
matrix metalloproteinase 19 (MMP19), transcri

72E11
1886
2717
U38320
Hs.154057
0
15
clone rasi-3 matrix metalloproteinase RASI-1

165H12
414
663
AW970676
Hs.154172
2.00E−22
1
EST382759 cDNA/gb = AW970676/gi = 8160521/ug =

37A4
1151
2746
M31210
Hs.154210
0
2
endothelial differentiation protein (edg-1) gene mR

597F4
1125
2395
NM_001400
Hs.154210
0
11
endothelial differentiation, sphingolipid G

106F2
24
1657
U22897
Hs.154230
0
2
nuclear domain 10 protein (ndp52) mRNA, comple

466E2
116
373
AB023149
Hs.154296
1.00E−131
2
mRNA for KIAA0932 protein, partial cds/cds = (0

107F11
1386
1743
AL117566
Hs.154320
0
1
cDNA DKFZp566J164 (from clone DKFZp566J1

166E12
4490
4894
D86967
Hs.154332
0
1
KIAA0212 gene, complete cds/cds = (58,2031)/

188D12
5148
5666
NM_014674
Hs.154332
0
2
KIAA0212 gene product (KIAA0212), mRNA/cds = (

66A1
88
615
M82882
Hs.154365
0
1
cis-acting sequence/cds = UNKNOWN/gb = M82882/

gi = 180

37C1
4320
4776
AB028999
Hs.154525
0
1
for KIAA1076 protein, partial cds/cds = (0

98D2
2317
4907
NM_000104
Hs.154654
0
6
cytochrome P450, subfamily I (dioxin-inducibl

37C4
4445
4907
U03688
Hs.154654
0
3
dioxin-inducible cytochrome P450 (CYP1B1) mRNA,

comp

464A5
1418
2027
NM_006636
Hs.154672
0
3
methylene tetrahydrofolate dehydrogenase (N

36C5
615
1689
X16396
Hs.154672
0
7
NAD-dependent methylene tetrahydrofolate d

67C8
1
397
U85773
Hs.154695
0
1
phosphomannomutase (PMM2) mRNA, complete cds/

cds = (

525D3
2084
2533
NM_002651
Hs.154846
0
1
phosphatidylinositol 4-kinase, catalytic, b

109A7
1979
3148
D10040
Hs.154890
0
2
for long-chain acyl-CoA synthetase, compl

167F6
1817
3359
NM_021122
Hs.154890
0
8
fatty-acid-Coenzyme A ligase, long-chain 2 (

182A1
344
793
NM_021825
Hs.154938
0
1
hypothetical protein MDS025 (MDS025), mRNA/

104E2
1254
1762
D87450
Hs.154978
0
1
KIAA0261 gene, partial cds/cds = (0,3865)/gb

519G10
4912
5303
NM_003489
Hs.155017
0
1
nuclear receptor interacting protein 1 (NRIP1

595C6
4067
4631
NM_006526
Hs.155040
0
2
zinc finger protein 217 (ZNF217), mRNA/cds = (2

105D4
1768
2418
L42373
Hs.155079
0
1
phosphatase 2A B56-alpha (PP2A) mRNA, complete

174B7
1768
2320
NM_006243
Hs.155079
0
1
protein phosphatase 2, regulatory subunit B (

75G4
920
1775
X59066
Hs.155101
0
2
mitochondrial ATP synthase (F1-ATPase) alpha

523G12
20
848
NM_004681
Hs.155103
0
3
eukaryotic translation initiation factor 1A,

74D7
292
1094
M16942
Hs.155122
0
3
MHC class II HLA-DRw53-associated glycoprotein

beta-

137D4
2500
2822
AL049761
Hs.155140
1.00E−176
1
DNA sequence from clone RP5-863C7 on

chromosome 20p12

471B5
908
1168
AK023379
Hs.155160
1.00E−141
1
cDNA FLJ13317 fis, clone OVARC1001577, highly

176C9
2104
2635
NM_003664
Hs.155172
0
1
adaptor-related protein complex 3, beta 1 sub

99F5
212
671
NM_005642
Hs.155188
0
1
TATA box binding protein (TBP)-associated fac

166E9
1215
1637
U18062
Hs.155188
0
1
TFIID subunit TAFII55 (TAFII55) mRNA, complete cds/c

163A11
60
3052
AL162086
Hs.155191
0
8
cDNA DKFZp762H157 (from clone DKFZp762H1

71E4
44
558
NM_003379
Hs.155191
1.00E−175
4
villin 2 (ezrin) (VIL2), mRNA/cds = (117,1877)

145D8
2135
2669
L47345
Hs.155202
0
1
elongin A mRNA, complete cds/cds = (32,2350)/g

477H9
357
2812
NM_014670
Hs.155291
0
2
KIAA0005 gene product (KIAA0005), mRNA/cds = (

58D8
38
336
NM_000518
Hs.155376
1.00E−100
1
hemoglobin, beta (HBB), mRNA/cds = (50,493)/g

48F11
576
2131
NM_006164
Hs.155396
0
2
nuclear factor (erythroid-derived 2)-like 2

65G11
426
1179
S74017
Hs.155396
0
1
Nrf2 = NF-E2-like basic leucine zipper transcriptional

act

480G12
852
1246
NM_001352
Hs.155402
0
1
D site of albumin promoter (albumin D-box) bind

182B12
245
592
NM_006899
Hs.155410
0
1
isocitrate dehydrogenase 3 (NAD+) beta (IDH3B

599C9
3188
3487
NM_021643
Hs.155418
1.00E−163
1
GS3955 protein (GS3955), mRNA/cds = (1225,2256

68H2
563
1749
AF037448
Hs.155489
0
2
RRM RNA binding protein Gry-rbp (GRY-RBP) mRNA

173F6
1243
1811
AF208043
Hs.155530
0
2
IFI16b (IFI16b) mRNA, complete cds/cds = (264,2

170B3
1061
1342
D50063
Hs.155543
1.00E−139
1
proteasome subunit p40_/Mov34 protein, comp

590E9
494
1323
NM_002811
Hs.155543
0
2
proteasome (prosome, macropain) 26S subunit,

522D11
1463
1710
AB029003
Hs.155546
1.00E−138
2
mRNA for KIAA1080 protein, partial cds/cds = (0

587A8
3514
3923
NM_001746
Hs.155560
0
1
calnexin (CANX), mRNA/cds = (89,1867)/gb = NM_0

39A6
830
1474
D63878
Hs.155595
0
1
KIAA0158 gene, complete cds/cds = (258,1343)

167F5
745
2735
NM_004404
Hs.155595
0
3
neural precursor cell expressed, developmenta

106E10
1922
2340
U15173
Hs.155596
1.00E−179
2
BCL2/adenovirus E1B 19 kD-interacting protein

524A8
1639
2229
NM_014666
Hs.155623
0
1
KIAA0171 gene product (KIAA0171), mRNA/cds = (

166D6
12177
12974
U47077
Hs.155637
0
3
DNA-dependent protein kinase catalytic subuni

488A10
1961
2426
NM_002827
Hs.155894
0
3
protein tyrosine phosphatase, non-receptor t

65D6
696
1107
S68271
Hs.155924
0
3
cyclic AMP-responsive element modulator (CRE

113E8
682
1435
NM_004054
Hs.155935
0
1
complement component 3a receptor 1 (C3AR1), mR

105F10
119
1591
U62027
Hs.155935
0
3
anaphylatoxin C3a receptor (HNFAG09) mRNA,

complete

111C1
4122
4779
NM_005541
Hs.155939
0
5
inositol polyphosphate-5-phosphatase, 145 kD

40A9
1727
2300
D76444
Hs.155968
0
1
hkf-1 mRNA, complete cds/cds = (922,2979)/gb =

124F1
1464
2121
NM_005667
Hs.155968
0
1
zinc finger protein homologous to Zfp103 in mo

481E12
2237
2691
NM_003588
Hs.155976
0
1
cullin 4B (CUL4B), mRNA/cds = (78,2231)/gb = NM

109H3
36
440
NM_020414
Hs.155986
0
1
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide

193B10
1103
1892
AK024974
Hs.156110
1.00E−180
5
cDNA: FLJ21321 fis, clone COL02335, highly sim

463H6
26
149
AI337347
Hs.156339
5.00E−57
1
tb98e10.x1 cDNA, 3′ end/clone = IMAGE: 2062410

107H5
34
253
AI146787
Hs.156601
7.00E−93
1
qb83f02.x1 cDNA, 3′ end/clone = IMAGE: 1706715

517E8
209
822
NM_015646
Hs.156764
0
3
RAP1B, member of RAS oncogene family (RAP1B),

478H11
456
768
NM_005819
Hs.157144
1.00E−172
1
syntaxin 6 (STX6), mRNA/cds = (0,767)/gb = NM_0

463G12
44
283
AI351144
Hs157213
3.00E−95
1
qt23f10.x1 cDNA, 3′ end/clone = IMAGE: 1948459

520A2
2359
2565
BC001913
Hs.157236
1.00E−95
2
Similar to membrane protein of cholinergic sy

473A8
2944
3570
AK026394
Hs.157240
0
1
cDNA: FLJ22741 fis, clone HUV00774/

cds = UNKNOW

464D5
433
601
AW207701
Hs.157315
8.00E−37
1
UI-H-BI2-age-e-03-0-UI.s1 cDNA, 3′ end/clon

464B8
288
633
BF184881
Hs.157396
2.00E−99
1
601843756F1 cDNA, 5′ end/clone = IMAGE: 4064508

463A6
225
554
AW976630
Hs.157447
1.00E−169
1
EST388739 cDNA/gb = AW976630/gi = 8167861/ug =

464G10
423
661
AI356405
Hs.157556
1.00E−103
1
qz26g04.x1 cDNA, 3′ end/clone = IMAGE: 2028054

464H3
396
642
AI568755
Hs.157564
1.00E−123
1
th15f03.x1 cDNA, 3′ end/clone = IMAGE: 2118365

466C1
110
384
AI760026
Hs.157569
1.00E−135
1
wh83c05.x1 cDNA, 3′ end/clone = IMAGE: 2387336

465A2
11
178
AI823541
Hs.157710
1.00E−79
1
wh55c11.x1 cDNA, 3′ end/clone = IMAGE: 2384660

464A8
2000
2248
AK023779
Hs.157777
1.00E−134
1
cDNA FLJ13717 fis, clone PLACE2000425/cds = UNK

464G1
122
447
AI361761
Hs.157813
1.00E−163
2
qz19a07.x1 cDNA, 3′ end/clone = IMAGE: 2021940

464G7
293
395
AI361849
Hs.157815
4.00E−30
1
qz19h11.x1 cDNA, 3′ end/clone = IMAGE: 2022021

145B8
238
598
BF303931
Hs.157850
1.00E−179
3
601886564F2 cDNA, 5′ end/clone = IMAGE: 4120574

115D1
111
712
NM_000661
Hs.157850
1.00E−159
2
ribosomal protein L9 (RPL9), mRNA/cds = (29,607

102F8
4161
4818
AB023198
Hs.158135
0
1
for KIAA0981 protein, partial cds/cds = (0

597H12
1253
2625
NM_000593
Hs.158164
0
5
ATP-binding cassette, sub-family B (MDR/TAP),

465A3
172
342
T78173
Hs.158193
5.00E−64
1
yd79c05.r1 cDNA, 5′ end/clone = IMAGE: 114440/

465H8
740
1171
NM_006354
Hs.158196
1.00E−149
1
transcriptional adaptor 3 (ADA3, yeast homolo

59H12
1646
6883
NM_002313
Hs.158203
0
4
actin-binding LIM protein (ABLIM), transcript

464A2
32
549
NM_004571
Hs.158225
0
1
PBX/knotted 1 hoemobox 1 (PKNOX1), mRNA/cds = (

124F12
6603
6907
AB007915
Hs.158286
1.00E−172
1
mRNA for KIAA0446 protein, partial cds/cds = (3

519F5
80
268
AI199223
Hs.158289
1.00E−86
1
qi47c06.x1 cDNA, 3′ end/clone = IMAGE: 1859626

463F8
33
286
BF433857
Hs.158501
1.00E−123
1
7q71b07.x1 cDNA/clone = IMAGE/gb = BF433857/g

137A8
204
452
AI370965
Hs.158653
5.00E−32
1
ta29b11.x1 cDNA, 3′ end/clone = IMAGE: 2045469

466A11
1
565
BE676408
Hs.158714
0
1
7f29b11.x1 cDNA, 3′ end/clone = IMAGE: 3296061

73C2
5
396
AW362008
Hs.158794
0
1
PM2-CT0265-211099-002-d04/gb = AW362008

465C6
242
433
AI378113
Hs.158877
2.00E−95
1
tc80c12.x1 cDNA, 3′ end/clone = IMAGE: 2072470

465C2
29
153
AI378457
Hs.158894
4.00E−60
2
tc79d10.x1 cDNA, 3′ end/clone = IMAGE: 2072371

465C10
47
442
AI379953
Hs.158943
0
1
tc81a07.x1 cDNA, 3′ end/clone = IMAGE: 2072532

477B9
151
396
AI380220
Hs.158965
1.00E−109
2
tf94a04.x1 cDNA, 3′ end/clone = IMAGE: 2106894

477B10
1
414
AI380236
Hs.158966
0
2
tf94b10.x1 cDNA, 3′ end/clone = IMAGE: 2106907

466F8
128
233
AI380388
Hs.158975
4.00E−30
1
tf96a03.x1 cDNA, 3′ end/clone = IMAGE: 2107084

467E12
109
350
AI799909
Hs.158989
1.00E−82
1
wc46c08.x1 cDNA, 3′ end/clone = IMAGE: 2321678

469G6
169
470
AI631850
Hs.158992
1.00E−119
1
wa36h07.x1 cDNA, 3′ end/clone = IMAGE: 2300221

467H4
17
292
BF508694
Hs.158999
1.00E−117
1
UI-H-BI4-aop-f-09-0-UI.s1 cDNA, 3′ end/clon

469B2
179
388
AI568751
Hs.159014
4.00E−94
1
th15d09.x1 cDNA, 3′ end/clone = IMAGE: 2118353

464E8
742
945
AL538276
Hs.159065
1.00E−110
1
AL538276 cDNA/clone = CS0DF027YC09-(5-prime)

469D9
1
413
AI431873
Hs.159103
0
1
ti26b11.x1 cDNA, 3′ end/clone = IMAGE: 2131581

122C7
1916
2375
NM_003266
Hs.159239
0
1
toll-like receptor 4 (TLR4), mRNA/cds = (284,26

462H4
79
239
BF307871
Hs.159336
7.00E−66
1
601890687F1 cDNA, 5′ end/clone = IMAGE: 4132028

179C1
428
734
AJ225093
Hs.159386
3.00E−88
1
single-chain antibody, complete cds

473D11
267
339
AI380255
Hs.159424
5.00E−34
1
tf94d08.x1 cDNA, 3′ end/clone = IMAGE: 2106927

107B2
1
617
BE783628
Hs.159441
1.00E−160
2
601471696F1 cDNA, 5′ end/clone = IMAGE: 3874823

590E12
52
654
BG290141
Hs.159441
0
6
602385221F1 cDNA, 5′ end/clone = IMAGE: 4514380

70E1
2095
2333
AK027194
Hs.159483
1.00E−119
1
FLJ23541 fis, clone LNG08276, highly sim

58A5
10448
12675
AF193556
Hs.159492
0
10
sacsin (SACS) gene, complete cds/cds = (76,1156

482E11
2064
2559
NM_000061
Hs.159494
0
1
Bruton agammaglobulinemia tyrosine kinase (B

147A11
755
2415
AF001622
Hs.159523
0
7
class-I MHC-restricted T cell associated mole

486H6
1164
1382
NM_019604
Hs.159523
1.00E−117
2
class-I MHC-restricted T cell associated mole

465A5
2693
3039
NM_000033
Hs.159546
1.00E−148
1
ATP-binding cassette, sub-family D (ALD), mem

60C4
1102
1962
AK024833
Hs.159557
1.00E−147
4
FLJ21180 fis, clone CAS11176, highly sim

465B11
457
1126
NM_016952
Hs.159565
0
1
surface glycoprotein, Ig superfamily member (

477A12
89
581
AI797788
Hs.159577
0
5
wh78b11.x1 cDNA, 3′ end/clone = IMAGE: 2386845

595H8
19
912
NM_004632
Hs.159627
0
2
death associated protein 3 (DAP3), mRNA/cds = (

74D2
7
2119
AF153609
Hs.159640
0
9
serine/threonine protein kinase sgk mRNA, com

71B2
8
533
NM_005627
Hs.159640
0
1
serum/glucocorticoid regulated kinase (SGK)

467G8
310
488
AW006352
Hs.159643
2.00E−92
1
wt04d12.x1 cDNA, 3′ end/clone = IMAGE: 2506487

467B8
11
363
AI392893
Hs.159655
1.00E−173
1
tg05d07.x1 cDNA, 3′ end/clone = IMAGE: 2107885

471F11
16
303
AI827950
Hs.159659
1.00E−162
1
wk31a11.x1 cDNA, 3′ end/clone = IMAGE: 2413916

467C11
18
501
BF508053
Hs.159673
0
1
UI-H-B14-apx-b-11-0-UI.s1 cDNA, 3′ end/clon

477F4
3
405
AI394671
Hs.159678
0
2
tg24a07.x1 cDNA, 3′ end/clone = IMAGE: 2109684

472F5
194
366
NM_018490
Hs.160271
1.00E−93
1
G protein-coupled receptor 48 (GPR48), mRNA/

468B11
72
481
AI393041
Hs.160273
0
1
tg25b10.x1 cDNA, 3′ end/clone = IMAGE: 2109787

477D3
5
484
AI393906
Hs.160401
0
2
tg05f08.x1 cDNA, 3′ end/clone = IMAGE: 2107911

477D12
11
389
AI393962
Hs.160405
1.00E−178
1
tg11d08.x1 cDNA, 3′ end/clone = IMAGE: 2108463

477D5
15
262
AI393992
Hs.160408
1.00E−138
1
tg06c05.x1 cDNA, 3′ end/clone = IMAGE: 2107976

65A9
4106
5547
AF137030
Hs.160417
0
5
transmembrane protein 2 (TMEM2) mRNA, complete

513A2
4109
5547
NM_013390
Hs.160417
0
5
transmembrane protein 2 (TMEM2), mRNA/cds = (14

463F12
688
1425
AF218032
Hs.160422
0
1
clone PP902 unknown mRNA/cds = (693,1706)/gb =

165C1
2625
2987
X85116
Hs.160483
0
1

H. sapiens epb72 gene exon 1/cds = (61,927)/

gb = X85116/gi = 1

469G4
145
550
AI634652
Hs.160795
0
1
wa07e10.x1 CDNA, 3′ end/clone = IMAGE: 2297418

472C7
343
565
AI760020
Hs.160951
1.00E−105
1
wh83b05.x1 cDNA, 3′ end/clone = IMAGE: 2387313

466F12
485
662
BF207290
Hs.160954
2.00E−62
1
601870777F1 cDNA, 5′ end/clone = IMAGE: 4100850

477C10
5
290
BF437585
Hs.160980
1.00E−149
1
7p74d12.x1 cDNA, 3′ end/clone = IMAGE: 3651526

61E8
4435
6593
U83115
Hs.161002
0
3
non-lens beta gamma-crystallin like protein (AIM1) m

458E5
1
462
R84314
Hs.161043
1.00E−159
1
yq23a02.r1 cDNA, 5′ end/clone = IMAGE: 274443/

466E12
117
447
BF001821
Hs.161075
0
1
7g93g02.x1 cDNA, 3′ end/clone = IMAGE: 3314066

102H4
7
219
AW963155
Hs.161786
1.00E−111
1
EST375228/gb = AW963155/gi = 8152991/ug =

118B6
2050
2260
NM_022570
Hs.161786
2.00E−75
1
C-type (calcium dependent, carbohydrate-reco

593C4
3863
4092
U86453
Hs.162808
9.00E−92
1
phosphatidylinositol 3-kinase catalytic subunit p1

467B7
129
455
AI023714
Hs.163442
1.00E−164
1
ow91h05.x1 cDNA, 3′ end/clone = IMAGE: 1654233

107G8
592
1016
AK023670
Hs.163495
0
1
FLJ13608 fis, clone PLACE1010628/cds = UNK

74F3
229
449
AA627122
Hs.163787
4.00E−77
1
nq70g02.s1 cDNA, 3′ end/clone = IMAGE: 1157714

68B3
1094
1771
AK023494
Hs.164005
0
5
FLJ13432 fis, clone PLACE1002537/cds = UNK

469H10
420
850
NM_002993
Hs.164021
0
1
small inducible cytokine subfamily B (Cys-X-C

464E9
86
424
AA811244
Hs.164168
1.00E−166
1
ob58h11.s1 cDNA, 3′ end/clone = IMAGE: 1335621

467E11
788
1330
NM_007063
Hs.164170
0
1
vascular Rab-GAP/TBC-containing (VRP), mRNA

597C5
59
1251
AY007135
Hs.164280
1.00E−126
3
clone CDABP0051 mRNA sequence/cds = (89,985)/

464H11
2
202
BF689700
Hs.164675
9.00E−65
1
602186609F1 cDNA, 5′ end/clone = IMAGE: 4298402

459D5
6
496
AI248204
Hs.165051
0
1
qh64h11.x1 cDNA, 3′ end/clone = IMAGE: 1849509

120F12
23
502
NM_001017
Hs.165590
1.00E−159
5
ribosomal protein S13 (RPS13), mRNA/cds = (32,4

469C11
301
613
AW364833
Hs.165681
1.00E−136
1
QV3-DT0043-211299-044-d03 cDNA/gb = AW364833

465D3
289
481
AI766638
Hs.165693
2.00E−62
1
wi02a10.x1 cDNA, 3′ end/clone = IMAGE: 2389050

465D6
107
238
AW850041
Hs.165695
3.00E−61
1
IL3-CT0216-170300-097-C07 cDNA/gb = AW850041

466C7
166
421
AI538546
Hs.165696
1.00E−122
1
td08b07.x1 cDNA, 3′ end/clone = IMAGE: 2075029

469C4
351
691
AI436561
Hs.165703
1.00E−148
1
ti03b03.x1 cDNA, 3′ end/clone = IMAGE: 2129357

62A12
32
256
AV727063
Hs.165980
1.00E−120
4
AV727063 cDNA, 5′ end/clone = HTCCED11/clone_—

107C2
2427
2613
AJ250865
Hs.165986
1.00E−82
1
for TESS 2 protein (TESS/cds = (128,1393)/

461D5
1762
1935
NM_004031
Hs.166120
8.00E−81
1
interferon regulatory factor 7 (IRF7), transc

147D11
38
1283
AL022097
Hs.166203
0
5
DNA sequence from PAC 256G22 on chromosome

6p24

595H12
1321
1597
NM_002636
Hs.166204
1.00E−135
2
PHD finger protein 1 (PHF1), mRNA/cds = (56,1429

58H7
41
2036
AL136711
Hs.166254
0
2
mRNA; cDNA DKFZp566I133 (from clone

DKFZp566I1

98D12
5559
6110
NM_014646
Hs.166318
0
1
lipin 2 (LPIN2), mRNA/cds = (239,2929)/gb = NM_0

468G1
146
509
AW873324
Hs.166338
1.00E−168
2
hl92a07.x1 cDNA, 3′ end/clone = IMAGE: 3009396

477D7
2900
3748
L14922
Hs.166563
0
1
DNA-binding protein (PO-GA) mRNA, complete cd

177E7
3265
3595
L23320
Hs.166563
0
1
replication factor C large subunit mRNA, complete cds

584H2
206
1613
NM_006925
Hs.166975
1.00E−112
5
splicing factor, arginine/serine-rich 5 (SFR

481F5
647
917
NM_002643
Hs.166982
1.00E−128
1
phosphatidylinositol glycan, class F (PIGF),

598E4
112
538
NM_002788
Hs.167106
1.00E−174
1
proteasome (prosome, macropain) subunit, alp

466D8
46
470
AI805131
Hs.167206
0
1
td11f04.x1 cDNA, 3′ end/clone = IMAGE:2075359

464C8
342
469
BE674762
Hs.167208
4.00E−50
1
7e98d05.x1 cDNA, 3′ end/clone = IMAGE: 3293193

468A6
1177
1417
NM_003658
Hs.167218
4.00E−85
1
BarH-like homeobox 2 (BARX2), mRNA/cds = (96,93

74H10
1
1271
AF107405
Hs.167460
0
12
pre-mRNA splicing factor (SFRS3) mRNA, comple

60E9
3154
3926
U43185
Hs.167503
1.00E−143
2
signal transducer and activator of transcription Sta

517G3
1129
2787
NM_006994
Hs.167741
0
3
butyrophilin, subfamily 3, member A3 (BTN3A3),

175H2
2261
2467
U90548
Hs.167741
2.00E−86
1
butyrophilin (BTF3) mRNA, complete cds/

cds = (171,192

588H5
1324
1735
NM_002901
Hs.167791
0
1
reticulocalbin 1, EF-hand calcium binding dom

331D7
53
625
AF116909
Hs.167827
4.00E−22
1
clone HH419 unknown mRNA/cds = (189,593)/gb = A

39C11
938
1672
AF026402
Hs.168103
0
1
U5 snRNP 100 kD protein mRNA, cds/cds = (39,2501

583C8
906
1669
NM_004818
Hs.168103
0
5
prp28, U5 snRNP 100 kd protein (U5-100K), mRNA

43B1
1156
1224
AF031167
Hs.168132
1.00E−22
1
interleukin 15 precursor (IL-15) mRNA, complet

479A7
424
801
NM_000585
Hs.168132
1.00E−149
1
interleukin 15 (IL15), mRNA/cds = (316,804)/g

67D6
1783
2336
AK024030
Hs.168232
0
1
FLJ13968 fis, clone Y79AA1001493, weakly

122H3
1646
2894
NM_023079
Hs.168232
0
2
hypothetical protein FLJ13855 (FLJ13855), mR

459H3
9
504
AI392830
Hs.168287
0
1
tg10b09.x1 cDNA, 3′ end/clone = IMAGE: 2108345

463G5
103
851
NM_003002
Hs.168289
0
1
succinate dehydrogenase complex, subunit D,

144G9
5588
5937
AL049935
Hs.168350
0
2
DKFZp564O1116 (from clone DKFZp564O

459A9
2293
2727
NM_000201
Hs.168383
0
2
intercellular adhesion molecule 1 (CD54), hum

123G3
2194
2675
AB046801
Hs.168640
0
2
mRNA for KIAA1581 protein, partial cds/cds = (0

112H10
505
864
AF007155
Hs.168694
1.00E−175
2
clone 23763 unknown mRNA, partial cds/cds = (0,

60H7
223
897
AF083420
Hs.168913
0
1
brain-specific STE20-like protein kinase 3 (

105C12
1698
2052
AK026671
Hs.169078
1.00E−176
1
FLJ23018 fis, clone LNG00903/cds = (27,14

181B9
1148
1610
NM_003937
Hs.169139
0
1
kynureninase (L-kynurenine hydrolase) (KYNU)

462B7
13
478
AA977148
Hs.169168
0
1
oq24g08.s1 cDNA, 3′ end/clone = IMAGE: 1587326

41H5
197
624
U58913
Hs.169191
0
1
chemokine (hmrp-2a) mRNA, complete cds/

cds = (71,484)

69G6
11
552
BF214508
Hs.169248
1.00E−160
4
601845758F1 cDNA, 5′ end/clone = IMAGE: 4076510

460B2
904
2904
NM_003202
Hs.169294
1.00E−161
2
transcription factor 7 (T-cell specific, HMG-

464G12
543
994
D26121
Hs.169303
0
1
mRNA for ZFM1 protein alternatively spliced product,

464B5
163
762
NM_013259
Hs.169330
0
1
neuronal protein (NP25), mRNA/cds = (49,897)/

593G4
787
1353
Z97989
Hs.169370
0
2
DNA sequence from PAC 66H14 on chromosome

6q21-22. Con

165F12
1177
1751
AK001725
Hs.169407
0
1
cDNA FLJ10863 fis, clone NT2RP4001575, highly

483B12
10871
11349
NM_004010
Hs.169470
0
1
dystrophin (muscular dystrophy, Duchenne and

518B3
22
1257
NM_002046
Hs.169476
0
5
glyceraldehyde-3-phosphate dehydrogenase (

67E7
1289
1597
U34995
Hs.169476
3.00E−88
1
normal keratinocyte substraction library mRNA, clon

47E9
2148
2452
NM_005461
Hs.169487
1.00E−172
1
Kreisler (mouse) maf-related leucine zipper h

69C3
846
3195
U41387
Hs.169531
0
24
Gu protein mRNA, partial cds/cds = (0,2405)/

gb = U41387

468G7
73
450
AI523598
Hs.169541
1.00E−178
1
th08g11.x1 cDNA, 3′ end/clone = IMAGE: 2117732

72E12
490
3074
AJ251595
Hs.169610
0
29
for transmembrane glycoprotein (CD44 gen

471F2
97
533
AW172306
Hs.169738
0
1
xj37a08.x1 cDNA, 3′ end/clone = IMAGE: 2659382

589D4
96
488
NM_000994
Hs.169793
1.00E−163
2
ribosomal protein L32 (RPL32), mRNA/cds = (34,4

105B6
1590
2215
AK027212
Hs.169854
0
1
FLJ23559 fis, clone LNG09844/cds = UNKNOW

462A8
1043
1529
NM_000305
Hs.169857
0
1
paraoxonase 2 (PON2), mRNA/cds = (32,1096)/gb

175D11
390
929
AF061736
Hs.169895
1.00E−132
2
ubiquitin-conjugating enzyme RIG-B mRNA, com

149A2
2442
2942
U75686
Hs.169900
0
1
polyadenylate binding protein mRNA, complete

524B9
2484
2709
NM_007049
Hs.169963
1.00E−125
2
butyrophilin, subfamily 2, member A1 (BTN2A1),

169G8
1192
1684
U90543
Hs.169963
0
1
butyrophilin (BTF1) mRNA, complete cds/

cds = (210,179

129E9
686
1227
X70340
Hs.170009
0
1
transforming growth factor alpha/cds = (3

589C1
1893
3451
NM_004350
Hs.170019
0
5
runt-related transcription factor 3 (RUNX3),

331E1
5084
5496
NM_001621
Hs.170087
0
1
aryl hydrocarbon receptor (AHR) mRNA/cds = (643

595H7
659
4185
NM_002838
Hs.170121
0
34
protein tyrosine phosphatase, receptor type,

184G8
1083
3762
Y00062
Hs.170121
0
10
T200 leukocyte common antigen (CD45, LC-A)/c

109D4
4529
4876
AF032885
Hs.170133
0
1
forkhead protein (FKHR) mRNA, complete cds/cd

98A12
4529
4882
NM_002015
Hs.170133
1.00E−160
1
forkhead box O1A (rhabdomyosarcoma) (FOXO1A),

99E3
2098
2334
NM_004761
Hs.170160
1.00E−125
1
RAB2, member RAS oncogene family-like (RAB2L),

498F10
3472
4909
AL161952
Hs.170171
0
28
mRNA; cDNA DKFZp434M0813 (from clone

DKFZp434M

465G7
390
462
AI475666
Hs.170288
2.00E−31
1
tc93c08.x1 cDNA, 3′ end/clone = IMAGE: 2073710

467E6
68
482
AK025743
Hs.170296
0
1
cDNA: FLJ22090 fis, clone HEP16084/cds = UNKNOW

459H9
4659
5168
NM_014636
Hs.170307
0
1
Ral guanine nucleotide exchange factor RalGPS

38D9
618
992
089678
Hs.170311
0
25
for A + U-rich element RNA binding factor,

589F11
1033
2022
NM_005463
Hs.170311
0
13
heterogeneous nuclear ribonucleoprotein D-I

469B9
127
573
AI436418
Hs.170326
0
1
ti01h02.x1 cDNA, 3′ end/clone = IMAGE: 2129235

183E4
2725
3777
NM_002444
Hs.170328
0
7
moesin (MSN), mRNA/cds = (100,1833)/gb = NM_002

170G2
1693
3305
Z98946
Hs.170328
0
4
DNA sequence from clone 376D21 on chromosome

Xq11.1-12

464F6
162
534
AI492865
Hs.170331
1.00E−163
1
th78a05.x1 cDNA, 3′ end/clone = IMAGE: 2124752

472F8
412
554
AI373163
Hs.170333
1.00E−75
1
qz13a07.x1 cDNA, 3′ end/clone = IMAGE: 2021364

473C3
376
610
AW291507
Hs.170381
1.00E−123
1
UI-H-BI2-aga-g-11-0-UI.s1 cDNA, 3′ end/clon

465E5
421
547
BE676049
Hs.170584
3.00E−54
1
7f21a03.x1 cDNA, 3′ end/clone = IMAGE: 3295276

477A3
25
202
AI475884
Hs.170587
4.00E−92
2
tc95c12.x1 cDNA, 3′ end/clone = IMAGE: 2073910

477A4
34
489
AI475905
Hs.170588
0
1
tc95f06.x1 cDNA, 3′ end/clone = IMAGE: 2073923

469F2
238
490
AI478556
Hs.170777
2.00E−84
1
tm53e03.x1 cDNA, 3′ end/clone = IMAGE: 2161852

472C5
357
474
AI479022
Hs.170784
1.00E−53
1
tm30a05.x1 cDNA, 3′ end/clone = IMAGE: 2158064

477D6
23
407
AI492034
Hs.170909
0
2
tg06f12.x1 cDNA, 3′ end/clone = lMAGE: 2108015

471D4
187
416
AI492181
Hs.170913
1.00E−106
1
tg07e06.x1 cDNA, 3′ end/clone = IMAGE: 2108098

464F8
14
142
AI492651
Hs.170934
7.00E−53
1
qz18b10.x1 cDNA, 3′ end/clone = IMAGE: 2021851

466D3
173
461
AI540204
Hs.170935
1.00E−131
1
td10h12.x1 cDNA, 3′ end/clone = IMAGE: 2075303

478F10
314
461
AI761144
Hs.171004
4.00E−45
1
wh97h01.x1 cDNA, 3′ end/clone = IMAGE: 2388721

476E2
187
253
AI494612
Hs.171009
2.00E−30
2
qz17a03.x1 cDNA, 3′ end/clone = IMAGE: 2021740

107G12
2413
2929
AK024436
Hs.171118
0
1
for FLJ00026 protein, partial cds/cds = (0

478H3
1237
1509
AL161725
Hs.171118
1.00E−107
1
DNA sequence from clone RP11-165F24 on

chromosome 9.

477H10
252
489
BE674709
Hs.171120
3.00E−87
1
7e94f05.x1 cDNA, 3′ end/clone = IMAGE: 3292833

477H11
18
521
AI524202
Hs.171122
0
1
th10d11.x1 cDNA, 3′ end/clone = IMAGE: 2117877

466C10
24
216
BE816212
Hs.171261
8.00E−81
1
MR1-BN0212-280600-001-c06 cDNA/gb = BE816212

470A4
22
562
AI628893
Hs.171262
0
1
ty95h02.x1 cDNA, 3′ end/clone = IMAGE: 2286867

477C4
216
464
AI540161
Hs.171264
1.00E−112
2
td10c10.x1 cDNA, 3′ end/clone = IMAGE: 2075250

519E12
1
321
NM_016468
Hs.171566
1.00E−167
2
hypothetical protein (LOC51241), mRNA/cds = (

44C11
5363
5829
AF012872
Hs.171625
0
1
phosphatidylinositol 4-kinase 230 (pi4K230)

517D4
19
559
NM_003197
Hs.171626
0
3
transcription elongation factor B (SIII), pol

48E9
1563
1809
NM_004417
Hs.171695
1.00E−138
2
dual specificity phosphatase 1 (DUSP1), mRNA

520H5
941
3667
NM_002719
Hs.171734
0
2
protein phosphatase 2, regulatory subunit B (

106G2
1
308
BF243010
Hs.171774
1.00E−167
2
601877795F1 cDNA, 5′ end/clone = IMAGE: 4106303

524A7
14
359
NM_015933
Hs.171774
0
14
hypothetical protein (HSPC016), mRNA/cds = (3

117A11
311
614
BF966361
Hs.171802
1.00E−143
2
602286929F1 cDNA, 5′ end/clone = IMAGE: 4375783

38H11
885
2087
M55543
Hs.171862
0
6
guanylate binding protein isoform II (GBP-2) mRNA,

co

512F8
232
1971
NM_004120
Hs.171862
0
12
guanylate binding protein 2, interferon-induc

111B9
3748
4161
NM_004941
Hs.171872
0
1
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide

192H11
5738
5903
NM_000937
Hs.171880
2.00E−68
1
polymerase (RNA) II (DNA directed) polypeptide

176F11
1322
4789
AL109935
Hs.171917
0
3
DNA sequence from clone RP5-1022P6 on

chromosome 20 C

596G12
2472
3152
NM_001110
Hs.172028
0
5
a disintegrin and metalloproteinase domain 10

170A5
2438
2767
AK023154
Hs.172035
0
1
FLJ13092 fis, clone NT2RP3002147/cds = (34

469D11
71
535
AI474074
Hs.172070
0
1
ti68h11.x1 cDNA, 3′ end/clone = IMAGE: 2137221

100G4
5574
5662
U02882
Hs.172081
3.00E−24
1
rolipram-sensitive 3′,5′-cyclic AMP phosphodiester

524A11
1
2517
AL110202
Hs.172089
0
20
mRNA; cDNA DKFZp586I2022 (from clone DKFZp586

49A2
929
2845
NM_002568
Hs.172182
0
30
poly(A)-binding protein, cytoplasmic 1 (PABP

54C5
929
2484
Y00345
Hs.172182
0
9
polyA binding protein/cds = (502,2403)/gb = Y0

586B1
1042
1504
NM_002408
Hs.172195
0
1
mannosyl (alpha-1,6-)-glycoprotein beta-1,2

169H6
5576
5958
D25538
Hs.172199
0
1
KIAA0037 gene, complete cds/cds = (265,3507)

115G7
4531
4976
NM_001114
Hs.172199
0
1
adenylate cyclase 7 (ADCY7), mRNA/cds = (265,35

120F2
1
2496
NM_007363
Hs.172207
0
11
non-POU-domain-containing, octamer-binding

74A3
860
1364
Y11289
Hs.172207
0
1
p54nrb gene, exon 3 (and joined/cds = (136,1551)

60B7
695
1160
NM_000202
Hs.172458
0
1
iduronate 2-sulfatase (Hunter syndrome) (IDS

479D10
4059
4347
NM_000632
Hs.172631
1.00E−125
1
integrin, alpha M (complement component recep

167B10
1
389
NM_003761
Hs.172684
0
4
vesicle-associated membrane protein 8 (endob

189E11
1773
2038
NM_001345
Hs.172690
1.00E−149
2
diacylglycerol kinase, alpha (80 kD) (DGKA), m

177C2
983
1489
X62535
Hs.172690
0
1
diacylglycerol kinase/cds = (103,2310)

458B12
535
1002
NM_012326
Hs.172740
0
1
microtubule-associated protein, RP/EB family

53A11
69
430
W26908
Hs.172762
1.00E−180
1
16b3/gb = W26908/gi = 1306136/ug = Hs.17276

151H2
2016
2572
M80359
Hs.172766
0
1
protein p78 mRNA, complete cds/cds = (171,2312)/

gb = M8

100G10
3983
4302
AB037808
Hs.172789
1.00E−149
1
for KIAA1387 protein, partial cds/cds = (0

515D9
354
548
NM_004182
Hs.172791
3.00E−65
1
ubiquitously-expressed transcript (UXT), mR

193D9
2282
2757
AL109669
Hs.172803
0
3
mRNA full length insert cDNA clone EUROIMAGE 31

460H10
12
490
NM_016466
Hs.172918
0
1
hypothetical protein (LOC51239), mRNA/cds = (

483D3
3473
3941
AB011102
Hs.173081
0
1
mRNA for KIAA0530 protein, partial cds/cds = (0,

195B9
380
854
NM_005729
Hs.173125
0
2
peptidylprolyl isomerase F (cyclophilin F) (

173H6
6008
6412
NM_006283
Hs.173159
0
1
transforming, acidic coiled-coil containing

113E6
142
240
AI554733
Hs.173182
3.00E−49
1
tn27f08.x1 cDNA, 3′ end/clone = IMAGE: 2168871

56G8
140
630
AK002009
Hs.173203
0
2
FLJ11147 fis, clone PLACE1006678, weakly

69E6
1
463
BF131656
Hs.173205
1.00E−147
8
601820483F1 cDNA, 5′ end/clone = IMAGE: 4052348

44A2
6
196
X06347
Hs.173255
1.00E−94
1
U1 small nuclear RNP-specific A protein/cds = clone

149G1
79
498
AY007165
Hs.173274
1.00E−117
2
CDABP0163 mRNA sequence/cds = UNKNOWN/g

464F3
53
500
AW005376
Hs.173280
0
1
ws94a12.x1 cDNA, 3′ end/clone = IMAGE: 2505598

587H5
3299
4083
NM_014633
Hs.173288
0
2
KIAA0155 gene product (KIAA0155), mRNA/cds = (

499B9
1032
1923
NM_012081
Hs.173334
0
2
ELL-RELATED RNA POLYMERASE II, ELONGATION

FAC

54F11
368
1923
U88629
Hs.173334
0
2
RNA polymerase II elongation factor ELL2, complete

cd

459A4
2170
2775
AK001362
Hs.173374
0
1
cDNA FLJ10500 fis, clone NT2RP2000369/cds = UNK

124B1
2566
3019
AB046825
Hs.173422
0
1
mRNA for KIAA1605 protein, partial cds/cds = (3

126H6
1080
1626
NM_006363
Hs.173497
0
1
Sec23 (S. cerevisiae) homolog B (SEC23B), mRNA

596D5
1233
1365
NM_004550
Hs.173611
8.00E−63
5
NADH dehydrogenase (ubiquinone) Fe-S protein

108C5
1709
1864
AK022681
Hs.173685
2.00E−83
1
FLJ12619 fis, clone NT2RM4001682/cds = (39

583D12
3
1960
AK025703
Hs.173705
0
4
cDNA: FLJ22050 fis, clone HEP09454/cds = UNKNOW

70B6
579
1140
AL049610
Hs.173714
0
2
DNA sequence from clone 1055C14 on chromosome

Xq22.1-

46D7
590
1150
NM_012286
Hs.173714
0
1
MORF-related gene X (KIAA0026), mRNA/cds = (305

467G5
17
283
AA534537
Hs.173720
1.00E−104
1
nf80h10.s1 cDNA, 3′ end/clone = IMAGE: 926275/

168H5
1
1066
D25274
Hs.173737
0
5
mRNA, clone: PO2ST9/cds = UNKNOWN/gb = D25274/

471B8
5347
5922
NM_014832
Hs.173802
0
1
KIAA0603 gene product (KIAA0603), mRNA/cds = (

177F4
1053
1622
U51166
Hs.173824
0
1
G/T mismatch-specific thymine DNA glycosylase

mRNA,

471C3
396
719
AF277292
Hs.173840
1.00E−176
1
C4orf1 mRNA/cds = (0,281)/gb = AF277292/gi = 96

477F7
2053
2694
U80735
Hs.173854
0
3
CAGF28 mRNA, partial cds/cds = (0,2235)/gb = U80

41F3
3595
3890
M37435
Hs.173894
1.00E−143
1
macrophage-specific colony-stimulating factor (CSF

460C8
1542
1939
NM_014225
Hs.173902
0
1
protein phosphatase 2 (formerly 2A), regulator

458A9
292
414
AI763121
Hs.173904
4.00E−57
1
wi06d12.x1 cDNA, 3′ end/clone = IMAGE: 2389463

170B10
1230
3510
AL137681
Hs.173912
1.00E−176
5
cDNA DKFZp434M0326 (from clone DKFZp434M

126E10
1061
1795
Z17227
Hs.173936
1.00E−111
2
mRNA for transmebrane receptor protein/cds = (4

72H7
1210
1907
U08316
Hs.173965
0
2
insulin-stimulated protein kinase 1 (ISPK-1) mRNA, c

123G7
554
858
NM_005777
Hs.173993
1.00E−168
1
RNA binding motif protein 6 (RBM6), mRNA/cds = (

469C8
261
528
BE674902
Hs.174010
1.00E−113
1
7e97a04.x1 cDNA, 3′ end/clone = IMAGE: 3293070

117G6
2450
2657
NM_003089
Hs.174051
1.00E−112
1
small nuclear ribonucleoprotein 70 kD polypept

103A5
4907
5011
NM_002209
Hs.174103
1.00E−48
1
integrin, alpha L (antigen CD11A (p180), lymph

159F4
333
925
AF261087
Hs.174131
0
7
DNA-binding protein TAXREB107 mRNA, complete

588F9
333
926
NM_000970
Hs.174131
0
8
ribosomal protein L6 (RPL6), mRNA/cds = (26,892

187A2
2993
3464
NM_001096
Hs.174140
0
2
ATP citrate lyase (ACLY), mRNA/cds = (84,3401)

41C6
3652
3992
X03663
Hs.174142
0
1
c-fms proto-oncogene/cds = (300,3218)/gb = X0

465G10
199
489
BE674951
Hs.174144
1.00E−152
1
7e97g10.x1 cDNA, 3′ end/clone = IMAGE: 3293154

468H10
28
159
AI524263
Hs.174193
6.00E−62
1
th11g07.x1 cDNA, 3′ end/clone = IMAGE: 2118012

99C7
402
733
NM_006435
Hs.174195
1.00E−179
2
interferon induced transmembrane protein 2 (

467E4
162
516
BF062628
Hs.174215
1.00E−157
1
7h62h05.x1 cDNA, 3′ end/clone = IMAGE: 3320601

74E5
2
485
D63789
Hs.174228
0
15
DNA for SCM-1beta precursor, complete cds/cd

470F11
108
305
AI590337
Hs.174258
1.00E−104
1
tn49c03.x1 cDNA, 3′ end/clone = IMAGE: 2171716

463D2
1
194
AV734916
Hs.175971
1.00E−94
1
AV734916 cDNA, 5′ end/clone = cdAAHE11/clone_—

477E5
75
222
AI380955
Hs.176374
2.00E−33
1
tg18b08.x1 cDNA, 3′ end/clone = IMAGE: 2109111

473A9
1
296
AI708327
Hs.176430
1.00E−162
1
at04c02.x1 cDNA, 3′ end/clone = IMAGE: 2354114

468C3
24
235
AW081098
Hs.176498
6.00E−91
1
xc29a12.x1 cDNA, 3′ end/clone = IMAGE: 2585662

479D11
595
1810
J04162
Hs.176663
0
14
leukocyte IgG receptor (Fc-gamma-R) mRNA,

complete c

108G2
388
579
AI638800
Hs.176920
6.00E−78
4
tt32e01.x1 cDNA, 3′ end/clone = IMAGE: 2242488

467A10
98
170
AI865603
Hs.177045
6.00E−27
1
wk47g03.x1 cDNA, 3′ end/clone = IMAGE: 2418580

117A6
1179
1403
AF116606
Hs.177415
1.00E−112
2
PRO0890 mRNA, complete cds/cds = (1020,1265)/

73F2
236
919
NM_016406
Hs.177507
0
4
hypothetical protein (HSPC155), mRNA/cds = (2

516D8
24
340
NM_006886
Hs.177530
1.00E−179
1
ATP synthase, H+ transporting, mitochondrial

479F4
163
676
NM_002414
Hs.177543
0
1
antigen identified by monoclonal antibodies 1

126A9
906
2105
NM_005534
Hs.177559
0
35
interferon gamma receptor 2 (interferon gamma

41H6
905
1826
U05875
Hs.177559
0
10
clone pSK1 interferon gamma receptor accessory

factor

37G1
1690
2420
U62961
Hs.177584
0
1
succinyl CoA: 3-oxoacid CoA transferase precursor (O

597H7
1764
2520
AF218002
Hs.177596
0
7
clone PP2464 unknown mRNA/cds = (675,2339)/gb

520B8
1036
1202
NM_006888
Hs.177656
4.00E−90
3
calmodulin 1 (phosphorylase kinase, delta) (C

151G7
2439
3048
J03473
Hs.177766
0
1
poly(ADP-ribose) synthetase mRNA, complete cds/

cds = clone

116C6
318
834
BC001980
Hs.177781
1.00E−144
4
MGC: 5618, mRNA, complete cds/cds = (156,

179C11
211
737
X07834
Hs.177781
0
3
manganese superoxide dismutase (EC 1.15.1.1)

98A9
213
648
M73547
Hs.178112
0
4
polyposis locus (DP1 gene) mRNA, complete cds/

cds = (82

459E10
149
789
AK023719
Hs.178357
0
1
cDNA FLJ13657 fis, clone PLACE1011563/cds = (8

120H6
137
404
NM_021029
Hs.178391
1.00E−136
1
ribosomal protein L44 (RPL44), mRNA/cds = (37,3

589E9
371
596
NM_000973
Hs.178551
1.00E−125
1
ribosomal protein L8 (RPL8), mRNA/cds = (43,816

142F5
1848
2210
D21090
Hs.178658
1.00E−179
1
XP-C repair complementing protein (p58/HHR23

120H11
402
532
AV716627
Hs.178703
9.00E−69
1
AV716627 cDNA, 5′ end/clone = DCBBCH05/clone_—

98G11
3287
6017
NM_004859
Hs.178710
0
5
clathrin, heavy polypeptide (Hc) (CLTC), mRNA

177H1
142
421
BF130300
Hs.178732
1.00E−139
1
601818357F1 cDNA, 5′ end/clone = IMAGE: 4041902

472A10
421
562
AI681868
Hs.178784
4.00E−63
1
tx50a12.x1 cDNA, 3′ end/clone = IMAGE: 2272990

467G6
194
292
AW138461
Hs.179003
1.00E−49
1
UI-H-BI1-adg-e-06-0-UI.s1 cDNA, 3′ end/clon

465C11
3312
3606
NM_016562
Hs.179152
1.00E−166
1
toll-like receptor 7 (LOC51284), mRNA/cds = (13

469F7
268
405
AI568459
Hs.179419
3.00E−45
1
tn39e07.x1 cDNA, 3′ end/clone = IMAGE: 2170020

99F11
750
2687
NM_006472
Hs.179526
0
73
upregulated by 1,25-dihydroxyvitamin D-3 (VD

39G9
526
2687
S73591
Hs.179526
0
17
brain-expressed HHCPA78 homolog VDUP1 (Gene)

102A1
2235
2659
AL034343
Hs.179565
0
1
DNA sequence from clone RP1-108C2 on

chromosome 6p12.

492B2
1074
2126
NM_002717
Hs.179574
1.00E−131
3
protein phosphatase 2 (formerly 2A), regulator

143F2
242
457
NM_005771
Hs.179608
1.00E−117
1
retinol dehydrogenase homolog (RDHL]) mRNA/

111G7
626
898
NM_002659
Hs.179657
1.00E−153
1
plasminogen activator, urokinase receptor (P

585D2
61
3189
AL162068
Hs.179662
0
6
mRNA; cDNA DKFZp762G106 (from clone

DKFZp762G1

125G4
1159
1627
NM_000389
Hs.179665
1.00E−130
2
cyclin-dependent kinase inhibitor 1A (p21, Ci

331A1
51
377
AK026642
Hs.179666
1.00E−161
2
FLJ22989 fis, clone KAT11824, highly sim

516H12
19
362
NM_000997
Hs.179779
1.00E−180
3
ribosomal protein L37 (RPL37), mRNA/cds = (28,3

170A11
1390
2087
L20298
Hs.179881
0
1
transcription factor (CBFB) mRNA, 3′ end/cds = (

195H8
1732
2110
NM_001755
Hs.179881
1.00E−173
1
core-binding factor, beta subunit (CBFB), tra

127G6
2406
2924
AK022499
Hs.179882
0
2
cDNA FLJ12437 fis, clone NT2RM1000118, weakly

461E6
610
1148
NM_014153
Hs.179898
0
1
HSPC055 protein (HSPC055), mRNA/cds = (1400,19

516B3
4
584
NM_000975
Hs.179943
1.00E−136
2
ribosomal protein L11 (RPL11), mRNA/cds = (0,53

62F8
24
537
X79234
Hs.179943
1.00E−175
1
ribosomal protein L11/cds = (0,536)/gb = tumor

471B11
1990
2496
NM_005802
Hs.179982
0
1
protein p53-binding protein (TP53BPL),

194B4
693
956
NM_004159
Hs.180062
1.00E−112
1
proteasome (prosome, macropain) subunit, bet

49D4
1002
1259
NM_002690
Hs.180107
1.00E−125
1
polymerase (DNA directed), beta (POLB), mRNA

184A11
26
515
AK024823
Hs.180139
0
2
FLJ21170 fis, clone CAS10946, highly sim

593A8
43
535
NM_006937
Hs.180139
0
13
SMT3 (suppressor of mif two 3, yeast) homolog 2

61D10
102
722
AF161415
Hs.180145
0
1
HSPC297 mRNA, partial cds/cds = (0,438)/gb = AF

178A4
131
628
NM_017924
Hs.180201
0
2
hypothetical protein FLJ20671 (FLJ20671), mR

463H9
54
171
NM_005507
Hs.180370
1.00E−60
1
cofilin 1 (non-muscle) (CFL1), mRNA/cds = (51,5

162B9
2139
2386
AB013382
Hs.180383
1.00E−124
1
for DUSP6, complete cds/cds = (351,1496)/

190B7
1743
2386
NM_001946
Hs.180383
1.00E−124
2
dual specificity phosphatase 6 (DUSP6), trans

589B11
21
1566
NM_006597
Hs.180414
0
11
heat shock 70 kD protein 8 (HSPA8), mRNA/cds = (8

73G2
21
1567
Y00371
Hs.180414
0
16
hsc70 gene for 71 kd heat shock protein/

cds = (83,2023)

62G1
985
1559
X89602
Hs.180433
0
1
rTS beta protein/cds = (17,1267)/gb = X896

98F9
1479
3653
L38951
Hs.180446
0
9
importin beta subunit mRNA, complete cds/cds = (

590F12
283
614
NM_001026
Hs.180450
0
1
ribosomal protein S24 (RPS24), mRNA/cds = (142,

597F2
2670
3046
AF187554
Hs.180532
0
47
sperm antigen-36 mRNA, complete cds/cds = (234,

482E2
85
366
AL571386
Hs.180546
1.00E−106
1
AL571386 cDNA/clone = CS0DI009YL09-(3-prime)

109C2
324
682
BE540238
Hs.180549
1.00E−143
1
601059809F1 cDNA, 5′ end/clone = IMAGE: 3446283

68G8
1447
3594
AF123094
Hs.180566
0
3
API2-MLT fusion protein (API2-MLT) mRNA, comp

180B9
1851
2142
NM_002087
Hs.180577
1.00E−160
2
granulin (GRN), mRNA/cds = (62,1843)/gb = NM_00

51E4
880
2466
NM_005066
Hs.180610
0
6
splicing factor proline/glutamine rich (poly

50G4
880
1280
X70944
Hs.180610
0
1
PTB-associated splicing factor/cds = (85

127C8
317
3175
AK023143
Hs.180638
0
5
cDNA FLJ13081 fis, clone NT2RP3002033/cds = (17

125E2
287
1692
AL117621
Hs.180777
0
2
mRNA; cDNA DKFZp564M0264 (from clone

DKFZp564

521F11
1969
2431
AF126964
Hs.180799
0
1
C3HC4-type zinc finger protein (LZK1) mRNA, co

479C11
1186
2245
AK000271
Hs.180804
1.00E−155
2
cDNA FLJ20264 fis, clone COLF7912/

cds = UNKNOWN

479C2
732
911
NM_001242
Hs.180841
3.00E−62
1
tumor necrosis factor receptor superfamily, m

596D2
67
942
NM_000977
Hs.180842
0
11
ribosomal protein L13 (RPL13), mRNA/cds = (51,6

41E9
884
1779
AL050337
Hs.180866
0
2
DNA sequence from clone 503F13 on chromosome

6q24.1-25

196C10
679
1338
NM_000416
Hs.180866
0
2
interferon gamma receptor 1 (IFNGR1), mRNA/cd

99A10
1
1655
AF218029
Hs.180877
0
11
clone PP781 unknown mRNA/cds = (113,523)/gb = A

65H9
1
1320
Z48950
Hs.180877
0
6
hH3.3B gene for histone H3.3/cds = (10,420)/gb = Z

160G1
2065
2538
AF045555
Hs.180900
0
2
wbscr1 (WBSCR1) and wbscr5 (WBSCR5) genes,

com

596B1
5
860
NM_001008
Hs.180911
0
5
ribosomal protein S4, Y-linked (RPS4Y), mRNA

192F11
1857
2521
AK000299
Hs.180952
0
1
cDNA FLJ20292 fis, clone HEP05374/cds = (21,140

75D10
94
1656
AY007118
Hs.181013
0
8
clone CDABP0006 mRNA sequence/cds = (20,784)/

46H2
105
1661
NM_002629
Hs.181013
0
5
phosphoglycerate mutase 1 (brain) (PGAM1), mR

107G10
4869
5527
AK024391
Hs.181043
0
1
FLJ14329 fis, clone PLACE4000259, highly

179A1
22
908
AK001934
Hs.181112
0
2
FLJ11072 fis, clone PLACE1004982/cds = (2

118D5
610
1130
NM_014166
Hs.181112
0
1
HSPC126 protein (HSPC126), mRNA/cds = (25,837)

483D9
659
915
X57809
Hs.181125
1.00E−123
1
rearranged immunoglobulin lambda light chain mRNA/c

596B10
499
1198
NM_005517
Hs.181163
0
2
high-mobility group (nonhistone chromosomal)

74A12
34
1674
AK026650
Hs.181165
0
192
FLJ22997 fis, clone KAT11962, highly sim

99H8
1079
2742
BC001412
Hs.181165
0
260
eukaryotic translation elongation factor 1

70F10
144
840
AB015798
Hs.181195
0
1
HSJ2 mRNA for DnaJ homolog, complete cds/cds = MRJ

64E10
72
856
BC002446
Hs.181195
0
2
gene for a member of protein family, clone

597F6
1119
1767
NM_001675
Hs.181243
0
3
activating transcription factor 4 (tax-respon

109D8
825
1233
D32129
Hs.181244
0
1
HLA class-I (HLA-A26) heavy chain, complete c

593H10
465
1222
NM_016057
Hs.181271
0
3
CGI-120 protein (LOC51644), mRNA/cds = (37,570

127H10
4782
5154
AB020335
Hs.181300
0
1
Pancreas-specific TSA305 mRNA, complete cds

150F7
509
1238
M11353
Hs.181307
1.00E−175
5
H3.3 histone class C mRNA, complete cds/

cds = (374,784)

127F7
895
1057
NM_002107
Hs.181307
3.00E−85
2
H3 histone, family 3A (H3F3A), mRNA/cds = (374,7

39H10
6
416
BF676042
Hs.181357
0
7
602084011F1 cDNA, 5′ end/clone = IMAGE: 4248195

99G12
193
842
NM_002295
Hs.181357
0
28
laminin receptor 1 (67 kD, ribosomal protein SA

66A12
312
1084
M20430
Hs.181366
0
4
MHC class II HLA-DR-beta (DR2-DQw1/DR4 DQw3)

mRNA, co

71H11
748
1096
NM_002125
Hs.181366
1.00E−176
1
major histocompatibility complex, class II,

56E4
272
521
AI827911
Hs.181400
1.00E−126
1
wf34e11.x1 cDNA, 3′ end/clone = IMAGE: 2357516

170F6
5255
5724
D63486
Hs.181418
0
1
KIAA0152 gene, complete cds/cds = (128,1006)

464A11
5981
6322
NM_014730
Hs.181418
1.00E−159
1
KIAA0152 gene product (KIAA0152), mRNA/cds = (

514F6
1
232
AW955745
Hs.181426
1.00E−117
1
EST367815 cDNA/gb = AW955745/gi = 8145428/ug = TRAF4

177E2
690
947
U81002
Hs.181466
1.00E−130
2
associated factor 1 mRNA, partial cds/c

99B5
260
1660
NM_001549
Hs.181874
0
6
interferon-induced protein with tetratricope

595H9
104
645
M90356
Hs.181967
0
1
BTF3 protein homologue gene, complete cds/

cds = (0,644

67E2
1057
1782
AK026664
Hs.182225
4.00E−85
3
FLJ23011 fis, clone LNG00572/cds = (288,7

190A3
319
1615
NM_014052
Hs.182238
0
7
GW128 protein (GW128), mRNA/cds = (698,889)/g

140B10
1770
2034
U46751
Hs.182248
2.00E−92
1
phosphotyrosine independent ligand p62 for the Lck S

158H11
371
597
D50420
Hs.182255
1.00E−126
1
OTK27, complete cds/cds = (94,480)/gb

584A12
95
1397
NM_005008
Hs.182255
0
3
non-histone chromosome protein 2 (S. cerevisia

40G2
735
908
Y00503
Hs.182265
7.00E−41
1
keratin 19/cds = (32,1234)/gb = Y00503/gi = 340

596E7
1
886
NM_001743
Hs.182278
0
3
calmodulin 2 (phosphorylase kinase, delta) (C

129E10
36
350
L29348
Hs.182378
1.00E−174
2
granulocyte-macrophage colony-stimulating

487G1
184
934
NM_002952
Hs.182426
0
3
ribosomal protein S2 (RPS2), mRNA/cds = (240,90

517G6
126
1497
NM_005742
Hs.182429
0
4
protein disulfide isomerase-related protein

60E12
10
1329
M16342
Hs.182447
0
4
nuclear ribonucleoprotein particle (hnRNP) C protein

98E9
10
1184
NM_004500
Hs.182447
0
8
heterogeneous nuclear ribonucleoprotein C (

496A4
87
1835
NM_014394
Hs.182470
0
2
PTD10 protein (PTD010), mRNA/cds = (129,1088)

110F11
947
1571
AF061738
Hs.182579
0
2
leucine aminopeptidase mRNA, complete cds/cd

124E1
1330
1889
NM_005739
Hs.182591
0
2
RAS guanyl releasing protein 1 (calcium and DA

143B2
32
565
Z47087
Hs.182643
0
1
RNA polymerase II elongation factor-like

103D2
161
538
NM_001015
Hs.182740
8.00E−97
5
ribosomal protein S11 (RPS11), mRNA/cds = (15,4

331C2
1310
1585
D64015
Hs.182741
1.00E−136
1
for T-cluster binding protein, complete c

59E9
27
269
BF245224
Hs.182825
1.00E−105
1
601863885F1 cDNA, 5′ end/clone = IMAGE: 4082396

525E3
12
261
NM_007209
Hs.182825
1.00E−135
2
ribosomal protein L35 (RPL35), mRNA/cds = (27,3

70C9
189
625
BE963551
Hs.182928
1.00E−129
1
601657346R1 cDNA, 3′ end/clone = IMAGE: 3866266

177B9
14
561
BF242969
Hs.182937
0
2
601877739F1 cDNA, 5′ end/clone = IMAGE: 4106289

519H3
34
526
NM_021130
Hs.182937
0
1
peptidylprolyl isomerase A (cyclophilin A) (

159A5
3163
3579
AK026491
Hs.182979
1.00E−141
2
FLJ22838 fis, clone KAIA4494, highly sim

106G11
2956
3527
AF204231
Hs.182982
1.00E−138
2
88-kDa Golgi protein (GM88) mRNA, complete cds

169A3
2117
2495
M33336
Hs.183037
1.00E−105
3
cAMP-dependent protein kinase type I-alpha subunit (

124H9
2767
2955
NM_002734
Hs.183037
7.00E−91
1
protein kinase, cAMP-dependent, regulatory,

107B3
2877
3182
U17989
Hs.183105
1.00E−170
1
nuclear autoantigen GS2NA mRNA, complete cds/

476A6
538
893
NM_016523
Hs.183125
0
1
killer cell lectin-like receptor F1 (KLRF1), m

75A1
629
1222
AK001433
Hs.183297
0
1
FLJ10571 fis, clone NT2RP2003121, weakly

597E11
97
1656
AF248966
Hs.183434
0
5
HT028 mRNA, complete cds/cds = (107,1159)/gb = cDNA

124A2
2015
2756
AK024275
Hs.183506
0
1
FLJ14213 fis, clone NT2RP3003572/cds = (11

74F2
2082
2418
U53347
Hs.183556
1.00E−177
2
neutral amino acid transporter B mRNA, complete cds/

482C5
1211
1688
NM_018399
Hs.183656
0
1
VNN3 protein (HSA238982), mRNA/cds = (45,1550)

594H12
1718
3458
NM_001418
Hs.183684
0
4
eukaryotic translation initiation factor 4 g

61H11
1457
2024
U73824
Hs.183684
0
2
p97 mRNA, complete cds/cds = (306,3029)/

gb = U73824/g

75H7
342
2258
M26880
Hs.183704
0
7
ubiquitin mRNA, complete cds/cds = (135,2192)/

gb = M26

599E7
2306
3111
D44640
Hs.183706
0
6
HUMSUPY040 cDNA/clone = 035-00-1/gb = D44640/

518H4
1554
1973
NM_002078
Hs.183773
0
1
golgi autoantigen, golgin subfamily a, 4 (GOL

520C3
98
255
NM_018955
Hs.183842
3.00E−64
1
ubiquitin B (UBB), mRNA/cds = (94,783)/gb = NM_—

102C11
1730
1808
M15182
Hs.183868
8.00E−33
2
beta-glucuronidase mRNA, complete cds/

cds = (26,1981

523D3
1730
2183
NM_000181
Hs.183868
0
2
glucuronidase, beta (GUSB), mRNA/cds = (26,198

187A12
122
828
NM_003589
Hs.183874
0
1
cullin 4A (CUL4A), mRNA/cds = (160,2139)/gb = N

156F4
228
907
AF119665
Hs.184011
0
4
inorganic pyrophosphatase complete cds

525B8
225
791
NM_021129
Hs.184011
0
2
pyrophosphatase (inorganic) (PP), nuclear ge

589B1
3
394
NM_000993
Hs.184014
0
10
ribosomal protein L31 (RPL31), mRNA/cds = (7,38

99D6
3909
4308
NM_004985
Hs.184050
1.00E−145
1
v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene

166B3
12
345
BE964596
Hs.184052
1.00E−90
1
601658521R1 cDNA, 3′ end/clone = IMAGE: 3885796

591G6
1348
1958
NM_022152
Hs.184052
0
3
PP1201 protein (PP1201), mRNA/cds = (66,1001)

114E11
1780
1942
AK025645
Hs.184062
4.00E−59
1
cDNA: FLJ21992 fis, clone HEP06554/cds = (60,84

597E4
8
407
NM_000982
Hs.184108
1.00E−114
6
ribosomal protein L21 (gene or pseudogene) (RP

162C5
295
1062
L41887
Hs.184167
0
3
splicing factor, arginine/serine-rich 7 (SFR

109F6
151
749
AF054182
Hs.184211
0
1
mitochondrial processing peptidase beta-subu

462C6
4590
5087
NM_015001
Hs.184245
0
1
KIAA0929 protein Msx2 interacting nuclear tar

517D1
1510
1936
NM_004252
Hs.184276
1.00E−162
7
solute carrier family 9 (sodium/hydrogen exch

55E3
174
427
NM_018370
Hs.184465
1.00E−107
1
hypothetical protein FLJ11259 (FLJ11259), mR

50F9
2484
3108
AB023182
Hs.184523
0
1
for KIAA0965 protein, partial cds/cds = (0

100A4
297
1941
AK025730
Hs.184542
1.00E−149
3
FLJ22077 fis, clone HEP12728, highly sim

113D4
950
1623
NM_016061
Hs.184542
0
1
CGI-127 protein (LOC51646), mRNA/cds = (125,49

145D11
41
339
BE730026
Hs.184582
1.00E−111
1
601562642F1 cDNA, 5′ end/clone = IMAGE: 3832258

595F4
69
548
NM_000986
Hs.184582
0
1
ribosomal protein L24 (RPL24), mRNA/cds = (39,5

108H10
250
701
U00946
Hs.184592
0
1
clone A9A2BRB5 (CAC)n/(GTG)n repeat-containing

mRN

43B5
4399
4488
AF104032
Hs.184601
3.00E−24
1
L-type amino acid transporter subunit LAT1 mRN

104F12
298
1713
NM_014999
Hs.184627
0
2
KIAA0118 protein (KIAA0118), mRNA/cds = (255,9

122E8
513
995
AF035307
Hs.184697
0
2
clone 23785 mRNA sequence/cds = UNKN0WN/

gb = AF

40H2
66
2605
M37197
Hs.184760
1.00E−177
4
CCAAT-box-binding factor (CBF) mRNA, complete cds/c

514E4
29
519
NM_000984
Hs.184776
0
3
ribosomal protein L23a (RPL23A), mRNA/cds = (2

589A7
736
983
AK025533
Hs.184793
1.00E−138
1
cDNA: FLJ21880 fis, clone HEP02743/cds = UNKNOW

142G5
1918
2157
AL049782
Hs.184938
8.00E−83
3
Novel human gene mapping to chomosome 13/

cds = UNKNOWN/gb = A

462G9
178
398
AI085568
Hs.185062
1.00E−76
1
oy68b05.x1 cDNA, 3′ end/clone = IMAGE: 1670961

470C12
81
333
T98171
Hs.185675
1.00E−105
1
ye56c12.s1 cDNA, 3′ end/clone = IMAGE: 121750/

463F2
3175
3359
NM_014686
Hs.186840
1.00E−72
1
KIAA0355 gene product (KIAA0355), mRNA/cds = (

461E4
907
1118
NM_018519
Hs.186874
4.00E−91
1
hypothetical protein PRO2266 (PRO2266), mRNA

155A1
53
379
AI619574
Hs.187362
1.00E−109
1
ty50c09.x1 cDNA, 3′ end/clone = IMAGE: 2282512

461C9
2948
3458
NM_014504
Hs.187660
0
1
putative Rab5 GDP/GTP exchange factor homologu

470F2
5
331
BE646499
Hs.187872
1.00E−156
1
7e87h02.x1 cDNA, 3′ end/clone = IMAGE: 3292179

68D12
590
740
AW963239
Hs.187908
4.00E−66
1
EST375312/gb = AW963239/gi = 8153075/ug =

75H12
2012
2585
AL110269
Hs.187991
0
1
cDNA DKFZp564A122 (from clone DKFZp564A1

167G4
1474
1958
NM_015626
Hs.187991
0
1
DKFZPS64A122 protein (DKFZP564A122), mRNA/c

137G3
54
197
AI625368
Hs.188365
2.00E−34
46
ts37c10.x1 cDNA, 3′ end/clone = IMAGE: 2230770

464C12
183
404
AA432364
Hs.188777
7.00E−94
1
zw76a09.s1 cDNA, 3′ end/clone = IMAGE: 782104/

467E9
29
183
AA576947
Hs.188886
1.00E−63
1
nm82b04.s1 cDNA, 3′ end/clone = IMAGE: 1074703

467B4
349
459
AI392805
Hs.189031
2.00E−49
1
tg04h03.x1 cDNA, 3′ end/clone = IMAGE: 2107829

461E2
242
473
BE674964
Hs.190065
1.00E−109
1
7f11b09.x1 cDNA, 3′ end/clone = IMAGE: 3294329

466F4
58
295
BG326781
Hs.190219
1.00E−132
1
602425659F1 cDNA, 5′ end/clone = IMAGE: 4563471

465H4
111
558
AA582958
Hs.190229
0
1
nn80d08.s1 cDNA, 3′ end/clone = IMAGE: 1090191

470F9
26
529
AI763206
Hs.190453
0
1
wh95e09.x1 cDNA, 3′ end/clone = IMAGE: 2388520

66H12
1
3459
D00099
Hs.190703
0
5
for Na, K-ATPase alpha-subunit, complete

472E1
338
540
AW294083
Hs.190904
2.00E−46
1
UI-H-BI2-ahg-b-05-0-UI.s1 cDNA, 3′ end/clon

522G10
433
970
NM_003757
Hs.192023
0
2
eukaryotic translation initiation factor 3,

54GB
29
410
AW838827
Hs.192123
0
1
CM1-LT0059-280100-108-e02/gb = AW838827

465G4
261
515
BF224348
Hs.192463
1.00E−104
1
7q86c05.x1 cDNA/clone = IMAGE/gb = BF224348/g

468F9
392
487
AI524039
Hs.192524
2.00E−36
1
tg99h02.x1 cDNA, 3′ end/clone = IMAGE: 2116947

466C6
111
392
AW972048
Hs.192534
1.00E−153
1
EST384032 cDNA/gb = AW972048/gi = 8161789/ug =

184F12
1
677
AF090927
Hs.192705
0
1
clone HQ0457 PRO0457 mRNA, complete cds/cds = (

464C11
1
65
BE298181
Hs.192755
3.00E−23
1
601118566F1 cDNA, 5′ end/clone = IMAGE: 3028193

465H3
108
706
BG036938
Hs.192965
0
1
602287708F1 cDNA, 5′ end/clone = IMAGE: 4375153

169F9
4138
4890
D87454
Hs.192966
0
1
KIAA0265 gene, partial cds/cds = (0,1205)/gb

118H10
1104
1858
AK024263
Hs.193063
1.00E−132
2
cDNA FLJ14201 fis, clone NT2RP3002955/cds = UNK

472F3
28
405
BF062295
Hs.193237
0
1
7k76b11.x1 cDNA, 3′ end/clone = IMAGE: 3481293

40A5
1933
2611
X12830
Hs.193400
0
1
interleukin-6 (IL-6) receptor/cds = (437,184

63B5
327
582
AW959162
Hs.193669
1.00E−103
1
EST371232/gb = AW959162/gi = 8148846/ug =

52G10
803
1173
M57627
Hs.193717
0
1
interleukin 10 (IL10) mRNA, complete cds/

cds = (30,566

469F5
2088
2438
AL110204
Hs.193784
1.00E−179
1
mRNA; cDNA DKFZp586K1922 (from clone

DKFZp586K

598H7
1428
1715
NM_014828
Hs.194035
1.00E−119
1
KIAA0737 gene product (KIAA0737), mRNA/cds = (

462B6
103
546
BE618004
Hs.194362
1.00E−165
1
601462354F1 cDNA, 5′ end/clone = IMAGE: 3865861

472F12
1177
1667
AB036737
Hs.194369
0
2
mRNA for RERE, complete cds/cds = (636,5336)/g

182E10
11785
13486
U82828
Hs.194382
0
5
ataxia telangiectasia (ATM) gene, complete cd

458F4
258
408
NM_022739
Hs.194477
2.00E−62
1
E3 ubiquitin ligase SMURF2 (SMURF2), mRNA/cd

583D2
1425
1732
NM_014232
Hs.194534
1.00E−136
1
vesicle-associated membrane protein 2 (synapt

38H8
1198
1620
U89387
Hs.194638
0
1
RNA polymerase II subunit hsRPB4 gene, complete

cds/

122H10
5292
5481
NM_023005
Hs.194688
4.00E−80
1
bromodomain adjacent to zinc finger domain, 1B

186G9
1
1908
AL136945
Hs.194718
0
2
mRNA; cDNA DKFZp586O012 (from clone

DKFZp586O0

113F3
1852
2375
NM_000634
Hs.194778
0
1
interleukin 8 receptor, alpha (IL8RA), mRNA/

106A3
35
404
U11870
Hs.194778
0
1
interleukin-8 receptor type A (IL8RBA) gene, promote

473B8
1001
1314
AF319438
Hs.194976
1.00E−172
1
SH2 domain-containing phosphatase anchor pro

57F9
442
1934
Y14039
Hs.195175
0
27
mRNA for CASH alpha protein/cds = (481,1923)/g

49E5
2314
2512
NM_018666
Hs.195292
2.00E−37
1
putative tumor antigen (SAGE), mRNA/cds = (167,

473B10
406
532
BE671815
Hs.195374
1.00E−54
1
7a47c12.x1 cDNA, 3′ end/clone = IMAGE: 3221878

595B5
59
311
AI653766
Hs.195378
6.00E−46
1
ty01b06.x1 cDNA, 3′ end/clone = IMAGE: 2277779

60G4
42
1554
D13642
Hs.195614
0
2
KIAA0017 gene, complete cds/cds = (136,1335)

473B9
739
927
AF241534
Hs.196015
2.00E−73
1
hydatidiform mole associated and imprinted (H

99C10
1075
1424
NM_000294
Hs.196177
1.00E−115
1
phosphorylase kinase, gamma 2 (testis) (PHKG2

45H9
956
1405
AF283645
Hs.196270
0
1
folate transporter/carrier mRNA, complete cd

54F9
2567
2954
U04636
Hs.196384
0
1
cyclooxygenase-2 (hCox-2) gene, complete cds/

cds = (1

38F12
401
606
AI984074
Hs.196398
1.00E−104
1
wz56c02.x1 cDNA, 3′ end/clone = IMAGE: 2562050

157G1
403
551
AJ006835
Hs.196769
7.00E−77
2
RNA transcript from U17 small nucleolar RNA ho

163F4
1
402
AI650871
Hs.197028
0
1
wa95f03.x1 cDNA, 3′end/clone = IMAGE: 2303933

160B3
408
476
AI832038
Hs.197091
5.00E−27
1
wj99e02.x1 3′end/clone = IMAGE: 2410970

105E8
1299
3674
AB020657
Hs.197298
0
6
for KIAA0850 protein, complete cds/cds = (

178G12
2097
3593
AF205218
Hs.197298
0
8
NS1-binding protein-like protein mRNA, compl

585F1
284
1711
NM_001469
Hs.197345
0
4
thyroid autoantigen 70 kD (Ku antigen) (G22P1)

39C10
545
1984
Z83840
Hs.197345
0
2
DNA sequence from clone CTA-216E10 on

chromosome 22 C

58E12
2162
3013
NM_001530
Hs.197540
0
2
hypoxia-inducible factor 1, alpha subunit (ba

125G11
3673
4059
D29805
Hs.198248
0
1
mRNA for beta-1,4-galactosyltransferase, complete

41H10
6
821
M33906
Hs.198253
1.00E−156
2
MHC class II HLA-DQA1 mRNA, complete cds/

cds = (43,810)

186A11
551
1031
NM_004544
Hs.198271
0
2
NADH dehydrogenase (ubiquinone) 1 alpha subco

126D8
993
1381
NM_021105
Hs.198282
0
1
phospholipid scramblase 1 (PLSCR1), mRNA/cds

174C12
4824
5257
NM_003070
Hs.198296
0
1
SWI/SNF related, matrix associated, actin dep

109C6
128
833
X04327
Hs.198365
0
1
erythrocyte 2,3-bisphosphoglycerate mutase mRNA

EC

64B12
4383
5289
NM_000189
Hs.198427
0
2
hexokinase 2 (HK2), mRNA/cds = (1490,4243)/gd

70B4
3267
5289
Z46376
Hs.198427
0
4
HK2 mRNA for hexokinase II/cds = (1490,4243)/gb = Z

478H6
186
475
AI978581
Hs.198694
1.00E−129
1
wq72d08.x1 cDNA, 3′ end/clone = IMAGE: 2476815

587G1
767
1143
NM_006837
Hs.198767
1.00E−170
1
COP9 (constitutive photomorphogenic, Arabido

465F12
373
554
BE621611
Hs.198802
2.00E−77
1
601493754T1 cDNA, 3′ end/clone = IMAGE: 3895836

123B3
310
3608
AB011108
Hs.198891
0
3
mRNA for KIAA0536 protein, partial cds/cds = (0,

157H3
3457
5268
D50929
Hs.198899
0
2
KIAA0139 gene, complete cds/cds = (128,4276)

477H1
35
592
NM_002229
Hs.198951
0
1
jun B proto-oncogene (JUNB), mRNA/cds = (253,12

53C5
979
1296
X51345
Hs.198951
1.00E−160
1
jun-B mRNA for JUN-B protein/cds = (253,1296)/

gb = X513

54H8
350
501
AW450874
Hs.199014
5.00E−81
1
UI-H-BI3-all-a-11-0-UI.s1 cDNA, 3′ end/clon

520E12
3506
3878
L04731
Hs.199160
0
1
translocation T(4:11) of ALL-1 gene to chromoso

57F4
5941
6266
NM_006267
Hs.199179
1.00E−158
1
RAN binding protein 2 (RANBP2), mRNA/cds = (127,

50B10
5
3645
D86984
Hs.199243
0
2
KIAA0231 gene, partial cds/cds = (0,1430)/gb

68E12
1757
2052
L25124
Hs.199248
1.00E−156
2
prostaglandin E2 receptor mRNA, complete cds/

484H3
1879
1958
NM_000958
Hs.199248
3.00E−33
1
prostaglandin E receptor 4 (subtype EP4) (PTGE

466G6
368
3287
NM_013233
Hs.199263
0
2
Ste-20 related kinase (SPAK), mRNA/cds = (173,1

464B9
633
1068
AF015041
Hs.199291
0
1
NUMB-R protein (NUMB-R) mRNA, complete cds/c

522F9
2
116
AI669591
Hs.200442
5.00E−59
1
tw34b09.x1 cDNA, 3′ end/clone = IMAGE: 2261561

60F11
4945
5114
AB040942
Hs.201500
7.00E−92
1
for KIAA1509 protein, partial cds/cds = (0

72D12
819
1293
AF104398
Hs.201673
0
1
comichon mRNA, complete cds/cds = (56,490)/g

105G5
1629
2130
AF091263
Hs.201675
0
1
RNA binding motif protein 5 (RBM5) mRNA, comple

116G3
1637
2854
NM_005778
Hs.201675
0
2
RNA binding motif protein 5 (RBM5), mRNA/cds = (

40A10
254
431
AI693179
Hs.201789
5.00E−85
1
wd68d12.x1 cDNA, 3′ end/clone = IMAGE: 2336759

473D4
421
547
BE551203
Hs.201792
3.00E−49
1
7b55h12.x1 cDNA, 3′ end/clone = IMAGE: 3232199

472D8
313
623
AW390251
Hs.202402
1.00E−123
1
CM4-ST0182-051099-021-b06 cDNA/gb = AW390251

66H5
176
482
AI271437
Hs.203041
1.00E−173
1
qi19c05.x1 cDNA, 3′ end/clone = IMAGE: 1856936

594C2
35
368
AW131782
Hs.203606
1.00E−147
2
xf34e08.x1 cDNA, 3′ end/clone = IMAGE: 2619974

138B12
101
420
AW194379
Hs.203755
1.00E−93
3
xm08h07.x1 3′ end/clone = IMAGE: 2683645

473D3
1
234
AI538474
Hs.203784
1.00E−117
1
td06h08.x1 cDNA, 3′ end/clone = IMAGE: 2074911

471A5
113
442
AI393908
Hs.203829
1.00E−153
1
tg05f10.x1 cDNA, 3′ end/clone = IMAGE: 2107915

40A4
1621
2037
AF004230
Hs.204040
0
1
monocyte/macrophage Ig-related receptor MIR

463H1
7
319
AW977671
Hs.204214
1.00E−161
1
EST389900 cDNA/gb = AW977671/gi = 8169049/ug =

478E7
25
434
AI762023
Hs.204610
0
2
wh89f04.x1 cDNA, 3′ end/clone = IMAGE: 2387935

55E11
324
469
AI741246
Hs.204656
100E−58
12
wg26g09.x1 cDNA, 3′ end/clone = IMAGE: 2366272

478G10
345
476
AI760901
Hs.204703
9.00E−34
1
wi09h06.x1 cDNA, 3′ end/clone = IMAGE: 2389787

470E11
374
507
AI762741
Hs.204707
2.00E−49
1
wh93h02.x1 cDNA, 3′ end/clone = IMAGE: 2388339

478F5
179
437
AI086035
Hs.204873
1.00E−110
1
oy70h04.x1 cDNA, 3′ end/clone = IMAGE: 1671223

464G4
33
320
AI749444
Hs.204929
5.00E−50
1
at24c03.x1 cDNA, 3′ end/clone = IMAGE: 2356036

472D2
88
198
AI760018
Hs.205071
4.00E−54
1
wh83b02.x1 cDNA, 3′ end/clone = IMAGE: 2387307

470D9
5
422
AW976641
Hs.205079
0
1
EST388750 cDNA/gb = AW976641/gi = 8167872/ug =

470D4
122
500
AA885473
Hs.205175
0
1
am10c12.s1 cDNA, 3′ end/clone = IMAGE: 1466422

473C5
285
525
BF679831
Hs.205319
2.00E−96
1
602154415F1 cDNA, 5′ end/clone = IMAGE: 4295595

470E7
295
521
AI762557
Hs.205327
9.00E−95
2
wh92f07.x1 cDNA, 3′ end/clone = IMAGE: 2388229

478F11
11
447
AI761141
Hs.205452
0
3
wh97g08.x1 cDNA, 3′ end/clone = IMAGE: 2388734

459A12
111
323
N72600
Hs.205555
9.00E−96
1
za46f08.s1 cDNA, 3′ end/clone = IMAGE: 295623/

470F4
214
481
AW977820
Hs.205675
1.00E−131
1
EST389824 cDNA/gb = AW977820/gi = 8168971/ug =

102G3
1
249
BF680988
Hs.205696
2.00E−78
1
602156272F1 cDNA, 5′ end/clone = IMAGE: 4297216

472B2
312
700
BF794256
Hs.206761
0
1
602255454F1 cDNA, 5′ end/clone = IMAGE: 4338949

470C1
1113
1643
AK024118
Hs.206868
0
1
cDNA FLJ14056 fis, clone HEMBB1000335/cds = UNK

469H7
1076
1215
U15177
Hs.206984
3.00E−69
1
cosmid CRI-JC2015 at D10S289 in 10sp13/

cds = (0,1214)

61F9
5
181
AW340421
Hs.207995
4.00E−94
1
hc96h02.x1 cDNA, 3′ end/clone = IMAGE: 2907891

473C2
239
551
BF439675
Hs.208854
1.00E−151
1
nab69e11.x1 cDNA/clone = IMAGE/gb = BF439675/

62G11
159
292
BE781611
Hs.208985
1.00E−60
1
601467463F1 cDNA, 5′ end/clone = IMAGE: 3870902

472E2
258
554
AI343473
Hs.209203
1.00E−135
1
tb97a08.x1 cDNA, 3′ end/clone = IMAGE: 2062262

471C10
148
498
AI768880
Hs.209511
0
1
wh71e04.x1 cDNA, 3′ end/clone = IMAGE: 2386206

470G9
416
561
AI798144
Hs.209609
4.00E−63
1
wh81g12.x1 cDNA, 3′ end/clone = IMAGE: 2387206

478C10
120
447
AI809310
Hs.210385
1.00E−158
2
wh75h08.x1 cDNA, 3′ end/clone = IMAGE: 2386623

476B7
64
341
AI075288
Hs.210727
1.00E−151
2
oy69h10.x1 cDNA, 3′ end/clone = IMAGE: 1671139

477G4
915
1541
AB040919
Hs.210958
0
1
mRNA for KIAA1486 protein, partial cds/cds = (1

468C2
215
498
AI832182
Hs.210995
1.00E−145
1
td13h11.x1 cDNA, 3′ end/clone = IMAGE: 2075589

472D11
1
300
AI860120
Hs.211024
1.00E−126
1
wh39e01.x1 cDNA, 3′ end/clone = IMAGE: 2383128

470D3
30
317
AW362304
Hs.211194
1.00E−137
1
CM3-CT0275-031199-031-a08 cDNA/gb = AW362304

179F6
105
551
AI823649
Hs.211535
0
1
wi85g03.x1 3′ end/clone = IMAGE: 2400148

477G12
2439
4050
NM_020993
Hs.211563
0
4
B-cell CLL/lymphoma 7A (BCL7A), mRNA/cds = (953

39A11
5178
5792
L10717
Hs.211576
0
2
T cell-specific tyrosine kinase mRNA, complete

187B9
5365
5790
NM_005546
Hs.211576
0
1
IL2-inducible T-cell kinase (ITK), mRNA/cds =

152C2
3965
4297
Z22551
Hs.211577
1.00E−174
1
kinectin gene/cds = (69,4139)/gb = Z22551/gi = 296

120A2
2556
2917
NM_005955
Hs.211581
0
1
metal-regulatory transcription factor 1 (MTF

147A2
2915
4407
M59465
Hs.211600
0
6
tumor necrosis factor alpha inducible protein A20 mRN

583B12
2404
3981
NM_006290
Hs.211600
0
11
tumor necrosis factor, alpha-induced protein

589F3
1905
2274
AF090693
Hs.211610
0
1
apoptosis-related RNA binding protein (NAPOR-

470G11
277
462
AI862623
Hs.211744
5.00E−99
1
wh99h10.x1 cDNA, 3′ end/clone = IMAGE: 2388931

473F2
195
423
BE675092
Hs.211828
2.00E−95
1
7f02d07.x1 cDNA, 3′ end/clone = IMAGE: 3293485

517D2
1059
1366
BC000747
Hs.211973
1.00E−162
2
Similar to homolog of Yeast RRP4 (ribosomal RN

109D9
391
533
AI922921
Hs.212553
2.00E−68
1
wn81c05.x1 cDNA, 3′ end/clone = IMAGE: 2452232

494H12
172
549
AI912585
Hs.213385
0
3
we11d07.x1 cDNA, 3′ end/clone = IMAGE: 2340781

596G11
4740
5687
AB007916
Hs.214646
0
8
mRNA for KIAA0447 protein, partial cds/cds = (2

104C12
843
1787
AL031282
Hs.215595
0
2
DNA sequence from clone 283E3 on chromosome

1p36.21-36

124F8
1391
2913
NM_002074
Hs.215595
0
4
guanine nucleotide binding protein (G protein)

157E8
1264
1627
AK001548
Hs.215766
0
4
FLJ10686 fis, clone NT2RP3000252, highly

519G3
1729
2094
NM_012341
Hs.215766
0
1
GTP-binding protein (NGB), mRNA/cds = (23,1924

473E7
2278
2472
AB022663
Hs.215857
3.00E−52
1
HFB30 mRNA, complete cds/cds = (236,1660)/gb =

104F7
4
1324
D00017
Hs.217493
0
3
for lipocortin II, complete cds/cds = (49,1

58G2
11
1324
NM_004039
Hs.217493
0
7
annexin A2 (ANXA2), mRNA/cds = (49,1068)/gb = N

467D4
27
443
AI392814
Hs.221014
1.00E−180
1
tg10a02.x1 cDNA, 3′ end/clone = IMAGE: 2108330

463B1
69
457
AV686223
Hs.221642
0
1
AV686223 cDNA, 5′ end/clone = GKCGXH11/clone_—

464D10
295
552
BF058398
Hs.221695
1.00E−115
1
7k30d01.x1 cDNA, 3′ end/clone = IMAGE: 3476785

466C12
1
427
AI540165
Hs.222186
0
1
td10d05.x1 cDNA, 3′ end/clone = IMAGE: 2075241

125H10
2596
2917
AB046830
Hs.222746
0
1
mRNA for KIAA1610 protein, partial cds/cds = (0

473C4
1
193
BF435098
Hs.222833
9.00E−72
1
7p05g01.x1 cDNA, 3′ end/clone = IMAGE: 3645097

37B4
18
371
AW389509
Hs.223747
1.00E−147
1
CM3-ST0163-051099-019-b11/gb = AW389509

470H7
106
357
AI766706
Hs.223935
1.00E−116
1
wi02g11.x1 cDNA, 3′ end/clone = IMAGE: 2389124

472D12
1
370
AL133721
Hs.224680
0
1
DKFZp761H09121_r1 cDNA, 5′ end/clone = DKFZp76

124E4
53
208
AI874107
Hs.224760
7.00E−50
3
wm49b01.x1 cDNA, 3′ end/clone = IMAGE: 2439241

477G3
146
412
AI400714
Hs.225567
1.00E−141
1
tg93g12.x1 cDNA, 3′ end/clone = IMAGE: 2116390

112F12
2313
2799
AL163279
Hs.225674
0
1
chromosome 21 segment HS21C079/cds = (0,6888)

118D12
6187
6775
NM_015384
Hs.225767
0
1
IDN3 protein (IDN3), mRNA/cds = (706,7182)/gb

109B7
2208
3315
AF119417
Hs.225939
0
2
nonfunctional GM3 synthase mRNA, alternativel

125A8
2877
3381
NM_006999
Hs.225951
0
1
topoisomerase-related function protein 4-1

129C8
5510
5893
AF012108
Hs.225977
0
1
Amplified in Breast Cancer (AIB1) mRNA, comple

39G12
4498
4859
NM_014977
Hs.227133
1.00E−93
2
KIAA0670 protein/acinus (KIAA0670), mRNA/cd

153D10
1
286
AF000145
Hs.227400
1.00E−139
2
germinal center kinase related protein kinase

464B12
901
1425
AL050131
Hs.227429
0
1
mRNA; cDNA DKFZp586I111 (from clone

DKFZp586I1

459D9
3828
4314
NM_004841
Hs.227806
0
1
ras GTPase activating protein-like (NGAP), mR

135E9
135
773
NM_004049
Hs.227817
0
1
BCL2-related protein A1 (BCL2A1), mRNA/cds = (

59F10
123
808
Y09397
Hs.227817
0
12
GRS protein/cds = (102,629)/gb = Y09397/

516H4
1901
2462
NM_014287
Hs.227823
0
1
pM5 protein (PM5), mRNA/cds = (0,3668)/gb = NM_0

107C12
2776
3390
Y15906
Hs.227913
0
1
for XAGL protein/cds = (132,1646)/gb = Y159

152C7
171
1390
AF052155
Hs.227949
0
2
clone 24761 mRNA sequence/cds = UNKNOWN/

gb = AF

522G8
108
293
AI917348
Hs.228486
2.00E−70
1
ts83d10.x1 cDNA, 3′ end/clone = IMAGE: 2237875

66C7
304
445
AI094726
Hs.228795
1.00E−26
1
qa08f05.x1 cDNA, 3′ end/clone = IMAGE: 1686177

585D1
51
294
AI199388
Hs.228817
5.00E−73
1
qs75e05.x1 cDNA, 3′ end/clone = IMAGE: 1943936

468E9
113
324
AI523873
Hs.228926
7.00E−77
2
tg97c12.x1 cDNA, 3′ end/clone = IMAGE: 2116726

466F1
44
139
AI380491
Hs.229374
3.00E−39
2
tf95b10.x1 cDNA, 3′ end/clone = IMAGE: 2107003

182F1
40
465
AI354231
Hs.229385
1.00E−138
4
qv12c04.x1 cDNA, 3′ end/clone = IMAGE: 1981350

465C1
237
318
AW812896
Hs.229868
3.00E−38
1
RC3-ST0186-250200-018-a11 cDNA/gb = AW812896

178H7
42
353
AI581732
Hs.229918
1.00E−68
5
ar74f03.x1 cDNA, 3′ end/clone = IMAGE: 2128349

72H6
48
534
AI818777
Hs.229990
1.00E−85
3
wl11f10.x1 cDNA, 3′ end/clone = IMAGE: 2424619

181E9
52
279
AI827451
Hs.229993
1.00E−66
1
wl17d11.x1 cDNA, 3′ end/clone = IMAGE: 2425173

38H1
225
311
AI579979
Hs.230430
1.00E−25
1
tq45a01.x1 cDNA, 3′ end/clone = IMAGE: 2211720

489G11
66
369
AI818596
Hs.230492
1.00E−112
5
wk74d04.x1 cDNA, 3′ end/clone = IMAGE: 2421127

118D6
40
161
AI025427
Hs.230752
6.00E−37
1
ow27g06.s1 cDNA, 3′ end/clone = IMAGE: 1648090

462H6
305
437
AI087055
Hs.230805
3.00E−67
1
oy70c09.x1 cDNA, 3′ end/clone = IMAGE: 1671184

107C11
93
240
AI796419
Hs.230939
1.00E−40
1
wj17f02.x1 cDNA, 3′ end/clone = IMAGE: 2403099

591A1
65
316
AA767883
Hs.231154
7.00E−59
4
oa30h07.s1 cDNA, 3′ end/clone = IMAGE: 1306525

471B3
177
519
BE407125
Hs.231510
1.00E−166
1
601301818F1 cDNA, 5′ end/clone = IMAGE: 3636412

64G11
609
950
AL542592
Hs.231816
1.00E−166
1
AL542592 cDNA/clone = CS0DE012YA05-(5-prime)

108G1
1
210
AW006867
Hs.231987
1.00E−109
1
ws15d07.x1 cDNA, 3′ end/clone = IMAGE: 2497261

115F3
44
185
AW016002
Hs.232000
7.00E−75
2
UI-H-BI0p-abh-h-06-0-UI.s1 cDNA, 3′ end/clo

138A6
4771
5194
D15050
Hs.232068
0
1
transcription factor AREB6, complete cds/cd

472A6
311
497
BF195579
Hs.232257
1.00E−78
1
7n85c03.x1 cDNA, 3′ end/clone = IMAGE: 3571205

111A7
285
463
AW026667
Hs.233261
1.00E−41
1
wv15d09.x1 cDNA, 3′ end/clone = IMAGE: 2529617

67G8
292
560
BE719483
Hs.233383
4.00E−94
3
MR1-HT0858-020800-001-c06/gb = BE719483

123B11
180
351
AW006045
Hs.233560
5.00E−82
1
wz81b09.x1 cDNA, 3′ end/clone = IMAGE: 2565209

472E3
1
319
AW027530
Hs.233564
1.00E−180
1
wv74c06.x1 cDNA, 3′ end/clone−IMAGE: 2535274

36F11
943
1896
Z85996
Hs.233750
0
6
DNA sequence from PAC 431A14 on chromosome

6p21. Conta

184G6
49
491
BF694761
Hs.233936
0
9
602080851F2 cDNA, 5′ end/clone = IMAGE: 4245133

599C7
12
540
NM_006471
Hs.233936
0
55
myosin, light polypeptide, regulatory, non-s

156B4
405
774
AF054185
Hs.233952
1.00E−164
1
proteasome subunit HSPC complete cds/c

595G5
85
315
NM_002792
Hs.233952
1.00E−126
1
proteasome (prosome, macropain) subunit, alp

67F5
108
556
AK000654
Hs.234149
0
1
FLJ20647 fis, clone KAT02147/cds = (90,836

591B6
1
555
NM_017918
Hs.234149
0
6
hypothetical protein FLJ20647 (FLJ20647), mR

111B7
1887
2217
AK023204
Hs.234265
1.00E−120
1
cDNA FLJ13142 fis, clone NT2RP3003212, modera

72F6
314
2581
AL035071
Hs.234279
0
2
DNA sequence from clone 1085F17 on chromosome

20q11.1

514H4
2105
2523
NM_012325
Hs.234279
0
1
microtubule-associated protein, RP/EB family

599A10
1
1163
NM_002300
Hs.234489
0
30
lactate dehydrogenase B (LDHB), mRNA/cds = (84

163A8
470
1153
X13794
Hs.234489
0
4
lactate dehydrogenase B gene exon 1 and (EC 1.1.1.

125E5
31
465
NM_000978
Hs.234518
1.00E−117
2
ribosomal protein L23 (RPL23), mRNA/cds = (25,4

471B1
1499
2033
L05148
Hs.234569
0
1
protein tyrosine kinase related mRNA sequence/

cds = UN

466D7
1050
1402
NM_013451
Hs.234680
0
1
fer-1 (C.elegans)-like 3 (myoferlin) (FER1L3)

108B11
407
742
X14008
Hs.234734
0
1
lysozyme gene (EC 3.2.1.17)/cds = (82,474)/

gb = X14008

476A12
3
440
AI076222
Hs.235042
0
2
oy65b09.x1 cDNA, 3′ end/clone = IMAGE: 1670681

464H7
994
2425
AL157426
Hs.235390
1.00E−22
1
mRNA; cDNA DKFZp761B101 (from clone

DKFZp761B1

472F2
2203
2431
AK024137
Hs.235498
7.00E−97
1
cDNA FLJ14075 fis, clone HEMBB1001905, weakly

63C7
1159
1751
AK000260
Hs.235712
0
1
FLJ20253 fis, clone COLF6895/cds = UNKNOWN

73C8
39
485
AI379474
Hs.235823
0
1
tc57g08.x1 cDNA, 3′ end/clone = IMAGE: 2068766

590H8
182
449
AA020845
Hs.235883
1.00E−145
3
ze64a07.r1 cDNA, 5′ end/clone = IMAGE: 363732/

182H3
468
2009
NM_001535
Hs.235887
1.00E−119
5
HMT1 (hnRNP methyltransferase, S. cerevisiae)

119B12
253
596
NM_003075
Hs.236030
0
1
SWI/SNF related, matrix associated, actin dep

461C5
654
1112
AK026410
Hs.236449
0
1
cDNA: FLJ22757 fis, clone KAIA0803/cds = (92,24

182G3
514
2817
AK023223
Hs.236494
0
2
FLJ13161 fis, clone NT2RP3003589, highly

469G7
857
1336
AK026359
Hs.236744
0
1
cDNA: FLJ22706 fis, clone HSI13163/cds = UNKNOW

592A9
1522
1888
NM_020135
Hs.236828
0
1
putative helicase RUVBL (LOC56897), mRNA/cds

177A1
1260
1704
AK001514
Hs.236844
1.00E−170
1
FLJ10652 fis, clone NT2RP2005886/cds = (50

594G2
916
1537
NM_018169
Hs.236844
0
2
hypothetical protein FLJ10652 (FLJ10652), mR

98D10
1881
1964
NM_006947
Hs.237825
9.00E−36
1
signal recognition particle 72 kD (SRP72), mRN

72C7
36
1214
M29696
Hs.237868
0
2
interleukin-7 receptor (IL-7) mRNA, complete cds/cd

591B10
577
1658
NM_002185
Hs.237868
0
9
interleukin 7 receptor (IL7R), mRNA/cds = (22,1

109G2
16
405
AF116682
Hs.238205
0
1
PRO2013 mRNA, complete cds/cds = (135,380)/gb

41E1
2163
2733
U60805
Hs.238648
0
1
oncostatin-M specific receptor beta subunit (OSMRB)

599C11
508
1734
AK026110
Hs.238707
0
5
cDNA: FLJ22457 fis, clone HRC09925/cds = (56,14

143E8
2
595
AV700542
Hs.238730
1.00E−177
6
AV700542 cDNA, 3′ end/clone = GKCAFD05/clone_—

596C11
77
658
AW955090
Hs.238954
0
5
EST367160 cDNA/gb = AW955090/gi = 8144773/ug =

169C7
1371
1634
AY004255
Hs.238990
1.00E−148
1
cdk inhibitor p27KIP1 mRNA, complete cds/cds =

173C1
1599
1859
BC001971
Hs.238990
1.00E−146
1
Similar to cyclin-dependent kinase inhibitor

458B5
1539
1809
AL136828
Hs.238996
1.00E−131
1
mRNA; cDNA DKFZp434K0427 (from clone

DKFZp434K

591H9
6104
6559
AL157902
Hs.239114
0
1
DNA sequence from clone RP4-675C20 on

chromosome 1p13

512G4
231
2376
NM_005746
Hs.239138
0
61
pre-B-cell colony-enhancing factor (PBEF), m

53D11
935
2053
U02020
Hs.239138
0
15
pre-B cell enhancing factor (PBEF) mRNA, complete

cds

38B7
2187
2263
AK025021
Hs.239189
1.00E−36
1
FLJ21368 fis, clone COL03056, highly sim

458E10
90
622
NM_016533
Hs.239208
0
1
ninjurin 2 (NINJ2), mRNA/cds = (56,484)/gb = NM

184G10
1608
2056
AK026535
Hs.239307
0
1
FLJ22882 fis, clone KAT03587, highly sim

194D9
1544
1683
NM_003680
Hs.239307
4.00E−57
1
tyrosyl-tRNA synthetase (YARS), mRNA/cds = (0,

110C7
450
1216
AF246221
Hs.239625
0
4
transmembrane protein BRI mRNA, complete cds

599G9
446
1205
NM_021999
Hs.239625
0
13
integral membrane protein 2B (ITM2B), mRNA/cd

515E4
1404
1671
NM_014515
Hs.239720
1.00E−132
1
CCR4-NOT transcription complex, subunit 2 (C

115H10
1124
2079
BC000105
Hs.239760
0
2
Similar to CG14740 gene product, clone MGC: 25

466E3
605
923
NM_005301
Hs.239891
1.00E−164
2
G protein-coupled receptor 35 (GPR35), mRNA/

52B5
993
1243
AJ223075
Hs.239894
1.00E−106
1
for TRIP protein/cds = (178,2532)/gb = AJ22

171E10
88
399
AW002624
Hs.240077
1.00E−145
1
wu60d10.x1 cDNA, 3′ end/clone = IMAGE: 990854/

75C5
325
1604
AK027191
Hs.240443
0
8
FLJ23538 fis, clone LNG08010, highly sim

597D3
1134
1792
BC001255
Hs.240770
0
1
nuclear cap binding protein subunit 2, 20 kD,

98A11
596
6834
NM_005385
Hs.241493
0
10
natural killer-tumor recognition sequence (N

98C10
1580
2204
AK027187
Hs.241507
0
40
cDNA: FLJ23534 fis, clone LNG06974, highly sim

463E8
324
846
AF047002
Hs.241520
0
1
transcriptional coactivator ALY mRNA, partia

514G6
802
1238
NM_012392
Hs.241531
0
3
peflin (PEF), mRNA/cds = (12,866)/gb = NM_01239

177G4
1375
1887
AF099149
Hs.241558
0
1
TRIAD1 type I mRNA, complete cds/cds = (144,1625

110E4
1320
1937
AK021704
Hs.241567
0
1
FLJ11642 fis, clone HEMBA 1004356, highly

513B12
700
1447
NM_016839
Hs.241567
0
3
RNA binding motif, single stranded interacting

500G10
910
1249
NM_000594
Hs.241570
0
1
tumor necrosis factor (TNF superfamily, membe

514B6
735
1032
NM_018630
Hs.241576
1.00E−155
1
hypothetical protein PRO2577 (PRO2577), mRNA

590H9
61
251
NM_016200
Hs.241578
1.00E−104
1
U6 snRNA-associated Sm-like protein LSm8 (LOC

50A6
200
311
AK026704
Hs.242868
3.00E−57
3
FLJ23051 fis, clone LNG02642/cds = UNKNOW

104C10
199
353
AA424812
Hs.243029
2.00E−74
1
zw04b02.s1 cDNA, 3′ end/clone = IMAGE: 768267/

72G4
182
415
AW081232
Hs.243321
1.00E−99
4
xc22e08.x1 cDNA, 3′ end/clone = IMAGE: 2585030

521D12
32
287
AW102836
Hs.243457
6.00E−96
1
xd38h12.x1 cDNA, 3′ end/clone = IMAGE: 2596103

102F3
79
157
W45562
Hs.243720
4.00E−26
1
zc26e07.s1 cDNA, 3′ end/clone = IMAGE: 323460/

56D6
193
454
M97856
Hs.243886
1.00E−122
1
histone-binding protein mRNA, complete cds/c

595D8
25
495
NM_002482
Hs.243886
0
1
nuclear autoantigenic sperm protein (histone-

46G5
2137
2661
AK000745
Hs.243901
0
1
cDNA FLJ20738 fis, clone HEP08257/

cds = UNKNOWN

477D4
141
250
AI394001
Hs.244666
4.00E−51
1
tg06d04.x1 cDNA, 3′ end/clone = IMAGE: 2107975

139B7
50
235
AW078847
Hs.244816
4.00E−32
2
xb18g07.x1 cDNA, 3′ end/clone = IMAGE: 2576700

472C4
74
464
AW139918
Hs.245138
0
1
UI-H-BI1-aee-d-05-0-UI.s1 cDNA, 3′ end/clon

459F7
45
229
AW080951
Hs.245616
7.00E−58
1
xc28c10.x1 cDNA, 3′ end/clone = IMAGE: 2585586

100A6
41
1795
L22009
Hs.245710
1.00E−143
3
hnRNP H mRNA, complete cds/cds = (72,1421)/

gb = L22009

592G8
41
1798
NM_005520
Hs.245710
0
6
heterogeneous nuclear ribonucleoprotein H1

71G4
382
583
AL136607
Hs.245798
1.00E−104
1
mRNA; cDNA DKFZp564I0422 (from clone DKFZp564

118B9
4495
5528
AK024391
Hs.246112
0
4
cDNA FLJ14329 fis, clone PLACE4000259, highly

471E5
148
464
AI568725
Hs.246299
1.00E−177
1
th15a01.x1 cDNA, 3′ end/clone = IMAGE: 2118312

464D11
26
526
N28843
Hs.246358
0
1
yx59d10.r1 cDNA, 5′ end/clone = IMAGE: 266035/

40H7
550
1108
S57235
Hs.246381
0
1
CD68 = 110 kda transmembrane glycoprotein [human,

promonocy

471E12
152
507
AW117189
Hs.246494
1.00E−149
1
xd83f08.x1 cDNA, 3′ end/clone = IMAGE: 2604231

479C1
47
345
AV739961
Hs.246796
1.00E−140
1
AV739961 cDNA, 5′ end/clone = CBFBRA10/clone_—

472C9
43
400
BF796642
Hs.246818
0
1
602259846F1 cDNA, 5′ end/clone = IMAGE: 4343171

47F11
2
227
AB015856
Hs.247433
1.00E−123
1
for ATF6, complete cds/cds = (68,2080)/gb

179H9
12
379
AL031313
Hs.247783
1.00E−111
1
DNA sequence from clone 581F12 on chromosome

Xq21. Co

167A9
5
352
Z00013
Hs.247792
1.00E−163
5

H. sapiens germilne gene for the leader peptide and

variable

72B8
402
672
L15006
Hs.247824
1.00E−139
2
Ig superfamily CTLA-4 mRNA, complete cds/cds =

488H10
135
672
NM_005214
Hs.247824
1.00E−146
5
cytotoxic T-lymphocyte-associated protein 4

188G8
1
255
NM_002991
Hs.247838
1.00E−135
1
small inducible cytokine subfamily A (Cys-Cys

153D11
401
720
AL049545
Hs.247877
1.00E−133
2
DNA sequence from clone 263J7 on chromosome

6q14.3-15

44D2
42
448
AL035604
Hs.247894
1.00E−133
1
DNA sequence from clone 38C16 on chromosome

6q22.33-2

180B7
10
271
L21961
Hs.247947
4.00E−72
1
Ig rearranged lambda-chain mRNA, subgroup VL3, V-

J re

110B11
311
803
U08626
Hs.247984
0
1
glutamine synthetase pseudogene/cds = (0,899)/gb = U

74G5
361
965
X14798
Hs.248109
0
1
DNA for c-ets-1 proto-oncogene/cds = (278,1603)/gb =

60H10
214
527
AW150084
Hs.248657
1.00E−99
3
xg36f03.x1 cDNA, 3′ end/clone = IMAGE: 2629661

64E2
329
536
BF512500
Hs.248689
1.00E−112
1
UI-H-BI3-alw-h-10-0-UI.s1 cDNA, 3′ end/clon

470C6
278
470
AI832183
Hs.249031
1.00E−103
1
wh80g09.x1 cDNA, 3′ end/clone = IMAGE: 2387104

146A9
1145
1422
S63912
Hs.249247
1.00E−113
1
D10S102 = FBRNP [human, fetal brain, mRNA, 3043

nt]/cds = (30,

519E8
37
628
NM_002136
Hs.249495
0
1
heterogeneous nuclear ribonucleoprotein A1

458C7
2232
2520
NM_000964
Hs.250505
1.00E−163
1
retinoic acid receptor, alpha (RARA), mRNA/cd

476A8
1060
1601
AF308285
Hs.250528
0
1
serologically defined breast cancer antigen N

123D7
436
2077
AL157499
Hs.250535
1.00E−153
3
mRNA; cDNA DKFZp434N2412 (from clone

DKFZp434

477A10
285
370
AW291304
Hs.250600
2.00E−34
1
UI-H-BI2-agg-b-11-0-UI.s1 cDNA, 3′ end/clon

172G12
726
1598
AF182420
Hs.250619
0
6
MDS019 (MDS019) mRNA, complete cds/cds = (231,1

167E11
11633
13714
NM_016252
Hs.250646
1.00E−180
2
baculoviral IAP repeat-containing 6 (BIRC6),

591E4
198
714
NM_002823
Hs.250655
4.00E−99
3
prothymosin, alpha (gene sequence 28) (PTMA),

40D9
2289
3010
M95585
Hs.250692
0
1
hepatic leukemia factor (HLF) mRNA, complete cds/

cds

110D9
2336
3259
NM_003144
Hs.250773
0
3
signal sequence receptor, alpha (translocon-a

166A3
1
302
AF103458
Hs.250806
6.00E−93
2
isolate donor N clone N168K immunoglobulin kap

110C12
629
1228
M35416
Hs.250811
0
1
GTP-binding protein (RALB) mRNA, complete cds/

cds = (1

458D12
1136
1714
AY007158
Hs.250820
0
1
clone CDABP0113 mRNA sequence/cds = UNKNOWN/g

177C5
658
823
J02621
Hs.251064
3.00E−32
1
non-histone chromosomal protein HMG-14 mRNA,

complet

126A2
658
1009
NM_004965
Hs.251064
0
3
high-mobility group (nonhistone chromosomal)

523G1
1
337
AE000660
Hs.251465
1.00E−178
2
T-cell receptor alpha delta locus from bases 5

40G1
4
781
X72308
Hs.251526
0
3
for monocyte chemotactic protein-3 (MCP-

188G7
1
1030
NM_002789
Hs.251531
0
3
proteasome (prosome, macropain) subunit, alp

61E12
578
2275
NM_006537
Hs.251636
0
2
ubiquitin specific protease 3 (USP3), mRNA/cd

38B10
995
1211
AK026594
Hs.251653
1.00E−107
1
FLJ22941 fis, clone KAT08078, highly sim

70C3
2022
2405
X52142
Hs.251871
0
1
CTP synthetase (EC 6.3.4.2)/cds = (75,1850)/

177E9
49
406
S80990
Hs.252136
1.00E−125
2
ficolin [human, uterus, mRNA, 1736 nt]/

cds = (532,1512)/gb

50F8
1841
2048
AK026712
Hs.252259
1.00E−114
15
FLJ23059 fis, clone LNG03912/cds = (41,16

585E12
16
194
AI383340
Hs.252300
1.00E−63
1
tc76g05.x1 cDNA, 3′ end/clone = IMAGE: 2070584

181E12
22
99
BE963374
Hs.252338
4.00E−30
1
601657137R1 cDNA, 3′ end/clone = IMAGE: 3866193

477H4
290
451
AI524022
Hs.252359
8.00E−87
1
tg99f02.x1 cDNA, 3′ end/clone = IMAGE: 2116923

188G11
95
700
NM_007104
Hs.252574
0
2
ribosomal protein L10a (RPL10A), mRNA/cds = (1

471H9
1
285
AV706014
Hs.252580
1.00E−145
1
AV706014 cDNA, 5′ end/clone = ADBAOB12/clone_—

134F9
1358
1464
AL359626
Hs.252588
5.00E−50
1
mRNA; cDNA DKFZp564F172 (from clone

DKFZp564F1

597B10
13
279
NM_000981
Hs.252723
1.00E−149
28
ribosomal protein L19 (RPL19), mRNA/cds = (28,6

120D7
962
1674
NM_006054
Hs.252831
0
5
reticulon 3 (RTN3), mRNA/cds = (124,834)/gb = N

593B10
102
467
AW191929
Hs.252989
7.00E−93
1
x177c10.x1 cDNA, 3′ end/clone = IMAGE: 2680722

482C11
32
122
AW195119
Hs.253151
3.00E−33
1
xn66b07.x1 cDNA, 3′ end/clone = IMAGE: 2699413

472C6
34
279
AW204029
Hs.253384
1.00E−137
1
UI-H-BI1-aen-d-02-0-UI.s1 cDNA, 3′ end/clon

472D4
27
440
AW205624
Hs.253502
0
1
UI-H-BI1-afr-e-01-0-UI.s1 cDNA, 3′ end/clon

472D1
120
362
BF750565
Hs.253550
1.00E−133
1
RC1-BN0410-261000-014-f11 cDNA/gb = BF750565

480F11
367
558
AW237483
Hs.253820
1.00E−105
1
xm72e01.x1 cDNA, 3′ end/clone = IMAGE: 2689752

472B5
35
363
AI432340
Hs.254006
1.00E−169
1
tg54e06.x1 cDNA, 3′ end/clone = IMAGE: 2112610

75E5
1
904
M14328
Hs.254105
0
5
alpha enolase mRNA, complete cds/cds = (94,1398)/

gb =

592A12
1
1100
NM_001428
Hs.254105
0
5
enolase 1, (alpha) (EN01), mRNA/cds = (94,1398)

472D10
183
414
AI364936
Hs.255100
1.00E−126
1
qz23c12.x1 cDNA, 3′ end/clone = IMAGE: 2027734

479H9
43
184
AW292772
Hs.255119
2.00E−70
1
UI-H-BW0-aij-d-03-0-UI.s1 cDNA, 3′ end/clon

480A2
18
523
AW293267
Hs.255178
0
1
UI-H-BW0-aii-e-10-0-UI.s1 cDNA, 3′ end/clon

480B7
16
298
AW293895
Hs.255249
1.00E−116
1
UI-H-BW0-ain-f-10-0-UI.s1 cDNA, 3′ end/clon

479H11
23
202
AW293955
Hs.255255
3.00E−79
1
UI-H-BW0-aik-d-05-0-UI.s1 cDNA, 3′ end/clon

480A4
415
598
AW294681
Hs.255336
5.00E−66
1
UI-H-BW0-ail-g-10-0-UI.s1 cDNA, 3′ end/clon

480A7
223
427
AW294695
Hs.255339
1.00E−103
1
UI-H-BW0-aim-a-02-0-UI.s1 cDNA, 3′ end/clon

480A8
26
338
BF514247
Hs.255340
1.00E−167
I
UI-H-BW1-ani-h-09-0-UI.s1 cDNA, 3′ end/clon

480C12
239
483
AW295088
Hs.255389
1.00E−124
1
UI-H-BW0-ait-d-09-0-UI.s1 cDNA, 3′ end/clon

480F9
1
423
BF531016
Hs.255390
0
1
602072345F1 cDNA, 5′ end/clone = IMAGE: 4215251

480B3
68
377
AW295610
Hs.255446
1.00E−161
1
UI-H-BW0-aip-c-03-0-UI.s1 cDNA, 3′ end/clon

460H5
44
427
AA455707
Hs.255452
1.00E−161
1
aa22d09.r1 cDNA, 5′ end/clone = IMAGE: 814001/

480B12
132
212
AW295664
Hs.255454
7.00E−39
1
UI-H-BW0-aip-g-12-0-UI.s1 cDNA, 3′ end/clon

472E7
163
489
AI439645
Hs.255490
1.00E−166
1
tc91e08.x1 cDNA, 3′ end/clone = IMAGE: 2073542

480D12
84
258
AW296005
Hs.255492
8.00E−90
1
UI-H-BW0-aiu-b-01-0-UI.s1 cDNA, 3′ end/clon

480F4
34
464
AW296063
Hs.255501
0
1
UI-H-BW0-aiu-g-08-0-UI.s1 cDNA, 3′ end/clon

480D5
18
404
AW296490
Hs.255554
0
2
UI-H-BW0-aiq-f-08-0-UI.s1 cDNA, 3′ end/clon

480E1
95
379
AW296532
Hs.255559
1.00E−101
1
UI-H-BW0-aiv-b-07-0-UI.s1 cDNA, 3′ end/clon

480E5
17
326
AW296545
Hs.255560
1.00E−128
1
UI-H-BW0-aiv-c-11-0-UI.s1 cDNA, 3′ end/clon

480F2
20
330
AW296730
Hs.255573
1.00E−160
1
UI-H-BW0-aix-f-12-0-UI.s1 cDNA, 3′ end/clon

480G7
38
479
AW296797
Hs.255579
0
1
UI-H-BW0-ajb-e-07-0-UI.s1 cDNA, 3′ end/clon

480C9
19
274
AW297339
Hs.255637
1.00E−117
1
UI-H-BW0-air-c-03-0-UI.s1 cDNA, 3′ end/clon

480C4
70
191
AW297400
Hs.255647
1.00E−49
1
UI-H-BW0-ais-a-05-0-UI.s1 cDNA, 3′ end/clon

480G5
17
242
AW297522
Hs.255661
2.00E−87
1
UI-H-BW0-aja-e-02-0-UI.s1 cDNA, 3′ end/clon

480F10
230
560
AW294654
Hs.255687
0
1
UI-H-BW0-ail-d-10-0-UI.s1 cDNA, 3′ end/clon

480G9
47
582
AW297813
Hs.255695
0
1
UI-H-BW0-aiy-g-09-0-UI.s1 cDNA, 3′ end/clon

480G10
31
453
AW297827
Hs.255697
0
1
UI-H-BW0-aiy-h-11-0-UI.s1 cDNA, 3′ end/clon

482G6
16
242
AW339651
Hs.255927
3.00E−78
1
he15g04.x1 cDNA, 3′ end/clone = IMAGE: 2919126

469B11
4
221
AW341086
Hs.256031
1.00E−99
1
xz92h04.x1 cDNA, 3′ end/clone = IMAGE: 2871703

140E7
2870
3589
M32315
Hs.256278
1.00E−84
2
tumor necrosis factor receptor mRNA, complete cds/cd

189H12
2839
3294
NM_001066
Hs.256278
0
2
tumor necrosis factor receptor superfamily, m

99H11
83
589
NM_005620
Hs.256290
0
4
S100 calcium-binding protein A11 (calgizzarin

58C7
1778
2264
AJ271747
Hs.256583
0
1
partial mRNA for double stranded RNA binding nu

482F4
373
628
AV719442
Hs.256959
1.00E−124
1
AV719442 cDNA, 5′ end/clone = GLCBNA01/clone_—

482F5
8
377
AW440866
Hs.256961
1.00E−179
1
he05f02.x1 cDNA, 3′ end/clone = IMAGE: 2918139

482F8
191
315
AW440974
Hs.256971
2.00E−62
1
he06e12.x1 cDNA, 3′ end/clone = IMAGE: 2918254

479E7
136
567
AW444482
Hs.256979
0
2
UI-H-BI3-akb-e-05-0-UI.s1 cDNA, 3′ end/clon

471H5
3
432
AI438957
Hs.257066
0
1
tc89b05.x1 cDNA, 3′ end/clone = IMAGE: 2073297

472G3
233
617
AW450350
Hs.257283
0
1
UI-H-B13-akn-c-01-0-UI.s1 cDNA, 3′ end/clon

472G11
112
338
AI809475
Hs.257466
1.00E−101
1
wh76d06.x1 cDNA, 3′ end/clone = IMAGE: 2386667

479F7
22
421
AW452467
Hs.257572
0
1
UI-H-BI3-als-e-09-0-UI.s1 cDNA, 3′ end/clon

479G9
95
304
AW452513
Hs.257579
1.00E−81
1
UI-H-BW1-ame-b-03-0-UI.s1 cDNA, 3′ end/clon

479F11
16
329
AW453021
Hs.257640
1.00E−163
1
UI-H-BW1-ama-c-02-0-UI.s1 cDNA, 3′ end/clon

479G4
45
441
AW453044
Hs.257646
0
1
UI-H-BW1-ama-e-01-0-UI.s1 cDNA, 3′ end/clon

482F9
11
256
AW467193
Hs.257667
1.00E−108
1
he07a04.x1 cDNA, 3′ end/clone = IMAGE: 2918286

482G2
9
271
AW467400
Hs.257680
1.00E−112
1
he10f11.x1 cDNA, 3′ end/clone = IMAGE: 2918637

482G8
108
428
AW467437
Hs.257682
1.00E−177
1
he17d05.x1 cDNA, 3′ end/clone = IMAGE: 2919273

482G12
1
417
AW467501
Hs.257687
0
1
he19e06.x1 cDNA, 3′ end/clone = IMAGE: 2919490

482H4
39
143
AW467746
Hs.257695
3.00E−51
1
he23d05.x1 cDNA, 3′ end/clone = IMAGE: 2919849

482H6
1
116
AW467863
Hs.257705
2.00E−59
1
he27c04.x1 cDNA, 3′ end/clone = IMAGE: 2920230

482H7
1
321
AW467864
Hs.257706
1.00E−156
1
he27c05.x1 cDNA, 3′ end/clone = IMAGE: 2920232

482H9
1
112
AW467992
Hs.257709
1.00E−47
1
he30b01.x1 cDNA, 3′ end/clone = IMAGE: 2920489

483A2
20
429
AW468207
Hs.257716
0
1
he34a12.x1 cDNA, 3′ end/clone = IMAGE: 2920894

483A9
11
373
AW468431
Hs.257727
0
1
he37h11.x1 cDNA, 3′ end/clone = IMAGE: 2921253

483B2
2
241
AW468621
Hs.257743
1.00E−119
1
he42e03.x1 cDNA, 3′ end/clone = IMAGE: 2921692

75B1
157
246
BE531180
Hs.258494
5.00E−44
1
601278313F1 cDNA, 5′ end/clone = IMAGE: 3610443

585F6
2200
4106
AL136549
Hs.258503
0
8
mRNA; cDNA DKFZp761I12121 (from clone

DKFZP761

169E2
5186
5415
U20489
Hs.258609
1.00E−119
2
glomerular epithelial protein 1 (GLEPP1) comple

127A5
2142
2477
AB037790
Hs.258730
1.00E−177
1
mRNA for KIAA1369 protein, partial cds/cds = (0

171B12
4202
4314
Y10129
Hs.258742
4.00E−45
2
mybpc3 gene/cds = (33,3857)/gb = Y10129/gi = 20583

75B7
531
682
L14542
Hs.258850
3.00E−81
1
lectin-like type II integral membrane protein (NKG2-E

471G5
344
473
AI144328
Hs.259084
3.00E−61
1
oy84g04.x1 cDNA, 3′ end/clone = IMAGE: 1672566

479B7
73
307
AF161364
Hs.259683
1.00E−123
1
HSPC101 mRNA, partial cds/cds = (0,556)/gb = AF

146B11
1942
2174
AL136842
Hs.260024
8.00E−92
1
DKFZp434A0530 (from clone DKFZp434A

584A1
1085
1470
AL022398
Hs.261373
1.00E−166
1
DNA sequence from PAC 434O14 on chromosome

1q32

148B1
119
817
X60656
Hs.261802
0
2
elongation factor 1-beta/cds = (95,772)

60G3
203
3170
NM_001634
Hs.262476
0
15
S-adenosylmethionine decarboxylase 1 (AMD1)

462E7
292
374
AW300868
Hs.262789
8.00E−40
1
xk07d09.x1 eDNA, 3′ end/clone = IMAGE: 2666033

56F11
33
234
BF243724
Hs.263414
4.00E−82
1
601877832F1 cDNA, 5′ end/clone = IMAGE: 4106359

119C5
2414
2664
NM_002108
Hs.263435
1.00E−137
1
histidine ammonia-lyase (HAL), mRNA/cds(297

105A4
3225
3775
AK025774
Hs.264190
0
3
FLJ22121 fis, clone HEP18876, highly sim

469H1
369
576
AI380111
Hs.264298
1.00E−103
1
tf98a11.x1 cDNA, 3′ end/clone = IMAGE: 2107292

181A3
2434
2768
NM_002535
Hs.264981
1.00E−148
2
2′-5′oligoadenylate synthetase 2 (OAS2), tra

41B7
3209
3885
M59911
Hs.265829
0
1
integrin alpha-3 chain mRNA, complete cds/

cds = (73,32

75F9
264
452
AW150944
Hs.265838
2.00E−96
1
xg42e09.x1 cDNA, 3′ end/clone = IMAGE: 2630248

99C3
2684
3155
AK000680
Hs.266175
0
2
cDNA FLJ20673 fis, clone KAIA4464/cds = (104,14

598E12
2417
2894
AK026669
Hs.266940
0
2
cDNA: FLJ23016 fis, clone LNG00874/cds = UNKNOW

468B6
863
1515
NM_016569
Hs.267182
0
1
TBX3-iso protein (TBX3-iso), mRNA/cds = (116,1

115E11
1234
1713
AF271994
Hs.267288
0
1
dopamine responsive protein DRG-1 mRNA, compl

114A4
31
382
NM_024095
Hs.267400
1.00E−179
1
hypothetical protein MGC5540 (MGC5540), mRNA

166C7
1315
1919
AK001749
Hs.267604
0
2
FLJ10887 fis, clone NT2RP4002018, weakly

56A8
564
3624
AB033054
Hs.267690
0
3
for KIAA1228 protein, partial cds/cds = (0

70B10
229
2138
AK001471
Hs.268012
0
3
FLJ10609 fis, clone NT2RP2005276, highly

178D10
1831
2796
NM_012255
Hs.268555
0
2
5′-3′exoribonuclease 2 (XRN2), mRNA/cds = (68,

168B9
451
881
AF068235
Hs.268763
0
1
barrier-to-autointegration factor mRNA, com

465F2
91
433
AA613224
Hs.270264
0
1
no19d06.s1 cDNA, 3′ end/clone = IMAGE: 1101131

469E2
302
422
BE857296
Hs.270293
1.00E−57
1
7g27b01.x1 cDNA, 3′ end/clone = IMAGE: 3307657

465D10
284
405
AI270476
Hs.270341
4.00E−51
1
qu88e12.x1 cDNA, 3′ end/clone = IMAGE: 1979182

473F10
831
1096
AK021517
Hs.270557
1.00E−140
1
cDNA FLJ11455 fis, clone HEMBA1001497/cds = UNK

193A10
458
563
AI818951
Hs.270614
5.00E−31
1
wj89e12.x1 cDNA, 3′ end/clone = IMAGE: 2410030

458E11
44
264
W03955
Hs.270717
1.00E−118
1
za62d04.r1 cDNA, 5′end/clone = IMAGE: 297127/

163C12
280
954
M30704
Hs.270833
1.00E−168
2
amphiregulin (AR) mRNA, complete cds, clones

lambda-A

196F4
208
567
NM_001657
Hs.270833
1.00E−158
1
amphiregulin (schwannoma-derived growth fac

464G2
378
529
AW172850
Hs.270999
4.00E−77
1
xj04f02.x1 cDNA, 3′ end/clone = IMAGE: 2656251

464F5
131
476
AW572930
Hs.271264
0
1
hf17f07.x1 cDNA, 3′ end/clone = IMAGE: 2932165

41G6
458
880
Y16645
Hs.271387
0
1
for monocyte chemotactic protein-2/cds =

464F2
139
220
AW975086
Hs.271420
2.00E−34
1
EST387192 cDNA/gb = AW975086/gi = 8166291/ug =

178E10
961
1452
AK021715
Hs.271541
0
1
cDNA FLJ11653 fis, clone HEMBA1004538/cds = UNK

129E1
73
441
NM_016049
Hs.271614
1.00E−136
1
CGI-112 protein (LOC51016), mRNA/cds = (158,78

40C9
4195
4949
X17033
Hs.271986
0
1
integrin alpha-2 subunit/cds = (48,3593)/gb

108E1
917
1331
NM_006811
Hs.272168
0
2
tumor differentially expressed 1 (TDE1), mRNA

155H10
232
715
AL021395
Hs.272279
1.00E−164
1
DNA sequence from clone RP1-269M15 on

chromosome 20q1

159D3
38
238
AL034343
Hs.272295
1.00E−106
4
DNA sequence from clone RP1-108C2 on

chromosome 6p12.

477C3
744
1166
AL133015
Hs.272307
0
2
mRNA; cDNA DKFZp434O2417 (from clone

DKFZp434O

173D12
228
594
AL121934
Hs.272340
1.00E−140
5
DNA sequence from clone RP11-209A2 on

chromosome 6. C

472D9
27
418
NM_016135
Hs.272398
0
1
transcription factor ets (TEL2), mRNA/cds = (7

465F9
1885
2345
NM_013351
Hs.272409
0
1
T-box 21 (TBX21), mRNA/cds = (211,1818)/gb = NM

41E11
1
277
NM_004167
Hs.272493
1.00E−113
1
small inducible cytokine subfamily A (Cys-Cys

462E11
8
526
NM_001503
Hs.272529
0
1
glycosylphosphatidylinositol specific phos

104C6
210
327
AE000659
Hs.272550
5.00E−61
1
T-cell receptor alpha delta locus from bases 2

596A3
411
1208
NM_013392
Hs.272736
0
5
nuclear receptor binding protein (NRBP), mRNA

75C2
1892
2188
AK000316
Hs.272793
1.00E−165
1
FLJ20309 fis, clone HEP07296/cds = (41,127

58C6
1
956
NM_006009
Hs.272897
0
2
Tubulin, alpha, brain-specific (TUBA3), mRNA

190H8
3246
3771
AK024471
Hs.273230
1.00E−165
2
mRNA for FLJ00064 protein, partial cds/cds = (0

590E11
1512
1860
NM_014230
Hs.273307
1.00E−168
4
signal recognition particle 68 kD (SRP68), mRN

588H2
696
1454
NM_000516
Hs.273385
0
3
guanine nucleotide binding protein (G protein)

165E9
3186
3695
NM_014871
Hs.273397
0
1
KIAA0710 gene product (KIAA0710), mRNA/cds = (

462A6
394
496
AA527312
Hs.273775
2.00E−42
1
ng36a08.s1 cDNA, 3′ end/clone = IMAGE: 936854/

587F1
1763
1978
AL050353
Hs.274170
1.00E−112
1
mRNA; cDNA DKFZp564C0482 (from clone

DKFZp564C

177E5
1448
1876
AK000765
Hs.274248
0
1
FLJ20758 fis, clone HEP01508/cds = (464,13

59E7
1
301
AF151049
Hs.274344
1.00E−159
3
HSPC215 mRNA, complete cds/cds = (92,451)/gb =

174A6
931
1352
NM_004301
Hs.274350
0
1
BAF53 (BAF53A), mRNA/cds = (136,1425)/gb = NM_0

99E2
718
1391
NM_018477
Hs.274369
0
4
uncharacterized hypothalamus protein HARP11

117F6
3046
3478
AB037844
Hs.274396
0
2
mRNA for KIAA1423 protein, partial cds/cds = (0

52F3
1724
2342
NM_005346
Hs.274402
1.00 E−149
48
heat shock 70 kD protein 1 (HSPA1B), mRNA/cds = (

516B1
719
1026
NM_018975
Hs.274428
1.00E−161
2
TRF2-interacting telomeric RAP1 protein (RAP

104A1
1943
2396
AK002127
Hs.274439
0
1
FLJ11265 fis, clone PLACE1009158/cds = (30

137D6
1697
1817
NM_001403
Hs.274466
8.00E−49
1
eukaryotic translation elongation factor 1 a

108D11
321
646
X16863
Hs.274467
1.00E−160
1
Fc-gamma RIII-1 cDNA for Fc-gamma receptor III-1

(CD

107F1
567
895
AF283771
Hs.274472
1.00E−168
1
clone TCBAP0774 mRNA sequence/cds = UNKNOWN/g

517B9
4
480
NM_002128
Hs.274472
0
3
high-mobility group (nonhistone chromosomal)

514C8
254
539
M12888
Hs.274474
1.00E−144
2
T-cell receptor germline beta-chain gene C-region C-

460G5
602
775
M12679
Hs.274485
3.00E−94
1
Cw1 antigen mRNA, complete cds/cds = (0,617)/

gb = M1267

463G7
163
744
D90145
Hs.274535
0
4
LD78 beta gene/cds = (86,367)/gb = D90145/

gi = 219907/

472E10
277
391
AI393960
Hs.274851
6.00E−59
1
tg11d04.x1 cDNA, 3′ end/clone = IMAGE: 2108455

115A11
156
446
NM_014624
Hs.275243
1.00E−157
8
S100 calcium-binding protein A6 (calcyclin) (

102C6
23
448
AA610514
Hs.275611
1.00E−161
1
np93h02.s1/clone = IMAGE: 1133907/gb = AA6

160E3
24
304
AA757952
Hs.275773
1.00E−74
3
zg49e07.s1 3′ end/clone = IMAGE: 396708/

500B8
26
536
NM_022551
Hs.275865
0
3
ribosomal protein S18 (RPS18), mRNA/cds = (46,5

522D9
184
593
NM_001959
Hs.275959
0
1
eukaryotic translation elongation factor 1 b

151H4
1
196
AA984890
Hs.276063
5.00E−58
1
am62e06.s1 cDNA, 3′ end/clone = IMAGE: 1576642

476B10
362
615
BF510670
Hs.276341
1.00E−116
1
UI-H-BI4-aof-b-08-0-UI.s1 cDNA, 3′ end/clon

144F10
73
279
Al318342
Hs.276662
8.00E−57
1
ta73c09.x1 3′ end/clone = IMAGE: 2049712

593G1
17
88
BE747210
Hs.276718
2.00E−26
1
601580926F1 cDNA, 5′ end/clone = IMAGE: 3929430

473E3
205
488
AI380791
Hs.276766
1.00E−144
1
tg04b12.x1 cDNA, 3′ end/clone = IMAGE: 2107775

598A2
72
427
NM_001803
Hs.276770
0
19
CDW52 antigen (CAMPATH-1 antigen) (CDW52), mR

170H2
83
432
X62466
Hs.276770
0
1
CAMPATH-1 (CDw52) antigen/cds = (33,218)

464F7
2
454
AI492640
Hs.276903
0
2
qz18a06.x1 cDNA, 3′ end/clone = IMAGE: 2021842

464E5
102
191
AI493726
Hs.276907
3.00E−44
2
qz12f08.x1 cDNA, 3′ end/clone = IMAGE: 2021319

50B5
42
308
AI581383
Hs.276988
5.00E−77
1
to71c02.x1 cDNA, 3′ end/clone = IMAGE: 2183714

468C6
40
279
AI740667
Hs.277201
1.00E−64
1
wg07b07.x1 cDNA, 3′ end/clone = IMAGE: 2364373

111D12
1
562
AI749435
Hs.277224
1.00E−118
9
at24b04.x1 cDNA, 3′ end/clone = IMAGE: 2356015

459B4
176
367
AI811065
Hs.277293
2.00E−38
1
tr03f05.x1 cDNA, 3′ end/clone = IMAGE: 2217249

477H3
6227
6584
NM_013449
Hs.277401
1.00E−132
1
bromodomain adjacent to zinc finger domain, 2A

54A8
34
301
AW050975
Hs.277672
3.00E−48
1
wz25f04.x1 cDNA, 3′ end/clone = IMAGE: 2559103

459E4
1532
2061
NM_006389
Hs.277704
0
1
oxygen regulated protein (150 kD) (ORP150), mR

109B6
3281
3721
U65785
Hs.277704
0
1
150 kDa oxygen-regulated protein ORP150 mRNA,

complet

524H7
2979
3350
NM_005899
Hs.277721
0
1
membrane component, chromosome 17, surface ma

472F10
425
556
AW082714
Hs.277738
5.00E−69
1
xb61f07.x1 cDNA, 3′ end/clone = IMAGE: 2580805

176D1
113
269
AW262728
Hs.277994
6.00E−32
1
xq94a12.x1 cDNA, 3′ end/clone = IMAGE: 2758270

464H4
2138
3563
NM_016733
Hs.278027
0
9
LIM domain kinase 2 (LIMK2), transcript varian

145C9
533
1446
D13316
Hs.278238
0
3
transcription factor, E4TF1-47, complete cds

161C3
339
560
NM_002041
Hs.278238
1.00E−123
1
GA-binding protein transcription factor, bet

74C9
345
1048
AK026632
Hs.278242
0
3
FLJ22979 fis, clone KAT11379, highly sim

59E2
255
782
L24804
Hs.278270
0
2
(p23) mRNA, complete cds/cds = (232,714)/

gb = L24804/

521H10
8
461
AI720536
Hs.278302
1.00E−114
4
as83c02.x1 cDNA, 3′ end/clone = IMAGE: 2335298

118C6
830
1104
NM_001995
Hs.278333
1.00E−148
1
fatty-acid-Coenzyme A ligase, long-chain 1 (

104E9
248
417
AF151054
Hs.278429
2.00E−78
1
HSPC220 mRNA, complete cds/cds = (288,818)/gb

594F10
379
1760
NM_016520
Hs.278429
0
4
hepatocellular carcinoma-associated antigen

126D11
7374
7716
NM_006289
Hs.278559
0
1
talin (TLN), mRNA/cds = (126,7751)/gb = NM_0062

589E6
3078
5778
NM_003105
Hs.278571
0
3
sortilin-related receptor, L(DLR class) A re

102C10
669
1180
D14041
Hs.278573
0
1
for H-2K binding factor-2, complete cds/

526H8
167
4709
NM_015874
Hs.278573
0
5
H-2K binding factor-2 (LOC51580), mRNA/cds = (

120A12
732
1305
AB029031
Hs.278586
0
1
mRNA for KIAA1108 protein, partial cds/cds = (0

126F4
3138
3515
AF035737
Hs.278589
0
2
general transcription factor 2-I (GTF2I) mRNA

40A7
3179
3864
U24578
Hs.278625
0
1
RP1 and complement C4B precursor (C4B) genes,

partial

50C4
4401
4581
AB002334
Hs.278671
2.00E−60
1
KIAA0336 gene, complete cds/cds = (253,5004)

106E12
104
1222
D50525
Hs.278693
0
11
TI-227H/cds = UNKNOWN/gb = D50525/gi = 1167502

467E10
168
542
BE973840
Hs.278704
1.00E−145
1
601680647F1 cDNA, 5′ end/clone = IMAGE: 3951154

75F2
1121
1772
J04755
Hs.278718
0
37
ferritin H processed pseudogene, complete cds/

cds = UN

170E12
204
843
AL121735
Hs.278736
0
2
Isoform of human GTP-binding protein G25K/

cds = (104,679)/

103F4
589
926
NM_019597
Hs.278857
0
1
heterogeneous nuclear ribonucleoprotein H2

37F8
3
519
UO1923
Hs.278857
0
1
BTK region clone ftp-3 mRNA/cds = UNKNOWN/

gb = U01923/

66B11
2195
2512
AB029027
Hs.279039
1.00E−172
1
for KIAA1104 protein, complete cds/cds = (

171G3
219
815
AK027258
Hs.279040
0
2
FLJ23605 fis, clone LNG15982, highly sim

172E12
18
95
NM_014065
Hs.279040
4.00E−27
2
HT001 protein (HT001), mRNA/cds = (241,1203)/

596A12
1
225
BE220869
Hs.279231
2.00E−78
1
hu01g02.x1 cDNA, 3′ end/clone = IMAGE: 3165362

61H2
20
220
BE279328
Hs.279429
2.00E−32
3
601157666F1 cDNA, 5′ end/clone = IMAGE: 3504328

458E12
1835
2473
NM_014160
Hs.279474
0
1
HSPC070 protein (HSPC070), mRNA/cds(331,158

110F3
983
1614
NM_016160
Hs.279518
0
1
amyloid precursor protein homolog HSD-2 (LOC5

37E5
39
732
AK001403
Hs.279521
0
1
FLJ10541 fis, clone NT2RP2001381/cds = (3

66D6
6
463
BE502919
Hs.279522
0
1
hz81b08.x1 cDNA, 3′ end/clone = IMAGE: 3214359

123A11
411
903
NM_013237
Hs.279529
0
2
px19-like protein (PX19), mRNA/cds = (176,835)

185A10
809
1324
NM_002817
Hs.279554
0
1
proteasome (prosome, macropain) 26S subunit,

472H9
88
543
AL582047
Hs.279555
0
1
AL582047 cDNA/clone = CS0DL003YD01-(3-prime)

41A2
1
326
AK000575
Hs.279581
1.00E−162
1
FLJ20568 fis, clone REC00775/cds = (6,422)

135F4
648
935
NM_016283
Hs.279586
1.00E−110
1
adrenal gland protein AD-004 (LOC51578), mRNA

69D9
841
935
D16217
Hs.279607
9.00E−40
1
calpastatin, complete cds/cds = (162,2288)/

116B6
938
1562
NM_001750
Hs.279607
0
1
calpastatin (CAST), mRNA/cds = (66,1358)/gb =

473F4
6847
7401
NM_007329
Hs.279611
0
1
deleted in malignant brain tumors 1 (DMBT1), tr

123C7
2488
2684
NM_021644
Hs.279681
1.00E−105
1
heterogeneous nuclear ribonucleoprotein H3

586E2
357
633
NM_014169
Hs.279761
3.00E−97
1
HSPC134 protein (HSPC134), mRNA/cds = (45,716)

464D6
383
524
NM_016154
Hs.279771
1.00E−33
1
ras-related GTP-binding protein 4b (RAB4B), m

99G9
1375
1835
NM_013388
Hs.279784
0
1
prolactin regulatory element binding (PREB),

590F4
1045
1540
NM_003883
Hs.279789
0
2
histone deacetylase 3 (HDAC3), mRNA/cds = (55,1

163E1
59
564
NM_015932
Hs.279813
0
3
hypothetical protein (HSPC014), mRNA/cds = (8

525G5
3914
4160
NM_014819
Hs.279849
1.00E−138
1
KIAA0438 gene product (KIAA0438), mRNA/cds = (

598A10
9
821
NM_003295
Hs.279860
0
19
tumor protein, translationally-controlled 1

526C8
734
1166
NM_016007
Hs.279867
0
1
CGI-59 protein (LOC51625), mRNA/cds = (2,1153)

183G12
758
1093
NM_017774
Hs.279893
0
1
hypothetical protein FLJ20342 (FLJ20342), mR

36B3
247
611
AK025623
Hs.279901
0
1
FLJ21970 fis, clone HEP05733, highly sim

592G3
479
1052
NM_016146
Hs.279901
0
4
PTD009 protein (PTD009), mRNA/cds = (257,916)

38F5
811
1256
AF151875
Hs.279918
0
4
CGI-117 protein mRNA, complete cds/cds = (456,9

161E3
542
862
NM_016391
Hs.279918
1.00E−151
1
hypothetical protein (HSPC111), mRNA/cds = (6

584F11
10
212
NM_014248
Hs.279919
1.00E−112
2
ring-box 1 (RBX1), mRNA/cds = (6,332)/gb = NM_0

588H7
400
1155
NM_003404
Hs.279920
0
12
tyrosine 3-monooxygenase/tryptophan 5-monoo

169C8
400
1155
X57346
Hs.279920
1.00E−131
2
HS1 protein/cds = (372,1112)/gb = X57346

147A1
209
1978
AK025927
Hs.279921
0
8
FLJ22274 fis, clone HRC03616, highly sim

591H11
48
1810
NM_016127
Hs.279921
1.00E−176
33
HSPC035 protein (LOC51669), mRNA/cds = (16,103

69D1
727
1776
NM_014366
Hs.279923
0
3
putative nucleotide binding protein, estradio

52C6
303
1151
V00522
Hs.279930
0
2
encoding major histocompatibility complex gene

158C11
2483
2785
D84224
Hs.279946
1.00E−166
2
methionyl tRNA synthetase, complete c

194E7
1525
1767
NM_004990
Hs.279946
1.00E−125
1
methionine- tRNA synthetase (MARS), mRNA/cds

62E5
215
701
U93243
Hs.279948
0
1
Ubc6p homolog mRNA, complete cds/cds = (27,983)

145G3
1
1882
AK024090
Hs.281434
1.00E−147
5
FLJ14028 fis, clone HEMBA1003838/cds = UN

473A6
1
310
BE552131
Hs.282091
1.00E−158
1
hw29b05.x1 cDNA, 3′ end/clone = IMAGE: 3184305

52C12
1
455
R67739
Hs.282401
0
1
yi28c06.r1 cDNA, 5′ end/clone = IMAGE: 140554/

112A3
5072
5274
NM_006165
Hs.282441
3.00E−83
1
nuclear factor related to kappa B binding prote

61H3
443
577
AV648638
Hs.282867
2.00E−68
4
AV648638 cDNA, 3′ end/clone = GLCBLE12/clone_—

37D3
38
766
AF287008
Hs.283022
0
5
triggering receptor expressed on monocytes 1

125C5
32
748
NM_018643
Hs.283022
0
13
triggering receptor expressed on myeloid cell

41B1
597
1084
NM_018636
Hs.283106
0
2
hypothetical protein PRO2987 (PRO2987), mRNA

111E9
1111
1405
AB037802
Hs.283109
1.00E−152
1
mRNA for KIAA1381 protein, partial cds/cds = (0

169D7
5
175
BE672733
Hs.283216
2.00E−37
1
7b75g07.x1 3′ end/clone = IMAGE: 3234108

74G11
47
384
BE676472
Hs.283267
1.00E−151
1
7f30c05.x1 cDNA, 3′ end/clone = IMAGE: 3296168

191A5
256
890
NM_018507
Hs.283330
0
3
hypothetical protein PRO1843 (PRO1843), mRNA

465B7
114
638
AW979262
Hs.283410
0
2
EST391372 cDNA/gb = AW979262/gi = 8170550/ug =

143E1
1970
2258
NM_020217
Hs.283611
1.00E−110
1
hypothetical protein DKFZp547I014 (DKFZp547I

54E9
385
739
AF116620
Hs.283630
0
3
PRO1068 mRNA, complete cds/cds = UNKNOWN/

gb = A

462D10
63
279
NM_007220
Hs.283646
1.00E−119
1
carbonic anhydrase VB, mitochondrial (CA5B),

518B11
359
690
NM_016056
Hs.283670
1.00E−167
2
CGI-119 protein (LOC51643), mRNA/cds = (0,776)

36H5
1
226
BE778549
Hs.283674
8.00E−85
1
601466063F1 cDNA, 5′ end/clone = IMAGE: 3869391

126H10
907
1431
NM_017801
Hs.283685
0
1
hypothetical protein FLJ20396 (FLJ20396), mR

69B1
2288
3232
AF103803
Hs.283690
0
6
clone H41 unknown mRNA/cds = (323,1099)/gb = AF

98B1
162
489
NM_018476
Hs.283719
1.00E−110
1
uncharacterized hypothalamus protein HBEX2

39C3
997
3088
NM_020151
Hs.283722
0
2
GTT1 protein (GTT1), mRNA/cds = (553,1440)/gb

592E4
13
2219
NM_020357
Hs.283728
0
2
PEST-containing nuclear protein (pcnp), mRNA

142F11
138
371
AF173296
Hs.283740
1.00E−130
1
e(y)2 homolog mRNA, complete cds/cds = (216,521

592F3
480
858
NM_013234
Hs.283781
0
2
muscle specific gene (M9), mRNA/cds = (171,827)

159E5
3
281
AL121916
Hs.283838
1.00E−113
6
DNA sequence from clone RP1-189G13 on

chromosome 20.

142H10
517
892
AL121585
Hs.283864
9.00E−70
2
DNA sequence from clone RP11-504H3 on

chromosome 20 C

166D3
1
227
X72475
Hs.283972
6.00E−70
1
for rearranged lg kappa light chain variable

134E8
980
1302
NM_014110
Hs.284136
0
47
PRO2047 protein (PRO2047), mRNA/cds = (798,968

596C5
30
705
NM_006134
Hs.284142
0
2
chromosome 21 open reading frame 4 (C21ORF4), m

74A4
1944
2157
AL359585
Hs.284158
1.00E−110
3
cDNA DKFZp762B195 (from clone DKFZp762B1

159A4
159
1414
AF165521
Hs.284162
0
4
ribosomal protein L30 isolog (L30) mRNA, compl

597F9
836
1000
NM_016304
Hs.284162
1.00E−88
1
60S ribosomal protein L30 isolog (LOC51187), m

462D2
655
1306
NM_016301
Hs.284164
0
1
protein × 0004 (LOC51184), mRNA/cds = (31,885)

458C6
720
910
AP001753
Hs.284189
1.00E−102
1
genomic DNA, chromosome 21q, section 97/105/

165D5
1482
2302
AB040120
Hs.284205
0
2
mRNA for BCG induced integral membrane protein

180C12
309
602
BF381953
Hs.284235
1.00E−148
2
601816251F1 cDNA, 5′ end/clone = IMAGE: 4050061

67D9
27
2026
AK024969
Hs.284249
0
10
FLJ21316 fis, clone COL02253, highly sim

39D1
307
2899
U90552
Hs.284283
0
5
butyrophilin (BTF5) mRNA, complete cds/

cds = (359,190

147C8
391
556
AF161451
Hs.284295
2.00E−58
1
HSPC333 mRNA, partial cds/cds = (0,443)/gb = AF

192C12
333
484
AV700210
Hs.284605
5.00E−57
1
AV700210 cDNA, 3′ end/clone = GKBALC03/clone_—

49G11
380
523
AV700636
Hs.284674
4.00E−33
1
AV700636 cDNA, 3′ end/clone = GKBAGH12/clone_—

115C11
375
1001
AK023291
Hs.285017
0
1
cDNA FLJ13229 fis, clone OVARC1000106/cds = (15

458H8
1544
2233
AK023459
Hs.285107
0
1
cDNA FLJ13397 fis, clone PLACE1001351/cds = (22

70F4
11
605
AV700298
Hs.285173
0
4
AV700298 cDNA, 3′ end/clone = GKCBVGO5/clone_—

66C6
684
1415
NM_001300
Hs.285313
0
5
core promoter element binding protein (COPEB),

169F2
4
460
BF684382
Hs.285555
0
2
602141836F1 5′ end/clone = IMAGE: 4302776

171F12
646
839
X58529
Hs.285823
6.00E−99
2
rearranged immunoglobulin mRNA for mu heavy chain

enh

142F10
1438
1728
AK025788
Hs.285833
1.00E−152
1
FLJ22135 fis, clone HEP20858/cds = UNKNOW

171H2
1
2500
AL050376
Hs.285853
5.00E−21
1
mRNA; cDNA DKFZp586J101 (from clone

DKFZp586J1

40C5
786
1163
AK026603
Hs.286124
0
2
FLJ22950 fis, clone KAT09618, highly sim

458D9
55
684
NM_016041
Hs.286131
0
1
CGI-101 protein (LOC51009), mRNA/cds = (6,635)

458D1
1
310
AK025886
Hs.286194
1.00E−151
1
cDNA: FLJ22233 fis, clone HRC02016/cds = (35,12

515C10
817
1136
AK021791
Hs.286212
1.00E−138
1
cDNA FLJ11729 fis, clone HEMBA1005394, modera

71C7
285
2441
AK026933
Hs.286236
0
7
cDNA: FLJ23280 fis, clone HEP07194/cds = (468,1

184B9
372
612
BE965319
Hs.286754
3.00E−66
2
601659229R1 cDNA, 3′ end/clone = IMAGE: 3895783

586C12
18
381
NM_000996
Hs.287361
0
3
ribosomal protein L35a (RPL35A), mRNA/cds = (6

36C6
152
685
AJ277247
Hs.287369
0
37
for interleukin 21 (IL-21 gene)/cds = (71,

513H8
17
690
NM_020525
Hs.287369
0
510
interleukin 22 (IL22), mRNA/cds = (71,610)/gb

586G2
3978
4107
NM_021621
Hs.287387
3.00E−68
1
caspase recruitment domain protein 7 (CARD7),

99D12
2330
2851
NM_015906
Hs.287414
0
1
transcriptional intermediary factor 1 gamma (

182A2
284
576
AK024331
Hs.287631
1.00E−156
1
cDNA FLJ14269 fis, clone PLACE1003864/cds = UN

465A11
2226
2321
AK024372
Hs.287634
1.00E−42
1
cDNA FLJ14310 fis, clone PLACE3000271/cds = (40

190A11
679
1126
AK026769
Hs.287725
0
1
cDNA: FLJ23116 fis, clone LNG07945, highly sim

75E2
479
837
AL390738
Hs.287788
1.00E−146
3
DNA sequence from clone RP11-438F9 on

chromosome 13 C

59B7
488
1071
AK022537
Hs.287863
0
1
FLJ12475 fis, clone NT2RM1000962/cds = (16

460E8
1611
1979
AK024092
Hs.287864
0
1
cDNA FLJ14030 fis, clone HEMBA1004086/cds = UNK

465F11
5714
6271
NM_006312
Hs.287994
0
1
nuclear receptor co-repressor 2 (NCOR2), mRNA

150E12
2041
2720
AK026834
Hs.287995
0
3
FLJ23181 fis, clone LNG11094/cds = UNKNOW

52D9
703
1482
AB016247
Hs.288031
0
1
for sterol-C5-desaturase, complete cds

37F4
1091
1655
AK025375
Hs.288061
1.00E−141
20
FLJ21722 fis, clone COLF0522, highly sim

188G5
1081
1753
NM_001101
Hs.288061
0
69
actin, beta (ACTB), mRNA/cds = (73,1200)/gb = N

171C12
2103
2426
AB046857
Hs.288140
1.00E−158
1
KIAA1637 protein, partial cds/cds = (0

104E8
1354
1790
AK023078
Hs.288141
0
1
FLJ13016 fis, clone NT2RP3000624, modera

181A4
1890
2507
AK022030
Hs.288178
0
2
cDNA FLJ11968 fis, clone HEMBB1001133/cds = UNK

129A1
3522
3748
J04144
Hs.288204
1.00E−125
1
angiotensin I-converting enzyme mRNA, complete cds/

598D12
1464
1947
AK025643
Hs.288224
0
3
cDNA: FLJ21990 fis, clone HEP06386/cds = (22,49

52E6
920
1388
AK023402
Hs.288416
0
2
FLJ13340 fis, clone OVARC1001942, weakly

165E3
303
640
NM_020666
Hs.288417
0
1
protein serine threonine kinase Clk4 (CLK4),

53D3
1
153
AK022280
Hs.288435
6.00E−76
1
FLJ12218 fis, clone MAMMA1001075, modera

586C2
223
448
BF110312
Hs.288443
1.00E−63
3
7n36d08.x1 cDNA, 3′ end/clone = IMAGE: 3566654

521F12
1922
2248
AK026923
Hs.288455
0
1
cDNA: FLJ23270 fis, clone COL10309, highly sim

120A11
825
1855
AK026078
Hs.288555
0
2
cDNA: FLJ22425 fis, clone HRC08686/

cds = UNKNOW

129D11
1723
1984
AK023470
Hs.288673
1.00E−143
2
FLJ13408 fis, clone PLACE1001672, weakly

109B12
1686
2086
AK025215
Hs.288708
1.00E−121
8
FLJ21562 fis, clone COL06420/cds = (238,2

178F11
387
558
NM_005402
Hs.288757
3.00E−93
1
v-ral simian leukemia viral oncogene homolog

58F8
1262
1604
AK022735
Hs.288836
0
1
cDNA FLJ12673 fis, clone NT2RM4002344/cds = (2,

163E11
360
1687
AK024094
Hs.288856
1.00E−25
2
FLJ14032 fis, clone HEMBA1004353, highly

105B4
741
1243
AK025092
Hs.288872
0
1
FLJ21439 fis, clone COL04352/cds = (206,1

106D10
1598
2291
AB014515
Hs.288891
0
3
for KIAA0615 protein, complete cds/cds = (

460F8
154
2487
NM_021818
Hs.288906
1.00E−150
2
WW Domain-Containing Gene (WW45), mRNA/cds = (

48A6
560
1258
NM_017644
Hs.288922
0
1
hypothetical protein FLJ20059 (FLJ20059), mR

168B10
1271
1747
AK023320
Hs.288929
0
1
FLJ13258 fis, clone OVARC1000862, modera

114E2
2395
2849
AK023256
Hs.288932
0
1
cDNA FLJ13194 fis, clone NT2RP3004378, weakly

586F9
368
730
AK026363
Hs.288936
1.00E−162
4
cDNA: FLJ22710 fis, clone HSI13340/cds = UNKNOW

180B4
831
959
NM_000344
Hs.288986
1.00E−32
1
survival of motor neuron 1, telomeric (SMN1),

149A12
10
1958
AK025467
Hs.289008
0
5
FLJ21814 fis, clone HEP01068/cds = UNKNOW

117B5
5160
5611
NM_012231
Hs.289024
1.00E−141
1
PR domain containing 2, with ZNF domain (PRDM2)

469A5
3132
3365
AK024456
Hs.289034
1.00E−106
1
mRNA for FLJ00048 protein, partial cds/cds = (2

461F6
396
473
AK024197
Hs.289037
7.00E−37
1
cDNA FLJ14135 fis, clone MAMMA1002728/cds = UN

176G11
1049
1811
AK024669
Hs.289069
0
4
cDNA: FLJ21016 fis, clone CAE05735/cds = (90,11

473A5
1343
1937
NM_013326
Hs.289080
0
1
colon cancer-associated protein Mic1 (MIC1),

591G2
14
2259
NM_005348
Hs.289088
0
14
heat shock 90 kD protein 1, alpha (HSPCA), mRNA

70D3
21
2912
X15183
Hs.289088
0
17
90-kDa heat-shock protein/cds = (60,2258)/g

37E8
780
1509
AK026033
Hs.289092
0
5
FLJ22380 fis, clone HRC07453, highly sim

74B10
408
791
X00453
Hs.289095
1.00E−153
2
gene fragment for DX alpha-chain signal peptide,

518B5
870
1128
NM_005313
Hs.289101
1.00E−119
1
glucose regulated protein, 58 kD (GRP58), mRNA

472A3
116
304
X83300
Hs.289103
4.00E−84
1

H. sapiens SMA4 mRNA/cds = (66,488)/gb = X83300/

gi = 603028/

112G6
1703
2550
NM_001166
Hs.289107
0
5
baculoviral IAP repeat-containing 2 (BIRC2),

37F11
1996
2580
U37547
Hs.289107
0
2
IAP homolog B (MIHB) mRNA, complete cds/

cds = (1159,301

169A12
371
588
X57812
Hs.289110
2.00E−84
1
rearranged immunoglobulin lambda light chain/c

472D6
2102
2424
AF294900
Hs.289118
1.00E−121
1
beta, beta-carotene 15, 15′-dioxygenase (BCD

151D1
2214
2294
AK025846
Hs.289721
1.00E−38
2
FLJ22193 fis, clone HRC01108/cds = UNKNOW

40A8
160
346
AI761924
Hs.289834
2.00E−94
1
wg68h03.x1 cDNA, 3′ end/clone = IMAGE: 2370293

468D5
42
105
AA719103
Hs.290535
5.00E−29
1
zh33d10.s1 cDNA, 3′ end/clone = IMAGE: 413875/

515B6
7
249
AA837754
Hs.291129
2.00E−61
1
oe10d02.s1 cDNA/clone = IMAGE: 1385475/gb = AA

594C9
16
319
NM_005745
Hs.291904
1.00E−150
1
accessory proteins BAP31/BAP29 (DXS1357E), m

476C10
180
311
AI184710
Hs.292276
8.00E−62
1
qd64a01.x1 cDNA, 3′ end/clone = IMAGE: 1734216

466G5
65
431
AA461604
Hs.292451
0
1
zx51d08.r1 cDNA, 5′ end/clone = IMAGE: 795759/

331F12
142
314
BF310166
Hs.292457
3.00E−85
1
601894826F1 cDNA, 5′ end/clone = IMAGE: 4124119

590D6
1
406
BG339050
Hs.292457
0
2
602436875F1 cDNA, 5′ end/clone = IMAGE: 4554643

150G5
160
431
AI440234
Hs.292490
6.00E−66
1
ti99h12.x1 cDNA, 3′ end/clone = IMAGE: 2140199

594F8
319
447
AA761571
Hs.292519
1.00E−57
1
nz23d06.s1 cDNA, 3′ end/clone = lMAGE: 1288619

122E2
91
307
AI582954
Hs.292553
4.00E−47
1
tr98e07.x1 cDNA, 3′ end/clone = IMAGE: 2227140

41E5
363
463
D59502
Hs.292590
3.00E−48
1
HUM041H11A cDNA, 3′ end/clone = GEN-041H11/cl

99B8
215
378
AI672433
Hs.292615
6.00E−62
4
wa03b05.x1 cDNA, 3′ end/clone = IMAGE: 2296977

72C6
198
484
AA719537
Hs.292877
1.00E−112
3
zh40g12.s1 cDNA, 3′ end/clone = IMAGE: 414598/

157H5
49
447
AI962127
Hs.292901
1.00E−126
1
wx77f07.x1 3′ end/clone = IMAGE: 2549701

115C2
2052
2613
NM_006310
Hs.293007
0
1
aminopeptidase puromycin sensitive (NPEPPS),

463F3
14
445
AW629485
Hs.293352
0
2
hi59b07.x1 cDNA, 3′ end/clone = IMAGE: 2976565

193H8
94
333
AI263141
Hs.293444
7.00E−58
1
qw90c01.x1 cDNA, 3′ end/clone = IMAGE: 1998336

170G9
46
713
AI452611
Hs.293473
9.00E−21
1
tj27g07.x1 cDNA, 3′ end/clone = lMAGE: 2142780

100F9
554
666
BE905040
Hs.293515
2.00E−43
1
601496859F1 cDNA, 5′ end/clone = IMAGE: 3898767

588G9
153
507
BF794089
Hs.293658
1.00E−143
1
602255649F1 cDNA, 5′ end/clone = IMAGE: 4338732

142G8
2
231
AV701332
Hs.293689
1.00E−79
1
AV701332 cDNA, 5′ end/clone = ADAABD03/clone_—

137A4
1
557
BF029654
Hs.293777
0
1
601765621F1 cDNA, 5′ end/clone = IMAGE: 3997900

478C6
442
622
BE748123
Hs.293842
3.00E−63
1
601571679F1 cDNA, 5′ end/clone = lMAGE: 3838675

100E7
198
488
BE748663
Hs.293842
1.00E−145
1
601571679T1 cDNA, 3′ end/clone = lMAGE: 3838675

110B4
246
469
NM_016398
Hs.293905
1.00E−122
1
hypothetical protein (HSPC131), mRNA/cds = (1

466D2
198
543
AW972477
Hs.294083
1.00E−180
1
EST384568 cDNA/gb = AW972477/gi = 8162323/ug =

100C10
1
398
AW963235
Hs.294092
0
2
EST375308/gb = AW963235/gi = 8153071/ug =

118F10
418
552
BF245076
Hs.294110
1.00E−48
1
601863910F1 cDNA, 5′ end/clone = IMAGE: 4082235

596H2
1150
2308
BC002450
Hs.294135
0
20
ribosomal protein L4, clone MGC: 776, mRNA, co

596B4
139
414
BE621121
Hs.294309
7.00E−73
3
601493943F1 cDNA, 5′ end/clone = IMAGE: 3896051

114D4
600
738
BE961923
Hs.294348
8.00E−33
1
601655335R1 cDNA, 3′ end/clone = IMAGE: 3845768

66D11
185
625
BE963811
Hs.294578
1.00E−127
6
601657462R1 cDNA, 3′ end/clone = IMAGE: 3875846

53E11
433
701
BE964149
Hs.294612
5.00E−81
1
601657833R1 cDNA, 3′ end/clone = IMAGE: 3875984

179A11
442
776
BF313856
Hs.294754
9.00E−79
1
601902261F1 5′ end/clone = IMAGE: 4134998

102B9
146
347
H71236
Hs.295055
7.00E−90
2
ys12f10.s1 cDNA, 3′ end/clone = IMAGE: 214603/

110F4
136
358
H80108
Hs.295107
1.00E−118
1
yu09f02.s1 cDNA, 3′ end/clone = IMAGE: 233307/

593F2
78
381
AF212224
Hs.295231
1.00E−172
3
CLK4 mRNA, complete cds/cds = (153,1514)/gb = A

50G9
355
415
AI052431
Hs.295451
1.00E−26
2
oz07e08.x1 cDNA, 3′ end/clone = IMAGE: 1674662

102E4
99
413
AI560651
Hs.295682
1.00E−146
8
tq60f01.x1 cDNA, 3′ end/clone = IMAGE: 2213209

486F7
263
489
BF572855
Hs.295806
1.00E−100
1
602079424F2 cDNA, 5′ end/clone = lMAGE: 4254172

39C1
2054
2315
AL050141
Hs.295833
1.00E−144
6
cDNA DKFZp586O031 (from clone DKFZp586O0

192D3
48
551
AW081320
Hs.295945
1.00E−158
4
xc30f12.x1 cDNA, 3′ end/clone = IMAGE: 2585807

102B7
753
850
AL117536
Hs.295969
5.00E−39
1
cDNA DKFZp434G012 (from clone DKFZp434G0

168D1
73
1193
AL360190
Hs.295978
1.00E−134
3
mRNA full length insert cDNA clone EUROIMAGE 74

47D6
103
331
AW150085
Hs.295997
3.00E−79
8
xg36f04.x1 cDNA, 3′ end/clone = lMAGE: 2629663

151H9
197
507
AW264291
Hs.296057
1.00E−113
1
xq97g08.x1 cDNA, 3′ end/clone = IMAGE: 2758622

56A1
1034
1220
AJ012504
Hs.296151
3.00E−74
1
activated in tumor suppression, clone TSA

525D12
42
545
AI922889
Hs.296159
1.00E−148
42
wn64g11.x1 cDNA, 3′ end/clone = IMAGE: 2450276

72C12
280
545
AW166001
Hs.296159
1.00E−84
10
xf43e11.x1 cDNA, 3′ end/clone = IMAGE: 2620844

99B1
21
286
BE259480
Hs.296183
4.00E−81
3
601106571F1 cDNA, 5′ end/clone = IMAGE: 3342929

143F5
18
178
BE962588
Hs.296183
1.00E−55
1
601655929R1 cDNA, 3′ end/clone = IMAGE: 3855823

110A10
2115
2237
AL096752
Hs.296243
1.00E−61
1
cDNA DKFZp434A012 (from clone DKFZp434A0

170G1
16
304
BE964134
Hs.296246
4.00E−96
1
601657818R1 CDNA, 3′ end/clone = IMAGE: 3876028

597G5
168
1564
NM_014456
Hs.296251
0
18
programmed cell death 4 (PDCD4), mRNA/cds = (84

184A12
686
1564
U96628
Hs.296251
0
2
nuclear antigen H731-like protein mRNA, compl

479H10
247
540
NM_002072
Hs.296261
1.00E−117
1
guanine nucleotide binding protein (G protein

179H11
48
250
BF315059
Hs.296266
3.00E−56
1
601899090F1 5′ end/clone = IMAGE: 4128334

182E9
1576
2251
AK023460
Hs.296275
0
2
FLJ13398 fis, clone PLACE1001377, highly

459B11
305
545
BF340402
Hs.296317
1.00E−79
1
602036746F1 cDNA, 5′ end/clone = IMAGE: 4184602

459B12
349
721
AK001838
Hs.296323
0
1
cDNA FLJ10976 fis, clone PLACE1001399/cds = UN

179F8
1
756
BF342246
Hs.296333
0
2
602013019F1 5′ end/clone = IMAGE: 4148741

171D1
12
330
AV693913
Hs.296339
1.00E−100
1
AV693913 cDNA, 5′ end/clone = GKCDVG04/clone_—

39B9
1
297
AB046771
Hs.296350
1.00E−167
1
for KIAA1551 protein, partial cds/cds = (0

36H12
547
1089
M96995
Hs.296381
0
2
epidermal growth factor receptor-binding pro

459F1
867
1020
NM_014499
Hs.296433
4.00E−76
1
putative purinergic receptor (P2Y10), mRNA/c

584A11
615
1287
NM_006392
Hs.296585
0
4
nucleolar protein (KKE/D repeat) (NOP56), mRN

593F7
209
752
NM_005678
Hs.296948
0
2
SNRPN upstream reading frame (SNURF), transcr

174F7
493
681
BE253125
Hs.297095
2.00E−60
5
601116648F1 cDNA, 5′ end/clone = IMAGE: 3357178

123H9
132
413
BE965554
Hs.297190
9.00E−88
1
601659486R1 cDNA, 3′ end/clone = IMAGE: 3896204

123D6
1105
1595
AF113676
Hs.297681
0
1
clone FLB2803 PRO0684 mRNA, complete cds/cds =

71C6
1076
1630
NM_003380
Hs.297753
0
2
vimentin (VIM), mRNA/cds = (122,1522)/gb = NM_0

586G5
1179
1452
NM_001908
Hs.297939
1.00E−142
1
cathepsin B (CTSB), mRNA/cds = (177,1196)/gb =

521E7
1
220
NM_001022
Hs.298262
1.00E−119
4
ribosomal protein S19 (RPS19), mRNA/cds = (22,4

466H7
9
339
AW614181
Hs.298654
1.00E−153
1
hg77d03.x1 cDNA, 3′ end/clone = IMAGE.2951621

464A4
675
1232
BC001077
Hs.299214
0
1
clone IMAGE: 2822295, mRNA, partial cds/cds =

466F3
49
337
AA132448
Hs.299416
1.00E−141
1
zo20a03.s1 cDNA, 3′ end/clone = IMAGE: 587404/

589B10
123
339
AW073707
Hs.299581
1.00E−55
30
xb01h03.x1 cDNA, 3′ end/clone = IMAGE: 2575061

521H4
3
371
NM_001000
Hs.300141
1.00E−125
4
ribosomal protein L39 (RPL39), mRNA/cds = (37,1

599F12
36
328
AW243795
Hs.300220
2.00E−67
1
xo56f02.x1 cDNA, 3′ end/clone = IMAGE: 2707995

479A6
173
356
AW262077
Hs.300229
3.00E−64
1
xq61e07.x1 cDNA, 3′ end/clone = IMAGE: 2755140

111C8
806
1350
NM_018579
Hs.300496
1.00E−147
6
mitochondrial solute carrier (LOC51312), mRN

459D8
1
679
NM_014478
Hs.300684
0
1
calcitonin gene-related peptide-receptor co

522C5
98
1360
NM_001154
Hs.300711
0
10
annexin A5 (ANXA5), mRNA/cds = (192,1154)/gb =

596B7
407
750
NM_003130
Hs.300741
2.00E−83
1
sorcin (SRI), mRNA/cds = (12,608)/gb = NM_00313

191A3
210
440
AA788623
Hs.301104
4.00E−34
9
ah29f09.s1 cDNA, 3′ end/clone = 1240265/clone

123E1
15
267
BE963194
Hs.301110
1.00E−60
11
601656811R1 cDNA, 3′ end/clone = IMAGE: 3865731

116F11
346
650
NM_014029
Hs.301175
2.00E−71
2
HSPC022 protein (HSPC022), mRNA/cds = (18,623)

58D4
489
611
AW863111
Hs.301183
8.00E−50
1
MR3-SN0009-010400-101-f02 cDNA/gb = AW863111

122D8
3644
4034
AB037808
Hs.301434
0
1
mRNA for KIAA1387 protein, partial cds/cds = (0

520F11
276
553
BE886472
Hs.301486
1.00E−111
1
601509688F1 cDNA, 5′ end/clone = IMAGE: 3911301

512E5
71
687
NM_001011
Hs.301547
0
8
ribosomal protein S7 (RPS7), mRNA/cds = (81,665

463F9
168
689
AV702152
Hs.301570
0
1
AV702152 cDNA, 5′ end/clone = ADBBFH05/clone_—

117A12
2239
2395
NM_007167
Hs.301637
5.00E−78
1
zinc finger protein 258 (ZNF258), mRNA/cds = (9

190A6
12942
13156
AF155238
Hs.301698
1.00E−114
1
BAC 180i23 chromosome 8 map 8q24.3 beta-galacto

594F12
1409
1841
NM_005442
Hs.301704
0
1
eomesodermin (Xenopus laevis) homolog (EOMES)

116G12
5477
5571
AB033081
Hs.301721
6.00E−47
1
mRNA for KIAA1255 protein, partial cds/cds = (0

123C4
23
579
BE260041
Hs.301809
1.00E−129
4
601150579F1 cDNA, 5′ end/clone = IMAGE: 3503419

192E12
1458
1854
NM_007145
Hs.301819
0
1
zinc finger protein 146 (ZNF146), mRNA/cds = (8

590G8
1100
1307
AF132197
Hs.301824
3.00E−57
1
PRO1331 mRNA, complete cds/cds = (422,616)/gb

482E5
1764
2139
NM_001295
Hs.301921
0
1
chemokine (C-C motif) receptor 1 (CCR1), mRNA

583C5
4283
4684
NM_014415
Hs.301956
0
1
zinc finger protein (ZNF-U69274), mRNA/cds = (

173G11
645
839
X58529
Hs.302063
1.00E−104
4
rearranged immunoglobulin mRNA for mu heavy chain

enh

597D11
30
369
AL137162
Hs.302114
1.00E−150
5
DNA sequence from clone RP5-843L14 on

chromosome 20.

191G9
182
353
AC004079
Hs.302183
9.00E−60
1
PAC clone RP1-167F23 from 7p15/cds = (0,569)/g

473D2
102
333
BF477640
Hs.302447
1.00E−126
1
7r01c05.x1 cDNA/clone = IMAGE/gb = BF477640/g

479A9
18
267
BE964028
Hs.302585
7.00E−79
1
601657601R1 cDNA, 3′ end/clone = IMAGE: 3875617

180A5
894
1325
NM_018295
Hs.302981
0
2
hypothetical protein FLJ11000 (FLJ11000), mR

593H6
950
1151
X00437
Hs.303157
1.00E−104
1
mRNA for T-cell specific protein/cds = (37,975)/gb = XC

51G12
274
533
BG054649
Hs.303214
1.00E−138
4
7o45b01.x1 cDNA, 3′ end/clone = IMAGE: 3576912

189B10
785
1024
NM_002138
Hs.303627
1.00E−133
2
heterogeneous nuclear ribonucleoprotein D (

99B11
1
529
NM_002982
Hs.303649
0
51
small inducible cytokine A2 (monocyte chemota

461E1
397
496
AI472078
Hs.303662
2.00E−28
1
tj85h03.x1 cDNA, 3′ end/clone = IMAGE: 2148341

103A1
359
687
AF130085
Hs.304177
1.00E−151
1
clone FLB8503 PRO2286 mRNA, complete cds/cds

180B11
52
240
AI824522
Hs.304477
4.00E−57
1
tx71d03.x1 cDNA, 3′ end/clone = lMAGE: 2275013

519A10
1
104
AI880542
Hs.304620
3.00E−26
1
at80h05.x1 cDNA, 3′ end/clone = IMAGE: 2378361

479F6
331
582
AA873734
Hs.304886
1.00E−131
1
oh55h07.s1 cDNA, 3′ end/clone = IMAGE: 1470589

176G3
61
324
AI904802
Hs.304919
2.00E−74
1
IL-BT067-190199-037 cDNA/gb = AI904802/gi = 6

471G6
169
397
AW592876
Hs.304925
1.00E−122
1
hg04d05.x1 cDNA, 3′ end/clone = IMAGE: 2944617

119D11
3
348
AL049282
Hs.306030
1.00E−179
1
mRNA; cDNA DKFZp564M113 (from clone

DKFZp564M1

112F7
2398
3008
U80743
Hs.306094
0
1
CAGH32 mRNA, partial cds/cds = (0,1671)/gb = U80

460C1
243
533
NM_001353
Hs.306098
5.00E−71
1
aldo-keto reductase family 1, member C1 (dihy

126A4
469
543
L08048
Hs.306192
2.00E−28
1
non-histone chromosomal protein (HMG-1)

retropseudo

119F3
2113
2237
AL096752
Hs.306327
3.00E−60
1
mRNA; cDNA DKFZp434A012 (from clone

DKFZp434A0

467F8
1860
2406
AL390039
Hs.307106
0
1
DNA sequence from clone RP13-383K5 on

chromosome Xq22

192B12
1
454
X72475
Hs.307183
0
6

H. sapiens mRNA for rearranged Ig kappa light chain

variable

116H11
60
402
AF067519
Hs.307357
1.00E−160
1
PITSLRE protein kinase beta SV1 isoform (CDC2L

472D3
150
478
AW975895
Hs.307486
1 .00E−124
1
EST388004 cDNA/gb = AW975895/gi = 8167117/ug =

458B4
87
354
AW206977
Hs.307542
1.00E−143
1
UI-H-BI1-afs-h-11-0-UI.s1 cDNA, 3′ end/clon

463A11
181
397
AI057025
Hs.307879
1.00E−69
1
oy75a12.x1 cDNA, 3′ end/clone = IMAGE: 1671646

479C6
138
403
BE264564
Hs.308154
1.00E−144
1
601192330F1 cDNA, 5′ end/clone = IMAGE: 3536383

468G10
118
446
AI361642
Hs.309028
0
1
qy86d04.x1 cDNA, 3′ end/clone = IMAGE: 2018887

461G12
64
466
AI379735
Hs.309117
7.00E−25
1
tc41c11.x1 cDNA, 3′ end/clone = IMAGE: 2067188

466H8
15
487
AI380278
Hs.309120
0
1
tf99f08.x1 cDNA, 3′ end/clone = IMAGE: 2107431

477C8
28
187
AI380449
Hs.309122
7.00E−84
1
tg02f12.x1 cDNA, 3′ end/clone = IMAGE: 2107631

477C9
47
537
AI380687
Hs.309127
0
1
tg03e04.x1 cDNA, 3′ end/clone = IMAGE: 2107710

465F4
68
631
AI440337
Hs.309279
0
1
tc88b03.x1 cDNA, 3′ end/clone = IMAGE: 2073197

465G6
313
404
AI475653
Hs.309347
9.00E−31
1
tc93b04.x1 cDNA, 3′ end/clone = IMAGE: 2073679

465E7
1
340
AI475827
Hs.309349
1.00E−171
2
tc87a05.x1 cDNA, 3′ end/clone = IMAGE: 2073104

517G11
62
516
AI707809
Hs.309433
1.00E−115
2
as28g09.x1 cDNA, 3′ end/clone = IMAGE: 2318560

468D11
290
497
AI523766
Hs.309484
1.00E−103
1
tg94f07.x1 cDNA, 3′ end/clone = IMAGE: 2116453

186F5
77
418
AI569898
Hs.309629
1.00E−81
1
tr57c12.x1 cDNA, 3′ end/clone = IMAGE: 2222422

116A12
8
158
AI735206
Hs.310333
2.00E−43
1
at07f03.x1 cDNA, 3′ end/clone = IMAGE: 2354429

126G12
35
170
AI866194
Hs.310948
1.00E−54
1
wl27a03.x1 cDNA, 3′ end/clone = IMAGE: 2426092

172G8
86
227
AI926251
Hs.311137
3.00E−44
1
wo41h05.x1 cDNA, 3′ end/clone = IMAGE: 2457945

477D8
1
115
AI968387
Hs.311448
4.00E−42
2
wu02e08.x1 cDNA, 3′ end/clone = IMAGE: 2515814

462F10
13
220
AW043857
Hs.311783
1.00E−107
1
wy81g04.x1 cDNA, 3′ end/clone = IMAGE: 2554998

185A9
46
423
AW130007
Hs.312182
1.00E−130
2
xf26f10.x1 cDNA, 3′ end/clone = IMAGE: 2619211

515F6
34
181
AW148618
Hs.312412
3.00E−58
2
xe99f02.x1 cDNA, 3′ end/clone = IMAGE: 2616699

583E12
5945
6393
AL133572
Hs.312840
0
1
mRNA; cDNA DKFZp434I0535 (from clone

DKFZp434I

471D5
306
411
AW298430
Hs.313413
1.00E−46
1
UI-H-BW0-ajI-c-09-0-UI.s1 cDNA, 3′ end/clon

482F7
1
449
AW440965
Hs.313578
0
1
he06d07.x1 cDNA, 3′ end/clone = IMAGE: 2918221

473B3
179
463
BG150461
Hs.313610
1.00E−135
1
7k01d08.x1 cDNA, 3′ end/clone = IMAGE: 3443006

479E9
138
434
AW450835
Hs.313715
1.00E−127
1
UI-H-BI3-alf-f-06-0-UI.s1 cDNA, 3′ end/clon

71B9
344
577
AI733018
Hs.313929
1.00E−115
1
oh60h01.x5 cDNA, 3′ end/clone = IMAGE: 1471441

479B6
217
443
AW629176
Hs.314085
2.00E−70
1
hi52a04.x1 cDNA, 3′ end/clone = IMAGE: 2975886

191F11
55
123
BE255377
Hs.314898
1.00E−26
1
601115405F1 cDNA, 5′ end/clone = IMAGE: 3355872

522F11
14
204
BE962883
Hs.314941
9.00E−83
3
601656423R1 cDNA, 3′ end/clone = IMAGE: 3856325

195F12
120
363
BE351010
Hs.315050
2.00E−77
1
ht22g04.x1 cDNA, 3′ end/clone = IMAGE: 3147510

173A5
429
824
BE410105
Hs.315263
1.00E−133
1
601302278F1 cDNA, 5′ end/clone = IMAGE: 3637002

481B2
1063
1283
NM_006255
Hs.315366
3.00E−72
1
protein kinase C, eta (PRKCH), mRNA/cds = (166,2

459G1
1428
1700
NM_006850
Hs.315463
1.00E−124
1
suppression of tumorigenicity 16 (melanoma di

113H4
22
359
BE901218
Hs.315633
1.00E−127
2
601676034F1 cDNA, 5′ end/clone = IMAGE: 3958617

583B7
510
754
BE963666
Hs.316047
2.00E−55
2
601656685R1 cDNA, 3′ end/clone = IMAGE: 3865820

466E10
488
644
AV729160
Hs.316771
1.00E−54
1
AV729160 cDNA, 5′ end/clone = HTCCAB04/clone_—

597A6
50
249
AV710763
Hs.316785
4.00E−31
2
AV710763 cDNA, 5′ end/clone = CuAAJH09/clone_—

123C3
41
529
BF183507
Hs.318215
1.00E−158
1
601809991R1 cDNA, 3′ end/clone = IMAGE: 4040470

193E12
15
2274
NM_006074
Hs.318501
0
7
stimulated trans-acting factor (50 kDa) (STAF

165D8
727
1344
BC002867
Hs.318693
0
1
clone IMAGE: 3940519, mRNA, partial cds/cds =

49F8
520
1094
M16942
Hs.318720
0
1
MHC class II HLA-DRw53-associated glycoprotein

beta-

172E10
310
944
NM_016018
Hs.318725
0
1
CGI-72 protein (LOC51105), mRNA/cds = (69,1400

585B1
51
296
BF696330
Hs.318782
6.00E−90
4
602125273F1 cDNA, 5′ end/clone = IMAGE: 4281906

45E12
208
737
NM_000636
Hs.318885
0
7
superoxide dismutase 2, mitochondrial (SOD2)

460G2
409
663
BG106948
Hs.318893
5.00E−96
1
602291361F1 cDNA, 5′ end/clone = IMAGE: 4386159

480C1
155
325
BF889206
Hs.319926
4.00E−74
1
RC6-TN0073-041200-013-H02 cDNA/gb = BF889206

178F1
1
387
BG112503
Hs.320972
1.00E−133
3
602282105F1 cDNA, 5′ end/clone = IMAGE: 4369633

176G4
1092
1339
AL110236
Hs.321022
1.00E−136
1
mRNA; cDNA DKFZp566P1124 (from clone

DKFZp566P

461H6
1701
2239
NM_024101
Hs.321130
0
1
hypothetical protein MGC2771 (MGC2771), mRNA

513F2
605
1614
AK001111
Hs.321245
0
2
cDNA FLJ10249 fis, clone HEMBB1000725, highly

525B4
9
251
BE871962
Hs.321262
6.00E−98
15
601448005F1 cDNA, 5′ end/clone = IMAGE: 3852001

467A4
1974
2223
AK026270
Hs.321454
6.00E−87
1
cDNA: FLJ22617 fis, clone HSI05379, highly sim

589F10
39
276
BF970928
Hs.321477
5.00E−77
1
602270204F1 cDNA, 5′ end/clone = IMAGE: 4358425

125A7
1102
1584
BC000627
Hs.321677
0
1
Signal transducer and activator of transcript

597H3
2786
2920
AL136542
Hs.322456
4.00E−46
2
mRNA; cDNA DKFZp761D0211 (from clone

DKFZp761D

465E2
40
107
BE747224
Hs.322643
7.00E−22
1
601580941F1 cDNA, 5′ end/clone = IMAGE: 3929386

515A12
1
698
AL050376
Hs.322645
0
2
mRNA; cDNA DKFZp586J101 (from clone

DKFZp586J1

589H11
26
265
BG283132
Hs.322653
4.00E−79
6
602406784F1 cDNA, 5′ end/clone = IMAGE: 4518957

586E5
1939
2162
AK025200
Hs.322680
1.00E−120
3
cDNA: FLJ21547 fis, clone COL06206/cds = UNKNOW

595A2
1
306
BG311130
Hs.322804
2.00E−70
2
ia55a08.y1 cDNA, 5′ end/clone_end = 5′/gb = BG3

459H11
742
951
BC002746
Hs.322824
1.00E−111
1
Similar to dodecenoyl-Coenzyme A delta isome

64C3
655
887
NM_020368
Hs.322901
1.00E−112
1
disrupter of silencing 10 (SAS10), mRNA/cds = (

591B8
3626
4574
D80006
Hs.322903
0
3
mRNA for KIAA0184 gene, partial cds/cds = (0,2591)/gb

458C3
5106
5198
NM_003035
Hs.323032
3.00E−43
1
TAL1 (SCL) interrupting locus (SIL), mRNA/cds

526B7
2132
2750
NM_024334
Hs.323193
0
2
hypothetical protein MGC3222 (MGC3222), mRNA

167F4
467
731
NM_014953
Hs.323346
1.00E−136
2
KIAA1008 protein (KIAA1008), mRNA/cds = (93,28

194B8
1913
3596
AB051480
Hs.323463
0
9
mRNA for KIAA1693 protein, partial cds/cds = (0

478H9
75
564
BF700502
Hs.323662
0
1
602128860F1 cDNA, 5′ end/clone = IMAGE: 4285502

119B1
1598
2284
NM_014664
Hs.323712
0
2
KIAA0615 gene product (KIAA0615), mRNA/cds = (

167H2
1410
3683
AB046771
Hs.323822
0
4
mRNA for KIAA1551 protein, partial cds/cds = (0

595C12
1
528
NM_021998
Hs.323950
0
6
zinc finger protein 6 (CMPX1) (ZNF6), mRNA/cd

462F1
1
356
AK026836
Hs.324060
1.00E−176
1
cDNA: FLJ23183 fis, clone LNG11477/cds = (226,7

122D10
217
424
AK026091
Hs.324187
2.00E−83
1
cDNA: FLJ22438 fis, clone HRC09232, highly sim

525B2
1028
3282
AL136739
Hs.324275
0
2
mRNA; cDNA DKFZp434D2111 (from clone

DKFZp434D

459B6
3
482
BF668584
Hs.324342
0
1
602123634F1 cDNA, 5′ end/clone = IMAGE: 4280408

583D10
232
466
NM_021104
Hs.324406
1.00E−130
2
ribosomal protein L41 (RPL41), mRNA/cds = (83,1

118F8
2262
2819
NM_016824
Hs.324470
0
1
adducin 3 (gamma) (ADD3), transcript variant 1

461A5
46
391
AW968541
Hs.324481
1.00E−111
1
EST380617 cDNA/gb = AW968541/gi = 8158382/ug =

467F11
927
1189
NM_000817
Hs.324784
1.00E−147
1
glutamate decarboxylase 1 (brain, 67 kD) (GAD1

103E12
1686
1771
AK024863
Hs.325093
9.00E−42
1
cDNA: FLJ21210 fis, clone COL00479/cds = UNKNOW

521E11
4276
4689
AB028990
Hs.325530
0
1
mRNA for KIAA1067 protein, partial cds/cds = (0

480A9
112
333
AA760848
Hs.325874
1.00E−108
1
nz14f06.s1 cDNA, 3′ end/clone = IMAGE: 1287779

71G8
2619
2868
NM_001964
Hs.326035
1.00E−116
1
early growth response 1 (EGR1), mRNA/cds = (270,

593D6
742
3372
NM_004735
Hs.326159
0
4
leucine rich repeat (in FLII) interacting prot

463G9
42
608
AW975482
Hs.326165
0
1
EST387591 cDNA/gb = AW975482/gi = 8166696/ug =

526B12
2380
2639
U83857
Hs.326247
1.00E−143
2
Aac11 (aac11) mRNA, complete cds/cds = (77,1663)/

gb =

36A1
63
338
AA010282
NA
1.00E−116
1
zi08h07.r1 Soares_fetal_liver_spleen_1NFLS_S1

cDNA

459D10
67
164
AA044450
NA
3.00E−47
1
zk55a02.r1 Soares_pregnant_uterus_NbHPU cDNA

clone

469E6
1
216
AA069335
NA
1.00E−104
1
zf74e10.r1 Soares_pineal_gland_N3HPG cDNA clone

463B2
4
205
AA077131
NA
4.00E−88
1
Brain cDNA Library cDNA clone 7B08E10

68H9
17
383
AA101212
NA
0
1
endothelial cell 937223 cDNA clone IMAGE: 549605 3′

458F3
120
498
AA115345
NA
0
1
zl09f11.r1 Soares_pregnant_uterus_NbHPU cDNA

clone

459E6
36
532
AA122297
NA
0
1
zk97a11.r1 Soares_pregnant_uterus_NbHPU cDNA

clone

462C5
1
122
AA136584
NA
2.00E−59
1
fetal retina 937202 cDNA clone IMAGE: 565899 3′

594A1
60
412
AA149078
NA
0
1
zl45e09.r1 Soares_pregnant_uterus_NbHPU cDNA

clone

515A9
329
449
AA182528
NA
2.00E−46
1
NT2 neuronal precursor 937230 cDNA clone

75H4
7
371
AA187234
NA
1.00E−119
1
endothelial cell 937223 cDNA clone IMAGE: 624540 3′

73F10
1
544
AA210786
NA
0
1
cDNA clone IMAGE: 682976 5′

525D8
1
119
AA214691
NA
6.00E−60
1
Express cDNA library cDNA 5′

37H4
250
401
AA243144
NA
3.00E−48
1
cDNA clone IMAGE: 685113 5′

463B10
145
408
AA250809
NA
1.00E−123
1
cDNA clone IMAGE: 684374 5′

464E10
1
303
AA251184
NA
1.00E−119
1
cDNA clone IMAGE: 684046 5′

477H8
1
123
AA252909
NA
4.00E−58
3
cDNA clone IMAGE: 669292 5′

465C3
1
279
AA258979
NA
1.00E−129
1
cDNA clone IMAGE: 687151 5′

588G6
275
529
AA280051
NA
2.00E−94
1
cDNA clone IMAGE: 705062 5′

465E9
74
429
AA282774
NA
0
1
cDNA clone IMAGE: 713136 5′

459E7
49
466
AA283061
NA
0
1
cDNA clone IMAGE: 713078 5′

164B4
41
329
AA284232
NA
1.00E−148
2
zc39c01.T7 Soares_senescent_fibroblasts_NbHSF

cDNA

461G8
289
532
AA290921
NA
1.00E−123
1
cDNA clone IMAGE: 700335 5′

470G7
29
441
AA290993
NA
0
1
cDNA clone IMAGE: 700425 5′

500A12
1
519
AA307854
NA
1.00E−174
1
(HCC) cell line cDNA 5′ end similar to

471F4
9
326
AA309188
NA
1.00E−153
1
cDNA

194B6
134
467
AA312681
NA
1.00E−163
1
cDNA 5′ end

69F3
5
321
AA314369
NA
1.00E−176
1
(HCC) cell line II cDNA 5′ end similar

67G10
1
171
AA319163
NA
3.00E−64
2
cDNA 5′ end

99A5
1
287
AA322158
NA
1.00E−136
1
cDNA 5′ end similar to similar to tropomyosin

171B1
13
310
AA332553
NA
1.00E−135
1
cDNA 5′ end

485D11
46
210
AA360634
NA
2.00E−75
1
cDNA 5′ end

462G2
1
183
AA377352
NA
4.00E−89
2
cDNA 5′ end

523A8
1
407
AA397592
NA
0
1
cDNA clone IMAGE: 728546 5′

171G10
1
409
AA401648
NA
0
2
cDNA clone IMAGE: 726936 5′

100F5
42
172
AA402069
NA
4.00E−60
1
cDNA clone IMAGE: 727161 5′

459H7
48
375
AA412436
NA
1.00E−163
1
cDNA clone IMAGE: 731446 5′

102A8
25
120
AA418765
NA
1.00E−46
1
cDNA clone IMAGE: 767795 5′

73A3
1
424
AA426506
NA
0
1
cDNA clone IMAGE: 768117 5′

72E10
1
442
AA427653
NA
0
11
tumor NbHOT cDNA clone IMAGE: 770045 5′

72A1
1
261
AA429783
NA
1.00E−142
1
zw57b01.r1 Soares_total_fetus_Nb2HF8_9w cDNA

clone

460D12
126
388
AA431959
NA
1.00E−93
1
cDNA clone IMAGE: 782188 3′

450B11
1
437
AA454987
NA
0
1
cDNA clone IMAGE: 811916 5′

518A8
1
329
AA457757
NA
1.00E−177
1
fetal retina 937202 cDNA clone IMAGE: 838756 5′

460F7
47
490
AA460876
NA
0
1
zx69d04.r1 Soares_total_fetus_Nb2HF8_9w cDNA

clone

118H12
1
304
AA476568
NA
1.00E−163
1
zx02f11.r1 Soares_total_fetus_Nb2HF8_9w cDNA

clone

40F11
1
533
AA479163
NA
0
1
cDNA clone IMAGE: 754246 5′ similar to gb: X15606

470F3
76
356
AA482019
NA
1.00E−142
1
cDNA clone IMAGE: 746046 3′

466C2
1
354
AA490796
NA
1.00E−148
1
cDNA clone IMAGE: 82101 5′

464A9
228
364
AA496483
NA
7.00E−71
1
tumor NbHOT cDNA clone IMAGE: 755690 5′ similar to

123D11
99
297
AA501725
NA
1.00E−103
1
cDNA clone IMAGE: 929806 similar to contains Alu

119G10
128
374
AA501934
NA
1.00E−134
1
cDNA clone IMAGE: 956346

166A11
19
140
AA516406
NA
1.00E−48
1
cDNA clone IMAGE: 923858 3′

36G1
5
480
AA524720
NA
0
1
cDNA clone IMAGE: 937468 3′

109H9
37
286
AA573427
NA
1.00E−130
2
cDNA clone IMAGE: 1028913 3′

477B2
8
273
AA579400
NA
1.00E−143
1
cDNA clone IMAGE: 915561 similar to contains Alu

178C10
1
354
AA588755
NA
1.00E−177
1
cDNA clone IMAGE: 1084243 3′

486G7
35
99
AA613460
NA
6.00E−28
1
cDNA clone IMAGE: 1144571 similar to contains

472E9
27
389
AA628833
NA
1 .00E−119
1
af37g04.s1 Soares_total_fetus_Nb2HF8_9w cDNA

clone

100C3
122
505
AA639796
NA
0
1
cDNA clone IMAGE: 1159029 3′

518A7
39
226
AA665359
NA
4.00E−83
1
cDNA clone IMAGE: 1205697 similar to

473D9
377
446
AA683244
NA
1.00E−30
1
schizo brain S11 cDNA clone IMAGE: 971252 3′

523D7
80
502
AA701667
NA
1.00E−158
1
zi43g09.s1 Soares_fetal_liver_spleen_1NFLS_S1

cDNA

472B1
37
130
AA744774
NA
1.00E−35
1
cDNA clone IMAGE: 1283731 3′

98C9
10
254
AA748714
NA
1.00E−111
1
cDNA clone IMAGE: 1270595 3′

196D7
3
442
AA806222
NA
0
1
cDNA clone IMAGE: 1409989 3′

118A8
10
381
AA806766
NA
0
1
cDNA clone IMAGE: 1338727 3′

98B3
56
159
AA826572
NA
7.00E−47
1
cDNA clone IMAGE: 1416447 3′

154D9
38
405
AA846378
NA
1.00E−164
1
cDNA clone IMAGE: 1394232 3′

459C2
1
491
AA909983
NA
0
2
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 1523142 3′

486A7
1
176
AA916990
NA
1.00E−72
1
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 1527333 3′

460D2
78
537
AA923567
NA
0
1
cDNA clone IMAGE: 1536231 3′

105F4
86
390
AA974839
NA
4.00E−94
1
cDNA clone IMAGE: 1567639 3′

461H7
295
383
AA974991
NA
2.00E−30
1
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 1560953 3′

162B1
398
470
AA976045
NA
9.00E−28
1
cDNA clone IMAGE: 1558392 3′

53D8
1
422
AA984245
NA
1.00E−162
1
schizo brain S11 cDNA clone IMAGE: 1629672 3′

524A5
3568
4037
AB020681
NA
0
1
mRNA for KIAA0874 protein, partial cds Length = 4440

174H3
81
271
AB021288
NA
1.00E−101
1
mRNA for beta 2-microglobulin, complete cds

Length = 925

115A2
1920
2309
AB034747
NA
0
4
SIMPLE mRNA for small integral membrane protein of

lysosome/late endos

39G7
1578
1920
AB040875
NA
1 .00E−135
3
hxCT mRNA for cystine/glutamate exchanger,

complete cds Length = 2000

149H2
430
713
AB044971
NA
1.00E−158
1
mRNA for nucleolar phosphoprotein Nopp34, complete

cds Length = 1005

458F6
780
1235
AB045118
NA
0
1
FRAT2 mRNA, complete cds Length = 2164

459D12
2694
3564
AB045278
NA
0
2
beta3GnT5 mRNA for beta1,3-N-

acetylglucosaminyltransferase 5, complete

103H7
1294
1933
AB049881
NA
1.00E−139
1
similar to Macaca fascicularis brain cDNA, clone: QnpA

18828 Length = 2517

102E11
1142
1772
AB050511
NA
0
1
similar to Macaca fascicularis brain cDNA, clone: QnpA-

18828 Length = 2518

460C3
798
930
AB050514
NA
9.00E−54
1
similar to Macaca fascicularis brain cDNA, clone: QnpA-

18828 Length = 2519

480A10
4649
5183
AB058677
NA
0
1
mRNA for MEGF11 protein (KIAA1781), complete cds

Length = 5702

142G10
2251
2430
AB060884
NA
6.00E−44
1
similar to Macaca fascicularis brain cDNA clone: QtrA-

13024, full insert sequence

494G5
1585
1998
AF005213
NA
0
1
ankyrin 1 (ANK1) mRNA, complete cds Length = 2651

154C6
520
826
AF005775
NA
1.00E−150
3
caspase-like apoptosis regulatory protein 2 (clarp)

mRNA, alternativel

186B6
772
1248
AF039575
NA
0
1
heterogeneous nuclear ribonucleoprotein D0B mRNA

partial cds

471A4
395
611
AF061944
NA
6.00E−84
1
kinase deficient protein KDP mRNA, partial cds

Length = 2653

37G5
277
525
AF067529
NA
1.00E−129
1
PITSLRE protein kinase beta SV18 isoform (CDC2L2)

mRNA, partial cds

479D1
1270
1570
AF070635
NA
1.00E−144
1
clone 24818 mRNA sequence Length = 1643

491E2
38
226
AF086214
NA
9.00E−74
1
full length insert cDNA clone ZD64D04 Length = 691

517C2
230
465
AF086431
NA
1.00E−113
1
full length insert cDNA clone ZD79H10 Length = 530

593C6
1
359
AF113210
NA
0
5
MSTP030 mRNA, complete cds Length = 1024

191A8
135
1169
AF113213
NA
0
3
MSTP033 mRNA, complete cds Length = 1281

144E9
799
943
AF116679
NA
9.00E−29
1
PRO2003 mRNA, complete cds Length = 1222

106E3
583
1187
AF116702
NA
0
2
PRO2446 mRNA, complete cds Length = 1356

72F8
878
1205
AF130094
NA
1.00E−175
1
clone FLC0165 mRNA sequence Length = 1548

458G9
730
1463
AF157116
NA
0
1
clone 274512, mRNA sequence Length = 2172

139F11
18
229
AF161430
NA
1.00E−115
1
HSPC312 mRNA, partial cds Length = 360

149H10
406
621
AF161455
NA
3.00E−95
2
HSPC337 mRNA, partial cds Length = 1033

68A9
19
243
AF173954
NA
2.00E−27
1
Cloning vector pGEM-URA3, complete sequence

Length = 4350

165B7
65
418
AF202092
NA
0
1
PC3-96 mRNA, complete cds Length = 1068

52H1
361
594
AF212226
NA
1.00E−34
1
RPL24 mRNA, complete cds Length = 1474

162H8
52
404
AF212233
NA
1.00E−179
1
microsomal signal peptidase subunit mRNA, complete

cds Length = 794

54E10
680
1316
AF212241
NA
0
3
CDA02 mRNA, complete cds Length = 2179

117D8
2052
2482
AF248648
NA
0
3
RNA-binding protein BRUNOL2 mRNA, complete cds

Length = 2615

75E3
326
662
AF249845
NA
0
2
isolate Siddi 10 hypervariable region 1, mitochondrial

sequence

459G12
791
1267
AF260237
NA
0
1
hairy/enhancer of split 6 (HES6) mRNA, complete cds

Length = 1286

177F6
1968
2423
AF267856
NA
0
1
HT033 mRNA, complete cds Length = 2972

115G8
996
1399
AF267863
NA
0
1
DC43 mRNA, complete cds Length = 2493

501H3
426
1152
AF279437
NA
0
107
interleukin 22 (IL22) mRNA, complete cds Length = 1167

174B4
900
1332
AF283771
NA
0
2
clone TCBAP0774 mRNA sequence Length = 1814

126C7
454
843
AF332864
NA
1.00E−116
2
similar to Mus Ras association domain family 3

protein (Rassf3) mRNA

105A9
232
624
AF333025
NA
1.00E−140
1
prokineticin 2 precursor (PROK2) mRNA, complete

cds Length = 1406

186F1
4543
5058
AF347010
NA
0
3
mitochondrion, complete genome Length = 16570

590B12
4684
5053
AF347013
NA
0
1
mitochondrion, complete genome Length = 16566

517H7
4669
5058
AF347015
NA
0
1
mitochondrion, complete genome Length = 16571

596E9
220
295
AI027844
NA
3.00E−34
1
cDNA clone IMAGE: 1671612 3′

599B3
608
609
AI039890
NA
1.00E−45
1
ox97d11.x1 Soares_senescent_fibroblasts_NbHSF

cDNA

189H9
22
524
AI041828
NA
0
1
oy34b08.x1 Soares_parathyroid_tumor_NbHPA cDNA

clone

471F6
63
526
AI084224
NA
0
1
cDNA clone IMAGE: 1671418 3′

142E9
6
372
AI091533
NA
1.00E−179
1
oo23d05.x1 Soares_NSF_F8_9W_OT_PA_P_S1

cDNA clone

72D2
65
529
AI131018
NA
0
6
qb82e07.x1 Soares_fetal_heart_NbHH19W cDNA

clone

468F6
9
428
AI223400
NA
0
1
cDNA clone IMAGE: 1838447 3′ similar to TR: O15383

185H1
94
199
AI267714
NA
5.00E−50
1
SB pool 1 cDNA clone IMAGE: 2038526

166A9
1
480
AI275205
NA
0
1
cDNA clone IMAGE: 1990616 3′

499F2
4
395
AI281442
NA
0
2
cDNA clone IMAGE: 1967452 3′

517H5
155
457
AI298509
NA
1.00E−158
1
cDNA clone IMAGE: 1896546 3′

144F7
24
364
AI299573
NA
0
1
cDNA clone IMAGE: 1900105 3′

519E9
52
408
AI352690
NA
1.00E−180
1
cDNA clone IMAGE: 1946884 3′

466F9
172
440
AI361839
NA
1.00E−109
1
cDNA clone IMAGE: 2022012 3′

144C9
118
373
AI362793
NA
7.00E−63
1
cDNA clone IMAGE: 2018948 3′ similar to gb: M60854

464B11
19
455
AI363001
NA
0
1
cDNA clone IMAGE: 2018452 3′ similar to contains

127B6
40
257
AI370412
NA
6.00E−96
1
cDNA clone IMAGE: 1987587 3′

166C4
58
271
AI371227
NA
1.00E−62
1
cDNA clone IMAGE: 1987633 3′ similar to

467G7
1
450
AI380016
NA
0
1
cDNA clone IMAGE: 2109169 3′ similar to

466C5
316
497
AI380390
NA
8.00E−44
1
cDNA clone IMAGE: 2107088 3′

466B5
200
477
AI381586
NA
1.00E−126
1
cDNA clone IMAGE: 2074796 3′

458G10
347
444
AI384128
NA
2.00E−40
1
cDNA clone IMAGE: 2088819 3′ similar to contains

467A8
415
522
AI391500
NA
1.00E−41
1
cDNA clone IMAGE: 2107686 3′

477D1
14
269
AI392705
NA
1.00E−137
2
cDNA clone IMAGE: 2109581 3′

467B11
1
293
AI393970
NA
1.00E−122
1
cDNA clone IMAGE: 2107950 3′

522D3
250
526
AI419082
NA
1.00E−127
1
cDNA clone IMAGE: 2103029 3′

149A11
25
313
AI440491
NA
1.00E−132
1
cDNA clone IMAGE: 2073277 3′

471C1
77
215
AI458739
NA
1.00E−50
1
cDNA clone IMAGE: 2149471 3′ similar to gb: S85655

116E10
162
503
AI469584
NA
1.00E−171
1
cDNA clone IMAGE: 2156522 3′

472C8
1
369
AI498316
NA
0
1
cDNA clone IMAGE: 2160886 3′ similar to TR: Q62717

468E8
2
451
AI523854
NA
3.00E−92
1
cDNA clone IMAGE: 2116683 3′

477B5
23
295
AI524624
NA
2.00E−86
1
cDNA clone IMAGE: 2075323 3′

193H3
368
489
AI525644
NA
4.00E−34
1
cDNA 5′

66F1
277
436
AI571519
NA
7.00E−84
2
cDNA clone IMAGE: 2225079 3′ similar to gb: J03909

171A11
225
429
AI581199
NA
1.00E−101
3
cDNA clone IMAGE: 2154787 3′ similar to

116F2
337
429
AI597917
NA
4.00E−42
1
cDNA clone IMAGE: 2258495 3′ similar to contains

461G10
9
398
AI627495
NA
1.00E−179
1
cDNA clone IMAGE: 2285386 3′

594D11
206
434
AI628930
NA
1.00E−110
1
cDNA clone IMAGE: 2281541 3′ similar to

489H9
1
507
AI633798
NA
0
4
cDNA clone IMAGE: 2242115 3′

171G7
212
431
AI634972
NA
1.00E−103
1
cDNA clone IMAGE: 2284157 3′

165C12
270
581
AI651212
NA
1.00E−175
1
cDNA clone IMAGE: 2304186 3′

64B3
1
529
AI678099
NA
0
1
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 2330166 3′

134H3
186
289
AI684022
NA
1.00E−34
1
cDNA clone IMAGE: 2267411 3′

110B8
169
496
AI688560
NA
1.00E−132
1
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 2330535 3′

459F2
160
542
AI697756
NA
0
1
cDNA clone IMAGE: 2341330 3′

481F11
21
340
AI700738
NA
1.00E−167
1
cDNA clone IMAGE: 2343628 3′

488C5
37
533
AI701165
NA
0
4
cDNA clone IMAGE: 2340734 3′

104D9
116
241
AI709236
NA
4.00E−60
1
HPLRB6 cDNA clone IMAGE: 2353865 3′ similar to

112E1
18
576
AI742850
NA
0
1
wg47a05.x1 Soares_NSF_F8_9W_OT_PA_P_S1

cDNA clone

113H12
5
140
AI748827
NA
1.00E−63
1
HPLRB6 cDNA clone IMAGE: 2356401 3′

458B8
150
474
AI760353
NA
0
1
cDNA clone IMAGE: 2387703 3′

461H11
334
578
AI762870
NA
1.00E−111
1
cDNA clone IMAGE: 2397996 3′

458D10
1
465
AI765153
NA
0
1
cDNA clone IMAGE: 2393531 3′

38B5
2
295
AI766963
NA
1.00E−140
1
cDNA clone IMAGE: 2400693 3′

471A2
320
394
AI796317
NA
2.00E−31
1
cDNA clone IMAGE: 2384100 3′

74D10
15
377
AI802547
NA
1.00E−124
2
cDNA clone IMAGE: 2186739 3′similar to TR: O15510

482C9
117
409
AI803065
NA
1.00E−164
1
tj47a07.x1 Soares_NSF_F8_9W_OT_PA_P_S1 cDNA

clone

480C5
177
517
AI807278
NA
0
1
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 2357909 3′

175B12
228
513
AI817153
NA
1.00E−132
1
cDNA clone IMAGE: 2413005 3′

66E10
14
268
AI858771
NA
1.00E−119
1
cDNA clone IMAGE: 2429769 3′

470H6
65
500
AI880607
NA
0
1
HPLRB6 cDNA clone IMAGE: 2355013 3′

181D12
7
512
AI884548
NA
0
1
cDNA clone IMAGE: 2437818 3′similar to gb: L06797

468H6
52
528
AI884671
NA
0
1
cDNA clone IMAGE: 2431488 3′

597C9
284
383
AI904071
NA
1.00E−48
1
cDNA

467C2
206
351
AI917642
NA
2.00E−59
1
cDNA clone IMAGE: 2392330 3′

459D1
25
575
AI948513
NA
0
1
cDNA clone IMAGE: 2470532 3′

166E11
152
280
AI954499
NA
4.00E−54
1
cDNA clone IMAGE: 2550263 3′

493D7
2032
2171
AJ001235
NA
4.00E−29
1
similar to Papio hamadryas ERV-9 like LTR insertion

Length = 2240

116B1
1169
1744
AJ009771
NA
0
1
mRNA for putative RING finger protein, partial

Length = 3038

137B9
296
407
AJ271637
NA
4.00E−32
1
similar to Elaeis guineensis microsatellite DNA, clone

mEgCIR0219

483E6
4250
4492
AJ278191
NA
1.00E−95
1
similar to Mus musculus mRNA for putative mc7

protein (mc7 gene)

144A8
988
1152
AK001163
NA
1.00E−75
1
cDNA FLJ10301 fis, clone NT2RM2000032 Length = 1298

525C11
49
496
AK001451
NA
0
1
cDNA FLJ10589 fis, clone NT2RP2004389

177D9
707
980
AK004265
NA
7.00E−76
1
similar to Mus 18 days embryo cDNA, RIKEN full-

length enriched library,

111E10
777
1121
AK004400
NA
1.00E−112
1
similar to Mus 18 days embryo cDNA, RIKEN full-

length enriched library,

458G4
650
1259
AK008020
NA
8.00E−86
1
similar to Mus adult male small intestine cDNA, RIKEN

full-length enrich

47G7
31
328
AK009988
NA
1.00E−111
1
similar to Mus adult male tongue cDNA, RIKEN full-

length enriched librar

69G7
1801
1987
AK012426
NA
5.00E−68
3
similar to Mus 11 days embryo cDNA, RIKEN full-

length enriched library,

62C10
1092
1267
AK013164
NA
6.00E−46
2
similar to Mus 10, 11 days embryo cDNA, RIKEN full-

length enriched libra

46D9
3243
3564
AK014408
NA
1.00E−104
1
similar to Mus 12 days embryo embryonic body below

diaphragm region

1078C11
2069
2326
AK016683
NA
9.00E−83
1
similar to Mus adult male testis cDNA, RIKEN full-

length enriched librar

102C12
698
1339
AK018758
NA
0
1
similar to Mus adult male liver cDNA, RIKEN full-

length enriched library

585B3
1278
1873
AK021925
NA
0
1
cDNA FLJ11863 fis, clone HEMBA1006926 Length = 2029

46F3
1377
2006
AK022057
NA
0
1
cDNA FLJ11995 fis, clone HEMBB1001443, highly

similar to Rattus norveg

73E7
344
1112
AK023512
NA
0
9
cDNA FLJ13450 fis, clone PLACE1003027, highly

similar to Homo sapiens

465B12
681
1338
AK024202
NA
0
1
cDNA FLJ14140 fis, clone MAMMA1002858, highly

similar to Rat cMG1

142D12
254
358
AK024740
NA
9.00E−27
1
cDNA: FLJ21087 fis, clone CAS03323 Length = 826

472F7
1330
1623
AK024764
NA
1.00E−164
1
cDNA: FLJ21111 fis, clone CAS05384, highly similar

to AF144700 Homo sa

521A3
26
195
AK024976
NA
2.00E−90
1
cDNA: FLJ21323 fis, clone COL02374 Length = 1348

465D1
2091
2255
AK025769
NA
1.00E−74
1
cDNA: FLJ22116 fis, clone HEP18520 Length = 2271

595E9
16
546
AK026264
NA
0
1
cDNA: FLJ22611 fis, clone HSI04961 Length = 1426

103E1
1353
1866
AK026334
NA
1.00E−126
1
cDNA: FLJ22681 fis, clone HSI10693 Length = 1903

524F3
1635
1742
AK026443
NA
9.00E−51
2
cDNA: FLJ22790 fis, clone KAIA2176, highly similar to

HUMPMCA

196H10
938
1286
AK026819
NA
6.00E−82
1
cDNA: FLJ23166 fis, clone LNG09880 Length = 1941

172F7
349
738
AK027258
NA
0
1
cDNA: FLJ23605 fis, clone LNG15982, highly similar

to AF113539 Homo sa

187B10
1583
2142
AK027260
NA
1.00E−129
1
cDNA: FLJ23607 fis, clone LNG16050 Length = 2560

190F11
76
636
AL042081
NA
0
1
(synonym: htes3) cDNA clone DKFZp434P171 3′

525A9
1
653
AL042370
NA
0
1
(synonym: htes3) cDNA clone DKFZp434A1821 5′

464G8
59
686
AL042376
NA
0
1
(synonym: htes3) cDNA clone DKFZp434A2421 5′

172B12
380
624
AL047171
NA
1.00E−131
1
(synonym: hute1) cDNA clone DKFZp586F2018 5′

193F3
915
1309
AL049305
NA
1.00E−133
1
mRNA; cDNA DKFZp564A186 (from clone

DKFZp564A186) Length = 1669

111H8
102
660
AL049356
NA
1.00E−146
1
mRNA; cDNA DKFZp566E233 (from clone

DKFZp566E233) Length = 808

526E6
118
551
AL049932
NA
1.00E−147
2
mRNA; cDNA DKFZp564H2416 (from clone

DKFZp564H2416) Length = 1865

37C8
707
996
AL050218
NA
1.00E−156
1
mRNA; cDNA DKFZp586I0923 (from clone

DKFZp58610923) Length = 1282

72A9
1235
1391
AL110164
NA
2.00E−70
1
mRNA; cDNA DKFZp586I0324 (from clone

DKFZp586I0324) Length = 1705

107C8
1042
1398
AL117644
NA
0
2
mRNA; cDNA DKFZp434M095 (from clone

DKFZp434M095) Length = 1455

62E7
1
475
AL120453
NA
1.00E−117
1
(synonym: hamy2) cDNA clone DKFZp761I208 5′

492A7
77
390
AL121406
NA
1.00E−101
1
(synonym: hmel2) cDNA clone DKFZp762G117 5′

598B1
443
812
AL133879
NA
1.00E−172
1
(synonym: hamy2) cDNA clone DKFZp761J0114 5′

458C10
47
351
AL133913
NA
5.00E−76
1
(synonym: hamy2) cDNA clone DKFZp761M2014 5′

98E7
922
2284
AL136558
NA
0
6
mRNA; cDNA DKFZp761B1514 (from clone

DKFZp761B1514) Length = 3453

157F6
3511
3847
AL136797
NA
0
1
mRNA; cDNA DKFZp434N031 (from clone

DKFZp434N031); complete cds

68B4
1009
1595
AL136932
NA
0
1
mRNA; cDNA DKFZp586H1322 (from clone

DKFZp586H1322); complete cds

458B6
278
955
AL137601
NA
0
1
mRNA; cDNA DKFZp434E0811 (from clone

DKFZp434E0811); partial cds

172C9
1866
2423
AL137608
NA
0
1
mRNA; cDNA DKFZp434J1111 (from clone

DKFZp434J1111); partial cds

72G1
194
474
AL138429
NA
1.00E−151
1
(synonym: htes3) cDNA clone DKFZp434E0629 3′

463H12
12
356
AL513780
NA
1.00E−124
1
cDNA clone CL0BA003ZF07 5 prime

181B6
43
638
AL520535
NA
0
1
cDNA clone CS0DB006YD20 3 prime

69B6
352
858
AL520892
NA
0
1
cDNA clone CS0DB002YG16 5 prime

182A5
119
617
AL521097
NA
0
1
cDNA clone CS0DB001YA13 3 prime

458E9
3
865
AL528020
NA
0
2
cDNA clone CS0DC028YO09 3 prime

485C11
1
431
AL532303
NA
0
1
cDNA clone CS0DM014YJ04 5 prime

196G3
78
698
AL532406
NA
0
1
cDNA clone CS0DM014YL03 5 prime

105H4
154
486
AL533737
NA
1.00E−156
1
cDNA clone CS0DF002YH09 5 prime

594G1
337
756
AL534564
NA
0
1
cDNA clone CS0DF004YI09 5 prime

524A9
403
906
AL540260
NA
0
1
cDNA clone CS0DF032YF03 3 prime

118H5
433
532
AL540399
NA
4.00E−39
1
cDNA clone CS0DE001YM08 5 prime

124C2
270
815
AL543900
NA
0
1
cDNA clone CS0DI005YK13 3 prime

471D3
216
403
AL550229
NA
9.00E−49
1
cDNA clone CS0DI039YD11 5 prime

191F2
324
844
AL554506
NA
0
1
cDNA clone CS0DI083YJ17 5 prime

166F6
64
576
AL556016
NA
0
1
cDNA clone CS0DK010YH04 5 prime

467G9
61
401
AL556919
NA
1.00E−138
1
cDNA clone CS0DK012YI02 5 prime

37D7
149
685
AL559029
NA
0
1
cDNA clone CS0DJ010YJ11 5 prime

590B3
76
287
AL559422
NA
1.00E−111
2
cDNA clone CS0DJ013YN07 5 prime

181H2
168
780
AL559555
NA
0
1
cDNA clone CS0DJ013YP21 5 prime

589E3
28
447
AL561074
NA
0
1
cDNA clone CS0DL001YN01 5 prime

487F9
326
739
AL561892
NA
1.00E−149
1
cDNA clone CS0DB006YL04 3 prime

68F10
12
658
AL562895
NA
0
1
cDNA clone CS0DC021YO20 3 prime

157D7
2
108
AL565736
NA
1.00E−28
1
cDNA clone CS0DF007YC06 3 prime

177B1
231
505
AL567986
NA
1.00E−128
1
cDNA clone CS0DF036YI04 3 prime

512E3
627
815
AL575666
NA
1.00E−94
1
cDNA clone CS0DI069YD02 3 prime

112E10
193
623
AL575755
NA
0
1
cDNA clone CS0DI070YG17 3 prime

70H7
197
757
AL576149
NA
0
1
cDNA clone CS0DI072YK21 3 prime

37F1
275
411
AL577970
NA
1.00E−43
1
cDNA clone CS0DK008YK22 3 prime

65D4
278
828
AL578975
NA
0
1
cDNA clone CS0DK012YN01 3 prime

182G2
70
684
AL579745
NA
0
1
cDNA clone CS0DJ003YG20 5 prime

194F9
450
669
AL582354
NA
3.00E−94
1
cDNA clone CS0DL006YH05 3 prime

184F2
27
501
AL583322
NA
2.00E−37
1
cDNA clone CS0DL012YI10 5 prime

40A3
432
638
AL583391
NA
4.00E−83
1
cDNA clone CS0DL012YA12 3 prime

53G7
6
462
AU117298
NA
0
1
sapiens cDNA clone HEMBA1001091 5′

37G7
218
706
AU118159
NA
0
1
sapiens cDNA clone HEMBA1002998 5′

180F9
174
698
AU120731
NA
0
1
sapiens cDNA clone HEMBB1001298 5′

191F1
298
608
AU135154
NA
1.00E−137
1
sapiens cDNA clone PLACE1001348 5′

466G7
11
125
AU158636
NA
1.00E−53
1
sapiens cDNA clone PLACE4000063 3′

67F9
1
453
AV648670
NA
0
2
cDNA clone GLCBLH08 3′

155D6
97
337
AV650434
NA
1.00E−104
1
cDNA clone GLCCEG06 3′

596H6
1
397
AV651615
NA
0
1
cDNA clone GLCCRF09 3′

99D5
41
232
AV653169
NA
6.00E−78
1
cDNA clone GLCDIB01 3′

331C10
33
365
AV654188
NA
1.00E−103
6
cDNA clone GLCDTC01 3′

121A12
70
188
AV659358
NA
3.00E−47
1
cDNA clone GLCFWC05 3′

460G9
69
476
AV687530
NA
0
1
cDNA clone GKCATH08 5′

470F5
1
174
AV689330
NA
2.00E−50
1
cDNA clone GKCDJE03 5′

109E8
71
471
AV705900
NA
0
1
cDNA clone ADBBFE11 5′

166C9
121
226
AV709955
NA
2.00E−26
1
cDNA clone ADCABF08 5′

117F1
69
582
AV710415
NA
0
1
cDNA clone CuAAND10 5′

523C9
41
536
AV716565
NA
0
6
cDNA clone DCBCAF01 5′

103D7
1
164
AV716644
NA
3.00E−77
2
cDNA clone DCBAUG10 5′

195F11
232
459
AV716791
NA
1.00E−113
2
cDNA clone DCBAZC04 5′

63C4
208
421
AV719659
NA
1.00E−101
1
cDNA clone GLCGRA09 5′

496C4
156
563
AV719938
NA
0
1
cDNA clone GLCFUC08 5′

479A1
120
469
AV720984
NA
1.00E−162
1
cDNA clone HTBBIC02 5′

499D6
70
406
AV721008
NA
1.00E−112
4
cDNA clone HTBBHG03 5′

461C8
182
676
AV723437
NA
0
1
cDNA clone HTBBUE10 5′

585G1
173
552
AV724531
NA
0
1
cDNA clone HTBARD04 5′

113B8
1
149
AV724559
NA
3.00E−40
1
cDNA clone HTBCFB08 5′

111H4
497
498
AV724665
NA
0
1
cDNA clone HTBAYG03 5′

458F5
1
534
AV730135
NA
0
1
cDNA clone HTFAHA06 5′

589F6
21
226
AV735258
NA
6.00E−70
1
cDNA clone cdAAIF03 5′

172C8
209
426
AV738173
NA
9.00E−98
1
cDNA clone CBMAHC04 5′

464G3
43
498
AV743635
NA
0
1
cDNA clone CBLBAC03 5′

72D4
43
384
AV745692
NA
1.00E−178
2
cDNA clone NPAACB06 5′

592G12
175
571
AV749844
NA
1.00E−176
1
cDNA clone NPCBVG08 5′

169F6
110
250
AV755117
NA
3.00E−28
1
cDNA cloneTPAABA12 5′

99H3
200
513
AV755367
NA
1.00E−131
2
cDNA clone BMFAIB02 5′

595G9
399
549
AV756188
NA
2.00E−31
1
cDNA clone BMFABD08 5′

595A12
8
572
AW002985
NA
0
2
cDNA clone IMAGE: 2475831 3′

586B7
184
330
AW004905
NA
8.00E−50
1
cDNA clone IMAGE: 2565317 3′ similar to

591D6
15
436
AW021037
NA
0
1
Cochlea cDNA clone IMAGE: 2483601 5′

188F1
135
476
AW021551
NA
0
1
Cochlea cDNA clone IMAGE: 2484414 5′

467E8
73
474
AW027160
NA
1.00E−162
1
Soares_thymus_NHFTh cDNA clone IMAGE: 2512983

3′ similar to

472G2
11
110
AW064187
NA
9.00E−38
1
CD4 intrathymic T-cell cDNA library cDNA 3′

598F3
43
453
AW071894
NA
0
1
cDNA clone IMAGE: 2501169 3′

181C7
10
96
AW131768
NA
8.00E−41
1
cDNA clone IMAGE: 2619947 3′

181D1
69
216
AW134512
NA
2.00E−77
1
UI-H-BI1-abv-e-05-0-UI.s1 NCI_CGAP_Sub3 cDNA

clone IMAGE: 2713065 3′

472B10
339
458
AW136717
NA
4.00E−54
1
UI-H-BI1-adm-a-03-0-UI.s1 NCI_CGAP_Sub3 cDNA

clone IMAGE: 2717092 3′

166B9
240
408
AW137104
NA
6.00E−88
1
UI-H-BI1-acp-e-02-0-UI.s1 NCI_CGAP_Sub3 cDNA

clone IMAGE: 2714979 3′

188C1
323
461
AW137149
NA
2.00E−72
1
UI-H-BI1-acq-a-05-0-UI.s1 NCI_CGAP_Sub3 cDNA

clone IMAGE: 2715152 3′

65B2
106
298
AW148765
NA
7.00E−75
1
cDNA clone IMAGE: 2616915 3′

524C3
234
429
AW151854
NA
1.00E−76
2
cDNA clone IMAGE: 2623546 3′ similar to

479A8
6
327
AW161820
NA
1.00E−151
1
brain 00004 cDNA clone IMAGE: 2781653 3′

585E10
7
391
AW166442
NA
0
1
Soares_NHCe_cervix cDNA clone IMAGE: 269740 3′

482C6
9
329
AW188398
NA
1.00E−133
1
cDNA clone IMAGE: 2665252 3′

522G11
39
516
AW248322
NA
0
1
cDNA clone IMAGE: 2820662 5′

473D5
283
416
AW274156
NA
4.00E−69
1
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 2814367 3′

71C12
20
530
AW293159
NA
0
2
UI-H-BW0-aii-b-08-0-UI.s1 NCI_CGAP_Sub6 cDNA

clone IMAGE: 2729414 3′

472H11
205
501
AW293424
NA
1.00E−151
1
UI-H-BI2-ahm-a-12-0-UI.s1 NCI_CGAP_Sub4 cDNA

clone IMAGE: 2727094 3′

465H11
17
124
AW293426
NA
1.00E−48
1
UI-H-BI2-ahm-b-02-0-UI.s1 NCI_CGAP_Sub4 cDNA

clone IMAGE: 2727122 3′

461H8
19
452
AW295965
NA
0
1
UI-H-BI2-ahh-f-07-0-UI.s1 NCI_CGAP_Sub4 cDNA

clone IMAGE: 2726917 3′

464B7
250
551
AW300500
NA
3.00E−95
1
cDNA clone IMAGE: 2774602 3′

465C7
1
322
AW338115
NA
0
1
cDNA clone IMAGE: 2833029 3′

466H5
10
523
AW341449
NA
0
1
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 2909026 3′ similar to

461D9
12
325
AW379049
NA
1.00E−134
1
HT0230 cDNA

186E8
51
277
AW380881
NA
1.00E−103
1
HT0283 cDNA

180D4
260
348
AW384988
NA
2.00E−30
1
HT0427 cDNA

472C1
13
404
AW390233
NA
1.00E−122
1
ST0181 cDNA

462G12
236
321
AW402007
NA
3.00E−40
1
UI-HF-BK0-aao-g-02-0-UI.r1 NIH_MGC_36 cDNA

clone IMAGE: 3054530 5′

177H2
18
338
AW405863
NA
9.00E−52
1
UI-HF-BL0-acf-e-06-0-UI.r1 NIH_MGC_37 cDNA clone

IMAGE: 3059026 5′

140G10
6
308
AW440517
NA
1.00E−152
1
cDNA clone IMAGE: 2890615 3′

482A10
1
231
AW440869
NA
1.00E−114
1
cDNA clone IMAGE: 2918151 3′ similar to contains

40B2
18
353
AW444632
NA
4.00E−45
1
UI-H-BI3-ajw-b-11-0-UI.s1 NCI_CGAP_Sub5 cDNA

clone IMAGE: 2733260 3′

61C2
21
392
AW444812
NA
0
1
UI-H-BI3-ajy-d-11-0-UI.s1 NCI_CGAP_Sub5 cDNA

clone IMAGE: 2733380 3′

461H10
151
248
AW449610
NA
8.00E−48
1
UI-H-BI3-aku-g-11-0-UI.s1 NCI_CGAP_Sub5 cDNA

clone IMAGE: 2735804 3′

479E10
9
425
AW451293
NA
0
1
UI-H-BI3-alh-f-06-0-UI.s1 NCI_CGAP_Sub5 cDNA

clone IMAGE: 2736899 3′

489G6
16
303
AW452023
NA
1.00E−125
1
UI-H-BI3-alm-f-06-0-UI.s1 NCI_CGAP_Sub5 cDNA

clone IMAGE: 2737306 3′

463H8
99
289
AW452096
NA
1.00E−103
1
UI-H-BI3-alo-d-02-0-UI.s1 NCI_CGAP_Sub5 cDNA

clone IMAGE: 3068186 3′

459B8
71
535
AW499658
NA
0
1
UI-HF-BR0p-ajj-c-07-0-UI.r1 NIH_MGC_52 cDNA

clone IMAGE: 3074677 5′

37A2
128
395
AW499828
NA
1.00E9−110
I
UI-HF-BN0-ake-c-06-0-UI.rl NIH_MGC_50 cDNA

clone IMAGE: 3076619 5′

112E5
88
557
AW499829
NA
0
1
UI-HF-BN0-ake-c-07-0-UI.r1 NIH_MGC_50 cDNA

clone IMAGE: 3076621 5′

523F5
435
517
AW500534
NA
4.00E−36
1
UI-HF-BN0-akj-d-04-0-UI.r1 NIH_MGC_50 cDNA

clone IMAGE: 3077406 5′

476E10
152
450
AW501528
NA
1.00E−129
1
UI-HF-BP0p-ajf-c-02-0-UI.r1 NIH_MGC_51 cDNA

clone IMAGE: 3073923 5′

67D10
36
413
AW504212
NA
0
1
UI-HF-BN0-alp-a-11-0-UI.r1 NIH_MGC_50 cDNA

clone IMAGE: 3080348 5′

100E10
29
364
AW504293
NA
1.00E−159
1
UI-HF-BN0-alg-b-10-0-UI.r1 NIH_MGC_50 cDNA

clone IMAGE: 3079267 5′

484D12
35
353
AW510795
NA
1.00E−167
1
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 2911933 3′ similar to

480B2
109
446
AW572538
NA
1.00E−162
1
cDNA clone IMAGE: 2832030 3′

465D2
272
464
AW573211
NA
2.00E−49
1
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 2933767 3′ similar to

47G6
125
126
AW614193
NA
1.00E−51
1
cDNA clone IMAGE: 2951662 3′

499D7
1
341
AW630825
NA
0
2
cDNA clone IMAGE: 2969854 5′

62H5
10
423
AW651682
NA
0
2
cDNA clone IMAGE: 2901099 5′

104A7
3
461
AW778854
NA
0
1
cDNA clone IMAGE: 3037337 3′

484H1
9
453
AW780057
NA
0
1
cDNA clone IMAGE: 3036046 3′

491E8
18
348
AW792856
NA
1.00E−164
2
UM0001 cDNA

65D11
64
648
AW810442
NA
0
3
ST0125 cDNA

596F6
49
623
AW813133
NA
0
1
ST0189 cDNA

518H1
131
386
AW819894
NA
1.00E−133
1
ST0294 cDNA

115A7
1
315
AW836389
NA
1.00E−169
3
LT0030 cDNA

486D9
32
237
AW837717
NA
1.00E−65
1
LT0042 cDNA

477B12
84
253
AW837808
NA
4.00E−67
1
LT0042 cDNA

121A11
253
444
AW842489
NA
1.00E−98
1
CN0032 cDNA

472E6
132
447
AW846856
NA
1.00E−149
1
CT0195 cDNA

164F9
1
462
AW856490
NA
0
1
CT0290 cDNA

103C4
23
366
AW859565
NA
0
1
CT0355 cDNA

129D3
81
295
AW866426
NA
1.00E−108
1
SN0024 cDNA

501F9
88
421
AW873028
NA
1.00E−170
3
cDNA clone IMAGE: 3120038 3′

98G4
1
294
AW873326
NA
1.00E−107
1
cDNA clone IMAGE: 3009400 3′

72D5
55
648
AW886511
NA
0
1
OT0083 cDNA

460A5
101
294
AW891344
NA
1.00E−102
1
NT0079 cDNA

459E9
196
260
AW945538
NA
8.00E−28
1
EN0024 cDNA

479H5
17
224
AW948395
NA
1.00E−102
1
FN0040 cDNA

165E7
2
599
AW949461
NA
0
1
MAGA cDNA

123G9
104
715
AW954112
NA
0
2
MAGC cDNA

183F3
84
503
AW954476
NA
1.00E−159
1
MAGC cDNA

196C6
8
189
AW954580
NA
5.00E−98
1
MAGC cDNA

515H10
1
512
AW955265
NA
0
1
MAGC cDNA

41E8
16
671
AW957139
NA
1.00E−145
2
MAGD cDNA

66A7
335
503
AW958538
NA
4.00E−85
1
MAGE cDNA

465G8
169
615
AW960484
NA
0
1
MAGF cDNA

519E6
44
290
AW960593
NA
1.00E−134
1
MAGF cDNA

594F4
306
571
AW963171
NA
1.00E−112
1
MAGH cDNA

155B2
30
673
AW964218
NA
0
3
MAGH cDNA

173B5
1
553
AW965078
NA
0
1
MAGI cDNA

176A6
7
312
AW965490
NA
1.00E−136
1
MAGI cDNA

498H9
1
456
AW965987
NA
0
2
MAGI cDNA

517D11
105
484
AW966098
NA
0
2
MAGI cDNA

166H7
63
559
AW967388
NA
0
1
MAGJ cDNA

462C8
69
212
AW967948
NA
2.00E−72
1
MAGJ cDNA

189C5
8
566
AW968561
NA
0
1
MAGJ cDNA

459C3
129
587
AW969359
NA
0
2
MAGK cDNA

174C1
155
527
AW969546
NA
1.00E−170
1
MAGK cDNA

191F6
158
543
AW973953
NA
1.00E−152
2
MAGM cDNA

461G9
311
437
AW974749
NA
7.00E−47
1
MAGN cDNA

104D1
182
594
AW993791
NA
0
1
BN0034 cDNA

188F5
734
1292
AY007110
NA
0
4
clone TCCCTA00084 mRNA sequence Length = 1656

48D7
692
1169
AY029066
NA
1.00E−76
4
Humanin (HN1) mRNA, complete cds Length = 1567

55B8
1802
2045
BC000141
NA
3.00E−96
1
Similar to myelocytomatosis oncogene, clone

MGC: 5183, mRNA

37A8
34
301
BC000374
NA
1.00E−101
1
ribosomal protein L18, clone MGC: 8373, mRNA,

complete cds

178E5
20
551
BC000408
NA
5.00E−53
1
acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl

Coenzyme A thiolase

596G2
27
263
BC000449
NA
3.00E−43
2
Similar to ubiquitin C, clone MGC: 8448, mRNA,

complete cds

179A3
693
1002
BC000514
NA
1.00E−160
3
ribosomal protein L13a, clone MGC: 8547, mRNA,

complete cds

158F10
169
522
BC000523
NA
1.00E−157
1
Similar to ribosomal protein S24, clone MGC: 8595,

mRNA, complete cds

515G5
34
270
BC000530
NA
7.00E−38
1
ribosomal protein L19, clone MGC: 8653, mRNA,

complete cds

39B6
286
1073
BC000590
NA
0
9
actin related protein 2/3 complex, subunit 2 (34 kD),

clone MGC: 1416,

169A4
929
1314
BC000672
NA
0
1
guanine nucleotide binding protein (G protein), beta

polypeptide 2-lik

166H4
1350
1745
BC000771
NA
1.00E−169
8
Similar to tropomyosin 4, clone MGC: 3261, mRNA,

complete cds

331F9
482
949
BC000967
NA
0
1
clone IMAGE: 3449287, mRNA, partial cds Length = 2156

526C6
633
829
BC001169
NA
1.00E−100
1
Similar to esterase 10, clone MGC: 1873, mRNA,

complete cds

135G12
1598
1766
BC001303
NA
6.00E−42
1
Similar to splicing factor, arginine/serine-rich 2 (SC-

35), clone MGC:

491C6
613
714
BC001385
NA
3.00E−34
1
Similar to leucine rich repeat (in FLII) interacting

protein 1, clone

108D10
234
641
BC001399
NA
2.00E−79
1
ferritin, heavy polypeptide 1, clone MGC: 1749, mRNA,

complete cds

196H5
1387
1899
BC001412
NA
6.00E−55
4
eukaryotic translation elongation factor 1 alpha 1,

clone MGC: 1332, mR

460F5
973
1350
BC001413
NA
0
1
clone IMAGE: 3140866, mRNA Length = 1634

520C5
348
472
BC001632
NA
5.00E−34
1
Similar to NADH dehydrogenase (ubiquinone)

flavoprotein 2 (24 kD), clon

520D10
1729
2205
BC001637
NA
0
2
ATP synthase, H+ transporting, mitochondrial F1

complex, alpha subunit

524A1
564
922
BC001660
NA
1.00E−94
2
ribonuclease 6 precursor, clone MGC: 1360, mRNA,

complete cds

121E7
275
381
BC001697
NA
2.00E−26
1
Similar to ribosomal protein S15a, clone MGC: 2466,

mRNA, complete cds

109D1
2441
2835
BC001798
NA
1.00E−123
1
clone MGC: 3157, mRNA, complete cds Length = 3041

180D9
741
921
BC001819
NA
5.00E−85
2
ribonuclease 6 precursor, clone MGC: 3554, mRNA,

complete cds

72H5
1264
2808
BC001854
NA
0
8
methionine adenosyltransferase II, alpha, clone

MGC: 4537, mRNA, comple

167H8
1099
1436
BC002409
NA
1.00E−49
1
actin, beta, clone MGC: 8647, mRNA, complete cds

Length = 1858

53H1
2398
2513
BC002538
NA
3.00E−41
1
serine (or cysteine) proteinase inhibitor, clade B

(ovalbumin), member

125B3
246
585
BC002711
NA
1.00E−40
1
cell division cycle 42 (GTP-binding protein, 25 kD),

clone MGC: 3497, mR

331H8
201
557
BC002837
NA
0
1
clone MGC: 4175, mRNA, complete cds Length = 1092

150C4
1699
2040
BC002845
NA
8.00E−29
1
eukaryotic translation elongation factor 1 alpha 1,

clone MGC: 3711, mR

70D7
345
850
BC002900
NA
0
1
Similar to proteasome (prosome, macropain) subunit,

alpha type, 2, clo

476B5
1431
1761
BC002929
NA
1.00E−141
1
clone IMAGE: 3954899, mRNA, partial cds Length = 2467

38D7
200
688
BC002971
NA
0
2
clone IMAGE: 3543711, mRNA, partial cds Length = 1934

74A11
652
1724
BC003063
NA
0
5
Similar to likely ortholog of yeast ARV1, clone

IMAGE: 3506392, mRNA

105H12
1148
1370
BC003090
NA
1.00E−105
1
COP9 homolog, clone MGC: 1297, mRNA, complete

cds Length = 1637

50F4
8
301
BC003137
NA
1.00E−115
1
ribosomal protein S3, clone MGC: 3657, mRNA,

complete cds

175G9
93
216
BC003352
NA
1.00E−33
1
tumor protein, translationally-controlled 1, clone

MGC: 5308, mRNA, com

587E9
72
554
BC003358
NA
4.00E−60
2
ribosomal protein L10, clone MGC: 5189, mRNA,

complete cds

71F8
491
911
BC003406
NA
0
1
cytidine monophosphate-N-acetylneuraminic acid

hydroxylase (CMP-N-acet

512E11
308
372
BC003563
NA
2.00E−27
1
guanine nucleotide binding protein (G protein), gamma

5, clone MGC: 196

118B11
76
343
BC003577
NA
1.00E−111
1
clone IMAGE: 3544292, mRNA, partial cds Length = 826

107E3
9
634
BC003697
NA
0
1
clone MGC: 5564, mRNA, complete cds Length = 2145

128D4
1408
1550
BC004186
NA
1.00E−34
1
guanine nucleotide binding protein, beta 1, clone

MGC: 2819, mRNA, comp

58H6
554
859
BC004245
NA
1.00E−171
2
ferritin, light polypeptide, clone MGC: 10465, mRNA,

complete cds

481D8
134
460
BC004258
NA
6.00E−73
1
hypothetical protein PRO1741, clone MGC: 10753,

mRNA, complete cds

520F6
160
1400
BC004317
NA
0
3
clone MGC: 10924, mRNA, complete cds Length = 1837

489G7
511
787
BC004458
NA
2.00E−60
1
enolase 1, (alpha), clone MGC: 4315, mRNA, complete

cds

115B8
1162
1640
BC004521
NA
0
2
ATP synthase, H+ transporting, mitochondrial F1

complex, alpha subunit

118A2
1126
1369
BC004805
NA
4.00E−38
1
similar to Mus musculus, clone IMAGE: 3584831,

mRNA Length = 1910

73D2
1174
1751
BC004872
NA
0
1
clone MGC: 11034, mRNA, complete cds Length = 2471

522E3
681
993
BC004900
NA
1.00E−175
10
ribosomal protein L13a, clone IMAGE: 3545758,

mRNA, partial cds

55G12
1
232
BC004928
NA
3.00E−68
1
clone MGC: 10493, mRNA, complete cds Length = 2567

520C2
3
139
BC004994
NA
1.00E−31
1
myosin regulatory light chain, clone MGC: 4405,

mRNA, complete cds

460H4
1577
1923
BC005101
NA
0
1
clone IMAGE: 3618561, mRNA Length = 2113

154F12
122
283
BC005128
NA
2.00E−46
1
ribosomal protein L7a, clone MGC: 10607, mRNA,

complete cds

592C8
647
925
BC005187
NA
2.00E−32
1
Similar to hypothetical protein, clone MGC: 12182,

mRNA, complete cds

591D1
726
837
BC005361
NA
5.00E−31
1
proteasome (prosome, macropain) subunit, alpha

type, 4, clone MGC: 1246

458A7
1307
1568
BC005816
NA
4.00E−98
1
Similar to deltex (Drosophila) homolog 1, clone

IMAGE: 3688330, mRNA, p

122C6
263
378
BC005928
NA
1.00E−29
1
S100 calcium-binding protein A8 (calgranulin A), clone

MGC: 14536, mRNA

47H11
273
854
BC006008
NA
0
1
clone IMAGE: 4285740, mRNA Length = 1040

598E1
850
1226
BC006176
NA
0
2
clone IMAGE: 4054156, mRNA, partial cds Length = 1423

175A1
570
887
BC006282
NA
1.00E−161
1
Similar to RIKEN cDNA 1110020N13 gene, clone

MGC: 10540

150H12
543
1098
BC006464
NA
0
1
calmodulin 2 (phosphorylase kinase, delta), clone

MGC: 2168

583E5
980
1246
BC006849
NA
1.00E−127
1
Similar to RIKEN cDNA 2410044K02 gene, clone

MGC: 5469

41H7
619
1308
BC007004
NA
0
2
Similar to oxysterol-binding protein-related protein 1,

clone IMAGE: 40

56C12
13
187
BC007063
NA
6.00E−27
1
peroxiredoxin 1, clone MGC: 12514, mRNA, complete

cds Length = 973

183C11
2986
3328
BC007203
NA
1.00E−169
1
hypothetical protein MGC10823, clone MGC: 12957,

mRNA, complete cds

109H10
1343
1627
BC007277
NA
1.00E−156
1
Similar to RIKEN cDNA 0610039P13 gene, clone

MGC: 15619, mRNA

588E11
423
1324
BC007299
NA
0
3
Similar to ATP synthase, H+ transporting,

mitochondrial F1 complex, al

164F12
72
336
BE002854
NA
1.00E−147
1
BN0090 cDNA

106A12
22
608
BE005703
NA
0
1
BN0120 cDNA

472E11
168
297
BE044364
NA
1.00E−66
1
Soares_NFL_T_GBC_S1 cDNA clone

IMAGE: 3040218 3′

458H11
2
510
BE049439
NA
0
1
cDNA clone IMAGE: 2834924 3′

46F7
18
527
BE061115
NA
0
1
BT0041 cDNA

105A8
1
166
BE085539
NA
3.00E−74
1
BT0669 cDNA

467F5
27
247
BE086076
NA
1.00E−115
1
BT0672 cDNA

469B6
5
188
BE091932
NA
6.00E−87
1
BT0733 cDNA

66D7
18
568
BE160822
NA
0
1
HT0422 cDNA

593F8
110
451
BE163106
NA
1.00E−165
1
HT0457 cDNA

468B10
1
461
BE168334
NA
0
1
HT0514 cDNA

192E1
1
602
BE176373
NA
0
1
HT0585 cDNA

109A9
100
377
BE177661
NA
1.00E−129
1
HT0598 cDNA

468B9
27
145
BE178880
NA
3.00E−31
1
HT0609 cDNA

526E11
6
222
BE217848
NA
1.00E−118
3
cDNA clone IMAGE: 3174941 3′

115H2
226
227
BE218938
NA
2.00E−97
1
cDNA clone IMAGE: 3176478 3′

126B3
1
509
BE222301
NA
1.00E−151
1
cDNA clone IMAGE: 3166180 3′

195F2
123
470
BE222392
NA
4.00E−91
1
cDNA clone IMAGE: 3166335 3′

170F7
1
375
BE242649
NA
0
1
acute myelogenous leukemia cell (FAB M1) Baylor-

HGSC

459F10
35
432
BE247056
NA
5.00E−84
1
cell acute lymphoblastic leukemia Baylor-HGSC

project = TCBA

491G11
269
516
BE253336
NA
1.00E−116
1
cDNA clone IMAGE: 3357826 5′

471H10
140
202
BE254064
NA
2.00E−26
1
cDNA clone IMAGE: 3354554 5′

521H9
22
605
BE292793
NA
0
2
cDNA clone IMAGE: 2987838 5′

472A9
33
436
BE297329
NA
0
1
cDNA clone IMAGE: 3532809 5′

99E10
59
423
BE328818
NA
0
1
cDNA clone IMAGE: 3181355 3′

192C3
4
335
BE348809
NA
0
1
cDNA clone IMAGE: 3152438 3′

140G6
206
405
BE348955
NA
3.00E−85
1
cDNA clone IMAGE: 3144625 3′

483D12
1
534
BE349148
NA
1.00E−160
1
cDNA clone IMAGE: 3150275 3′

491H12
1
526
BE379820
NA
0
1
cDNA clone IMAGE: 3510960 5′

481D5
212
333
BE464239
NA
3.00E−45
1
cDNA clone IMAGE: 3194693 3′

469H8
31
179
BE466500
NA
2.00E−71
1
cDNA clone IMAGE: 3195395 3′

56D11
72
353
BE467470
NA
1.00E−113
1
cDNA clone IMAGE: 3212950 3′

471D10
1
249
BE502246
NA
1.00E−119
2
cDNA clone IMAGE: 3197344 3′

471C2
255
486
BE502992
NA
1.00E−128
1
cDNA clone IMAGE: 3214462 3′

56A2
291
669
BE538333
NA
1.00E−164
1
cDNA clone IMAGE: 3454710 5′

191F12
488
587
BE547584
NA
9.00E−28
1
cDNA clone IMAGE: 3461312 5′

525F3
5
236
BE550944
NA
1.00E−125
1
cDNA clone IMAGE: 3233200 3′

473B7
46
228
BE551867
NA
4.00E−86
1
cDNA clone IMAGE: 3195555 3′

467C6
48
404
BE569141
NA
1.00E−162
1
cDNA clone IMAGE: 3681180 5′

110D3
193
473
BE613237
NA
1.00E−157
2
cDNA clone IMAGE: 3856357 3′

140F9
20
344
BE614297
NA
1.00E−84
1
cDNA clone IMAGE: 3906037 3′

473B12
63
216
BE645630
NA
3.00E−51
1
cDNA clone IMAGE: 3288143 3′ similar to contains

460C2
156
594
BE646470
NA
0
1
cDNA clone IMAGE: 3292133 3′

172E5
329
491
BE670804
NA
7.00E−72
8
cDNA clone IMAGE: 3285031 3′ similar to gb: J04130

469D4
50
553
BE674685
NA
0
1
cDNA clone IMAGE: 3292800 3′ similar to TR: O60688

171F2
10
280
BE676054
NA
1.00E−96
1
cDNA clone IMAGE: 3295273 3′

102E12
102
357
BE737348
NA
2.00E−93
1
cDNA clone IMAGE: 3640772 5′

121C11
198
488
BE748663
NA
1.00E−150
1
cDNA clone IMAGE: 3838675 3′

126D1
208
449
BE763412
NA
1.00E−122
1
NT0036 cDNA

172H5
52
581
BE768647
NA
0
1
FT0010 cDNA

176F12
178
646
BE792125
NA
0
1
cDNA clone IMAGE: 3936215 5′

71A6
16
437
BE825187
NA
0
1
CN0028 cDNA

115F11
14
132
BE858152
NA
4.00E−60
1
cDNA clone IMAGE: 3306735 3′

61A11
1
448
BE872245
NA
0
1
cDNA clone IMAGE: 3850435 5′

171B8
155
377
BE875145
NA
8.00E−88
1
cDNA clone IMAGE: 3891244 5′

108A6
370
539
BE876375
NA
7.00E−72
2
cDNA clone IMAGE: 3889033 5′

166B1
1
472
BE877115
NA
1.00E−153
1
cDNA clone IMAGE: 3887598 5′

63D11
208
496
BE878973
NA
1.00E−141
1
cDNA clone IMAGE: 3895002 5′

525C3
208
400
BE879482
NA
7.00E−88
1
cDNA clone IMAGE: 3894277 5′

526F7
335
603
BE881113
NA
1.00E−126
1
cDNA clone IMAGE: 3894306 5′

152G12
122
659
BE881351
NA
0
2
cDNA clone IMAGE: 3892808 5′

589H4
118
510
BE882335
NA
0
2
cDNA clone IMAGE: 3907044 5′

51B12
199
631
BE884898
NA
3.00E−56
1
cDNA clone IMAGE: 3908551 5′

114C1
286
530
BE887646
NA
1.00E−121
1
cDNA clone IMAGE: 3913468 5′

120H2
282
706
BE888744
NA
0
1
cDNA clone IMAGE: 3915133 5′

107D11
172
497
BE891242
NA
0
1
cDNA clone IMAGE: 3917201 5′

513G4
263
662
BE891269
NA
0
1
cDNA clone IMAGE: 3917064 5′

166B8
7
453
BE891928
NA
0
1
cDNA clone IMAGE: 3920185 5′

185G9
23
390
BE894437
NA
1.00E−145
1
cDNA clone IMAGE: 3918224 5′

189A8
211
485
BE896691
NA
1.00E−82
1
cDNA clone IMAGE: 3925062 5′

598A7
78
301
BE897669
NA
1.00E−83
1
cDNA clone IMAGE: 3923346 5′

191D9
189
575
BE899595
NA
0
3
cDNA clone IMAGE: 3952215 5′

331F2
109
287
BF001438
NA
3.00E−96
2
cDNA clone IMAGE: 3313517 3′

192C9
57
419
BF033741
NA
0
1
cDNA clone IMAGE: 3857635 5′

117H4
73
454
BF056055
NA
0
1
cDNA clone IMAGE: 3443950 3′ similar to contains

104B10
6
412
BF058599
NA
1.00E−177
1
cDNA clone IMAGE: 3477311 3′

331A12
13
164
BF059133
NA
1.00E−72
1
cDNA clone IMAGE: 3480249 3′

40H1
81
507
BF060725
NA
0
1
7j59h07.x1 Soares_NSF_F8_9W_OT_PA_P_S1

cDNA clone

464F1
1
510
BF061421
NA
0
1
7j52c11.x1 Soares_NSF_F8_9W_OT_PA_P_S1

cDNA clone

71E11
1
441
BF105172
NA
0
1
cDNA clone IMAGE: 4042560 5′

129D7
92
561
BF116224
NA
0
2
cDNA clone IMAGE: 3570793 3′

145E10
83
624
BF131060
NA
0
1
cDNA done IMAGE: 4051731 5′

113B6
105
410
BF194880
NA
1.00E−157
1
cDNA clone IMAGE: 3643600 3′

157E9
102
308
BF197153
NA
1.00E−108
2
cDNA clone IMAGE: 3561933 3′

127H8
1
173
BF197762
NA
3.00E−92
1
cDNA clone IMAGE: 3653139 3′

462D1
29
177
BF221780
NA
7.00E−78
1
cDNA clone IMAGE: 3578603 3′

472B8
7
229
BF306204
NA
9.00E−70
1
cDNA clone IMAGE: 4138980 5′

62A3
187
612
BF309911
NA
1.00E−162
1
cDNA clone IMAGE: 4138171 5′

476G4
316
487
BF330908
NA
5.00E−66
1
BT0333 cDNA

524D1
86
258
BF339088
NA
8.00E−88
1
cDNA clone IMAGE: 4182956 5′

58G4
13
606
BF341359
NA
0
2
cDNA clone IMAGE: 4149195 5′

480E7
68
288
BF357523
NA
4.00E−97
1
HT0945 cDNA

116C9
8
170
BF364413
NA
2.00E−81
1
NN1068 cDNA

168F4
11
595
BF369763
NA
0
1
GN0120 cDNA

495F1
1
318
BF373638
NA
1.00E−108
2
FT0176 cDNA

98E1
81
499
BF377518
NA
0
2
TN0115 cDNA

169C5
17
500
BF380732
NA
0
1
UT0073 cDNA

464E11
12
272
BF432643
NA
1.00E−129
1
cDNA clone IMAGE: 3406531 3′

183G2
119
548
BF433058
NA
1.00E−112
1
cDNA clone IMAGE: 3565500 3′

473F9
21
411
BF433353
NA
0
1
cDNA clone IMAGE: 3703678 3′

117C9
179
462
BF433657
NA
2.00E−99
1
cDNA clone IMAGE: 3702965 3′ similar to contains

514A3
170
245
BF435621
NA
2.00E−34
2
Lupski_sciatic_nerve cDNA clone IMAGE: 3394901 3′

similar to

459G8
78
417
BF445405
NA
1.00E−179
1
cDNA clone IMAGE: 3699337 3′

483D10
12
474
BF447885
NA
0
1
cDNA clone IMAGE: 3706147 3′

519H12
319
394
BF449068
NA
3.00E−27
1
cDNA clone IMAGE: 3579069 3′

584H11
78
487
BF475501
NA
7.00E−50
1
Lupski_sciatic_nerve cDNA clone IMAGE: 3396242 3′

471G8
214
400
BF478238
NA
9.00E−61
1
cDNA clone IMAGE: 3700476 3′ similar to contains

109F10
20
329
BF507849
NA
1.00E−172
1
UI-H-BI4-apv-h-02-0-UI.s1 NCI_CGAP_Sub8 cDNA

clone IMAGE: 3088755 3′

173E10
147
231
BE510393
NA
1.00E−39
1
UI-H-BI4-aon-h-07-0-UI.s1 NCI_CGAP_Sub8 cDNA

clone IMAGE: 3085669 3′

464D1
32
460
BF513602
NA
1.00E−106
1
UI-H-BW1-amt-a-11-0-UI.s1 NCI_CGAP_Sub7 cDNA

clone IMAGE: 3070773 3′

118D9
106
248
BF514341
NA
4.00E−46
1
UI-H-BW1-and-h-10-0-UI.s1 NCI_CGAP_Sub7 cDNA

clone IMAGE: 3082218 3′

462E3
29
197
BF515538
NA
1.00E−87
1
UI-H-BW1-anq-b-09-0-UI.s1 NCI_CGAP_Sub7 cDNA

clone IMAGE: 3083081 3′

459C7
70
661
BF525720
NA
0
1
cDNA clone IMAGE: 4212877 5′

462F8
151
684
BF526421
NA
0
1
cDNA clone IMAGE: 4213536 5′

174H6
1
367
BF530382
NA
0
1
cDNA clone IMAGE: 4214327 5′

477C5
183
689
BF569545
NA
0
1
cDNA clone IMAGE: 4310435 5′

46C3
2
626
BF571362
NA
0
1
cDNA clone IMAGE: 4252059 5′

465B1
350
508
BF591040
NA
3.00E−39
1
cDNA clone IMAGE: 3319177 3′

477G7
6
127
BF592138
NA
2.00E−57
1
cDNA clone IMAGE: 3573334 3′

180B2
53
264
BF593930
NA
1.00E−114
1
nab48e03.x1 Soares_NSF_F8_9W_OT_PA_P_S1

cDNA clone

185F12
139
578
BF663116
NA
0
1
cDNA clone IMAGE: 4308392 5′

471F9
77
590
BF667621
NA
0
1
cDNA clone IMAGE: 4278888 5′

41D10
16
664
BF668050
NA
0
2
cDNA clone IMAGE: 4279827 5′

491G6
87
275
BF670567
NA
1.00E−97
1
cDNA clone IMAGE: 4290961 5′

112B4
17
303
BF671020
NA
1.00E−120
1
cDNA clone IMAGE: 4292143 5′

194H6
6
196
BF678298
NA
1.00E−100
1
cDNA clone IMAGE: 4248916 5′

514H9
96
179
BF691178
NA
2.00E−32
1
cDNA clone IMAGE: 4332544 5′

99H1
146
327
BF691895
NA
2.00E−69
1
cDNA clone IMAGE: 4333460 5′

465E12
29
681
BF725383
NA
0
1
cDNA (Un-normalized, unamplified): BX cDNA clone

69B10
17
96
BF726114
NA
3.00E−37
1
cDNA (Un-normalized, unamplified): BY cDNA clone

151H10
18
366
BF732404
NA
0
1
cDNA clone IMAGE: 3434918 3′

124D2
36
378
BF736784
NA
1.00E−179
1
KT0018 cDNA

463H5
30
152
BF740663
NA
3.00E−56
1
HB0031 cDNA

469D2
164
398
BF744387
NA
6.00E−74
1
BT0636 cDNA

72E1
17
128
BF749089
NA
1.00E−44
3
BN0386 cDNA

98C3
9
515
BF758480
NA
0
1
CT0539 cDNA

46E11
26
162
BF773126
NA
5.00E−57
1
IT0048 cDNA

124C8
32
257
BF773393
NA
1.00E−115
1
IT0039 cDNA

166G8
312
549
BF797348
NA
1.00E−108
1
cDNA clone IMAGE: 4340490 5′

146D8
222
288
BF805164
NA
5.00E−29
1
CI0173 cDNA

49G4
99
460
BF813798
NA
0
5
CI0084 cDNA

469F8
31
455
BF816700
NA
4.00E−88
1
CI0128 cDNA

98C1
37
375
BF818594
NA
1.00E−163
1
CI0184 cDNA

62C9
166
359
BF821451
NA
3.00E−28
1
RT0038 cDNA

51F8
28
367
BF827734
NA
1.00E−175
1
HN0025 cDNA

56F7
15
429
BF845167
NA
9.00E−84
1
HT1035 cDNA

476D11
1
303
BF869167
NA
1.00E−165
2
ET0119 cDNA

476H4
12
262
BF875575
NA
1.00E−131
2
ET0100 cDNA

68D6
242
452
BF877979
NA
3.00E−98
1
ET0109 cDNA

37C10
1
381
BF897042
NA
0
3
MT0179 cDNA

465B3
63
193
BF898285
NA
5.00E−60
1
MT0229 cDNA

331C7
274
485
BF899464
NA
3.00E−83
1
MT0211 cDNA

72D8
50
334
BF904425
NA
1.00E−152
1
MT0245 cDNA

159F6
333
417
BF906114
NA
2.00E−35
1
MT0267 cDNA

108H5
6
409
BF926187
NA
0
1
NT0193 cDNA

71F9
192
286
BF928644
NA
1.00E−43
1
NT0216 cDNA

481D4
27
334
BF938959
NA
1.00E−102
1
cDNA clone IMAGE: 3706689 3′

189B11
69
183
BF939014
NA
4.00E−29
1
cDNA clone IMAGE: 3706658 3′

115G2
85
399
BF940103
NA
1.00E−177
1
cDNA clone IMAGE: 3439383 3′

463B3
304
449
BF940291
NA
8.00E−62
1
cDNA clone IMAGE: 3577096 3′

122G1
8
339
BF950968
NA
1.00E−170
1
NN1186 cDNA

470B4
251
320
BF962743
NA
2.00E−28
1
NN0045 cDNA

516D5
39
208
BF962934
NA
5.00E−69
1
NN0045 cDNA

593G10
242
597
BF965068
NA
1.00E−177
2
cDNA clone IMAGE: 4356776 5′

101A1
6
356
BF965438
NA
1.00E−132
1
cDNA clone IMAGE: 4356453 5′

477F3
25
653
BF965960
NA
0
1
cDNA clone IMAGE: 4365102 5′

588E4
67
562
BF966028
NA
1.00E−134
1
cDNA clone IMAGE: 4364887 5′

467F10
11
282
BF966049
NA
1.00E−122
1
cDNA clone IMAGE: 4364941 5′

59E12
81
355
BF966269
NA
1.00E−144
1
cDNA clone IMAGE: 4375212 5′

480E11
416
755
BF968628
NA
8.00E−41
1
cDNA clone IMAGE: 4359351 5′

37H8
200
500
BF968963
NA
1.00E−148
1
cDNA clone IMAGE: 4358390 5′

98H5
396
397
BF969990
NA
1.00E−133
1
cDNA clone IMAGE: 4360614 5′

597C3
15
571
BF971075
NA
0
1
cDNA clone IMAGE: 4358911 5′

101F1
188
305
BF971984
NA
6.00E−42
1
cDNA clone IMAGE: 4329095 5′

464H5
246
602
BF980139
NA
0
1
cDNA clone IMAGE: 4373963 3′

63B6
130
597
BF981080
NA
0
1
cDNA clone IMAGE: 4401411 5′

167A3
223
418
BF981263
NA
1.00E−101
1
cDNA clone IMAGE: 4400757 5′

512C12
1
494
BF981634
NA
0
1
cDNA clone IMAGE: 4397101 5′

187H7
26
433
BF997765
NA
1.00E−180
2
GN0127 cDNA

458E4
54
242
BG006820
NA
3.00E−62
1
GN0227 cDNA

106A7
1
604
BG024761
NA
0
1
cDNA clone IMAGE: 4363858 5′

459H6
1
524
BG026279
NA
0
1
cDNA clone IMAGE: 4386607 5′

460B9
264
512
BG028577
NA
1.00E−105
1
cDNA clone IMAGE: 4387518 5′

49E9
100
537
BG033909
NA
0
1
cDNA clone IMAGE: 4402729 5′

54C10
1
582
BG033953
NA
0
2
cDNA clone IMAGE: 4402647 5′

182B3
1
489
BG034799
NA
0
1
cDNA clone IMAGE: 4413514 5′

166F8
13
586
BG036101
NA
0
1
cDNA clone IMAGE: 4414135 5′

104A12
56
240
BG054966
NA
1.00E−100
1
cDNA clone IMAGE: 3441756 3′

171H10
4
269
BG056668
NA
3.00E−85
1
cDNA clone IMAGE: 4169714 3′

146G11
13
522
BG057282
NA
0
5
cDNA clone IMAGE: 4140477 3′ similar to contains

472A11
69
358
BG057892
NA
1.00E−145
1
7f76e08.x1 Lupski_dorsal_root_ganglion cDNA clone

513B4
2
418
BG058599
NA
0
1
cDNA clone IMAGE: 4141266 3′

134B4
201
519
BG058739
NA
1.00E−75
4
cDNA clone IMAGE: 4140551 3′

163E7
83
327
BG110599
NA
1.00E−126
1
cDNA clone IMAGE: 4368492 5′

118A7
180
577
BG110835
NA
0
1
cDNA clone IMAGE: 4366502 5′

37F12
38
649
BG111212
NA
0
5
cDNA clone IMAGE: 4369233 5′

464A10
57
673
BG111773
NA
0
1
cDNA clone IMAGE: 4372861 5′

464A7
56
411
BG118529
NA
1.00E−167
1
cDNA clone IMAGE: 4443519 5′

458D8
186
715
BG121288
NA
0
1
cDNA clone IMAGE: 4450407 5′

166H12
25
339
BG149747
NA
1.00E−177
1
cDNA clone IMAGE: 3367325 3′

51H4
4
224
BG149986
NA
1.00E−121
1
cDNA clone IMAGE: 3406766 3′

75G3
70
280
BG150273
NA
1.00E−115
4
cDNA clone IMAGE: 3442930 3′

500F10
18
677
BG163237
NA
0
3
cDNA clone IMAGE: 4446802 5′

519E4
39
575
BG164898
NA
0
3
cDNA clone IMAGE: 4453661 5′

119E5
21
276
BG165998
NA
1.00E−120
1
cDNA clone IMAGE: 4456017 5′

519B8
29
214
BG166279
NA
5.00E−86
1
cDNA clone IMAGE: 4455496 5′

103B8
377
499
BG170647
NA
1.00E−45
1
cDNA clone IMAGE: 4426826 5′

470F8
184
307
BG180098
NA
4.00E−63
1
cDNA clone IMAGE: 4430875 5′

585C4
4
98
BG230563
NA
5.00E−46
1
cDNA clone IMAGE: 4143330 3′ similar to contains

48G7
2
298
BG231557
NA
1.00E−119
1
cDNA clone IMAGE: 4142471 3′

73C4
188
430
BG231805
NA
1.00E−130
1
cDNA clone IMAGE: 4142814 3′

148H4
2
525
BG231961
NA
1.00E−133
12
cDNA clone IMAGE: 4143104 3′

484B5
364
533
BG235942
NA
5.00E−81
1
cDNA clone IMAGE: 4141389 3′

137B5
97
523
BG236015
NA
6.00E−87
1
cDNA clone IMAGE: 4141365 3′

489B11
12
294
BG236084
NA
4.00E−75
2
cDNA clone IMAGE: 4141856 3′ similar to

45H2
1
492
BG249224
NA
1.00E−139
1
cDNA clone IMAGE: 4470038 5′

172F1
1
562
BG254117
NA
0
1
cDNA clone IMAGE: 4475233 5′

588F3
66
202
BG254292
NA
9.00E−43
1
cDNA clone IMAGE: 4477042 5′

583B5
8
183
BG272304
NA
7.00E−45
1
cDNA clone IMAGE: 4257371

73A4
119
311
BG282346
NA
3.00E−42
1
cDNA clone IMAGE: 4545131 5′

586A2
99
511
BG283706
NA
1.00E−160
1
cDNA clone IMAGE: 4519866 5′

152F12
1
676
BG286649
NA
0
5
cDNA clone IMAGE: 4499224 5′

479A12
228
601
BG286817
NA
1.00E−142
1
cDNA clone IMAGE: 4500259 5′

99B4
1
449
BG288308
NA
0
2
cDNA clone IMAGE: 4512706 5′

584G2
54
468
BG288554
NA
0
1
cDNA clone IMAGE: 4517068 5′

464E2
244
549
BG289048
NA
1.00E−159
2
cDNA clone IMAGE: 4512868 5′

113H1
149
436
BG289347
NA
1.00E−161
1
cDNA clone IMAGE: 4516241 5′

39G6
1
503
BG290577
NA
0
1
cDNA clone IMAGE: 4517986 5′

48D8
38
440
BG291970
NA
0
1
cDNA clone IMAGE: 4517457 5′

60E7
1
398
BG319445
NA
0
4
Keratinocyte Subtraction Library-Downregulated

Transcripts Homo

168C2
3
221
BG319498
NA
1.00E−111
2
Keratinocyte Subtraction Library-Downregulated

Transcripts Homo

461B12
1
393
BG387694
NA
0
2
cDNA clone IMAGE: 4521084 5′

174G11
3
542
BG391695
NA
0
1
cDNA clone IMAGE: 4537243 5′

597A4
164
612
BG396292
NA
0
2
cDNA clone IMAGE: 4581548 5′

190B10
469
667
BG397564
NA
3.00E−62
2
cDNA clone IMAGE: 4564968 5′

593C3
35
461
BG403635
NA
0
1
cDNA clone IMAGE: 4526364 5′

57H10
121
495
BG413494
NA
0
1
7j54e06.x1 Soares_NSF_F8_9W_OT_PA_P_S1

cDNA clone

155G11
119
347
BG424974
NA
3.00E−52
1
cDNA clone IMAGE: 4591378 5′

45G3
17
332
BG427404
NA
1.00E−159
1
cDNA clone IMAGE: 4612518 5′

185C9
16
185
BG432194
NA
3.00E−62
1
cDNA clone IMAGE: 4610035 5′

331D4
60
386
BG434865
NA
1.00E−179
1
cDNA clone IMAGE: 4605025 5′

464H12
97
295
BG438232
NA
1.00E−105
1
cDNA clone IMAGE: 4622433 5′

521F2
280
534
BG468330
NA
1.00E−111
1
cDNA clone IMAGE: 4644153 5′

56F6
167
582
BG473228
NA
0
2
cDNA clone IMAGE: 4646938 5′

61G3
8
185
BG473813
NA
2.00E−95
1
cDNA clone IMAGE: 4647416 5′

119E9
7
377
BG482798
NA
1.00E−178
3
cDNA clone IMAGE: 4616253 5′

125F8
47
318
BG489375
NA
1.00E−149
1
cDNA clone IMAGE: 4636634 5′

73H3
55
154
BG493253
NA
5.00E−49
1
cDNA clone IMAGE: 4672787 5′

111H9
79
754
BG497765
NA
0
1
cDNA clone IMAGE: 4665582 5′

171A10
74
476
BG501063
NA
0
1
cDNA clone IMAGE: 4668643 5′

471G1
65
197
BG501895
NA
1.00E−63
1
cDNA clone IMAGE: 4654344 5′

111E1
16
181
BG503693
NA
4.00E−85
2
cDNA clone IMAGE: 4657381 5′

121B6
77
553
BG505271
NA
0
2
cDNA clone IMAGE: 4664028 5′

599F2
379
484
BG505379
NA
3.00E−45
1
cDNA clone IMAGE: 4657121 5′

105C1
208
646
BG505961
NA
0
1
cDNA clone IMAGE: 4072795 5′

521E10
23
440
BG506168
NA
0
4
cDNA clone IMAGE: 4072226 5′

119A5
188
596
BG506472
NA
1.00E−103
1
cDNA clone IMAGE: 4070820 5′

479D7
34
308
BG527060
NA
1.00E−121
1
cDNA clone IMAGE: 4685209 5′

71H3
27
542
BG527658
NA
0
1
cDNA clone IMAGE: 4685854 5′

186A7
2
336
BG531486
NA
5.00E−96
1
cDNA clone IMAGE: 4699409 5′

187H11
186
662
BG532345
NA
0
1
cDNA clone IMAGE: 4699954 5′

64G4
166
650
BG532470
NA
0
1
cDNA clone IMAGE: 4699923 5′

486E6
224
561
BG533994
NA
1.00E−168
5
cDNA clone IMAGE: 4663102 5′

116F9
188
392
BG536394
NA
7.00E−67
1
cDNA clone IMAGE: 4689645 5′

75C7
1
452
BG536641
NA
0
2
cDNA clone IMAGE: 4691078 5′

175D10
3
114
BG537502
NA
2.00E−49
1
cDNA clone IMAGE: 4690780 5′

599E1
356
659
BG538731
NA
1.00E−111
1
cDNA clone IMAGE: 4691392 5′

191H9
80
631
BG541679
NA
0
1
cDNA clone IMAGE: 4695805 5′

466A4
1
408
BG542394
NA
0
1
cDNA clone IMAGE: 4696046 5′

67G12
29
698
BG547561
NA
0
3
cDNA clone IMAGE: 4703738 5′

467B6
60
234
BG547627
NA
3.00E−93
2
cDNA clone IMAGE: 4703608 5′

488F8
2041
2132
D10495
NA
9.00E−31
1
mRNA for protein kinase C delta-type, complete cds

Length = 2163

525B6
21
222
D17042
NA
1.00E−100
2
HepG2 partial cDNA, clone hmd3f07m5 Length = 222

471E4
2287
2877
D17391
NA
0
2
mRNA for alpha 4(IV) collagen, C-terminal Length = 3558

134D8
561
694
D28589
NA
2.00E−59
1
mRNA (KIAA00167), partial sequence Length = 792

112D1
1614
2159
D30036
NA
0
1
mRNA for phosphatidylinositol transfer protein (PI-

TPalpha), complete

98H4
1
357
F11941
NA
1.00E−180
1
brain cDNA cDNA clone c-33f05

585G7
15
264
F13765
NA
1.00E−136
1
(1992) cDNA clone FII112 3′

47D11
1
296
F35665
NA
1.00E−146
1
cDNA clone sH5-000005-0/E06

465F5
34
225
H03298
NA
1.00E−70
1
cDNA clone IMAGE: 151865 5′

481A6
43
362
H51796
NA
1.00E−123
1
spleen 1NFLS cDNA clone IMAGE: 194250 5′

100E3
116
205
H56344
NA
1.00E−37
1
spleen 1NFLS cDNA clone IMAGE: 203711 5′ similar

to

464F9
10
398
H57221
NA
5.00E−45
2
spleen 1NFLS cDNA clone IMAGE: 204710 5′

66C3
10
77
H78395
NA
8.00E−28
1
liver spleen 1NFLS cDNA clone IMAGE: 233597 3′

105D11
63
365
H81660
NA
1.00E−154
1
2NbHM cDNA clone IMAGE: 249138 5′

60G10
1
189
H86841
NA
1.00E−100
1
cDNA clone IMAGE: 220310 5′ similar to SP: S44265

470D6
1
314
H92914
NA
1.00E−146
1
Soares_pineal_gland_N3HPG cDNA clone

IMAGE: 231988 3′

483E5
839
944
K02885
NA
1.00E−26
1
T-cell receptor active beta-chain V-D-J-beta-1.2-C-

beta-1 (TCRB) mRNA,

516F5
1753
2047
L11284
NA
1.00E−131
1

Homo sapiens ERK activator kinase (MEK1) mRNA

Length = 2222

525E11
105
738
L40557
NA
1.00E−112
1
perforin (PRF1) mRNA, 3′ end Length = 818

74F1
661
826
M11124
NA
5.00E−41
1
MHC HLA DQ alpha-chain mRNA from DRw9 cell line

Length = 835

121E3
1323
1870
M12824
NA
0
4
T-cell differentiation antigen Leu-2/T8 mRNA, partial

cds Length = 197

66H2
713
1190
M17783
NA
0
1
glia-derived nexin (GDN) mRNA, 5′ end Length = 1191

41A9
698
883
M32577
NA
4.00E−28
1
MHC HLA-DQ beta mRNA, complete cds Length = 1104

478D10
436
605
M55674
NA
4.00E−33
1
(clone M212) phosphoglycerate mutase 2 (muscle

specific isozyme) (PGAM

469B8
5
377
N20190
NA
0
1
2NbHM cDNA clone IMAGE: 264340 3′

109E4
21
449
N23307
NA
0
2
2NbHM cDNA clone IMAGE: 267836 3′

171D9
80
381
N25486
NA
1.00E−147
1
2NbHM cDNA clone IMAGE: 264068 5′

73H12
1
398
N27575
NA
1.00E−144
2
2NbHM cDNA clone IMAGE: 264499 5′

490A11
25
475
N31700
NA
0
1
2NbHM cDNA clone IMAGE: 267025 5′

599D6
185
483
N34261
NA
1.00E−150
1
2NbHM cDNA clone IMAGE: 267967 5′

188F3
112
357
N36787
NA
1.00E−107
1
2NbHM cDNA clone IMAGE: 273145 3′

465B10
7
558
N49836
NA
0
1
yz08a11.s1 Soares_multiple_sclerosis_2NbHMSP

cDNA

40D4
199
575
N58136
NA
1.00E−153
1
spleen 1NFLS cDNA clone IMAGE: 247587 3′

183E2
227
366
N80578
NA
2.00E−53
1
Soares_fetal_lung_NbHL19W cDNA clone

IMAGE: 300873 3′ similar to

139G6
9
269
N94511
NA
1.00E−125
1
zb80g04.s1 Soares_senescent_fibroblasts_NbHSF

cDNA

126B8
1
256
N99577
NA
1.00E−137
2
spleen 1NFLS cDNA clone IMAGE: 295067 5′

118A10
893
5056
NC_001807
NA
0
7
mitochondrion, complete genome Length = 16568

41B2
1
471
NM_000873
NA
0
1
intercellular adhesion molecule 2 (ICAM2), mRNA

Length = 1035

62A8
1877
1958
NM_000958
NA
1.00E−37
4
prostaglandin E receptor 4 (subtype EP4) (PTGER4),

mRNA

179H10
53
265
NM_000983
NA
1.00E−44
1
ribosomal protein L22 (RPL22), mRNA Length = 602

331D3
71
343
NM_001024
NA
1.00E−144
5
ribosomal protein S21 (RPS21), mRNA Length = 343

41G10
3162
3565
NM_001243
NA
3.00E−47
1
tumor necrosis factor receptor superfamily, member 8

(TNFRSF8), mRNA

591E9
1027
1483
NM_002211
NA
0
2
integrin, beta 1 (fibronectin receptor, beta polypeptide,

antigen CD29

497C6
4946
5064
NM_002460
NA
9.00E−36
2
interferon regulatory factor 4 (IRF4), mRNA Length = 5065

597D8
1232
1461
NM_005356
NA
2.00E−48
1
lymphocyte-specific protein tyrosine kinase (LCK),

mRNA Length = 2032

166G2
50
319
NM_005745
NA
2.00E−90
1
accessory proteins BAP31/BAP29 (DXS1357E),

mRNA Length = 1314

468D2
3245
3480
NM_011086
NA
8.00E−63
1
similar to Mus phosphoinositide kinase, fyve-

containing (Pikfyve), mRNA

599A4
1335
1630
NM_014644
NA
2.00E−69
1
KIAA0477 gene product (KIAA0477), mRNA Length = 5676

69C2
818
1361
NM_014905
NA
0
3
glutaminase (GLS), mRNA Length = 4606

495C6
622
838
NM_015435
NA
1.00E−104
1
double ring-finger protein, Dorfin (DORFIN), mRNA

Length = 1640

463D11
480
632
NM_015995
NA
1.00E−77
1
Kruppel-like factor 13 (KLF13), mRNA Length = 1079

49C10
817
964
NM_019604
NA
3.00E−28
1
class-I MHC-restricted T cell associated molecule

(CRTAM), mRNA

188E4
390
643
NM_019997
NA
6.00E−79
1
similar to Mus musculus cDNA sequence AB041581

(AB041581)

103H2
1421
1662
NM_021432
NA
3.00E−66
1
similar to Mus RIKEN cDNA 1110020M21 gene

(1110020M21Rik)

465G11
1685
1761
NM_021777
NA
1.00E−34
1
a disintegrin and metalloproteinase domain 28

(ADAM28), transcirpt var

166D8
1265
1951
NM_022152
NA
0
1
PP1201 protein (PP1201), mRNA Length = 2309

459G6
1
123
NM_024567
NA
2.00E−36
1
hypothetical protein (FLJ21616), mRNA

Length = 1858

461G2
667
1182
NM_025977
NA
1.00E−28
1
similar to Mus RIKEN cDNA 2510048L02 gene

(2510048L02Rik)

62A5
759
1200
NM_030780
NA
0
1
folate transporter/carrier (LOC81034), mRNA Length = 2534

52C11
1277
1954
NM_030788
NA
0
1
DC-specific transmembrane protein (LOC81501),

mRNA Length = 1974

108A7
910
3014
NM_031419
NA
0
4
molecule possessing ankyrin repeats induced by

lipopolysaccharide

74E11
47
464
NM_031435
NA
0
1
hypothetical protein DKFZp56410422

(DKFZP56410422), mRNA

56B3
1518
1962
NM_031453
NA
1.00E−176
1
hypothetical protein MGC11034 (MGC11034), mRNA

Length = 3301

46F2
118
663
NM_031480
NA
1.00E−105
1
hypothetical protein AD034 (AD034), mRNA Length = 2495

192B3
51
290
R11456
NA
1.00E−105
1
spleen 1NFLS cDNA clone IMAGE: 129880 5′ similar

to

458B9
43
359
R64054
NA
1.00E−159
1
cDNA clone IMAGE: 139969 5′

169F11
1
429
R85137
NA
0
1
brain N2b4HB55Y cDNA clone IMAGE: 180492 5′

465B5
16
392
R88126
NA
1.00E−164
1
cDNA clone IMAGE: 186850 5′

477F8
1
525
T77017
NA
0
1
1NIB cDNA clone IMAGE: 23326 5′

39G11
162
455
T80378
NA
1.00E−145
1
1NIB cDNA clone IMAGE: 24693 5′

107D7
1
371
T80654
NA
0
1
spleen 1NFLS cDNA clone IMAGE: 108950 5′

465A1
6
314
T85880
NA
1.00E−114
1
spleen 1NFLS cDNA clone IMAGE: 112441 5′

48D12
2300
2533
U08015
NA
1.00E−128
1
NF-ATc mRNA, complete cds Length = 2743

121F1
13
380
U46388
NA
1.00E−150
1
cell line Patu 8988t cDNA clone xs425

127B12
3
330
U52054
NA
0
4
S6 H-8 mRNA expressed in chromosome 6-

suppressed melanoma cells

487C2
4054
4187
U52682
NA
2.00E−28
1
lymphocyte specific interferon regulatory

factor/interferon regulatory

110B3
1404
2081
U53530
NA
0
1
cytoplasmic dynein 1 heavy chain mRNA, partial cds

Length = 2694

466C8
34
175
U75805
NA
3.00E−47
1
cDNA clone f46

148G12
1513
1639
U87954
NA
1.00E−27
1
erbB3 binding protein EBP1 mRNA, complete cds

Length = 1648

70A4
564
1381
U94359
NA
0
2
glycogenin-2 like mRNA sequence Length = 4066

158E4
843
945
U97075
NA
1.00E−33
1
FLICE-like inhibitory protein short form mRNA,

complete cds

459A1
227
446
W00466
NA
1.00E−60
1
2NbHM cDNA clone IMAGE: 291193 5′

459A2
60
350
W00491
NA
1.00E−126
1
2NbHM cDNA clone IMAGE: 291255 5′ similar to

459B1
76
551
W02600
NA
0
1
spleen 1NFLS cDNA clone IMAGE: 296099 5′

166C10
10
415
W16552
NA
0
1
Soares_fetal_lung_NbHL19W cDNA clone

IMAGE: 301703 5′

471C6
3
383
W19201
NA
1.00E−149
1
Soares_fetal_lung _NbHL19W cDNA clone

IMAGE: 303118 5′ similar to

520A8
75
382
W19487
NA
1.00E−154
1
zb36f09.r1 Soares_parathyroid_tumor_NbHPA cDNA

clone

459B7
57
158
W25068
NA
9.00E−50
1
Soares_fetal_lung _NbHL19W cDNA clone

IMAGE: 308696 5′

188D3
39
283
W26193
NA
2.00E−91
1
randomly primed sublibrary cDNA

75B12
8
386
W27656
NA
1.00E−166
1
randomly primed sublibrary cDNA

163F8
74
330
W47229
NA
1.00E−117
1
zc39c01.r1 Soares_senescent_fibroblasts_NbHSF

cDNA

478E6
2
322
W56487
NA
3.00E−51
1
zc59c07.r1 Soares_parathyroid _tumor_NbHPA cDNA

clone

73H4
76
297
W72392
NA
1.00E−121
1
Soares_fetal_heart_NbHH19W cDNA clone

IMAGE: 345661 3′

66D5
1
457
W74397
NA
0
3
Soares_fetal_heart_NbHH19W cDNA clone

IMAGE: 345236 5′

496D4
85
450
W79598
NA
0
1
Soares_fetal_heart_NbHH1

9W cDNA clone

IMAGE: 347020 5′

165D1
108
287
W80882
NA
4.00E−94
1
Soares_fetal_heart_NbHH19W cDNA clone

IMAGE: 347240 5′

463G1
5
406
W86427
NA
0
1
zh61c11.s1 Soares_fetal_liver spleen_1NFLS_S1

cDNA

469G11
1276
1621
X06180
NA
0
1
mRNA for CD7 antigen (gp40) Length = 1656

113E11
126
885
X65318
NA
0
1
Cloning vector pGEMEX-2 Length = 3995

482E1
921
1168
X79536
NA
1.00E−102
1
mRNA for hnRNPcore protein A1 Length = 1198

123G8
408
848
XM_002068
NA
8.00E−73
1
glutamate-ammonia ligase (glutamine synthase)

(GLUL), mRNA

185E1
508
734
XM_002158
NA
1.00E−27
1
proteasome (prosome, macropain) subunit, alpha

type, 5 (PSMA5), mRNA

71A9
1131
1252
XM_002269
NA
4.00E−29
1
ARP3 (actin-related protein 3, yeast) homolog

(ACTR3), mRNA

49G7
1
257
XM_003189
NA
1.00E−142
3
similar to eukaryotic translation initiation factor 4A,

isoform 2 (H.

128B5
783
980
XM_003304
NA
6.00E−41
1
toll-like receptor 2 (TLR2), mRNA Length = 2600

185G10
853
1057
XM_003507
NA
2.00E−26
1
small inducible cytokine subfamily B (Cys-X-CyS),

member 5 (epithelial

41C9
588
1221
XM_003593
NA
0
1
CD38 antigen (p45) (CD38), mRNA Length = 1227

156C4
127
270
XM_004020
NA
6.00E−71
1
ribosomal protein S23 (RPS23), mRNA Length = 488

66E2
1344
1577
XM_004500
NA
1.00E−46
1
CD83 antigen (activated B lymphocytes,

immunoglobulin superfamily) (CD

61C6
474
987
XM_004611
NA
2.00E−80
1
Ras homolog enriched in brain 2 (RHEB2), mRNA

Length = 987

184A7
971
1361
XM_004720
NA
0
1
hypothetical protein FLJ11000 (FLJ11000), mRNA

Length = 1680

128E6
580
741
XM_004839
NA
5.00E−38
1
pre-B-cell colony-enhancing factor (PBEF), mRNA

Length = 2377

55A11
1096
1305
XM_005162
NA
1.00E−60
1
GTP-binding protein overexpressed in skeletal muscle

(GEM), mRNA

519C4
1307
1441
XM_005543
NA
1.00E−69
1
aquaporin 3 (AQP3), mRNA Length = 1441

129F1
1854
2367
XM_005693
NA
0
1
inositol polyphosphate-5-phosphatase, 40 kD

(INPP5A), mRNA

522C10
700
916
XM_005698
NA
7.00E−53
1
programmed cell death 4 (PDCD4), mRNA Length =

1622

180G6
1884
2290
XM_005799
NA
1.00E−166
1
integrin, beta 1 (fibronectin receptor, beta polypeptide,

antigen CD29

55F4
2573
2748
XM_005883
NA
4.00E−73
1
early growth response 2 (Krox-20 (Drosophila)

homolog) (EGR2), mRNA

492H7
976
1176
XM_005980
NA
4.00E−33
1
proteoglycan 1, secretory granule (PRG1), mRNA

Length = 1176

476B4
1541
1918
XM_006741
NA
0
1
hypothetical protein FLJ10701 (FLJ10701), mRNA

Length = 2299

493H5
145
379
XM_006881
NA
2.00E−56
1
interleukin 22 (IL22), mRNA Length = 676

499B4
11117
11410
XM_007156
NA
3.00E−34
1
spastic ataxia of Charlevoix-Saguenay (sacsin)

(SACS), mRNA

183D7
4270
4376
XM_007189
NA
5.00E−37
1
forkhead box O1A (rhabdomyosarcoma) (FOXO1A),

mRNA Length = 5037

115B6
4151
4408
XM_007606
NA
2.00E−50
2
thrombospondin 1 (THBS1), mRNA Length = 5719

587B4
31
264
XM_007650
NA
1.00E−114
3
beta-2-microglobulin (B2M), mRNA Length = 918

598H5
206
300
XM_008062
NA
1.00E−31
1
ribosomal protein S15a (RPS15A), mRNA Length =

435

73E4
3252
3505
XM_008082
NA
1.00E−119
1
adaptor-related protein complex 1, gamma 1 subunit

(AP1G1), mRNA

64F7
186
334
XM_008449
NA
1.00E−47
1
small inducible cytokine A4 (homologous to mouse

Mip-1b) (SCYA4)

585E1
904
1020
XM_009533
NA
1.00E−26
1
CGI-06 protein (LOC51604), mRNA Length = 2146

75B8
710
1406
XM_009574
NA
0
1
nucleolar protein (KKE/D repeat) (NOP56), mRNA

Length = 1910

467A5
210
620
XM_009641
NA
0
1
v-src avian sarcoma (Schmidt-Ruppin A-2) viral

oncogene homolog (SRC),

44A3
480
854
XM_009917
NA
0
1
splicing factor 3a, subunit 1, 120 kD (SF3A1), mRNA

Length = 2614

114D12
2269
2491
XM_009929
NA
7.00E−56
1
LIM domain kinase 2 (LIMK2), mRNA Length = 3699

52F6
1
230
XM_010593
NA
2.00E−36
1
signaling lymphocytic activation molecule (SLAM),

mRNA Length = 1791

185E5
1576
1695
XM_010897
NA
3.00E−32
1
neural precursor cell expressed, developmentally

down-regulated 5 (NED

106C3
1359
1824
XM_011080
NA
0
1
T cell activation, increased late expression (TACTILE),

mRNA

56H11
40
617
XM_011082
NA
0
1
interleukin 21 (IL21), mRNA Length = 617

53B2
2711
2839
XM_011714
NA
3.00E−29
1
neutral sphingomyelinase (N-SMase) activation

associated factor (NSMAF

47A3
896
1231
XM_011865
NA
1.00E−55
1
isopentenyl-diphosphate delta isomerase (IDI1),

mRNA Length = 1835

159E9
17
178
XM_011914
NA
1.00E−73
1
ribosomal protein S24 (RPS24), mRNA Length = 515

39E6
339
535
XM_012059
NA
1.00E−44
1
hypothetical protein MDS025 (MDS025), mRNA

Length = 1225

142F6
623
745
XM_012328
NA
2.00E−40
1
granzyme B (granzyme 2, cytotoxic T-lymphocyte-

associated serine ester

118D4
329
765
XM_012649
NA
1.00E−114
1
small inducible cytokine A7 (monocyte chemotactic

protein 3) (SCYA7),

168H9
2502
2616
XM_015180
NA
2.00E−33
1
apolipoprotein L, 6 (APOL6), mRNA Length = 2915

58D2
1582
1742
XM_015921
NA
2.00E−30
1
putative chemokine receptor; GTP-binding protein

(HM74), mRNA

466H9
86
440
XM_016138
NA
2.00E−45
1
hypothetical protein FLJ12439 (FLJ12439), mRNA

Length = 1614

184G1
2651
3584
XM_016481
NA
0
3
hypothetical protein (DJ328E19.C1.1), mRNA

Length = 3603

107G9
8199
8786
XM_016721
NA
0
1
zinc finger protein 106 (ZFP106), mRNA Length =

10462

39F11
2719
3671
XM_016972
NA
0
2
similar to hypothetical protein (H. sapiens)

(LOC82646), mRNA

159A7
19
561
XM_018498
NA
1.00E−167
3
ribosomal protein L5 (RPL5), mRNA Length = 984

459H2
2956
3450
Y16414
NA
0
1
mRNA for exportin (tRNA) Length = 3497

TABLE 3B

Identified Genomic Regions that code for novel human mRNA's

Example
Genome

Number

Clone
Start
End
Accession
Probability
Clones
Genbank Description

172H5
12457
13616
AC000015
0
2
chromosome 4 clone B271E1 map 4q25,

complete sequence L

464A9
21144
21280
AC000068
2.00E−70
1
Chromosome 22q11.2 Cosmid Clone 102g9

In DGCR Region, c

472B10
20340
20745
AC000087
2.00E−67
1
Chromosome 22q11.2 Cosmid Clone 83c5 In

DGCR Region, co

103C4
93389
93611
AC000119
0
5
BAC clone RG104I04 from 7q21-7q22,

119111
119521
AC000119

complete sequence [H

119522
119890
AC000119

119989
121059
AC000119

514A3
201218
201293
AC000353
5.00E−34
2
Chromosome 11q13 BAC Clone 18h3,

complete sequence Leng

524A9
24315
24820
AC002073
0
3
PAC clone RP3-515N1 from 22q11.2-q22,

24879
25274
AC002073

complete sequence

458D10
28080
28625
AC002297
0
1
Genomic sequence from 9q34, complete

sequence [Homo sap

476D3
106080
106289
AC002302
1.00E−86
1
Chromosome 16 BAC clone CIT987-SKA-

345G4-complete geno

471D10
34638
34885
AC002306
1.00E−118
2
DNA from chromosome 19-cosmid R33799,

genomic sequence,

596F6
75526
76327
AC002467
0
1
BAC clone CTA-364P16 from 7q31, complete

sequence [Homo

473F3
74912
75540
AC002549
0
2
Xp22 BAC GS-377014 (Genome Systems

BAC library) complet

111E12
24581
24992
AC003086
0
1
BAC clone CTB-104F4 from 7q21-q22,

complete sequence Le

471E9
39706
40014
AC003103
1.00E−151
1
chromosome 17, clone HCIT268N12,

complete sequence Leng

526B9
39477
39615
AC003695
3.00E−29
1
chromosome 17, clone hRPC.859_O_20,

complete sequence L

331A3
47793
48492
AC003976
1.00E−164
5
chromosome 17, clone hCIT.91_J_4,

complete sequence Len

105C1
115642
116079
AC004067
0
1
chromosome 4 clone B366O24 map 4q25,

complete sequence

469H8
35828
35976
AC004080
5.00E−71
1
PAC clone RP1-170O19 from 7p15-p21,

complete sequence L

55F9
114263
114415
AC004169
3.00E−46
1
chromosome 4 clone C0236G06 map 4p16,

complete sequence

487F9
35319
35718
AC004187
0
1
clone UWGC: y17c131 from 6p21, complete

sequence Length

459H7
13409
13739
AC004190
1.00E−166
1
from UWGC: y18c282 from 6p21, complete

sequence Length =

464D1
28530
29042
AC004221
1.00E−106
1
DNA from chromosome 19, cosmid R29144

(LLNLR-252D12) an

468A7
53111
53416
AC004386
5.00E−80
2

Homo Sapiens Chromosome X clone

bWXD691, complete seque

188F1
859
1200
AC004520
0
1
BAC clone CTB-119C2 from 7p15, complete

sequence Length

523F5
38269
38756
AC004644
3.00E−38
1
chromosome 16, cosmid clone 367E12

(LANL), complete seq

142E4
113118
114014
AC004686
0
14
chromosome 17, clone hRPC.1073_F_15,

117050
117275
AC004686

complete sequence

135F10
39469
39637
AC004762
3.00E−75
1
chromosome 20, P1 clone 28 (LBNL H134),

complete sequen

472C8
120427
120603
AC004838
6.00E−92
1
PAC clone RP4-589D8 from 7q31.1-q31.3,

complete sequenc

464F11
64853
65242
AC004849
5.00E−59
2
PAC clone RP4-659J6 from 7q33-q35,

complete sequence Le

460D2
54796
55320
AC004854
0
1
PAC clone RP4-673M15 from 7p13-p11.2,

complete sequence

513B4
94866
95147
AC004858
2.00E−57
1
PAC clone RP4-687K1 from 14, complete

sequence Length =

463C7
53959
54083
AC004906
1.00E−44
1
PAC clone RP5-852O24 from 7p22,

complete sequence Lengt

584D3
56155
56311
AC004913
5.00E−36
1
clone DJ0876A24, complete sequence

Length = 98870

171B1
23796
24098
AC004918
1.00E−145
1
PAC clone RP5-894A10 from 7q32-q32,

complete sequence L

463B10
33758
34061
AC004923
1.00E−135
1
PAC clone RP5-901A4, complete sequence

Length = 94851

101A1
50075
50425
AC004997
1.00E−129
1
PAC clone RP1-130H16 from 22q12.1-qter,

complete sequen

465G8
28181
28635
AC005014
0
1
BAC clone GS1-166A23 from 7p21, complete

sequence Lengt

470C3
93162
93469
AC005068
1.00E−160
1
BAC clone CTB-137N13 from 7, complete

sequence Length =

119E5
28806
29061
AC005156
1.00E−119
1
PAC clone RP5-1099C19 from 7q21-q22,

complete sequence

98C3
24385
25049
AC005192
0
1
BAC clone CTB-163K11 from 7q31, complete

sequence Lengt

140G6
37679
37878
AC005280
6.00E−85
1
PAC clone RP1-240K6 from 14, complete

sequence Length =

476A10
12753
12826
AC005306
8.00E−33
1
chromosome 19, cosmid R27216 (LLNLR-

232D4) and 3′ overl

331A12
34177
34328
AC005391
2.00E−72
1
chromosome 19, cosmid R29942, complete

sequence Length

111H11
85156
86081
AC005488
0
2
clone NH0313P13, complete sequence

Length = 185737

472H11
22517
22813
AC005531
1.00E−150
1
PAC clone RP4-701O16 from 7q33-q36,

complete sequence L

139G6
96577
97117
AC005540
0
3
clone RP11-533I8, complete sequence

116180
116836
AC005540

Length = 133761

472F4
70951
71038
AC005593
3.00E−41
1
chromosome 5, P1 clone 1369f10 (LBNL

H28), complete seq

469D4
27949
28457
AC005667
0
1
chromosome 17, clone hRPK.329_E_11,

complete sequence L

463A7
127455
127799
AC005740
1.00E−154
1
chromosome 5p, BAC clone 50g21 (LBNL

H154), complete se

126B8
27782
28073
AC005837
1.00E−160
2
chromosome 17, clone hRPK.318_A_15,

complete sequence L

479D2
202167
202536
AC005859
2.00E−46
1
Xp22-83 BAC GSHB-324M7 (Genome

Systems BAC Library) com

39G6
62582
63099
AC005920
0
1
chromosome 17, clone hRPK.700_H_6,

complete sequence Le

63E1
39129
39250
AC006006
3.00E−59
1
PAC clone RP4-813F11 from 7q32-q34,

complete sequence L

461B11
140287
140770
AC006010
1.00E−154
2
clone DJ0935K16

119G10
81312
81740
AC006033
0
1
BAC clone RP11-121A8 from 7p14-p13,

complete sequence L

64A2
109063
109613
AC006050
0
2
chromosome 17, clone hRPK.268_F_2,

complete sequence Le

459B7
13630
14294
AC006077
0
1
chromosome 5, P1 clone 254f11 (LBNL

H62), complete sequ

37H4
58820
59068
AC006111
1.00E−67
1
chromosome 16 clone RP11-461A8,

complete sequence Lengt

512E3
39935
40123
AC006139
3.00E−94
1
clone UWGC: y55c068 from 6p21, complete

sequence Length

171H10
33704
33969
AC006165
8.00E−78
1
clone UWGC: y54c125 from 6p21, complete

sequence Length

72A1
106659
106958
AC006207
1.00E−149
1
12p13.3 BAC RPCI3-488H23 (Roswell Park

Cancer Institute

195H12
38763
38930
AC006323
2.00E−61
1
clone RP5-1151M5, complete sequence

Length = 86267

113B6
36330
36635
AC006344
1.00E−157
1
PAC clone RP4-726N20 from 7q32-q34,

complete sequence L

588G6
174012
174265
AC006449
2.00E−93
1
chromosome 17, clone hCIT.58_E_17,

complete sequence Le

463B2
65534
66031
AC006483
0
1
BAC clone CTB-161C1 from 7, complete

sequence Length =

115F11
71976
72094
AC006511
8.00E−60
1
12p13.1 (17.1-21.3 cM) BAC RPCI11-69M1

(Roswell Park Ca

187H11
34068
34544
AC006536
0
1
chromosome 14 clone BAC257P13 map

14q31, complete seque

477E6
106567
106656
AC007009
6.00E−30
1
BAC clone RP11-560C1 from 7p22-p21,

complete sequence L

53E10
123408
123785
AC007040
0
1
BAC clone RP11-298H3 from 2, complete

sequence Length =

462C8
164080
164223
AC007068
4.00E−72
2
12p BAC RPCI11-75L1 (Roswell Park

174303
174379
AC007068

Cancer Institute BAC

478C7
27207
27305
AC007097
4.00E−43
1
BAC clone RP11-332E22 from 7q35-q36,

complete sequence

181A8
4600
4798
AC007201
5.00E−59
2
chromosome 19, cosmid R34383, complete

sequence Length

159F6
111852
112188
AC007263
1.00E−151
1
chromosome 14 clone RP11-79J20

containing gene for chec

163F10
94927
95303
AC007283
1.00E−126
2
BAC clone RP11-536I18 from 2, complete

sequence Length

124G4
192082
192785
AC007318
0
3
clone RP11-420C9, complete sequence

Length = 204230

331A5
117939
118047
AC007383
3.00E−51
1
BAC clone RP11-310K15 from 2, complete

sequence Length

463C5
101528
101815
AC007444
9.00E−41
1
clone RP11-340F1 from 7p14-15, complete

sequence Length

485D5
94681
95267
AC007458
1.00E−152
8
12q15 BAC RPCI11-444B24 (Roswell Park

95517
95826
AC007458

Cancer Institute

95858
96487
AC007458

96742
96838
AC007458

187608
187732
AC007458

181B6
95554
96149
AC007488
0
2
3q27 BAC RPCI11-246B7 (Roswell Park

Cancer Institute BA

102E12
12533
12977
AC007540
4.00E−93
1
12q24.1 BAC RPCI11-128P10 (Roswell Park

Cancer Institut

471C6
9877
10401
AC007561
1.00E−160
1
clone RP11-394E1, complete sequence

Length = 106093

471C1
27629
27769
AC007676
1.00E−27
1
clone RP11-9B17, complete sequence

Length = 152138

40D4
120766
121349
AC007882
0
1
BAC clone RP11-499D5 from 7p11.2-q11.2,

complete sequen

166C10
90374
90790
AC007899
0
1
BAC clone RP11-531C11 from 2, complete

sequence Length

492A7
11200
11376
AC007911
7.00E−57
1
chromosome 18, clone RP11-520K18,

complete sequence Len

459B3
65768
66232
AC008009
0
2
3q26.2-27 BAC RPCI11-436A20 (Roswell

Park Cancer Instit

463F10
127622
127783
AC008083
3.00E−85
1
12 BAC RP11-493L12 (Roswell Park Cancer

Institute BAC L

585C4
176255
176348
AC008124
6.00E−38
1
Chromosome 12q13-62.7-72 BAC RPCI11-

352M15 (Roswell Par

468E6
134033
134685
AC008279
0
2
BAC clone RP11-427F22 from 2, complete

sequence Length

112E9
37565
37926
AC008408
0
4
chromosome 5 clone CTC-278H1, complete

37996
38360
AC008408

sequence Length

145C5
131866
132484
AC008592
1.00E−141
8
chromosome 5 clone CTC-576H9, complete

134190
134862
AC008592

sequence Length

458D8
82521
83080
AC008623
0
1
chromosome 19 clone CTB-14D10, complete

sequence Length

584G2
44371
44929
AC008723
0
2
chromosome 5 clone CTB-95B16, complete

sequence Length

144F7
73662
74295
AC008750
2.00E−54
2
chromosome 19 clone CTD-2616J11,

complete sequence Leng

149G2
99171
99875
AC008760
1.00E−121
6
chromosome 19 clone CTD-3128G10,

complete sequence Leng

194H6
52930
53250
AC008795
5.00E−89
2
chromosome 5 clone CTD-2052F19,

57088
57263
AC008795

complete sequence Lengt

117H9
101321
102169
AC008860
0
11
chromosome 5 clone CTD-2185A1, complete

102715
102980
AC008860

sequence Length

103113
103402
AC008860

155D6
34277
34517
AC008982
1.00E−103
1
chromosome 19 clone LLNLF-172E10,

complete sequence Len

458E4
33802
34039
AC008985
8.00E−77
1
chromosome 19 clone LLNLF-198H7,

complete sequence Leng

176A6
170428
170746
AC009073
1.00E−138
1
chromosome 16 clone RP11-31O11,

complete sequence Lengt

146D8
11633
11699
AC009086
1.00E−28
1
chromosome 16 clone RP11-368N21,

complete sequence Leng

458B8
176406
176888
AC009120
0
1
chromosome 16 clone RP11-484E3,

complete sequence Lengt

73C4
136885
137479
AC009299
0
1
BAC clone RP11-26B22 from 2, complete

sequence Length =

54F4
202039
202564
AC009312
0
1
clone RP11-425F6, complete sequence

Length = 204834

480E2
143559
143986
AC009313
0
1
BAC clone RP11-440P12 from 2, complete

sequence Length

519E9
13492
13848
AC009404
1.00E−178
1
BAC clone RP11-28H22 from 2, complete

sequence Length =

129D12
81260
81769
AC009466
1.00E−151
1
chromosome 11, clone RP11-87N22,

complete sequence Leng

37E10
124522
125457
AC009477
0
3
BAC clone RP11-209H16 from 2, complete

sequence Length

129A12
6750
7331
AC009506
0
1
clone RP11-542H1, complete sequence

Length = 191764

515H10
5494
5990
AC009812
3.00E−69
4
chromosome 3, clone RP11-48B3, complete

74019
74540
AC009812

sequence Length

165D1
53879
54343
AC009951
0
1
clone RP11-107E5, complete sequence

Length = 159791

53D8
30308
30860
AC010132
1.00E−159
1
BAC clone RP11-111K18 from 7p11.2-p2,

complete sequence

487F11
16839
17267
AC010480
1.00E−130
3
chromosome 5 clone CTD-2315M5,

complete sequence Length

461G10
8988
9327
AC010677
1.00E−163
1
BAC clone CTD-2304L4 from 7, complete

sequence Length =

115H2
19073
19679
AC010789
4.00E−97
2
chromosome 10, clone RP11-190J1,

126247
126428
AC010789

complete sequence Leng

168A9
78976
79540
AC010877
0
2
BAC clone RP11-218F6 from Y, complete

sequence Length =

468G6
98034
98744
AC010878
1.00E−107
3
clone RP11-230E20, complete sequence

Length = 154115

477B12
167367
167895
AC010913
0
1
BAC clone RP11-44N22 from 2, complete

sequence Length =

192E1
10683
11328
AC011245
0
1
clone RP11-498O5, complete sequence

Length = 56793

467C2
4521
4890
AC011462
1.00E−178
1
chromosome 19 clone CTC-435M10,

complete sequence Lengt

189F3
12090
12208
AC011495
8.00E−60
1
chromosome 19 clone CTB-33G10, complete

sequence Length

144C9
38166
38421
AC011500
1.00E−62
1
chromosome 19 clone CTB-60E11, complete

sequence Length

162E8
41387
41499
AC012005
8.00E−30
1
clone RP11-533E23, complete sequence

Length = 189557

158G6
70285
70462
AC012170
3.00E−95
1
chromosome 15 clone RP11-562A8 map

15q21.1, complete se

189B11
19127
19241
AC013436
8.00E−29
3
BAC clone RP11-105B9 from 7, complete

23196
23655
AC013436

sequence Length =

98C9
178883
179326
AC015651
1.00E−107
1
chromosome 17, clone RP11-55A13,

complete sequence Leng

69F8
57839
58168
AC015819
0
1
chromosome 18, clone RP11-405M12,

complete sequence Len

47F9
3198
3826
AC016395
0
1
chromosome 10 clone RP11-153K11,

complete sequence Leng

480E3
39766
40155
AC016623
2.00E−35
1
chromosome 5 clone CTD-2345N17,

complete sequence Lengt

196G12
59552
60523
AC016637
0
2
chromosome 5 clone RP11-34J15, complete

sequence Length

518A8
61011
61433
AC016751
0
1
BAC clone RP11-504O20 from 2, complete

sequence Length

36C11
54765
54868
AC017002
2.00E−30
2
clone RP11-68E19, complete sequence

Length = 205662

489H9
108513
109049
AC017003
0
2
clone RP11-78C11, complete sequence

Length = 118385

479H6
142657
142930
AC017020
8.00E−45
1
BAC clone RP11-185K15 from Y, complete

sequence Length

483D10
99413
99875
AC017101
0
1
clone RP11-556A11, complete sequence

Length = 195635

112B4
87464
88155
AC018511
1.00E−129
2
chromosome 10 clone RP11-77G23,

117653
117940
AC018511

complete sequence Lengt

171F2
157933
158203
AC018673
2.00E−96
1
clone RP11-145A4, complete sequence

Length = 187099

166H12
116351
116665
AC018682
1.00E−177
1
clone RP11-417F21, complete sequence

Length = 181405

123F8
140561
141314
AC018904
0
3
chromosome 15 clone RP11-50C13 map

15q21.3, complete se

116C9
191414
191866
AC019206
0
1
BAC clone RP11-401N16 from 2, complete

sequence Length

472E9
148765
149172
AC020550
1.00E−140
1
BAC clone RP11-198M19 from 2, complete

sequence Length

129D1
66284
67154
AC020595
0
3
BAC clone RP11-358M9 from 2, complete

sequence Length =

465H10
82476
83166
AC020629
0
2
12q BAC RP11-76E16 (Roswell Park Cancer

Institute BAC L

182E2
83346
83465
AC020716
1.00E−33
2
clone RP11-449G13, complete sequence

84373
84451
AC020716

Length = 171805

37G8
35257
35957
AC020750
0
1
chromosome 3 clone RP11-105H19 map 3p,

complete sequenc

125F8
43854
44125
AC022007
1.00E−149
1
chromosome 3 clone RP11-481H17 map 3p,

complete sequenc

523A8
2991
3475
AC022149
0
1
chromosome 19 clone CTD-3093B17,

complete sequence Leng

459E7
90726
91104
AC022173
0
1
chromosome 7 clone RP11-29B3, complete

sequence Length

469F8
53281
53724
AC022336
6.00E−92
1
3 BAC RP11-71H17 (Roswell Park Cancer

Institute BAC Lib

463H5
75118
75256
AC022382
5.00E−72
1
chromosome 3 clone RP11-266J6 map 3p,

complete sequence

466G7
20276
20522
AC023058
2.00E−53
2
3 BAC CTB-187G23 (CalTech BAC Library

21327
21875
AC023058

B) complete seque

470B8
127894
128301
AC024568
1.00E−169
1
chromosome 5 clone CTD-2179L22,

complete sequence Lengt

473E11
21558
21818
AC024939
1.00E−117
1
12 BAC RP11-485K18 (Roswell Park Cancer

institute BAC L

470E1
150190
150573
AC025165
1.00E−171
1
12 BAC RP11-571M6 (Roswell Park Cancer

Institute BAC Li

480B5
107499
107766
AC025253
9.00E−66
1
12 BAC RP11-499A10 (Roswell Park Cancer

Institute BAC L

583B5
27783
27958
AC025257
1.00E−44
1
12 BAC RP11-56G10 (Roswell Park Cancer

Institute BAC Li

37H8
86118
86418
AC026425
1.00E−148
1
chromosome 5 clone CTD-2183D23,

complete sequence Lengt

166A9
119110
119797
AC026794
0
1
chromosome 5 clone CTD-2276B5, complete

sequence Length

103D4
105697
105794
AC034240
5.00E−40
2
chromosome 5 clone CTD-2335C11,

complete sequence Lengt

117H4
49581
49962
AC053513
0
1
clone RP11-359J14, complete sequence

Length = 155958

459B8
64143
64709
AC066580
0
1
chromosome 3 clone RP11-109J15 map 3p,

complete sequenc

174D1
41807
42055
AC067945
2.00E−69
2
clone RP11-629B4, complete sequence

115078
115365
AC067945

Length = 162471

178F5
105048
105223
AC068492
7.00E−37
1
BAC clone RP11-809C23 from 2, complete

sequence Length

66E6
2116
2578
AC068499
1.00E−135
2
chromosome 19, cosmid R26574 (LLNL-

R_225F10), complete

178C12
15618
15959
AC068789
0
1
12 BAC RP11-1049A21 (Roswell Park

Cancer Institute BAC

145F12
110468
110647
AC069298
3.00E−89
4
chromosome 3 clone RP11-56K23, complete

110779
111202
AC069298

sequence Length

141211
141790
AC069298

519F3
159763
160355
AC069304
0
1
BAC clone RP11-632K21 from 7, complete

sequence Length

464B11
52608
53051
AC073347
0
1
BAC clone RP11-775L16 from 7, complete

sequence Length

469E12
85540
85930
AC073917
0
2
12q BAC RP11-415D21 (Roswell Park

Cancer Institute BAC

118C12
141407
141495
AC083868
6.00E−70
3
chromosome 7 clone RP11-148L5, complete

142293
142607
AC083868

sequence Length

168G5
6632
7097
AC087065
0
2
chromosome 22q11 clone cos6, complete

sequence Length =

479G12
127024
127342
AC090942
1.00E−119
1
chromosome 3 clone RP11-220D14 map 3p,

complete sequenc

122G1
41957
42383
AC091118
0
1
chromosome 16 clone CTC-510K1, complete

sequence Length

479D7
153992
154141
AF001549
6.00E−29
1
Chromosome 16 BAC clone CIT987SK-A-

270G1, complete sequ

461H7
21977
22331
AF015262
2.00E−69
1
chromosome 21 clone Pac 255P7 map 21q-

AML, complete seq

463E9
27006
27615
AF015725
0
1
chromosome 21 clone cosmid clone D68F9

map 21q22.2, com

480D9
15848
16252
AF027207
1.00E−123
1
chromosome 21 clone cosmid D13C2 map

21q22.2, complete

465E9
296143
296800
AF131216
0
1
chromosome 8 map 8p23-p22 clones CTB-

164D9, CTB-169o5,

469D2
23811
24045
AF161800
2.00E−78
1
chromosome 8q21.2 BAC 189m5, complete

sequence Length =

37G7
200214
200755
AJ003147
0
2
complete genomic sequence between

201078
201309
AJ003147

D16S3070 and D16S3275

459A1
36969
37402
AL008730
8.00E−82
2
DNA sequence from PAC 487J7 on

chromosome 6q21-22.1. Co

480C8
37929
38457
AL008733
0
1
DNA sequence from clone RP1-163G9 on

chromosome 1p36.2-

462D9
36712
37037
AL021878
0
2
DNA sequence from clone RP1-257I20 on

40603
40772
AL021878

chromosome 22q13.

182H1
30506
30760
AL022238
3.00E−96
2
DNA sequence from clone RP5-1042K10 on

chromosome 22q13

166F6
75035
75547
AL022240
0
1
DNA sequence from clone 328E19 on

chromosome 1q12-21.2

165C12
179455
179766
AL022329
1.00E−175
1
DNA sequence from clone CTA-407F11 on

chromosome 22q12

465A12
26329
26834
AL022331
0
1
DNA sequence from clone CTA-440B3 on

chromosome 22q12.1

524D1
70719
70891
AL022394
2.00E−87
1
DNA sequence from clone RP3-511B24 on

chromosome 20q11.

53E3
129077
129538
AL022396
0
1
DNA sequence from PAC 380E11 on

chromosome 6p22.3-p24.

126D1
69809
70220
AL031178
0
1
DNA sequence from clone RP3-341E18 on

chromosome 6p11.2

466A9
103757
104346
AL031277
0
1
DNA sequence from clone 1177E19 on

chromosome 1p36.12-3

472E11
41594
41778
AL031595
9.00E−97
1
DNA sequence from clone RP4-671O14 on

chromosome 22q13.

462E8
72042
72629
AL031672
0
1
DNA sequence from clone RP4-691N24 on

chromosome 20p11.

478C2
29633
29708
AL031708
9.00E−28
1
DNA sequence from clone LA16-315G5 on

chromosome 16, co

53B1
30963
31311
AL031729
1.00E−163
1
DNA sequence from clone RP1-159A19 on

chromosome 1p36.1

178B2
38674
38800
AL033383
3.00E−27
1
DNA sequence from clone RP5-1013A10 on

chromosome 6p24.

104A7
40604
41062
AL033397
0
1
DNA sequence from clone 27K12 on

chromosome 6p11.2-12.3

190F11
77693
78285
AL033519
0
1
DNA sequence from clone RP3-340B19 on

chromosome 6p21.2

121A11
15252
15679
AL034344
9.00E−52
1
DNA sequence from clone RP1-118B18 on

chromosome 6p24.1

173B5
102500
102752
AL034384
7.00E−58
1
chromosome Xq28, cosmid clones 7H3,

14D7, C1230, 11E7,

121A12
34566
34684
AL034397
6.00E−47
1
DNA sequence from clone 159A1 on

chromosome Xq12-13.3.

104B10
73639
74045
AL034418
1.00E−176
1
DNA sequence from clone RP5-1049G16 on

chromosome 20q12

471F1
37083
37364
AL034553
1.00E−150
1
DNA sequence from clone RP5-914P20 on

chromosome 20q13.

463H8
97563
97753
AL035405
1.00E−102
1
DNA sequence from clone 21O18 on

chromosome 1p35.1-36.2

472E6
20949
21271
AL035413
1.00E−155
1
DNA sequence from clone RP4-657E11 on

chromosome 1p35.1

121F1
65029
65503
AL035455
0
1
DNA sequence from clone RP5-1018E9 on

chromosome 20q13.

465B1
37269
37445
AL035530
2.00E−47
1
DNA sequence from clone RP1-111C20 on

chromosome 6q25.3

482C9
64837
65129
AL035662
1.00E−163
1
DNA sequence from clone RP4-599F21 on

chromosome 20q12-

166B9
39808
39976
AL049715
1.00E−87
1
DNA sequence from clone RP4-646P11 on

chromosome 1, com

591D6
65470
65892
AL049795
0
1
DNA sequence from clone RP4-622L5 on

chromosome 1p34.2-

72G1
82160
82440
AL049829
1.00E−148
1
chromosome 14 DNA sequence *** IN

PROGRESS *** BAC R-12

112H3
2111
2535
AL050330
0
2
DNA sequence from clone RP1-3E1 on

chromosome 6p21.23-2

479G5
18853
19244
AL096712
1.00E−125
1
DNA sequence from clone RP4-744I24 on

chromosome 6p12.1

464C10
80145
80583
AL096773
4.00E−85
1
DNA sequence from clone 1000E10 on

chromosome 1p12-13.3

123D11
34999
35510
AL096808
1.00E−166
1
genomic region containing hypervariable

minisatellites

129F10
1148
2507
AL109616
0
95
chromosome 21 Cosmid LLNLc116L1110,

complete sequence L

469B8
13155
13527
AL109755
0
1
DNA sequence from clone RP3-340H11 on

chromosome 6q24.1

105F4
57995
58306
AL109758
5.00E−98
1
chromosome 14 DNA sequence *** IN

PROGRESS *** BAC R-87

465H5
136248
136356
AL109847
7.00E−29
1
chromosome 14 DNA sequence BAC R-

603H7 of library RPCI-

60G8
84706
84959
AL109914
1.00E−135
1
DNA sequence from clone RP11-27F12 on

chromosome 6p22.3

102A8
169378
169473
AL109918
2.00E−34
1
DNA sequence from clone RP1-152L7 on

chromosome 6p11.2-

471D6
63862
64021
AL117186
4.00E−80
1
chromosome 14 DNA sequence *** IN

PROGRESS *** BAC R-29

176E10
145991
146554
AL117258
3.00E−63
1
chromosome 14 DNA sequence BAC R-

244E17 of library RPCI

480E7
2975
3356
AL117352
1.00E−153
1
DNA sequence from clone RP5-876B10 on

chromosome 1q42.1

110D3
48631
48886
AL121573
3.00E−65
2
DNA sequence from clone RP1-306F2 on

chromosome 6p12.1-

40B2
106788
107123
AL121657
2.00E−42
1
BAC sequence from the SPG4 candidate

region at 2p21-2p2

52B9
56473
56690
AL121899
1.00E−104
2
DNA sequence from clone RP11-128M1 on

chromosome 20. Co

485A6
5475
7084
AL121985
1.00E−138
7
DNA sequence from clone RP11-404F10 on

15867
16574
AL121985

chromosome 1q23.

17098
17504
AL121985

24037
24292
AL121985

40E4
54176
54528
AL121998
1.00E−179
1
DNA sequence from clone RP5-1103B4 on

chromosome 1 Cont

118H12
21398
21744
AL132838
0
1
chromosome 14 DNA sequence BAC R-

85G20 of library RPCI-

599F11
153822
154345
AL133153
0
1
chromosome 14 DNA sequence BAC R-

895M11 of library RPCI

478G8
115784
116115
AL133243
1.00E−120
1
BAC sequence from the SPG4 candidate

region at 2p21-2p2

107H8
119760
120729
AL133330
0
22
DNA sequence from clone RP1-68D18 on

121182
121863
AL133330

chromosome 11p12-1

122773
122940
AL133330

143751
144379
AL133330

146057
147016
AL133330

159262
159639
AL133330

471E7
127891
128013
AL133340
6.00E−46
1
DNA sequence from clone RP11-204H22 on

chromosome 20. C

118H5
3922
4021
AL133392
1.00E−38
2
DNA sequence from clone CITF22-45C1 on

4557
5184
AL133392

chromosome 22 Co

40A3
96202
96785
AL133412
0
3
DNA sequence from clone RP11-131A5 on

97177
97568
AL133412

chromosome 9q22.1

482A5
28668
29037
AL133415
3.00E−34
4
DNA sequence from clone RP11-124N14 on

51083
51210

chromosome 10. C

54G9
54866
55153
AL135783
1.00E−154
1
DNA sequence from clone RP3-527F8 on

chromosome Xq25-27

515C12
72222
72601
AL135818
1.00E−146
2
chromosome 14 DNA sequence BAC C-

2547L24 of library Cal

109A9
53171
53447
AL136320
1.00E−137
1
DNA sequence from clone RP3-323N1 on

chromosome 10. Con

476H10
127150
127680
AL137017
0
1
DNA sequence from clone RP11-120J1 on

chromosome 9 Cont

192C3
122511
122837
AL137100
1.00E−117
1
chromosome 14 DNA sequence BAC R-

108M12 of library RPCl

55G3
38923
39058
AL137142
7.00E−44
2
DNA sequence from clone RP11-173P16 on

42456
42686
AL137142

chromosome 13q12

466G2
24290
24402
AL137144
9.00E−42
1
DNA sequence from clone RP11-210E23 on

chromosome 13q31

140F9
27354
27715
AL137798
8.00E−82
1
DNA sequence from clone RP5-1182A14 on

chromosome 1 Con

37A2
134590
134750
AL137800
3.00E−69
1
DNA sequence from clone RP1 -127C7 on

chromosome 1q25.1-

493C2
734
1052
AL138714
1.00E−157
1
DNA sequence from clone RP11-121J7 on

chromosome 13q32.

468B9
1911
2509
AL138717
9.00E−70
1
DNA sequence from clone RP11-11D8 on

chromosome 6 Conta

194F9
46595
46814
AL138755
6.00E−94
1
DNA sequence from clone RP11-48M17 on

chromosome 9p24.1

483D12
80220
80755
AL138776
1.00E−157
1
DNA sequence from clone RP11-20H6 on

chromosome 1q25.1-

464G9
14032
14659
AL139020
0
1
chromosome 14 DNA sequence BAC R-

164H13 of library RPCI

59G1
34476
34936
AL139274
0
1
DNA sequence from clone RP11-393I2 on

chromosome 6, com

129D3
65447
65661
AL139289
1.00E−107
2
DNA sequence from clone RP1-92O14 on

66950
67158
AL139289

chromosome 1p33-34

464C2
55616
56289
AL139328
0
1
DNA sequence from clone RP11-84N7 on

chromosome 13. Con

57H10
155342
155810
AL139330
0
2
DNA sequence from clone RP11-266C7 on

chromosome 6q25.2

470G6
44695
44978
AL139399
1.00E−130
1
DNA sequence from clone RP11-574A21 on

chromosome Xq2l.

476F5
42969
43159
AL139801
5.00E−98
1
DNA sequence from clone RP11-247M1 on

chromosome 13, co

107G11
139776
140378
AL157402
0
2
DNA sequence from clone RP11-553K8 on

chromosome 1q31.2

172B12
136072
136492
AL157768
1.00E−155
1
DNA sequence from clone RP11-481A22 on

chromosome 13 Co

149A11
438
663
AL157776
1.00E−123
1
DNA sequence from clone RP11-68J15 on

chromosome 6, com

165E7
66361
67034
AL157789
0
1
chromosome 14 DNA sequence BAC R-

880O3 of library RPCI-

192B3
51907
52253
AL157938
1.00E−176
1
DNA sequence from clone RP11-544A12 on

chromosome 9q34.

50A11
5753
5886
AL158136
1.00E−59
1
DNA sequence from clone RP1-44N23 on

chromosome 6 Conta

472F9
84638
85232
AL158159
0
1
DNA sequence from clone RP11-498N2 on

chromosome 9, com

462G12
132520
132708
AL160155
2.00E−95
1
DNA sequence from clone RP11-461N23 on

chromosome 13, c

117H6
1976
2518
AL160233
0
1
chromosome 14 DNA sequence BAC C-

2373J19 of library Cal

460B9
207
739
AL160408
1.00E−104
2
DNA sequence from clone RP4-781K5 on

2023
2537
AL160408

chromosome 1q42.1-

467F10
8461
8829
AL161627
1.00E−122
1
DNA sequence from clone RP11-287A8 on

chromosome 9, com

469A10
81966
82313
AL161781
1.00E−175
1
DNA sequence from clone RP11-297B17 on

chromosome 9, co

598H2
222231
222679
AL162151
0
1
chromosome 14 DNA sequence *** IN

PROGRESS*** BAC C-31

466C5
147064
147687
AL162578
0
1
DNA sequence from clone RP11-2J18 on

chromosome 6, comp

467C9
216403
216544
AL163303
3.00E−38
1
chromosome 21 segment HS21C103

Length = 340000

462H9
63385
63502
AL163853
6.00E−59
1
chromosome 14 DNA sequence BAC R-

248B10 of library RPCI

464A10
63421
63807
AL353744
2.00E−55
1
clone RP13-100-A9 on chromosome X

99E10
6789
7153
AL353804
0
1
DNA sequence from clone RP13-216E22 on

chromosome Xq13.

477D10
49708
50171
AL354716
4.00E−96
1
DNA sequence from clone RP11-86F4 on

chromosome 6, comp

518F10
3379
3602
AL354891
2.00E−94
1
DNA sequence from clone RP11-44I7 on

chromosome 13, com

464D8
122494
122702
AL354977
1.00E−87
2
DNA sequence from clone RP11-509J21 on

chromosome 9, co

459H6
109525
109864
AL355520
1.00E−179
1
DNA sequence from clone RP4-595C2 on

chromosome 1q24.1-

196C6
21603
21783
AL355615
7.00E−96
2
DNA sequence from clone RP11-33E24 on

chromosome 6, com

110B8
11907
12312
AL355797
1.00E−145
1
DNA sequence from clone RP1-9E2 on

chromosome 6, comple

180B2
142517
142726
AL355871
1.00E−72
1
DNA sequence from clone RP11-47K11 on

chromosome 1, com

464H5
50106
50463
AL356276
0
2
DNA sequence from clone RP11-367J7 on

chromosome 1. Con

105H4
32156
32236
AL356379
2.00E−27
2
DNA sequence from clone RP1-63P18 on

32440
32804
AL356379

chromosome 1. Cont

113H1
22550
22837
AL356481
1.00E−160
1
DNA sequence from clone RP11-216B9 on

chromosome 9, com

170F7
46442
46855
AL357374
0
1
DNA sequence from clone RP11-353C18 on

chromosome 20 Co

522D3
113148
113424
AL360182
1.00E−127
1
DNA sequence from clone RP11-549L6 on

chromosome 10, co

36E9
38157
38346
AL390196
4.00E−47
9
clone RP11-60E24 on chromosome 6

587E3
15704
16062
AL442128
1.00E−173
2
DNA sequence from clone RP11-365P13 on

chromosome 13, c

468E8
52779
53344
AL445201
1.00E−123
1
DNA sequence from clone RP11-358L16 on

chromosome 10, c

39G11
106047
106169
AL445687
2.00E−26
1
clone RP11-567B20 on chromosome 1

101F1
1538
1656
AL449244
5.00E−44
2
Novel human gene mapping to chomosome

1676
2096
AL449244

22 Length = 2315

466D1
56761
56929
AL450344
5.00E−85
1
DNA sequence from clone RP11-136K14 on

chromosome 6 Con

142E9
116227
116568
AL590763
0
8
chromosome X sequence from 6 PACs 1

116669
117358
AL590763

BAC and 1 cosmid, r

154792
155165
AL590763

459E9
26826
26890
AP000471
2.00E−27
1
genomic DNA, chromosome 21q22.3,

clone:B2308H15 Length

472C1
95646
96035
AP000501
1.00E−101
1
genomic DNA, chromosome 8p11.2,

clone:91h23 to 9-41 Len

464A7
7930
8285
AP000526
1.00E−178
1
genomic DNA, chromosome 22q11.2, Cat

Eye Syndrome regio

165E11
643
1244
AP000554
1.00E−147
2
genomic DNA, chromosome 22q11.2,

BCRL2 region, clone:KB

72D8
27091
27486
AP000555
0
1
genomic DNA, chromosome 22q11.2,

BCRL2 region, clone:KB

470B4
15634
15703
AP001429
5.00E−28
1
genomic DNA, chromosome 21q22.2,

clone:T1212, LB7T-ERG

59E12
59103
59520
AP001574
1.00E−144
2
genomic DNA, chromosome 8q23, clone:

60671
61189
AP001574

KB1991G8 Length =

138G5
313261
313931
AP001693
1.00E−31
27
genomic DNA, chromosome 21q, section

315877
315967
AP001693

37/105 Length = 34

319062
319564
AP001693

319957
320293
AP001693

320563
321212
AP001693

328757
329184
AP001693

158G11
107888
108375
AP001721
0
1
genomic DNA, chromosome 21q, section

65/105 Length = 34

462F9
330129
330645
AP001728
1.00E−133
1
genomic DNA, chromosome 21q, section

72/105 Length = 34

479A12
74529
74902
AP002907
1.00E−141
1
genomic DNA, chromosome 8q23, clone:

KB431C1 Length = 9

470B2
123506
123689
AP003117
4.00E−72
2
genomic DNA, chromosome 8q23, clone:

KB1958F4 Length =

46D1
79174
79657
AP003471
1.00E−164
2
genomic DNA, chromosome 8q23, clone:

83490
84099
AP003471

KB1552D7 Length =

496C4
745790
746197
NT_004406
0
1
chromosome 1 working draft sequence

segment

468E10
2015
2118
NT_004452
2.00E−32
2
chromosome 1 working draft sequence

segment

479H12
394087
394676
NT_004480
0
1
chromosome 1 working draft sequence

segment

472G2
268543
268642
NT_004525
3.00E−42
1
chromosome 1 working draft sequence

segment

477D9
231154
231469
NT_004531
1.00E−177
1
chromosome 1 working draft sequence

segment

460F7
786014
786511
NT_004623
0
1
chromosome 1 working draft sequence

segment

171F11
1E+06
1036701
NT_004658
1.00E−26
1
chromosome 1 working draft sequence

segment

184H1
2E+06
1770512
NT_004698
0
4
chromosome 1 working draft sequence

2E+06
1822054
NT_004698

segment

2E+06
1832854
NT_004698

514H9
289858
289941
NT_004705
1.00E−29
1
chromosome 1 working draft sequence

segment

463G1
175158
175615
NT_004725
0
1
chromosome 1 working draft sequence

segment

466C9
543567
544240
NT_004753
0
1
chromosome 1 working draft sequence

segment

496D7
2E+06
1515549
NT_004754
0
1
chromosome 1 working draft sequence

segment

583G8
733247
733667
NT_004771
1.00E−128
1
chromosome 1 working draft sequence

segment

124D2
107397
107739
NT_004916
1.00E−178
1
chromosome 1 working draft sequence

segment

479A8
285973
286345
NT_005130
1.00E−165
1
chromosome 2 working draft sequence

segment

165F7
1E+06
1435537
NT_005151
1.00E−125
1
chromosome 2 working draft sequence

segment

465F7
773772
774502
NT_005166
0
2
chromosome 2 working draft sequence

segment

73A3
80919
81448
NT_005182
0
2
chromosome 2 working draft sequence

81502
81742
NT_005182

segment

124G7
2E+06
1859389
NT_005204
1.00E−180
1
chromosome 2 working draft sequence

segment

479G6
552674
553005
NT_005229
1.00E−141
5
chromosome 2 working draft sequence

1E+06
1122605
NT_005229

segment

194C2
481052
481444
NT_005230
1.00E−101
1
chromosome 2 working draft sequence

segment

159F11
795978
796616
NT_005275
0
1
chromosome 2 working draft sequence

segment

472B1
1013
1410
NT_005311
0
1
chromosome 2 working draft sequence

segment

470G7
375182
375594
NT_005399
0
1
chromosome 2 working draft sequence

segment

100C3
803712
804094
NT_005420
0
2
chromosome 2 working draft sequence

970577
971108
NT_005420

segment

98H4
2E+06
1829143
NT_005423
0
1
chromosome 2 working draft sequence

segment

105A10
1E+06
1144092
NT_005435
1.00E−167
2
chromosome 2 working draft sequence

segment

465C3
13444
13890
NT_005471
0
1
chromosome 2 working draft sequence

segment

112E5
3169
3793
NT_005485
0
1
chromosome 2 working draft sequence

segment

111H6
146878
146999
NT_005499
2.00E−55
1
chromosome 3 working draft sequence

segment

467G7
198880
199329
NT_005505
0
1
chromosome 3 working draft sequence

segment

182F12
140059
140193
NT_005516
1.00E−144
3
chromosome 3 working draft sequence

140754
141039
NT_005516

segment

112B5
137689
138300
NT_005529
0
4
chromosome 3 working draft sequence

segment

64B3
55213
55793
NT_005535
0
1
chromosome 3 working draft sequence

segment

465E12
866776
867258
NT_005769
0
2
chromosome 3 working draft sequence

1E+06
1021292
NT_005769

segment

470D5
1E+06
1395364
NT_005795
1.00E−147
3
chromosome 3 working draft sequence

2E+06
1749621
NT_005795

segment

479G2
294179
294607
NT_005910
0
1
chromosome 3 working draft sequence

segment

112E1
392884
393490
NT_005973
0
1
chromosome 3 working draft sequence

segment

466H5
339511
340153
NT_005985
0
2
chromosome 3 working draft sequence

segment

189A8
22414
22869
NT_005991
1.00E−110
1
chromosome 3 working draft sequence

segment

45H8
1E+06
1012040
NT_006098
1.00E−113
1
chromosome 4 working draft sequence

segment

104D1
282259
282753
NT_006102
0
2
chromosome 4 working draft sequence

segment

459G8
367701
368248
NT_006111
0
1
chromosome 4 working draft sequence

segment

480E11
486179
486804
NT_006114
0
1
chromosome 4 working draft sequence

segment

115G2
4E+06
3514655
NT_006204
1.00E−177
1
chromosome 4 working draft sequence

segment

479G3
71744
72258
NT_006258
0
1
chromosome 4 working draft sequence

segment

461H11
378023
378482
NT_006397
0
1
chromosome 4 working draft sequence

segment

462F11
80360
81081
NT_006410
0
1
chromosome 4 working draft sequence

segment

463A5
2E+06
1609976
NT_006489
1.00E−138
1
chromosome 5 working draft sequence

segment

464C5
190095
190533
NT_006611
0
2
chromosome 5 working draft sequence

segment

109H9
89260
89769
NT_006946
0
3
chromosome 5 working draft sequence

segment

137B5
2E+06
1613357
NT_006951
1.00E−86
4
chromosome 5 working draft sequence

segment

73H4
992358
992685
NT_007288
0
1
chromosome 6 working draft sequence

segment

174H6
431672
432054
NT_007308
0
1
chromosome 6 working draft sequence

segment

124C8
282413
283138
NT_007951
0
1
chromosome 7 working draft sequence

segment

174G11
829762
830370
NT_007972
0
1
chromosome 8 working draft sequence

segment

471H11
613132
613314
NT_007978
9.00E−96
1
chromosome 8 working draft sequence

segment

471G8
189279
189630
NT_008012
1.00E−147
1
chromosome 8 working draft sequence

segment

67C5
287017
287563
NT_008037
0
2
chromosome 8 working draft sequence

segment

479H4
90555
90944
NT_008047
1.00E−174
1
chromosome 8 working draft sequence

segment

100D7
64180
64371
NT_008050
1.00E−134
6
chromosome 8 working draft sequence

331150
331412
NT_008050

segment

45B9
479878
480193
NT_008060
1.00E−165
12
chromosome 8 working draft sequence

489788
490607
NT_008060

segment

169F11
291836
292284
NT_008081
0
1
chromosome 8 working draft sequence

segment

468H11
106661
106897
NT_008128
1.00E−121
2
chromosome 8 working draft sequence

110374
110691
NT_008128

segment

470H6
520107
520754
NT_008139
0
1
chromosome 8 working draft sequence

segment

471F9
392744
393279
NT_008157
0
1
chromosome 8 working draft sequence

segment

469G8
433686
434156
NT_008338
0
1
chromosome 9 working draft sequence

segment

193E6
1E+06
1228306
NT_008445
6.00E−56
1
chromosome 9 working draft sequence

segment

480D2
90407
90990
NT_008484
0
1
chromosome 9 working draft sequence

segment

58G4
1E+06
1055972
NT_008513
1.00E−139
1
chromosome 9 working draft sequence

segment

490F10
669853
669980
NT_008653
5.00E−39
2
chromosome 10 working draft sequence

743459
744217
NT_008653

segment

463B3
1E+06
1369815
NT_008682
0
1
chromosome 10 working draft sequence

segment

116E10
1E+06
1462064
NT_008769
0
5
chromosome 10 working draft sequence

2E+06
2026887
NT_008769

segment

2E+06
2027460
NT_008769

2E+06
2028265
NT_008769

190A9
806672
807345
NT_008774
0
4
chromosome 10 working draft sequence

segment

473B7
75339
75524
NT_008783
4.00E−72
2
chromosome 10 working draft sequence

75869
76181
NT_008783

segment

490A11
484304
484753
NT_008921
0
1
chromosome 10 working draft sequence

segment

585E10
328767
329151
NT_008978
0
1
chromosome 11 working draft sequence

segment

458B9
955258
955846
NT_009073
0
1
chromosome 11 working draft sequence

segment

471F4
288811
289312
NT_009107
0
1
chromosome 11 working draft sequence

segment

478H7
1E+06
1255050
NT_009184
1.00E−92
1
chromosome 11 working draft sequence

segment

109F10
1E+06
1136705
NT_009314
1.00E−171
1
chromosome 11 working draft sequence

segment

117F1
401530
402043
NT_009334
0
2
chromosome 11 working draft sequence

2E+06
1600694
NT_009334

segment

467B6
3E+06
3011938
NT_009338
5.00E−93
2
chromosome 11 working draft sequence

segment

158H6
351515
351940
NT_009438
0
2
chromosome 12 working draft sequence

segment

471C2
977560
977791
NT_009452
1.00E−127
1
chromosome 12 working draft sequence

segment

182G2
21455
21913
NT_009458
0
3
chromosome 12 working draft sequence

167133
167630
NT_009458

segment

462B12
518389
518876
NT_009464
0
1
chromosome 12 working draft sequence

segment

458A3
2E+06
1890445
NT_009471
0
1
chromosome 12 working draft sequence

segment

470D7
9540
10050
NT_009540
0
1
chromosome 12 working draft sequence

segment

525F3
163261
163590
NT_009616
1.00E−125
1
chromosome 12 working draft sequence

segment

186E8
2E+06
1502030
NT_009714
0
1
chromosome 12 working draft sequence

segment

465G2
2E+06
1787964
NT_009759
1.00E−130
2
chromosome 12 working draft sequence

segment

476C1
321714
322118
NT_009763
1.00E−170
1
chromosome 12 working draft sequence

segment

476G8
2E+06
1609230
NT_009770
6.00E−26
1
chromosome 12 working draft sequence

segment

588E4
1E+06
1136791
NT_010036
1.00E−134
1
chromosome 14 working draft sequence

segment

479H5
2E+06
2151529
NT_010062
0
1
chromosome 14 working draft sequence

segment

178C10
6E+06
6026576
NT_010113
0
1
chromosome 14 working draft sequence

segment

192C9
5E+06
5344032
NT_010194
0
1
chromosome 15 working draft sequence

segment

119F12
3E+06
2680702
NT_010204
1.00E−128
1
chromosome 15 working draft sequence

segment

67G10
112609
112890
NT_010222
1.00E−132
2
chromosome 15 working draft sequence

segment

98C1
6684
7232
NT_010237
0
1
chromosome 15 working draft sequence

segment

458G10
478693
479052
NT_010253
1.00E−120
1
chromosome 15 working draft sequence

segment

459D1
2E+06
2123962
NT_010289
0
1
chromosome 15 working draft sequence

segment

110G1
303146
303706
NT_010308
0
1
chromosome 15 working draft sequence

segment

73A4
758542
758734
NT_010310
6.00E−42
1
chromosome 15 working draft sequence

segment

470F5
495497
496038
NT_010360
0
1
chromosome 15 working draft sequence

segment

469B6
1E+06
1095404
NT_010419
1.00E−123
1
chromosome 16 working draft sequence

segment

479E10
468259
468674
NT_010432
0
1
chromosome 16 working draft sequence

segment

100F5
177425
177795
NT_010505
1.00E−169
1
chromosome 16 working draft sequence

segment

462C5
22345
22727
NT_010523
0
1
chromosome 16 working draft sequence

segment

71H3
125549
125838
NT_010530
5.00E−77
1
chromosome 16 working draft sequence

segment

161E8
1E+06
1067677
NT_010641
1.00E−123
1
chromosome 17 working draft sequence

segment

464D9
120516
121079
NT_010657
0
1
chromosome 17 working draft sequence

segment

114G3
385825
386329
NT_010672
1.00E−152
3
chromosome 17 working draft sequence

387069
387398
NT_010672

segment

424808
425286
NT_010672

459E6
262663
263161
NT_010757
0
1
chromosome 17 working draft sequence

segment

134H3
583781
583868
NT_010799
7.00E−32
1
chromosome 17 working draft sequence

segment

467E5
1E+06
1376833
NT_010808
0
1
chromosome 17 working draft sequence

segment

462A11
436300
437040
NT_010816
0
2
chromosome 17 working draft sequence

segment

460C2
168998
169554
NT_010833
0
1
chromosome 17 working draft sequence

segment

467A8
480458
480865
NT_010986
0
1
chromosome 18 working draft sequence

segment

480F8
137902
138430
NT_011029
0
1
chromosome 18 working draft sequence

segment

470F8
472324
472740
NT_011141
0
1
chromosome 19 working draft sequence

segment

100E3
445588
445677
NT_011145
2.00E−37
2
chromosome 19 working draft sequence

445757
446041
NT_011145

segment

104A12
169627
169811
NT_011240
2.00E−99
1
chromosome 19 working draft sequence

segment

69B10
358921
359000
NT_011245
6.00E−37
1
chromosome 19 working draft sequence

segment

465C7
243467
243788
NT_011269
0
1
chromosome 19 working draft sequence

segment

464E7
1E+06
1182829
NT_011597
1.00E−107
1
chromosome X working draft sequence

segment

61A11
67055
67582
NT_011724
0
1
chromosome X working draft sequence

segment

140G10
761394
761693
NT_015805
1.00E−138
3
chromosome 2 working draft sequence

761753
762151
NT_015805

segment

486C4
503899
504524
NT_016354
0
2
chromosome 4 working draft sequence

segment

480G4
260275
260648
NT_016355
0
1
chromosome 4 working draft sequence

segment

461G8
276786
277233
NT_016593
0
1
chromosome 4 working draft sequence

segment

118D9
413201
413343
NT_016968
7.00E−46
1
chromosome 6 working draft sequence

segment

68C9
2E+06
2193260
NT_017568
1.00E−169
1
chromosome 9 working draft sequence

segment

470E5
526603
527148
NT_017582
1.00E−131
2
chromosome 9 working draft sequence

segment

127H8
248872
249411
NT_019390
0
1
chromosome 5 working draft sequence

segment

47G6
204946
205445
NT_019447
0
1
chromosome 7 working draft sequence

segment

467E8
210239
210638
NT_021889
1.00E−170
1
chromosome 1 working draft sequence

segment

480C6
210001
210545
NT_021897
0
1
chromosome 1 working draft sequence

segment

69H11
94439
94993
NT_021903
1.00E−104
1
chromosome 1 working draft sequence

segment

107D7
466791
467280
NT_021918
0
1
chromosome 1 working draft sequence

segment

471E11
418049
418124
NT_021967
8.00E−32
1
chromosome 1 working draft sequence

segment

468F11
370984
371480
NT_022103
0
1
chromosome 1 working draft sequence

segment

464H12
1E+06
1024449
NT_022171
1.00E−155
1
chromosome 2 working draft sequence

segment

462B11
242113
242753
NT_022174
0
1
chromosome 2 working draft sequence

segment

196D7
65778
66218
NT_022315
0
5
chromosome 2 working draft sequence

66514
66886
NT_022315

segment

100E10
148157
148338
NT_022358
4.00E−95
1
chromosome 2 working draft sequence

segment

142F9
193054
193433
NT_022457
0
6
chromosome 3 working draft sequence

240726
241196
NT_022457

segment

286545
287198
NT_022457

595A12
40034
40650
NT_022488
0
2
chromosome 3 working draft sequence

segment

75A2
24792
25256
NT_022555
1.00E−133
1
chromosome 3 working draft sequence

segment

468G12
276616
277068
NT_022751
0
1
chromosome 4 working draft sequence

segment

471F6
403620
404200
NT_022765
6.00E−89
1
chromosome 4 working draft sequence

segment

463H12
197991
198185
NT_022795
2.00E−88
1
chromosome 4 working draft sequence

segment

473E4
408745
409322
NT_022840
1.00E−123
2
chromosome 4 working draft sequence

segment

461C8
544633
545127
NT_022844
0
1
chromosome 4 working draft sequence

segment

470G10
148269
148781
NT_022855
0
1
chromosome 4 working draft sequence

segment

480F3
471820
472173
NT_023178
1.00E−138
1
chromosome 5 working draft sequence

segment

176G2
98388
98683
NT_023529
1.00E−153
1
chromosome 7 working draft sequence

segment

71F2
62180
62604
NT_023654
0
1
chromosome 8 working draft sequence

segment

459F2
324390
324869
NT_023660
0
1
chromosome 8 working draft sequence

segment

124F9
275971
276413
NT_023666
0
1
chromosome 8 working draft sequence

segment

111H9
388593
389283
NT_023676
0
1
chromosome 8 working draft sequence

segment

460D12
527418
527528
NT_023703
3.00E−43
1
chromosome 8 working draft sequence

segment

129D7
104058
104672
NT_023833
1.00E−170
1
chromosome 8 working draft sequence

segment

183G2
183398
183840
NT_023923
1.00E−112
1
chromosome 9 working draft sequence

segment

478G6
41677
41996
NT_023945
1.00E−137
1
chromosome 9 working draft sequence

segment

163E7
1E+06
1455953
NT_023959
1.00E−126
1
chromosome 9 working draft sequence

segment

472G12
21182
21574
NT_024016
0
1
chromosome 9 working draft sequence

segment

466B7
471195
471690
NT_024040
1.00E−138
1
chromosome 10 working draft sequence

segment

459D2
315088
315482
NT_024091
0
1
chromosome 10 working draft sequence

segment

468B10
791272
792086
NT_024101
0
2
chromosome 10 working draft sequence

segment

175D1
270651
271264
NT_024115
0
2
chromosome 10 working draft sequence

segment

472D7
16139
16549
NT_024223
0
1
chromosome 11 working draft sequence

segment

476G3
71426
71803
NT_024498
1.00E−144
1
chromosome 13 working draft sequence

segment

138B6
2E+06
1638986
NT_024680
0
2
chromosome 15 working draft sequence

segment

466A4
308514
309137
NT_024767
0
1
chromosome 16 working draft sequence

segment

583D6
551386
551654
NT_024781
1.00E−133
1
chromosome 16 working draft sequence

segment

468F10
91355
92043
NT_024815
1.00E−132
2
chromosome 16 working draft sequence

segment

461D9
406470
406916
NT_024897
0
2
chromosome 17 working draft sequence

440400
440720
NT_024897

segment

520A8
168514
168868
NT_024997
0
1
chromosome 18 working draft sequence

segment

128F5
113027
113221
NT_025378
6.00E−82
1
chromosome X working draft sequence

segment

467B11
519341
519633
NT_025635
1.00E−113
1
chromosome 1 working draft sequence

segment

464E11
8932
9161
NT_025657
1.00E−126
1
chromosome 2 working draft sequence

segment

188C1
1E+06
1221531
NT_025823
4.00E−72
1
chromosome 10 working draft sequence

segment

468B2
156035
156630
NT_025900
1.00E−150
2
chromosome 16 working draft sequence

segment

470F3
427484
428029
NT_026379
0
2
chromosome 10 working draft sequence

segment

36G1
483362
484059
NT_026443
0
1
chromosome 15 working draft sequence

segment

466B5
19929
20420
NT_026455
1 .00E−123
1
chromosome 16 working draft sequence

segment

105A8
3431
3518
U12202
6.00E−34
1
ribosomal protein S24 (rps24) gene,

complete cds Length

175D10
18139
18285
U18671
8.00E−45
2
Stat2 gene, complete cds Length = 18648

BAC956, complete sequence Length =

116F9
68889
69093
U85199
6.00E−69
1
105232

598F3
22246
22656
U91318
0
1
chromosome 16 BAC clone CIT987SK-A-

962B4, complete sequ

471G1
1
109
Z56926
9.00E−54
1
CpG island DNA genomic Mse1 fragment,

clone 153c6, forw

516D5
1
143
Z62429
4.00E−53
1
CpG island DNA genomic Mse1 fragment,

clone 69a1, forwa

107D11
81
292
Z63603
1.00E−104
1
CpG island DNA genomic Mse1 fragment,

clone 87h3, forwa

481D4
12379
12686
Z69304
1.00E−101
1
DNA sequence from cosmid V311G7,

between markers DXS366

461G6
23967
24497
Z69715
1.00E−173
2
DNA sequence from clone LL22NC03-74G7

on chromosome 22

465F5
15468
15659
Z77852
3.00E−70
1
DNA sequence from cosmid LUCA2 on

chromosome 3p21.3 con

459B2
26193
26772
Z82248
0
2
DNA sequence from clone LL22NC03-44A4

on chromosome 22

478E5
49480
49615
Z83847
6.00E−50
1
DNA sequence from clone RP3-496C20 on

chromosome 22 Con

469E6
4705
5229
Z83851
0
1
DNA sequence from clone 989H11 on

chromosome 22q13.1-13

517H5
128852
129155
Z85986
1.00E−156
1
DNA sequence from clone 108K11 on

chromosome 6p21 Conta

114C1
15995
16486
Z93016
1.00E−121
3
DNA sequence from clone RP1-211D12 on

77940
78185
Z93016

chromosome 20q12-

118A8
117801
118272
Z97989
0
2
DNA sequence from PAC 66H14 on

132708
132773
Z97989

chromosome 6q21-22. Cont

TABLE 3C

Table of novel human nucleotide sequences compared to assembled human sequences,

depicting putative exon-intron structure

Exon

Exon

Clone

Genome

Clone

Genome

Clone
Accession
Start
Stop
Start
Stop
Start
Stop
Start
Stop

47D11
NT_008060
90
407
480193
479876
406
586
478843
478662

53G7
NT_008060
4
204
478642
478842
204
459
479917
480171

62C9
NT_015169
29
224
220269
220464
321
384
220540
220603

62G9
NT_006328
1
145
566357
566213
144
219
565724
565649

65B1
NT_006098
243
454
2418134
2418345
303
462
2421648
2421807

65D10
NT_025892
218
401
369301
369483
404
541
370290
370427

65D11
NT_025892
98
241
367311
367453
240
425
369301
369486

65D12
NT_025892
98
219
367333
367453
218
399
369301
369483

72D4
NT_008060
1
198
478646
478843
197
489
479876
480168

73A7
NT_008060
1
197
478646
478842
197
538
479917
480259

75B12
NT_010265
1
171
309301
309471
169
267
315278
315376

NT_010265
587
658
319041
319112

100B5
NT_006098
16
142
556012
556138
143
336
560579
560772

105B11
NT_022315
2
226
66662
66886
429
491
89124
89186

170F9
NT_010194
4
324
6405068
6405386
323
465
6407864
6408006

144F5
NT_011595
1
280
125097
124818
345
491
120524
120378

166H7
NT_009729
59
130
537939
537668
127
281
537177
537023

NT_009729
579
672
491513
491419

171A10
NT_009151
2
244
6556227
6556469
245
396
6556693
6558846

98E1
NT_006098
12
138
556012
556138
139
328
560579
560768

134B4
NT_011512
3
251
12517461
12517709
252
338
12519881
12519967

172E5
NT_009935
5
449
1427508
1427952
448
551
1434457
1434560

176F12
NT_011520
48
309
6163505
6163766
308
409
6163866
6163967

51B9
NT_021980
75
578
120596
121099
3
79
120203
120279

51B12
NT_007140
1
85
309298
309214
79
609
300215
299684

191F6
NT_010194
7
330
6405063
6405386
329
473
6407864
6408008

459F10
NT_008982
1
121
92783
92903
116
314
93005
93202

461H12
NT_023539
19
94
332693
332768
92
166
334220
334294

463C3
NT_010478
1
186
1307774
1307960
183
314
1308993
1309124

465B3
NT_010222
41
227
700806
700992
227
414
701556
701743

513G4
NT_005130
1
134
384702
384569
133
204
383722
383651

515E10
NT_023563
1
169
9743
9575
169
309
8111
7971

466B10
NT_006292
1
331
936306
935977
244
745
935875
935374

466F9
NT_024872
17
186
64694
64525
184
295
61751
61640

121B6
NT_023169
2
98
183171
183075
258
455
164976
164779

462D1
NT_023923
139
298
191231
191072
297
528
190168
189937

64G9
NT_025892
68
210
367311
367453
209
394
369301
369486

467C6
NT_010101
1
73
1265999
1266071
218
330
1295695
1295807

NT_010101
546
687
1334907
1335047

467G9
NT_011157
69
142
917117
917044
142
253
916090
915979

476G4
NT_007592
58
121
2382380
2382443
120
362
2382598
2382840

477E1
NT_008680
1
116
1185208
1185323
116
472
1186107
1186462

477A11
NT_006292
1
325
936300
935977
238
851
935875
935262

480A3
NT_010478
1
99
2220394
2220492
181
525
2221546
2221890

518H1
NT_005337
1
73
2383056
2383128
125
229
2386650
2386754

519A9
NT_016632
64
193
172305
172434
191
279
176990
177078

521F2
NT_023563
3
107
7651
7756
110
254
7968
8111

597A4
NT_023563
1
109
7647
7755
109
256
7964
8111

491G11
NT_010265
1
127
284740
284866
123
242
288529
288648

494B11
NT_007343
25
246
3168142
3167921
244
334
3162477
3162387

479A1
NT_015169
1
109
293941
293833
112
217
289082
288977

47D11
NT_008060

53G7
NT_008060

62C9
NT_015169
449
518
220668
220737
517
774
220958
221215

62G9
NT_006328
217
315
563987
563889
315
418
563775
563672

65B1
NT_006098

65D10
NT_025892

65D11
NT_025892
423
562
370288
370427
561
690
376519
376648

65D12
NT_025892
402
541
370290
370427

72D4
NT_008060
491
585
489271
489365

73A7
NT_008060

75B12
NT_010265
264
441
316976
317153
440
588
317239
317387

NT_010265

100B5
NT_006098
331
416
561268
561353

105B11
NT_022315

170F9
NT_010194

144F5
NT_011595
279
347
123833
123765
490
559
118816
118747

166H7
NT_009729
282
362
529971
529891
363
581
495632
495414

NT_009729

171A10
NT_009151

98E1
NT_006098
330
506
561271
561447

134B4
NT_011512
336
448
12523936
12524048

172E5
NT_009935

176F12
NT_011520

51B9
NT_021980

51B12
NT_007140

191F6
NT_010194

459F10
NT_008982

461H12
NT_023539
164
298
334438
334572
300
470
335340
335510

463C3
NT_010478
315
429
1309210
1309324
427
559
1309492
1309625

465B3
NT_010222

513G4
NT_005130
202
281
378695
378616
287
346
299615
299556

515E10
NT_023563

466B10
NT_006292

466F9
NT_024872
294
626
59515
59185

121B6
NT_023169
460
576
163071
162955

462D1
NT_023923

64G9
NT_025892
392
531
370288
370427

467C6
NT_010101
330
468
1315073
1315211
467
547
1315798
1315878

NT_010101

467G9
NT_011157

476G4
NT_007592

477E1
NT_008680

477A11
NT_006292

480A3
NT_010478

518H1
NT_005337
227
366
2393104
2393243

519A9
NT_016632

521F2
NT_023563

597A4
NT_023563
258
452
9575
9771

491G11
NT_010265

494B11
NT_007343

479A1
NT_015169
218
338
285931
285811

TABLE 4

The Library Browser at the NCBI UniGene web site was used

to identify genes that are specifically expressed in

leukocyte cell populations.

Sequences before

Library
Library Name
Category
reduction
Sequences on array*

Lib. 2228
Human_leukocyte_MATCHMAKER_cDNA_Library
other/unclassified
4
3

Lib. 238
RA-MO-III (activated monocytes from RA patient)
Blood
2
1

Lib. 242
Human_peripheral_blood_(Whole)_(Steve_Elledge)
Blood
4
2

Lib. 2439
Subtracted_cDNA_libraries_from_human_Jurkat_cells
other/unclassified
4
1

Lib. 323
Activated_T-cells_I
other/unclassified
19
3

Lib. 327
Monocytes,_stimulated_II
Blood
92
35

Lib. 387
Macrophage_I
other/unclassified
84
24

Lib. 409
Activated_T-cells_IV
other/unclassified
37
10

Lib. 410
Activated_T-cells_VIII
other/unclassified
27
10

Lib. 411
Activated_T-cells_V
other/unclassified
41
9

Lib. 412
Activated_T-cells_XII
other/unclassified
29
12

Lib. 413
Activated_T-cells_XI
other/unclassified
13
6

Lib. 414
Activated_T-cells_II
other/unclassified
69
30

Lib. 429
Macrophage_II
other/unclassified
56
24

Lib. 4480
Homo_sapiens_rheumatoid_arthritis_fibroblast-like_synovial
other/unclassified
7
6

Lib. 476
Macrophage,_subtracted_(total_cDNA)
other/unclassified
11
1

Lib. 490
Activated_T-cells_III
other/unclassified
9
5

Lib. 491
Activated_T-cells_VII
other/unclassified
27
8

Lib. 492
Activated_T-cells_IX
other/unclassified
16
5

Lib. 493
Activated_T-cells_VI
other/unclassified
31
15

Lib. 494
Activated_T-cells_X
other/unclassified
18
5

Lib. 498
RA-MO-I (activated peripheral blood monocytes from RA patient)
Blood
2
1

Lib. 5009
Homo_Sapiens_cDNA_Library_from_Periph-
other/unclassified
3
3

eral_White_Blood_Cell

Lib. 6338
human_activated_B_lymphocyte
Tonsils
9
8

Lib. 6342
Human_lymphocytes
other/unclassified
2
2

Lib. 646
Human_leukocyte_(M. L. Markelov)
other/unclassified
1
1

Lib. 689
Subtracted_cDNA_library_of_activated_B_lymphocyte
Tonsil
1
1

Lib. 773
PMA-induced_HL60_cell_subtraction_library (leukemia)
other/unclassified
6
3

Lib. 1367
cDNA_Library_from_rIL-2_activated_lymphocytes
other/unclassified
3
2

Lib. 5018
Homo_sapiens_CD4+_T-cell_clone_HA1.7
other/unclassified
6
3

Lib. 376
Activated_T-cells_XX
other/unclassified
999
119

Lib. 669
NCI_CGAP_CLL1 (Lymphocyte)
Blood
353
81†

Lib. 1395
NCI_CGAP_Sub6 (germinal center b-cells)
B cells germinal
389
100†

Lib. 2217
NCI_CGAP_Sub7 (germinal center b-cells)
B cells germinal
605
200†

Lib. 289
NCI_CGAP_GCB1 (germinal center b-cells)
Tonsil
935
200†

Total

3914
939

*Redundancy of UniGene numbers between the libraries was eliminated.

†A subset of genes flagged as “Found only in this library” were taken.

TABLE 5

Nucleotide sequence databases used for analysis

Threshold of

Significance

Database
Version
Description
Location of file
Used

nr
Release
GenBank + EMBL + DDBJ + P
ftp:/ncbi.nlm.nih.gov/
Expect value

123.0
DB sequences (but no EST,
blast/nt.Z
(e) < 10⁻²⁵

STS, GSS, or HTGS

sequences). No longer “non-

redundant”.

dbEST
Apr. 10, 2001
Non-redundant Database of
ftp:/ncbi.nlm.nih.gov/
Expect value

GenBank + EMBL + DDBJ
blast/est_human.Z
(e) < 10⁻²⁵

EST Division

UniGene_unique
Build 132
One sequence selected from
ftp:/ncbi.nlm.nih.gov/
Expect value

each UniGene cluster (the
pub/shuler/unigene/
(e) < 10⁻²⁵

one with the longest region of
Hs.seq.uniq.Z

high-quality sequence data).

Human Genome
Build 22
Sequence data of all contigs
ftp:/ncbi.nlm.nih.gov/
Expect value

used to assemble the human
genomes/H_sapiens/
(e) < 10⁻²⁵

genome
CHR_#/hs_chr#.fa.gz

TABLE 6

Algorithms used for exon and polypeptide prediction

Algorithm
Description
Web address

Genscan
Predicts the locations and exon-intron
genes.mit.edu/GENSCAN.html

structures of genes in genomic

sequences.

Genomescan
Incorporates protein homology
genes.mit.edu/genomescan.html

information when predicting genes.

GrailEXP
Predicts exons, genes, promoters,
Grail.lsd.ornl.gov/grailexp/

polyAs, CpG islands, EST similarities,

and repetitive elements within a DNA

sequence.

G-Known
Predicts genes and features of a DNA
cse.ucsc.edu/research/compbio/pgf/

sequence at user-specified levels of

complexity. Can incorporate extra

information supplied by user including

gene predictions from other gene finding

programs, EST hits, similarities to

known proteins, synteny between

corresponding genomic regions in related

organisms, methylation of the bases,

regulatory binding sites, and topology

information.

FGENES
Uses linear and hidden Markov models
genomic.sanger.ac.uk/gf/gf.shtml

for exon prediction

TABLE 7

Databases and algorithms used for Protein Analysis

Algorithm
Description
Web address

BLASTP, version 2.0
Identification of unknown protein or
.ncbi.nlm.nih.gov/BLAST/

subunit based on similarity to known

proteins or subunits.

BLASTX
Algorithm for translating a nucleotide
.ncbi.nlm.nih.gov/BLAST/

query sequence and aligning the

translation to sequences in protein

databases

TBLASTN
Algorithm for aligning an unidentified
ncbi.nlm.nih.gov/BLAST/

peptide sequence to predicted

translations of nucleotide sequences

SWISS-PROT,
Protein sequence database
expasy.ch/cgi-bin/

release 39.0

sprot-search-de

Protein International
Protein sequence database
nbrf.georgetown.edu/

Resource (PIR)

pirwww/

GenPept
Amino acid translations from
ncbi.nlm.nih.gov/genbank/

GenBank/EMBL/DDBJ records that are
genpept.fsa.gz

annotated with one or more CDS features

TrEMBL
Contains the translations of all coding
ebi.ac.uk/swissprot/

sequences present in the EMBL

Nucleotide Sequence Database, which

are not yet integrated into SWISS-PROT

Prosite, release 16.39
Database of protein families and
expasy.ch/prosite/

domains. Consists of biologically

significant sites, patterns and profiles.

Pfam, version 6.2
Collection of multiple sequence
.sanger.ac.uk/Software/

alignments and hidden Markov models
Pfam/

covering many common protein domains

ProDom, version 2001.1
Domain arrangements of proteins and
protein.toulouse.inra.fr/

protein families
prodom.html

TMpred
Prediction of transmembrane regions to
ch.embnet.org/software/

aid in subcellular localization and
TMPRED_form.html

function predictions

TABLE 8

SEQ

ID
Origin
Unigene
Locus
GI
Nominal Description
Strand
Probe Sequence

1
cDNA
Hs.100001
NM_005074
4827009
solute carrier family 17 (sodium
1
AGAGCACTTGCAGAGCCTGGGACAA

T-cells

phosphate), member 1 (SLC17A1).

CCTCCTTATTGAAGGGAAGAGGGAC

2
cDNA
Hs.104157
AW968823
8158664
EST380899 cDNA/gb =
1
TGGTCTCAAAGATTTACATGGCAACA

T-cells

AW968823 direction unknown

TTCGAAAGTCCCCAGAGAAGTCCT

3
cDNA
Hs.104157
AW968823
8158664
Complement of EST380899 cDNA
−1
AGGACTTCTCTGGGGACTTTCGAATG

T-cells

/gb = AW968823 direction

TTGCCATGTAAATCTTTGAGACCA

unknown

4
literature
Hs.1051
NM_004131
7262379
granzyme B (granzyme 2,
1
AGGTGCCAGCAACTGAATAAATACCT

cytotoxic T-lymphocyte-associated

CTCCCAGTGTAAATCTGGAGCCAA

serine esterase 1) (GZMB).

5
cDNA
Hs.105230
AA489227
2218829
aa57f07.s1 cDNA, 3′ end
1
GGGTGTCTTTAAATAGCACTAGCCAA

T-cells

/clone = IMAGE:825061 strand

ATCACATATCTCCAACACTCCTTA

unknown

6
cDNA
Hs.105230
AA489227
2218829
Complement, aa57f07.s1 cDNA, 3′
−1
TAAGGAGTGTTGGAGATATGTGATTT

T-cells

end/clone = IMAGE:825061 strand

GGCTAGTGCTATTTAAAGACACCC

unknown

7
cDNA
Hs.107979
NM_014313
7657594
small membrane protein 1 (SMP1),
1
CCCACAGTGCAATTCAGAATATGCTC

T-cells

mRNA/cds = (99,

AGGGAATGCCAGCCACCTTGTAAA

8
cDNA
Hs.10888
AK025212
10437679
cDNA: FLJ21559 fis, clone
1
GCCAAGACAATAAGCTAGGCTACTGG

T-cells

COL05406/cds = UNKNOW

GTCCAGCTACTACTTTGGTGGGAT

9
cDNA
Hs.10888
AK025212
10437679
complement cDNA: FLJ21559 fis,
−1
ATCCCACCAAAGTAGTAGCTGGACCC

T-cells

clone COL06406/cds = UNKNOW

AGTAGCCTAGCTTATTGTCTTGGC

10
cDNA
Hs.1100
M55654
339491
TATA-binding protein mRNA,
1
AATTTATAACTCCTAGGGGTTATTTCT

T-cells

complete cds/cds = (241, 12

GTGCCAGACACATTCCACCTCTC

11
cDNA
Hs.11000
NM_015344
7662509
MY47_BRAIN MY047 PROTEIN
1
ACTAATTGCATTGGCAGCATTGTGTC

T-cells

TTTGACCTTGTATACTAGCTTGAC

12
cDNA
Hs.1101
NM_002698
4505958
POU domain, class 2, transcription
1
AAACCAAAAATAATCACAACAGAAAC

T-cells

factor 2 (P

CAGCTGCCCCAAAGGAACCAGAGG

13
cDNA
Hs.11238
AB014522
3327057
KIAA0622 protein; Drosophila
1
TCCCACCAGGACTTTGCTAACAATAA

T-cells

“multiple asters” (Mast)-like

TGTTTGGAAATAAAGAAGTGCTCT

homolog 1

14
cDNA
Hs.116481
NM_001782
4502682
CD72, B cell differentiation
1
TGACACTCATGCCAACAAGAACCTGT

T-cells

antigen

GCCCCTCCTTCCTAACCTGAGGCC

15
cDNA
Hs.295726
M14648
340306
cell adhesion protein (vitronectin)
1
ACAAATTTTACCCTAACAGTTTTACCA

T-cells

receptor alpha s Platelets,

CCTAGCAACAGTCATTTCTGAAA

megakaryocytes

16
cDNA
Hs.119155
AL109786
5725475
mRNA full length insert cDNA
1
TTTATTGGTACTTCCTAAAGATAGAGA

T-cells

clone EUROIMAGE 81

CTAAAGTCATGGTAGTATTGGCC

17
cDNA
Hs.119155
AL109786
5725475
Complement of mRNA full length
−1
GGCCAATACTACCATGACTTTAGTCT

T-cells

insert cDNA clone EUROIMAGE

CTATCTTTAGGAAGTACCAATAAA

82

18
cDNA
Hs.119537
NM_006559
5730026
GAP-associated tyrosine
1
CCTCCCATTTTGTTCTCGGAAGATTA

T-cells

phosphoprotein p62 (Sam88)

AATGCTACATGTGTAAGTCTGCCT

19
cDNA
Hs.121025
NM_014205
7656935
chromosome 11 open reading
1
CCGTGCCCGGAAACAGGCCGTGGCT

T-cells

frame 5 (C11ORF5), m

AGAGAAGAGCGAGATCATCTTTACC

20
literature
Hs.126256
NM_000576
10835144
interleukin 1-beta (IL1B) mRNA,
1
GGTCTAATTTATTCAAAGGGGGCAAG

monocytes, macrophages

AAGTAGCAGTGTCTGTAAAAGAGC

21
cDNA
Hs.126925
AK023275
10435137
FLJ13213 fis, clone
1
AGATGGGTGAATCAGTTGGGTTTTGT

T-cells

NT2RP4001126, weakly

AAATACTTGTATGTGGGGAAGACA

22
cDNA
Hs.1279
AK024951
10437374
FLJ21298 fis, clone COL02040,
1
TCTCTAGTTGTCACTTTCCTCTTCCAC

T-cells

highly sim

TTTGATACCATTGGGTCATTGAA

23
cDNA
Hs.129780
NM_003327
4507578
OX40 homolog, ACT35 Antigen,
1
TCAAAAGAAAGCCTTCTGGATGCTGT

T-cells

TNF receptor superfamily,

TAAGATGTACCCTTCAGGTGAACC

member 4

24
cDNA
Hs.1309
M28825
180035
thymocyte antigen CD1a mRNA
1
CCCCCTTTCCTTCTAATTTTTCAGCTC

T-cells

CTTCAATGCAAAGTACATGTATT

25
cDNA
Hs.1349
NM_000758
4503076
colony stimulating factor 2
1
CCTCCAACCCCGGAAACTTCCTGTGC

T-cells

(granulocyte-macrophage) (CSF2).

AACCCAGACTATCACCTTTGAAAG

26
cDNA
Hs.136375
BF513274
11598453
ESTs, Weakly similar to S65824
1
GGAAGGTAGTCTTCATTTGCAATCAG

T-cells

reverse transcriptase homolog

GAAAACGAACGTAAAGGCACAGGT

(3′ EST read)

27
cDNA
Hs.138375
BF513274
11598453
Complement of ESTs, Weakly
−1
ACCTGTGCCTTTACGTTCGTTTTCCT

T-cells

similar to S65824 reverse

GATTGCAAATGAAGACTACCTTCC

transcriptase homolog

(3′ EST read)

28
cDNA
Hs.137548
NM_003874
4502686
CD84 antigen (leukocyte antigen)
1
TGTTTTCCTCACTACATTGTACATGTG

T-cells

(CD84)

GGAATTACAGATAAACGGAAGCC

29
cDNA
Hs.1418
M15059
182447
Fc-epsilon receptor (IgE receptor)
1
CAGAGCAAGACCCTGAAGACCCCCA

T-cells

mRNA, complete cd

ACCACGGCCTAAAAGCCTCTTTGTG

30
cDNA
Hs.142023
NM_005816
5032140
TACT_T-CELL SURFACE
1
GCTTCATATGTATGGCTGTTGCTTTG

T-cells

PROTEIN

CTTCATGTGTATGGCTATTTGTAT

31
cDNA
Hs.1481
NM_002112
4504364
histidine decarboxylase
1
CAGATGGGTTCAGCAGTCTGGTCAGT

T-cells

(EC 4.1.1.22) (HDC).

GAGAAAGGGCCGAGGGTAGACAGG

32
cDNA
Hs.150403
NM_000790
4503260
dopa decarboxylase (aromatic
1
TCCAGGGCAATCAATGTTCACGCAAC

T-cells

L-amino acid decarboxylase)

TTGAAATTATATCTGTGGTCTTCA

33
cDNA
Hs.1513
NM_000629
10835182
interferon (alpha, beta and omega)
1
TCATCCCGAGAACATTGGCTTCCACA

T-cells

receptor 1 (IFNAR1).

TCACAGTATCTACCCTTACATGGT

34
literature
Hs.153053
NM_001774
4502662
leukocyte antigen CD37
1
CGCTCTCGATATTCCTGTGCAGAAAC

CTGGACCACGTCTACAACCGGCTC

35
cDNA
Hs.153952
X55740
23896
placental cDNA coding for
1
CCTGCTCAGCTCTGCATAAGTAATTC

T-cells

5′nucleotidase (EC 3.1.3.5)

AAGAAATGGGAGGCTTCACCTTAA

36
cDNA
Hs.155595
NM_004404
4758157
Neural precursor cell expressed,
1
GGAGGACCCACACTGCTACACTTCTG

T-cells

developmentally down-regulated 5

ATCCCCTTTGGTTTTACTACCCAA

37
cDNA
Hs.1570
Z34897
510295
H1 histamine receptor
1
GAAGAACAGCAGATGGCGGTGATCA

T-cells

GCAGAGAGATTGAACTTTGAGGAGG

38
cDNA
Hs.159557
AK024833
10437239
FLJ21180 fis, clone CAS11176,
1
GGAATTTCCTATCTTGCAGCATCCTG

T-cells

highly sim

TAAATAAACATTCAAGTCCACCCT

39
cDNA
Hs.160417
NM_013390
7019554
transmembrane protein 2
1
CCTCAAAGTGCTACCGATAAACCTTT

T-cells

(TMEM2), mRNA/cds = (14

CTAATTGTAAGTGCCCTTACTAAG

40
cDNA
Hs.16488
BC007911
14043948
calreticulin
1
AGTGGGTCCCAGATTGGCTCACACT

T-cells

GAGAATGTAAGAACTACAAACAAAA

41
cDNA
Hs.166120
NM_004031
4809287
interferon regulatory factor 7
1
CTGTCCAGCGCCAACAGCCTCTATGA

T-cells

(IRF7), transc

CGACATCGAGTGCTTCCTTATGGA

42
cDNA
Hs.166975
NM_006925
5902077
splicing factor, arginine/serine-rich
1
AAATTCTGGTAAGTATGTGCTTTTCTG

T-cells

5 (SFR

TGGGGGTGGGATTTGGAAGGGGG

43
literature
Hs.167988
S71824
632775
N-CAM = 145 kda neural cell
1
ATGGGTGAAGAGAACCGAGCAAAGA

adhesion molecule

TCAAAATAAAAAGTGACACAGCAGC

44
cDNA
Hs.168103
AF026402
2655201
U5 snRNP 100 kD protein mRNA,
1
GCTGTGTCCATCTTTGTCACTGAGTG

T-cells

cds/cds = (39, 2501

AAATCTCTGTTTTCTATTCTCTGA

45
cDNA
Hs.168132
U14407
540098
interleukin 15 (IL15) mRNA
1
ATGTGCTGTCAAAACAAGTTTTTCTGT

T-cells

CAAGAAGATGATCAGACCTTGGA

46
literature
Hs.168383
NM_000201
4557877
intercellular adhesion molecule 1
1
CAGTGATCAGGGTCCTGCAAGCAGT

(CD54), rhinovirus receptor

GGGGAAGGGGGCCAAGGTATTGGAG

(ICAM1).

47
cDNA
Hs.169191
U58913
4204907
chemokine (hmrp-2a) mRNA,
1
TGGACACACGGATCAAGACCAGGAA

T-cells

complete cds/cds = (71, 484)

GAATTGAACTTGTCAAGGTGAAGGG

48
literature
Hs.169610
AJ251595
6491738
transmembrane glycoprotein
1
AACAGACCCCCTCTAGAAATTTTTCA

(CD44 gene).

GATGCTTCTGGGAGACACCAAAGG

49
cDNA
Hs.170311
D89678
3218539
50 for A + U-rich element RNA
1
GTCAGTAGGTGCGGTGTCTAGGGTA

T-cells

binding factor.

GTGAATCCTGTAAGTTCAAATTTAT

50
cDNA
Hs.170311
D89678
3218539
60 for A + U-rich element RNA
1
AGTTGTGTGGTCAGTAGGTGCGGTG

T-cells

binding factor.

TCTAGGGTAGTGAATCCTGTAAGTTC

AAATTTATG

51
cDNA
Hs.170311
D89678
3218539
70 for A + U-rich element RNA
1
TTTAAGTTGTGTGGTCAGTAGGTGCG

T-cells

binding factor.

GTGTCTAGGGTAGTGAATCCTGTAAG

TTCAAATTTATGATTAGG

52
cDNA
Hs.171763
X59350
36090
mRNA for B cell membrane
1
GTTTGAGATGGACACACTGGTGTGGA

T-cells

protein CD22

TTAACCTGCCAGGGAGACAGAGCT

53
cDNA
Hs.171917
AB037855
7243265
mRNA for KIAA1434 protein,
1
TTGTGACTCTGAATCCCATGTTCTCA

T-cells

partial cds

AACTACGCTGCCTTCCGAAGTCTG

54
cDNA
Hs.172089
AL110202
5817121
cDNA DKFZp586I2022 (from
1
TTTAAGTACTAAGTCATCATTTGCCTT

T-cells

clone DKFZp586I

GAAAGTTTCCTCTGCATTGGGTT

55
cDNA
Hs.172089
AL110202
5817121
Complement of cDNA
−1
AACCCAATGCAGAGGAAACTTTCAAG

T-cells

DKFZp586I2022 (from clone

GCAAATGATGACTTAGTACTTAAA

DKFZp586I

56
literature
Hs.1722
M28983
186279
50 interleukin 1 alpha (IL 1)
1
TACCTGGGCATTCTTGTTTCATTCAAT

mRNA, macrophages

TCCACCTGCAATCAAGTCCTACA

57
literature
Hs.1722
M28983
186279
60 interleukin 1 alpha (IL 1)
1
CCATTAAACTTACCTGGGCATTCTTG

mRNA, macrophages

TTTCATTCAATTCCACCTGCAATCAAG

TCCTACA

58
literature
Hs.1722
M28983
186279
70 interleukin 1 alpha (IL 1)
1
CACCTGCAATCAAGTCCTACAAGCTA

mRNA, macrophages

AAATTAGATGAACTCAACTTTGACAA

CCATGAGACCACTGTTAT

59
literature
Hs.1724
X01057
33812
50 mRNA for interleukin-2
1
AATGCGTACGTTTCCTGAGAAGTGTC

receptor

TAAAAACACCAAAAAGGGATCCGT

60
literature
Hs.1724
X01057
33812
60 mRNA for interleukin-2
1
ACGTTTCCTGAGAAGTGTCTAAAAAC

receptor

ACCAAAAAGGGATCCGTACATTCAAT

GTTTATGC

61
literature
Hs.1724
X01057
33812
70 mRNA for interleukin-2
1
CAAATCAATGCGTACGTTTCCTGAGA

receptor

AGTGTCTAAAAACACCAAAAAGGGAT

CCGTACATTCAATGTTTA

62
cDNA
Hs.172631
J04145
189068
neutrophil adherence receptor
1
CTCCGGGAGAGGGGACGGTCAATCC

T-cells

alpha-M subunit mRNA

TGTGGGTGAAGACAGAGGGAAACAC

63
cDNA
Hs.305870
NM_003781
14043025
vesicle-associated membrane
1
GGCTGGGAAACTGTTGGTGGCCAGT

T-cells

protein 8 (endob

GGGTAATAAAGACCTTTCAGTATCC

64
cDNA
Hs.172791
NM_004182
4759297
ubiquitously-expressed transcript
1
TGCTAGAGGGGCTTAGAGAACTACAA

T-cells

(UXT), mR

GGCCTGCAGAATTTCCCAGAGAAG

65
literature
Hs.173894
NM_000757
4503074
macrophage-specific colony-
1
CTGACTCAGGATGACAGACAGGTGG

stimulating factor (CSF-1)

AACTGCCAGTGTAGAGGGAATTCTA

66
cDNA
Hs.174103
NM_002209
4504756
integrin, alpha L (CD11A (p180),
1
GTAAAGGCTATACTTGTCTTGTTCAC

T-cells

lymphocyte function-associated

CTTGGGATGACGCCGCATGATATG

antigen 1; alpha polypeptide)

67
cDNA
Hs.174142
X03663
29899
c-fms proto-oncogene Monocytes
1
CAAGCAGGAAGCACAAACTCCCCCA

T-cells

AGCTGACTCATCCTAACTAACAGTC

68
cDNA
Hs.169610
AA156937
1728552
zl19c02.s1
1
TCTTCAACAGACCCCCTCTAGAAATT

T-cells

Soares_pregnant_uterus_NbHPU

TTTCAGATGCTTCTGGGAGACACC

69
cDNA
Hs.17483
NM_000616
10835168
CD4 antigen (p55) (CD4).
1
GTCCTCCACGCCATTTCCTTTTCCTT

T-cells

CAAGCCTAGCCCTTCTCTCATTAT

70
cDNA
Hs.177559
U05875
463549
clone pSK1 interferon gamma
1
GGCCCTTCATGTACATCCATGGTGTG

T-cells

receptor accessory factor

CTGGCTTAAAATGTAATTAATCTT

71
cDNA
Hs.179526
S73591
688296
brain-expressed HHCPA78
1
AAGATGCCCAACCCTGTGATCAGAAC

T-cells

homolog VDUP1 (Gene)

CTCCAAATACTGCCATGAGAAACT

72
cDNA
Hs.1799
J04142
619799
(lambda-gt11ht-5) MHC class I
1
CAGGAGTTTGTGTGTCTTTTATAAAAA

T-cells

antigen-like gl

GTTTGCCCTGGATGTCATATTGG

73
cDNA
Hs.180804
AK000271
7020240
cDNA FLJ20264 fis, clone
1
CCCTGAGTGACAGTCACGACAGAAC

T-cells

COLF7912/cds = UNKNOWN

AAAACCACAAGACCAGACCACATTT

74
cDNA
Hs.180866
NM_000416
4557879
interferon gamma receptor 1
1
CCTTTACATCCAGATAGGTTACCAGT

T-cells

(IFNGR1).

AACGGAACATATCCAGTACTCCTG

75
cDNA
Hs.181165
AK026650
10439548
FLJ22997 fis, clone KAT11962,
1
TGCATCGTAAAACCTTCAGAAGGAAA

T-cells

highly sim

GGAGAATGTTTTGTGGACCACTTT

76
cDNA
Hs.181357
NM_002295
9845501
laminin receptor 1 (67 kD,
1
GGCCACTGAATGGGTAGGAGCAACC

T-cells

ribosomal protein SA

ACTGACTGGTCTTAAGCTGTTCTTG

77
cDNA
Hs.187660
NM_014504
7657495
Major histocompatibility complex,
1
TGTAGGGTAAATGTGACTGGAATACA

T-cells

class I, E (HLA-E)

CCTTTGGAACGGAATTCTTTATCA

78
cDNA
Hs.182740
NM_001015
14277698
ribosomal protein S11 (RPS11),
1
AGGCTGGACATCGGCCCGCTCCCCA

T-cells

mRNA/cds = (15, 4

CAATGAAATAAAGTTATTTTCTCAT

79
cDNA
Hs.187660
NM_014504
7657495
putative Rab5 GDP/GTP exchange
1
TGTAGGGTAAATGTGACTGGAATACA

T-cells

factor homologu

CCTTTGGAACGGAATTCTTTATCA

80
cDNA
Hs.197345
NM_001469
4503840
thyroid autoantigen 70 kD
1
GTTGCCATGGTGATGGTGTAGCCCTC

T-cells

(Ku antigen) (G22P1).

CCACTTTGCTGTTCCTTACTTTAC

81
cDNA
Hs.198253
M33906
184194
MHC class II HLA-DQA1 mRNA,
1
CCACCCACCCCTCAATTAAGGCAACA

T-cells

complete cds/cds = (43, 810)

ATGAAGTTAATGGATACCCTCTGC

82
cDNA
Hs.197345
NM_001469
4503840
thyroid autoantigen 70 kD
1
GTTGCCATGGTGATGGTGTAGCCCTC

T-cells

(Ku antigen) (G22P1).

CCACTTTGCTGTTCCTTACTTTAC

83
cDNA
Hs.198253
M33906
184194
MHC class II HLA-DQA1 mRNA,
1
CCACCCACCCCTCAATTAAGGCAACA

T-cells

complete cds/cds = (43, 810)

ATGAAGTTAATGGATACCCTCTGC

84
cDNA
Hs.1987
NM_006139
5453610
CD28 antigen (Tp44) (CD28)
1
GCTCACCTATTTGGGTTAAGCATGCC

T-cells

AATTTAAAGAGACCAAGTGTATGT

85
cDNA
Hs.336769
NM_002074
11321584
guanine nucleotide binding protein
1
TCCACCTTTTGTATTTAATTTTAAAGT

T-cells

(G protein)

CAGTGTACTGCAAGGAAGCTGGA

86
cDNA
Hs.211576
L10717
307507
T cell-specific tyrosine kinase
1
CCCTATCCCGCAAAATGGGCTTCCTG

T-cells

mRNA, complete

CCTGGGTTTTTCTCTTCTCACATT

87
cDNA
Hs.336769
NM_002074
11321584
guanine nucleotide binding protein
1
TCCACCTTTTGTATTTAATTTTAAAGT

T-cells

(G protein)

CAGTGTACTGCAAGGAAGCTGGA

88
cDNA
Hs.2188
AF119850
7770136
PRO1608 mRNA, complete cds
1
AGATCTTCAAGTGAACATCTCTTGCC

T-cells

/cds = (1221, 2174)/

ATCACCTAGCTGCCTGCACCTGCC

89
cDNA
Hs.21907
NM_007067
5901961
histone acetyltransferase (HBOA),
1
GCTAATTTTAAGCATGTTCAGTGGCA

T-cells

mRNA/cds =

GCTCCCCTCCAGTTTCAGTGTCAC

90
cDNA
Hs.2200
NM_005041
4826941
Perforin 1 (pore forming protein;
1
CCTGTGATCAGGCTCCCAAGTCTGGT

T-cells

PRF1)

TCCCATGAGGTGAGATGCAACCTG

91
cDNA
Hs.2233
NM_000759
4503078
granulocyte colony-stimulating
1
ACATGGTTTGACTCCCGAACATCACC

T-cells

factor 3 (CFS3)

GACGTGTCTCCTGTTTTTCTGGGT

92
cDNA
Hs.2236
Z29067
479172
NEK3_SERINE/THREONINE-
1
TCAGAGCTGAAGAAGCGAGCTGGAT

T-cells

PROTEIN KINASE NEK3

GGCAAGGCCTGTGCGACAGATAATG

93
cDNA
Hs.233938
NM_006471
5453739
myosin, light polypeptide,
1
TCAGCCATTTTGGGCATATGTATCTTT

T-cells

regulatory, non-s

ATAATCAGACTGGAAACGGGACT

94
cDNA
Hs.236449
NM_024898
13376352
cDNA: FLJ22757 fis, clone
1
ATCCTGGCAACCTTACAATTCCTCTC

T-cells

KAIA0803/cds = (92, 24

GGCATTTGTCACTTCCATCTCAGC

95
cDNA
Hs.238848
NM_003999
4557039
oncostatin-M specific receptor beta
1
AGCTTACTACAGTGAAAGAATGGGAT

T-cells

subunit (OSMRB)

TGGCAAGTAACTTCTGACTTACTG

96
cDNA
Hs.238707
NM_024901
13378358
cDNA: FLJ22457 fis, clone
1
ATTATAACATCTTCAACACAGAACACA

T-cells

HRC09925/cds = (56, 14

CTTTGTGGTCGAAAGGCTCAGCC

97
cDNA
Hs.239138
NM_005746
5031976
pre-B-cell colony-enhancing factor
1
TGTCAGAGATTGCCTGTGGCTCTAAT

T-cells

(PBEF), m

ATGCACCTCAAGATTTTAAGGAGA

98
cDNA
Hs.239189
NM_014905
7662327
glutaminase (GLS).
1
TGTCTGGCAGGGACTGAATGACCTG

T-cells

ATGTCAGATTTAGATTCTTCCTGGG

99
cDNA
Hs.241392
NM_002985
4506848
small inducible cytokine A5
1
GGGAGGAACACTGCACTCTTAAGCTT

T-cells

(RANTES) (SCYA5).

CCGCCGTCTCAACCCCTCACAGGA

100
cDNA
Hs.241587
NM_016838
8400721
RNA binding motif, single
1
ATGAAGAAGGGTGTGAAGGCTGAAC

T-cells

stranded interacting

AATCATGGATTTTTCTGATCAATTG

101
cDNA
Hs.241570
NM_000594
10835154
Tumor necrosis factor (TNF
1
GCCTCTGCTCCCCAGGGAGTTGTGT

T-cells

superfamily, member 2

CTGTAATCGGCCTACTATTCAGTGG

102
cDNA
Hs.247885
NM_022304
13435404
Histamine receptor H2 (HRH2)
1
GGATGCTACTGATGGGAATGATTAAG

T-cells

GGAGCTGCTGTTTAGGTGGTGCTG

103
cDNA
Hs.248156
NM_020530
10092620
oncostatin M (OSM).
1
TCAGGAACAACATCTACTGCATGGCC

T-cells

CAGCTGCTGGACAACTCAGACACG

104
cDNA
Hs.298469
NM_000789
4503272
dipeptidyl carboxypeptidase 1
1
CTTACATCAGGTACTTTGTCAGCTTC

T-cells

(angiotensin I converting enzyme)

ATCATCCAGTTCCAGTTCCACGAG

(ACE)

105
cDNA
Hs.336780
NM_006088
5174734
tubulin, beta, 2 (TUBB2), mRNA
1
CATCCAGGAGCTGTTCAAGCGCATCT

T-cells

CCGAGCAGTTCACGGCCATGTTCC

106
cDNA
Hs.252723
NM_000981
4506608
ribosomal protein L19 (RPL19),
1
ACCTCCCACTTTGTCTGTACATACTG

T-cells

mRNA/cds = (28, 6

GCCTCTGTGATTACATAGATCAGC

107
cDNA
NA
X53795
35832
R2 mRNA for an inducible
1
GTCTTTGAGAATATGATGTCAGACAT

T-cells

membrane protein/cds = (156, 95

TTTCGGATGGGCTGTTTAGATGTT

108
literature
Hs.25648
NM_001250
4507580
Tumor necrosis factor receptor
1
GGTCACCCAGGAGGATGGCAAAGAG

superfamily, member 5

AGTCGCATCTCAGTGCAGGAGAGAC

109
cDNA
Hs.258503
AF160973
5816319
P53 inducible protein
1
AGACCCTTATCTGGAGGAGGAAGAG

T-cells

AAGCAGGAGAGAGAAAGCCACAGCC

110
cDNA
Hs.265829
NM_002204
4504748
integrin, alpha 3 (antigen
1
GGCTGTGTCCTAAGGCCCATTTGAGA

T-cells

CD49C, alpha 3 subunit of

AGCTGAGGCTAGTTCCAAAAACCT

VLA-3 receptor) (ITGA3).

111
cDNA
Hs.271387
Y18645
2916795
for monocyte chemotactic
1
GTGCTCCTGTAAGTCAAATGTGTGCT

T-cells

protein-2/cds =

TTGTACTGCTGTTGTTGAAATTGA

112
cDNA
Hs.272493
NM_004167
14602450
small inducible cytokine subfamily
1
CAGAGACATAAAGAGAAGATGC

T-cells

A (Cys—Cys

CAAGGCCCCCTCCTCCACCCACC

GCTAA

113
cDNA
Hs.176683
NM_000570
10835138
Fc fragment of IgG, low affinity
1
ATGGGAGTAATAAGAGCAGTGGCAG

T-cells

IIIb, receptor for (CD16)

CAGCATCTCTGAACATTTCTCTGGA

(FCGR38).

114
literature
Hs.278443
NM_004001
4557021
Fc fragment of IgG, low affinity
1
CCACTAATCCTGATGAGGCTGACAAA

IIb, receptor for (CD32)

GTTGGGGCTGAGAACACAATCACC

(FCGR2B).

115
cDNA
Hs.62954
J04755
182512
ferritin H processed pseudogene,
1
TGTTGGGGTTTCCTTTACCTTTTCTAT

T-cells

complete cds/cds = UN

AAGTTGTACCAAAACATCCACTT

116
cDNA
Hs.279581
AK000575
7020763
FLJ20588 fis, clone REC00775
1
CAGAGTAGGCATCTGGGCACCAAGA

T-cells

/cds = (6, 422)

CCTTCCCTCAACAGAGGACACTGAG

117
cDNA
Hs.279930
V00522
32122
encoding major histocompatibility
1
CTTTGCCTAAACCCTATGGCCTCCTG

T-cells

complex gene

TGCATCTGTACTCACCCTGTACCA

118
cDNA
Hs.181357
NM_002295
9845501
Laminin receptor 1 (67 kD,
1
GGCCACTGAATGGGTAGGAGCAACC

T-cells

ribosomal protein SA)

ACTGACTGGTCTTAAGCTGTTCTTG

119
cDNA
Hs.283722
NM_020151
9910251
GTT1 protein (GTT1), mRNA
1
TGATTCTGCACTTGGGGTCTGTCTGT

T-cells

/cds = (553, 1440)/gb

ACAGTTACTCATGTCATTGTAATG

120
cDNA
Hs.78961
NM_014110
13899255
PRO2047 protein (PRO2047),
1
TGTGTAATAGGCCTTTTCATGCTTTAT

T-cells

mRNA/cds = (798, 988

GTGTAGCTTTTTACCTGTAACCT

121
cDNA
Hs.334853
NM_006013
5174430
cDNA DKFZp762B195 (from
1
AAGTTATCATGTCCATCCGCACCAAG

T-cells

clone DKFZp762B195)

CTGCAGAACAAGGAGCATGTGATT

122
cDNA
Hs.334853
NM_006013
5174430
Complement cDNA
−1
AAGTTATCATGTCCATCCGCACCAAG

T-cells

DKFZp762B195 (from clone

CTGCAGAACAAGGAGCATGTGATT

DKFZp762B195)

123
cDNA
Hs.284283
U90552
2082705
butyrophilin (BTF5) mRNA,
1
TGGTGGATGTTAAACCAATATTCCTTT

T-cells

complete cds/cds = (359, 190

CAACTGCTGCCTGCTAGGGAAAA

124
cDNA
Hs.286212
AK021791
10433048
cDNA FLJ11729 fis, clone
1
TGAACTTGCTGAATGTAAGGCAGGCT

T-cells

HEMBA1005394, modera

ACTATGCGTTATAATCTAATCACA

125
cDNA
Hs.287369
NM_020525
10092624
50 interleukin 22 (IL22), mRNA
1
ATTTGACCAGAGCAAAGCTGAAAAAT

T-cells

/cds = (71, 610)/gb

GAATAACTAACCCCCTTTCCCTGC

126
cDNA
Hs.287369
NM_020525
10092624
60 interleukin 22 (IL22), mRNA
1
GCAATTGGAGAACTGGATTTGCTGTT

T-cells

/cds = (71, 610)/gb

TATGTCTCTGAGAAATGCCTGCATTT

GACCAGAG

127
cDNA
Hs.287369
NM_020525
10092624
70 interleukin 22 (IL22), mRNA
1
TTTGACCAGAGCAAAGCTGAAAAATG

T-cells

/cds = (71, 610)/gb

AATAACTAACCCCCTTTCCCTGCTAG

AAATAACAATTAGATGCC

128
cDNA
Hs.288061
NM_001101
5016088
actin, beta (ACTB).
1
CCCTTTTTGTCCCCCAACTTGAGATG

T-cells

TATGAAGGCTTTTGGTCTCCCTGG

129
cDNA
Hs.315054
NM_032921
14249707
hypothetical protein MGC15875
1
ATTAGACCAGACCAGTGTATTTCTAA

T-cells

(MGC15875).

AGAAAATCCTGACATGCACACCCA

130
cDNA
Hs.289088
NM_005348
13129149
heat shock 90 kD protein 1,
1
GACCCTACTGCTGATGATACCAGTGC

T-cells

alpha (HSPCA).

TGCTGTAACTGAAGAAATGCCACC

131
cDNA
Hs.29052
AK000196
7020122
FLJ20189 fis, clone COLF0657
1
ACAGGCAAAGTGACAGGGGAAAAGG

T-cells

/cds = (122, 84

AATTAGTCTAAGAGTAAGGGGATGA

132
cDNA
Hs.291129
AA837754
2912953
oe10d02.s1 cDNA
1
CTTTCCTCTTGCTGCTGGGGCCTAGG

T-cells

/clone = IMAGE:

TCTTCTTGCTGCTGCTTCCTTTTC

1385475/gb = AA

133
cDNA
Hs.292590
O59502
960608
HUM041H11A cDNA, 3′ end
1
AGAGTTTTTGTTGGTAGACTGGAGCT

T-cells

/clone = GEN-041H11/cl

GGGATGTTGAATCAACCTCAGGCA

134
cDNA
Hs.292590
D59502
960608
Complement HUM041H11A
−1
TGCCTGAGGTTGATTCAACATCCCAG

T-cells

cDNA, 3′ end/clone =

CTCCAGTCTACCAACAAAAACTCT

GEN-041H11/cl

135
cDNA
Hs.99858
X61923
36646
Ribosomal protein L7a Gene with
1
CTGACGATCAGCTTGGAACAGCCAAA

T-cells

exons/introns

CAGAATTAACGCAACTAATAACCT

136
cDNA
Hs.323483
AL050141
4884352
cDNA DKFZp586O031 (from
1
TCCTTTTATGCATTGGAGGAAAAACA

T-cells

clone DKFZp586O0

TGTTGGCTTTTCTCTTGACGTGGG

137
cDNA
Hs.323463
AL050141
4884352
Complement cDNA
−1
CCCACGTCAAGAGAAAAGCCAACATG

T-cells

DKFZp586O031 (from clone

TTTTTCCTCCAATGCATAAAAGGA

DKFZp586O1

138
cDNA
Hs.323822
AB046771
10047166
for KIAA1551 protein, partial
1
CTCAGGAAACCCGACAGAAGAAA

T-cells

cds/cds = (0

CATGTAACACAGAACTCACGTCC

ACTA

139
cDNA
NA
AF347015
13273284
Mitochondial DNA, chyochrome B
1
ACTCGAGACGTAAATTATGGCTGAAT

T-cells

gene

CATCCGCTACCTTCACGCCAATGG

140
cDNA
Hs.30035
U61267
1418285
putative splice factor
1
TGCTGTTTTCATTCTGCATTTGTGTAG

T-cells

transformer2-beta mRN

TTTGGTGCTTTGTTCCAAGTTAA

141
cDNA
Hs.30909
NM_019081
11464998
KIAA0430 gene product
1
AAAAATGACAAAAGTTATCACCAAAA

T-cells

(KIAA0430), mRNA/cds = (

CCCCCTTTCCCATCTTGCACTGTT

142
cDNA
Hs.3195
NM_002995
4506852
sapiens small inducible cytokine
1
AGCTTTTAATGCTCCAAATGCTGACC

T-cells

subfamily C, member 1

CATGCAATATTTCCTCATGTGATC

(lymphotactin) (SCYC1).

143
cDNA
Hs.322645
AL050376
4914609
mRNA; cDNA DKFZp586J101
1
AAAAGAAATGCAGGTTTATTATCCAG

T-cells

(from clone DKFZp586J1

CACTGAGAGAGTTAACAAGGACTG

144
cDNA
Hs.324481
AL050376
4914609
Complement mRNA; cDNA
−1
AGAGAGACTTCTCATTGGCTGTGAAG

T-cells

DKFZp586J101 (from clone

GTAGAGCTTTTGGGGAAATTCCTG

DKFZp586J2

145
cDNA
Hs.324481
AW968541
8158382
Complement EST380617 cDNA
−1
CAGGAATTTCCCCAAAAGCTCTACCT

T-cells

/gb = AW968541 unknown

TCACAGCCAATGAGAAGTCTCTCT

coding strand

146
cDNA
Hs.324481
AW968541
8158382
EST380617 cDNA/gb =
1
AGAGAGACTTCTCATTGGCTGTGAAG

T-cells

AW968541 unknown coding strand

GTAGAGCTTTTGGGGAAATTCCTG

147
cDNA
Hs.327
NM_001558
4504632
interleukin-10 receptor mRNA,
1
CATCTCAGCCCTGCCTTTCTCTGGAG

T-cells

complete IL10RA

CATTCTGAAAACAGATATTCTGGC

148
cDNA
Hs.32970
NM_003037
4506968
signaling lymphocytic activation
1
TCATGATAACCTGCAGACCTGATCAA

T-cells

molecule (S

GCCTCTGTGCCTCAGTTTCTCTCT

149
literature
Hs.334687
NM_000569
12056966
Fc fragment of IgG, low affinity
1
ATGGGGGTAATAAGAGCAGTAGCAG

IIIa, receptor for (CD18)

CAGCATCTCTGAACATTTCTCTGGA

(FCGR3A)

150
cDNA
Hs.303649
M26683
184641
interferon gamma treatment
1
GAAATTGCTTTTCCTCTTGAACCACA

T-cells

inducible mRNA Monocytes

GTTCTACCCCTGGGATGTTTTGAG

151
cDNA
Hs.105938
X53961
34415
lactoferrin/cds = (294, 2429)
1
AATTCCTCAGGAAGTAAAACCGAAGA

T-cells

Neutrophils

AGATGGCCCAGCTCCCCAAGAAAG

152
cDNA
Hs.38
D12614
219911
lymphotoxin (TNF-beta), complete
1
AACATCCAAGGAGAAACAGAGACAG

T-cells

cds T-cells, B-cells

GCCCAAGAGATGAAGAGTGAGAGGG

153
cDNA
Hs.278870
AB034205
6899845
Acid-inducible phosphoprotein
1
TCGTGTGAATCAGACTAAGTGGGATT

T-cells

TCATTTTTACAACTCTGCTCTACT

154
cDNA
Hs.3886
NM_002267
4504898
karyopherin alpha 3 (importin
1
GCATATACAAGTTGGAAGACTAAAGA

T-cells

alpha 4) (KPNA3)

GGTGCAATGTGATCTGAGCCTCCA

155
cDNA
Hs.394
NM_001124
4501944
adrenomedullin (ADM).
1
TGAGTGTGTTTGTGTGCATGAAAGAG

T-cells

AAAGACTGATTACCTCCTGTGTGG

156
literature
Hs.40034
NM_000885
6006032
integrin, alpha 4 (antigen
1
AGCTGTTCCCAAATTTTCTAACGAGT

CD49D, alpha 4 subunit of VLA-4

GGACCATTATCACTTTAAAGCCCT

receptor) (ITGA4)

157
cDNA
Hs.41724
NM_002190
4504650
interleukin 17 (cytotoxic
1
ATCAACAGACCAACATTTTTCTCTTCC

T-cells

T-lymphocyte-associated serine

TCAAGCAACACTCCTAGGGCCTG

esterase 8)

158
cDNA
Hs.44163
NM_018838
10092656
13 kDa differentiation-associated
1
TATGACTGATGATCCTCCAACAACAA

T-cells

protein (L

AACCACTTACTGCTCGTAAATTCA

159
cDNA
Hs.44926
X60708
35335
pcHDP7 mRNA for liver
1
AAAATACTGATGTTCCTAGTGAAAGA

T-cells

dipeptidyl peptidase IV/cds = (75

GGCAGCTTGAAACTGAGATGTGAA

160
literature
Hs.46
D10202
219975
for platelet-activating factor
1
GGAAGACTTTAAACCACCTAGTTCTC

receptor.

CCACTGGGGCATCGGTCTAAAGCT

161
cDNA
Hs.48433
NM_014345
7657183
endocrine regulator
1
CCCTGTTCCACAAACCCATATGTATC

T-cells

(HRIHFB2436), mRNA/cds =

CTTTCCTCAACCTCCTCCTTTCCC

162
cDNA
Hs.50002
AB000887
2189952
for EBI1-ligand chemokine,
1
GTGTGTGAGTGTGAGTGTGAGCGAG

T-cells

complete cds

AGGGTGAGTGTGGTCAGAGTAAAGC

163
cDNA
Hs.50404
U86358
2388626
chemokine (TECK) mRNA,
1
TCTGGTCATTCAAGGATCCCCTCCCA

T-cells

complete cds/cds = (0, 452)/gb

AGGCTATGCTTTTCTATAACTTTT

164
cDNA
Hs.50984
NM_001712
4502404
carcinoembryonic antigen-related
1
GGCAGCTCAGGACCACTCCAATGAC

T-cells

cell adhesion molecule 1

CCACCTAACAAGATGAATGAAGTTA

(CEACAM1)

165
cDNA
Hs.301921
NM_001295
4502630
chemokine (C—C motif)
1
TGTTCTTCATCTAAGCCTTCTGGTTTT

T-cells

receptor 1 (CCR1).

ATGGGTCAGAGTTCCGACTGCCA

166
cDNA
Hs.54457
NM_004358
4757943
CD81 antigen (target of
1
GCCTTCATGCACCTGTCCTTTCTAAC

T-cells

antiproliferative antibody 1)

ACGTCGCCTTCAACTGTAATCACA

167
cDNA
Hs.54460
U46573
1280140
eotaxin precursor mRNA, complete
1
CCCTCTCCTCTCTTCCTCCCTGGAAT

T-cells

cds/cds = (53, 346)/

CTTGTAAAGGTCCTGGCAAAGATG

168
cDNA
Hs.54609
NM_014291
7857117
glycine C-acetyltransferase
1
CTGGGCTGGGACGTGACCTGTGCTG

T-cells

(2-amino-3-keto

AGGGCTGTGAGAATGTGAAACAACA

169
cDNA
Hs.55921
NM_004446
4758293
glutamyl-prolyl-tRNA synthetase
1
GGGATGAACGAAAGCCCCCTCTTCAA

T-cells

(EPRS), mRN

CTCCTCTCACTTTTTAAAGCATTG

170
cDNA
Hs.57987
NM_022898
12597634
B-cell lymphoma/leukaemia 11B
1
ACAATGTTGAGTTCAGCATGTGTCTG

T-cells

(BCL11B), mRNA

CCATTTCATTTGTACGCTTGTTCA

171
cDNA
Hs.59403
NM_004863
4758667
serine palmitoyltransferase, long
1
TTTCAGTCCCAGAACCTACAGATACC

T-cells

chain base subunit 2 (SPTLC2)

CTGCTACTTGCTTCACGTGGATGC

172
cDNA
Hs.5985
NM_020240
9910377
non-kinase Cdc42 effector protein
1
AATTCAGTTAGCTCCATTCAGAACCA

T-cells

SPEC2 (LOC56990).

AATGCAGTCCAAGGGAGGTTATGG

173
cDNA
Hs.6179
BG929114
14323837
Does not hit the NM_numbers two
1
CCCATCTTACAGAAGTTGAGGCCAAG

T-cells

splice variants. Direction unknown

GGAGAATGGTAGGCACAGAAGAAA

174
cDNA
Hs.62192
J02931
339501
placental tissue factor
1
TGTGTTAAGTGCAGGAGACATTGGTA

T-cells

(two forms) mRNA, complete cd

TTCTGGGCACCTTCCTAATATGCT

175
cDNA
Hs.62192
NM_001993
10518499
coagulation factor III
1
TGTGTTAAGTGCAGGAGACATTGGTA

T-cells

(thromboplastin, tissue factor)

TTCTGGGCAGCTTCCTAATATGCT

(F3), mRNA.

176
literature
Hs.624
NM_000584
10834977
interleukin 8 (IL8).
1
AGCTGTGTTGGTAGTGCTGTGTTGAA

TTACGGAATAATGAGTTAGAACTA

177
literature
Hs.62954
NM_002032
4503794
50 ferritin, heavy polypeptide 1
1
TGTTGGGGTTTCCTTTACCTTTTCTAT

(FTH1), mRNA/c

AAGTTGTACCAAAACATCCACTT

178
literature
Hs.62954
NM_002032
4503794
60 ferritin, heavy polypeptide 1
1
TGCATGTTGGGGTTTCCTTTACCTTTT

(FTH1), mRNA/c

CTATAAGTTGTACCAAAACATCCACTT

AAGTTC

179
literature
Hs.62954
NM_002032
4503794
70 ferritin, heavy polypeptide 1
1
TGTTGGGGTTTCCTTTACCTTTTCTAT

(FTH1), mRNA/c

AAGTTGTACCAAAACATCCACTTAAG

TTCTTTGATTTGTACCA

180
literature
Hs.652
NM_000074
4557432
tumor necrosis factor (ligand)
1
TCTACCTGCAGTCTCCATTGTTTCCA

superfamily, member 5, TNFSF5

GAGTGAACTTGTAATTATCTTGTT

181
cDNA
Hs.66053
AB051540
12698050
mRNA for KIAA1753 protein,
1
GTGTGCGTGTGTGTGTGCCTGTCCA

T-cells

partial cds/cds = (0

GTGTATATTGTGTCTTAGCTTCCAT

182
cDNA
Hs.66151
AL157438
7018513
mRNA; cDNA DKFZp434A115
1
CTGAAGGGAAGAGAGCCTTGAATAG

T-cells

(from clone DKFZp434A1

ACTGAAGCGAAGACGGTTCTGCAAG

183
cDNA
Hs.6975
NM_014088
7662589
PRO1073 protein (PRO1073).
1
TTCTCTGCATCTAGGCCATCATACTG

T-cells

CCAGGCTGGTTATGACTCAGAAGA

184
cDNA
Hs.70188
NM_003169
4507312
suppressor of Ty (S. cerevisiae)
1
CTTCCTGTACCTCCTCCCCACAGCTT

T-cells

5 homolog (SUP

GCTTTTGTTGTACCGTCTTTCAAT

185
cDNA
Hs.70258
N21089
1126259
IMAGE:265324 Foreskin 3′
1
AACCTGCACAAGCATGTAATAAAAGA

T-cells

read 2.0 kb

GCACACTTAAAAACATTCTGACCA

186
cDNA
Hs.70258
N21089
1126259
Complement IMAGE:265324
−1
TGGTCAGAATGTTTTTAAGTGTGCTC

T-cells

Foreskin 3′ read 2.0 kD

TTTTATTACATGCTTGTGCAGGTT

187
cDNA
Hs.70258
AA743863
2783214
IMAGE:1308639 5′ read,
1
CCTTCTGAAGGTGTATAGATACAGCT

T-cells

perfect hit.

TGTCTTGAAATGTCTTTCTCCACA

188
cDNA
Hs.70258
AA743863
2783214
Complement IMAGE:1308639 5′
−1
TGTGGAGAAAGACATTTCAAGACAAG

T-cells

read, perfect hit.

CTGTATCTATACACCTTCAGAAGG

189
cDNA
Hs.72918
NM_002981
4506832
small inducible cytokine A1
1
TGCTAGGTCACAGAGGATCTGCTTGG

T-cells

(I-309, homologous to mouse

TCTTGATAAGCTATGTTGTTGCAC

Tca-3) (SCYA1)

190
cDNA
Hs.73165
U64198
1685027
II-12 receptor beta2 mRNA,
1
CTAGAGGACCATTCATGCAATGACTA

T-cells

complete cds/cds = (640, 322

TTTCTAAAGCACCTGCTACACAGC

191
cDNA
Hs.737
NM_004907
4758313
immediate early protein (ETR101),
1
GGGAGTTTCTGAGGGTCTGCTTTGTT

T-cells

mRNA/cds = (

TACCTTTCGTGCGGTGGATTCTTT

192
cDNA
Hs.73742
NM_001002
4506666
ribosomal protein, large, P0
1
TCGGAGGAGTCGGACGAGGATATGG

T-cells

(RPLP0).

GATTTGGTCTCTTTGACTAATCACC

193
cDNA
Hs.73792
J03565
181919
Epstein-Barr virus complement
1
TTCCTTCCTCGGTGGTGTTAATCATTT

T-cells

receptor type II (cr2)

CGTTTTTACCCTTTACCTTCGGA

194
cDNA
Hs.73798
NM_002415
4505184
macrophage migration inhibitory
1
GTCTACATCAACTATTACGACATGAA

T-cells

factor (MIF)

CGCGGCCAATGTGGGCTGGAACAA

195
cDNA
Hs.738
NM_003973
4506800
ribosomal protein L14 (RPL14),
1
CAGAAGGGTCAAAAAGCTCCAGCCC

T-cells

mRNA/cds = (17, 6

AGAAAGCACCTGCTCCAAAGGCATC

196
cDNA
Hs.73800
NM_003005
6031196
selectin P (granule membrane
1
GACCTTCCTGCCACCAGTCACTGTCC

T-cells

protein 140 kD, antigen CD62)

CTCAAATGACCCAAAGACCAATAT

(SELP)

197
cDNA
Hs.73817
D90144
219905
LD78 alpha precursor, complete
1
GAGATGGGGAGGGCTACCACAGAGT

T-cells

cds/c

TATCCACTTTACAACGGAGACACAG

198
cDNA
Hs.73818
NM_006004
5174744
ubiquinol-cytochrome c reductase
1
ATGGGTTTGGCTTGAGGCTGGTAGCT

T-cells

hinge prote

TCTATGTAATTCGCAATGATTCCA

199
cDNA
Hs.73839
NM_002935
4508550
ribonuclease, RNase A family,
1
CATCCCTCCATGTACTCTGGGTATCA

T-cells

3 (eosinophil cationic protein)

GCAACTGTCCTCATCAGTCTCCAT

(RNASE3)

200
cDNA
Hs.73917
M13982
186334
interleukin 4 (IL-4) mRNA
1
ACCTTACAGGAGATCATCAAAACTTT

T-cells

GAACAGCCTCACAGAGCAGAAGAC

201
cDNA
Hs.74011
NM_002286
11693297
lymphocyte-activation gene 3
1
GAGAAGACAGTGGCGACCAAGACGA

T-cells

(LAG3).

TTTTCTGCCTTAGAGCAAGGGATTC

202
cDNA
Hs.74085
X54870
35082
NKG2-D gene/cds = (338, 988)
1
CAGGGGATCAGTGAAGGAAGAGAAG

T-cells

/gb = X54870/gi = 3

GCCAGCAGATCAGTGAGAGTGCAAC

203
cDNA
Hs.74335
NM_007355
6880306
heat shock 90 kD protein 1,
1
CCCATTCCCTCTCTACTCTTGACAGC

T-cells

beta (HSPCB), mRNA/

AGGATTGGATGTTGTGTATTGTGG

204
cDNA
Hs.74821
NM_000311
4508112
prion protein (p27-30)
1
ACTTAATATGTGGGAAACCCTTTTGC

T-cells

(Creutzfeld-Jakob dis

GTGGTCCTTAGGCTTACAATGTGC

205
cDNA
Hs.75249
D31885
505097
ADP-ribosylation factor-like 6
1
AAAATACAAGGGCTGTTGGTGAGAGC

T-cells

interacting protein

AGACTTGAGGTGATGATAGTTGGC

206
cDNA
Hs.75348
NM_008263
5453989
proteasome (prosome, macropain)
1
CCAGATTTTCCCCAAACTTGCTTCTG

T-cells

activator subunit 1 (PA28 alpha)

TTGAGATTTTTCCCTCACCTTGCC

(PSME1).

207
cDNA
Hs.75545
X52425
33833
interleukin 4 receptor
1
ACCTTGGGTTGAGTAATGCTCGTCTG

T-cells

TGTGTTTTAGTTTCATCACCTGTT

208
cDNA
Hs.75596
NM_000878
4504664
interleukin 2 receptor, beta
1
AAACTCCCCTTTCTTGAGGTTGTCTG

T-cells

(IL2RB).

AGTCTTGGGTCTATGCCTTGAAAA

209
literature
Hs.75813
M24795
178670
CD36 antigen mRNA
1
CTCAGTGTTGGTGTGGTGATGTTTGT

TGCTTTTATGATTTCATATTGTGC

210
cDNA
Hs.75678
NM_006732
5803018
FBJ murine osteosarcoma viral
1
CTGTATCTTTGACAATTCTGGGTGCG

T-cells

oncogene homolo

AGTGTGAGAGTGTGAGCAGGGCTT

211
cDNA
Hs.75703
J04130
178017
50 activation (Act-2) mRNA,
1
GATAAGTGTCCTATGGGGATGGTCCA

T-cells

complete cds/cds = (108, 386)

CTGTCACTGTTTCTCTGCTGTTGC

212
cDNA
Hs.75703
J04130
178017
60 activation (Act-2) mRNA,
1
TTTAGCCAAAGGATAAGTGTCCTATG

T-cells

complete cds/cds = (108, 386)

GGGATGGTCCACTGTCACTGTTTCTC

TGCTGTTG

213
cDNA
Hs.75703
J04130
178017
70 activation (Act-2) mRNA,
1
ATTTATATTAGTTTAGCCAAAGGATAA

T-cells

complete cds/cds = (108, 386)

GTGTCCTATGGGGATGGTCCACTGTC

ACTGTTTCTCTGCTGTT

214
cDNA
Hs.75968
NM_021109
11056060
thymosin, beta 4, X chromosome
1
GAAGGAAGAAGTGGGGTGGAAGAAG

T-cells

(TMSB4X), mRNA

TGGGGTGGGACGACAGTGAAATCTA

215
cDNA
Hs.76506
NM_002298
7382490
lymphocyte cytosolic protein 1
1
CCATCAATGAGGTATCTTCTTTAGTG

T-cells

(L-plastin) (L

GTGGTATGTAATGGAACTTAGCCA

216
cDNA
Hs.76640
NM_014059
7682650
RGC32 protein (RGC32), mRNA
1
AAAGACGTGCACTCAACCTTCTACCA

T-cells

/cds = (148, 499)/g

GGCCACTCTCAGGCTCACCTTAAA

217
cDNA
Hs.76753
NM_000118
4557554
endoglin (Oster-Rendu-Weber
1
CCAAGCTGCTTGTCCTGGGCCTGCC

T-cells

syndrome 1) (ENG).

CCTGTGTATTCACCACCAATAAATC

218
cDNA
Hs.77039
NM_001006
4508722
ribosomal protein S3A (RPS3A),
1
CACTGGGGACGAGACAGGTGCTAAA

T-cells

mRNA/cds = (36, 8

GTTGAACGAGCTGATGGATATGAAC

219
literature
Hs.77318
L13385
349823
Miller-Dieker lissencephaly protein
1
CGTTGCTGAAGTGGTAATTGAGGAAA

(LIS1)

ACAGTTCCCCAGATTGTTAAGAGT

220
cDNA
Hs.77424
X14358
31331
high affinity Fc receptor
1
CTCCCCGTGAGCACTGCGTACAAACA

T-cells

(FcRI)/cds = (36, 118

TCCAAAAGTTCAACAACACCAGAA

221
cDNA
Hs.77502
BC001854
12804818
, methionine adenosyltransferase
1
AGTGCCTTTCAGGATCTATTTTTGGA

T-cells

II, alpha, c

GGTTTATTACGTATGTCTGGTTCT

222
cDNA
Hs.77729
NM_002543
4505500
oxidised low density lipoprotein
1
AGAACAAACTAAGCCAGGTATGCAAA

T-cells

(lectin-like

TATCGCTGAATAGAAACAGATGGA

223
cDNA
Hs.77729
AB010710
2828355
lectin-like oxidized LDL receptor
1
AGAACAAACTAAGCCAGGTATGCAAA

T-cells

TATCGCTGAATAGAAACAGATGGA

224
cDNA
Hs.78148
M28526
189775
platelet endothelial cell adhesion
1
GCAATTCCTCAGGCTAAGCTGCCGGT

T-cells

molecule (PECAM-1)

TCTTAAATCCATCCTGCTAAGTTA

225
cDNA
Hs.78225
NM_000700
4502100
annexin A1 (ANXA1),
1
TCCTGGTGGCTCTTTGTGGAGGAAAC

T-cells

mRNA/cds = (74, 1114)/gb = N

TAAACATTCCCTTGATGGTCTCAA

226
literature
Hs.785
NM_000419
6006009
integrin, alpha 2b (platelet
1
CTTTGGGTTGGAGCTGTTCCATTGGG

glycoprotein IIb

TCCTCTTGGTGTCGTTTCCCTCCC

227
cDNA
Hs.78713
NM_002635
4505774
solute carrier family 25
1
AGAAAAAGCTTGGGTTAACTCAGTAG

T-cells

(mitochondrial carri

TTAGATCAAAGCAAATGTGGACTG

228
cDNA
Hs.78864
M31932
182473
IgG low affinity Fc fragment
1
ACAGATGTAGCAACATGAGAAACGCT

T-cells

receptor (FcRIIa) mRNA, c

TATGTTACAGGTTACATGAGAGCA

229
cDNA
Hs.789
X54489
34825
melanoma growth stimulatory
1
TGTTTAATGGTAGTTTTACAGTGTTTC

T-cells

activity (MGSA)

TGGCTTAGAACAAAGGGGCTTAA

230
literature
Hs.78996
BC000491
12653440
proliferating cell nuclear antigen
1
TGCCAGCATATACTGAAGTCTTTTCT

GTCACCAAATTTGTACCTCTAAGT

231
cDNA
Hs.79008
NM_012245
6912675
SKI-INTERACTING PROTEIN
1
GCTGCATATGAGTAAAGTTACCCCAA

T-cells

(SNW1), mRNA/cds = (2

CCACAGTGAGGAGGAAGATGTTCA

232
cDNA
Hs.79022
U10550
762886
Gem GTPase (gem) mRNA,
1
AAACCTCCAGTACTTTGGTTGACCCT

T-cells

complete cds/cds = (213, 1103)/

TGTATGTCACAGCTCTGCTCTATT

233
cDNA
Hs.79110
NM_005381
4885510
nucleolin (NCL).
1
ACCTGATCAATGACAGAGCCTTCTGA

T-cells

GGACATTCCAAGACAGTATACAGT

234
cDNA
Hs.79197
NM_004233
4757945
CD83 antigen (activated B
1
GCCCTTCCCTTCTTGGTTTCCAAAGG

T-cells

lymphocytes, immuno

CATTTATTGCTGAGTTATATGTTC

235
cDNA
Hs.79630
S75217
241773
mb-1 = IgM-alpha
1
CTGATTGTAGCAGCCTCGTTAGTGTC

T-cells

ACCCCCTCCTCCCTGATCTGTCAG

236
cDNA
Hs.80358
NM_004653
4759149
SMC (mouse) homolog, Y
1
ACCAAAAAGAATAGGGAAAAA

T-cells

chromosome (SMCY), mRNA

CAAGAATTTCATGACTCTACCTGT

GGTCT

237
cDNA
Hs.80420
U84487
1888522
CX3C chemokine precursor,
1
GACTTTTCCAACCCTCATCACCAACG

T-cells

mRNA, alternatively splice

TCTGTGCCATTTTGTATTTTACTA

238
cDNA
Hs.80617
NM_001020
14591912
ribosomal protein S16 (RPS16),
1
GCTCGCTACCAGAAATCCTACCGATA

T-cells

mRNA/cds = (37, 4

AGCCCATCGTGACTCAAAACTCAC

239
cDNA
Hs.80642
L78440
1479978
STAT4 mRNA, complete cds
1
ACCTGAGTCCCACAACAATTGAAACT

T-cells

/cds = (81, 2327)/gb = L

GCAATGAAGTCTCCTTATTCTGCT

240
cDNA
Hs.81226
X60992
29817
CD8 mRNA for T cell
1
AATTGATGAGGATGCTCCTGGGAGG

T-cells

glycoprotein CD8/cds = (120, 152

GATGCGTGACTATGTGGTGTTGCAC

241
cDNA
Hs.8128
NM_014338
13489111
phosphatidylserine decarboxylase
1
TGAAATATGGGAAAGTTGCTGCTATT

T-cells

(PISD).

GATTCAGGGTCTGTCTTGGAGGCA

242
cDNA
Hs.81584
NM_002619
4505732
platelet factor 4 (PF4),
1
CAACTGATAGCCACGCTGAAGAATGG

T-cells

mRNA.

AAGGAAAATTTGCTTGGACCTGCA

243
cDNA
Hs.81665
X06182
34084
c-kit proto-oncogene mRNA
1
TGTGTAAATACATAAGCGGCGTAAGT

T-cells

/cds = (21, 2951)/gb = X06182

TTAAAGGATGTTGGTGTTCCACGT

244
cDNA
Hs.82132
NM_002460
4505286
50 interferon regulatory factor 4
1
AACCCTCCTCCAATGGAAATTCCCGT

T-cells

(IRF4), mRNA/

GTTGCTTCAAACTGAGACAGATGG

245
cDNA
Hs.82132
NM_002460
4505286
60 interferon regulatory factor 4
1
CCTCCAATGGAAATTCCCGTGTTGCT

T-cells

(IRF4), mRNA/

TCAAACTGAGACAGATGGGACTTAAC

AGGCAATG

246
cDNA
Hs.82132
NM_002460
4505286
70 interferon regulatory factor 4
1
CCAACCCTCCTCCAATGGAAATTCCC

T-cells

(IRF4), mRNA/

GTGTTGCTTCAAACTGAGACAGATGG

GACTTAACAGGCAATGGG

247
literature
Hs.82359
X63717
28741
APO-1 cell surface antigen
1
AATCATCATCTGGATTTAGGAATTGC

/cds = (220, 122

TCTTGTCATACCCCCAAGTTTCTA

248
literature
Hs.82401
NM_001781
4502680
CD69 antigen (p60, early T-cell)
1
GCAAGACATAGAATAGTGTTGGAAAA

Activated B & T cells.

TGTGCAATATGTGATGTGGCAAAT

249
cDNA
Hs.279841
NM_006296
5454163
vaccinia related kinase 2
1
TCTCCATCTTGGTATAAATACACTTCC

T-cells

(VRK2), mRNA/cds = (1

ACAGTCAGCACGGGGATCACAGA

250
cDNA
Hs.82829
M25393
190740
protein tyrosine phosphatase
1
TCTCCTTACTGGGATAGTCAGGTAAA

T-cells

(PTPase) mRNA, complete

CAGTTGGTCAAGACTTTGTAAAGA

251
literature
Hs.82848
NM_000655
5713320
selectin L (lymphocyte adhesion
1
ACCCATGATGAGCTCCTCTTCCTGGC

molecule 1) (

TTCTTACTGAAAGGTTACCCTGTA

252
cDNA
Hs.83077
D49950
1405318
for interferon-gamma inducing
1
TGACATCATATTCTTTCAGAGAAGTG

T-cells

activated macrophages

TCCCAGGACATGATAATAAGATGC

253
cDNA
Hs.83086
L38935
1008845
GT212 mRNA/cds = UNKNOWN
1
ATCAGAAACCGAAGATTAACTACACA

T-cells

/gb = L38935/gi = 100884

GCTCCAGAAGACTCAGACCTCAAA

254
cDNA
Hs.83583
NM_005731
5031598
actin related protein 2/3 complex,
1
CAGGTTCTTAAGGGATTCTCCGTTTT

T-cells

subunit 2 (

GGTTCCATTTTGTACACGTTTGGA

255
cDNA
Hs.83731
NM_001772
4502654
CD33 antigen (gp67) (CD33),
1
CTAGAAGATCCACATCCTCTACAGGT

T-cells

mRNA.

CGGGGACCAAAGGCTGATTCTTGG

256
cDNA
Hs.838
NM_005191
4885122
CD80 antigen (CD28 antigen
1
CTTCTTTTGCCATGTTTCCATTCTGCC

T-cells

ligand 1, B7-1 antig

ATCTTGAATTGTCTTGTCAGCCA

257
literature
Hs.83968
NM_000211
4557885
integrin, beta 2 (antigen CD18
1
CATGGAGACTTGAGGAGGGCTTGAG

(p95), macrophage antigen 1

GTTGGTGAGGTTAGGTGCGTGTTTC

(mac-1)

258
literature
Hs.84
D11086
303611
interleukin 2 receptor gamma chain
1
CCCATGTAAGCACCCCTTCATTTGGC

ATTCCCCACTTGAGAATTACCCTT

259
cDNA
Hs.845
U31120
1045451
interleukin-13 (IL-13) precursor
1
CTTGGGCCAGACTGTCAGGGTTCAA

T-cells

gene, activated T cells

GGAGGGCATCAGGAGCAGACGGAGA

260
cDNA
Hs.85258
M12824
339426
T-cell differentiation antigen
1
CCTCCGCTCAACTAGCAGATACAGG

T-cells

Leu-2/T8 mRNA

GATGAGGCAGACCTGACTCTCTTAA

261
cDNA
Hs.85266
X51841
33910
mRNA for integrin beta(4)subunit
1
CAGCGGAACCCTTAGCACCCACATG

T-cells

GACCAACAGTTCTTCCAAACTTGAC

262
literature
Hs.856
NM_000619
10835170
interferon, gamma (IFNG), mRNA
1
ATGCCTGGTGCTTCCAAATATTGTTG

T-cells, NK cells

ACAACTGTGACTGTACCCAAATGG

263
cDNA
Hs.87149
M35999
183532
platelet glycoprotein IIIa
1
CCTCTCTCCAAACCCGTTTTCCAACA

T-cells

(GPIIIa) mRNA, complete c

TTTGTTAATAGTTACGTCTCTCCT

264
cDNA
Hs.87409
X14787
37464
thrombospondin/cds = (111, 3823)
1
TCATTTGTTGTGTGACTGAGTAAAGA

T-cells

/gb = X14787

ATTTTTGGATCAAGCGGAAAGAGT

265
cDNA
Hs.88474
M59979
189886
prostaglandin endoperoxide
1
TGAGGATGTAGAGAGAACAGGTGGG

T-cells

synthase

CTGTATTCACGCCATTGGTTGGAAG

266
cDNA
Hs.88820
NM_018849
7705402
HDCMC28P protein
1
GAAATTAAATGGGTTCCAGGTCTTAA

T-cells

(HDCMC28P).

AGAAAGTGCAGAAGAGATGGTCAA

267
cDNA
NA
AQ338195
4143104
cDNA clone IMAGE:4143104
1
AACCACTATCATCTACGGCACAAACT

T-cells

blood 3′ read

TGCAAAAGCTGTCCACACCATTTT

268
literature
Hs.89137
X13916
34338
LDL-receptor related protein
1
CCCGTTTTGGGGACGTGAACGTTTTA

ATAATTTTTGCTGAATTCTTTACA

269
cDNA
Hs.89414
AF147204
6002763
chemokine receptor CXCR4-Lo
1
TCAGTTTTCAGGAGTGGGTTGATTTC

T-cells

(CXCR4) mRNA, alt

AGCACCTACAGTGTACAGTCTTGT

270
cDNA
Hs.89476
M16338
180093
T-cell surface antigen CD2
1
AGCCTATCTGCTTAAGAGACTCTGGA

T-cells

(T11) mRNA, complete cds, c

GTTTCTTATGTGCCCTGGTGGACA

271
cDNA
Hs.89575
M89957
179311
immunoglobulin superfamily
1
GAGTAGAAGGACAACAGGGCAGCAA

T-cells

member B cell receptor co

CTTGGAGGGAGTTCTCTGGGGATGG

272
literature
Hs.89879
NM_000586
10835148
50 interleukin 2 (IL2).
1
GTTCTGGAACTAAAGGGATCTGAAAC

AACATTCATGTGTGAATATGCAGA

273
literature
Hs.89879
NM_000586
10835148
60 interleukin 2 (IL2).
1
TGGAACTAAAGGGATCTGAAACAACA

TTCATGTGTGAATATGCAGATGAGAC

AGCAACCA

274
literature
Hs.89879
NM_000588
10835148
70 interleukin 2 (IL2).
1
CAGGGACTTAATCAGCAATATCAACG

TAATAGTTCTGGAACTAAAGGGATCT

GAAACAACATTCATGTGT

275
cDNA
Hs.89751
NM_021950
11386188
CD20 antigen
1
ACCCATTCCATTTATCTTTCTACAGG

T-cells

GCTGACATTGTGGCACATTCTTAG

276
cDNA
Hs.89887
D38081
533325
thromboxane A2 receptor
1
TGAACCTCCAACAGGGAAGGCTCTGT

T-cells

CCAGAAAGGATTGAATGTGAAACG

277
cDNA
Hs.93304
U24577
1314245
LDL-phospholipase A2 mRNA,
1
TGAAGGAGATGATGAGAATCTTATTC

T-cells

complete cds/cds = (216, 15

CAGGGACCAACATTAACACAACCA

278
cDNA
Hs.93649
NM_003367
4507846
upstream transcription factor 2,
1
CTCTCTGGAGGTACTGAGACAGGGT

T-cells

c-fos intera

GCTGATGGGAAGGAGGGGAGCCTTT

279
literature
Hs.93913
X04430
32673
IFN-beta 2a mRNA for interferon-
1
CTCTTCGGCAAATGTAGCATGGGCAC

beta-2, T-cells, macrophages

CTCAGATTGTTGTTGTTAATGGGC

280
cDNA
Hs.960
NM_000590
10834979
interleukin 9 (IL9).
1
TTCCAGAAAGAAAAGATGAGAGGGAT

T-cells

GAGAGGCAAGATATGAAGATGAAA

281
cDNA
Hs.96023
M28170
882622
cell surface protein CD19 (CD19)
1
GGCCAGCCTGGACCCAATCATGAGG

T-cells

gene, Most B cells

AAGATGCAGACTCTTATGAGAACAT

282
cDNA
Hs.96487
BF222826
11130003
ESTs, Highly similar to SO8228
1
AATGTTTGCCCAGAATAAAGAAAATA

T-cells

ribosomal protein S2, cytosolic

AGCTTTGCACACACTCTCAATTCT

283
cDNA
Hs.9663
NM_013374
7019486
programmed cell death 6-
1
GGGAAAGAAATACCAACCCTGCAATA

T-cells

interacting protein (PDCD6IP).

AGTGTACTAAACTCTACGCTCTGG

284
cDNA
Hs.96731
AB014555
3327123
mRNA for KIAA1375 protein,
1
CACCAGCGCCTTGGCTTTGTGTTAGC

T-cells

partial cds/cds = (0

ATTTCCTCCTGAAGTGTTCTGTTG

285
literature
Hs.99863
NM_001972
4503548
elastase 2, neutrophil (ELA2).
1
ACATCGTGATTCTCCAGCTCAACGGG

TCGGCCACCATCAACGCCAACGTG

286
cDNA
Hs.99899
NM_001252
4507604
tumor necrosis factor (ligand)
1
AGCTACGTATCCATCGTGATGGCATC

T-cells

superfamily, member 7 (TNFSF7)

TACATGGTACACATCCAGGTGACG

287
literature
Hs.169476
NM_002048
7669491
50 Glyceraldehyde-3-phosphate
1
CCACACTGAATCTCCCCTCCTCACAG

dehydrogenase

TTGCCATGTAGACCCCTTGAAGAG

288
literature
Hs.169476
NM_002048
7689491
60 Glyceraldehyde-3-phosphate
1
CAGTCCCCCACCACACTGAATCTCCC

dehydrogenase

CTCCTCACAGTTGCCATGTAGACCCC

TTGAAGAG

289
literature
Hs.169476
NM_002048
7669491
70 Glyceraldehyde-3-phosphate
1
CCATGTAGACCCCTTGAAGAGGGGA

dehydrogenase

GGGGCCTAGGGAGCCGCACCTTGTC

ATGTACCATCAATAAAGTAC

290
literature
Hs.169478
NM_002048
7669491
50 Complement Glyceraldehyde-3-
−1
CTCTTCAAGGGGTCTACATGGCAACT

phosphate dehydrogenase

GTGAGGAGGGGAGATTCAGTGTGG

291
literature
Hs.169476
NM_002048
7669491
60 Complement Glyceraldehyde-3-
−1
CTCTTCAAGGGGTCTACATGGCAACT

phosphate dehydrogenase

GTGAGGAGGGGAGATTCAGTGTGGT

GGGGGACTG

292
literature
Hs.169476
NM_002048
7669491
70 Complement Glyceraldehyde-3-
−1
GTACTTTATTGATGGTACATGACAAG

phosphate dehydrogenase

GTGCGGCTCCCTAGGCCCCTCCCCT

CTTCAAGGGGTCTACATGG

293
literature
Hs.182937
NM_021130
10883926
50 peptidylprolyl isomerase A
1
TTTCCTTGTTCCCTCCCATGCCTAGC

(cyclophilin A), clone

TGGATTGCAGAGTTAAGTTTATGA

294
literature
Hs.182937
NM_021130
10883926
60 peptidylprolyl isomerase A
1
TTTCCTTGTTCCCTCCCATGCCTAGC

(cyclophilin A), clone

TGGATTGCAGAGTTAAGTTTATGATT

ATGAAATA

295
literature
Hs.182937
NM_021130
10883926
70 peptidylprolyl isomerase A
1
GTTCCATGTTTTCCTTGTTCCCTCCC

(cyclophilin A), clone

ATGCCTAGCTGGATTGCAGAGTTAAG

TTTATGATTATGAAATAA

296
literature
Hs.182937
NM_021130
10863926
50 complement peptidylprolyl
−1
TCATAAACTTAACTCTGCAATCCAGC

isomerase A (cyclophilin A), clone

TAGGCATGGGAGGGAACAAGGAAA

297
literature
Hs.182937
NM_021130
10883926
60 complement peptidylprolyl
−1
TATTTCATAATCATAAACTTAACTCTG

isomerase A (cyclophilin A), clone

CAATCCAGCTAGGCATGGGAGGGAA

CAAGGAAA

298
literature
Hs.182937
NM_021130
10883926
70 complement peptidylprolyl
−1
TTATTTCATAATCATAAACTTAACTCT

isomerase A (cyclophilin A), clone

GCAATCCAGCTAGGCATGGGAGGGA

ACAAGGAAAACATGGAAC

299
literature
Hs.288883
NM_005877
5032088
mRNA for splicing factor (SF3A1)
1
GTCATCCACCTGGCCCTCAAGGAGA

(120 kD)

GAGGCGGGAGGAAGAAGTAGACAAG

300
literature
Hs.12084
NM_003321
4507732
Tu translation elongation factor,
1
TGACTGAGGAGGAGAAGAATATCAAA

mitochondrial (TUFM)

TGGGGTTGAGTGTGCAGATCTCTG

301
literature
Hs.75887
NM_004371
6996002
coatomer protein complex, subunit
1
TGGTTTTCCAAAATGCACACTGCGGG

alpha (COPA)

TTATTGATTTGTTCTTTACAACTA

302
literature
Hs.182278
NM_001743
4502548
calmodulin 2 (phosphorylase
1
ACTGTCAGCATGTTGTTGTTGAAGTG

kinase, delta) (CALM2).

TGGAGTTGTAACTCTGCGTGGACT

303
literature
Hs.2795
NM_005568
5031856
mRNA for lactate dehydrogenase-
1
TGAGTCACATCCTGGGATCCAGTGTA

A (LDH-A, EC 1.1.1.27)

TAAATCCAATATCATGTCTTGTGC

304
literature
Hs.1708
NM_005998
5174726
chaperonin containing TCP1,
1
GTTCTGCTACTGCGAATTGATGACAT

subunit 3 (gamma) (CCT3).

CGTTTCAGGCCACAAAAAGAAAGG

305
literature
Hs.75428
NM_000454
4507148
superoxide dismutase (SOD-1)
1
ACATTCCCTTGGATGTAGTCTGAGGC

mRNA, complete cds.

CCCTTAACTCATCTGTTATCCTGC

306
literature
Hs.2271
NM_001955
4503460
Arabidopsis endothelin-1 (EDN1)
1
ACTGGCTTCCATCAGTGGTAACTGCT

TTGGTCTCTTCTTTCATCTGGGGA

307
literature
NA
X56062
16208
Arabidopsis CAB photosystem 1
1
CCATTGGAGAACTTGGCAACTCACTT

chlorophyll a/b-binding protein

GGCGGATCCATGGCACAACAACAT

(500 bp)

308
literature
NA
X14212
16470
Arabidopsis RCA RUBISCO
1
TTTTCTCCTTTGTGTAATTGTGGATTG

activase (513)

GATCTTGTCCTCTTTTGTTCCCT

309
literature
NA
U91968
1928871
Arabidopsis RBCL ribulose-1,5-
1
TATTCTTTCGTGTCAGGGCTTGAACC

biophosphate carboxylase/

AAGTATCCCCGCTTCTTCTACCCC

oxygenase large subunit

310
literature
NA
AF159801
8571922
Arabidopsis lipid transfer protein 4
1
CATCAAGTGAAGTGGGGAATAACGAC

(527)

ATCATTTGCCTGAAGAGTATGGTT

311
literature
NA
AF159803
8571926
Arabidopsis lipid transfer protein 6
1
AATGAGGGCATTGGTTTGCTAGTTGC

(477)

TAATTGATCAGTGATGTATTGTCA

312
literature
NA
AF191028
6708182
Arabidopsis papain-type cysteine
1
TGGAATCAACAAGATGGCTTCTTTCC

endopepetidase (507)

CCACCAAAACTAAGTGATCATCAG

313
literature
NA
AF168390
6137137
Arabidopsis root cap 1 (533)
1
TGGACCGTAATGAATGAATGTACACG

CCATAAACGCCCTTTGTTCAAGCA

314
literature
NA
AF198054
6649235
Arabidopsis NAC1 (457)
1
CCTCACTCTTGTACCCACGGTAGATT

CATGTAAAATACCACTTATGACGC

315
literature
NA
AF247559
7839390
Arabidopsis triosphosphate
1
GGTTAGCGACCTTGTTGTTGTTGTTG

isomerase (498)

TGTTCTTACATCTTCTTCTTGAAC

316
literature
NA
X58149
16440
Arabidopsis PRKase gene for
1
GGCGAAAAGGACGGTCTTGCTTGTTT

ribulose-5-phosphate kinase (497)

GTAATTTGTGTGGAGATAAAAAGA

317
literature
Hs.288061
NM_001101
5016088
actin, beta (ACTB).
1
CCCTTTTTGTCCCCCAACTTGAGATG

TATGAAGGCTTTTGGTCTCCCTGG

318
literature
Hs.77356
XM_002788
4507456
50 Transferrin receptor
1
TGAAATATCAGACTAGTGACAAGCTC

CTGGTCTTGAGATGTCTTCTCGTT

319
literature
Hs.77356
XM_002788
4507456
60 Transferrin receptor
1
GGTTGAGTTACTTCCTATCAAGCCAG

TACCGTGCTAACAGGCTCAATATTCC

TGAATGAA

320
literature
Hs.77356
XM_002788
4507456
70 Transferrin receptor
1
GTTGAGTTACTTCCTATCAAGCCAGT

ACCGTGCTAACAGGCTCAATATTCCT

GAATGAAATATCAGACTA

321
literature
Hs.77356
XM_002788
4507456
50 Complement Transferrin
−1
AACGAGAAGACATCTCAAGAC

receptor

CAGGAGCTTGTCACTAGTCTGA

TATTTCA

322
literature
Hs.77356
XM_002788
4507456
60 Complement Transferrin
−1
TTCATTCAGGAATATTGAGCCTGTTA

receptor

GCACGGTACTGGCTTGATAGGAAGTA

ACTCAACC

323
literature
Hs.77356
XM_002788
4507456
70 Complement Transferrin
−1
TAGTCTGATATTTCATTCAGGAATATT

receptor

GAGCCTGTTAGCACGGTACTGGCTT

GATAGGAAGTAACTCAAC

324
Table 3A
NA

36E9
1
TTTCAAGACAGAAAGTGACGCA

GAGAACCTCCCCGGCCCAGTCTCG

ACGC

325
Table 3A
NA

38E9
−1
GCGTCGAGACTGGGCCGGGGAGGTT

CTCTGCGTCACTTTCTGTCTTGAAA

326
Table 3A
NA

47D11
1
CCTAGACACCTGCATCAGTCAAGGTC

ATGGATATTGGGAAGACAGACAGC

327
Table 3A
NA

47D11
−1
GCTGTCTGTCTTCCCAATATCCATGA

CCTTGACTGATGCAGGTGTCTAGG

328
Table 3A
NA

53G7
1
AAATAAGAAGAGGAAAGAGAGAGGC

CTGCCCTAACCCACTGTTGTGCTGA

329
Table 3A
NA

53G7
−1
TCAGCACAACAGTGGGTTAGGGCAG

GCCTCTCTCTTTCCTCTTCTTATTT

330
Table 3A
NA

82C9
1
CTCATGCCTGCAGTGCTGCTCATGTT

GCCCCCTTGGAATTACTTGTTCAA

331
Table 3A
NA

82C9
−1
TTGAACAAGTAATTCCAAGGGGGCAA

CATGAGCAGCACTGCAGGCATGAG

332
Table 3A
NA

82G9
1
CCAATTTCTATAATTATTGAACAGCTT

TTCGTGGGGCCAGCACAAAGTCT

333
Table 3A
NA

82G9
−1
AGACTTTGTGCTGGCCCCACGAAAAG

CTGTTCAATAATTATAGAAATTGG

334
Table 3A
NA

65B1
1
TGGCTACAAATAGAGTAGAGAACAGA

CTCCAGTCCTCAAAGACTTTCAGT

335
Table 3A
NA

65B1
−1
ACTGAAAGTCTTTGAGGACTGGAGTC

TGTTCTCTACTCTATTTGTAGCCA

336
Table 3A
NA

65D10
1
AGTTAAGATGGAAGAATATAGAGACC

TTCTGAAGAGCACTGTAGCTTGGA

337
Table 3A
NA

65D10
−1
TCCAAGCTACAGTGCTCTTCAGAAGG

TCTCTATATTCTTCCATCTTAACT

338
Table 3A
NA

100D7
1
CACTCCTATGGCATGTGGAAGCAGGT

CTGAGCAGTGTGCATAGAAGAAAA

339
Table 3A
NA

100D7
−1
TTTTCTTCTATGCACACTGCTCAGAC

CTGCTTCCACATGCCATAGGAGTG

340
Table 3A
NA

107H8
1
GCTCTCCGTTGACAATGGCCAAAGAA

TAGAAGCTCTAGACCTTCCTTATT

341
Table 3A
NA

107H8
−1
AATAAGGAAGGTCTAGAGCTTCTATT

CTTTGGCCATTGTCAACGGAGAGC

342
Table 3A
NA

129F10
1
GGCAAAACGCACCTGGCACAACAGA

ACGAATAATACAGAAGCTGGATGAC

343
Table 3A
NA

129F10
−1
GTCATCCAGCTTCTGTATTATTCGTTC

TGTTGTGCCAGGTGCGTTTTGCC

344
Table 3A
NA

137B5
1
TAGCCATTTCTTCCTGATTGTGCCTA

GTATATCCCAGACAGTTTGTTTCT

345
Table 3A
NA

137B5
−1
AGAAACAAACTGTCTGGGATATACTA

GGCACAATCAGGAAGAAATGGCTA

346
Table 3A
NA

139G6
1
GGTTGGAATGGTGATCGGGATGCAG

TGAGATACTCTTGTGAGAGGGCAAA

347
Table 3A
NA

139G6
−1
TTTGCCCTCTCACAAGAGTATCTCAC

TGCATCCCGATCACCATTCCAACC

348
Table 3A
NA

142E4
1
GCCATGAGATTCAACAGTCAACATCA

GTCTGATAAGCTACCCGACAAAGT

349
Table 3A
NA

142E4
−1
ACTTTGTCGGGTAGCTTATCAGACTG

ATGTTGACTGTTGAATCTCATGGC

350
Table 3A
NA

142E9
1
AAGAGGACAAGTTTGAGAGGCAACA

CTTAAACACTAGGGCTACTGTGGCA

351
Table 3A
NA

142E9
−1
TGCCACAGTAGCCCTAGTGTTTAAGT

GTTGCCTCTCAAACTTGTCCTCTT

352
Table 3A
NA

142F9
1
ATTTGCTTTAAATTGAGTTTCCTTGCC

ATTGCACACTCCTATCTTTCTGA

353
Table 3A
NA

142F9
−1
TCAGAAAGATAGGAGTGTGCAATGGC

AAGGAAACTCAATTTAAAGCAAAT

354
Table 3A
NA

331A3
1
AAAAGTCACTACCAGGCTGGCAGGG

AATGGGGCAATCTATTCATACTGAT

355
Table 3A
NA

331A3
−1
ATCAGTATGAATAGATTGCCCCATTC

CCTGCCAGCCTGGTAGTGACTTTT

356
Table 3A
NA

138G5
1
ATATTGATTTGGATACGGTGAATAAG

CTGGACAAGATGTTGAGGAGAGGG

357
Table 3A
NA

138G5
−1
CCCTCTCCTCAACATCTTGTCCAGCT

TATTCACCGTATCCAAATCAATAT

358
Table 3A
NA

145C5
1
AATGTGCAAGGTGAAATGCTTTTGGA

TAAACGTAAGCCTATTTTCTGACG

359
Table 3A
NA

145C5
−1
CGTCAGAAAATAGGCTTACGTTTATC

CAAAAGCATTTCACCTTGCACATT

360
Table 3A
NA

184H1
1
TTCATCTCTAAGGCACACTTGCTACC

CCTCTTTGCTGACCCCAGATTGTG

361
Table 3A
NA

184H1
−1
CACAATCTGGGGTCAGCAAAGAGGG

GTAGCAAGTGTGCCTTAGAGATGAA

362
Table 3A
NA

45B9
1
TTCTGGCAAGCTCTTGTCATGGTGTT

CGACACTTCCTTCTGTCTTCTTGG

363
Table 3A
NA

45B9
−1
CCAAGAAGACAGAAGGAAGTGTCGA

ACACCATGACAAGAGCTTGCCAGAA

364
Table 3A
NA

112B5
1
GGTCAATGTAGCCAATTATTTGTTTCA

ACAGTTGCAGAACAGATATTTCA

365
Table 3A
NA

112B5
−1
TGAAATATCTGTTCTGCAACTGTTGA

AACAAATAATTGGCTACATTGACC

366
Table 3A
NA

117H9
1
TGAAAAGACAGCTAATTTGGTCCAAC

AAACATGACTGGGTCTAGGGCACC

367
Table 3A
NA

117H9
−1
GGTGCCCTAGACCCAGTCATGTTTGT

TGGACCAAATTAGCTGTCTTTTCA

368
Table 3A
NA

515H10
1
TGGATCATTGCCCAAAGTTGCACGCA

CTGACTCCTTACCTGTGAGGAATG

369
Table 3A
NA

515H10
−1
CATTCCTCACAGGTAAGGAGTCAGTG

CGTGCAACTTTGGGCAATGATCCA

370
Table 3A
NA

103C4
1
TTAAAACATTAAAAGATTGACTCCACT

TTGTGCCAAGCTCTGCGGGTAGG

371
Table 3A
NA

103C4
−1
CCTACCCGCAGAGCTTGGCACAAAG

TGGAGTCAATCTTTTAATGTTTTAA

372
Table 3A
NA

116E10
1
TGAATTTGGAGTCCCTGGCACATAAA

TCTACCTTCAAATCAGAGGTCCTT

373
Table 3A
NA

116E10
−1
AAGGACCTCTGATTTGAAGGTAGATT

TATGTGCCAGGGACTCCAAATTCA

374
Table 3A
NA

196D7
1
TGGGTCAGAGACGAAAAGGGCTATTA

TTAGGTCAAACATTACAGAAATCA

375
Table 3A
NA

196D7
−1
TGATTTCTGTAATGTTTGACCTAATAA

TAGCCCTTTTCGTCTCTGACCCA

376
Table 3A
NA

524A9
1
CTGATTTAACAGGTGGTTCTGCGGGC

GTCCAGGTCAACATCTTTTTGTCC

377
Table 3A
NA

524A9
−1
GGACAAAAAGATGTTGACCTGGACG

CCCGCAGAACCACCTGTTAAATCAG

378
Table 3A
NA

485A6
1
GTCACTTTAGCGAGCGGGAAAACAAT

GGCGGAAAGGGAAAACCTGGAAAG

379
Table 3A
NA

485A6
−1
CTTTCCAGGTTTTCCCTTTCCGCCAT

TGTTTTCCCGCTCGCTAAAGTGAC

380
Table 3A
NA

485D5
1
TAATTAATAGAGCTCACTTAAGATTGC

CCATCAAGAAACAGGAGGGTGGT

381
Table 3A
NA

485D5
−1
ACCACCCTCCTGTTTCTTGATGGGCA

ATCTTAAGTGAGCTCTATTAATTA

382
Table 3A
NA

479G6
1
AGTCCTGCTGAATCATTGGTTTATAG

AAGACTATCTGGAGGGCCTGATAG

383
Table 3A
NA

479G6
−1
CTATCAGGCCCTCCAGATAGTCTTCT

ATAAACCAATGATTCAGCAGGACT

384
Table 3A
NA

482A5
1
ATGTGATTCCATGATAATCAAATAGT

GAATACATTATAAAGTCAGCAACT

385
db mining
Hs.195219
W83776
1371377
hypothetical protein FLJ14486
1
ATATATGGGGGCTGGGCCTCGGGAC

(FLJ14486), mRNA/cds =

TCTCGCTCTAATAAAGGACTGTAGG

(80, 1615)

386
Table 3A
Hs.183454
AK027789
14042727
cDNA FLJ14883 fis, clone
1
TTTTGACCCAGATGATGGTTCCTTTA

PLACE1003596, moderately

CAGAACAATAAAATGGCTGAACAT

similar to OLIGOSACCHARYL

TRANSFERASE STT3

SUBUNIT/cds = (2, 862)

387
db mining
Hs.69171
NM_006256
5453973
protein kinase C-like 2
1
TGAGCACTGGAAACAGTTTCATGGAG

(PRKCL2), mRNA/cds = (9, 2963)

TTTAAGTTGAGTGAACATCGGCCA

388
Table 3A
Hs.131828
R67468
840106
EST390979 cDNA
1
ATGCATTTAGTTTTTGGCACCGTAGT

TTAAGGGTGGGATTGCCAGTTTTT

389
Table 3A
Hs.181297
AA010282
1471308
tc35a11.x1 cDNA, 3′ end
1
GGTTGTGTCTCTGGTTTCCCCTTTTC

/clone = IMAGE:2066588/

CCCGTGGTTTTAATTTTTAAGAAC

clone_end = 3′

390
Table 3A
Hs.235883
AA020845
1484616
602628774F1 cDNA, 5′ end
1
GGAGGACACCCCTGTGTGTTGCTGC

/clone = IMAGE:4753483/

TGCCTTCCGTGCTGTCTACTGTATC

clone_end = 5′

391
Table 3A
Hs.330145
AA044450
1522307
RST29149 cDNA
1
GCATCAGAGAGAATATGGAAGGACAT

CGACCCTAACTTCATCCAGTGAGG

392
Table 3A
Hs.189468
AA069335
1576904
tm30a06.x1 cDNA, 3′ end
1
ACCATAGCAGACAGGGTCAGATGGA

/clone = IMAGE:2158066/

ATATTAGCGGTTTAGGTGAAGAACC

clone_end = 3′

393
Table 3A
Hs.205675
AA111921
1664016
EST389824 cDNA
1
AGACAGAAGACAAGGCCAAATGGGT

GTCTCTGGAATGATAGACTTAGAAA

394
Table 3A
Hs.13859
AA115345
1670525
mRNA; cDNA DKFZp586F2423
1
ATCCACATTCTTACCTTTGGTAGTCA

(from clone DKFZp586F2423)

GGTTTGGCTACTTTGCAGCTCGCC

/cds = UNKNOWN

395
Table 3A
Hs.11861
AA122297
1678553
thyroid hormone receptor-
1
ATAGCAGTGGATTACCAACACCTTGA

associated protein, 240 kDa

CTTCTTGTACAGTGCTAACATCTT

subunit (TRAP240), mRNA/cds =

(77, 6601)

396
Table 3A
Hs.183454
AA149078
1719368
cDNA FLJ14883 fis, clone
1
TAGTAAAAGTGAAAGAGAAAGGGTTT

PLACE1003596, moderately

TTCCTGCCACAGGATATAACTTTT

similar to OLIGOSACCHARYL

TRANSFERASE STT3

SUBUNIT/cds = (2, 862)

397
Table 3A
Hs.124601
AA203497
1799265
zx58g05.r1 cDNA, 5′ end
1
AAAGCGGTCGTTTCCCCACAAGGTGT

/clone = IMAGE:446744/

CCAACTTTGCGGTACTCACACTTA

clone_end = 5′

398
Table 3A
Hs.73798
AA210788
1809440
macrophage migration inhibitory
1
CTAGGCCCGCCCACCCCAACCTTCT

factor (glycosylation-inhibiting

GGTGGGGAGAAATAAACGGTTTAGA

factor) (MIF), mRNA/cds =

(97, 444)

399
Table 3A
NA
AA214691
1814479
Express cDNA library cDNA 5′
1
TGCACTAAACAGTTGCCCCAAAAGAC

ATATCTTGTTTTAAGGCCCAGACC

400
Table 3A
NA
AA243144
1874139
cDNA clone IMAGE:685113 5′
1
TTGGATGAAGCTGAAAAGACACTAAG

ACCTTCTGTGCCTCAGATCCCTGA

401
Table 3A
Hs.135187
AA250809
1885832
zs06a08.r1 cDNA, 5′ end
1
GTGTGGCCTAAGGAACACCTCTTGTG

GGGAGTAAGAGCCAGCCCTTCTCC

402
Table 3A
Hs.100651
AA251184
1886149
golgi SNAP receptor complex
1
AAGGATGAAGGACTGATGGAGGGCA

member 2 (GOSR2), mRNA/cds =

GAGGAACTGGAGGCAGCAGGCACAA

(0, 638)

403
Table 3A
NA
AA252909
1885512
cDNA clone IMAGE:669292 5′
1
AGATGTCTGTATAAACAACCTTTGGG

TAGCAGGTGGTCAGTTAGGCAGGA

404
Table 3A
Hs.194480
AA258979
1894268
EST389427 cDNA
1
TGCTTGTCTTTTAAACACCTTCACAGA

TATCATTTGCACCTTGCCAAAGG

405
Table 3A
Hs.5241
AA280051
1921589
fatty acid binding protein 1, liver
1
GGGTAGGCAGCTTGCACCCAGTTCT

(FABP1), mRNA/cds = (42, 425)

CCTTTATCTCAACTTATTTTCCTGG

406
Table 3A
NA
AA282774
1925825
cDNA clone IMAGE:713136 5′
1
CCGGTGTCCCTGAGTGAGGGCAAAG

TTGTAATAACACTTGTTCTCTCCTT

407
Table 3A
Hs.89072
AA283061
1926050
hypothetical protein MGC4618
1
ACGGCGTTCTGAAATTTAGCACACTG

(MGC4618), mRNA/cds =

GGAAGTCCACATGGTTCATCTGAA

(107, 1621)

408
Table 3A
Hs.291448
AA290921
1938772
EST388168 cDNA
1
AATGAGATCACAGATGGTGACACTGA

GCGGAAGGATGCAGTACCTCGGAG

409
Table 3A
Hs.211866
AA290993
1938989
wh99f02.x1 cDNA, 3′ end
1
TCCTTGCAAAACATTTGGCTAGTGGT

/clone = IMAGE:2388891/

GTTCAGAGAAATACCAAAACGTGT

clone_end = 3′

410
Table 3A
Hs.323950
AA307854
1960203
zinc finger protein 6 (CMPX1)
1
GGCAAAGGGGAAGGATGATGCCATG

(ZNF6), mRNA/cds =

TAGATCCTGTTTGACATTTTTATGG

(1285, 3381)

411
Table 3A
Hs.100293
AA312681
1965030
O-linked N-acetylglucosamine
1
ACTGTTAACCAAATTTTGAGCAAGGA

(GlcNAc) transferase (UDP-N-

GTCTCAAAGGTAATTCTGAACCAG

acetylglucosamine:polypeptide-N-

acetylglucosaminyl transferase)

(OGT), mRNA/cds = (2039, 4801)

412
Table 3A
Hs.217493
AA314369
1966698
annexin A2 (ANXA2), mRNA
1
ACTAGCAGATTGAATCGATATTCATTA

/cds = (49, 1068)

AGTTAGGAATGGTTGGTGGTCCT

413
Table 3A
Hs.85844
AA322158
1974484
neurotrophic tyrosine kinase,
1
AATTGTGCTTTGTATCAGTCAGTGCT

receptor, type 1 (NTRK1),

GGAGAAATCTTGAATAGCTTATGT

mRNA/cds = (0, 2390)

414
Table 3A
Hs.260238
AA332553
1984806
hypothetical protein FLJ10842
1
AGGAAACCAAGCCCTCACAGGAAAG

(FLJ10842), mRNA/cds =

AAAGCCTGAATCAAGAAAACAAAGT

(39, 1307)

415
Table 3A
Hs.323463
AA360634
2012954
mRNA for KIAA1693 protein,
1
ACTGAGCAGGACAACTGACCTGTCTC

partial cds/cds = (0, 2707)

CTTCACATAGTCCATATCACCACA

416
Table 3A
NA
AA377352
2029681
EST89924 Small intestine II cDNA
1
GCGTAAAACGCCAGGGCCATCTTCTT

5′ end

ACTTAAGCCACATCCTGAACCAGG

417
Table 3A
Hs.27973
AA397592
2050712
KIAA0874 protein (KIAA0874),
1
AGCGACAAGAAGGAATCTGGTGAATT

mRNA/cds = (0, 6188)

TTAGTCATCCCAGCTTTTTAGTCT

418
Table 3A
Hs.343557
AA401648
2056830
601500320F1 cDNA, 5′ end
1
GCTGGGGCTGAGAGAGGGTCTGGGT

/clone = IMAGE:3902237/

TATCTCCTTCTGATCTTCAAAACAA

clone_end = 5′

419
Table 3A
Hs.186674
AA402069
2056860
qf56f06.x1 cDNA, 3′ end
1
TCATGGACACAAACTTTGGAGTATAA

/clone = IMAGE:1754051/

GCGACATCCCTTAAGCAACAGGCT

clone_end = 3′

420
Table 3A
Hs.301985
AA412436
2071006
602435787F1 cDNA, 5′ end
1
ATTCAAGTCAGGGCCTCTCTGCCCTT

/clone = IMAGE:4553884/

TTCCCTCCAGAAACAAAACCAAGA

clone_end = 5′

421
Table 3A
Hs.9691
AA418765
2080566
cDNA: FLJ23249 fis, clone
1
TGTTTGTACCACTAGCATTCTTATGTC

COL04196/cds = UNKNOWN

TGTACTTGAACGTGTAGTTAGCA

422
Table 3A
Hs.24143
AA426506
2106769
Wiskott-Aldrich syndrome protein
1
AATATAGCTCCACTAAAGGACCATAG

interacting protein (WASPIP),

GGAAGAGCCAGCCTTGCCTTTTCT

mRNA/cds = (108, 1619)

423
Table 3A
Hs.303214
AA427653
2111519
7o45b01.x1 cDNA, 3′ end
1
GACAGTCCATTAAGTTGATTTCCAGT

/clone = IMAGE:3576912/

GGTGAAGGGTCAGACACGCCTCCC

clone_end = 3′

424
Table 3A
Hs.89519
AA429783
2112974
KIAA1046 protein (KIAA1046),
1
CCTGGGTTGCCTTGTAATGAAAAGGG

mRNA/cds = (577, 1782)

AGATCGAGCCATTGTACCACCTTA

425
Table 3A
Hs.112071
AA442585
2154463
zv57f09.r1 cDNA, 5′ end
1
GTTCACTGTTTAACAGCCAGAAGCCA

/clone = IMAGE:757769/

GAGCCTGCGTACTAGAAGTGGATG

clone_end = 5′

426
Table 3A
Hs.8832
AA454036
2167705
zx48b04.r1 cDNA, 5′ end
1
TTGTCAAGTGGATCTGCCCCAAAGTT

/clone = IMAGE:795439/

TGCTTTGAGGAAACGGGCCTCCCT

clone_end = 5′

427
Table 3A
Hs.286148
AA454987
2177763
stromal antigen 1 (STAG1),
1
CTTGTATGGAAAACAGATGCTGACAG

mRNA/cds = (400, 4176)

AATTGTAGACTACCATGCCACACA

428
Table 3A
Hs.255452
AA455707
2178483
aa22d09.r1 cDNA, 5′ end
1
AAATCTAAGACACCCAAACCCCTCTT

/clone = IMAGE:814001/

TGTCCCTAAGTAGCCCTAGCCTGG

clone_end = 5′

429
Table 3A
NA
AA457757
2180477
fetal retina 937202 cDNA clone
1
AGCTGTTTAATTGAATTGGAATCGTT

IMAGE:838756 5′

CCACTTGGAACCCAAGTTTGGAAA

430
Table 3A
Hs.82772
AA460876
2185996
collagen, type XI, alpha 1
1
TTTTTCTACGTTATCTCATCTCCTTGT

(COL11A1), mRNA/cds =

TTTCAGTGTGCTTCAATAATGCA

(161, 5581)

431
Table 3A
Hs.292451
AA461604
2185468
zx51d08.r1 cDNA, 5′ end
1
CTCCCATCTGCACACCTGGATCAAGG

/clone = IMAGE:795759/

TAGCCTCTCTGCACAAGGGCAGGT

clone_end = 5′

432
Table 3A
Hs.13809
AA476568
2204779
mRNA for KIAA1525 protein,
1
TGTTTTTGCTTCCTCAGAAACTTTTTA

partial cds/cds = (0, 2922)

TTGCATCTGCCATCCTTCATTGG

433
Table 3A
Hs.83733
AA479163
10433041
cDNA FLJ11724 fis, clone
1
ACAGCCAACTGGAAAGATATAAAAGT

HEMBA1005331/cds =

TTGGGTCTGTCTCCTCTCCTTCAG

UNKNOWN

434
Table 3A
Hs.190154
AA490796
2219969
td07e03.x1 cDNA, 3′ end
1
ACTCCTGCTTTAGAGAGAAGCCACCA

/clone = IMAGE:2074972/

TGAAAAGTCCTCATCATCAGGGGA

clone_end = 3′

435
Table 3A
Hs.119960
AA496483
2229804
mRNA; cDNA DKFZp727G051
1
TCCGTACTGTATGTGATATAGTGCCA

(from clone DKFZp727G051);

TTTTCAGTAACTGCTGTACACACA

partial cds/cds = (0, 1423)

436
Table 3A
Hs.75470
AB000115
2564034
hypothetical protein, expressed in
1
ACTTGCCATTACTTTTCCTTCCCACTC

osteoblast (GS3686), mRNA

TCTCCAACATCACATTCACTTTA

/cds = (241, 1482)

437
Table 3A
Hs.50002
AB000887
2189952
small inducible cytokine
1
GTGAGTGTGAGCGAGAGGGTGAGTG

subfamily A (Cys—Cys),

TGGTCAGAGTAAAGCTGCTCCACCC

member 19 (SCYA19),

mRNA/cds = (138, 434)

438
Table 3A
Hs.76730
AB002299
2224542
mRNA for KIAA0301 gene, partial
1
TAATATGCTGGCTTTGCAGCAGAATG

cds/cds = (0, 6144)

AAAAGGATGAGTTGGTGTAGCCTT

439
Table 3A
Hs.7911
AB002321
2224586
mRNA for KIAA0323 gene, partial
1
TTCCTTCCCTGGAGGAACTCTTTGGT

cds/cds = (0, 2175)

TGCAGGGCTAAACTTAGAGGCTGC

440
Table 3A
Hs.7720
AB002323
2224590
mRNA for KIAA0325 gene, partial
1
TCTGACGGTTGGGAGTGGTGGAAATT

cds/cds = (0, 6285)

GGAAGGATACCAGGAGGTATTTGG

441
Table 3A
Hs.278671
AB002334
2224612
KIAA0338 gene product
1
TGATTACAAAAGGCGTATTCTTTCAT

(KIAA0338), mRNA/cds =

GGTTTCTGCAATGAGAGGAAGTGT

(253, 5004)

442
Table 3A
Hs.23311
AB002365
2224674
mRNA for KIAA0367 gene, partial
1
TCATGCATTGGATTGCTCAGAATAAA

cds/cds = (0, 2150)

GTGTCTGTTAGACTTCGTTTTGGT

443
Table 3A
Hs.3852
AB002368
2224876
mRNA for KIAA0368 gene, partial
1
TGACGTTAACACCAGGAATCTCCATG

cds/cds = (0, 4327)

TTTATTATTTTTCGTGGAAACTCC

444
Table 3A
Hs.70500
AB002368
2224680
mRNA for KIAA0370 gene, partial
1
TTGCAAAGACTCACGTTTTTGTTGTTT

cds/cds = (0, 2406)

TCTCATCATTCCATTGTGATACT

445
Table 3A
Hs.63302
AB002369
2224682
myotubularin related protein 3
1
AGCTGTACATATAACCCTTTTCTCCTA

(MTMR3), mRNA/cds =

AAGAGGAGTCAGTCAGTGCTCCT

(247, 3843)

446
Table 3A
Hs.32556
AB002377
6634024
mRNA for KIAA0379 protein,
1
AGTTCAGGAGATCTCTAAGTGTAGCT

partial cds/cds = (0, 3180)

GTAAATTTTGGGGTTAATTTGGCT

447
Table 3A
Hs.101359
AB002384
2224712
mRNA for KIAA0386 gene,
1
TGTTTGGTTGAGGGGTGCTTTTAGTT

complete cds/cds = (177, 3383)

GTGTGGCATTTGTATTCATTGATC

448
Table 3A
Hs.100955
AB007859
6834028
mRNA for KIAA0399 protein,
1
TCAGCCTGAGTGAGTTCAGCCTGTAA

partial cds/cds = (0, 2961)

AAAGGATGTTAAGCTGTGGGTAAA

449
Table 3A
Hs.118047
AB007861
2662082
602971981F1 cDNA, 5′ end
1
AGGGGAAAAGAGGGGAGAAAAACAG

/clone = IMAGE:5111324/

GAGTGATGTCATTTCTTTTTCATGT

clone_end = 5′

450
Table 3A
Hs.28578
AB007888
2887430
muscleblind (Drosophila)-like
1
ACTTTCTGCTTGTAGTTGCTTAAAATT

(MBNL), mRNA/cds =

ATGTATTTTGTCTTGGGCTGCAA

(1414, 2526)

451
Table 3A
Hs.32168
AB007902
2662164
KIAA0442 mRNA, partial cds
1
AAGCAACTGAATCTTCAGCATGTTCT

/cds = (0, 3519)

CATCGGCGGAGCCTTCTTGTGTAA

452
Table 3A
Hs.158286
AB007915
6634034
mRNA for KIAA0446 protein,
1
TGATTGGAGCACTGAGGAACAAGGG

partial cds/cds = (3480, 4586)

AATGAAAAGGCAGACTCTCTGAACG

453
Table 3A
Hs.214646
AB007916
6683704
mRNA for KIAA0447 protein,
1
TTGTCCAAACGAAGCAGCCGTGGTA

partial cds/cds = (233, 1633)

GTAGCTGTCTATGATTCTTGCTCAG

454
Table 3A
Hs.28169
AB007928
3413879
mRNA for KIAA0459 protein,
1
TGGTGCAATAGAAGCTGCAAAGATGT

partial cds/cds = (0, 461)

GCCACTTTATCTATGAAATGGAGT

455
Table 3A
Hs.7764
AB007938
3413899
KIAA0469 gene product
1
GGCTTCCATGTCCAGAATCCTGCTTA

(KIAA0469), mRNA/cds =

AGGTTTTAGGGTACCTTCAGTACT

(184, 1803)

456
Table 3A
Hs.92381
AB007956
3413930
mRNA, chromosome 1 specific
1
TTTTGGCCAGCTTTTCTAGATAAGGT

transcript KIAA0487/cds =

TGTATTGCTACTGCAACTAACAAA

UNKNOWN

457
Table 3A
Hs.306193
AB011087
9558752
hypothetical protein (LQFBS-1),
1
CACACATCCTGGTACCCTTGGTCTTC

mRNA/cds = (0, 743)

AAAGGCCATTTCCAGCAGACCCTC

458
Table 3A
Hs.59403
AB011098
3043575
serine palmitoyltransferase, long
1
AAACATGTCTTTTTCTCGCCTCAACTT

chain base subunit 2 (SPTLC2),

TATCCACATGAAATGTGTGCCCA

mRNA/cds = (188, 1876)

459
Table 3A
Hs.173081
AB011102
3043583
mRNA for KIAA0530 protein,
1
TAAGCATAAAACCTGACACGTTAAAA

partial cds/cds = (0, 4692)

TCCCTGCCCTTTGGTGAGCCCACT

460
Table 3A
Hs.198891
AB011108
3043595
mRNA for KIAA0536 protein,
1
AACTTGCATTTTAGCAGTGCATGTTT

partial cds/cds = (0, 3087)

CTAATTGACTTACTGGGAAACTGA

461
Table 3A
Hs.62209
AB011114
6635200
mRNA for KIAA0542 protein,
1
AGGCCTCAGGCCACCTCCAGGAACA

partial cds/cds = (390, 4028)

GAACACAGTTTTAAGTTTGATTTTT

462
Table 3A
Hs.13273
AB011164
3043707
mRNA for KIAA0592 protein,
1
TGAGTCTTAGCAATATGGGAGCAGGT

partial cds/cds = (0, 4061)

TTTCACTGAATTCTGAGGGTGCCT

463
Table 3A
Hs.20141
AB011169
3043717
mRNA for KIAA0597 protein,
1
GTTGTCCTGGCACACAAGGAGGCGA

partial cds/cds = (0, 2915)

GGCTATGCGTTCGAGGCCAACCTAG

464
Table 3A
Hs.118087
AB011182
3043743
DNA sequence from clone RP11-
1
TGGGAACACATAGAACTGATGGAGG

251J8 on chromosome 13 Contains

CTTTTCCTAAGGCCAAGGATAATGT

ESTs, STSs, GSSs and a CpG

island. Contains two novel genes

with two isoforms each and the

KIAA0610 gene with two

isoforms/cds = (61, 2061)

465
Table 3A
Hs.9075
AB011420
3834353
serine/threonine kinase 17a
1
GGATTGAACAGTTCAGTTGTATCTAT

(apoptosis-inducing) (STK17A),

GCCCCACAGTGACCAGTAAAGTCC

mRNA/cds = (117, 1361)

466
Table 3A
Hs.120996
AB011421
3834355
serine/threonine kinase 17b
1
CGATGACTCATTACCCAATCCCCATG

(apoptosis-inducing) (STK17B),

AACTTGTTTCAGATTTGCTCTGTT

mRNA/cds = (261, 1379)

467
Table 3A
Hs.180383
AB013382
3869139
dual specificity phosphatase 6
1
GTCGCAAAGGGGATAATCTGGGAAA

(DUSP6), transcript variant 1,

GACACCAAATCATGGGCTCACTTTA

mRNA/cds = (351, 1496)

468
Table 3A
Hs.323712
AB014515
3327043
KIAA0615 gene product
1
ACTCAAGCTCACACCTGTACCTGATG

(KIAA0615), mRNA/cds =

GGAATGAACATAATGTGAAGAAAC

(237, 2927)

469
Table 3A
Hs.11238
AB014522
3327057
mRNA for KIAA0622 protein,
1
CACCAAAATAGTTATGTTGGCACTGT

partial cds/cds = (0, 3869)

GTTCACACGCATGGTCCCCACACC

470
Table 3A
Hs.12259
AB014530
3327073
mRNA for KIAA0630 protein,
1
GTGCGCTTTCTTTTACAACAAGCCTC

partial cds/cds = (0, 1473)

TAGAAACAGATAGTTTCTGAGAAT

471
Table 3A
Hs.31921
AB014548
3327109
mRNA for KIAA0648 protein,
1
GTGTGTATAATGTAAAGTAGTTTTGC

partial cds/cds = (0, 2557)

ATATTCTTGTGCTGCACATGGGCT

472
Table 3A
Hs.8118
AB014550
3327113
mRNA for KIAA0650 protein,
1
AGGAATCCTTTTCTACATTTGAGCAA

partial cds/cds = (0, 2548)

ATACTGAGGTTCATGTTGTACCAA

473
Table 3A
Hs.96731
AB014555
3327123
mRNA for KIAA0655 protein,
1
CGCCTTGGCTTTGTGTTAGCATTTCC

partial cds/cds = (0, 3253)

TCCTGAAGTGTTCTGTTGGCAATA

474
Table 3A
Hs.65450
AB014558
3327129
reticulon 4a mRNA, complete cds
1
AGAGATTTTCTATTGCTGGGAAGGTG

/cds = (141, 3719)

TGTTTCTCCCACAATTTGTTTGTG

475
Table 3A
Hs.6727
AB014560
3327133
mRNA for KIAA0660 protein,
1
TGCAACCAAATTGGCTTTACCATCTT

complete cds/cds = (120, 1568)

GGCTTTAGTAGGTATAGAAGACAA

476
Table 3A
Hs.52526
AB014569
3327151
KIAA0669 gene product
1
TGTCAAATAAAAGAGAACGAACAGGT

(KIAA0669), mRNA/cds =

AGTTTGGTGGAGCTGAGCTAGTGT

(1016, 3358)

477
Table 3A
Hs.5734
AB014579
3327171
meningioma expressed antigen 5
1
TCCTGTAGAAAACGAACTGTAAAAGA

(hyaluronidase) (MGEA5), mRNA

CCATGCAAGAGGCAAAATAAAACT

/cds = (395, 3145)

478
Table 3A
Hs.153293
AB014601
3327215
mRNA for KIAA0701 protein,
1
ACAGTAGCTTTGTAGTGGGTTTTCTG

partial cds/cds = (0, 1892)

TGCTGTGCTTTTTAATTTCATGTA

479
Table 3A
Hs.192705
AB015798
11087388
PRO0457 protein (PRO0457),
1
GATTCCTGTCATGAAGGAAAGCAAGA

mRNA/cds = (985, 1431)

CAGCTCACAGACCAGCGGCATCTG

480
Table 3A
Hs.247433
AB015856
3953530
activating transcription factor 6
1
TTTTCTGTACCTTTCTAAACCTCTCTT

(ATF6), mRNA/cds = (42, 2054)

CCCTCTGTGATGGTTTTGTGTTT

481
Table 3A
Hs.288031
AB016247
3721881
sterol-C5-desaturase (fungal
1
AAATCTTATTCCTCCTCTTCTCCCCTC

ERG3, delta-5-desaturase)-like

ACTTTTCCCTACTTCCTCTGCAA

(SC5DL), mRNA/cds = (48, 947)

482
Table 3A
Hs.179729
AB016811
4514825
collagen, type X, alpha 1 (Schmid
1
TGGAATCAGACATCTTCCAGATGGTT

metaphyseal chondrodysplasia)

TGGACCCTGTCCATGTGTAGGTCA

(COL10A1), mRNA/cds =

(0, 2042)

483
Table 3A
Hs.10458
AB018249
4033626
gene for CC chemokine LEC,
1
AATTTAGCACCTCAGGAATAACTTATT

complete cds

GGTTTAGGTCAGTTCTTGGCGGG

484
Table 3A
Hs.19822
AB018298
3882230
SEC24 (S. cerevisiae) related gene
1
AACCATGTAACTCCATTGAACATTTTT

family, member D (SEC24D),

CAACTTAAGGTCTGCATAGCAGA

mRNA/cds = (200, 3298)

485
Table 3A
Hs.5378
AB018305
3882244
mRNA for KIAA0762 protein,
1
AAACCAGGTTAATGGCTAAGAATGGG

partial cds/cds = (0, 1874)

TAACATGACTCTTGTTGGATTGTT

486
Table 3A
Hs.21264
AB018325
3882284
mRNA for KIAA0762 protein,
1
CTCTTGGCTGAGCTTCTACAGGGCTG

partial cds/cds = (0, 3540)

AGAGCTGCGCTTTGGGGACTTCAG

487
Table 3A
Hs.8182
AB018339
3882312
mRNA for KIAA0796 protein,
1
TTTCCTTTGGGGCATGATGTTTTAAC

partial cds/cds = (0, 3243)

CTTTGCTTTAGAAGCACAAGCTGT

488
Table 3A
Hs.55947
AB018348
3882330
mRNA for KIAA0805 protein,
1
ATAGAATGAGCTTGGTTAAGCACCTC

partial cds/cds = (0, 3985)

TCCTTTGCCCTTCACCCTGACTCC

489
Table 3A
Hs.181300
AB020335
6518494
Pancreas-specific TSA305 mRNA,
1
TTGAGTAGAACTCTGATTTTCCCTAG

complete cds/cds = (45, 2429)

AGGCCAAATTCTTTTTATCTGGGT

490
Table 3A
Hs.22960
AB020623
3985929
breast carcinoma amplified
1
TTCTAAACACATTCTTGATCACCAAAC

sequence 2 (BCAS2), mRNA/

AACTTCAGAAAGACAGTGACTGT

cds = (48, 725)

491
Table 3A
Hs.45719
AB020630
4240131
CAAX box protein TIMAP
1
TGGAGTTGCTTCCAGCTGCCAAGGC

mRNA, complete cds/cds =

CTGTGACAGAATTCGCTGTTAAGAG

(52, 1755)

492
Table 3A
Hs.123654
AB020631
4240136
mRNA for KIAA0824 protein,
1
AATGATGCAAAGTTTTATTCTTGAACT

partial cds/cds = (0, 4936)

TGGACACTGATGCCATCAAACAA

493
Table 3A
Hs.334700
AB020640
14133218
mRNA for KIAA0833 protein,
1
GGCCAGTAAATTCCATGTTTTTGGCT

partial cds/cds = (0, 5017)

ATATCTCATCCAAACTGAGCAGTT

494
Table 3A
Hs.14945
AB020644
4240162
mRNA for KIAA0837 protein,
1
TTCCCATTGTCCTCCTACTCAACTAAA

partial cds/cds = (0, 2237)

ATTCATAGTTGGCTTTAAGCCCA

495
Table 3A
Hs.197298
AB020657
4240188
NS1-binding protein-like protein
1
GCATGTCCTAATGCTTGCTGCTGATT

mRNA, complete cds/cds =

TAAACACATTAAAGGTACTTTGCA

(555, 2483)

496
Table 3A
Hs.13264
AB020683
4240200
mRNA for KIAA0856 protein,
1
ACAATGGCATAAAAGTAACTTTCTCT

partial cds/cds = (0, 3212)

GAAGATGTGATGTTCAGGCTGTGA

497
Table 3A
Hs.104315
AB020669
4240212
suppressor of clear, C. elegans,
1
AATGGAAGGCAGGTGAAGATATAAAA

homolog of (SHOC2), mRNA

CCCTAGAATGCTTAAATGTGCTGT

/cds = (277, 2025)

498
Table 3A
Hs.18166
AB020877
6635136
mRNA for KIAA0870 protein,
1
TTAATGCCAGTCCTCATGTAACCTCA

partial cds/cds = (0, 3061)

GGTATCTTCAGCTTGTGGAGAATA

499
Table 3A
Hs.27973
AB020681
4240236
KIAA0874 protein (KIAA0874),
1
TGGAGTATATGCCTGAAAAGGTTTTG

mRNA/cds = (0, 6188)

GATTCAGAAAGAAAAAGGATGGTT

500
Table 3A
Hs.75415
AB021288
4038732
cDNA: FLJ22810 fis, clone
1
AAAGTAAGGCATGGTTGTGGTTAATC

KAIA2933, highly similar to

TGGTTTATTTTTGTTCCACAAGTT

AB021288 mRNA for beta 2-

microglobulin/cds = UNKNOWN

501
Table 3A
Hs.215857
AB022683
5019617
HFB30 mRNA, complete cds
1
GGTGTGTGTGTCCAGAGTGAGCAAG

/cds = (238, 1660)

GATTATGTTTTTGGATTGTCAAAGA

502
Table 3A
Hs.104305
AB023143
4589483
death effector filament-forming
1
AACCATTTGCCTCTGGCTGTGTCACA

Ced-4-like apoptosis protein

GGGTGAGCCCCAAAATTGGGGTTC

(DEFCAP), transcript variant B,

mRNA/cds = (522, 4811)

503
Table 3A
Hs.154296
AB023149
4589507
mRNA for KIAA0932 protein,
1
GAAAGTGGAGAGGACCTAACATATGT

partial cds/cds = (0, 2782)

CTCTACCTAGAAAGGATGGTTTCA

504
Table 3A
Hs.4014
AB023163
4589535
mRNA for KIAA0946 protein,
1
ACCAACTATAAACCCAGTTCTAAAGT

partial cds/cds = (0, 2005)

TGTGTATGATGGTGAACCTTTGGG

505
Table 3A
Hs.75478
AB023173
4589555
mRNA for KIAA0956 protein,
1
GGACCTGAGACACTGTGGCTGTCTAA

partial cds/cds = (0, 2020)

TGTAATCCTTTAAAAATTCTCTGC

506
Table 3A
Hs.184523
AB023182
4589573
mRNA for KIAA0965 protein,
1
TTTGGTGTTCAGTTACTGAGTTTCAAA

partial cds/cds = (0, 1392)

AATGTTTTGGTGGCATGAGGACA

507
Table 3A
Hs.103329
AB023187
14133226
KIAA0970 protein (KIAA0970),
1
CCTGTTTAAGAAAGTGAAATGTTATG

mRNA/cds = (334, 2687)

GTCTCCCCTCTTCCAATGAGCTTA

508
Table 3A
Hs.158135
AB023198
4589605
mRNA for KIAA0981 protein,
1
ACGGACCAGGCCATTCATTATTCCTC

partial cds/cds = (0, 1737)

AAGTGTTAATATACTGACTTATGC

509
Table 3A
Hs.75381
AB023200
4589609
mRNA for KIAA0983 protein,
1
ACAGTTTTGTCAAAAAGTGTATCTTGA

complete cds/cds = (55, 2106)

CCCCACCATCAGTACTCCATTCT

510
Table 3A
Hs.343557
AB023216
14133228
601500320F1 cDNA, 5′ end
1
TTTGGTTCATCCGTGTGCTGTTCTTTT

/clone = IMAGE:3902237/

GGGTTCTGAGAGGGTTTTGCCAT

clone_end = 5′

511
Table 3A
Hs.23860
AB023227
4589669
mRNA for KIAA1010 protein,
1
GGCAGTAATGCAAGAGTCCTTTTGTG

partial cds/cds = (0, 3949)

AAGAGTGTTTCTATGTAGAGATGT

512
Table 3A
Hs.90093
AB023420
4579908
mRNA for heat shock protein
1
AAATGCAGAGCAGAATGGACCAGTG

apg-2, complete cds/cds =

GATGGACAAGGAGACAACCCAGGCC

(278, 2800)

513
Table 3A
Hs.6790
AB026908
5931603
microvascular endothelial
1
AGTGTTCCTGCTGCCAGTTCTTTCCT

differentiation gene 1 (MDG1),

CTTTAGGCGTGGTTGAGAAAAAGC

mRNA/cds = (202, 873)

514
Table 3A
Hs.21542
AB028958
5689406
KIAA1035 protein (KIAA1035),
1
CAGTCTCTGCCACTTGTGCTAGTTTT

mRNA/cds = (88, 3648)

TGTGTGGTGTTTAGAAACATGGGC

515
Table 3A
Hs.9846
AB028963
5689416
mRNA for KIAA1040 protein,
1
TTCCACTTAGGTTTGGCATTTTGGCA

partial cds/cds = (0, 1636)

GATAAGCTAATCTTGTATAAAGCA

516
Table 3A
Hs.89519
AB028969
5889428
KIAA1046 protein (KIAA1046),
1
GTAAATGCCCTACATGGTGTGATGCT

mRNA/cds = (577, 1782)

GCATTATATATAAAACTGTGTGCA

517
Table 3A
Hs.126084
AB028978
5689446
mRNA for KIAA1055 protein,
1
AGCTCCTGTGCTGACCTTCAAGTTAC

partial cds/cds = (0, 2607)

GTTTTGGAACTGTAATACTAAAGG

518
Table 3A
Hs.7243
AB028980
5689450
mRNA for KIAA1057 protein,
1
ACACTAGGGAAGAACCTTAATTCTAA

partial cds/cds = (0, 2934)

ATTTGGTTCATGTGTGGCAAAGTT

519
Table 3A
Hs.8021
AB028981
5689452
mRNA for KIAA1058 protein,
1
TAACTGGAATCACTGCCCTGCTGTAA

partial cds/cds = (0, 4604)

TTAAACATTCTGTACCACATCTGT

520
Table 3A
Hs.76118
AB028986
5689462
ubiquitin carboxyl-terminal
1
CCCCCAGTGCTTTGTAGTCTCTCCTA

esterase L1 (ubiquitin thiolesterase)

TGTCATAATAAAGCTACATTTTCT

(UCHL1), mRNA/cds = (31, 669)

521
Table 3A
Hs.325530
AB028990
5689470
mRNA for KIAA1067 protein,
1
GACAGACTTGGACACAAAACCGATCC

partial cds/cds = (0, 2072)

ATAGAAGGGCTTCCCAAACCTTGT

522
Table 3A
Hs.154525
AB028999
5689488
mRNA for KIAA1076 protein,
1
CCATATGTAACTTGTTTTGAAGAGAA

partial cds/cds = (0, 2415)

GTGTTTCCGTTGTGTGTCTTGATG

523
Table 3A
Hs.155546
AB029003
5689496
mRNA for KIAA1080 protein,
1
GTATCATCTGCCAAGACCAGGGCCT

partial cds/cds = (0, 1554)

GCTTCACCACAGCCACAATAAAGTC

524
Table 3A
Hs.26334
AB029008
5689502
mRNA for KIAA1083 protein,
1
AATGAACCATTTACAGTTCGGTTTTG

complete cds/cds = (221, 1975)

GACTCTGAGTCAAAGGATTTTCCT

525
Table 3A
Hs.54886
AB029015
5689520
mRNA for KIAA1092 protein,
1
GCCGAGTCAGCACATGGGTAGAGAT

partial cds/cds = (0, 3484)

GATGTAAAAGCAGCCAATCTGGAAA

526
Table 3A
Hs.117333
AB029016
14133234
mRNA for KIAA1093 protein,
1
ACCTTCTGGGAGGAGGGTCGGATTC

partial cds/cds = (179, 5382)

AATCTGAACTTAGAACTTTCAACTC

527
Table 3A
Hs.279039
AB029027
5689544
KIAA1104 protein (KIAA1104),
1
GCACCATGTAGAATTTTCACTTTGTA

mRNA/cds = (494, 2281)

CTGGCAGGCTCGTTTTACCTCATT

528
Table 3A
Hs.278586
AB029031
5689552
mRNA for KIAA1108 protein,
1
TCTCCAGTCCTGATTACTGTACACAG

partial cds/cds = (0, 2291)

TAGCTTTAGATGGCGTGGACGTGA

529
Table 3A
Hs.7910
AB029551
6714542
YEAF1 mRNA for YY1 and
1
TTCCTGTTACTGGCATGTGCACGACT

E4TF1 associated factor 1,

ATGTTATTAGAAGCCACTTTATCA

complete cds/cds = (198, 878)

530
Table 3A
Hs.14805
AB031050
7664246
solute carrier family 21
1
GCCAGCTTGGAGGATGGACATTTCTG

(organic anion transporter),

GATACACATACACATACAAAACAG

member 11 (SLC21A11),

mRNA/cds = (193, 2325)

531
db mining
Hs.91600
AB031479
6539431
SEEK1 protein (SEEK1),
1
TCAGCTCCTTGATCTAAGCCTCCCAG

mRNA/cds = (274, 732)

AGAGACCCCTAGAATGTTTCCCTC

532
db mining
Hs.146824
AB031480
6539433
SPR1 protein (SPR1),
1
CCGGCGGCAGGAACTATCAGTAGAC

mRNA/cds = (315, 725)

AGCTGCTGCTTCCATGAAACGGAAA

533
Table 3A
Hs.99872
AB032251
6683491
BPTF mRNA for bromodomain
1
TGTTGCCTTGAATATAACAGTACAATT

PHD finger transcription factor,

TGTCAATTACTCTGCACCAGGCT

complete cds/cds = (471, 8816)

534
Table 3A
Hs.8858
AB032252
6683493
bromodomain adjacent to zinc
1
AAAAGTAACACCCTCCCTTTTTCCTG

finger domain, 1A (BAZ1A),

ACAGTTCTTTCAGCTTTACAGAAC

mRNA/cds = (115, 5139)

535
Table 3A
Hs.288430
AB032948
6329727
601655928R1 cDNA, 3′ end
1
AATGAAATGTAGTTGGGTTCTTCCTG

/clone = IMAGE:3855679/

TAATGCGCTATTATGTCTTGGGCT

clone_end = 3′

536
Table 3A
Hs.44087
AB032952
6329754
mRNA for KIAA1126 protein,
1
AACCTCCTTGTGTCTGTTTCTCTGTTC

partial cds/cds = (0, 1857)

CTCTGTGGCTGACTCAATAAACT

537
Table 3A
Hs.153489
AB032972
6330026
mRNA for KIAA1146 protein,
1
GTGGGAGGGTGAGATGTGAAGATGT

partial cds/cds = (0, 815)

GGGATGAACCTGGAATGAACGAATT

538
Table 3A
Hs.12461
AB032973
6330032
mRNA for KIAA1147 protein,
1
GGCCTAAAGAAAGCTGGGGTTAATCC

partial cds/cds = (0, 589)

TGAAGCTAAAAGTAAATGTTTCTT

539
Table 3A
Hs.343199
AB032976
6330050
EST374106 cDNA
1
TCCCATCCTTTCCATCAAGACCTTCA

TTAGCTTATGATATTTGCTGCCGA

540
Table 3A
Hs.6298
AB032977
6382017
mRNA for KIAA1151 protein,
1
GGAGGTCTCTTCCAGATTGCTCTTCT

partial cds/cds = (0, 689)

GCCGAATTATTTGTATCTATTCCG

541
Table 3A
Hs.290398
BF341403
11287894
602013389F1 cDNA, 5′ end
1
GCACACCTCGTCAGAGGACCATAAC

/clone = IMAGE:4149209/

CGTGTGGGGACAATAACCGCAGGGG

clone_end = 5′

542
Table 3A
Hs.7041
AB033034
6382021
mRNA for KIAA1208 protein,
1
ACAATGGATTTGTGAAGAGCAGATTC

partial cds/cds = (24, 2015)

CATGAGTAACTCTGACAGGTATTT

543
Table 3A
Hs.29679
AB033042
6330568
cofactor required for Sp1
1
TGAGAGACATTGTTAATTTTGGGGGA

transcriptional activation,

ATTGGCATTGCGAAAGACTTGAAA

subunit 3 (130 kD) (CRSP3),

mRNA/cds = (119, 4225)

544
Table 3A
Hs.7252
AB033050
6330623
mRNA for KIAA1224 protein,
1
TGCTAGACATTTCTATACTCTGTTGTA

partial cds/cds = (0, 1908)

ACACTGAGGTATCTCATTTGCCC

545
Table 3A
Hs.267690
AB033054
6330689
mRNA for KIAA1228 protein,
1
GTGGGGGATGGGGGTTAAAAAGTAG

partial cds/cds = (0, 2176)

AGAACCTCCTTTCTGTTCAACTAAT

546
Table 3A
Hs.9873
AB033076
14133246
mRNA for KIAA1250 protein,
1
CAGGTGAGTAGTTGCCGCGTAATATC

partial cds/cds = (139, 5472)

ATTGGAGTACATTCTTTATACTGT

547
Table 3A
Hs.146888
AB033079
6382025
mRNA for KIAA1253 protein,
1
CCCCAACCTTATTCTGTGTGTAGACA

partial cds/cds = (0, 1416)

TTGTATTCCACAATTTTGAATGGC

548
Table 3A
Hs.301721
AB033081
6330899
mRNA for KIAA1255 protein,
1
CGAATGGCTTAAACTAATTTGCTATG

partial cds/cds = (0, 2866)

ATCCTCTAACACCGAAATTTCCCA

549
Table 3A
Hs.40193
AB033085
6330932
mRNA for KIAA1259 protein
1
AGAGGGAATCAGAAAAATGCCAAGC

CTTTTCTCTTTGAATGTGCTATTTT

550
Table 3A
Hs.43141
AB033093
6331205
mRNA for KIAA1267 protein,
1
CACCCTTCTCTGTTAACCTTGTGCCT

partial cds/cds = (94, 3411)

GTCTCCTGTATGATCACATCACCA

551
Table 3A
Hs.42179
AB033112
6331388
mRNA for KIAA1288 protein,
1
TGTGTCTCTGTCGCGTCTGCTGTGAA

partial cds/cds = (197, 3841)

GCACATGATGCTCTATTTATTGTA

552
Table 3A
Hs.63126
AB033118
6331442
mRNA for KIAA1292 protein,
1
TGAGAGTAAGCACATGACAGCGTCTG

partial cds/cds = (0, 1788)

CTTGCGTTGTGTCTGTTTTATGTT

553
Table 3A
Hs.278870
AB034205
6899845
acid-inducible phosphoprotein
1
TCGTGTGAATCAGACTAAGTGGGATT

(OA48-18), mRNA/cds =

TCATTTTTACAACTCTGCTCTACT

(275, 445)

554
Table 3A
Hs.76507
AB034747
12862475
LPS-induced TNF-alpha factor
1
TGCAACGAATATGGATACCACATAGT

(PIG7), mRNA/cds =

ACTTTGGTGTTACCTGCTTTTGAA

(233, 919)

555
db mining
Hs.184
AB036432
6691625
advanced glycosylation end
1
AGAACTGAATCAGTCGGAGGAACCT

product-specific receptor (AGER),

GAGGCAGGCGAGAGTAGTACTGGAG

mRNA/cds = (0, 1214)

556
Table 3A
Hs.194369
AB036737
8096339
mRNA for RERE, complete cds
1
TTGCCATGAGATAACACAGTGTAAAC

/cds = (638, 5336)

AGTAGACACCCAGAAATCGTGACT

557
Table 3A
Hs.125037
AB037752
7243042
hypothetical protein FLJ20548
1
GCTGTTAGGCTAAGAGGGTGCAGGG

(FLJ20548), mRNA/cds =

CTAGACACGAAGCTTAAACTATTCA

(167, 1432)

558
Table 3A
Hs.22941
AB037784
7243106
mRNA for KIAA1383 protein,
1
CCAGTGTGGAGGTAGCAAAGCATCTA

partial cds/cds = (0, 1293)

TCTATTCTGAATCATGTTTGGAAA

559
Table 3A
Hs.258730
AB037790
7243118
mRNA for KIAA1369 protein,
1
GCCAGTATGCCACAGAATGTCCTAAA

partial cds/cds = (0, 1963)

CCCTTGCTGCCTCTTATCAAAACC

560
Table 3A
Hs.29716
AB037791
7243120
mRNA for KIAA1370 protein,
1
TTTGTACTGTTGAAACCACTTCATTG

partial cds/cds = (49, 3372)

GACATGTTGCAATAGCAAAACCCC

561
Table 3A
Hs.9663
AB037796
7243130
mRNA for KIAA1375 protein,
1
AGGGGGAACATTGTAAAGAAAC

partial cds/cds = (0, 1640)

AAAAAGGTCCAGATGAATGTATGC

TAGA

562
Table 3A
Hs.24684
AB037797
7243132
mRNA for KIAA1376 protein,
1
GGTGCTGAATATGTCCTTGTAGGCTC

partial cds/cds = (143, 1456)

TGTTTTAAGAAAACAATATGTGGG

563
Table 3A
Hs.6685
AB037801
7243140
mRNA for KIAA1380 protein,
1
ACATTGGCTTGCTTTTGTTAAAGTGC

partial cds/cds = (0, 3798)

AAGTGTTACATATGGCTTTGTACA

564
Table 3A
Hs.334878
NM_032837
14249549
hypothetical protein FLJ14775
1
TTGGTAGTGTCAGCGGGCACCTTTTA

(FLJ14775), mRNA/cds =

CACCTTCTAGTAGCTCAAGCTAGT

(171, 533)

565
Table 3A
Hs.301434
AB037808
7243154
mRNA for KIAA1387 protein,
1
TCCTGGAATCGTTTAATCTAAAGCAG

partial cds/cds = (0, 2852)

TTTCCCCTGTTTTGGAGATTTTGT

566
Table 3A
Hs.301434
AB037808
7243154
mRNA for KIAA1387 protein,
1
TCCTGGAATCGTTTAATCTAAAGCAG

partial cds/cds = (0, 2852)

TTTCCCCTGTTTTGGAGATTTTGT

567
Table 3A
Hs.15370
AB037828
7243194
mRNA for KIAA1407 protein,
1
TGAGAAAGTCCTGTGCAGTCCTGAGA

partial cds/cds = (0, 2235)

TGATTACTCTTATTTGGTGTGCTG

568
Table 3A
Hs.274396
AB037844
7243226
mRNA for KIAA1423 protein,
1
TCGTCTTTTGCGAATGGCTTAATTCT

partial cds/cds = (0, 1851)

GACACTACCTTTCTGGGAAATGTT

569
Table 3A
Hs.149918
AB037901
10567183
GASC-1 mRNA, complete cds
1
TTTGATTGTGTCTGATGGGAACTGAG

/cds = (150, 3320)

TTGTTGGCCTTTGTGAAATGAAAT

570
Table 3A
Hs.284205
AB040120
12657580
up-regulated by BCG-CWS
1
TTGACAAAGCCCAACAATGATCTCAG

(LOC64116), mRNA/cds =

GAATTACATTTTCCAACAGACCAA

(477, 1859)

571
Table 3A
Hs.6682
AB040875
13516845
solute carrier family 7, (cationic
1
ACCTGTCACGCTTCTAGTTGCTTCAA

amino acid transporter, y+ system)

CCATTTTATAACCATTTTTGTACA

member 11 (SLC7A11), mRNA/

cds = (235, 1740)

572
Table 3A
Hs.109694
AB040884
7959160
mRNA for KIAA1451 protein,
1
TCCTTAAGGTGCACAGTAAATGTACA

partial cds/cds = (0, 1467)

GATAGTTATAGGCCACTGTTTTGT

573
Table 3A
Hs.210958
AB040919
7959232
mRNA for KIAA1486 protein,
1
AGCTCATATGAACACTGCTCTGAACT

partial cds/cds = (11, 2044)

CCTCTGACTTAGCATTCAACTTAA

574
Table 3A
Hs.20237
AB040922
7959238
mRNA for KIAA1489 protein,
1
CATGACAAACATTACTAGCATGTTCA

partial cds/cds = (1619, 3154)

ACTGCACCATGTTCTGGCACTGTA

575
Table 3A
Hs.35089
AB040929
7959252
mRNA for KIAA1496 protein,
1
ACCTCTTTCCTACCAATTTCACATTTT

partial cds/cds = (0, 2763)

GCAGAAACTTGTTCACATTTCCA

576
Table 3A
Hs.201500
AB040942
7959278
mRNA for KIAA1509 protein,
1
GGGTTGTGTATTAAATAGCCATTCAT

partial cds/cds = (0, 3982)

TCTGGAACTCAAGGACAGGACTGT

577
Table 3A
Hs.93836
AB040959
7959318
mRNA for KIAA1526 protein,
1
GCCTTGCAGGTGACCAGCAGTGTCA

partial cds/cds = (0, 2892)

TTGTATTTATATACAGAGCTTATGA

578
Table 3A
Hs.89135
AB040961
7959322
mRNA for KIAA1528 protein,
1
CTGGACGGGCGTGGGTTCTGGGTCA

partial cds/cds = (4, 2226)

GCTTCTTTTACCTCAATTTTGTTTG

579
Table 3A
Hs.85752
AB040974
7959348
mRNA for KIAA1541 protein,
1
AAAGTCTGAGGTGTGGAACAGTTATT

partial cds/cds = (908, 2341)

TAAGCATTAGTCAACCCTGGTCCT

580
Table 3A
Hs.18259
AB044661
11094140
XPA binding protein 1; putative
1
TGGGCAAGACATGATTAATGAATCAG

ATP(GTP)-binding protein

AATCCTGTTTCATTGGTGACTTGG

(NTPBP), mRNA/cds =

(24, 1148)

581
Table 3A
Hs.142838
AB044971
13699901
nucleolar protein interacting with
1
CCTGTGTAAAAGAAGAAATACAAGAG

the FHA domain of pKi-67

ACTCAAACACCTACACATTCACGG

(NIFK), mRNA/cds = (54, 935)

582
Table 3A
Hs.140720
AB045118
13365650
FRAT2 mRNA, complete cds
1
TGGCTTGTTCATCCTCCAGATGTAGC

/cds = (129, 830)

TATTGATGTACACTTCGCAACGGA

583
Table 3A
Hs.136414
AB045278
13588433
UDP-GlcNAc:betaGal beta-1,3-N-
1
AACTATCAGCTTGGATGGTCACTTGA

acetylglucosaminyltransferase 5

ATAGAAGATGGTTATACACAGTGT

(B3GNT5), mRNA/cds =

(129, 1265)

584
Table 3A
Hs.127270
AB046765
10047154
mRNA for KIAA1545 protein,
1
CCACGGTGGACCCTGTTTGTTTTAAA

partial cds/cds = (0, 2445)

TATTCTGTTCCCATGTCAATCAGT

585
Table 3A
Hs.65641
AB048766
10047156
hypothetical protein FLJ20073
1
TTGTGTAGGAAACTTTTGCAGTTTGA

(FLJ20073), mRNA/cds =

CACTAAGATAACTTCTGTGTGCAT

(16, 1908)

586
Table 3A
Hs.323822
AB046771
10047168
mRNA for KIAA1551 protein,
1
ACTCAAATCAGTTAGCTTCAAACAAA

partial cds/cds = (0, 3750)

AACGAAAGTTAGACCAAGGGAACG

587
Table 3A
Hs.323822
AB048771
10047166
mRNA for KIAA1551 protein,
1
ACTCAAATCAGTTAGCTTCAAACAAA

partial cds/cds = (0, 3750)

AACGAAAGTTAGACCAAGGGAACG

588
Table 3A
Hs.17767
AB046774
10047172
mRNA for KIAA1554 protein,
1
TTGTGTGCTGTGCTTCAAAGCCTTAA

partial cds/cds = (0, 3983)

CTGTCAAATCTTGCATTATCTTGT

589
Table 3A
Hs.44054
AB046785
10047194
ninein (GSK3B interacting protein)
1
ACATTATCATGGCATGACTTAAGGGA

(NIN), mRNA/cds = (202, 6345)

ACATTGGTTTGTGAAGGAAAAACA

590
Table 3A
Hs.168640
AB046801
10047236
mRNA for KIAA1581 protein,
1
TGTGTGACTTTCATGCTTCTGGGGTT

partial cds/cds = (0, 1839)

GGAGCTTAAAGATCCAAACTGAGA

591
Table 3A
Hs.129750
AB046805
10047244
mRNA for KIAA1585 protein,
1
TGCTGGTATTCTCACTGCCACATTTTT

partial cds/cds = (27, 1814)

GGAAACCTGTATTACACCTTAAA

592
Table 3A
Hs.18587
AB046808
10047250

Homo sapiens, clone MGC:15071
1
TTGAGTGTCTGCAGCAGCCCTGGACT

IMAGE:4110510, mRNA,

TCCAGACTTCTATCACATGAGAAA

complete cds/cds = (977, 2212)

593
Table 3A
Hs.11123
AB046813
10047260
mRNA for KIAA1593 protein,
1
TGGTGCTGATGCTTAGTTGTCTCATG

partial cds/cds = (477, 3338)

CCATTAAATTGTAAAAGTGAGTTG

594
Table 3A
Hs.343582
AB046825
10047284
RC6-HT0592-270300-011-D11
1
GGAGGTCAGTTGATTTCCCCAGGTAC

cDNA

ATTCATGGTGTGACAGACACATGG

595
Table 3A
Hs.222748
AB046830
10047294
mRNA for KIAA1610 protein,
1
AGATCCTTTCAGTCCCTAGACCTCCA

partial cds/cds = (0, 1458)

TTCACTCTGTTTCTCTTCTGCTGG

596
Table 3A
Hs.6639
AB046844
10047324
mRNA for KIAA1624 protein,
1
GATCCGATCATGGTGATGTACGGGG

partial cds/cds = (0, 1800)

TGAATTCTCTTGCCGTGTTGCAAAT

597
Table 3A
Hs.288140
AB046857
10047350
mRNA for KIAA1637 protein,
1
ATGGTTTCAAAATTCAAGGTCCCCAA

partial cds/cds = (0, 1441)

ATGGCAGCATTTTATGTTCTGACC

598
Table 3A
Hs.44566
AB046861
10047358
KIAA1841 protein (KIAA1641),
1
CAAGTATGTATGCAACTTTGCACACC

mRNA/cds = (40, 453)

AACAACTGTTAATCTGTAGCTAGT

599
Table 3A
Hs.82113
AB049113
10257384
dUTP pyrophosphatase (DUT),
1
TGGTGATTCTCCAGGCCATTTAATAC

mRNA/cds = (29, 523)

CCTGCAATGTAATTGTCCCTCTGT

600
Table 3A
Hs.323463
AB051480
12697930
mRNA for KIAA1693 protein,
1
TTCTGCCTCAATGTTTACTGTGCCTTT

partial cds/cds = (0, 2707)

GTTTTTGCTAGTTTGTGTTGTTG

601
Table 3A
Hs.19597
AB051481
12697932
mRNA for KIAA1694 protein,
1
ACTACTGTCACGTAGCTGTGTACAAA

partial cds/cds = (0, 2274)

GAGATGTGAAATACTTTCAGGCAA

602
Table 3A
Hs.20281
AB051487
12697944
mRNA for KIAA1700 protein,
1
TGTTGAACGGTTAAACTGTGCATTTC

partial cds/cds = (108, 2180)

TCATTTTGATGTGTCATGTATGTT

603
Table 3A
Hs.7076
AB051492
12697954
mRNA for KIAA1705 protein,
1
AATGGTCAAGGTTCAGCATATTCTAT

partial cds/cds = (1713, 3209)

ATGAAGATCACAAGGTGGTATCGT

604
Table 3A
Hs.25127
AB051512
12697994
mRNA for KIAA1725 protein,
1
TGTGAACTTGTGCGCAAATGTGCAGA

partial cds/cds = (0, 3129)

TTCAATGTTCTTGTTACAGATTGA

605
Table 3A
Hs.66053
AB051540
12698050
mRNA for KIAA1753 protein,
1
CCCCTTGGGCTCAGCACGAAAGGGC

partial cds/cds = (0, 2457)

TTTCAATGAATTAAGTGAAAACTTT

606
Table 3A
Hs.7187
AB051544
12698058
mRNA for KIAA1757 protein,
1
AATGAGTTGTGTTGAAGCCTCCGTCT

partial cds/cds = (347, 4576)

CCCATCCTTGCCTGTAGCCCGTAG

607
Table 3A
Hs.248367
AB058677
14017778
MEGF11 protein (MEGF11),
1
AGCCTAAACATGTATACTGTGCATTTT

mRNA/cds = (159, 3068)

ATGGGTGACTTTGAAAGATCTGT

608
Table 3A
Hs.227400
AF000145
3095031
mitogen-activated protein kinase
1
ACCAGGTTTTAGCAAAATGCACACTT

kinase kinase kinase 3 (MAP4K3),

TTGGCTCTTTTTGGTATATGTTCT

mRNA/cds = (360, 3014)

609
Table 3A
Hs.8180
AF000852
2795862
syndecan binding protein
1
CCTGACTCCTCCTTGCAAACAAAATG

(syntanin) (SDCBP), mRNA/

ATAGTTGACACTTTATCCTGATTT

cds = (148, 1044)

610
Table 3A
Hs.147916
AF000982
2580549
DEAD/H (Asp—Glu—Ala—
1
TTGTATTGGCATAATCAGTGACTTGT

Asp/His) box polypeptide 3

ACATTCAGCAATAGCATTTGAGCA

(DDX3), transcript variant 2,

mRNA/cds = (856, 2844)

611
Table 3A
Hs.13980
AF000993
2580571
ubiquitously transcribed
1
TTGTTAAGTTGCAATTACTGCAATGA

tetratricopeptide repeat gene, X

CAGACCAATAAACAATTGCTGCCA

chromosome (UTX), mRNA

/cds = (26, 4231)

612
Table 3A
Hs.159523
AF001622
3930162
class-I MHC-restricted T cell
1
ACAGCAAACTTTGGCATTTATGTGGA

associated molecule (CRTAM),

GCATTTCTCATTGTTGGAATCTGA

mRNA/cds = (0, 1181)

613
Table 3A
Hs.58435
AF001862
2232149
FYN-binding protein
1
TGGTCATTCTGCTGTGTTCATTAGGT

(FYB-120/130) (FYB),

GCCAATGTGAAGTCTGGATTTTAA

mRNA/cds = (30, 2381)

614
Table 3A
Hs.78918
AF002020
2276462
Niemann-Pick disease, type C1
1
GGCATGAAATGAGGGACAAAGAAAG

(NPC1), mRNA/cds = (123, 3959)

CATCTCGTAGGTGTGTCTACTGGGT

615
Table 3A
Hs.18792
AF003938
2897941
thioredoxin-like, 32 kD (TXNL),
1
AATCTTGACACATGCAATTGTAAATAA

mRNA/cds = (205, 1074)

AAGTCACCACTTTTGCCAAGCTT

616
Table 3A
Hs.337778
AF004230
2343108
hypothetical protein FLJ11068
1
TGATGCCTTCATCTGTTCAGTCATCT

(FLJ11068), mRNA/cds =

CCAAAAACAGTAAAAATAACCACT

(163, 1188)

617
Table 3A
Hs.183805
AF005213
2843115
ankyrin 1, erythrocytic (ANK1),
1
GGCCAAGCTGAATGCCATGAATATCA

transcript variant 3, mRNA

GTGAGACGCGTTATAAGGAATCCT

/cds = (84, 5726)

618
Table 3A
Hs.42915
AF006082
2282029
ARP2 (actin-related protein 2,
1
CCTGCCAGTGTCAGAAAATCCTATTT

yeast) homolog (ACTR2), mRNA

ATGAATCCTGTCGGTATTCCTTGG

/cds = (74, 1258)

619
Table 3A
Hs.6895
AF006086
2282037
actin related protein 2/3 complex,
1
TCAAGAATTTGGGTGGGAGAAAAGAA

subunit 3 (21 kD) (ARPC3),

AGTGGGTTATCAAGGGTGATTTGA

mRNA/cds = (25, 581)

620
Table 3A
Hs.82425
AF006088
2282041
actin related protein 2/3 complex,
1
CAAACTGGTGCAGAAATTCTATAAAC

subunit 5 (18 kD) (ARPC5),

TCTTTGCTGTTTTTGATACCTGCT

mRNA/cds = (24, 479)

621
Table 3A
Hs.22670
AF006513
2645428
chromodomain helicase DNA
1
GCTACTTGTTTACATTGTACACTGCG

binding protein 1 (CHD1),

ACCACCTTGCCGCTTTTCATCACA

mRNA/cds = (163, 5292)

622
Table 3A
Hs.24752
AF006516
2245670
spectrin SH3 domain binding
1
ACTGGATGCTACAGACTTATAACAGC

protein 1 (SSH3BP1),

ATAGTGAATGGTAAGACTAGTGCA

mRNA/cds = (81, 1607)

623
Table 3A
Hs.321149
AF007155
2852635
cDNA FLJ10257 fis, clone
1
CCTCCCCTATGCCTCAGCCCCATCTC

HEMBB1000887/cds =

TGCTCCTGTTTGAATTTTGTTATT

UNKNOWN

624
Table 3A
Hs.5409
AF008442
2266928
RNA polymerase I subunit
1
CCAGTGTGACTAGGGATCCTGAGTTT

(RPA40), mRNA/cds = (22, 1050)

TCTGGGACAATTCCAGCTTTAATC

625
Table 3A
Hs.225977
AF012108
2331249
nuclear receptor coactivator 3
1
TGACCCTTCTTTAAGTTATGTGTGTG

(NCOA3), mRNA/cds =

GGGAGAAATAGAATGGTGCTCTTA

(183, 4421)

626
Table 3A
Hs.334874
AF012872
2326226
phosphatidylinositol 4-kinase 230
1
GTGTGAGTCCTCTGTTTGCACTGGAC

(pl4K230) mRNA, complete cds

ATATTCCCTACCTGTCTTATTTCA

/cds = (0, 6134)

627
Table 3A
Hs.199291
AF015041
4102706
NUMB-R protein (NUMB-R)
1
AGGGGAAGGGGTGCCTGGCGGGTAC

mRNA, complete cds/cds =

TTTTCTATCTTTTATTTCCAGATTT

(209, 2038)

628
Table 3A
Hs.51233
AF016266
2529582
TRAIL receptor 2 mRNA,
1
TCATGCTTCTGCCCTGTCAAAGGTCC

complete cds/cds = (117, 1439)

CTATTTGAAATGTGTTATAATACA

629
Table 3A
Hs.76807
AF016270
2655005
major histocompatibility complex,
1
AGCTAGCAGATCGTAGCTAGTTTGTA

class II, DR alpha (HLA-DRA),

TTGTCTTGTCAATTGTACAGACTT

mRNA/cds = (26, 790)

630
Table 3A
Hs.104624
AF016495
6560598
aquaporin 9 (AQP9), mRNA
1
AGCCCAGAATTCCCAAAGGCATTAGG

/cds = (286, 1173)

TTTCCCAACTGCTTTGTGCTGATA

631
Table 3A
Hs.10958
AF021819
2460317
RNA-binding protein regulatory
1
GTGTCTATACATTTCTAAGCCTTGTTT

subunit (DJ-1), mRNA/cds =

GCAGAATAAACAGGGCATTTAGC

(20, 589)

632
Table 3A
Hs.125134
AF023142
4102966
pre-mRNA splicing SR protein rA4
1
TAGAGGTGTACAGATGCTATATTATA

mRNA, partial cds/cds = (0, 3473)

TCCGCTCCCGGTGTACTGCAGCCC

633
Table 3A
Hs.108809
AF028292
2559009
chaperonin containing TCP1,
1
TTTTACAAGGAAGGGGTAGTAATTGG

subunit 7 (eta) (CCT7),

CCCACTCTCTTCTTACTGGAGGCT

mRNA/cds = (68, 1699)

634
Table 3A
Hs.168103
AF026402
2655201
prp28, U5 snRNP 100 kd protein
1
ACACGGTGAACTGGCTGTGTCCATCT

(U5-100K), mRNA/cds =

TTGTCACTGAGTGAAATCTCTGTT

(39, 2501)

635
Table 3A
Hs.9573
AF027302
2522533
ATP-binding cassette, sub-family F
1
TGAGGACTTGGGGCAGGAAAGGAAT

(GCN20), member 1 (ABCF1),

GCTGCTGAACTTGAATTTCCCTTTA

mRNA/cds = (94, 2517)

636
Table 3A
Hs.168132
AF031167
2739159
interleukin 15 (IL15), mRNA
1
TCAGACCTTGGATCAGATGAACTCTT

/cds = (316, 804)

AGAAATGAAGGCAGAAAAATGTCA

637
Table 3A
Hs.170133
AF032885
2895491
forkhead box O1A
1
CCACGTTCTTGTTCCGATACTCTGAG

(rhabdomyosarcoma) (FOXO1A),

AAGTGCCTGATGTTGATGTACTTA

mRNA/cds = (385, 2352)

638
Table 3A
Hs.74276
AF034607
4426566
chloride intracellular channel 1
1
GCCTGGGTCAGATTTTTATTGTGGGG

(CLIC1), mRNA/cds = (236, 961)

TGGGATGAGTAGGACAACATATTT

639
Table 3A
Hs.106890
AF035306
2681087
clone 23771 mRNA sequence
1
GGGTGCCCACCTGCATGTGAAGGGG

/cds = UNKNOWN

AGGCAGTTCTCAATTTATTTCAATA

640
Table 3A
Hs.184897
AF035307
2661068
clone 23785 mRNA sequence
1
CAGTCACTGGGTCTATATTAAACAGC

/cds = UNKNOWN

AACCAGAGCAACAAATGGCAAACA

641
Table 3A
Hs.278589
AF035737
2827179
general transcription factor II, i
1
TGACATGGTAGCAGAAATAGGCCCTT

(GTF2i), transcript variant 1,

TTATGTGTTGCTTCTATTTTACCT

mRNA/cds = (370, 3366)

642
Table 3A
Hs.8257
AF035947
9695283
cytokine-inducible inhibitor of
1
AGCAAAGAACAGTTTGGTGGTCTTTT

signalling type 1b mRNA,

CTCTTCCACTGATTTTTCTGTAAT

complete cds/cds = (3131, 3925)

643
Table 3A
Hs.8900
AF037204
2906012
ring finger protein 13 (RNF13),
1
AGCCCTGCTAAACTATGTACAGAGGA

mRNA/cds = (151, 1296)

AACTGTTCAAGTATTGGATTTGAA

644
Table 3A
Hs.155489
AF037448
3037012
NS1-associated protein 1 (NSAP1),
1
TGTCAACGATGTTTCCAGTAGTGTTT

mRNA/cds = (204, 1892)

AGATTTGGTGTCTTCAAAGGTAGT

645
Table 3A
Hs.12311
AF038202
2795923
clone 23570 mRNA sequence
1
GGCTTTTTGCCCATCAAGAATAAAAA

/cds = UNKNOWN

GAAATAAAACCAAAGGGTTACCGG

646
Table 3A
Hs.76807
AF038564
2708328
major histocompatibility complex,
1
TGCCTGTTGCACATCTTGTAAAATTG

class II, DR alpha (HLA-DRA),

GACAATGGCTCTTTAGAGAGTTAT

mRNA/cds = (26, 790)

647
Table 3A
Hs.303627
AF039575
2773157
heterogeneous nuclear
1
TGCGGCTAGTTCAGAGAGATTTTTAG

ribonucleoprotein D (AU-rich

AGCTGTGGTGGACTTCATAGATGA

element RNA-binding protein 1,

37 kD) (HNRPD), transcript

variant 1, mRNA/cds =

(285, 1352)

648
Table 3A
Hs.29417
AF039942
4730928
HCF-binding transcription factor
1
AATGGAAGGATTAGTATGGCCTATTT

Zhangfei (ZF), mRNA/cds =

TTAAAGCTGCTTTGTTAGGTTCCT

(457, 1275)

649
Table 3A
Hs.8185
AF042284
5256829
CGI-44 protein; sulfide
1
CCATGTGGGCTACTCATGATGGGCTT

dehydrogenase like (yeast)

GATTCTTTGGGAATAATAAAATGA

(CGI-44), mRNA/cds = (76, 1428)

650
db mining
Hs.298727
AF042838
2815887
MEK kinase 1 (MEKK1) mRNA,
1
AACGAGGCCAGTGGGGAACCCTTAC

partial cds/cds = (0, 4487)

CTAAGTATGTGATTGACAAATCATG

651
Table 3A
Hs.82280
AF045229
2908029
regulator of G-protein signalling 10
1
CCTCTCAGGACGTGCCGGGTTTATCA

(RGS10), mRNA/cds = (43, 546)

TTGCTTTGTTATTTGTAAGGACTG

652
Table 3A
Hs.62112
AF046001
2895869
zinc finger protein 207 (ZNF207),
1
CCACTGCCTGAAAGGTTTGTACAGAT

mRNA/cds = (202, 1838)

GCATGCCACAGTAGATGTCCACAT

653
Table 3A
Hs.241520
AF047002
2896145
transcriptional coactivator ALY
1
TTTTGGGATAAATTTTACTGGTTGCTG

mRNA, partial cds/cds = (0, 701)

TTGTGGAGAAGGTGGCGTTTCCA

654
Table 3A
Hs.132904
AF047033
5051627
sodium bicarbonate cotransporter 3
1
TGAAGTATAAGCCTCTACTGGGTCTA

(SLC4A7) mRNA, complete cds

TATTGTGAATCATCCTGCCTTTCA

/cds = (71, 3715)

655
Table 3A
Hs.50785
AF047442
3335139
SEC22, vesicle trafficking protein
1
CTCGTCTATTGGCCCCTGTAGAAAGT

(S. cerevisiae)-like 1 (SEC22L1),

TAACCTTTGTTGTTTTCCTTTTAT

mRNA/cds = (119, 766)

656
Table 3A
Hs.40323
AF047472
2921872
BUB3 (budding uninhibited by
1
TCCCCTTCTGTCCCCTAGTAAGCCCA

benzimidazoles 3, yeast) homolog

GTTGCTGTATCTGAACAGTTTGAG

(BUB3), mRNA/cds = (70, 1056)

657
Table 3A
Hs.26584
AF051782
2947237
diaphanous 1 (HDIA1) mRNA,
1
AAACCTATTTCCCTTGCCTCATAGGC

complete cds/cds = (0, 3746)

TTCTGGGATGTCATCACCTCCAGT

658
Table 3A
Hs.313
AF052124
3360431
secreted phosphoprotein 1
1
GAATTTGGTGGTGTCAATTGCTTATTT

(osteopontin, bone sialoprotein I,

GTTTTCCCACGGTTGTCCAGCAA

early T-lymphocyte activation 1)

(SPP1), mRNA/cds = (67, 989)

659
Table 3A
Hs.227949
AF052155
3360468
SEC13 (S. cerevisiae)-like 1
1
CTATTTTGGGTCATTTTTATGTACCTT

(SEC13L1), mRNA/cds =

TGGGTTCAGGCATTATTTGGGGG

(60, 1028)

660
literature
Hs.115770
AF053712
3057145
tumor necrosis factor (ligand)
1
TAATTGTTGAACAGGTGTTTTTCCACA

superfamily, member 11

AGTGCCGCAAATTGTACCTTTTT

(TNFSF11), transcript variant 1,

mRNA/cds = (156, 1109)

661
Table 3A
Hs.178710
AF054174
3341991
clathrin, heavy polypeptide (Hc)
1
CCCCCTCAGAAGAATCATGAATTTGC

(CLTC), mRNA/cds = (172, 5199)

AACAGACCTAATTTTTGGTTACTT

662
Table 3A
Hs.233952
AF054185
4092057
proteasome (prosome; macropain)
1
GGCCTTTCCATTCCATTTATTCACACT

subunit, alpha type, 7 (PSMA7),

GAGTGTCCTACAATAAACTTCCG

mRNA/cds = (24, 770)

663
Table 3A
Hs.158164
AF054187
4092059
transporter 1, ATP-binding
1
TGGTGTCTCAAAGGAGTAACTGCAGC

cassette, sub-family B (MDR/TAP)

TTGGTTTGAAATTTGTACTGTTTC

(TAP1), mRNA/cds = (30, 2456)

664
Table 3A
Hs.334826
AF054284
4033734
splicing factor 3b, subunit 1,
1
TGCCAGTAGTGACCAAGAACACAGTG

155 kD (SF3B1), mRNA/cds =

ATTATATACACTATACTGGAGGGA

(0, 3914)

665
Table 3A
Hs.13131
AF055581
3845720
lymphocyte adaptor protein (LNK),
1
AGGACACATCTGACATCCTGTGTTTG

mRNA/cds = (357, 2084)

GTTAAAATATACAGCACATTGTGA

666
Table 3A
Hs.278501
AF056322
3252910
SPG-100 (SP100) gene, partial cds;
1
TGGGGGTTGTAAATTGGCATGGAAAT

and high mobility group 1-like

TTAAAGCAGGTTCTTGTTAGTGCA

protein L3 (HMG1L3)

retropseudogene sequence/cds =

(0, 617)

667
Table 3A
Hs.6856
AF056717
3046994
ash2 (absent, small, or homeotic,
1
TGTGAAAGAAACTTGCTTGCAGCTTT

Drosophila, homolog)-like

AACAAAATGAGAAACTTCCCAAAT

(ASH2L), mRNA/cds = (4, 1890)

668
Table 3A
Hs.169895
AF061738
4335938
ubiquitin-conjugating enzyme
1
GTATATATCCTCCAGCATTCAGTCCA

E2L 6 (UBE2L6), mRNA/cds =

GGGGGAGCCACGGAAACCATGTTC

(47, 508)

669
Table 3A
Hs.182579
AF061738
4335940
leucine aminopeptidase
1
TGTGATGCTAGGAACATGAGCAAACT

(LOC51058), mRNA/cds =

GAAAATTACTATGCACTTGTCAGA

(188, 1745)

670
Table 3A
Hs.184592
AF061944
6933863
protein kinase, lysine deficient 1
1
AACCCAGTATATCTGTGTTATCTGAT

(PRKWNK1), mRNA/cds =

GGGACGGTTGACAGTGGTCAGGGA

(0, 7148)

671
Table 3A
Hs.79015
AF063591
12002013
antigen identified by monoclonal
1
ATCCAGTGGCCTAGGAATTAAAGTGT

antibody MRC OX-2 (MOX2),

TGTTGTTTTTGCTGTTAAATTGGA

mRNA/cds = (57, 866)

672
Table 3A
Hs.11000
AF083805
4071360
MY047 protein (MY047), mRNA
1
GCATTGGCAGCATTGTGTCTTTGACC

/cds = (84, 479)

TTGTATACTAGCTTGACATAGTGC

673
Table 3A
Hs.129708
AF064090
3283355
tumor necrosis factor (ligand)
1
TTTCATGGTGTGAAGGAAGGAGCGT

superfamily, member 14

GGTGCATTGGACATGGGTCTGACAC

(TNFSF14), mRNA/cds =

(48, 770)

674
Table 3A
Hs.83530
AF064839
4206051
map 3p21; 3.15 cR from WI-9324
1
AGACTGCACAACCAAGAAGTTACTCA

repeat region, complete sequence

AAGCTCTGTGGGAGCCCCTGCCTG

/cds = UNKNOWN

675
Table 3A
Hs.4747
AF067008
3873220
dyskeratosis congenita 1, dyskerin
1
CAGTGCTCACCTAAATCCATCTGACT

(DKC1), mRNA/cds = (92, 1836)

ACTTGTTCCTGTGCCCTCTTGTTT

676
Table 3A
Hs.307357
AF067519
3850317
PITSLRE protein kinase beta SV1
1
GTGACGACGACCTGAAGGAGACGGG

isoform (CDC2L2) mRNA,

CTTCCACCTTACCACCACGAACCAG

complete cds/cds = (79, 2412)

677
Table 3A
Hs.307357
AF067529
3850337
PITSLRE protein kinase beta SV1
1
AACAGGATAAAGCTCGCCGGGAATG

isoform (CDC2L2) mRNA,

GGAAAGACAGAAGAGAAGGGAAATG

complete cds/cds = (79, 2412)

678
Table 3A
Hs.268763
AF068235
4321975
Breakpoint cluster region protein,
1
CCTCACCCCCACCCTCACTTTCAATC

uterine leiomyoma, 1; barrier to

CGTTTGATACCATTTGGCTCCTTT

autointegration factor (BCRP1),

mRNA/cds = (507, 776)

679
Table 3A
Hs.341182
AF068836
3192908
602417258F1 cDNA, 5′ end
1
ATGGAAAGATGTGGTCTGAGATGGGT

/clone = IMAGE:4538829/

GCTGCAAAGATCATAATAAAGTCA

clone_end = 5′

680
Table 3A
Hs.92384
AF070523
3764088
vitamin A responsive; cytoskeleton
1
CCATGACTTCACAGACATGGTCTAGA

related (JWA), mRNA/cds =

ATCTGTACCCTTACCCACATATGA

(89, 655)

681
Table 3A
Hs.151903
AF070525
3387880
clone 24706 mRNA sequence
1
CTGTGAATGTTTGCAGTCTCCTACCG

/cds = UNKNOWN

TCTCAACTACAGCTGCAGTTGCTA

682
Table 3A
Hs.26118
AF070582
3387954
hypothetical protein MGC13033
1
CAGCCTGAATTGCCTCTGGGAAGAG

(MGC13033), mRNA/cds =

GGGTGGGAATGACTTTTCAATGTAC

(200, 304)

683
Table 3A
Hs.106823
AF070635
3283905
mRNA for KIAA1823 protein,
1
AATGGCCTAGAATTTGTGGTAGTTGC

partial cds/cds = (52, 1185)

CAAAGAGGTTCTCCTAGGTGGTCT

684
Table 3A
Hs.108112
AF070640
3283913

Homo sapiens, histone fold protein
1
CAGTGAAAAGTTTGTGAGTGAAGAAT

CHRAC17; DNA polymerase

GCTGAGAAGATTGTAATGCTTTGT

epsilon p17 subunit, clone

MGC:2725 IMAGE:2822216,

mRNA, complete cds/cds =

(80, 523)

685
Table 3A
Hs.76691
AF070673
3978241
stannin mRNA, complete cds
1
TTGTCTCAAAGCTACCAAGTTTGTGC

/cds = (175, 441)

AATAAGTGGAAGGGATGTCATCCT

686
Table 3A
Hs.223615
AF070874
3978243
RC2-BN0074-150400-018-c08
1
ACATCGAAGGTGTGCATATATGTTGA

cDNA

ATGACATTTTAGGGACATGGTGTT

687
Table 3A
Hs.112255
AF071076
4545098
nucleoporin 98 kD (NUP98),
1
GGCTATCTCAGGCAATATGGCCAGCA

mRNA/cds = (124, 5262)

CCTGGGTCTTTATGCATGAAGATA

688
Table 3A
Hs.76095
AF071596
3851531
immediate early response 3
1
GCTGTCACGGAGCGACTGTCGAGAT

(IER3), mRNA/cds = (11, 481)

CGCCTAGTATGTTCTGTGAACACAA

689
Table 3A
Hs.18571
AF072860
3290197
protein kinase, interferon-inducible
1
AGCTGCTGACTTGACTGTCATCCTGT

double stranded RNA dependent

TCTTGTTAGCCATTGTGAATAAGA

activator (PRKRA), mRNA

/cds = (96, 1037)

690
Table 3A
Hs.79877
AF072928
3916215
myotubularin related protein 6
1
CTCACAGGTGGACTGAGAAATCAGTT

mRNA, partial cds/cds = (0, 1398)

ACATCTTAAGTGACCTACAGGGTA

691
Table 3A
Hs.143648
AF073310
4511968
insulin receptor substrate-2 (IRS2)
1
GTGCATTGTATTTAGTCTGTATTGATC

mRNA, complete cds/cds =

ATGGATGCCCTCCTTAATAGCCA

(518, 4532)

692
Table 3A
Hs.151411
AF075587
3319325
KIAA0916 protein (KIAA0916),
1
CCTGTACAATTGCATCACGGGTGGG

mRNA/cds = (146, 14071)

GATAAAAAGAGGAATATTCTGGTTT

693
Table 3A
Hs.550
AF076485
5430704
phosducin (PDC), transcript variant
1
AAACAGAGCTGTCTTCAGCAACATTA

PhLOP2, mRNA/cds = (5, 358)

TTAGTAGACAAAGAGGATGTGGAT

694
Table 3A
Hs.4311
AF079566
4574148
SUMO-1 activating enzyme
1
ACTCAAGTTTTCAGTTTGTACCGCCT

subunit 2 (UBA2), mRNA/cds =

GGTATGTCTGTGTAAGAAGCCAAT

(25, 1947)

695
db mining
Hs.159376
AF080577
3551871
RAG2 mRNA, partial cds/cds =
1
TGACTCCTGCCAAGAAATCCTTTCTT

(0, 324)

AGAAGGTTGTTTGATTAGTTTTGC

696
Table 3A
Hs.107979
AF081282
4336324
small membrane protein 1
1
TTGTATTATCTGCTTTGCTGATGTAGA

(SMP1), mRNA/cds = (99, 572)

CAAGAGTTAACTGAGTAGCATGC

697
Table 3A
Hs.36794
AF082589
4206702
cyclin D-type binding-protein 1
1
AAAGATTGTTGGTTAGGCCAGATTGA

(CCNDBP1), mRNA/cds =

CACCTATTTATAAACCATATGCGT

(87, 1172)

698
Table 3A
Hs.8765
AF083255
3435311
RNA helicase-related protein
1
TGGTAACTGTTCCAGGATTGCTCCAG

(RNAHP), mRNA/cds =

GTTTGAGATGGTATTGCTAAATTT

(17, 2148)

699
Table 3A
Hs.168913
AF083420
5326765
serine/threonine kinase 24
1
TGCACCTTGTAGTGGATTCTGCATAT

(Ste20, yeast homolog) (STK24),

CATCTTTCCCACCTAAAAATGTCT

mRNA/cds = (78, 1373)

700
Table 3A
Hs.327546
AF084555
5813858
hypothetical protein MGC10786
1
CACTAGCACTTGTGATGCAATAGAAC

(MGC10786), mRNA/cds =

ACTTCGCCTGTACTGAAAGGGCCA

(38, 169)

701
Table 3A
Hs.211610
AF090693
4249665
apoptosis-related RNA binding
1
ACGCAGGCTTTCCTATTTCTACAACT

protein (NAPOR-3) mRNA,

GATTGTACTTATGCATTTTGTACC

complete cds/cds = (67, 1593)

702
Table 3A
Hs.5437
AF090891
6690159
Tax1 (T-cell leukemia virus type I)
1
CAGGAGCTACTTTGAGTTTGGTGTTA

binding protein 1 (TAX1BP1),

CTAGGATCAGGGTCAGTCTTTGGC

mRNA/cds = (83, 2326)

703
Table 3A
Hs.192705
AF090927
6890220
PRO0457 protein (PRO0457),
1
TAGAGAGAGGCCCGTGGCCTGAGGT

mRNA/cds = (985, 1431)

AGTGCAGAGGAGGATAGTAGAGCAG

704
Table 3A
Hs.201675
AF091263
4140646
RNA binding motif protein 5
1
TTTTGGAAGATTTTCAGTCTAGTTGC

(RBM5), mRNA/cds = (148, 2595)

CAAATCTGGCTCCTTTACAAAAGA

705
Table 3A
Hs.241558
AF099149
3930775
ariadne (Drosophila) homolog 2
1
AAGTTAATTGAGGCAATGTCATCTGC

(ARIH2), mRNA/cds =

TCAAAGTTGAGTGGTTTATTCACA

(144, 1825)

706
Table 3A
Hs.306357
AF103458
4378245
isolate donor N clone N168K
1
TTGCAGTGTATTACTGTCAGCAGTAT

immunoglobulin kappa light chain

GGTAGCTCACCGTGGACGTTCGGC

variable region mRNA, partial cds

/cds = (0, 303)

707
Table 3A
Hs.184601
AF104032
4426639
L-type amino acid transporter
1
TATTCTGTGTTAATGGCTAACCTGTTA

subunit LAT1 mRNA, complete

CACTGGGCTGGGTTGGGTAGGGT

cds/cds = (66, 1589)

708
Table 3A
Hs.294603
AF104398
4063708
601657573R1 cDNA, 3′ end
1
AAACTGAATGAGAGAAAATTGTATAA

/clone = IMAGE:3875611/

CCATCCTGCTGTTCCTTTAGTGCA

clone_end = 3′

709
Table 3A
Hs.7043
AF104921
9409793
succinate-CoA ligase, GDP-
1
TGACACTGGTCTTGCAGTACAACTGG

forming, alpha subunit (SUCLG1),

AAGCCAAAACAAGGTGGAAGATGT

mRNA/cds = (31, 1032)

710
Table 3A
Hs.4876
AF105366
5106522
solute carrier family 12
1
GGTCAAGTATATTTGGACCTATTATC

(potassium/chloride transporters),

CTCGGCAAGCCAAGATGCAAACAT

member 6 (SLC12A6),

mRNA/cds = (51, 3350)

711
Table 3A
Hs.167460
AF107405
5531903
pre-mRNA splicing factor (SFRS3)
1
AGTTCACAATATGGTTCAAATGTAAC

mRNA, complete cds/cds =

AGTGCAGAATTGAATATGGAGGCA

(95, 589)

712
Table 3A
Hs.79335
AF109733
4566529
SWI/SNF related, matrix
1
TTGCATCTTTCCAGGAGAGCCTCACA

associated, actin dependent

TTCTTCTTCCAGGTTGTATCACCC

regulator of chromatin,

subfamily d, member 1

(SMARCD1), mRNA/cds =

(265, 1572)

713
Table 3A
Hs.274472
AF113008
6642739
high-mobility group (nonhistone
1
GTGAGTCAGGAGCAGGAGCGTGCGG

chromosomal) protein 1 (HMG1),

ACCAAAAATCCTCAGCCCTTACGAC

mRNA/cds = (52, 699)

714
Table 3A
Hs.180946
U66589
1575566
ribosomal protein L5 pseudogene
1
TCACCTTATGCAATGTGAATTATCACT

mRNA, complete cds/cds =

ACAGAACTCCATCTTACTCCAGA

UNKNOWN

715
Table 3A
Hs.109441
AF113213
11640573
cDNA FLJ14235 fis, clone
1
TTTGATGTAATATAACCTAACGTTGTG

NT2RP4000167/cds = (82, 2172)

CTGGTACCTGTTTTACCATGTGT

716
Table 3A
Hs.297681
AF113676
6855600
clone FLB2803 PRO0684 mRNA,
1
CTCCATCCCTGGCCCCCTCCCTGGAT

complete cds/cds = (1108, 2364)

GACATTAAAGAAGGGTTGAGCTGG

717
Table 3A
Hs.297681
AF113676
6855600
clone FLB2803 PRO0684 mRNA,
1
CTCCATCCCTGGCCCCCTCCCTGGAT

complete cds/cds = (1108, 2364)

GACATTAAAGAAGGGTTGAGCTGG

718
Table 3A
Hs.75117
AF113702
6855838
interleukin enhancer binding
1
GGCTTAGCTGCCAGTCTCCCATTTGT

factor 2, 45 kD (ILF2),

GACCTATGCCATCCATCTATAATG

mRNA/cds = (39, 1259)

719
Table 3A
Hs.177415
AF116606
7959715
PRO0890 mRNA, complete cds
1
GGCCCCAATGCCAACTCTTAAGTCTT

/cds = (1020, 1265)

TTGTAATTCTGGCTTTCTCTAATA

720
Table 3A
Hs.321158
AF116620
8924006
hypothetical protein PRO1068
1
TGTCAGGTTTGGGTCTTGGGTTCAAG

(PRO1068), mRNA/cds =

TGTATATATTCCTGTAAGTTTCTT

(1442, 1750)

721
Table 3A
Hs.288036
AF116679
7959856
tRNA isopentenylpyrophosphate
1
TGCATCGTAAAACCTTCAGAAGGAAA

transferase (IPT), mRNA

GGAGAATGTTTTGTGGACCACTTT

/cds = (60, 1040)

722
Table 3A
Hs.238205
AF116682
7959882
PRO2013 mRNA, complete cds
1
TTGACATTCTGCGAAAGCAACAAGCA

/cds = (135, 380)

AACTGAAGACCAACTCCTATGAGA

723
Table 3A
Hs.83583
NM_005731
5031598
actin related protein 2/3 complex,
1
CGCCTCTTCAGGTTCTTAAGGGATTC

subunit 2 (34 kD) (ARPC2),

TCCGTTTTGGTTCCATTTTGTACA

mRNA/cds = (84, 986)

724
Table 3A
Hs.128740
AF118274
4680228
DNb-5 mRNA, partial cds
1
CCTTGTTGGACAGGGGGACAGGCTG

/cds = (0, 1601)

CCTACTGGAATGTAAATATGTGATA

725
Table 3A
Hs.225939
AF119417
7670074
sialyltransferase 9 (CMP-
1
TTTCTGAATGCCTACCTGGCGGTGTA

NeuAc:lactosylceramide alpha-2,3-

TACCAGGCAGTGTCCCAGTTTAAA

sialyltransferase; GM3 synthase)

(SIAT9), mRNA/cds = (277, 1365)

726
Table 3A
Hs.184011
AF119665
6563255
pyrophosphatase (inorganic) (PP),
1
TGTGCAAGGGGAGCACATATTGGAT

nuclear gene encoding

GTATATGTTACCATATGTTAGGAAA

mitochondrial protein,

mRNA/cds = (77, 946)

727
Table 3A
Hs.2186
AF119850
7770136

Homo sapiens, eukaryotic
1
TCAAGTGAACATCTCTTGCCATCACC

translation elongation factor 1

TAGCTGCCTGCACCTGCCCTTCAG

gamma, clone MGC:4501

IMAGE:2964623, mRNA,

complete cds/cds = (2278, 3231)

728
Table 3A
Hs.111334
AF119897
7770230
PRO2760 mRNA, complete cds
1
CCGAGGAGAAGCGCGAGGGCTACGA

/cds = UNKNOWN

GCGTCTCCTGAAGATGCAAAACCAG

729
Table 3A
Hs.9851
AF123073
12698331
C/EBP-induced protein
1
GCAGCTGTTTGAAGTTTGTATATTTTC

(LOC81558), mRNA/cds =

CGTACTGCAGAGCTTACACAAAA

(30, 1391)

730
Table 3A
Hs.180566
AF123094
5669089
mucosa associated lymphoid tissue
1
GCCTGTGAAATAGTACTGCACTTACA

lymphoma translocation gene 1

TAAAGTGAGACATTGTGAAAAGGC

(MALT1), mRNA/cds =

(164, 2638)

731
Table 3A
Hs.7540
AF126026
7158285
unknown mRNA/cds = (0, 1261)
1
GCTCTGATTGTACAAGAATTACCTGT

GCTAGTCAAGTTGTTGTTTTTCCT

732
Table 3A
Hs.15259
AF127139
6724085
BCL2-associated athanogene 3
1
CTGTCTTTTGTAGCTCTGGACTGGAG

(BAG3), mRNA/cds =

GGGTAGATGGGGAGTCAATTACCC

(306, 2033)

733
Table 3A
Hs.304177
AF130085
11493474
clone FLB8503 PRO2286 mRNA,
1
GGTACAACCTTCAACTATTTCTTCCAT

complete cds/cds = UNKNOWN

GCGGACCCCCTCCTGCCAAAAGA

734
Table 3A
Hs.279789
AF130094
11493492
histone deacetylase 3 (HDAC3),
1
GCAATTCTCCCTGCGTCATGGATTTC

mRNA/cds = (55, 1341)

AAGGTCTTTTAATCACCTTCGGTT

735
Table 3A
Hs.6456
AF130110
11493523
clone FLB6303 PRO1633 mRNA,
1
CCTTCGCTTTAACATAGGTCTAATTTA

complete cds/cds = (2546, 3097)

TTTGCCGTGCCATTTTCCATACA

736
Table 3A
Hs.333555
AF131753
4406571
cytoplasmic protein mRNA,
1
TGGTTGGAAGTGGGTGGGGTTATGA

complete cds/cds = (236, 3181)

AATTGTAGATGTTTTTAGAAAAACT

737
Table 3A
Hs.64001
AF131762
4406584
clone 25218 mRNA sequence
1
ACCTTCCTCCAGGAAAAGCCATTCAA

/cds = UNKNOWN

GCCTGATTATTTTTCTAAGTAACT

738
Table 3A
Hs.8148
AF131856
4406702
selenoprotein T (LOC51714),
1
CTGTATAGCTTTCCCCACCTCCCACA

mRNA/cds = (138, 629)

AAATCACCCAGTTAATGTGTGTGT

739
Table 3A
Hs.301824
AF132197
11493539
hypothetical protein PRO1331
1
GGGGTACCTGTGTTGAGTTGATAAAC

(PRO1331), mRNA/cds =

ATTTCCATCTTCATTAAAACTGCT

(422, 616)

740
Table 3A
Hs.79933
AF135162
7259481
cyclin I (CCNI), mRNA/cds =
1
TGTCCACCTTTGCAGCCTGTTTCTGT

(0, 1133)

CATGTAGTTTCAACAAGTGCTACC

741
Table 3A
Hs.160417
AF137030
6649056
transmembrane protein 2
1
ATGCTACCTCAAAGTGCTACCGATAA

(TMEM2), mRNA/cds =

ACCTTTCTAATTGTAAGTGCCCTT

(148, 4299)

742
Table 3A
Hs.70337
AF138903
7767238
nectin-like protein 2 (NECL2)
1
AGCACCCATTCCGACCATAGTATAAT

mRNA, complete cds/cds =

CATATCAAAGGGTGAGAATCATTT

(3, 1331)

743
Table 3A
Hs.65450
AF148537
10039550
reticulon 4a mRNA, complete cds
1
TGTGGTTTAAGCTGTACTGAACTAAA

/cds = (141, 3719)

TCTGTGGAATGCATTGTGAACTGT

744
Table 3A
Hs.334468
AF151049
7106819
hypothetical protein (LOC51245),
1
ATTACGAAGATGAACCAGTAAACGAG

mRNA/cds = (0, 359)

GACATGGAGTGACTATCGGGGCGG

745
Table 3A
Hs.278429
AF151054
7106829
hepatocellular carcinoma-
1
TCCTCCAGCTGACAGAAAAATCCAGG

associated antigen 59 (LOC51759),

ATGAGATCAGAAGGATACTGGTGT

mRNA/cds = (27, 896)

746
db mining
Hs.274509
AF151103
5758136
T-cell receptor aberrantly
1
TTTACACGCCCTGAAGCAGTCTTCTT

rearranged gamma-chain mRNA

TGCTAGTTGAATTATGTGGTGTGT

from cell line

HPB-MLT/cds = UNKNOWN

747
Table 3A
Hs.279918
AF151875
4929702
hypothetical protein (HSPC111),
1
GTTCACGGAAAAGCCAGAACCTGCT

mRNA/cds = (62, 598)

GTTTTCAGGGTGGGTGATGTAAATA

748
Table 3A
Hs.31323
AF153419
13133509
IkappaBkinase complex-associated
1
AGTGCTCTTGCTTTGGATAACTGTAA

protein (IKBKAP) mRNA,

AGGGACCCATGCTGATAGACTGGA

complete cds/cds = (310, 4308)

749
Table 3A
Hs.296323
AF153609
5231142
serum/glucocorticoid regulated
1
TGCCCCAGTTGTCAGTCAGAGCCGTT

kinase (SGK), mRNA/cds =

GGTGTTTTTCATTGTTTAAAATGT

(42, 1337)

750
Table 3A
Hs.22350
AF157116
8571911
cDNA: FLJ23595 fis, clone
1
AAACCAATGGACAAACTTCTTGCTTC

LNG15262/cds = UNKNOWN

AAGGAACAAACTCTTAGGTTGGCA

751
Table 3A
Hs.5548
AF157323
7688696
p45SKP2-like protein mRNA,
1
AAACATCATGAGAGTGGAGGCCTGC

complete cds/cds = (37, 2061)

CACCCAGAAAGGCACATACTAGTGC

752
Table 3A
Hs.19807
AF161339
6841091
rho-gtpase activating protein
1
AGTGGATTAACCCCTGCTTCTCTTCT

ARHGAP9 (ARHGAP9),

TGTTCCCTGTTATCATTCCTCCCC

mRNA/cds = (406, 2658)

753
Table 3A
Hs.259683
AF161384
6841141
HSPC101 mRNA, partial cds
1
GTCTGCTTATTCGTGTCTCTTACTAG

/cds = (0, 556)

GTTCAATTTCTTGGAGGCCGTGAT

754
Table 3A
Hs.180145
AF161415
6841243
HSPC297 mRNA, partial cds
1
TGGCCTGACTGACATGCAGTTCCATA

/cds = (0, 438)

AATGCAGATGTTTGTCTCATTACC

755
Table 3A
Hs.339814
AF161430
6841273
nt85d12.s1 cDNA
1
GCCAGACTTGAAAGAGGGCTCCAGA

/clone = IMAGE:1205303

AAAAGTAGATGCGTATCTGTACAAA

756
Table 3A
Hs.284295
AF161451
6841315
HSPC333 mRNA, partial cds
1
CGTCTTAATGTTCACCGTCCACAGCT

/cds = (0, 443)

TTGGAATAAACCATCCTGGGAAGT

757
Table 3A
Hs.284295
AF161455
6841323
HSPC333 mRNA, partial cds
1
TTAATGTTCACCGTCCACAGCTTTGG

/cds = (0, 443)

AATAAACCATCCTGGGAAGTTGCT

758
Table 3A
Hs.284162
AF165521
9294748
60S ribosomal protein L30 isolog
1
TCTAGCCCAGCATTGATCTAGAAGCA

(LOC51187), mRNA/cds =

GAGGAATCCCAGCGCCTTTTAAAA

(143, 634)

759
Table 3A
Hs.283740
AF173296
9622516
DC6 protein (DC6), mRNA
1
TTGCTCAGCATGCCAGCCTTTAAGAT

/cds = (161, 466)

TGAATTAGATTGTGTTGTTGTGGT

760
Table 3A
NA
AF173954
6002958
Cloning vector pGEM-URA3
1
AAAAGGTATAGAAATGCTGGTTGGAA

TGCTTATTTGAAAAAGACTGGCCA

761
Table 3A
Hs.81001
AF174605
6164752
F-box protein Fbx25 (FBX25)
1
CTGCTTCACGCCTGTGTCTCCGCAGC

mRNA, partial cds/cds = (0, 818)

ACTTCATCGACCTCTTCAAGTTTT

762
Table 3A
Hs.288836
AF176706
6573265
hypothetical protein FLJ12673
1
AGAGCAGCTTGTGTATGTAAACGCTT

(FLJ12673), mRNA/cds =

CAGTGAACTTGCTAATGATCCAAT

(2, 1687)

763
Table 3A
Hs.250619
AF182420
10197639
phorbolin-like protein MDS019
1
TCAAACCTACTAATCCAGCGACAATT

(MDS019), mRNA/cds =

TGAATCGGTTTTGTAGGTAGAGGA

(231, 1385)

764
Table 3A
Hs.279789
AF187554
6653225
histone deacetylase 3 (HDAC3),
1
TCAACCTCCGTCATGTTTTAGAAACC

mRNA/cds = (55, 1341)

TTTTATCTTTTCCTTCCTCATGCT

765
Table 3A
Hs.49163
AF189011
8886721
ribonuclease III (RN3) mRNA,
1
TTTCCATCTGTGTCCCAGATTGTGAC

complete cds/cds = (245, 4369)

CCTAGACTTTCAATTGACAAGTAA

766
Table 3A
Hs.106778
AF189723
6826913
calcium transport ATPase ATP2C1
1
CATGTCGTTAGATGGAACATGGAAGC

(ATP2C1A) mRNA, complete cds

CATTGTCTAATCAACTCTATCATT

/cds = (202, 2913)

767
Table 3A
Hs.102506
AF193339
7341090
eukaryotic translation initiation
1
ATGTAATCCTGTAGGTTGGTACTTCC

factor 2-alpha kinase 3

CCCAAACTGATTATAGGTAACAGT

(EIF2AK3), mRNA/cds =

(72, 3419)

768
Table 3A
Hs.179573
AF193556
6907041
collagen, type I, alpha 2
1
TGAATGATCAGAACTGACATTTAATTC

(COL1A2), mRNA/cds =

ATGTTTGTCTCGCCATGCTTCTT

(139, 4239)

769
Table 3A
Hs.126550
AF195514
11225484
VPS4-2 ATPase (VPS42) mRNA,
1
TTTGCACATTTTACATATGCTATGTGG

complete cds/cds = (201, 1535)

TTGCCTTTGGGTTTTCTGTACAG

770
Table 3A
Hs.56542
AF195530
9739016

Homo sapiens, X-prolyl
1
TGGTCATGTTCCAGGTGCTAGTACAT

aminopeptidase (aminopeptidase P)

CATTCATGATCACCTTAATGCTCA

1, soluble, clone MGC:15561

IMAGE:3139868, mRNA,

complete cds/cds = (140, 2011)

771
Table 3A
Hs.44143
AF197569
11385353
BAF180 (BAF180) mRNA,
1
AGCATAAAGAGTTGTGGATCAGTAGC

complete cds/cds = (96, 4844)

CATTTTAGTTACTGGGGGTGGGGG

772
Table 3A
Hs.160999
AF198614
7582270
AV648418 cDNA, 3′ end
1
TCAACACTTTGCTTTATTTGACACAAC

/clone = GLCBJC04/

CAGACTTTCTCAGTTCCTGTTCT

clone_end = 3′

773
Table 3A
Hs.26367
AF202092
11493699
PC3-96 protein (PC3-96), mRNA
1
ATGAAGAAAATCATTGAGACTGTTGC

/cds = (119, 586)

AGAAGGAGGGGGAGAACTTGGAGT

774
Table 3A
Hs.182982
AF204231
6808610
88-kDa Golgi protein (GM88)
1
ACTGAAAGACTTTTGCTTAAAGTGGC

mRNA, complete cds/cds =

ATTATTGACTGCTGATGTGATGCT

(342, 2237)

775
Table 3A
Hs.197298
AF205218
12003206
NS1-binding protein-like protein
1
TTGGTTGGTAACTCTGTAATTCCTAA

mRNA, complete cds/cds =

CTATCACTGGTTTGGTTCTGGACT

(555, 2483)

776
Table 3A
Hs.155530
AF208043
6644296
IFI16b (IFI16b) mRNA, complete
1
CCACCATATATACTAGCTGTTAATCCT

cds/cds = (264, 2312)

ATGGAATGGGGTATTGGGAGTGC

777
literature
Hs.185708
AF208502
6630993
early B-cell transcription factor
1
AGAGGAATCTGAAAGTGCAGGGTGTT

(EBF) mRNA, partial cds/cds =

GGTTAAAGTTGTACCTCCCAAGTA

(0, 1761)

778
Table 3A
Hs.5862
AF208844
7582275
hypothetical protein (BM-002),
1
TTTTTCTCCATCCTGTTTCTAGCACAA

mRNA/cds = (39, 296)

AAATTTGCCTGCTGTGTTACAAA

779
Table 3A
Hs.82911
AF208850
7582287
BM-008 mRNA, complete cds
1
CAGATTGATTTGAAAGGTGTGCAGCC

/cds = (341, 844)

TGATTTAAAACCAAACCCTGAACC

780
Table 3A
Hs.12830
AF208855
7582297
hypothetical protein (LOC51320),
1
GCAACTAATAAGCCAAGGAATCGACA

mRNA/cds = (67, 459)

TATATTAGGTGCGTGTACTGTTTC

781
Table 3A
Hs.295231
AF212224
9437514
CLK4 mRNA, complete cds
1
TGTCCAGTGATAAATGTGATTGATCT

/cds = (153, 1514)

TGCCTTTTGTACATGGAGGTCACC

782
Table 3A
Hs.284162
AF212226
13445483
60S ribosomal protein L30 isolog
1
TCTAGCCCAGCATTGATCTAGAAGCA

(LOC51187), mRNA/cds =

GAGGAATCCCAGCGCCTTTTAAAA

(143, 634)

783
Table 3A
Hs.68644
AF212233
13182746
microsomal signal peptidase
1
AGGGAACAGTGTGGAGATGTTTTTGT

subunit mRNA, complete cds/

CTTGTCCAAATAAAAGATTCACCA

cds = (57, 635)

784
Table 3A
Hs.332404
AF212241
13182760
CDA02 protein (CDA02), mRNA
1
ACCCATTGGTATACACAGAATATTCC

/cds = (2, 1831)

TGTGCCCACACTTAATGTCAATCT

785
Table 3A
Hs.9414
AF217190
11526792
MLEL1 protein (MLEL1) mRNA,
1
TTGATGATACCACCAGTAAAAATAGG

complete cds/cds = (73, 3099)

ATGTTTACCCCAAAACAAGTGTCA

786
Table 3A
Hs.288850
AF220656
7107358
cDNA: FLJ22528 fis, clone
1
TTTCAACCGAAAGGGCAGATCCAATA

HRC12825/cds = UNKNOWN

GAAGACCCGCTCCTTAAATAAACA

787
Table 3A
Hs.46847
AF223469
7578788
TRAF and TNF receptor-
1
ACAGAGGCAAAGTTAAGCTTGATGAT

associated protein (AD022),

GGTTAAAATCGGTTTGATAGCACC

mRNA/cds = (16, 1104)

788
Table 3A
Hs.79025
AF226044
9295326
HSNFRK (HSNFRK) mRNA,
1
TGGTTGATTTCCCTCATTGTGTAAAC

complete cds/cds = (641, 2938)

ATTGACAGGTATGTGACAAATGGG

789
Table 3A
Hs.112242
AF228422
12656020
normal mucosa of esophagus
1
CACAAACTAGATTCTGGACACCAGTG

specific 1 (NMES1), mRNA/

TGCGGAAATGCTTCTGCTACATTT

cds = (189, 440)

790
Table 3A
Hs.55173
AF231023
7407145
cadherin, EGFLAG seven-pass G-
1
GGCCCTCTTTCCTGTCTGTGTAAATT

type receptor 3, flamingo

GTTCCGTGAAGCCGCGCTCTGTTT

(Drosophila) homolog (CELSR3),

mRNA/cds = (281, 10219)

791
Table 3A
Hs.4788
AF240468
9992877
nicastrin mRNA, complete cds
1
CACTGTCCTTTCTCCAGGCCCTCAGA

/cds = (142, 2271)

TGGCACATTAGGGTGGGCGTGCTG

792
Table 3A
Hs.196015
AF241534
9502099
hydatidiform mole associated and
1
AGGAGCTATGATTAGACTTCTGTTAG

imprinted (HYMAI) mRNA,

ACTTCCTCACTCTATCACCCACAT

complete sequence/cds =

UNKNOWN

793
Table 3A
Hs.81897
AF241785
12005486
NPD012 (NPD012) mRNA,
1
ACCCACTTTCTCCTTGGTAAAGCGTT

complete cds/cds = (552, 2252)

TACTTAACAAAATAATACCCGAGA

794
Table 3A
Hs.153042
AF244129
10197716
cell-surface molecule Ly-9 mRNA,
1
GTCACACATGACACAAGATGTACATA

complete cds/cds = (30, 1994)

ATATCATGCTCACGCCTGGAGTGT

795
Table 3A
Hs.20597
AF244137
7670839
host cell factor homolog (LCP),
1
ATGTGCATGTGAATGGCCTAGAGAAC

mRNA/cds = (316, 1536)

CTATTTTTGTGTCTAAAGTTTACA

796
Table 3A
Hs.145956
AF246126
8571416
zinc finger protein mRNA,
1
AGATCCTGTCCTCCTTTAGCCTCACT

complete cds/cds = (1073, 3133)

AATCAAGTTGGGTCCTATCTTCCC

797
Table 3A
Hs.239625
AF246221
7658294
integral membrane protein 2B
1
AGTTGTTAGTTGCCCTGCTACCTAGT

(ITM2B), mRNA/cds = (170, 970)

TTGTTAGTGCATTTGAGCACACAT

798
Table 3A
Hs.6289
AF246238
12005510
hypothetical protein FLJ20886
1
AATCCTTTAACTCTGCGGATAGCATT

(FLJ20886), mRNA/cds = (0, 524)

TGGTAGGTAGTGATTAACTGTGAA

799
Table 3A
Hs.81248
AF248648
9246972
CUG triplet repeat, RNA-binding
1
GGAGGAGGAGCTTATTTCTTGGTGTA

protein 1 (CUGBP1), mRNA

CTTGAATCAGAAGGTCCCTGCAAG

/cds = (137, 1585)

800
Table 3A
Hs.81248
AF248648
9248972
CUG triplet repeat, RNA-binding
1
GGAGGAGGAGCTTATTTCTTGGTGTA

protein 1 (CUGBP1), mRNA

CTTGAATCAGAAGGTCCCTGCAAG

/cds = (137, 1585)

801
Table 3A
Hs.183434
AF248966
12005668
ATPase, H+ transporting,
1
AAGTGGAAGTGGGTGAATTCTACTTT

lysosomal (vacuolar proton pump)

TTATGTTGGAGTGGACCAATGTCT

membrane sector associated

protein M8-9 (APT6M8-9),

mRNA/cds = (102, 1154)

802
Table 3A
Hs.24125
AF251039
7547030
putative zinc finger protein
1
TGGGATTCATTGGCCCATAGGTACAT

(LOC51780), mRNA/cds =

TGGAAAATGTATATCTCTCCAGCT

(744, 4997)

803
Table 3A
Hs.103521
AF254411
9438032
ser/arg-rich pre-mRNA splicing
1
GGGACCCCCAGGAGGCTGAGGATGG

factor SR-A1 (SR-A1) gene

GAGACAGAGACCAGACTGTGACTTG

804
Table 3A
Hs.42949
AF260237
14009497
hypothetical protein HES6 (HES6),
1
TGTTTGTAGCACACTTGAGTTTGTGT

mRNA/cds = (0, 674)

ATTCCATTGACATCAAATGTGACA

805
Table 3A
Hs.174131
AF261087
9802305
ribosomal protein L6 (RPL6),
1
CGATCTGTGTTTGCTCTGACGAATGG

mRNA/cds = (26, 892)

AATTTATCCTCACAAATTGGTGTT

806
Table 3A
Hs.153612
AF261091
10179833
iron inhibited ABC transporter 2
1
CCAGGAGCGTGGTTTTCTGATTGTGA

mRNA, complete cds/cds =

TCTGAGGTTCTGCCCCAACTGCAC

(111, 1982)

807
Table 3A
Hs.44198
AF263613
8453173
membrane-associated calcium-
1
ACATTACCTAATATTCTCACTAGCTAT

independent phospholipase A2

GTTCTCCAATCCACACTGCCTTT

gamma mRNA, complete cds/

cds = (225, 2573)

808
Table 3A
Hs.107707
AF265439
12005981
mitochondrial ribosomal protein
1
AGACAGCCCTGCCAAAGCCATACCAA

S15 (MRPS15), mRNA/cds =

AGACACTCAAAGACAGCCAATAAA

(0, 851)

809
Table 3A
Hs.8084
AF287856
12006038
HT033 mRNA, complete cds
1
AGAGATAGCACAGATGGACCAAAGG

/cds = (203, 931)

TTATGCACAGGTGGGAGTCTTTTGT

810
Table 3A
Hs.8084
AF267856
12006038
HT033 mRNA, complete cds
1
AGAGATAGCACAGATGGACCAAAGG

/cds = (203, 931)

TTATGCACAGGTGGGAGTCTTTTGT

811
Table 3A
Hs.77690
AF267863
12006052
RAB5B, member RAS oncogene
1
GCCTTTCTTCCTCTCCCAACATAACA

family (RAB5B), mRNA/cds =

ATCGTGGTAACAGAATGCGACTGC

(20, 687)

812
Table 3A
Hs.8203
AF269150
9755050
endomembrane protein emp70
1
ACCGTGTAAAGTGGGGATGGGGTAA

precursor isolog (LOC58889),

AAGTGGTTAACGTACTGTTGGATCA

mRNA/cds = (19, 1779)

813
Table 3A
Hs.267288
AF271994
8515856
dopamine responsive protein
1
GCCCAGTGCTTAAAAACGCCTTCTTG

DRG-1 mRNA, complete cds/

CATGAGGGGATTGAACTATACAAT

cds = (15, 938)

814
Table 3A
Hs.147644
AF272148
8575774
zinc finger protein 331: zinc finger
1
GCGGGAAGGCATGTAACCACCTAAA

protein 463 (ZNF361), mRNA

CCATCTCCGAGAACATCAGAGGATC

/cds = (376, 1767)

815
Table 3A
Hs.339912
AF277292
9664852
qh07h06.x1 cDNA, 3′ end
1
TGTCAGGCTGGCTTGGTTAGGTTTTA

/clone = IMAGE:1844027/

CTGGGGCAGAGGATAGGGAATCTC

clone_end = 3′

816
Table 3A
Hs.287389
AF279437
10719561
interleukin 22 (IL22), mRNA
1
GGTGGATTCCAAATGAACCCCTGCGT

/cds = (71, 610)

TAGTTACAAAGGAAACCAATGCCA

817
Table 3A
Hs.196270
AF283645
11545416
folate transporter/carrier
1
ATTTATCGTAAACATCCACGAGTGCT

(LOC81034), mRNA/cds =

GTTGCACTACCATCTATTTGTTGT

(128, 1075)

818
Table 3A
Hs.324278
L08048.1
184250
mRNA: cDNA DKFZp566M063
1
TGGGGGTTGTAAATTGGCATGGAAAT

(from clone DKFZp566M063)

TTAAAGCAGGTTCTTGTTGGTGCA

/cds = UNKNOWN

819
Table 3A
Hs.116481
AF283777
10281735
CD72 antigen (CD72), mRNA
1
GATAGGGGCGGCCCGGAGCCAGCCA

/cds = (108, 1187)

GGCAGTTTTATTGAAATCTTTTTAA

820
Table 3A
Hs.283022
AF287008
9624485
triggering receptor expressed on
1
CATTTGTACCCTAGGCCCACGAACCC

myeloid cells 1 (TREM1),

ACGAGAATGTCCTCTGACTTCCAG

mRNA/cds = (47, 751)

821
Table 3A
Hs.44865
AF288571
9858157
lymphoid enhancer factor-1 (LEF1)
1
AGTGGGATTTTATGCCAGTTGTTAAA

mRNA, complete cds/cds =

ATGAGCATTGATGTACCCATTTTT

(654, 1853)

822
Table 3A
Hs.212172
AF294900
10242315
beta-carotene 15,15′-dioxygenase
1
CTTTCCTTTGCTCCCTCCCATGTTTCT

(BCDO), mRNA/cds = (218, 1861)

GGTGGACTAAATTGTGTATCTGG

823
Table 3A
Hs.7886
AF302505
10242358
pellino (Drosophila) homolog 1
1
AGTTTTCTAGATTGTCACATGCTTTGT

(PELI1), mRNA/cds =

GACTAATGCAAGAAAGCAAGTCC

(4038, 5294)

824
Table 3A
Hs.47783
AF307339
12751140
B aggressive lymphoma gene
1
GAAACACTTTCAGGACCTTCCTTCCT

(BAL), mRNA/cds =

CTTGCAGTTGTTCTTTAATCTCCT

(228, 2792)

825
Table 3A
Hs.250528
AF308285
12060821

Homo sapiens, clone IMAGE:
1
CTCGAGGGGCCAATTACAGGAGCAC

4098694, mRNA, partial cds/

AGGAAGGTTCTGATTACACACCTCT

cds = (0, 2501)

826
Table 3A
Hs.153057
AF311312
10863767
infertility-related sperm protein
1
TTGAGTTAAGTTGCATTTCTTTGGGC

mRNA, complete cds/cds =

TATGAAGGAGTCCTCTTAAGTTTG

(198, 2978)

827
Table 3A
Hs.6151
AF315591
11139703
pumilio (Drosophila) homolog 2
1
AGGGATTGTTTCTGGACCAGTTTGTC

(PUM2), mRNA/cds =

TAAGTCCTGGCTCTTATTGGTTCA

(23, 3217)

828
Table 3A
Hs.194976
AF319438
12667351
SH2 domain-containing
1
TGAACTGCTGCTACATCCAGACACTG

phosphatase anchor protein 1

TGCAAATAAATTATTTCTGCTACC

(SPAP1), mRNA/cds =

(303, 1070)

829
Table 3A
Hs.36752
AF319476
11762083
protein kinase anchoring protein
1
ACTATGCAGTTTTTCTTGAAGGAACT

GKAP42 (GKAP42), mRNA

AAAAGCAACTAGCTCCCTAATGGT

/cds = (174, 1274)

830
Table 3A
Hs.114309
AF323540
12408012
apolipoprotein L-I mRNA, splice
1
GTCTTTCCAGCATCCACTCTCCCTTG

variant B, complete cds

TCCTCCTGGGGGCATATCTCAGTC

/cds = (273, 1517)

831
Table 3A
Hs.27721
AF332469
12642816
Wolf-Hirschhom syndrome
1
GCAGTAGGTAGGCTCACTTCTCTTTC

candidate 1-like 1 (WHSC1L1),

CCTTCAAAATGCTTTTCATAGGCT

transcript variant long,

mRNA/cds = (518, 4831)

832
Table 3A
Hs.203181
AF333025
13936737
Bv8 protein (BV8) mRNA,
1
TCTGCTGTTGGGCTGGTGTGTGGAC

partial cds/cds = (0, 358)

AGAAGGAATGGAAAGCCAAATTAAT

833
Table 3A
NA
AI904802
6495189
1q12-21.2 Contains a cyclophilin-
1
CCACTTGGAATAGGAATATCACCCCT

like gene, a novel gene,

ATCTTGGAAGACCAGGTGGAGGCT

ESTs, GSSs and STS

834
Table 3A
Hs.5122
AJ001235
12418001
602293015F1 cDNA, 5′ end
1
GCCCTATGGCGTTGTTAAACACGAGC

/clone = IMAGE:4387778/

GTATGCTAGTAAGTATCATTCATA

clone_end = 5′

835
Table 3A
Hs.9071
AJ002030
2570006
progesterone receptor membrane
1
GTGGGTGCATGGGGCTGTGGAGTGG

component 2 (PGRMC2),

GTGTCAGTATGGATGTGTCTGAATG

mRNA/cds = (6, 677)

836
Table 3A
Hs.196769
AJ006835
3236105
RNA transcript from U17 small
1
CATTCGTCTGTATGCCCAGTCCCATC

nucleolar RNA host gene, variant

CGTGTCCTGCTGTAACTACATAGA

U17HG-AB/cds = UNKNOWN

837
Table 3A
Hs.181461
AJ009771
3846273
ariadne (Drosophila) homolog,
1
TGTCTGCTTCTTCCATTTTCTCGTCTC

ubiquitin-conjugating enzyme E2-

TCTCCCCTCTTCCCCCATTATCC

binding protein, 1 (ARIH1),

mRNA/cds = (314, 1987)

838
Table 3A
Hs.18259
AJ010842
3846129
XPA binding protein 1: putative
1
TGGGCAAGACATGATTAATGAATCAG

ATP(GTP)-binding protein

AATCCTGTTTCATTGGTGACTTGG

(NTPBP), mRNA/cds = (24, 1148)

839
Table 3A
Hs.109281
AJ011895
3758818
Nef-associated factor 1 (NAF1),
1
CCAGATTAGGGTGGCTGTCCATCCCT

mRNA/cds = (110, 2017)

GGATAGCTATTTGCACGAATCATG

840
Table 3A
Hs.306328
AJ012504
5441364
mRNA activated in tumor
1
CGGAGCTCTGGCTCTGCTGTAGGAA

suppression, clone TSAP13

GCCCGGTACGTCCTTCATGACAGCA

extended/cds = UNKNOWN

841
Table 3A
Hs.118958
AJ012506
5441365
syntaxin 11 (STX11), mRNA
1
GCACTGAATATCGAACAAGCACTCAA

/cds = (183, 1046)

ATTGAAGTATCAGTCATGTTTTGT

842
Table 3A
Hs.58103
AJ131693
4584422
mRNA for AKAP450 protein
1
AGCTCGAGGTGTCCTGCACTTTTCTT

/cds = (222, 11948)

ATAAGGCTACTGAAGTTACATGTT

843
Table 3A
Hs.59757
AJ132592
6822171
zinc finger protein 281 (ZNF281),
1
TGCCATTGGAATGTTTCTACACGATC

mRNA/cds = (23, 2710)

CTATTAAGAATAATGTGATGCCCT

844
Table 3A
Hs.326159
AJ223075
3355596
leucine rich repeat (in FLII)
1
GGATAACAAGTAAATGTCTGAAAGCA

interacting protein 1 (LRRFIP1),

TGAGGGGCTTTATTTGCCTTTACC

mRNA/cds = (178, 2532)

845
Table 3A
Hs.137548
AJ223324
3392916
CD84 antigen (leukocyte antigen)
1
TGTTTTCCTCACTACATTGTACATGTG

(CD84), mRNA/cds = (44, 1030)

GGAATTACAGATAAACGGAAGCC

846
Table 3A
Hs.333140
AJ225093
3090427
mRNA for single-chain antibody,
1
AAAACTCATCTCAGAAGAGGATCTGA

complete cds (scFv2)/cds =

ATGGGGCCGCACATCACCATCATC

(0, 806)

847
Table 3A
Hs.27182
AJ238243
4826530
mRNA for phospholipase A2
1
AAACCCCTTTAAATGAGGGCCAGTAT

activating protein/cds =

TATCTCTGCTTTCAGAAGTAGACA

(28, 2244)

848
Table 3A
Hs.6947
AJ238403
12697195
mRNA for huntingtin interacting
1
GACCTGACTCCACTCTTAAACCTGGG

protein 1

TCTTCTCCTTGGCGGTGCTGTCAG

849
Table 3A
Hs.54842
AJ243721
6006497
methionine adenosyltransferase II,
1
CTTTTATAGCAGTTTATGGGGAGCAC

beta (MAT2B), mRNA/cds =

TTGAAAGAGCGTGTGTACATGTAT

(0, 1004)

850
Table 3A
Hs.55968
AJ245539
6688168
partial mRNA for GalNAc-T5
1
AGATCCTGAAAGTAGCTGCCTGTGAC

(GALNT5 gene)/cds = (0, 2006)

CCAGTGAAGCCATATCAAAAGTGG

851
Table 3A
Hs.18827
AJ250014
8250235
cylindromatosis (turban tumor
1
TACTGCTAAGTGCTTGGTTGGGGTGG

syndrome) (CYLD), mRNA

TGAGATGATGATTAGATCAGGGGT

/cds = (391, 3261)

852
Table 3A
Hs.250905
AJ250865
6688221
hypothetical protein (LOC51234),
1
TTGTACCCAGAGACTATGATTTATATT

mRNA/cds = (0, 551)

GATTGCACTTGCCTGCCATGATT

853
Table 3A
Hs.169610
AJ251595
6491738
mRNA for transmembrane
1
TTTCAGATGCTTCTGGGAGACACCAA

glycoprotein (CD44 gene)

AGGGTGAAGCTATTTATCTGTAGT

/cds = (178, 2406)

854
Table 3A
Hs.107393
AJ270952
7687995
chromosome 3 open reading
1
TTGTGGTAATATGATGTGCCTTTCCTT

frame 4 (C3orf4), mRNA/

GCCTAAATCCCTTCCTGGTGTGT

cds = (880, 1641)

855
Table 3A
Hs.135187
AJ271326
12043566
unc93 (C. elegans) homolog B
1
CACAAGGTGCGCGGTTACCGCTACTT

(UNC938), mRNA/cds =

GGAGGAGGACAACTCGGACGAGAG

(41, 1834)

856
Table 3A
Hs.126355
AJ271684
6900101
C-type (calcium dependent,
1
TAGACTCACGAACAAATCCACCTGAG

carbohydrate-recognition domain)

ATCAGCAGAGCCACCCTAGATCAG

lectin, superfamily member 5

(CLECSF5), mRNA/cds =

(197, 763)

857
Table 3A
Hs.334647
AJ271747
9714271
hypothetical protein FLJ20011
1
CCTCAGAGGCTTACTCTAACCCATCC

(FLJ20011), mRNA/cds =

CAGAATAAATGGAGACTTCATGTG

(380, 856)

858
Table 3A
Hs.88414
AJ271878
12666977
BTB and CNC homology 1, basic
1
AGGCTGTTGATGCTTATTCTCTGTAA

leucine zipper transcription factor 2

CTAAGAATTTTACCTTTTGGGGGA

(BACH2), mRNA/cds =

(708, 3233)

859
Table 3A
Hs.150601
AJ272212
7981276
mRNA for protein serine kinase
1
GTAAACGTATCCTCTGTATTCAGTAA

(PSKH1 gene)/cds =

ACAGGCTGCCTCTCCAGGGAGGGC

(130, 1404)

860
Table 3A
Hs.287389
AJ277247
9968293
interleukin 22 (IL22), mRNA
1
AACTAACCCCCTTTCCCTGCTAGAAA

/cds = (71, 610)

TAACAATTAGATGCCCCAAAGCGA

861
Table 3A
Hs.56247
AJ277832
9968295
mRNA for inducible T-cell co-
1
GCCTCGACACATCCTCATCCCCAGCA

stimulator (ICOS gene)/cds =

TGGGACACCTCAAGATGAATAATA

(67, 668)

862
Table 3A
Hs.14512
AJ278191
8745180
DIPB protein (HSA249128),
1
GCACAGTGACATTCCCTCCTTAGGAA

mRNA/cds = (177, 1211)

TCTTCCCCTTCCACCCTTTACA

863
Table 3A
Hs.134342
AJ278245
12227251
mRNA for LanC-like protein 2
1
TTTGAGGTTCTTTGGTTTTGTTAGTAA

(lancl2 gene)/cds = (186, 1538)

AAGCCAGTTCTGTGGTGATGACC

864
Table 3A
Hs.279860
AJ400717
7573518
tumor protein, translationally-
1
CATCTGAAGTGTGGAGCCTTACCCAT

controlled 1 (TPT1), mRNA/cds =

TTCATCACCTACAACGGAAGTAGT

(94, 612)

865
Table 3A
Hs.130881
AJ404611
11558481
B-cell CLL/lymphoma 11A (zinc
1
TTTTGGCAGTTGTCTGCATTAACCTG

finger protein) (BCL11A),

TTCATACACCCATTTTGTCCCTTT

mRNA/cds = (228, 2735)

866
Table 3A
Hs.10647
AK000005
7209310
mRNA for FLJ00005 protein,
1
TGGTGTTTATGTACTACTCTATAGAAC

partial cds/cds = (0, 337)

TCTTGGCTTGCACTTCTACAGCT

867
Table 3A
Hs.29052
AK000196
7020122
hypothetical protein FLJ20189
1
ACAGGCAAAGTGACAGGGGAAAAGG

(FLJ20189), mRNA/cds =

AATTAGTCTAAGAGTAAGGGGATGA

(122, 841)

868
Table 3A
Hs.79110
AK000221
7020163
nucleolin (NCL), mRNA
1
TGGTCTCCTTGGAAATCCGTCTAGTT

/cds = (111, 2234)

AACATTTCAAGGGCAATACCGTGT

869
Table 3A
Hs.20157
NM_025197
13376787
hypothetical protein FLJ13680
1
GTCTACCAGGCGAAAACCACAGATTC

similar to CDK5 activator-

TCCTTCTAGTTAGTATAGCGGACT

binding protein C53 (FLJ13660),

mRNA/cds = (993, 2252)

870
Table 3A
Hs.180804
AK000271
7020240
cDNA FLJ20264 fis, clone
1
ACTTCTCTTGATGTAGAAAGAGATGA

COLF7912/cds = UNKNOWN

CGTTGTTACCCTGAGTGACAGTCA

871
Table 3A
Hs.180952
AK000299
7020288
cDNA FLJ20292 fis, clone
1
TGAGCTAAGTGTCATGCATATTTGTG

HEP05374/cds = (21, 1403)

AAGAAACACCCTTGTTTGGTCCCT

872
Table 3A
Hs.272793
AK000316
7020318
hypothetical protein FLJ20309
1
CTGAGCAAGGCAGATGACCTAATCAC

(FLJ20309), mRNA/cds =

CTCACGACAGCAATACAGCAGTGA

(41, 1279)

873
Table 3A
Hs.102669
AK000354
7020383
cDNA FLJ20347 fis, clone
1
TTTGTACTATTGCTAGACCCTCTTCTG

HEP13790/cds = (708, 1481)

TAATGGGTAATGCGTTTGATTGT

874
Table 3A
Hs.26434
AK000367
7020405
hypothetical protein FLJ20360
1
TGCTATGCTAATGTCTAGAAAGGCAT

(FLJ20360), mRNA/cds =

ACGATGCTACTATTATGCTCTGTT

(79, 2304)

875
Table 3A
Hs.120769
AK000470
7020580
cDNA FLJ20483 fis, clone
1
ACTGCTCTTTCTCAGGCCCAAGGTAA

KAT08143/cds = UNKNOWN

AAAGGTTTTTGGTCTCATGTTGAC

876
Table 3A
Hs.5811
AK000474
7020586
chromosome 21 open reading
1
TCACCAGCTGATGACACTTCCAAAGA

frame 59 (C21ORF59),

GATTAGCTCACCTTTCTCCTAGGC

mRNA/cds = (360, 776)

877
Table 3A
Hs.279581
AK000575
7020763
hypothetical protein FLJ20568
1
CAGAGTAGGCATCTGGGCACCAAGA

(FLJ20568), mRNA/cds = (6, 422)

CCTTCCCTCAACAGAGGACACTGAG

878
Table 3A
Hs.75884
AK000639
7020863
DKFZP586A011 protein
1
TGCATGAAGCACTGTTTTTAAACCCA

(DKFZP586A011), mRNA

AGTAAAGACTGCTTGAAACCTGTT

/cds = (330, 632)

879
Table 3A
Hs.234149
AK000654
7020886
hypothetical protein FLJ20647
1
TGATTTTGCAACTTAGGATGTTTTTGA

(FLJ20647), mRNA/cds =

GTCCCATGGTTCATTTTGATTGT

(90, 836)

880
Table 3A
Hs.266175
AK000680
7020924
cDNA FLJ20673 fis, clone
1
TTTGAGCGATCTCTCACATGATGGGG

KAIA4464/cds = (104, 1402)

TTCTTTAGTACATGGTAACAGCCA

881
Table 3A
Hs.30882
AK000689
7020935
cDNA FLJ20682 fis, clone
1
CCCGGCCTGGGACTCAGCATTTCTG

KAIA3543, highly similar to

ATATGCCTTAAGAATTCATTCTGTT

AF131826 clone 24945 mRNA

sequence/cds = UNKNOWN

882
Table 3A
Hs.243901
AK000745
7021025
cDNA FLJ20738 fis, clone
1
AGTTTTGCTGAAGACTGGCCTTATTA

HEP08257/cds = UNKNOWN

ATGGACAGCTTTCCTAACAAGAGA

883
Table 3A
Hs.274248
AK000765
7021058
hypothetical protein FLJ20758
1
GGGTCAATAGTTTCCCAATTTCAGGA

(FLJ20758), mRNA/cds =

TATTTCGATGTCAGAAATAACGCA

(464, 1306)

884
Table 3A
Hs.93872
AK000987
7021958
mRNA for KIAA1682 protein,
1
TGAGAGCTGAAATGAGACCATTTACT

partial cds/cds = (19, 2346)

TTGTTTAAAATGCTGTACTGTGCA

885
Table 3A
Hs.321245
AK001111
7022169
cDNA FLJ10249 fis; clone
1
TTGAGCTAAGACCTTAGGAAATTCAC

HEMBB1000725, highly similar to

TTTCTGCATGATAAAATGACCCAA

Rattus norvegicus GTPase Rab8b

mRNA/cds = UNKNOWN

886
Table 3A
Hs.117950
AK001163
7022244
multifunctional polypeptide similar
1
TGTCATTGTACACTTTATTTCCCTCAC

to SAICAR synthetase and AIR

ACTGTGTTATGCTCTGATGTGCT

carboxylase (ADE2H1),

mRNA/cds = (24, 1301)

887
Table 3A
Hs.194676
AK001313
7022490
tumor necrosis factor receptor
1
GGTCTCTTTGACTAATCACCAAAAAG

superfamily, member 6b, decoy

CAACCAACTTAGCCAGTTTTATTT

(TNFRSF6B), transcript variant 2,

mRNA/cds = (827, 4486)

888
Table 3A
Hs.7837
AK001319
7022500
phosphoprotein regulated by
1
AGGTTCTTCCTGTACATACGTGTATA

mitogenic pathways (C8FW),

TATGTGAACAGTGAGATGGCCGTT

mRNA/cds = (273, 1391)

889
Table 3A
Hs.44672
AK001332
7022524
hypothetical protein FLJ10470
1
ACTTGGATGCTGCCGCTACTGAATGT

(FLJ10470), mRNA/cds =

TTACAAATTGCTTGCCTGCTAAAG

(6, 2054)

890
Table 3A
Hs.76556
AK001381
7022572
protein phosphatase 1, regulatory
1
GGGAGGCGTGGCTGAGACCAACTGG

(inhibitor) subunit 15A

TTTGCCTATAATTTATTAACTATTT

(PPP1R15A), mRNA/cds =

(240, 2264)

891
Table 3A
Hs.173374
AK001382
7022574
cDNA FLJ10500 fis, clone
1
TCTCCCAGAATGTACTTATCTTACCTC

NT2RP2000369/cds =

GGCATGTACTGTAGTCACTCAGT

UNKNOWN

892
Table 3A
Hs.808
AK001364
7022577
heterogeneous nuclear
1
TGTGCACTGTTGTAAACCATTCAGAA

ribonucleoprotein F (HNRPF),

TTTTCCTGCTAGGCCCTTGATGCT

mRNA/cds = (323, 1570)

893
Table 3A
Hs.279521
AK001403
7022638
hypothetical protein FLJ20530
1
CATCGGCCAGACAGAGTTGAATGCAA

(FLJ20530), mRNA/cds =

GCAATCCAGAAGAAGTGTTACAGC

(10, 1683)

894
Table 3A
Hs.108332
AK001428
7022679
cDNA FLJ10566 fis, clone
1
TGCTCTAGCCATCAGGTTCTTTCAAA

NT2RP2002959, highly similar to

TGCATCTTTACACTCTTGCACAAA

UBIQUITIN-CONJUGATING

ENZYME E2-17 KD 2

(EC 6.3.2.19)/cds = UNKNOWN

895
Table 3A
Hs.183297
AK001433
7022686
enhancer of polycomb 1 (EPC1)
1
TGAGCATGAAATGGGATCCTGCATCA

mRNA, complete cds/cds =

CTTGTTTTAACTATTTATTTTGCC

(151, 2442)

896
Table 3A
Hs.7943
AK001437
7022693
RPB5-mediating protein (RMP),
1
TTTGCGGCTAGTTGGCTATTCAAGAA

mRNA/cds = (465, 1991)

ACCTCGCCCCTCTGAATGTCATAC

897
Table 3A
Hs.343211
AK001451
7022717
602321909F1 cDNA, 5′ end
1
GTTTACGTGGAAGAAACGCTAAGGGT

/clone = IMAGE:4425098/

TTGCTCCCAGGAAAGGAGAGGAAG

clone_end = 5′

898
Table 3A
Hs.268012
AK001471
7022749
fatty-acid-Coenzyme A ligase,
1
TGCTCAAATCAGGACTTAAATCATAG

long-chain 3 (FACL3), mRNA

GCACCACATTTTTCATGTCAGACT

/cds = (142, 2304)

899
Table 3A
Hs.238844
AK001514
7022816
hypothetical protein FLJ10652
1
TGAAATTCTACCCATCTTGAGGGAGG

(FLJ10652), mRNA/cds =

ACCGTTCCTCAGTTAAGGACTTGT

(50, 1141)

900
Table 3A
Hs.215766
AK001548
7022888
GTP-binding protein (NGB),
1
ATGAGTGTGTCGGAATCCCGTGCTTA

mRNA/cds = (23, 1924)

AAATACGCTCTTAAATTATTTTCT

901
Table 3A
Hs.18063
AK001630
7023001
cDNA FLJ10768 fis, clone
1
AAATCAGAACTGAGGTAGCTTAGAGA

NT2RP4000150/cds =

TGTAGCGATGTAAGTGTCGATGTT

UNKNOWN

902
Table 3A
Hs.14347
AK001685
7023061
cDNA FLJ12877 fis, clone
1
AGGCTTTAGCAAAGATGGATATATTG

NT2RP2003825/cds =

GTGACTGAGACAGAAGAACTGGCA

(313, 738)

903
Table 3A
Hs.12457
AK001676
7023081
hypothetical protein FLJ10814
1
AGTGGGCCTAACTCATGTGAGCTTGA

(FLJ10814), mRNA/cds =

TAACTGATGAACTCATTGGGAGCA

(92, 3562)

904
Table 3A
Hs.169407
AK001725
7023165
SAC2 (suppressor of actin
1
AACACTAACCTCTCCCCTCCTGGCTC

mutations 2, yeast, homolog)-like

AAGAATTACTCCGAAGTCAGTCTG

(SACM2L), mRNA/cds =

(0, 2165)

905
Table 3A
Hs.267604
AK001749
7023206
hypothetical protein FLJ10450
1
TCTGTCAGGAAATGTAACTTTGGTTTT

(FLJ10450), mRNA/cds =

ATTTTTGGCTTATTCCAAGGGGT

(68, 1622)

906
Table 3A
Hs.110445
AK001779
7023263
CGI-97 protein (LOC51119),
1
AAATTGTGCCGGACTTACCTTTCATT

mRNA/cds = (170, 922)

GAACATGCTGCCATAACTTAGATT

907
Table 3A
Hs.12999
AK001822
7023330
cDNA FLJ10960 fis, clone
1
TGGCAGGGAGCTGGGACCTGGAGAG

PLACE1000564/cds =

ACAACTCCTGTAAATAAAACACTTT

UNKNOWN

908
Table 3A
Hs.296323
AK001838
7023355
serum/glucocorticoid regulated
1
AGGGAGATAATGGAGTCCACTTTAAT

kinase (SGK), mRNA/cds =

TTGGAATTCTGTGTGAGCTATGAT

(42, 1337)

909
Table 3A
Hs.81648
AK001883
7023426
hypothetical protein FLJ11021
1
AGATCAGTGATACTGGTGTTAGTGTT

similar to splicing factor,

GTAATCAGGTTAAACCCACTTCCA

arginine/serine-rich 4

(FLJ11021), mRNA/cds =

(446, 1054)

910
Table 3A
Hs.181112
AK001934
7023506
HSPC126 protein (HSPC126),
1
CCATTTGACAGTAAAGGCTCTTGGCT

mRNA/cds = (25, 837)

TCTGTTGGAGGCATGGGAAATTGT

911
Table 3A
Hs.4863
AK001942
7023519
cDNA FLJ11080 fis, clone
1
TTTAACAGCCTGTCCTCCCGGCATCA

PLACE1005181/cds =

GGAGTCATTGAACAATCATGGATT

UNKNOWN

912
Table 3A
Hs.30822
AK001972
7023569
hypothetical protein FLJ11110
1
AATACTTATTGTTTGGCAGGTCATCC

(FLJ11110), mRNA/cds =

ACACACTTCTGCCCCCACTGCATT

(44, 1033)

913
Table 3A
Hs.173203
AK002009
7023629
beta-1,3-N-
1
TTATCAGATGGGATACTGGGGACTAT

acetylglucosaminyltransferase

AAACAATGGAAATAAAGCCACTGT

(BETA3GNT), mRNA/cds =

(235, 1428)

914
Table 3A
Hs.8033
AK002026
7023858
hypothetical protein FLJ11164
1
CCCTGTGCCTTTCCTTTGAGAGTGAA

(FLJ11164), mRNA/cds =

GGTGGGTGGAGTTGACCAGAGAAA

(56, 1384)

915
Table 3A
Hs.92918
AK002059
7023711
hypothetical protein (BM-009),
1
TGTGTGCGTAGAATATTACGTATGCA

mRNA/cds = (385, 1047)

TGTTCATGTCTAAAGAATGGCTGT

916
Table 3A
Hs.155313
AK002127
7023814
DNA sequence from clone
1
TCTACATGTGACTGGCTTTCTTGCCC

RP5-885L7 on chromosome

TCGTCTCTTGAATGTTTAGACTCT

20q13.2-13.33

Contains ESTs, STSs, GSSs

and eight CpG islands. Contains

the 3′ end of the NTSR1 gene

for high affinity neurotensin

receptor 1, a putative novel gene,

a novel gene similar to a fly gene,

the gene for opioid growth factor

receptor (7-60 protein), the

COL9A3 gene for collagen IX

alpha 3, a putative novel gene

similar to a fly gene, the TCFL5

gene for basic helix-loop-helix

transcription factor-like 5, an

ARF4 (ADP-ribosylation factor 4)

pseudogene, a novel gene and the

3′ end of the gene for a novel

protein similar to mouse death

inducer obliterator 1 (DIO-1)

(contains KIAA0333)/cds =

(0, 3129)

917
Table 3A
Hs.5518
AK002173
7023889
cDNA FLJ11311 fis, clone
1
TGGTACCCAAACTCACCATTTGGTCC

PLACE1010102/cds =

TCTTTAATCTTTGAGGGTTTCAAT

UNKNOWN

918
Table 3A
Hs.270557
AK021517
10432713
cDNA FLJ11455 fis, clone
1
TTCCATTTATTCATGTACATTGGCCAG

HEMBA1001497/cds =

TTCCTGGTCCTTGTCTGACTTCT

UNKNOWN

919
Table 3A
Hs.126707
AK021519
10432715
hypothetical protein FLJ11457
1
AACCATCTGGAGTCAGTACAGATCAT

(FLJ11457), mRNA/cds =

CAATCCTTCCACATATACAAGTTC

(103, 867)

920
Table 3A
Hs.77558
AK021563
10432767
cDNA FLJ11501 fis, clone
1
GGCCACCTGCTGACTATTTGTGGTTT

HEMBA1002100/cds =

AAAATAAAAGGTTTACTTGTCTGC

UNKNOWN

921
Table 3A
Hs.11571
AK021632
10432852
cDNA FLJ11570 fis, clone
1
TCTTTGTAAAGCACGATGATACAAAT

HEMBA1003309/cds =

CTGGTGCCAGTGTTATATTTTGCA

UNKNOWN

922
Table 3A
Hs.12315
AK021670
10432901
hypothetical protein FLJ11608
1
CATGGATATCATGTATCCTTCCTGGT

(FLJ11608), mRNA/cds =

GCTCACACACCTGTCACCTTGTAA

(561, 1184)

923
Table 3A
Hs.241567
AK021704
10432943
RNA binding motif, single
1
ATAAGGTGCATAAAACCCTTAAATTC

stranded interacting protein 1

ATCTAGTAGCTGTTCCCCCGAACA

(RBMS1), transcript variant

MSSP-2, mRNA/cds = (265, 1434)

924
Table 3A
Hs.271541
AK021715
10432954
cDNA FLJ11653 fis, clone
1
TGGACCGGAGTCTGCTGAGTTTATAA

HEMBA1004538/cds =

GGTTCCAAAAATATGGTAAAATCT

UNKNOWN

925
Table 3A
Hs.5019
AK021776
10433029
cDNA FLJ11714 fis, clone
1
ACTCGACCTTGGTAAACGGAAATGTT

HEMBA1005219, weakly similar

GGGGGTGAAGAGAAACAATCACTA

to NUCLEAR PROTEIN SNF7

/cds = UNKNOWN

926
Table 3A
Hs.288212
AK021791
10433048
hypothetical protein FLJ11729
1
TTCAAGGTTCTGCGAAATTAATTGGG

(FLJ11729), mRNA/cds =

CAGGTTAATTGTGTACCTGAAACT

(311, 1150)

927
Table 3A
Hs.9096
AK021925
10433223
hypothetical protein FLJ20473
1
TCCCCAGGATGGGGCCTCATACAAC

(FLJ20473), mRNA/cds =

CCTTCATCTGCACTCAACATTTAAT

(57, 1472)

928
Table 3A
Hs.288178
AK022030
10433346
cDNA FLJ11968 fis, clone
1
TTTTAGACATGGAGTGCAGGTGGACA

HEMBB1001133/cds =

CTGTGTGAACTGTTTTTGGTCAGT

UNKNOWN

929
Table 3A
Hs.22265
AK022057
10433376
pyruvate dehydrogenase
1
CAAGAAACTTGGTCTGCAGTCTGGAA

phosphatase (PDP), mRNA/

GCTTGTCTGCTCTATAGAAATGAA

cds = (131, 1855)

930
Table 3A
Hs.22265
AK022057
10433376
pyruvate dehydrogenase
1
CAAGAAACTTGGTCTGCAGTCTGGAA

phosphatase (PDP), mRNA/

GCTTGTCTGCTCTATAGAAATGAA

cds = (131, 1855)

931
Table 3A
Hs.20281
AK022103
10433424
mRNA for KIAA1700 protein,
1
TGTTGAACGGTTAAACTGTGCATTTC

partial cds/cds = (108, 2180)

TCATTTTGATGTGTCATGTATGTT

932
Table 3A
Hs.9043
AK022215
10433563
cDNA FLJ12153 fis, clone
1
CCCCTTCAACTGAGGGTCATTTTACC

MAMMA1000458/cds =

AGAGTCAATAAAGGCCAACCCTTC

UNKNOWN

933
Table 3A
Hs.94576
AK022267
10433826
cDNA FLJ12205 fis, clone
1
ATTCTGAGGGTGACTGAGGCTACAG

MAMMA1000931/cds =

CTGCTATCACATGCCGAACTTTCTT

UNKNOWN

934
Table 3A
Hs.318725
AK022280
10433640
CGI-72 protein (LOC51105),
1
TGGTATCAGGAGTTGGGATTTCTCAG

mRNA/cds = (69, 1400)

CACTGCTAATGAAGATCCCCTCTT

935
Table 3A
Hs.132221
AK022463
10433867
hypothetical protein FLJ12401
1
CGCAGAGAGGAGAAAAGGAGACAGC

(FLJ12401), mRNA/cds =

AAGACGCCAATAAAGAAACACAACT

(3, 1526)

936
Table 3A
Hs.105779
AK022481
10433892
cDNA FLJ12419 fis, clone
1
CCCGCACGGGCAGCTGAAGGCCGCT

MAMMA1003047, highly similar

GTTTTCTAATATTTGTATTCTAATT

to protein inhibitor of

activated STAT protein

PIASy mRNA/cds =

UNKNOWN

937
Table 3A
Hs.8068
AK022497
10433916
hematopoietic PBX-interacting
1
CCCCTGGGAGATGTAGCAAATTGAGT

protein (HPIP), mRNA/

GTGGGTTTTGGAGTCTGAGCCTCA

cds = (80, 2275)

938
Table 3A
Hs.179882
AK022499
10433920
hypothetical protein FLJ12443
1
GCAGAGGGAGGGTTGCCATGAAGGA

(FLJ12443), mRNA/cds =

ACTTGGGATTTTCAATGGAATAAAT

(187, 900)

939
Table 3A
Hs.287863
AK022537
10433983
hypothetical protein FLJ12475
1
CCTTTCACGTCTGGACGAATTACCAA

(FLJ12475), mRNA/cds =

ATGCCATGAATTGCCACTGTGTGT

(16, 1065)

940
Table 3A
Hs.332541
AK022546
10433997

Homo sapiens, Similar to RIKEN
1
AGGAAGATGGCGCTGTTATCAGCGG

cDNA 2700083B06 gene, clone

GGAAATGTACTATTTAAGATCAGCT

MGC:4669 IMAGE:3531883,

mRNA, complete cds/cds =

(67, 1050)

941
Table 3A
Hs.21938
AK022554
10434010
hypothetical protein FLJ12492
1
ATCCAAGTCTGAAACTCTGCGCTCTA

(FLJ12492), mRNA/cds =

GTACTGCTGTTAAGATACACAACT

(172, 1848)

942
Table 3A
Hs.7010
AK022568
10434032

Homo sapiens, clone MGC:14452
1
TGGATAGCCATTTCTGCTCAACCACA

IMAGE:4304209, mRNA,

CATTCTCTAAGAAACAGCTTGAAA

complete cds/cds = (88, 1953)

943
Table 3A
Hs.11556
AK022628
10434128
cDNA FLJ12568 fis, clone
1
TGTTGTATGTGGATGGGGAAGTTTTG

NT2RM4000852/cds =

TTTCTCCTCTTAGCATTTGTTTCT

UNKNOWN

944
Table 3A
Hs.173885
AK022681
10434216
hypothetical protein FLJ12619
1
TCTGAATGATCCTACTCCTTTGGAGT

(FLJ12619), mRNA/cds =

AAAACTAGTGCTTACCAGTTTCCA

(391, 1080)

945
Table 3A
Hs.288836
AK022735
10434309
hypothetical protein FLJ12673
1
TCCTTTTGTAGCCACTTTGAGTCTGC

(FLJ12673), mRNA/cds =

AGTTGTCAGTAAGCCTTTTTAAAG

(2, 1687)

946
Table 3A
Hs.9908
AK022758
10434350
cDNA FLJ12696 fis, clone
1
GGGGGAAATTACCAGTAGAATGCCTT

NT2RP1000513, highly similar to

GGTCTGAATATTTGATAGAACCAA

NifU-like protein (hNifU)

mRNA/cds = UNKNOWN

947
Table 3A
Hs.77573
AK022790
10434395
uridine phosphorylase (UP),
1
CTGGTACTTTACAGTTTTGCACCAAC

mRNA/cds = (352, 1284)

TCTGCCAAGCCACTGGATCTTACA

948
Table 3A
Hs.27475
AK022611
10434426
cDNA FLJ12749 fis, clone
1
ATCCAGTCACTCATCAAGTGTAATCT

NT2RP2001149/cds =

GTCTCCTAAATATCTCTGGAACCT

UNKNOWN

949
Table 3A
Hs.58488
AK022834
10434461
catenin (cadherin-associated
1
AGCTTTTGGGGTCAGATCTCTGGAAC

protein), alpha-like 1 (CTNNAL1),

ATCATGTGATGAAGCTGACATTTT

mRNA/cds = (43, 2247)

950
Table 3A
Hs.108779
AK022874
10434520
cDNA FLJ12812 fis, clone
1
AGCAGTTAGGCTTGACTTTGAGGAGA

NT2RP2002498/cds = (3, 2360)

GGCTGTGATGTTTATGATCCCTGA

951
Table 3A
Hs.56847
AK022936
10434613
cDNA FLJ12874 fis, clone
1
GCTGTCCACAGAAAACGCCCTTAAGT

NT2RP2003769/cds =

AGCCCTACCTTACTCCTTAGAGCT

UNKNOWN

952
Table 3A
Hs.14347
AK022939
10434618
cDNA FLJ12877 fis, clone
1
CATGGGTATTAATAGTCTTTGCTGCT

NT2RP2003825/cds = (313, 738)

GGTAATACTGAAAGAACCTGCTTT

953
Table 3A
Hs.4859
AK022974
10434675
cyclin L ania-6a (LOC57018),
1
AGGATTTGATTTCTTGAAACCCTCTA

mRNA/cds = (54, 1634)

GGTCTCTAGAACACTGAGGACAGT

954
Table 3A
Hs.193313
AK023013
10434731

Homo sapiens, NADH
1
GGACTCAGGAGCTAATACTGTCTACA

dehydrogenase (ubiquinone) 1,

GTGGAGCTTGGTGCAATTAGAAGC

subcomplex unknown, 2 (14.5 kD,

B14.5b), clone MGC:1432

IMAGE:2990088, mRNA,

complete cds/cds = (150, 509)

955
Table 3A
Hs.288141
AK023078
10434831
hypothetical protein MGC3156
1
ACCAGGAGGACAGAGTTTGCTTTCAT

(MGC3156), mRNA/cds =

ATTTTCCCTGTAAGTAAGAGGGCT

(156, 2501)

956
Table 3A
Hs.17279
AK023088
10434845
tyrosylprotein sulfotransferase 1
1
CCATGAAGAAGCAAGACGAAAACACA

(TPST1), mRNA/cds = (81, 1193)

CAGGAGGGAAAATCCTGGGATTCT

957
Table 3A
Hs.142442
AK023129
10434909
cDNA FLJ13067 fis, clone
1
TTGGAATTTGTGTTGCATGTAAGGCA

NT2RP3001712, highly similar

ATCTTTCCTGTTGTAAATCTTCCT

to HP1-BP74 protein mRNA/

cds = UNKNOWN

958
Table 3A
Hs.180838
AK023143
10434930
hypothetical protein FLJ13081
1
AGGAAACTGAGTAGACTCCTGTGTAA

(FLJ13081), mRNA/cds =

CCCTGTTTGGAACTTTGCCTTCTT

(170, 2098)

959
Table 3A
Hs.172035
AK023154
10434948
cDNA FLJ13092 fis, clone
1
TTTACAAGGCAGAATGGGGTGTAACA

NT2RP3002147/cds = (34, 606)

GTTGAATTAAACTAGCAATCACGT

960
Table 3A
Hs.7797
AK023166
10434966
TERF1 (TRF1)-interacting nuclear
1
TAGTAGGAATGAAGTGGAAGTCCAG

factor 2 (TINF2), mRNA

GCTTGGATTGCCTAACTACACTGCT

/cds = (262, 1326)

961
Table 3A
Hs.72782
AK023183
10434995
hypothetical protein FLJ11171
1
AGTGTTTAGTCTCATGTTGGGAACAC

(FLJ11171), mRNA/cds =

ATGAATGTGATGAACATAGTGAAT

(134, 2446)

962
Table 3A
Hs.234265
AK023204
10435025
cDNA FLJ13142 fis, clone
1
ACCCTTTGAGAGTTCCACAAGTGGTA

NT2RP3003212, moderately

GTAGAGTGGTTTAACGTCTTTCCT

similar to Rattus norvegicus

lamina associated polypeptide 1C

(LAP1C) mRNA/cds = (55, 1443)

963
Table 3A
Hs.236494
AK023223
10435057
RAB10, member RAS oncogene
1
TTGCCCCTTTTCTGTAAGTCTCTTGG

family (RAB10), mRNA/

GATCCTGTGTAGAAGCTGTTCTCA

cds = (90, 692)

964
Table 3A
Hs.288932
AK023256
10435106
hypothetical protein FLJ13194
1
ACTCATCAATTGAAAAGTCCTCCAAA

(FLJ13194), mRNA/cds =

AAGAGAACTATTGGGAAACCATGG

(300, 809)

965
Table 3A
Hs.126925
AK023275
10435137
hypothetical protein FLJ13213
1
AGATGGGTGAATCAGTTGGGTTTTGT

(FLJ13213), mRNA/cds =

AAATACTTGTATGTGGGGAAGACA

(233, 1669)

966
Table 3A
Hs.75748
AK023290
10435162
cDNA FLJ13228 fis, clone
1
TCAGACCTGGTTGATTTTGTACTTTG

OVARC1000085, highly similar to

GAACTGTACCTTGGATGGTTTTGT

mRNA for proteasome subunit

HC5/cds = UNKNOWN

967
Table 3A
Hs.285017
AK023291
10435163
hypothetical protein FLJ21799
1
GTATCTCATGGCCTCTTGATGTGGAA

(FLJ21799), mRNA/cds =

AGAAGTTGACAGAGGGTTGCAGGG

(159, 923)

968
Table 3A
Hs.288929
AK023320
10435204
hypothetical protein FLJ13258
1
AGTTCAGTGAGAAGAAACCAGA

similar to fused toes (FLJ13258),

ACACTTGTTCCTAGTGTTGTGTTG

mRNA/cds = (163, 1041)

TTTT

969
Table 3A
Hs.227400
AK023362
10435266
mitogen-activated protein kinase
1
GCAGATGGCTATGTGCTAGAGGGCA

kinase kinase kinase 3 (MAP4K3),

AAGAGTTGGAGTTCTATCTTAGGAA

mRNA/cds = (360, 3014)

970
Table 3A
Hs.155180
AK023379
10435291

Homo sapiens, Similar to splicing
1
TTGGTGTCAATGATCTGGTGACAATA

factor, arginine/serine-rich 2

GGATTACATTGGAGCCAATTGAAT

(SC-35), clone MGC:2622

IMAGE:3501687, mRNA,

complete cds/cds = (30, 878)

971
Table 3A
Hs.125034
AK023402
10435324
mRNA for putative
1
AACTAGAAGATGTACTTCGACAGCAT

N-acetyltransferase/cds =

CCATTTTACTTCAAGGCAGCAAGA

(208, 2808)

972
Table 3A
Hs.285107
AK023459
10435401
hypothetical protein FLJ13397
1
ATACACTTTTCCAAATTTGTCCCAACA

(FLJ13397), mRNA/cds =

GCCCTGTAAGCCAGCTTTCTTCT

(221, 1558)

973
Table 3A
Hs.172028
AK023460
10435403
a disintegrin and metalloproteinase
1
GCATTTTCTTCACTTGCAGGCAAACT

domain 10 (ADAM10), mRNA

TGGCTCTCAATAAACTTTTACCAC

/cds = (469, 2715)

974
Table 3A
Hs.315054
AK023470
10435414
hypothetical protein MGC15875
1
ATTAGACCAGACCAGTGTATTTCTAA

(MGC15875), mRNA/cds =

AGAAAATCCTGACATGCACACCCA

(651, 1178)

975
Table 3A
Hs.164005
AK023494
10435442
cDNA FLJ13432 fis, clone
1
AGCCAAATGTGTCATACATCAAATCT

PLACE1002537/cds =

TCAGCAGCTTTTGCATAATCCAGG

UNKNOWN

976
Table 3A
Hs.129872
AK023512
10435467
sperm associated antigen 9
1
TCCTCAAAGGGGAAAACTATGAAGGG

(SPAG9), mRNA/cds =

GAAGAAGACAAACCTAAGATACCA

(110, 2410)

977
Table 3A
Hs.63525
AK023529
10435489
cDNA FLJ13467 fis, clone
1
AGATGGACTGGAGCTTTTTCTTTGTG

PLACE1003519, highly similar

AATAGAAACTGGATGCCACAGTGA

to hnRNP-E2 mRNA/cds =

UNKNOWN

978
Table 3A
Hs.116278
AK023633
10435617
cDNA FLJ13571 fis, clone
1
AGTTGTCAGAAGACTCCTGGGTGTAC

PLACE1008405/cds =

AGAGCAAATCAAGCTGCATCAGTA

UNKNOWN

979
Table 3A
Hs.43047
AK023647
10435832
cDNA FLJ13585 fis, clone
1
AGTGGCTTCATAGCTACTGACAAATG

PLACE1009150/cds =

TCTGAACTATTGTCGTGCCCTTCA

UNKNOWN

980
Table 3A
Hs.163495
AK023670
10435662
cDNA FLJ13608 fis, clone
1
GCCTGTACAAACATTCAAGTTAGTTG

PLACE1010628/cds =

GCAGTCTATAAATGTGAGTTGGGT

UNKNOWN

981
Table 3A
Hs.17448
AK023680
10435678
cDNA FLJ13618 fis, clone
1
AAGGAAGGTAAAGTTAGGGGACTAG

PLACE1010925/cds =

AAGACTCTAAATTGGCTTCTACAGA

UNKNOWN

982
Table 3A
Hs.178357
AK023719
10435734
hypothetical protein FLJ13657
1
AGAACTAATTGCCCATGTTTAATTATA

(FLJ13657), mRNA/cds =

GCAGACACGCCATTCTAACAGGT

(87, 1172)

983
Table 3A
Hs.30818
AK023743
10435768
cDNA FLJ13681 fis, clone
1
AACTTGGTATTGTTGTAGTTTATGTAG

PLACE2000014, weakly similar to

TAAGTGACTTGGCACCCATCAGA

HYPOTHETICAL HELICASE

C28H8.3 IN CHROMOSOME III/

cds = UNKNOWN

984
Table 3A
Hs.157777
AK023779
10435815
cDNA FLJ13717 fis, clone
1
AGTTTAACTTTTCCTCACCCCTGTATA

PLACE2000425/cds =

GAAAATGCCTTGCCTCTCAAGAG

UNKNOWN

985
Table 3A
Hs.7871
AK023813
10435861
cDNA FLJ13751 fis, clone
1
GTCTTGGGCTGGATGGGTTATAGAG

PLACE3000339, weakly similar to

CTGAGCGGCTGTGATGGTTCTGTTT

GLUCOAMYLASE S1/S2

PRECURSOR (EC 3.2.1.3)/

cds = (436, 2805)

986
Table 3A
Hs.49391
AK023825
10435876
cDNA FLJ13763 fis, clone
1
GACACATCTAGAATGTTTTTCTTTCAC

PLACE4000089/cds =

CGTACCTCCAAAAGAGGCAATTT

(58, 547)

987
Table 3A
Hs.119908
AK023975
10436193
nucleolar protein NOP5/NOP58
1
ACCAGGGATGCTCTCTAACGTAATCA

(NOP5/NOP58), mRNA/cds =

AGGGAAGGTTCAGTAAGACAAAGT

(0, 1589)

988
Table 3A
Hs.26039
AK023999
10436234
cDNA FLJ13937 fis, clone
1
ACACAGTTCAGTTTTTGAGGGAACTA

Y79AA1000805/cds =

GTTTTGTCATAATACTACACCCCT

UNKNOWN

989
Table 3A
Hs.23170
AK024023
10436276
homolog of yeast SPB1 (JM23),
1
TGCAGTGGGAATTCTTGAGTGAGGTC

mRNA/cds = (300, 1289)

TTACCTCTTCTTTAAACCTCTTCA

990
Table 3A
Hs.24719
AK024029
10436287
cDNA FLJ13987 fis, clone
1
AAGGCAGAATAGAATGCTGAGATTGG

Y79AA1001402, weakly similar to

TTAAGTTTGCAATGACCATCTTGA

paraneoplastic cancer-testis-brain

antigen (MA4) mRNA/cds =

(684, 1397)

991
Table 3A
Hs.168232
AK024030
10438289
hypothetical protein FLJ13855
1
TGCCCTAATCTTGAGTTGAGGAAATA

(FLJ13855), mRNA/cds =

TATGCACAGGAGTCAAAGAGATGT

(314, 1054)

992
Table 3A
Hs.129872
AK024068
10436350
sperm associated antigen 9
1
GCTAGATTGTGAAGTACATGGGATTT

(SPAG9), mRNA/cds =

CATGAGCCAGAGGAGGCATTTGGA

(110, 2410)

993
Table 3A
Hs.333300
AK024088
10438379
hypothetical protein FLJ14026
1
GCCTCAAAGAAAACCCAGAGTGCCCT

(FLJ14026), mRNA/cds =

GTTCTAAAACGTAGTTCTGAATCC

(57, 1826)

994
Table 3A
Hs.281434
AK024090
10436383
cDNA FLJ14028 fis, clone
1
AATCCCAGGGCTTGGTTAAGTGCTGT

HEMBA1003838/cds =

GTGATAACTTGTTTGGATGAGACT

UNKNOWN

995
Table 3A
Hs.287864
AK024092
10436385
cDNA FLJ14030 fis, clone
1
AGGTTTCTTACCCAACACAAATGGAC

HEMBA1004086/cds =

AGTGGATTTGACTTTCTAAAGACT

UNKNOWN

996
Table 3A
Hs.288856
AK024094
10436388
prefoldin 5 (PFDN5), mRNA
1
CCTGGTGATGGGAAGGGTCTTGTGTT

/cds = (423, 926)

TTAATGCCAATAAATGTGCCAGCT

997
Table 3A
Hs.206868
AK024118
10436421
cDNA FLJ14056 fis, clone
1
AAAATATTGAGCCAGGCCCTGGGGA

HEMBB1000335/cds =

AGTGGGAAGTGAGAGCCAGAGCGGC

UNKNOWN

998
Table 3A
Hs.118990
AK024119
10436422
cDNA FLJ14057 fis, clone
1
AGCACACAAGGAATCCCAGAAAATGT

HEMBB1000337/cds =

TGGCTGAAGGAATAAATGGATGGA

UNKNOWN

999
Table 3A
Hs.235498
AK024137
10436443
hypothetical protein FLJ14075
1
CACTGCCTACCGCCATTCATGATTAA

(FLJ14075), mRNA/cds =

ACCATCCAGAAATACCATCCCTGT

(111, 2027)

1000
Table 3A
Hs.289037
AK024197
10436518
cDNA FLJ14135 fis, clone
1
AAATGAGATGGCCTCTGCGGACACAT

MAMMA1002728/cds =

GAAAGGGTACTTCAGCTTACCAAA

UNKNOWN

1001
Table 3A
Hs.289088
AK024202
10436523
heat shock 90 kD protein 1, alpha
1
TGGACTAGGAGAGACTTGATTTTGGT

(HSPCA), mRNA/cds = (60, 2258)

GCTAAAGTTCCCCAGTTCATATGT

1002
Table 3A
Hs.14070
AK024228
10436554
hypothetical protein FLJ14166
1
CTCACAGCCAGCACGACCCCCAGAA

(FLJ14166), mRNA/cds =

AGAGGCGTCCCACAATAAACACGTC

(203, 568)

1003
Table 3A
Hs.24115
AK024240
10436567
cDNA FLJ14178 fis, clone
1
ACAGAACATTGAGATGTGCCTAGTTC

NT2RP2003339/cds =

CGTATTTACAGTTTGGTCTGGCTG

UNKNOWN

1004
Table 3A
Hs.193063
AK024263
10436597
cDNA FLJ14201 fis, clone
1
TGAATTTCAGATGGGTGATTTAAGTG

NT2RP3002955/cds =

AGTCACAAGTCACAAAACTTTGCT

UNKNOWN

1005
Table 3A
Hs.183506
AK024275
10436615
hypothetical protein FLJ14213
1
TGTACTTAAGTGCTGATGACTGTTAG

(FLJ14213), mRNA/cds =

CCAGTTTACAACTTTTTACCATCG

(119, 841)

1006
Table 3A
Hs.109441
AK024297
10436644
cDNA FLJ14235 fis, clone
1
TTCTGAACATTTTAGTCAAGCTACAAC

NT2RP4000167/cds =

AGGTTTGGAAAACCTCTGTGGGG

(82, 2172)

1007
Table 3A
Hs.9343
AK024327
10436684
cDNA FLJ14265 fis, clone
1
TGTCAAGGGCATTAAAAGCCTCCTGA

PLACE1002256/cds =

AGCATAATCTTATCAAAGGGATAC

UNKNOWN

1008
Table 3A
Hs.287631
AK024331
10436690
cDNA FLJ14269 fis, clone
1
TCAGTCCATCTCAAGACCTGTGCCTG

PLACE1003864/cds =

TCAGATTTCACAATTATGGAGATT

UNKNOWN

1009
Table 3A
Hs.287634
AK024372
10436742
hypothetical protein FLJ14310
1
GGTAGGAGTGAAATCTCTCTCTCAAA

(FLJ14310), mRNA/cds =

CTCTAGGAAAGCCCGAGTCATACT

(406, 768)

1010
Table 3A
Hs.246112
AK024391
10436767
cDNA FLJ14329 fis, clone
1
ACAGCAGGTGTCATGGGTCAAGCATA

PLACE4000259, highly similar

AATCATATATAGCATTTTCAGGCA

to gene for U5 snRNP-specific

200 kD protein/cds = (188, 5623)

1011
Table 3A
Hs.246112
AK024391
10436767
cDNA FLJ14329 fis, clone
1
ACAGCAGGTGTCATGGGTCAAGCATA

PLACE4000259, highly similar

AATCATATATAGCATTTTCAGGCA

to gene for U5 snRNP-specific

200 kD protein/cds = (188, 5623)

1012
Table 3A
Hs.137354
AK024426
10440360
mRNA for FLJ00015 protein,
1
TGTGGGTCCCTATGAGTGTAGAGCC

partial cds/cds = (373, 1296)

CATATCCCCATAGAGTCTACCTAGA

1013
Table 3A
Hs.171118
AK024436
10440380
DNA sequence from clone RP11-
1
TGTTTTCATTTCAGAACATTGTGCTGT

165F24 on chromosome 9.

CTGTCAGCATATGTATATCAGCT

Contains the 3′ end of the gene

for a novel protein (similar to

Drosophila CG6630 and CG11376,

KIAA1058, rat TRG), an RPL12

(60S ribosomal protein L12)

pseudogene, ESTs, STSs, GSSs

and a CpG island/cds = (0, 4617)

1014
Table 3A
Hs.43816
AK024439
14020950
mRNA for FLJ00029 protein,
1
TGGCTACTGCAAAACCAGTTTTGACA

partial cds/cds = (0, 723)

GGTCAGATTTTCATATGTATAGGT

1015
Table 3A
Hs.132569
AK024449
10440411
mRNA for FLJ00041 protein,
1
AGAGGTTCTGAAAGGTCTGTGTCTTG

partial cds/cds = (0, 994)

TCAAAACAAGTAAACGGTGGAACT

1016
Table 3A
Hs.289034
AK024456
10440425
mRNA for FLJ00048 protein,
1
ATGCGTCCTGGTTTTCAATCGCTGCT

partial cds/cds = (2940, 3380)

GAACAAACCTATCAAAAATGTAGC

1017
Table 3A
Hs.273230
AK024471
10440455
mRNA for FLJ00064 protein,
1
AGTATGATCCCTCAAAACCTCACTAA

partial cds/cds = (0, 830)

CTGGAAGGATGATTTTGTCTCAGT

1018
Table 3A
Hs.41045
AK024474
10440461
mRNA for FLJ00067 protein,
1
GAGGGTTCCTCACTGAGGTTGAGAG

partial cds/cds = (1209, 2933)

GTGTGTTGGATAGGACTGATCCCAC

1019
Table 3A
Hs.7049
AK024478
10440469
mRNA for FLJ00071 protein,
1
AAGTGTGGTTCCTGAAGGCTGTCTTT

partial cds/cds = (3020, 3772)

GTAACTTTTTGTAGTTCTTTGTGT

1020
Table 3A
Hs.6289
AK024539
10436843
hypothetical protein FLJ20886
1
AATCCTTTAACTCTGCGGATAGCATT

(FLJ20886), mRNA/cds = (0, 524)

TGGTAGGTAGTGATTAACTGTGAA

1021
Table 3A
Hs.108854
AK024569
10436879
cDNA: FLJ20916 fis, clone
1
CTGGAAAGGGGGCTAAGATCAGGGC

ADSE00738, highly similar to

CTTCATTCTGGATCAGGCGAAATTT

AF161512 HSPC163 mRNA

/cds = UNKNOWN

1022
Table 3A
Hs.10382
AK024597
10436910
cDNA: FLJ20944 fis, clone
1
GTTCCTCTTCGGGAAGCTTTTGATAA

ADSE01780/cds = UNKNOWN

GGAATTCTCAGACCGATAGGGTGT

1023
Table 3A
Hs.289089
AK024689
10437005
hypothetical protein FLJ21016
1
AGTTTTGTACTTTTCACATAGCTTGTT

(FLJ21016), mRNA/cds =

GCCCCGTAAAAGGGTTAACAGCA

(90, 1193)

1024
Table 3A
Hs.10600
AK024740
10437104
DNA sequence from clone RP11-
1
TTGGATCTGGTTCTGAGGAGGACACA

353C18 on chromosome 20

CCTGGCATCGGATGACCTTTATAA

Contains ESTs, STSs, GSSs and

CpG islands. Contains the NIFS

gene for cysteine desulfurase,

two genes for novel proteins and

the gene for the splicing factor

CC1.3 with a second isoform

(CC1.4)/cds = (68, 839)

1025
Table 3A
Hs.12293
AK024756
10437124
hypothetical protein FLJ21103
1
TAGACATGCTTGTGTCCACACAGCAC

(FLJ21103), mRNA/cds =

ACCAATGTGATACTTCCACTGACC

(88, 1143)

1026
Table 3A
Hs.23410
AK024764
10437139
translocase of inner mitochondrial
1
ATGGGATGCGGTGGGTTGCCCAATA

membrane 13 (yeast) homolog B

AACGGCTGTGGAGTGGAAATTCCTC

(TIMM13B), mRNA/cds =

(46, 333)

1027
Table 3A
Hs.180139
AK024823
10437226
SMT3 (suppressor of mif two 3,
1
TTTGTACGTAGCTGTTACATGTAGGG

yeast) homolog 2 (SMT3H2),

CAATCTGTCTTTAAGTAGGGATAA

mRNA/cds = (90, 377)

1028
Table 3A
Hs.159557
AK024833
10437239
karyopherin alpha 2 (RAG
1
GGAATTTCCTATCTTGCAGCATCCTG

cohort 1, importin alpha 1)

TAAATAAACATTCAAGTCCACCCT

(KPNA2), mRNA/cds =

(132, 1721)

1029
Table 3A
Hs.325093
AK024863
10437271
cDNA: FLJ21210 fis, clone
1
GAGATGAGTTTTGTTATTTTGGGGTT

COL00479/cds = UNKNOWN

TTCAAGCATTGGAACCAAAGGCCA

1030
Table 3A
Hs.306720
AK024890
10437303
cDNA: FLJ21237 fis, clone
1
TCACTTAGACCCCTGTAACAGGTTAA

COL01114/cds = UNKNOWN

ATCTTCATGGTGTTCTGTTTCCTA

1031
Table 3A
Hs.135570
AK024921
10437337
cDNA: FLJ21268 fis, clone
1
GCTCTCCAGACTGTTACAGTGCATGA

COL01718/cds = UNKNOWN

GTGATAATAAAAATGAGTCAGTCA

1032
Table 3A
Hs.6019
AK024941
10437362
cDNA: FLJ21288 fis, clone
1
GGAGGTAAACATTGGAGATGTTTGTG

COL01927/cds = UNKNOWN

AAAATATTACTCTTGCTGTGAGGT

1033
Table 3A
Hs.1279
AK024951
10437374
cDNA: FLJ21298 fis, clone
1
GGCCCCTTTCTTTCTTCTGAGGATTG

COL02040, highly similar to

CAGAGGATATAGTTATCAATCTCT

HSC1R mRNA for complement

component C1r/cds = UNKNOWN

1034
Table 3A
Hs.29977
AK024961
10437386
hypothetical protein FLJ21308
1
TCAACAGCACTTAAACTGAAGTTTGG

(FLJ21308), mRNA/cds =

GTTGCTCATACAATAAACAGATTG

(287, 1792)

1035
Table 3A
Hs.166254
AK024969
10437398
hypothetical protein
1
GGGCCATTTTATGATGCATTGCACAC

DKFZp566I133 (DKFZP566I133),

CCTCTGGGGAAATTGATCTTTAAA

mRNA/cds = (133, 1353)

1036
Table 3A
Hs.156110
AK024974
10437403
cDNA: FLJ21321 fis, clone
1
TTTTCCACAGGGGACCTACCCCTATT

COL02335, highly similar to

GCGGTCCTCCAGCTCATCTTTCAC

HSA010422 mRNA for

immunoglobulin kappa light

chain/cds = UNKNOWN

1037
Table 3A
Hs.323376
AK024978
10437405
coated vesicle membrane protein
1
GGGTGAGAACACTTGCAACAGTTTAT

(RNP24), mRNA/cds = (27, 632)

TAATGAGGTGACTTTCACCTTAGG

1038
Table 3A
Hs.21056
AK025019
10437453
cDNA: FLJ21386 fis, clone
1
AATGTACCATCAATAAAATTGGCTGC

COL03012, highly similar to

TTGGGCAGTTTTAGTTACCACCTT

AB002445 mRNA from

chromosome 5q21-22

/cds = UNKNOWN

1039
Table 3A
Hs.337266
AK025021
10437455
RC-BT163-140599-023 cDNA
1
TTTTCAGAGGCTTCCTAATTAATCTTG

CCCTCCTCCATTTCAGTCCATTT

1040
Table 3A
Hs.120170
AK025068
10437507
hypothetical protein FLJ21415
1
AGCTCCAACCTTACGATGGAGAATTA

(FLJ21415), mRNA/cds =

AACTTGCTTGTATTTCCACTTTGT

(138, 755)

1041
Table 3A
Hs.288872
AK025092
10437538
mRNA for KIAA1840 protein,
1
AGCTTCCTCTTCCTCAGGACAGCTTC

partial cds/cds = (71, 4384)

TACTTTAGATGATCCAATAATGAT

1042
Table 3A
Hs.14555
AK025168
10437628
cDNA: FLJ21513 fis, clone
1
CACTGACTTCTATTCCATGAGCTTTTT

COL05778/cds = UNKNOWN

CAAGGCGCTTATTTTATGGCAGC

1043
Table 3A
Hs.83623
AK025198
10437682
nuclear receptor subfamily 1,
1
TGTTTCGTAAATTAAATAGGTCTGGC

group I, member 3 (NR1I3),

CCAGAAGACCCACTCAATTGCCTT

mRNA/cds = (272, 1318)

1044
Table 3A
Hs.322680
AK025200
10437664
cDNA: FLJ21547 fis, clone
1
GGAAGACCCAAGGAAATCCGGAATTT

COL06206/cds = UNKNOWN

CGCACCAGAGGACCCACCACGTCC

1045
Table 3A
Hs.10888
AK025212
10437679
hypothetical protein FLJ21709
1
TCTTGTTACTTCCAAGGAGAACCAAG

(FLJ21709), mRNA/cds =

AATGGCTCTGTCACACTCGAAGCC

(55, 2316)

1046
Table 3A
Hs.288708
AK025215
10437682
hypothetical protein FLJ21562
1
TCTTTCTCTAAAGCTTGTTTGATGAAA

(FLJ21562), mRNA/cds =

CTGGTTGGTCCTTTCAGTGAACA

(238, 2145)

1047
Table 3A
Hs.337581
AK025269
10437749
hypothetical protein FLJ21616
1
GCTGTGTGACTTAGTAGATAAAATAC

(FLJ21616), mRNA/cds =

TGCCTTCTGCCTTTGGGACCATGA

(119, 1093)

1048
Table 3A
Hs.2083
AK025306
10437795
cDNA: FLJ21853 fis, clone
1
TCTGTAATTGGACAGCTCTCTCGAAG

COL08586, highly similar to

AGATCTTACAGACTGTATCAGTCT

HUMKINCDC protein kinase

mRNA/cds = UNKNOWN

1049
Table 3A
Hs.76230
AK025353
10437852
cDNA: FLJ21700 fis, clone
1
GGTCGTGGACGTGGTCAGCCACCTC

COL09849, highly similar to

AGTAAAATTGGAGAGGATTCTTTTG

HSU14972 ribosomal protein

S10 mRNA/cds = UNKNOWN

1050
Table 3A
Hs.117268
AK025384
10437866
cDNA: FLJ21711 fis, clone
1
AAAGTGAAACCAAGAGTACAA

COL10156/cds = UNKNOWN

GAGACAGGTGAAATTAAAGAGCC

CCTTGA

1051
Table 3A
Hs.5181
AK025387
10437869
proliferation-associated 2G4,
1
GTCCAGGATGCAGAGCTAAAGGCCC

38 kD (PA2G4), mRNA/cds =

TCCTCCAGAGTTCTACAAGTCGAAA

(97, 1281)

1052
Table 3A
Hs.288061
AK025375
10437878
actin, beta (ACTB), mRNA
1
CCAACTTGAGATGTATGAAGGCTTTT

/cds = (73, 1200)

GGTCTCCCTGGGAGTGGGTGGAGG

1053
Table 3A
Hs.14040
AK025425
10437933
cDNA: FLJ21772 fis, clone
1
TTCCTCATCCCATTTACAGTTTTTCTA

COLF7808/cds = UNKNOWN

ACTCCAGGGTAGTGTTTAGTGTT

1054
Table 3A
Hs.85963
AK025446
10437961
cDNA: FLJ21793 fis, clone
1
CATGCCAAAGACTCAACTGCTTTCAA

HEP00468/cds = UNKNOWN

AGATAATGTGGGTGCTAGATGCAG

1055
Table 3A
Hs.82689
AK025459
10437979
tumor rejection antigen (gp96) 1
1
TCCCCTTCTCCCCTGCACTGTAAAAT

(TRA1), mRNA/cds = (105, 2516)

GTGGGATTATGGGTCACAGGAAAA

1056
Table 3A
Hs.289008
AK025467
10437988
cDNA: FLJ21814 fis, clone
1
ACCATGCATAGAGTCAATCAAATCCT

HEP01068/cds = UNKNOWN

TGTGATGTTTTGTATGGACTTTGA

1057
Table 3A
Hs.22678
AK025485
10438014
chromosome 10 open reading
1
TGTGCTGCCTCAAGACTGCTGGAGTC

frame 2 (C10orf2), mRNA/cds =

AGGACATTTTATAGAGCCTTTTCC

(32, 1552)

1058
Table 3A
Hs.184793
AK025533
10438078

Homo sapiens, clone IMAGE:
1
GTGCAGTCTCTTAGCAGACTTCAGGC

3865907, mRNA, partial cds/

CCAAACTGTATTCTTCACTCAGGC

cds = (0, 1534)

1059
Table 3A
Hs.121849
AK025556
10438108
microtubule-associated proteins
1
GTTAGTGAAAGCTGTTTACTGTAACG

1A/1B light chain 3

GGGAAAACCAGATTCTTTGCATCT

(MAP1A/1BLC3), mRNA/cds =

(84, 461)

1060
Table 3A
Hs.110771
AK025557
10438108
cDNA: FLJ21904 fis, clone
1
GCTTCTGTAAATGCCATCCCAATGTG

HEP03585/cds = UNKNOWN

GTTTGGTTTTGTTGAACAGAAACC

1061
Table 3A
Hs.82845
AK025583
10438142
cDNA: FLJ21930 fis, clone
1
TTGCCTCGATAAGTTTCCAAGTCACT

HEP04301, highly similar to

GAAATCTGCTGAAGGTTTTACTGT

HSU90918 clone 23815 mRNA

sequence/cds = UNKNOWN

1062
Table 3A
Hs.27268
AK025586
10438146
cDNA: FLJ21933 fis, clone
1
ACTTCTGAACTGAGGAATTTGCTGTT

HEP04337/cds = UNKNOWN

GACAGCCAAAGTATAGTGTACAAG

1063
Table 3A
Hs.7567
AK025615
10438186
cDNA: FLJ21962 fis, clone
1
AGAGCCATCTGGTGTGAAGAACTCTA

HEP05564/cds = UNKNOWN

TATTTGTATGTTGAGAGGGCATGG

1064
Table 3A
Hs.5985
AK025620
10438193
cDNA: FLJ21967 fis, clone
1
AGAACAAGTTTGCCTTGATTTTGTTTA

HEP05652, highly similar to

AAATGACTTCTGCTAAGCACCCA

AF131831 clone 25188 mRNA

sequence/cds = UNKNOWN

1065
Table 3A
Hs.279901
AK025623
10438197
PTD009 protein (PTD009),
1
CCTGCCAAAGCAAGAAGAAGGCTTG

mRNA/cds = (257, 918)

GTCCCCAGAAACAAACAGTAGTCAT

1066
Table 3A
Hs.339696
AK025643
10438224
ribosomal protein S12 (RPS12),
1
GGAGTCTCAGGCCAAGGATGTCATT

mRNA/cds = (80, 478)

GAAGAGTATTTCAAATGCAAGAAAT

1067
Table 3A
Hs.339696
AK025643
10438224
ribosomal protein S12 (RPS12),
1
GGAGTCTCAGGCCAAGGATGTCATT

mRNA/cds = (80, 478)

GAAGAGTATTTCAAATGCAAGAAAT

1068
Table 3A
Hs.334489
AK025645
10438227
hypothetical protein FLJ21992
1
TTTCATCTGAATCCAGAGGTGCATCA

(FLJ21992), mRNA/cds =

AATTAAATGACAGCTCCACTTGGC

(60, 845)

1069
Table 3A
Hs.92414
AK025683
10438280
cDNA: FLJ22030 fis, clone
1
TTGACACGTTCCACTTCCTTTGCAATT

HEP08669/cds = UNKNOWN

ATTGTATTTAGTTGTGCACTAGT

1070
Table 3A
Hs.173705
AK025703
10438305
cDNA: FLJ22050 fis, clone
1
CCAAATCAACTGTGTGAACTGTTTCT

HEP09454/cds = UNKNOWN

GCACTGCTTGCTAATGGTTTCATC

1071
Table 3A
Hs.13277
AK025707
10438310
hypothetical protein FLJ22054
1
ATTGAGACGGGAAAAACTCGCTGTAA

(FLJ22054), mRNA/cds =

AATAATGCCAACCTAGATAATGCT

(144, 956)

1072
Table 3A
Hs.5798
AK025729
10438338
pelota (Drosophila) homolog
1
TGTTCTTGCATTGCATTTAATGATCCC

(PELO), mRNA/cds = (259, 1416)

TTTTCTCCCCACCTCCACACACT

1073
Table 3A
Hs.184542
AK025730
10438339
CGI-127 protein (LOC51648),
1
TGCAGATTCCTAGTAGCATGCCTTAC

mRNA/cds = (125, 490)

CTACAGCACTATGTGCATTTGCTG

1074
Table 3A
Hs.75811
AK025732
10438341
N-acylsphingosine amidohydrolase
1
GCAAGACCGTTTGTCCACTTCATTTT

(acid ceramidase) (ASAH),

GTATAATCACAGTTGTGTTCCTGA

mRNA/cds = (17, 1204)

1075
Table 3A
Hs.77910
AK025738
10438345
cDNA: FLJ22083 fis, clone
1
AATTTAACTTTTGGGTGCCAGGAAAT

HEP14459, highly similar to

GGGTTTTCTCAAAGTCCATTGCCG

HUM3H3M 3-hydroxy-3

methylglutaryl coenzyme A

synthase mRNA/cds =

UNKNOWN

1076
Table 3A
Hs.170298
AK025743
10438355
cDNA: FLJ22090 fis, clone
1
TCGTGGAAGGGAGAGCCATCAGCAG

HEP16084/cds = UNKNOWN

AAAGAGACCCTGAGATCTTCGCCTG

1077
Table 3A
NA
AK025767
10438384
FLJ22114 fis, clone HEP18441
1
AAACACACCAGGGAGACACCAT

AAAACAGACCAAGACTAACTTAA

AAACA

1078
Table 3A
Hs.34497
AK025769
10438386
hypothetical protein FLJ22116
1
AACCACAATCAAACATATAAATAAGC

(FLJ22116), mRNA/cds =

CTGGAAAACCAACTACAACCAGCA

(270, 3545)

1079
Table 3A
Hs.5822
AK025773
10438391
cDNA: FLJ22120 fis, clone
1
TTTCCTGATTATTTGATGCTAGCTGG

HEP18874/cds = UNKNOWN

AATTCAAGAAATGGCATTGACCTT

1080
Table 3A
Hs.264190
AK025774
10438392
cDNA: FLJ22121 fis, clone
1
TCACCCCAAGTAGCATGACTGATCTG

HEP18876, highly similar to

CAATTTAAAATTCCTGTGATCTGT

AF191298 vacuolar sorting

protein 35 (VPS35) mRNA/

cds = UNKNOWN

1081
Table 3A
Hs.12245
AK025775
10438393
cDNA: FLJ22122 fis, clone
1
TGAGAAGTGCGGAATAGGTTGCTTCT

HEP19214/cds = UNKNOWN

ACCACCTGTTCTTAATGTAACAGT

1082
Table 3A
Hs.26367
AK025778
10438396
PC3-96 protein (PC3-96),
1
TCGAATGAGTGGTCAGGTAGTCTTAA

mRNA/cds = (119, 586)

AGAGCCTCATGTTAAATAGACACA

1083
Table 3A
Hs.285833
AK025788
10438408
cDNA: FLJ22135 fis, clone
1
TGAAGTGCAAATAAAAGCACTGCTAC

HEP20858/cds = UNKNOWN

TATAAGACATTCTGGAATGGTTGT

1084
Table 3A
Hs.90421
AK025800
10438421
cDNA: FLJ22147 fis, clone
1
GCAGTCCCCAGATCCAGAACATGGG

HEP22163, highly similar to

AAGTTAGGGAAAATGTGTGATTTTG

AF113020 clone FLB9138 mRNA

sequence/cds = UNKNOWN

1085
Table 3A
Hs.289721
AK025846
10438485
cDNA: FLJ22193 fis, clone
1
AGGTATGACAGGAACTGTCTTCATGT

HRC01108/cds = UNKNOWN

CCTTACCCAAGCAAGTCATCCATG

1086
Table 3A
Hs.286194
AK025886
10438538
hypothetical protein FLJ22233
1
AATTTTGAATTTCTCCTTGCCACGTTA

(FLJ22233), mRNA/cds =

ATAAAGCCAAAAGCAGCGGGTGC

(35, 1204)

1087
Table 3A
Hs.279921
AK025927
10438592
HSPC035 protein (LOC51669),
1
TGACTCTGTGCTGGCAAAAATGCTTG

mRNA/cds = (16, 1035)

AAACCTCTATATTTCTTTCGTTCA

1088
Table 3A
Hs.105684
AK025947
10438619
hypothetical protein FLJ22294
1
GCTCTCCCACAGAAACCTTTGTCCTT

(FLJ22294), mRNA/cds =

GCAACTTTATCCTTTGTCCCGATT

(240, 602)

1089
Table 3A
Hs.55024
AK026024
10438731
hypothetical protein FLJ10307
1
TTGCCTTAGCCAGTGTACCTCCTACC

(FLJ10307), mRNA/cds =

TCAGTCTATGTGAGAGGAAGAGAA

(28, 462)

1090
Table 3A
Hs.289092
AK026033
10438744

Homo sapiens, coactosin-like
1
ACTGTATTGGGATTGTAAAGAACATC

protein, clone MGC:19733

TCTGCACTCAGACAGTTTACAGAA

IMAGE:3604770, mRNA,

complete cds/cds = (158, 586)

1091
Table 3A
Hs.288555
AK026078
10438812
cDNA: FLJ22425 fis, clone
1
GTGTGTGTGCATGTGTGTGTTAGCAG

HRC08686

AGGTATTTTACTCAGAAAATAGGT

1092
Table 3A
Hs.333500
AK026091
10438829
cDNA: FLJ22438 fis, clone
1
GCCAGTCAAAAAGTAAAATGAA

HRC09232, highly similar to

GAGAGGCACGCCAACCACTCCAA

AF093250 P38IP (P38IP)

AATTT

mRNA/cds = UNKNOWN

1093
Table 3A
Hs.238707
AK026110
10438854
hypothetical protein FLJ22457
1
CACTTTGTGGTCGAAAGGCTCAGCCT

(FLJ22457), mRNA/cds =

CTCTACATGAAGTCTGTGGACATG

(56, 1462)

1094
Table 3A
Hs.77385
AK026164
10438926
cDNA: FLJ22511 fis, clone
1
AGGCTTTCTTGTCTCAGCAACTTTCC

HRC11837, highly similar to

CATCTTGTCTCTCTTGGATGATGT

HUMMYLCB non-muscle myosin

alkali light chain mRNA/cds =

UNKNOWN

1095
Table 3A
Hs.13179
AK026239
10439028
cDNA: FLJ22586 fis, clone
1
TTTTTCTTTTTGAAGCATGGAAAACAA

HSI02774/cds = UNKNOWN

ATCTTTTATGCCACTCCAGCCAT

1096
Table 3A
Hs.27774
AK026264
10439083
602386841F1 cDNA, 5′ end
1
CCATGATATAAGGAAGGGCCGTGCC

/clone = IMAGE:4515730/

TCATGGAAAAGCAACAGGTGGCCTC

clone_end = 5′

1097
Table 3A
Hs.297666
AK026270
10439073
cDNA: FLJ22617 fis, clone
1
TAAAGGCGAGCACCGTCAGGAGCGC

HSI05379, highly similar to

AGAGATCGGCCCTACTAGATGCAGA

HSEWS EWS mRNA/cds =

UNKNOWN

1098
Table 3A
Hs.31137
AK026334
10439167
protein tyrosine phosphatase,
1
TGAGCCTGACACCTGTGTTTCAGCAT

receptor type, E (PTPRE),

TTGGAGACATCCCCATGTTATTCT

mRNA/cds = (51, 2153)

1099
Table 3A
Hs.236744
AK026359
10439200
cDNA: FLJ22706 fis, clone
1
CTGAGCCACATCCAAGCCTGGTTTGC

HSI13163/cds = UNKNOWN

TGCACTCTATTGCCAAAGACTGAC

1100
Table 3A
Hs.288936
AK026363
10439205
mitochondrial ribosomal protein L9
1
ACTTGCCTCATTCTCATCATCCAAACT

(MRPL9), mRNA/cds = (14, 817)

GAACATTTGTATCCCAAGCAGAA

1101
Table 3A
Hs.143631
AK028372
10439218
cDNA: FLJ22719 fis, clone
1
GTATGAAGAAGGAAGCCCAGCAGAG

HSI14307/cds = UNKNOWN

CAGGAGGCAGCAGCAACAATGAGAG

1102
Table 3A
Hs.157240
AK026394
10439245
hypothetical protein MGC4737
1
CTGTGTGTGTCCATGTCTGCAAGCAG

(MGC4737), mRNA/cds =

TTCTTCAATAAATGGCCTGCCTCC

(2350, 2985)

1103
Table 3A
Hs.112497
AK026396
10439247
cDNA: FLJ22743 fis, clone
1
TCAAAGCAGAGCACAGAGTTATTTGG

HUV00901/cds = UNKNOWN

TGTTTGCTGAAGACAGCCTTTGTG

1104
Table 3A
Hs.236449
AK026410
10439266
hypothetical protein FLJ22757
1
ACTTCCATCTCAGCTAATGCACCCAC

(FLJ22757), mRNA/cds =

CAGCTCAAACACACCAATAAAGCT

(92, 2473)

1105
Table 3A
Hs.89555
AK026432
10439295
hemopoietic cell kinase (HCK),
1
TGCAATCCACAATCTGACATTCTCAG

mRNA/cds = (168, 1685)

GAAGCCCCCAAGTTGATATTTCTA

1106
Table 3A
Hs.343522
AK026443
10439309
ATPase, Ca++ transporting,
1
CAGAAACCAATACTGCTGTGCACTGA

plasma membrane 4 (ATP2B4),

GAATAAAAACTCATGCCCCCTTGT

mRNA/cds = (397, 4014)

1107
Table 3A
Hs.32148
AK026455
10439325
AD-015 protein (LOC558929),
1
CACCAGTGAGGATTACTGATGTGGAC

mRNA/cds = (30, 644)

AGTTGATGGGGTTTGTTTCTGTAT

1108
Table 3A
Hs.75415
AK026463
10439333
cDNA: FLJ22810 fis, clone
1
AAAGTAAGGCATGGTTGTGGTTAATC

KAIA2933, highly similar to

TGGTTTATTTTTGTTCCACAAGTT

AB021288 mRNA for beta

2-microglobulin/cds =

UNKNOWN

1109
Table 3A
Hs.118183
AK026488
10439358
hypothetical protein FLJ22833
1
TAAGGGGTAGACAAGATACCGAATAA

(FLJ22833), mRNA/cds =

TCTCCACAAGTTTATTTGTGGTCT

(479, 883)

1110
Table 3A
Hs.182979
AK026491
10439364
cDNA: FLJ22838 fis, clone
1
ACATCAACAGTGGTGCTGTGGAATGC

KAIA4494, highly similar to

CCAGCCAGTTAAGCACAAAGGAAA

HUML12A ribosomal protein

L12 mRNA/cds = UNKNOWN

1111
Table 3A
Hs.2795
AK026515
10439391
lactate dehydrogenase A (LDHA),
1
ACAAACAATGCAACCAACTATCCAAG

mRNA/cds = (97, 1095)

TGTTATACCAACTAAAACCCCCAA

1112
Table 3A
Hs.334807
AK026528
10439405

Homo sapiens, ribosomal protein
1
TTCACCTACAAAATTTCACCTGCAAA

L30, clone MGC:2797, mRNA,

CCTTAAACCTGCAAAATTTTCCTT

complete cds/cds = (29, 376)

1113
Table 3A
Hs.239307
AK026535
10439414
tyrosyl-tRNA synthetase (YARS),
1
GGGTACTTCTCCATAAGGCATCTCAG

mRNA/cds = (0, 1586)

TCAAATCCCCATCACTGTCATAAA

1114
Table 3A
Hs.251653
AK026594
10439481
tubulin, beta, 2 (TUBB2),
1
CTTGCTGTTTTCCCTGTCCACATCCA

mRNA/cds = (0, 1337)

TGCTGTACAGACACCACCATTGAA

1115
Table 3A
Hs.277477
AK026595
10439482
major histocompatibility complex,
1
AAGTCAATTCCTGGAATTTGAAAGAG

class I, C (HLA-C),

CAAATAAAGACCTGAGAACCTTCC

mRNA/cds = (0, 1100)

1116
Table 3A
Hs.334729
AK026603
10439492
cDNA FLJ20161 fis, clone
1
AAGCTACTGTGTGTGTGAATGAACAC

COL09252, highly similar to

TCTTGCTTTATTCCAGAATGCTGT

L33930 CD24 signal transducer

mRNA/cds = UNKNOWN

1117
Table 3A
Hs.334842
AK026632
10439528
tubulin, alpha, ubiquitous
1
TGTCATGCTCCCAGAATTTCAGCTTC

(K-ALPHA-1), mRNA/cds =

AGCTTAACTGACAGATGTTAAAGC

(67, 1422)

1118
Table 3A
Hs.179668
AK026642
10439539
uncharactorized hypothalamus
1
AGGTGGTACTCAAGCCATGCTGCCTC

protein HSMNP1 (HSMNP1),

CTTACATCCTTTTTGGAACAGAGC

mRNA/cds = (231, 1016)

1119
Table 3A
Hs.288036
AK026850
10439548
tRNA isopentenylpyrophosphate
1
TGCATCGTAAAACCTTCAGAAGGAAA

transferase (IPT), mRNA

GGAGAATGTTTTGTGGACCACTTT

/cds = (60, 1040)

1120
Table 3A
Hs.301404
AK026664
10439564
RNA binding motif protein 3
1
TGTGGTTAGGAAGCAATTTCCCAATG

(RBM3), mRNA/cds = (276, 749)

TACCTATAAGAAATGTGCATCAAG

1121
Table 3A
Hs.266940
AK026669
10439570
cDNA: FLJ23016 fis, clone
1
GCCTGCGTTGCCACTTGTCTTAACTC

LNG00874/cds = UNKNOWN

TGAATATTTCATTTCAAAGGTGCT

1122
Table 3A
Hs.288468
IU00944
405046
clone A9A2BRB6 (CAC)n/(GTG)n
1
AGCTAATATTGCTGCAATGGCTGGCA

repeat-containing mRNA

GGAAACAGGTGATCAAGAGTGTCA

/cds = UNKNOWN

1123
Table 3A
Hs.242868
AK026704
10439618
cDNA: FLJ23051 fis, clone
1
TCGACCCCAGAGGTGAATGTATTGTT

LNG02642/cds = UNKNOWN

ATTATTGTTTTGTTGTTGTTGTGA

1124
Table 3A
Hs.334861
AK026712
10439629
hypothetical protein FLJ23059
1
TCCTTGGCAGCTGTATTCTGGAGTCT

(FLJ23059), mRNA/cds =

GGATGTTGCTCTCTAAAGACCTTT

(41, 1881)

1125
Table 3A
Hs.12969
AK026747
10439670
cDNA: FLJ23094 fis, clone
1
TTTGCCATGTCCAGTACAGAATAATTT

LNG07379, highly similar to

GTACTTAGTATTTGCAGCAGGGT

HST000007 mRNA full length

insert cDNA clone EUROIMAGE

293605/cds = UNKNOWN

1126
Table 3A
Hs.90077
AK026766
10439693
TGFB-induced factor (TALE
1
TAGAGAACCTATAGCATCTTCTCATT

family homeobox) (TGIF),

CCCATGTGGAACAGGATGCCCACA

mRNA/cds = (311, 1129)

1127
Table 3A
Hs.287725
AK026769
10439697
cDNA: FLJ23116 fis, clone
1
AACTCATGTGCAGGTTTGATAAACAC

LNG07945, highly similar to

CAGAACAGAAGACAGTGATGCTGT

HSU79240 serine/threonine

kinase mRNA/cds = UNKNOWN

1128
Table 3A
Hs.124292
AK026776
10439707
cDNA: FLJ23123 fis, clone
1
TGGCCCTGACAGTATTCATTATTTCA

LNG08039/cds = UNKNOWN

GATAATTCCCTGTGATAGGACAAC

1129
Table 3A
Hs.20242
AK026819
10439764
hypothetical protein FLJ12788
1
ACCTGGAGAGAGAAGGTATTGAAACA

(FLJ12788), mRNA/cds = (9, 866)

TCTCCTTTATGTGTGACTTTCCCA

1130
Table 3A
Hs.287995
AK026834
10439781
cDNA: FLJ23181 fis, clone
1
AGAAATACCCACTAACAAAGAACAAG

LNG11094/cds = UNKNOWN

CATTAGTTTTGGCTGTCATCAACT

1131
Table 3A
Hs.324060
AK026836
10439784
hypothetical protein FLJ23183
1
ATGGGCAAATTCTTAGGTAAGACAAA

(FLJ23183), mRNA/cds =

AACACAGCCCCAAGGGCAGGTAGT

(226, 732)

1132
Table 3A
Hs.6906
AK028850
10439805
cDNA: FLJ23197 fis, clone
1
GCTGATGCCACTACCCGATTTGTTTA

REC00917/cds = UNKNOWN

TTTGCAATTTGAGCCATTTAAAGA

1133
Table 3A
Hs.288455
AK026923
10439895
cDNA: FLJ23270 fis, clone
1
CCTGTTCCCTTCAGCCAACCCGTTTC

COL10309, highly similar to

TGCAGTAAAATTAAGCCTGTCAAA

HSU33271 normal keratinocyte

mRNA/cds = UNKNOWN

1134
Table 3A
Hs.286238
AK026933
10439907
mRNA for KIAA1856 protein,
1
TGGCTTAAACCAGTGTTCAGTCTGGT

partial cds/cds = (0, 3404)

GCCAAACTTCGAATGGAATACAAA

1135
Table 3A
Hs.91065
AK026954
10439935
cDNA: FLJ23301 fis, clone
1
TGTGAGTTGTGACCATGTAACATGAG

HEP11120/cds = (2, 1888)

AGGTTTTGCTAGGGCCTATTATTT

1136
Table 3A
Hs.88044
AK026960
10439945
cDNA: FLJ23307 fis, clone
1
AGCTGAGTAATTCTAATCTCTTCTGT

HEP11549, highly similar to

GTTTTCCTTGCCTTAACCACAAAT

AF041037 novel antagonist of

FGF signaling (sprouty-1)

mRNA/cds = UNKNOWN

1137
Table 3A
Hs.298442
AK026983
10439978
adaptor-related protein complex 3,
1
AATTTGCTAGAATCCAGTAAATCATTT

mu 1 subunit (AP3M1),

TGGTAGCTCTGGCTGTGCTATCA

mRNA/cds = (69, 1325)

1138
Table 3A
Hs.301732
AK027018
10440025
hypothetical protein MGC5306
1
TGGCTCGAAGTTTCTCTAGTGTTTTC

(MGC5306), mRNA/cds =

TGTGGAAGGAATAAAAATTTGAGT

(206, 1042)

1139
Table 3A
Hs.3382
AK027064
10440089
protein phosphatase 4, regulatory
1
ACTCTTGGGAGTGCTGCAGTCTTTAA

subunit 1 (PPP4R1), mRNA

TCATGCTGTTTAAACTGTTGTGGC

/cds = (93, 2894)

1140
Table 3A
Hs.85567
AK027067
10440093
suppressor of variegation 3-9
1
TTTACATGATTGGACCCTCAGATTCT

(Drosophila) homolog 2:

GTTAACCAAAATTGCAGAATGGGG

hypothetic (SUV39H2),

mRNA/cds = (37, 1089)

1141
Table 3A
Hs.48320
AK027070
10440098
mRNA for ring-IBR-ring domain
1
TGAAATCAAAGCACGGTGCAGAACTT

containing protein Dorfin,

GTACCAAGTACAAAAGGTCCATGT

complete cds/cds = (317, 2833)

1142
Table 3A
Hs.115659
AK027114
10440156
hypothetical protein MGC5521
1
CCTTACTCTGTCCTTGATGGAGGGGA

(MGC5521), mRNA/cds =

GAAGGGAGGGCAAAGAAGTTAAAT

(163, 708)

1143
Table 3A
Hs.113205
AK027136
10440188
cDNA: FLJ23483 fis, clone
1
CACCGCCATGCAACTCCATGCCTATT

KAIA04052/cds = UNKNOWN

TACTGGAAACCTGTTATGCCAAAC

1144
Table 3A
Hs.289071
AK027187
10440255
cDNA: FLJ22245 fis, clone
1
CAAGAGAATGAAGGAGGCTAAGGAG

HRC02612/cds = UNKNOWN

AAGCGCCAGGAACAAATTGCGAAGA

1145
Table 3A
Hs.240443
AK027191
10440260
cDNA: FLJ23538 fis, clone
1
AGTCTCGGGTATGCTGTTGTGAAATT

LNG08010, highly similar to

GAAACTGTAAAAGTAGATGGTTGA

BETA2 MEN1 region clone

epsilon/beta mRNA/cds =

UNKNOWN

1146
Table 3A
Hs.323502
AK027192
10440261
nuclear RNA export factor 1
1
ACTAAACTACCCGAAGGACTTAGGTG

(NXF1), mRNA/cds = (0, 1679)

CTTTGTGTACTTAACCCCAGGACC

1147
Table 3A
Hs.159483
AK027194
10440263
chromosome 1 open reading
1
GCCACCACTGTCTGTTTGAGACTCCT

frame 7 (C1orf7),

TCATGAGCAAAGATTGATGTATGG

mRNA/cds = (46, 1590)

1148
Table 3A
Hs.334853
AK027197
10440266
hypothetical protein FLJ23544
1
ATGAATTTGAAGACATGGTGGCTGAA

(FLJ23544), mRNA/cds =

AAGCGGCTCATCCCAGATGGTTGT

(125, 517)

1149
Table 3A
Hs.91448
AK027210
10440285
MKP-1 like protein tyrosine
1
AGCTTCAGTCTCTACTGGATTAGCCC

phosphatase (MKP-L),

TACTCTTTCCTTTCCCCTCCATTA

mRNA/cds = (233, 829)

1150
Table 3A
Hs.169854
AK027212
10440288
hypothetical protein SP192
1
AGATGTGGTTATCACAAGTCTCGAGG

(SP192), mRNA/cds = (179, 1603)

GGGAAACTACTGCATAAAATAACT

1151
Table 3A
Hs.57209
AK027232
10440314
hypothetical protein
1
TCAGTAAAAATGCCTGTTGTGAGATG

DKFZp566J091 (DKFZP566J091),

AACCTCCTGTAACTTCTATCTGTT

mRNA/cds = (212, 529)

1152
Table 3A
Hs.54890
AK027243
10440328
cDNA FLJ14739 fis, clone
1
AGTTAACTGCGGAGCCAAGAGTTGG

NT2RP3002402/cds =

ACTATAATTAAATTACCTTCCTTGT

(156, 2048)

1153
Table 3A
Hs.279040
AK027258
10440392
HT001 protein (HT001),
1
CCGGTTTGGGTTGTTAATGGTTGAAA

mRNA/cds = (241, 1203)

ACTTAGAGGAACATAGTGAGGCCT

1154
Table 3A
Hs.279040
AK027258
10440392
HT001 protein (HT001),
1
CCGGTTTGGGTTGTTAATGGTTGAAA

mRNA/cds = (241, 1203)

ACTTAGAGGAACATAGTGAGGCCT

1155
Table 3A
Hs.152925
AK027260
10440394
mRNA for KIAA1268 protein,
1
CCAGTGATTTGATTAACTCAGGGCAA

partial cds/cds = (0, 3071)

GGCTGAATATCAGAGTGTATCGCA

1156
Table 3A
Hs.183454
AK027789
14042727
cDNA FLJ14883 fis, clone
1
TTTTGACCCAGATGATGGTTCCTTTA

PLACE1003596, moderately

CAGAACAATAAAATGGCTGAACAT

similar to OLIGOSACCHARYL

TRANSFERASE STT3

SUBUNIT/cds = (2, 882)

1157
Table 3A
Hs.122487
AL040371
5409324
602365288F1 cDNA, 5′ end
1
ACTGGACATCGCCCTACGCAACCTCC

/clone = IMAGE:4473836/

TCGCCATGACTGATAAGTTCCTTT

clone_end = 5′

1158
Table 3A
Hs.79709
AL042370
5421708
phosphotidylinositol transfer
1
ACTGCTGGTAGCATTTATCTGACTTG

protein (PITPN), mRNA/cds =

GAAAGTTGGAGAAGAGGCATTCCT

(216, 1028)

1159
Table 3A
Hs.252721
AL042376
5421714
602022214F1 cDNA, 5′ end
1
CTTCCGAAGAGAAGAGGCTGGGGCT

/clone = IMAGE:4157715/

GTAACTGGAAAGGGGAAGCGCACAG

clone_end = 5′

1160
Table 3A
Hs.182278
AL048016
5434110

Homo sapiens, calmodulin 2
1
CCTGACCTTGAGCTCTAGTCTCCCCT

(phosphorylase kinase, delta),

TTAAATCTTACCTTGGCAGTAACA

clone MGC:1447 IMAGE:

3504793, mRNA, complete

cds/cds = (93, 542)

1161
Table 3A
NA
AL047171
5936355
(synonym: hute1) cDNA clone
1
TTGGTCCCACAGTTTTTATGTGTCCT

DKFZp588F2018 5′

ACTTGAAATTATGTTTGCTCCCGT

1162
Table 3A
Hs.168757
AL049282
4500041

Homo sapiens, clone MGC:5584,
1
TGGAGGATTTTTGTTAAGTCAAGTGT

mRNA, complete cds/cds =

CAATCGAAGTTAAAAAGCAAGGGT

(227, 304)

1163
Table 3A
Hs.104918
AL049305
4500074
hypothetical protein FLJ21940
1
ATGGCTCTTTTCCTATTAGAGCAACTT

(FLJ21940), mRNA/cds =

GTGTTTCCCTGATAATGTGTACA

(92, 2107)

1164
Table 3A
Hs.99821
AL049319
4500092
hypothetical protein FLJ14547
1
GTCGTGACTGACTTGGTGTGTTGCTA

(FLJ14547), mRNA/cds =

TTGTGTTTCTATATACTCCGTCCA

(25, 711)

1165
Table 3A
Hs.77311
AL049332
4500108
mRNA; cDNA DKFZp564L176
1
TTTAGTCCAGTGGTTTCCACAGCTGG

(from clone DKFZp564L176)

CTAAGCCAGGAGTCACTTGGAGGC

/cds = UNKNOWN

1166
Table 3A
Hs.86405
AL049340
4500124
mRNA; cDNA DKFZp564P056
1
TGGAAGACAGTAAAGAACAGCCCTCT

(from clone DKFZp564P056)

GTAGTCAGTAAAGTTTCACCTTCT

/cds = UNKNOWN

1167
Table 3A
Hs.42915
AL049358
4500146
ARP2 (actin-related protein 2,
1
TGGGTGGAGTATTATGTTTAACTGGA

yeast) homolog (ACTR2),

GTTGTCAAGTATGAGTCCCTCAGG

mRNA/cds = (74, 1258)

1168
Table 3A
Hs.184938
AL049782
4902604
Novel gene mapping to
1
AAAGTAGTAAATCGGGCTGTCTTAAT

chomosome 13/cds = UNKNOWN

AGTGCGCCTGTTACTAATGGAATT

1169
Table 3A
Hs.326248
AK025724
10438333
cDNA: FLJ22071 fis, clone
1
ATGTCAAGCTTTGGGTCTCTGGAGTA

HEP11691/cds = UNKNOWN

TAACTTTTTGTAACATTAGCCATT

1170
Table 3A
Hs.139240
AL049942
4884185
mRNA; cDNA DKFZp564F1422
1
ATCTAGGACACCTCCATCAAACCTCC

(from clone DKFZp564F1422)/

TCTTGCACTTTCCCTCTGGCTTCC

cds = (0, 1491)

1171
Table 3A
Hs.22370
AL049951
4884198
mRNA; cDNA DKFZp564O0122
1
TGTGATGGGAACAGTGTCTTAGGGA

(from clone DKFZp564O0122)/

GATGCAGCTTGGACTTGAGGTAAAT

cds = UNKNOWN

1172
Table 3A
Hs.150580
AL050005
4884260
mRNA; cDNA DKFZp564A153
1
AGAATGGGAGGCCAACCTTCTATCAG

(from clone DKFZp564A153)/

AGTTAAACTTTTGACAAGGGAACA

cds = UNKNOWN

1173
Table 3A
Hs.14846
AL050021
4884264
mRNA; cDNA DKFZp564D016
1
AAAAATGTGAAACTGCCCTGCCTCCC

(from clone DKFZp564D016)/

CTTTTTGCTGACAACACTGTGTAC

cds = UNKNOWN

1174
Table 3A
Hs.133130
AL050035
4884276
mRNA; cDNA DKFZp566H0124
1
GGCCCCATTACAAAACTCCTTAGGAA

(from clone DKFZp566H0124)/

CCTCGCCCTCTCTCTGCTGTAAGG

cds = UNKNOWN

1175
Table 3A
Hs.27371
AL050061
4884292
mRNA; cDNA DKFZp566J123
1
GCTGCTGTCTAGATTTATGTGTGCTC

(from clone DKFZp566J123)/

TGACAAGAAATGTTTTGTGTAACA

cds = UNKNOWN

1176
Table 3A
Hs.227429
AL050131
4884338
mRNA; cDNA DKFZp586I111
1
CCAGGCTGCGGTGAGAATGCCAAGA

(from clone DKFZp586I111);

AGGCACTACCTCCCACCCACATCAC

partial cds/cds = (0, 617)

1177
Table 3A
Hs.323463
AL050141
4884352
mRNA for KIAA1693 protein,
1
CCAGTTGTCTTGAACAGCCTGACTCC

partial cds/cds = (0, 2707)

TGCCAGCCCTATGGAAGTTCCTTT

1178
Table 3A
Hs.323463
AL050141
4884352
mRNA for KIAA1693 protein,
1
CCAGTTGTCTTGAACAGCCTGACTCC

partial cds/cds = (0, 2707)

TGCCAGCCCTATGGAAGTTCCTTT

1179
Table 3A
Hs.26295
AL050166
4884381
mRNA; cDNA DKFZp586D1122
1
TCTTTAAGAAGACCACCACATAGAAT

(from clone DKFZp586D1122)/

ACCCCTTCCTATCAGCTCGCTCTG

cds = UNKNOWN

1180
Table 3A
Hs.80285
AL050192
4884408
mRNA; cDNA DKFZp586C1723
1
TTTGACTTTCAGGATGTCATACTACTT

(from clone DKFZp586C1723)/

CTGTACCTAGCATTTTCAGTCCT

cds = UNKNOWN

1181
Table 3A
Hs.26613
AL050205
4884444
mRNA; cDNA DKFZp586F1323
1
TGCTTAGATTTGTTCCTGTTGTCAAAA

(from clone DKFZp586F1323)/

CTGTTACCCCCAAAATTGGTGTG

cds = UNKNOWN

1182
Table 3A
Hs.15020
AL050218
4884459
DNA sequence from clone 51J12
1
AACAAGGTACATGCATTATGTGTCAC

on chromosome 6q26-27.

ATTACTGGGCAAACTGTTCAAGTA

Contains the 3′ part of the

alternatively spliced gene for

the orthologs of mouse QKI-7

and QKI-7B (KH Domain RNA

Binding proteins) and zebrafish

ZKQ-1 (Quaking protein

homolog). Contains ESTs, STSs

and GSSs/cds = (0, 692)

1183
Table 3A
Hs.3842
AL050268
4886442
RAB1, member RAS oncogene
1
AGCACAAGCAGTGTCTGTCACTTTCC

family (RAB1), mRNA/cds =

ATGCATAAAGTTTAGTGAGATGTT

(50, 667)

1184
Table 3A
Hs.12305
AL050272
4886498
DKFZP566B183 protein
1
AGTGACTAAATACTGGGAACCTATTT

(DKFZP566B183), mRNA

TCTCAATCTTCCTCCATGTTGTGT

/cds = (351, 749)

1185
Table 3A
Hs.274170
AL050353
4914574
mRNA; cDNA DKFZp564C0482
1
CTTCAGGACTGTATGAGCCGAGCAGT

(from clone DKFZp564C0482)

TACAAGACACAAAGAAGTTAAAAA

/cds = UNKNOWN

1186
Table 3A
Hs.8128
AL050371
4914606
phosphatidylserine decarboxylase
1
AGGGCCAGATTTCATGTTGACCCTGG

(PISD), mRNA/cds = (223, 1350)

GGATGCTGTGAATTTCTCCTGCAG

1187
Table 3A
Hs.322645
AL050376
4914609
mRNA; cDNA DKFZp586J101
1
AAATGCAGGTTTATTATCCAGCACTG

(from clone DKFZp586J101)

AGAGAGTTAACAAGGACTGGAAAA

/cds = UNKNOWN

1188
Table 3A
Hs.322645
AL050376
4914609
mRNA; cDNA DKFZp586J101
1
AAATGCAGGTTTATTATCCAGCACTG

(from clone DKFZp586J101)

AGAGAGTTAACAAGGACTGGAAAA

/cds = UNKNOWN

1189
Table 3A
Hs.321247
AL050391
4914591
mRNA; cDNA DKFZp586A181
1
CCCTCCTTAATCAACTTCAAGGAGCA

(from clone DKFZp586A181);

CCTTCATTAGTACAGCTTGCATAT

partial cds/cds = (0, 314)

1190
Table 3A
Hs.12813
AL080156
5282614
mRNA; cDNA DKFZp434J214
1
AAACCAGTGACTCCTAATCTTTTTCAA

(from clone DKFZp434J214);

GTTAAGACACCTTACCATTGCTT

partial cds/cds = (0, 1081)

1191
Table 3A
Hs.52792
AL080213
5262703
mRNA; cDNA DKFZp586I1823
1
AAGGGAACACAAAACTGTGGTCCTGA

(from clone DKFZp586I1823)

CAATACTAATTCTACCCGTTTTCA

/cds = UNKNOWN

1192
Table 3A
Hs.111801
AL096723
5419856
mRNA; cDNA DKFZp564H2023
1
TTTTTGTACGATCAGCCTTACTGCTAA

(from clone DKFZp564H2023)

TAAAAGCACTTCCACAGGGAAAA

/cds = UNKNOWN

1193
Table 3A
Hs.306327
AL098752
5419888
mRNA; cDNA DKFZp434A012
1
AAATTCTACAAAGGAGAGGTTGGGCG

(from clone DKFZp434A012)

TTACAAAGGCATTGTGAATCTAAT

/cds = UNKNOWN

1194
Table 3A
Hs.308327
AL096752
5419888
mRNA; cDNA DKFZp434A012
1
AAATTCTACAAAGGAGAGGTTGGGCG

(from clone DKFZp434A012)

TTACAAAGGCATTGTGAATCTAAT

/cds = UNKNOWN

1195
Table 3A
Hs.172803
AL109669
5689801
mRNA full length insert cDNA
1
TTCACCGAGGACATGAAACTCCACCT

clone EUROIMAGE 31839/

TGCGGGGATAAAGAGAGAAAAACA

cds = UNKNOWN

1196
Table 3A
Hs.119155
AL109788
5725475
mRNA full length insert cDNA
1
TGTGCTCTTCAGTAGAGGATTTTCTG

clone EUROIMAGE 814975/

TGATCCTACAATGAAGGGAAAGCT

cds = UNKNOWN

1197
Table 3A
Hs.75875
AL110132
5817027
ubiquitin-conjugating enzyme E2
1
TTTGTGTAAAACCACCTTTTGAAGCA

variant 1 (UBE2V1), transcript

GCAACTATCAAGTCTGAAAAGCAA

variant 2, mRNA/cds = (69, 734)

1198
Table 3A
Hs.128797
AL110151
5817052
mRNA; cDNA DKFZp586D0824
1
AGTGGGTGAATCACAGTAATTTCCCT

(from clone DKFZp586D0824);

GTAAAATGTGGTACCTGAAGTCAT

partial cds/cds = (0, 1080)

1199
Table 3A
Hs.193700
AL110164
5817089
cDNA: FLJ22008 fis, clone
1
TAGGCTCATAGCCTTGTATTTCGTTTT

HEP06934/cds = UNKNOWN

AGATTGTAAGCTCAATGGCAGGG

1200
Table 3A
Hs.73851
AL110183
5817095
ATP synthase, H+ transporting,
1
GCTCAAGCAAATGTTTGGTAATGCAG

mitochondrial F0 complex,

ACATGAATACATTTCCCACCTTCA

subunit F6 (ATP5J), mRNA/cds =

(1, 327)

1201
Table 3A
Hs.172089
AL110202
5817121
mRNA; cDNA DKFZp586I2022
1
AAGTCATCATTTGCCTTGAAAGTTTC

(from clone DKFZp586I2022)/

CTCTGCATTGGGTTTGAAGTAGTT

cds = UNKNOWN

1202
Table 3A
Hs.193784
AL110204
5817123
mRNA; cDNA DKFZp586K1922
1
GAGCAGGGGTGGGAGTGGCTGTAAC

(from clone DKFZp586K1922)/

TTCACAATCCTAATACAGTAAATGT

cds = UNKNOWN

1203
Table 3A
Hs.321022
AL110236
5817178
mRNA; cDNA DKFZp566P1124
1
TTCTTAAGGAGTCTTAACTCGGTACT

(from clone DKFZp566P1124)/

TGGGTTAACGCCAGAAATTACTTT

cds = UNKNOWN

1204
Table 3A
Hs.187991
AL110269
5817043
DKFZP564A122 protein
1
TTGGTGAGTTGCCAAAGAAGCAATAC

(DKFZP564A122), mRNA

AGCATATCTGCTTTTGCCTTCTGT

/cds = (2570, 2908)

1205
Table 3A
Hs.109727
AL117407
5911992
mRNA; cDNA DKFZp434D2050
1
AGGCCTTGTTTTTCAGCTTCATCTGC

(from clone DKFZp434D2050);

AGTTCTATGTGAAGATTGATAAAT

partial cds/cds = (110, 1720)

1206
Table 3A
Hs.26797
AL117448
5911896
mRNA; cDNA DKFZp586B1417
1
TGCAACTTAGAAACCAGCTACAGTAT

(from clone DKFZp586B1417);

GGCCCACTTAATAAAACACCTGAA

partial cds/cds = (0, 3878)

1207
Table 3A
Hs.7200
AL117502
5912009
hypothetical protein MGC16714
1
AGTTTATTGTTAGCCAGGTTGCTTGA

(MGC16714), mRNA/cds =

AAGGTTGAGAGTGGAGTGGTTTGG

(394, 990)

1208
Table 3A
Hs.22583
AL117513
5912025
mRNA; cDNA DKFZp434K2235
1
GCATAACTGCTCTAGCTTCTTGTTTA

(from clone DKFZp434K2235);

CCATAGTACTGTGGCTTCAGATTT

partial cds/cds = (0, 1086)

1209
Table 3A
Hs.303154
AL117536
5912065
popaye protein 3 (POP3),
1
TGTATCTTTTCCTGTTAAACACACAGA

mRNA/cds = (147, 1022)

CCCCTCCCCAATCTGGACATTGA

1210
Table 3A
Hs.6607
AL117565
5912115
URAX1 mRNA, complete cds
1
GCCTTGCCAGCCTGTGTGCTTGTGG

/cds = (191, 1960)

GAACACCTTGTACCTGAGCTTACAG

1211
Table 3A
Hs.154320
AL117568
5912116
ubiquitin-activating enzyme E1C
1
GCATGAATGGGCAATATTTTCATCTG

(homologous to yeast UBA3)

TTTACTTGTAGTGCCATAGAGGCC

(UBE1C), mRNA/cds = (0, 1328)

1212
Table 3A
Hs.4055
AL117595
5912159
mRNA; cDNA DKFZp564C2063
1
GGCCTTCTATGTGCTTAGCCATAACA

(from clone DKFZp564C2063)

ATTCCATTAAGCAAGAAGGTAAGC

/cds = UNKNOWN

1213
Table 3A
Hs.180777
AL117621
5912202
mRNA; cDNA DKFZp564M0264
1
AATTGAACAATAACCATTGGTGACTG

(from clone DKFZp564M0264)

GAGCAGGTAATTATAGCCTGCAGA

/cds = UNKNOWN

1214
Table 3A
Hs.87794
AL117637
5912225
mRNA; cDNA DKFZp434I225
1
AGGGGTCCCAAGAGCCTGTCCTCTTT

(from clone DKFZp434I225);

TGTTCAAAATACATCTTGAAACGT

partial cds/cds = (0, 1281)

1215
Table 3A
Hs.79709
AL117644
5912234
phosphotidylinositol transfer
1
CCTGCTGGGACTCCCTGACTTACTTT

protein (PITPN), mRNA/cds =

GGTTGGTTCCTAGTGCTACTTGTT

(216, 1028)

1216
Table 3A
NA
AL120453
5928352
(synonym: hamy2) cDNA clone
1
GGAAAGCTCGTCAGTTTAGTAGGCTC

DKFZp761I208 5′

CGAAATAGAATAGCAGTTGTCACT

1217
Table 3A
Hs.6986
AL121406
5927407
glucose transporter pseudogene
1
AGAAGGTAACTTTATAGAAGTAACAC

/cds = UNKNOWN

CAATATCCTAGTCTGCTTGCCCCG

1218
Table 3A
Hs.274481
AL121735
6012990
cellular growth-regulating protein
1
GCTGCTCCCTGGTTCCACTCTGGAGA

(LOC51038), mRNA/cds =

GTAATCTGGGACATCTTAGTGTTT

(612, 785)

1219
Table 3A
Hs.272307
AL133015
6453493
mRNA; cDNA DKFZp434O2417
1
CTCTCCTCTTCCCACCTCTGTATCCC

(from clone DKFZp434O2417);

ACACAGGCATCTGGTGATGTTCTC

partial cds/cds = (0, 724)

1220
Table 3A
Hs.75497
AL133074
6453517
p53DINP1 mRNA for p53DINP1b,
1
ACACCTGTTCTTTGTAATTGGGTTGT

complete cds/cds = (39, 533)

GGTGCATTTTGCACTACCTGGAGT

1221
Table 3A
Hs.76853
AL133098
6453550
mRNA; cDNA DKFZp434N1728
1
AGCCTAGGTGAAAATCTATTTATAAAT

(from clone DKFZp434N1728)

GGACCACAACTCTGGGGTGTCGT

/cds = UNKNOWN

1222
Table 3A
Hs.109150
AL133111
6453598
mRNA; cDNA DKFZp434H068
1
CATGAAGCTCTCAAGTCCTGCATCCT

(from clone DKFZp434H068)

GAGGATCCAGATGGATGACAAGGA

/cds = UNKNOWN

1223
Table 3A
Hs.199009
AL133572
8599150
PCCX2 mRNA for protein
1
GGTGGTGTTTCCTAGACCTTCCCTGA

containing CXXC domain 2,

TGCGATTTTACCTTTGTTGAATTT

partial cds/cds = (0, 2483)

1224
Table 3A
Hs.25382
AL133811
6599222
mRNA; cDNA DKFZp434O1317
1
ACGATGCTGTTTGCTCTGGAATGTTC

(from clone DKFZp434O1317)

ATCTTTTAGACAGGTTTTGGCTCA

/cds = UNKNOWN

1225
Table 3A
Hs.224680
AL133721
6601909
DKFZp761H09121_r1 cDNA,
1
TCCGAGGGATGAGATTAAGGCAGAG

5′ end/clone = DKFZp761H09121

GCAAAAGTTTCACACAAAGTTTCTG

/clone_end = 5′

1226
Table 3A
Hs.306155
AL133879
6602066
chorionic somatomammotropin
1
GCCACAACTCCCATAGATGCCAATGT

hormone 1 (placental lactogen)

TTTGATAGCCTCAGTTTCTCAACG

(CSH1), transcript variant 2,

mRNA/cds = (116, 886)

1227
Table 3A
Hs.322456
AL138542
12044472
hypothetical protein
1
TGACCCACCCACCAAGGAAGAAAGC

DKFZp761D0211

AGAATAAACATTTTTGCACTGCCTG

(DKFZP761D0211), mRNA/

cds = (164, 1822)

1228
Table 3A
Hs.258503
AL138549
6807648
mRNA; cDNA DKFZp761I12121
1
CATGCTCTCCCATGACATCTCCATGC

(from clone DKFZp761I12121);

TGGTTTCTCCATAGCATAAATGAA

complete cds/cds = (138, 3899)

1229
Table 3A
Hs.177537
AL136558
13276622
hypothetical protein
1
GGTGCCGTGCATCACCAAATGAAAGT

DKFZp761B1514

TTGTATTTAACGAGGAGGTGCTTT

(DKFZp761B1514), mRNA/

cds = (72, 1028)

1230
Table 3A
Hs.245798
AL136607
12052739
hypothetical protein
1
AAATCCTCTCTGCTGTTCACATTATCC

DKFZp564I0422

TTTGTTTAACGTATGAACCAGGT

(DKFZP564I0422), mRNA/

cds = (510, 1196)

1231
Table 3A
Hs.4750
AL136610
12052745
hypothetical protein
1
GTGTAGAATTCCCGGAGCGTCCGTG

DKFZp564K0822

GTTCAGAGTAAACTTGAAGCAGATC

(DKFZP564K0822), mRNA/

cds = (9, 527)

1232
Table 3A
Hs.108548
AL136640
12052805
mRNA; cDNA DKFZp564F163
1
TGGGTAGGTTAAGCTGCCATACGTGT

(from clone DKFZp564F163);

TCAGTGTGAATAGTGTTTAAGTTG

complete cds/cds = (149, 532)

1233
Table 3A
Hs.27181
AL136656
12052835
nuclear receptor binding factor-2
1
TGATGCAAGAGTGGACGTAATGCTAG

(NRBF-2), mRNA/cds =

TTGGCAGTATTTTATTGTAAGAAA

(179, 1042)

1234
Table 3A
Hs.57209
AL136703
12052925
hypothetical protein
1
TCAGTAAAAATGCCTGTTGTGAGATG

DKFZp566J091 (DKFZP566J091),

AACCTCCTGTAACTTCTATCTGTT

mRNA/cds = (212, 529)

1235
Table 3A
Hs.168254
AL136711
12052941
hypothetical protein
1
GGGCCATTTTATGATGCATTGCACAC

DKFZp566I133 (DKFZP566I133),

CCTCTGGGGAAATTGATCTTTAAA

mRNA/cds = (133, 1353)

1236
Table 3A
Hs.324275
AL136739
12052996
WW domain-containing protein 1
1
AAAATGCTGCTGGCTTTTCTGAAGAC

(WWP1), mRNA/cds = (10, 2778)

AGGTGCTTGAACTTGTCAGTTTGT

1237
Table 3A
Hs.273294
AL136797
12053106
mRNA; cDNA DKFZp434N031
1
CCGCCCAAAAGTCTGTTCTGATGGCA

(from clone DKFZp434N031);

CTGAGTTTTCATTGTTCTGGATGT

complete cds/cds = (18, 3608)

1238
Table 3A
Hs.76698
AL136807
12053124
mRNA; cDNA DKFZp434L1621
1
TGGTTGTGCTAAATTCATAGCAGGTG

(from clone DKFZp434L1621);

CCTTATTCTTTGCTTTTAGTCAAA

complete cds/cds = (315, 515)

1239
Table 3A
Hs.238996
AL136828
12053164
hypothetical protein
1
TTTGCCAGGGTAATCTTCAGTTGGCC

DKFZp434K0427

CTGATTCAATTAAATGGCCTTAAT

(DKFZP434K0427),

mRNA/cds = (341, 1813)

1240
Table 3A
Hs.146037
AL136874
12053252
hypothetical protein
1
ACACTCCTTAAGTTCCAAATGTTTTCC

DKFZp434C135

GCTAATAGTCTGTCCTAAAGCCT

(DKFZP434C135),

mRNA/cds = (118, 1208)

1241
Table 3A
Hs.103378
AL136885
12053268
hypothetical protein MGC11034
1
AGGACTCTTGAACATCTGAGCAGTTT

(MGC11034), mRNA/cds =

TGTGCTTTGAGCCACTTTTTGACA

(245, 840)

1242
Table 3A
Hs.37892
AL136932
12053358
KIAA0922 protein (KIAA0922),
1
CGCCTATATGAACCTGGACATATGGA

mRNA/cds = (122, 3841)

CTACCACAGCGAATAGGAATGCAA

1243
Table 3A
Hs.37892
AL136932
12053358
KIAA0922 protein (KIAA0922),
1
CGCCTATATGAACCTGGACATATGGA

mRNA/cds = (122, 3841)

CTACCACAGCGAATAGGAATGCAA

1244
Table 3A
Hs.108338
AL136941
12053376
hypothetical protein
1
TTTCCTATTTTGCTCCAGACTATGTTT

DKFZp586C1924

TCAGCATACCTTGGGTCTGAACA

(DKFZp586C1924),

mRNA/cds = (105, 692)

1245
Table 3A
Hs.194718
AL136945
12053384
mRNA; cDNA DKFZp586O012
1
TTGTGCTTTCTGTATTTAAAACTTTGG

(from clone DKFZp586O012)

CTGTACTAAGCAAATGCAAGGTT

/cds = UNKNOWN

1246
Table 3A
Hs.7392
AL137423
6807979
nucleolar protein GU2 (GU2),
1
GGTCATCATAGTTGAGGTATGTGTCT

mRNA/cds = (107, 2320)

GCTATTTGCAAAGAAGTTGGTCGT

1247
Table 3A
Hs.21015
AL137576
6808287
mRNA; cDNA DKFZp564L0864
1
TTCAGGACCCTAGAGGAGAGCTTTAT

(from clone DKFZp564L0864);

ACAATTACCGATGTGAATTTCTCT

partial cds/cds = (0, 568)

1248
Table 3A
Hs.122752
AL137601
6808346
TATA box binding protein (TBP)-
1
TGTTTTGCTTAATGTGGACAATTTACA

associated factor, RNA polymerase

CACCCAACACATACTGTTTCCAA

II, B, 150 kD (TAF2B),

mRNA/cds = (57, 3656)

1249
Table 3A
Hs.145612
AL137608
6808357
RNA helicase (RIG-I),
1
GAGATCAACGGGATGAGGTGTTACA

mRNA/cds = (157, 2934)

GCTGCCTCCCTCTTCATGCAATCTG

1250
Table 3A
Hs.173912
AL137681
6807931
eukaryotic translation initiation
1
AGGTAGGGTTTAATCCCCAGTAAAAT

factor 4A, isoform 2

TGCCATATTGCACATGTCTTAATG

(EIF4A2), mRNA/cds =

(15, 1238)

1251
Table 3A
Hs.306195
AL137721
6808159
over-expressed breast tumor
1
AGGGGGTGATTTTTGCTCTTGTCCTG

protein (OBTP), mRNA/cds =

AGAAATAACAGTGCTGTTTTAAAA

(0, 224)

1252
Table 3A
Hs.12144
AL137753
6808455
mRNA; cDNA DKFZp434K1412
1
ACTTGAGTGGGGTTTTCCTTTTCCCC

(from clone DKFZp434K1412)

CAATTCTAAGAGAATATAATGTGT

/cds = UNKNOWN

1253
Table 3A
Hs.77646
AL137938
6851002
mRNA; cDNA DKFZp761M0223
1
GCGTCTGTTGTTAGCAAAGAATAGAT

(from clone DKFZp761M0223)

TCACACAGTCTAAGGTTTCCTTCC

/cds = UNKNOWN

1254
Table 3A
Hs.235390
AL157426
7018455
mRNA; cDNA DKFZp761B101
1
CCCTCTTAGCCTATCCATCTTAAGCC

(from clone DKFZp761B101)

CCAAGCTGAGTGTGGTTCTGGTAA

/cds = UNKNOWN

1255
Table 3A
Hs.66151
AL157438
7018513
mRNA; cDNA DKFZp434A115
1
TAAGGAGAATTAGACTCCCAAGTAGA

(from clone DKFZp434A115)

CACCAGAGTCACTGTTTGGTTGGT

/cds = UNKNOWN

1256
Table 3A
Hs.110702
AL157477
7018497
mRNA; cDNA DKFZp761E212
1
ACGTGTTTTTGGGATATGTTTCCAAT

(from clone DKFZp761E212)

CTTTAAATGACCTTGCCCTGTCCA

/cds = UNKNOWN

1257
Table 3A
Hs.250535
AL157499
7018548
mRNA; cDNA DKFZp434N2412
1
AACCATTTGTTAACTGTACTGAAGGT

(from clone DKFZp434N2412)

GTGTCCTCAAGAAGAAAGTGTTCA

/cds = UNKNOWN

1258
Table 3A
Hs.170171
AL161952
7328002
mRNA; cDNA DKFZp434M0813
1
AAACAAACTGTGTAACTGCCCAAAGC

(from clone DKFZp434M0813);

AGCACTTATAAATCAGCCTAACAT

partial cds/cds = (430, 768)

1259
Table 3A
Hs.71252
AL161991
7328122
mRNA; cDNA DKFZp761C169
1
AAACTGATCACACTGACTGGATCTGT

(from clone DKFZp761C169);

CCACGACATGGAAAATAAACTGGA

partial cds/cds = (996, 2474)

1260
Table 3A
Hs.99908
AL162047
7328089
nuclear receptor coactivator 4
1
TTGCATTGATGAATTTTGTATCTGCTT

(NCOA4), mRNA/cds =

CCATTAAAAGCATAACAGCCACA

(140, 1984)

1261
Table 3A
Hs.78829
AL162049
7328093
mRNA; cDNA DKFZp762E1712
1
ATCTCTCCTTCAGTCTGCTCTGTTTAA

(from clone DKFZp762E1712);

TTCTGCTGTCTGCTCTTCTCTAA

partial cds/cds = (0, 2477)

1262
Table 3A
Hs.302649
AL162068
7328143
HSP22-like protein interacting
1
TTGAAGTTTTAAGGGACGTCAGTGTT

protein (LOC64165), mRNA/cds =

TATGCCATTTTTCCAGTTCCAAAA

(0, 155)

1263
Table 3A
Hs.17377
AL162070
7328146
mRNA; cDNA DKFZp762H186
1
GGTCGGCTCTTATAGAGTGGCCATAG

(from clone DKFZp762H186);

TGTTCTGTCAAAACACTTGCTTCC

complete cds/cds = (0, 1489)

1264
Table 3A
Hs.155191
AL162086
7328174
villin 2 (ezrin) (VIL2),
1
TTCTCCTTCACAGCTAAGATGCCATG

mRNA/cds = (117, 1877)

TGCAGGTGGATTCCATGCCGCAGA

1265
Table 3A
Hs.3576
AL357536
8249879

Homo sapiens, Similar to RIKEN
1
CATGATTCCAAGGATCAGCCTGGATG

cDNA 5730494N06 gene, clone

CCTAGAGGACTAGATCACCTTAGT

MGC:13348 IMAGE:4132400,

mRNA, complete cds/cds =

(132, 494)

1266
Table 3A
Hs.29797
AL359585
8855645
mRNA; cDNA DKFZp762B195
1
AGTGAAGATCTGGCTGAACCAGTTCC

(from clone DKFZp762B195)

ACAAGGTTACTGTATACATAGCCT

/cds = UNKNOWN

1267
Table 3A
Hs.252588
AL359626
8655704
mRNA; cDNA DKFZp564F172
1
AGGCCATCATTCTATACCTCATTTAA

(from clone DKFZp564F172)

GCCATTGTTATCAAGGGTTTACCC

/cds = UNKNOWN

1268
Table 3A
Hs.33758
AL359654
8670873
mRNA full length insert cDNA
1
AGAGTACATGGAAAGTTAGGTGTTCA

clone EUROIMAGE 196784

AATTCACATCTAATTTCCCTGGGA

/cds = UNKNOWN

1269
Table 3A
Hs.3840
AL359940
8977897
mRNA; cDNA DKFZp762P1915
1
GTTTTCAGTTTTCCCCTTTACAGTCTT

(from clone DKFZp762P1915)

CTCCCCTCACCTCCAGGACCCTC

/cds = UNKNOWN

1270
Table 3A
Hs.318501
AL360190
8919391
stimulated trans-acting factor
1
ATCCTTCAGAATGTGTTGGTTTACCA

(50 kDa) (STAF50),

GTGACACCCCATATTCATCACAAA

mRNA/cds = (122, 1450)

1271
Table 3A
Hs.7104
AL390127
9368821
mRNA; cDNA DKFZp761P06121
1
GTCTGGCCTTGGCTTGCTCGGATAAA

(from clone DKFZp761P06121)

ACTTTGTATGTATTTTGTATGGCA

/cds = UNKNOWN

1272
Table 3A
Hs.49822
AL390132
9368828
mRNA; cDNA DKF2p547E107
1
TGCTGAGCATGGGGAATGTGGCTGC

(from clone DKFZp547E107)

TGCAGAGACGTTATGAAACACTTCT

/cds = UNKNOWN

1273
Table 3A
Hs.98026
AL442083
10241762
mRNA for KIAA1784 protein,
1
TCTCCATCCTTGTGAATGTCCTCGTC

partial cds/cds = (0, 3505)

TGTTTCAAATACAGTGCAGTCAGT

1274
Table 3A
Hs.77868
AL513780
12777274
ORF (LOC51035), mRNA
1
TGGTTCTTCTGATGAGCAAGGGAACA

/cds = (135, 1031)

ACACTGAGAATGAGGAGGAAGGAGT

1275
Table 3A
Hs.181309
AL520892
12784385
proteasome (prosome, macropain)
1
TGAAGTTAAGGATTACTTGGCTGCCA

subunit, alpha type, 2 (PSMA2),

TAGCATAACAATGAAGTGACTGAA

mRNA/cds = (0, 704)

1276
Table 3A
Hs.16648
AL523085
12786578
AL523085 cDNA/clone =
1
GGCTTTCTTGTTTTGGTGTCTTGGAG

CS0DC001YF21-(5-prime)

TGCTGGGTAAGGTTCAGTGGATAT

1277
Table 3A
Hs.37617
AL532303
12795796
602144947F1 cDNA, 5′ end
1
CTATCTACACCATCATGCGCTGGTTC

/clone = IMAGE:4308683/

CGGAGACACAAGGTGCGGGCTCAC

clone_end = 5′

1278
Table 3A
Hs.83583
AL532406
12795899
actin related protein 2/3 complex,
1
GAAGCGGCTGGCAACTGAAGGCTGG

subunit 2 (34 kD) (ARPC2),

AACACTTGCTACTGGATAATCGTAG

mRNA/cds = (84, 986)

1279
Table 3A
Hs.30120
AL533737
12797230
602272333F1 cDNA, 5′ end
1
AAGCAAGAGATTGTAAACCGGGTACA

/clone = IMAGE:4360233/

GAATCCAAGAGATGAGAGAGGACC

clone_end = 5′

1280
Table 3A
Hs.179999
AL534564
12798057

Homo sapiens, clone IMAGE:
1
AGACGAATGCTTGTCAGTTGTAGCTT

3457003, mRNA/cds =

TCCAGGATTCTGCTCCAATGAGGA

UNKNOWN

1281
Table 3A
Hs.159065
AL538276
12801769
AL538276 cDNA/clone =
1
CAAACTGATTGCGGGGCAGGGACTT

CS0DF027YC09-(5-prime)

GAGTATGGGGAGAGGCTGCAAAAGA

1282
Table 3A
Hs.285401
AL540399
12870508
colony stimulating factor 2
1
GAACATCAGGAGAGGAGTCCAGAGC

receptor, beta, low-affinity

CCACGTCTACTGCGGAAAAGTCAGG

(granulocyte-macrophage)

(CSF2RB), mRNA/cds =

(28, 2721)

1283
Table 3A
Hs.181400
AL542592
12874788
602650370T1 cDNA, 3′ end
1
AGTTGGAGAGTTACTCGAACCTCAGG

/clone = IMAGE:4761353/

TGACAGTTGTAAGGCAGACATAGT

clone_end = 3′

1284
Table 3A
Hs.271599
AL550229
12886998
cDNA FLJ12347 fis, clone
1
CTCCTCCAGGCCTCTCGGATGCCTCT

MAMMA1002298/cds =

GTTGGGACAGCTAAGTTCCTCTTC

UNKNOWN

1285
Table 3A
NA
NC_001807
13959823
Mitochondrial Sequence
1
TCCTCCATATATCCAAACAACAAAGC

ATAATATTTCGCCCACTAAGCCAA

1286
Table 3A
Hs.218329
AL556016
12898299
mRNA for KIAA1245 protein,
1
TGCTGTTGCAAAAGAAGAAGACATCT

partial cds/cds = (701, 3379)

CTGCCTGAGTTTTAATTTTGTCCA

1287
Table 3A
Hs.250465
AL556919
12900027
mRNA; cDNA DKFZp434E2023
1
TTTCTGCTGGAGTCCCCTGTGTCCTC

(from clone DKFZp434E2023)

AGCCATCCCAAGAAGGGTTTGCTG

/cds = UNKNOWN

1288
Table 3A
Hs.90035
AL558028
12902157
AL558028 cDNA/clone =
1
CTGGTTGGATCTGCATCTCACGCCCA

CS0DJ002YF02-(5-prime)

CTGCACACCGTTCCTCTCCATCTG

1289
Table 3A
Hs.301756
AL559029
12904124

Homo sapiens, clone MGC:17544
1
ACCTCGACTCCCTGGTGCTCTTTGCA

IMAGE:3482146, mRNA,

GAGTTGGGCAGTGAAATTACCTTT

complete cds/cds = (256, 894)

1290
Table 3A
Hs.119274
AL559422
12904908
RAS p21 protein activator (GTPase
1
ATACACAGCACGACGTATCCTTGTAC

activating protein) 3

CGACTTCTCCCGGTTCTTGTTTGA

(Ins(1,3,4,5)P4-binding protein)

(GAP1IP4BP), mRNA/cds =

(46, 2550)

1291
Table 3A
Hs.218329
AL559555
12905153
mRNA for KIAA1245 protein,
1
GTACTTAGGAAGACACAGCTAGATGG

partial cds/cds = (701, 3379)

ACAACAGCATTGGGAGGCTTAGCC

1292
Table 3A
Hs.33026
AL561074
12908145
mRNA for FLJ00037 protein,
1
CATCTCTGGTTGTGTCTGTGCCGACT

partial cds/cds = (3484, 3921)

CGGTGTTGAATCAAATCAGGTGTG

1293
Table 3A
Hs.335883
BE262308
9135208
601462961T1 cDNA, 3′ end
1
CAACAATAGGAGGTGGAATGCTGCAA

/clone = IMAGE:3866222/

GGGGCTGCAAATGAGGGCAATGCA

clone_end = 3′

1294
Table 3A
NA
NC_001807
13959823
mitochondrial COX3
1
ATATTTCACTTTACATCCAAACATCAC

TTTGGCTTCGAAGCCGCCGCCTG

1295
Table 3A
Hs.287797
AU117298
10932256
mRNA for FLJ00043 protein,
1
TGGCAAATTCTGCGAGTGTGATAATT

partial cds/cds = (0, 4248)

TCAACTGTGATAGATCCAATGGCT

1296
Table 3A
Hs.1600
AU118159
10933184

Homo sapiens, clone IMAGE:
1
TCTCACATGTCCATTTGAACCACCCA

3543711, mRNA, partial cds/cds =

AACCAAAAACAAAGCATAAGCTGG

(0, 1620)

1297
Table 3A
Hs.181165
AU120731
10935966
eukaryotic translation elongation
1
TCCAGGATGTCTACAAAATTGGTGGT

factor 1 alpha 1 (EEF1A1),

ATTGGTACTGTTCCTGTTGGCCGA

mRNA/cds = (53, 1441)

1298
Table 3A
Hs.172028
AU135154
10995693
a disintegrin and metalloproteinase
1
TGGACATAGCAGCACATACTACTTCA

domain 10 (ADAM10), mRNA

GAGTTCATGATGTAGATGTCTGGT

/cds = (469, 2715)

1299
Table 3A
NA
AV686223
10288088
AV886223 cDNA, 5′ end
1
AACAGAAGACGAGGACACAGAGCGA

/clone = GKCGXH11/clone_—

GAATAAGCACAACTCAGACAACACA

1300
Table 3A
Hs.343475
AV687530
10289393
601558208T1 cDNA, 3′ end
1
TGACCACTTATGCACTTTCTGAATTTG

/clone = IMAGE:3826392/

CTTTCCATGCTCAGAGTTCTGCT

clone_end = 3′

1301
Table 3A
NA
AV689330
10291193
cDNA clone GKCDJE03 5′
1
CTTTGACCCCACCTTGTGGAAACCCA

GCTGTCTACTGGCAGACATTGGTG

1302
Table 3A
Hs.28739
AV691642
10293505
602593745F1 cDNA, 5′ end
1
AAACACCAGTTTGCAGGAAGAA

/clone = IMAGE:4721002/

AGGAAGAGAATGGAAATTGCTTCT

clone_end = 5′

GGAA

1303
Table 3A
NA
AV693913
13959823
mitochondrion, complete genome
1
CCCTACCATGAGCCCTACAAACAACT

AACCTGCCACTAATAGTTATGTCA

1304
Table 3A
Hs.324602
AW969923
8159767
EST382001 cDNA
1
AGTCGTATTAGAGCCTTGGCGTAATC

ATGGTCATAGCTGTTTCCTGTGTG

1305
Table 3A
Hs.301570
AV702152
10718482
602585120F1 cDNA, 5′ end
1
TTGCTGCCTGATCTGACATACATGAT

/clone = IMAGE:4712861/

CCATCGGGTTTTGTTACAAGGAAC

clone_end = 5′

1306
Table 3A
Hs.7312
AV702692
10719022
AV702692 cDNA, 5′ end
1
CATGTTCATAGGTAATCTTTGTACTCT

/clone = ADBBQC12/

GTGTGCAGCAGTATTTGGTTTGC

clone_end = 5′

1307
Table 3A
NA
AV705900
10723195
Partial Cloning Vector
1
AATTCGCCCTATAGTGAGTCGATTAC

CAATCACTGCCCGCGTTTACAACG

1308
Table 3A
Hs.167130
AV706014
10723303
hypothetical protein (PRED22),
1
ACAGGTAACTGAAGATCAAAGTAAAG

mRNA/cds = (245, 1021)

CAACAGAGGAATGTACATCTACCT

1309
Table 3A
Hs.134829
AV706481
10723761
AV706481 cDNA, 5′ end
1
AACAGTTGGGCACCCTGAATGGCAAA

/clone = ADBBYF02/

TGGCAAATTTGGAGCGCTAATAAT

clone_end = 5′

1310
Table 3A
NA
NC_001807
13959823
mitochondrion, complete genome
1
GCCAATCACTTTATTGACTCCTAGCC

GCAGACCTCCTCATTCTAACCTGA

1311
Table 3A
Hs.90960
AV710415
10729044
602563938F1 cDNA, 5′ end
1
ATGTGGGAGGGGCATGGCAGCTATG

/clone = IMAGE:4688769/

AAGGACCTCCTACCTCTGGTTTCTG

clone_end = 5′

1312
Table 3A
Hs.316785
AV710763
10730069
AV710763 cDNA, 5′ end
1
CATGGGACGGGGAGAAAAAGCAAAC

/clone = CuAAJH09/

CCTGGCACTTGGGAATACTTATACC

clone_end = 5′

1313
Table 3A
Hs.135167
AV712376
10731682
AV712376 cDNA, 5′ end
1
TTGTGCCCTTGACTGGGTATTTCTTG

/clone = DCAAND12/

AAGCCCTTGGATCTACCTTTGGTC

clone_end = 5′

1314
Table 3A
Hs.89104
AV716500
10798017
602590917F1 cDNA, 5′ end
1
ACATAATACGGTTGTGCGAGCAGAGA

/clone = IMAGE:4717348/

ATCTACCTTTCCACTTCTAAGCCT

clone_end = 5′

1315
Table 3A
Hs.237868
AV716565
10813717
interleukin 7 receptor (IL7R),
1
CCAGCCTTTGCCTCTTCCTTCAATGT

mRNA/cds = (22, 1401)

GGTTTCCATGGGAATTTGCTTCAG

1316
Table 3A
Hs.178703
AV716627
10813779
AV716627 cDNA, 5′ end
1
AAAACCTCGAGTCATGGTGAATGAGT

/clone = DCBBCH05/

GTCTCGGAGTTGCTCGTGTGTGTA

clone_end = 5′

1317
Table 3A
Hs.17481
AV716644
10813796
mRNA; cDNA DKFZp434G2415
1
GTGAGCACGGACATGCGGCATCATC

(from clone DKFZp434G2415)

GAGTGAGACTGGTGTTCCAAGATTC

/cds = UNKNOWN

1318
Table 3A
Hs.256959
AV719442
10816594
AV719442 cDNA, 5′ end
1
CACCACAGTCTCAGTGCAGGGCTGG

/clone = GLCBNA01/

GAAGTGAAAGACGATTCACCAGACC

clone_end = 5′

1319
Table 3A
NA
AV719659
10816811
cDNA clone GLCGRA09 5′
1
TTTGTGGGTGGGTGATTAGTCGTTGC

TGATGAGATATTTTGAGGGTGGGG

1320
Table 3A
Hs.127160
AV719938
10817090
AV659177 cDNA, 3′ end
1
ACCTTGTAAGTGCCTAAGAAATGAGA

/clone = GLCFUC08/

CTACAAGCTCCATTTCAGCAGGAC

clone_end = 3′

1321
Table 3A
Hs.21536
AV720984
10818136
yl69a03.s1 cDNA, 3′ end
1
GCCGAGATCTGCTCAGACTACATGG

/clone = IMAGE:27414/

CTTCCACTATAGGGTTCTACAGTGT

clone_end = 3′

1322
Table 3A
Hs.119908
AV721008
10818160
nucleolar protein NOP5/NOP58
1
AAATCAGAATTCATTTAGCTCACCAC

(NOP5/NOP58), mRNA/cds =

ATCTCTTGAATGTGATTGACCTAC

(0, 1589)

1323
Table 3A
Hs.247474
AV723437
10826838
hypothetical protein FLJ21032
1
AGGTGTTTAACAGTGTTATTTTGCCA

(FLJ21032), mRNA/cds =

CTGGTAATGTGTAAACTGTGAGTG

(235, 1005)

1324
Table 3A
Hs.76728
AV724531
10829010
602570065F1 cDNA, 5′ end
1
TGGAGTTTCCAGGAGAAAAATAATCA

/clone = IMAGE:4694321/

CCTTTGAAGGTTTTTAGAGCATGT

clone_end = 5′

1325
Table 3A
Hs.280261
BE382869
9328234
601297762F1 cDNA, 5′ end
1
GGTAACAACATCCGTCTGAAAGGGTC

/clone = IMAGE:3627806/

GGACCTCGTCCAAAGGAGATAGGC

clone_end = 5′

1326
Table 3A
Hs.21351
AV724665
10829278
qd15g09.x1 cDNA, 3′ end
1
ACATTTTGATTTCTTCTCTCTGTGGG

/clone = IMAGE:1723840/

GTGGCAAGTTGAGGGAGCATTCTT

clone_end = 3′

1327
Table 3A
Hs.44656
AV726117
10832185
AV726117 cDNA, 5′ end
1
CGTAAACCAATGTGGTACACTAGTTG

/clone = HTCAXB05/

GCCCGAACTTGGTATAAACCGCCT

clone_end = 5′

1328
Table 3A
Hs.245798
AV727063
10836484
hypothetical protein
1
TCTTTAAGTCTGTCAAACCAGAACTC

DKFZp584I0422

TTTGAAGCACTTTGAACAATGCCC

(DKFZP584I0422),

mRNA/cds = (510, 1196)

1329
Table 3A
Hs.316771
AV729160
10838581
AV729160 cDNA, 5′ end
1
AGCTGGCGTAATAGCGAAGAGGCCC

/clone = HTCCAB04/

GCACCGATCGCCTTTCCAACAAGTG

clone_end = 5′

1330
Table 3A
Hs.22003
AV730135
10839556
solute carrier family 6
1
AGATGCATTTTAAATGTCTATAAATGG

(neurotransmitter transporter,

TGTCATAACTAGAGCACGGGCGT

GABA), member 1 (SLC6A1),

mRNA/cds = (234, 2033)

1331
Table 3A
Hs.175971
AV734916
10852461
AV734916 cDNA, 5′ end
1
ATTAAAACGCTTGGAAGAAAATCCCC

/clone = cdAAHE11/

TTTTGGCAGGTGGGGGAAAAAGCA

clone_end = 5′

1332
Table 3A
NA
AV735258
10852803
mitochondrion, complete genome
1
ATTCAACCAATAGCCCTTGCCGTACC

GCCTACCCGTAACATTACTGGAGG

1333
Table 3A
NA
NC_001807
10855754
Mitochondrial Sequence
1
CGCCTATAGCACTCGAATAATTCTTC

TCACCCTAACAGGTCAACCTCGCT

1334
Table 3A
Hs.246798
AV739961
10857542
AV739961 cDNA, 5′ end
1
GTTGTGCATGATTCCCCACGTGTCTC

/clone = CBFBRA10/

TGTTTATCCAGATAAGAAAAGATA

clone_end = 5′

1335
Table 3A
Hs.122431
AV743635
10861216
AV713062 cDNA, 5′ end
1
TCTTTTAGGATTTGTCTTTTAGAATCT

/clone = DCAADD12/

CCAGTCCTCACAGGAAAACCCCC

clone_end = 5′

1336
Table 3A
Hs.42915
AV745692
10865139
ARP2 (actin-related protein 2,
1
TGGGTGGAGTATTATGTTTAACTGGA

yeast) homolog (ACTR2),

GTTGTCAAGTATGAGTCCCTCAGG

mRNA/cds = (74, 1258)

1337
Table 3A
Hs.26670
AV749844
10907692
PAC clone RP3-515N1 from
1
ACCTCATTCTGACACCTGCATATAGT

22q11.2-q22/cds = (0, 791)

GTGGGAAATTGCTCTGCATTTGAC

1338
Table 3A
Hs.31409
AV752358
10910206
602685862F1 cDNA, 5′ end
1
GTTCTGGAGGACAGGAAGGGTGACC

/clone = IMAGE:4818566/

CACAGAGGATTATACCACCGGGGTG

clone_end = 5′

1339
Table 3A
Hs.335863
AV755117
10912965
601462961T1 cDNA, 3′ end
1
GCCGCAGACCTCCTCATTCTAACCTG

/clone = IMAGE:3866222/

AATCGAAGGACAACCAGTAAGCTA

clone_end = 3′

1340
Table 3A
Hs.339696
AV755367
10913215
ribosomal protein S12 (RPS12),
1
TGAGTCGTATTACAATTCACTGGCCG

mRNA/cds = (80, 478)

TCGTTTTACAACGTCGTGACTGGG

1341
Table 3A
Hs.181165
AV756188
10914036
eukaryotic translation elongation
1
TAAGATTATCAACCTTGGGGTCGTTT

factor 1 alpha 1 (EEF1A1),

TGTTGTTCGCGGATTGAGCACGGA

mRNA/cds = (53, 1441)

1342
Table 3A
Hs.58643
AV760147
10917995
602438603F1 cDNA, 5′ end
1
CTGGGCTGAAGCCTATTCCTATGGG

/clone = IMAGE:4564968/

GCTCTGGAATGTTTGTGACTGAATG

clone_end = 5′

1343
Table 3A
Hs.93194
AV762642
10920490
apolipoprotein A-I (APOA1),
1
TTGTCCATTTGGAACAGAGTCACTAT

mRNA/cds = (38, 841)

AAAGAACGGGCTCAACTGGGCACC

1344
Table 3A
Hs.301553
AW021037
5874567
karyopherin alpha 6
1
GCAGACATAGGCGAAGAAAACATGG

(importin alpha 7)

CATTGAGTGTGCTGAGTCCAGACAA

(KPNA6), mRNA/cds =

(55, 1665)

1345
Table 3A
Hs.232400
AW021551
5875081
heterogeneous nuclear
1
CTTTTCCCACCCCCTCCCCCTCCATG

ribonucleoprotein A2/B1

TGAAGATTTGGGTGCTTAACATAT

(HNRPA2B1), transcript variant

B1, mRNA/cds = (169, 1230)

1346
Table 3A
Hs.95835
AW248322
6591315
RST8356 cDNA
1
GGCACTGCCTCCTTACCTGTGAGGAA

TGCAAAATAAAGCATGGATTAAGT

1347
Table 3A
Hs.340753
AW362008
6866658
tw50h12.x1 cDNA, 3′ end
1
AAACCACACCAGGAACTCCTTGCATG

/clone = IMAGE:2263175/

GCAAAAGCTGAACAGTACAAATCC

clone_end = 3′

1348
Table 3A
Hs.127574
BG436386
13342892
602509044F1 cDNA, 5′ end
1
ACACAGTCATCCCCATGCAGAAACCT

/clone = IMAGE:4619579/

CAGAAAACACCAATGTATTACACA

clone_end = 5′

1349
Table 3A
Hs.8024
AW390233
6894892
IK cytokine, down-regulator of
1
GTCTGAACGAGACTCAATTCCTCTCC

HLA II (IK), mRNA/

GAGGCTCCCCAAACAAATTGTAGC

cds = (111, 1784)

1350
Table 3A
NA
AW402007
6920693
UI-HF-BKD-aao-g-02-0-UI.r1
1
GTGCAGTCCATCAGATCCAAGCCTGT

NIH_MGC_38 cDNA clone

CTCTTGAGGAACAACCGCGCAGAC

IMAGE:3054530 5′

1351
Table 3A
Hs.181125
AW405863
6924920

Homo sapiens, clone MGC:12849
1
GACCCAGGCTATGGATGAGGCTGAC

IMAGE:4308973, mRNA, complete

TATTACTGTCAGGCGTGGGACAGCA

cds/cds = (24, 725)

1352
Table 3A
NA
AW499658
7111531
UI-HF-BR0p-ajj-c-07-0-UI.r1
1
TGGTGGCAAATCTGATTTTTGGAAAC

NIH_MGC_52 cDNA clone

GAGTATTGGAGGACTATAAAACAA

IMAGE:3074677 5′

1353
Table 3A
NA
AW499828
7111870
UI-HF-BN0-ake-c-06-0-UI.r1
1
ACATTTCTTGTTGGCACTACAGCAAC

NIH_MGC_50 cDNA clone

CACATACAGTACAGACAACCTCCA

IMAGE:3076819 5′

1354
Table 3A
Hs.181461
AW499829
7111872
ariadne (Drosophila) homolog,
1
TGGGATAAAGGTGTGTCGGTTTAGCA

ubiquitin-conjugating enzyme E2-

CCTCTGGAAGACCTATCTAGAGCT

binding protein, I (ARIH1),

mRNA/cds = (314, 1987)

1355
Table 3A
Hs.145668
AW500534
7113240
fmfc5 cDNA/clone = CR6-21
1
CCTGGCACATGTTGTCTGGAGTCTGG

CACACTGGTTATCAATAGCACATT

1356
Table 3A
Hs.304900
AW501528
7115141
602288147F1 cDNA, 5′ end
1
GCATGTTCTCACCGTGAAGGAGAGT

/clone = IMAGE:4373963/

GATGCAGGGAGATACTACTGTGCAG

clone_end = 5′

1357
Table 3A
Hs.37892
AW504212
7141879
KIAA0922 protein (KIAA0922),
1
AAAGTGGGTGGAAGACTTCCTGGTG

mRNA/cds = (122, 3841)

CAGGAGGCTCACTCCGATTTAAGGT

1358
Table 3A
Hs.120996
AW504293
7141960
serine/threonine kinase 17b
1
CTGTGGTCTGTTATATGAGAGAGATC

(apoptosis-inducing) (STK17B),

CTTTAACTAGAGCAAAGAGGGAGT

mRNA/cds = (261, 1379)

1359
Table 3A
Hs.182937
AW630825
7377615
peptidylprolyl isomerase A
1
GCTTGCTGTTCCTTAGAATTTTGCCTT

(cyclophilin A) (PPIA),

GTAAGTTCTAGCTCAAGTTGGGG

mRNA/cds = (44, 541)

1360
Table 3A
Hs.102647
AW651682
7412932
602271538F1 cDNA, 5′ end
1
TTTCTCAGAGCTGGAGGTTGCTGGG

/clone = IMAGE:4359609/

CACCTAAATGATGTTTCATGATAGC

clone_end = 5′

1361
Table 3A
NA
AW792856
7844778
UM0001 cDNA
1
CTTTTTGTAAGTTACAACATTCCACTG

GATCCTTATATTGCCTGTAGTGG

1362
Table 3A
NA
AW810442
7903438
ST0125 cDNA
1
CTCATCTATGTCTTCTAAAGCTTTTCT

GCATTCTTCCACCTGGGATTCAA

1363
Table 3A
NA
AW812896
7905890
RC3-ST0186-250200-018-a11
1
CTGTCTTTGGAAGGAGACACAAGAAC

cDNA/gb = AW812896

CTGATAACATTGGTTGTCTTCGGG

1364
Table 3A
Hs.44577
AW813133
7906127
602388170F1 cDNA, 5′ end
1
AAACAAGAACCCACTTAAACACAGCA

/clone = IMAGE:4517129/

TCAAACTCTACCATGAAATGAAGA

clone_end = 5′

1365
Table 3A
Hs.23128
AW819894
7912888

Homo sapiens, Similar to RIKEN
1
TTCTTCCTGGTCATATTCCTCTTTTGA

cDNA 4931428D14 gene, clone

TTTTCTAAGAACTTCCCTCAGGA

MGC:15407 IMAGE:4309613,

mRNA, complete cds/cds =

(123, 1151)

1366
Table 3A
Hs.165895
AW850041
7945558
IL3-CT0216-170300-097-C07
1
ACACAAGATACTGCCACTTTCTCTAC

cDNA

ACAAAGACCCACCCAAACACCAGC

1367
Table 3A
Hs.301756
AW866426
8000478

Homo sapiens, clone MGC:17544
1
CTTTCTCAGGAAGTGGCTCTGCCAGG

IMAGE:3482146, mRNA,

CAGGACTATGTGGGAAAGGGTTTT

complete cds/cds = (256, 894)

1368
Table 3A
Hs.130729
AW898615
8082820
RC1-NN0073-090500-012-t02
1
ATTACATGCTAACTCAAACTTACAAAA

cDNA

TCAAGCTCTCTGTGATCCTGGTT

1369
Table 3A
Hs.166975
AW949461
8139088
splicing factor, arginine/serine-
1
GATTAAAGGCTTCCATCGATTGGGTA

rich 5 (SFRS5), mRNA/cds =

GTGTCCTTCAAGTGGGTGGCGAAG

(218, 541)

1370
Table 3A
Hs.172028
AW954112
8143795
a disintegrin and metalloproteinase
1
TGTATTAACAGGCTTATTGCTATGCA

domain 10 (ADAM10),

GGGAAATAGAAGGGGCATTACAAA

mRNA/cds = (469, 2715)

1371
Table 3A
Hs.76728
AW954476
8144159
802570085F1 cDNA, 5′ end
1
TGGTGGATGGATGGAAACACATACCT

/clone = IMAGE:4694321/

CCTAATTAACCTGTTGGTGGAAAC

clone_end = 5′

1372
Table 3A
Hs.292457
AW954580
8144263

Homo sapiens, clone MGC:16382
1
GCCTTGGAGTGTGACATTTCTGCGAG

IMAGE:3927795, mRNA,

AATGCTTAAATACCGATTTCCCGC

complete cds/cds = (498, 635)

1373
Table 3A
Hs.95835
AW955265
8144948
RST8356 cDNA
1
AGGGAGTCGTTTTACCAATTCACTGG

CCCGTGTTTTACAAACGTCTGACT

1374
Table 3A
Hs.205353
AW957139
8146822
ectonucleoside triphosphate
1
TGGAGAGCTTGGGACAAGGTCAGAA

diphosphohydrolase 1 (ENTPD1),

TGAAAACATACCAGTCAATCCTGCT

mRNA/cds = (67, 1599)

1375
Table 3A
Hs.289088
AW958538
8148222
heat shock 90 kD protein 1, alpha
1
ACCTGTGCTCTTTGGATACCTAATGC

(HSPCA), mRNA/cds = (60, 2258)

GACATTTAAGTTGTATTTGACAGT

1376
Table 3A
Hs.14453
AW960484
8150168
interferon consensus sequence
1
AGGCTGGGCACAAAGGAGAAAGGAG

binding protein 1 (ICSBP1),

GACATGGAAAATCCGACAATTCGAA

mRNA/cds = (47, 1327)

1377
Table 3A
Hs.198427
AW960593
8150277
hexokinase 2 (HK2),
1
ATCTCAAATCCTTGAGCACTCAGTCT

mRNA/cds = (1490, 4243)

AGTGAAGATGTTGTCATTATGTACA

1378
Table 3A
Hs.237868
AW963171
8153007
interleukin 7 receptor (IL7R),
1
GGGTCATAGGTTCATGGGTTTGTTGA

mRNA/cds = (22, 1401)

GAATTGTGGCTCCTGGTTTCTGGT

1379
Table 3A
Hs.56205
AW964218
8154054
insulin induced gene 1 (INSIG1),
1
GCCTTCTTTCTGCTGACTGGGGGCTT

mRNA/cds = (414, 1247)

TCATTTAAAAGGAGTCTTTTTAAT

1380
Table 3A
Hs.30212
AW985078
8154914
thyroid receptor interacting
1
TGTAAACAGTGGCAGGAGCGTGGAC

protein 15 (TRIP15),

TTAAAACAAGGCTTGCTTATTTGGT

mRNA/cds = (15, 1346)

1381
Table 3A
Hs.124764
AW965490
8155326
602388504F1 cDNA, 5′ end
1
GCCCTTTGGGTTAAGCCTTTACATTC

/clone = IMAGE:4515481/

ATGAAGACCCCTCCAGGGTAGAAT

clone_end = 5′

1382
Table 3A
Hs.132739
AW965967
8155823
EST378080 cDNA/
1
AAAAGGAAAACGAAAAAGGAAA

AGGTGGCCAATGTGGAAAAAGTTT

CAAT

1383
Table 3A
Hs.293418
AW966098
8155934
EST385296 cDNA
1
ACTCTCAGGAGCCATGAAAGCTGCAC

AGTTACTTTATATACCACGAGGCA

1384
Table 3A
Hs.25130
AW967388
8157225
cDNA FLJ14923 fis, clone
1
TTATGTCACCAGAATGTTTGCCAACA

PLACE1008244, weakly similar to

CCCCGAAAAGGAACCAGAGGACTT

VEGETATIBLE

INCOMPATIBILITY

PROTEIN HET-E-1/cds =

UNKNOWN

1385
Table 3A
Hs.343615
AW968581
8158402
602621493F1 cDNA, 5′ end
1
AGGTTATTTGAGCACAGTGAAAGCAG

/clone = IMAGE:4755166/

AGTACTATGGTTGTCCAACACAGG

clone_end = 5′

1386
Table 3A
Hs.82712
AW969359
8159203
fragile X mental retardation,
1
GGCCTGCCATCCGAGGGACTGTGTT

autosomal homolog 1 (FXR1),

GTAGATTGTGATCAAGGTTGATTGG

mRNA/cds = (12, 1877)

1387
Table 3A
Hs.199160
AW969548
8159390
translocation T(4:11) of ALL-1
1
ACAGGTAGTTGAATAATTGTTTCAAG

gene to chromosome 4/

AGCTCAACAGATGACAAGCTTCTT

cds = UNKNOWN

1388
Table 3A
Hs.293744
AW973953
8165038
602279577F1 cDNA, 5′ end
1
AATACACTTTGTGCCAAGGGAAGAAC

/clone = IMAGE:4387322/

ACTGCATGCCCTGGGTCTTCAGTC

clone_end = 5′

1389
Table 3A
Hs.43148
AW993524
8253690
602554063F1 cDNA, 5′ end
1
GGGAACTGGAGGTGAGAAGCATTAT

/clone = IMAGE:4663887/

AATAGCCTCTCTGCCTTTATCTACA

clone_end = 5′

1390
Table 3A
Hs.238990
AY004255
9652559

Homo sapiens, Similar to cyclin-
1
ACAAGCCAAAGTGGCATGTTTTGTGC

dependent kinase inhibitor 1B

ATTTGTAAATGCTGTGTTGGGTAG

(p27, Kip1), clone MGC:5304

IMAGE:3458141, mRNA,

complete cds/cds = (377, 973)

1391
Table 3A
Hs.16773
AY007106
9955998
clone TCCCIA00427 mRNA
1
AACAGACTGTCGTAGAAAACTGTCTT

sequence/cds = UNKNOWN

TGCTTCCAAATCAGCAGAGGACCA

1392
Table 3A
Hs.285013
AY007110
9956004
putative HLA class II associated
1
GCCCCTCAGAAGAGCCAAACTTTGAG

protein I (PHAP1),

TTTTATGTCTGTTTGTCATTGATA

mRNA/cds = (148, 897)

1393
Table 3A
Hs.24435
AY007126
9956024
clone CDABP0028 mRNA
1
CCTTGTGTCCAACGGGAATAGGAAGA

sequence/cds = UNKNOWN

ATTAGTTACTGACTTCACCTGAGA

1394
Table 3A
Hs.330838
BE910568
10407295
601501121F1 cDNA, 5′ end
1
CCCACAATTGGACTGATAGGGGGAG

/clone = IMAGE:3903053/

AAAATCCAAAGAGACGGAGCAACTG

clone_end = 5′

1395
Table 3A
Hs.250820
AY007158
9956071
hypothetical protein FLJ14827
1
AACGGCAACTGGGAGATTTGTGAGT

(FLJ14827), mRNA/cds =

GAACACTGTTTCATCTTAATATGCT

(468, 1277)

1396
Table 3A
Hs.173274
AY007165
9956080
integrin cytoplasmic domain-
1
ACATCTGAGAAACCCTGAATCCTGCA

associated protein 1 (ICAP-1A),

ATCAAGTAGAAGTCAACTTCATCT

transcript variant 1,

mRNA/cds = (168, 770)

1397
Table 3A
Hs.105484
AY007243
12621025
regenerating gene type IV
1
GCCATAGGAAGGTTTACCAGTAGAAT

(REG-IV), mRNA/cds =

CCTTGCTAGGTTGATGTGGGCCAT

(181, 657)

1398
Table 3A
Hs.5298
AY029066
14017398
CGI-45 protein (LOC51094),
1
TCATCTCAACTTAGTATTATACCCACA

mRNA/cds = (182, 1294)

CCCACCCAAGAACAGGGTTTGTT

1399
Table 3A
Hs.79070
BC000141
12652778
v-myc avian myelocytomatosis
1
GACTGAAAGATTTAGCCATAATGTAA

viral oncogene homolog (MYC),

ACTGCCTCAAATTGGACTTTGGGC

mRNA/cds = (558, 1877)

1400
Table 3A
Hs.334602
BC000167
13096801
cDNA FLJ14539 fis, clone
1
GGCACTGTCTGTGTCCTTCCTTGAAC

NT2RM2001345, weakly similar

TGTCTACCCTGTTGCTTTTCACAA

to VEGETATIBLE

INCOMPATIBILITY

PROTEIN HET-E-1/

cds = (7, 1434)

1401
Table 3A
Hs.75458
BC000374
12653212
ribosomal protein L18 (RPL18),
1
GGCCAGCCGAGGCTACAAAAACTAA

mRNA/cds = (15, 581)

CCCTGGATCCTACTCTCTTATTAAA

1402
Table 3A
Hs.278544
BC000408
12853278
acetyl-Coenzyme A
1
ACTAGGTTGCAATATGTGAAATCAGA

acetyltransferase 2 (acetoacetyl

GGACCAAAGTACAGATGGAAACCA

Coenzyme A thiolase) (ACAT2),

mRNA/cds = (37, 1230)

1403
Table 3A
Hs.183704
BC000449
12653358
ubiquitin mRNA, complete cds
1
CCCTGTCTGACTACAACATCCAGAAA

/cds = (135, 2192)

GAGTCCACTCTGCACTTGGTCCTG

1404
Table 3A
Hs.151242
BC000514
12653484
serine (or cysteine) proteinase
1
GGCATCGCCCATGCTCCTCACCTGTA

inhibitor, clade G (C1 inhibitor),

TTTTGTAATCAGAAATAAATTGCT

member 1 (SERPING1),

mRNA/cds = (60, 1562)

1405
Table 3A
Hs.180450
BC000523
12653502
ribosomal protein S24 (RPS24),
1
AAAGCAACGAAAGGAACGCAAGAAC

transcript variant 1,

AGAATGAAGAAAGTCAGGGGGACTG

mRNA/cds = (37, 429)

1406
Table 3A
Hs.272822
BC000530
12653516
RuvB (E. coli homolog)-like 1
1
TCCCACTTTGTCTGTACATACTGGCC

(RUVBL1), mRNA/cds =

TCTGTGATTACATAGATCAGCCAT

(76, 1446)

1407
Table 3A
Hs.83583
BC000590
12653824
actin related protein 2/3 complex,
1
GAAGCGGCTGGCAACTGAAGGCTGG

subunit 2 (34 kD) (ARPC2),

AACACTTGCTACTGGATAATCGTAG

mRNA/cds = (84, 986)

1408
literature
Hs.153026
BC000616
12653666
mRNA for KIAA0640 protein,
1
CAGTCACGTCAGTTATGTAGATACTG

partial cds/cds = (0, 1812)

CATGGCAGGAGAGCTTTACGCTAA

1409
Table 3A
Hs.321677
BC000627
12653884
signal transducer and activator of
1
GCCACCCCTCACACAGCCAAACCCC

transcription 3 (acute-phase

AGATCATCTGAAACTACTAACTTTG

response factor) (STAT3),

mRNA/cds = (220, 2532)

1410
Table 3A
Hs.5662
BC000672
12653772
guanine nucleotide binding protein
1
GCAGGTGACCATTGGCACACGCTAG

(G protein), beta polypeptide 2-

AAGTTTATGGCAGAGCTTTACAAAT

like 1 (GNB2L1), mRNA/cds =

(95, 1048)

1411
Table 3A
Hs.4147
BC000687
12853796

Homo sapiens, translocating chain-
1
TGCCATGCTGCTAGGAAATTGTCCTT

associating membrane protein,

TTTCTTTCTAGCTGTTAACCTACT

clone MGC:784 IMAGE:3347823,

mRNA, complete cds/cds =

(91, 1215)

1412
Table 3A
Hs.44468
BC000758
12653928

Homo sapiens, clone MGC:2698
1
AACTTATTCCAGTGTTGATCGCAAGC

IMAGE:2820737, mRNA,

TGTTGATGCACAGGCGTCTTGTGG

complete cds/cds = (168, 266)

1413
Table 3A
Hs.101514
BC000764
12653940
hypothetical protein FLJ10342
1
TGAAAAGGATTAAAGCTGGTATTCTA

(FLJ10342), mRNA/cds =

GAACATGCCCTTCACTGGTTGTGT

(533, 1144)

1414
Table 3A
Hs.85844
BC000771
12653954
neurotrophic tyrosine kinase,
1
GGTAAGGTTTCTAGGAGGTCTGTTAG

receptor, type 1 (NTRK1),

GTGTACATCCTGCAGCTTATTGGC

mRNA/cds = (0, 2390)

1415
Table 3A
Hs.195870
BC000987
13111833
chronic myelogenous leukemia
1
TGATTCTGTAAAGCTGTGGAATGAAG

tumor antigen 66 mRNA,

CTGCAGATTTAGAGAACATTGGCT

complete cds, alternatively

spliced/cds = (232, 1983)

1416
Table 3A
Hs.299214
BC001077
12654494

Homo sapiens, clone
1
CGATTTTACACGGCTGGGTAGAATTT

IMAGE:2822295, mRNA,

GTAGAAAAGATCCACAGGGCAAGC

partial cds/cds = (0, 661)

1417
Table 3A
Hs.82193
BC001169
12654662
cDNA FLJ11763 fis, clone
1
GCTACTACTTCATTGCAACCTTTATTA

HEMBA1005679/cds =

CTGACCACATCAGACATCATGCT

UNKNOWN

1418
Table 3A
Hs.240770
BC001255
12654824

Homo sapiens, nuclear cap binding
1
GGGCTGAAGTACCTAAGTGTGAATGT

protein subunit 2, 20 kD, clone

CTCTCCCGTTAAACTGAGTGTAGA

MGC:4991 IMAGE:3458927,

mRNA, complete cds/cds =

(26, 496)

1419
Table 3A
Hs.73957
BC001267
12654846

Homo sapiens, RAB5A, member
1
AGGAAAACGGTTCACCAGTGTTTAGT

RAS oncogene family, clone

TTTATATTGAGGTGCTCAGGTTGG

MGC:5048 IMAGE:3483669,

mRNA, complete cds/cds =

(165, 812)

1420
Table 3A
Hs.73965
BC001303
12654914
splicing factor, arginine/serine-
1
CCGGGCCTTGCATATAAATAACGGAG

rich 2 (SFRS2), mRNA/cds =

CATACAGTGAGCACATCTAGCTGA

(155, 820)

1421
Table 3A
Hs.62954
BC001399
12655094
ferritin, heavy polypeptide 1
1
ATAATGAAAGCTAAGCCTCGGGCTAA

(FTH1), mRNA/cds = (91, 663)

TTTCCCCATAGCCGTGGGGTGACT

1422
Table 3A
Hs.288038
BC001412
12655120
tRNA isopentenylpyrophosphate
1
TGCATCGTAAAACCTTCAGAAGGAAA

transferase (IPT),

GGAGAATGTTTTGTGGACCACTTT

mRNA/cds = (60, 1040)

1423
Table 3A
Hs.3459
BC001413
13937593
cDNA: FLJ22003 fis, clone
1
TGCTCTGTTCTGGTTTCTGTTTTCAAA

HEP06764/cds = UNKNOWN

TCAAATGCCTGTTTGGGAGGAGA

1424
Table 3A
Hs.51299
BC001632
12804450
NADH dehydrogenase
1
CAAAATCCCAAAACCAGGGCCAAGG

(ubiquinone) flavoprotein 2

AGTGGACGCTTCTCTTGTGAGCCAG

(24 kD) (NDUFV2), mRNA/

cds = (18, 767)

1425
Table 3A
Hs.155101
BC001637
12804460
mRNA for KIAA1578 protein,
1
ACAAATTTCTTGGCTGGATTTGAAGC

partial cds/cds = (0, 3608)

TTAAACTCCTGTGGATTCACATCA

1426
Table 3A
Hs.318069
BC001646
12804476
cDNA FLJ20350 fis, clone
1
TCCACGGTTGTGCCTTATTGTTCCAT

HEP13972, highly similar to

TAAAATTGTATCTTCGATCCATCA

Z184_ZINC FINGER

PROTEIN 184/cds = UNKNOWN

1427
Table 3A
Hs.8297
BC001660
12804498
cDNA FLJ10907 fis, clone
1
GGTCTGAGAGTCTGTGAAGATGGCC

OVARC1000060/cds = (319, 696)

CAGTCTTCTATCCCCCACCTAAAAA

1428
Table 3A
Hs.17279
BC001697
12804560
tyrosylprotein sulfotransferase 1
1
ACACACAGGAGGGAAAATCCTGGGA

(TPST1), mRNA/cds = (81, 1193)

TTCTTTTTCTAGGGATGTAATACAT

1429
Table 3A
Hs.284291
BC001798
12804732
sorting nexin 6 (SNX6),
1
CTGTTTGAACTGTTGAGTTTCCGTTG

mRNA/cds = (497, 1369)

CTGGCTGAGTGCGTTTTGTCCTTC

1430
Table 3A
Hs.8297
BC001819
12804758
cDNA FLJ10907 fis, clone
1
GGTCTGAGAGTCTGTGAAGATGGCC

OVARC1000060/cds = (319, 696)

CAGTCTTCTATCCCCCACCTAAAAA

1431
Table 3A
Hs.77502
BC001854
12804818

Homo sapiens, methionine
1
GGTACAGAGAAGCCAGCTTGTTTACA

adenosyltransferase II, alpha,

TGCTTATTCCATGACTGCTTGCCC

clone MGC:4537

IMAGE:3010820, mRNA,

complete cds/cds = (116, 1303)

1432
Table 3A
Hs.77502
BC001854
12804818

Homo sapiens, methionine
1
GGTACAGAGAAGCCAGCTTGTTTACA

adenosyltransferase II, alpha,

TGCTTATTCCATGACTGCTTGCCC

clone MGC:4537

IMAGE:3010820, mRNA,

complete cds/cds = (116, 1303)

1433
Table 3A
Hs.13580
BC001909
12804912

Homo sapiens, clone
1
GGGAGAATGAATGTGCAACGTGGCT

IMAGE:3537447, mRNA,

GAAATCTATTTTGTGTAATAAAAGG

partial cds/cds = (0, 790)

1434
Table 3A
Hs.157236
BC001913
12804920

Homo sapiens, clone
1
CCCCACCACCCCATTACCACAGCTGC

MGC:3015 IMAGE:3162543,

CTTTGTGTGTTTGTGTCAATAAAA

mRNA, complete cds/cds =

(332, 1234)

1435
Table 3A
Hs.318885
BC001980
12805046
superoxide dismutase 2,
1
CCAGCAAGATAATGTCCTGTCTTCTA

mitochondrial (SOD2),

AGATGTGCATCAAGCCTGGTACAT

mRNA/cds = (4, 672)

1436
Table 3A
Hs.288061
BC002409
12803202
actin, beta (ACTB),
1
CCAACTTGAGATGTATGAAGGCTTTT

mRNA/cds = (73, 1200)

GGTCTCCCTGGGAGTGGGTGGAGG

1437
Table 3A
Hs.284214
BC002435
12803242
putative zinc finger protein
1
GCTACTAGAGAGCAAGGGGCTTTCTT

(LOC55818), mRNA/cds =

ACCACCAGTGCTGAGGAGAAAAGT

(299, 3937)

1438
Table 3A
Hs.334822
12803270
12803270

Homo sapiens, Similar to
1
ACCAAGAAACCAGCCCCTGAAA

ribosomal protein L4,

AGAAGCCTGCAGAGAAGAAACCTA

clone MGC:2966

CTAC

IMAGE:3139805, mRNA,

complete cds/cds =

(1616, 2617)

1439
Table 3A
Hs.104879
BC002538
12803428

Homo sapiens, serine
1
TTTCCTCATCTATGAATTGTCATTCAC

(or cysteine) proteinase

ACACCTACTTTTCTGCTTCGTTT

inhibitor, clade B (ovalbumin),

member 9, clone MGC:2131

IMAGE:3140427, mRNA,

complete cds/cds = (92, 1222)

1440
Table 3A
Hs.104879
BC002538
12803428

Homo sapiens, serine
1
TTTCCTCATCTATGAATTGTCATTCAC

(or cysteine) proteinase

ACACCTACTTTTCTGCTTCGTTT

inhibitor, clade B (ovalbumin),

member 9, clone MGC:2131

IMAGE:3140427, mRNA,

complete cds/cds = (92, 1222)

1441
Table 3A
Hs.146409
BC002711
12803746
cell division cycle 42
1
AATAATGACAAATGCCCTGCACCTAC

(GTP-binding protein, 25 kD)

CCACATGCACTCGTGTGAGACAAG

(CDC42), mRNA/cds = (69, 644)

1442
Table 3A
Hs.322824
BC002746
12803812

Homo sapiens, Similar to
1
GTGCCCCTGTGGGTCCCAGGGAGGT

dodecenoyl-Coenzyme A delta

CTTAAACAAGGTATTTTTCAACTTA

isomerase (3.2 trans enoyl-

Coenzyme A isomerase), clone

MGC:3903 IMAGE:3830566,

mRNA, complete cds/cds =

(15, 872)

1443
Table 3A
Hs.46448
BC002796
12803898
lymphoblastic leukemia derived
1
CAGTGAAGACGTCAGGGGCAAGGTC

sequence 1 (LYL1),

TCGGGGGTCCGGAAGGGTGATCATC

mRNA/cds = (0, 803)

1444
Table 3A
Hs.322404
BC002837
12803976
hypothetical protein MGC4175
1
TGCAAGGGAGACATATCCTAGATCAC

(MGC4175), mRNA/cds =

TTTGCTTTTTCTTTAAGGAGCTGA

(221, 577)

1445
Table 3A
Hs.288036
BC002845
12803990
tRNA isopentenylpyrophosphate
1
TGCATCGTAAAACCTTCAGAAGGAAA

transferase (IPT),

GGAGAATGTTTTGTGGACCACTTT

mRNA/cds = (60, 1040)

1446
Table 3A
Hs.318693
BC002887
12804028

Homo sapiens, clone
1
TTGGGGGAGGTTAGGGACTTATCCT

IMAGE:3940519, mRNA,

GTGCTTGTAAATAAATAAGGTCATG

partial cds/cds = (0, 902)

1447
Table 3A
Hs.181309
BC002900
12804094
proteasome (prosome, macropain)
1
ACTTGGCTGCCATAGCATAACAATGA

subunit, alpha type, 2 (PSMA2),

AGTGACTGAAAAATCCAGAATTTC

mRNA/cds = (0, 704)

1448
Table 3A
Hs.96757
12804148
12804148
suppressor of Ty (S. cerevisiae) 3
1
AAAATATTAAACACAAACTACCACCTA

homolog (SUPT3H),

CCTCCCTCACCAAAGCCCATAAA

mRNA/cds = (71, 1024)

1449
Table 3A
Hs.1600
BC002971
12804224

Homo sapiens, clone
1
AGCTGTTTGGTAACCATAGTTTCACT

IMAGE:3543711, mRNA, partial

TGTTCAAAGCTGTGTAATCGTGGG

cds/cds = (0, 1620)

1450
Table 3A
Hs.1600
BC002971
12804224

Homo sapiens, clone
1
AGCTGTTTGGTAACCATAGTTTCACT

IMAGE:3543711, mRNA, partial

TGTTCAAAGCTGTGTAATCGTGGG

cds/cds = (0, 1620)

1451
Table 3A
Hs.75193
BC003090
13111846
COP9 homolog (COP9),
1
TGTCGCCTTTTAGAAGGAGAAACTTA

mRNA/cds = (49, 678)

AGTGTGGAATGCATTATATGGGCA

1452
Table 3A
Hs.334861
BC003137
13111932
hypothetical protein FLJ23059
1
TCCTTGGCAGCTGTATTCTGGAGTCT

(FLJ23059), mRNA/cds =

GGATGTTGCTCTCTAAAGACCTTT

(41, 1681)

1453
Table 3A
Hs.326456
BC003352
13097158
hypothetical protein FLJ20030
1
TTTGGAGTGGAGGCATTGTTTTTAAG

(FLJ20030), mRNA/cds =

AAAAACATGTCATGTAGGTTGTCT

(1, 1239)

1454
Table 3A
Hs.77091
NM_006730
5803006
deoxyribonuclease I-like 1
1
TGGCTGGGACGCTAGAAGGGTCATG

(DNASE1L1), mRNA/cds =

TGTTAACTATAATCACATTTATGGT

(794, 1702)

1455
Table 3A
Hs.24697
BC003406
13097305
cDNA FLJ20709 fis, clone
1
ATTCTGGTTAACCGCTCACATGCATA

KAIA1124, highly similar to

ACAATAATGCTAGAAATTCAGGAA

D86324 mRNA for CMP-N-

acetylneuraminic acid/cds =

UNKNOWN

1456
Table 3A
Hs.42712
BC003525
13097617

Homo sapiens, Similar to
1
TGCTGATTTCTAGTGTATACTCTGTA

Max, clone MGC:10775

GTCTCAGTTCGTGTTTGATTCCAT

IMAGE:3807261, mRNA,

complete cds/cds = (115, 570)

1457
Table 3A
Hs.5322
BC003583
13097716
guanine nucleotide binding
1
AAATGAATCTTTCAAAGGTTTC

protein (G protein), gamma 5

CCAAACCACTCCTTATGATCCAG

(GNG5), mRNA/cds =

TGATA

(333, 539)

1458
Table 3A
Hs.334861
BC003577
13097758
hypothetical protein FLJ23059
1
TCCTTGGCAGCTGTATTCTGGAGTCT

(FLJ23059), mRNA/cds =

GGATGTTGCTCTCTAAAGACCTTT

(41, 1681)

1459
Table 3A
Hs.56851
BC003581
13097767
hypothetical protein MGC2668
1
TGCGTGTGCCTCAGTTTCCTCCTCCA

(MGC2668), mRNA/cds =

CAACTGAATATTTATAGTGGCTGA

(20, 325)

1460
Table 3A
Hs.188757
BC003897
13277575

Homo sapiens, clone MGC:5564,
1
GGGATGTGGAGGATTTTTGTTAAGTG

mRNA, complete cds/cds =

TCAATCGAAGTTAAAAAGCAAGGG

(227, 304)

1461
Table 3A
Hs.215595
BC004186
13278842
guanine nucleotide binding protein
1
AGCTCTCTGCACCCTTACCCCTTTCC

(G protein), beta polypeptide 1

ACCTTTTGTATTTAATTTTAAAGT

(GNB1), mRNA/cds = (280, 1302)

1462
Table 3A
Hs.111334
BC004245
13279004
PRO2760 mRNA, complete cds
1
CCCTCCAGCCAATAGGCAGCTTTCTT

/cds = UNKNOWN

AACTATCCTAACAAGCCTTGGACC

1463
Table 3A
Hs.70333
BC004258
13279043
mRNA for KIAA1844 protein,
1
CGTGGTTGTGGGAGGGGAAAGAGGA

partial cds/cds = (0, 1105)

AACAGAGCTAGTCAGATGTGAATTG

1464
Table 3A
Hs.9788
BC004317
13279217
hypothetical protein MGC10924
1
ACAATGTGTTAGCAGAAACCAGTGGG

similar to Nedd4 WW-binding

TTATAATGTAGAATGATGTGCTTT

protein 5 (MGC10924),

mRNA/cds = (104, 769)

1465
Table 3A
Hs.254105
BC004458
13325288
enolase 1, (alpha) (ENO1),
1
GCTAGATCCCCGGTGGTTTTGTGCTC

mRNA/cds = (94, 1398)

AAAATAAAAAGCCTCAGTGACCCA

1466
Table 3A
Hs.155101
BC004521
13325447
mRNA for KIAA1578 protein,
1
ACAAATTTCTTGGCTGGATTTGAAGC

partial cds/cds = (0, 3608)

TTAAACTCCTGTGGATTCACATCA

1467
Table 3A
Hs.17132
BC004805
13937690
602326876F1 cDNA, 5′ end
1
GCTGTGGTTGGTTGCATTACATGACA

/clone = IMAGE:4427970/

CAGAAAACTGTCCTCTACCTCACG

clone_end = 5′

1468
Table 3A
Hs.103378
BC004872
13438100
hypothetical protein MGC11034
1
GCCCTGGTAGGCTCCTTTAGAAGGA

(MGC11034), mRNA/cds =

CCATTTCTGTTCCTAGAGCTTAACT

(245, 840)

1469
Table 3A
Hs.151242
BC004900
13438172
serine (or cysteine) proteinase
1
GGCATCGCCCATGCTCCTCACCTGTA

inhibitor, clade G (C1 inhibitor),

TTTTGTAATCAGAAATAAATTGCT

member 1 (SERPING1),

mRNA/cds = (60, 1582)

1470
Table 3A
Hs.74335
BC004928
13436256
heat shock 90 kD protein 1,
1
TTTCCCTCTCCTGTCCTTGTGTTGAA

beta (HSPCB),

GGCAGTAAACTAAGGGTGTCAAGC

mRNA/cds = (0, 2174)

1471
Table 3A
Hs.336916
BC004994
13436445
death-associated protein 6
1
AGACTGGAAATGGGGATGAGGGTGT

(DAXX), mRNA/cds =

AAATTGTATTGAAAAAGATCGCGAA

(147, 2369)

1472
Table 3A
Hs.60377
BC005101
13937700
mRNA for KIAA1298 protein,
1
CCATGAGTTGTTTGGTTTTCCAGAAG

partial cds/cds = (55, 2271)

CTGCCAGTGGGTTCCCGTGAATTG

1473
Table 3A
Hs.99858
BC005128
13477308
ribosomal protein L7a (RPL7A),
1
GATACGATGAGATCCGCCGTCACTG

mRNA/cds = (31, 831)

GGGTGGCAATGTCCTGGGTCCTAAG

1474
Table 3A
Hs.177507
BC005187
13528770
hypothetical protein (HSPC155),
1
AGTCTTTCTGGTTTCTGGAGATAACC

mRNA/cds = (240, 743)

CATCAATAAAGCTGCTTCCTCTGG

1475
Table 3A
Hs.251531
BC005361
13529190
proteasome (prosome, macropain)
1
CGATGATGGTTACCCTTCATGGACGT

subunit, alpha type, 4 (PSMA4),

CTTAATCTTCCACACACATCCCCT

mRNA/cds = (59, 844)

1476
Table 3A
Hs.100000
BC005928
13543538
S100 calcium-binding protein A8
1
GGCCCCTGGACATGTACCTGCAGAA

(calgranulin A) (S100A8),

TAATAAAGTCATCAATACCTAAAAA

mRNA/cds = (55, 339)

1477
Table 3A
Hs.334573
BC006008
13937718
clone IMAGE:4285740,
1
GCAAACCTGCAGATTCCCAAGATGTT

mRNA/cds = UNKNOWN

CACGAGCTTGTGCTTTCTAAAGAA

1478
Table 3A
Hs.101150
BC006176
13544094
clone IMAGE:4054158.
1
TCCCCATTGTGCCGCCTTTATCAATT

GCCTGTTTTGTTTTGTTTGTTTTT

1479
Table 3A
Hs.108824
BC006282
13623362
hypothetical protein MGC10540
1
CTTTAGCTGCTGTTGCCTCCCTTCTC

(MGC10540), mRNA/cds =

AGGCTGGTGCTGGATCCTTCCTAG

(49, 579)

1480
Table 3A
Hs.239884
BC008464
13623874
H2B histone family, member L
1
CTGCTTATGGCACAATTTGCCTCAAA

(H2BFL), mRNA/cds = (0, 380)

ATCCATTCCAAGTTGTATATTTGT

1481
Table 3A
Hs.19574
BC006849
13905123
hypothetical protein MGC5469
1
CTGCTTCTGGGTGCATGGTAGACTTT

(MGC5469), mRNA/cds =

GTGGCATTTGATACAACTTGGACA

(69, 1124)

1482
Table 3A
Hs.252716
BC007004
13937807
oxysterol-binding protein-related
1
CTTATAGTATTTATCCACCCAAACCC

protein 1 (FLJ10217),

CAGACTGAGATACTGCTCCCAGGG

mRNA/cds = (174, 3026)

1483
Table 3A
Hs.180909
BC007063
13937906
peroxiredoxin 1 (PRDX1),
1
GAGAGACCAGCCTTTCTTCCTTTGGT

mRNA/cds = (60, 659)

AGGAATGGCCTGAGTTGGCGTTGT

1484
Table 3A
Hs.238730
BC007203
13938171
hypothetical protein MGC10823
1
CAGAGGTGGGAGTAACTGCTGGTAG

(MGC10823), mRNA/cds =

TGCCTTCTTTGGTTGTGTTGCTCAG

(63, 1235)

1485
Table 3A
Hs.334837
BC007277
13938298
hypothetical protein MGC15619
1
CTGTGTGCCCCAGCTGCATCAGCCA

(MGC15619), mRNA/cds =

GCTTCTAGGTGGCTCCATTGTTTTC

(744, 1454)

1486
Table 3A
Hs.298262
BE250027
9120132
ribosomal protein S19 (RPS19),
1
AGAGCAGAATAGCAATATAAGAGCAC

mRNA/cds = (69, 506)

AGACGAACATAGACACGACAGCGA

1487
Table 3A
Hs.297095
BE253125
9123276
601116648F1 cDNA, 5′ end
1
CTATTAGGACCCAGTGATTATGCTAC

/clone = IMAGE:3357178/

CTTGGCACGGTTAGGGTACTGCGG

clone_end = 5′

1488
Table 3A
NA
BE253338
9123402
cDNA clone IMAGE:3357826 5′
1
AAAGAAGCATGCACACTTATCACAAA

CAACTCTCTCAGGTGGCCAGTCTG

1489
Table 3A
Hs.75313
BE254064
9124489
aldo-keto reductase family 1,
1
TGCTGCCTATATGAAGTCTTTGAGAA

member B1 (aldose reductase)

AGCCCCTCTTGGAGTCTGTGCCTT

(AKR1B1), mRNA/cds = (45, 995)

1490
Table 3A
Hs.314898
BE255377
9125816
601115405F1 cDNA, 5′ end
1
GATATACGAGGACAAAACCCATCTAC

/clone = IMAGE:3355872/

CAGGCAGCTAACAAACCGCCGCCA

clone_end = 5′

1491
Table 3A
Hs.296183
BE259480
9129918
601106571F1 cDNA, 5′ end
1
GCCACTTTATTAGTAATGGTCGATAG

/clone = IMAGE:3342929/

TCCGAATCGATGGCTAGGGTGACT

clone_end = 5′

1492
Table 3A
Hs.301809
BE260041
9131017
601150579F1 cDNA, 5′ end
1
TAATCTGGCGGGTTATACCCCCGTGT

/clone = IMAGE:3503419/

TCTCCGGATTATATTTCGGGACAC

clone_end = 5′

1493
Table 3A
Hs.308154
BE264584
9138121
601192330F1 cDNA, 5′ end
1
GCTGGATTTGTGGGTATGGGGGCGG

/clone = IMAGE:3536383/

TTTTTGGGCGAAGGTTGGTTGTTAC

clone_end = 5′

1494
Table 3A
Hs.279429
BE279328
9154319
601157666F1 cDNA, 5′ end
1
CCACATCATCGGGGGCGAAATAGAA

/clone = IMAGE:3504328/

GCCCAGAGAGAGGCTAGGTGTAGGA

clone_end = 5′

1495
Table 3A
Hs.95835
BE292793
9175433
RST8356 cDNA
1
AGGGAGACTCTCAGCCTTCAGCTTCC

TAAATTCTGTGTCTGTGACTTTCG

1496
Table 3A
Hs.142737
BE293343
9176482
601143758F1 cDNA, 5′ end
1
TTGTCAAGCTGCTGCTGTCTTCAAGA

/clone = IMAGE:3051493/

TCTACCTGGTCAGAATCTCCTGCT

clone_end = 5′

1497
Table 3A
Hs.337988
BE297329
9180903

Homo sapiens, clone MGC:17431
1
GGCCAGTCTCTATGTGTCTTAATCCC

IMAGE:2984883, mRNA,

TTGTCCTTCATTAAAAGCAAAACT

complete cds/cds =

(1338, 1494)

1498
Table 3A
Hs.192755
BE298181
9181768
601118566F1 cDNA, 5′ end
1
TCTCTCACATTCTGTCTTTCCCCTCCT

/clone = IMAGE:3028193/

CCTTCACCTTCCCTCCGTCCCTC

clone_end = 5′

1499
Table 3A
Hs.336628
BE311727
9148186
ribosomal protein L36a (RPL36A),
1
ACACGAGACTATAGAGAATGCAGCAC

mRNA/cds = (30, 350)

ACAGATGAGAGCAGAGCAAATAGA

1500
Table 3A
Hs.129872
BE379820
9325198
sperm associated antigen 9
1
GCATCCAGATGGTGGTTTACTCTGCA

(SPAG9), mRNA/cds =

ACAGTCTAATGTTCTTCACTTCCA

(110, 2410)

1501
Table 3A
Hs.231510
BE407125
9343575
601301818F1 cDNA, 5′ end
1
GGGGTTTTCACCCTACCTAAAGATGC

/clone = IMAGE:3636412/

TTTAATTGCTGTTTTCCAAATTGT

clone_end = 5′

1502
Table 3A
Hs.315263
BE410105
9346555
601302278F1 cDNA, 5′ end
1
ATGCCTAACAAGCAACATGATCCTAT

/clone = IMAGE:3837002/

AAATCCACCCCAAGCCAATCTGGT

clone_end = 5′

1503
Table 3A
Hs.258494
BE531180
9759916

Homo sapiens, Similar to
1
CCACCATCTGGTACGTTTTTACTTCC

hypothetical protein FLJ22376,

TCACCCGCGTGTACTCCGATTACC

clone MGC:16044

IMAGE:3610443, mRNA,

complete cds/cds = (478, 1776)

1504
Table 3A
Hs.13328
BE537908
9766464
602268829F1 cDNA, 5′ end
1
GAGTATATTCCCCCAGTTATTTGCTC

/clone = IMAGE:4356968/

TTCCCCACACAGGGTGGTAGTACC

clone_end = 5′

1505
Table 3A
Hs.125819
BE538333
9766978
putative dimethyladenosine
1
CAAAGGAAGGGGCGTGAAGGGGTGA

transferase (HSA9761),

GAAAAATATGGGACCCAAATTGTGG

mRNA/cds = (78, 1019)

1506
Table 3A
Hs.5122
BE539096
9767741
602293015F1 cDNA, 5′ end
1
TTTCCTTACAGGCGGTAACACCGGTC

/clone = IMAGE:4387778/

CACACAGTTCTTGCCAAAACAAAG

clone_end = 5′

1507
Table 3A
Hs.180549
BE540238
9768883
601059809F1 cDNA, 5′ end
1
AATTTTCTCTCACCTCATCACTCGGG

/clone = IMAGE:3448283/

ACCTCCCCAGTGATAATAACCCGG

clone_end = 5′

1508
Table 3A
Hs.155101
BE547584
9776229
mRNA for KIAA1578 protein,
1
GCGGGTGTAAGGGGATATCTTGATAA

partial cds/cds = (0, 3608)

ACTGGAGCCCAGGAAGATTACAAA

1509
Table 3A
Hs.74861
BE549137
9777782
activated RNA polymerase II
1
ACGCCGACAATCAAGAAAATGTGAGT

transcription cofactor 4 (PC4),

TATAACGGACAAGGTTGTATTATG

mRNA/cds = (0, 383)

1510
Table 3A
NA
BE569141
9812861
cDNA clone IMAGE:3681180 5′
1
GATATTGGTAGTAAAGGGGTTACCTG

TGAACTTCCAAAATTCCTTGGGGC

1511
Table 3A
NA
BE612847
9894444
601452239F1 5′ end
1
TAAAGATGTCCGGGTACACTTCGCCA

/clone = IMAGE:3856304

AGGGTTAGCGTCTTTGGGCATTTC

1512
Table 3A
Hs.194362
BE618004
9888942
DNA sequence from clone RP11-
1
TCCTAATTTCTTCTGTGAACCTTCTCA

248N6 on chromosome 13

AATCCCCCAGCATGCGTGTAGTG

Contains ESTs, STSs and GSSs.

Contains two olfactory receptor

pseudogenes, an NPM1

(nucleophosmin, nucleolar

phosphoprotein B23, numatrin)

pseudogene and a BCR

(breakpoint cluster region)

pseudogene/cds = (0, 887)

1513
Table 3A
Hs.294309
BE821121
9892059
601493943F1 cDNA, 5′ end
1
CTGCATGATGTCATCAACCTGCTGTA

/clone = IMAGE:3896051/

GTGCGGAAACGACCACAACACACA

clone_end = 5′

1514
Table 3A
Hs.184582
BE730026
10144018
ribosomal protein L24 (RPL24),
1
AAAGACGAACGAGACACGAAAGCAA

mRNA/cds = (39, 512)

CGAACGAACACAGAGCACGCCGCAC

1515
Table 3A
Hs.76572
BE730376
10144368
ATP synthase, H+ transporting,
1
TTTCAACACGCATCCCTTATGGGCGA

mitochondrial F1 complex,

ACTGTCCTCAAACAACAACAAGTG

O subunit (oligomycin sensitivity

conferring protein) (ATP5O),

mRNA/cds = (38, 677)

1516
Table 3A
Hs.77496
BE737248
10151226
small nuclear ribonucleoprotein
1
TAGGACGAGAAACGAAGAAGGACAG

polypeptide G (SNRPG),

AGCGAGAACAAGTAAGCAGGGACAC

mRNA/cds = (83, 313)

1517
Table 3A
Hs.271272
BE737348
10151340
DKFZp434K1715_r1 cDNA,
1
GGTGGAGAATCAAAACGACCCCGCA

5′ end/clone =

AATAAACATGGCGATTTGGCTTGGG

DKFZp434K1715/

clone_end = 5′

1518
Table 3A
Hs.58066
BE739287
10153279
602389077F1 cDNA, 5′ end
1
TGGCCTTTTAAATAACTGGGCTTCTC

/clone = IMAGE:4517875/

ACAACCATAGTGAACAGAAACAGC

clone_end = 5′

1519
Table 3A
Hs.127951
BE745645
10159837
hypothetical protein FLJ14503
1
ATTGTGACATGGTGATGCCTCATTGC

(FLJ14503), mRNA/cds =

TGATATGGTCCTGTGGTTATGTGC

(19, 2217)

1520
Table 3A
Hs.276718
BE747210
10161202
601473284T1 cDNA, 3′ end
1
GGAAGAGATAACACCACAAC

/clone = IMAGE:3876165/

GAAAGAGCAGGCAAGAGAGACCAA

clone_end = 3′

AGCACA

1521
Table 3A
Hs.285647
BE747224
10161216
cDNA FLJ14704 fis, clone
1
GGTAAAAGGCGTTACTCTCCGCCCTC

NT2RP3000526/cds =

TTCAAGGAACGGCCAAGAGTATAA

UNKNOWN

1522
Table 3A
Hs.293842
BE748123
10162115
601571679F1 cDNA, 5′ end
1
ACCCAAGGGTCTCGCCAGTGGGGTT

/clone = IMAGE:3838875/

AAGTCACAATATTACTACACAAGGG

clone_end = 5′

1523
Table 3A
Hs.283874
BE778549
10199747
hypothetical protein MGC2495
1
ACAGTACACAATCACCTGCAAGGGAC

(MGC2495), mRNA/cds =

ATAGCACACAAACCGCTAAAGAGG

(0, 416)

1524
Table 3A
Hs.61472
BE779284
10200482
601464557F1 cDNA, 5′ end/
1
TCTCACAGCGAGAGGAGGAGACGGG

clone = IMAGE:3867566/clone_end =

ATGACCGAGAGGTAGACGATTATAC

5′

1525
Table 3A
Hs.43273
BE781009
10202207
602642428F1 cDNA, 5′ end/
1
CGCTGGTGTTGTCCCCAAGTGATTTA

clone = IMAGE:4773534/clone_end =

TTCTACTGGAGTGCCTGGTGTCTT

5′

1526
Table 3A
Hs.102558
BE781611
10202895
601467463F1 cDNA, 5′ end/
1
TTCCGGCTTTTAACAAACACACACCA

clone = IMAGE:3870902/clone_end =

CACTAACACAACAACACAAACAAA

5′

1527
Table 3A
Hs.40334
BE782824
10204022
602557448F1 cDNA, 5′ end/
1
AAGACTTGCCTCTTTAAAATTGCTTTG

clone = IMAGE:4686562/clone_end =

TTTTCTGCAGTACTATCTGTGGT

5′

1528
Table 3A
Hs.79914
BE783628
10204826
lumican (LUM), mRNA/cds = (84,
1
GAACTCGTCCACTCTTCTCGGGCCAC

1100)

TATTCTGGTTCAGGGAATCTTGGG

1529
Table 3A
Hs.135056
BE786820
10208018
DNA sequence from clone RP5-850E9
1
AGCAATAAACCGAAGCAGCTAGACAG

on chromosome 20. Contains part of

CGAAGAAGTACAGCAAAGAGACGA

the gene for a novel C2H2 type zinc

finger protein similar to Drosophila

Scratch (Scrt), Slug and Xenopus

Snail, a novel gene similar to

Drosophila CG6762, STSs, GSSs and

five CpG islands/cds = (0, 397)

1530
Table 3A
Hs.11355
BE788546
10209744
thymopoietin (TMPO), mRNA/
1
CGCCCATACTAGAGAAGTTTGCCCTC

cds = (204, 2288)

TATTGTCTCTCACACCACAATGAG

1531
Table 3A
Hs.75458
BE790474
10211672
ribosomal protein L18 (RPL18),
1
CACAGACATCCACGGACACAAAAGG

mRNA/cds = (15, 581)

CGGGGACCACCACCACAATGAACAC

1532
Table 3A
Hs.20225
BE792125
10213323
tuftelin-interacting protein (TIP39),
1
GCGTCGATTGATATCAGACAGCATCG

mRNA/cds = (263, 2776)

TCTCTGCGAGCACAAAGATCTGTT

1533
Table 3A
Hs.11607
BE794595
10215793
602429913F1 cDNA, 5′ end/
1
GGAACAGGGTTAATGGCCAGGCCCT

clone = IMAGE:4547787/clone_end =

TTGCCGCCCCTTTTAAAGGGAATCC

5′

1534
Table 3A
Hs.58297
BE867841
10316617
CLLL8 protein (CLLD8), mRNA/
1
ACAGAGTAACATGGGATATGGGTATG

cds = (825, 2984)

AGTGGGATGTGCTGAGAAGGAACT

1535
Table 3A
Hs.179703
BE868349
10317165
tripartite motif protein 13 (TRIM14),
1
GGGGGCAAAGAAAGTACATTGGGTG

mRNA/cds = (10, 1230)

AAAATTTAAAAAGGTATGGAGCATT

1536
Table 3A
NA
BE871962
10320738
601448005F1 cDNA, 5′ end/
1
CAAACGAACAGCGAAGACAA

clone = IMAGE:3852001

CAACTCACGATGCTGCACAACGCGA

CCAAC

1537
Table 3A
Hs.31314
BE872245
10321021
retinoblastoma-binding protein 7
1
ACATTTTATAAGGCATTTGTGTTAGCC

(RBBP7), mRNA/cds = (287, 1584)

ACTCAGTCATCTTTGGGTGCTGC

1538
Table 3A
Hs.47334
BE872760
10321536
hypothetical protein FLJ14495
1
GTCACAGCAACGTGTCGCTCCCCAG

(FLJ14495), mRNA/cds = (83, 1141)

ATCATTTATTAGCGTCGATTGTTGT

1539
Table 3A
Hs.8820
BE875609
10324385
602418418F1 cDNA, 5′ end/
1
ATTCCAAACGGGATCTGCTGAGACCT

clone = IMAGE:4525397/clone_end =

CACAGAGGTGGGCCGCGATTATAA

5′

1540
Table 3A
Hs.158164
BE876375
10325061
transporter 1, ATP-binding cassette,
1
CCTAGGGTGAAACACGTGACAGAAG

sub-family B (MDR/TAP) (TAP1),

AATAAAGACTATTGAATAGTCCTCT

mRNA/cds = (30, 2456)

1541
Table 3A
Hs.237868
BE877115
10325891
interleukin 7 receptor (IL7R), mRNA/
1
CCAGCCTTTGCCTCTTCCTTCAATGT

cds = (22, 1401)

GGTTTCCATGGGAATTTGCTTCAG

1542
Table 3A
Hs.24181
BE877357
10326133
601485590F1 cDNA, 5′ end/
1
CCCCTTGTTTACTCTGTCTGTATGTAT

clone = IMAGE:3887951/clone_end =

GTCAAAAGCGTGGCAAAACCTCT

5′

1543
Table 3A
Hs.237868
BE878973
10327749
interleukin 7 receptor (IL7R), mRNA/
1
CATGATCTCAGAGGAAACTGTCGCTG

cds = (22, 1401)

ACCCTGGACATGGGTACGTTTGAC

1544
Table 3A
NA
BE879482
13959823
mitochondrion, complete genome
1
CCTCTACCTGCACGACAATACATAAT

GACCCACCAATCACATGCCTATCA

1545
Table 3A
NA
BE881113
10329889
cDNA clone IMAGE:3894308 5′
1
ATTTGGAAGCGCCACCCTAGCAAATA

TACAAACCATTAAACCTTCCCTCT

1546
Table 3A
Hs.323950
BE881351
10330127
zinc finger protein 6 (CMPX1) (ZNF6),
1
TTTACCAATGATTTTCAGGTGACCTG

mRNA/cds = (1265, 3361)

GGCTAAGTCATTTAAACTGGGTCT

1547
Table 3A
Hs.111554
BE882335
10331111
ADP-ribosylation factor-like 7 (ARL7),
1
AGTTTACATCGACAGCATATCCAC

mRNA/cds = (14, 592)

TGATTTCTAAATGGGCTGGTCCCA

1548
Table 3A
NA
BE884898
10333674
cDNA clone IMAGE:3908551 5′
1
ATCTGGAGTGGGACCCTTCAAACCAT

GTCTGTGCTTATGCGGGAAACAAT

1549
Table 3A
Hs.142838
BE886127
10340315
nucleolar protein interacting with the
1
GCGGAGAGAAGAAGAGGTAGATATG

FHA domain of pKi-67 (NIFK),

AGAACAGTGTGTGGTATATGATAGT

mRNA/cds = (54, 935)

1550
Table 3A
Hs.301488
BE886472
10340792
601509888F1 cDNA, 5′ end/
1
GAAATCCCACCGGCAAGTTAAGGTCA

clone = IMAGE:3911301/clone_end =

CGGAGCAAGTGAATAAACGCGGAG

5′

1551
Table 3A
Hs.250824
BE887646
10343176
cDNA: FLJ23435 fis, clone HRC12631/
1
GTGATCAAACAAATTCACAGCACAGA

cds = UNKNOWN

CACCGCGCAACAACGCAACTTCTC

1552
Table 3A
Hs.320836
BE888304
10344472
60154033F1 cDNA, 5′ end/
1
GGTATTTGTGTTGTTGAGTATTGTGT

clone = IMAGE:3915177/clone_end =

CTGGGTGTGGGTATTTGATTCTTT

5′

1553
Table 3A
Hs.169274
BE888744
10345354
AL528777 cDNA/
1
GGGTTCGTCCAGGGCTGCGCTAAAT

clone = CS0DD001YG24-(3-prime)

TATTCTCAATGATTTGTCTCTTTGC

1554
Table 3A
Hs.71941
BE889075
10346019
hypothetical protein MGC15677
1
CAATGACGCAGTCGGACCCTCGGAT

(MGC15677), mRNA/cds = (298, 807)

CCAAGTCCTGCTTTGGGTGTGGACC

1555
Table 3A
Hs.188757
BE891242
10350376

Homo sapiens, clone MGC:5564,
1
GGGTTATAATAGATGGACGGGTCTTT

mRNA, complete cds/cds = (227, 304)

CACGGTGGTGACAGCACCCTTTCC

1556
Table 3A
Hs.171802
BE891269
10350433
RST31551 cDNA
1
TCCGCTGCAATTTGAGTTTAGCTTTA

CAGATTGTGCCGGGTGTTTAACCT

1557
Table 3A
Hs.4055
BE891928
10351744
mRNA, cDNA DKFZp564C2063 (from
1
CTCCTTCCCAAAGACTTGAGTGGAAC

clone DKFZp564C2063)/

TTCCCTTTCATGTGCGTATCGGTC

cds = UNKNOWN

1558
Table 3A
Hs.3297
BE895166
10358288
ribosomal protein S27a (RPS27A),
1
AAATTAGTCGCCTTCGTCGAGAGTGC

mRNA/cds = (38, 508)

CCTTCTGATGAATGTGGTGCTGGG

1559
Table 3A
NA
BE896691
10361375
cDNA clone IMAGE:3925062 5′
1
GACAGTACTCCTAAGACCCCTGTGTG

TGTCCCGATGAGATCATGACTGGG

1560
Table 3A
NA
NC_001807
13959823
COX2 gene of mitochondria
1
CATGCCCATCGTCCTAGAATTAATTC

CCCTAAAAATCTTTGAAATAGGGC

1561
Table 3A
NA
BE899595
10367264
cDNA clone IMAGE:3952215 5′
1
GGCGTATCATCAACTGGTGAGCCCG

AAGGGATATTATTTCTAAGGCCTCT

1562
Table 3A
Hs.285122
BE901218
10390179

Homo sapiens, hypothetical protein
1
CCAGAATCGTAAGGGGGCTGACGGA

FLJ21839, clone MGC:2851

GGATGAGAGGGGGCACCCAGAGATC

IMAGE:2967512, mRNA, complete

cds/cds = (444, 2618)

1563
Table 3A
Hs.293515
BE905040
10397924
602286727T1 cDNA, 3′ end/
1
CGGTGTTTTCTGATCGGTTTTTGTTTT

clone = IMAGE:4375662/clone_end =

CTGCTTACATATGATGTACTTGT

3′

1564
Table 3A
Hs.278704
BE973840
10567176
RST30930 cDNA
1
ACAGAATGCAGCGGTGCAACACCGG

CAAGGTTCCACACGCCACAAAGAAA

1565
Table 3A
Hs.217493
D00017
219909
annexin A2 (ANXA2), mRNA/
1
TGGAAGTGAAGTCTATGATGTGAAAC

cds = (49, 1068)

ACTTTGCCTCCTGTGTACTGTGTC

1566
Table 3A
Hs.25
D00022
219653

Homo sapiens, Similar to ATP
1
CCAAAAAGCTTCATTTTTCTATATAGG

synthase, H+ transporting,

CTGCACAAGAGCCTTGATTGAAG

mitochondrial F1 complex, beta

polypeptide, clone MGC:19754

IMAGE:3629237, mRNA, complete

cds/cds = (12, 1601)

1567
Table 3A
Hs.76549
D00099
219941
mRNA for Na, K-ATPase alpha-
1
TCACAAGACAGTCATCAGAACCAGTA

subunit, complete cds/cds = (318, 3389)

AATATCCGTCTGCCAGTTCGATCA

1568
Table 3A
Hs.76549
D00099
219941
mRNA for Na, K-ATPase alpha-
1
TCACAAGACAGTCATCAGAACCAGTA

subunit, complete cds/cds = (318, 3389)

AATATCCGTCTGCCAGTTCGATCA

1569
Table 3A
Hs.154890
D10040
219899
fatty-acid-Coenzyme A ligase, long-
1
GCTGTCATTTGTACATTTAAAGCAGC

chain 2 (FACL2), mRNA/

TGTTTTGGGGTCTGTGAGAGTACA

cds = (13, 2109)

1570
Table 3A
Hs.46
D10202
219975
platelet-activating factor receptor
1
TATCCTGAGTCCCTTAATCTTATGGG

(PTAFR), mRNA/cds = (25, 1053)

GCCGGAAGGAATGTCAGGGCCAGG

1571
Table 3A
Hs.155342
D10495
520586
protein kinase C, delta (PRKCD),
1
CTCTGCCTTCGGAGGGAAATTGTAAA

mRNA/cds = (58, 2088)

TCCTGTGTTTCATTACTTGAATGT

1572
Table 3A
Hs.330716
D10522
219893
cDNA FLJ14368 fis, clone
1
AAACTCCTGCTTAAGGTGTTCTAATTT

HEMBA 1001122/cds = UNKNOWN

TCTGTGAGCACACTAAAAGCGAA

1573
Table 3A
Hs.137555
D10923
219866
putative chemokine receptor, GTP-
1
GGGTGCACGTTCCTCCTGGTTCCTTC

binding protein (HM74), mRNA/

GCTTGTGTTTCTGTACTTACCAAA

cds = (60, 1223)

1574
Table 3A
Hs.301921
D10925
219882
chemokine (C—C motif) receptor 1
1
GGGGTTGGGAGGAAGTGTCTACTAG

(CCR1), mRNA/cds = (52, 1129)

GAGGGTGGGTGAGATCTGTGTTGAT

1575
Table 3A
Hs.238893
D11086
303611
od15g01.s1 cDNA/
1
ATCTACCCTCCGATTGTTCCTGAACC

clone = IMAGE:1368048

GATGAGAAATAAAGTTTCTGTTGA

1576
Table 3A
Hs.61153
D11094
219930
proteasome (prosome, macropain)
1
AAGTCTTATGCCAAATTCAGTGCTAC

26S subunit, ATPase, 2 (PSMC2),

TCCTCGTTACATGACATACAACTG

mRNA/cds = (66, 1387)

1577
Table 3A
Hs.38
D12614
219911
lymphotoxin alpha (TNF superfamily,
1
CACACGGAGGCATCTGCACCCTCGA

member 1) (LTA), mRNA/

TGAAGCCCAATAAACCTCTTTTCTC

cds = (140, 757)

1578
Table 3A
Hs.333114
D13316
286022
AV713318 cDNA, 5′ end/
1
ACAACGTCGTGACTGGGAAAACCCT

clone = DCAAAC09/clone_end = 5′

GGCGTTACCCAACTTAATCGCCTTG

1579
Table 3A
Hs.15071
D13627
286010
chaperonin containing TCP1, subunit 8
1
CCAAGCCTCCAAGTGGGAAGAAAGA

(theta) (CCT8), mRNA/cds = (28,

CTGGGATGATGACCAAAATGATTGA

1674)

1580
Table 3A
Hs.195614
D13842
285998
splicing factor 3b, subunit 3, 130 kD
1
CAACTACTTGTGGCATGCATTGGCAC

(SF3B3), mRNA/cds = (156, 3809)

TCGGAATAAAGCGCACTATTGTCA

1581
Table 3A
Hs.2471
D13645
286008
KIAA0020 gene product (KIAA0020),
1
GAAGGGGTAGGGTCCACCATACTGG

mRNA/cds = (418, 1944)

TAATTGGGGTACTCTGTATATGTGT

1582
Table 3A
Hs.278573
D14041
2326266
H-2K binding factor-2 (LOC51580),
1
GCTCAGTTCCATATTTCATCCGTGAA

mRNA/cds = (238, 1500)

AAACTTGCAATACGAGCAGTTTCA

1583
Table 3A
Hs.43910
D14043
219924
CD164 antigen, sialomucin (CD164),
1
AATTGTCATTTACCTGGGTATGAATTC

mRNA/cds = (79, 648)

CCTGACACACATTCATGTCAACA

1584
Table 3A
Hs.111894
D14696
285962
lysosomal-associated protein
1
GTGACTTGACTGTGGAAGATGATGGT

transmembrane 4 alpha (LAPTM4A),

TGCATGTTTCTAGTTTGTATATGT

mRNA/cds = (148, 849)

1585
Table 3A
Hs.232068
D15050
457560
transcription factor 8 (represses
1
CAGTGCTGTAATACAGACGGCAATGC

interleukin 2 expression) (TCF8),

AATAGCCTATTTAAAGAACTACGT

cds = (66, 1358)

1586
Table 3A
Hs.279607
D16217
303598
calpastatin (CAST), mRNA/
1
AGCTGGTGGATGGTGACTTTTGAAGA

cds = (66, 1358)

ACAAAAGGCTTTGGCAACAGAAAA

1587
Table 3A
Hs.146812
D16481
473711
hydroxyacyl-Coenzyme A
1
TCTGTTGTCACTAAAGACTAAATGAG

dehydrogenase/3-ketoacyl-Coenzyme

GGTTTGCAGTTGGGAAAGAGGTCA

A thiolase/enoyl-Coenzyme A

hydratase (trifunctional protein), beta

subunit (HADHB), mRNA/

cds = (46, 1470)

1588
Table 3A
Hs.50651
D17042
598768
Janus kinase 1 (a protein tyrosine
1
GCGGAGTTGACCAAAATAATATCTGA

kinase) (JAK1), mRNA/cds = (75,

GGATGATTGCTTTTCCCTGCTGCC

3503)

1589
Table 3A
Hs.180828
D17391
440365
collagen, type IV, alpha 4 (COL4A4),
1
CATCTTGAACTTGGCCTGAGAACATT

mRNA/cds = (208, 5280)

TTCTGGGAAGAGGTAAGGGTGACA

1590
Table 3A
Hs.176658
D21090
498147
RAD23 (S. cerevisiae) homolog B
1
TCTGTGGAATCTCCTTCATTGGCATT

(RAD23B), mRNA/cds = (313, 1542)

GTTATTTAATCATAAACGGGGCAG

1591
Table 3A
Hs.75337
D21262
434764
mRNA for KIAA0035 gene, partial cds/
1
TGTACTGTTCATGCTGACACAGATAT

cds = (0, 2125)

TTCAGTCTGCATGGTAAAAGTTCT

1592
Table 3A
Hs.79768
D21853
434770
KIAA0111 gene product (KIAA0111),
1
TAATGGGGTTTATATGGACTTTCTTCT

mRNA/cds = (214, 1449)

CATAAATGGCCTGCCGTCTCCCT

1593
Table 3A
Hs.334822
D23660
432358

Homo sapiens, Similar to ribosomal
1
ACCAAGAAACCAGCCCCTGAAAA

protein L4, clone MGC:2966

GAAGCCTGCAGAGAAGAAACCTA

IMAGE:3139805, mRNA, complete

CTAC

cds/cds = (1816, 2617)

1594
Table 3A
Hs.75512
D23662
432362
neural precursor cell expressed,
1
AGTCCTGTGTGCTTCCCTCTCTTATG

developmentally down-regulated 8

ACTGTGTCCCTGGTTGTCAATAAA

(NEDD8), mRNA/cds = (99, 344)

1595
Table 3A
Hs.35804
D25215
517114
hect domain and RLD 3 (HERC3),
1
ACCCACCACCTCTTGCACTCTCGCTT

mRNA/cds = (166, 3318)

TTGGAGCAAGTTGCATTAACTATT

1596
Table 3A
Hs.173737
D25274
464185
ras-related C3 botulinum toxin
1
TGACAGTTGCAGAATTGTGGAGTGTT

substrate 1 (rho family, small GTP

TTTACATTGATCTTTTGCTAATGC

binding protein Rac1) (RAC1),

transcript variant Rac1b, mRNA/

cds = (0, 635)

1597
Table 3A
Hs.172199
D25538
436217
adenylate cyclase 7 (ADCY7), mRNA/
1
ATGACAGACACACGTATCTAACAAAC

cds = (265, 3507)

AAACAAACAGTGACCTTCTCCATG

1598
Table 3A
Hs.82502
D26018
436221
mRNA for KIAA0039 gene, partial cds/
1
GCAAGGGATAATACAAATCCTATGAT

cds = (0, 1475)

CTCTATGCCCAATATGCTGCCTCA

1599
Table 3A
Hs.169303
D26121
785998
mRNA for ZFM1 protein alternatively
1
AGTACTTTTCACAGCGTGGCCTTTCA

spliced product, complete cds/

CCATAATTTTATATTTCTCCCCCT

cds = (382, 624)

1600
Table 3A
Hs.90315
D26488
452522
mRNA for KIAA0007 gene, partical
1
TCTTAAGAGCCAGAGCCATATAAGCA

cds/cds = (0, 2062)

TCTTGGGAAAGCAAGTTTGAACCA

1601
Table 3A
Hs.17719
D28589
460714
EBP50-PDZ interactor of 64 kD
1
AAGCCGGTCATGAGATTATATGTGGT

(EPI64), mRNA/cds = (24, 1550)

AAAGTTAATTGACTAACAACCCCA

1602
Table 3A
Hs.196246
D29605
474986
UDP-Gat.betaGlcNAc beta 1,4-
1
AGGGGGCTGTGTCTGATCTTGGTGTT

galactosyltransferase, polypeptide 1

CAAAACAGAACTGTATTTTTGCCT

(B4GALT1), mRNA/cds = (72, 1268)

1603
Table 3A
Hs.79709
D30036
1060902
phosphotidylinositol transfer protein
1
GTTCATAGCTTCCTGCAACTTGACAG

(PITPN), mRNA/cds = (216, 1028)

AGCCTGAGTTTGCCTCTTAGTGGG

1604
Table 3A
Hs.115263
D30783
2381480
epiregulin (EREG), mRNA/
1
CATATGGGAGAAGGGGGAGTAATGA

cds = (166, 675)

CTTGTACAAACAGTATTTCTGGTGT

1605
Table 3A
Hs.75416
D31767
505091
DAZ associated protein 2 (DAZAP2),
1
ACATGTGATGTTTGACTGTACCATTG

mRNA/cds = (69, 575)

ACTGTTATGGAAGTTCAGCGTTGT

1606
Table 3A
Hs.3094
D31884
505095
KIAA0063 gene product (KIAA0063),
1
TCTTGCTTTTATTCCTTTTTGTTGTTG

mRNA/cds = (279, 867)

GCCTTGTGCTGCGTTTGTTTACA

1607
Table 3A
Hs.75249
D31885
505097
mRNA for KIAA0069 gene, partial cds/
1
AGTGTTGTTTTCTCCTCTTTAATATTG

cds = (0, 680)

CTGTGAACAGTGGTGCCCATTGT

1608
Table 3A
Hs.3100
D32053
2366751
lysyl-tRNA synthetase (KARS),
1
AATTCTTGTGTGCTGCTTTCCATTTGA

mRNA/cds = (40, 1833)

CACCGCAGTTCTGTTCAGCCATC

1609
Table 3A
Hs.181244
D32129
699597
major histocompatibility complex, class
1
GAGGTGTCTCCATCTCTGCCTCAACT

I, A (HLA-A), mRNA/cds = (0, 1097)

TCATGGTGCACTGAGCTGTAACTT

1610
Table 3A
Hs.89887
D38081
533325
thromboxane A2 receptor (TBXA2R),
1
TGAACCTCCAACAGGGAAGGCTCTGT

mRNA/cds = (991, 2022)

CCAGAAAGGATTGAATGTGAAACG

1611
Table 3A
Hs.138593
D38524
633070
5′-nucleotidase (purine), cytosolic type
1
TATTTTCTTCCATTCTTGTCATTGGTC

B (NT5B), mRNA/cds = (83, 1768)

AATAGGGGAGGGTAGATTAGCTG

1612
Table 3A
Hs.77257
D38549
559702

Homo sapiens. Similar to selective
1
TCCCCTGCTTCCACTAAATCCAGTTG

hybridizing clone, clone MGC:13167

TGACAAAATCTAACGTGACATCAG

IMAGE:3163591, mRNA, complete

cds/cds = (52, 3813)

1613
Table 3A
Hs.81848
D38551
1531549
RAD21 (S. pombe) homolog (RAD21),
1
ACCTGGTCAACTTAGCTTTTAAGCAG

mRNA/cds = (184, 2079)

ACGATGCTGTAAAAACTAACGGCT

1614
Table 3A
Hs.81964
D38555
559716
SEC24 (S. cerevisiae) related gene
1
ACCTGGGATGCCCCTGCTCTGGACC

family, member C (SEC24C), mRNA/

TCTCATTTCTCTTCATTGGTTTATT

cds = (114, 3491)

1615
Table 3A
Hs.78871
D42039
577290
mRNA for KIAA0081 gene, partial cds/
1
ATCTATCCTTGCCAGCCTTGGGCATC

cds = (0, 702)

ACATTTACCAGTTTAATAGATTGT

1616
Table 3A
Hs.75243
D42040
577292
bromodomain-containing 2 (BRD2),
1
GCCCTGATCTGGAGTTACCTGAGGC

mRNA/cds = (1701, 4106)

CATAGCTGCCCTATTCACTTCTAAG

1617
Table 3A
Hs.79123
D42043
577298
mRNA for KIAA0084 gene, partial cds/
1
CTTGACCAAACCCACAGCCTGTCTCT

cds = (0, 1946)

TCTCTTGTTTAGTTACTTACGGCA

1618
literature
Hs.1560
D42045
577302
mRNA for KIAA0086 gene, complete
1
CCTTAGAAGAGGAAGCAAAGGCAGA

cds/cds = (918, 4040)

TTCAGGGACCAAAAGGATTAATGAT

1619
Table 3A
Hs.151791
D42054
577310
KIAA0092 gene product (KIAA0092),
1
ATGTGTCAACCACCATTTCAGCTATT

mRNA/cds = (53, 1477)

AAAAACTCCTGTTATCTCCTTGTT

1620
Table 3A
Hs.129914
D43968
966996
AML1 mRNA for AML1b protein
1
AGCCACCAGAGCCTTCCTCTCTTTGT

(alternatively spliced product),

ACCACAGTTTCTTCTGTAAATCCA

complete cds/cds = (1576, 2939)

1621
Table 3A
Hs.163706
D44640
1572115
HUMSUPY040 cDNA/clone =
1
ACATGAAATATAGTTGCATATATGGA

035-00-1

CACCGACTTGGGAGGACAGGTCCT

1622
Table 3A
Hs.1119
D49728
1813881
nuclear receptor subfamily 4, group A,
1
CTTTCCAGCCTCCTGCTGGGCTCTCT

member 1 (NR4A1), mRNA/

CTTCCTACCCTCCTTCCACATGTA

cds = (110, 1906)

1623
Table 3A
Hs.83077
D49950
1405316
Interleukin 1B (interferon-gamma-
1
AGATAGCCAGCCTAGAGGTATGGCT

inducing factor) (IL18), mRNA/

GTAACTATCTCTGTGAAGTGTGAGA

cds = (177, 758)

1624
Table 3A
Hs.155543
D50063
971269
proteasome (prosome, macropain)
1
TGGCATCCTCAGGGGTTGTGATCCA

26S subunit, non-ATPase, 7 (Mov34

GCTCCATATATTGTTTACCTTCAAA

homolog) (PSMD7), mRNA/

cds = (83, 1057)

1625
Table 3A
Hs.182255
D50420
2618577
non-histone chromosome protein 2 (S.
1
CATGAGGAGAGTGCTAGTTCATGTGT

cerevisiae)-like 1 (NHP2L1), mRNA/

TCTCCATTCTTGTGAGCATCCTAA

cds = (94, 480)

1626
Table 3A
Hs.699
D50525
1167502
peptidylprolyl isomerase B (cyclophilin
1
CAGCAAATCCATCTGAACTGTGGAGG

B) (PPIB), mRNA/cds = 21, 671)

AGAAGCTCTCTTTACTGAGGGTGC

1627
Table 3A
Hs.82028
D50683
1827474
mRNA for TGF-betaIIR alpha,
1
TCAGCATAAACTGGAATGTAGTGTCA

complete cds/cds = (1572, 3275)

GAGGATACTGTGGCTTGTTTTGTT,

1628
Table 3A
Hs.90998
D50918
1469178
mRNA for KIAA0128 gene, partial cds/
1
TGGTGAAACAAAACCAGTCATTAGAA

cds = (0, 1276)

ATGGTCTGTGCTTTTATTTTCCCA

1629
Table 3A
Hs.70359
D50926
1469194
genomic DNA, chromosome 21q22.2,
1
ACTATGCTTTATTGGTCCCATGTTTTG

PCR fragment from BAC

TGCAATTTTAAAGAGATGGCTTT

clone:KB739C11, CBR1-HLCS region/

cds = (0, 2854)

1630
Table 3A
Hs.198899
D50929
1469200
eukaryotic translation initiation factor 3,
1
AAAGATGAACTATTTGGTCTCATTGA

subunit 10 (theta, 150/170 kD)

AGCCAACACAGAACTTGCTGCTGT

(EIF3S10), mRNA/cds = (113, 4261)

1631
Table 3A
Hs.77152
D55716
1255616
minichromosome maintenance
1
GGAGCCCCTCTTTCTCCCATGCTGCA

deficient (S. cerevisiae) 7 (MCM7),

CTTACTCCTTTTGCTAATAAAAGT

mRNA/cds = (544, 2175)

1632
Table 3A
Hs.181418
D63486
1469885
KIAA0152 gene product (KIAA0152),
1
CCTTCCATGTCCCACCCCACTCCCAC

mRNA/cds = (128, 1006)

CAAAAAGTACAAAATCAGGATGTT

1633
Table 3A
Hs.3195
D63789
1754608
small inducible cytokine subfamily C,
1
TGATGGTAACCATAATGGAAGAGATT

member 1 (lymphotactin) (SCYC1),

CTGGCTAGTGTCTATCAGAGGTGA

mRNA/cds = (20, 364)

1634
Table 3A
Hs.274472
D63874
968887
high-mobility group (nonhistone
1
GTCCTGGTGGTATCTTCAATAGCCAC

chromosomal) protein 1 (HMG1),

TAACCCTGCCTGGTACAGTATGGG

mRNA/cds = (52, 699)

1635
Table 3A
Hs.87726
D63876
961443
ADP-ribosylation factor-binding protein
1
CCCAGCTCTGCTGCCCTTGTTTTGCT

GGA3 (GGA3), mRNA/cds = (8, 2080)

GCATGTTAAATAAAACCATTTTCA

1636
Table 3A
Hs.155595
D63878
961447
neural precursor cell expressed,
1
CCCACACTGCTACACTTCTGATCCCC

developmentally down-regulated 5

TTTGGTTTTACTACCCAAATCTAA

(NEDD5), mRNA/cds = (258, 1343)

1637
Table 3A
Hs.182741
D64015
2281005
TIA1 cytotoxic granule-associated
1
CTGTAATACCTCCTCCTAACCAAGCC

RNA-binding protein-like 1 (TIAL1),

GGATATGGTATGGCAAGTTACCAA

transcript variant 2, mRNA/

cds = (157, 954)

1638
Table 3A
Hs.75232
D67029
1669538
SEC14 (S. cerevisiae)-like 1
1
CCCTTGTAAGGGAATTCTGGGGCAG

(SEC14L1), mRNA/cds = (303, 2450)

CTATGGTTTGAGTATGCAGTTTGCA

1639
Table 3A
Hs.155968
D76444
1945614
zinc finger protein homologous to
1
ACCATCTCTGTCCAGCACCTCTTGGT

Zfp103 in mouse (ZFP103), mRNA/

TAAATAATGTATGCTGTGAGACAT

cds = (922, 2979)

1640
Table 3A
Hs.80905
D79990
1136395
Ras association (RalGDS/AF-6)
1
ACAGGGCCTCAGCAAGGGAGCCATA

domain family 2 (RASSF2), mRNA/

CATTTTTGTAACATTTTGATATGTT

cds = (196, 1176)

1641
Table 3A
Hs.76666
D80005
1136425
mRNA for KIAA0183 gene, partial cds/
1
TTGACTGTCGATGGATTGTGGTGTGG

cds = (0, 3190)

TGTATCTGAAGGCTATTGAATGCA

1642
Table 3A
Hs.322903
D80006
1136427
mRNA for KIAA0184 gene, partial cds/
1
TTCTGTTCCAAACAAGTATTCTGTAGA

cds = (0, 2591)

TCCAAATGGATTACCAGTGTGCT

1643
Table 3A
Hs.79389
D83018
1827484
nel (chicken)-like 2 (NELL2), mRNA/
1
ATCTTCAGAATCAGTTAGGTTCCTCA

cds = (96, 2546)

CTGCAAGAAATAAAATGTCAGGCA

1644
Table 3A
Hs.89385
D83243
1304113
nuclear protein, ataxia-telangiectasia
1
TGAACCTTACTGCAAAAACTTGTGAT

locus (NPAT), mRNA/cds = (34, 4317)

GTAAGAAATTTGTATGGTGTGGCA

1645
Table 3A
Hs.12413
D83776
1228034
mRNA for KIAA0191 gene, particl cds/
1
GCTGTCTCAAGGGTATCCGTACCTCA

cds = (0, 4552)

ATGTCAGTTACATTCAGCAGAAAA

1646
Table 3A
Hs.22559
D83781
1228044
mRNA for KIAA0197 gene, partial cds/
1
TTGGTCAGATTTAGAAGCATTCATGC

cds = (0, 3945)

TCACAAGTTTTGGGAAAGTGAAAA

1647
Table 3A
Hs.343517
D84224
7804467
methionine-tRNA synthetase (MARS),
1
CCCTAAAGGCAAGAAGAAAAAGTAAA

mRNA/cds = (23, 2725)

AGACCTTGGCTCATAGAAAGTCAC

1648
Table 3A
Hs.21899
D84454
1526437
protein translocase, JM26 protein,
1
GTGTGTGCATGGAAGATGCCTGGGC

UDP-galactose translocator, pim-2

TGTCTTTGCTATATGTAAATAGAGC

protononcogene homolog pim-2h, and

shal-type potassium channel genes,

complete cds; JM12 protein and

transcription factor IGHM enhancer 3

genes, partial cds; and unknown gene/

cds = (323, 1504)

1649
Table 3A
Hs.300391
D85429
1816451
Ul-H-Bl4-aoq-d-01-0-Ul.s1 cDNA, 3′
1
GCCTTGGCTTTATTTGCAGGCTACTA

end/clone = IMAGE:3085848/

AAGCTGCTTTTACTTTGTAACTTT

clone_end = 3′

1650
Table 3A
Hs.75842
D86550
1772437
mRNA for serine/threonine protein
1
ACAGTTTGGTTACAGGACTTCTGTGC

kinase, complete cds/cds = (1473, 3737)

ATTGTAAACATAAACAGCATGGAA

1651
Table 3A
Hs.36927
D86956
1503985
heat shock 105 kD (HSP105B), mRNA/
1
TGTGAAAGTGTGGAATGGAAGAAATG

cds = (313, 2757)

TCGATCCTGTTGTAACTGATTGTG

1652
Table 3A
Hs.17211
D86964
1504001
mRNA for KIAA0209 gene, partial cds/
1
ACAACCAACCAGTTTCTTTTCTAGCC

cds = (0, 5530)

AATCATCTCTGAAGAGTTGCTGTT

1653
Table 3A
Hs.154332
D86967
1504007
KIAA0212 gene product (KIAA0212),
1
GAACTCCCTGATTCTATACCCTCTTC

mRNA/cds = (58, 2031)

CTTCTTTCTGCAAGGCAGAGGAAT

1654
Table 3A
Hs.110613
D86974
1504021
Pl-3-kinase-related kinase SMG-1
1
CACCCTCAGCTCCACCCTCAGCAGAT

(SMG1), mRNA/cds = (132, 9227)

GATAATATCAAGACACCTGCCGAG

1655
Table 3A
Hs.199243
D86984
1504041
mRNA for KIAA0231 gene, partial cds/
1
TTGGCCCTCAGGTTTACTGTGTAAAT

cds = (0, 1430)

CTGCATTTTTGGTGGTAAATCCCT

1656
Table 3A
Hs.79276
D86985
6634002
mRNA for KIAA0232 protein, partial
1
GCATTTCCATAGCACTGAAGTACCAG

cds/cds = (0, 3836)

TTTCCATTCCTGGGCTGAGATTGT

1657
Table 3A
Hs.10315
D87432
1565758
solute carrier family 8 (cationic amino
1
CTCCTTTTAAFCGTGTTATTGACA

acid transporter, y+ system), member 6

AACCTCCCCAAAAGAATATGCAA

(SLC7A6), mRNA/cds = (261, 1808)

TTGT

1658
Table 3A
Hs.75912
D87446
1665780
mRNA for KIAA0257 gene, partial cds/
1
AACATTCAGTTGAGACCATATGCATT

cds = (0, 5418)

TTCTGTGCTGTTTGTACTTGAGGT

1659
Table 3A
Hs.154978
D87450
1665788
mRNA for KIAA0261 gene, partial cds/
1
TTAACCCTCAGAGAACTCTGCATTTT

cds = (0, 3865)

AGGGTACTTGAGGCTGACTTAACT

1660
Table 3A
Hs.192968
D87454
1665796
mRNA for KIAA0265 gene, partial cds/
1
AGCGACCTCTTCTCTAGTCCGGTGTT

cds = (0, 1205)

ACGAACAGAAGTTCTGAGTTGTGC

1661
Table 3A
Hs.40888
D87468
1944419
mRNA for KIAA0278 gene, partial cds/
1
TAAATGTCGGTCCAGGCCCTGTGCAC

cds = (0, 1383)

CTTACCCCAGAGACAGACTCTTTT

1662
Table 3A
Hs.77495
D87684
1663703
mRNA for KIAA0242 protein, partial
1
ATAAGGCTGTAAAATGAGAATTCTGC

cds/cds = (0, 1590)

CCCCTCACCTCTTACCCCAGTACT

1663
Table 3A
Hs.75789
D87953
1596166
N-myc downstream regulated
1
AAAAGTCGGGGATCGGGGCAAGAGA

(NDRG1), mRNA/cds = (110, 1294)

GGCTGAGTACGGATGGGAAACTATT

1664
Table 3A
Hs.75367
D89077
1694681
Src-like-adapter (SLA), mRNA/
1
GAGCACCCAGAGGGATTTTTCAGTG

cds = (41, 871)

GGAAGCATTACACTTTGCTAAATCA

1665
Table 3A
Hs.170311
D89678
3218539
heterogeneous nuclear
1
TGATTAGGTGACGAGTTGACATTGAG

ribonucleoprotein D-like (HNRPDL),

ATTGTCCTTTTCCCCTGATCAAAA

transcript variant 1, mRNA/

cds = (580, 1842)

1666
Table 3A
Hs.121102
D89974
5541649
vanin 2 (VNN2), mRNA/
1
TGTATGTATGGGAGTGAGGAGTTTCA

cds = (11, 1573)

GGGCCATTGCAAACATAGCTGTGC

1667
Table 3A
Hs.73817
D90144
219905
gene for LD78 alpha precursor,
1
ACAGAGTTATCCACTTTACAACGGAG

complete cds

ACACAGTTCTGGAACATTGAAACT

1668
Table 3A
Hs.218387
H03298
866231
tc88c11.x1 cDNA, 3′ end/
1
ATACGGGACAATAAAATCTGCCTTTT

clone = IMAGE:2073236/clone_end =

GCTCTGGAGGGAGATACTACCTCT

3′

1669
Table 3A
Hs.70258
H06786
870318
yl83g05.r1 cDNA, 5′ end/
1
GGGCAAACAACTTTAGGAATACTAGT

clone = IMAGE:44737/clone_end = 5′

TACTCACTTAACATGGAGGGCGGG

1670
Table 3A
Hs.32149
H14103
878951
ym62a02.r1 cDNA, 5′ end/
1
AAAGGCCGCGCAGATTGTTTAATTCT

clone = IMAGE:163466/clone_end = 5′

GGAAAGTCAATCCCCGGATTTAGC

1671
Table 3A
Hs.94881
H51796
991637
602387588F1 cDNA, 5′ end
1
GGGACTCCATGGGAATATTTGCCCAG

clone = IMAGE:4516388/clone_end =

TAATGGTAAGGAAATCTTTCGGGT

5′

1672
Table 3A
Hs.178703
H56344
1004988
AV716627 cDNA, 5′ end/
1
CCAGAAAGGTGATGAATGAATAGGAC

clone = DCBBCH05/clone_end = 5′

TGAGAGTCACAGTGAATGTGGCAT

1673
Table 3A
Hs.270192
H57221
1010053
ESTs
1
TCCCAAGGTTGTTAGTGACTGATAAG

CTTCCAAACTACAGTACAGTTTTT

1674
Table 3A
Hs.237146
H88841
1068420
mRNA for zinc finger protein RINZF
1
GTTTTCTTGTAGTTGCGGGTCCCTCG

(RINZF gene)/cds = (598, 3141)

CGAAAGTTCATTCATGGCCCCACT

1675
Table 3A
Hs.76807
J00194
188231
major histocompatibility complex,
1
CATGGGGCTCTCTTGTGTACTTATTG

class II, DR alpha (HLA-DRA),

TTTAAGGTTTCCTCAAACTGTGAT

mRNA/cds = (26, 790)

1676
Table 3A
Hs.251064
J02621
184229
high-mobility group (nonhistone
1
ACAAATTGAAATGTCTGTACTGATCC

chromosomal) protein 14 (HMG14),

TCAACCAATAAAATCTCAGCCGAA

mRNA/cds = (150, 452)

1677
Table 3A
Hs.62192
J02931
339501
coagulation factor III (thromboplastin,
1
TGCAGGAGACATTGGTATTCTGGGCA

tissue factor) (F3), mRNA/

GCTTCCTAATATGCTTTACAATCT

cds = (123, 1010)

1678
Table 3A
Hs.1513
J03171
184645
interferon (alpha, beta and omega)
1
TCATCCCGAGAACATTGGCTTCCACA

receptor 1 (IFNAR1), mRNA/

TCACAGTATCTACCCTTACATGGT

cds = (78, 1751)

1679
Table 3A
Hs.317
J03250
339805
topoisomerase (DNA) 1 (TOP1),
1
GGCATTGTTAGTTTAGTGTGTGTGCA

mRNA/cds = (247, 2544)

GAGTCCATTTCCCACATCTTTCCT

1680
Table 3A
Hs.81118
J03459
187172
leukotriene A4 hydrolase (LTA4H),
1
GACTGCAATGCTGGTGGGGAAAGAC

mRNA/cds = (68, 1903)

TTAAAAGTGGATTAAAGACCTGCGT

1681
Table 3A
Hs.177766
J03473
337423
ADP-ribosyltransferase (NAD+; poly
1
GCTTTCCTTCTCCAGGAATACTGAAC

(ADP-ribose) polymerase) (ADPRT),

ATGGGAGCTCTTGAAATATGTAGT

mRNA/cds = (159, 3203)

1682
Table 3A
Hs.73792
J03565
181919
complement component (3d/Epstein
1
TGGGAATCAAGATTTAATCCTAGAGA

Barr virus) receptor 2 (CR2), mRNA/

TTTGGTGTACAATTCAGGCTTTGG

cds = (69, 3170)

1683
Table 3A
Hs.727
J03634
181946
inhibin. beta A (activin A, activin AB
1
GCAGTAGTGTGGACTAGAACAACCCA

alpha polypeptide) (INHBA), mRNA/

AATAGCATCTAGAAAGCCATGAGT

cds = (85, 1365)

1684
Table 3A
Hs.86948
J03798
338264
small nuclear ribonucleoprotein D1
1
TGTGTAATGTACCTGTCAGTGCCTCC

polypeptide (16 kD) (SNRPD1),

TTTATTAAGGGGTTCTTTGAGAAT

mRNA/cds = (150, 509)

1685
Table 3A
Hs.75703
J04130
178017
small inducible cytokine A4
1
CCACTGTCACTGTTTCTCTGCTGTTG

(homologous to mouse Mip-1b)

CAAATACATGGATAACACATTTGA

(SCYA4), mRNA/cds = (108, 386)

1686
Table 3A
Hs.1799
J04142
619799
CD1D antigen, d polypeptide (CD1D),
1
AGTTTGCCCTGGATGTCATATTGGCA

mRNA/cds = (164, 1171)

GTTGGAGGACACAGTTTCTATTGT

1687
Table 3A
Hs.298469
J04144
178285
dipeptidyl carboxypeptidase 1
1
CCAAGTTCCACATTCCTTCTAGCGTG

(angiotensin 1 converting enzyme)

CCTTACATCAGGTACTTTGTCAGC

(ACE), mRNA/cds = (22, 3942)

1688
Table 3A
Hs.176663
J04162
183036
leukocyte IgG receptor (Fc-gamma-R)
1
AGCTGTCTCCTGTTTTGTAAGCTTTC

mRNA, complete cds/cds = (17, 718)

AGTGCAACATTTCTTGGTTCCAAT

1689
Table 3A
Hs.82954
J04755
182512
ferritin, heavy polypeptide 1 (FTH1),
1
TGCATGTTGGGGTTTCCTTTACCTTTT

mRNA/cds = (91, 663)

CTATAAGTTGTACCAAAACATCC

1690
Table 3A
Hs.288156
J05016
181507
cDNA: FLJ21819 fis, clone HEP01185/
1
GGGTTTGTGCTATACACTGGGATGTC

cds = UNKNOWN

TAATTGCAGCAATAAAGCCTTTCT

1691
Table 3A
Hs.80758
J05032
179101
aspartyl-tRNA synthetase (DARS),
1
GCCACACTTATTCTTTTCAGTAACCT

mRNA/cds = (93, 1595)

GCTAGTGCACAGGCTGTACTTTAG

1692
Table 3A
Hs.850
J05272
186393
IMP (inosine monophosphate)
1
CAGTCGAAGGCTTTAACTTTGCACAC

dehydrogenase 1 (IMPDH1), mRNA/

TTGGGATCACAGTTGCGTCATTGT

cds = (600, 2144)

1693
Table 3A
Hs.84298
K01144
188469
CD74 antigen (invariant polypeptide of
1
TTCCCTTTCCCCAGCATCACTCCCCA

major histocompatibility complex, class

AGGAAGAGCCAATGTTTTCCACCC

II antigen-associated) (CD74), mRNA/

cds = (7, 705)

1694
Table 3A
Hs.79070
K02276
188927
v-myc avian myelocytomatosis viral
1
AGCCATAATGTAAACTGCCTCAAATT

oncogene homolog (MYC), mRNA/

GGACTTTGGGCATAAAAGAACTTT

cds = (558, 1877)

1695
Table 3A
Hs.1290
K02766
179725
complement component 9 (C9),
1
TTGCTTTTACTAGTCTTAGCTCTACGA

mRNA/cds = (4, 1683)

TTTAAATCCATGTGTCCAAGGGG

1696
Table 3A
Hs.303157
K02885
338928
mRNA for T-cell specific protein/
1
CACACCTGCACACTCACGGCTGAAAT

cds = (37, 975)

CTCCCTAACCCAGGGGGACCTTAG

1697
Table 3A
Hs.21595
L03428
340386
DNA segment on chromosome X and
1
AGCTGTAACGTTCGCGTTAGGAAAGA

Y (unique) 155 expressed sequence

TGGTGTTTATTCCAGTTTGCATTT

(DXYS155E), mRNA/cds = (168,

1323)

1698
Table 3A
Hs.199160
L04731
339921
translocation T(4:11) of ALL-1 gene to
1
AGGGGTTCCACTAGTGTCTGCTTTCC

chromosome 4/cds = UNKNOWN

TTTATTATTGCACTGTGTGAGGTT

1699
Table 3A
Hs.234569
L05148
340038
protein tyrosine kinase related mRNA/
1
CATCCTCAGGTGGTCAGGCGTAGAT

sequence/cds = UNKNOWN

CACCAGAATAAACCCAGCTTCCCTC

1700
Table 3A
Hs.75528
L05425
179284
nucleolar GTPase (HUMAUANTIG),
1
ACACACAACGTGAAAAATAGGAA

mRNA/cds = (79, 2274)

CAGGAACAAAAAGAAGACCAATG

ACTC

1701
Table 3A
Hs.284192
L06132
340198
clone HQ0072/cds = UNKNOWN
1
TTTAGAGTCTTCCATTTTGTTGGAATT

AGATCCTCCCCTTCAAATGCTGT

1702
Table 3A
Hs.1845
L06175
189448
MHC class I region ORF (P5-1),
1
CTAATTTCAGTGCTTGTGCTTGGTTG

mRNA/cds = (304, 735)

TTCAGGGCCATTTCAGGTTTGGGT

1703
Table 3A
Hs.75348
L07833
186512
proteasome (prosome, macropain)
1
CCAGATTTTCCCCAAACTTGCTTCTG

activator subunit 1 (PA28 alpha)

TTGAGATTTTTCCCTCACCTTGCC

(PSME1), mRNA/cds = (92, 841)

1704
Table 3A
Hs.324278
L08048
184250
mRNA; cDNA DKFZp566M063 (from
1
TGGGGGTTGTAAATTGGCATGGAAAT

clone DKFZp566M063)/

TTAAAGCAGGTTCTTGTTGGTGCA

cds = UNKNOWN

1705
Table 3A
Hs.94
L08069
306713
heat shock protein, DNAJ-like 2
1
AGGTGGTGTTCAGTGTCAGACCTCTT

(HSJ2), mRNA/cds = (82, 1275)

AATGGCCAGTGAATAACACTCACT

1706
Table 3A
Hs.99899
L08096
307127
tumor necrosis factor (ligand)
1
GGGGGTAGTTTGTGGCAGGACAAGA

superfamily, member 7 (TNFSF7),

GAAGGCATTGAGCTTTTTCTTTCAT

mRNA/cds = (137, 718)

1707
Table 3A
Hs.1652
L08176
183484
chemokine (C—C motif) receptor 7
1
TCGTTAAGAGAGCAACATTTTACCCA

(CCR7), mRNA/cds = (66, 1202)

CACACAGATAAAGTTTTCCCTTGA

1708
Table 3A
Hs.211576
L10717
307507
IL2-inducible T-cell kinase (ITK),
1
CCCTATCCCGCAAAATGGGCTTCCTG

mRNA/cds = (2021, 3883)

CCTGGGTTTTTCTCTTCTCACATT

1709
Table 3A
Hs.3069
L11066
307322
heat shock 70 kD protein 9B (mortalin-
1
AAACAAGGTAGGAATGAGGCTAGAC

2) (HSPA9B), mRNA/cds = (29, 2068)

CTTTAACTTCCCTAAGGCATACTTT

1710
Table 3A
Hs.3446
L11284
307183
mitogen-activated protein kinase
1
TTCCCCATATCCAAGTACCAATGCTG

kinase 1 (MAP2K1), mRNA/

TTGTAAACAACGTGTATAGTGCCT

cds = (72, 1253)

1711
Table 3A
Hs.1183
L11329
559539
dual specificity phosphatase 2
1
TGAGCCTTTCACACCTGTGCTGGCGC

(DUSP2), mRNA/cds = (85, 1029)

TGGAAAATTATTTGTGCTCAGCTG

1712
Table 3A
Hs.220
L11695
431034
transforming growth factor, beta
1
TGGGATTGTACTATACCAGTAAGTGC

receptor I (activin A receptor type II-

CACTTCTGTGTCTTTCTAATGGAA

like kinase, 53 kD) (TGFBR1), mRNA/

cds = (76, 1587)

1713
Table 3A
Hs.150395
L12052
179892
cAMP phosphodiesterase PDE7
1
TTTTTCCTCACAGGAGCGGAAGAACT

(PDE7A1) mRNA, complete cds/

AGGGGGAGCAGGAGCTGCAATGCG

cds = (50, 1498)

1714
Table 3A
Hs.104125
L12168
178083
adenylyl cyclase-associated protein
1
TCTACCCATTTCCTGAGGCCTGTGGA

(CAP), mRNA/cds = (62, 1489)

AATAAACCTTTATGTACTTAAAGT

1715
Table 3A
Hs.78944
L13463
292054
regulator of G-protein signalling 2,
1
GTGTCCGTTATGAGTGCCAAAAATCT

24 kD (RGS2), mRNA/cds = (32, 667)

GTCTTGAAGGCAGCTACACTTTGA

1716
Table 3A
Hs.258850
L14542
292360
killer cell lectin-like receptor subfamily
1
CTGTGCAATGCTACATGTACGTGGAC

C, member 3 (KLRC3), transcript

TTATATCAGACCAGTGTGGATCTT

variant NKG2-E, mRNA/cds = (45,

767)

1717
Table 3A
Hs.161125
L21961
405227

Homo sapiens, clone MGC:12849
1
AGTCCCCTGTCCTGGTCATCTATCAA

IMAGE:4308973, mRNA, complete

GATAACAAGCGGCCCTCAGGGATC

cds/cds = (24, 725)

1718
Table 3A
Hs.247824
NM_005214
291928
cytotoxic T-lymphocyte-associated
1
GGGTCTATGTGAAAATGCCCCCAACA

protein 4 (CTLA4), mRNA/cds = (0,

GAGCCAGAATGTGAAAAGCAATTT

671)

1719
Table 3A
Hs.179881
L20298
388306
core-binding factor, beta subunit
1
CTTGCCTTAAGCTACCAGATTGCTTT

(CBFB), transcript variant 2, mRNA/

TGCCACCATTGGCCATACTGTGTG

cds = (11, 559)

1720
Table 3A
Hs.83658
L20688
404044
Rho GDP dissociation inhibitor (GDI)
1
CCCCTGCCAGAGGGAGTTCTTCTTTT

beta (ARHGDIB), mRNA/

GTGAGAGACACTGTAAACGACACA

cds = (152, 757)

1721
Table 3A
Hs.89582
L20814
493133
glutamate receptor, ionotropic, AMPA
1
TGCAGCCACTATTGTTAGTCTCTTGA

2 (GRIA2), mRNA/cds = (160, 2811)

TTCATAATGACTTAAGCACACTTG

1722
Table 3A
Hs.161125
L22009
347313

Homo sapiens, clone MGC:12849
1
TGACTATTACTGTCAGGCGTGGGACA

IMAGE:4308973, mRNA, complete

CCAACACTGCGGTATTCGGCGGAG

cds/cds = (24, 725)

1723
Table 3A
Hs.245710
L23332
408689
heterogeneous nuclear
1
TTTGAGACGCAATACCAATACTTAGG

ribonucleoprotein H1 (H) (HNRPH1),

ATTTTGGTCTTGGTGTTTGTATGA

mRNA/cds = (72, 1421)

1724
Table 3A
Hs.79117
L23320
410217
mRNA for corticotrophin releasing
1
TCCTTCCAGGGCTTCTTTGTGTCTGT

factor receptor/cds = (226, 1473)

GTTCTACTGTTTCCTCAATAGTGA

1725
Table 3A
Hs.79117
L24498
403127
mRNA for corticotrophin releasing
1
CCATGTCCATCCCCACCTCCCCAACC

factor receptor/cds = (226, 1473)

CGTGTCAGCTTTCACAGCATCAAG

1726
db mining
Hs.80409
NM_021998
11527399
gadd45 gene, complete cds/
1
TGCCCTCAAGTAAAAGAAAAGCCGAA

cds = (2327, 2824)

AGGGTTAATCATATTTGAAAACCA

1727
Table 3A
Hs.326801
l25124
435049
DNA sequence from PAC 75N13 on
1
ATGCTACTTGGGAGAAAACTCTCACT

chromosome Xq21.1. Contains ZNF6

AACTGTCTCACCGGGTTTCAAAGC

like gene, ESTs, STSs and CpG

islands/cds = (587, 2882)

1728
Table 3A
Hs.199248
L25080
407696
prostaglandin E receptor 4 (subtype
1
GGACTTTGCGAATATCAGAGACCTCA

EP4) (PTGER4), mRNA/

GACTCTTCACAGGGTCAGGACTCA

cds = (388, 1854)

1729
Table 3A
Hs.199248
L25851
4406707
prostaglandin E receptor 4 (subtype
1
AGCTCCCTGCAAGTCACATTTCCCAG

EP4) (PTGER4), mRNA/

TGAAACACTGAACTTATCAGAAAA

cds = (388, 1854)

1730
Table 3A
Hs.241545
L25931
438638

Homo sapiens. Similar to hypothetical
1
TTCCTTCAGGATGATCTAGAGCAGCA

protein, clone MGC:1824

TGGAGCTGTTGGTAGAATATTAGT

IMAGE:3509518, mRNA, complete

cds/cds = (533, 1504)

1731
Table 3A
Hs.152931
L29218
632967
lamin B receptor (LBR), mRNA/
1
GGGGAGGAAGGAAGGACATTAAATT

cds = (75, 1922)

CTTTCCCTGGTAATGAAAAGAGCCC

1732
Table 3A
Hs.73986
L26953
537529
CDC-like kinase 2 (CLK2), transcript
1
GCCTTGTACATAATACTATTCCATCCA

variant phclk2, mRNA/cds = (129,

CACAGTTTCCACCCTCACCTGCC

1628)

1733
Table 3A
Hs.29877
L27071
951045
TXK tyrosine kinase (TXK), mRNA/
1
AGCAAGATAGCCAAATGTGACATCAA

cds = (86, 1669)

GCTCCATTGTTTCGGAAATCCAGG

1734
Table 3A
Hs.73986
L42572
1160962
CDC-like kinase 2 (CLK2), transcript
1
GCCGAGTGAGGTAACCAGGTGGCAT

variant phclk2, mRNA/cds = (129,

CTACCCCATGTTTTATAAGGAATTT

1628)

1735
Table 3A
Hs.78504
L29348
460282
inner membrane protein, mitochondrial
1
TTCTTTCCATTTGCTATCATGTCAGTG

(mitofilin) (IMMT), mRNA/

AACGCCAGGAGTGCTTTCTTTGC

cds = (92, 2368)

1736
Table 3A
Hs.1742
L33075
536843
IQ motif containing GTPase activating
1
TGAATTTACTTCCTCCCAAGAGTTTG

protein 1 (IQGAP1), mRNA/

GACTGCCCGTCAGATTGTTTCTGC

cds = (467, 5440)

1737
Table 3A
Hs.137232
L33842
602457
yq19a04.r1 cDNA, 5′ end/
1
ACCCTCATTTCCAGGGGGAGCCTCA

clone = IMAGE:274063/clone_end = 5′

GGCCCCGAGATAAATGTGCTCCATG

1738
Table 3A
Hs.1697
L35249
522192
ATPase, H+ transporting, lysosomal
1
TTCTCTGAGGGCTGGGGGTTGGGGG

(vacuolar proton pump), beta

AGTCAGCATGATTATATTTTAATGT

polypeptide,56/58 kD, isoform 2

(ATP6B2), mRNA/cds = (25, 1560)

1739
Table 3A
Hs.79107
L35263
603916
mitogen-activated protein kinase 14
1
ACTTGGCTGTAATCAGTTATGCCGTA

(MAPK14), mRNA/cds = (362, 1444)

TAGGATGTCAGACAATACCACTGG

1740
Table 3A
Hs.75217
L36870
685175
mitogen-activated protein kinase
1
TGGAGCTCAGTAACATAACTGCTTCT

kinase 4 (MAP2K4), mRNA/

TGGAGCTTTGGAATATTTTATCCT

cds = (9, 1208)

1741
Table 3A
Hs.83086
L38935
1008845
GT212 mRNA/cds = UNKNOWN
1
AAATTTCACAAGCAATACTTTGGACC

ACTGGGGTTCAGGCCCCAAGAAAT

1742
Table 3A
Hs.180446
L38951
893287
importin beta subunit mRNA, complete
1
ACACACAAAACAGCAAACTTCAGGTA

cds/cds = (337, 2967)

ACTATTTTGGATTGCAAACAGGAT

1743
Table 3A
Hs.41726
L40377
1160926
serine (or cysteine) proteinase
1
TCTTGCCTTAATTAACATTCCCTGTGA

inhibitor, clade B (ovalbumin), member

CCTAGTTGGTGCAGTGGCTTGAA

8 (SERPINB8), mRNA/cds = (83,

1207)

1744
Table 3A
Hs.155079
L42373
1000887
protein phosphatase 2, regulatory
1
ACTTGCAGTTGTGTGGAAAACTGTTT

subunit B (B56), alpha isoform

TGTAATGAAAGATCTTCATTGGGG

(PPP2R5A), mRNA/cds = (571, 2031)

1745
Table 3A
Hs.78504
L78440
1479978
inner membrane protein, mitochondrial
1
TGTGATCTCTACTACTGTTGATTTTGC

(mitofilin) (IMMT), mRNA/

CCTCGGAGCAAACTGAATAAAGC

cds = (92, 2368)

1746
Table 3A
Hs.80642
L47345
992562
signal transducer and activator of
1
TAGGAAATGTTTGACATCTGAAGCTC

transcription 4 (STAT4), mRNA/

TCTTCACACTCCCGTGGCACTCCT

cds = (81, 2327)

1747
Table 3A
Hs.75678
L49169
1082037
FBJ murine osteosarcoma viral
1
CGTCCCCTCTCCCCTTGGTTCTGCAC

oncogene homolog B

TGTTGCCAATAAAAAGCTCTTAAA

1748
Table 3A
Hs.80642
M11353
184092
signal transducer and activator of
1
GGGAGTGTTGTGACTGAAATGCTTGA

transcription 4 (STAT4), mRNA/

AACCAAAGCTTCAGATAAACTTGC

cds = (81, 2327)

1749
Table 3A
Hs.181307
M10901
183032
H3 histone, family 3A (H3F3A),
1
AGGGGACAGAAATCAGGTATTGGCA

mRNA/cds = (374, 784)

GTTTTTCCATTTTCATTTGTGTGTG

1750
Table 3A
Hs.198253
M11124
188109
major histocompatibility complex, class
1
AGCCGCCCAGCTACCTAATTCCTCAG

II, DQ alpha 1 (HLA-DQA1), mRNA/

TAACATCGATCTAAAATCTCCATG

cds = (43, 810)

1751
Table 3A
Hs.181307
M12679
187911
H3 histone, family 3A (H3F3A),
1
ACATGCAAGTACATGTTTTTAATGTTG

mRNA/cds = (374, 784)

TCTGTCTTCTGTGCTGTTCCTGT

1752
Table 3A
Hs.277477
M11717
184416
major histocompatibility complex, class
1
CCTGTGTGGGACTGAGATGCAGGAT

I, C (HLA-C), mRNA/cds = (0, 1100)

TTCTTCACACCTCTCCTTTGTGACT

1753
Table 3A
Hs.277477
M12824
339426
major histocompatibility complex, class
1
GGCATCTGAATGTGTCTGCGTTCCTG

I, C (HLA-C), mRNA/cds = (0, 1100)

TTAGCATAATGTGAGGAGGTGGAG

1754
Table 3A
Hs.85258
M14328
182113
CD8 antigen, alpha polypeptide (p32)
1
CTGAGAGCCCAAACTGCTGTCCCAAA

(CD8A), mRNA/cds = (65, 772)

CATGCACTTCCTTGCTTAAGGTAT

1755
Table 3A
Hs.254105
M12824
339426
enolase 1, (alpha) (ENO1), mRNA/
1
AAGCTCCCTGGAGCCCTGTTGGCAG

cds = (94, 1398)

CTCTAGCTTTTGCAGTCGTGTAATG

1756
Table 3A
Hs.122007
M12888
338836
qn52b08.x1 cDNA, 3′ end/
1
AGCCCTCTTTCTCTCCACCCAATGCT

clone = IMAGE:1901847/clone_end =

GCTTTCTCCTGTTCATCCTGATGG

3′

1757
Table 3A
Hs.82085
M14083
189566
serine (or cysteine) proteinase
1
TCCACAGGGGTGGTGTCAAATGCTAT

inhibitor, clade E (nexin, plasminogen

TGAAATTGTGTTGAATTGTATGCT

activator inhibitor type 1), member 1

(SERPINE1), mRNA/cds = (75, 1283)

1758
Table 3A
Hs.254105
M15182
183232
enolase 1, (alpha) (ENO1), mRNA/
1
GCTAGATCCCCGGTGGTTTTGTGCTC

cds = (94, 1398)

AAAATAAAAAGCCTCAGTGACCCA

1759
Table 3A
Hs.183868
M14648
340306
glucuronidase, beta (GUSB), mRNA/
1
GACTTCCACAGCAGCAGAACAAGTG

cds = (26, 1981)

CCTCCTGGACTGTTCACGGCAGACC

1760
Table 3A
Hs.1416
M15059
182447
Fc fragment of IgE, low affinity II,
1
TATCCCCAGCTCAGGTGGTGAGTCCT

receptor for (CD23A) (FCER2),

CCTGTCCAGCCTGCATCAATAAAA

mRNA/cds = (213, 1178)

1761
Table 3A
Hs.183868
M15330
186283
glucuronidase, beta (GUSB), mRNA/
1
CTGGGTTTTGTGGTCATCTATTCTAG

cds = (26, 1981)

CAGGGAACACTAAAGGTGGAAATA

1762
Table 3A
Hs.126256
M15353
306486
interleukin 1, beta (IL1B), mRNA/
1
AGCTATGGAATCAATTCAATTTGGAC

cds = (86, 895)

TGGTGTGCTCTCTTTAAATCAAGT

1763
Table 3A
Hs.79306
M16342
184266
eukaryotic translation initiation factor
1
TGGCTCAAGTAGAAAAGCAGTCCCAT

4E (EIF4E), mRNA/cds = (18, 671)

TCATATTAAGACAGTGTACAAAAC

1764
Table 3A
Hs.182447
M15796
181271
heterogeneous nuclear
1
AGCTCTTGAAAGCAGCTTTGAGTTAG

ribonucleoprotein C (C1/C2) (HNRPC),

AAGTATGTGTGTTACACCCTCACA

transcript variant 1, mRNA/

cds = (191, 1102)

1765
Table 3A
Hs.80887
M16038
187268
v-yes-1 Yamaguchi sarcoma viral
1
AACCGGATATATACATAGCATGACAT

related oncogene homolog (LYN),

TTCTTTGTGCTTTGGCTTACTTGT

mRNA/cds = (297, 1835)

1766
Table 3A
Hs.89476
M16336
180093
CD2 antigen (p50), sheep red blood
1
AGCCTATCTGCTTAAGAGACTCTGGA

cell receptor (CD2), mRNA/

GTTTCTTATGTGCCCTGGTGGACA

cds = (6, 1061)

1767
Table 3A
Hs.182447
M16342
188352
heterogeneous nuclear
1
AAAGTTGATACTGTGGGATTTTTGTG

ribonucleoprotein C (C1/C2) (HNRPC),

AACAGCCTGATGTTTGGGACCTTT

transcript variant 1, mRNA/

cds = (191, 1102)

1768
Table 3A
Hs.318720
M16660
184420

Homo sapiens, clone MGC:12387
1
CTTCCTTAGCTCCTGTTCTTGGCCTG

IMAGE:3933019, mRNA, complete

AAGCCTCACAGCTTTGATGGCAGT

cds/cds = (63, 863)

1769
Table 3A
Hs.318720
M16942
188352

Homo sapiens, clone MGC:12387
1
TTTGTGCTTCCCTTTACCTAAACTGTC

IMAGE:3933019, mRNA, complete

CTGCCTCCCATGCATCTGTACCC

cds/cds = (63, 863)

1770
Table 3A
Hs.318720
M16942
188437

Homo sapiens, clone MGC:12387
1
TTTGTGCTTCCCTTTACCTAAACTGTC

IMAGE:3933019, mRNA, complete

CTGCCTCCCATGCATCTGTACCC

cds/cds = (63, 863)

1771
Table 3A
Hs.308026
M16967
182411
major histocompatibility complex, class
1
CTTGTGGCTTCCTCAGCTCCTGCCCT

II, DR beta 5 (HLA-DRB5), mRNA/

TGGCCTGAAGTCCCAGCATTGATG

cds = (29, 829)

1772
Table 3A
Hs.75709
M16985
187282
mannose-6-phosphate receptor (cation
1
ATTTGTTTGCATCCCTCCCCCACACC

dependent) (M6PR), mRNA/

CTGGTGTTTTAAAATGAAGAAAAA

cds = (170, 1003)

1773
Table 3A
Hs.21858
M17783
183063
trinucleotide repeat containing 3
1
CATCCGACATAATCCTACAGGTGCTG

(TNRC3), mRNA/cds = (517, 1356)

TGTTATTCATGGGGCAGATAAACA

1774
Table 3A
Hs.694
M20137
186328
interleukin 3 (colony-stimulating factor,
1
AGTGGGGTGGGGAGCATGTTCATTT

multiple) (IL3), mRNA/cds = (9, 467)

GTACCTCGAGTTTTAAACTGGTTCC

1775
Table 3A
Hs.308026
M20430
187182
major histocompatibility complex, class
1
CCTAAACCGTATGGCCTCCCGTGCAT

II, DR beta 5 (HLA-DRB5), mRNA/

CTGTATTCACCCTGTATGACAAAC

cds = (29, 829)

1776
Table 3A
Hs.62848
M20661
183684
selectin L (lymphocyte adhesion
1
TTTCATCTCAGGCCTCCCTCAACCCC

molecule 1) (SELL), mRNA/

ACCACTTCTTTTATAACTAGTCCT

cds = (88, 1206)

1777
Table 3A
Hs.237519
M20867
183059
yz35c09.s1 cDNA, 3′ end/
1
GCATGGCTTAACCTGGTGATAAAAGC

clone = IMAGE:285040/clone_end = 3′

AGTTATTAAAAGTCTACGTTTTCC

1778
Table 3A
Hs.241392
M21121
339420
small inducible cytokine A5 (RANTES)
1
AGCTTCCGCCGTCTCAACCCCTCACA

(SCYA5), mRNA/cds = (26, 301)

GGAGCTTACTGGCAAACATGAAAA

1779
literature
Hs.76422
M22430
190888
phospholipase A2, group IIA (platelets,
1
TCTCCTCCACCTCAACTCCGTGCTTA

synovial fluid) (PLA2G2A), nuclear

ACCAAAGAAGCTGTACTCCGGGGG

gene encoding mitochondrial protein,

mRNA/cds = (135, 569)

1780
db mining
Hs.51299
M22538
986883
NADH dehydrogenase (ubiquinone)
1
ACCCAAGGGACCTGGATTTGGTGTAC

flavoprotein 2 (24 kD) (NDUFV2),

AAGCAGGCCTTTAATTTATATTGA

mRNA/cds = (18, 767)

1781
Table 3A
Hs.82848
M25280
188555
selectin L (lymphocyte adhesion
1
AGCTCCTCTTCCTGGCTTCTTACTGA

molecule I) (SELL), mRNA/

AAGGTTACCCTGTAACATGCAATT

cds = (88, 1206)

1782
Table 3A
Hs.73798
M25393
190740
macrophage migration inhibitory factor
1
GTCTACATCAACTATTACGACATGAA

(glycosylation-inhibiting factor) (MIF),

CGCGGCCAATGTGGGCTGGAACAA

mRNA/cds = (97, 444)

1783
Table 3A
Hs.73798
M25639
188627
macrophage migration inhibitory factor
1
CCACCCCAACCTTCTGGTGGGGAGA

(glycosylation-inhibiting factor) (MIF),

AATAAACGGTTTAGAGACAGCTCTG

mRNA/cds = (97, 444)

1784
db mining
Hs.624
M26383
184641
interleukin 8 (IL8), mRNA/
1
GCCAAGGGCCAAGAGAATATCCGAA

cds = (74, 373)

CTTTAATTTCAGGAATTGAATGGGT

1785
Table 3A
Hs.303649
M26683
186289
small inducible cytokine A2 (monocyte
1
GAAATTGCTTTTCCTCTTGAACCACA

chemotactic protein 1, homologous to

GTTCTACCCCTGGGATGTTTTGAG

mouse Sig-je) (SCYA2), mRNA/

cds = (53, 352)

1786
Table 3A
Hs.82112
M26880
340067
interleukin 1 receptor, type I (IL1R1),
1
CCGGTTGTTAAAACTGGTTTAGCACA

mRNA/cds = (82, 1791)

ATTTATATTTTCCCTCTCTTGCCT

1787
Table 3A
Hs.82112
M27492
180035
interleukin 1 receptor, I (IL1R1),
1
ATTAAAGCACCAAATTCATGTACAGC

mRNA/cds = (82, 1791)

ATGCATCACGGATCAATAGACTGT

1788
Table 3A
Hs.1309
M28170
862622
thymocyte antigen CD1a mRNA,
1
TAGCCGTACTTTGCTAACTGTGCTCC

complete cds/cds = (533, 1516)

TCACTTCCTCTTCTTCATTGCAGT

1789
Table 3A
Hs.78146
M28526
189775
platelet/endothelial cell adhesion
1
AGGCTAAGCTGCCGGTTCTTAAATCC

molecule (CD31 antigen) (PECAM1),

ATCCTGCTAAGTTAATGTTGGGTA

mRNA/cds = (141, 2357)

1790
Table 3A
Hs.1309
M28825
186279
thymocyte antigen CD1a mRNA,
1
AATATATGCATCCCTGGTGAAGGATC

complete cds/cds = (533, 1516)

TTGCCTGCATGAAACATGTTCTCA

1791
Table 3A
Hs.1722
M28983
186365
interleukin 1, alpha (IL1A), mRNA/
1
ACCTGGGCATTCTTGTTTCATTCAATT

cds = (36, 581)

CCACCTGCAATCAAGTCCTACAA

1792
Table 3A
Hs.237868
M29064
337452
interleukin 7 receptor (IL7R), mRNA/
1
CTCCCTCACAGCACAGAGAAGACAAA

cds = (22, 1401)

ATTAGCAAAACCCCACTACACAGT

1793
Table 3A
Hs.237868
M29696
180259
interleukin 7 receptor (IL7R), mRNA/
1
GTTCAGTGGCACTCAACATGAGTCAA

cds = (22, 1401)

GAGCATCCTGCTTCTACCATGTGG

1794
Table 3A
Hs.89538
M30142
181464
cholesteryl ester transfer protein,
1
CTTGAGCTAGAAGTCTCCAAGGAGGT

plasma (CETP), mRNA/

CGGGATGGGGCTTGTAGCAGAAGG

cds = (130, 1611)

1795
Table 3A
Hs.89538
M30185
179039
cholesteryl ester transfer protein,
1
CTCCCAACTCCTCCCTATCCTAAAGG

plasma (CETP), mRNA/

CCCACTGGCATTAAAGTGCTGTAT

cds = (130, 1611)

1796
db mining
Hs.270833
M30704
339994
amphiregulin (schwannoma-derived
1
TCGGTCCTCTTTCCAGTGGATCATAA

growth factor) (AREG), mRNA/

GACAATGGACCCTTTTTGTTATGA

cds = (209, 967)

1797
Table 3A
Hs.29352
M31165
184485
tumor necrosis factor, alpha-induced
1
AACACACAGTGTTTATGTTGGAATCT

protein 6 (TNFAIP6), mRNA/

TTTGGAACTCCTTTGATCTCACTG

cds = (68, 901)

1798
Table 3A
Hs.149923
M31210
181948
X-box binding protein 1 (XBP1),
1
GGGGCTCTTTCCCTCATGTATACTTC

mRNA/cds = (48, 833)

AAGTAAGATCAAGAATCTTTTGTG

1799
Table 3A
Hs.1012
M31452
190501
complement component 4-binding
1
TCATCCTCTGTGTGGCTCATGTTTTT

protein, alpha (C4BPA), mRNA/

GCTTTTCAACACACAAAGCACAAA

cds = (138, 1931)

1800
Table 3A
Hs.101047
M31523
339477
transcription factor (E2A) mRNA,
1
TGGATGATTGGGACTTTAAAACGACC

complete cds/cds = (30, 1994)

CTCTTTCAGGTGGATTCAGAGACC

1801
db mining
Hs.149923
M31827
182473
X-box binding protein 1 (XBP1),
1
TGTAGCTTCTGAAAGGTGCTTTCTCC

mRNA/cds = (48, 833)

ATTTATTTAAAAACTACCCATGCA

1802
Table 3A
Hs.78864
M31932
188194
Fc fragment of IgG, low affinity IIa,
1
TGTAGCAACATGAGAAACGCTTATGT

receptor for (CD32) (FCGR2A),

TACAGGTTACATGAGAGCAATCAT

mRNA/cds = (11, 958)

1803
Table 3A
Hs.73931
M32011
189267
major histocompatibility complex, class
1
CTGATGGCTGTGACCCTGCTTCCTGC

II, DQ beta 1 (HLA-DQB1), mRNA/

ACTGACCCAGAGCCTCTGCCTGTG

cds = (57, 842)

1804
Table 3A
Hs.256278
M32315
189185
tumor necrosis factor receptor
1
TGTGTGTTGATCCCAAGACAATGAAA

superfamily, member 1B (TNFRSF1B),

GTTTGCACTGTATGCTGGACGGCA

mRNA/cds = (89, 1474)

1805
Table 3A
Hs.73931
M32577
183628
major histocompatibility complex, class
1
CTCTCCTCAGACTGCTCAAGAGAAGC

II, DQ beta 1 (HLA-DQB1), mRNA/

ACATGAAAACCATTACCTGACTTT

cds = (57, 842)

1806
Table 3A
Hs.75765
M33336
1526989
GRO2 oncogene (GRO2), mRNA/
1
GCCAGTAAGATCAATGTGACGGCAG

cds = (74, 397)

GGAAATGTATGTGTGTCTATTTTGT

1807
Table 3A
Hs.198253
M33906
184194
major histocompatibility complex, class
1
GCAACAATGAAGTTAATGGATACCCT

II, DQ alpha 1 (HLA-DQA1), mRNA/

CTGCCTTTGGCTCAGAAATGTTAT

cds = (43, 810)

1808
Table 3A
Hs.87773
M34181
189982
protein kinase, cAMP-dependent,
1
TGTCTTTCGGTTATCAAGTGTTTCTG

catalytic, beta (PRKACB), mRNA/

CATGGTAATGTCATGTAAATGCTG

cds = (47, 1102)

1809
Table 3A
Hs.26045
M34888
190738
protein tyrosine phosphatase, receptor
1
TATCATGGGGAGTAATAGGACCAGAG

type, A (PTPRA), mRNA/

CGGTATCTCTGGCACCACACTAGC

cds = (695, 3103)

1810
Table 3A
Hs.119663
M34671
180152
CD59 antigen p18-20 (antigen
1
TGATCTTGGCTGTATTTAATGGCATA

identified by monoclonal antibodies

GGCTGACTTTTGCAGATGGAGGAA

16.3A5, EJ16, EJ30, EL32 and G344)

(CD59), mRNA/cds = (29, 415)

1811
Table 3A
Hs.250811
M35416
190851
v-ral simian leukemia viral oncogene
1
AGTACTGAGAAAAATCCCTTCAGCTC

homolog B (ras related: GTP binding

TAAGAACACTGAAAAATCCACCGA

protein) (RALB), mRNA/cds = (170,

790)

1812
Table 3A
Hs.87149
M35999
183532
integrin, beta 3 (platelet glycoprotein
1
ACTTTGCACACATTTGCATCCACATAT

IIIa, antigen CD61) (ITGB3), mRNA/

TAGGGAAGGAATAAGTAGCTGCA

cds = (16, 2382)

1813
Table 3A
Hs.75765
M36820
183628
GRO2 oncogene (GRO2), mRNA/
1
ATGCAGTGTTTCCCTCTGTGTTAGAG

cds = (74, 397)

CAGAGAGGTTTCGATATTTATTGA

1814
Table 3A
Hs.89690
M38821
183632
GRO3 oncogene (GRO3), mRNA/
1
TGCTGAAGTTTCCCTTAGACATTTTAT

cds = (77, 397)

GTCTTGCTTGTAGGGCATAATGC

1815
Table 3A
Hs.82212
M37033
184059
CD53 antigen (CD53), mRNA/
1
CACTGGACCATTGTCACAACCCTCTG

cds = (93, 752)

TTTCTCTTTGACTAAGTGCCCTGG

1816
Table 3A
Hs.119192
M37583
179968
H2A histone family, member Z
1
AAGTGTTACTGTGGCTTCAAAGAAGC

(H2AFZ), mRNA/cds = (106, 492)

TATTGATTCTGAAGTAGTGGGTTT

1817
Table 3A
Hs.173894
NM_000757
4503074
macrophage-specific colony-
1
GCTGCTTATATATTTAATAATAAAAGA

stimulating factor (CSF-1) mRNA,

AGTGCACAAGCTGCCGTTGACGT

complete cds/cds = (105, 1769)

1818
Table 3A
Hs.119192
M37583
189988
H2A histone family, member Z
1
AACAAACATTTGGTTTTGTTCAGACCT

(H2AFZ), mRNA/cds = (106, 492)

TATTTCCACTCTGGTGGATAAGT

1819
Table 3A
Hs.315366
M55284
189988
protein kinase C, eta (PRKCH), mRNA/
1
GAGAGAGGGCACGAGAACCCAAAGG

cds = (166, 2214)

AATAGAGATTCTCCAGGAATTTCCT

1820
Table 3A
Hs.315366
M55284
189988
protein kinase C, eta (PRKCH), mRNA/
1
TTCCCAGCATCAGCCTTAGAACAAGA

cds = (166, 2214)

ACCTTACCTTCAAGGAGCAAGTGA

1821
Table 3A
Hs.171862
M55543
829176
guanylate binding protein 2, interferon-
1
CTGTCCAGCTCCCTCTCCCCAAGAAA

inducible (GBP2), mRNA/

CAACATGAATGAGCAACTTCAGAG

cds = (156, 1931)

1822
Table 3A
Hs.2055
M58028
340071
ubiquitin-activating enzyme E1 (A1S9T
1
CTGTAACGACGAGAGCGGCGAGGAT

and BN75 temperature sensitivity

GTCGAGGTTCCCTATGTCCGATACA

complementing) (UBE1), mRNA/

cds = (32, 3208)

1823
Table 3A
NA
M55674
189870
one single clone, artifact?
1
ACCTAGTCATCAGGACACTGAGCCAG

GGCTGCAACCACTCCATGAGTTTG

1824
Table 3A
Hs.72918
M57506
184505
small inducible cytokine A1 (1-309,
1
CCCCAACCCTCTGGGCTCTTGGATTT

homologous to mouse Tca-3) (SCYA1),

CAGAGTGAAAACTTGATGGCATTG

mRNA/cds = (72, 362)

1825
Table 3A
Hs.193717
M57627
186270
interleukin 10 (IL10), mRNA/
1
TCAATTCCTCTGGGAATGTTACATTG

cds = (30, 566)

TTTGTCTGTCTTCATAGCAGATTT

1826
Table 3A
Hs.1051
M57888
183154
granzyme B (granzyme 2, cytotoxic T-
1
ACCAGTTTCTTTCCCTTCTAGATCAC

lymphocyte-associated serine esterase

CCTGTTCTGAAGCCAGCCTCTCTC

1) (GZMB), mRNA/cds = (33, 776)

1827
Table 3A
Hs.2055
M58028
189177
ubiquitin-activating enzyme E1 (A1S9T
1
CTACCTGAACCCCTCTTGCCACTGCC

and BN75 temperature sensitivity

TTCTACCTTGTTTGAAACCTGAAT

complementing) (UBE1), mRNA/

cds = (32, 3208)

1828
Table 3A
Hs.83426
M58597
182070
nuclear factor of kappa light
1
AACTCGAGACCTTTTCAACTTGGCTT

polypeptide gene enhancer in B-cells 1

CCTTTCTTGGTTCATAAATGAATT

(p105) (NFKB1), mRNA/

cds = (397, 3303)

1829
Table 3A
Hs.83428
M58603
186496
nuclear factor of kappa light
1
AGCTGCTGCTGGATCACAGCTGCTTT

polypeptide gene enhancer in B-cells 1

CTGTTGTCATTGCTGTTGTCCCTC

(p105) (NFKB1), mRNA/

cds = (397, 3303)

1830
Table 3A
Hs.265829
M59465
177865
integrin, alpha 3 (antigen CD49C,
1
GGCTGTGTCCTAAGGCCCATTTGAGA

alpha 3 subunit of VLA-3 receptor)

AGCTGAGGCTAGTTCCAAAAACCT

(ITGA3), transcript, variant a, mRNA/

cds = (73, 3228)

1831
Table 3A
Hs.2175
M59820
183048
colony stimulating factor 3 receptor
1
ATCCAGCCCCACCCAATGGCCTTTTG

(granulocyte) (CSF3R), mRNA/

TGCTTGTTTCCTATAACTTCAGTA

cds = (169, 2679)

1832
Table 3A
Hs.265829
M60278
183866
integrin, alpha 3 (antigen CD49C,
1
CCTTCTTTGTATATAGGCTTCTCACC

alpha 3 subunit of VLA-3 receptor)

GCGACCAATAAACAGCTCCCAGTT

(ITGA3), transcript variant a, mRNA/

cds = (73, 3228)

1833
Table 3A
Hs.799
M60724
189507
diphtheria toxin receptor (heparin-
1
AAAACGATGAAGGTATGCTGTCATGG

binding epidermal growth factor-like

TCCTTTCTGGAAGTTTCTGGTGCC

growth factor) (DTR), mRNA/

cds = (261, 887)

1834
Table 3A
Hs.86658
M60826
182882
ribosomal protein S6 kinase, 70 kD,
1
AATGCGAAATTATTGGTTGGTGTGAA

polypeptide 1 (RPS6KB1), mRNA/

GAAAGCCAGACAACTTCTGTTTCT

cds = (27, 1604)

1835
Table 3A
Hs.88858
M61906
189424
ribosomal protein S6 kinase, 70 kD,
1
CTGTGGCTCGTTTGAGGGATTGGGG

polypeptide 1 (RPS6KB1), mRNA/

TGGACCTGGGGTTTATTTTCAGTAA

cds = (27, 1604)

1836
Table 3A
Hs.6241
M61199
181122
P13-kinase associated p85 mRNA
1
GCTTCCCCACCCCAGTTTTTGTTGCT

sequence/cds = UNKNOWN

TGAAAATATTGTTGTCCCGGATTT

1837
Table 3A
Hs.6241
M61906
190734
P13-kinase associated p85 mRNA
1
TGGACTGTTTTGTTGGGCAGTGCCTG

sequence/cds = UNKNOWN

ATAAGCTTCAAAGCTGCTTTATTC

1838
Table 3A
Hs.50651
M63180
339679
Janus kinase 1 (a protein tyrosine
1
CCTGCCGTGCCCACCTAACTGTCCA

kinase) (JAK1), mRNA/cds = (75,

GATGAGGTTTATCAGCTTATGAGAA

3503)

1839
Table 3A
Hs.84318
M63488
337488
replication protein A1 (70 kD) (RPA1),
1
CGAGCTGAGAAGCGGTCATGAGCAC

mRNA/cds = (69, 1919)

CTGGGGATTTTAGTAAGTGTGTCTT

1840
Table 3A
Hs.50651
M64174
190446
Janus kinase 1 (a protein tyrosine
1
ACCATCCAATCGGACAAGCTTTCAGA

kinase) (JAK1), mRNA/cds = (75,

ACCTTATTGAAGGATTTGAAGCAC

3503)

1841
Table 3A
Hs.82159
M64992
178996
proteasome (prosome, macropain)
1
TGCTGATGAACCTGCAGAAAAGGCTG

subunit, alpha type, 1 (PSMA1),

ATGAACCAATGGAACATTAAGTGA

mRNA/cds = (105, 896)

1842
Table 3A
Hs.11482
M69043
167290
splicing factor, arginine/serine-rich 11
1
TCTTATGCACACGGTGATTTCATGTT

(SFRS11), mRNA/cds = (83, 1537)

ATATATGCAAAGTAGGCAACTGTT

1843
Table 3A
Hs.155160
M72709
179073

Homo sapiens. Similar to splicing
1
AACATAGGAGTGGATTCCTGCCCCAA

factor, arginine/serine-rich 2 (SC-35),

CCAAACCGCATTCGTGTGGATTTT

clone, MGC:2622 IMAGE:3501687,

mRNA, complete cds/cds = (30, 878)

1844
Table 3A
Hs.1117
M73047
339879
tripeptidyl peptidase II (TPP2), mRNA/
1
AATAAATTTGCAAAACCAAGATCACA

cds = (23, 3772)

GTACACCATATGCACTCTGGTACC

1845
Table 3A
Hs.178112
M73547
190161
polyposis locus (DP1 gene) mRNA,
1
AAATGACCTCATGTTGTGGTTTAAAC

complete cds/cds = (82, 639)

AGCAACTGCACCCACTAGCACAGC

1846
Table 3A
Hs.11482
M74002
184045
splicing factor, arginine/serine-rich 11
1
TGTGCAGTAGAAACAAAAGTAGGCTA

(SFRS11), mRNA/cds = (83, 1537)

CAGTCTGTGCCATGTTGATGTACA

1847
Table 3A
Hs.811
M74525
189511
ubiquitin-conjugating enzyme E2B
1
CTGTTTATTCTGGGAAATGTTTTAATG

(RAD6 homolog) (UBE2B), mRNA/

CCAGGGCCTGCTGAGTTGCTTCT

cds = (421, 879)

1848
Table 3A
Hs.172766
M80359
182353
MAP/microtubule affinity-regulating
1
CCTTAAGACCAGTTCATAGTTAATAC

kinase 3 (MARK3), mRNA/

AGGTTTACAGTTCATGCCTGTGGT

cds = (171, 2312)

1849
Table 3A
Hs.153179
M81601
339442
fatty acid binding protein 5 (psoriasis-
1
TCATCACTTTGGACAGGAGTTAATTA

associated) (FABP5), mRNA/

AGAGAATGACCAAGCTCAGTTCAA

cds = (48, 455)

1850
Table 3A
Hs.119537
M88108
189499
GAP-associated tyrosine
1
AGTCTGCCTAAATAGGTAGCTTAAAC

phosphoprotein p62 (Sam68) (SAM68),

TTATGTCAAAATGTCTGCAGCAGT

mRNA/cds = (106, 1437)

1851
Table 3A
Hs.89575
M89957
179311
CD79B antigen (immunoglobulin-
1
CTGGCCTCCAGTGCCTTCCCCCGTG

associated beta) (CD79B), transcript

GAATAAACGGTGTGTCCTGAGAAAC

variant 1, mRNA/cds = (94, 783)

1852
Table 3A
Hs.181967
M90356
179575
BTF3 protein homologue gene,
1
AGCTAATTAAGCTGCAGAACGTGGGA

complete cds

AATAAAGTTCGAAACAAAGGTTAA

1853
Table 3A
Hs.82127
M90391
4153827
putative IL-16 protein precursor,
1
GGACAGGTGTGCCGACAGAAGGAAC

mRNA, complete cds/cds = (303, 2198)

CAGCGTGTATATGAGGGTATCAAAT

1854
Table 3A
Hs.73722
M92444
183779
apurinic/apyrimidinic endonuclease
1
CCCTTCGTGGGGCTACACATTCTCTT

(HAP1) gene, complete cds

CCTCATATTTTCATGCACACAAGT

1855
Table 3A
Hs.145279
M93651
338038
SET translocation (myeloid leukemia-
1
TTCTGCACAGGTCTCTGTTTAGTAAA

associated) (SET), mRNA/cds = (3,

TACATCACTGTATACCGATCAGGA

836)

1856
Table 3A
Hs.7647
M94046
187393
MYC-associated zinc finger protein
1
CACCCTCCACCCCTTCCTTTTGCGCG

(purine-binding transcription factor)

GACCCCATTACAATAAATTTTAAA

(MAZ), mRNA/cds = (91, 1584)

1857
Table 3A
Hs.153179
M95585
184223
fatty acid binding protein 5 (psoriasis-
1
CATGCAGCTATTTCAAAGTGTGTTGG

associated) (FABP5), mRNA/

ATTAATTAGGATCATCCCTTTGGT

cds = (48, 455)

1858
Table 3A
Hs.250692
M95585
337810
hepatic leukemia factor (HLF) mRNA,
1
TGGAGAATTGTGGAAGGATTGTAACA

complete cds/cds = (322, 1209)

TGGACCATCCAAATTTATGGCCGT

1859
Table 3A
Hs.74592
M98982
338262
special AT-rich sequence binding
1
TTCACGGGATGCACCAAAGTGTGTAC

protein 1 (binds to nuclear

CCCGTAAGCATGAAACCAGTGTTT

matrix/scaffold-associating DNA's)

(SATB1), mRNA/cds = (214, 2505)

1860
Table 3A
Hs.296381
M96995
181975
growth factor receptor-bound protein 2
1
TCTGTCCATCAGTGCATGACGTTTAA

(GRB2), mRNA/cds = (78, 731)

GGCCACGTATAGTCCTAGCTGACG

1861
Table 3A
Hs.74592
M97856
184432
special AT-rich sequence binding
1
TCCTATAATTATTTCTGTAGCACTCCA

protein 1 (binds to nuclear

CACTGATCTTTGGAAACTTGCCC

matrix/scaffold-associating DNA's)

(SATB1), mRNA/cds = (214, 2505)

1862
Table 3A
Hs.243886
M97935
2281070
nuclear autoantigenic sperm protein
1
GGGACACTGGAGGCTGGAGCTACAG

(histone-binding) (NASP), mRNA/

TTGAAAGCACTGCATGTTAAGAGGG

cds = (85, 2446)

1863
Table 3A
Hs.21486
M98399
180112
signal transducer and activator of
1
TGCTACCACAACTATATTATCATGCAA

transcription 1, 91 kD (STAT1),

ATGCTGTATTCTTCTTTGGTGGA

mRNA/cds = (196, 2448)

1864
Table 3A
Hs.75613
N27575
1142056
CD36 antigen (collagen type I
1
GCAACTTACGCTTGGCATCTTCAGAA

receptor, thrombospondin receptor)

TGCTTTTCTAGCATTAAGAGATGT

(CD36), mRNA/cds = (132, 1550)

1865
Table 3A
Hs.198427
N25486
1139799
hexokinase 2 (HK2), mRNA/
1
TTTACAAGAATTGTCCATGTGCTTCC

cds = (1490, 4243)

CTAGGCTGAGCTGGCATTGGTCTG

1866
Table 3A
Hs.198427
N99577
1271009
hexokinase 2 (HK2), mRNA/
1
AAAACTTCCCACCCTACTTTTCCAAG

CDS = (1490, 4243)

AGTGCCAGTTGGATTCTGAATCTG

1867
Table 3A
Hs.73965
N28843
1147079
splicing factor, arginine/serine-rich 2
1
TAGACCAATTCTCTGATCTCGAGTTG

(SFRS2), mRNA/cds = (155, 820)

TTTTTGTTTGGATACAGCCCTTTT

1868
Table 3A
Hs.5122
N31700
1152099
602293015F1 cDNA, 5′ end/
1
AACATTCTACATAGCACAGGAGCTTA

clone = IMAGE:4387778/clone_end =

AGAGTGGCATTATCTTCTCGCCTT

5′

1869
Table 3A
Hs.66151
N3426
1155403
mRNA; cDNA DKFZp434A115 (from
1
AGATACGCAGACATTGTGGCATCTGG

clone DKFZp434A115)/

GTAGAAGAATACTGTATTGTGTGT

cds = UNKNOWN

1870
Table 3A
Hs.73965
Z22642
296907
splicing factor, arginine/serine-rich 2
1
TTTGACCAGAAGCCCTTAGTAAGTAC

(SFRS2), mRNA/cds = (155, 820)

GTGCCTGAAACTGAAACCATGTGC

1871
Table 3A
Hs.166563
L14922
307337
DNA-binding protein (PO-GA) mRNA,
1
ACACCTGGCTTGGAGTCAGATTTAGT

complete cds/cds = (393, 3836)

TAACAATAATGAGCCTGGAGCAGT

1872
literature
Hs.75772
M10901
183032
nuclear receptor subfamily 3, group C,
1
TCTAATAGCGGGTTACTTTCACATAC

member 1 (NR3C1), mRNA/

AGCCCTCCCCCAGCAGTTGAATGA

cds = (132, 2465)

1873
literature
Hs.74561
NM_000014
6226959
alpha-2-macroglobulin (A2M), mRNA/
1
CTGAAAAGTGCTTTGCTGGAGTCCTG

cds = (43, 4467)

TTCTCTGAGCTCCACAGAAGACAC

1874
db mining
Hs.172670
NM_000020
4557242
activin A receptor type II-like 1
1
AAGCCTAAAGTGATTCAATAGCCCAG

(ACVRL1), mRNA/cds = (282, 1793)

GAGCACCTGATTCCTTTCTGCCTG

1875
Table 3A
Hs.1217
NM_000022
4557248
adenosine diaminase (ADA), mRNA/
1
TGGGCATGGTTGAATCTGAAACCCTC

cds = (95, 1186)

CTTCTGTGGCAACTTGTACTGAAA

1876
Table 3A
Hs.99931
NM_000023
4506910
sarcoglycan, alpha (50 kD dystrophin-
1
GGGGTGGGGTGGGGTGAGAGTGTGT

associated glycoprotein) (SGCA),

GGAGTAAGGACATTCAGAATAAATA

mRNA/cds = (11, 1174)

1877
literature
Hs.207776
NM_000027
4557272
aspartylglucosaminidase (AGA),
1
AGAAGTTGTGCGCGTGCTTTCTCAGC

mRNA/cds = (170, 1210)

AGCATTTTTCCTTCAAAATCATCT

1878
Table 3A
Hs.159548
NM_000033
7262392
ATP-binding cassette, sub-family D
1
CTTGCCAGCCAGGAGTGCGGACACC

(ALD), member 1 (ABCD1), mRNA/

ATGTTCCCAGCTCAGTGCCAAAGAG

cds = (386, 2623)

1879
Table 3A
Hs.75081
NM_000038
4557318
adenomatosis polyposis coli (APC),
1
ATTTGGGGAGAGAAAACCTTTTTAAG

mRNA/cds = (38, 8569)

CATGGTGGGGCACTCAGATAGGAG

1880
literature
Hs.36820
NM_000057
4557364
Bloom syndrome (BLM), mRNA/
1
ACCCTCTTTCTTGTTTGTCAGCATCT

cds = (74, 4327)

GACCATCTGTGACTATAAAGCTGT

1881
literature
Hs.34012
NM_000059
4502450
breast cancer 2, early onset (BRCA2),
1
TGGTCATCCAAACTCAAACTTGAGAA

mRNA/cds = (228, 10484)

AATATCTTGCTTTCAAATTGACAC

1882
Table 3A
Hs.159494
NM_000061
4557376
Bruton agammaglobulinemia tyrosine
1
ACCGAATTTGGCAAGAATGAAATGGT

kinase (BTK), mRNA/cds = (163,

GTCATAAAGATGGGAGGGGAGGGT

2142)

1883
Table 3A
Hs.1282
NM_000085
4559405
complement component 6 (C6),
1
AGCCTGTGACATTAAGCATTCTCACA

mRNA/cds = (155, 2959)

ATTAGAAATAAGAATAAAACCCAT

1884
Table 3A
Hs.2259
NM_000073
4557428
CD3G antigen, gamma polypeptide
1
AAAAATAAAAACAAATACTGT

(TiT3 complex) (CD3G), mRNA/

GTTTCAGAAGCGCCACCTATTGGG

cds = (37, 585)

GAAAA

1885
Table 3A
Hs.36508
NM_000081
4502838
Chediak-Higashi syndrome 1 (CHS1),
1
TTATCACAAGCTCTGTTACCTTTATAT

mRNA/cds = (189, 11594)

ACGCTGCCTCTTCAATTTGGAAA

1886
literature
Hs.32967
NM_000082
4557466
Cockayne syndrome 1 (classical)
1
GCAGAAAATATCCTGGCAGGGAATCT

(CKN1), mRNA/cds = (36, 1226)

GGCTTAAACATGAAATGCTGTAAT

1887
Table 3A
Hs.154654
NM_000104
13325059
cytochrome P450, subfamily 1 (dioxin-
1
TGTGTGCATAATAGCTACAGTGCATA

inducible), polypeptide 1 (glaucoma 3,

GTTGTAGACAAAGTACATTCTGGG

primary infantile) (CYP1B1), mRNA/

cds = (372, 2003)

1888
literature
Hs.77602
NM_000107
4557514
damage-specific DNA binding protein
1
TCTCAGTGGGTGGTAGCAGAGGGAT

2 (48 kD) (DDB2), mRNA/

CAAGCAGTTATTTGATTTGTGCTCT

cds = (175, 1458)

1889
Table 3A
Hs.74635
NM_000108
5016092
dihydrolipoamide dehydrogenase (E3
1
GTCTATTTACGGAACTCAAATACGTG

component of pyruvate dehydrogenase

GGCATTCAAATGTATTACAGTGGG

complex, 2-oxo-glutarate complex,

branched chain keto acid

dehydrogenase complex) (DLD),

mRNA/cds = (82, 1611)

1890
Table 3A
Hs.1602
NM_000110
455874
dihydropyrimidine dehydrogenase
1
TGCACTTTTAGAAATGCATATTTGCCA

(DPYD), mRNA/cds = (101, 3178)

CAAAACCTGTATTACTGAATAAT

1891
Table 3A
Hs.2985
NM_000117
4557552
emerin (Emery-Dreifuss muscular
1
GGGAGGGGATTAACCAAAGGCCACC

dystrophy) (EMD), mRNA/

CTGACTTTGTTTTTGTGGACACACA

cds = (58, 822)

1892
Table 3A
Hs.76753
NM_000118
4557554
endoglin (Osier-Rendu-Weber
1
GCCTGCCCCTGTGTATTCACCACCAA

syndrome 1) (ENG), mRNA/

TAAATCAGACCATGAAACCTGAAA

cds = (350, 2227)

1893
Table 3A
Hs.77929
NM_000122
4557562
excision repair cross-complementing
1
AGGTGTATTTATGTTACCGTTCTGAAT

rodent repair deficiency,

AAACAGAATGGACCATTGAACCA

complementation group 3 (xeroderma

pigmentosum group B complementing)

(ERCC3), mRNA/cds = (95, 2443)

1894
literature
Hs.48576
NM_000123
4503600
excision repair cross-complementing
1
TGTAATGAATTTGTCGCAAAGACGTA

rodent repair deficiency,

ATAAAATTAACTGGTGGCACGGTC

complementation group 5 (xeroderma

pigmentosum, complementation group

G (Cockayne syndrome)) (ERCC5),

mRNA/cds = (197, 3757)

1895
literature
Hs.99924
NM_000124
4557564
excision repair cross-complementing
1
TGTCAATGGAAGTTGGCTGCACTTGA

rodent repair deficiency,

TGTTTGTTTGCATGATGTCTACCT

complementation group 6 (ERCC6),

mRNA/cds = (79, 3757)

1896
db mining
Hs.1657
NM_000125
4503602
estrogen receptor 1 (ESR1), mRNA/
1
TCGAGCACCTGTAAACAATTTTCTCA

cds = (360, 2147)

ACCTATTTGATGTTCAAATAAAGA

1897
Table 3A
Hs.80424
NM_000129
9961355
coagulation factor XIII, A1 polypeptide
1
AACTTTACTAAGTAATCTCACAGCATT

(F13A1), mRNA/cds = (101, 2299)

TGCCAAGTCTCCCAATATCCAAT

1898
literature
Hs.284153
NM_000135
4503654
Fanconi anemia, complementation
1
TAAGATCTTTAAACTGCTTTATACACT

group A (FANCA), mRNA/

GTCACGTGGCTTCATCAGCTGTG

cds = (31, 4398)

1899
literature
Hs.37953
NM_000136
4557588
Fanconi anemia, complementation
1
AAAACCACTACCCTCAGAGAGAGCCA

group C (FANCC), mRNA/

AAAATACAGAAGAGGCGGAGAGCG

cds = (255, 1928)

1900
Table 3A
Hs.1437
NM_000152
11496988
glucosidase, alpha; acid (Pompe
1
CGAGCAAGCCTGGGAACTCAGGAAA

disease, glycogen storage disease type

ATTCACAGGACTTGGGAGATTCTAA

II) (GAA), mRNA/cds = (441, 3299)

1901
Table 3A
Hs.273
NM_000153
4557612
galatosylceramidase (Krabbe
1
GGCTTAGCTACAGTGAAGTTTTGCAT

disease) (GALC), mRNA/

TGCTTTTGAAGACAAGAAAAGTGC

cds = (263, 2272)

1902
Table 3A
Hs.66724
NM_000161
4503948
GTP cyclohydrolase 1 (dopa-
1
ACTTCAAAATTACCTTTTCATATCCAT

responsive dystonia) (GCH1), mRNA/

GATCTTGAGTCCATTTGGGGGAT

cds = (148, 900)

1903
Table 3A
Hs.1466
NM_000167
4504006
glycerol kinase (GK), mRNA/
1
CAAACACTTTTGGGCCAGGATTTGAG

cds = (66, 1640)

TCTCTGCATGACATATACTTGATT

1904
Table 3A
Hs.1144
NM_000174
4504076
glycoprotein IX (platelet) (GP9),
1
CAGACTCCACCAAGCCTGGTCAGCC

mRNA/cds = (222, 755)

CAAACCACCAGAAGCCCAGAATAAA

1905
Table 3A
Hs.75772
NM_000176
4504132
nuclear receptor subfamily 3, group C,
1
AGTGCAGAATCTCATAGGTTGCCAAT

member 1 (NR3C1), mRNA/

AATACACTAATTCCTTTCTATCCT

cds = (132, 2465)

1906
literature
Hs.3248
NM_000179
4504190
mutS (E. coli) homolog 6 (MSH6),
1
AGACTGACTACATTGGAAGCTTTGAG

mRNA/cds = (87, 4169)

TTGACTTCTGACCAAAGGTGGTAA

1907
Table 3A
Hs.183868
NM_000181
4504222
glucuronidase, beta (GUSB), mRNA/
1
CTGGGTTTTGTGGTCATCTATTCTAG

cds = (26, 1981)

CAGGGAACACTAAAGGTGGAAATA

1908
literature
Hs.75860
NM_000182
4504324
hydroxyacyl-Coenzyme A
1
GTGGTGAGGGCAGTTCTGCACCCAG

dehydrogenase/3-ketoacyl-Coenzyme

CCAAACACATAACAATAAAAACCAA

A thiolase/enoyl-Coenzyme A

hydratase (trifunctional protein), alpha

subunit (HADHA), mRNA/

cds = (27, 2318)

1909
Table 3A
Hs.146812
NM_000183
4504326
hydroxyacyl-Coenzyme A
1
TCTGTGTCCTAAAGATGTGTTCTCTAT

dehydrogenase/3-ketoacyl-Coenzyme

AAAATACAAACCAACGTGCCTAA

A thiolase/enoyl-Coenzyme A

hydratase (trifunctional protein), beta

subunit (HADHB), mRNA/

cds = (46, 1470)

1910
Table 3A
Hs.198427
NM_000189
4504392
hexokinase 2 (HK2), mRNA/
1
CTAGTCATAGAAATACCTCATTCGCC

cds = (1490, 4243)

TGTGGGAAGAGAAGGGAAGCCTCT

1911
Table 3A
Hs.83951
NM_000195
4504484
Hermansky-Pudlak syndrome (HPS),
1
AGCAGCGGCTGGATGTGATATGTCTA

mRNA/cds = (206, 2308)

GTTTAACCAGTCCCCTTGATCTTT

1912
Table 3A
Hs.168383
NM_000201
4557877
intercellular adhesion molecule 1
1
TATTGGAGGACTCCCTCCCAGCTTTG

(CD54), rhinovirus receptor (ICAM1).

GAAGGGTCATCCGCGTGTGTGTGT

mRNA/cds = (57, 1655)

1913
Table 3A
Hs.172458
NM_000202
5360215
iduronate 2-sulfatase (Hunter
1
ATACAAAGCAAACAAACTCAAGTTAT

syndrome) (IDS), transcript variant 1,

GTCATACCTTTGGATACGAAGACC

mRNA/cds = (331, 1983)

1914
Table 3A
Hs.238893
NM_000206
4557881
od15g01.s1 cDNA/
1
ATCTACCCTCCGATTGTTCCTGAACC

clone = IMAGE:1388048

GATGAGAAATAAAGTTTCTGTTGA

1915
Table 3A
Hs.83968
NM_000211
4557885
integrin, beta 2 (antigen CD18 (p95),
1
CATGGAGACTTGAGGAGGGCTTGAG

lymphocyte function-associated antigen

GTTGGTGAGGTTAGGTGCGTGTTTC

1; macrophage antigen 1 (mac-1) beta

subunit) (ITGB2), mRNA/

cds = (72, 2381)

1916
literature
Hs.99877
NM_000215
4557680
Janus kinase 3 (a protein tyrosine
1
GCCCAAAGAAGCAAGGAACCAAATTT

kinase, leukocyte) (JAK3), mRNA/

AAGACTCTCGCATCTTCCCAACCC

cds = (95, 3489)

1917
literature
Hs.1770
NM_000234
4557718
ligase I, DNA, ATP-dependent (LIG1),
1
CCGGAGTCTGGGATTCATCCCGTCAT

mRNA/cds = (120, 2879)

TTCTTTCAATAAATAATTATTGGA

1918
db mining
Hs.3076
NM_000246
4557748
MHC class II transactivator
1
GCAATGGCAGCCTTGGCAAACGCTA

(MHC2TA), mRNA/cds = (138, 3530)

AATGAAAATCGTGACAACACTTGTG

1919
literature
Hs.57301
NM_000249
4557756
mutL (E. coli) homolog 1 (colon
1
AGTGTTGGTAGCACTTAAGACTTATA

cancer, nonpolyposis type 2) (MLH1),

CTTGCCTTCTGATAGTATTCCTTT

mRNA/cds = (21, 2291)

1920
literature
Hs.78934
NM_000251
4557760
mutS (E. coli) homolog 2 (colon
1
AACTGAGGACTGTTTGCAATTGACAT

cancer, nonpolyposis type 1) (MSH2),

AGGCAATAATAAGTGATGTGCTGA

mRNA/cds = (66, 2672)

1921
Table 3A
Hs.75514
NM_000270
4557800
nucleoside phosphorylase (NP),
1
GGGCTCAGTTCTGCCTTATCTAAATC

mRNA/cds = (109, 978)

ACCAGAGACCAAACAAGGACTAAT

1922
Table 3A
Hs.76918
NM_000271
4557802
Niemann-Pick disease, type C1
1
GGCATGAAATGAGGGACAAAGAAAG

(NPC1), mRNA/cds = (123, 3959)

CATCTCGTAGGTGTGTCTACTGGGT

1923
Table 3A
Hs.1023
NM_000284
4505684
pyruvate dehydrogenase (lipoamide)
1
TCTTGGAAACTTCCATTAAGTGTGTA

alpha 1 (PDHA1), mRNA/

GATTGAGCAGGTAGTAATTGCATG

cds = (105, 1277)

1924
Table 3A
Hs.78771
NM_000291
4505762
phosphoglycerate kinase 1 (PGK1),
1
ACTACTCAGCATGGAAACAAGATGAA

mRNA/cds = (79, 1332)

ATTCCATTTGTAGGTAGTGAGACA

1925
Table 3A
Hs.196177
NM_000294
4505784
phosphorylase kinase, gamma 2
1
CACTAATGATCCTGCTACCCTCTTGA

(testis) (PHKG2), mRNA/

AGACCAGCCCGGTACCTCTCTCCC

cds = (93, 1313)

1926
Table 3A
Hs.169857
NM_000305
4505952
paraoxonase 2 (PON2), mRNA/
1
GTGACCTCACTTCTGGCACTGTGACT

cds = (32, 1096)

ACTATGGCTGTTTAGAACTACTGA

1927
Table 3A
Hs.3873
NM_000310
4506030
palmitoyl-protein thioesterase 1 (ceroid-
1
AAGCCTTATTCTTCAACTAAAAGATGA

lipofuscinosis, neuronal 1, infantile)

GGATTAAGAGCAAGAAGTTGGGG

(PPT1), mRNA/cds = (13, 933)

1928
Table 3A
Hs.74621
NM_000311
4506112
prion protein (p27-30) (Creutzfeld-
1
GCACTGAATCGTTTCATGTAAGAATC

Jakob disease, Gerstmann-Strausler-

CAAAGTGGACACCATTAACAGGTC

Scheinker syndrome, fatal familial

insomnia) (PRNP), mRNA/

cds = (49, 810)

1929
Table 3A
Hs.288986
NM_000344
13259515
survival of motor neuron 1, telomeric
1
GGTGCTCACATTCCTTAAATTAAGGA

(SMN1), transcript variant d, mRNA/

GAAATGCTGGCATAGAGCAGCACT

cds = (163, 1047)

1930
Table 3A
Hs.2316
NM_000346
4557852
SRY (sex determining region Y)-box 9
1
CTTTTGTTCTCTCCGTGAAACTTACCT

(campomelic dysplasia, autosomal sex-

TTCCCTTTTTCTTTCTCTTTTTT

reversal) (SOX9)

1931
Table 3A
Hs.118787
NM_000358
4507466
transforming growth factor, beta-
1
TGGTATGTAGAGCTTAGATTTCCCTA

induced, 68 kD (TGFBI), mRNA/

TTGTGACAGAGCCATGGTGTGTTT

cds = (47, 2098)

1932
literature
Hs.2030
NM_000361
4507482
Thrombomodulin
1
TGGAGATAATCTAGAACACAGGCAAA

ATCCTTGCTTATGACATCACTTGT

1933
Table 3A
Hs.83848
NM_000365
4507644
triosephosphate isomerase 1 (TPI1),
1
GTGCCTCTGTGCTGTGTATGTGAACC

mRNA/cds = (34, 783)

ACCCATGTGAGGGAATAAACCTAG

1934
db mining
Hs.123078
NM_000369
4507700
thyroid stimulating hormone receptor
1
TGCAAACGGTTTTGTAAGTTAACACT

(TSHR), mRNA/cds = (100, 2394)

ACACTACTCACAATGGTAGGGGAA

1935
literature
Hs.75593
NM_000375
4557872
uroporphyrinogen III synthase
1
CCTGTGCCCAGCAGGAAGGAAGTCA

(congenital erythropoietic porphyria)

AATAAACCACACTGACTACCTGTGC

(UROS), mRNA/cds = (198, 993)

1936
db mining
Hs.2157
NM_000377
4507908
Wiskott-Aldrich syndrome (eczema-
1
CCCAACAATCCCAAGGCCCTTTTTAT

thrombocytopenia) (WAS), mRNA/

ACAAAAATTCTCAGTTCTCTTCAC

cds = (34, 1542)

1937
Table 3A
Hs.250
NM_000379
9257259
xanthene dehydrogenase (XDH),
1
TGTCTGTTTTAATCATGTATCTGGAAT

mRNA/cds = (81, 4082)

AGGGTCGGGAAGGGTTTGTGCTA

1938
literature
Hs.192803
NM_000380
4507936
xeroderma pigmentosum,
1
CACGATGGTGGAAACAGTGGGGAAC

complementation group A (XPA),

TACTGCTGGAAAAAGCCCTAATAGC

mRNA/cds = (26, 847)

1939
Table 3A
Hs.179665
NM_000389
11386202
cyclin-dependent kinase inhibitor 1A
1
CCCTGGAGGCACTGAAGTGCTTAGT

(p21, Cip1) (CDKN1A), mRNA/

GTACTTGGAGTATTGGGGTCTGACC

cds = (75, 569)

1940
Table 3A
Hs.83942
NM_000396
4503150
cathepsin K (pyenodysostosis)
1
ACAAGTTTACATGATAAAAA

(CTSK), mRNA/cds = (129, 1118)

GAAATGTGATTTGTCTTCCCTTCTT

TGCAC

1941
Table 3A
Hs.88974
NM_000397
6996020
cytochrome b-245, beta polypeptide
1
TTGTATGTGAATAATTCTAGCGGGGG

(chronic granulomatous disease)

ACCTGGGAGATAATTCTACGGGGA

(CYBB), mRNA/cds = (14, 1726)

1942
Table 3A
Hs.1395
NM_000399
9845523
early growth response 2 (Krox-20
1
ATCTATTCTAACGCAAAACCACTAACT

(Drosophila) homolog) (EGR2),

GAAGTTCAGATATAATGGATGGT

mRNA/cds = (337, 1768)

1943
Table 3A
Hs.180866
NM_000416
4557879
interferon gamma receptor 1
1
GTAACGGAACATATCCAGTACTCCTG

(IFNGR1), mRNA/cds = (43, 1512)

GTTCCTAGGTGAGCAGGTGATGCC

1944
Table 3A
Hs.1724
NM_000417
4557666
interleukin 2 receptor, alpha (IL2RA),
1
ACTAATTTGATGTTTACAGGTGGACA

mRNA/cds = (159, 977)

CACAAGGTGCAAATCAATGCGTAC

1945
Table 3A
Hs.75545
NM_000418
4557668
interleukin 4 receptor (IL4R), mRNA/
1
TGTGTGTTTTACTTTCATCACCTGTTA

cds = (175, 2652)

TCTGTGTTTGCTGAGGAGAGTGG

1946
Table 3A
Hs.785
NM_000419
6006009
integrin, alpha 2b (platelet glycoprotein
1
TTGGAGCTGTTCCATTGGGTCCTCTT

IIb of IIb/IIIa complex, antigen CD41B)

GGTGTCGTTTCCCTCCCAACAGAG

(ITGA2B), mRNA/cds = (32, 3151)

1947
Table 3A
Hs.77318
NM_000430
5031206
platelet-activating factor
1
ATTTGTTGCTCTCAGACTGTGTAAAA

acetylhydrolase, isoform Ib, alpha

CAAAATTTATTCATGTTTTCTGCA

subunit (45 kD) (PAFAH1B1), mRNA/

cds = (555, 1787)

1948
Table 3A
Hs.949
NM_000433
6557786
neutrophil cytosolic factor 2 (65 kD,
1
CTGAACCATTACTGTAATTGGCTCTT

chronic granulomalous disease.

AAGGCTTGAAGTAACCTTATAGGT

autosomal 2) (NCF2), mRNA/

cds = (67, 1647)

1949
Table 3A
Hs.78146
NM_000442
4505706
platelet/endothelial cell adhesion
1
GCTAAGCTGCCGGTTCTTAAATCCAT

molecule (CD31 antigen) (PECAM1),

CCTGCTAAGTTAATGTTGGGTAGA

mRNA/cds = (141, 2357)

1950
db mining
Hs.166891
NM_000449
4557842
regulatory factor X, 5 (influences HLA
1
TGTAACCAATAAATCTGTAGTGACCT

class II expression) (RFX5), mRNA/

TACCTGTATTCCCTGTGCTATCCT

cds = (161, 2011)

1951
Table 3A
Hs.75428
NM_000454
4507148
superoxide dismutase 1, soluble
1
ACATTCCCTTGGATGTAGTCTGAGGC

(amyotrophic lateral sclerosis 1 (adult))

CCCTTAACTCATCTGTTATCCTGC

(SOD1), mRNA/cds = (0, 464)

1952
Table 3A
Hs.83918
NM_000480
4502078
adenosine monophosphate deaminase
1
ATTTCTCCCTTATCTACTGTGATGACT

(isoform E) (AMPD3), mRNA/

TCAGAAGATACAATGGTCCCAGG

cds = (344, 2674)

1953
Table 3A
Hs.88251
NM_000487
7262293
arylsulfatase A (ARSA), mRNA/
1
TGTCTGGAGGGGGTTTGTGCCTGATA

cds = (375, 1898)

ACGTAATAACACCAGTGGAGACTT

1954
Table 3A
Hs.663
NM_000492
6995995
cystic fibrosis transmembrane
1
ACACTGCCTTCTCAACTCCAAACTGA

conductance regulator. ATP-binding

CTCTTAAGAAGACTGCATTATATT

cassette (sub-family C, member 7)

(CFTR), mRNA/cds = (132, 4574)

1955
Table 3A
Hs.273385
NM_000516
8659565
guanine nucleotide binding protein (G
1
AGATGTTCCAAATTTAGAAAGCTTAA

protein), alpha stimulating activity

GGCGGCCTACAGAAAAAGGAAAAA

polypeptide 1 (GNAS1), mRNA/

cds = (68, 1252)

1956
Table 3A
Hs.155376
NM_000518
13788565
hemoglobin, beta (HBB), mRNA/
1
AAGTCCAACTACTAAACTGGGGGATA

cds = (50, 493)

TTATGAAGGGCCTTGAGCATCTGG

1957
Table 3A
Hs.119403
NM_000520
13128865
hexosaminidase A (alpha polypeptide)
1
ATCCACCTCCCTCCCCTAGAGCTATT

(HEXA), mRNA/cds = (26, 1815)

CTCCTTTGGGTTTCTTGCTGCTGC

1958
Table 3A
Hs.51043
NM_000521
13128866
hexosaminidase B (beta polypeptide)
1
AAAAGGCCACAGCAATCTGTACTACA

(HEXB), mRNA/cds = (75, 1745)

ATCAACTTTATTTTGAAATCATGT

1959
literature
Hs.111749
NM_000534
11496979
postmeiotic segregation increased (S.
1
GATTAGTTACCATTGAAATTGGTTCT

cerevisiae) 1 (PMS1), mRNA/

GTCATAAAACAGCATGAGTCTGGT

cds = (80, 2878)

1960
literature
Hs.177548
NM_000535
11125773
postmeiotic segregation increased (S.
1
AAAAATACACATCACACCCATTTAAAA

cerevisiae) 2 (PMS2), mRNA/

GTGATCTTGAGAACCTTTTCAAA

cds = (24, 2612)

1961
db mining
Hs.301461
NM_000538
4506500
601845227F1 cDNA, 5′ end/
1
ACAGCAACAGCTATTAAATCAGCAAG

clone = IMAGE:4070407/clone_end =

TTTTGGAGCAAAGACAACAGCAGT

5′

1962
literature
Hs.150477
NM_000553
5739523
Werner syndrome (WRN), mRNA/
1
TGACCAGGGCAGTGAAAATGAAACC

cds = (231, 4529)

GCATTTTGGGTGCCATTAAATAGGG

1963
Table 3A
Hs.82212
NM_000560
10834971
CD53 antigen (CD53), mRNA/
1
CAATTTCTTTATTAGAGGGCCTTATTG

cds = (93, 752)

ATGTGTTCTAAGTCTTTCCAGAA

1964
Table 3A
Hs.77424
NM_000566
10835132
Fc fragment of IgG, high affinity Ia,
1
AGAGCTGAAATGTCAGGAACAAAAAG

receptor for (CD64) (FCGR1A),

AAGAACAGCTGCAGGAAGGGGTGC

mRNA/cds = (0, 1124)

1965
literature
Hs.334687
NM_000569
12056966
Fc fragment of IgG, high affinity IIIa,
1
GGTAATAAGAGCAGTAGCAGCAGCAT

receptor for (CD16) (FCGR3A),

CTCTGAACATTTCTCTGGATTTGC

mRNA/cds = (33, 797)

1966
Table 3A
Hs.1369
NM_000574
10835142
decay accelerating factor for
1
AGAGTTTGGAAAAAGCCTGTG

complement (CD55, Cromer blood

AAAGGTGTCTTCTTTGACTTAATG

group system) (DAF), mRNA/

TCTTT

cds = (65, 1210)

1967
Table 3A
Hs.1722
NM_000575
13238493
interleukin 1, alpha (IL1A), mRNA/
1
GTATGGTAGATTCAAATGAACCACTG

cds = (36, 851)

AAAAGGCATTTAGTTTCTTGTCCC

1968
Table 3A
Hs.126256
NM_000576
10835144
interleukin 1, beta (1L1B), mRNA/
1
AGCTATGGAATCAATTCAATTTGGAC

cds = (86, 895)

TGGTGTGCTCTCTTTAAATCAAGT

1969
literature
Hs.54443
NM_000579
4502638
chemokine (C—C motif) receptor 5
1
GCTCTTAAGTTGTGGAGAGTGCAACA

(CCR5), mRNA/cds = (357, 1415)

GTAGCATAGGACCCTACCCTCTGG

1970
Table 3A
Hs.313
NM_000582
4759165
secreted phosphoprotein 1
1
GAATTTGGTGGTGTCAATTGCTTATTT

(osteopontin, bone sialoprotein I, early

GTTTTCCCACGGTTGTCCAGCAA

T-lymphocyte activation 1) (SPP1),

mRNA/cds = (87, 989)

1971
Table 3A
Hs.624
NM_000584
10834977
interleukin 8 (IL8), mRNA/
1
AAAACAGCCAAAACTCCACAGTCAAT

cds = (74, 373)

ATTAGTAATTTCTTGCTGGTTGAA

1972
Table 3A
Hs.168132
NM_000585
10835152
interleukin 15 (IL15), mRNA/
1
TAGCATTTGTTTAAGGGTGATAGTCA

cds = (316, 804)

AATTATGTATTGGTGGGGCTGGGT

1973
Table 3A
Hs.89679
NM_000586
10835148
interleukin 2 (IL2), mRNA/
1
GCAGATGAGACAGCAACCATTGTAGA

cds = (47, 517)

ATTTCTGAACAGATGGATTACCTT

1974
Table 3A
Hs.694
NM_000588
4504666
interleukin 3 (colony-stimulating factor,
1
TCTAATTTCTGAAATGTGCAGCTCCC

multiple) (IL3), mRNA/cds = (9, 467)

ATTTGGCCTTGTGCCGGTTGTGTTC

1975
literature
Hs.73917
NM_000589
4504668
interleukin 4 (IL4), mRNA/
1
ACCAGAGTACGTTGGAAAACTTCTTG

cds = (65, 526)

GAAAGGCTAAAGACGATCATGAGA

1976
Table 3A
Hs.75627
NM_000591
4557416
CD14 antigen (CD14), mRNA/
1
TGAGGACTTTTCGACCAATTCAACCC

cds = (119, 1246)

TTTGCCCCACCTTTATTAAAATCT

1977
Table 3A
Hs.158164
NM_000593
9665247
transporter 1, ATP-binding cassette,
1
GCTGGCCCATAAACACCCTGTAGGTT

sub-family B (MDR/TAP) (TAP1),

CTTGATATTTATAATAAAATTGGT

mRNA/cds = (30, 2456)

1978
Table 3A
Hs.241570
NM_000594
10835154
tumor necrosis factor (TNF
1
CCCAGGGAGTTGTGTCTGTAATCGG

superfamily, member 2) (TNF), mRNA/

CCTACTATTCAGTGGCGAGAAATAA

cds = (65, 786)

1979
Table 3A
Hs.119663
NM_000611
10835164
CD59 antigen p18-20 (antigen
1
TGATCTTGGCTGTATTTAATGGCATA

identified by monoclonal antibodies

GGCTGACTTTTGCAGATGGAGGAA

16.3A5, EJ16, EJ30, EL32 and G344)

(CD59), mRNA/cds = (29, 415)

1980
Table 3A
Hs.856
NM_000619
10835170
interferon, gamma (IFNG), mRNA/
1
TTGTTGACAACTGTGACTGTACCCAA

cds = (108, 608)

ATGGAAAGTAACTCATTTGTTAAA

1981
Table 3A
Hs.172631
NM_000632
6006013
integrin, alpha M (complement
1
GTCAAGATTGTGTTTTGAGGTTTCCT

component receptor 3, alpha: also

TCAGACAGATTCCAGGCGATGTGC

known as CD11b (p170), macrophage

antigen alpha polypeptide) (ITGAM),

mRNA/cds = (75, 3533)

1982
Table 3A
Hs.194778
NM_000634
4504680
interleukin 8 receptor, alpha (IL8RA),
1
TCACCAGTCCCTCCCCAAATGCTTTC

mRNA/cds = (100, 1152)

CATGAGTTGCAGTTTTTTCCTAGT

1983
Table 3A
Hs.318885
NM_000636
10835186
superoxide dismutase 2, mitochondrial
1
TACTTTGGGGACTTGTAGGGATGCCT

(SOD2), mRNA/cds = (4, 672)

TTCTAGTCCTATTCTATTGCAGTT

1984
Table 3A
Hs.2007
NM_000639
4557328
tumor necrosis factor (ligand)
1
CCATCGGTGAAACTAACAGATAAGCA

superfamily, member 6 (TNFSF6),

AGAGAGATGTTTTGGGGACTCATT

mRNA/cds = (157, 1002)

1985
Table 3A
Hs.82846
NM_000655
5713320
selectin L (lymphocyte adhesion
1
AGCTCCTCTTCCTGGCTTCTTACTGA

molecule 1) (SELL), mRNA/

AAGGTTACCCTGTAACATGCAATT

cds = (88, 1206)

1986
Table 3A
Hs.1103
NM_000660
10863872
transforming growth factor, beta 1
1
CACCAGGAACCTGCTTTAGTGGGGG

(TGFB1), mRNA/cds = (841, 2016)

ATAGTGAAGAAGACAATAAAAGATA

1987
Table 3A
Hs.157850
NM_000661
4506664

Homo sapiens, clone MGC:15545
1
GGCTACAGAAAGAAGATGCCAGATG

IMAGE:3050745, mRNA, complete

ACATTAAGACCTACTTGTGATATT

cds/cds = (1045, 1623)

1988
Table 3A
Hs.89499
NM_000698
4502056
arachidonate 5-lipoxygenase (ALOX5),
1
GCATTTCCACACCAAGCAGCAACAGC

mRNA/cds = (44, 2068)

AAATCACGACCACTGATAGATGTC

1989
Table 3A
Hs.78225
NM_000700
4502100
annexin A1 (ANXA1), mRNA/
1
TCCCCAAACCATAAAACCCTATACAA

cds = (74, 1114)

GTTGTTCTAGTAACAATACATGAG

1990
db mining
Hs.89485
NM_000717
9951925
carbonic anhydrase IV (CA4), mRNA/
1
GCTTCCGGTCCTTAGCCTTCCCAGGT

cds = (46, 984)

GGGACTTTAGGCATGATTAAAATA

1991
Table 3A
Hs.97087
NM_000734
4557430
CD3Z antigen, zeta polypeptide (TiT3
1
TGCTATTGCCTTCCTATTTTGCATAAT

complex) (CD3Z), mRNA/

AAATGCTTCAGTGAAAATGCAGC

cds = (178, 669)

1992
db mining
Hs.28408
NM_000752
4505032
leukotriene b4 receptor (chemokine
1
GGAAGAAGAGGGAGAGATGGAGCAA

receptor-like 1) (LTB4R), mRNA/

AGTGAGGGCCGAGTGAGAGCGTGCT

cds = (1717, 2775)

1993
Table 3A
Hs.2175
NM_000760
4503080
colony stimulating factor 3 receptor
1
ATCCAGCCCCACCCAATGGCCTTTTG

(granulocyte) (CSF3R), mRNA/

TGCTTGTTTCCTATAACTTCAGTA

cds = (169, 2679)

1994
literature
Hs.82568
NM_000784
13904863
cytochrome P450, subfamily XXVIIA
1
CTCAGCTAAAAGGCCACCCCTTTATC

(steroid 27-hydroxylase,

GCATTGCTGTCCTTGGGTAGAATA

cerebrotendinous xanthomalosis),

polypeptide 1 (CYP27A1),

mitochondrial protein encoded by

nuclear gene, mRNA/cds = (201, 1796)

1995
Table 3A
Hs.709
NM_000788
4503268
deoxycytidine kinase (DCK), mRNA/
1
ACCTTATGAACTACAGTGGAGCTACA

cds = (159, 941)

CTCATTGAAATGTAATTTCAGTTC

1996
Table 3A
Hs.150403
NM_000790
4503280
dopa decarboxylase (aromatic L-amino
1
TCCAGGGCAATCAATGTTCACGCAAC

acid decarboxylase) (DDC), mRNA/

TTGAAATTATATCTGTGGTCTTCA

cds = (69, 1511)

1997
Table 3A
Hs.83765
NM_000791
7262376
dihydrofolate reductase (DHFR),

GCCAGATTTGGGGCATTTGGAAAGAA

mRNA/cds = (479, 1042)

GTTCATTGAAGATAAAGCAAAAGT

1998
Table 3A
Hs.179661
NM_000801
4503724

Homo sapiens, tubulin, beta 5, clone
1
CTGCACCCTTCCCCCAGCACCATTTA

MGC:4029 IMAGE:3617988, mRNA,

TGAGTCTCAAGTTTTATTATTGCA

complete cds/cds = (1705, 3039)

1999
Table 3A
Hs.324784
NM_000817
4503872
glutamate decarboxylase 1 (brain,
1
TTTTGAAGAAGGGAAATTCACACTGT

67 kD) (GAD1), transcript variant

GCGTTTTGAGTATGCAAGAAGAAT

GAD67, mRNA/cds = (550, 2334)

2000
Table 3A
Hs.11899
NM_000859
4557642
3-hydroxy-3-methylglutaryl-Coenzyme
1
TGTTGTGACTTTTTAGCCAGTGACTTT

A reductase (HMGCR), mRNA/

TTCTGAGCTTTTCATGGAAGTGG

cds = (50, 2716)

2001
literature
Hs.1570
NM_000861
13435403
histamine receptor H1 (HRH1), mRNA/
1
ACTTCACACAGACAAGTGGCTAAGTG

cds = (178, 1641)

TCCATTATTTACCTTGAACAATCA

2002
Table 3A
Hs.83733
NM_000873
10433041
cDNA FLJ11724 fis, clone
1
ACAGCCAACTGGAAAGATATAAAAGT

HEMBA 1005331/cds = UNKNOWN

TTGGGTCTGTCTCCTCTCCTTCAG

2003
Table 3A
Hs.82112
NM_000877
4504658
interleukin 1 receptor, type I (IL1R1),
1
ATTAAAGCACCAAATTCATGTACAGC

mRNA/cds = (82, 1791)

ATGCATCACGGATCAATAGACTGT

2004
Table 3A
Hs.75596
NM_000878
4504664
interleukin 2 receptor, beta (IL2RB),
1
ATGGAAATTGTATTTGCCTTCTCCACT

mRNA/cds = (131, 1786)

TTGGGAGGCTCCCACTTCTTGGG

2005
Table 3A
Hs.2247
NM_000879
4504670
interleukin 5 (colony-stimulating factor,
1
TCAGAGGGAAAGTAAATATTTCAGGC

eosinophil) (IL5), mRNA/cds = (44,

ATACTGACACTTTGCCAGAAAGCA

448)

2006
db mining
Hs.72927
NM_000880
4504676
interleukin 7 (IL7), mRNA/
1
GTGTAACACAGTGCCTTCAATAAATG

cds = (384, 917)

GTATAGCAAATGTTTTGACATGAA

2007
literature
Hs.673
NM_000882
4504638
interleukin 12A (natural killer cell
1
TGGGACTATTACATCCACATGATACC

stimulatory factor 1, cytotoxic

TCTGATCAAGTATTTTTGACATTT

lymphocyte maturation factor 1, p35)

(IL12A), mRNA/cds = (169, 828)

2008
Table 3A
Hs.75432
NM_000884
4504688
IMP (inosine monophosphate)
1
CATTCGTATGAGAAGCGGCTTTTCTG

dehydrogenase 2 (IMPDH2), mRNA/

AAAAGGGATCCAGCACACCTCCTC

cds = (47, 1591)

2009
Table 3A
Hs.40034
NM_000885
6006032
integrin, alpha 4 (antigen CD49D,
1
CTTCAGACTGAACATGTACACCT

alpha 4 subunit of VLA-4 receptor)

GGTTTGAGCTTAGTGAAATGACTT

(ITGA4), mRNA/cds = (1151, 4267)

CCGG

2010
Table 3A
Hs.51077
NM_000887
6006014
integrin, alpha X (antigen CD11C
1
TTTAAATGTTTGTGTTAATACACATTA

(p150), alpha polypeptide) (ITGAX),

AAACATCGCACAAAAACGATGCA

mRNA/cds = (56, 3549)

2011
Table 3A
Hs.1741
NM_00889
4504776
integrin, beta 7 (ITGB7), mRNA/
1
GCAACCTTGCATCCATCTGGGCTACC

cds = (151, 2547)

CCACCCAAGTATACAATAAAGTCT

2012
Table 3A
Hs.81118
NM_000895
4505028
leukotriene A4 hydrolase (LTA4H),
1
TGCTGGTGGGGAAAGACTTAAAAGTG

mRNA/cds = (68, 1903)

GATTAAAGACCTGCGTATTGATGA

2013
literature
Hs.456
NM_000897
4505040
leukotriene C4 synthase (LTC4S),
1
AGGGGCGCTCGCCTTCCGCATCCTAG

mRNA/cds = (96, 548)

TCTCTATCATTAAAGTTCTAGTGAC

2014
Table 3A
Hs.171880
NM_000937
14589948
polymerase (RNA) II (DNA directed)
1
AGCTGATCCTCGGGAAGAACAAAGCT

polypeptide A (220 kD) (POLR2A),

AAAGCTGCCTTTTGTCTGTTATTT

mRNA/cds = (386, 6298)

2015
Table 3A
Hs.183842
NM_000942
4758949
ubiquitin B (UBB), mRNA/
1
CACAGGCCCATGGACTCACTTTTGTA

cds = (94, 783)

ACAAACTCCTACCAACACTGACCA

2016
Table 3A
Hs.74519
NM_000947
4506052
primase, polypeptide 2A (58 kD)
1
AGGAGGAGTTTCTATTAAAATCTGTC

(PRIM2A), mRNA/cds = (87, 1616)

ACTTGAGTGATGTCATTTAAGTCC

2017
Table 3A
Hs.199248
NM_000958
4506258
prostaglandin E receptor 4 (subtype
1
CCTGTGCAATAGACACATACATGTCA

EP4) (PTGER4), mRNA/

CATTTAGCTGTGCTCAGAAGGGCT

cds = (388, 1854)

2018
Table 3A
Hs.199248
NM_000958
4506258
prostaglandin E receptor 4 (subtype
1
CCTGTGCAATAGACACATACATGTCA

EP4) (PTGER4), mRNA/

CATTTAGCTGTGCTCAGAAGGGCT

cds = (388, 1854)

2019
Table 3A
Hs.250505
NM_000964
4506418
retinoic acid receptor, alpha (RARA),
1
TGCACCTGTTACTGTTGGGCTTTCCA

mRNA/cds = (102, 1490)

CTGAGATCTACTGGATAAAGAATA

2020
Table 3A
Hs.119598
NM_000967
4506648
ribosomal protein L3 (RPL3), mRNA/
1
AAGAAGGAGCTTAATGCCAGGAACA

cds = (6, 1217)

GATTTTGCAGTTGGTGGGGTCTCAA

2021
Table 3A
Hs.174131
NM_000970
4506656
ribosomal protein L6 (RPL6), mRNA/
1
AGGGCTACCTGCGATCTGTGTTTGCT

cds = (26, 892)

CTGACGAATGGAATTTATCCTCAC

2022
Table 3A
Hs.153
NM_000971
4506658
ribosomal protein L7 (RPL7), mRNA/
1
CCATGATTATTTTTCTAAGCTGGTTG

cds = (10, 756)

GTTAATAAACAGTACCTGCTCTCA

2023
Table 3A
Hs.99858
NM_000972
4506660
ribosomal protein L7a (RPL7A),
1
AAAGGCTAAAGAACTTGCCACTAAAC

mRNA/cds = (31, 831)

TGGGTTAAATGTACACTGTTGAGT

2024
Table 3A
Hs.178551
NM_000973
4506662
ribosomal protein L8 (RPL8), mRNA/
1
GGAACCAAGACTGTGCAGGAGAAAG

cds = (43, 816)

AGAACTAGTGCTGAGGGCCTCAATA

2025
Table 3A
Hs.179943
NM_000975
4508594
ribosomal protein L11 (RPL11),
1
TGGTTCCAGCAGAAGTATGATGGGAT

mRNA/cds = (0, 536)

CATCCTTCCTGGCAAATAAATTCC

2026
Table 3A
Hs.180842
NM_000977
4506598
ribosomal protein L13 (RPL13),
1
TTGGTTGTTTGGTTAGTGACTGATGT

mRNA/cds = (51, 686)

AAAACGGTTTTCTTGTGGGGAGGT

2027
Table 3A
Hs.234518
NM_000978
14591907
ribosomoal protein L23 (RPL23)
1
ATGCTGGCAGCATTGCATGATTCTCC

AGTATATTTGTAAAAAATAAAAAA

2028
Table 3A
Hs.75458
NM_000979
4506606
ribosomal protein L18 (RPL18),
1
CGGGCCAGCCGAGGCTACAAAAACT

mRNA/cds = (15, 581)

AACCCTGGATCCTACTCTCTTATTA

2029
Table 3A
Hs.272822
NM_000981
4506608
RuvB (E. coli homolog)-like 1
1
ACCTCCCACTTTGTCTGTACATACTG

(RUVBL1), mRNA/cds = (76, 1446)

GCCTCTGTGATTACATAGATCAGC

2030
Table 3A
Hs.184108
NM_000982
4506610
ribosomal protein L21 (gene or
1
TTCAACTAAAGCGCCACCTGCTCCAC

pseudogene) (RPL21), mRNA/

CCAGAGAAGCACACTTTGTGAGAA

cds = (33, 515)

2031
Table 3A
Hs.326249
NM_000983
4506612
ribosomal protein L22 (RPL22),
1
TTGGAAATCATAGTCAAAGGGCTTCC

mRNA/cds = (51, 437)

TTGGTTCGCCACTCATTTATTTGT

2032
Table 3A
Hs.326249
NM_000983
4506612
ribosomal protein L22 (RPL22),
1
TTGGAAATCATAGTCAAAGGGCTTCC

mRNA/cds = (51, 437)

TTGGTTCGCCACTCATTTATTTGT

2033
Table 3A
Hs.184776
NM_000984
4506614
ribosomal protein L23a (RPL23A),
1
CCTGATGGAGAGAAGAAGGCATATGT

mRNA/cds = (23, 493)

TCGACTGGCTCCTGATTACGATGC

2034
Table 3A
Hs.82202
NM_000985
14591906
ribosomal protein L17 (RPL17),
1
CAGAAGAAACTGAAGAAACAA

mRNA/cds = (286, 840)

AAACTTATGGCACGGGAGTAAATT

CAGCA

2035
Table 3A
Hs.184582
NM_000986
4506618
ribosomal protein L24 (RPL24),
1
GTTTCAGCTCCCCGAGTTGGTGGAAA

mRNA/cds = (39, 512)

ACGCTAAACTGGCAGATTAGATTT

2036
Table 3A
Hs.192760
NM_000987
4506620
kinesin family member 5A (KIF5A),
1
CTCCTGTTGGGTAAGGGTGTTGAGTG

mRNA/cds = (148, 3246)

TGACTTGTGCTGAAAACCTGGTTC

2037
Table 3A
Hs.111611
NM_000988
4506622
ribosomal protein L27 (RPL27),
1
GAACAAGTGGTTCTTCCAGAAACTGC

mRNA/cds = (17, 427)

GGTTTTAGATGCTTTGTTTTGATC

2038
Table 3A
Hs.76064
NM_000990
14141189
ribosomal protein L27a (RPL27A),
1
GGCTTGAAGCCACATGGAGGGAGTT

mRNA/cds = (22, 468)

TCATTAAATGCTAACTACTTTTAAA

2039
Table 3A
Hs.184014
NM_000993
4506632
ribosomal protein L31 (RPL31),
1
ATCTACAGACAGTCAATGTGGATGAG

mRNA/cds = (7, 384)

AACTAATCGCTGATCAAATAACGT

2040
Table 3A
Hs.169793
NM_000994
4506634
ribosomal protein L32 (RPL32),
1
GCGCAGTGAAGAAAATGAGTAGGCA

mRNA/cds = (34, 441)

GCTCATGTGCACGTTTTCTGTTTAA

2041
Table 3A
Hs.289093
NM_000996
4506638
cDNA FLJ11509 fis, clone
1
CAATCTTCCTGCTAAGGCCATTGGAC

HEMBA1002166/cds = UNKNOWN

ACAGAATCCGAGTGATGCTGTACC

2042
Table 3A
Hs.179779
NM_000997
4506640
ribosomal protein L37 (RPL37),
1
GGCAGCTGTTGCAGCATCCAGTTCAT

mRNA/cds = (28, 321)

CTTAAGAATGTCAACGATTAGTCA

2043
Table 3A
Hs.5566
NM_000998
4506642
ribosomal protein L37a (RPL37A),
1
AGACGCTCCTCTACCTCTTTGGA

mRNA/cds = (17, 295)

GACATCACTGGCCTATAATAAAT

GGGTT

2044
Table 3A
Hs.300141
NM_001000
4506648
cDNA FLJ14163 fis, clone
1
TCTGTTATGAACACGTTGGTTGGCTG

NT2RP1000409/cds = UNKNOWN

GATTCAGTAATAAATATGTAAGGC

2045
Table 3A
Hs.119500
NM_001004
4506670
ribosomal protein, large P2 (RPLP2),
1
TGAGAAGAAGGAGGAGTCTGAAGAG

mRNA/cds = (74, 421)

TCAGATGATGACATGGGATTTGGCC

2046
Table 3A
Hs.155101
NM_001006
4506722
mRNA for KIAA1578 protein, partial
1
GCTAAAGTTGAACGAGCTGATGGATA

cds/cds = (0, 3608)

TGAACCACCAGTCCAAGAATCTGT

2047
Table 3A
Hs.180911
NM_001008
4506726
ribosomal protein S4, Y-linked
1
GCTGGCCACCAAACAGAGCAGTGGC

(RPS4Y), mRNA/cds = (12, 603)

TAAATTGCAGTAGCAGCATATCTTT

2048
Table 3A
Hs.76194
NM_001009
13904869
ribosomal protein S5 (RPS5), mRNA/
1
GCCAAGTCCAACCGCTGATTTTCCCA

cds = (53, 667)

GCTGCTGCCCAATAAACCTGTCTG

2049
Table 3A
Hs.301547
NM_001011
4506740
ribosomal protein S7 (RPS7), mRNA/
1
TGGTGTCTATAAGAAGCTCACGGGCA

cds = (81, 665)

AGGATGTTAATTTTGAATTCCCAG

2050
Table 3A
Hs.182740
NM_001015
14277698
ribosomal protein S11 (RPS11),
1
AGGCTGGACATCGGCCCGCTCCCCA

mRNA/cds = (33, 509)

CAATGAAATAAAGTTATTTTCTCAT

2051
Table 3A
Hs.165590
NM_001017
14591910
ribosomal protein S13 (RPS13),
1
CATCTACAGCCTCTGCCCTGGTCGCA

mRNA/cds = (32, 487)

TAAATTTGTCTGTGTACTCAAGCA

2052
Table 3A
Hs.80617
NM_001020
14591912
ribosomal protein S16 (RPS16),
1
CTACCAGAAATCCTACCGATAAGCCC

mRNA/cds = (52, 492)

ATCGTGACTCAAAACTCACTTGTA

2053
Table 3A
Hs.5174
NM_001021
14591913
ribosomal protein S17 (RPS17),
1
CTCGGGGACCTGTTTGAATTTTTTCT

mRNA/cds = (25, 432)

GTAGTGCTGTATTATTTTCAATAA

2054
Table 3A
Hs.298262
NM_001022
14591914
ribosomal protein S19 (RPS19),
1
GCTGCCAACAAGAAGCATTAGAACAA

mRNA/cds = (69, 506)

ACCATGCTGGGTTAATAAATTGCC

2055
Table 3A
Hs.182979
NM_001024
14670385
cDNA: FLJ22838 fis, clone KAIA4494,
1
GATGGCATCGTCTCAAAGAACTTTTG

highly similar to HUML12A ribosomal

ACTGGAGAGAATCACAGATGTGGA

protein L12 mRNA/cds = UNKNOWN

2056
Table 3A
Hs.182979
NM_001024
14670385
cDNA: FLJ22838 fis, clone4
1
GATGGCATCGTCTCAAAGAACTTTTG

KAIA4494, highly similar to

ACTGGAGAGAATCACAGATGTGGA

HUML12A ribosomal protein L12

mRNA/cds = UNKNOWN

2057
Table 3A
Hs.215664
NM_001025
14790142
DNA for insulin-like growth factor II
1
CCAATGTTTCTCTTTTGGCCCTATACA

(IGF-2); exon 7 and additional ORF

AAGGCAAGAAGGAAAGACCAAGA

cds = (0, 233)

2058
Table 3A
Hs.180450
NM_001026
14916502
ribosomal protein S24 (RPS24),
1
CTGGCAAAAAGCCGAAGGAGTAAAG

transcript variant 1, mRNA/

GTGCTGCAATGATGTTAGCTGTGGC

cds = (37, 429)

2059
Table 3A
Hs.113029
NM_001028
1451918
ribosomal protein S25 (RPS25),
1
TGGTGAAGATGCATGAATAGGTCCAA

mRNA/cds = (63, 440)

CCAGCTGTACATTTGGAAAAATAA

2060
Table 3A
Hs.539
NM_001032
13904868
ribosomal protein S29 (RPS29),
1
GCCAGTGTTTCCGTCAGTACGCGAA

mRNA/cds = (30, 200)

GGATATCGGTTTCATTAAGTTGGAC

2061
Table 3A
Hs.2934
NM_001033
4506748
ribonucleotide reductase M1
1
GAGTGATAACTCATGAGAAGTACTGA

polypeptide (RRM1), mRNA/

TAGGACCTTTATCTGGATATGGTC

cds = (187, 2565)

2062
Table 3A
Hs.172129
NM_001046
4506974
cDNA: RLJ21409 fis, clone COL03924
1
GGTGATTCTTCTCTGTTGAACTGAAG

cds = UNKNOWN

TTTGTGAGAGTAGTTTTCCTTTGC

2063
Table 3A
Hs.256278
NM_001066
4507576
tumor necrosis factor receptor
1
TGTGTGTTGATCCCAAGACAATGAAA

superfamily, member 1B (TNFRSF1B),

GTTTGCACTGTATGCTGGACGGCA

mRNA/cds = (89, 1474)

2064
literature
Hs.156346
NM_001067
4507632
topoisomerase (DNA) II alpha (170 kD)
1
GGGGAAGGTGTTTTTAGTACAAGACA

(TOP2A), mRNA/cds = (36, 4631)

TCAAAGTGAAGTAAAGCCCAAGTG

2065
Table 3A
Hs.75248
NM_001068
11225253
topoisomerase (DNA) II beta (180 kD)
1
AGGAAAACATCCAAAACAACAAG

(TOP2B), mRNA/cds = (0, 4865)

CAAGAAACCGAAGAAGACATCTT

TTGA

2066
Table 3A
Hs.174140
NM_001096
4501864
ATP citrate lyase (ACLY), mRNA/
1
AGCTGCCACCTCAGTCTCTTCTCTGT

cds = (84, 3401)

ATTATCATAGTCTGGTTTAAATAA

2067
Table 3A
Hs.288061
NM_001101
5016088
actin, beta (ACTB), mRNA/
1
GGAGGCAGCCAGGGCTTACCTGTAC

cds = (73, 1200)

ACTGACTTGAGACCAGTTGAATAAA

2068
db mining
Hs.150402
NM_001105
10862690
activin A receptor, type I (ACVR1),
1
AGCAAAGATTTCAGTAGAATTTTAGT

mRNA/cds = (340, 1869)

CCTGAACGCTACGGGGAAAATGCA

2069
Table 3A
Hs.172028
NM_001110
4557250
a disintegrin and metalloproteinase
1
TGGTGGTATTCAGTGGTCCAGGATTC

domain 10 (ADAM10), mRNA/

TGTAATGCTTTACACAGGCAGTTT

cds = (469, 2715)

2070
Table 3A
Hs.7957
NM_001111
7669471
adenosine deaminase, RNA-specific
1
TGCTTTTATGTGTCCCTTGATAACAGT

(ADAR), transcript variant ADAR-a,

GACTTAACAATATACATTCCTCA

mRNA/cds = (187, 3867)

2071
Table 3A
Hs.172199
NM_001114
4557254
adenylate cyclase 7 (ADCY7), mRNA/
1
TTGTTTCAAAATGCTGTTTCATTTTTA

cds = (265, 3507)

TAAAGTACCAGTGTTTAGCTGCT

2072
Table 3A
Hs.3416
NM_001122
4557260
adipose differentiation-related protein
1
AGAGATGGACAAGAGCAGCCAGGAG

(ADFP), mRNA/cds = (0, 1313)

ACCCAGCGATCTGAGCATAAAACTC

2073
literature
Hs.394
NM_001124
4501944
adrenomedulin (ADM), mRNA/
1
TGAAAGAGAAAGACTGATTACCTCCT

cds = (156, 713)

GTGTGGAAGAAGGAAACACCGAGT

2074
literature
Hs.278398
NM_001151
4502096
DNA sequence from clone RP1-
1
GGAATACCTCCAGAAGAGATGCT

202D23 on chromosome 6q14.1-15

TCATTGAGTGTTCATTAAACCACA

Contains part of the gene for N-

CATG

acetylglucosamine-phosphate mutase.

part of a gene for a novel protein,

ESTs, STSs and GSSs/cds = (0, 5916)

2075
Table 3A
Hs.300711
NM_001154
4809273
annexin A5 (ANXA5), mRNA/
1
ACCATGATACTTTAATTAGAAGCTTAG

cds = (192, 1154)

CCTTGAAATTGTGAACTCTTGGA

2076
Table 3A
Hs.300711
NM_001154
4809273
annexin A5 (ANXA5), mRNA/
1
ACCATGATACTTTAATTAGAAGCTTAG

cds = (192, 1154)

CCTTGAAATTGTGAACTCTTGGA

2077
Table 3A
Hs.118796
NM_001155
4809274
annexin A6 (ANXA6), transcript variant
1
GCCTCTGCCCTGGTTTGGCTATGTCA

1, mRNA/cds = (170, 2191)

GATCCAATAAACATCCTGAACCTC

2078
Table 3A
Hs.75510
NM_001157
4557316
annexin A11 (ANXA11), mRNA/
1
TGCCTTTTCTACCCCATCCCTCACAG

cds = (178, 1695)

CCTCTTGCTGCTAAAATAGATGTT

2079
Table 3A
Hs.14142
NM_001161
4502124
nudix (nucleoside diphosphate linked
1
GGCCAGGCCCAAGTAAGTGTACCTT

moiety X)-type motif 2 (NUDT2),

GTACTTTATAAATAAACCTCAAGCA

mRNA/cds = (174, 617)

2080
Table 3A
Hs.289107
NM_001166
10880127
baculoviral IAP repeat containing 2
1
GCCGAATTGTCTTTGGTGCTTTTCAC

(BIRC2), mRNA/cds = (1159, 3015)

TTGTGTTTTAAAATAAGGATTTTT

2081
Table 3A
Hs.83656
NM_001175
10835001
Rho GDP dissociation inhibitor (GDI)
1
CCCCTGCCAGAGGGAGTTCTTCTTTT

beta (ARHGDIB), mRNA/

GTGAGAGACACTGTAAACGACACA

cds = (152, 757)

2082
Table 3A
Hs.74515
NM_001178
4502232
aryl hydrocarbon receptor nuclear
1
AGAAGTCCCCCATGTGGATATTTCTT

translocator-like (ARNTL), mRNA/
1
ATACTAATTGTATCATAAAGCCGT

cds = (145, 1896)

2083
Table 3A
Hs.6551
NM_001183
4557340
ATPase, H+ transporting, lysosomal
1
GGGCAGGAGCATGGGGTGCTTGGTT

(vacuolar proton pump), subunit 1

GTTTCCTTCCTAATAAAATAAACGC

(ATP6S1), mRNA/cds = (1353, 2198)

2084
literature
Hs.77613
NM_001184
4502324
ataxia telangiectasia and Rad3 related
1
ATGCATTTGGTATGAATCTGTGGTTG

(ATR), mRNA/cds = (79, 8013)

TATCTGTTCAATTCTAAAGTACAA

2085
literature
Hs.2556
NM_001192
4507572
tumor necrosis factor receptor
1
TTCTCTAGGTTACTGTTGGGAGCTTA

superfamily, member 17 (TNFRSF17),

ATGGTAGAAACTTCCTTGGTTTCA

mRNA/cds = (218, 772)

2086
literature
Hs.158303
NM_001198
4557362
PR domain containing 1, with ZNF
1
CCTCCCAGCAACCCACTACCTCTGGT

domain (PRDM1), mRNA/

ACCTGTAAAGGTCAAACAAGAAAC

cds = (223, 2592)

2087
db mining
Hs.87223
NM_001203
4502430
bone morphogenetic protein receptor,
1
CCGTGTCTGTTTGTAGGCGGAGAAAC

type IB (BMPR1B), mRNA/

CGTTGGGTAACTTGTTCAAGATAT

cds = (273, 1781)

2088
Table 3A
Hs.53250
NM_001204
4755129
bone morphogenetic protein receptor,
1
TGAGGGTGAGGGCAGGCTGAGGCAA

type II (serine/threonine kinase)

CGAGTGGGAGGTTCAAACAAGAGTG

(BMPR2), mRNA/cds = (408, 3524)

2089
Table 3A
Hs.101025
NM_001207
4502464
basic transcription factor 3 (BTF3),
1
CCCAAACAATCTGTGGATGGAAAAGC

mRNA/cds = (0, 476)

ACCACTTGCTACTGGAGAGGATGA

2090
Table 3A
Hs.321247
NM_001225
4502576
mRNA: cDNA DKFZp586A181 (from
1
AATCAACTTCAAGGAGCACCTTCATT

clone DKFZp586A181): partial cds/

AGTACAGCTTGCATATTTAACATT

cds = (0, 314)

2091
db mining
Hs.19949
NM_001228
4502582
mRNA for MACH-alpha-1 protein
1
AGGCGATGATATTCTCACCATCCTGA

cds = (291, 1730)

CTGAAGTGAACTATGAAGTAAGCA

2092
literature
Hs.514
NM_001239
4502622
cyclin H (CCNH), mRNA/
1
TGACGACCTGGTAGAATCTCTCTAAC

cds = (60, 1031)

CATTTGAAGTTGATTTCTCAATGC

2093
Table 3A
Hs.180841
NM_001242
4507586
tumor necrosis factor receptor
1
GCTGCGAAAGACCCACATGCTACAA

superfamily, member 7 (TNFRSF7),

GACGGGCAAAATAAAGTGACAGATG

mRNA/cds = (100, 882)

2094
Table 3A
Hs.1314
NM_001243
4507588
tumor necrosis factor receptor
1
CGCCCATGATGGGAGGGATTGACAT

superfamily, member 8 (TNFRSF8),

GTTTCAACAAAATAATGCACTTCCT

mRNA/cds = (222, 2009)

2095
literature
Hs.1313
NM_001244
4507606
tumor necrosis factor (ligand)
1
TCTTTCAGATAGCAGGCAGGGAAGCA

superfamily, member 8 (TNFSF8),

ATGTAGTGTGGTGGGCAGAGCCCC

mRNA/cds = (114, 818)

2096
db mining
Hs.25648
NM_001250
4507580
tumor necrosis factor receptor
1
CAGGAGGATGGCAAAGAGAGTCGCA

superfamily, member 5 (TNFSF5),

TCTCAGTGCAGGAGAGACAGTGAGG

mRNA/cds = (47, 880)

2097
Table 3A
Hs.99899
NM_001252
4507604
tumor necrosis factor (ligand)
1
GGGGGTAGTGGTGGCAGGACAAGAG

superfamily, member 7 (TNFSF7),

AAGGCATTGAGCTTTTTCTTTCATT

mRNA/cds = (137, 718)

2098
db mining
Hs.76688
NM_001266
7262373
carboxylesterase 1
1
GCCATGAAGGAGCAAGTTTTGTATTT

(monocyte.macrophage serine

GTGACCTCAGCTTTGGGAATAAAG

esterase 1) (CES1), mRNA/

cds = (67, 1767)

2099
Table 3A
Hs.22670
NM_001270
4557446
chromodomain helicase DNA binding
1
GCTACTTGTTTACATTGTACACTGCG

protein 1 (CHD1), mRNA/

ACCACCTTGCCGCTTTTCATCACA

cds = (163, 5292)

2100
literature
Hs.20295
NM_001274
4502802
CHK1 (checkpoint, S. pombe) homolog
1
ACCAAGTTTCAGGGGACATGAGTTTT

(CHEK1), mRNA/cds = (34, 1464)

CCAGCTTTTATACACACGTATCTC

2101
db mining
Hs.306440
NM_001278
4502642
mRNA; cDNA DKFZp566L084 (from
1
GGCAAATGAGGAACAGGGCAATAGT

clone DKFZp566L084)/

ATGATGAATCTTGATTGGAGTTGGT

cds = UNKNOWN

2102
Table 3A
Hs.301921
NM_001295
4502630
chemokine (C—C motif) receptor 1
1
TGTTCTTCATCTAAGCCTTCTGGTTTT

(CCR1), mRNA/cds = (62, 1129)

ATGGGTCAGAGTTCCGACTGCCA

2103
Table 3A
Hs.285313
NM_001300
9961348
core promoter element binding protein
1
TATACCATGAGATGAGATGACCACCA

(COPEB)

ATCATTTCCTTGGGGGGAGGGGGT

2104
Table 3A
Hs.90073
NM_001316
4503072
chromosome segregation 1 (yeast
1
CCTAGGAAATCACAGGCTTCTGAGCA

homolog)-like (CSE1L), mRNA/

CAGCTGCATTAAAACAAAGGAAGT

cds = (123, 3038)

2105
Table 3A
Hs.82890
NM_001344
4503252
defender against cell death 1 (DAD1),
1
AAATGTAACCTTTTGCTTTCCAAATTA

mRNA/cds = (66, 407)

AAGAACTCCATGCCACTCCTCAA

2106
Table 3A
Hs.172690
NM_001345
11415023
diacylglycerol kinase, alpha (80 kD)
1
ACACACATACACACACCCCAAAACAC

(DGKA), mRNA/cds = (103, 2310)

ATACATTGAAAGTGCCTCATCTGA

2107
Table 3A
Hs.301305
NM_001352
4503262

Homo sapiens, clone MGC:13202
1
GACCCTATCCTCCCACCGCCTCCGTT

IMAGE:3877838, mRNA, complete

AACACGATCCTGAATAAATCTTGA

cds/cds = (366, 2330)

2108
Table 3A
Hs.306098
NM_001353
5453542
aldo-keto reductase family 1, member
1
ACAGCAAAGCCCATTGGCCAGAAAG

C1 (dihydrodiol dehydrogenase 1: 20-

GAAAGACAATAATTTTGTTTTTTCA

alpha (3-alpha)-hydroxysteroid

dehydrogenase) (AKR1C1), mRNA/

cds = (6, 977)

2109
Table 3A
Hs.74578
NM_001357
13514819
DEAD/H (Asp-Glu-Ala-Asp/His) box
1
AAGGAGTAAAGATTTGCCTTTAAATA

polypeptide 9 (RNA helicase A, nuclear

ACTTGGTATTTTCCTGGCTTTCGT

DNA helicase II; leukophysin) (DDX9),

transcript variant 1, mRNA/

cds = (80, 3919)

2110
Table 3A
Hs.4747
NM_001383
4503336
dyskeratosis congenita 1, dyskerin
1
GGCCTCGTTTACTTTTAAAAAATGAAA

(DKC1), mRNA/cds = (92, 1636)

TTGTTCATTGCTGGGAGAAGAAT

2111
Table 3A
Hs.77462
NM_001379
4503350
DNA (cytosine-5-)methyltransferase 1
1
TCAACTAATGATTTAGTGATCAAATTG

(DNMT1), mRNA/cds = (237, 5087)

TGCAGTACTTTGTGCATTCTGGA

2112
Table 3A
Hs.154210
NM_001400
13027635
endothelial differentiation, sphingolipid
1
TAGGTTTCTGACTTTTGTGGATCATTT

G-protein-coupled receptor, 1 (EDG1),

TGCACATAGCTTTATCAACTTTT

mRNA/cds = (243, 1391)

2113
Table 3A
Hs.274488
NM_001403
4503472
eukaryotic translation elongation factor
1
AAATCAGTACTTTTTAATGGAAACAAC

1 alpha 1-like 14 (EEF1A1L14),

TTGACCCCCAAATTTGTCACAGA

mRNA/cds = (620, 1816)

2114
Table 3A
Hs.2186
NM_001404
4503480

Homo sapiens, eukaryotic translation
1
AGATCTTCAAGTGAACATCTCTTGCC

elongation factor 1 gamma, clone

ATCACCTAGCTGCCTGCACCTGCC

MGC:4501 IMAGE:2964823, mRNA,

complete cds/cds = (2278, 3231)

2115
Table 3A
Hs.129673
NM_001416
4503528
eukaryotic translation initiation factor
1
CAGGAGGGGGGAGGGAAGGGAGCC

4A, isoform 1 (EIF4A1), mRNA/

AAGGGATGGACATCTTGTCATTTTTT

cds = (16, 1236)

2116
Table 3A
Hs.93379
NM_001417
4503532
eukaryotic translation initiation factor
1
GCAAGTATGCTGCTCTCTCTGTTGAT

4B (EIF4B), mRNA/cds = (0, 1835)

GGTGAAGATGAAAATGAGGGAGAA

2117
Table 3A
Hs.183684
NM_001418
4503538
eukaryotic translation initiation factor 4
1
TTGTGGGTGTGAAACAAATGGTGAGA

gamma, 2 (EIF4G2), mRNA/

ATTTGAATTGGTCCCTCCTATTAT

cds = (306, 3029)

2118
Table 3A
Hs.229533
NM_001420
5231299
ol06d12.s1 cDNA, 3′ end/
1
AAAGGGAAAAAGACCTCGTGGA

clone = IMAGE:1522679/clone_end =

GAATTTTTACTGGGGATTCTTGAA

3′

CTTG

2119
Table 3A
Hs.151139
NM_001421
4503554
E74-like factor 4 (els domain
1
AAATGTATTTACTATGCGTGTTTCCAG

transcription factor) (ELF4), mRNA/

CAGTTGGCATTAAAGTGCCTTTT

cds = (382, 2373)

2120
Table 3A
Hs.79368
NM_001423
4503558
epithelial membrane protein 1 (EMP1),
1
ATTTGCATTACTCTGGTGGATTGTTCT

mRNA/cds = (218, 691)

AGTACTGTATTGGGCTTCTTCGT

2121
Table 3A
Hs.9999
NM_001425
4503562
epithelial membrane protein 3 (EMP3),
1
GAGGAGGTCTCTTCTATGCCACCGG

mRNA/cds = (241, 732)

CCTCTGCCAGCTTTGCACCAGCGTG

2122
Table 3A
Hs.254105
NM_001428
4503570
enolase 1, (alpha) (ENO1), mRNA/
1
GCTAGATCCCCGGTGGTTTTGTGCTC

cds = (94, 1398)

AAAATAAAAAGCCTCAGTGACCCA

2123
Table 3A
Hs.115263
NM_001432
4557566
epiregulin (EREG), mRNA/
1
TTTGAAGAGCCATTTTGGTAAACGGT

cds = (166, 675)

TTTTATTAAAGATGCTATGGAACA

2124
Table 3A
Hs.99853
NM_001436
12056464
fibrillarin (FBL), mRNA/cds = (59,
1
GTCAGGATTGCGAGAGATGTGTGTTG

1024)

ATACTGTTGCACGTGTGTTTTTCT

2125
Table 3A
Hs.153179
NM_001444
4557580
fatty acid binding protein 5 (psoriasis-
1
CATGCAGCTATTTCAAAGTGTGTTGG

associated) (FABP5), mRNA/

ATTAATTAGGATCATCCCTTTGGT

cds = (48, 455)

2126
Table 3A
Hs.14845
NM_001455
4503738
forkhead box O3A (FOXO3A), mRNA/
1
TAATGGCCCCTTACCCTGGGTGAAGC

cds = (924, 2945)

ACTTACCCTTGGAACAGAACTCTA

2127
Table 3A
Hs.428
NM_001459
4503750
fms-related tyrosine kinase 3 ligand
1
AAGGCCTCATCCTGGGGAGGATACG

(FLT3LG), mRNA/cds = (92, 799)

TAGGCACACAGAGGGGAGTCACCAG

2128
Table 3A
Hs.99855
NM_001462
4503780
formyl peptide receptor-like 1 (FPRL1),
1
TGGGGTAAGTGGAGTTGGGAAATAC

mRNA/cds = (772, 1827)

AAGAAGAGAAAGACCAGTGGGGATT

2129
Table 3A
Hs.58435
NM_001465
4503820
FYN-binding protein (FYB-120/130)
1
ACCTAGCGGACAATGATGGAGAGAT

(FYB), mRNA/cds = (30, 2381)

CTATGATGATATTGCTGATGGCTGC

2130
Table 3A
Hs.197345
NM_001469
4503840
thyroid autoantigen 70 kD (Ku antigen)
1
GTGATGGTGTAGCCCTCCCACTTTGC

(G22P1), mRNA/cds = (17, 1846)

TGTTCCTTACTTTACTGCCTGAAT

2131
Table 3A
Hs.56845
NM_001494
6598322
GDP dissociation inhibitor 2 (GDI2),
1
GCCTCTACTTCTGTCTCAAAATGGCT

mRNA/cds = (152, 1489)

CCAAATGATTTCTGTACTGCAAAA

2132
Table 3A
Hs.272529
NM_001503
4504088
glycosylphosphatidylinositol specific
1
TCTCCTTCCACAGTTTATTTCCTCGCT

phospholipase D1 (GPLD1), mRNA/

TCCTTTGCATCTAAACCTTTCTT

cds = (32, 2557)

2133
literature
Hs.191356
NM_001515
6681761
general transcription factor IIH,
1
ACACTGTTGCCCTGGCTGTATTCATA

polypeptide 2 (44 kD subunit)

AGATTCCAGCTCCTTCAGGTGTTT

(GTF2H2), mRNA/cds = (0, 1187)

2134
literature
Hs.90304
NM_001516
4504198
general transcription factor IIH,
1
GTCAATATTCTGCAATTTCAGCCCCA

polypeptide 3 (34 kD subunit)

TTTGTACTACGTGCGAGACAGCCT

(GTF2H3), mRNA/cds = (0, 911)

2135
literature
Hs.102910
NM_001517
4504200
general transcription factor IIH,
1
GGCGGGACTGGGCGGGGCGGGGCA

polypeptide 4 (52 kD subunit)

TCAGAACTCAGGTGTTTTTTATTTAC

(GTF2H4), mRNA/cds = (127, 1515)

2136
Table 3A
Hs.187540
NM_001530
4504384
hypoxia-inducible factor 1, alpha
1
TTCCTTTTGCTCTTTGTGGTTGGATCT

subunit (basic helix-loop-helix

AACACTAACTGTATTGTTTTGTT

transcription factor) (HIF1A), mRNA/

cds = (264, 2744)

2137
Table 3A
Hs.235887
NM_001535
4504494
HMT1 (hnRNP methyltransferase, S.
1
ACGTCTTCCAAATAAATTATGTGTTG

cerevisiae)-like 1 (HRMT1L1),

GTGCCATCGCACATGCTCAATAAA

mRNA/cds = 165, 1466)

2138
Table 3A
Hs.94
NM_001539
4504510
heat shock protein, DNAJ-like 2
1
AGGTGGTGTTCAGTGTCACACCTCTT

(HSJ2), mRNA/cds = (82, 1275)

AATGGCCAGTGAATAACACTCACT

2139
Table 3A
Hs.20315
NM_001548
4504584
interferon-induced protein with
1
CTGAGACTGGCTGCTGACTTTGAGAA

tetratricopeptide repeats 1 (IFIT1),

CTCTGTGAGACAAGGTCCTTAGGC

mRNA/cds = (64, 1500)

2140
Table 3A
Hs.181874
NM_001549
4504588
interferon-induced protein with
1
GCAGGGAAGCTTTGCATGTTGCTCTA

tetratricopeptide repeats 4 (IFIT4),

AGGTACATTTTTAAAGAGTTGTTT

mRNA/cds = (61, 1533)

2141
Table 3A
Hs.7879
NM_001550
4504606
interferon-related developmental
1
CGAACCAAAGCTAGAAGCAAATGTCG

regulator 1 (IFRD1), mRNA/

AGATAAGAGAGCAGATGTTGGAGA

cds = (219, 1580)

2142
Table 3A
Hs.239189
NM_001551
4557882
glutaminase (GLS), mRNA/
1
GGAAGGAAAAGAGTGCTGAGAAATG

cds = (19, 2028)

GCTCTGTATAATCTATGGCTATCCG

2143
db mining
Hs.846
NM_001557
4504682
interleukin 8 receptor, beta (IL8RB),
1
ACCAAGGCTAGAACCACCTGCCTATA

mRNA/cds = (408, 1490)

TTTTTTGTTAAATGATTTCATTCA

2144
Table 3A
Hs.327
NM_001558
4504632
interleukin 10 receptor, alpha
1
CCTCTGCCAAAGTACTCTTAGGTGCC

(IL10RA), mRNA/cds = (61, 1797)

AGTCTGGTAACTGAACTCCCTCTG

2145
literature
Hs.73895
NM_001561
5730094
tumor necrosis factor receptor
1
AAAATAATGCACCACTTTTAACAGAA

superfamily, member 9 (TNFRSF9),

CAGACAGATGAGGACAGAGCTGGT

mRNA/cds = (139, 906)

2146
Table 3A
Hs.83077
NM_001562
4504652
interleukin 18 (interferon-gamma-
1
GAATTGGGGGATAGATCTATAATGTT

inducing factor) (IL18), mRNA/

CACTGTTCAAAACGAAGACTAGCT

cds = (177, 758)

2147
Table 3A
Hs.107153
NM_001564
4504694
inhibitor of growth family, member 1-
1
CCGTTTGCTTTCAGAAAATGTTTTAG

like (ING1L), mRNA/cds = (91, 933)

GGTAAATGCATAAGACTATGCAAT

2148
Table 3A
Hs.2248
NM_001565
4504700
small inducible cytokine subfamily B
1
CCCAAATTCTTTCAGTGGCTACCTAC

(Cys-X-Cys), member 10 (SCYBI0),

ATACAATTCCAAACACATACAGGA

mRNA/cds = (66, 362)

2149
Table 3A
Hs.32944
NM_001566
4504704
inositol polyphosphate-4-phosphatase,
1
AAATTAATAAGTCACAAGAAAAA

type I, 107 kD (INPP4A), transcript

CAAAAGTGCCAGAAGATGTCCAG

variant b. mRNA/cds = (294, 3158)

CCAC

2150
Table 3A
Hs.106673
NM_001568
4503520
eukaryotic translation initiation factor 3,
1
AGAGGCTCCTAACTGGGCAACTCAA

subunit 6 (48 kD) (EIF3S6), mRNA/

GATTCTGGCTTCTACTGAAGAACCA

cds = (22, 1359)

2151
Table 3A
Hs.14376
NM_001614
11038618
actin, gamma 1 (ACTG1), mRNA/
1
GGTTTTCTACTGTTATGTGAGAACATT

cds = (74, 1201)

AGGCCCCAGCAACACGTCATTGT

2152
Table 3A
Hs.83636
NM_001619
6138971
adrenergic, beta, receptor kinase 1
1
CAGCTTCTGCCACTTCCCAGGTAAGC

(ADRBK1), mRNA/cds = (85, 2154)

AGGAGGAGGTGCCAACAGTGTTAG

2153
Table 3A
Hs.170087
NM_001621
5016091
aryl hydrocarbon receptor (AHR),
1
ACCATTTTTGTTACTCCTCTTCCA

mRNA/cds = (643, 3189)

CATGTTACTGGATAAATTGTTTA

GTGG

2154
Table 3A
Hs.75313
NM_001628
4502048
aldo-keto reductase family 1, member
1
GTGCCACTAACGGTTGAGTTTTGACT

B1 (aldose reductase) (AKR1B1),

GCTTGGAACTGGAATCCTTTCAGC

mRNA/cds = (45, 995)

2155
Table 3A
Hs.100194
NM_001629
4502058
arachidonate 5-lipoxygenase-activating
1
TCTCCACCACCATCTCCCCTCTACTT

protein (ALOX5AP), mRNA/

CTCATTTCCTAACTCTCTGCTGAA

cds = (30, 515)

2156
Table 3A
Hs.262476
NM_001634
5209326
S-adenosylmethionine decarboxylase
1
GGTGTTGGACTTAAATCAGTTGAAAT

1 (AMD1), mRNA/cds = (320, 1324)

GTATTTCTGTACCACAATTTACGC

2157
Table 3A
Hs.82542
NM_001637
4502114
acyloxyacyl hydrolase (neutrophil)
1
CCCTTCCGCTGTTCCTGAAATAACCT

(AOAH), mRNA/cds = (274, 2001)

TTCATAAAGTGCTTTGGGTGCCAT

2158
Table 3A
Hs.73722
NM_001641
4502136
APEX nuclease (multifunctional DNA
1
TTCTCATGTATAAAACTAGGAATCCTC

repair enzyme) (APEX), mRNA/

CAACCAGGCTCCTGTGATAGAGT

cds = (205, 1161)

2159
literature
Hs.288850
NM_001650
4755123
aquaporin 4 (AQP4), transcript variant
1
AGACACGTCTATCAGCTTATTCCTTC

a. mRNA/cds = (39, 1010)

TCTACTGGAATATTGGTATAGTCA

2160
Table 3A
Hs.792
NM_001656
4502196
ADP-ribosylation factor domain protein
1
TGTCTGGTAACAAGATGTGACTTTTT

1, 64 kD (ARFD1), mRNA/

GGTAGCACTGTTGTGGTTCATTCT

cds = (22, 1746)

2161
Table 3A
Hs.270833
NM_001657
4502198
amphiregulin (schwannoma-derived
1
TCCTCTTTCCAGTGGATCATAAGACA

growth factor) (AREG), mRNA/

ATGGACCCTTTTTGTTATGATGGT

cds = (209, 967)

2162
literature
Hs.74571
NM_001658
6995997
ADP-ribosylation factor 1 (ARF1),
1
ACTGTTTTGTATACTTGTTTTCAGTTT

mRNA/cds = (75, 620)

TCATTTCGACAAACAAGCACTGT

2163
literature
Hs.183153
NM_001661
4502206
ADP-ribosylation factor 4-like
1
ACATAGTTTTTATTTTTGTGTCTGTGA

(ARF4L), mRNA/cds = (158, 761)

AAGTGCCAAGAACCCCTCCCCAC

2164
Table 3A
Hs.77273
NM_001664
10835048
ras homolog gene family, member A
1
TCACCTGGACTTAAGCGTCTGGCTCT

(ARHA), mRNA/cds = (151, 732)

AATTCACAGTGCTCTTTCTCCTCA

2165
Table 3A
Hs.3109
NM_001666
11386132
Rho GTPase activating protein 4
1
AGATGCCTGGCAGGGCTGGGTGGCG

(ARHGAP4), mRNA/cds = (42, 2882)

ATTCATAAAGACCTCGTGTTGATTC

2166
Table 3A
Hs.181243
NM_001675
4502264
activating transcription factor 4 (tax-
1
GGATAGTCAGGAGCGTCAATGTGCTT

responsive enhancer element B67)

GTACATAGAGTGCTGTAGCTGTGT

(ATF4), mRNA/cds = (881, 1936)

2167
Table 3A
Hs.76941
NM_001679
4502280
ATPase, Na+/K+ transporting, beta 3
1
TTGTGAAATATCTTGTTACTGCTTTTA

polypeptide (ATP1B3), mRNA/

TTTAGCAGACTGTGGACTGTAAT

cds = (0, 839)

2168
Table 3A
Hs.73851
NM_001685
4502292
ATP synthase, H+ transporting,
1
CTGGAGGACCTGTTGATGCTAGTTCA

mitochondrial F0 complex, subunit F6

GAGTATCACCAAGAGCTGGAGAGG

(ATP5J), mRNA/cds = (1, 327)

2169
Table 3A
Hs.8110
NM_001686
4502294
L-3-hydroxyacyl-Coenzyme A
1
GCTGCACAAGAGCCTTGATTGAAGAT

dehydrogenase, short chain

ATATTCTTTCTGAACAGTATTTAA

(HADHSC), mRNA/cds = (87, 1031)

2170
Table 3A
Hs.81634
NM_001688
4502298
ATP synthase, H+ transporting,
1
TTGCCTTTATAAAAACTTGCTGCCTG

mitochondrial F0 complex, subunit b,

ACTAAAGATTAACAGGTTATAGTT

isoform 1 (ATP5F1), mRNA/

cds = (32, 802)

2171
Table 3A
Hs.1697
NM_001693
4502310
ATPase, H+ transporting, lysosomal
1
TGGTTCTGCTTTTTGACCTCTCTCTAC

(vacuolar proton pump), beta

CTTTTCAGGGTAATCTTTGTGGC

polypeptide, 56/58 kD, isoform 2

(ATP6B2), mRNA/cds = (25, 1560)

2172
Table 3A
Hs.86905
NM_001695
4502314
ATPase, H+ transporting, lysosomal
1
CCTGTCCTTGTGTTTGTGTGTGCTAA

(vacuolar proton pump) 42 kD

CAGAAATAAGTTGCAGTATGGTCG

(ATP6C), mRNA/cds = (166, 1314)

2173
Table 3A
Hs.76572
NM_001697
4502302
ATP synthase, H+ transporting,
1
AAAAGTGTTGGTTTTCTGCCATCAGT

mitochondrial F1 complex, O subunit

GAAAATTCTTAAACTTGGAGCAAC

(oligomycin sensitivity conferring

protein) (ATP5O), mRNA/

cds = (36, 677)

2174
db mining
Hs.155024
NM_001706
4502382
B-cell CLL/lymphoma 6 (zinc finger
1
AGGGTTTGGCTGTGTCTAAACTGCAT

protein 51) (BCL6), mRNA/

TACCGCGTTGTAAAAAATAGCTGT

cds = (327, 2447)

2175
literature
Hs.2243
NM_001715
4502412
B lymphoid tyrosine kinase (BLK),
1
CCTAGGCTGCGCTCCAGCACTGCGG

mRNA/cds = (222, 1739)

GGCTTTTCTGCAATAAAGTCACGAG

2176
literature
Hs.113916
NM_001716
14589867
Burkitt lymphoma receptor 1, GTP-
1
GGCAGCACAGAGACCCCCGGAACAA

binding protein (BLR1), transcript

GCCTAAAAATTGTTTCAAAATAAAA

variant 2, mRNA/cds = (268, 1271)

2177
Table 3A
Hs.77054
NM_001731
4502472
B-cell translocation gene 1, anti-
1
AAGTCTTTTCCACAAACCACCATCTAT

proliferative (BTG1), mRNA/

TTTGTGAACTTTGTTTAGTCATCT

cds = (308, 823)

2178
db mining
Hs.263812
NM_001736
4502508
nuclear distribution gene C
1
TGGCAAGTTGGAAAATATGTAACTGG

(A. nidulans) homolog (NUDC),

AATCTCAAAAGTTCTTTGGGACAA

mRNA/cds = (90, 1085)

2179
Table 3A
Hs.182278
NM_001743
4502548

Homo sapiens, calmodulin 2
1
TCTGCTTATGGCACAATTTGCCTCAA

(phosphorylase kinase, delta), clone

ATCCATTCCAAGTTGTATATTTGT

MGC:1447 IMAGE:3504793, mRNA,

complete cds/cds = (93, 542)

2180
Table 3A
Hs.155560
NM_001746
10716562
calnexin (CANX), mRNA/
1
CCATTGTTGTCAAATGCCCAGTGTCC

cds = (89, 1867)

ATCAGATGTGTTCCTCCATTTTCT

2181
Table 3A
Hs.76288
NM_001748
12408845
calpain 2, (m/II) large subunit
1
GCTGCCTCTGTAAATTCATGTATTCA

(CAPN2), mRNA/cds = (14, 2244)

AAGGAAAAGACACCTTGCCTATAA

2182
Table 3A
Hs.279607
NM_001750
5729759
calpastatin (CAST), mRNA/
1
TCAAGTCAGCAACAGAGCAAAATAAA

cds = (66, 1358)

GGTTAGATAAGTCCTTGTGTAGCA

2183
Table 3A
Hs.179881
NM_001755
13124872
core-binding factor, beta subunit
1
CTTGCCTTAAGCTACCAGATTGCTTT

(CBFB), transcript variant 2, mRNA/

TGCCACCATTGGCCATACTGTGTG

cds = (11, 559)

2184
Table 3A
Hs.75586
NM_001759
4502616
cyclin D2 (CCND2), mRNA/
1
TGGTTTTGAATGCAATTAGGTTATGC

cds = (269, 1138)

TATTTGGACAATAAACTCACCTTG

2185
Table 3A
Hs.83173
NM_001760
4502618
cyclin D3 (CCND3), mRNA/
1
TGCAAGGTTTAGGCTGGTGGCCCAG

cds = (165, 1043)

GACCATCATCCTACTGTAATAAAGA

2186
Table 3A
Hs.1973
NM_001761
4502620
cyclin F (CCNF), mRNA/
1
GTGTGGTCGGGGTGAGAACCCAAGC

cds = (43, 2403)

GTTGGAACTGTAGACCCGTCCTGTC

2187
literature
Hs.343474
NM_001762
4502642
601885667F1 cDNA, 5′ end/
1
AGCAGCAGTGACATAAAATTCCATGT

clone = IMAGE:4104184/clone_end =

TAGATAAGCATATGTTACTTACCT

5′

2188
Table 3A
Hs.66052
NM_001775
4502664
CD38 antigen (p45) (CD38), mRNA/
1
CTCCACAATAAGGTCAATGCCAGAGA

cds = (69, 971)

CGGAAGCCTTTTTCCCCAAAGTCT

2189
literature
Hs.205353
NM_001776
4502666
ectonucleoside triphosphate
1
TGGAGGTATTCAATATCCTTTGCCTC

diphosphohydrolase 1 (ENTPD1),

AAGGACTTCGGCAGATACTGTCTC

mRNA/cds = (67, 1599)

2190
Table 3A
Hs.901
NM_001778
4502674
CD48 antigen (B-cell membrane
1
GGTGCCCACCATTCTTGGCCTGTTAC

protein) (CD48), mRNA/cds = (36,

TTACCTGAGATGAGCTCTTTTAAC

767)

2191
Table 3A
Hs.287995
NM_001779
4502676
cDNA: FLJ23181 fis, clone LNG11094
1
TTAAGAAGAAATACCCACTAACAAAG

cds = UNKNOWN

AACAAGCATTAGTTTTGGCTGTCA

2192
Table 3A
Hs.82401
NM_001781
4502680
CD69 antigen (p60, early T-cell
1
GCAAGACATAGAATAGTGTTGGAAAA

activation antigen) (CD69), mRNA/

TGTGCAATATGTGATGTGGCAAAT

cds = (81, 680)

2193
Table 3A
Hs.116481
NM_001782
4502682
CD72 antigen (CD72), mRNA/
1
GGGCGGCCCGGAGCCAGCCAGGCA

cds = (108, 1187)

GTTTTATTGAAATCTTTTTAAATAAT

2194
Table 3A
Hs.79830
NM_001783
4502684
CD79A antigen (immunoglobulin-
1
CTGATTGTAGCAGCCTCGTTAGTGTC

associated alpha) (CD79A), transcript

ACCCCCTCCTCCCTGATCTGTCAG

variant 1, mRNA/cds = (36, 716)

2195
literature
Hs.184298
NM_001799
4502742
cyclin-dependent kinase 7 (homolog of
1
AGAGAACACTGGACAACATTTTACTA

Xenopus MO15 cdk-activating kinase)

CTGAGGGAAATAGCCAAAAAGGCA

(CDK7), mRNA/cds = (34, 1074)

2196
Table 3A
Hs.276770
NM_001803
4502760
CDW52 antigen (CAMPATH-1
1
CATGGGGGCAACAGCCAAAATAGGG

antigen) (CDW52), mRNA/

GGGTAATGATGTAGGGGCCAAGCAG

cds = (24, 209)

2197
Table 3A
Hs.10029
NM_001814
4503140
cathepsin C (CTSC), mRNA/
1
TTCTGGAAGATGGTCAGCTATGAAGT

cds = (33, 1424)

AATAGAGTTTGCTTAATCATTTGT

2198
literature
Hs.41
NM_001816
4502794
carcinoembryonic antigen-related cell
1
GGGTGGCTCTGATATAGTAGCTCTGG

adhesion molecule 8 (CEACAM8),

TGTAGTTTCTGCATTTCAAGAAGA

mRNA/cds = (32, 1081)

2199
Table 3A
Hs.83758
NM_001827
4502858
CDC28 protein kinase 2 (CKS2),
1
TTCCAGTCAGTTTTTCTCTTAAGTGCC

mRNA/cds = (95, 334)

TGTTTGAGTTTACTGAAACAGTT

2200
literature
Hs.158324
NM_001837
4502636
chemokine (C—C motif) receptor 3
1
AAGGACCAAGGAGATGAAGCAAACA

(CCR3), mRNA/cds = (31, 1098)

CATTAAGCCTTCCACACTCACCTCT

2201
Table 3A
Hs.3462
NM_001867
4502992
cytochrome c oxidase subunit VIIc
1
AGGTGCAGCCTCTGGAAGTGGATCA

(COX7C), mRNA/cds = (18, 209)

AACTAGAACTCATATGCCATACTAG

2202
Table 3A
Hs.75360
NM_001873
4503008
carboxypeptidase E (CPE), mRNA/
1
ACTTAAAAGTTTAGGGTTTTCTCTTGG

cds = (290, 1720)

TTGTAGAGTGGCCCAGAATTGCA

2203
Table 3A
Hs.1940
NM_001885
4503056
crystallin, alpha B (CRYAB), mRNA/
1
GTCTTGTGACTAGTGCTGAAGCTTAT

cds = (25, 552)

TAATGCTAAGGGCAGGCCCAAATT

2204
Table 3A
Hs.19904
NM_001902
4503124
cystathionase (cystathionine gamma-
1
CCAGAGCTGCTATTAGAAGCTGCTTC

lyase) (CTH), mRNA/cds = (33, 1250)

CTGTGAAGATCAATCTTCCTGAGT

2205
literature
Hs.178452
NM_001903
4503126
catenin (cadherin-associated protein),
1
TCCTCTTTCTCCCAGCTTCAAATGCA

alpha 1 (102 kD) (CTNNA1), mRNA/

CAATTCATCATTGGGCTCACTTCT

cds = (4, 2727)

2206
Table 3A
Hs.297939
NM_001908
4503138
cathepsin B (CTSB), mRNA/
1
CAGCTTCACCCTGTCAAGTTAACAAG

cds = (177, 1196)

GAATGCCTGTGCCAATAAAAGGTT

2207
Table 3A
Hs.78056
NM_001912
4503154
cathepsin L (CTSL), mRNA/
1
CTCGAATCATTGAAGATCCGAGTGTG

cds = (288, 1289)

ATTTGAATTCTGTGATATTTTCAC

2208
literature
Hs.289271
NM_001916
4503184
cytochrome c-1 (CYC1), mRNA/
1
CTTCATCTGGAAGAAGAGGCAAGGG

cds = (8, 985)

GGCAGGAGACCAGGCTCTAGCTCTG

2209
Table 3A
Hs.77494
NM_001929
4503318
deoxyguanosine kinase (DGUOK),
1
AGACTTTGCCATTGTTGCCATTGTTTT

mRNA/cds = (11, 793)

CTTTTGTACCTGAAGCATTTTGA

2210
db mining
Hs.334626
NM_032332
14150113
hypothetical protein MGC4238
1
AAAAGTAGGGGAGGGGCTGGGTCTG

(MGC4238), mRNA/cds = (30, 977)

CAAATTAATAAATAGAAGAGGGGGT

2211
Table 3A
Hs.180383
NM_001946
4503418
dual specificity phosphatase 6
1
GTCGCAAAGGGGATAATCTGGGAAA

(DUSP6), transcript variant 1, mRNA/

GACACCAAATCATGGGCTCACTTTA

cds = (351, 1496)

2212
Table 3A
Hs.82113
NM_001948
4503422
dUTP pyrophosphatase (DUT), mRNA/
1
TCAGTAAACAAATTCTTTCACAAGGTA

cds = (29, 523)

CAAAATCTTGCATAAGCTGAACT

2213
Table 3A
Hs.42287
NM_001952
12669917
E2F transcription factor 6 (E2F6),
1
GTTTTACTTAGGACAAGTTGTACCTT

mRNA/cds = (0, 845)

GCCCTCTCTCCAGCTCTGCTCCCA

2214
literature
Hs.2271
NM_001955
4503460
endothelin 1 (EDN1), mRNA/
1
ACTGGCTTCCATCAGTGGTAACTGCT

cds = (336, 974)

TTGGTCTCTTCTTTCATCTGGGGA

2215
Table 3A
Hs.275959
NM_001959
4503476
eukaryotic translation elongation factor
1
TGGATGTGGCTGCTTTCAACAAGATC

1 beta 2 (EEF1B2), mRNA/

TAAAATCCATCCTGGATCATGGCA

cds = (235, 912)

2216
Table 3A
Hs.326035
NM_001964
4503492
early growth response 1 (EGR1),
1
TGTGGTGTATATCCTTCCAAAAAATTA

mRNA/cds = (270, 1901)

AAACGAAAATAAAGTAGCTGCGA

2217
Table 3A
Hs.79306
NM_001968
4503534
eukaryotic translation initiation factor
1
GTCTTCCATGTGAACAGCATAAGTTT

4E (EIF4E), mRNA/cds = (18, 671)

GGAGCACTAGTTTGATTATTATGT

2218
literature
Hs.99863
NM_001972
4503548
elastase 2, neutrophil (ELA2), mRNA/
1
GCCCACACCCACACTCTCCAGCATCT

cds = (38, 841)

GGCACAATAAACATTCTCTGTTTT

2219
db mining
Hs.211956
NM_012099
6912245
CD3-epsilon-associated protein;
1
AGCTGTTTCCTGGGTAAATCTAGAGT

antisense to ERCC-1 (ASE-1), mRNA/

GGGGTTTTGGTTCTTTATTTTCCC

cds = (488, 2020)

2220
Table 3A
Hs.62192
NM_001993
10518499
coagulation factor III (thromboplastin,
1
GCAGGAGACATTGGTATTCTGGGCA

tissue factor) (F3), mRNA/

GCTTCCTAATATGCTTTACAATCTG

cds = (123, 1010)

2221
Table 3A
Hs.278333
NM_001995
4503650
fatty-acid-Coenzyme A ligase, long-
1
TGGTTTTCATATCAAAAGATCATGTTG

chain 1 (FACL1), nuclear gene

GGATTAACTTGCCTTTTTCCCCA

encoding mitochondrial protein, mRNA/

cds = (73, 2172)

2222
Table 3A
Hs.77393
NM_002004
4503684
famesyl diphosphate synthase
1
ATCTACAAGCGGAGAAAGTGACCTAG

(famesyl pyrophosphate synthetase,

AGATTGCAAGGGCGGGGAGAGGAG

dimethylallyltranstransferase,

geranyltranstransferase) (FDPS),

mRNA/cds = (114, 1373)

2223
Table 3A
Hs.170133
NM_002015
9257221
forkhead box O1A
1
TGTTTAAATGGCTTGGTGTCTTTCTTT

(rhabdomyosarcoma) (FOXO1A),

TCTAATTATGCAGAATAAGCTCT

mRNA/cds = (385, 2352)

2224
Table 3A
Hs.89764
NM_002024
4503764
fragile X mental retardation 1 (FMR1),
1
AAAACTGTACTTTGATTCACATGTTTT

mRNA/cds = (219, 2117)

CAAATGGAGTTGGAGTTCATTCA

2225
Table 3A
Hs.138381
NM_002027
4503770
famesyltransferase, CAAX box, alpha
1
TCCATCAGAGCTGGTCTGCACACTCA

(FNTA), mRNA/cds = (6, 1145)

CATTATCTTGCTATCACTGTAACC

2226
Table 3A
Hs.753
NM_002029
4503778
formyl peptide receptor 1 (FPR1),
1
GACACTTTCGAGCTCCCAGCTCCAGC

mRNA/cds = (81, 1113)

TTCGTCTCACCTTGAGTTAGGCTG

2227
Table 3A
Hs.82954
NM_002032
4503794
ferritin, heavy polypeptide 1 (FTH1),
1
TGTTGGGGTTTCCTTTACCTTTTCTAT

mRNA/cds = (91, 663)

AAGTTGTACCAAAACATCCACTT

2228
Table 3A
Hs.278238
NM_002041
8051596
GA-binding protein transcription factor,
1
AGGAGTCTTTTACCCGGTGTGCTTTG

beta subunit 2 (47 kD) (GABPB2),

CCGCAGTCATCCAAAATAAATTCA

transcript variant gamma, mRNA/

cds = (169, 1251)

2229
Table 3A
Hs.169476
NM_002046
7669491

Homo sapiens, glyceraldehyde-3-
1
TAGGGAGCCGCACCTTGTCATGTACC

phosphate dehydrogenase, clone

ATCAATAAAGTACCCTGTGCTCAA

MGC:10926 IMAGE:3628129, mRNA/

complete cds/cds = (2306, 3313)

2230
db mining
Hs.334695
NM_002050
4503926
GATA-binding protein 2 (GATA2),
1
GCTGTATATAAACGTGTCCCGAGCTT

mRNA/cds = (193, 1617)

AGATTCTGTATGCGGTGACGGCGG

2231
Table 3A
Hs.62661
NM_002053
4503938
guanylate binding protein 1, interferon-
1
TGTCTTATGTGTCAAAAGTCCTAGGA

inducible, 67 kD (GBP1), mRNA/

AAGTGGTTGATGTTTTCTTATAGCA

cds = (68, 1846)

2232
Table 3A
Hs.1674
NM_002056
4503980
glutamine-fructose-6-phosphate
1
GCTGAATGACATATTTTATCTTGTTCT

transaminase 1 (GFPT1), mRNA/

TTAAAATCACAACACAGAGCTGC

cds = (122, 2167)

2233
Table 3A
Hs.296261
NM_002072
4504044
guanine nucleotide binding protein (G
1
TGTCTCTCTCTCTTTTTCTTTTCTATG

protein), q polypeptide (GNAQ),

GAGCAAAACAAAGCTGATTTCCC

mRNA/cds = (220, 1299)

2234
Table 3A
Hs.215595
NM_002074
11321584
guanine nucleotide binding protein (G
1
CAGTGTACTGCAAGGAAGCTGGATG

protein), beta polypeptide 1 (GNB1),

CAAGATAGATACTATATTAAACTGT

mRNA/cds = (280, 1302)

2235
Table 3A
Hs.183773
NM_002078
6715599
golgi autoantigen, golgin subfamily a. 4
1
TGTATTGTATGCAAATCTGTGATTGTT

(GOLGA4), mRNA/cds = (285, 6977)

GGCAGTGTCATCTCTGAGAAACA

2236
Table 3A
Hs.180577
NM_002087
4504150
granulin (GRN), mRNA/cds = (62,
1
GGGGTGTTTGTGTGTGTGCGCGTGT

1843)

GCGTTTCAATAAAGTTTGTACACTT

2237
Table 3A
Hs.2707
NM_002094
4504166
G1 to S phase transition 1 (GSPT1),
1
TTTAGTATTTTTCCCCCAGGCCAGAT

mRNA/cds = (648, 2147)

CATTCGTGAGTGTGCGAGTGTGTG

2238
Table 3A
Hs.75113
NM_002097
4753158
general transcription factor IIIA
1
TGCTTTGTTTAAAGGACTGCAGACCA

(GTF3A), mRNA/cds = (19, 1290)

AGGAGTCGAGCTTTCTCTCAGAGC

2239
Table 3A
Hs.119192
NM_002106
4504254
H2A histone family, member Z
1
ACCTTATTTCCACTCTGGTGGATAAG

(H2AFZ), mRNA/cds = (106, 492)

TTCAATAAAGGTCATATCCCAAAC

2240
Table 3A
Hs.181307
NM_002107
4504278
H3 histone, family 3A (H3F3A),
1
AATGTTGTCTGTCTTCTGTGCTGTTC

mRNA/cds = (374, 784)

CTGTAAGTTTGCTATTAAAATACA

2241
Table 3A
Hs.263435
NM_002108
4809282
histidine ammonia-lyase (HAL),
1
ACCTTCCTCATTTCACAGATAAGGAA

mRNA/cds = (297, 2270)

TCTTTGGGGATTAACCAACCTCCT

2242
literature
Hs.77798
NM_002109
6996013
histidyl-tRNA synthetase (HARS),
1
AGATACCTCCCCACCACCAATTGCCA

mRNA/cds = (455, 1984)

AAGGTCCAATAAAATGCCTCAACC

2243
Table 3A
Hs.89555
NM_002110
4504356
hemopoietic cell kinase (HCK), mRNA/
1
GCAATCCACAATCTGACATTCTCAGG

cds = (168, 1685)

AAGCCCCCAAGTTGATATTTCTAT

2244
db mining
Hs.277477
NM_002117
11321588
major histocompatibility complex, class
1
TCTCAGGCTGCGTGCAGCAACAGTG

I, C (HLA-C), mRNA/cds = (0, 1100)

CCCAGGGCTCTGATGAGTCTCTCAT

2245
Table 3A
Hs.814
NM_002121
4504404
major histocompatibility complex, class
1
GCCTCCAACCATGTTCCCTTCTTCTT

II, DP beta 1 (HLA-DPB1), mRNA/
1
AGCACCACAAATAATCAAAACCCA

cds = (19, 795)

2246
Table 3A
Hs.308026
NM_002125
4504412
major histocompatibility complex, class
1
CTCATCTTCAACTTTTGTGCTCCCCTT

II, DR beta 5 (HLA-DRB5), mRNA/

TGCCTAAACCCTATGGCCTCCTG

cds = (29, 829)

2247
Table 3A
Hs.324278
NM_002128
4504424
mRNA; cDNA DKFZp566M063 (from
1
TGGGGGTTGTAAATTGGCATGGAAAT

clone DKFZp566M063)/

TTAAAGCAGGTTCTTGTTGGTGCA

cds = UNKNOWN

2248
Table 3A
Hs.80684
NM_002129
14141173
high-mobility group (nonhistone
1
TGTGTGTATGGTAGCACAGCAAACTT

chromosomal) protein 2 (HMG2),

GTAGGAATTAGTATCAATAGTAAA

mRNA/cds = (190, 819)

2249
Table 3A
Hs.1119
NM_002135
4504440
nuclear receptor subfamily 4, group A,
1
CCTGCCTGGCTCTCTCTTCCTACCCT

member 1 (NR4A1), mRNA/

CCTTCCACATGTACATAAACTGTC

cds = (110, 1906)

2250
Table 3A
Hs.249495
NM_002136
4504444
heterogeneous nuclear
1
AGATGGGAATGAAGCTTGTGTATCCA

ribonucleoprotein A1 (HNRPA1),

TTATCATGTGTAATCAATAAACGA

transcript variant 2, mRNA/

cds = (104, 1222)

2251
Table 3A
Hs.232400
NM_002137
14043073
heterogeneous nuclear
1
TTAAGATTTTTCTCAAAGTTTTGAAAA

ribonucleoprotein A2/B1 (HNRPA2B1),

GCTATTAGCCAGGATCATGGTGT

transcript variant B1, mRNA/

cds = (169, 1230)

2252
Table 3A
Hs.303827
NM_002138
14110413
heterogenous nuclear
1
TGCGGCTAGTTCAGAGAGATTTTTAG

ribonucleoprotein D (AU-rich element

AGCTGTGGTGGACTTCATAGATGA

RNA-binding protein 1, 37 kD)

(HNRPD), transcript variant 1, mRNA/

cds = (285, 1352)

2253
Table 3A
Hs.146381
NM_002139
4504450
RNA binding motif protein, X
1
CCATTTTGCCTTTCTGACATTTCCTTG

chromosome (RBMX), mRNA/

GGAATCTGCAAGAACCTCCCCTT

cds = (11, 1186)

2254
Table 3A
Hs.2733
NM_002145
4504464
homeo box B2 (HOXB2), mRNA/
1
TTCCGTTTGGTAGACTCCTTCCAATG

cds = (78, 1148)

AAATCTCAGGAATAATTAAACTCT

2255
Table 3A
Hs.3268
NM_002155
4504514
heat shock 70 kD protein 6 (HSP70B*)
1
GGCAGAGAAGGAGGAGTATGAGCAT

(HSPA6), mRNA/cds = (0, 1931)

CAGAAGAGGGAGCTGGAGCAAATCT

2256
Table 3A
Hs.79037
NM_002156
4504520

Homo sapiens, heat shock 60 kD
1
AGCAGCCTTTCTGTGGAGAGTGAGAA

protein 1 (chaperonin), clone

TAATTGTGTACAAAGTAGAGAAGT

MGC:19755 IMAGE:3630225, mRNA/

complete cds/cds = (1705, 3396)

2257
Table 3A
Hs.1197
NM_002157
4504522
heat shock 10 kD protein 1 (chaperonin
1
AATGATAACTAATGACATCCAGTGTC

10) (HSPE1), mRNA/cds = (41, 349)

TCCAAAATTGTTTCCTTGTACTGA

2258
db mining
Hs.93177
NM_002176
4504602
interferon, beta 1, fibroblast (IFNB1),
1
TCCCTCTGGGACTGGACAATTGCTTC

mRNA/cds = (0, 563)

AAGCATTCTTCAACCAGCAGATGC

2259
Table 3A
Hs.82065
NM_002184
4504674
interleukin 6 signal transducer (gp130,
1
CGGCTACATGCCTCAGTGAAGGACTA

oncostatin M receptor) (IL6ST),

GTAGTTCCTGCTACAACTTCAGCA

mRNA/cds = (255, 3011)

2260
Table 3A
Hs.237888
NM_002185
4504678
interleukin 7 receptor (IL7R), mRNA/
1
CATGAGTCAAGAGCATCCTGCTTCTA

cds = (22, 1401)

CCATGTGGATTTGGTCACAAGGTT

2261
db mining
Hs.1702
NM_002186
4504684
interleukin 9 receptor precursor (IL9R)
1
GTCAGAGGTCCTGTCTGGATGGAGG

gene, complete cds/cds = (214, 1779)

CTGGAGGCTCCCCCCTCAACCCCTC

2262
db mining
Hs.674
NM_002187
4504640
interleukin 12B (natural killer cell
1
CCTGATACACAATTATGACCAGAAAA

stimulatory factor 2, cytotoxic

TATGGCTCCATGAAGGTGCTACTT

lymphocyte maturation factor 2, p40)

(IL12B), mRNA/cds = (13, 999)

2263
Table 3A
Hs.41724
NM_002190
4504650
interleukin 17 (cytotoxic T-lymphocyte-
1
ATTCAATTCCAGAGTAGTTTCAAGTTT

associated serine esterase 8) (IL17),

CACATCGTAACCATTTTCGCCCG

mRNA/cds = (53, 520)

2264
Table 3A
Hs.80645
NM_002198
4504720
interferon regulatory factor 1 (IRF1),
1
TGGAAATGTCATCTAACCATTAAGTC

mRNA/cds = (197, 1174)

ATGTGTGAACACATAAGGACGTGT

2265
Table 3A
Hs.83795
NM_002199
4755144
interferon regulatory factor 2 (IRF2),
1
AATTCCCAGATTTGAAGACAAAAATA

mRNA/cds = (177, 1226)

CTCTAATTCTAACCAGAGCAAGCT

2266
Table 3A
Hs.334450
NM_002200
4504726
interferon regulatory factor 5 (IRF5),
1
TGGCAGCTACCCCCTTCTTGAGAGTC

transcript variant 1, mRNA/

CAAGAACCTGGAGCAGAAATAATT

cds = (102, 1616)

2267
Table 3A
Hs.241545
NM_002208
6007850

Homo sapiens, Similar to hypothetical
1
TTCCTTCAGGATGATCTAGAGCAGCA

protein, clone MGC:1824

TGGAGCTGTTGGTAGAATATTAGT

IMAGE:3509518, mRNA, complete

cds/cds = (533, 1504)

2268
Table 3A
Hs.174103
NM_002209
4504756
integrin, alpha L (antigen CD11A
1
TGCCAAGCACAGTGCCTGCATGTATT

(p180), lymphocyte function-associated

TATCCAATAAATGTGAAATTCTGT

antigen 1: alpha polypeptide) (ITGAL),

mRNA/cds = (88, 3600)

2269
Table 3A
Hs.287797
NM_002211
4504766
mRNA for FLJ00043 protein, partial
1
ACCACTGTATGTTTACTTCTCACCATT

cds/cds = (0, 4248)

TGAGTTGCCCATCTTGTTTCACA

2270
Table 3A
Hs.5215
NM_002212
4504770
integrin beta 4 binding protein
1
GGCTGAGGGTTCTGCTGTCCTGTGC

(ITGB4BP), mRNA/cds = (70, 807)

CACCCCATTAAAGTGCAGTTCCTCC

2271
Table 3A
Hs.50651
NM_002227
4504802
Janus kinase 1 (a protein tyrosine
1
ACCATCCAATCGGACAAGCTTTCAGA

kinase) (JAK1), mRNA/cds = (75,

ACCTTATTGAAGGATTTGAAGCAC

3503)

2272
Table 3A
Hs.198951
NM_002229
4504808
jun B proto-oncogene (JUNB)
1
AGTCTCTAAAGAGTTTATTTTAAGACG

TGTTTGTGTTTGTGTGTGTTTGT

2273
Table 3A
Hs.3886
NM_002267
4504898
karyopherin alpha 3 (importin alpha 4)
1
TGGAAGACTAAAGAGGTGCAATGTGA

(KPNA3), mRNA/cds = (91, 1656)

TCTGAGCCTCCATCATTGTCCTCC

2274
Table 3A
Hs.74011
NM_002286
11693297
lymphocyte-activation gene 3 (LAG3),
1
GCAGCCAGCAGATCTCAGCAGCCCA

mRNA/cds = (349, 1938)

GTCCAAATAAACGTCCTGTCTAGCA

2275
Table 3A
Hs.334822
NM_002295
9845501

Homo sapiens. Similar to ribosomal
1
GGTAGGAGCAACCACTGACTGGTCTT

protein L4, clone MGC:2966

AAGCTGTTCTTGCATAGGCTCTTA

IMAGE:3139805, mRNA, complete

cds/cds = (1616, 2617)

2276
Table 3A
Hs.152931
NM_002298
4504960
lamin B receptor (LBR), mRNA/
1
TCAGCTACACTTTGTTTTTAAGTTTGT

cds = (75, 1922)

TTTTGACATGTTTATTTGGCAAA

2277
Table 3A
Hs.76506
NM_002298
7382490
lymphocyte cytosolic protein 1 (L-
1
TCCCCCCTCCGCCTCCCAGGAAGAA

plastin) (LCP1), mRNA/

AGAATGTTACTGCCTTAATAAAAAA

cds = (173, 2056)

2278
Table 3A
Hs.234489
NM_002300
4557031

Homo sapiens, lactate dehydrogenase
1
GTGAATTTGGGCTCACAGAATCAAAG

B, clone MGC:3600 IMAGE:3028947,

CCTATGCTTGGTAGCTCTTGAACA

mRNA, complete cds/cds = (1745,

2749)

2279
Table 3A
Hs.2250
NM_002309
6006018
leukemia inhibitory factor (cholinergic
1
TCCTTCCTTTCCACTGAAAAGCACAT

differentiation factor) (LIF), mRNA/

GGCCTTGGGTGACAAATTCCTCTT

cds = (64, 672)

2280
Table 3A
Hs.2798
NM_002310
6042197
leukemia inhibitory factor receptor
1
AGAAATGTTCAGTAATGAAAAAATATA

(LIFR), mRNA/cds = (153, 3446)

TCCAATCAGAGCCATCCCGAAAA

2281
literature
Hs.166091
NM_002312
4504996
ligase IV, DNA, ATP-dependent
1
TTTTAACTTTTAAGGTTGAAAAGA

(LIG4), mRNA/cds = (474, 3008)

CAATAGCCCAAATCCAAGAAAGA

AAA

2282
Table 3A
Hs.158203
NM_002313
6006043
actin binding LIM protein 1 (ABLIM),
1
GCACTCCTTTGTCATATACTCTGCAT

transcript variant ABLIM-1, mRNA/

CACTGTCATACTCACAACTTCGTG

cds = (99, 2435)

2283
Table 3A
Hs.890
NM_002341
4505034
lymphotoxin beta (TNF superfamily,
1
TGGCAGTGGGAAAAATGTAGGAGAC

member 3) (LTB), transcript variant 1,

TGTTTGGAAATTGATTTTGAACCTG

mRNA/cds = (8, 742)

2284
literature
Hs.1116
NM_002342
4505038
lymphotoxin beta receptor (TNFR
1
CATGCAAATAAAAAGAATGGGACCTA

superfamily, member 3) (LTBR),

AACTCGTGCCGCTCGTGCCGAATT

mRNA/cds = (168, 1475)

2285
Table 3A
Hs.105938
NM_002343
4505042
lactotransferrin (LTF), mRNA/
1
GGATTGCCCATCCATCTGCTTACAAT

cds = (294, 2429)

TCCCTGCTGTCGTCTTAGCAAGAA

2286
Table 3A
Hs.210
NM_002344
4505044
leukocyte tyrosine kinase (LTK),
1
GAGCACTGGATTGCTTTCCCATTATG

mRNA/cds = (170, 2581)

AGCGTCCTTCATCTGGGCAGACCC

2287
Table 3A
Hs.80887
NM_002350
4505054
v-yes-1 Yamaguchi sarcoma viral
1
AACCGGATATATACATAGCATGACAT

related oncogene homolog (LYN),

TTCTTTGTGCTTTGGCTTACTTGT

mRNA/cds = (297, 1835)

2288
Table 3A
Hs.75709
NM_002355
10947032
mannose-6-phosphate receptor (cation
1
ATTTGTTTGCATCCCTCCCCCACACC

dependent) (M6PR), mRNA/

CTGGTGTTTTAAAATGAAGAAAAA

cds = (170, 1003)

2289
Table 3A
Hs.330716
NM_002356
11125771
cDNA FLJ14368 fis, clone
1
AAACTCCTGCTTAAGGTGTTCTAATTT

HEMBA1001122/cds = UNKNOWN

TCTGTGAGCACACTAAAAGCGAA

2290
Table 3A
Hs.69547
NM_002385
4505122
myelin basic protein (MBP), mRNA/
1
GACATGCGGGCTGGGCAGCTGTTAG

cds = (10, 570)

AGTCCAACGTGGGGCAGCACAGAGA

2291
Table 3A
Hs.172195
NM_002408
6031183
mannosyl (alpha-1,6-)-glycoprotein
1
ACCAAAATTCAGTGAAGGCATTCTAC

beta-1,2-N-

AAGTTTTGAGTTAGCATTACATTT

acetylglucosaminyltransferase

(MGAT2), mRNA/cds = (489, 1832)

2292
literature
Hs.1384
NM_002412
4505176
O-6-methylguanine-DNA
1
TAACACTGCATCGGATGCGGGGCGT

methyltransferase (MGMT), mRNA/
1
GGAGGCACCGCTGTATTAAAGGAAG

cds = (40, 663)

2293
Table 3A
Hs.177543
NM_002414
4505182
antigen identified by monoclonal
1
TCCATCGAGCACGTCTGAAACCCCTG

antibodies I2E7, F21 and O13 (MIC2),

GTAGCCCCGACTTCTTTTTAATTA

mRNA/cds = (123, 680)

2294
db mining
Hs.83169
NM_002421
13027798
matrix metalloproteinase 1 (interstitial
1
CAGTCACTGGTGTCACCCTGGATAG

collagenase) (MMP1), mRNA/

GCAAGGGATAACTCTTCTAACACAA

cds = (71, 1480)

2295
db mining
Hs.83326
NM_002422
13027803
matrix metalloproteinase 3
1
GGGAAGCACTCGTGTGCAACAGACA

(stromelysin 1, progelatinase) (MMP3),

AGTGACTGTATCTGTGTAGACTATT

mRNA/cds = (63, 1496)

2296
db mining
Hs.2256
NM_002423
13027804
matrix metalloproteinase 7 (matrilysin,
1
TCTATGAGCTTTGTCAGTGCGCGTAG

uterine) (MMP7), mRNA/cds = (47,

ATGTCAATAAATGTTACATACACA

850)

2297
db mining
Hs.73862
NM_002424
4505220
matrix metalloproteinase 8 (neutrophil
1
ATATGGTGCTGTTTTCTACCCTTGGA

collagenase) (MMP8), mRNA/

AAGAAATGTAGATGATATGTTTCG

cds = (71, 1474)

2298
db mining
Hs.2258
NM_002425
4505204
matrix metalloproteinase 10
1
TTGCTAGGCGAGATAGGGGGAAGAC

(stromelysin 2) (MMP10), mRNA/

AGATATGGGTGTTTTTAATAAATCT

cds = (22, 1452)

2299
db mining
Hs.1695
NM_002426
4505206
matrix metalloproteinase 12
1
AAGTTGCTTCCTAACATCCTTGGACT

(macrophage elastase) (MMP12),

GAGAAATTATACTTACTTCTGGCA

mRNA/cds = (12, 1424)

2300
db mining
Hs.2936
NM_002427
13027796
matrix metalloproteinase 13
1
CTCAGGCAAAGAAAATGAAATGCATA

(collagenase 3) (MMP13), mRNA/

TTTGCAAAGTGTATTAGGAAGTGT

cds = (28, 1443)

2301
literature
Hs.82380
NM_002431
4505224
menage a trois 1 (CAK assembly
1
TGGAAGAGAGGAATAAATAATTCACC

factor) (MNAT1), mRNA/cds = (34,

TATATGTGTTTGAGGTTGTGACAG

963)

2302
literature
Hs.79396
NM_002434
4505232
N-methylpurine-DNA glycosylase
1
GCCTGAGCAAAGGGCCTGCCCAGAC

(MPG), mRNA/cds = (146, 1042)

AAGATTTTTTAATTGTTTAAAAACC

2303
Table 3A
Hs.1861
NM_002436
6006024
membrane protein, palmitoylated 1
1
AAATGACACATCTGTGCAATAGAATG

(55 kD) (MPP1), mRNA/

ATGTCTGCTCTAGGGAAACCTTCA

cds = (115, 1515)

2304
literature
Hs.42674
NM_002439
4505248
mutS (E. coli) homolog 3 (MHS3),
1
ATATTTTTATTTGTTTCAGTTCAGATA

mRNA/cds = (16, 3402)

ATTGGCAACTGGGTGAATCTGGC

2305
literature
Hs.115246
NM_002440
4505250
mutS (E. coli) homolog 4 (MSH4),
1
TTCCCAGGACCGAACAAGTTCCAGAA

mRNA/cds = (41, 2851)

AAGACTGAAGAATAATCACAATTC

2306
literature
Hs.112193
NM_002441
4505252
mRNA for G7 protein (G7 gene
1
TTCCTTATCTCCCTCAGACGCAGAGT

located in the class III region of the

TTTTAGTTTCTCTAGAAATTTTGT

major histocompatibility complex/

cds = (56, 2611)

2307
Table 3A
Hs.288742
NM_002444
4505256
cDNA: FLJ22712 fis, clone HSI13435/
1
TTTTGGAGGGGTTTATGCTCAATCCA

cds = UNKNOWN

TGTTCTATTTCAGTGCCAATAAAA

2308
literature
Hs.388
NM_002452
4505274
nudix (nucleoside diphosphate linked
1
CATTGAGTGGGCGCAGAGCCGGGTTT

moiety X)-type motif 1 (NUDT1),

CATCTGGAATTAACTGGATGGAAGG

mRNA/cds = (26, 496)

2309
Table 3A
Hs.82132
NM_002460
4505286
interferon regulatory factor 4 (IRF4),
1
TGGAAATTCCCGTGTTGCTTCAAACT

mRNA/cds = (105, 1460)

GAGACAGATGGGACTTAACAGGCA

2310
Table 3A
Hs.82132
NM_002460
4505286
interferon regulatory factor 4 (IRF4)
1
TGGAAATTCCCGTGTTGCTTCAAACT

mRNA/cds = (105, 1460)

GAGACAGATGGGACTTAACAGGCA

2311
Table 3A
Hs.76391
NM_002462
4505290
myxovirus (influenza) resistance 1,
1
CGTCCTGCGGAGCCCTGTCTCCTCT

homolog of murine (interferon-inducible

CTCTGTAATAAACTCATTTCTAGCC

protein p78) (MX1), mRNA/

cds = (345, 2333)

2312
Table 3A
Hs.926
NM_002463
11342663
myxovirus (influenza) resistance 2,
1
TTTCCCTGATTATGATGAGCTTCCATT

homolog of murine (MX2), mRNA/

GTTCTGTTAAGTCTTGAAGAGGA

cds = (104, 2251)

2313
Table 3A
Hs.79070
NM_002467
12962934
v-myc avian myelocytomatosis viral
1
CAAATGCAACCTCACAACCTTGGCTG

oncogene homolog (MYC), mRNA/

AGTCTTGAGACTGAAAGATTTAGC

cds = (558, 1877)

2314
Table 3A
Hs.243886
NM_002482
4505332
nuclear autoantigenic sperm protein
1
GGGACACTGGAGGCTGGAGCTACAG

(histone-binding) (NASP), mRNA/

TTGAAAGCACTGCATGTTAAGAGGG

cds = (85, 2448)

2315
Table 3A
Hs.25812
NM_002485
6996019
Nijmegen breakage syndrome 1
1
TCTGTCATGCCCACAATCCCTTTCTA

(nibrin) (NBS1), mRNA/cds = (52,

AGGAAGACTGCCCTACTATAGCAG

2316)

2316
Table 3A
Hs.19236
NM_002492
4505382
NADH dehydrogenase (ubiquinone) 1
1
GGAGAAATAGGAATTTGTGAACCCCT

beta subcomplex, 5 (16 kD, SGDH)

AAAATTGTAGCAACTTTGAAAGGT

(NDUFB5), mRNA/cds = (6, 575)

2317
Table 3A
Hs.10758
NM_002495
4505368
NADH dehydrogenase (ubiquinone) Fe
1
ACAAGAGTATCCACAAAATAGGTTGG

S protein 4 (18 kD) (NADH-coenzyme

CACTGACTATATCTCTGCTTGACT

Q reductase) (NDUFS4), mRNA/

cds = (8, 535)

2318
literature
Hs.1827
NM_002507
4505392
nerve growth factor receptor (TNFR
1
GCCCTCCTGAAACTTACACACAAAAC

superfamily, member 16) (NGFR),

GTTAAGTGATGAACATTAAATAGC

mRNA/cds = (113, 1396)

2319
Table 3A
Hs.82226
NM_002510
4505404
glycoprotein (transmembrane) nmb
1
AAACCATCTACTATATGTTAGACATGA

(GPNMB), mRNA/cds = (91, 1773)

CATTCTTTTTCTCTCCTTCCTGA

2320
Table 3A
Hs.214
NM_002515
4505424
neuro-oncoligcal ventral antigen 1
1
GTGTATCTCGTGGAATCAGTGGTTAG

(NOVA1), transcript variant 1, mRNA/

CATTGCCGCTATTATATTTACTCA

cds = (60, 1592)

2321
Table 3A
Hs.89385
NM_002519
4505430
nuclear protein, ataxia-telangiectasia
1
TTGTGATGTTAAGAAATTTGTATGGT

locus (NPAT), mRNA/cds = (34, 4317)

GTGGCAGTGGTCTATTCCTAAGGA

2322
Table 3A
Hs.9614
NM_002520
10835082
nucleophosmin (nucleolar
1
CGGATGACTGACCAAGAGGCTATTCA

phosphoprotein B23, numatrin)

AGATCTCTGGCAGTGGAGGAAGTC

(NPM1), mRNA/cds = (0, 884)

2323
Table 3A
Hs.153952
NM_002526
4505466
5′ nucleotidase (CD73) (NT5), mRNA/
1
CCTAAATCTGTGTGTGTATTGTGAAG

cds = (49, 1773)

TGGTATAAGAAATGACTTTGAACC

2324
Table 3A
Hs.66198
NM_002528
6224977
nth (E. coli endonuclease III)-like 1
1
CAGGCTGAGGTGGACCAAGAAGGCA

(NTHL1), mRNA/cds = (0,938)

ACCAAGTCCCCAGAGGAGACCCGCG

2325
Table 3A
Hs.264981
NM_002535
4505484
Z-5′-oligoadenylate synthetase 2 (69-
1
GAATGTAGGGAAGAGGTGCCAAGCC

71 kD) (OAS2), transcript variant 2,

AACCGTGGGGTTAGCTCTAATTATT

mRNA/cds = (19, 2082)

2326
Table 3A
Hs.74563
NM_002537
9845508
ornithine decarboxylase antizyme 2
1
ACGGGGATGTCAGGGAGGCAAGTGT

(OAZ2), mRNA/cds = UNKNOWN

GTTGTGTTACTGTGTCAATAAACTG

2327
Table 3A
Hs.75212
NM_002539
4505488
ornithine decarboxylase 1 (ODC1)
1
GGCAGAATGGGCCAAAAGCTTAGTG

mRNA/cds = (334, 1719)

TTGTGACCTGTTTTTAAAATAAAGT

2328
literature
Hs.96398
NM_002542
7949101
8-oxoguanine DNA glycosylase
1
CAAGATGGGGTGGGGGATATTGAGG

(OGG1), nuclear gene encoding

GAGACAGCGCTAAGGATGGTTTTAT

mitochondrial protein, transcript variant

1b, mRNA/cds = (1266, 2240)

2329
Table 3A
Hs.77729
NM_002543
4505500
oxidised low density lipoprotein (lectin-
1
TAGGCTTCTATTTCCTTTCCACCCACT

like) receptor 1 (OLR1), mRNA/

CTTCACAGGCTATTCTACTTTAA

cds = (61, 882)

2330
literature
Hs.81791
NM_002548
4507566
tumor necrosis factor receptor
1
GGTAACCAGGTCCAATCAGTAAAAAT

superfamily, member 11b

AAGCTGCTTATAACTGGAAATGGC

(osteoprotegerin) (TNFRSF11B),

mRNA/cds = (94, 1299)

2331
Table 3A
Hs.172182
NM_002568
4505574
poly(A)-binding protein, cytoplasmic 1
1
TCTGTTTTAAGTAACAGAATTGATAAC

(PABPC1), mRNA/cds = (502, 2403)

TGAGCAAGGAAACGTAATTTGGA

2332
Table 3A
Hs.75718
NM_002575
4505594
serine (or cysteine) proteinase
1
TGCCTTTAATTGTTCTCATAATGAAGA

inhibitor, clade B (ovalbumin) member

ATAAGTAGGTACCCTCCATGCCC

2 (SERPINB2), mRNA/cds = (72,

1319)

2333
Table 3A
Hs.188
NM_002600
4505662
phosphodiesterase 4B, cAMP-specific
1
TGCCATTAAGCAGGAATGTCATGTTC

(dunce (Drosophila)-homolog

CAGTTCATTACAAAAGAAAACAAT

phosphodiesterase E4) (PDE4B),

mRNA/cds = (765, 2459)

2334
literature
Hs.37040
NM_002607
4505678
platelet-derived growth factor alpha
1
ACCTGTTTTGTATACCTGAGAGCCTG

polypeptide (PDGFA), mRNA/

CTATGTTCTTCTTTTGTTGATCCA

cds = (403, 993)

2335
literature
Hs.1976
NM_002608
4505680
platelet-derived growth factor beta
1
CTGCTTCCTTCAGTTTGTAAAGTCGG

polypeptide (simian sarcoma viral (v-

TGATTATATTTTTGGGGGCTTTCC

sis) oncogene homolog) (PDGFB),

mRNA/cds = (1022, 1747)

2336
literature
Hs.81564
NM_002619
4505732
platelet factor 4 (PF4), mRNA/
1
AGCATACTTCTTTTTTCCAGTTTCAAT

cds = (7, 312)

CTAACTGTGAAAGAAACTTCTGA

2337
Table 3A
Hs.53155
NM_002621
4505738
properdin P factor, complement (PFC),
1
GAACTCTAACACTTCTCTCCTCCACT

mRNA/cds = (242, 1651)

CTGAGCCCCCTGACCTTCCAAACC

2338
literature
Hs.99910
NM_002627
11321600
phosphofructokinase, platelet (PFKP),
1
CCAGTGCGTGCTGTCTGTGGAGTGT

mRNA/cds = (33, 2387)

GTCTCATGCTTTCAGATGTGCATAT

2339
Table 3A
Hs.181013
NM_002629
4505752
phosphoglycerate mutase 1 (brain)
1
CCCTGCCACATGGGTCCAGTGTTCAT

(PGAM1), mRNA/cds = (31, 795)

CTGAGCATAACTGTACTAAATCCT

2340
Table 3A
Hs.78713
NM_002635
4505774
solute carrier family 25 (mitochondrial
1
TGCTTAAGGCAAGAGTTTCAGATTTA

carrier; phosphate carrier), member 3

CTGTTGAAATAAACCCAACTGTTC

(SLC25A3), nuclear gene encoding

mitochondrial protein, transcript variant

1b, mRNA/cds = (48, 1133)

2341
Table 3A
Hs.166204
NM_002638
13435395
PHD finger protein 1 (PHF1), transcript
1
CCTGACCCCTCCCATCCTTCCCATTT

variant 2, mRNA/cds = (215, 1916)

CCTTTGATGTTATTTTGTTACAGC

2342
Table 3A
Hs.112341
NM_002638
4505786
protease inhibitor 3, skin-derived
1
TAAGTCCCTGCTGCCCTTCCCCTTCC

(SKALP) (PI3), mRNA/cds = (119,

CACACTGTCCATTCTTCCTCCCAT

472)

2343
Table 3A
Hs.250697
NM_002643
4505796
ras-like protein (TC10), mRNA/
1
TGATGTGATTGTAGCTTTTTAAACTAT

cds = (0, 641)

GAAACCCCTGAGAGATTGTACCT

2344
db mining
Hs.32942
NM_002649
4505802
phosphoinositide-3-kinase, catalytic,
1
CCCAAAGGTTCCTAAGCCTGGCTGCA

gamma polypeptide (PIK3CG), mRNA/

AAGAAGAATCAACAGGGACACTTT

cds = (323, 3628)

2345
Table 3A
Hs.154846
NM_002651
4505808
phosphatidylinositol 4-kinase, catalytic,
1
TAGAAGTTTGCTTTTTCCCTGCCTGT

beta polypeptide (PIK4CB), mRNA/

CTTGGTCACTACCACCTCTTCCCT

cds = (69, 2555)

2346
Table 3A
Hs.77274
NM_002658
4505862
plasminogen activator, urokinase
1
TGACCAGCACTGTCTCAGTTTCACTT

(PLAU), mRNA/cds = (76, 1371)

TCACATAGATGTCCCTTTCTTGGC

2347
Table 3A
Hs.179657
NM_002659
4505864
plasminogen activator, urokinase
1
CTGCCCATCTCAGCCTCACCATCACC

receptor (PLAUR), mRNA/

CTGCTAATGACTGCCAGACTGTGG

cds = (426, 1433)

2348
Table 3A
Hs.77438
NM_002664
4505878
pleckstrin (PLEK), mRNA/
1
TTCCTGAAGCTGTTCCCACTCCCAGA

cds = (60, 1112)

TGGTTTTATCAATAGCCTAGAGGT

2349
Table 3A
Hs.44499
NM_002687
4505922
pinin, desmosome associated protein
1
GGATTACCTTTCCTTGTAAAGAGGAT

(PNN), mRNA/cds = (30, 2261)

GCTGCCTTAAGAATTGCATGTTGT

2350
Table 3A
Hs.180107
NM_002690
4505930
polymerase (DNA directed), beta
1
GGGTCTTTGGTGTTTTTAAATGATTGT

(POLB), mRNA/cds = (113, 1120)

TTCTTCTTCATGCTTTTGCTTGC

2351
literature
Hs.99890
NM_002691
4505932
polymerase (DNA directed), delta 1,
1
CATGGGGCGGGGGCGGGACCAGGG

catalytic subunit (125 kD) (POLD1),

AGAATTAATAAAGTTCTGGACTTTTG

mRNA/cds = (53, 3378)

2352
Table 3A
Hs.334828
AB058697
14017804
mRNA for KIAA1794 protein, partial
1
ATTTAAAGCACAGTTTGTTTTTTCT

cds/cds = (1592, 4000)

GTCACCTATAGAGTGCAAGAATG

CAC

2353
Table 3A
Hs.79402
NM_002694
14702172
polymerase (RNA) II (DNA directed)
1
CAGCACTGTCTCCAGATAGGAACATG

polypeptide C (33 kD) (POLR2C),

CACAAAGCAGTTAATTAGGCAGCC

transcript variant gamma, mRNA/

cds = (57, 684)

2354
Table 3A
Hs.1101
NM_002698
4505958
POU domain, class 2, transcription
1
CTCCCCTCCCATTCCTCTGGTCCCTG

factor 2 (POU2F2), mRNA/

CCTTGGTCCCTTGCCTGGGAAGAG

cds = (54, 1445)

2355
Table 3A
Hs.2164
NM_002704
4505980
pro-platelet basic protein (includes
1
AAGGTTGGTTAAAAGATGGCAGAAAG

platelet basic protein, beta-

AAGATGAAAATAAATAAGCCTGGT

thromboglobulin, connective tissue-

activating peptide III, neutrophil-

activating peptide-2) (PPBP), mRNA/

cds = (68, 452)

2356
Table 3A
Hs.17883
NM_002707
4505998
protein phosphatase 1G (formerly 2C),
1
CTCATCACCGGTTCTGTGCCTGTGCT

magnesium-dependent, gamma

CTGTTGTGTTGGAGGGAAGGACTG

isoform (PPM1G), mRNA/

cds = (24, 1664)

2357
Table 3A
Hs.77876
NM_002709
4506004

Homo sapiens, Similar to RIKEN
1
TTTGCTTGGCAACACGACTTGAAATA

cDNA 2410153K17 gene, clone

AATAAAACTTTGTTTCTTAGGAGA

MGC:19595 IMAGE:3840843, mRNA,

complete cds/cds = (469, 1899)

2358
Table 3A
Hs.79081
NM_002710
4506006
protein phosphatase 1, catalytic
1
AAAAGAAATCTGTTTCAACAGATGAC

subunit, gamma isoform (PPP1CC),

CGTGTACAATACCGTGTGGTGAAA

mRNA/cds = (154, 1125)

2359
Table 3A
Hs.36587
NM_002712
4506012
protein phosphatase 1, regulatory
1
GACGCCACACACCATTTTCAGATGCC

subunit 7 (PPP1R7), mRNA/

GTTGCAATTAAATCTTGCCACACT

cds = (15, 1097)

2360
Table 3A
Hs.179574
NM_002717
4506018
protein phosphatase 2 (formerly 2A),
1
ATGTTTTAGTAACAGTTGGCTGTAAT

regulatory subunit B (PR 52), alpha

CACTCCTCGCCGTGTCTGGCACTG

isoform (PPP2R2A), mRNA/

cds = (105, 1448)

2361
Table 3A
Hs.171734
NM_002719
4506022
protein phosphatase 2, regulatory
1
AGTTCTGCGTTTGGCATCTTCACTCT

subunit B (B56), gamma isoform

TTCCAAAATGTATCTGTACATCAG

(PPP2R5C), mRNA/cds = (88, 1632)

2362
Table 3A
Hs.1908
NM_002727
4506044
proteoglycan 1, secretory granule
1
TGTGTTTGCAGAGCTAGTGGATGTGT

(PRG1), mRNA/cds = (24, 500)

TTGTCTACAAGTATGATTGCTGTT

2363
Table 3A
Hs.183037
NM_002734
4506062
protein kinase, cAMP-dependent,
1
AAATCTGGGGAAGAGGTTTTATTTAC

regulatory, type I, alpha (tissue specific

ATTTTAGGGTGGGTAAGAAAGCCA

extinguisher I) (PRKAR1A), mRNA/

cds = (87, 1232)

2364
Table 3A
Hs.2499
NM_002741
4506072
protein kinase C-like 1 (PRKCL1),
1
CAGAGCGGAGGCTGGGATCTAGCGA

mRNA/cds = (84, 2912)

GAGAGATGCAGAAGATGTGAAGAAA

2365
literature
Hs.324473
NM_002745
4506088
40 kDa protein kinase related to rat
1
CGTTTGGAGGGGCGGTTTCTGGTAG

ERK2/cds = (134, 1180)

TTGTGGCTTTTATGCTTTCAAAGAA

2366
literature
Hs.267445
NM_002750
4506094
mRNA; cDNA DKFZp434B231 (from
1
GGGGTGGGAGGGATGGGGAGTCGG

clone DKFZp434B231)/

TTAGTCATTGATAGAACTACTTTGAA

cds = UNKNOWN

2367
literature
Hs.274382
NM_002759
4506102
protein kinase, interferon-inducible
1
TGCAGAAACAGAAAGGTTTTCTTCTT

double stranded RNA dependent

TTTGCTTCAAAAACATTCTTACAT

(PRKR), mRNA/cds = (435, 2090)

2368
db mining
Hs.56
NM_002764
4506126
phosphoribosyl pyrophosphate
1
AGATTAACTGCTGGACCTCCTACCTG

synthetase 1 (PRPS1), mRNA/

CATTATCTCATTCTGGCTTCCTTG

cds = (66, 1022)

2369
Table 3A
Hs.82159
NM_002786
4506178
proteasome (prosome, macropain)
1
CTTTGTGGTTTTAAAGACAACTGTGA

subunit, alpha type. 1 (PSMA1),

AATAAAATTGTTTCACCGCCTGGT

mRNA/cds = (105, 896)

2370
Table 3A
Hs.167106
NM_002788
4506182
proteasome (prosome, macropain)
1
GAACTCAGCTGGGTTGGTGAATTAAC

subunit, alpha type, 3 (PSMA3),

TAATGGAAGACATGAAATTGTTCC

mRNA/cds = (5, 772)

2371
Table 3A
Hs.251531
NM_002789
4506184
proteasome (prosome, macropain)
1
ACGATGATGGTTACCCTTCATGGACG

subunit, alpha type, 4 (PSMA4),

TCTTAATCTTCCACACACATCCCC

mRNA/cds = (59, 844)

2372
Table 3A
Hs.76913
NM_002790
4506186
proteasome (prosome, macropain)
1
TTCAGTTCTAATAATGTCCTTAAATTT

subunit, alpha type, 5 (PSMA5),

TATTTCCAGCTCCTGTTCCTTGG

mRNA/cds = (21, 746)

2373
Table 3A
Hs.233952
NM_002792
4506188
proteasome (prosome, macropain)
1
GCCTTTCCATTCCATTTATTCACACTG

subunit, alpha type, 7 (PSMA7),

AGTGTCCTACAATAAACTTCCGT

mRNA/cds = (24, 770)

2374
Table 3A
Hs.89545
NM_002796
4506198
proteasome (prosome, macropain)
1
TGCATTATCCAGAACTGAAGTTGCCC

subunit, beta type, 4 (PSMB4), mRNA/

TACTTTTAACTTTGAACTTGGCTA

cds = (23, 817)

2375
Table 3A
Hs.118065
NM_002799
4506202
proteasome (prosome, macropain)
1
GCCCAGTAAGACACTCATGTGGCTAG

subunit, beta type, 7 (PSMB7), mRNA/

TGTTTGCCGAATGAAACTCAACTC

cds = (14, 847)

2376
Table 3A
Hs.61153
NM_002803
4506208
proteasome (prosome, macropain)
1
TAAGTCTTATGCCAAATTCAGTGCTA

28S subunit, ATPase, 2 (PSMC2),

CTCCTCGTTACATGACATACAACT

mRNA/cds = (66, 1367)

2377
Table 3A
Hs.79387
NM_002805
4506212
proteasome (prosome, macropain)
1
AAGTGAGTGGACAGCCTTTGTGTGTA

26S subunit, ATPase, 5 (PSMC5),

TCTCTCCAATAAAGCTCTGTGGGC

mRNA/cds = (0, 1220)

2378
Table 3A
Hs.341867
NM_002807
4506224
z172b08.r1 cDNA, 5′ end/
1
TCTCCAAGTCTTTGGTTGAAGAGAAG

clone = IMAGE:727663/clone_end =

ATATATGACTGTTGAGTGTGCTCT

5′

2379
Table 3A
Hs.74619
NM_002808
4506226
proteasome (prosome, macropain)
1
GGGGAATTGTCGCCTCCTGCTCTTTT

26S subunit, non-ATPase, 2 (PSMD2),

GTTACTGAGTGAGATAAGGTTGTT

mRNA/cds = (112, 2673)

2380
Table 3A
Hs.155543
NM_002811
4506230
proteasome (prosome, macropain)
1
TGGCATCCTCAGGGGTTGTGATCCA

26S subunit, non-ATPase, 7 (Mov34

GCTCCATATATTGTTTACCTTCAAA

homolog) (PSMD7), mRNA/

cds = (83, 1057)

2381
Table 3A
Hs.78468
NM_002812
4506232
proteasome (prosome, macropain)
1
CGGGCACTGGGTGGGGCAGGGCAC

26S subunit, non-ATPase, 8 (PSMD8),

GAGTTATTTAAAACAGTTACACTGCA

mRNA/cds = (70, 843)

2382
Table 3A
Hs.306328
NM_002817
4506222
mRNA activated in tumor suppression,
1
CGGACATCTTTTCCGTTGCGGTTTGA

clone TSAP13 extended/

GAATGTTCCTATAATAAACCCCTC

cds = UNKNOWN

2383
Table 3A
Hs.250855
NM_002823
4506276
prothymosin, alpha (gene sequence
1
TTTGGCCTGTTTTGATGTATGTGTGA

28) (PTMA), mRNA/cds = (155, 487)

AACAATGTTGTCCAACAATAAACA

2384
Table 3A
Hs.155894
NM_002827
4506288
protein tyrosine phosphatase, non-
1
AGCGAGCTGCTCTGCTATGTCCTTAA

receptor type 1 (PTPN1), mRNA/

GCCAATATTTACTCATCAGGTCAT

cds = (72, 1379)

2385
Table 3A
Hs.82829
NM_002828
4506290
protein tyrosine phosphatase, non-
1
TGTAGTTGGGGTAGATTATGATTTAG

receptor type 2 (PTPN2), mRNA/

GAAGCAAAAGTAAGAAGCAGCATT

cds = (60, 1307)

2386
Table 3A
Hs.63489
NM_002831
4506296
protein tyrosine phosphatase, non-
1
GCGATGGACAGACTCACAACCTGAA

receptor type 6 (PTPN6), mRNA/

CCTAGGAGTGCCCCATTGCTTTTGTA

cds = (144, 1931)

2387
Table 3A
Hs.35
NM_002832
4506298
protein tyrosine phosphatase, non-
1
GCTCAGGAGGGTACAAGCTCCAGAA

receptor type 7 (PTPN7), mRNA/

CAGTAACCAAGTGGGAAAATAAAGA

cds = (155, 1174)

2388
Table 3A
Hs.62
NM_002835
4506286
protein tyrosine phosphatase, non-
1
CTGGATTCATGCAGCCAGCTTTGCAG

receptor type 12 (PTPN12), mRNA/

GTTATCAGAGATCAAAGATTGTAA

cds = (19, 2361)

2389
Table 3A
Hs.26045
NM_002836
4506302
protein tyrosine phosphatase, receptor
1
TATCATGGGGAGTAATAGGACCAGAG

type, A (PTPRA), mRNA/

CGGTATCTCTGGCACCACACTAGC

cds = (695, 3103)

2390
Table 3A
Hs.170121
NM_002838
4506308
protein tyrosine phosphatase, receptor
1
CTGTGGAAAAATATTTAAGATAGTTTT

type, C (PTPRC), mRNA/

GCCAGAACAGTTTGTACAGACGT

cds = (86, 4000)

2391
Table 3A
Hs.2050
NM_002852
4506332
pentaxin-related gene, rapidly induced
1
ACTCTCAAATAATTAAAAAGGACTGTA

by IL-1 beta (PTX3), mRNA/

TTGTTGAACAGAGGGACAATTGT

cds = (67, 1212)

2392
literature
Hs.7179
NM_002853
4506384
RAD1 (S. pombe) homolog (RAD1),
1
AACTCATGGGAATAATTGTGAGTCAG

mRNA/cds = (437, 1285)

CGTAACATTTCAAGAGTCTAAAGG

2393
Table 3A
Hs.151536
NM_002870
4506362
RAB13, member RAS oncogene
1
TGCTCCTGTTCTGTCACTTGTCATGG

family (RAB13), mRNA/cds = (139,

TCTTTCTTGGTATTAAAGGCCACC

750)

2394
literature
Hs.16184
NM_002873
4506382
RAD17 (S. pombe) homolog (RAD17),
1
GGGGTTGTAAATATCAACTATTCAAC

mRNA/cds = (642, 2654)

AGTTTAGGATGCAATTACGAGTGT

2395
literature
Hs.23044
NM_002875
4506388

Homo sapiens, Similar to RIKEN
1
AATCTTATGTTTCCAAGAGAACTAAA

cDNA 2610036L13 gene, clone

GCTGGAGAGACCTGACCCTTCTCT

MGC:16386 IMAGE:3938081, mRNA,

complete cds/cds = (82, 840)

2396
literature
Hs.11393
NM_002876
4506390
RAD51 (S. cerevisiae) homolog C
1
TGCACCAGGTGTTGGAAAAACACAAT

(RAD51C), mRNA/cds = (16, 423)

TATGGTAAAATAAAGTGTTCTCCT

2397
literature
Hs.100669
NM_002877
10835028
RAD51 (S. cerevisiae)-like 1
1
AATGGGCACACAGGGAACAGGAAAT

(RAD51L1), mRNA/cds = (70, 1122)

GGGAATGAGAGCAAGGGTTGGGTTG

2398
literature
Hs.125244
NM_002878
4506392
RAD51 (S. cerevisiae)-like 3
1
TCTTCTTCATCTCTGTTTTGCTCTTAA

(RAD51L3), mRNA/cds = (124, 993)

AAATATAAAAAGGCAATTCCCCG

2399
literature
Hs.89571
NM_002679
4506394
RAD52 (S. cerevisiae) homolog
1
AGATGTAACCCACCTTGACCATAAAT

(RAD52), mRNA/cds = (31, 1290)

TGGCTTTTCATAGTGCTCAGATGT

2400
Table 3A
Hs.279474
NM_002880
8850222
HSPC070 protein (HSPC070), mRNA/
1
CTAGGCTCTGGGCACATTTCCTGTTC

cds = (331, 1581)

TTGAATTCTGCTCCTGAAGAGGGT

2401
Table 3A
Hs.24763
NM_002882
6382077
RAN binding protein 1 (RANBP1)
1
TACCCTGCCCCTCTTTTTCGGTTTGT

TTTTATTCTTTCATTTTTACAAGG

2402
Table 3A
Hs.758
NM_002890
4506430
RAS p21 protein activator (GTPase
1
GCTGCCTAACTTATCCATCTTTGAAC

activating protein) 1 (RASA1),

TTCTGACTACTTGTTGTATCTGCT

transcript variant 1, mRNA/

cds = (118, 3261)

2403
Table 3A
Hs.29287
NM_002894
4506440
retinoblastoma-binding protein 8
1
CCTTTAAAACAATAAGGCGCTTTCATT

(RBBP8), mRNA/cds = (298, 2991)

TTGCACTCTAACTTAAGAGTTTT

2404
Table 3A
Hs.6108
NM_002896
4506444
RNA binding motif protein 4 (RBM4),
1
TCCTGCCTCCTGCGGCTGTTGGATTT

mRNA/cds = (55, 1155)

GGGAATGACCTTGGTGAGAGTCTC

2405
Table 3A
Hs.167791
NM_002901
4506454
reticulocalbin 1, EF-hand calcium
1
ATACTCTGAGCTGTGGACTGAACTGG

binding domain (RCN1), mRNA/

CAGACACAACCTGTACAGATTGAA

cds = (52, 1047)

2406
literature
Hs.115521
NM_002912
4506482
REV3 (yeast homolog)-like, catalytic
1
AAGGAATTATGTGGTCAGTGCATTGT

subunit of DNA polymerase zeta

TTTTTAAACTGGAAATCATTTTGT

(REV3L), mRNA/cds = (822, 9980)

2407
Table 3A
Hs.75256
NM_002922
4506514
regulator of G-protein signalling 1
1
TGCTCTTAAAACCAGGGAGTCAGATA

(RGS1), mRNA/cds = (14, 604)

TATTTGTAAGGTTAAATCATTGGT

2408
Table 3A
Hs.78944
NM_002923
4506516
regulator of G-protein signalling 2,
1
GCCAAAAATCTGTCTTGAAGGCAGCT

24 kD (RGS2), mRNA/cds = (32, 667)

ACACTTTGAAGTGGTCTTTGAATA

2409
Table 3A
Hs.82280
NM_002925
11184225
regulator of G-protein signalling 10
1
CCTCTCAGGACGTGCCGGGTTTATCA

(RGS10), mRNA/cds = (43, 548)

TTGCTTTGTTATTTGTAAGGACTG

2410
Table 3A
Hs.1010
NM_002932
4506544
regulator of mitotic spindle assembly 1
1
TGACTATCTGTAATGGATCAATTTTG

(RMSA1), mRNA/cds = (774, 2030)

GATATGACTTTGGGTGGGGGTAAA

2411
Table 3A
Hs.64318
NM_002945
4506582
replication protein A1 (70 kD) (RPA1),
1
CGAGCTGAGAAGCGGTCATGAGCAC

mRNA/cds = (69, 1919)

CTGGGGATTTTAGTAAGTGTGTCTT

2412
Table 3A
Hs.79411
NM_002946
4506584
replication protein A2 (32 kD) (RPA2),
1
GGTAGTGCCTCCAGGGGCAGAGGAA

mRNA/cds = (77, 889)

AAGAAGAAGTGTTACTGCATTTTGT

2413
literature
Hs.1608
NM_002947
4506588
replication protein A3 (14 kD) (RPA3),
1
ATGGTCAGATTAGATGCAAGAATAAA

mRNA/cds = (30, 395)

GCAGTTGTCCGAGTCTAAGTTTCT

2414
Table 3A
Hs.2280
NM_002950
4506674
ribophorin I (RPN1), mRNA/
1
TGGTATTCTGTTCTGAAGTCTAGGAT

cds = (137, 1960)

ATTTTTCAGCCTATAAAGCCCCCT

2415
Table 3A
Hs.169476
NM_002951
4506676

Homo sapiens, glyceraldehyde-3-
1
ACTTACCCAGATGTTGCTTTTGAAAA

phosphate dehydrogenase, clone

GTTGAAATGTGTAATTGTTTTGGA

MGC:10926 IMAGE:3628129, mRNA,

complete cds/cds = (2306, 3313)

2416
Table 3A
Hs.182426
NM_002952
4506718
ribosomal protein S2 (RPS2), mRNA/
1
AGCGGACTCAGGCTCCAGCTGTGGC

cds = (11, 892)

TACAACATAGGGTTTTTATACAAGA

2417
Table 3A
Hs.3297
NM_002954
4506712
ribosomal protein S27a (RPS27A),
1
TTATTGTGGCAAATGTTGTCTGACTTA

mRNA/cds = (38, 508)

CTGTTTCAACAAACCAGAAGACA

2418
db mining
Hs.20084
NM_002957
10862707
retinoid X receptor, alpha (RXRA),
1
TGGACAGTAGCATTAGAATTGTGGAA

mRNA/cds = (75, 1463)

AAGGAACACGCAAAGGGAGAAGTG

2419
Table 3A
Hs.79350
NM_002958
11863158
RYK receptor-like tyrosine kinase
1
CTGGTAAATTTTGTGCTTATCTTCAAG

(RYK), mRNA/cds = (103, 1917)

GCTGGCTTAAGTATAAAATTGTT

2420
Table 3A
Hs.81256
NM_002961
9845514
S100 calcium-binding protein A4
1
CCCTGGCTCCTTCAGACACGTGCTTG

(calcium protein, calvasculin,

ATGCTGAGCAAGTTCAATAAAGAT

metastasin, murine placental homolog)

(S100A4), transcript variant 1, mRNA/

cds = (69, 374)

2421
Table 3A
Hs.100000
NM_002964
9845519
S100 calcium-binding protein A8
1
GTTAACTTCCAGGAGTTCCTCATTCT

(calgranulin A) (S100A8), mRNA/

GGTGATAAAGATGGGCTGGCAGCC

cds = (55, 339)

2422
Table 3A
Hs.23978
NM_002967
4506778
scaffold attachment factor B (SAFB),
1
CCTGTCTCGTGGCAACAAGGCTATGT

mRNA/cds = (53, 2800)

TCTGTTAGGAGTTACCTTAAACTG

2423
Table 3A
Hs.28491
NM_002970
4506788
spermidine/spermine N1-
1
AGTCAGATCTTTCTCCTTGAATATCTT

acetyltransferase (SAT), mRNA/

TCGATAAACAACAAGGTGGTGTG

cds = (165, 680)

2424
Table 3A
Hs.74592
NM_002971
4506790
special AT-rich sequence binding
1
TCCTATAATTATTTCTGTAGCACTCCA

protein 1 (binds to nuclear

CACTGATCTTTGGAAACTTGCCC

matrix/scaffold-assocating DNA's)

(SATB1), mRNA/cds = (214, 2505)

2425
Table 3A
Hs.112842
NM_002978
4506818
sodium channel, nonvoltage-gated 1,
1
CCACGGGTGATGCTTCCAGGGGTTC

delta (SCNN1D), mRNA/cds = (0,

TGGCGGGAGTCTCAGCCGAAGAGAG

1916)

2426
Table 3A
Hs.303649
NM_002982
4506840
small inducible cytokine A2 (monocyte
1
GAAATTGCTTTTCCTCTTGAACCACA

chemotactic protein 1, homologous to

GTTCTACCCCTGGGATGTTTTGAG

mouse Sig-je) (SCYA2), mRNA/

cds = (53, 352)

2427
Table 3A
Hs.73817
NM_002983
4506842
small inducible cytokine A3
1
ACCAGACTGACAAATGTGTATCGGAT

(homologous to mouse Mip-1a)

GCTTTTGTTCAGGGCTGTGATCGG

(SCYA3), mRNA/cds = (83, 361)

2428
Table 3A
Hs.75703
NM_002984
4506844
small inducible cytokine A4
1
CCACTGTCACTGTTTCTCTGCTGTTG

(homologous to mouse Mip-1b)

CAAATACATGGATAACACATTTGA

(SCYA4), mRNA/cds = (108, 386)

2429
db mining
Hs.66742
NM_002987
4506828
small inducible cytokine subfamily A
1
CGAAGAAGAGCCACAGTGAGGGAGA

(Cys—Cys), member 17 (SCYA17),

TCCCATCCCCTTGTCTGAACTGGAG

mRNA/cds = (52, 338)

2430
cytokine
Hs.57907
NM_002989
4506834
small inducible cytokine subfamily A
1
GACCTGATACGGCTCCCCAGTACAC

arrays

(Cys—Cys), member 21 (SCYA21),

CCCACCTCTTCCTTGTAAATATGAT

mRNA/cds = (58, 462)

2431
Table 3A
Hs.97203
NM_002990
4506836
small inducible cytokine subfamily A
1
CTCAAGCGTCCTGGGATCTCCTTCTC

(Cys—Cys), member 22 (SCYA22),

CCTCCTGTCCTGTCCTTGCCCCTC

mRNA/cds = (19, 300)

2432
Table 3A
Hs.247838
NM_002991
4506838
small inducible cytokine subfamily A
1
CCTCAAGGGAGGAGTGATCTTCACCA

(Cys—Cys), member 24 (SCYA24),

CCAAGAAGGGCCAGCAGTTCTGTG

mRNA/cds = (0, 359)

2433
Table 3A
Hs.164021
NM_002993
4506850
small inducible cytokine subfamily B
1
TCCTGTGTGTCATGTTGGTTTTTGGT

(Cys-X-Cys), member 6 (granulocyte

ACTTGTATTGTCATTTGGAGAAAC

chemolactic protein 2) (SCYB6),

mRNA/cds = (63, 407)

2434
Table 3A
Hs.89714
NM_002994
4506848
small inducible cytokine subfamily B
1
TCCTGTGATGGAAATACAACTGGTAT

(Cys-X-Cys), member 5 (epithelial-

CTTCACTTTTTTAGGAATTGGGAA

derived neutrophil-activating peptide

78) (SCYB5), mRNA/cds = (106, 450)

2435
Table 3A
Hs.3195
NM_002995
4506852
small inducible cytokine subfamily C,
1
AATTTGCAGTAAACTTTTAATTAAATG

member 1 (lymphotactin) (SCYC1),

CTCATCTGGTAACTCAACACCCC

mRNA/cds = (20, 364)

2436
Table 3A
Hs.3577
NM_003001
9257243
succinate dehydrogenase complex,
1
GCTGCTTTTGAGGAGAAAATATATAG

subunit C, integral membrane protein,

CTTTGGACACGAGGAAGATCTAGA

15 kD (SDHC), nuclear gene encoding

mitochondrial protein, mRNA/

cds = (26, 535)

2437
Table 3A
Hs.168289
NM_003002
4506864
succinate dehydrogenase complex,
1
AAACGCTTGGAGTGCTTCTGAATATA

subunit D, integral membrane protein

CAGAAGTTCCATTTAAGGGCAAGT

(SDHD), nuclear gene encoding

mitochondrial protein, mRNA/

cds = (11, 490)

2438
Table 3A
Hs.75232
NM_003003
4506866
SEC14 (S. cerevisiae)-like 1
1
TGCATCGTGTTTCTACCTTTAGTACCT

(SEC14L1), mRNA/cds = (303, 2450)

TGCCACTCTTTTAAAACGCTGCT

2439
Table 3A
Hs.73800
NM_003005
6031196
selectin P (granule membrane protein
1
GACCTTCCTGCCACCAGTCACTGTCC

140 kD, antigen CD62 (SELP), mRNA/

CTCAAATGACCCAAAGACCAATAT

cds = (95, 2587)

2440
Table 3A
Hs.79283
NM_003006
6031197
selectin P ligand (SELPLG), mRNA/
1
AGACCTTTCTTTGGGACTGTGTGGAC

cds = (59, 1267)

CAAGGAGCTTCCATCTAGTGACAA

2441
Table 3A
Hs.75217
NM_003010
4506888
mitogen-activated protein kinase
1
GCTCAGTAACATAACTGCTTCTTGGA

kinase 4 (MAP2K4), mRNA/

GCTTTGGAATATTTTATCCTGTAT

cds = (9, 1208)

2442
Table 3A
Hs.145279
NM_003011
4506890
SET translocation (myeloid leukemia-
1
TTCTGCACAGGTCTCTGTTTAGTAAA

associated) (SET), mRNA/cds = (3,

TACATCACTGTATACCGATCAGGA

836)

2443
Table 3A
Hs.73965
NM_003016
4506898
splicing factor, arginine/serine-rich 2
1
CGGGCCTTGCATATAAATAACGGAGC

(SFRS2), mRNA/cds = (155, 820)

ATACAGTGAGCACATCTAGCTGAT

2444
Table 3A
Hs.14388
NM_003022
4506924
SH3 domain binding glutamic acid-rich
1
AGAGATGCCTTTGTTTGATGAGATTC

protein like (SH3BGRL), mRNA/

AAACTTGATGCTATGCTTTAAAAT

cds = (78, 422)

2445
Table 3A
Hs.2554
NM_003032
4506948
sialyltransferase 1 (beta-galactoside
1
AGTCCCATTCTTCCTTTTCAATACCTA

alpha-2,6-sialytransferase) (SIAT1),

CCCCCAAATCTTCTCCTAACCCT

mRNA/cds = (310, 1530)

2446
Table 3A
Hs.323032
NM_003035
4506956
TAL 1 (SCL) interrupting locus (SIL),
1
TGTCACACTGGCTATCAAAGAATAAG

mRNA/cds = (380, 4243)

AAAATTATTGAGTATGAGTGTGTT

2447
Table 3A
Hs.32970
NM_003037
4506968
signaling lymphocytic activation
1
GCAAAACCCAGAAGCTAAAAAGT

molecule (SLAM), mRNA/

CAATAAACAGAAAGAATGATTTT

cds = (133, 1140)

GAGA

2448
Table 3A
Hs.198296
NM_003070
4507068
SWI/SNF related, matrix associated,
1
TTGTGACCAAATGGGCCTCAAAGATT

actin dependent regulator of chromatin,

CAGATTGAAACAAACAAAAAGCTT

subfamily a, member 2 (SMARCA2),

mRNA/cds = (297, 5015)

2449
Table 3A
Hs.236030
NM_003075
4507080
SWI/SNF related matrix associated,
1
AAGGTTCTATTAACCACTTCTAAGGG

actin dependent regulator or chromatin,

TACACCTCCCTCCAAACTACTGCA

subfamily c, member 2 (SMARCC2),

mRNA/cds = (22, 3663)

2450
Table 3A
Hs.79335
NM_003076
4507082
SWI/SNF related, matrix associated,
1
GTTGTATCACCCCCGAGTTAGCATAT

actin dependent regulator of chromatin,

CCCAGGCTCGCAGACTCAACACAG

subfamily d, member 1 (SMARCD1),

mRNA/cds = (285, 1572)

2451
Table 3A
Hs.174051
NM_003089
4507118
small nuclear ribonucleoprotein 70 kD
1
CCACTTGAGTTTGTCCTCCAAGGGTA

polypeptide (RNP antigen) (SNRP70),

GGTGTCTCATTTGTTCTGGCCCCT

mRNA/cds = (680, 2524)

2452
Table 3A
Hs.31121
NM_003098
4507136
syntrophin, alpha 1 (dystrophin-
1
TCCTGTCTCTCTCCTCCTTACTCTTG

associated protein A1, 59 kD, acidic

GATAAATAAACAGCCTGTGAGCAC

component) (SNTA1), mRNA/

cds = (37, 1554)

2453
Table 3A
Hs.11183
NM_003100
4507140
sorting nexin 2 (SNX2), mRNA/
1
CCTGACCCTCTTTGAATTAAGTGGAC

cds = (29, 1588)

TGTGGCATGACATTCTGCAATACT

2454
Table 3A
Hs.92909
NM_003103
4507152
NREBP mRNA, complete cds/
1
TCTAAACTTTATTTTCAAAAGCTTAAG

cds = (49, 7209)

GCCCAAATACAAACTTCTCTGGA

2455
Table 3A
Hs.278571
NM_003105
6325473
sortilin-related receptor, L (DLR class)
1
CATGGTGATAGCCTGAAAGAGCTTTC

A repeats-containing (SORL1), mRNA/

CTCACTAGAAACCAAATGGTGTAA

cds = (197, 6841)

2456
Table 3A
Hs.21293
NM_003115
4507758
UDP-N-acetylglucosamine
1
GGAGAAGGATTAGAAAGTTATGTGGC

pyrophosphorylase 1 (UAP1), mRNA/

AGATAAAGAATTCCATGCACCTCT

cds = (0, 1517)

2457
Table 3A
Hs.71465
NM_003129
6806899
squalene epoxidase (SQLE), mRNA/
1
ACAGTTTTTCTTTTGAATTTAGTATTT

cds = (214, 1938)

GAGATGAGTTGTTGGGACATGCA

2458
Table 3A
Hs.300741
NM_003130
4507206
sorcin (SRI), mRNA/cds = (12, 608)
1
GATCTAGTCTGTTACACCATTTAGAA

CTTTCCTCAGCCATTATCAGTCAT

2459
Table 3A
Hs.75975
NM_003133
4507216
signal recognition particle 9 kD (SRP9),
1
AGCATGGTAAGTTCCCTTAGCTATAT

mRNA/cds = (106, 366)

GAATTTTGGCATGTTTCAGAGAGA

2460
Table 3A
Hs.75761
NM_003137
4507218
SFRS protein kinase 1 (SRPK1),
1
ACATTTTTATTCTTTCTACTGAGGGCA

mRNA/cds = (108, 2075)

TTGTCTGTTTTCTTTGTAAATGC

2461
Table 3A
Hs.83715
NM_003142
10835066
Sjogren syndrome antigen B
1
AAAAGGAAAACCGAATTAGGTCCACT

(autoantigen La) (SSB), mRNA/

TCAATGTCCACCTGTGAGAAAGGA

cds = (72, 1298)

2462
Table 3A
Hs.250773
NM_003144
6552340
signal sequence receptor, alpha
1
CCTATCCCCGGATGTGTGAGAATAAT

(translocon-associated protein alpha)

GTGTTCATAAAGCATGGATCTCGT

(SSR1), mRNA/cds = (111, 971)

2463
Table 3A
Hs.74564
NM_003145
6552341
signal sequence receptor, beta
1
CCAGTGTCTATTCTGGGTTAGAGAAG

(translocon-associated protein beta)

TGCTTACTAAGGGGTTTTCTAATA

(SSR2), mRNA/cds = (50, 601)

2464
Table 3A
Hs.321677
NM_003150
4507252
signal transducer and activator of
1
GGGTGATCTGCTTTTATCTAAATGCA

transcription 3 (acute-phase response

AATAAGGATGTGTTCTCTGAGACC

factor) (STAT3), mRNA/

cds = (220, 2532)

2465
Table 3A
Hs.80642
NM_003151
4507254
signal transducer and activator of
1
GGGAGTGTTGTGACTGAAATGCTTGA

transcription 4 (STAT4), mRNA/

AACCAAAGCTTCAGATAAACTTGC

cds = (81, 2327)

2466
literature
Hs.251664
NM_003153
4507258
DNA for insulin-like growth factor II
1
GAGCCAATCCACTCCTTCCTTTCTAT

(IGF-2); exon 7 and additional ORF/

CATTCCCCTGCCCACCTCCTTCCA

cds = (0, 233)

2467
Table 3A
Hs.70186
NM_003169
4507312
suppressor of Ty (S. cerevisiae) 5
1
CTTCCTGTACCTCCTCCCCACAGCTT

homolog (SUPT5H), mRNA/

GCTTTTGTTGTACCGTCTTTCAAT

cds = (48, 3311)

2468
Table 3A
Hs.12303
NM_003170
11321572
suppressor of Ty (S. cerevisiae) 6
1
GCTGCTGCCACCGCTTCCTGCCTGT

homolog (SUPT6H), mRNA/

CATTTGAATAAACAGTGTTTCTATT

cds = (1164, 5975)

2469
Table 3A
Hs.106469
NM_003171
4507314
suppressor of var1 (S. cerevisiae) 3-
1
TGGGACTCATCCAAAAGGGACGAGA

like 1 (SUPV3L1), mRNA/

AGAAAGAAGAAGGAACCTGATTCGG

cds = (0, 2360)

2470
Table 3A
Hs.3196
NM_003172
4507318
surfeit 1 (SURF1), mRNA/
1
TCAAGACTGCCTTTATGCTGGATCAT

cds = (14, 916)

GTGCTACTGGTATAAAGTTCTGGC

2471
Table 3A
Hs.37938
NM_003173
4507320
suppressor of variegation 3-9
1
GTACACCCCTCAACCCTATGCAGCCT

(Drosophila) homolog 1 (SUV39H1),

GGAGTGGGCATCAATAAAATGAAC

mRNA/cds = (45, 1283)

2472
literature
Hs.74101
NM_003177
4507328
spleen tyrosine kinase (SYK), mRNA/
1
CCATGAGACTGATCCCTGGCCACTGA

cds = (148, 1986)

AAAGCTTTCCTGACAATAAAAATG

2473
Table 3A
Hs.32675
NM_003193
6006029
tubulin-specific chaperone e (TBCE),
1
TTGGGAAGTGACCATTTCTAGGCTTA

mRNA/cds = (80, 1663)

TACATAATAGCAATAATAAAGGCT

2474
Table 3A
Hs.171626
NM_003197
6006030
transcription elongation factor B (SIII),
1
ATGTGGTAAAACCCAGAAAGCATCCA

polypeptide 1-like (TCEB1L), mRNA/

TCATGAATGCAAGATACTTTCAAT

cds = (101, 592)

2475
Table 3A
Hs.75133
NM_003201
4507400
transcription factor 6-like 1
1
TTCACATTGTATTCAGAGTTGATGGTT

(mitochrondrial transcription factor 1-

GTACATATAAGTGATTGCTGGTT

like) (TCF6L1), mRNA/cds = (132,

872)

2476
Table 3A
Hs.169294
NM_003202
4507402
transcription factor 7 (T-cell specific,
1
GCCACTGGTTTCTCAGAATCCAAAGA

HMG-box) (TCF7), mRNA/

TCACATATTCTAGTGTAACACTGC

cds = (79, 885)

2477
Table 3A
Hs.74637
NM_003217
4507432
testis enhanced gene transcript
1
CTGTGCTTTTTGCTTGGGATAATGGA

(TEGT), mRNA/cds = (40, 753)

GTTTTTCTTTAGAAACAGTGCCAA

2478
Table 3A
Hs.77356
NM_003234
4507456
transferrin receptor (p90, CD71)
1
TATCAGACTAGTGACAAGCTCCTGGT

(TFRC), mRNA/cds = (263, 2545)

CTTGAGATGTCTTCTCGTTAAGGA

2479
Table 3A
Hs.79059
NM_003243
4507470
transforming growth factor, beta
1
AGGGCTTGAGGTGAATTTCATTAAAT

receptor III (betaglycan, 300 kD)

GGAATAATATGATGCCACTTTGCA

(TGFBR3), mRNA/cds = (348, 2897)

2480
Table 3A
Hs.87409
NM_003246
4507484
thrombospondin 1 (THBS1), mRNA/
1
TTGACCTCCCATTTTTACTATTTGCCA

cds = (111, 3623)

ATACCTTTTTCTAGGAATGTGCT

2481
Table 3A
Hs.63668
NM_003264
4507528
toll-like receptor 2 (TLR2), mRNA/
1
AGCGGGAAGGATTTTGGGTAAATCTG

cds = (129, 2483)

AGAGCTGCGATAAAGTCCTAGGTT

2482
Table 3A
Hs.159239
NM_003266
4507532
toll-like receptor 4 (TLR4), mRNA/
1
TGATGTTTGATGGACCTATGAATCTA

cds = (284, 2683)

TTTAGGGAGACACAGATGGCTGGG

2483
Table 3A
Hs.31130
NM_003273
4507546
transmembrane 7 superfamily member
1
AGCCCTGAGGATGAACAACCTCAGA

2 (TM7SF2), mRNA/cds = (254, 2023)

GAAGAGGTGGTTTAGAGCAAGGAAA

2484
Table 3A
Hs.1117
NM_003291
4507656
tripeptidyl peptidase II (TPP2), mRNA/
1
AATAAATTTGCAAAACCAAGATCACA

cds = (23, 3772)

GTACACCATATGCACTCTGGTACC

2485
Table 3A
Hs.326456
NM_003295
4507668
hypothetical protein FLJ20030
1
TTTGGAGTGGAGGCATTGTTTTTAAG

(FLJ20030), mRNA/cds = (1, 1239)

AAAAACATGTCATGTAGGTTGTCT

2486
Table 3A
Hs.5542
NM_003315
4507712
tetratricopeptide repeat domain 2
1
GCGGGGGTGGACAGGGAGGCAGCTT

(TTC2), mRNA/cds = (26, 1480)

GTGAATTTTTGTTTTACTGTTTAAC

2487
Table 3A
Hs.178551
NM_003316
10835036
ribosomal protein L8 (RPL8), mRNA/
1
AACTTCAGATACTTGTGAACATGCCT

cds = (43, 816)

TATATTTGTCCAACAACTGTCAGA

2488
Table 3A
Hs.274401
NM_003321
4507732
mRNA; cDNA DKFZp434P086 (from
1
GAAGGGTTGGCCTGCCTGGCTGGGG

clone DKFZp434P086); partial cds/

AGGTCAGTAAACTTTGAATAGTAAG

cds = (798, 1574)

2489
literature
Hs.129780
NM_003327
4507578
tumor necrosis factor receptor
1
AAGATGTACCCTTCAGGTGAACCTGG

superfamily, member 4 (TNFRSF4),

TATCAGACCCACAGTACTTGCTGT

mRNA/cds = (5, 838)

2490
Table 3A
Hs.29877
NM_003328
4507742
TXK tyrosine kinase (TXK), mRNA/
1
AGCAAGATAGCCAAATGTGACATCAA

cds = (86, 1669)

GCTCCATTGTTTCGGAAATCCAGG

2491
Table 3A
Hs.13046
NM_003330
4507746
thioredoxin reductase 1 (TXNRD1),
1
AGTGGAATGTTCTATCCCCACAAGAA

mRNA/cds = (439, 1932)

GGATTATATCTTATAGACTTGTCT

2492
Table 3A
Hs.5308
NM_003333
4507760
ubiquitin A-52 residue ribosomal
1
CCCGTGGCCCTGGAGCCTCAATAAA

protein fusion product 1 (UBA52),

GTGTCCCTTTCATTGACTGGAGCAG

mRNA/cds = (37, 423)

2493
Table 3A
Hs.80612
NM_003338
4507768
ubiquitin-conjugating enzyme E2A
1
TTATGCATTTATCACTTCCAAATCTAA

(RAD6 homolog) (UBE2A), mRNA/

CTTTGCACAAGTAACCCATGTAA

cds = (120, 578)

2494
Table 3A
Hs.811
NM_003337
4507770
ubiquitin-conjugating enzyme E2B
1
TCCGCACTATATAATTCGCACACATT

(RAD6 homolog) (UBE28), mRNA/

AATTAGGGTTTATGTACCATACAA

cds = (421, 879)

2495
literature
Hs.75355
NM_003348
4507792
ubiquitin-conjugating enzyme E2N
1
GCTTGTGACCATTTTGTATGGCTTGT

(homologous to yeast UBC13)

CTGGAAACTTCTGTAAATCTTATG

(UBE2N), mRNA/cds = (63, 521)

2496
Table 3A
Hs.283667
NM_003349
12025659
arginyl aminopeptidase
1
TGCTGATTTATGCAAAGGGCTGGCAT

(aminopeptidase B) (RNPEP), mRNA/

TCTGATGCTTTTCAGGTTTAATCC

cds = (9, 1982)

2497
literature
Hs.79300
NM_003350
12025664
ubiquitin-conjugating enzyme E2
1
TGCATTCTGGCAGTTCTTTTAGGATT

variant 2 (UBE2V2), mRNA/

ATAGGTTGCAAATTATCCAAATAT

cds = (21, 458)

2498
Table 3A
Hs.80658
NM_003355
13259540
uncoupling protein 2 (mitochondrial,
1
CCGACAGCCCAGCCTAGCCCACTTG

proton carrier) (UCP2), nuclear gene

TCATCCATAAAGCAAGCTCAACCTT

encoding mitochondrial protein, mRNA/

cds = (380, 1309)

2499
literature
Hs.78853
NM_003362
6224978
uracil-DNA glycosylase (UNG),
1
TTTGCTGTTAGTCGGGTTAGAGTTGG

mRNA/cds = (106, 1020)

CTCTACGCGAGGTTTGTTAATAAA

2500
Table 3A
Hs.77500
NM_003363
4507852
ubiquitin specific protease 4 (proto-
1
CAGACTGCTAGTGTTCTGTCTAAAAA

oncogene) (USP4), mRNA/

CCAGACAAGGAAATACCCTTCTTT

cds = (3, 2894)

2501
literature
Hs.173554
NM_003366
4507842
ubiquinol-cytochrome c reductase core
1
TTTTCCAGTGAGGTAAAATAAGGCAT

protein II (UQCRC2), mRNA/

AAATGCAGGTAATTATTCCCAGCT

cds = (53, 1414)

2502
Table 3A
Hs.93649
NM_003367
4507846
upstream transcription factor 2, c-fos
1
CCGGCACTTCTAGTGGTCTCACCTGG

interacting (USF2), mRNA/

AGGCAAGAGGGAGGGTACAGAGCC

cds = (0, 1040)

2503
Table 3A
Hs.284192
NM_003374
4507878
clone HQ0072/cds = UNKNOWN
1
TTTAGAGTCTTCCATTTTGTTGGAATT

AGATCCTCCCCTTCAAATGCTGT

2504
Table 3A
Hs.155191
NM_003379
9257254
villin 2 (ezrin) (VIL2), mRNA/
1
TTCTCCTTCACAGCTAAGATGCCATG

cds = (117, 1877)

TGCAGGTGGATTCCATGCCGCAGA

2505
Table 3A
Hs.297753
NM_003380
4507894
vimentin (VIM), mRNA/
1
TTTCCAGCAAGTATCCAACCAACTTG

cds = (122, 1522)

GTTCTGCTTTCAATAAATCTTTGGA

2506
Table 3A
Hs.24143
NM_003387
8400739
Wiskott-Aldrich syndrome protein
1
ATGACTTGCATCCCAGCTTTCCACCA

interacting protein (WASPIP), mRNA/

ACCAAATTCAAACATTCACTGCTT

cds = (108, 1619)

2507
literature
Hs.150930
NM_003401
12408643
X-ray repair complementing defective
1
TGTATGAGACTTTTTGTTGCAAAGGA

repair in Chinese hamster cells 4

CACATTTATCATATTCATTCACAC

(XRCC4), transcript variant 3, mRNA/

cds = (175, 1179)

2508
Table 3A
Hs.279920
NM_003404
4507948
tyrosine 3-monooxygenase/tryptophan
1
TGATCTGTCCAGTGTCACTCTGTACC

5-monooxygenase activation protein,

CTCAACATATATCCCTTGTGCGAT

beta polypeptide (YWHAB), mRNA/

cds = (372, 1112)

2509
Table 3A
Hs.75544
NM_003405
4507950
tyrosine 3-monooxygenase/tryptophan
1
AATTCACCCCTCCCACCTCTTTCTTC

5-monooxygenase activation protein,

AATTAATGGAAAAGCGTTAAGGGA

eta polypeptide (YWHAH), mRNA/

cds = (200, 940)

2510
Table 3A
Hs.75103
NM_003406
4507952
tyrosine 3-monooxygenase/tryptophan
1
CTCAGTACTTTGCAGAAAACACCAAA

5-monooxygenase activation protein,

CAAAAATGCCATTTTAAAAAAGGT

zeta polypeptide (YWHAZ), mRNA/

cds = (84, 621)

2511
Table 3A
Hs.55481
NM_003447
4508000
ainc finger protein 165 (ZNF165),
1
AGCCTTCAGTCAGAGCTCAAACCTTA

mRNA/cds = (587, 2024)

GTCAACACCAGAGAATTCACATGA

2512
Table 3A
Hs.88219
NM_003454
4508012
zinc finger protein 200 (ZNF200),
1
AACCCTCTAAGAATACCTGTTTAAGT

mRNA/cds = (239, 1423)

CTTGAGTGTTGAAAGGAATTGTTT

2513
Table 3A
Hs.62112
NM_003457
4508018
zinc finger protein 207 (ZNF207),
1
CCACTGCCTGAAAGGTTTGTACAGAT

mRNA/cds = (202, 1638)

GCATGCCACAGTAGATGTCCACAT

2514
Table 3A
Hs.89414
NM_003467
4503174
chemokine (C-X-C motif), receptor 4
1
TCAGGAGTGGGTTGATTTCAGCACCT

(fusin) (CXCR4), mRNA/

ACAGTGTACAGTCTTGTATTAAGT

cds = (88, 1146)

2515
Table 3A
Hs.78683
NM_003470
4507856
ubiquitin specific protease 7 (herpes
1
CCTTCAGTTATACTTTCAATGACCTTT

virus-associated) (USP7), mRNA/

TGTGCATCTGTTAAGGCAAAACA

cds = (199, 3507)

2516
Table 3A
Hs.110713
NM_003472
4503248
DEK oncogene (DNA binding) (DEK),
1
AAGTGAACAAAATAAGCAACTAAATG

mRNA/cds = (33, 1160)

AGACCTAATAATTGGCCTTCGATT

2517
Table 3A
Hs.155017
NM_003489
4505454
nuclear receptor interacting protein 1
1
CACAACCAAATTTGATGCGATCTGCT

(NRIP1), mRNA/cds = (287, 3763)

CAGTAATATAATTTGCCATTTTTA

2518
Table 3A
Hs.28777
NM_003512
4504244
H2A histone family, member L
1
ACATTGTAATAGAAACAGATTTCCCA

(H2AFL), mRNA/cds = (97, 489)

AATTCCAGCCTGGCATGAGGTAAT

2519
literature
Hs.2178
NM_003528
4504276
H2B histone family, member Q
1
CAGACTGAATAGATCTTAACTGTCTC

(H2BFQ), mRNA/cds = (42, 422)

CTACATGTGTGTTTTCAAATGTGT

2520
Table 3A
Hs.278571
NM_003563
4507182
sortilin-related receptor, L (DLR class)
1
GATATCCCAGCGGTGGTACTTCGGA

A repeats-containing (SQRL1), mRNA/

GACACCTGTCTGCATCTGACTGAGC

cds = (197, 6841)

2521
Table 3A
Hs.2864
NM_003566
4503488
early endosome antigen 1, 162 kD
1
ACACTTTCCTCTGCCTTTTTCTCTTAT

(EEA1), mRNA/cds = (136, 4368)

ATGTGGGTTCATGGTTCAGTTCG

2522
Table 3A
Hs.9006
NM_003574
4507866
VAMP (vesicle-associated membrane
1
AGATAATGTCACCAGTCCTCTTCCTT

protein)-associated protein A (33 kD)

CACTTCTTGTTGTAATTGCAGCCA

(VAPA), mRNA/cds = (0, 728)

2523
literature
Hs.66718
NM_003579
4506396
RAD54 (S. cerevisiae)-like (RAD54L),
1
CCGGCACACAGGGACTAGGTCTAGT

mRNA/cds = (100, 2343)

GAGAACATCAGGAGCAGCGAGGGAT

2524
Table 3A
Hs.78687
NM_003580
4505484
neutral sphingomyelinase (N-SMase)
1
CATCGGGTTTTGGGTGTGTGTTTTCA

activation associated factor (NSMAF),

TAGCGTGGTTACTTTCTATAATGC

mRNA/cds = (12, 2765)

2525
Table 3A
Hs.14611
NM_003584
4503414
dual specificity phosphatase 11
1
ATGTATTTCTTTCTGACTAGACTTGTG

(RNA/RNP complex 1-interacting)

ATATGCGTGTGTTTATGTACAGA

(DUSP11), mRNA/cds = (124, 1116)

2526
Table 3A
Hs.155976
NM_003588
13270466
cullin 4B (CUL4B), mRNA/
1
GTTCTGTATCAGTTGAATTTTTGTGCT

cds = (78, 2231)

CTTTTCCCTGTGTACGTGGTGGT

2527
Table 3A
Hs.183874
NM_003589
11140810
cullin 4A (CUL4A), mRNA/
1
CATTTATGAGTTCCATGATATGTGGT

cds = (160, 2139)

CTAAGAAAGACCAAACAGATTTCT

2528
Table 3A
Hs.82919
NM_003591
4503162
cullin 2 (CUL2), mRNA/
1
AAATCGGTTGGGTACCATGCTTTTTC

cds = (146, 2383)

TCCCCTTCACGTTTGCAGTTGATG

2529
Table 3A
Hs.14541
NM_003592
4503160
cullin 1 (CUL1), mRNA/
1
GTTCATGTTGGAAAGAATGAAAACAA

cds = (124, 2382)

CTTCAAGTTCATAGGCAGCCAGCC

2530
Table 3A
Hs.9456
NM_003601
4507074
SWI/SNF related, matrix associated,
1
TGTCATTTAAAGACATCAGGTTCATCT

actin dependent regulator of chromatin,

GTTTACTGAGCTAGAAACATAGT

subfamily a, member 5 (SMARCA5),

mRNA/cds = (202, 3360)

2531
Table 3A
Hs.100293
NM_003605
6006036
O-linked N-acetylglucosamine
1
ATCTGGTGCCAAATGAAGATTTTTAG

(GlcNAc) transferase (UDP-N-

GAGTGATTACTAATTATCAAGGGC

acetylglucosamine:polypeptide-N-

acetylglucosaminyl transferase) (OGT),

mRNA/cds = (2039, 4801)

2532
Table 3A
Hs.131924
NM_003608
4507420
G protein-coupled receptor 65
1
TTCTGCACTGGGAGGTGTAATACATC

(GPR65), mRNA/cds = (0, 1013)

ACAAAGACAAAGAAAACGCATACT

2533
Table 3A
Hs.104925
NM_003633
4505460
ectodermal-neural cortex (with BTB-
1
AGTTGAAGGAAAATGTTCATGTTCAT

like domain) (ENC1), mRNA/

ATGTACTTGTTTGCTATGACTACA

cds = (399, 2166)

2534
db mining
Hs.323879
NM_003639
4504630
cDNA FLJ20588 fis, clone KAT09466,
1
CACTGGGGAAGTCAAGAATGGGGCC

highly similar to AF091453 NEMO

TGGGGCTCTCAGGGAGAACTGCTTC

protein/cds = UNKNOWN

2535
Table 3A
Hs.146360
NM_003641
4504580
interferon induced transmembrane
1
CCCTAGATACAGCAGTTTATACCCAC

protein 1 (9-27) (IFITM1), mRNA/

ACACCTGTCTACAGTGTCATTCAA

cds = (110, 487)

2536
Table 3A
Hs.167218
NM_003658
6633797
BarH-like homeobox 2 (BARX2),
1
GAAAGTGCTTAGCTCTCTCCCTCCTG

mRNA/cds = (96, 935)

ACCTCTGGGCAGCCAGTCATCAAA

2537
Table 3A
Hs.155172
NM_003664
4501974
adaptor-related protein complex 3,
1
ATCATGTATGCAATACTTTCCCCCTTT

beta 1 subunit (AP3B1), mRNA/

TTGCTTTGCTAACCAAAGAGCAT

cds = (53, 3334)

2538
Table 3A
Hs.239307
NM_003680
4507946
tyrosyl-tRNA synthetase (YARS),
1
CTGCTGTCTCTTCAGTCTGCTCCATC

mRNA/cds = (0, 1586)

CATCACCCATTTACCCATCTCTCA

2539
Table 3A
Hs.82548
NM_003882
4505070
MAP-kinase activating death domain
1
TATAGAAAATGTACAGTTGTGTGAAT

(MADD), mRNA/cds = (325, 5091)

GTGAAATAAATGTCCTCAACTCCC

2540
literature
Hs.47504
NM_003688
4504368
exonuclease 1 (EXO1), mRNA/
1
GGCCGTGTTCAAAGAGCAATATTCCA

cds = (218, 2629)

GTAAATGCAGACTGCTGCAAAGCT

2541
Table 3A
Hs.18571
NM_003690
4505580
protein kinase, interferon-inducible
1
AGCTGCTGACTTGACTGTCATCCTGT

double stranded RNA dependent

TCTTGTTAGCCATTGTGAATAAGA

activator (PRKRA), mRNA/

cds = (96, 1037)

2542
db mining
Hs.296776
NM_003721
4506498
regulatory factor X-associated ankyrin-
1
GAACTGACTTCAAAGGCAGCTTCTGG

containing protein (RFXANK), mRNA/

ACAGGTGGTGGGAGGGACCCTTC

cds = (417, 1199)

2543
Table 3A
Hs.118633
NM_003733
11321576
2′-5′oligoadenylate synthetase-like
1
GGAGAGGCTCTGTTTCCAGCCAGTTA

(OASL), mRNA/cds = (6, 1550)

GTTTTCTCTGGGAGACTTCTCTGT

2544
Table 3A
Hs.5120
NM_003748
4505812
dynein, cytoplasmic, light polypeptide
1
TTTCTATTCCATACTTCTGCCCACGTT

(PIN), mRNA/cds = (93, 362)

GTTTTCTCTCAAAATCCATTCCT

2545
Table 3A
Hs.57783
NM_003751
4503528
eukaryotic translation initiation factor 3,
1
CCTGTACACAGCCGAGCAGCATTTCC

subunit 9 (eta, 116 kD) (EIF3S9),

GTTGAAGGACTTGCATCCCCATTG

mRNA/cds = (53, 2674)

2546
Table 3A
Hs.57973
NM_003753
4503522
caspase recruitment domain protein
1
TTGATGCTTAGTGGAATGTGTGTCTA

10 mRNA, complete cds/

ACTTGCTCTCTGACATTTAGCAGA

cds = (40, 3138)

2547
Table 3A
Hs.58189
NM_003756
4503514
eukaryotic translation initiation factor 3,
1
AAGAAGTTAACATGAACTCTTGAAGT

subunit 3 (gamma, 40 kD) (EIF3S3),

CACACCAGGGCAACTCTTGGAAGA

mRNA/cds = (5, 1063)

2548
Table 3A
Hs.192023
NM_003757
4503512
eukaryotic translation initiation factor 3,
1
GGTGGATCTCCAACCAGGCCAGAGA

subunit 2 (beta, 36 kD) (EIF3S2),

AGATTCTCACAGAAGGTTTTGAACT

mRNA/cds = (17, 994)

2549
Table 3A
Hs.172684
NM_003761
14043025
vesicle-associated membrane protein
1
GGCTGGGAAACTGTTGGTGGCCAGT

8 (endobrevin) (VAMP8), mRNA/

GGGTAATAAAGACCTTTCAGTATCC

cds = (53, 355)

2550
Table 3A
Hs.77608
NM_003769
4506902
splicing factor, arginine/serine-rich 9
1
GGTTCGCTCTACTATGGAGATCAACA

(SFRS9), mRNA/cds = (52, 717)

GTTACTGTGACTGAGTCGGCCCAT

2551
db mining
Hs.89862
NM_003789
13378136
TNFRSF1A-associated via death
1
GCTCACACTCAGCGTGGGACCCCGA

domain (TRADD), mRNA/

ATGTTAAGCAATGATAATAAAGTAT

cds = (66, 1004)

2552
db mining
Hs.251216
NM_003790
4507568
hypothetical protein DKFZp434A196
1
CTGCTCGFCCCCTATCGCTCCAGCCAA

(DKFZP434A196), mRNA/

GGCGAAGAAGCACGAACGAATGTC

cds = (168, 2732)

2553
Table 3A
Hs.75890
NM_003791
4506774
membrane-bound transcription factor
1
ACCTGCCACCATGTTTTGTAATTTGA

protease, site 1 (MBTPS1), mRNA/

GGTCTTGATTTCACCATTGTCGGT

cds = (496, 3654)

2554
Table 3A
Hs.7943
NM_003796
4506542
RPB5-mediating protein (RMP),
1
AACGAAAGGAAGTTCTGTTGGAAGCA

mRNA/cds = (465, 1991)

TCTGAAGAAACTGGAAAGAGGGTT

2555
db mining
Hs.155566
NM_003805
4503030
CASP2 and RIPK1 domain containing
1
ACATTTACCTGAATGTTGTCTGAGGA

adaptor with death domain (CRADD),

CTGAACTGTGGACTTTACTATTCA

mRNA/cds = (37, 636)

2556
Table 3A
Hs.87247
NM_003806
4504492
harakiri, BCL2-interacting protein
1
AAATCCAGCTGCAGAAACAGACACCC

(contains only BH3 domain) (HRK),

CAATGCTATTTACATACAGCTCTA

mRNA/cds = (120, 395)

2557
literature
Hs.54673
NM_003808
4507598
tumor necrosis factor (ligand)
1
CCCCGTTCCTCAGTTTTCCCTTTTCAT

superfamily, member 13 (TNFSF13),

TCCCACCCCCTAGACTTTGATTT

mRNA/cds = (281, 1033)

2558
literature
Hs.26401
NM_003809
4507596
tumor necrosis factor (ligand)
1
TTCAGGCACTAAGAGGGGCTGGACC

superfamily, member 12 (TNFSF12),

TGGCGGCAGGAAGCCAAAGAGACTG

mRNA/cds = (17, 768)

2559
literature
Hs.83429
NM_003810
4507592
tumor necrosis factor (ligand)
1
CGCAACAATCCATCTCTCAAGTAGTG

superfamily, member 10 (TNFSF10),

TATCACAGTAGTAGCCTCCAGGTT

mRNA/cds = (87, 932)

2560
literature
Hs.1524
NM_003811
4507608
tumor necrosis factor (ligand)
1
CCCAGGCTAGGGGGCTATAGAAACA

superfamily, member 9 (TNFSF9),

TCTAGAAATAGACTGAAAGAAAATC

mRNA/cds = (3, 767)

2561
Table 3A
Hs.2442
NM_003816
4501914
a disintegrin and metalloproteinase
1
ACCTACAAAAAAGTTACTGTGGTATC

domain 9 (meltrin gamma) (ADAM9),

TATGAGTTATCATCTTAGCTGTGT

mRNA/cds = (78, 2537)

2562
literature
Hs.279899
NM_003820
4507570
tumor necrosis factor receptor
1
TGGTGTTTAGTGGATACCACATCGGA

superfamily, member 14 (herpesvirus

AGTGATTTTCTAAATTGGATTTGA

entry mediator) (TNFRSF14), mRNA/

cds = (293, 1144)

2563
db mining
Hs.86131
NM_003824
4505228
Fas (TNFRSF6)-associated via death
1
TCACTATCTTTCTGATAACAGAATTGC

domain (FADD), mRNA/cds = (129,

CAAGGCAGCGGGATCTCGTATCT

755)

2564
literature
Hs.114676
NM_003839
4507564
tumor necrosis factor receptor
1
GAAAAGATGGAGAAAATGAACAG

superfamily, member 11a, activator of

GACATGGGGCTCCTGGAAAGAAA

NFKB (TNFRSF11A), mRNA/

GGGC

cds = (38, 1888)

2565
literature
Hs.129844
NM_003840
4507562
tumor necrosis factor receptor
1
GTGGTTTTAGGATGTCATTCTTTGCA

superfamily, member 10d, decoy with

GTTCTTCATCATGAGACAAGTCTT

truncated death domain (TNFRSF10D),

mRNA/cds = (82, 1242)

2566
literature
Hs.119664
NM_003841
10835042
tumor necrosis factor receptor
1
AAGGGTGAGGATGAGAAGTGGTCAC

superfamily, member 10c, decoy

GGGATTTATTCAGCCTTGGTCAGAG

without an intracellular domain

(TNFRSF10C), mRNA/cds = (29, 928)

2567
literature
Hs.249190
NM_003844
4507558
tumor necrosis factor receptor
1
GAGAAGATTCAGGACCTCTTGGTGGA

superfamily, member 10a

CTCTGGAAAGTTCATCTACTTAGA

(TNFRSF10A), mRNA/cds = (0, 1406)

2568
Table 3A
Hs.7043
NM_003849
11321580
succinate-CoA ligase, GDP-forming,
1
AGTACAACTGGAAGCCAAAACA

alpha subunit (SUCLG1), mRNA/

AGGTGGAAGATGTCCTGAATTAAG

cds = (31, 1032)

ACGT

2569
Table 3A
Hs.5085
NM_003859
4503362
dolichyl-phosphate
1
GTTGCTGGCCTAATGAGCAATGTTCT

mannosyltransferase polypeptide 1,

CAATTTTCGTTTTCATTTTGCTGT

catalytic subunit (DPM1), mRNA/

cds = (0, 782)

2570
Table 3A
Hs.153687
NM_003866
4504706
inositol polyphosphate-4-phosphatase,
1
ACAGACCTCCAGAGGGGACTTATGG

type II, 105 kD (INPP4B), mRNA/

AAAAGCTGACACCTAAGTTTACCAA

cds = (121, 2895)

2571
Table 3A
Hs.1742
NM_003870
4506786
IQ motif containing GTPase activating
1
TGAATTTACTTCCTCCCAAGAGTTTG

protein 1 (IQGAP1), mRNA/

GACTGCCCGTCAGATTGTTTCTGC

cds = (467, 5440)

2572
Table 3A
Hs.279789
NM_003883
13128861
histone deacetylase 3 (HDAC3),
1
TGGCTTTATGTCCATTTTACCACTGTT

mRNA/cds = (55, 1341)

TTTATCCAATAAACTAAGTCGGT

2573
Table 3A
Hs.76095
NM_003897
4503326
immediate early response 3 (IER3),
1
GCTGTCACGGAGCGACTGTCGAGAT

mRNA/cds = (11, 481)

CGCCTAGTATGTTCTGTGAACACAA

2574
Table 3A
Hs.7165
NM_003904
4508020
zinc finger protein 259 (ZNF259),
1
CCTTTAAGGTTGGAACTTTGAAGTTG

mRNA/cds = (28, 1407)

GAGAAGGTGGAATAAAGTTACACC

2575
Table 3A
Hs.61828
NM_003905
4502168
amyloid beta precursor protein-binding
1
TGCCTTCGGGTTGTGCTTTAGTCTGT

protein 1, 59 kD (APPBP1), mRNA/

AAAATTCTAAAGGAGAGCTGCTAA

cds = (73, 1677)

2576
Table 3A
Hs.8991
NM_003917
4503842
adaptor-related protein complex 1,
1
GCAAAAACCTGGGACCAGCCCCCTT

gamma 2 subunit (AP1G2), mRNA/

CTCCCACAAATAAAGCCCAATAAAG

cds = (45, 2402)

2577
Table 3A
Hs.58589
NM_003918
5453673
glycogenin 2 (GYG2), mRNA/
1
GTCATCGGCTTTCAGAGGGAGACCA

cds = (283, 1788)

CGGGAATGTTCAGGGAAACAATGTC

2578
Table 3A
Hs.306359
NM_003922
4557025
clone 25038 mRNA sequence/
1
TGAATTGCCTGTTCAGGGTTCCTTAT

cds = UNKNOWN

GCAGAGAAATAAAGCAGATTCAGG

2579
literature
Hs.35947
NM_003925
4505120
methyl-CpG binding domain protein 4
1
ACCAACCACCTTTCCAGCCATAGAGA

(MBD4), mRNA/cds = (176, 1918)

TTTTAATTAGCCCAACTAGAAGCC

2580
literature
Hs.194685
NM_003935
4507634
topoisomerase (DNA) III beta
1
CTACTTTGTATGATGACCCTGTCCTC

(TOP3B), mRNA/cds = (113, 2701)

CCTCACCCAGGCTGCAGTGCCATG

2581
Table 3A
Hs.169139
NM_003937
4504936
kynureninase (L-kynurenine hydrolase)
1
AAAGAGGAGTGGTTTGTGACAAGCG

(KYNU), mRNA/cds = (106, 1503)

GAATCCAAATGGCATTCGAGTGGCT

2582
Table 3A
Hs.24322
NM_003945
4502318
ATPase, H+ transporting, lysosomal
1
GAAGAGCCATCTCAACAGAATCGCAC

(vacuolar proton pump) 9 kD (ATP6H),

CAAACTATACTTTCAGGATGAATT

mRNA/cds = (62, 307)

2583
Table 3A
Hs.47007
NM_003954
4505396
mitogen-activated protein kinase
1
TCTGGGTTGTAGAGAACTCTTTGTAA

kinase kinase 14 (MAP3K14), mRNA/

GCAATAAAGTTTGGGGTGATGACA

cds = (232, 3075)

2584
literature
Hs.24439
NM_003958
4504868
ring finger protein (C3HC4 type) 8
1
CTGCTGTCCACTTTCCTTCAGGCTCT

(RNF8), mRNA/cds = (112, 1569)

GTGAATACTTCAACCTGCTGTGAT

2585
Table 3A
Hs.108371
NM_003973
4506600
E2F transcription factor 4, p107/p130-
1
GCACCTGCTCCAAAGGCATCTGGCA

binding (E2F4), mRNA/cds = (62,

AGAAAGCATAAGTGGCAATCATAAA

1303)

2586
Table 3A
Hs.10315
NM_003983
4507052
solute carrier family 7 (cationic amino
1
CTCCTTTTAACGTGTTATTGACAAACC

acid transporter, y+ system), member 6

TCCCCAAAAGAATATGCAATTGT

(SLC7A6), mRNA/cds = (261, 1808)

2587
Table 3A
Hs.339840
NM_003992
4502884

Homo sapiens, clone MGC:16360
1
AGCTGCCAGAAAGCACAGATTTGACC

IMAGE:3927645, mRNA, complete

CAAGCTATTTATATGTTATAAAGT

cds/cds = (561, 731)

2588
Table 3A
Hs.83426
NM_003998
10835176
nuclear factor of kappa light
1
AGCTGCTGCTGGATCACAGCTGCTTT

polypeptide gene enhancer in B-cells 1

CTGTTGTCATTGCTGTTGTCCCTC

(p105) (NFKB1), mRNA/

cds = (397, 3303)

2589
literature
Hs.278443
NM_004001
4557021
Fc fragment of IgG, low affinity IIb,
1
GATGAGGCTGACAAAGTTGGGGCTG

receptor for (CD32) (FCGR2B),

AGAACACAATCACCTATTCACTTCT

mRNA/cds = (0, 875)

2590
Table 3A
Hs.12068
NM_004003
4755131
carnitine acetyltransferase (CRAT),
1
TCCTGCCCCCGCCCTGCTGTATGATA

nuclear gene encoding mitochondrial

TTAATGTGGAAGGTCATCAATAAA

protein, transcript variant peroxisomal,

mRNA/cds = (296, 2113)

2591
Table 3A
Hs.169470
NM_004010
5032314
dystrophin (muscular dystrophy,
1
AAACTGTAAATCATAATGTAACTGAA

Duchenne and Becker types), includes

GCATAAACATCACATGGCATGTTT

DXS142, DXS164, DXS206, DXS230,

DXS239, DXS268, DXS269, DXS270,

DXS272 (DMD), transcript variant

Dp427p2, mRNA/cds = (702, 11390)

2592
Table 3A
Hs.460
NM_004024
4755127
activating transcription factor 3 (ATF3),
1
ACAAGGACGCTGGCTACTGTCTATTA

mRNA/cds = (164, 520)

AAATTCTGATGTTTCTGTGAAATT

2593
Table 3A
Hs.186120
NM_004031
4809287
interferon regulatory factor 7 (IRF7),
1
CTTCCTTATGGAGCTGGAGCAGCCC

transcript variant d, mRNA/

GCCTAGAACCCAGTCTAATGAGAAC

cds = (335, 1885)

2594
Table 3A
Hs.78637
NM_004034
4809278
annexin A7 (ANXA7), transcript variant
1
TGCATCTCATTTTGCCTAAATTGGTTC

2, mRNA/cds = (60, 1526)

TGTATTCATAAACACTTTCCACA

2595
Table 3A
Hs.217493
NM_004039
4757755
annexin A2 (ANXA2), mRNA/
1
AGTGAAGTCTATGATGTGAAACACTT

cds = (49, 1088)

TGCCTCCTGTGTACTGTGTCATAA

2596
Table 3A
Hs.227817
NM_004049
14574570
BCL2-related protein A1 (BCL2A1),
1
TTGATGATGTAACTTGACCTTCCAGA

mRNA/cds = (183, 710)

GTTATGGAAATTTTGTCCCCATGT

2597
Table 3A
Hs.155935
NM_004054
4757887
complement component 3a receptor 1
1
AGCTCACACGTTCCACCCACTGTCCC

(C3AR1), mRNA/cds = (0, 1448)

TCAAACAATGTCATTTCAGAAAGA

2598
Table 3A
Hs.153640
NM_004073
4758015
cytokine-inducible kinase (CNK),
1
GGACCACTTTTATTTATTGTCAGACA

mRNA/cds = (38, 1859)

CTTATTTATTGGGATGTGAGCCCC

2599
Table 3A
Hs.108080
NM_004078
4758085
cysteine and glycine-rich protein I
1
GGGCTGTACCCAAGCTGATTTCTCAT

(CSRP1), mRNA/cds = (54, 635)

CTGGTCAATAAAGCTGTTTAGACC

2600
literature
Hs.78394
NM_004092
12707569
enoyl Coenzyme A hydratase, short
1
GCTCTGAGGGAAACGCTGTCTGCTG

chain, 1, mitochondrial (ECHS1),

CCTTCATACAGATGCTGATTAAAGT

nuclear gene encoding mitochondrial

protein, mRNA/cds = (71, 943)

2601
literature
Hs.4756
NM_004111
6325465
chromosome 11, BAC CIT-HSP-311e8
1
TTTTAGCTCAGGAAAATATGTCAGGC

(BC269730) containing the hFEN1

TCAAACCACTTCTCAGGCAGTTTA

gene/cds = (2644, 3786)

2602
Table 3A
Hs.171862
NM_004120
6996011
guanylate binding protein 2, interferon-
1
TTGTTGAACCATAAAGTTTGCAAAGT

inducible (GBP2), mRNA/

AAGGTTAAGTATGAGGTCAATGT

cds = (156, 1931)

2603
Table 3A
Hs.284265
NM_004124
4758441
pRGR1 mRNA, partial cds/
1
TGTGGTTTCAGTCTCTGCTAGTTCAT

cds = (0, 538)

ATTGCATGTTTATTTTGGACAGTC

2604
Table 3A
Hs.3069
NM_004134
4758569
heat shock 70 kD protein 9B (mortalin-
1
AGCAGAAATTTTGAAGCCAGAAGGAC

2) (HSPA9B), mRNA/cds = (29, 2068)

AACATATGAAGCTTAGGAGTGAAG

2605
Table 3A
Hs.80350
NM_004156
4758951
protein phosphatase 2 (formerly 2A),
1
ACTGCTTCATCTCCTTTTGCGCTTATT

catalytic subunit, beta isoform

TGGAAATTTTAGTTATAGTGTTT

(PPP2CB), mRNA/cds = (21, 950)

2606
Table 3A
Hs.180062
NM_004159
4758969
proteasome (prosome, macropain)
1
GAGAGAGTACGGGCTCAGCAGCCAG

subunit, beta type 8 (large

AGGAGGCCGGTGAAGTGCATCTTCT

multifunctional protease 7) (PSMB8),

mRNA/cds = (220, 1038)

2607
Table 3A
Hs.272493
NM_004166
14589962
small inducible cytokine subfamily A
1
CCCAGTCACCCTCTTGGAGCTTCCCT

(Cys—Cys) member 15 (SCYA15),

GCTTTGAATTAAAGACCACTCATG

transcript variant 2, mRNA/

cds = (474, 815)

2608
Table 3A
Hs.272493
NM_004167
14602450
small inducible cytokine subfamily A
1
CCCAGTCACCCTCTTGGAGCTTCCCT

(Cys—Cys), member 15 (SCYA15),

GCTTTGAATTAAAGACCACTCATG

transcript variant 2, mRNA/

cds = (474, 815)

2609
Table 3A
Hs.469
NM_004168
4759079
succinate dehydrogenase complex,
1
GGAGCGTGGCACTTACCTTTGTCCCT

subunit A, flavoprotein (Fp) (SDHA),

TGCTTCATTCTTGTGAGATGATAA

nuclear gene encoding mitochondrial

protein, mRNA/cds = (24, 2018)

2610
Table 3A
Hs.75379
NM_004172
4759125
solute carrier family 1 (glial high
1
GCATACACATGCACTCAGTGTGGACT

affinity glutamate transporter), member

GGGAAGCATTACTTTGTAGATGTA

3 (SLC1A3), nuclear gene encoding

mitochondrial protein, mRNA/

cds = (178, 1806)

2611
Table 3A
Hs.172791
NM_004182
4759297
ubiquitously-expressed transcript
1
AAGCCTCACCATTGACTTCTTCCCCC

(UXT), mRNA/cds = (56, 529)

CATCCTCAGACATTAAAGAGCCTG

2612
literature
Hs.212680
NM_004195
4759245
tumor necrosis factor receptor
1
CTGACCTCGGCCCAGCTTGGACTGC

superfamily, member 18 (TNFRSF18),

ACATCTGGCAGCTGAGGAGTCAGTG

mRNA/cds = (0, 725)

2613
Table 3A
Hs.18720
NM_004208
4757731
programmed cell death 8 (apoptosis-
1
GGAAGATCATTAAGGACGGTGAGCA

inducing factor) (PDCD8), mRNA/

GCATGAAGATCTCAATGAAGTAGCC

cds = (42, 1883)

2614
Table 3A
Hs.79197
NM_004233
4757945
CD83 antigen (activated B
1
TTACCTCTGTCTTGGCTTTCATGTTAT

lymphocytes, immunoglobulin

TAAACGTATGCATGTGAAGAAGG

superfamily) (CD83), mRNA/

cds = (41, 858)

2615
RG
Hs.6566
NM_004237
11321608
thyroid hormone receptor interactor 13
1
AGTTACTGGTCTCTTTCTGCCGAATG

house-

(TRIP13), mRNA/cds = (45, 1343)

TTATGTTTTGCTTTTATCTCACAG

keeping

genes

2616
Table 3A
Hs.85092
NM_004239
10863904
thyroid hormone receptor interactor 11
1
CACAAAGTGGCCTTTGGGGAGAAAG

(TRIP11), mRNA/cds = (356, 6295)

TCATGTATTTGTTCGCAATTATGCT

2617
Table 3A
Hs.151787
NM_004247
4759279
U5 snRNP-specific protein, 116 kD
1
ATTTACTCCAAGTCCTCTCCCCAGCT

(U5-116 KD), mRNA/cds = (60, 2978)

ACCACCAGTCCCTTACTCTGTTCT

2618
Table 3A
Hs.184276
NM_004252
4759139
solute carrier family 9
1
GCCCATCCCTGAGCCAGGTACCACC

(sodium/hydrogen exchanger), isoform

ATTGTAAGGAAACACTTTCAGAAAT

3 regulatory factor 1 (SLC9A3R1),

mRNA/cds = (212, 1288)

2619
literature
Hs.31442
NM_004260
4759029
RecQ protein-like 4 (RECQL4),
1
AGGACCGACGCTTCTGGAGAAAATAC

mRNA/cds = (0, 3626)

CTGCACCTGAGCTTCCATGCCCTG

2620
Table 3A
Hs.90606
NM_004261
4759095
15 kDa selenoprotein (SEP15), mRNA/
1
TTCACAAAGATTTGCGTTAATGAAGA

cds = (4, 492)

CTACACAGAAAACCTTTCTAGGGA

2621
Table 3A
Hs.15259
NM_004281
14043023
BCL2-associated athanogene 3
1
ATACCTGACTTTAGAGAGAGTAAAAT

(BAG3), mRNA/cds = (306, 2033)

GTGCCAGGAGCCATAGGAATATCT

2622
Table 3A
Hs.341182
NM_004288
8670550
602417256F1 cDNA, 5′ end/
1
ATGGAAAGATGTGGTCTGAGATGGGT

clone = IMAGE:4538829/clone_end =

GCTGCAAAGATCATAATAAAGTCA

5′

2623
Table 3A
Hs.75393
NM_004300
4757713
acid phosphatase 1, soluble (ACP1),
1
ACATCCAGAAAGAAGGACACTTGTAT

transcript variant a, mRNA/

GCTAGTCTATGGTCAGTTGAGGAA

cds = (775, 1251)

2624
Table 3A
Hs.274350
NM_004301
4757717
BAF53 (BAF53A), mRNA/
1
TTGACTAGTAAAAGTTACTGCCTAGT

cds = (138, 1425)

CTTTTTACCTTAGGCTTACAGAAT

2625
Table 3A
Hs.109918
NM_004310
4757769
ras homolog gene family, member H
1
TTGCCCAGGCCAGTTAGAAAATCCCT

(ARHH), mRNA/cds = (579, 1154)

TGGGGAACTGTGATGAATATTCCA

2626
Table 3A
Hs.75811
NM_004315
4757785
N-acylsphingosine amidohydrolase
1
ATAATCACAGTTGTGTTCCTGACACT

(acid ceramidase) (ASAH), mRNA/

CAATAAACAGTCACTGGAAAGAGT

cds = (17, 1204)

2627
literature
Hs.234799
NM_004327
11038638
breakpoint cluster region (BCR),
1
TGACCGGATTCCCTCACTGTTGTATC

transcript variant 1, mRNA/

TTGAATAAACGCTGCTGCTTCATC

cds = (488, 4303)

2628
db mining
Hs.2534
NM_004329
4757853
bone morphogenetic protein receptor,
1
CCAAAGTTGGAGCTTCTATTGCCATG

type IA (BMPR1A), mRNA/

AACCATGCTTACAAAGAAAGCACT

cds = (309, 1907)

2629
literature
Hs.82794
NM_004344
4757901
centrin, EF-hand protein, 2 (CETN2),
1
GTGAACTCCTGCACTGGCATTTGGAT

mRNA/cds = (47, 565)

GTGTGTTAATGCTATTTGTTTTGT

2630
Table 3A
Hs.170019
NM_004350
4757917
runl-related transcription factor 3
1
GCTGGGTGGAAACTGCTTTGCACTAT

(RUNX3), mRNA/cds = (9, 1256)

CGTTTGCTTGGTGTTTGTTTTTAA

2631
Table 3A
Hs.84298
NM_004355
10835070
CD74 antigen (invariant polypeptide of
1
GCTTGTTATCAGCTTTCAGGGCCATG

major histocompatibility complex, class

GTTCACATTAGAATAAAAGGTAGT

II antigen-associated) (CD74), mRNA/

cds = (7, 705)

2632
Table 3A
Hs.75564
NM_004357
4757941
CD151 antigen (CD151), mRNA/
1
CTTTGCCTTGCAGCCACATGGCCCCA

cds = (84, 845)

TCCCAGTTGGGGAAGCCAGGTGAG

2633
Table 3A
Hs.75887
NM_004371
6996002
coatomer protein complex, subunit
1
TGCGGGTTATTGATTTGTTCTTTACAA

alpha (COPA), mRNA/cds = (466,

CTATTGTTCTCATATTTCTCACA

4140)

2634
Table 3A
Hs.79194
NM_004379
4758053
cAMP responsive element binding
1
AGTTATTAGTTCTGCTTTAGCTTTCCA

protein 1 (CREB1), mRNA/

ATATGCTGTATAGCCTTTGTCAT

cds = (198, 7526)

2635
Table 3A
Hs.23598
NM_004380
4758055
CREB binding protein (Rubinstein-
1
GCTGTTTTCAACATTGTATTTGGACTA

Taybi syndrome) (CREBBP), mRNA/

TGCATGTGTTTTTTCCCCATTGT

cds = (198, 7526)

2636
Table 3A
Hs.76053
NM_004398
13514826
DEAD/H (Asp-Glu-Ala-Asp/His) box
1
AAGTAAATGTACAGTGATTTGAAATA

polypeptide 5 (RNA helicase, 68 kD)

CAATAATGAAGGCAATGCATGGCC

(DDX5), mRNA/cds = (170, 2014)

2637
Table 3A
Hs.155595
NM_004404
4758157
neural precursor cell expressed,
1
CCCACACTGCTACACTTCTGATCCCC

developmentally down-regulated 5

TTTGGTTTTACTACCCAAATCTAA

(NEDD5), mRNA/cds = (258, 1343)

2638
Table 3A
Hs.171695
NM_004417
7108342
dual specificity phosphatase 1
1
TCTTAAGCAGGTTTGTTTTCAGCACT

(DUSP1), mRNA/cds = (248, 1351)

GATGGAAAATACCAGTGTTGGGTT

2639
Table 3A
Hs.1183
NM_004418
12707563
dual specificity phosphatase 2
1
GGGGTTGGAAACTTAGCACTTTATAT

(DUSP2), mRNA/cds = (85, 1029)

TTATACAGAACATTCAGGATTTGT

2640
Table 3A
Hs.2128
NM_004419
12707565
dual specificity phosphatase 5
1
ACCCGTGTGAATGTGAAGAAAAGCAG

(DUSP5), mRNA/cds = (210, 1364)

TATGTTACTGGTTGTTGTTGTTGT

2641
Table 3A
Hs.74088
NM_004430
4756251
early growth response 3 (EGR3),
1
TTGCACTGTGAGCAAATGCTAATACA

mRNA/cds = (357, 1520)

GTAAATATATTGTGTTTGCTGACA

2642
Table 3A
Hs.55921
NM_004446
4758293
glutamyl-prolyl-tRNA synthetase
1
AAATGAAGTCACACAGGACAATTATT

(EPRS), mRNA/cds = (58, 4380)

CTTATGCCTAAGTTAACAGTGGAT

2643
Table 3A
Hs.48876
NM_004462
4758349
famasyl-diphosphate
1
GTCGCTGCATATGTGACTGTCATGAG

famesyltransferase 1 (FDFT1),mRNA/

ATCCTACTTAGTATGATCCTGGCT

cds = (44, 1297)

2644
Table 3A
Hs.76362
NM_004492
4758485
general transcription factor IIA, 2
1
AAGGACAAAAGTTGTTGCCTTCCTAA

(12 kD subunit) (GTF2A2), mRNA/

GAACCTTCTTTAATAAACTCATTT

cds = (141, 470)

2645
Table 3A
Hs.103804
NM_004501
14141160
heterogeneous nuclear
1
CTGCATTTTGATTCTGAAAAGAAAGC

ribonucleoprotein U (scaffold

TGGCTTTGCCCATTTCTTATTAAA

attachment factor A) (HNRPU),

transcript variant 1, mRNA/

cds = (217, 2691)

2646
db mining
Hs.171545
NM_004504
7262381
HIV-1 Rev binding protein (HRB),
1
ACCTGTCTGCATAATAAAGCTGATCA

mRNA/cds = (243, 1931)

TGTTTTGCTACAGTTTGCAGGTGA

2647
literature
Hs.152983
NM_004507
4758575
HUS1 (S. pombe) checkpoint homolog
1
TACTGGTAGATGTGCTCATTCTCCCT

(HUS1), mRNA/cds = (60, 902)

GAAACATACCCATCATATTGTCCT

2648
Table 3A
Hs.38125
NM_004510
4758587
interferon-induced protein 75, 52 kD
1
AGGAAGCAATGTGGTTGGACCTGGTT

(IFI75), mRNA/cds = (170, 1396)

AAGGGAAAGGCTGATTACGGAAAT

2649
Table 3A
Hs.75117
NM_004515
4758601
interleukin enhancer binding factor 2,
1
AACTAATACTTTGCTGTTGAAATGTTG

45 kD (ILF2), mRNA/cds = (39, 1259)

TGAAATGTTAAGTGTCTGGAAAT

2650
Table 3A
Hs.6198
NM_004517
4758605
integrin-linked kinase (ILK), mRNA/
1
GAGCTTTGTCACTTGCCACATGGTGT

cds = (156, 1514)

CTTCCAACATGGGAGGGATCAGCC

2651
db mining
Hs.111301
NM_004530
11342665
matrix metalloproteinase 2 (gelatinase
1
CCCTGTTCACTCTACTTAGCATGTCC

A, 72 kD gelatinase, 72 kD type IV

CTACCGAGTCTCTTCTCCACTGGA

collagenase) (MMP2), mRNA/

cds = (289, 2271)

2652
Table 3A
Hs.198271
NM_004544
4758767
NADH dehydrogenase (ubiquinone) 1
1
TGCACATTGTTTTTCTTCTGACTTCCA

alpha subcomplex, 10 (42 kD)

GAAATAAAAGTGTTTCCATGGGA

(NDUFA10), mRNA/cds = (21, 1088)

2653
Table 3A
Hs.173611
NM_004550
4758785
NADH dehydrogenase (ubiquinone)
1
ACTAAAAAAGGAGAAATTATAATAAAT

Fe S protein 2 (49 kD) (NADH-

TAGCCGTCTTGCGCCCCTAGGCC

coenzyme Q reductase) (NDUFS2),

mRNA/cds = (6, 1397)

2654
Table 3A
Hs.80595
NM_004552
4758789
NADH dehydrogenase (ubiquinone) Fe
1
ACGACAAACCTCCTTGTCAAAGTGTG

S protein 5 (15 kD) (NADH-coenzyme

TAAAAATAAAGGATTGCTCCATCC

Q reductase) (NDUFS5), mRNA/

cds = (71, 391)

2655
Table 3A
Hs.91640
NM_004556
4758805
nuclear factor of kappa light
1
CCACTGGGGAAGGGAAGTTTCAGTA

polypeptide gene enhancer in B-cells

ACATGACACTAAAATGGCAGAGACG

inhibitor, epsilon (NFKBIE), mRNA/

cds = (33, 1535)

2656
Table 3A
Hs.74497
NM_04559
4758829
nuclease sensitive element binding
1
AAAGATTGGAGCTGAAGACCTAAAGT

protein 1 (NSEP1), mRNA/

GCTTGCTTTTTGCCCGTTGACCAG

cds = (234, 1202)

2657
Table 3A
Hs.158225
NM_004571
4758929
PBX/knotted 1 hoemobox 1
1
GAAGTCAGTGGGAAACACACAG

(PKNOX1), mRNA/cds = (85, 1392)

AAATTTATTTTAAAATCTTTCAGG

AGCT

2658
Table 3A
Hs.7688
NM_004576
4758953
protein phosphatase 2 (formerly 2A),
1
AGATGTATTAGAAGTCCTGACTTTCA

regulatory subunit B (PR 52), beta

AGTGTAATTTGCTTTGGAGGAGGA

isoform (PPP2R2B), mRNA/

cds = (525, 1856)

2659
literature
Hs.240457
NM_004584
4759021
RAD9 (S. pombe) homolog (RAD9),
1
CTGTGCAGAAGAGCTGCCAGGCAGT

mRNA/cds = (76, 1251)

GTCTTAGATGTGAGACGGAGGCCAT

2660
Table 3A
Hs.75498
NM_004591
4759075
small inducible cytokine subfamily A
1
ACATCATGGAGGGTTTAGTGCTTATC

(Cys—Cys), member 20 (SCYA20),

TAATTTGTGCCTCACTGGACTTGT

mRNA/cds = (58, 348)

2661
Table 3A
Hs.30035
NM_004593
4759097
splicing factor, arginine/serine-rich
1
TTGCTTACCAAAGGAGGCCCAATTTC

(transformer 2 Drosophila homolog) 10

ACTCAAATGTTTTGAGAACTGTGT

(SFRS10), mRNA/cds = (121, 987)

2662
Table 3A
Hs.53125
NM_004597
7242206
small nuclear ribonucleoprotein D2
1
TCACTCCTCTGTCCTATGAAGACCGC

polypeptide (16.5 kD) (SNRPD2),

TGCCATTGGTGTTGAGAATAATAA

mRNA/cds = (30, 366)

2663
literature
Hs.91175
NM_004618
10835217
topoisomerase (DNA) III alpha
1
GTTAAGCCAGGACATCCAGAATTCAT

(TOP3A), mRNA/cds = (177, 3182)

TGCTTTAATAAAGAACCCAGGCCG

2664
Table 3A
Hs.75066
NM_004822
4759269
translin (TSN), mRNA/cds = (81, 767)
1
TCAGTTTTAACAAATGCTATTAAAGTG

GAGAAGCACACTCTGGTCTTGGA

2665
db mining
Hs.320
NM_004628
4759331
xeroderma pigmentosum,
1
CTCACTGCCTCTTTGCAGTAGGGGAG

complementation group C (XPC),

AGAGCAGAGAAGTACAGGTCATCT

mRNA/cds = (191, 2662)

2666
literature
Hs.8047
NM_004629
4759335
Fanconi anemia, complementation
1
TTGACTTTGCTCGAGGCACCTTTTTT

group G (FANCG), mRNA/

CCTGTTTCTCCTTTTCTGTTGTCG

cds = (492, 2360)

2667
Table 3A
Hs.159627
NM_004632
4756117
death associated protein 3 (DAP3),
1
AAATGGGTTTCACTGTGAATGCGTGA

mRNA/cds = (73, 1269)

CAATAAGATATTCCCTTGTTCCTA

2668
Table 3A
Hs.237955
NM_004637
13794266
mRNA for RAB7 protein/
1
AACGAATTTCCTGAACCTATCAAACT

cds = (602, 1225)

GGACAAGAATGACCGGGCCAAGGC

2669
Table 3A
Hs.25911
NM_004638
4758107
HLA-B associated transcript 2 (BAT2),
1
CTTCCCCTGGTCCCCTGTCCCTGGG

mRNA/cds = (101, 6529)

GCTGTTTGTTAAAAAAGAGTAATAA

2670
Table 3A
Hs.966
NM_004645
4758023
coilin (COIL), mRNA/cds = (22, 1752)
1
ACCGTGAAAATTGGTTTCATTTAACAA

AAGATCAGATCCCTCCTTCAGCT

2671
Table 3A
Hs.77576
NM_004652
11641424
ubiquitin specific protease 9, x
1
TTTCTTGTTACACCCACTGCACTCTG

chromosome (Drosophila fat facets

CAACCAGTGTTGCCTGCCTCATGG

related) (USP9X), transcript variant 1,

mRNA/cds = (59, 7750)

2672
Table 3A
Hs.80358
NM_004653
4759149
SMC (mouse) homolog, Y
1
GGGAAAAACAAGAATTTCATGACTCT

chromosome (SMCY), mRNA/

ACCTGTGGTCTATCTTTAATTTCA

cds = (275, 4694)

2673
Table 3A
Hs.121102
NM_004665
4759313
vanin 2 (VNN2), mRNA/
1
GCTGTGCCCTTGAAGAGAATAGTAAT

cds = (11, 1573)

GATGGGAATTTAGAGGTTTATGAC

2674
Table 3A
Hs.6856
NM_004674
4757789
ash2 (absent, small, or homeotic,
1
TCCAAGGAAATGGTAACCTGTTTCTG

Drosophila, homolog)-like (ASH2L),

AGAACACCTGAAATCAATGGCTAT

mRNA/cds = (4, 1890)

2675
Table 3A
Hs.155103
NM_004681
4758253
eukaryotic translation initiation factor
1
TTCATTGTAATCCACTGTTTTGGCTTT

1A, Y chromosome (EIF1AY), mRNA/

CATGAACAAGTAAATTACAGTGT

cds = (132, 588)

2676
Table 3A
Hs.54483
NM_004688
4758813
N-myc (and STAT) interactor (NMI),
1
ACTTATTTCCATGTTTCTGAATCTTCT

mRNA/cds = (280, 1203)

TTGTTTCAAATGGTGCTGCATGT

2677
Table 3A
Hs.5097
NM_004710
4759201
synaptogyrin 2 (SYNGR2), mRNA/
1
ATGCCCGGCCTGGGATGCTGTTTGG

cds = (29, 703)

AGACGGAATAAATGTTTTCTCATTC

2678
Table 3A
Hs.40323
NM_004725
4757879
BUB3 (budding uninhibited by
1
TACTCTAAACCTGTTATTTCTGTGCTA

benzimidazoles 3, yeast) homolog

ATAAACGAGATGCAGAACCCTTG

(BUB3), mRNA/cds = (70, 1056)

2679
Table 3A
Hs.77324
NM_004730
4759033
eukaryotic translation termination
1
TGCAGAGAGATACTAAGCAGCAAAAT

factor 1 (ETF1), mRNA/

CTTGGTGTTGTGATGTACAGAAAT

cds = (135, 1448)

2680
Table 3A
Hs.326159
NM_004735
4758689
leucine rich repeat (in FLII) interacting
1
AGTCTTTGATCTTGAACCGATACTTTT

protein 1 (LRRFIP1), mRNA/

GGATCTCATTGTTGATATACCTG

cds = (178, 2532)

2681
Table 3A
Hs.333513
NM_004757
4758265
small inducible cytokine subfamily E,
1
TGGAATCAAATAAAATGCTTCCACTA

member 1 (endothelial monocyte-

CCAAAAGACATTAGAGAAAACCTT

activating) (SCYE1), mRNA/

cds = (49, 987)

2682
Table 3A
Hs.9075
NM_004760
4758191
serine/threonine kinase 17a (apoptosis-
1
TGCCGAATACCTTAAAGTAACTAATTA

inducing) (STK17A), mRNA/

TCCTTACACACAAAAGGCTCAGT

cds = (117, 1361)

2683
Table 3A
Hs.170160
NM_004761
4758531
RAB2, member RAS oncogene family-
1
CTTTCCCAGGATCAAGGCCACAGGG

like (RAB2L), mRNA/cds = (0, 2333)

AGGAAGATTGCACGGGCACTGTTCT

2684
Table 3A
Hs.1050
NM_004762
4758963
pleckstrin homology. Sec7 and
1
CTTGTAAACTAGCGCCAAGGAACTGC

coiled/coil domains 1 (cytohesin 1)

AGCAAATAAACTCCAACTCTGCCC

(PSCD1), transcript variant 1, mRNA/

cds = (69, 1265)

2685
Table 3A
Hs.11482
NM_004768
4759099
splicing factor, arginine/serine-rich 11
1
TGTGCAGTAGAAACAAAAGTAGGCTA

(SRFS11), mRNA/cds = (83, 1537)

CAGTCTGTGCCATGTTGATGTACA

2686
Table 3A
Hs.15589
NM_004774
4759265
PPAR binding protein (PPARBP),
1
AGGAGGGTTTAAATAGGGTTCAGAGA

mRNA/cds = (235, 4935)

TCATAGGAATATTAGGAGTTACCT

2687
Table 3A
Hs.26703
NM_004779
4758945
CCR4-NOT transcription complex,
1
TGGTGGAAGTAAAAACTGGTAACTCA

subunit 8 (CNOT8), mRNA/

CTCAAGTGAATGAATGGTCTTGCA

cds = (244, 1122)

2688
Table 3A
Hs.23965
NM_004790
4759041
solute carrier family 22 (organic anion
1
GCAGGAAAGGGAAACAGACGCGACA

transporter), member 6 (SLC22A6),

GCAACAAGAGCACCAGAAGTATATG

mRNA/cds = (0, 1652)

2689
Table 3A
Hs.77965
NM_004792
4758105
peptidyl-prolyl isomerase G (cyclophilin
1
TCCATTCTGTTTCGGATTTTAAGTTTG

G) (PPIG), mRNA/cds = (157, 2421)

AGAGACTTGCTAATGAATCTCCT

2690
Table 3A
Hs.28757
NM_004800
4758873
transmembrane 9 superfamily member
1
CCTTCAGAAACACCGTAATTCTAAAT

2 (TM9SF2), mRNA/cds = (133, 2124)

AAACCTCTTCCCATACACCTTTCC

2691
Table 3A
Hs.49587
NM_004811
4758669
leupaxin (LPXN), mRNA/
1
CTGGACAACTTTGAGTACTGACATCA

cds = (93, 1253)

TTGATAAATAAACTGGCTTGTGGT

2692
Table 3A
Hs.168103
NM_004818
4759277
prp28, U5 snRNP 100 kd protein (U5-
1
CCCAGGGGATTTTTTAAGTAGATGGG

100K), mRNA/cds = (39, 2501)

GGGACACGGTGAACTGGCTGTGTC

2693
Table 3A
Hs.3628
NM_004834
4758523
mitogen-activated protein kinase
1
ACTCCAAAATAAATCAAGGCTGCAAT

kinase kinase kinase 4 (MAP4K4),

GCAGCTGGTGCTGTTCAGATTCCA

mRNA/cds = (79, 3576)

2694
Table 3A
Hs.102508
NM_004836
4758891
eukaryotic translation initiation factor 2-
1
TGAAATCTTAAGTGTCTTATATGTAAT

alpha kinase 3 (EIF2AK3), mRNA/

CCTGTAGGTTGGTACTTCCCCCA

cds = (72, 3419)

2695
Table 3A
Hs.227806
NM_004841
4758807
RAS protein activator like 2 (RASAL2),
1
TGGGAGTCTTCTCTTTTAGACAGGGG

mRNA/cds = (125, 3544)

CTTTTTGTTTTTAACCCCAATTGT

2696
db mining
Hs.78364
NM_004847
6680470
allograft inflammatory factor 1 (AIF1),
1
TGACCCAGATATGGAAACAGAAGACA

transcript variant 2, mRNA/

AAATTGTAAGCCAGAGTCAACAAA

cds = (453, 851)

2697
Table 3A
Hs.10649
NM_004848
4758579
basement membrane-induced gene
1
AGGTTTCATCAGGTGGTTAAAGTCGT

(ICB-1), mRNA/cds = (128, 982)

CAAAGTTGTAAGTGACTAACCAAG

2698
Table 3A
Hs.274472
NM_004850
6633807
high-mobility group (nonhistone
1
ATGCTGTCAAAGTTACAGTTTACGCA

chromosomal) protein 1 (HMG1),

GGACATTCTTGCCGTATTCTCATG

mRNA/cds = (52, 699)

2699
Table 3A
Hs.178710
NM_004859
4758011
clathrin, heavy polypeptide (Hc)
1
TGTGTGTTTACTAACCCTTCCCTGAG

(CLTC), mRNA/cds = (172, 5199)

GCTTGTGTATGTTGGATATTGTGG

2700
Table 3A
Hs.76507
NM_004862
4758913
LPS-induced TNF-alpha factor (PIG7),
1
TCTGTAATCAAATGATTGGTGTCATTT

mRNA/cds = (233, 919)

TCCCATTTGCCAATGTAGTCTCA

2701
Table 3A
Hs.59403
NM_004863
4758667
serine palmitoyltransferase, long chain
1
TGCCCAGCAGCCATCTTAATACATTA

base subunit 2 (SPTLC2), mRNA/

AACCAGTTTAAAAAATACCTTCCA

cds = (188, 1876)

2702
Table 3A
Hs.5409
NM_004875
4759045
RNA polymerase I subunit (RPA40),
1
GCCAGAGTTGCCAACCCCCGGCTGG

mRNA/cds = (22, 1050)

ATACCTTCAGCAGAGAAATCTTCCG

2703
Table 3A
Hs.66371
NM_004876
4758513
zinc finger protein 254 (ZNF254),
1
AATCCATTAACACCTGCTCACATCTTA

mRNA/cds = (134, 1195)

CTCAAAATTGTAGAGTTCATAGT

2704
Table 3A
Hs.75258
NM_004893
4758495
H2A histone family, member Y
1
ATTTGCAATTTGGAATTTGTGTGAGTT

(H2AFY), mRNA/cds = (173, 1288)

GATTTAGTAAAATGTTAAACCGC

2705
Table 3A
Hs.80426
NM_004899
4757871
brain and reproductive organ-
1
AAGTAAAGCCTCAGGAATGCCCACG

expressed (TNFRSF1A modulator)

CCTTTCTTCCAAAGCCTTTGTCTCT

(BRE), mRNA/cds = (146, 1297)

2706
Table 3A
Hs.145696
NM_004902
4757925
splicing factor (CC1.3) (CC1.3),
1
TCAAACAAATGACTTTCATATTGCAAC

mRNA/cds = (149, 1723)

AATCTTTGTAAGAACCACTCAAA

2707
Table 3A
Hs.119
NM_004906
4758635
Wilms' tumor 1-associating protein
1
GGGGAATGTGTTCCTTCATTGTATTT

(KIAA0105), mRNA/cds = (124, 579)

GGGCCTTTTGTATTGCACTCTTGA

2708
Table 3A
Hs.737
NM_004907
4758313

Homo sapiens, Similar to kinesin
1
TTGTTTACCTTTCGTGCGGTGGATTC

family member 5B, clone MGC:15265

TTTTTAACTCCGTCTACCTGGCGT

IMAGE:4297793, mRNA, complete

cds/cds = (424, 1566)

2709
Table 3A
Hs.288156
NM_004911
4758303
cDNA: FLJ21819 fis, clone HEP01185/
1
GGGGTTTGTGCTATACACTGGGATGT

cds = UNKNOWN

CTAATTGCAGCAATAAAGCCTTTC

2710
Table 3A
Hs.81964
NM_004922
4758833
SEC24 (S. cerevisiae) related gene
1
ACCTGGGATGCCCCTGCTCTGGACC

family, member C (SEC24C), mRNA/

TCTCATTTCTCTTCATTGGTTTATT

cds = (114, 3491)

2711
Table 3A
Hs.333417
NM_004930
4826658
capping protein (actin filament) muscle
1
AGCCTGCTTCTGCCACACCTCGCTCT

Z-line, beta (CAPZB), mRNA/

CAGTCTCTCCACATTTCCATAGAG

cds = (0, 818)

2712
Table 3A
Hs.2299
NM_004931
4826666
CD8 antigen, beta polypeptide 1 (p37)
1
AAGTTTCTCAGCTCCCATTTCTACTCT

(CD8B1), mRNA/cds = (50, 682)

CCCATGGCTTCATGCTTCTTTCA

2713
Table 3A
Hs.171872
NM_004941
4826689
DEAD/H (Asp-Glu-Ala-Asp/His) box
1
GAGCTACTGTGCTCATCTAAAGTGTT

polypeptide 8 (RNA helicase) (DDX8),

TGCCCCACTTCCCACCCCGTCTCC

mRNA/cds = (73, 3735)

2714
Table 3A
Hs.251064
NM_004965
4826757
high-mobility group (nonhistone
1
ATGTTAAGATTTGTGTACAAATTGAAA

chromosomal) protein 14 (HMG14),

TGTCTGTACTGATCCTCAACCAA

mRNA/cds = (150, 452)

2715
Table 3A
Hs.808
NM_004966
14141150
heterogeneous nuclear
1
TCTGTTGATAGCTGGAGAACTTTAGT

ribonucleoprotein F (HNRPF), mRNA/

TTCAAGTACTACATTGTGAAAGCA

cds = (323, 1570)

2716
literature
Hs.115541
NM_004972
13325062
Janus kinase 2 (a protein tyrosine
1
TGAGGGGTTTCAGAATTTTGCATTGC

kinase) (JAK2), mRNA/

AGTCATAGAAGAGATTTATTTCCT

cds = (494, 3892)

2717
Table 3A
Hs.40154
NM_004973
11863151
jumonji (mouse) homolog (JMJ),
1
CCTTGGGAGGGAGACTTCATGTGGTT

mRNA/cds = (244, 3984)

TATTGCGAGTTTTTTGTTTACTTT

2718
Table 3A
Hs.184050
NM_004985
4826811
v-Ki-ras2 Kirsten rat sarcoma 2 viral
1
GTATGTTAATGCCAGTCACCAGCAGG

oncogene homolog (KRAS2), mRNA/

CTATTTCAAGGTCAGAAGTAATGA

cds = (192, 758)

2719
Table 3A
Hs.279946
NM_004990
14043021
methionine-tRNA synthetase (MARS),
1
GCCCCTAAAGGCAAGAAGAAAA

mRNA/cds = (23, 2725)

AGTAAAAGACCTTGGCTCATAGAA

AGTC

2720
Table 3A
Hs.75103
NM_005005
6274549
tyrosine 3-monooxygenase/tryptophan
1
AGTGAAATATGTTACAGAACATGCAC

5-monooxygenase activation protein,

TTGCCCTAATAAAAAATCAGTGAA

zeta polypeptide (YWHAZ), mRNA/

cds = (84, 621)

2721
Table 3A
Hs.8248
NM_005006
4826855
NADH dehydrogenase (ubiquinone) Fe
1
TGCAGATGCTCTTAAAAGCATTGATA

S protein 1 (75 kD) (NADH-coenzyme

ACCTTTGTGACGAACATAAAGAGA

Q reductase) (NDUFS1), mRNA/

cds = (46, 2229)

2722
Table 3A
Hs.182255
NM_005008
4826859
non-histone chromosome protein 2 (S.
1
GCTAGTTCATGTGTTCTCCATTCTTGT

cerevisiae)-like 1 (NHP2L1), mRNA/

GAGCATCCTAATAAATCTGTTCC

cds = (94, 480)

2723
Table 3A
Hs.151134
NM_005015
4826879
oxidase (cytochrome c) assembly 1-
1
AACCCTCCCAATATCCCTAGCAGCAG

like (OXA1L), mRNA/cds = (0, 1487)

CAGCAAACCAAAGTCAAAGTATCC

2724
Table 3A
Hs.75721
NM_005022
4826897
profilin 1 (PFN1), mRNA/
1
CACCTCCCCCTACCCATATCCCTCCC

cds = (127, 549)

GTGTGTGGTTGGAAAACTTTTGTT

2725
db mining
Hs.100724
NM_005037
4826929
peroxisome proliferative activated
1
GAGTCCTGAGCCACTGCCAACATTTC

receptor, gamma (PPARG), mRNA/

CCTTCTTCCAGTTGCACTATTCTG

cds = (172, 1608)

2726
literature
Hs.180455
NM_005053
4826963
RAD23 (S. cerevisiae) homolog A
1
CCCCACCCCAGAACAGAACCGTGTC

(RAD23A), mRNA/cds = (38, 1127)

TCTGATAAAGGTTTTGAAGTGAATA

2727
Table 3A
Hs.180610
NM_005066
4826997
splicing factor proline/glutamine rich
1
CCCATTTCTTGTTTTTAAAAGACCAAC

(polypyrimidine tract-binding protein-

AAATCTCAAGCCCTATAAATGGC

associated) (SFPQ), mRNA/

cds = (85, 2208)

2728
Table 3A
Hs.149923
NM_005080
14110394
X-box binding protein 1 (XBP1),
1
AGTGTAGCTTCTGAAAGGTGCTTTCT

mRNA/cds = (48, 833)

CCATTTATTTAAAACTACCCATGC

2729
Table 3A
Hs.1579
NM_005082
4827064
zinc finger protein 147 (estrogen-
1
GAGTGCCCGATTCCTCTTAGAGAAAA

responsive finger protein) (ZNF147),

TCCATAGCCTTCAGATCTTGGTGT

mRNA/cds = (39, 1931)

2730
Table 3A
Hs.82712
NM_005087
4826735
fragile X mental retardation, autosomal
1
ACTTTGACACCTACTGTGTTATAAAAT

homolog 1 (FXR1), mRNA/

ATATCATCAGATGTGCCTTGAGA

cds = (12, 1877)

2731
Table 3A
Hs.21595
NM_005088
10835221
DNA segment on chromosome X and
1
AGCTGTAACGTTCGCGTTAGGAAAGA

Y (unique) 155 expressed sequence

TGGTGTTTATTCCAGTTTGCATTT

(DXYS155E), mRNA/cds = (166,

1323)

2732
literature
Hs.248197
NM_005092
4827033
tumor necrosis factor (ligand)
1
TGATATTCAACTCTGAGCATCAGGTT

superfamily, member 18 (TNFSF18),

CTAAAAAATAATACATACTGGGGT

mRNA/cds = (0, 533)

2733
Table 3A
Hs.75243
NM_005104
12408641
bromodomain-containing 2 (BRD2),
1
GTCATCTCCCCATTTGGTCCCCTGGA

mRNA/cds = (1701, 4106)

CTGTCTTTGTTGATTCTAACTTGT

2734
Table 3A
Hs.95220
NM_005109
4826877
oxidative-stress responsive 1 (OSR1),
1
GAGAATAATGATGTACCAATAAGTGG

mRNA/cds = (342, 1925)

AGATTCCTCCTTATGATGTATGCT

2735
literature
Hs.241382
NM_005118
4827031
tumor necrosis factor (ligand)
1
ACAAGACAGACTCCACTCAAAATTTA

superfamily, member 15 (TNFSF15),

TATGAACACCACTAGATACTTCCT

mRNA/cds = (1123, 1647)

2736
Table 3A
Hs.11861
NM_005121
4827043
thyroid hormone receptor-associated
1
TCCATACCATTGTGTGTGGAGGATTT

protein, 240 kDa subunit (TRAP240),

ACAGCTAAGCTGTAGTTGCAGAGT

mRNA/cds = (77, 6601)

2737
Table 3A
Hs.3382
NM_005134
4826933
protein phosphatase 4, regulatory
1
ACACTTTTGATTGTTTTCTAGATGTCT

subunit 1 (PPP4R1), mRNA/

ACCAATAAATGCAATTTGTGACC

cds = (93, 2894)

2738
Table 3A
Hs.75981
NM_005151
4827049
ubiquitin specific protease 14 (tRNA-
1
ACTGTACAATTTCTGAAGATGGTTATT

guanine transglycosylase) (USP14),

AACACTGTGCTGTTAAGCATCCA

mRNA/cds = (91, 1575)

2739
Table 3A
Hs.152818
NM_005154
4827053
ubiquitin specific protease 8 (USP8),
1
TCAGTCCTTTCTTAGGGAAATGACAG

mRNA/cds = (317, 3673)

GGCAAAGCAATTTTTCTGTTGGCT

2740
Table 3A
Hs.89399
NM_005176
6671590
ATP synthase, H+ transporting,
1
AGTACAAGGCCCGAAGGGTAGTGAT

mitochondrial F0 complex, subunit c

GGTGCTAAACTCAACATGGATTTGG

(subunit 9), isoform 2 (ATP5G2),

mRNA/cds = (59, 484)

2741
Table 3A
Hs.431
NM_005180
4885094
murine leukemia viral (bmi-1)
1
CCCCAGTCTGCAAAAGAAGCACAATT

oncogene homolog (BMI1), mRNA/

CTATTGCTTTGTCTTATAGT

cds = (479, 1459)

2742
Table 3A
Hs.838
NM_005191
4885122
CD80 antigen (CD28 antigen ligand 1,
1
CTTCTTTTGCCATGTTTCCATTCTGCC

B7-1 antigen) (CD80), mRNA/

ATCTTGAATTGTCTTGTCAGCCA

cds = (375, 1241)

2743
Table 3A
Hs.247824
NM_005214
4885166
cytotoxic T-lymphocyte-associated
1
GGGTCTATGTGAAAATGCCCCCAACA

protein 4 (CTLA4), mRNA/cds = (0,

GAGCCAGAATGTGAAAAGCAATTT

671)

2744
literature
Hs.211567
NM_005215
4885174
deleted in colorectal carcinoma (DCC),
1
CCTTCTTTCACAGGCATCAGGAATTG

mRNA/cds = (0, 4343)

TCAAATGATGATTATGAGTTCCCT

2745
literature
Hs.34789
NM_005216
4885176
dolichyl-diphosphooligosaccharide-
1
CATCTTCAGCATCGTCTTCTTGCACA

protein glycosyltransferase (DDOST),

TGAAGGAGAAGGAGAAGTCCGACT

mRNA/cds = (0, 1370)

2746
literature
Hs.89296
NM_005238
4885216
excision repair cross-complementing
1
GGGAATGCTGCAAATGCCAAACAGCT

rodent repair deficiency,

TTATGATTTCATTCACACCTCTTT

complementation group 4 (ERCC4),

mRNA/cds = (0, 2750)

2747
Table 3A
Hs.129953
NM_005243
4885224
Ewing sarcoma breakpoint region 1
1
TTAAAAATGGTTGTTTAAGACTTTAAC

(EWSR1), transcript variant EWS,

AATGGGAACCCCTTGTGAGCATG

mRNA/cds = (43, 2013)

2748
Table 3A
Hs.1422
NM_005248
4885234
Gardner-Rasheed feline sarcoma viral
1
GGGAGAAGTTTGCAGAGCACTTCCC

(v-fgr) oncogene homolog (FGR),

ACCTCTCCTGAATAGTGTGTATGTGT

mRNA/cds = (147, 1736)

2749
Table 3A
Hs.79022
NM_005261
4885262
GTP-binding protein overexpressed in
1
TGGTTGACCCTTGTATGTCACAGCTC

skeletal muscle (GEM), mRNA/

TGCTCTATTTATTATTATTTTGCA

cds = (213, 1103)

2750
Table 3A
Hs.73172
NM_005263
4885266
growth factor independent 1 (GFI1),
1
TGGGAAGGAAGGCTCTGTCTTCAACT

mRNA/cds = (267, 1535)

CTTTGACCCTCCATGTGTACCATA

2751
Table 3A
Hs.237519
NM_005271
4885280
yz35c09.s1 cDNA, 3′ end/
1
GCATGGCTTAACCTGGTGATAAAAGC

clone = IMAGE:285040/clone_end =

AGTTATTAAAAGTCTACGTTTTCC

3′

2752
Table 3A
Hs.239891
NM_005301
4885320
G protein-coupled receptor 35
1
CTCCCCGTGCTAAGGCCCACAAAAG

(GPR35), mRNA/cds = (0, 929)

CCAGGACTCTCTGTGCGTGACCCTC

2753
Table 3A
Hs.289101
NM_005313
4885358
glucose regulated protein, 58 kD
1
AATTCAAGAAGAAAAACCCAAG

(GRP58), mRNA/cds = (0, 1517)

AAGAAGAAGAAGGCACAGGAGGAT

CTCT

2754
literature
Hs.89578
NM_005316
4885364

Homo sapiens, general transcription
1
TCCCAGAGCTGATGCTATTGTACTTG

factor I/H, polypeptide 1 (62 kD

CACATTGGAGACTGAAAGGAAAGA

subunit), clone MGC:8323 IMAGE:

2819217, mRNA, complete cds/cds =

(169, 1815)

2755
literature
Hs.136657
NM_005320
4885376
H1 histone family, member 3 (H1F3),
1
GGGGAAGCCGAAGGTTACAAAGGCA

mRNA/cds = (0, 665)

AAGAAGGCAGCTCCGAAGAAAAAGT

2756
Table 3A
Hs.14601
NM_005335
4885404
hematopoietic cell-specific Lyn
1
TCCCTGAAGAAATATCTGTGAACCTT

substrate 1 (HCLS1), mRNA/

CTTTCTGTTCAGTCCTAAAATTCG

cds = (42, 1502)

2757
Table 3A
Hs.132834
NM_005337
4885410
hematopoietic protein 1 (HEM1),
1
CCTCTCCGACCTTCATCACTATTCTTA

mRNA/cds = (1582, 3423)

GGATAATGCTGGCGGGCAGAGAT

2758
Table 3A
Hs.193989
NM_005345
5579469
TAR DNA binding protein (TARDBP),
1
ACTGCCATCTTACGACTATTTCTTCTT

mRNA/cds = (88, 1332)

TTTAATACACTTAACTCAGGCCA

2759
Table 3A
Hs.274402
NM_005346
5579470
heat shock 70 kD protein 1B
1
AGGGTGTTTCGTTCCCTTTAAATGAA

(HSPA1B), mRNA/cds = (152, 2077)

TCAACACTGCCACCTTCTGTACGA

2760
Table 3A
Hs.289088
NM_005348
13129149
heat shock 90 kD protein 1, alpha
1
GACCCTACTGCTGATGATACCAGTGC

(HSPCA), mRNA/cds = (60, 2258)

TGCTGTAACTGAAGAAATGCCACC

2761
Table 3A
Hs.1765
NM_005356
4885448
lymphocyte-specific protein tyrosine
1
CATTTCCTGAGACCACCAGAGAGAG

kinase (LCK), mRNA/cds = (51, 1580)

GGGAGAAGCCTGGGATTGACAGAAG

2762
Table 3A
Hs.1765
NM_005356
4885448
lymphocyte-specific protein tyrosine
1
CATTTCCTGAGACCACCAGAGAGAG

kinase (LCK), mRNA/cds = (51, 1580)

GGGAGAAGCCTGGGATTGACAGAAG

2763
db mining
Hs.75862
NM_005359
4885456
MAD (mothers against
1
GCTAAGAAGCCTATAAGAGGAATTTC

decapentaplegic, Drosophila) homolog

TTTTCCTTCATTCATAGGGAAAGG

4 (MADH4), mRNA/cds = (128, 1786)

2764
Table 3A
Hs.297939
NM_005385
6631099
cathepsin B (CTSB), mRNA/
1
ACTGACAGAGTGAACTACAGAAATAG

cds = (177, 1196)

CTTTTCTTCCTAAAGGGGATTGTT

2765
literature
Hs.301862
NM_005395
4885552
postmeiotic segregation increased 2-
1
CAGACAATGGATGTGGGGTAGAAGA

like 9 (PMS2L9), mRNA/cds = (0, 794)

AGAAACTTTGAAGGCTTAATCTCT

2766
Table 3A
Hs.288757
NM_005402
4885568
v-ral simian leukemia viral oncogene
1
AAAAGAAGAGGAAAAGTTTAGC

homolog A (ras related) (RALA),

CAAGAGAATCAGAGAAAGATGCTG

mRNA/cds = (0, 629)

CATT

2767
literature
Hs.103982
NM_005409
14790145
small inducible cytokine subfamily B
1
AGTGCACATATTTCATAACCAAATTAG

(Cys-X-Cys), member 11 (SCYB11),

CAGCACCGGTCTTAATTTGATGT

mRNA/cds = (93, 377)

2768
Table 3A
Hs.72988
NM_005419
4885614
signal transducer and activator of
1
TAGACCTCTTTTTCTTACCAGTCTCCT

transcription 2, 113 kD (STAT2),

CCCCTACTCTGCCCCCTAAGCTG

mRNA/cds = (57, 2612)

2769
literature
Hs.129727
NM_005431
4885656
X-ray repair complementing defective
1
AGCACAGTAAAAGTAAAGACTATTCT

repair in Chinese hamster cells 2

GTTTCTAGGCTGTTGAATCAAAGT

(XRCC2), mRNA/cds = (86, 928)

2770
literature
Hs.99742
NM_005432
12408644
X-ray repair complementing defective
1
CATGGGCACAGTGGTGACCCCCTTG

repair in Chinese hamster cells 3

ATTCCCACCGTACAACCCCCTCCAC

(XRCC3), mRNA/cds = (353, 1393)

2771
literature
Hs.75238
NM_005441
4885104
chromatin assembly factor 1, subunit B
1
CGTTATCCAGTGTGAAAATCAGTGAG

(p60) (CHAF1B), mRNA/

TCCTCCCTGGCATCCTCGTGAAAG

cds = (62, 1741)

2772
Table 3A
Hs.301704
NM_005442
11321608
eomesodermin (Xenopus laevis)
1
GCTGAAGAGTATAGTAAAGACACCTC

homolog (EOMES), mRNA/

AAAAGGCATGGGAGGGTATTATGC

cds = (0, 2060)

2773
Table 3A
Hs.169487
NM_005461
4885446
Kreisler (mouse) maf-related leucine
1
TTCAGACTGGTTTCTGTTTTTTGGTTA

zipper homolog (KRML), mRNA/

TTAAAATGGTTTCCTATTTTGCT

cds = (73, 1044)

2774
Table 3A
Hs.170311
NM_005463
14110410
heterogeneous nuclear
1
TTTATGATTAGGTGACGAGTTGACAT

ribonucleoprotein D-like (HNRPDL),

TGAGATTGTCCTTTTCCCCTGATC

transcript variant 1, mRNA/

cds = (580, 1642)

2775
literature
Hs.24284
NM_005484
11496991
ADP-ribosyltransferase (NAD+;
1
CCCCAACCAGGTCCGTATGCGGTAC

poly(ADP-ribose) polymerase)-like 2

CTTTTAAAGGTTCAGTTTAATTTCC

(ADPRTL2), mRNA/cds = (149, 1753)

2776
literature
Hs.271742
NM_005485
11496992
ADP-ribosyltransferase (NAD+; poly
1
TCCTGCAAGFGCTGGACTGTGATCTTC

(ADP-ribose) polymerase)-like 3

AATCATCCTGCCCATCTCTGGTAC

(ADPRTL3), mRNA/cds = (246, 1847)

2777
Table 3A
Hs.180370
NM_005507
5031634
cofilin 1 (non-muscle) (CFL1), mRNA/
1
GGTCACGGCTACTCATGGAAGCAGG

cds = (51, 551)

ACCAGTAAGGGACCTTCCGATTAAAA

2778
literature
Hs.184926
NM_005508
5031626
chemokine (C—C motif) receptor 4
1
CCTTCTAACCTGAACTGATGGGTTTC

(CCR4), mRNA/cds = (182, 1264)

TCCAGAGGGAATTGCAGAGTACTG

2779
Table 3A
Hs.77961
NM_005514
5031742
major histocompatibility complex, class
1
ATGTGTAGGAGGAAGAGTTCAGGTG

I, B (HLA-B), mRNA/cds = (0, 1088)

GAAAAGGAGGGAGCTACTCTCAGGC

2780
Table 3A
Hs.334767
NM_005517
5031748
hypothetical protein MGC5629
1
AACGATTGTCTGCCCATGTCCTGCCT

(MGC5829), mRNA/cds = (285, 539)

GAAATACCATGATTGTTTATGGAA

2781
Table 3A
Hs.245710
NM_005520
5031752
heterogeneous nuclear
1
TTCCTTTTAGGTATATTGCGCTAAGT

ribonucleoprotein H1 (H) (HNRPH1),

GAAACTTGTCAAATAAATCCTCCT

mRNA/cds = (72, 1421)

2782
Table 3A
Hs.177559
NM_005534
5031782
interferon gamma receptor 2
1
GTCTTGACTTTGGCAAATGAGCCGGA

(interferon gamma transducer 1)

GCCCCTTGGGCAGGTCACACAACC

(IFNGR2), mRNA/cds = (648, 1661)

2783
literature
Hs.121544
NM_005535
5031784
interleukin 12 receptor, beta 1
1
GATACAGAGTTGTCCTTGGAGGATGG

(IL12RB1), mRNA/cds = (64, 2052)

AGACAGGTGCAAGGCCAAGATGTG

2784
Table 3A
Hs.155939
NM_005541
5031798
inositol polyphosphate-5-phosphatase,
1
TCCCATGATGGAAGTCTGCGTAACCA

145 kD (INPP5D), mRNA/

ATAAATTGTGCCTTTCTCACTCAA

cds = (140, 3706)

2785
Table 3A
Hs.56205
NM_005542
5031800
insulin induced gene 1 (INSIG1),
1
TCTACATGTCTTGGGGGCGGGCTCA

mRNA/cds = (414, 1247)

AATTCTTCGAAAGTGGTTGGATTAA

2786
Table 3A
Hs.211576
NM_005546
5031810
IL2-inducible T-cell kinase (ITK),
1
ACCTGTTATCCTTTGTAGAGCACACA

mRNA/cds = (2021, 3883)

GAGTTAAAAGTTGAATATAGCAAT

2787
Table 3A
Hs.23881
NM_005556
5031842
keratin 7 (KRT7), mRNA/
1
TGAGCTTCTCCAGCAGTGCGGGTCC

cds = (56, 1465)

TGGGCTCCTGAAGGCTTATTCCATC

2788
Table 3A
Hs.81915
NM_005563
13518023
stathmin 1/oncoprotein 18 (STMN1),
1
GCATGTCCTCATCCTTTCCTGCCATA

mRNA/cds = (91, 540)

AAAGCTATGACACGAGAATCAGAA

2789
Table 3A
Hs.2488
NM_005565
7382491
lymphocyte cytosolic protein 2 (SH2
1
ACCCCTCCCCATGAACACAAGGGTTT

domain-containing leukocyte protein of

TATCCTTTCCTTTAAAAACAGTGT

76 kD) (LCP2), mRNA/cds = (207,

1808)

2790
Table 3A
Hs.314760
NM_005566
5031856
HOA7-1-F8 cDNA
1
TGCAACCAACTATCCAAGTGTTATAC

CAACTAAAACCCCCAATAAACCTT

2791
db mining
Hs.153883
NM_005585
5031898
Smad6 mRNA, complete cds/
1
ATGCCCAGACAAAAAGCTAATACCAG

cds = (936, 2426)

TCACTCGATAATAAAGTATTCGCA

2792
literature
Hs.20555
NM_005590
5031920
meiotic recombination (S. cerevisiae)
1
TGGCACTGAGAAACATGCAAGATACA

11 homolog A (MRE11A), mRNA/

GGAAAAATGAAAATGTTACAAGCT

cds = (170, 2296)

2793
Table 3A
Hs.158164
NM_005594
5031930
transporter 1, ATP-binding cassette,
1
TCTCAAAGGAGTAACTGCAGCTTGGT

sub-family B (MDR/TAP) (TAP1),

TTGAAATTTGTACTGTTTCTATCA

mRNA/cds = (30, 2456)

2794
Table 3A
Hs.18069
NM_005606
5031990

Homo sapiens, protease, cysteine, 1
1
GTCAACCTTTGTGAGAAGCCGTATCC

(legumain), clone MGC:15832

ACTTCACAGGATAAAATTGTCCAT

IMAGE:3507728, mRNA, complete

cds/cds = (1124, 2425)

2795
Table 3A
Hs.256290
NM_005620
5032058
S100 calcium-binding protein A11
1
ATCTCCACAGCCCACCCATCCCCTGA

(caligizzarin) (S100A11), mRNA/

GCACACTAACCACCTCATGCAGGC

cds = (120, 437)

2796
Table 3A
Hs.8180
NM_005625
5032082
syndecan binding protein (syntenin)
1
TTTCCTGACTCCTCCTTGCAAACAAA

(SDCBP), mRNA/cds = (148, 1044)

ATGATAGTTGACACTTTATCCTGA

2797
Table 3A
Hs.76122
NM_005626
5032088
splicing factor, arginine/serine-rich 4
1
CCTGCAGTAACCCATAGGAAATAAAC

(SFRS4), mRNA/cds = (47, 1531)

TGTAGAGTTCCATATTCTGCGGCC

2798
Table 3A
Hs.296323
NM_005627
5032090
serum/glucocorticoid regulated kinase
1
TAGAAAGGGTTTTTATGGACCAATGC

(SGK), mRNA/cds = (42, 1337)

CCCAGTTGTCAGTCAGAGCCGTTG

2799
Table 3A
Hs.155188
NM_005642
14717406
TATA box binding protein (TBP)-
1
TGTGATGACGTGAGATCAATAAGAAG

associated factor, RNA polymerase II,

AACCTAGTCTAGAGACAATGATGC

F, 55 kD (TAF2F), mRNA/

cds = (740, 1789)

2800
literature
Hs.100030
NM_005652
5032168
telomeric repeat binding factor 2
1
GTGCTTGCTGTCTCTCCCGGACACCC

(TERF2), mRNA/cds = (124, 1626)

TTAAAGACTGTCTTTTTAGCAAAA

2801
Table 3A
Hs.82173
NM_005655
5032176
TGFB inducible early growth response
1
AACATTGTTTTTGTATATTGGGTGTAG

(TIEG), mRNA/cds = (123, 1565)

ATTTCTGACATCAAAACTTGGAC

2802
literature
Hs.170263
NM_005657
5032188
tumor protein p53-binding protein, 1
1
TGTGTAACTGGATTCCTTGCATGGAT

(TP53BP1), mRNA/cds = (173, 6091)

CTTGTATATAGTTTTATTTGCTGA

2803
Table 3A
Hs.2134
NM_005658
5032192
TNF receptor-associated factor 1
1
CAGGACCTCCAAGCCACTGAGCAAT

(TRAF1), mRNA/cds = (75, 1325)

GTATAACCCCAAAGGGAATTCAAAA

2804
Table 3A
Hs.7381
NM_005662
5032220
voltage-dependent anion channel 3
1
GATCTGACCCACCAGTTTGTACATCA

(VDAC3), mRNA/cds = (99, 950)

CGTCCTGCATGTCCCACACCATTT

2805
Table 3A
Hs.155968
NM_005667
5031824
zinc finger protein homologous to
1
ACAATCTCTGTCCAGCACCTCTTGGT

Zfp103 in mouse (ZFP103), mRNA/

TAAATAATGTATGCTGTGAGACAT

cds = (922, 2979)

2806
Table 3A
Hs.172813
NM_005678
13027652
PAK-interacting exchange factor beta
1
TGCGTCTTGTGAAATTGTGTAGAGTG

(P85SPR), mRNA/cds = (473, 2413)

TTTGTGAGCTTTTTGTTCCCTCAT

2807
Table 3A
Hs.30570
NM_005710
5031956
polyglutamine binding protein 1
1
CTTCGGCCTCCCTGGCCCTGGGTTA

(PQBP1), mRNA/cds = (257, 1054)

AAATAAAAGCTTTCTGGTGATCCTG

2808
Table 3A
Hs.82425
NM_005717
5031592
actin related protein 2/3 complex,
1
TGAGCTTGTGCTTAGTATTTACATTG

subunit 5 (16 kD) (ARPC5), mRNA/

GATGCCAGTTTTGTAATCACTGAC

cds = (24, 479)

2809
Table 3A
Hs.6895
NM_005719
5031596
actin related protein 2/3 complex,
1
ATTTGAAATTTTCTGCAGCATTAAAGC

subunit 3 (21 kD) (ARPC3), mRNA/

TGGCGCTTAATAAGAATAAGTAA

cds = (25, 561)

2810
Table 3A
Hs.10927
NM_005721
7262289
HSZ78330 cDNA/clone = 2.49-(CEPH)
1
TCGCATTCTGTTTCTTGCTTTAAAAGA

AGAGTAAAGACAAGAGTGTTGGA

2811
Table 3A
Hs.42915
NM_005722
5031570
ARP2 (actin-related protein 2, yeast)
1
CCTGCCAGTGTCAGAAAATCCTATTT

homolog (ACTR2), mRNA/

ATGAATCCTGTCGGTATTCCTTGG

cds = (74, 1258)

2812
Table 3A
Hs.173125
NM_005729
5031986
peptidylprolyl isomerase F (cyclophilin
1
CTGTCAGCCAAGGTGCCTGAAACGAT

F) (PPIF), mRNA/cds = (83, 706)

ACGTGTGCCCACTCCACTGTCACA

2813
Table 3A
Hs.83583
NM_005731
5031598
actin related protein 2/3 complex,
1
GAAGCGGCTGGCAACTGAAGGCTGG

subunit 2 (34 kD) (ARPC2), mRNA/

AACACTTGCTACTGGATAATCGTAG

cds = (84, 988)

2814
literature
Hs.41587
NM_005732
5032016
Rad50 (Rad50) mRNA, complete cds/
1
TCGATCAGTGCTCAGAGATTGTGAAA

cds = (388, 4326)

TGCAGTGTTAGCTCCCTGGGATTC

2815
Table 3A
Hs.182591
NM_005739
6382080
RAS guanyl releasing protein 1
1
AGGACAAATCTTGTTGTATTAACAGC

(calcium and DAG-regulated)

AGGGTCACTTCTCATTTTCTTTGC

(RASGRP1), mRNA/cds = (103, 2498)

2816
Table 3A
Hs.182429
NM_005742
5031972
protein disulfide isomerase-related
1
AGTCGTATTCTGTCACATAATATTTTG

protein (P5), mRNA/cds = (94, 1416)

AAGAAAACTTGGCTGTCGAAACA

2817
Table 3A
Hs.291904
NM_005745
10047078
accessory proteins BAP31/BAP29
1
AGGAGGGTGGGTGGAACAGGTGGAC

(DXS1357E), mRNA/cds = (136, 876)

TGGAGTTTCTCTTGAGGGCAATAAA

2818
Table 3A
Hs.291904
NM_005745
10047078
accessory proteins BAP31/BAP29
1
AGGAGGGTGGGTGGAACAGGTGGAC

(DXS1357E), mRNA/cds = (138, 876)

TGGAGTTTCTCTTGAGGGCAATAAA

2819
Table 3A
Hs.239138
NM_005748
5031976
pre-B-cell colony-enhancing factor
1
TGCACCTCAAGATTTTAAGGAGATAA

(PBEF), mRNA/cds = (27, 1502)

TGTTTTTAGAGAGAATTTCTGCTT

2820
Table 3A
Hs.179608
NM_005771
5032034
retinol dehydrogenase homolog
1
GCTTATGGTCCCCAGCATTTACAGTA

(RDHL), mRNA/cds = (7, 978)

ACTTGTGAATGTTAAGTATCATCT

2821
Table 3A
Hs.173993
NM_005777
5032032
RNA binding motif protein 6 (RBM6),
1
CTTGTTTTGTTTGTCTCTCCTTTTCTT

mRNA/cds = (133, 3504)

TTGTTACTGTTCTTGCTGCTAGA

2822
Table 3A
Hs.201675
NM_005778
5032030
RNA binding motif protein 5 (RBM5),
1
TTTTGGAAGATTTTCAGTCTAGTTGC

mRNA/cds = (148, 2595)

CAAATCTGGCTCCTTTACAAAAGA

2823
Table 3A
Hs.152720
NM_005792
5031918
M-phase phosphoprotein 6
1
TCAAGAATAAAAATGCCTCTCCAGCC

(MPHOSPH6), mRNA/cds = (32, 514)

TTAAGTATTTACATGCTCCCAGGT

2824
Table 3A
Hs.179982
NM_005802
5032190
tumor protein p53-binding protein
1
TCTGGAAATGTGTTATAAGCTAGGAG

(TP53BPL), mRNA/cds = (540, 2987)

AATCCCTTTGGACAGTCTTTATTT

2825
Table 3A
Hs.143460
NM_005813
6563384
protein kinase C, nu (PRKCN), mRNA/
1
ATTTCCTATCACCATACTTTTCCATGT

cds = (555, 3227)

GAAAACCTGAGCCTATTTCTAGT

2826
Table 3A
Hs.142023
NM_005816
5032140
T cell activation, increased late
1
TGGCTGTTGCTTTGCTTCATGTGTAT

expression (TACTILE), mRNA/

GGCTATTTGTATTTAACAAGACTT

cds = (928, 2637)

2827
Table 3A
Hs.157144
NM_005819
5032130
syntaxin 6 (STX6), mRNA/cds =
1
ATAGCCATCCTCTTTGCAGTCCTGTT

(0, 767)

GGTTGTGCTCATCCTCTTCCTAGT

2828
Table 3A
Hs.99491
NM_005825
5031822
RAS guanyl releasing protein 2
1
AGGGCCAGGGCTGGTGTCCCTAAGG

(calcium and DAG-regulated)

TTGTACAGACTCTTGTGAATATTTG

(RASGRP2), mRNA/cds = (253, 2082)

2829
Table 3A
Hs.15265
NM_005826
14141188
heterogeneous nuclear
1
GCCGTGACAATTTGTTCTTTGATGTG

ribonucleoprotein R (HNRPR), mRNA/

ATTGTATTTCCAATTTCTTGTTCA

cds = (90, 1991)

2830
Table 3A
Hs.18192
NM_005839
5032118
Ser/Arg-related nuclear matrix protein
1
TGGTATATACAACTTTCAGAGCCTCT

(plenty of prolines 101-like) (SRM160),

TGTATTTGGAAGGCTGGAAGGGCC

mRNA/cds = (5, 2467)

2831
Table 3A
Hs.29117
NM_005859
5032006
purine-rich element binding protein A
1
GCTACTGCAGGGTGAGGAAGAAGGG

(PURA), mRNA/cds = (59, 1027)

GAAGAAGATTGATCAAACAGAATGA

2832
Table 3A
Hs.23964
NM_005870
12056471
sin3-associated polypeptide. 18 kD
1
TGTTTCAAGCCCTTCTGTAAAATATGA

(SAP18), mRNA/cds = (573, 1034)

AGAAAAGTCTCTTAGCATTCTGT

2833
Table 3A
Hs.22960
NM_005872
5031652
breast carcinoma amplified sequence
1
TTCTAAACACATTCTTGATCACCAAAC

2 (BCAS2), mRNA/cds = (48, 725)

AACTTCAGAAAGACAGTGACTGT

2834
Table 3A
Hs.21756
NM_005875
5031710
translation factor sui1 homolog
1
ATCTTTGTGAGCAATTATGCTCCCAA

(GC20), mRNA/cds = (241, 582)

ATCTAAGCAAGTAATAAAGAAGGG

2835
Table 3A
Hs.21189
NM_005880
7549807
DnaJ (Hsp40) homolog, subfamily A,
1
TGTAAAGTTTGTACAATTTGTCCTGAA

member 2 (DNAJA2), mRNA/

GCTTTGTGTTTGGCTGCACCTGC

cds = (52, 1290)

2836
Table 3A
Hs.277721
NM_005899
14110374
membrane component, chromosome
1
ACAGTATAACTCCTGAATGCTACTTA

17, surface marker 2 (ovarian

AATAAACCAGGATTCAAACTGCAA

carcinoma antigen CA125) (M17S2),

transcript variant 2, mRNA/

cds = (459, 3359)

2837
db mining
Hs.82483
NM_005901
5174510
MAD (mothers against
1
AGAAGCAGATTTTCCTGTAGAAAAAC

decapentaplegic, Drosophila) homolog

TAATTTTTCTGCCTTTTACCAAAA

2 (MADH2), mRNA/cds = (55, 1458)

2838
db mining
Hs.288261
NM_005902
5174512
cDNA: FLJ23037 fis, clone LNG02036,
1
GAGCTTGCTCCAGATTCTGATGCATA

highly similar to HSU88019 mad

CGGCTATATTGGTTTATGTAGTCA

protein homolog (hMAD-3) mRNA/

cds = UNKNOWN

2839
db mining
Hs.100602
NM_005904
5174516
MAD (mothers against
1
ATGGGTGTTATCACCTAGCTGAATGT

decapentaplegic, Drosophila) homolog

TTTCTAAAGGAGTTTATGTTCCA

7 (MADH7), mRNA/cds = (295, 1575)

2840
Table 3A
Hs.75375
NM_005917
5174538
malate dehydrogenase 1, NAD
1
ACGTGCTTCTTGGTACAGGTTTGTGA

(soluble) (MDH1), mRNA/

ATGACAGTTTATCGTCATGCTGTT

cds = (55, 1059)

2841
Table 3A
Hs.32353
NM_005922
5803087
mitogen-activated protein kinase
1
TGTTGTTGTTGGCAAGCTGCAGGTTT

kinase kinase 4 (MAP3K4), transcript

GTAATGCAAAAGGCTGATTACTGA

variant 1, mRNA/cds = (142, 4965)

2842
Table 3A
Hs.68583
NM_005932
5174566
mitochondrial intermediate peptidase
1
TCATTGTTCGCTTCTGTAATTCTGAAA

(MIPEP), nuclear gene encoding

AACTTTAAACTGGTAGAACTTGG

mitochondrial protein, mRNA/

cds = (74, 2215)

2843
Table 3A
Hs.211581
NM_005955
5174588
metal-regulatory transcription factor 1
1
CCAGTGCTGTTTGGTGGTCTGCCTTC

(MTF1), mRNA/cds = (83, 2344)

TTTTTAATGGTATTTTCTTCCTCA

2844
Table 3A
Hs.78103
NM_005969
5174612
nucleosome assembly protein 1-like 4
1
GCCCCACCATTCATCCTGTCTGAAGG

(NAP1L4), mRNA/cds = (149, 1278)

TCCTGGGTTTGGTGTGACCGCTTG

2845
Table 3A
Hs.48029
NM_005985
5174686
snail 1 (drosophila homolog), zinc
1
CCGACAGGTGGGCCTGGGAGGAAAA

finger protein (SNAI1), mRNA/

TGTTTACATTTTTAAAGGCACACTG

cds = (61, 855)

2846
Table 3A
Hs.12570
NM_005993
8400735
tubulin-specific chaperone d (TBCD),
1
GGGGTGGACGCCTCTGCCTTCACTT

mRNA/cds = (109, 3667)

GAACACAAATGTGCTTCCTATAAAA

2847
Table 3A
Hs.1708
NM_005998
5174726
chaperonin containing TCP1, subunit 3
1
GGCAGCCCCCAGTCCCTTTCTGTCC

(gamma) (CCT3), mRNA/cds = (0,

CAGCTCAGTTTTCCAAAAGACACTG

1634)

2848
Table 3A
Hs.3712
NM_006003
5174742
ubiquinol-cytochrome c reductase,
1
CTGTTAAGCACTGTTATGCTCAGTCA

Rieske iron-sulfur polypeptide 1

TACACGCGAAAGGTACAATGTCTT

(UQCRFS1), nuclear gene encoding

mitochondrial protein, mRNA/

cds = (90, 914)

2849
Table 3A
Hs.73818
NM_006004
5174744
ubiquinol-cytochrome c reductase
1
ATGGGTTTGGCTTGAGGCTGGTAGCT

hinge protein (UQCRH), mRNA/

TCTATGTAATTCGCAATGATTCCA

cds = (36, 311)

2850
Table 3A
Hs.3776
NM_006007
5174754
zinc finger protein 216 (ZNF216),
1
TTCAGTTTTGCTTTCAATTTTATGTAC

mRNA/cds = (288, 929)

CTTAGTTCTGAGTTAGACCTGCA

2851
Table 3A
Hs.272897
NM_006009
5174732
Tubulin, alpha, brain-specific (TUBA3),
1
AAGGATTATGAGGAGGTTGGTGTGCA

mRNA/cds = (0, 1355)

TTCTGTTGAAGGAGAGGGTGAGGA

2852
Table 3A
Hs.75412
NM_006010
5174392
arginine-rich, mutated in early stage
1
TCCCTTCCTTCTGTTGCTGGTGTACT

tumors (ARMET), mRNA/

CTAGGACTTCAAAGTGTGTCTGGG

cds = (132, 836)

2853
Table 3A
Hs.43910
NM_006016
5174406
CD164 antigen, sialomucin (CD164),
1
AGTTCATTAAAAACTGCAAAACCAAT

mRNA/cds = (79, 648)

CTGTATCATGTACCAAACTGACTT

2854
Table 3A
Hs.137555
NM_006018
5174460
putative chemokine receptor, GTP-
1
TGCACGTTCCTCCTGGTTCCTTCGCT

binding protein (HM74), mRNA/

TGTGTTTCTGTACTTACCAAAAAT

cds = (60, 1223)

2855
Table 3A
Hs.46465
NM_006019
5174620
T-cell, immune regulator 1 (TCIRG1),
1
TGCCAGACCTCCTTCCTGACCTCTGA

mRNA/cds = (57, 2546)

GGCAGGAGAGGAATAAAGACGGTC

2856
literature
Hs.54418
NM_006020
5174384
alkylation repair, alkB homolog (ABH),
1
AGTCCCAAGGGTGTTTTGTTACTGTT

mRNA/cds = (223, 1122)

TTCTCCATGAATAAACTCACTTGA

2857
Table 3A
Hs.43628
NM_006021
5174494
deleted in lymphocytic leukemia, 2
1
ATTAATGTCATTTCTGGAAGTGTGAA

(DLEU2), mRNA/cds = (240, 494)

AATGTTAATGTTCAACAAGCAACA

2858
Table 3A
Hs.82043
NM_006023
5174422
D123 gene product (D123), mRNA/
1
GCGGGTGGGCCGAGCAGTGTGGACA

cds = (280, 1290)

TCAGCCACTTTTTATATTCATGTAC

2859
Table 3A
Hs.997
NM_006025
5174622
protease, serine, 22 (P11), mRNA/
1
CCACTGAGAACTAAATGCTGTACCAC

cds = (154, 1263)

AGAGCCGGGTGTGAACTATGGTTT

2860
Table 3A
Hs.109804
NM_006026
5174448
H1 histone family, member X (H1FX),
1
AAACAATCGCTCCGGGCTCAGGGCT

mRNA/cds = (101, 742)

GCGCGGCTCTTCCCTTCATTCCATG

2861
Table 3A
Hs.24594
NM_006048
5174482
ubiquitination factor E4B (homologous
1
TGTCCTCTGTTCAATTCCTAACGCAA

to yeast UFD2) (UBE4B), mRNA/

ACTACAATAAATGGTGACACACGT

cds = (85, 3993)

2862
Table 3A
Hs.274243
NM_006054
5174654
receptor tyrosine kinase-like orphan
1
AGCACCTAAGGAGCTTGAATCTTGGT

receptor 1 (ROR1), mRNA/

TCCTGTAAAATTTCAAATTGATGT

cds = (375, 3188)

2863
Table 3A
Hs.54452
NM_006060
5174500
zinc finger protein, subfamily 1A, 1
1
ACCAACACTGTCCCAAGGTGAAATGA

(lkeros) (ZNFN1A1), mRNA/

AGCAACAGAGAGGAAATTGTACAT

cds = (168, 1727)

2864
Table 3A
Hs.318501
NM_006074
5174698
stimulated trans-acting factor (50 kDa)
1
TGTCAGCCATTTCAATGTCTTGGGAA

(STAF50).

ACAATTTTTTGTTTTTGTTCTGTT

2865
Table 3A
Hs.8024
NM_006083
11038650
IK cytokine, down-regulator of HLA II
1
AGAGCTTGATCGCCAGTGGAAGAAG

(IK), mRNA/cds = (111, 1784)

ATTAGTGCAATCATTGAGAAGAGGA

2866
Table 3A
Hs.1706
NM_006084
5174474
interferon-stimulated transcription
1
TTTCCCTCTTCCCTGACCTCCCAACT

factor 3, gamma (48 kD) (ISGF3G),

CTAAAGCCAAGCACTTTATATTTT

mRNA/cds = (34, 1215)

2867
Table 3A
Hs.5662
NM_006098
5174446
guanine nucleotide binding protein (G
1
GGCAGGTGACCATTGGCACACGCTA

protein), beta polypeptide 2-like 1

GAAGTTTATGGCAGAGCTTTACAAA

(GNB2L1), mRNA/cds = (95, 1048)

2868
Table 3A
Hs.284142
NM_006134
8659558
chromosome 21 open reading frame 4
1
CTGTTTGTAGATAGGTTTTTTATCTCT

(C21orf4), mRNA/cds = (158, 634)

CAGTACACATTGCCAAATGGAGT

2869
Table 3A
Hs.1987
NM_006139
5453610
CD28 antigen (Tp44) (CD28), mRNA/
1
GCTCACCTATTTGGGTTAAGCATGCC

cds = (222, 884)

AATTTAAAGAGACCAAGTGTATGT

2870
Table 3A
Hs.82646
NM_006145
5453689
heat shock 40 kD protein 1 (HSPF1),
1
TAGACTCATTGTAAGTTGCCACTGCC

mRNA/cds = (40, 1062)

AACATGAGACCAAAGTGTGTGACT

2871
Table 3A
Hs.334851
NM_006148
5453709
LIM and SH3 protein 1 (LASP1),
1
CAAACCTTTCTGGCCTGTTATGATTC

mRNA/cds = (75, 860)

TGAACATTTGACTTGAACCACAAG

2872
Table 3A
Hs.40202
NM_006152
5453723
lymphoid-restricted membrane protein
1
GGGAAAGTATAGCATGAAACCAGAG

(LRMP), mRNA/cds = (574, 2241)

GTTCTCAGAATGACCGTAAGATAGC

2873
Table 3A
Hs.75512
NM_006156
5453759
neural precursor cell expressed,
1
AGTCCTGTGTGCTTCCCTCTCTTATG

developmentally down-regulated 6

ACTGTGTCCCTGGTTGTCAATAAA

(NEDD8), mRNA/cds = (99, 344)

2874
Table 3A
Hs.79389
NM_006159
5453765
nel (chicken)-like 2 (NELL2), mRNA/
1
ATCTTCAGAATCAGTTAGGTTCCTCA

cds = (96, 2546)

CTGCAAGAAATAAAATGTCAGGCA

2875
Table 3A
Hs.96149
NM_006162
5453771
transcription factor (NF-ATc/B) mRNA/
1
CTTCTGGCACCCCTGGGGTTCAATAC

complete cds/cds = (369, 2646)

TGGAAGTGCCTTATTTAACCAGAC

2876
Table 3A
Hs.75643
NM_006163
5453773
nuclear factor (erythroid-derived 2),
1
GGTCTTTAGCCTCCACCTTGTCTAAG

45 kD (NFE2), mRNA/cds = (273,

CTTTGGTCTATAAAGTGCGCTACA

1394)

2877
Table 3A
Hs.155396
NM_006164
5453775
nuclear factor (erythroid-derived 2)-like
1
TGATGATATGACATCTGGCTAAAAAG

NFE2L2), mRNA/cds = (39,

AAATTATTGCAAAACTAACCACGA

1808)

2878
Table 3A
Hs.95262
NM_006165
5453777
nuclear factor related to kappa B
1
TCCAAAGCAGTCTCCACTGTTGTTGT

binding protein (NFRKB), mRNA/

GACTACAGCTCCGTCTCCTAAACA

cds = (2220, 5216)

2879
Table 3A
Hs.15243
NM_006170
5453791
nucleolar protein 1 (120 kD) (NOL1),
1
ATTGTCACCAGGTTGGAACTCTTGCC

mRNA/cds = (0, 2567)

TCTGTGAGGATGCCTTCTCTACTG

2880
Table 3A
Hs.82120
NM_006186
5453821
nuclear receptor subfamily 4, group A,
1
TTTTCTTTGTATATTTCTAGTATGGCA

member 2 (NR4A2), mRNA/

CATGATATGAGTCACTGCCTTTT

cds = (317, 2113)

2881
Table 3A
Hs.41694
NM_006190
5453829
origin recognition complex, subunit 2
1
TGACCTTCATGATACCAGTGAGAAGC

(yeast homolog)-like (ORC2L), mRNA/

CAGGCTAGAGAAATAAAATCCTGA

cds = (186, 1919)

2882
Table 3A
Hs.2853
NM_006196
14141164
poly(rC)-binding protein 1 (PCBP1),
1
ACGGATTGGTTAAAAAATGCTTCATA

mRNA/cds = (177, 1247)

TTTGAAAAAGCTGGGAATTGCTGT

2883
Table 3A
Hs.79709
NM_006224
5453907
phosphotidylinositol transfer protein
1
GTCTCTCTCCATTGTGTTCCGATCCA

(PITPN), mRNA/cds = (216, 1028)

TTTCTGTGTGTTCCCCCAACCTTT

2884
Table 3A
Hs.89040
NM_006228
11079650
prepronociceptin (PNOC), mRNA/
1
GCCACTGCCATAACTTGTTTGTAAAA

cds = (211, 741)

GAGCTGTTCTTTTTGACTGATTGT

2885
literature
Hs.168846
NM_006231
5453925
polymerase (DNA directed), epsilon
1
GAACATTGCCCAGCACTACGGCATGT

(POLE), mRNA/cds = (44, 6904)

CGTACCTCCTGGAGACCCTGGAGT

2886
Table 3A
Hs.155079
NM_006243
5453949
protein phosphatase 2, regulatory
1
ATCTTCATTGGGGGATTGAGCAGCAT

subunit B (B56), alpha isoform

TTAATAAAGTCTATGTTTGTATTT

(PPP2R5A), mRNA/cds = (571, 2031)

2887
Table 3A
Hs.9247
NM_006251
5453963
protein kinase, AMP-activated, alpha 1
1
TTATAACCGAGGGCTGGCGTTTTGGA

catalytic subunit (PRKAA1), mRNA/

ATCGAATTTCGACAGGGATTGGAA

cds = (23, 1675)

2888
Table 3A
Hs.315366
NM_006255
5453971
protein kinase C, eta (PRKCH), mRNA/
1
TTCCCAGCATCAGCCTTAGAACAAGA

cds = (166, 2214)

ACCTTACCTTCAAGGAGCAAGTGA

2889
Table 3A
Hs.75348
NM_006263
5453989
proteasome (prosome, macropain)
1
CCAGATTTTCCCCAAACTTGCTTCTG

activator subunit 1 (PA28 alpha)

TTGAGATTTTTCCCTCACCTTGCC

(PSME1), mRNA/cds = (92, 841)

2890
Table 3A
Hs.81848
NM_006265
5453993
RAD21 (S. pombe) homolog (RAD21),
1
AACCAAGGAGTTTTCCCCGTTTGTAA

mRNA/cds = (184, 2079)

AAAGACATTGTAGATAATTGAATG

2891
Table 3A
Hs.199179
NM_006267
6382078
RAN binding protein 2 (RANBP2),
1
ACCATGTTCTTTCGTTAAAGATTTGCT

mRNA/cds = (127, 9801)

TTATACAAGATTGTTGCAGTACC

2892
Table 3A
Hs.173159
NM_006283
5454099
transforming, acidic coiled-coil
1
CACATCTGCTTCCACTGTGTTCCCAC

containing protein 1 (TACC1), mRNA/

GGGTGCCATGAAGTGTGTGAGGAG

cds = (320, 2737)

2893
Table 3A
Hs.89657
NM_006284
5454105
TATA box binding protein (TBP)-
1
CGCACTACTTCACCTGAGCCACCCAA

associated factor, RNA polymerase II,

CCTAAATGTACTTATCTGTCCCCA

H, 30 kD (TAF2H), mRNA/

cds = (17, 673)

2894
Table 3A
Hs.116481
NM_001782
4502682
CD72 antigen (CD72), mRNA/
1
GGGCGGCCCGGAGCCAGCCAGGCA

cds = (108, 1187)

GTTTTATTGAAATCTTTTTAAATAAT

2895
Table 3A
Hs.18420
NM_006289
5454129
talin 1 (TLN1), mRNA/cds = (126,
1
CTCTCCAAGAGTATTATTAACGCTGC

7751)

TGTACCTCGATCTGAATCTGCCGG

2896
Table 3A
Hs.211600
NM_006290
5454131
tumor necrosis factor, alpha-induced
1
TCCCTAATAGAAAGCCACCTATTCTTT

protein 3 (TNFAIP3), mRNA/

GTTGGATTTCTTCAAGTTTTTCT

cds = (66, 2438)

2897
Table 3A
Hs.101382
NM_006291
5454133
tumor necrosis factor, alpha-induced
1
AGTACTGCTTTTGTATGTATGTTGAAC

protein 2 (TNFAIP2), mRNA/

AGGATCCAGGTTTTTATAGCTTG

cds = (131, 2095)

2898
Table 3A
Hs.118910
NM_006292
5454139
tumor susceptibility gene 101
1
CACTTTCTATCCTCTGTAAACTTTTTG

(TSG101), mRNA/cds = (90, 1262)

TGCTGAATGTTGGGACTGCTAAA

2899
Table 3A
Hs.131255
NM_006294
5454151
ubiquinol-cytochrome c reductase
1
GAAGAATGGGCAAAGAAGTAATCATG

binding protein (UQCRB), mRNA/

TAGTTGAAGTCTGTGGATGCAGCT

cds = (32, 367)

2900
Table 3A
Hs.279841
NM_018062
8922359
hypothetical protein FLJ10335
1
CAAAGGTTCTTGAGACTCTTGATATTT

(FLJ10335), mRNA/cds = (33, 1160)

CTGTCTTCTCCTTGTGCTTTCCT

2901
literature
Hs.98493
NM_006297
5454171
X-ray repair complementing defective
1
CCGATGGATCTACAGTTGCAATGAGA

repair in Chinese hamster cells 1

AGCAGAAGTTACTTCCTCACCAGC

(XRCC1), mRNA/cds = (105, 2006)

2902
Table 3A
Hs.293007
NM_006310
5453987
aminopeptidase puromycin sensitive
1
TTCCTGCATAACTCAATCTGAACCAA

(NPEPPS), mRNA/cds = (404, 3031)

GGATTGTAGTTTAGTTTTCCTCCT

2903
Table 3A
Hs.287994
NM_006312
5454073
nuclear receptor co-repressor 2
1
GCAGGGTGGTGGTATTCTGTCATTTA

(NCOR2), mRNA/cds = (1, 7554)

CACACGTCGTTCTAATTAAAAAGC

2904
Table 3A
Hs.10842
NM_006325
6042206
RAN, member RAS oncogene family
1
GCACTTTTTGTTTGAATGTTAGATGCT

(RAN), mRNA/cds = (114, 764)

TAGTGTGAAGTTGATACGCAAGC

2905
db mining
Hs.12540
NM_006330
5453721
lysophospholipase I (LYPLA1), mRNA/
1
GCAAGAAATATTCCATTGAAATATTGT

cds = (35, 727)

GCTGTAACATGGGAAAGTGTAAA

2906
literature
Hs.19400
NM_006341
6006019
MAD2 (mitotic arrest deficient, yeast,
1
GCCAACACTGTCTGTCTCAAATACTG

homolog)-like 2 (MAD2L2), mRNA/

TGCTGTGAGTTGTTTCAATAAAGG

cds = (111, 746)

2907
Table 3A
Hs.104019
NM_006342
5454101
transforming, acidic coiled-coil
1
GACCTCATCTCCAAGATGGAGAAGAT

containing protein 3 (TACC3),

CTGACCTCCACGGAGCCGCTGTCC

mRNA/cds = (108, 2624)

2908
Table 3A
Hs.43913
NM_008346
5453889
PIBF1 gene product (PIBF1),
1
CTTTACTAAAAAAGAAGCACCTGAGT

mRNA/cds = (0, 2276)

GGTCTAAGAAACAAAAGATGAAGA

2909
Table 3A
Hs.158196
NM_006354
5454103

Homo sapiens, Similar to
1
GCCTGGAAGACTCTGAAGGAGCGTG

transcriptional adaptor 3 (ADA3, yeast

AGAGCATCCTGAAGCTGCTGGATGG

homolog)-like (PCAF histone acetylase

complex), clone MGC:3508

IMAGE:3009860, mRNA, complete

cds/cds = (557, 1666)

2910
Table 3A
Hs.307099
NM_006356
5453558
clone 023e08 My032 protein mRNA,
1
CAGGAGGAAGCTCTGGCCCTTGTATT

complete cds/cds = (46, 459)

ACACATTCTGGACATTAAAAATAA

2911
Table 3A
Hs.69469
NM_006360
5453653
dendritic cell protein (GA17),
1
GCCTTTTGAGTCTTTCCGATACCTGA

mRNA/cds = (51, 1175)

GTTTTTATGCTTATAATTTTTGTT

2912
Table 3A
Hs.173497
NM_006363
14591927
Sec23 (S. cerevisiae) homolog B
1
TTAAGCTGAGGATACAACCAGGAAAT

(SEC23B), transcript variant 3,

GCAACGGTGTCAGATTGTGTTCAA

mRNA/cds = (112, 2415)

2913
Table 3A
Hs.104125
NM_006367
10938021
adenylyl cyclase-associated protein
1
TCTACCCATTTCCTGAGGCCTGTGGA

(CAP), mRNA/cds = (62, 1489)

AATAAACCTTTATGTACTTAAAGT

2914
Table 3A
Hs.79089
NM_006378
5454049
sema domain, immunoglobulin domain
1
AGCAATAAACTCTGGATGTTTGTGCG

(lg), transmembrane domain (TM) and

CGTGTGTGGACAGTCTTATCTTCC

short cytoplasmic domain,

(semaphorin) 4D (SEMA4D),

mRNA/cds = (87, 2675)

2915
Table 3A
Hs.279939
NM_008389
13699881
mitochondrial carrier homolog 1
1
AGCTGTTGATGCTGGTTGGACAGGTT

(MTCH1), nuclear gene encoding

TGAGTCAAATTGTACTTTGCTCCA

mitochondrial protein,

mRNA/cds = (0, 1118)

2916
Table 3A
Hs.296585
NM_006392
5453793
nucleolar protein (KKE/D) repeat)
1
AGGTGACATTTCCCACCCTGTGCCCG

(NOP56), mRNA/cds = (21, 1829)

TGTTCCCAATAAAAACAAATTCAC

2917
Table 3A
Hs.84153
NM_006400
13259506
dynactin 2 (p50) (DCTN2),
1
CTGTGGCTGACTGTAATACTGTACAA

mRNA/cds = (136, 1358)

CTGTTTCTGACCATTAAATGCTGT

2918
Table 3A
Hs.80261
NM_006403
5453679
enhancer of filamentation 1 (cas-like
1
ACATATGCAGACCTGACACTCAAGAG

docking; Crk-associated substrate

TGGCTAGCTACACAGAGTCCATCT

related) (HEF1),

mRNA/cds = (163, 2667)

2919
Table 3A
Hs.92384
NM_006407
7669496
vitamin A responsive; cytoskeleton
1
TGACTTCACAGACATGGTCTAGAATC

related (JWA), mRNA/cds = (89, 855)

TGTACCCTTACCCACATATGAAGA

2920
Table 3A
Hs.139120
NM_006413
5454023

Homo sapiens, ribonuclease P (30kD),
1
CCCAGTCTCTGTCAGCACTCCCTTCT

clone MGC:12256 IMAGE:3827681,

TCCCTTTTATAGTTCATCAGCCAC

mRNA, complete cds/cds = (294, 1100)

2921
Table 3A
Hs.82921
NM_006416
5453620
solute carrier family 35 (CMP-sialic
1
TGACTGAGTACCCCTTTAGTGAGTAC

acid transporter), member 1

CCCTTTAGTGCTATATTTGTGCCA

(SLC35A1), mRNA/cds = (27, 1040)

2922
Table 3A
Hs.82316
NM_006417
5453743
interferon-induced, hepatitis C-
1
TGCCTTTTGAGCAAATAGGGAATCTA

associated microtubular aggregate

AGGGAGGAAATTATCAACTGTGCA

protein (44kD) (MTAP44),

mRNA/cds = (0, 1334)

2923
db mining
Hs.100431
NM_006419
5453576
small inducible cytokine B subfamily
1
GCGGGGCCGGGGGGACTCTGGTATC

(Cys-X-Cys motif), member 13 (B-cell

TAATTCTTTAATGATTCCTATAAAT

chemoattractant) (SCYB13),

mRNA/cds = (90, 419)

2924
Table 3A
Hs.94631
NM_006421
6715588
brefeldin A-inhibited guanine
1
ACAACTTTCTGTACAATATTGATTCCC

nucleotide-exchange protein 1 (BIG1),

ATCTGGCATATTCTAATCAGGTT

mRNA/cds = (141, 5690)

2925
Table 3A
Hs.108809
NM_006429
5453806
chaperonin containing TCP1, subunit 7
1
TTTTACAAGGAAGGGGTAGTAATTGG

(eta) (CCT7), mRNA/cds = (68, 1699)

CCCACTCTCTTCTTACTGGAGGCT

2926
Table 3A
Hs.119529
NM_006432
5453677
epididymal secretory protein (19.5kD)
1
AACAACATTAACTTGTGGCCTCTTTCT

(HE1), mRNA/cds = (10, 465)

ACACCTGGAAATTTACTCTTGAA

2927
Table 3A
Hs.174195
NM_006435
10835237
interferon induced transmembrane
1
ACAGCCGAGTCCTGCATCAGCCCTTT

protein 2 (1-8D) (IFITM2),

ATCCTCACACGCTTTTCTACAATG

mRNA/cds = (279, 677)

2928
Table 3A
Hs.77225
NM_006437
11496990
ADP-ribosyltransferase (NAD+; poly
1
GTCAAGGCTAAGTCAAATGAAACTGA

(ADP-ribose) polymerase)-like 1

ATTTTAAACTTTTTGCATGCTTCT

(ADPRTL1), mRNA/cds = (106, 5280)

2929
Table 3A
Hs.118131
NM_006441
5453745
5,10-methenyltetrahydrofolate
1
AAACGACATGAAGGTAGATGAAGTCC

synthelase (5-formyltetrahydrofolate

TTTACGAAGACTCGTCAACAGCTT

cyclo-ligase) (MTHFS),

mRNA/cds = (13, 624)

2930
Table 3A
Hs.340268
NM_006461
5453831
qy37e05.x1 cDNA, 3′
1
CCCAATACCAAGACCAACTGGCATAG

end/clone =

AGCCAACTGAGATAAATGCTATTT

IMAGE:2014208/clone_end = 3′

2931
Table 3A
Hs.233936
NM_006471
5453739
myosin, light polypeptide, regulatory,
1
GGGTCTATACAGAGTCAATATATTTTT

non-sarcomeric (20kD) (MLCB),

TCAGAGAAAGTTAGTTCGGCTCG

mRNA/cds = (114, 629)

2932
Table 3A
Hs.179526
NM_006472
5454161
upregulated by 1,25-dihydroxyvitamin
1
CCAGAAAGTGTGGGCTGAAGATGGT

D-3 (VDUP1),

TGGTTTCATGTGGGGGTATTATGTA

mRNA/cds = (221, 1396)

2933
Table 3A
Hs.5509
NM_006495
5729817
ecotropic viral integration site 2B
1
TCCAACCTTGAGATCCAGTGTCAGGA

(EVI2B), mRNA/cds = (0, 1346)

GTTCTCTATTCCTCCCAACTCTGA

2934
literature
Hs.155573
NM_006502
5729981
polymerase (DNA directed), eta
1
TGGCACAGAAAAGGGACCAAGTTTAA

(POLH), mRNA/cds = (237, 2378)

AAAAGGGTTTTAAATGTAATGAGA

2935
db mining
Hs.858
NM_006509
5730006
v-rel avian reticuloendotheliosis viral
1
GGGGTAGGTTGGTTGTTCAGAGTCTT

oncogene homolog B (nuclear factor of

CCCAATAAAGATGAGTTTTTGAGC

kappa light polypeptide gene enhancer

in B-cells 3) (RELB),

mRNA/cds = (144, 1883)

2936
Table 3A
Hs.4888
NM_006513
5730028
seryl-tRNA synthetase (SARS),
1
TGGGCATAGGGACCCATCATTGATGA

mRNA/cds = (75, 1619)

CTGATGAAACCATGTAATAAAGCA

2937
Table 3A
Hs.155040
NM_006526
5730123
zinc finger protein 217 (ZNF217),
1
ATTTTCCTACAGCCCTTTGTACTTCAA

mRNA/cds = (271, 3417)

AATATGTTTTTGTGTCCATCAGT

2938
Table 3A
Hs.251636
NM_006537
5730109
ubiquitin specific protease 3 (USP3),
1
TCAGCACTAACTAAATAAATTTGTTGG

mRNA/cds = (93, 1658)

TTCAGTTGTACTTGTCCTGCAAA

2939
Table 3A
Hs.86088
NM_006548
5729881
IGF-II mRNA-binding protein 1 (IMP-
1
AGAGGGTGGATCACACCTCAGTGGG

1), mRNA/cds = (9, 1742)

AAGAAAAATAAAATTTCCTTCAGGT

2940
Table 3A
Hs.119537
NM_006559
5730026
GAP-associated tyrosine
1
TGTGTAAGTCTGCCTAAATAGGTAGC

phosphoprotein p62 (Sam68) (SAM68),

TTAAACTTATGTCAAAATGTCTGC

mRNA/cds = (106, 1437)

2941
Table 3A
Hs.59106
NM_006568
5729764
cell growth regulatory with ring finger
1
TCCTTTCTGCTTAGTGAATGAATACT

domain (CGR19),

GGAATCCATCTGTGTTGATACAAT

mRNA/cds = (27, 1025)

2942
db mining
Hs.270737
NM_006573
5730096
tumor necrosis factor (ligand)
1
GCAATACCAAGAGAAAATGCACAAAT

superfamily, member 13b (TNFSF13B),

ATCACTGGATGGAGATGTCACATT

mRNA/cds = (0, 857)

2943
Table 3A
Hs.4069
NM_006582
13435376
glucocorticoid modulatory element
1
TGGGGATCTCAGGGCCAGGAGTTAT

binding protein 1 (GMEB1), transcript

GTTTTGATTTGGAATTTTAATTATT

variant 1, mRNA/cds = (138, 1859)

2944
Table 3A
Hs.12820
NM_006590
5730024
SnRNP assembly defective 1 homolog
1
CCAGTAACTTCGCTCTGTTAGAGGTG

(SAD1), mRNA/cds = (492, 1466)

GAGGATTTTCCTATGTTCCCCCCA

2945
literature
Hs.241517
NM_006596
5729983
DNA polymerase theta (POLQ)
1
TGCTGAAAAGATTGTACTTTGTGATC

mRNA, complete cds/cds = (0, 8174)

CCAATCAGAGGGATGGAGCTAATC

2946
Table 3A
Hs.180414
NM_006597
5729876
heat shock 70kD protein 8 (HSPA8),
1
TCAGACTGCTGAGAAGGAAGAATTTG

mRNA/cds = (83, 2023)

AACATCAACAGAAAGAGCTGGAGA

2947
Table 3A
Hs.154672
NM_006836
13699869
methylene tetrahydrofolate
1
TGGGCAGCTTGGGTAAGTACGCAAC

dehydrogenase (NAD+ dependent),

TTACTTTTCCACCAAAGAACTGTCA

methenyltetrahydrofolate

cyclohydrolase (MTHFD2), nuclear

gene encoding mitochondrial protein,

mRNA/cds = (76, 1110)

2948
Table 3A
Hs.38927
NM_006644
5729878
heat shock 105kD (HSP105B),
1
TGTGAAAGTGTGGAATGGAAGAAATG

mRNA/cds = (313, 2757)

TCGATCCTGTTGTAACTGATTGTG

2949
Table 3A
Hs.1845
NM_006674
5729965
MHC class I region ORF (P5-1),
1
CTAATTTCAGTGCTTGTGCTTGGTTG

mRNA/cds = (304, 735)

TTCAGGGCCATTTCAGGTTTGGGT

2950
Table 3A
Hs.76807
NM_006696
5730052
major histocompatibility complex, class
1
AGCTAGCAGATCGTAGCTAGTTTGTA

II, DR alpha (HLA-DRA),

TTGTCTTGTCAATTGTACAGACTT

mRNA/cds = (26, 790)

2951
Table 3A
Hs.5300
NM_006698
5729737
bladder cancer associated protein
1
ATGGGCCAGGCAGAGAACAGAACTG

(BLCAP), mRNA/cds = (254, 517)

GAGGCAGTCCATCTAGGGAATGGGA

2952
Table 3A
Hs.75207
NM_006708
5729841
glyoxalase I (GLO1),
1
GTTTCCTTTTTGGGTGAAATGGATTTA

mRNA/cds = (87, 641)

TGTGAGTGCTTTAAACAAATAGC

2953
Table 3A
Hs.74861
NM_006713
5729967
activated RNA polymerase II
1
GAACAATGGAGCCAGCTGAAGGAAC

transcription cofactor 4 (PC4),

AGATTTCTGACATAGATGACGCAGT

mRNA/cds = (0, 383)

2954
Table 3A
Hs.195471
NM_006732
5803016
6-phosphofructo-2-kinase/fructose-2,6-
1
CGTCCCCTCTCCCCTTGGTTCTGCAC

biphosphatase 3 (PFKFB3),

TGTTGCCAATAAAAAGCTCTTAAA

mRNA/cds = (114, 1676)

2955
Table 3A
Hs.75367
NM_006748
5803170
Src-like adapter (SLA),
1
GAGCACCCAGAGGGATTTTTCAGTG

mRNA/cds = (41, 871)

GGAAGCATTACACTTTGCTAAATCA

2956
Table 3A
Hs.77837
NM_006759
13027637
UDP-glucose pyrophosphorylase 2
1
AGCACAGATGGTGCAATACTTTCCTT

(UGP2), mRNA/cds = (84, 1610)

CTTTGAAGAGATCCCAAAGTTAGT

2957
Table 3A
Hs.75462
NM_006783
5802987
BTG family, member 2 (BTG2),
1
TGGAAGAATGTACAGCTTATGGACAA

mRNA/cds = (71, 547)

ATGTACACCTTTTTGTTACTTTAA

2958
Table 3A
Hs.100555
NM_006773
13787205
DEAD/H (Asp—Glu—Ala—Asp/His)
1
TTTTGGAGCAAAAACTATGGGTTGTA

box polypeptide 18 (Myc-regulated)

ATTTGAATAAAGTGTCACTAAGCA

(DDX18), mRNA/cds = (71, 2063)

2959
Table 3A
Hs.143604
NM_006777
10048402
Kaiso (ZNF-kaiso),
1
TTCAGCAGGAAAATGATTCAATTTTTA

mRNA/cds = (0, 2018)

AACAAAATGTAACAGATGGCAGT

2960
Table 3A
Hs.33085
NM_006784
5803220
WD repeat domain 3 (WDR3),
1
AAGTAGCCAAGCTAAGATGCCTGGCT

mRNA/cds = (47, 2878)

GGGCTTCTGAGGAATTAATACACT

2961
Table 3A
Hs.4943
NM_006787
10863906
hepatocellular carcinoma associated
1
CTGACCGCCACTCTCACATTTGGGCT

protein; breast cancer associated gene

CTTCGCTGGCCTTGGTGGAGCTGG

1 (JCL-1), mRNA/cds = (69, 1889)

2962
Table 3A
Hs.6353
NM_006791
5803101
MORF-related gene 15 (MRG15),
1
TGCATTGTGTAGCTAGTTTTCTGGAA

mRNA/cds = (131, 1102)

AAGTCAATCTTTTAGGAATTGTTT

2963
Table 3A
Hs.88764
NM_006800
5803103
male-specific lethal-3 (Drosophila)-like
1
ACAGCTATACTTTGTTGTGTAATGTTA

1 (MSL3L1), mRNA/cds = (105, 1670)

TGGTTCCCTTTCTGTAAAATGTT

2964
Table 3A
Hs.77897
NM_006802
5803166
splicing factor 3a, subunit 3, 60kD
1
GACAGGATCCCCCAGAGACCCCATTT

(SF3A3), mRNA/cds = (8, 1513)

GCCTCTCAACACTCAGACCTTCAA

2965
Table 3A
Hs.272168
NM_006811
5803192
DNA sequence from clone RP1-
1
TTTGGTTTAAAATGTAAGATAGGAAA

179M20 on chromosome 20 Contains a

TGTTGGATATTTGAGGCCATGCT

3′ end of a novel gene similar to cellular

retinaldehyde-binding protein, the

TDE1 gene (Tumour differentially

expressed 1), the PKIG gene encoding

protein kinase (cAMP-dependent,

catalytic) inhibitor gamma, the 3′ end of

the ADA gene encoding adenosine

deaminase, 2 CpG islands, ESTs,

STSs and GSSs/cds = (69, 1490)

2966
Table 3A
Hs.75969
NM_006813
5802981
proline-rich protein with nuclear
1
AATCTACATTTTCTTACCAGGAGCAG

targeting signAl (B4-2),

CATTGAGGTTTTTGAGCATAGTAC

mRNA/cds = (113, 1096)

2967
Table 3A
Hs.75841
NM_006817
13124889
chromosome 12 open reading frame 8
1
ACTAACCCACGATTCTGAGCCCTGAG

(C12orf8), mRNA/cds = (11, 796)

TATGCCTGGACATTGATGCTAACA

2968
Table 3A
Hs.75612
NM_006819
5803180
stress-induced-phosphoprotein 1
1
TTATTCTGCGTCCCCTTCTCCAATAAA

(Hsp70/Hsp90-organizing protein)

ACAAGCCAGTTGGGCGTGGTTAT

(STIP1), mRNA/cds = (62, 1693)

2969
Table 3A
Hs.75470
NM_006820
5803026
hypothetical protein, expressed in
1
TCCTTCCCACTCTCTCCAACATCACA

osteoblast (GS3688),

TTCACTTTAAATTTTTCTGTATAT

mRNA/cds = (241, 1482)

2970
Table 3A
Hs.74405
NM_006826
5803226
tyrosine 3-monooxygenase/typtophan
1
AGTCCCAAAAAAGCCTTGTGAAAATG

5-monooxygenase activation protein,

TTATGCCCTATGTAACAGCAGAGT

theta-polypeptide (YWHAQ),

mRNA/cds = (100, 837)

2971
Table 3A
Hs.15591
NM_006833
5803095
COP9 subunit 6 (MOV34 homolog, 34
1
AGGGGAGGGCACTACACTTCCTTGA

kD) (MOV34-34KD),

GAGAAACCGCTGTCATTAATAAAAG

mRNA/cds = (43, 938)

2972
Table 3A
Hs.79933
NM_006835
5802991
cycline I (CCNI), mRNA/cds =
1
AGGCTGTAGAAGGAAATATACCTTAA

(0, 1133)

CAGGCTGATTTGGAGTGACCCAGA

2973
Table 3A
Hs.278613
NM_006837
5803045
interferon, alpha-inductible protein 27
1
ACCAGTTACCCAAAATCTGATTAGAA

(IF127), mRNA/cds = (54, 422)

GTATAAGGTGCTCTGAAGTGTCCT

2974
Table 3A
Hs.78504
NM_006839
5803114
inner membrane protein, mitochondrial
1
TGAGGCTTGTGAGGCCAATCAAAATA

(mitofilin) (IMMT),

ATGTTTGTGATCTCTACTACTGTT

mRNA/cds = (92, 2368)

2975
Table 3A
Hs.75916
NM_006842
5803154
splicing factor 3b, subunit 2, 145kD
1
CAGTTCCCAAGGACTTGTCATTTCAT

(SF3B2), mRNA/cds = (48, 2666)

GTTCTTATTTTAGACCTGTTTTGT

2976
db mining
Hs.105928
NM_006847
5803063
leukocyte immunoglobulin-like
1
ACCACTAGAAGATTCCGGGAACGTTG

receptor, subfamily B (with TM and

GGAGTCACCTGATTCTGCAAAGAT

ITIM domains), member 3 (LILRB3),

mRNA/cds = (49, 1944)

2977
Table 3A
Hs.315463
NM_006850
5803085
interleukin 24 (IL24),
1
GTCAAGCTGACCTTGCTGATGGTGAC

mRNA/cds = (274, 894)

ATTGCACCTGGATGTACTATCCAA

2978
Table 3A
Hs.64639
NM_006851
5803150
glioma pathogenesis-related protein
1
ACAGCTCAAGTACCCTAATTTAGTTC

(RTVP1), mRNA/cds = (128, 928)

TTTTGGACTAATACAATTCAGGAA

2979
db mining
Hs.113277
NM_006865
5803061
leukocyte immunoglobulin-like
1
GATGACGCTGGGCACAGAGGGTCAG

receptor, subfamily A (without TM

GTCCTGTCAAGAGGAGCTGGGTGTC

domain), member 3 (LILRA3),

mRNA/cds = (62, 1381)

2980
Table 3A
Hs.82143
NM_006874
6857815
E74-like factor 2 (ets domain
1
AACATCTCTCTTCTCCTTCCCAACTAC

transcription factor) (ELF2),

TGCATGAAGAAATTCTACTTCCA

mRNA/cds = (121, 1722)

2981
Table 3A
Hs.80205
NM_006875
5803124
pim-2-oncogene (PIM2),
1
TTCCTGCCTGGATTATTTAAAAAGCC

mRNA/cds = (185, 1189)

ATGTGTGGAAACCCACTATTTAAT

2982
Table 3A
Hs.177530
NM_006886
5901895
ATP synthase, H+ transporting,
1
TGCTACATTTCCAAGGTGAAGATGTG

mitochondrial F1 complex, epsilon

TGGGCACATGTTATGGCAGATTGA

subunit (ATP5E),

mRNA/cds = (91, 246)

2983
Table 3A
Hs.177656
NM_006888
5901911
calmodulin 1 (phosphorylase kinase,
1
ACAACCATCAACATTGCTGTTCAAAG

delta) (CALM1),

AAATTACAGTTTACGTCCATTCCA

mRNA/cds = (199, 648)

2984
Table 3A
Hs.155410
NM_006899
5901981
isocitrate dehydrogenase 3 (NAD+)
1
CCCACCCATAGGCCCTGTCCATACCC

beta (IDH38), mRNA/cds = (79, 1236)

ATGTAAGGTGTTCAATAAAGAACA

2985
Table 3A
Hs.118684
NM_006923
14141194
stromal cell-derived factor 2 (SDF2),
1
ACTCTTCAGGAGCTTGGCATCATGGA

mRNA/cds = (39, 674)

CTGTTAATGTATGTGATTTTCCCC

2986
Table 3A
Hs.166975
NM_006925
5902077
splicing factor, arginino/serine-rich 5
1
GGTCAAGGGTGTCCTCCACTCTTTAA

(SFRS5), mRNA/cds = (218, 541)

CAGCTGCTGGACAGACACATTAGA

2987
Table 3A
Hs.7594
NM_006931
5902089
solute carrier family 2 (facilitated
1
GCAACTTCATGTCAACTTTCTGGCTC

glucose transpoter), member 3

CTCAAACAGTAGGTTGGCAGTAAG

(SLC2A3), mRNA/cds = (242, 1732)

2988
Table 3A
Hs.180139
NM_006937
5902097
SMT3 (suppressor of mil two 3, yeast)
1
CCAAGTGGAGACGGGGATGGGGAAA

homolog 2 (SMT3H2),

AATACTGATTCTGTGGAAAATACCC

mRNA/cds = (90, 377)

2989
Table 3A
Hs.88948
NM_006938
5902101
small nuclear ribonucleoprotein D1
1
TGTGTAATGTACCTGTCAGTGCCTCC

polypeptide (16kD) (SNRPD1),

TTTATTAAGGGGTTCTTTGAGAAT

mRNA/cds = (150, 509)

2990
Table 3A
Hs.237825
NM_006947
5902123
signal recognition particle 72kD
1
GCAGGGGCTCCAGCAACAAAAAAGA

(SRP72), mRNA/cds = (0, 2015)

AACAGCAACAGAAAAAGAAGAAAGG

2991
Table 3A
Hs.108642
NM_006983
5902159

Homo sapiens, zinc finger protein 22
1
AGACTCACTTACCCTCTTGGAAAGCT

(KOX 15), clone MGC:9735

GGTACAGAAGGAAGTCTGTGGCTG

IMAGE:3852749, mRNA, complete

cds/cds = (133, 807)

2992
Table 3A
Hs.167741
NM_006994
6325463
butyrophilin, subfamily 3, member A3
1
CCTGGTCATTGGTGGATGTTAAACCC

(BTN3A3), mRNA/cds = (171, 1925)

ATATTCCTTTCAACTGCTGCCTGC

2993
Table 3A
Hs.225951
NM_006999
6631114
topoisomerase-related function protein
1
AATGAATTGGCCTGGCTACCACTGTG

4-1 (TRF4), mRNA/cds = (37, 1665)

GTCGCGTGCTACAGGTTTGACAAA

2994
Table 3A
Hs.97932
NM_007015
5901931
chondromodulin 1 precursor (CHM-1),
1
TTGATTTGCCATAAGTCTTCCCTTGCT

mRNA/cds = (0, 1004)

TGCATCTTCCAAAGCTATTTCGA

2995
Table 3A
Hs.93502
NM_007020
5902143
U1-snRNP binding protein homolog
1
AGTGAAGTTACAGTGGAAATGAGTGG

(70kD) (U1SNRNPBP), transcript

AGGGGGATTGTCTTTCAACGCAGC

variant 1, mRNA/cds = (213, 953)

2996
Table 3A
Hs.149443
NM_007022
5901883
putative tumor suppressor (101F6),
1
GCTTGGTCATTATGAACCAGGTGAGC

mRNA/cds = (0, 668)

AATGCCTACCTATACCGCAAGAGG

2997
literature
Hs.41693
NM_007034
6631084
DnaJ-like heat shock protein 40
1
AAGGCACTGAAAATATAAAAGGACTG

(HLJ1), mRNA/cds = (176, 1189)

GTAGTTTACTGATGTAGATGTGAA

2998
Table 3A
Hs.87497
NM_007047
5901905
butyrophilin, subfamily 3, member A2
1
GCAGAAAAGGGGAACTCATTTAGCTC

(BTN3A2), mRNA/cds = (188, 1147)

ACGAGTGGTCGAGTGAAGATTGAA

2999
Table 3A
Hs.169963
NM_007049
5921460
butyrophilin, subfamily 2, member A1
1
TATCTTGAGACGCCTTACAAATGATG

(BTN2A1), mRNA/cds = (210, 1793)

GAGGATTCCAAAGAGTTTTTGTTT

3000
Table 3A
Hs.164170
NM_007063
5902153
vascular Rab-GAP/TBC-containing
1
AAAATGTTGTTGTGTACATACCATGC

(VRP), mRNA/cds = (1117, 3810)

TTTCAATGTTGGCTTCCAAGTTTT

3001
Table 3A
Hs.21907
NM_007067
5901961
histone acetyltransferase (HBOA),
1
GGTAGAATGTGCTCTTCTATATCTAC

mRNA/cds = (42, 1877)

TCCTCAATAAAGCATGTTCTCTGC

3002
literature
Hs.37181
NM_007068
5901995
DMC1 (dosage suppressor of mck1,
1
CCACAAGAGGATTTAAGGGAGGAAT

yeast homolog) meiosis-specific

GTTTATAGGACACACACACAAAAGC

homologous recombination (DMC1),

mRNA/cds = (53, 1075)

3003
Table 3A
Hs.109606
NM_007074
5902133
coronin, actin-binding protein, 1A
1
CTCCAGCAGGGTCAGCCATTCACAC

(CORO1A), mRNA/cds = (100, 1485)

CCATCCACTCACCTCCCATTCCCAG

3004
Table 3A
Hs.252574
NM_007104
6325471
ribosomal protein L10a (RPL10A),
1
AAACTGGCAGAATGTCCGGGCCTTAT

mRNA/cds = (15, 668)

ATACAAGAGCACCATGGGCAAGC

3005
Table 3A
Hs.29352
NM_007115
6005905
tumor necrosis factor, alpha-induced
1
AACACACAGTGTTTATGTTGGAATCT

Protein 6 (TNFAIP6)

TTTGGAACTCCTTTGATCTCACTG

mRNA/cds = (68, 901)

3006
Table 3A
Hs.301819
NM_007145
6005965
zinc finger protein 146 (ZNF146),
1
TGGGAGTGAGGATGGGAATGCTGTA

mRNA/cds = (856, 1734)

TCTGTGGAAGTCATGTTATACTGGA

3007
Table 3A
Hs.260523
NM_007158
6005738
neuroblastoma RAS viral (v-ras)
1
TGCTTAGATCACTGCAGCTTCTAGGA

oncogene homolog (NRAS),

CCCGGTTTCTTTTACTGATTTAAA

mRNA/cds = (253, 822)

3008
Table 3A
Hs.301637
NM_007187
6005977
zinc finger protein 258 (ZNF258),
1
CTGAACTACCAAATAGCTGTGGGCTT

mRNA/cds = (93, 2264)

TCTGGAACTGCTGGCTGGGTTGCT

3009
Table 3A
Hs.14963
NM_007192
6005756
chromatin-specific transcription
1
GCTCTGTGACTTTAAGAGAAGAAGGG

elongation factor, 140 kDa subunit

GGGAGGGGTCCCGGATTTTATGTT

(FACTP140), mRNA/cds = (291, 3434)

3010
literature
Hs.146329
NM_007194
6005849
protein kinase Chk2 (RAD53),
1
AGAAATGTCCTTCTTTCACTCTGCAT

mRNA/cds = (0, 1631)

CTTTCTTTTCTTTGAGTCGTTTTT

3011
literature
Hs.271699
NM_007195
6005847
polymerase (DNA directed) iota
1
TCCAGATAAAGCAAGAATAGTTGCAA

(POLI), mRNA/cds = (64, 2211)

GAAGTAAATTCTGGCACAAAGCGT

3012
literature
Hs.251398
NM_007205
6005917
three prime repair exonuclease 2
1
CCCACAATGGCTTTGATTATGATTTC

(TREX2), mRNA/cds = (0, 710)

CCCCTGCTGTGTGCCGAGCTGCGG

3013
literature
Hs.79086
NM_007208
6005861
mitochondrial ribosomal protein L3
1
AAATTACAGAAACATGTTAAAGGCCG

(MRPL3), mRNA/cds = (76, 1122)

GACAAAGGAAAGACAATAAAATCA

3014
Table 3A
Hs.182825
NM_007209
6005859
ribosomal protein L35 (RPL35),
1
GAAGTACGCGGTCAAGGCCTGAGGG

mRNA/cds = (27, 398)

GCGCATTGTCAATAAAGCACAGCTG

3015
Table 3A
Hs.151676
NM_007210
13124893
UDP-N-acetyl-alpha-D-
1
TCTACAGCCATGTCCTATTCCTTGAT

galactosamine:polypeptide N-

CATCCAAAGCACCTGCAGAGTCCA

acetylgalactosaminyltransferase 6

(GalNAc-T6) (GALNT6),

mRNA/cds = (0, 1868)

3016
Table 3A
Hs.28866
NM_007217
6005897
programmed cell death 10 (PDCD10),
1
AATGTAGCTTAATCATAATCTCACACT

mRNA/cds = (153, 791)

GAAGATTTTGCATCACTTTTGCT

3017
Table 3A
Hs.28285
NM_007218
6005911
patched related protein translocated in
1
TGATGATGATGTTCAAAGAGAAAGAA

renal cancer (TRC8),

ATGGAGTGATTCAGCACACAGGCG

mRNA/cds = (0, 1994)

3018
Table 3A
Hs.283646
NM_007220
6005722
carbonic anhydrase VB, mitochondrial
1
GCCACCAGCCAAGCAACCCCCTAAA

(CA5B), nuclear gene encoding

ACATTCATATCTAGGCAGTATTTTG

mitochondrial protein,

mRNA/cds = (137, 1090)

3019
Table 3A
Hs.94446
NM_007221
6005831
polyamine-modulated factor 1 (PMF1),
1
GCCTTTACCATGTTCTCTCCACATCC

mRNA/cds = (111, 608)

GTAAATAAACTTCCTTCACTACAA

3020
literature
Hs.334676
NM_007248
6005752
three prime repair exonuclease 1
1
CCACACCTGGCGAGTAGGCCAAGAA

(TREX1), mRNA/cds = (256, 1170)

GGAAAATCTGACGAATAAAGACCCC

3021
literature
Hs.78016
NM_007254
6005835
polynucleotide kinase 3′-phosphatase
1
GGGCTGAGCCCCGCCCAGCTCCCCT

(PNKP), mRNA/cds = (0, 1565)

CCACAATAAACGCTGTTTCTCCTTG

3022
Table 3A
Hs.10958
NM_007262
6005748
RNA-binding protein regulatory subunit
1
TTTCTCAGCCTACAAATTGTGTCTATA

(DJ-1), mRNA/cds = (20, 589)

CATTTCTAAGCCTTGTTTGCAGA

3023
db mining
Hs.10326
NM_007263
6005734
coatomer protein complex, subunit
1
GAGCCCACCCCCAGCACCCCCATCT

epsilon (COPE), mRNA/cds = (42, 968)

GTTAATAAATATCTCAACTCCAAAA

3024
Table 3A
Hs.8813
NM_007269
6005885
syntaxin binding protein 3 (STXBP3),
1
TGGAGTGATTTCACAGTGTGTACTGT

mRNA/cds = (51, 1829)

TTTGCCACATACTTCTAAAGAACA

3025
Table 3A
Hs.8724
NM_007271
6005813
serine threonine protein kinase (NDR),
1
CCCTTTGGAAATGGTGAAGGAACCAG

mRNA/cds = (595, 1992)

CCCAATAGAAGTACAGAGCCAGCT

3026
Table 3A
Hs.7771
NM_007273
6005853
B-cell associated protein (REA),
1
CTCCCTCAAGGCTGGGAGGAGATAA

mRNA/cds = (9, 906)

ACACCAACCCAGGAATTCTCAATAA

3027
Table 3A
Hs.7719
NM_007278
6005763
GABA(A) receptor-associated protein
1
AGGGACTGAAATTGTGGGGGGAAGG

(GABARAP), mRNA/cds = (104, 457)

TAGGAGGCACATCAATAAAGAGGAA

3028
Table 3A
Hs.1298
NM_007289
6042203
membrane metallo-endopeptidase
1
TGGGGCAAAACCTTGCTAATTTTCTC

(neutral endopeptidase, enkephalinase,

AAAAGCATTTATCATTCTTGTTGC

CALLA, CD10) (MME), transcript

variant 2b, mRNA/cds = (228, 2480)

3029
literature
Hs.194143
NM_007295
6552300
breast cancer 1, early onset (BRCA1),
1
CCCCCAGTGTGCAAGGGCAGTGAAG

transcript variant BRCA1b,

ACTTGATTGTACAAAATACGTTTTG

mRNA/cds = (397, 5988)

3030
Table 3A
Hs.21486
NM_007315
6274551
signal transducer and activator of
1
AGATGGCGAGAACCTAAGTTTCAGTT

transcription 1, 91kD (STAT1),

GATTTTACAATTGAAATGACTAAA

mRNA/cds = (196, 2448)

3031
Table 3A
Hs.3260
NM_007318
7549812
presenilin 1 (Alzheimer disease 3)
1
TGTCAGACCTTCTTCCACAGCAAATG

(PSEN1), transcript variant I-463,

AGATGTATGCCCAAAGCGGTAGAA

mRNA/cds = (553, 1944)

3032
Table 3A
Hs.279611
NM_007329
6633800
deleted in malignant brain tumors 1
1
GTTGCAGGGCGAGGTCAAGAGAGTT

(DMBT1), transcript variant 2,

CTGACCTGGATGGCCCATAGACCTG

mRNA/cds = (106, 7347)

3033
Table 3A
Hs.74335
NM_007355
6680306
heat shock 90kD protein 1, beta
1
GACAGCAGGATTGGATGTTGTGTATT

(HSPCB), mRNA/cds = (0, 2174)

GTGGTTTATTTTATTTTCTTCATT

3034
Table 3A
Hs.74085
NM_007360
6679051
DNA segment on chromosome 12
1
AGTGCCTTCCCTGCCTGTGGGGGTC

(unique) 2489 expressed sequence

ATGCTGCCACTTTTAATGGGTCCTC

(D12S2489E), mRNA/cds = (338, 988)

3035
Table 3A
Hs.172207
NM_007363
7657382
non-POU-domain-containing, octamer-
1
TTTGGAGTTTTTCTGAAAAATGGAGC

binding (NONO),

AGTAATGCAGCATCAACCTATTAA

mRNA/cds = (138, 1551)

3036
Table 3A
Hs.158135
NM_011086
6755061
mRNA for KIAA0981 protein, partial
1
CAATGGACAAGTATTTCCTAATGGTA

cds/cds = (0, 1737)

CCAGACCACTGGACAGGCTTGGGT

3037
Table 3A
Hs.9754
NM_012068
12597624
activating transcription factor 5 (ATF5),
1
GTGTTGGAGAGGGGCTGTGTCTGGG

mRNA/cds = (319, 1167)

TGAGGGATGGCGGGGTACTGATTTT

3038
Table 3A
Hs.97199
NM_012072
11496985
complement component C1q receptor
1
GTGCTTTGAGGGTCAGCCTTTAGGAA

(C1QR), mRNA/cds = (148, 2106)

GGTGCAGCTTTGTTGTCCTTTGAG

3039
Table 3A
Hs.173334
NM_012081
6912353
ELL-RELATED RNA POLYMERASE
1
GGCTCACATCAAAAGGCTAATAGGTG

II, ELONGATION FACTOR (ELL2),

AATTTGACCAACAGCAAGCAGAGT

mRNA/cds = (0, 1922)

3040
Table 3A
Hs.1710
NM_012089
9961243
ATP-binding cassette, sub-family B
1
CAGAAAGCAAACAACACAATTA

(MDR/TAP), member 10 (ABCB10),

CAAGGTTGAATCTGAGGAAAATAA

nuclear gene encoding mitochondrial

TCCT

protein, mRNA/cds = (43, 2259)

3041
Table 3A
Hs.342849
NM_012097
6912243
xv24a05.x1 cDNA, 3′
1
TCTCTCTGTGTTCTCTGTATTGTACTA

end/close =

ACCAACCTCCCAAATCGCTGAGC

IMAGE:2814032/clone_end = 3′

3042
Table 3A
Hs.33979
NM_012123
6912299
CGI-02 protein (CGI-02),
1
CCTGGAATAAAACTCAACATGCAGAT

mRNA/cds = (268, 2124)

TTGCCTACTCATAGGGACTTTGCC

3043
Table 3A
Hs.22857
NM_012124
6912303
chord domain-containing protein 1
1
TGCCTCCCTGATGGAAAACTATATAA

(CHP1), mRNA/cds = (84, 1082)

AATTGTAGACTTAAAAGGTTTGTG

3044
Table 3A
Hs.36794
NM_012142
6912335
cyclin D-type binding-protein 1
1
TTCATTGTAAAGATGTTGATGGTCTC

(CCNDBP1), mRNA/cds = (87, 1172)

AATAAAATGCTAACTTGCCAGTGA

3045
Table 3A
Hs.83363
NM_012151
12056462
coagulation factor VIII-associated
1
CGTCCGCACGGTACGTCTTCATGGG

(intronic transcript) (FBA),

AGTCATTTTATTCCTTACAGCTTCC

mRNA/cds = (57, 1172)

3046
Table 3A
Hs.24178
NM_012155
6912355
microtubule-associated protein like
1
TGGTGTTTGGTTTGGGGTGTTTTTTA

echinoderm EMAP (EMAP-2),

AGTTTTTTCTTTTATATCATCCAG

3047
Table 3A
Hs.5912
NM_012179
7106310
F-box only protein 7 (FBXO7),
1
CTCCCTGCTCTTGGTTCTCCTCTAGA

mRNA/cds = (205, 1773)

TTGAAGTTTGTTTTCTGATGCTGT

3048
Table 3A
Hs.79381
NM_012198
6912387
grancalcin, EF-hand calcium-binding
1
TGAAGACATAGTTCACCTAAAATGGC

protein (GCA), mRNA/cds = (119, 772)

ATCCTGCTCTGAATCTAGACTTTT

3049
Table 3A
Hs.14520
NM_012199
6912351
eukaryotic translation initiation factor
1
CCCTTTGAGATTTGTGTTTGTGTCCT

2C, 1 (EIF2C1),

GCTTTGAGCTGTACCTTGTCCAGT

mRNA/cds = (213, 2786)

3050
Table 3A
Hs.5734
NM_012215
11024697
meningioma expressed antigen 5
1
TCCTGTAGAAAACGAACTGTAAAAGA

(hyaluronidase) (MGEA5),

CCATGCAAGAGGCAAAATAAAACT

mRNA/cds = (395, 3145)

3051
literature
Hs.271353
NM_012222
6912519
mutY (E. coli) homolog (MUTYH),
1
CCAGTGACACCTCTGAAAGCCC

mRNA/cds = (134, 1774)

CCATTCCCTGAGAATCCTGTTGTT

AGTA

3052
Table 3A
Hs.26719
NM_012231
10092605
PR domain containing 2, with ZNF
1
CCTGGTCAGTGGTGGTCTTCAAGAC

domain (PRDM2),

GACAGCTCTGTATCTGCCATGTGAA

mRNA/cds = (855, 6014)

3053
Table 3A
Hs.44017
NM_012237
13775599
sirtuin (silent mating type information
1
CCCACTTCCCATGCTGGATGGGCAG

regulation 2, S. cerevisiae, homolog) 2

AAGACATTGCTTATTGGAGACAAAT

(SIRT2), transcript variant 1,

mRNA/cds = (200, 1369)

3054
Table 3A
Hs.31176
NM_012238
13775598
sirtuin (silent mating type information
1
TTACTGGCATATGTTTTGTAGACTGTT

regulation 2, S. cerevisiae, homolog) 1

TAATGACTGGATATCTTCCTTCA

(SIRT1), mRNA/cds = (53, 2296)

3055
Table 3A
Hs.22891
NM_012244
6912669
solute carrier family 7 (cationic amino
1
AATGTAAGGTTGTTTTGGGGGATGGA

acid transporter, y+ system), member 8

GTTAGAACCTTAATGATAATTTCT

(SLC7A8), mRNA/cds = (730, 2337)

3056
Table 3A
Hs.79008
NM_012245
6912675
SKI-INTERACTING PROTEIN
1
TTTGGAGTGGGCAAAGTAACCTCTTG

(SNW1), mRNA/cds = (27, 1637)

CTTGGTGCAACTATTTGTTTCAAA

3057
Table 3A
Hs.268555
NM_012255
6912743
5′-3′ exoribonuclease 2 (XRN2),
1
GCTTATAAACACATTTGAGGAATAGG

mRNA/cds = (68, 2920)

AGGTCCGGGTTTTCCATAATGGGT

3058
Table 3A
Hs.10882
NM_012257
6912409
HMG-box containing protein 1 (HBP1),
1
TCTTATCATTGCATACATTTTCTGGAT

mRNA/cds = (23, 1567)

GCTTGAGCCATCAGATATCAGCT

3059
Table 3A
Hs.23170
NM_012280
7110660
homolog of yeast SPB1 (JM23),
1
TGCAGTGGGAATTCTTGAGTGAGGTC

mRNA/cds = (300, 1289)

TTACCTCTTCTTTAAACCTCTTCA

3060
Table 3A
Hs.173714
NM_012286
6912447
MORF-related gene X (KIAA0026),
1
TGCATTATTGTGTAGCCACGGTTTTC

mRNA/cds = (305, 1171)

TGGAAAAGTTGATATTTTAGGAAT

3061
Table 3A
Hs.18895
NM_012290
6912719
tousled-like kinase 1 (TLK1),
1
ATTACATTGGAAGGGAGCTTTCAAGA

mRNA/cds = (212, 2575)

TGGTAGGATATTGACTAACTGAGC

3062
Table 3A
Hs.30687
NM_012296
6912459
GRB2-associated binding protein 2
1
CATGGTACAGGCTTGGAGCTTGCAG

(GAB2), mRNA/cds = (160, 2076)

GTCCCTTTCTACTGTGGTGTTGGAG

3063
Table 3A
Hs.120165
NM_012318
6912481
leucine zipper-EF-hand containing
1
TGTGCAGGGACAGTTGGCTTCCAGA

transmembrane protein 1 (LETM1),

GGTTTCAGCTTTCAGTTATTTGAGA

mRNA/cds = (297, 2516)

3064
Table 3A
Hs.234279
NM_012325
6912493
microtubule-associated protein, RP/EB
1
AATTCCATTTTATTGGGAACCCATTTT

family, member 1 (MAPRE1),

CCACCTGGTCTTTCTTGACAGGG

mRNA/cds = (64, 870)

3065
Table 3A
Hs.172740
NM_012326
10800411
microtubule-associated protein, RP/EB
1
AAATAAACTTGTGTGGTAAAAGTACA

family, member 3 (MAPRE3),

TGCCATGTGTCCCTCAACTGAAAA

mRNA/cds = (153, 998)

3066
Table 3A
Hs.18625
NM_012332
6912517
Mitochondrial Acyl-CoA Thioesterase
1
TTCAAGACAATTTTAATTGTGAACCTA

(MT-ACT48),

CCATGTTGCCTCCCATCTTCTGA

mRNA/cds = (147, 1367)

3067
Table 3A
Hs.215766
NM_012341
6912531
GTP-binding protein (NGB),
1
TTTGTAAGAGCTGGGAGCAAACACGT

mRNA/cds = (23, 1924)

TTATGAGTGTGTCGGAATCCCGTG

3068
Table 3A
Hs.74420
NM_012381
6912561
origin recognition complex, subunit 3
1
CCCAAACAGGCATGTATCAAAACACC

(yeast homolog)-like (ORC3L),

TGTGGAGTACTTTAGACTCCAACA

mRNA/cds = (26, 2161)

3069
Table 3A
Hs.241531
NM_012392
6912581
PEF protein with a long N-terminal
1
TGGGGCCAAAAGTCCAGTGAAATTGT

hydrophobic domain (peflin) (PEF),

AAGCTTCAATAAAAGGATGAAACT

mRNA/cds = (12, 866)

3070
Table 3A
Hs.21807
NM_012406
9055315
PR domain containing 4 (PRDM4),
1
TGGGCTGGAGTAGAGGACTCTGGTG

mRNA/cds = (122, 2527)

GGAAGGTTTTGCTGCTAATGTATTT

3071
Table 3A
Hs.79033
NM_012413
9257235
glutaminyl-peptide cyclotransferase
1
AGCTAAACAGTACTTAAATAGCGGTT

(glutaminyl cyclase) (QPCT),

GGAACTAGGTAGCCTTTCGAATTT

mRNA/cds = (11, 1098)

3072
literature
Hs.128501
NM_012415
6912621
RAD54, S. cerevisiae, homolog of, B
1
TGTCATTCATTTTTCAGAATATAACCA

(RAD54B), mRNA/cds = (80, 2812)

CTCAAGCTACTGGCACATAGTGA

3073
Table 3A
Hs.333212
NM_012417
6912623
retinal degeneration B beta (RDGBB),
1
TCTGATAGAGAAAAAGACTGCTTTGT

mRNA/cds = (0, 998)

CACTCAAACATGTTCCTTCGACCT

3074
Table 3A
Hs.151242
NM_012423
14591905
serine (or cysteine) proteinase
1
GGCATCGCCCATGCTCCTCACCTGTG

inhibitor, clade G (C1 inhibitor),

TTTTGTAATCAGAAATAAATTGCT

member 1 (SERPING1),

mRNA/cds = (60, 1562)

3075
Table 3A
Hs.334826
NM_012433
6912653
splicing factor 3b, subunit 1, 155kD
1
TTTGATGTTAAACAGTAAATGCCAGT

(SF3B1), mRNA/cds = (0, 3914)

AGTGACCAAGAACACAGTGATTAT

3076
literature
Hs.159737
NM_012444
6912679
SPO11, meiotic protein covalently
1
CCTTTGCCTTTATACTTTAGGGGTCTT

bound to DSB (S. cerevisiae)-like

ACTCCATTAATTCATTTGTTACA

(SPO11), mRNA/cds = (108, 1298)

3077
literature
Hs.244613
NM_012448
6912687
signal transducer and activator of
1
TGCACGTTATGGTGTTTCTCCCTCTC

transcription 5B (STAT5B),

ACTGTCTGAGAGTTTAGTTGTAGC

mRNA/cds = (146, 2509)

3078
Table 3A
Hs.109571
NM_012456
6912707
translocase of inner mitochondrial
1
CTGTAGAGAGTCTTCAAGATCCCGGA

membrane 10 (yeast) homolog

GTGGTAGCGCTGTCTCCTGGTGAA

(TIMM10), mRNA/cds = (129, 401)

3079
Table 3A
Hs.7797
NM_012461
6912715
TERF1 (TRF1)-interacting nuclear
1
TAGTAGGAATGAAGTGGAAGTCCAG

factor 2 (TINF2),

GCTTGGATTGCCTAACTACACTGCT

mRNA/cds = (262, 1326)

3080
Table 3A
Hs.105806
NM_012483
7108345
granulysin (GNLY), transcript variant
1
GATCCAGAATCCACTCTCCAGTCTCC

519, mRNA/cds = (280, 669)

CTCCCCTGACTCCCTCTGCTGTCC

3081
Table 3A
Hs.199263
NM_013233
7019542
Ste-20 related kinase (SPAK),
1
ATTCCATTCTATTGTTTACACAACGAT

mRNA/cds = (173, 1816)

TACTCGAAGATGACTGCAAAGGT

3082
Table 3A
Hs.283781
NM_013234
10801344
muscle specific gene (M9),
1
AGCCAAGAAGAGAGCATTAAACCCAA

mRNA/cds = (171, 827)

GAACATTGTGGAGAAGATTGACTT

3083
Table 3A
Hs.13493
NM_013236
7106298
like mouse brain protein E46 (E46L),
1
TATATTGTACTTACTGTGACAGCAGA

mRNA/cds = (198, 1625)

TAATAAACCAGTCTCTTGGAGGGC

3084
Table 3A
Hs.279529
NM_013237
7019508
px19-like protein (PX19),
1
CTTATTCTCCCATTGGGCAGCTGAGG

mRNA/cds = (176, 835)

ACCGAGGCACAGAGGTGCGGTGAC

3085
Table 3A
Hs.126355
NM_013252
10281668
C-type (calcium dependent,
1
TCACTGTATACCACTGGAGTTTTCTG

carbohydrate-recognition domain)

GTTATCTCTCGTATAGCAAAATCT

lectin, superfamily member 5

(CLECSF5), mRNA/cds = (197, 763)

3086
Table 3A
Hs.169330
NM_013259
10047091
neuronal protein (NP25),
1
GCTGCCACCTCCTGTTCATTTAGAAC

mRNA/cds = (49, 897)

TATGCAAAGACTCCGCTTCCGTTT

3087
Table 3A
Hs.136748
NM_013269
7019446
lectin-like NK cell receptor (LLT1),
1
ACAGCAAAGCCCCAACTAATCTTTAG

mRNA/cds = (13, 588)

AAGCATATTGGAACTGATAACTCC

3088
Table 3A
Hs.14805
NM_013272
7706713
solute carrier family 21 (organic anion
1
GCCAGCTTGGAGGATGGACATTTCTG

transporter), member 11 (SLC21A11),

GATACACATACACATACAAAACAG

mRNA/cds = (193, 2325)

3089
literature
Hs.129903
NM_013274
7019490
polymerase (DNA-directed), lambda
1
GTCAACATCATCCGGCACCCTCTGG

(POLL), mRNA/cds = (371, 2098)

GGTAGGAGAACAGCCATTCCACATG

3090
Table 3A
Hs.54642
NM_013283
11034824
methionine adenosyltransferase II,
1
TCATATGTGTGGTTATACTCATAATAA

beta (MAT2B), mRNA/cds = (0, 1004)

TGGGCCTTGTAAGCCTTTTCACC

3091
literature
Hs.252646
NM_013284
7019492
wm25f06.x1 cDNA, 3′
1
CTGCTTGACTCACCGGCTTCCTATTT

end/clone =
1
GATGCACCCAGGCCCCCTTGTGGC

IMAGE:2436995/clone_end = 3′

3092
Table 3A
Hs.75528
NM_013285
7019418
nucleolar GTPase (HUMAUANTIG),
1
GGGACAGAAACACAAACGCAAA

mRNA/cds = (79, 2274)

AAATTCAGACAAAAGCAGTAATGT

TTAA

3093
Table 3A
Hs.106260
NM_013322
7019538
sorting nexin 10 (SNX10),
1
GCGATCCTCATCCCTTCAGCAATATG

mRNA/cds = (128, 733)

TATTTGAGTTCACACTATTTCTGT

3094
Table 3A
Hs.289080
NM_013326
7019454
colon cancer-associated protein Mic1
1
TTTTGAACAGCGAAACCAGCGTTTGC

(MIC1), mRNA/cds = (76, 1905)

GAGGGAGCCCCAATTTCACACCAG

3095
literature
Hs.283018
NM_013347
9558730
replication protein A complex 34 kd
1
TTCCAAAAGAAAAACTAGTTGCAGTC

subunit homolog Rpa4 (HSU24186),

AGGGAGCCAGCGAAAAGACAAAAA

mRNA/cds = (404, 1189)

3096
Table 3A
Hs.272409
NM_013351
7019548
T-box 21 (TBX21),
1
ACTGAGAGTGGTGTCTGGATATATTC

mRNA/cds = (211, 1818)

CTTTTGTCTTCATCACTTTCTGAA

3097
Table 3A
Hs.58636
NM_013352
7019520
squamous cell carcinoma antigen
1
GCATGCATTCATTGGTTGTTCAATAA

recognized by T cell (SART-2),

GTGAGATGATTACAGATAATACTG

mRNA/cds = (149, 3025)

3098
literature
Hs.189138
NM_013368
7019514
RPA-binding trans-activator (RBT1),
1
CTGATTTCATAACCAGGCCGGACCAC

mRNA/cds = (291, 881)

GTGCAATAGGGTGGAAACCAAACT

3099
Table 3A
Hs.138713
NM_013378
7019566
pre-B lymphocyte gene 3 (VPREB3),
1
GAAGACGACGCGGATTACTACTGCTC

mRNA/cds = (42, 413)

TGTTGGCTACGGCTTTAGTCCCTA

3100
Table 3A
Hs.279784
NM_013388
7019502
protactin regulatory element binding
1
TGAACCTCAGCCCATTAGGCAGGAAA

(PREB), mRNA/cds = (131, 1384)

AGTTGATATTTAATAAACAAGGAA

3101
Table 3A
Hs.171825
NM_013390
7019554
basic helix-loop-helix domain
1
CCAAGGCACTTGGTTTTTCTGTTTTAT

containing, class B, 2 (BHLHB2),

ATACTAATAATCAGGGCCTAAGT

mRNA/cds = (196, 1434)

3102
Table 3A
Hs.272736
NM_013392
7019332
nuclear receptor binding protein
1
GGGGGCCATTCGATTCGCCTCAGTT

(NRBP), mRNA/cds = (112, 1719)

GCTGCTGTAATAAAAGTCTACTTTT

3103
Table 3A
Hs.7838
NM_013446
7305272
makorin, ring finger protein, 1
1
ACTTTAAGAAAAAACAAATAATT

(MKRN1), mRNA/cds = (122, 1570)

GTTGCAGAGGTCTCTGTATTTTG

CAGC

3104
Table 3A
Hs.8858
NM_013448
7304918
bromodomain adjacent to zinc finger
1
CTGTACCAGTGCTGGCTGCAGGTATT

domain, 1A (BAZ1A),

AAGTCCAAGTTTATTAACTAGATA

mRNA/cds = (115, 5139)

3105
Table 3A
Hs.277401
NM_013449
7304920
bromodomain adjacent to zinc finger
1
GCCACCTCTGTGTTCCTGTCATAGCA

domain, 2A (BAZ2A),

AATATGGGACCATCACCAGCTTAC

mRNA/cds = (739, 6375)

3106
Table 3A
Hs.234680
NM_013451
7305052
fer-1 (C. elegans)-like 3 (myoferlin)
1
TCCTGAGGTGATATACTTCATATTTGT

(FER1L3), mRNA/cds = (96, 6281)

AATCAACTGAAAGAGCTGTGCAT

3107
literature
Hs.100299
NM_013975
7710125
ligase III, DNA, ATP-dependent
1
TGCTGGGTTTGCCATCTTTTTTTGT

(LIG3), transcript variant alpha,

TTTCTTTGAAAAGCAGCTTAGTT

mRNA/cds = (323, 3091)

ACCC

3108
Table 3A
Hs.8262
NM_013995
7669502
lysosomal-associated membrane
1
CCACTAGTTGATGTATGGTATCTTTA

protein 2 (LAMP2), transcript variant

GATATTTGCCTGTCTGTTTGCTCA

LAMP2b, mRNA/cds = (137, 1369)

3109
Table 3A
Hs.127649
NM_014007
7662099
KIAA0414 protein (KIAA0414),
1
AATGGCCTACAACCAAGCTATTTGTC

mRNA/cds = (1132, 2535)

CCCTACTTTGAGTCTTAACTGTGG

3110
Table 3A
Hs.301175
NM_014029
7661739
HSPC022 protein (HSPC022),
1
ATCCTGAGCTGCACTTACCTGTGAGA

mRNA/cds = (18, 623)

GTCTTCAAACTTTTAAACCTTGCC

3111
Table 3A
Hs.11125
NM_014041
7661745
HSPC033 protein (HSPC033),
1
TGCTCTGAGATGGGGAACAGAACAC

mRNA/cds = (168, 443)

ACAAGTATGAAGTTTCTTTCAGGTG

3112
Table 3A
Hs.182238
NM_014052
7661715
GW128 protein (GW128)
1
AAGCACACCCGTGGTTGTGAAAATAG

TATAGCAAAAAAGAAAAATCCCCCG

3113
Table 3A
Hs.76640
NM_014059
7662650
RGC32 protein (RGC32),
1
TGTTTACCTGCTTGCAGCATATTAGA

mRNA/cds = (146, 499)

ACAGACGATCCATGCTAATATTGT

3114
Table 3A
Hs.279040
NM_014065
7661837
HT001 protein (HT001),
1
AATCCTTACTTAAAATTCTTCCGTTAC

mRNA/cds = (241, 1203)

CACCCTTGAAACAATTAGCTTTT

3115
Table 3A
Hs.5327
NM_014106
7662624
PRO1914 protein (PRO1914),
1
ATAACAGTTCTATTTGGAATGATACC

mRNA/cds = (1222, 1425)

CACAACTCTACAAGCATCTTATCC

3116
Table 3A
Hs.78961
NM_014110
13699255
protein phosphatase 1, regulatory
1
AGAGATTTGTACATTTGTGTAATAGG

(inhibitor) subunit 8 (PPP1R8),

CCTTTTCATGCTTTATGTGTAGCT

mRNA/cds = (935, 1318)

3117
Table 3A
Hs.26102
NM_014112
7657658
trichorhinophalangeal syndrome I gene
1
TCTTGGTGTATTTCTTATGCAAACAAT

(TRPS1), mRNA/cds = (638, 4483)

CTTCAGGCAGCAAAGATGTCTGT

3118
Table 3A
Hs.179898
NM_014153
7661761
HSPC055 protein (HSPC055),
1
AACCTGTACTGTTGGTATTGTGTTAG

mRNA/cds = (1400, 1903)

TGTATGGACCAATACTGCCTGTAA

3119
Table 3A
Hs.279474
NM_014160
8850222
HSPC070 protein (HSPC070),
1
AATTGAGGGACCATCAGATAACTGTA

mRNA/cds = (331, 1581)

TTTTGTCAGGTGCAATAAAAACAA

3120
Table 3A
Hs.5232
NM_014165
7661785
HSPC125 protein (HSPC125),
1
CTATGTGTACTCCTCATCCCTCCTGC

mRNA/cds = (79, 608)

TGTATATTTTCTCATTTTTTGCGT

3121
Table 3A
Hs.181112
NM_014168
7661787
HSPC126 protein (HSPC126),
1
TTAAAAGTAACAAAAACTGCCA

mRNA/cds = (25, 837)

TTTGACAGTAAAGGCTCTTGGCTT

CTGT

3122
Table 3A
Hs.279761
NM_014169
7661793
HSPC134 protein (HSPC134),
1
GCTCCCTTCTCTTTGATAGCAGTTAT

mRNA/cds = (45, 716)

AATGCCCTTGTTCCCAATAAAACT

3123
Table 3A
Hs.13645
NM_014174
7661803
HSPC144 protein (HSPC144),
1
CTGAGATACTGCTGCTGGAATGGGC

mRNA/cds = (446, 1123)

GAGACATTGCTGCAAAGAAGTCAAG

3124
Table 3A
Hs.30026
NM_014188
7661831
cDNA FLJ13048 fis, clone
1
CTGCGGCGTGTTAGGAATGACCTGG

NT2RP3001399, weakly similar to

AATTGTCAATAAACAGATGCTGCTG

SSU72 PROTEIN/cds = (27, 488)

3125
Table 3A
Hs.121025
NM_014205
7656935
chromosome 11 open reading frame 5
1
AGCTCCCTAGCTGAACGGGTTACCCT

(C11orf5), mRNA/cds = (45, 1256)

GGTCATTAATAAAGCTGTGACTGG

3126
Table 3A
Hs.58685
NM_014207
7656964
CD5 antigen (p56—62) (CD5),
1
CTCATCTAAAGACACCTTCCTTTCCA

mRNA/cds = (72, 1559)

CTGGCTGTCAAGCCACAGGGCACC

3127
Table 3A
Hs.70499
NM_014210
7657074
ecotropic viral integration site 2A
1
GGCAGAATCCACACCAGCTTATCAAC

(EVI2A), mRNA/cds = (219, 917)

CAACACAGCTAATTTTAGAATAGG

3128
Table 3A
Hs.173902
NM_014225
7657474
protein phosphatase 2 (formerly 2A),
1
GACAGGACAGTGACCTTGGGAGGAA

regulatory subunit A (PR65), alpha

GGGGCTACTCCGCCATCCTTAAAAG

isoform (PPP2R1A),

mRNA/cds = (138, 1907)

3129
Table 3A
Hs.273307
NM_014230
7657616
signal recognition particle 68kD
1
GGACAAGTTGGAACAGAAGACCAAG

(SRP68), mRNA/cds = (0, 1859)

AGTGGCCTCACTGGATACATCAAGG

3130
Table 3A
Hs.332724
NM_014232
7657674
AV705126 cDNA, 5′
1
CCCCAATTCTGTGGCGCATCCCAGATT

end/clone =

GTGAAAATGTACAATAAATGTGTA

ADBCFB08/clone_end = 5′

3131
Table 3A
Hs.14084
NM_014245
7657521
ring finger protein 7 (RNF7),
1
TTCAGAGAACTTTTTGCATGCTTATG

mRNA/cds = (53, 394)

GTTGATCAGTTAAAAAAGAATGTT

3132
Table 3A
Hs.279919
NM_014248
7657507
ring-box 1 (RBX1),
1
TGCTGTTTCTGTAGCCATATTGTATTC

mRNA/cds = (6, 332)

TGTGTCAAATAAAGTCCAGTTGG

3133
Table 3A
Hs.74711
NM_014280
7657610
splicing factor similar to dnaJ (SPF31),
1
ACGCCACCCAAACCTTTCACTTTCCA

mRNA/cds = (7, 801)

AAGAGCTAGCCGTCCTCCACCCAG

3134
Table 3A
Hs.227823
NM_014287
10947030
pM5 protein (PM5),
1
GCATCTGAGATCCTGTTGGAAACCAC

mRNA/cds = (0, 3668)

AGCAACCTGTATTCATTATTAGGA

3135
Table 3A
Hs.54609
NM_014291
7657117
glycine C-acetyltransferase (2-amino-3-
1
GGACGTGACCTGTGCTGAGGGCTGT

ketobutyrate coenzyme A ligase)

GAGAATGTGAAACAACAGTGTGAAA

(GCAT), mRNA/cds = (3, 1262)

3136
Table 3A
Hs.10729
NM_014306
7657014
hypothetical protein (HSPC117),
1
GCCATCAGATTGATCTTCTTCACACC

mRNA/cds = (75, 1592)

AAGCTCTGTTTACATTCCGAGAGG

3137
literature
Hs.5212
NM_014311
7657596
cDNA FLJ10927 fis, clone
1
CCTTTCCTCACAGGGACCAAGACAAA

OVARC 1000488/cds = UNKNOWN

GCATGGGACATGAAATTAAGAGTG

3138
Table 3A
Hs.278994
NM_014313
7657594
Rhesus blood group, CcEe antigens
1
AAGCATGATTCCCACAAGGACTAAGT

(RHCE), mRNA/cds = (0, 1253)

ATCAGTGATTTGTAATTTTCCTGT

3139
Table 3A
Hs.20597
NM_014315
7657300
host cell factor homolog (LCP),
1
ACCTGTTGGTTTTAATGTGCATGTGA

mRNA/cds = (316, 1536)

ATGGCCTAGAGAACCTATTTTTGT

3140
Table 3A
Hs.7256
NM_014319
7706606
integral inner nuclear membrane
1
CCGACCAAGATCCCTCCCTGCAAGA

protein (MAN1),

CAGATGGGAATGTGTATAATAACTA

mRNA/cds = (6, 2741)

3141
Table 3A
Hs.76556
NM_014330
9790902
protein phosphatase 1, regulatory
1
GGGAGGCGTGGCTGAGACCAACTGG

(inhibitor) subunit 15A (PPP1R15A),

TTTGCCTATAATTTATTAACTATTT

mRNA/cds = (240, 2264)

3142
Table 3A
Hs.38738
NM_014343
7858980
claudin 15 (CLDN15),
1
GGACGGTGTCCCCGCACGTTTGTATT

mRNA/cds = (254, 940)

GTGTATAAATACATTCATTAATAA

3143
Table 3A
Hs.48433
NM_014345
7657183
endocrine regulator (HRIHFB2436),
1
ATCCTTTCCTCAACCTCCTCCTTTCC

mRNA/cds = (621, 6920)

CAATTAATTTCAACCATAGTACGA

3144
Table 3A
Hs.17839
NM_014350
7657123
TNF-induced protein (GG2-1),
1
GCCAGCTATGTCCTCTAGGAAATGAC

mRNA/cds = (197, 769)

AGACCCAACCACCAGCAATAAACA

3145
Table 3A
Hs.283737
NM_014366
7857047
AD-017 protein (LOC58830),
1
CTGTAAAAAGACAATTCATCTCATTGT

mRNA/cds = (118, 1233)

GAGTGGAAGTAGTTATCTGGAAT

3146
Table 3A
Hs.97101
NM_014373
7857135
putative G protein-coupled receptor
1
GCATTTCAGAATGTGTCTTTTGAAGG

(GPCR150), mRNA/cds = (321, 1337)

GCTATACCAGTTATTAAATAGTGT

3147
literature
Hs.279843
NM_014381
7857338
mutl. (E. coli) homolog 3 (MLH3),
1
CCAGGGTTTCTGCACTGGTCCCCTCT

mRNA/cds = (114, 4403)

TTTCCCTTCAGTCTTCTTCACTTC

3148
Table 3A
Hs.182470
NM_014394
7657479
PTD010 protein (PTD010),
1
ACACTGCTACACCATTACTTTCTTGA

mRNA/cds = (129, 1088)

GACATTTGTAAGTCCTTTGATACA

3149
Table 3A
Hs.128342
NM_014406
7657252
potassium large conductance calcium-
1
TGAATAACTAGTGATACCCTCAATAA

activated channel, subfamily M, beta

AACAGGGATTGCCAAGAAGGGAAC

member 3-like (KCNMB3L),

mRNA/cds = (243, 1918)

3150
Table 3A
Hs.27258
NM_014412
7656951
calcyclin binding protein (CACYBP),
1
ACCTTTAACATGTAAAGATGCTCACC

mRNA/cds = (117, 603)

TTGTTCAGAAGAGAATAAACCAGT

3151
Table 3A
Hs.301956
NM_014415
7657702
zinc finger protein (ZNF-U69274),
1
TATGTCATAAACATGTAAATAAAAGAT

mRNA/cds = (161, 3322)

GTTGAATCTTGTTGAAAGCGCGG

3152
Table 3A
Hs.14125
NM_014454
7657436
p53 regulated PA26 nuclear protein
1
TTGTATTCTGGAAGCGTGAATTGCTT

(PA26), mRNA/cds = (11, 1668)

TTGAAGTCTGTCAGTATTACTGGT

3153
Table 3A
Hs.326248
NM_014456
7657448
cDNA:FLJ22071 fls, clone
1
TTTGTAAGCGAAGGAGATGGAGGTC

HEP11691/cds = UNKNOWN

GTCTTAAACCAGAGAGCTACTGAAT

3154
Table 3A
Hs.111632
NM_014463
7657314
Lsm3 protein (LSM3),
1
ACTCACAACTTCTTAAGCTAAATGGT

mRNA/cds = (29, 337)

ATTTTCATTTTTCTCAAGCTCTCC

3155
Table 3A
Hs.127011
NM_014464
7857644
tubulointerstitial nephrilis antigen (TIN-
1
AGTTTAGCAATATGACATTCTTGGTG

AG), mRNA/cds = (1, 1431)

ACAGTGGAATCTTTGTCTCTTCAC

3156
Table 3A
Hs.300684
NM_014478
7656976
calcitonin gene-related peptide-
1
GCCACTGACCTTGGCTCACCTTAGAG

receptor component protein (CGRP-

GAATTTCCTCGAGAACAACAGAGA

RCP), mRNA/cds = (61, 507)

3157
literature
Hs.154149
NM_014481
7856891

Homo sapiens, apurinic/apyrimidinic
1
ACTTCTGTCTTTGCTGGAAAGTGTAT

endonuclease (APEX nuclease)-like 2

TTGTGCATAAATAAAGTCTGTGTA

protein, clone MGc:1418

IMAGE:3139156, mRNA, complete

cds/cds = (38, 1594)

3158
Table 3A
Hs.120766
NM_014487
13384595
nucleolar cysteine-rich protein
1
TTCTCTTTCTTCACAATGTATGTCCTC

(HSA6591), mRNA/cds = (173, 1135)

AGTGGTACCTATTATTGATGCCT

3159
Table 3A
Hs.296433
NM_014499
10092632
putative purinergic receptor (P2Y10),
1
CTGTGACCCGCTCCCGCCTCATGAG

mRNA/cds = (0, 1019)

CAAGGAGAGTGGTTCATCAATGATT

3160
Table 3A
Hs.187660
NM_014504
7857495
putative Rab5 GDP/GTP exchange
1
TGTAGGGTAAATGTGACTGGAATACA

factor homologue (RABEX5),
1
CCTTTGGAACGGAATTCTTTATCA

mRNA/cds = (77, 1552)

3161
db mining
Hs.278457
NM_014512
7857276
killer cell immunoglobulin-like
1
AGAACTTCCAAATGCTGAGCCCAGAT

receptor, three domains, short

CCAAAGTTGTCTTCTGTCCACGAG

cytoplasmic tall, 1 (KIR3DS1),

mRNA/cds = (11, 1174)

3162
Table 3A
Hs.239720
NM_014515
7857384
CCR4-NOT transcription complex,
1
TGACAAATTAGAAGAACGGCCTCACC

subunit 2 (CNOT2),

TGCCATCCACCTTCAACTACAACC

mRNA/cds = (115, 1737)

3163
Table 3A
Hs.17667
NM_014521
7657561
SH3-domain binding protein 4
1
TGGATATTTTAACCTGTTAAGTGTGT

(SH3BP4),

GTGTGTTTTCTGTACCCAACCAGA

3164
Table 3A
Hs.275243
NM_014624
9845517
S100 calcium-binding protein A6
1
TAAATAGGGAAGATGGAGACACCTCT

(calcyclin) (S100A6),

GGGGGTCCTCTCTGAGTCAAATCC

mRNA/cds = (102, 374)

3165
Table 3A
Hs.173288
NM_014633
7661949
KIAA0155 gene product (KIAA0155),
1
TGTGTTAGGTTGAATAAGGTGTGGAA

mRNA/cds = (86, 3607)

3166
Table 3A
Hs.170307
NM_014636
7662069
Ral quanine nucleotide exchange
1
GCAGTAACCACTGAACGTCAATCAGC

factor RalGPS1A (RalGPS1A),

CCTCCATGGGGTTCTTTCGATTTT

mRNA/cds = (267, 1940)

3167
Table 3A
Hs.323580
NM_014644
11036643
cDNA FLJ10757 fis, clone
1
GTTTGAAGTTGTGACTCTCCTGCTAC

NT2RP3004578, highly similar to

CAATTAAATAAAGCTTACTTTGCC

mRNA for KIAA0477

protein/cds = UNKNOWN

3168
Table 3A
Hs.166318
NM_014646
7662021
lipin 2 (LPIN2),
1
TGCAAGATGAATGGCTAATATTTTGG

mRNA/cds = (239, 2929)

TGCAGTGTTTGATGTTCAAAACAA

3169
Table 3A
Hs.323712
NM_014664
7662203
KIAA0615 gene product (KIAA0615),
1
CTGCCTGTTCAGAACTGTTTAATAGC

mRNA/cds = (237, 2927)

AGTTACTCTTGAGTGTATTTACCT

3170
Table 3A
Hs.132853
NM_014666
7661967
KIAA0171 gene product (KIAA0171),
1
ATTCTAGAGTTTGGAATGCAAAATTAA

mRNA/cds = (101, 1978)

TTGTTTTACCCTCAAGCTGGGAA

3171
Table 3A
Hs.155291
NM_014670
7661849
KIAA0005 gene product (KIAA0005),
1
TGGGGTGAATTTGTTAAAATGAGTAA

mRNA/cds = (80, 1339)

CTTTGATAAAGTTTTTCATGCACA

3172
Table 3A
Hs.154332
NM_014874
7662001
KIAA0212 gene product (KIAA0212),
1
AAAAGTATAGAGTTGGAAACTCTGGG

mRNA/cds = (58, 2031)

AAAACTTACGGAAATACACAAATG

3173
Table 3A
Hs.151791
NM_014879
7661899
KIAA0092 gene product (KIAA0092),
1
ATGTGTCAACCACCATTTCAGCTATT

mRNA/cds = (53, 1477)

AAAAACTCCTGTTATCTCCTTGTT

3174
Table 3A
Hs.186840
NM_014686
7662075
KIAA0355 gene product (KIAA0355),
1
TACAATGCTTCCAAACTGGAACTCTA

mRNA/cds = (838, 4050)

CATTTTGTATCTTTTAAAGCTCCT

3175
Table 3A
Hs.111894
NM_014713
13518239
lysosomal-associated protein
1
GTGACTTGACTGTGGAAGATGATGGT

transmembrane 4 alpha (LAPTM4A),

TGCATGTTTCTAGTTTGTATATGT

mRNA/cds = (148, 849)

3176
Table 3A
Hs.181418
NM_014730
7661947
KIAA0152 gene product (KIAA0152),
1
CCTTCCATGTCCCACCCCACTCCCAC

mRNA/cds = (128, 1006)

CAAAAAGTACAAAATCAGGATGTT

3177
Table 3A
Hs.81892
NM_014736
7661905
KIAA0101 gene product (KIAA0101),
1
TGGTGTTTGATTATTGGAATGGTGCC

mRNA/cds = (61, 396)

ATATTGTCACTCCTTCTACTTGCT

3178
Table 3A
Hs.80905
NM_014737
7661963
Ras association (RatGDS/AF-6)
1
ACAGGGCCTCAGCAAGGGAGCCATA

domain family 2 (RASSF2),

CATTTTTGTAACATTTTGATATGTT

mRNA/cds = (196, 1176)

3179
Table 3A
Hs.108920
NM_014739
7661957
HT018 mRNA, complete
1
GGCTAAACGATTCTTACTCAGTGTGA

cds/cds = (451, 1179)

TGTATAATGATGCAACAGGGACCC

3180
Table 3A
Hs.79768
NM_014740
7661919
KIAA0111 gene product (KIAA0111),
1
TAATGGGGTTTATATGGACTTTCTTCT

mRNA/cds = (214, 1449)

CATAAATGGCCTGCCGTCTCCCT

3181
Table 3A
Hs.77724
NM_014749
7662189
KIAA0586 gene product (KIAA0586),
1
ATACCTTCTGAACGGGAAGAGACAGC

mRNA/cds = (274, 4875)

CAGCACAGTGTTTATGCCACTGGT

3182
Table 3A
Hs.77685
NM_014752
7661907
KIAA0102 gene product (KIAA0102),
1
TTCCACTAGTATATCCCTGTTGATTTG

mRNA/cds = (307, 678)

TTTGTGCCTTTTATTAACTGCCA

3183
Table 3A
Hs.77329
NM_014754
7662646
phosphatidylserine synthase 1
1
TCATCTGTGCCATGCTCTAGAACCTT

(PTDSS1), mRNA/cds= (102, 1523)

GACCTTGATAGTTCACCACGTCTG

3184
Table 3A
Hs.76988
NM_014757
13376996
mastermind (drosophila)-like 1
1
ACTGCCCTTAACTCTGGTATACACCA

(MAML1), mRNA/cds = (263, 3313)

AAAAGAAATCTTTACTTTCCTTGT

3185
Table 3A
Hs.75824
NM_014761
7661971
KIAA0174 gene product (KIAA0174),
1
AGGCAGCCTTTCTTTAATGTTTTCAGT

mRNA/cds = (63, 1157)

TGGTTTGTATTTTGTAGCTCAGT

3186
Table 3A
Hs.75574
NM_014763
7661911
mitochondrial ribosomal protein L19
1
CCAGAATGGTCTTTAATGAGCATGGA

(MRPL19), mRNA/cds = (34, 876)

ACCTGAGCAAAGGGAATAGGTGGG

3187
Table 3A
Hs.75416
NM_014764
7661885
DAZ associated protein 2 (DAZAP2),
1
TCTCTCTCTACACTGTGGTGCACTTA

mRNA/cds = (69, 575)

ACTTGTGGAATTTTTATACTAAAA

3188
Table 3A
Hs.74583
NM_014767
7662035
KIAA0275 gene product (KIAA0275),
1
ACTCAGCCTAAGGAAACAAGTACACT

mRNA/cds = (316, 1590)

CCACACATGCATAAAGGAAATCAA

3189
Table 3A
Hs.52528
NM_014779
7662235
KIAA0669 gene product (KIAA0669),
1
TGTCAAATAAAAGAGAACGAACAGGT

mRNA/cds = (1016, 3358)

AGTTTGGTGGAGCTGAGCTAGTGT

3190
Table 3A
Hs.28020
NM_014805
7662293
KIAA0766 gene product (KIAA0766),
1
TTTGCATCATGTAGTCATTGAGTGAG

mRNA/cds = (116, 1939)

GGGGAGATATAAGCCAAGGATTTT

3191
Table 3A
Hs.23488
NM_014814
7661913
KIAA0107 gene product (KIAA0107),
1
GCTTACTTCACAATGTGCCCAGGTCA

mRNA/cds = (25, 1194)

GCTGTATAAAATAAATACTGCATT

3192
Table 3A
Hs.279849
NM_014819
7662123
KIAA0438 gene product (KIAA0438),
1
TGTAATGGTTGGTTTATTGTTCTATAA

mRNA/cds = (117, 2243)

CCCCAGCCCATCATTTTCTGTGT

3193
Table 3A
Hs.17969
NM_014827
7662231
KIAA0663 gene product (KIAA0663),
1
AGTCAATGTTTCGTGTTCCGCATTATT

mRNA/cds = (213, 2645)

TGAACCATTTGCCCTTACAGAAA

3194
Table 3A
Hs.194035
NM_014828
7662273
KIAA0737 gene product (KIAA0737),
1
AGGGAGCAGTGCTTTTGGGTCCTAG

mRNA/cds = (32, 1897)

AACCTGTTGAGTTTCTAATGAATAT

3195
Table 3A
Hs.173802
NM_014832
7662197
KIAA0603 gene product (KIAA0603),
1
AATGACTTGTTATAGCTCAGTGTGCC

mRNA/cds = (347, 4246)

CTTGAATCCATACAGTTTCTTAAA

3196
Table 3A
Hs.15087
NM_014837
7662023
KIAA0250 gene product (KIAA0250),
1
TGTTTTGTTTTCTGGGTTTTGTTTTTT

GTTTTTGTCTGTGCAAGACCTGC

3197
Table 3A
Hs.7764
NM_014851
7662139
KIAA0469 gene product (KIAA0469),
1
GGCTTCCATGTCCAGAATCCTGCTTA

mRNA/cds = (184, 1803)

AGGTTTTAGGGTACCTTCAGTACT

3198
Table 3A
Hs.6684
NM_014858
7662151
KIAA0476 gene product (KIAA0476),
1
CCTGACCTGTGCAATAAGGATTGTTC

mRNA/cds = (588, 4728)

CCTGCGAAGTTTTGTTGGATGTAA

3199
Table 3A
Hs.8338
NM_014859
7662241
KIAA0672 gene product (KIAA0672),
1
GAGTCTGGGGTAAGGGTGGGGGTTG

mRNA/cds = (300, 2756)

AAAGTTGTTATCTTTAAATACATGT

3200
Table 3A
Hs.5737
NM_014864
7662149
KIAA0475 gene product (KIAA0475),
1
TTGATCTGCCAAGGATTTCCTCTCAG

mRNA/cds = (336, 1585)

AGCTGTTGCACAGACAGAGATTGT

3201
Table 3A
Hs.5094
NM_014868
7662652
ring finger protein 10 (RNF10),
1
GGGGGTTTCCACAATGTGAGGGGGA

mRNA/cds = (698, 2983)

ACCAAGAAAATTTTAAATACAGTGT

3202
Table 3A
Hs.273397
NM_014871
7662257
KIAA0710 gene product (KIAA0710),
1
TGCCTGTCCCAAGTTTTGTTCCATTTT

mRNA/cds = (203, 3550)

TTAAAAATTTGTTGTAAACTGCA

3203
Table 3A
Hs.3085
NM_014877
7661883
helicase KIAA0054 (KIAA0054),
1
TATTGTTACATATGTTTGCATCAAGCT

mRNA/cds = (145, 5973)

AGCAGCCAAGAGGTTAATTGTGC

3204
Table 3A
Hs.1528
NM_014882
7661881
KIAA0053 gene product (KIAA0053),
1
AAACCAGAACAAGCAACAAACTGTAT

mRNA/cds = (193, 2109)

TTATGCAAGCAAAATTGATGAGAA

3205
Table 3A
Hs.8170
NM_014886
7662676
hypothetical protein (YR-29),
1
TGATGTTTCTGAATACTACCAAACAG

mRNA/cds = (82, 864)

CCATACATGTCTGCAATGAAGAGA

3206
Table 3A
Hs.23518
NM_014887
7656970
hypothetical protein from BCRA2
1
TATCATCCTCCTTCTCAACCCATCTC

region (CG005),

CCTAACCCCACATGCTTGCCAGTT

mRNA/cds = (165, 1916)

3207
Table 3A
Hs.239189
NM_014905
7662327
glutaminase (GLS),
1
TTCTGAAATTGGGAAACATTTATTTTA

mRNA/cds = (19, 2028)

AATGCAATCAGGTAGTGTTGCTT

3208
Table 3A
Hs.131915
NM_014913
7662345
KIAA0863 protein (KIAA0863),
1
GACTGAATTTGACATCTGGTATGCTG

mRNA/cds = (185, 3580)

GTATGTAGCTCAGACATCAAGAGT

3209
Table 3A
Hs.110488
NM_014918
7662433
KIAA0990 protein (KIAA0990),
1
TTGTACTTTTCAGAACCATTTTGTCTC

mRNA/cds = (494, 2902)

ATTATTCCTGTTTTAGCTGAAGA

3210
Table 3A
Hs.104305
NM_014922
14719827
death effector filament-forming Cad-4
1
CTGGCTGTGTCACAGGGTGAGCCCC

like apoptosis protein (DEFCAP),

AAAATTGGGGTTCAGCGTGGGAGGC

transcript variant B,

mRNA/cds = (522, 4811)

3211
Table 3A
Hs.211576
NM_005546
5031810
IL2-inducible T-cell kinase (ITK),
1
AATGGTCCCCTGTGTTTGTAGAGAAC

mRNA/cds = (2021, 3883)

TCCCTTATACAGAGTTTTGGTTCT

3212
Table 3A
Hs.70266
NM_014933
7662389
yeast Sec31p homolog (KIAA0905),
1
TTCTTTCATGTCCTCCCTACTTCCTCA

mRNA/cds = (53, 3715)

GTGTCAATCAGATTAAAGTGTGT

3213
Table 3A
Hs.42959
NM_014939
7662447
KIAA1012 protein (KIAA1012),
1
TTTGAACTTTGGTCATAGAGTCTTCAT

mRNA/cds = (57, 4364)

ATTTCAGTATTTGGTGGTCCCTA

3214
Table 3A
Hs.24083
NM_014950
7662437
KIAA0997 protein (KIAA0997),
1
ACCCTAGAGTTACTCTCTTTTGGGAA

mRNA/cds = (282, 2196)

CATAAGGAGGTATACAGAACTGCA

3215
Table 3A
Hs.323346
NM_014953
7662443
KIAA1008 protein (KIAA1008),
1
TTGATGTGTCACAAAACATTACTCATT

mRNA/cds = (93, 2879)

TGATTTCCCCCACCCCCGCCAAC

3216
Table 3A
Hs.10031
NM_014959
7662403
KIAA0955 protein (KIAA0955),
1
TCAGGGCGTTTGAATGTGAATTAGGA

mRNA/cds = (313, 1608)

CCAGCGCAATGAATGCTCAAGTTG

3217
Table 3A
Hs.227133
NM_014977
7662237
KIAA0670 protein/acinus (KIAA0670),
1
AGTTCCCAGTCTCTTCTGTCCTGCAG

mRNA/cds = (327, 4352)

CCCTTGCCTCTTTCCCACAGGTTC

3218
Table 3A
Hs.184827
NM_014999
7661921
KIAA0118 protein (KIAA0118),
1
GTAGAATCAGGCACTGCTCGCAGAA

mRNA/cds = (255, 932)

GGAACACAGATTGTAGAGATTAACA

3219
Table 3A
Hs.184245
NM_015001
14790189
SMART/HDAC1 associated repressor
1
TTTTCTCAGCGCAGTTTTGTTTTGTGT

protein (SHARP),

GTCCATTGGATTACAAACTTTAT

mRNA/cds = (204, 11198)

3220
Table 3A
Hs.151411
NM_015057
7662379
KIAA0916 protein (KIAA0916),
1
TGCCTCATTATCTTGCAGCTGTAAAC

mRNA/cds = (146, 14071)

ATATTGGAATGTACATGTCAATAA

3221
Table 3A
Hs.132942
NM_015071
7662207
GTPase regulator associated with the
1
GCCATAGCCTGAATCTTTTAGGGGTA

focal adhesion kinase pp125(FAK);

TTAAGGTCAGCCTCTCACTCTTCC

KIAA0621 protein (KIAA0621),

mRNA/cds = (423, 2667)

3222
Table 3A
Hs.306117
NM_015125
11056033
capicua protein (CIC) mRNA,
1
AGCCGCCTTCCAGGCCCGCTATGCA

complete cds/cds = (40, 4866)

GACATCTTTCCCTCCAAGGTTTGTC

3223
Table 3A
Hs.79337
NM_015148
8923825
KIAA0135 protein (KIAA0135),
1
AGCAGCTTTCTTCAAGTCGCTCTTTA

mRNA/cds = (1803, 3791)

GCCCTTTGTGGTTAATCTCTCAGT

3224
Table 3A
Hs.11000
NM_015344
7662509
MY047 protein (MY047)
1
TGCACTGATACAACATTACCATTCTTC

mRNA/cds = (84, 479)

TATGGAAAGAAAACTTTTGATGA

3225
Table 3A
Hs.287586
NM_015384
7661841
cDNA FLJ13648 fls, clone
1
ATAGAGGAGGAGGCACTTCAGGGGT

PLACE1011340, weakly similar to

GAGGCGGAGGAGGAGTCAACGTATT

IDN3-B mRNA/cds = UNKNOWN

3226
Table 3A
Hs.105460
NM_015393
7661631
DKFZP564O0823 protein
1
ATACCCACACAGCAACTGGTCCACTG

(DKFZP564O0823),

CTTTACTGTCTGTTGGATAATGGC

mRNA/cds = (170, 904)

3227
Table 3A
Hs.99843
NM_015400
7661691
DKFZP586N0721 protein
1
AGATTTGTGTCCTCTCATTCCCTCTCT

(DKFZP586N0721),

TCCTCTTGTAAGTGCCCTTCTAA

mRNA/cds = (726, 1151)

3228
Table 3A
Hs.75884
NM_015416
7661659
DKFZP588A011 protein
1
GCACTGTTTTTAAACCCAAGTAAAGA

(DKFZP586A011),

CTGCTTGAAACCTGTTGATGGAAA

mRNA/cds = (330, 832)

3229
Table 3A
Hs.64595
NM_015423
7661649
aminoadipate-semlaldehyde
1
AGATTTCCCCTCAGTTTCCATTGACTT

dehydrogenase-phosphopantetheinyl

AGATCAGGTTACAGAGAAAGGCA

transferase (AASDHPPT),

mRNA/cds = (166, 1095)

3230
Table 3A
Hs.48320
NM_015435
13491169
mRNA for ring-IBR-ring domain
1
AGATCGAGATCTTCAGTCCTCTGCTT

containing protein Dorfin, complete

CATCTGTGAGCTTGCCTTCAGTCA

cds/cds = (317, 2833)

3231
Table 3A
Hs.12305
NM_015509
7661639
DKFZP566B183 protein
1
AGTGACTAAATACTGGGAACCTATTT

(DKFZP566B183),

TCTCAATCTTCCTCCATGTTGTGT

mRNA/cds = (351, 749)

3232
Table 3A
Hs.6880
NM_015530
7661569
DKFZP434D156 protein
1
TGGCACTCTGTGGCTCCTTGTAGTAT

(DKFZP434D156),

TATAGCTATACTGGGAAAGCATAG

mRNA/cds = (230, 1384)

3233
Table 3A
Hs.187991
NM_015626
7661595
DKFZP564A122 protein
1
TTGGTGAGTTGCCAAAGAAGCAATAC

(DKFZP564A122),

AGCATATCTGCTTTTGCCTTCTGT

mRNA/cds = (2570, 2908)

3234
Table 3A
Hs.156764
NM_015646
7661677
RAP1B, member of RAS oncogene
1
AATTGACCAACCTAATGTTACAACTA

family (RAP1B),

CTTTGAGGTGGCCAAATGTAAACT

mRNA/cds = (148, 702)

3235
Table 3A
Hs.44563
NM_015697
7661549

Homo sapiens, Similar to RIKEN
1
CTACTACGCTGCCCTGGGTGCTGTA

cDNA 2310002F18 gene, clone

GGAGCCCATCTGACTCACCAGAAAT

MGC:10413 IMAGE:3954787,

mRNA/cds = (16, 1131)

3236
Table 3A
Hs.5324
NM_015702
7661547
hypothetical protein (CL25022),
1
AAGGCCTCAGTTTTAATTATTTTCTTC

mRNA/cds = (157, 1047)

CCAAAATAAATCACACATTTGGT

3237
Table 3A
Hs.110707
NM_015726
7657147
H326 (H326), mRNA/cds = (176, 1969)
1
GGTGGGGTGATAGGGTGGGCTAAAA

ACCATGCACTCTGGAATTTGTTGTA

3238
Table 3A
Hs.25674
NM_015832
7710144
methyl-CpG binding domain protein 2
1
AGAGGCAGCTTCTAGACAGAGTTGCT

(MBD2), transcript variant testis-

TAATGAAAGGGTTTGTAATACTTT

specific, mRNA/cds = (229, 1137)

3239
Table 3A
Hs.278573
NM_015874
7706215
H-2K binding factor-2 (LOC51580),
1
GCTCAGTTCCATATTTCATCCGTGAA

mRNA/cds = (238, 1500)

AAACTTGCAATACGAGCAGTTTCA

3240
Table 3A
Hs.104640
NM_015898
7705374
HIV-1 inducer of short transcripts
1
CAACGGCCAGGAGAAGCACTTTAAG

binding protien (FBI1),

GACGAGGACGAGGACGAGGACGTGG

mRNA/cds = (0, 1754)

3241
Table 3A
Hs.287414
NM_015906
7706235
transcriptional intermediary factor 1
1
ATACAGCCCCGGCAGAAAACGCCTA

gamma (TIF1GAMMA), transcript

AAGTCAGATGAGAGACCAGTACATA

variant alpha, mRNA/cds = (84, 3467)

3242
Table 3A
Hs.145956
NM_015919
7706241
zinc finger protein mRNA, complete
1
ACCAGAAACTTCAAATGTGTCACAAA

cds/cds = (1073, 3133)

AGATGAGCAGAACTATCCCGAGGT

3243
Table 3A
Hs.279813
NM_015932
7705428
hypothetical protein (HSPC014),
1
AAAGCGAAGTCATGGGAGAGCCACA

mRNA/cds = (82, 507)

CTTGATGGTGGAATATAAACTTGGT

3244
Table 3A
Hs.171774
NM_015933
7705430
hypothetical protein (HSPC016),
1
TCCCTGCCATAACATCTTTTGCCACG

mRNA/cds = (38, 232)

TATAGCTGGAATTAAGTGTTGTCT

3245
Table 3A
Hs.119908
NM_015934
7706253
nucleolar protein NOP5/NOP58
1
CTGGTGACTCCACACTTCCAACCTGC

(NOP5/NOP58), mRNA/cds = (0, 1589)

TCTAAAAAACGCAAAATAGAACAG

3246
Table 3A
Hs.84038
NM_015937
7706257
CGI-06 protein (LOC51604),
1
TGTGTAGTGGATGGAGTTTACTGTTT

mRNA/cds = (6, 1730)

GTGGAATAAAAACGGCTGTTTCCG

3247
Table 3A
Hs.5798
NM_015946
7705599
pelota (Drosophila) homolog (PELO),
1
ACAGGGATTTCTTATGTCTTTGGCTA

mRNA/cds = (259, 1416)

CACTAGATATTTTGTGATTGGCAA

3248
Table 3A
Hs.7236
NM_015953
7705715
eNOS interacting protein (LOC51070),
1
AGGCCTGAGTGTGTGCGGGAGACCA

mRNA/cds = (44, 949)

AATAAACCGGCTTGGGTGCGCAAAA

3249
Table 3A
Hs.7104
NM_015995
7706289
mRNA; cDNA DKFZp761P06121
1
AAGAAAGAAGAGAGAGAACTTG

(from clone

ATGCCAAGTCCACGAAAAAACAA

DKFZp781P06121)/cds = UNKNOWN

TTTTT

3250
Table 3A
Hs.6153
NM_016001
7705764
CGI-48 protein (LOC51096),
1
GATCCAGCTGTGCTTAAGAGCCAGTA

mRNA/cds = (107, 1872)

ATGTCTTAATAAACATGTGGCAGC

3251
Table 3A
Hs.7194
NM_016007
7706297
CGI-74 protein
1
AAGCACTTGTTTTATTTTGTGTGTGGA

GTATAAAGGCTACACCCTTATTG

3252
Table 3A
Hs.318725
NM_016018
7705782
CGI-72 protein (LOC51105),
1
CCTTTTTCTACAGAATCATCAGGCAT

mRNA/cds = (69, 1400)

GGGTAAGGTGGCTAACGCTGAGAT

3253
Table 3A
Hs.110803
NM_016039
7706321
CGI-99 protein (LOC51637),
1
TGGGTATGTTCTAGAGATTTACCACC

mRNA/cds = (161, 895)

ATTGCTTATTGCTTTTTTCTTTAA

3254
Table 3A
Hs.286131
NM_016041
7705603
CGI-101 protein (LOC51009),
1
TCTTCTTGATAGATGAGGCCATGGTG

mRNA/cds = (6, 635)

TAAATGGAAGTTTCAGAGAGGACA

3255
Table 3A
Hs.271614
NM_016049
7705615
CGI-112 protein (LOC51016),
1
GTGGGTTGGTCCCACTAATGGAAATG

mRNA/cds = (158, 784)

GAAATGCCTGAGCCAGGCCAGCGG

3256
Table 3A
Hs.283670
NM_016058
7706334
CGI-119 protein (LOC51643),
1
AATCTATTCCTGCACCTGTTACGGTT

mRNA/cds = (0, 776)

TCTGGAAGCAGTTAATAAAAAGTA

3257
Table 3A
Hs.181271
NM_016057
7708338
CGI-120 protein (LOC51644),
1
GCATGGAGTCAGGAGAAAACCACCTT

mRNA/cds = (37, 570)

CATAAACTGCTCTGTGCAAAGAGG

3258
Table 3A
Hs.27693
NM_016059
7706338
peptidylprolyl isomerase (cyclophilin)-
1
ACAAATGCCCCTGTTTATCAATAGGT

like 1 (PPIL1), mRNA/cds = (227, 727)

GACTACTTACTACACATGGAACCA

3259
Table 3A
Hs.184542
NM_016061
7706340
CGI-127 protein (LOC51646),
1
TGATTATATGCAGATTCCTAGTAGCA

mRNA/cds = (125, 490)

TGCCTTACCTACAGCACTATGTGC

3260
Table 3A
Hs.32826
NM_016063
7705623
CGI-130 protein (LOC51020),
1
GGTCATTGAGCCTCAGGTAGGGAATA

mRNA/cds = (63, 575)

TATCAACCCGATTTCTTCCTCTCT

3261
Table 3A
Hs.5887
NM_016090
9994184
RNA binding motif protein 7 (RBM7),
1
TTTCAAAGTGCCCAGACTGTGTACAA

mRNA/cds = (21, 821)

AGACACATGTAATGGAGATTGTAC

3262
Table 3A
Hs.119503
NM_016091
7705432
HSPC025 (HSPC025),
1
AGGACCGAAGTGTTTCAAGTGGATCT

mRNA/cds = (33, 1727)

CAGTAAAGGATCTTTGGAGCCAGA

3263
Table 3A
Hs.7953
NM_016099
7705820
HSPC041 protein (LOC51125),
1
AGTTTCACTGTCAGAGATATTGTAGG

mRNA/cds = (141, 455)

TGCTAATACTGGATTTCGTCTCAG

3264
Table 3A
Hs.27023
NM_016108
7706370
vesicle transport-related protein
1
AGTTAGAAGAGCAATATGTTTCCTTC

(RA410), mRNA/cds = (7, 1929)

TCTGTAACAGTGTCCTAACAGTGA

3265
db mining
Hs.306603
NM_016115
7705830
cDNA FLJ11517 fis, clone
1
AGCTGCCACTTCCCAGAAGCCTACAT

HEMBA 1002337/cds = UNKNOWN

AATTATTTGCTCTATGAAGACGTT

3266
Table 3A
Hs.142295
NM_016123
7705840
putative protein kinase NY-REN-64
1
GCCACTAATAACATTGGGCTAATATC

antigen (LOC51135),

TGCTGTGCTTCTCTGACAGGTAGT

mRNA/cds = (49, 1431)

3267
Table 3A
Hs.279921
NM_016127
7706384
HSPC035 protein (LOC51669),
1
AGCATGCAGTTCTCTGTGAAATCTCA

mRNA/cds = (18, 1035)

AATATTGTTGTAATAGTCTGTTTC

3268
Table 3A
Hs.102950
NM_016128
11559928
coat protein gamma-cop (LOC51137),
1
TGAATCTATCCCCCAAGAAACCATCT

mRNA/cds = (15, 2639)

TATCCCTGTAATAAATCAGCATGT

3269
Table 3A
Hs.272398
NM_016135
7706730
transcription factor ets (TEL2),
1
GTGCTTCCAGGCGGCACTGACAGCC

mRNA/cds = (75, 1100)

TCAGTAACAATAAAAACAATGGTAG

3270
Table 3A
Hs.108969
NM_016145
7706664
PTD008 protein (PTD008),
1
GTCCATGTTTCTAGGGGTATTCATTT

mRNA/cds = (233, 553)

GCTTTCTCGTTGAAACCTGTTGTT

3271
Table 3A
Hs.279901
NM_016146
7706666
PTD009 protein (PTD009),
1
TAGGTCCATAAATGTTGTAATAAATAT

mRNA/cds = (257, 916)

TCCTTTGATCTTGGTGTTTGCGT

3272
Table 3A
Hs.306706
NM_016154
7706872
cDNA:FLJ21192 fls, clone COL00107,
1
GCTAGTACCTGTTATTTATTACCTGG

highly similar to AF165522 ras-related

AGGCCTGTCCAGCACCCACCCTAC

GTP-binding protein 4b (RAB4B)

mRNA/cds = UNKNOWN

3273
Table 3A
Hs.279518
NM_016160
4502146
amytoid beta (AF) precursor-like
1
CCCACTATGCACAGATTAAACTTCAC

protein 2 (APLP2),

CTACAAACTCCTTAATATGATCTG

mRNA/cds = (72, 2363)

3274
Table 3A
Hs.75251
NM_016166
7706636
DEAD/H (Asp—Glu—Ala—Asp/His)
1
TGTGCTCTGTTTTACCTTACTCTGTTT

box binding protein 1 (DDXBP1),

AGAAAAGTATACAAGCGTGTTTT

mRNA/cds = (96, 2051)

3275
Table 3A
Hs.241578
NM_018200
7706424
U6 snRNA-associated Sm-like protein
1
TGAGTGTGTCTCTGGATTTTGACCCC

LSm8 (LOC51691),

TTATTGATTCATTGTAATATGTAA

mRNA/cds = (82, 372)

3276
literature
Hs.135756
NM_016218
7705343
polymerase (DNA-directed) kappa
1
ACATTTGTAAGGGCTCTCAAAGATTC

(POLK), mRNA/cds = (172, 2784)

ACACATGCCTATATTATCATAAGA

3277
Table 3A
Hs.7905
NM_016224
7706705
SH3 and PX domain-containing protein
1
TCCGCATCCATTATTTAAACCAGTGG

SH3PX1 (SH3PX1),

AAATTGTCTCTATTTTTGGAAAGT

mRNA/cds = (43, 1830)

3278
Table 3A
Hs.108636
NM_016227
7705321
membrane protein CH1 (CH1),
1
ACGGAGCTGTAGTGCCATTAGAAACT

mRNA/cds = (124, 4341)

GTGAATTTCCAAATAAATCTGAAC

3279
Table 3A
Hs.5741
NM_016230
7705898
flavohemoprotein b5 + b5R
1
AGCCTTCAGTTTCTTAAATGAAATCAA

(LOC51167), mRNA/cds = (6, 1469)

ATGTTCCTTCAGTACAGGTAACT

3280
Table 3A
Hs.127561
NM_016239
7705900
myosin XVA (MYO15A),
1
CCAGACCCCCATCACTTGATGGGCC

mRNA/cds = (338, 10930)

ACACAAGTTTGAGAGTGGTACAAGG

3281
Table 3A
Hs.250646
NM_016252
10442821
baculovairl Iap repeat-containing 6
1
TCAGGTTAAACCCAGCAGCAGCAAAG

(BIRC6), mRNA/cds = (0, 14489)

AACTCCCCAGTGACTTCCAGTTAT

3282
Table 3A
Hs.107740
NM_016270
7706468
Kruppel-like factor (LOC51713),
1
GGTGGGCATTTTTGGGCTACCTGGTT

mRNA/cds = (84, 1151)

CGTTTTTATAAGATTTTGCTGGGT

3283
Table 3A
Hs.8148
NM_016275
7706470
selenoprotein T (LOC51714),
1
AGTGCAATAATACTGTATAGCTTTCC

mRNA/cds = (138, 629)

CCCACCTCCCACAAAATCACCCAG

3284
Table 3A
Hs.279588
NM_018283
7706211
adrenal gland protein AD-004
1
AATCATGTTGCAGAACCAGCAGGTGG

(LOC51578), mRNA/cds = (341, 859)

ATAGTATATAGGTTTATGCCTGGG

3285
Table 3A
Hs.6406
NM_016289
7706480
MO25 protein (LOC51719),
1
GGTGCAGCGTGTCAGACACAACATTC

mRNA/cds = (53, 1078)

ATGTTACTCTTACATTGGAATCTG

3286
literature
Hs.182366
NM_016292
7706484
heat shock protein 75 (TRAP1),
1
GGACTGACACCACAGATGACAGCCC

mRNA/cds = (4, 2118)

CACCTCCTTGAGCTTTATTTACCTA

3287
Table 3A
Hs.14770
NM_016293
7706486
bridging integrator 2 (BIN2),
1
ACGACCCATTTTGCAAGACTTAAAGC

mRNA/cds = (38, 1735)

CGGAAGAACACATTTTCAGATTGT

3288
Table 3A
Hs.284164
NM_016301
9994188
protein x 0004 (LOC51184),
1
AGGAATTACTGTAACAAAATATGTAT

mRNA/cds = (31, 885)

GTCCGAAGGGAAAAAGCTGCAAGG

3289
Table 3A
Hs.102897
NM_016302
10047097
CGI-47 protein (LOC51095),
1
TCCTGTGGAATCTGATATGTCTGGTA

mRNA/cds = (131, 1348)

GCATGTCATTGATGGGACATGAAG

3290
Table 3A
Hs.284162
NM_016304
10047101
60S ribosomal protein L30 isolog
1
ATGGCACTAGGCAGCATTTGTATAGT

(LOC51187), mRNA/cds = (143, 634)

AACTAATGGCAAAAATTCATGGCT

3291
Table 3A
Hs.334811
NM_016312
7706500
Npw38-binding protien NpwBP
1
ATTTGATTAAAATTATTTCCCACTGAC

(LOC51729), mRNA/cds = (143, 2066)

CTAAACTTTCAGTGATTTGTGGG

3292
literature
Hs.110347
NM_016316
7706880
REV1 (yeast homolog)-like (REV1L),
1
AAAGCAAGTGTTTTGTACATTTCTTTT

mRNA/cds = (212, 3967)

CAAAAAGTGCCAAATTTGTCAGT

3293
Table 3A
Hs.83761
NM_016325
7706506
zinc finger protein 274 (ZNF274),
1
AATCTGCACTGATATTACATCCACAG

mRNA/cds = (401, 2266)

TACCACAGTATTTATGTGTATGAA

3294
Table 3A
Hs.16085
NM_016334
7706703
putative G-protein coupled receptor
1
ATGGTAGCTGAGCCAAACACGTAGG

(SH120), mRNA/cds = (103, 1470)

ATTTCCGTTTTAAGGTTCACATGGA

3295
Table 3A
Hs.279918
NM_016391
7705450
hypothetical protein (HSPC111),
1
AAGCCAGAACCTGCTGTTTTCAGGGT

mRNA/cds = (62, 598)

GGGTGATGTAAATATAGTGTGTAC

3296
Table 3A
Hs.239720
NM_016398
7705464
CCR4-NOT transcription complex,
1
TGACAAATTAGAAGAACGGCCTCACC

subunit 2 (CNOT2),

TGCCATCCACCTTCAACTACAACC

mRNA/cds = (115, 1737)

3297
Table 3A
Hs.334788
NM_016406
7705480
hypothetical protein FLJ14639
1
TCTTTCTGGTTTCTGGAGATAACCCA

(FLJ14639), mRNA/cds = (273, 689)

TCAATAAAAGCTGCTTCCTCTGGT

3298
Table 3A
Hs.98289
NM_016440
7705992
VRK3 for vaccine related kinase 3
1
GGGACCCCTCCTACCCTTGACTCCTC

(LOC51231), mRNA/cds = (118, 1542)

TGTGCTTTGGTAATAAATTGTTTT

3299
Table 3A
Hs.3059
NM_016451
7705368
coatomer protein complex, subunit
1
GTTCTGAATGCTGTCCTCAAAGTATA

beta (COPB), mRNA/cds = (178, 3039)

TAATGTTTCATGTACCAAGACCCT

3300
Table 3A
Hs.172918
NM_016466
7706006
hypothetical protein (LOC51239),
1
GACATCTGCTCCCTCCTCCTGCAACA

mRNA/cds = (0, 527)

CAGCCCAGCCCTGAAGGCCATCCG

3301
Table 3A
Hs.171566
NM_016468
7706010
hypothetical protein (LOC51241),
1
TGGGAAGATCCTGACCTCCTCCAAG

mRNA/cds = (0, 320)

GAAGAAATCCAGAAAGCCTTAAGAC

3302
Table 3A
Hs.75798
NM_016470
7705508
hypothetical protein (HSPC207),
1
AGCCAGTGATCTCTCTGACTTTCAAT

mRNA/cds = (0, 620)

CAGTTTCCAAGCTTAACCAGGGCA

3303
Table 3A
Hs.55847
NM_016497
7706044
hypothetical protein (LOC51258),
1
AAACGCATCCGCTATCTCTACAAACA

mRNA/cds = (0, 386)

CTTTAACCGACATGGGAAGTTTCG

3304
Table 3A
Hs.278429
NM_016520
7706556
hepatocellular carcinoma-associated
1
TCCTCCAGCTGACAGAAAAATCCAGG

antigen 59 (LOC51759),

ATGAGATCAGAAGGATACTGGTGT

mRNA/cds = (27, 896)

3305
Table 3A
Hs.183125
NM_016523
7705573
killer cell lectin-like receptor subfamily
1
TTCCAGGCTTTTGCTACTCTTCACTC

F, member 1 (KLRF1),

AGCTACAATAAACATCCTGAATGT

mRNA/cds = (64, 759)

3306
Table 3A
Hs.75425
NM_016525
8394498
ubiquitin associated protein (UBAP),
1
ACACCTAGTCATAGAAATCAGTCTCT

mRNA/cds = (172, 1680)

CTGGTTTGTTTTGTATTATGTTGT

3307
Table 3A
Hs.239208
NM_016533
7706622
ninjurin 2 (NINJ2),
1
CACTGCTTCCTTCTGCTCCAGGCCTC

mRNA/cds = (56, 484)

AATTTTCCCTTCTTGTAAAATGGA

3308
Table 3A
Hs.10071
NM_016551
7706574
seven transmembrane protein
1
ACTTTCGGAGGGAGTTTATTATTGAG

TM7SF3 (TM7SF3),

TCTTTATCTGTGACAGTATTTGGA

mRNA/cds = (37, 1749)

3309
Table 3A
Hs.179152
NM_018582
7706092
toll-like receptor 7 (LOC51264),
1
ATAGAGAGGTAATTAAATTGCTGGAG

mRNA/cds = (135, 3284)

CCAACTATTTCACAACTTCTGTAA

3310
Table 3A
Hs.18552
NM_016565
7706098
E2IG2 protein (LOC51287),
1
GTTCCACCAGTATTTACCAGGAAAAC

mRNA/cds = (131, 421)

AAAGAATGTGTTAAGGGATGCTCC

3311
Table 3A
Hs.267182
NM_016569
7706728
T-box 3 (ulnar mammary syndrome)
1
TGCTATTTCCTATTTTCACCAAAATTG

(TBX3), mRNA/cds = (116, 1908)

GGGAAGGAGTGCCACTTTCCAGC

3312
Table 3A
Hs.14896
NM_016598
7706132
DHHC1 protein (LOC51304),
1
TGCTGCCACTTTTCAATTCTGTCAGT

mRNA/cds = (214, 1197)

GCTTCCACATGGAAACAAAATGCA

3313
Table 3A
Hs.24125
NM_016604
7706598
putative zinc finger protein
1
TCACTTTCTGTATTTTAATTTTGTTGA

(LOC51780), mRNA/cds = (744, 4997)

AGGGCTGATTGGGATTTCCATGT

3314
Table 3A
Hs.46847
NM_016614
7705261
TRAF and TNF receptor-associated
1
GCATGAAGAGACATAGCCTTTTAGTT

protein (AD022),

TTGCTAATTGTGAAATGGAAATGC

mRNA/cds = (16, 1104)

3315
Table 3A
Hs.107139
NM_016619
7706157
hypothetical protein (LOC51316),
1
TGTTGTCCCTGAACTTAGCTAAATGG

mRNA/cds = (101, 448)

TGCAACTTAGTTTCTCCTTGCTTT

3316
db mining
Hs.106826
NM_016621
7706159
cDNA FLJ13196 fis, clone
1
TCATAGTGTCAGTGAGGTCCCGTGAG

NT2RP3004426, weakly similar to

TCTTTGTGAGTCCTTGTGTCATCG

CHROMODOMAIN

HELICASE-DNA-BINDING

PROTEIN 4/cds = (385, 2289)

3317
Table 3A
Hs.92918
NM_016623
7705303
hypothetical protien (BM-009),
1
GTGCGTAGAATATTACGTATGCATGT

mRNA/cds = (385, 1047)

TCATGTCTAAAGAATGGCTGTTGA

3318
Table 3A
Hs.70333
NM_016628
7706169
mRNA for KIAA1844 protein, partial
1
CGTGGTTGTGGGAGGGGAAAGAGGA

cds/cds = (0, 1105)

AACAGAGCTAGTCAGATGTGAATTG

3319
Table 3A
Hs.71475
NM_016630
13699804
acid cluster protein 33 (ACP33),
1
GGACATTGGTTATTTTATGCTTTCTTG

mRNA/cds = (176, 1102)

GATATAACCATGATCAGAGTGCC

3320
Table 3A
Hs.278027
NM_016733
8051617
LIM domain kinase 2 (LIMK2),
1
GCAAGTGTAGGAGTGGTGGGCCTGA

transcript variant 2b,

ACTGGGCCATTGATCAGACTAAATA

mRNA/cds = (315, 2168)

3321
literature
Hs.342801
NM_018734
9951919
paired box gene 5 (B-cell lineage
1
AATCAGAAGAGCCTGGAAAAAG

specific activator protein) (PAX5),

ACCTAGCCCAACTTCCCTTGTGGG

mRNA/cds = (448, 1623)

AAAC

3322
Table 3A
Hs.324470
NM_016824
9943847
adducin 3 (gamma) (ADD3), transcript
1
TCAACAAAGGGGATTTTGTACACATA

variant 1, mRNA/cds = (31, 2151)

ACATGGGTTATTTAGTTTAACTCT

3323
Table 3A
Hs.77273
NM_016936
9055373
ras homolog gene family, member A
1
CTTTTGTGCAGCGACTATGTTGGTGT

(ARHA), mRNA/cds = (151, 732)

TAGGGGTGGTGTGGAGATTGTTAA

3324
Table 3A
Hs.159565
NM_018952
8393083
surface glycoprotein, lg superfamily
1
ATTTATGCCTTAAATGTTTTCTTCCCC

member (CDO), mRNA/cds = (0, 3722)

ATTCCTTCCTCCCCCTCGGTAGG

3325
Table 3A
Hs.9082
NM_017426
8393857
nuceloporin p54 (NUP54),
1
TTTGTATTTGTGAACTCATCTGTGGG

mRNA/cds = (25, 1542)

AGGAGTAAAGAAAATCCAAAAGCA

3326
Table 3A
Hs.83551
NM_017459
9665258
microfibrillar-associated protein 2
1
CCCCCGTGGGCATGGACCACCTTTAT

(MFAP2), transcript variant 1,

TTTATACAAAATTAAAAACAAGTT

mRNA/cds = (114, 685)

3327
Table 3A
Hs.85100
NM_017491
9257256
WD repeat domain 1 (WDR1),
1
ACTGTAAACTAATCTGTCATTGTTTTT

transcript variant 1,

ACCTTCCTTTTCTTTTTCAGTGC

mRNA/cds = (202, 2022)

3328
Table 3A
Hs.139262
NM_017523
8923794
XIAP associated factor-1
1
TACTTGCTGTGGTGGTCTTGTGAAAG

(HSXIAPAF1), mRNA/cds = (0, 953)

GTGATGGGTTTTATTCGTTGGGCT

3329
Table 3A
Hs.119018
NM_017544
8923943
transcription factor NRF (NRF),
1
AAAGAATTAGTGTATGCTTCCTGAAT

mRNA/cds = (653, 1819)

AAAAAGGAGCCAAAGTTGATCAGA

3330
Table 3A
Hs.306195
NM_017601
8922168
over-expressed breast tumor protein
1
AGGGGGTGATTTTTGCTCTTGTCCTG

(OBTP), mRNA/cds = (0, 224)

AGAAATAACAGTGCTGTTTTAAAA

3331
Table 3A
Hs.32922
NM_017632
8923039
hypothetical protein FLJ20036
1
AGCTTAAGGTTTTAAAAATGTTGCCC

(FLJ20036), mRNA/cds = (162, 1904)

GTAATGTTGAACGTGTCTGTTAGA

3332
Table 3A
Hs.246875
NM_017644
8923080
hypothetical protein FLJ20059
1
GGATGCACGTACAGAATACATTCAGC

(FLJ20059), mRNA/cds = (25, 1290)

CGTCAGGTAATAACATGAAGCAGT

3333
Table 3A
Hs.7942
NM_017657
8923087
hypothetical protein FLJ20080
1
GGACAGTTTCTATTGCTTTTCCTTTTT

(FLJ20080), mRNA/cds = (315, 3044)

TCCATCCCTTCCCTACCATCAAA

3334
Table 3A
Hs.26389
NM_017748
8923268
hypothetical protein FLJ20287
1
AGACTTACATTACTGCTTTAACGTGTA

(FLJ20287), mRNA/cds = (131, 2920)

TATCACTGGGCATCCCCAAGGGC

3335
Table 3A
Hs.8928
NM_017748
8923270
hypothetical protein FLJ20291
1
GTCAGGTTAGGTCAAAGCCAGGGAG

(FLJ20291), mRNA/cds = (117, 1394)

TGACAGAATCTGGGAAATCAAACAA

3336
Table 3A
Hs.7862
NM_017761
8923294
hypothetical protein FLJ20312
1
CCTCTTGATGCCTAAGCAGGTAAGCA

(FLJ20312), mRNA/cds = (133, 552)

GATGCCTAAGCTGTATTTCTCCAA

3337
Table 3A
Hs.126721
NM_017762
8923296
hypothetical protein FLJ20313
1
TGGATCTGTCAAACTAACACTTATGC

(FLJ20313), mRNA/cds = (344, 1699)

CTTTAGTCTCATTGTATGAGGTGT

3338
Table 3A
Hs.306668
NM_017774
8923317
cDNA FLJ14089 fis, clone
1
ACCTGCCATCATTGGTCTTTACTAAG

MAMMA1000257/cds = UNKNOWN

TGAAGTGACTTCTTTCTTTAACAA

3339
Table 3A
Hs.105461
NM_017780
8923329
hypothetical protein FLJ20357
1
GCTGCCAACTGTAGTAATGATGCTTT

(FLJ20357), mRNA/cds = (35, 2083)

TAATAAAAGTGACCCATGATATGC

3340
Table 3A
Hs.6831
NM_017792
8923351
hypothetical protein FLJ20373
1
ACTGTTGTCCCCCCACCCTTTTTTCC

(FLJ20373), mRNA/cds = (268, 849)

TTAAATAAAGTAAAAATGACACCC

3341
Table 3A
Hs.283685
NM_017801
8923369
hypothetical protein FLJ20396
1
TGTGAATACTGTGTAGCAGGATCTTG

(FLJ20396), mRNA/cds = (107, 658)

AGAGTCCTTGTTCTTACATAGGCA

3342
Table 3A
Hs.14220
NM_017827
8923420
hypothetical protein FLJ20450
1
AAGAGGCTTCCATCCCTCCTTCCTTC

(FLJ20450), mRNA/cds = (27, 1583)

TTTCCTCCTACAGTGCTGAGCAAA

3343
Table 3A
Hs.132071
NM_017830
8923426
ovarian carcinoma immunoreactive
1
GTTGAATTGGGGTGGATGGGGGGAG

antigen (OCIA), mRNA/cds = (167, 904)

CAAGCATAATTTTTAAGTGTGAAGC

3344
Table 3A
Hs.5811
NM_017835
8923436
chromosome 21 open reading frame
1
TCACCAGCTGATGACACTTCCAAAGA

59 (C21ORF59),

GATTAGCTCACCTTTCTCCTAGGC

mRNA/cds = (360, 776)

3345
Table 3A
Hs.5080
NM_017840
8923447
mitochondrial ribosomal protein L16
1
CCCACTGAAGTCTTTGGGTAGCTCTT

(MRPL16), mRNA/cds = (111, 866)

AAGCCATAACTAAGGAGCAGCATT

3346
Table 3A
Hs.39850
NM_017859
8923486
hypothetical protein FLJ20517
1
AGTGACGAGGAGGAAGTGGCCTACA

(FLJ20517), mRNA/cds = (44, 1690)

CGGGTTAGCTGCCCAGTGAGCCATC

3347
Table 3A
Hs.44344
NM_017867
8923502
hypothetical protein FLJ20534
1
AACAGAAGTCAAGAGAACATAG

(FLJ20534), mRNA/cds = (20, 1060)

ACCAACTTGCTGCATGAGTAAGGT

GGCT

3348
Table 3A
Hs.107213
NM_017892
8923548
hypothetical protein FLJ20585
1
TTTTCCCTGCTATTGAGGAAGTATTTT

(FLJ20585), mRNA/cds = (99, 746)

GCCTTCCCTACTCACTGAGAAGT

3349
Table 3A
Hs.55781
NM_017897
8923558
hypothetical protein FLJ20604
1
CGGAACCAGAATTTGATCTCAACTAT

(FLJ20604), mRNA/cds = (99, 1476)

GTTCCACTAAAGGCACAGGAATGG

3350
Table 3A
Hs.18791
NM_017899
8923562
hypothetical protein FLJ20607
1
CGCACCTTGTGTCTTGTAGGGTATGG

(FLJ20607), mRNA/cds = (48, 698)

TATGTGGGACTTCGCTGTTTTTAT

3351
Table 3A
Hs.52184
NM_017903
8923570
hypothetical protein FLJ20618
1
AGCAGTTATATTGCCCCTTGGTTTTTA

(FLJ20618), mRNA/cds = (318, 725)

TTCAGTTTAACTACTGTTTCCAA

3352
Table 3A
Hs.49376
NM_017917
8923599
hypothetical protein FLJ20644
1
AGCAAAATCCTCAGAAATGGTCTAAA

(FLJ20644), mRNA/cds = (276, 1637)

TAAAACACTTGATATGCCTAGAGA

3353
Table 3A
Hs.234149
NM_017918
8923601
hypothetical protein FLJ20647
1
TGATTTTGCAACTTAGGATGTTTTTGA

(FLJ20647), mRNA/cds = (90, 838)

GTCCCATGGTTCATTTTGATTGT

3354
Table 3A
Hs.180201
NM_017924
8923614
hypothetical protein FLJ20671
1
TTACCTGGATTCCATTGGCTGGTTTT

(FLJ20671), mRNA/cds = (72, 494)

ACCACTCCTATCAGATTGTAGTGT

3355
Table 3A
Hs.48712
NM_017948
8923662
hypothetical protein FLJ20736
1
CTCTTTGCCCTCTATCCTGAGTAACT

(FLJ20736), mRNA/cds = (130, 1851)

AATGGACATCTTCTCATGCAAGGT

3356
Table 3A
Hs.279937
NM_014980
7662439
KIAA1001 protein (KIAA1001),
1
GCCACAGAATGGTCACCCAGCTTATT

mRNA/cds = (458, 2035)

TAGGTGTAGACAAGTATGACACAG

3357
Table 3A
Hs.280978
NM_018114
8922464
hypothetical protein FLJ10496
1
GCCACAGAGGCTCCAATACCTGGGA

(FLJ10498), mRNA/cds = (13, 429)

ATGTTCACAAAGTCATCAACTGGAA

3358
Table 3A
Hs.55024
NM_018053
8922341
hypothetical protein FLJ10307
1
AGAATGTGTGTGCCTGTGGGTCTCTA

(FLJ10307), mRNA/cds = (28, 462)

CAAGTGACAGATGTGTTGTTTTCA

3359
Table 3A
Hs.100895
NM_018099
8922433
hypothetical protein FLJ10462
1
TCCAAATTGTTTCCTAACATTCTATTT

(FLJ10462), mRNA/cds = (147, 1694)

TATGCCTTTGCGTATTAAACGTG

3360
Table 3A
Hs.4997
NM_018107
8922449
hypothetical protein FLJ10482
1
GCCTCTACTGTGGCCTCAACCCTGG

(FLJ10482), mRNA/cds = (149, 1369)

CAATTATAGCTACTCCCATCCCTTA

3361
Table 3A
Hs.236844
NM_018169
8922572
hypothetical protein FLJ10652
1
AACTGAACACAATTTTGGGACAACGT

(FLJ10652), mRNA/cds = (50, 1141)

TTAAACATTACTTTTCATACTTGA

3362
Table 3A
Hs.66048
NM_018174
8922582
chromosome 19 open reading frame 5
1
CTGAGCCCAGCCCGCCTGTCCCTAG

(c19orf5), mRNA/cds = (175, 2193)

ATTCAGCCACATCAGAAATAAACTG

3363
Table 3A
Hs.8083
NM_018210
8922653
hypothetical protein FLJ10769
1
ACTGTGCCATGGACATTTTTCCTCTG

(FLJ10769), mRNA/cds = (14, 1186)

GGGAATTAACATCTAAATTCTGGT

3364
Table 3A
Hs.59838
NM_018227
8922683
hypothetical protein FLJ10808
1
ACAACGCTCTTAGAGAATCCGTGAAT

(FLJ10808), mRNA/cds = (180, 1559)

GTGAACAGACAAATGTGGCTAACC

3365
Table 3A
Hs.18851
NM_018253
8922730
hypothetical protein FLJ10875
1
TAGGAGAATAAGAGTCTGGAGACTG

(FLJ10875), mRNA/cds = (100, 2037)

GGAGCCTTCACTTCGGCCTCCGATT

3366
Table 3A
Hs.8739
NM_018255
8922734
hypothetical protein FLJ10879
1
TGCTGAGTGGTTACACTTTGCAAGCT

(FLJ10879), mRNA/cds = (10, 2490)

GTGGTGAAGATCACACTGTGAAGA

3367
Table 3A
Hs.143954
NM_018270
8922763
hypothetical protein FLJ10914
1
CCCAGTGCTGATGGAGATGCCACTTT

(FLJ10914), mRNA/cds = (71, 685)

CGTGTGACTGCGAACATTAAAGCA

3368
Table 3A
Hs.6118
NM_018285
8922793
mitochondrial ribosomal protein S4
1
TGTTCAGGATCTCCTCCCTTGTTTAA

(MRPS4), mRNA/cds = (47, 601)

ATGTCAATAAATGCCCCAACTGCT

3369
Table 3A
Hs.302981
NM_018295
8922813
hypothetical protein FLJ11000
1
TTATTCATATATTCCTGTCCAAAGCCA

(FLJ11000), mRNA/cds = (223, 780)

CACTGAAAACAGAGGCAGAGACA

3370
Table 3A
Hs.30822
NM_018326
8922872
hypothetical protein FLJ11110
1
AGGTCATCCACACACTTCTGCCCCCA

(FLJ11110), mRNA/cds = (44, 1033)

CTGCATTGAATTTTTTGCTTATGT

3371
Table 3A
Hs.105216
NM_018331
8922883
hypothetical protein FLJ11125
1
TTTTCGTTCTCCTCCTACCCCAGATC

(FLJ11125), mRNA/cds = (203, 712)

TCTACAAGGACATTGCCCCTAAGC

3372
Table 3A
Hs.8033
NM_018346
8922910
hypothetical protein FLJ11164
1
GTGTTTGTAATTCTTCTTTGTCCTTTT

(FLJ11164), mRNA/cds = (58, 1384)

ACCTACAGAAATGGTCACATGGT

3373
Table 3A
Hs.184465
NM_018370
8922957
hypothetical protein FLJ11259
1
AGGATGTTTGTAGTGCTATAATATAG

(FLJ11259), mRNA/cds = (87, 485)

AATGGGATTTACTCTGCTTTACCA

3374
Table 3A
Hs.11260
NM_018371
8922959
hypothetical protein FLJ11264
1
AGCTAATTATCTCTTTGAGTCCTTGCT

(FLJ11264), mRNA/cds = (362, 1189)

TCTGTTTGCTCACAGTAAGCTCA

3375
Table 3A
Hs.26194
NM_018384
8922984
hypothetical protein FLJ11296
1
TCCTACTTATTTAAGCTATTTGAGCTC

(FLJ11296), mRNA/cds = (303, 1226)

CGGGTCTCTTCTACCTGCATTCT

3376
literature
Hs.266514
NM_018394
8923000
hypothetical protein FLJ11342
1
AGTGATTGCCACCTAAATCAGAAGAC

(FLJ11342), mRNA/cds = (10, 930)

GTTCTAAAGTCAGTAAGAAAGTGT

3377
Table 3A
Hs.183856
NM_018399
9055235
VNN3 protein (HSA238982),
1
CACGCTTAGGGCAGGGATCTGGGAA

mRNA/cds = (45, 1550)

ATTCCAGTGATCTCCTTTAGCAGAG

3378
Table 3A
Hs.123090
NM_018450
8922086
BRG1-Associated Factor 250a
1
TTTCTAATCGAGGTGTGAAAAAGTTC

(BAF250a) mRNA, complete

TAGGTTCAGTTGAAGTTCTGATGA

cds/cds = (378, 7235)

3379
Table 3A
Hs.7731
NM_018453
8922092
uncharacterized bone marrow protein
1
TCATTCTGTTTTTGATGAACATTTGGA

BM036 (BM036), mRNA/cds = (95, 796)

AACTGTCGGGCTTTTTATTAAAG

3380
Table 3A
Hs.6375
NM_018471
8923807
uncharacterized hypothalamus protein
1
CAATGCCCTGTGTTAAATTGTTTAAAA

HT010 (HT010),

GTTTCCCTTTTCTTTTTTGCCAA

mRNA/cds = (226, 1419)

3381
Table 3A
Hs.334370
NM_018476
8923715
brain expressed, X-linked 1 (BEX1),
1
ACCTATTGCATGGAAAGATGCTCATT

mRNA/cds = (171, 548)

ATAGTGAAGTTAATAAAGCACCTT

3382
Table 3A
Hs.274369
NM_018477
8923711
uncharacterized hypothalamus protein
1
AGAGGACTATAGTGGAAGTGAAAGCA

HARP11 (HARP11),

TTCTGTGTTTACTCTTTGCATTAA

mRNA/cds = (80, 1333)

3383
db mining
Hs.10669
NM_018482
8923867
mRNA for KIAA1249 protein, partial
1
TGAATTGCACTGTGAAAAGCACTCTT

cds/cds = (0, 2850)

CCCTCTCAGTTTTCGTTCATCCTG

3384
Table 3A
Hs.102652
NM_018489
8922080
hypothetical protein ASH1 (ASH1),
1
CCATGGGGTCAGAAGGGCACGGTAG

mRNA/cds = (309, 9218)

TTCTTGCAATTATTTTTGTTTTACC

3385
Table 3A
Hs.160271
NM_018490
8923700
G protein-coupled receptor 48
1
AATGTGGGAAGGATTTATTTACAGTG

(GPR48), mRNA/cds = (444, 3299)

TGTTGTAATTTTGTAAGGCCAACT

3386
Table 3A
Hs.7535
NM_018491
13236498
COBW-like protein (LOC55871),
1
AGCTACTGTGACAGAAACAGAA

mRNA/cds = (64, 1251)

AAGCAGTGGACAACACGTTTCCAA

GAAG

3387
Table 3A
Hs.104741
NM_018492
8923876
PDZ-binding kinase; T-cell originated
1
TGCTCATGCTGACTTAAAACACTAGC

protein kinase (TOPK),

AGTAAAACGCTGTAAACTGTAACA

mRNA/cds = (154, 1122)

3388
Table 3A
Hs.283330
NM_018507
8924082
hypothetical protein PRO1843
1
TCCAATGCAGTCCCATTCTTTATGGC

(PRO1843), mRNA/cds = (964, 1254)

CTATAGTCTCACTCCCAACTACCC

3389
Table 3A
Hs.186874
NM_018519
8924144
hypothetical protein PRO2266
1
GGTGTCTGACTTAATGACTCCTGCTG

(PRO2266), mRNA/cds = (258, 826)

AAGTTGAATTGTGAGATGTTATCC

3390
Table 3A
Hs.343477
AF119911
7770258
PRO2975 mRNA, complete
1
CATTTGTCTGGAAATGCTGCCGGGAG

cds/cds = UNKNOWN

CCTATTGTGTAAATGTAGGTATTT

3391
Table 3A
Hs.147644
NM_018555
10092612
zinc finger protein 331:zinc finger
1
GCGGGAAGGCATGTAACCACCTAAA

protein 463 (ZNF381),

CCATCTCCGAGAACATAGAGGATC

mRNA/cds = (376, 1767)

3392
Table 3A
Hs.300496
NM_018579
8924027
mitochondria solute carrier protein
1
CAGGTCAACCCCCACCGGACCTACA

(MSCP) mRNA, complete cds,

ACCCGCAGTCCCACATCATCTCAGG

alternatively spliced/cds = (44, 511)

3393
Table 3A
Hs.300496
NM_018579
6924027
mitochondria solute carrier protein
1
CAGGTCAACCCCCACCGGACCTACA

(MSCP) mRNA, complete cds,

ACCCGCAGTCCCACATCATCTCAGG

alternatively spliced/cds = (44, 511)

3394
Table 3A
Hs.52881
NM_018807
13699664
hypothetical protein PRO1853)
1
TTTAGGGTTGTGACTGGCTTTGGTGC

(PRO1653), mRNA/cds = (472, 771)

AAATGTGTGCTCAAGCTAATAAGT

3395
Table 3A
Hs.103657
NM_018823
8924137
PRO2219 mRNA, complete
1
ACTTGTGTTTTGTTTGGGGGCTGGGA

cds/cds = (823, 1056)

AATGTATTTTTACATTGTAGCCAA

3396
Table 3A
Hs.241576
NM_018630
8924181
hypothetical protein PRO2577
1
AACATTGTGCTCTAACAGTATGACTA

(PRO2577), mRNA/cds = (491, 664)

TTCTTTCCCCCACTCTTAAACAGT

3397
Table 3A
Hs.283022
NM_018643
8924261
triggering receptor expressed on
1
CCAAGGGAGGAGGGAGGAGGTAAAA

myeloid cells 1 (TREM1),

GGCAGGGAGTTAATAACATGAATTA

mRNA/cds = (47, 751)

3398
Table 3A
Hs.14317
NM_018646
8923941
nucleolar protein family A, member 3
1
TACTCTTTGGCATCCAGTCTCTCGTG

(H/ACA small nucleolar RNPs)

GCGATTGATTATGCTTGTGTGAGG

(NOLA3), mRNA/cds = (97, 291)

3399
Table 3A
Hs.195292
NM_018666
8924241
putative tumor antigen (SAGE),
1
CCTTCCAGAAGCTACGAAAAAGGGA

mRNA/cds = (167, 2881)

GCTGTTTAAATTTAATAAATCTCTG

3400
Table 3A
Hs.8117
NM_018695
8923908
erbb2-interacting protein ERBIN
1
AAGTGCCATAGAAGACCAATAACTGT

(ERBB2IP), mRNA/cds = (323, 4438)

TTAGTTGAGGCTAGTCTGGAACCT

3401
Table 3A
Hs.78825
NM_018834
10047081
matrin 3 (MATR3),
1
TGGATTCAAGTTACTGAAGTGAATAC

mRNA/cds = (254, 2800)

CAATAAAAAGAAAACCCTAGGCCA

3402
Table 3A
Hs.44163
NM_018838
10092656
13kDa differentiation-associated
1
AGGAGTGGATCCCACCTTCAACACCT

protein (LOC55967),

TACAAGTAAAGACAATGAAGAACA

mRNA/cds = (53, 490)

3403
Table 3A
Hs.183842
NM_018955
11024713
ubiquitin B (UBB),
1
CAGTAATAGCTGAACCTGTTCAAAAT

mRNA/cds = (94, 783)

GTTAATAAAGGTTTCGTTGCATGG

3404
db mining
Hs.44234
NM_018965
9507202
triggering receptor expressed on
1
AGGGAGTGGGGAGGTGGTAAGAACA

myeloid cells 2 (TREM2),

CCTGACAACTTCTGAATATTGGACA

mRNA/cds = (94, 786)

3405
Table 3A
Hs.274428
NM_018975
9507032
TRF2-interacting talomeric RAP1
1
AAAATTAGTGGATTGACTCCACTTTG

protein (RAP1),

TTGTGTTGTTTTCATTGTTGAAAA

mRNA/cds = (136, 1034)

3406
Table 3A
Hs.61053
NM_018986
9506676
hypothetical protein (FLJ20356),
1
AATGGAGGCACGAACGCAGGGGCCA

mRNA/cds = (91, 3285)

AATAGCAATAAATGGGTTTTGTTTT

3407
Table 3A
Hs.80618
NM_018996
9506648
hypothetical protein (FLJ20015),
1
TGTTTTGATTGTTTTGCAAGGAAGAA

mRNA/cds = (31, 522)

AGACAATGGAATAACATACCTTCA

3408
Table 3A
Hs.83954
NM_019006
9506852
protein associated with PRK1 (AWP1),
1
TCATTGCTGTCTACAGGTTTCTTTCA

mRNA/cds = (244, 804)

GATTATGTTCATGGGTTTGTGTGT

3409
Table 3A
Hs.98324
NM_019044
9506632
hypothetical protein (FLJ10996),
1
GAAAACAGACCTTGTGCTGAGGACAC

mRNA/cds = (135, 857)

GTCAATAAAAATTATACCTTCCCC

3410
db mining
Hs.110746
NM_019052
9506772
HCR (a-helix coiled-coil rod)
1
GGGATACCAGCTGAGTCTGAATTCTG

homologue) (HCR),

CTCTAAATAAAGACGACTACAGAG

mRNA/cds = (79, 2427)

3411
Table 3A
Hs.274248
NM_019059
9506858
hypothetical protein FLJ20758
1
TGGCTCGGATAAGAGATGGGACATC

(FLJ20758), mRNA/cds = (464, 1306)

ATTCAGTCACTAGTTGGATGGCACA

3412
Table 3A
Hs.124835
NM_019062
9506662
hypothetical protein (FLJ20225),
1
AACTTGATGAAAGTATTGCAGTATTG

mRNA/cds = (177, 860)

ATGCCATTGTAGAATAGAACTGGA

3413
Table 3A
Hs.30909
NM_019081
11464998
KIAA0430 gene product (KIAA0430),
1
TTTGTGTGTTGGGACCAAACAGTTGT

mRNA/cds = (0, 3599)

CAATAAACTTTACAAGCGAGCATC

3414
Table 3A
Hs.76807
NM_019111
9506780
major histocompatibility complex, class
1
CATGGGGCTCTCTTGTGTACTTATTG

II, DR alpha (HLA-DRA),

TTTAAGGTTTCCTCAAACTGTGAT

mRNA/cds = (26, 790)

3415
Table 3A
Hs.25951
NM_019555
9506400
Rho guanine nucleotide exchange
1
AGGTGGTCAATGAATGTTTTGATGAA

factor (GEF) 3 (ARHGEF3),

ATGAATGTTTTTGTATAATGGCCT

mRNA/cds = (127, 1707)

3416
Table 3A
Hs.278857
NM_019597
14141155
heterogeneous nuclear
1
ACGGGACAATTTTAAGATGTAATACC

ribonucleoprotein H2 (H′) (HNRPH2),

AATACTTTAGAAGTTTGGTCGTGT

mRNA/cds = (78, 1427)

3417
Table 3A
Hs.159523
NM_019604
9624976
class-I MHC-restricted T cell
1
ACAGCAAACTTTGGCATTTATGTGGA

associated molecule (CRTAM),

GCATTTCTCATTGTTGGAATCTGA

mRNA/cds = (0, 1181)

3418
Table 3A
Hs.159523
NM_019604
9624976
class-I MHC-restricted T cell
1
ACAGCAAACTTTGGCATTTATGTGGA

associated molecule (CRTAM),

GCATTTCTCATTGTTGGAATCTGA

mRNA/cds = (0, 1181)

3419
Table 3A
Hs.324743
NM_019853
9790172
protein phosphatase 4 regulatory
1
ACTTTTATGTAAAAAAGTGCACCTTTA

subunit 2 (PPP4R2),

GTTTTACAAGTAAAGCAGGTTGT

mRNA/cds = (417, 1778)

3420
Table 3A
NA
NM_019997
9910435
Mus musculus cDNA sequence
1
TCTTAATAATAATGAAGACGACTTACC

AB041581 (AB041581), mRNA.

CTGTGGAATTGAACACACTGGTG

3421
Table 3A
Hs.5392
NM_020122
10047127
potassium channel modulatory factor
1
GCTGCTGTGTGTATTTATGAATATTAA

(DKFZP434L1021),

TGAATAAAAACTGCTTGGATGGT

mRNA/cds = (53, 1198)

3422
Table 3A
Hs.8203
NM_020123
10047129
endomembrane protein emp70
1
ACCGTGTAAAGTGGGGATGGGGTAA

precursor isolog (LOC56889),

AAGTGGTTAACGTACTGTTGGATCA

mRNA/cds = (19, 1779)

3423
Table 3A
Hs.236628
NM_020135
9910349
putative helicase RUVBL (LOC56897),
1
TAAATTTATTTATTTATGAAAAAACT

mRNA/cds = (238, 1575)

CGTGCCGAATTCTTGGCCTCGAG

3424
Table 3A
Hs.110796
NM_020150
9910541
GTP-binding protein SAR1 (SAR1)
1
GGGTTTCCGCTGGCTCTCCCAGTATA

mRNA, complete cds/cds = (124, 720)

TTGACTGATGTTTGGACGGTGAAA

3425
Table 3A
Hs.334775
NM_020151
9910251

Homo sapiens, Similar to RIKEN
1
GTACAGTTACTCATGTCATTGTAATG

cDNA 1200014H14 gene, clone

ATTTCACTCCTAACTGTGACATTT

IMAGE:3139657, mRNA partial

cds/cds = (0, 523)

3426
literature
Hs.21320
NM_020165
14550404
postreplication repair protein hRAD18p
1
ACTGAGTTGTCAGAAATTATGTCAAA

(RAD18), mRNA/cds = (77, 1564)

ATGAAAACTGTTTGTTTCATGACA

3427
Table 3A
Hs.6879
NM_020188
9910183
DC13 protein (DC13),
1
ACCTGACTTCACCATGTTTATTCCCTT

mRNA/cds = (175, 414)

TGCCTACAACCAGTTAATATCTG

3428
Table 3A
Hs.7045
NM_020194
9910247
GL004 protein (GL004),
1
TCATGCGTGAACAATTTAAAAAACGA

mRNA/cds = (72, 726)

CAGAATAAGGTACAAATGTAGTGT

3429
literature
Hs.9822
NM_020196
9910259
HCNP protein; XPA-binding protein 2
1
CCCATCCCCCCTCCCCACCCCCATC

(HCNP),

CCCAATACAGCTACGTTTGTACATC

3430
Table 3A
Hs.283611
NM_020217
9910199
hypothetical protein DKFZp5471014
1
CCAACAAAATTGGGATCATCCAAACT

(DKFZp5471014),

GAGTCCATCTGGCTAATTCTAAAT

mRNA/cds = (1774, 2166)

3431
Table 3A
Hs.79457
NM_017860
8923488
hypothetical protein FLJ20519
1
TGACTGGAACTGAGAGTAAATTGGGA

(FLJ20519), mRNA/cds = (74, 604)

ATGTATGACCAATCTTAGACCCTG

3432
Table 3A
Hs.4859
NM_020307
9945319
cyclin L ania-6a (LOC57018),
1
TGTTTAAATGATGGTGAATACTTTCTT

mRNA/cds = (54, 1834)

AACACTGGTTTGTCTGCATGTGT

3433
Table 3A
Hs.283728
NM_020357
9966826
PEST-containing nuclear protein
1
ACCTAAGGTCAAGCTGGGAGAGAGA

(pcnp), mRNA/cds = (18, 554)

AATGACTGAGATGAATGTCTTTACT

3434
Table 3A
Hs.322901
NM_020368
9968798
disrupter of silencing 10 (SAS10),
1
GCTTAGGGAAATTTCACAGTTCATTG

mRNA/cds = (161, 1600)

TGGAGTGTTAAACTTAGAACATGT

3435
Table 3A
Hs.111988
NM_020382
9966854
PR/SET domain containing protein 07
1
TGTTACAGGTTTCCAAGGTGGACTTG

(SET07), mRNA/cds = (150, 1331)

AACAGATGGCCTTATATTACCAAA

3436
Table 3A
Hs.12450
NM_020403
14589940
protocadherin 9 (PCDH9),
1
TGTTACTGCTTTGCCAGTTCTACGTT

mRNA/cds = (118, 3729)

ATTTACAATTATTCAGCTCTTGCA

3437
Table 3A
Hs.286233
NM_020414
14251213
sperm autoantigenic protein 17
1
TTTCTGTATTGCAGTGTTTATAGGCTT

(SPA17), mRNA/cds = (1210, 1665)

CTTGTGTGTTAAACTTGATTTCA

3438
Table 3A
Hs.287369
NM_020525
10092624
interleukin 22 (IL22),
1
AACTAACCCCCTTTCCCTGCTAGAAA

mRNA/cds = (71, 610)

TAACAATTAGATGCCCCAAAGCGA

3439
Table 3A
Hs.81328
NM_020529
10092618
nuclear factor of kappa light
1
GTTTGTGTTACCCTCCTGTAAATGGT

polypeptide gene enhancer in B-cells

GTACATAATGTATTGTTGGTAATT

inhibitor, alpha (NFKBIA),

mRNA/cds = (94, 1047)

3440
Table 3A
Hs.78888
NM_020548
10140852
diazepam binding inhibitor (GABA
1
GCTCACCATACGGCTCTAACAGATTA

receptor modulator, acyl-Coenzyme A

GGGGCTAAAACGATTACTGACTTT

binding protein) (DBI),

mRNA/cds = (0, 314)

3441
literature
Hs.247302
NM_020648
10190663
twisted gastrulation (TSG),
1
CGGCTGATGGGACAGGAATTGAAGA

mRNA/cds = (13, 684)

AGAGAATTGACTCGTATGAACAGGA

3442
literature
Hs.149342
NM_020661
10190699
activation-induced cytidine deaminase
1
TGGTGCTACGAAGCCATTTCTCTTGA

(AICDA), mRNA/cds = (76, 672)

TTTTTAGTAAACTTTTATGACAGC

3443
Table 3A
Hs.295231
NM_020666
10190705
CLK4 mRNA, complete
1
TGAGAAACTGTTTGACCTGGTTCGAA

cds/cds = (153, 1514)

GAATGTTAGAATATGATCCAACTC

3444
Table 3A
Hs.105052
NM_020979
10280625
adaptor protein with pleckstrin
1
GGTGGGACACGCCAAGCTCTTCAGT

homology and src homology 2 domains

GAAGACACGATGTTATTAAAAGCCT

(APS), mRNA/cds = (127, 2025)

3445
Table 3A
Hs.104624
NM_020980
11038852
aquaporin 9 (AQP9),
1
TGCTTTGAAGCTACCTGGATATTTCC

mRNA/cds = (286, 1173)

TATTTGAAATAAAATTGTTCGGTC

3446
Table 3A
Hs.211563
NM_020993
10337612
B-cell CLL/lymphoma 7A (BCL7A),
1
ATCGCCAAGAACCTGGTTAGAGGCAT

mRNA/cds = (953, 1648)

AAAGACCTTTTTTCACCGTTACCT

3447
Table 3A
Hs.6574
NM_021008
10337616
suppressin (nuclear deformed)
1
TGCTGCGACGCACATACATACGTGTT

epidermal autoregulatory factor-1

GTGTCTGTCAATAAAGTGTAAATA

(DEAF-1)-related) (SPN),

mRNA/cds = (356, 2011)

3448
Table 3A
Hs.178391
NM_021029
10445222
ribosomal protein L44 (RPL44),
1
TGGGAGGAGATAAGAAGAGAAAGGG

mRNA/cds = (37, 357)

CCAAGTGATCCAGTTCTAAGTGTCA

3449
Table 3A
Hs.28578
NM_021038
10518339
muscleblind (Drosophila)-like (MBNL),
1
TGCAGTAGTTGACTTTGCTGTATGGA

mRNA/cds = (1414, 2526)

AAAATAAAGTGAAATTGCCCTAAT

3450
literature
Hs.51011
NM_021064
10800131
H2A histone family, member P
1
GCTAAATAAGGAATACTCATGCCAAG

(H2AFP), mRNA/cds = (30, 422)

ATCATCGAATTGTGCCTCCTCCCT

3451
Table 3A
Hs.51299
NM_021074
10835024
NADH dehydrogenase (ubiquinone)
1
ACCCAAGGGACCTGGATTTGGTGTAC

flavoprotein 2 (24kD) (NDUFV2),

AAGCAGGCCTTTAATTTATATTGA

mRNA/cds = (18, 767)

3452
Table 3A
Hs.63302
NM_021090
10835108
myotubularin related protein 3
1
GGAGTCAGTCAGTGCTCCTATATTTT

(MTMR3)

TCATTTTTTGTCAAAGCAAGAAGT

3453
Table 3A
Hs.324406
NM_021104
10883874
ribosomal protein L41 (RPL41),
1
TTTGTGGCCGAGTGTAACAACCATAT

mRNA/cds = (83, 160)

AATAAATCACCTCTTCCGCTGTTT

3454
Table 3A
Hs.196282
NM_021105
10863876
phospholipid scramblase 1 (PLSCR1),
1
TTCTACATGAAATGTTTAGCTCTTACA

mRNA/cds = (256, 1212)

CTCTATCCTTCCTAGAAAATGGT

3455
Table 3A
Hs.75968
NM_021109
11056080
thymosin, beta 4, X chromosome
1
GGACGACAGTGAAATCTAGAGTAAAA

(TMSB4X), mRNA/cds = (77, 211)

CCAAGCTGGCCCAAGTGTCCTGCA

3456
Table 3A
Hs.154890
NM_021122
12669908
fatty-acid-Coenzyme A ligase,long-
1
TGTTTTGGGGTCTGTGAGAGTACATG

chain 2 (FACL2),

TATTATATACAAGCACAACAGGGC

mRNA/cds = (13, 2109)

3457
Table 3A
Hs.96
NM_021127
10863922
phorbol-12-myristate-13-acetate-
1
AGGAACAGTTAGTTCTCATCTAGAAT

induced protein 1 (PMAIP1),

GAAAGTTCCATATATGCATTGGTG

mRNA/cds = (173, 337)

3458
Table 3A
Hs.71818
NM_021128
14589958
polymerase (RNA) II (DNA directed)
1
TGTGTGTGTATCCCATACCCCACTCT

polypeptide L (7.6kD) (POLR2L),

GGAAGGAACCATCCAGTAAAGGTC

mRNA/cds = (21, 224)

3459
Table 3A
Hs.184011
NM_021129
11056043
pyrophosphatase (inorganic) (PP),
1
GTGCAAGGGGAGCACATATTGGATG

nuclear gene encoding mitochondrial

TATATGTTACCATATGTTAGGAAAT

protein, mRNA/cds = (77, 948)

3460
Table 3A
Hs.267690
NM_021130
10863926
mRNA for KIAA1228 protein, partial
1
TTTCCTTGTTCCCTCCCATGCCTAGC

cds/cds = (0, 2176)

TGGATTGCAGAGTTAAGTTTATGA

3461
literature
Hs.84981
NM_021141
12408850
X-ray repair complementing defective
1
ACCCAGTCACCTCTGTCTTCAGCACC

repair in Chinese hamster cells 5

CTCATAAGTCGTCACTAATACACA

(double-strand-break rejoining; Ku

autoantigen, 80kD) (XRCC5),

mRNA/cds = (33, 2231)

3462
Table 3A
Hs.12743
NM_021151
10863952
camitine O-octanoyltransferase
1
TGAATCACATTGTCAGAATTTTTTCCT

(CROT), mRNA/cds = (136, 1974)

CCTCGCTGTTCAATTTTGTAGTT

3463
Table 3A
Hs.7137
NM_021188
10863994
clones 23667 and 23775 zinc finger
1
AGATGCCTTGTTGCTTTGAAGAAGGG

protein (LOC57862),

AGTGATGTCAATTCTCTTGTTACA

mRNA/cds = (182, 1618)

3464
Table 3A
Hs.8185
NM_021199
10864010
CGI-44 protein; sulfide dehydrogenase
1
CCATGTGGGCTACTCATGATGGGCTT

like (yeast) (CGI-44),

GATTCTTTGGGAATAATAAAATGA

mRNA/cds = (76, 1428)

3465
Table 3A
Hs.12152
NM_021203
14917112
APMCF1 protein (APMCF1),
1
AAAAGTTCTCTGTAGATTTCTGAAGT

mRNA/cds = (16, 831)

GCATATTCATTGATGCCAAGAAAA

3466
Table 3A
Hs.25726
NM_021211
10864022
transposon-derived Buster1
1
GGAGGAGTTTGCATGTCTCATGATAA

transposese-like protein (LOC58486),

CCAAATGTAAGATGAAAATAAAAG

mRNA/cds = (468, 2549)

3467
Table 3A
Hs.29417
NM_021212
10864024
HCF-binding transcription factor
1
TTGGTGACTTAGTGATTTTGTCATTTT

Zhangfei (ZF), mRNA/cds = (457, 1275)

TTACATCAACTTCATGGTCTTGT

3468
literature
Hs.274363
NM_021257
10864064
neuroglobin (NGB),
1
CGCCCGGCAGCCCCCATCCATCTGT

mRNA/cds = (0, 455)

3469
Table 3A
Hs.19520
NM_021603
11125763
FXYD domain-containing ion transport
1
GTCTGTCTGTTGGCCTGTATCTGTT

regulator 2 (FXYD2), transcript variant

CACCTCATGCTTATAATAAAGCCGG

b, mRNA/cds = (67, 261)

3470
Table 3A
Hs.104305
NM_021621
14719827
death effector filament-forming Ced-4-
1
CTGGCTGTGTCACAGGGTGAGCCCC

like apoptosis protein (DEFCAP),

AAAATTGGGGTTCAGCGTGGGAGGC

transcript variant B,

mRNA/cds = (522, 4811)

3471
Table 3A
Hs.17757
NM_021622
11055985
pleckstrin homology domain-
1
GCCGTCCTCAGTTACCTTTCATGAGG

containing, family A (phosphoinositide

CTTCTAGCCAAAGATGATAAAGGG

binding specific) member 1

(PLEKHA1), mRNA/cds = (66, 1260)

3472
Table 3A
Hs.106747
NM_021626
11055991
serine carboxypeptidase 1 precursor
1
AGGATAAAATCATTGTCTCTGGAGGC

protein (HSCP1),

AATTTGGAAATTATTTCTGCTTCT

mRNA/cds = (32, 1390)

3473
Table 3A
Hs.3826
NM_021633
11056005
cDNA FLJ14750 fis, clone
1
CGGGTGATTACAGGCACCAGTGCAG

NT2RP3002948, weakly similar to

TGATGATTGTACTTATTTGACACAT

RING CANAL PROTEIN/cds =

(200, 1906)

3474
Table 3A
Hs.155418
NM_021643
11056053
GS3955 protein (GS3955),
1
GCCTCTGGTGCTTTGTCCTGTATTTG

mRNA/cds = (1225, 2256)

GTTTAATGTTTTTGTCCTAATCTC

3475
Table 3A
Hs.279681
NM_021644
14141158
heterogeneous nuclear
1
TTGATGTGAATTCAGTTATTGAACTTG

ribonucleoprotein H3 (2H9) (HNRPH3),

TTACTTGTTTTTGCCAGAAATGT

transcript variant 2H9,

mRNA/cds = (118, 1158)

3476
Table 3A
Hs.174030
NM_021777
11496993
a disintegrin and metalloproteinase
1
AAGCTTCGAACTCAAAATCATGGAAA

domain 28 (ADAM28), transcript variant

GGTTTTAAGATTTGAGGTTGGTTT

1, mRNA/cds = (47, 2374)

3477
Table 3A
Hs.288906
NM_021818
11141888
WW Domain-Containing Gene
1
CCCAGTTAGATATCAGTGAGTTTGAA

(WW45), mRNA/cds = (215, 1366)

TAACTGAAGAAATGTTGACAATGT

3478
Table 3A
Hs.10724
NM_021821
11141894
MDS023 protein (MDS023),
1
AAGTACACCTGTCAGCTGTTTCTTAC

mRNA/cds = (335, 1018)

CACTTCGATGGTTGTGATTAATTT

3479
Table 3A
Hs.154938
NM_021825
11141900
hypothetical protein MDS025
1
TGTTTGCTTGAACAGTTGTGTAAATC

(MDS025), mRNA/cds = (5, 769)

ATACAGGATTTTGTGGGTATTGGT

3480
literature
Hs.302003
NM_021922
11345453
Fanconi anemia, complementation
1
TGACCTTCTGTGTTTTTGTTTCTGACT

group E (FANCE),

TGAATAATTTATCAATGGTGTTG

mRNA/cds = (185, 1795)

3481
Table 3A
Hs.7174
NM_021931
11345467
hypothetical protein FLJ22759
1
CCAGGGCTGCTTTGCTGTGATGATGA

(FLJ22759), mRNA/cds = (2, 2113)

TTGCATTTCAACACATGCCAGATG

3482
Table 3A
Hs.89751
NM_021950
11386188
membrane-spanning 4-domains,
1
GAGTTACCACACCCCATGAGGGAAG

subfamily A, member 2 (Fe fragment of

CTCTAAATAGCCAACACCCATCTGT

lgE, high affinity I, receptor for, beta

polypeptide) (MS4A2),

mRNA/cds = (90, 983)

3483
Table 3A
Hs.2484
NM_021966
11415027
T-cell leukemia/lymphoma 1A
1
TTCTATCCTTGACTTAGATTCTGGTG

(TCL1A), mRNA/cds = (45, 389)

GAGAGAAGTGAGAATAGGCAGCCC

3484
Table 3A
Hs.75569
NM_021975
11496238
v-rel avian reticuloendotheliosis viral
1
TCTTGCTCTTTCTACTCTGAACTAATA

oncogene homolog A (nuclear factor of

AAGCTGTTGCCAAGCTGGACGGC

kappa light polypeptide gene enhancer

in B-cells 3 (p65))) (RELA),

mRNA/cds = (38, 1651)

3485
literature
Hs.245342
NM_021979
13676856
hypothetical protein FLJ14642
1
TGCAAACAAATGCATAAATGCAAATG

(FLJ14642), mRNA/cds = (23, 583)

TAAAGTAAAGCTGAAATTGATCTC

3486
Table 3A
Hs.326801
NM_021998
11527399
DNA sequence from PAC 75N13 on
1
ATGCTACTTGGGAGAAAACTCTCACT

chromosome Xq21.1. Contains ZNF6

AACTGTCTCACCGGGTTTCAAAGC

like gene, ESTs, STSs and CpG

islands/cds = (567, 2882)

3487
Table 3A
Hs.293970
NM_021999
11527401
methylmalonate-semialdehyde
1
TGCAATGGAATATAAATATCACAAAG

dehydrogenase (ALDH6A1),

TTGTTTAACTAGACTGCGTGTTGT

mRNA/cds = (42, 1649)

3488
Table 3A
Hs.82407
NM_022059
11545764
CXC chemokine ligand 16 (CXCL16),
1
TTTCACCTCCTCAGTCCCTTGCCTAC

mRNA/cds = (423, 1244)

CCCAGTGAGAGTCTGATCTTGTTT

3489
Table 3A
Hs.136164
NM_022117
11545834
cutaneous T-cell lymphoma-
1
CGCCTCTCCCCGTGGACCCTGTTAAT

associated tumor antigen se20-4

CCCAATAAAATTCTGAGCAAGTTC

(SE20-4), mRNA/cds = (129, 2210)

3490
Table 3A
Hs.24633
NM_022136
11545870
SAM domain, SH3 domain and
1
AGGATTCGCTGTTGAAACAAGTTGTC

nuclear localisation signals, 1

CAAGCAATGTTATATTCATTTTTA

(SAMSN1), mRNA/cds = (82, 1203)

3491
Table 3A
Hs.184052
NM_022152
11545897
PP1201 protein (PP1201),
1
GGAAGGGGGACAAGGGTCAGTCTGT

mRNA/cds = (75, 1010)

CGGGTGGGGGCAGAAATCAAATCAG

3492
Table 3A
Hs.184052
NM_022152
11545897
PP1201 protein (PP1201),
1
GGAAGGGGGACAAGGGTCAGTCTGT

mRNA/cds = (75, 1010)

CGGGTGGGGGCAGAAATCAAATCAG

3493
literature
Hs.294030
NM_022447
13937360
topoisomerase-related function protein
1
TTTTTCCCAGCTCGCCACAGAATGGA

4-2 (TRF4-2), mRNA/cds = (336, 869)

TCATGAAGACTGACAACTGCAAAA

3494
Table 3A
Hs.74899
NM_022451
11967984
hypothetical protein FLJ12820
1
AGGAGTGGCCTAAGAAATGCGTGTTT

(FLJ12820), mRNA/cds = (156, 1451)

CAGTGACTAGATTATAAATATTCT

3495
Table 3A
Hs.15220
NM_022473
11968022
zinc finger protein 106 (ZFP106),
1
AGCTGTGAACTTCGTAACTTTGTAAA

mRNA/cds = (335, 5986)

GCAAGATATAAAGCAAATACAAGA

3496
Table 3A
Hs.27556
NM_022485
11968038
hypothetical protein FLJ22405
1
AGGAGGGATCACCTGCACTGAGAAT

(FLJ22405), mRNA/cds = (81, 1334)

GAGGCAGTTTGACACAGATCACAAA

3497
Table 3A
Hs.26367
NM_022488
11968042
PC3-98 protein (PC3-96),
1
TGTTCCACTACCAGCCTTACTTGTTTA

mRNA/cds = (119, 586)

ATAAAAATCAGTGCAAAGAGAAA

3498
Table 3A
Hs.22353
NM_022494
11968052
hypothetical protein FLJ21952
1
ACCTCAGATTTTGTTACCTGTCTTTTA

(FLJ21952), mRNA/cds = (424, 1665)

AAAATGCAGATTTTGTCAAATCA

3499
Table 3A
Hs.23259
NM_022496
11968056
hypothetical protein FLJ13433
1
TTAACGGCTTCACTGGACAGTTTTCC

(FLJ13433), mRNA/cds = (35, 1225)

TTAGAAGGTAGTTTTGTGTGACTG

3500
Table 3A
Hs.275885
NM_022551
14165467
mRNA; cDNA DKFZp586A0618 (from
1
ACCGTGGGTGTGTCCAAGAAGAAATA

clone DKFZp586A0818)/cds =

AGTCTGTAGGCCTTGTCTGTTAAT

UNKNOWN

3501
Table 3A
Hs.161788
NM_022570
13384803
C-type (calcium dependent,
1
CCAATGGATATTTCTGTATTACTAGG

carbohydrate-recognition domain)

GAGGCATTTACAGTCCTCTAATGT

lectin, superfamily member 12

(CLECSF12), mRNA/cds = (71, 676)

3502
literature
Hs.65328
NM_022725
12232378
Fanconi anemia, complementation
1
TAGCTTTAGAAAATAACAGTTTGTGAA

group F (FANCF),

CTTACTTCCCTATATTTGCAGCT

mRNA/cds = (13, 1137)

3503
Table 3A
Hs.83809
NM_022727
12232380
Hpall tiny fragments locus 9C
1
CTTTGTGGACTAGCCAAGGCTGTGAG

(HTF9C), mRNA/cds = (235, 1662)

GGCCAGAATAAACAACTGCTCAAC

3504
Table 3A
Hs.7503
NM_022738
12232392
hypothetical protein FLJ14153
1
GCCGAGCAATGACCCTTTTCAATTTC

(FLJ14153), mRNA/cds = (30, 1427)

TTATTTCTGTGTTACTGAGGACCC

3505
Table 3A
Hs.194477
NM_022739
12232398
E3 ubiquitin ligase SMURF2
1
GAAACATGTGGATTTGCTGTGGAATG

(SMURF2), mRNA/cds = (8, 2254)

ACAAGCTTCAAGGATTTACCCAGG

3506
Table 3A
Hs.34516
NM_022766
12232440
mRNA for KIAA1646 protein, partial
1
TTTGATCTGAAATGTTTGAGAAGACA

cds/cds = (0, 1446)

CGAATAAAGTTACTTGGGCAGAAA

3507
Table 3A
Hs.154057
NM_022790
13027789
matrix metalloproteinase 19 (MMP19),
1
TCCCATCAAAAAGGTATCAAATGCCT

transcript variant rasi-3,

TGGAAGCTCCCTGATCCTACAAAA

mRNA/cds = (1642, 1899)

3508
Table 3A
Hs.121849
NM_022818
13699868
microtubule-associated proteins 1A/1B
1
ATCTGACATTATTGTAACTACCGTGT

light chain 3 (MAP1A/1BLC3),

GATCAGTAAGATTCCTGTAAGAAA

mRNA/cds = (84, 461)

3509
Table 3A
Hs.148123
NM_022894
12587626
hypothetical protein FLJ12972
1
ACCTTGTACCATGGAAAACATGAAAA

(FLJ12972), mRNA/cds = (168, 1076)

GAGTCTTAGAAGTAAAGAACAACA

3510
Table 3A
Hs.57987
NM_022898
12697634
B-cell lymphoma/leukaemia 11B
1
AGCATGTGTCTGCCATTTCATTTGTA

(BCL11B), mRNA/cds = (267, 2738)

CGCTTGTTCAAAACCAAGTTTGTT

3511
Table 3A
Hs.128003
NM_022900
12597838
hypothetical protein FLJ21213
1
TGAGCTGTATTACCATAAGTAGAATTT

(FLJ21213), mRNA/cds = (74, 1042)

TAAGTAAACTGGTGAATTTGGGC

3512
Table 3A
Hs.194688
NM_023005
14670389
bromodomain adjacent to zinc finger
1
GCCCCATTAAAGGGTGAACTTGTAAT

domain, 1B (BAZ1B), transcript variant

AAATTGGAATTTCAAATAAACCTC

1, mRNA/cds = (352, 4803)

3513
Table 3A
Hs.168232
NM_023079
12751494
hypothetical protein FLJ13855
1
TGCCCTAATCTTGAGTTGAGGAAATA

(FLJ13855), mRNA/cds = (314, 1054)

TATGCACAGGAGTCAAAGAGATGT

3514
db mining
Hs.37026
NM_024013
13128949
interferon, alpha 1 (IFNA1),
1
AACGTCATGTGCACCTTTACACTGTG

mRNA/cds = (67, 636)

GTTAGTGTAATAAAACATGTTCCT

3515
Table 3A
Hs.302981
NM_024033
8922813
hypothetical protein FLJ11000
1
TTATTCATATATTCCTGTCCAAAGCCA

(FLJ11000), mRNA/cds = (223, 780)

CACTGAAAACAGAGGCAGAGACA

3516
Table 3A
Hs.115960
NM_024036
13128987
hypothetical protein MGC3103
1
GCAGCCACCCACTGGGAGTCTTGTTT

(MGC3103), mRNA/cds = (10, 984)

TTATTTATAATAAAATTGTTGGGG

3517
Table 3A
Hs.7392
NM_024045
13129005
nucleolar protein GU2 (GU2),
1
ATCCACCAAAAATTAGGTCATCATAG

mRNA/cds = (107, 2320)

TTGAGGTATGTGTCTGCTATTTGC

3518
Table 3A
Hs.103834
NM_024056
13129025
hypothetical protein MGC5576
1
CCATTGGCTGGAACATGGATTGGGG

(MGC5576), mRNA/cds = (51, 803)

ATTTGATAGAAAAATAAACCCTGCT

3519
Table 3A
Hs.115659
NM_024061
13129035
hypothetical protein MGC5521
1
GTTCCTTACTCTGTCCTTGATGGAGG

(MGC5521), mRNA/cds = (163, 708)

GGAGAAGGGAGGGCAAAGAAGTTA

3520
Table 3A
Hs.267400
NM_024095
13129097
hypothetical protein MGC5540
1
TGGTTTTCCTTTGGGGACGTGGTTAA

(MGC5540), mRNA/cds = (77, 943)

CGGTCCAGAAGAATCCCTTCTAGA

3521
Table 3A
Hs.321130
NM_024101
13129107
hypothetical protein MGC2771
1
ACCCCTTTCACTCTTGGCTTTCTTATG

(MGC2771), mRNA/cds = (184, 1986)

TTGCTTTCATGAATGGAATGGAA

3522
Table 3A
Hs.109701
NM_024292
13236509
ubiquitin-like 5 (UBL5),
1
CCCATCCTCATCCCCCACACTGGGAT

mRNA/cds = (65, 286)

AGATGCTTGTTTGTAAAAACTCAC

3523
Table 3A
Hs.78768
NM_024298
13236521
malignant cell expression-enhanced
1
TCAGGCCGCCTAGCTGCCCCTTTGC

gene/tumor progression-enhanc

CAGGTTAATAAAGCACTGACTTGTT

(LENG4), mRNA/cds = (1101, 1700)

3524
Table 3A
Hs.323193
NM_024334
13236586
hypothetical protein MGC3222
1
AAGGATTTTAAATAACTGCCGACTTC

(MGC3222), mRNA/cds = (149, 1351)

AAAAGTGTTCTTAAAACGAAAGAT

3525
Table 3A
Hs.15961
NM_024348
13259513
dynactin 3 (p22) (DCTN3), transcript
1
CACCCACCCTCCCCCCAATCAGTGTT

variant, 2 mRNA/cds = (16, 546)

CTTATTTCAGTGACAATAAACCAT

3526
Table 3A
Hs.8121
NM_024408
13249343
Notch (Drosophila) homolog 2
1
ATAGCTGGTGACAAACAGATGGTTGC

(NOTCH2), mRNA/cds = (12, 7427)

TCAGGGACAAGGTGCCTTCCAATG

3527
db mining
Hs.12315
NM_004557
13375722
hypothetical protein FLJ11608
1
CATGGATATCATGTATCCTTCCTGGT

(FLJ11608), mRNA/cds = (561, 1184)

GCTCACACACCTGTCACCTTGTAA

3528
Table 3A
Hs.337561
NM_024567
13375737
hypothetical protein FLJ21616
1
GCTGTGTGACTTAGTAGATAAAATAC

(FLJ21616), mRNA/cds = (119, 1093)

TGCCTTCTGCCTTTGGGACCATGA

3529
db mining
Hs.236449
NM_024898
13376352
hypothetical protein FLJ22757
1
ACTTCCATCTCAGCTAATGCACCCAC

(FLJ22757), mRNA/cds = (92, 2473)

CAGCTCAAACACACCAATAAAGCT

3530
literature
Hs.72241
NM_030662
13489053
mitogen-activated protein kinase
1
GCTGCTGTGTGTGGTCTCAGAGGCT

kinase 2 (MAP2K2),

CTGCTTCCTTAGGTTACAAAACAAA

mRNA/cds = (263, 1465)

3531
Table 3A
Hs.196270
NM_030780
13540550
folate transporter/carrier (LOC81034),
1
ATTTATCGTAAACATCCACGAGTGCT

mRNA/cds = (128, 1075)

GTTGCACTACCATCTATTTGTTGT

3532
Table 3A
Hs.211458
NM_030788
13540564
DC-specific transmembrane protein
1
CCCCACAATGGTCTCTTTTCTCCCTG

(LOC81501), mRNA/cds = (51, 1463)

CTCCCTTATTAAAGAACTCTTTCT

3533
cytokine
Hs.46468
NM_031409
14043039
chemokine (C—C motif) receptor 6
1
CAGTGGTTCCCATTGATTCTCCCCAT

arrays

(CCR6), transcript variant 2,

ATCTTTTTGCTCTCAGGCTCTGGC

mRNA/cds = (551, 1675)

3534
Table 3A
Hs.301183
NM_031419
13899228
molecule possessing ankyrin repeats
1
CTTGTATCTCTAAATATGGTGTGATAT

induced by lipopolysaccharide (MAJL),

GAACCAGTCCATTCACATTGGAA

homolog of mouse (MAJL),

mRNA/cds = (48, 2204)

3535
Table 3A
Hs.245798
NM_031435
13899258
hypothetical protein DKFZp56410422
1
ACATAGATTTTCTGCCAACAAATCCT

(DKFZP56410422),

CTCTGCTGTTCACATTATCCTTTG

mRNA/cds = (510, 1196)

3536
db mining
Hs.238730
NM_031437
13899264
hypothetical protein MGC10823
1
CAGAGGTGGGAGTAACTGCTGGTAG

(MGC10823), mRNA/cds = (63, 1235)

TGCCTTCTTTGGTTGTGTTGCTCAG

3537
Table 3A
Hs.103376
NM_031453
13899290
hypothetical protein MGC11034
1
TTAGAACCAAAGTTATTCTTAATAAAA

(MGC11034), mRNA/cds = (245, 640)

ATCACCACATGCTTGGACCATGC

3538
Table 3A
Hs.281397
NM_031480
13899339
hypothetical protein AD034 (AD034),
1
GCTCTTACACTTCGTCTTTAATGTTCT

mRNA/cds = (195, 1880)

TTTTGGAGTTAGGACCTCTCAGT

3539
RG
Hs.334691
NM_032223
1419927
hypothetical protein FLJ22427
1
ACCTTGACATGGGTTGTCTAATAAAA

house-

(FLJ22427), mRNA/cds = (40, 2631)

CTCGGACCCTTCTTGTGAAATCAA

keeping

genes

3540
Table 3A
NA
R11456
764191
spleen 1NFLS cDNA clone
1
ATCCCAGTGCACAGTGAGTTGTATAT

IMAGE:129880 5′ similar to

CACAAATAGGAGGCCACTTCAGGA

3541
RG
Hs.170222
R14692
768965
Na+/H+ exchanger NHE-1 isoform
1
GAAGCTGCTAGGGGAAGGACTGGCC

house-

[human, heart, mRNA, 4516 nl]/cds =

TGGCTCCAGAATGTTGTTGCCTTTT

keeping

(577, 3024)

genes

3542
Table 3A
Hs.100896
R18757
772387
yg17e04.r1 cDNA, 5′
1
GGGAAGGAAAAGGGGTGTGGCAGCT

end/clone =

GGGAGCGTTTATTTATGTTCTTTCT

IMAGE:32522/clone _end = 5′

3543
RG
Hs.82927
AK025706
10438309
cDNA:FLJ22053 fis, clone HEP09502,
1
GAGTGGTGTTCCCAGTGTGGCTCCC

house-

highly similar to HUMAMPO2 AMP

AGAGCTTTGACCAGATTGTGATCCC

keeping

deaminase (AMPD2)

genes

mRNA/cds = UNKNOWN

3544
RG
Hs.240013
R44202
822065
mRNA; cDNA DKFZp547A166 (from
1
CTTTGCATTTAGGGACACAGCCCGGA

house-

clone DKFZp547A166)/cds =

GCCGCAGAAGGTCAGCAGGGAGCA

keeping

UNKNOWN

genes

3545
RG
Hs.12163
NM_003908
4503504
DNA sequence from clone RP1-64K7
1
CATTGCCTACTTTAACACCTGTCAGA

house-

on chromosome 20q11.21-11.23.

GAAACGTGATATGGGGTAAGGAGG

keeping

Contains the EIF2B2 gene for

genes

eukaryotic translation initiation factor 2

subunit 2 (beta, 38kD), a putative novel

gene, the gene for heterogenous

nuclear ribonucleoprotein RALY or

autoantigen P542, an RPS2 (RPS4)

(40S ribosomal protein S2)

pseudogene, ESTs, STS, GSSs and

two CpG islands/cds = (138, 1139)

3546
RG
Hs.26320
R56088
826194
mRNA for TRABID protein (TRABID)
1
GCAATCTGGGAGCAGCACATTGTTGA

house-

gene)/cds = (406, 2532)

TGGAGTCCAAGTGAGCACATTTCA

keeping

genes

3547
Table 3A
Hs.208603
R64054
835933
7f01d11.x1 cDNA, 3′
1
CTCTCCTGGACTGTTGCAGTTGGGTG

end/clone =

TGGCTGATTTGAAATTGTGCTTCA

IMAGE:3293397/clone_end = 3′

3548
Table 3A
Hs.181400
R67739
840377
602650370T1 cDNA, 3′
1
TAACAAGAATTGCATTGAGGAAACAA

end/clone =

GGCTCCACAGGGCCAATCTTCTGG

IMAGE:4761353/clone_end = 3′

3549
Table 3A
Hs.161043
R84314
942720
602415728F1 cDNA, 5′
1
AAGAAGTTACATCTTCAATGTCCAGG

end/clone =

GATGATCGTTTGAAGAGAACCTCT

IMAGE:4523958/clone_end = 5′

3550
Table 3A
NA
R85137
943543
brain N2b4HB55Y cDNA clone
1
AAAACATTGCCAGACCATTTAGTCCT

IMAGE:180492 5′

CTTGGAAGGGCCTCTCCGGTGGGG

3551
Table 3A
Hs.134025
R88126
946939
UL-H-B12-agp-a-07-0-UL.s1 cDNA, 3′
1
AGGGATAATAAGGTTAGCTGTTAACC

end/clone =

AAGCAACTGAGCTTTTAACCAAAG

IMAGE:2724781/clone_end = 3′

3552
Table 3A
Hs.85289
S53911
264768
CD34 antigen (CD34),
1
CAAGACACTGTGGACTTGGTCACCAG

mRNA/cds = (90, 1076)

CTCCTCCCTTGTTCTCTAAGTTCC

3553
Table 3A
Hs.246381
S57235
298664
CD68 antigen (CD68),
1
TCTTTGACGGGGTTTTCCTTGCTCCT

mRNA/cds = (15, 1079)

GCCAGGATTAAAAGTCCATGAGTT

3554
Table 3A
Hs.75258
S59049
299704
regulator of G-protein signalling 1
1
CTTAAAGTATATGTTTTCAAATTGCCA

(RGS1), mRNA/cds = (14, 604)

TTGCTACTATTGCTTGTCGGTGT

3555
Table 3A
Hs.279518
S60099
300168
amyloid beta (A4) precursor-like
1
CTCCTGTCACCGGCCTTGTGACATTC

protein 2 (APLP2),

ACTCAGAGAAGACCACACCAAGGA

mRNA/cds = (72, 2363)

3556
Table 3A
Hs.300697
S62140
386156
mRNA for immunoglobulin lambda
1
GTCGGACTATGTAATTGTAACTATAC

heavy chain/cds = (65, 1498)

CTCTGGTTCCCATTAAAAGTGACC

3557
Table 3A
Hs.249247
S63912
399757
heterogeneous nuclear
1
GCTAGTGTTTGAATATGCTCTCTTGTT

ribonucleoprotein A3 (HNRPA3),

GCTCTAATTCTGTGCCTCCGTGC

mRNA/cds = (30, 839)

3558
Table 3A
Hs.155924
S68271
545204
cAMP responsive element modulator
1
AGAGGAACTTGAAACCTTGAAA

(CREM), mRNA/cds = (0, 998)

GACATTTGTTCTCCCAAAACTGAT

TACT

3559
Table 3A
Hs.89545
S71381
551546
proteasome (prosome, macropain)
1
ACTGGGATATTGCCCACATGATCAGT

subunit, beta type, 4 (PSMB4),

GGCTTTGAATGAAATACAGATGCA

mRNA/cds = (23, 817)

3560
Table 3A
Hs.179526
S73591
688298
upregulated by 1,25-dihydroxyvitamin
1
CCAGAAAGTGTGGGCTGAAGATGGT

D-3 (VDUP1), mRNA/cds = (221, 1396)

TGGTTTCATGTGGGGGTATTATGTA

3561
Table 3A
Hs.155396
S74017
693841
nuclear factor (erythroid-derived 2)-like
1
TTTCTTAGGACACCATTTGGGCTAGT

2 (NFE2L2), mRNA/cds = (39, 1808)

TTCTGTGTAAGTGTAAATACTACA

3562
Table 3A
Hs.274401
S75463
833998
mRNA, cDNA DKFZp434P086 (from
1
GAAGGGTTGGCCTGCCTGGCTGGGG

clone DKFZp434P086); partial

AGGTCAGTAAACTTTGAATAGTAAG

cds/cds = (798, 1574)

3563
Table 3A
Hs.73090
S76638
243420
p50-NF-kappa B homolog (human
1
TTAACACCCCACACCCACCCCTCAGT

peripheral blood T cells, mRNA, 3113

TGGGACAAATAAAGGATTCTCATG

nt)/cds = 250, 2952)

3564
Table 3A
Hs.252136
S80990
1911529
ficolin (collagen/fibrinogen domain-
1
CAAGCCGCCACATGCCCACAACCTC

containing) 1 (FCN1),

ACCAGAGGGAGAATTATGTTTCTAA

mRNA/cds = (92, 1072)

3565
Table 3A
Hs.301497
T77017
694220
arginine-tRNA-protein transferase 1-1p
1
GTGTATTGATCCAAGTAGTCAAAGTG

(ATE1) mRNA, alternatively spliced

TCTTAAAGGGCACCTATTTGTCCT

product, partial cds/cds = (0, 1544)

3566
Table 3A
Hs.158183
T78173
696682
yd79c05.r1 cDNA, 5′
1
AGTGCTTTCCAAATGTGATTGTTCTG

end/clone =

GGTGATGGGACATATGGGCAGTTG

IMAGE:114440/clone_end = 5′

3567
Table 3A
NA
T80378
698887
1NIB cDNA clone IMAGE:24693 5′
1
CGGGGGAATAGGAGGAAAAACATGG

CATGGAACAAACCAACATAAAAGGT

3568
Table 3A
NA
T80854
703539
spleen 1NFLS cDNA clone
1
ACTAATTCTGCTCTTTGGACAAGTGC

IMAGE:108950 5′

CTGACATCTGCTTCATTGGGTTTT

3569
Table 3A
Hs.189744
T85880
714232
qz25e11.x1 cDNA, 3′
1
AGGAATAAAGTTAAGTATTTCCCACTT

end/clone =

GGAAATTGTACCACTCCTGGGGT

IMAGE:2027948/clone_end = 3′

3570
Table 3A
Hs.327
U00672
482802
interleukin 10 receptor, alpha
1
CCTCTGCCAAAGTACTCTTAGGTGCC

(IL10RA), mRNA/cds = (61, 1797)

AGTCTGGTAACTGAACTCCCTCTG

3571
Table 3A
Hs.184592
U00946
405048
protein kinase, lysine deficient 1
1
GTCTGGTAAGCCGATGCTAATGGCA

(PRKWNK1), mRNA/cds = (0, 7148)

GAACCAATAGAAGTCCAAGGCACTA

3572
Table 3A
Hs.278857
U01923
460085
heterogeneous nuclear
1
ACGGGACAATTTTAAGATGTAATACC

ribonucleoprotein H2 (H′) (HNRPH2),

AATACTTTAGAAGTTTGGTCGTGT

mRNA/cds = (78, 1427)

3573
Table 3A
Hs.303627
U02019
433343
heterogeneous nuclear
1
CTCTCAGTTCCCAAGATGGCCCCACA

ribonucleoprotein D (AU-rich element

TTCCCATTGTTTTCCCCAAGAGAA

RNA-binding protein 1,37kD)

(HNRPD), transcript variant 1,

mRNA/cds = (285, 1352)

3574
Table 3A
Hs.239138
U02020
404012
pre-B-cell colony-enhancing factor
1
GGTTGTTGTATTGTACCAGTGAAATG

(PBEF), mRNA/cds = (27, 1502)

CCAAATTTGAAAGGCCTGTACTGC

3575
Table 3A
Hs.172081
U02882
433348
rolipram-sensitive 3′, 5′-cyclic AMP
1
TTGTTTGCCATCTGTTGATCAGGAAC

phosphodiesterase mRNA, complete

TACTTCAGCTACTTGCATTTGATT

cds/cds = (108, 1922)

3576
Table 3A
Hs.75969
U03105
476094
proline-rich protein with nuclear
1
AATCTACATTTTCTTACCAGGAGCAG

targeting signal (B4-2),

CATTGAGGTTTTTGAGCATAGTAC

mRNA/cds = (113, 1096)

3577
Table 3A
Hs.89421
U03644
476104
CBF1 interacting corepressor (CIR),
1
ACAGAGAGCACCCAGGAGGTACACA

mRNA/cds = (0, 1352)

TACTAAAGTGACACAAAGAGAATGA

3578
Table 3A
Hs.154654
U03688
501030
cytochrome P450, subfamily I (dioxin-
1
TGTGTGCATAATAGCTACAGTGCATA

inducible), polypeptide 1 (glaucoma 3,

GTTGTAGACAAAGTACATTCTGGG

primary infantile) (CYP1B1),

mRNA/cds = (372, 2003)

3579
Table 3A
Hs.75546
U03851
433307
capping protein alpha mRNA, partial
1
AGCATGTTGTTTAATTTCTTTTTAAAA

cds/cds = (16, 870)

ATCACTGTTGGGCTTTGAAAGCA

3580
Table 3A
Hs.196384
U04636
496975
prostaglandin-endoperoxide synthase
1
GCTGACAAAACCTGGGAATTTGGGTT

2 (prostaglandin G/H synthase and

GTGTATGCGAATGTTTCAGTGCCT

cyclooxygenase) (PTGS2),

mRNA/cds = (134, 1948)

3581
Table 3A
Hs.118962
U05040
460151
far upstream element (FUSE) binding
1
TCACTTTCCAAATGCCTGTTTTGTGCT

protein 1 (FUBP1),

TTACAATAAATGATATGAAACCT

mRNA/cds = (26, 1960)

3582
Table 3A
Hs.79630
U05259
452561
MB-1 gene, complete cds
1
TTTATGCGTATTTAAGCCTTGGAAAC

ACAGGGACTATCTTGTGGATTGGG

3583
Table 3A
Hs.177559
U05875
463549
interferon gamma receptor 2
1
GTCTTGACTTTGGCAAATGAGCCGGA

(interferon gamma transducer 1)

GCCCCTTGGGCAGGTCACACAACC

(IFNGR2), mRNA/cds = (648, 1661)

3584
Table 3A
Hs.1197
U07550
469170
heat shock 10kD protein 1 (chaperonin
1
ACATCCAGTGTCTCCAAAATTGTTTC

10) (HSPE1), mRNA/cds = (41, 349)

CTTGTACTGATATAAACACTTCCA

3585
Table 3A
Hs.78909
U07802
984508
Tis11d gene, complete
1
GGTACAGTTGGAGCACTATATGTACT

cds/cds = (291, 1739)

CTCTGGACTACTTTGGACAGAAGT

3586
Table 3A
Hs.173965
U08316
475587
ribosomal protein S6 kinase, 90kD,
1
AAAATCACCTCAACAGCCCTGTGAAG

polypeptide 3 (RPS8KA3),

TGACCTCAGTGAGATATTTGGATC

mRNA/cds = (0, 2222)

3587
Table 3A
Hs.170171
U08626
551473
glutamine synthetase pseudogene
1
TTAAAGTGCACCTTCCAAAATGTCTC

CCATAAGTAGGTAAGACCAACCTG

3588
Table 3A
Hs.333513
U10117
498909
small inducible cytokine subfamily E.
1
AATGATGAGTGTGTGGCTACATACAA

member 1 (endothelial monocyte-

AGGAGTTCCCTTTGAGGTGAAAGG

activating) (SCYE1),

mRNA/cds = (49, 987)

3589
Table 3A
Hs.40202
U10485
505685
lymphoid-restricted membrane protein
1
GGGAAAGTATAGCATGAAACCAGAG

(LRMP), mRNA/cds = (574, 2241)

GTTCTCAGAATGACCGTAAGATAGC

3590
Table 3A
Hs.79022
U10550
762886
GTP-binding protein overexpressed in
1
TGGTTGACCCTTGTATGTCACAGCTC

skeletal muscle (GEM),

TGCTCTATTTATTATTATTTTGCA

mRNA/cds = (213, 1103)

3591
Table 3A
Hs.194776
U11870
511804
interleukin B receptor, alpha (ILBRA),
1
TTGTCCACAAGTAAAAGGAAATCCTC

mRNA/cds = (100, 1152)

CTCCAGGGAGTCTCAGCTTCACCC

3592
Table 3A
Hs.80561
U12767
924281
mitogen induced nuclear orphan
1
CATTGCTCTTTAGTGTGTGTTAACCT

receptor (MINOR) mRNA, complete

GTGGTTTGAAAGAAATGCTCTTGT

cds/cds = (209, 1972)

3593
Table 3A
Hs.184411
U13044
531892
albumin (ALB), mRNA/cds = (39, 1888)
1
GTCTGGCTTAACTATTTTTGAAAATAT

AACTGTTTCCCCTCTCTGCTGCT

3594
Table 3A
Hs.78915
U13045
531894
GA-binding protein transcription factor,
1
AAAAGCAATTACCCTTAAAACTG

beta subunit 1 (53kD) (GABPB1),

TACTCTGGCCTACTTTTCTATTT

transcript variant beta,

TGCA

mRNA/cds = (169, 1356)

3595
Table 3A
Hs.1162
U15085
557701
major histocompatibility complex, class
1
GGCTCTCAGTGTGCCATAGAGGACA

II, DM beta (HLA-DMB),

GCAACTGGTGATTGTTTCAGAGAAA

mRNA/cds = (233, 1024)

3596
Table 3A
Hs.155596
U15173
558843
BCL2/adenovirus E1B 19kD-
1
AAACTGTTTCTTTGGTGTCCTTTACAT

interacting protein 2 (BNIP2),

TGAAATAAATTGTGTTTGTGCCT

mRNA/cds = (211, 1155)

3597
Table 3A
Hs.2128
U15932
9911129
dual specificity phosphatase 5
1
ACCCGTGTGAATGTGAAGAAAAGCAG

(DUSP5), mRNA/cds = (210, 1364)

TATGTTACTGGTTGTTGTTGTTGT

3598
Table 3A
Hs.64639
U16307
1100927
glioma pathogenesis-related protein
1
AGAGAGGGAACATCAAATGCTGGCA

(RTVP1), mRNA/cds = (128, 928)

CTATATACATACGATCAGCCTGATT

3599
Table 3A
Hs.183105
U17989
805094
nuclear autoantigen (GS2NA),
1
GTCTTCCGAGAAACTTTTCTGATCAG

mRNA/cds = (204, 2345)

TTTGCGAGTTTTGATGAGTTTTGT

3600
Table 3A
Hs.155188
U18062
842794
TATA box binding protein (TBP)-
1
GCTGCTGTTGCTGCTTTGTGATGACG

associated factor, RNA polymerase II,

TGAGATCAATAAGAAGAACCTAGT

F, 55kD (TAF2F),

mRNA/cds = (740, 1789)

3601
Table 3A
Hs.2488
U20158
806765
lymphocyte cytosolic protein 2 (SH2
1
AGGACTGAACTGAACCCCTCCCCATG

domain-containing leukocyte protein of

AACACAAGGGTTTTATCCTTTCCT

76kD) (LCP2), mRNA/cds = (207, 1808)

3602
Table 3A
Hs.78913
U20350
665580
G protein-coupled receptor V28
1
GATGTGGTAACTGTTAAATTGCTGTG

mRNA, complete cds/cds = (87, 1154)

TATCTGATAGCTCTTTGGCAGTCT

3603
Table 3A
Hs.154230
U22897
984296
nuclear domain 10 protein (NDP52),
1
GATCAAAAGGGCTATGGGAAGGGCA

mRNA/cds = (54, 1394)

GACCCCGCCAATGATTTCTCTTCAC

3604
Table 3A
Hs.2437
U23028
806853
eukaryotic initiation factor 2B-epsilon
1
GAACAGCTTTGTGCTCCGGCTTTCCC

mRNA, partial cds/cds = (0, 1925)

TCAGGGAACAGCAGAGAGCAGTTG

3605
Table 3A
Hs.93304
U24577
1314245
phospholipase A2, group VII (platelet-
1
TCCAGGGACCAACATTAACACAACCA

activating factor acetylhydrolase,

ATCAACACATCATGTTACAGAACT

plasma) (PLA2G7),

mRNA/cds = (161, 1486)

3606
Table 3A
Hs.278625
U24578
1125049
RP1 and complement C4B precursor
1
TATTAAAGGCTTTTGGCAGCAAAGTG

(C4B) genes,

TCAGTGTTGGCAGCGAAGTGTCAG

3607
Table 3A
Hs.3144
U26710
862406
Cas-Br-M (murine) ectropic retroviral
1
TTCACAAGATGCTTTGAAGGTTCTGA

transforming sequence b (CBLB),

TTTTCAACTGATCAAACTAATGCA

mRNA/cds = (322, 2634)

3608
Table 3A
Hs.1724
U29607
903981
interleukin 2 receptor, alpha (IL2RA),
1
ACTAATTTGATGTTTACAGGTGGACA

mRNA/cds = (159, 977)

CACAAGGTGCAAATCAATGCGTAC

3609
Table 3A
Hs.75981
U30888
940181
ubiquitin specific protease 14 (tRNA-
1
ACTGTACAATTTCTGAAGATGGTTATT

guanine transglycosylase (USP14),

AACACTGTGCTGTTAAGCATCCA

mRNA/cds = (91, 1575)

3610
Table 3A
Hs.845
U31120
1045451
interleukin-13 (IL-13) precursor gene,
1
CTGTGTCTGGCACCACCCACACATCC

complete cds

ATGTCTCCCTCACAACCCAGGAGG

3611
Table 3A
Hs.64310
U32324
975336
interleukin 11 receptor, alpha
1
CATGTATGTAGGTGCCTGGGAGTGT

(IL11RA), mRNA/cds = (5, 1273)

GTGTGGTCCTTGCTCTGGCCCTTTC

3612
Table 3A
Hs.41724
U32659
1155222
interleukin 17 (cytotoxic T-lymphocyte-
1
ATTCAATTCCAGAGTAGTTTCAAGTTT

associated serine esterase 8) (IL17),

CACATCGTAACCATTTTCGCCCG

mRNA/cds = (53, 520)

3613
Table 3A
Hs.108327
U32986
1136227
damage-specific DNA binding protein
1
TCTTCGGAAAGAAGAAGGTGGGAGG

1 (127kD) (DDB1),

ATGTGAATTGTTAGTTTCTGAGTTT

mRNA/cds = (109, 3531)

3614
Table 3A
Hs.32970
U33017
984968
signaling lymphocytic activation
1
ATCAAGCCTCTGTGCCTCAGTTTCTC

molecule (SLAM),

TCTCAGGATAAAGAGTGAATAGAG

mRNA/cds = (133, 1140)

3615
Table 3A
Hs.2533
U34252
1049218
aldehyde dehydrogenase 9 (gamma-
1
GCGATAGAGGAAATCTACTCCCTATC

aminobutyraldehyde dehydrogenase,

TTGGGTCCTTGAACTACAGCCTGC

E3 isozyme) (ALDH9),

mRNA/cds = (377, 1858)

3616
Table 3A
Hs.169476
U34995
1497857

Homo sapiens, glyceraldehyde-3-
1
CTAGGGAGCCGCACCTTGTCATGTAC

phosphate dehydrogenase, clone

CATCAATAAAGTACCCTGTGCTCA

MGC:10926 IMAGE:3828129,

mRNA, complete cds/cds = (2306, 3313)

3617
Table 3A
Hs.289107
U37547
1145292
baculoviral IAP repeat-containing 2
1
TTTCTCCCCCTAGTTTGTGAGAAACA

(BIRC2), mRNA/cds = (1159, 3015)

TCTCAATAAAGTGCTTTCCAAAAA

3618
Table 3A
Hs.154057
U38320
2228241
matrix metalloproteinase 19 (MMP19),
1
TCCCATCAAAAAGGTATCAAATGCCT

transcript variant rasi-3,

TGGAAGCTCCCTGATCCTACAAAA

mRNA/cds = (1642, 1899)

3619
Table 3A
Hs.151518
U38847
1184691
TAR (HIV) RNA-binding protein 1
1
TGCCAAAAGTTTGCCATGTGCCTTAA

(TARBP1), mRNA/cds = (0, 4865)

ACATATTACTATATATTTTCCCCT

3620
Table 3A
Hs.75916
U41371
1173904
splicing factor 3b, subunit 2, 145kD
1
CAGTTCCCAAGGACTTGTCATTTCAT

(SF3B2), mRNA/cds = (48, 2666)

GTTCTTATTTTAGACCTGTTTTGT

3621
Table 3A
Hs.169531
U41387
1230563
DEAD/H (Asp—Glu—Ala—Asp/His)
1
TTACCAAGAAGGACTTAAGGGAGTAA

box polypeptide 21 (DDX21),

GGGGCGCAGATTAGCATTGCTCAA

mRNA/cds = (265, 2412)

3622
Table 3A
Hs.57304
U41654
2058395
Ras-related GTP-binding protein
1
GATATGCACATCAAAGCCTTTACCAG

(RAGA), mRNA/cds = (31, 972)

TATCTTCCTGTATTCCGTATCAGA

3623
Table 3A
Hs.167503
U43185
1151169
signal transducer and activator of
1
CTCTGAGGCGTGAGGACTCGCAGTC

transcription 5A (STAT5A),

AGGGGCAGCTGACCATGGAAGATTG

mRNA/cds = (640, 3024)

3624
Table 3A
Hs.54460
U46573
1280140
small inducible cytokine subfamily A
1
CCTCTCTTCCTCCCTGGAATCTTGTA

(Cys—Cys), member 11 (eolaxin)

AAGGTCCTGGCAAAGATGATCAGT

(SCYA11), mRNA/cds = (53, 346)

3625
Table 3A
Hs.279891
U46751
3077821
truncated calcium binding protein
1
GCCTCCTGGTCTCTTCACCACTGTAG

(LOC51149), mRNA/cds = (219, 695)

TTCTCTCATTTCCAAACCATCAGC

3626
Table 3A
Hs.155637
U47077
13570016
DNA-dependent protein kinase
1
TTTTCCTTCTAACACTTGTATTTGGAG

catalytic subunit (DNA-PKcs)

GCTCTTCTGTGATTTTGAGAAGT

mRNA, complete cds/cds = (57, 12443)

3627
Table 3A
Hs.306359
U50078
4220427
clone 25038 mRNA
1
TGAATTGCCTGTTCAGGGTTCCTTAT

sequence/cds = UNKNOWN

GCAGAGAAATAAAGCAGATTCAGG

3628
Table 3A
Hs.173824
U51166
1378106
thymine-DNA glycosylase (TDG),
1
GGACATCCACTAGAGTGGGTTTGAG

mRNA/cds = (399, 1631)

GATTTTCCAAGCGTGTAATAATGA

3629
Table 3A
Hs.78993
U51903
1262925
IQ motif containing GTPase activating
1
TTGCACGCAGAGCCTTTAAGTGACTA

protein 2 (IQGAP2),

AGGAACAACATAGATAGTGAGCAT

mRNA/cds = (222, 4949)

3630
Table 3A
Hs.74170
U52054
1377850
602708243F1 cDNA, 5′
1
ACTTTAATCTGATCTTGTGTCTTAGAG

end/clone =

AAGCCCCCATACCTGGTAGAGCA

IMAGE:4844914/clone_end = 5′

3631
Table 3A
Hs.82132
U52682
1378108
interferon regulatory factor 4 (IRF4),
1
TGTAGGAAAGGATGCTTCACAAACTG

mRNA/cds = (105, 1460)

AGGTAGATAATGCTATGCTGTCGT

3632
Table 3A
Hs.82132
U52682
1378108
interferon regulatory factor 4 (IRF4),
1
TGTAGGAAAGGATGCTTCACAAACTG

mRNA/cds = (105, 1460

AGGTAGATAATGCTATGCTGTCGT

3633
Table 3A
Hs.183556
U53347
1478280
solute carrier family 1 (neutral amino
1
CTGGGGAGAGGCTGAGGACAAATAC

acid transporter), member 5 (SLC1A5),

CTGCTGTCACTCCAGAGGACATTTT

mRNA/cds = (590, 2215)

3634
Table 3A
Hs.333527
U53530
1314642
cDNA FLJ13685 fis, clone
1
CATTACTTGTGAGCTGCTGAACAAAC

PLACE2000039, highly similar to

AAGTCAAGGTGAGCCCGGACATGG

DYNEIN HEAVY CHAIN,

CYTOSOLIC/cds = UNKNOWN

3635
Table 3A
Hs.58189
U54559
2351379
eukaryotic translation initiation factor 3,
1
AAGAAGTTAACATGAACTCTTGAAGT

subunit 3 (gamma, 40kD) (EIF3S3),

CACACCAGGGCAACTCTTGGAAGA

mRNA/cds = (5, 1063)

3636
Table 3A
Hs.44585
U58334
1399804
tumor protein p53-binding protein, 2
1
GAAACTTGCTACAGACTTACCCGTAA

(TP538P2), mRNA/cds = (756, 3773)

TATTTGTCAAGATCATAGCTGACT

3637
Table 3A
Hs.169191
U58913
4204907
small inducible cytokine subfamily A
1
TGGACACACGGATCAAGACCAGGAA

(Cys—Cys), member 23 (SCYA23),

GAATTGAACTTGTCAAGGTGAAGGG

mRNA/cds = (71, 433)

3638
Table 3A
Hs.11383
U59808
4097420
small inducible cytokine subfamily A
1
TGCTAAATATGTTATTGTGGAAAGAT

(Cys—Cys), member 13 (SCYA13),

GAATGCAATAGTAGGACTGCTGAC

mRNA/cds = (75, 371)

3639
Table 3A
Hs.79089
U60800
1663568
sema domain, immunoglobulin domain
1
AGCAATAAACTCTGGATGTTTGTGCG

(lg), transmembrane domain (TM) and

CGTGTGTGGACAGTCTTATCTTCC

short cytoplasmic domain,

(semaphorin) 4D (SEMA4D),

mRNA/cds = (87, 2875)

3640
Table 3A
Hs.238648
U60805
1794210
oncostatin M receptor (DSMR),
1
TCCTCTTTTCTTTCAAGAACTATATAT

mRNA/cds = (367, 3306)

AAATGACCTGTTTTCACGCGGCC

3641
Table 3A
Hs.77256
U61145
1575348
enhancer of zeste (Drosophila)
1
AGCTGCAAAGTGTTTTGTACCAGTGA

homolog 2 (EZH2),

ATTTTTGCAATAATGCAGTATGGT

mRNA/cds = (57, 2297)

3642
Table 3A
Hs.30035
U61287
1418285
splicing factor, arginine/serine-rich
1
TTGCTTACCAAAGGAGGCCCAATTTC

(transformer 2 Drosophila homolog) 10

ACTCAAATGTTTTGAGAACTGTGT

(SFRS10), mRNA/cds = (121, 987)

3643
Table 3A
Hs.155935
U82027
1511643
complement component 3a receptor 1
1
ACATAGTGAAAGTTTATAAGAGGATG

(C3AR1), mRNA/cds = (0, 1448)

AAGTGATATGGTGAGCAGCGGACT

3644
Table 3A
Hs.177584
U62981
1519051
3-oxoacid CoA transferase (OXCT),
1
AACAGCCTTTCTGGCTGACCACATGG

nuclear gene encoding mitochondrial

TTAAATGCATACCTTCCCAGTACT

protein, mRNA/cds = (98, 1660)

3645
Table 3A
Hs.75498
U64197
1778716
small inducible cytokine subfamily A
1
TGTGCCTCACCTGGACTTGTCCAATT

(Cys—Cys), member 20 (SCYA20),

AATGAAGTTGATTCATATTGCATC

mRNA/cds = (58, 348)

3646
Table 3A
Hs.73165
U64198
1685027
interleukine 12 receptor, beta 2
1
CTATAGATGAAGACATAAAAGACACT

(IL12RB2), mRNA/cds = (640, 3228)

GGTAAACACCAATGTAAAAGGGCC

3647
Table 3A
Hs.279939
U65590
1794218
mitochondrial carrier homolog 1
1
AGCTGTTGATGCTGGTTGGACAGGTT

(MTCH1), nuclear gene encoding

TGAGTCAAATTGTACTTTGCTCCA

mitochondrial protein,

mRNA/cds = (0, 1118)

3648
Table 3A
Hs.73172
U67369
1898891
growth factor independent 1 (GFI1),
1
TGGGAAGGAAGGCTCTGTCTTCAACT

mRNA/cds = (267, 1535)

CTTTGACCCTCCATGTGTACCATA

3649
Table 3A
Hs.84264
U70439
1698782

Homo sapiens, acidic protein rich in
1
GATTCTTGCTGTAGCGTGGATAGCTG

leucines, clone MGC:8650

TGATTGGTGAGTCAACCGTCTGTG

IMAGE:2961642, mRNA, complete

cds/cds = (211, 966)

3650
Table 3A
Hs.82116
U70451
1763090
myleoid differentiation primary
1
TGGGCATTTTAAAGCCATCTCAAGAG

response protein My088 mRNA,

GCATCTTCTACATGTTTTGTACGC

complete cds/cds = (32, 922)

3651
Table 3A
Hs.117005
U71383
2411474
sialic acid binding lg-like lectin 5
1
AAGTCAGGGACCACTTGCTGAAGCA

(SIGLEC5), mRNA/cds = (142, 1797)

CGAAGAGCCCTTGTGGCAATGTTAA

3652
Table 3A
Hs.12045
U72514
2276395

Homo sapiens, Similar to gene rich
1
GACTGCTGGAAGATGATCTTTCTGCA

cluster, C2f gene, clone MGC:16358

CTGAGACTGTGGAGTTTGGGGAAG

IMAGE:3927564, mRNA, complete

cds/cds = (278, 733)

3653
Table 3A
Hs.183684
U73824
1857236
eukaryotic translation initiation factor 4
1
TTGTGGGTGTGAAACAAATGGTGAGA

gamma, 2 (EIF4G2),

ATTTGAATTGGTCCCTCCTATTAT

mRNA/cds = (306, 3029)

3654
Table 3A
NA
U75686
2801402
Poly(A)-binding protein, cytoplasmic 4
1
AATTCCAGCTGAGCGCCGGTCGCTA

(inducible form)

CCATTACCGTTGGTCTTGGTGTCAA

3655
Table 3A
Hs.20191
U76248
2673967
hSIAH2 mRNA, complete
1
CCCCAACCCTCAAATTAAAACTAGAA

cds/cds = (526, 1500)

CTATAGATCCACATGAACGCACGC

3656
Table 3A
Hs.81361
U76713
1814273
heterogeneous nuclear
1
AGCTTTTGAAATAAAATTTAAAAACCC

ribonucleoprotein A/B (HNRPAB),

CAAGCCTGGGTGAGTGTGGGAAA

transcript variant 1,

mRNA/cds = (224, 1219)

3657
Table 3A
Hs.76507
U77396
1684871
LPS-induced TNF-alpha factor (PIG7),
1
TCTGTAATCAAATGATTGGTGTCATTT

mRNA/cds = (233, 919)

TCCCATTTGCCAATGTAGTCTCA

3658
Table 3A
Hs.78103
U77456
1879778
nucleosome assembly protein 1-like 4
1
GCCCCACCATTCATCCTGTCTGAAGG

(NAP1L4), mRNA/cds = (149, 1276)

TCCTGGGTTTGGTGTGACCGCTTG

3659
Table 3A
Hs.80205
U77735
1750275
pim-2 oncogene (PIM2),
1
TTCCTGCCTGGATTATTTAAAAAGCC

mRNA/cds = (185, 1189)

ATGTGTGGAAACCCACTATTTAAT

3660
Table 3A
Hs.55481
U78722
1699000
zinc finger protein 165 (ZNF165),
1
AGCCTTCAGTCAGAGCTCAAACCTTA

mRNA/cds = (567, 2024)

GTCAACACCAGAGAATTCACATGA

3661
Table 3A
Hs.71848
U79277
1710245
clone 23548 mRNA
1
GAATTTTCAGTTTGTGCTTACATTTTC

sequence/cds = UNKNOWN

TAACATTGGATGTTTGCTTTGGC

3662
Table 3A
Hs.173854
U80735
2565045
CAGF28 mRNA, partial
1
TATGACTTTAAGAGCCCACATTAGGT

cds/cds = (0, 2235)

TTTATGATTCATTTGCCAGGTTTT

3663
Table 3A
Hs.306094
U80743
2565060
mRNA for KIAA1818 protein, partial
1
GGCGTGCCGTTGAGGGGGAAAACGA

cds/cds = (0, 3473)

AGCCCAGTATTTGCTACTGTTTTTC

3664
Table 3A
Hs.181466
U81002
4580010
cDNA FLJ14502 fis, clone
1
CTCTTGGGCATAAAATCTCAGAGGAA

NT2RM1000244, highly similar to

GCTACTTAGGACATCATCTTGGCC

TRAF4 associated factor 1

mRNA/cds = (UNKNOWN)

3665
Table 3A
Hs.181002
U82828
2072424
non-lens beta gamma-crystallin like
1
TCTACAGTAGCCTGTGCTGAACTGAT

protein (AIM1) mRNA, parital

CTCTTAAATAAACTTGCTTCTGGT

cds/cds = (0, 4913)

3666
Table 3A
Hs.334457
U83115
2623760
Aac11 (aac11) mRNA, complete
1
TTCTCAAGTTTGATACTGAGTTGACT

cds/cds = (77, 1663)

GTTCCCTTATCCCTCACCGTTCCC

3667
Table 3A
Hs.80420
U83857
1888522
small inducible cytokine subfamily D
1
AGACTTTTCCAACCCTCATCACCAAC

(Cys-X3-Cys), member 1 (fractalkine,

GTCTGTGCCATTTTGTATTTTACT

neurotactin) (SCYD1),

mRNA/cds = (79, 1272)

3668
Table 3A
Hs.154685
U84487
2218086
phosphomannomutase 2 (PMM2),
1
CCAGCGGCATCTTTCCTTGTCGAATG

mRNA/cds = (48, 788)

ATACTGTAATGACCTTCCAAAGTG

3669
Table 3A
Hs.50404
U85773
2388626
small inducible cytokine subfamily A
1
TCTGGTCATTCAAGGATCCCCTCCCA

(Cys—Cys), member 25 (SCYA25),

AGGCTATGCTTTTCTATAACTTTT

mRNA/cds = (0, 452)

3670
Table 3A
Hs.162808
U86453
2317893
phosphatidylinositol 3-kinase catalytic
1
TGTGGGTTGAGACCAGCACTCTGTGA

subunit p11Odella mRNA, complete

AACCTTGAAATGAGAAGTAAAGGC

cds/cds = (195, 3329)

3671
Table 3A
Hs.74407
U88602
1835785
nucleolar protein p40; homolog of
1
TGAATACAAAGAACCAAGAAAA

yeast EBNA1-binding protein (P40),

AGGAATGAAGACTCGCAATTTCAC

mRNA/cds = (142, 1082)

GACA

3672
Table 3A
Hs.5181
U87954
4099505
proliferation-associated 2G4, 38kD
1
CTGAATTTGGTTTTGGGAGGTGAGGC

(PA2G4), mRNA/cds = (97, 1281)

TTCCCAACCACGGAAGACTACTTT

3673
Table 3A
Hs.173334
U88629
1946346
ELL-RELATED RNA POLYMERASE
1
GGCTCACATCAAAAGGCTAATAGGTG

II, ELONGATION FACTOR (ELL2),

AATTTGACCAACAGCAAGCAGAGT

mRNA/cds = (0, 1922)

3674
Table 3A
Hs.169963
U90543
2062887
butyrophilin, subfamily 2, member A1
1
GACGCCTTACAAATGATGGAGGATTC

(BTN2A1), mRNA/cds = (210, 1793)

CAAAGAGTTTTTGTTTATTTGGGT

3675
Table 3A
Hs.167741
U90548
2062697
butryophilin, subfamily 3, member A3
1
CCTGGTCATTGGTGGATGTTAAACCC

(BTN3A3), mRNA/cds = (171, 1925)

ATATTCCTTTCAACTGCTGCCTGC

3676
Table 3A
Hs.284283
U90552
2062705
butyrophilin (BTF5) mRNA, complete
1
TGGTGGATGTTAAACCAATATTCCTTT

cds/cds = (359, 1900)

CAACTGCTGCCTGCTAGGGAAAA

3677
Table 3A
Hs.83724
U90904
1913882

Homo sapiens, clone IMAGE:3451448,
1
CAGCTCTGGAAATAGAAGACTAGG

mRNA, partial cds/cds = (0, 901)

GTTGTTTCTTAAATTTAGCTCATGT

3678
Table 3A
Hs.279948
U93243
6649661
HSPC205 mRNA, complete
1
TGACTTATGAGCTGTGACTCAACTGC

cds/cds = (190, 681)

TTCATTAAACATTCTGCATTGGGT

3679
Table 3A
Hs.7811
U94856
2055430
eukaryotic translation initiation factor 3,
1
ACACTGAGATAGTCAGTTGTGTGTGA

subunit 5 (epsilon, 47kD) (EIF3S5),

CTCTAATAAACGGAGCCTACCTTT

mRNA/cds = (8, 1079)

3680
Table 3A
Hs.328248
U98828
2343084
cDNA:FLJ22071 fis, clone
1
TTTGTAAGCGAAGGAGATGGAGGTC

HEP11691/cds = UNKNOWN

GTCTTAAACCAGAGAGCTACTGAAT

3681
Table 3A
Hs.195175
U97075
2253880
mRNA for CASH alpha
1
GGATGATAACACCCTATGCCCATTGT

protein/cds = (481, 1923)

CCTGATCTGAAAATTCTTGGAAAT

3682
Table 3A
Hs.308026
V00522
32122
major histocompatibility complex, class
1
CTTTGCCTAAACCCTATGGCCTCCTG

II, DR beta 5 (HLA-DRB5),

TGCATCTGTACTCACCCTGTACCA

mRNA/cds = (29, 829)

3683
Table 3A
Hs.25647
V01512
29903
cellular oncogene c-fos (complete
1
AAAAGCATTTAAGTTGAATGCGACCA

sequence)

ACCTTGTGCTCTTTTCATTCTGGA

3684
Table 3A
Hs.44189
W00466
1271875
yz99f01.r1 cDNA, 5′
1
CCTTGAGAAACACCCATCTCCACTCC

end/clone =

TAGACAAACCAATGAACATTAGTC

IMAGE:291193/clone_end = 5′

3685
Table 3A
NA
W00491
1271910
2NbHM cDNA clone IMAGE:291255 5′
1
TCTTAAGGTGTGGCAGAGACAGGGT

similar to

ATTTGGGATATACTTTTCAGACTCC

3686
Table 3A
NA
W02600
1274578
spleen 1NFLS cDNA clone
1
AACAATAAAATATGGCTAGACTGGCC

IMAGE:296099 5′

TCTGGTTGCCTAAACAGAGCATCA

3687
Table 3A
NA
W03955
1275820
za62d04.rf cDNA, 5′
1
CTTAACTGAGGGCTTGTCCTGGTTAT

end/clone = IMAGE:297127/

AAATGTCTGGGTGGGGGTGGGCAC

3688
Table 3A
Hs.306117
W16552
1290934
capicua protein (CIC) mRNA,
1
AACTGTGAGGCAAATAAAATGCTTCT

complete cds/cds = (40, 4866)

CAAACTGTGTGGCTCTTATGGGGT

3689
Table 3A
Hs.17778
W19201
1295429
neuropilin 2 (NRP2),
1
GTGGCTAAGTCATTGCAGGAACGGG

mRNA/cds = (0, 2780)

GCTGTGTTCTCTGCTGGGACAAAAC

3690
Table 3A
Hs.235883
W19487
1295576
602626774F1 cDNA, 5′
1
ATTGCGACTGTATGGAGAAGAACTGT

end/clone =

TTGTCATTCAGTGCCGTGGGATAT

IMAGE:4753483/clone_end = 5′

3691
Table 3A
Hs.340717
W25068
1302933
we58c01.x1 cDNA, 3′
1
TTTATAGAACAATTCCTTTCTCTTCTC

end/clonde =

TTGAATGTGGCAGTCATTACTGC

IMAGE:2345280/clone_end = 3′

3692
Table 3A
Hs.173334
W47229
1331889
ELL-RELATED RNA POLYMERASE
1
TTGATTAGAGCAATGGGAAGCATACT

II, ELONGATION FACTOR (ELL2),

GTGGCCTACCAGCATCTGGAAGTG

mRNA/cds = (0, 1922)

3693
Table 3A
NA
W56487
1358345
zc59c07 rf
1
TCAATTGAGGCCCCTTCCCTAAGATT

Soares_parathyroid_tumor_NbHPA

ACAACATTGATAACCTGTCCTTTT

cDNA clone

3694
Table 3A
Hs.21812
W74397
1384683
AL562895
1
CAGCCCTCCGTCGCTTTTTATAAAAC

cDNA/clone = CS0DC021YO20-

TTTGTGTGAGAAGAATATATTGAT

(3-prime)

3695
Table 3A
Hs.163846
W79598
1390869
putative N6-DNA-methyltransferase
1
ACTTCAGATCCTTTTGTGTTTAAATAA

(N6AMT1), mRNA/cds = (29, 673)

AGGAAAAGCTGCACATCCAAAAA

3696
Table 3A
Hs.8294
W80882
1391906
KIAA0196 gene product (KIAA0196),
1
AGCCTACCTCCTACCCCAGCTGTCTG

mRNA/cds = (273, 3752)

TTGAGAGCAGTGCTGACCCCAGCA

3697
Table 3A
Hs.303157
X00437
36748
mRNA for T-cell specific
1
GAAGAGCTGCTCTCACCTCTCTGCAT

protein/cds = (37, 975)

CCCAATAGATATCCCCCTATGTGC

3698
Table 3A
Hs.75514
X00737
35564
nucleoside phosphorylase (NP),
1
GGGCTCAGTTCTGCCTTATCTAAATC

mRNA/cds = (109, 978)

ACCAGAGACCAAACAAGGACTAAT

3699
Table 3A
Hs.1724
X01057
33812
interleukin-2 receptor
1
AAATACAAACATTCTAATTAAAGGCTT

TGCAACACATGCCTTGTCTGTTT

3700
Table 3A
Hs.95327
X01451
36774
CD3D antigen, delta polypeptide (TIT3
1
GCCATTACCAACTGTACCTTCCCTTC

complex) (CD3D), mRNA/cds = (0, 515)

TTGCTCAGCCAATAAATATATCCT

3701
Table 3A
Hs.1103
X02812
37092
tranforming growth factor, beta 1
1
CACCAGGAACCTGCTTTAGTGGGGG

(TGFB1), mRNA/cds = (841, 2016)

ATAGTGAAGAAGACAATAAAAGATA

3702
Table 3A
Hs.1217
X02994
28379
adenosine deaminase (ADA),
1
TGGGCATGGTTGAATCTGAAACCCTC

mRNA/cds = (95, 1186)

CTTCTGTGGCAACTTGTACTGAAA

3703
Table 3A
Hs.2233
X03656
31687
gene for granuloctye colony-stimulating
1
CTGGGGAGGAGGTCCAGGGAGGAG

factor (G-CSF)

GAGGAAAGTTCTCAAGTTCGTCTGAC

3704
Table 3A
Hs.174142
X03663
29899
colony stimulating factor 1 receptor,
1
AACTAACAGTCACGCCGTGGGATGTC

formerly McDonough feline sarcoma

TCTGTCCACATTAAACTAACAGCA

viral (v-fms) oncogene homolog

(CSF1R), mRNA/cds = (300, 3218)

3705
Table 3A
Hs.14376
X04098
28338
actin, gamma 1 (ACTG1),
1
GGTTTTCTACTGTTATGTGAGAACATT

mRNA/cds = (74, 1201)

AGGCCCCAGCAACACGTCATTGT

3706
Table 3A
Hs.74451
X04106
35327
calpain 4, small subunit (30K)
1
TTTGTCTATATTCTGCTCCCAGCCTG

(CAPN4), mRNA/cds = (158, 964)

CCAGGCCAGGAGGAAATAAACATG

3707
Table 3A
Hs.198365
X04327
29480
2,3-bisphosphoglycerate mutase
1
TTCCTCTTTGGCCACAAGAATAAGCA

(BPGM), mRNA/cds = (110, 889)

GCAAATAAACAACTATGGCTGTTG

3708
Table 3A
Hs.58685
X04391
37186
CD5 antigen (P56-62) (CD5),
1
CTCATCTAAAGACACCTTCCTTTCCA

mRNA/cds = (72, 1559)

CTGGCTGTCAAGCCACAGGGCACC

3709
Table 3A
Hs.93913
X04430
32673
interleukine B (interferon, beta 2) (IL6),
1
GCAGTTTGAATATCCTTTGTTTCAGA

mRNA/cds = (62, 700)

GCCAGATCATTTCTTGGAAAGTGT

3710
Table 3A
Hs.2253
X04481
34627
complement component 2 (C2),
1
CCCTGGTTGACTTGACTCATGCTTGT

mRNA/cds = (36, 2294)

TTCACTTTCACATGGAATTTCCCA

3711
Table 3A
Hs.2247
X04688
33835
interleukin 5 (colony-stimulating factor,
1
TCAGAGGGAAAGTAAATATTTCAGGC

eosinophil) (IL5), mRNA/cds = (44, 448)

ATACTGACACTTTGCCAGAAAGCA

3712
Table 3A
Hs.79015
X05323
34742
MRC OX-2 gene signal sequence
1
CACAAGGTAAAGAAACTCAATTCCCC

TGCTTGGAGCCCAGCAAACACAAT

3713
Table 3A
Hs.78225
X05908
34387
annexin A1 (ANXA1),
1
TGTGGAGGAAACTAAACATTCCCTTG

mRNA/cds = (74, 1114)

ATGGTCTCAAGCTATGATCAGAAG

3714
Table 3A
Hs.36972
X06180
29819
CD7 antigen (p41) (CD7),
1
GGAGGAGACCAGTCCCCCACCCAGC

mRNA/cds = (0, 722)

CGTACCAGAAATAAAGGCTTCTGTG

3715
Table 3A
Hs.81665
X06182
34084
v-kit Hardy-Zuckerman 4 feline
1
TGTGTAAATACATAAGCGGCGTAAGT

sarcoma viral oncogene homolog (KIT),

TTAAAGGATGTTGGTGTTCCACGT

mRNA/cds = (21, 2951)

3716
Table 3A
Hs.173255
X06347
37540
small nuclear ribonucleoprotein
1
CGCTGTTAGGCCGGAATTAAAGTGG

polypeptide A (SNRPA),

CTTTTTGAGGTTTGGTTTTTCACAA

mRNA/cds = (125, 973)

3717
db mining
Hs.2014
X06557
37003
mRNA for T-cell receptor
1
GGGGTTTATGTCCTAACTGCTTTGTA

delta/cds = UNKNOWN

TGCTGTTTTATAAAGGGATAGAAG

3718
Table 3A
Hs.153003
X06956
32014
serine/threonine kinase 16 (STK16),
1
ACACCAACCTGCTTCCACTTTATTCTT

mRNA/cds = (118, 1050)

GTTTACACATTCTCCTGCTCCCA

3719
Table 3A
Hs.77202
X07109
35492
protein kinase C, beta 1 (PRKCB1),
1
AAGATGTTTGTGGAAATGTTCATTTGT

mRNA/cds = (136, 2151)

ATCTGGATCTCTGTTATGTGCCA

3720
Table 3A
Hs.89751
X07203
29775
membrane-spanning 4-domains,
1
GAGTTACCACACCCCATGAGGGAAG

subfamily A, member 2 (Fc fragment of

CTCTAAATAGCCAACACCCATCTGT

IgE, high affinity I, receptor for; beta

polypeptide) (MS4A2),

mRNA/cds = (90, 983)

3721
Table 3A
Hs.77438
X07743
35517
pleckstrin (PLEK),
1
TTCCTGAAGCTGTTCCCACTCCCAGA

mRNA/cds = (60, 1112)

TGGTTTTATCAATAGCCTAGAGGT

3722
Table 3A
Hs.318885
X07834
36517
superoxide dismutase 2, mitochondrial
1
TACTTTGGGGACTTGTAGGGATGCCT

(SOD2), mRNA/cds = (4, 672)

TTCTAGTCCTATTCTATTGCAGTT

3723
Table 3A
Hs.78056
X12451
29714
cathepsin L (CTSL),
1
TCGAATCATTGAAGATCCGAGTGTGA

mRNA/cds = (288, 1289)

TTTGAATTCTGTGATATTTTCACA

3724
Table 3A
Hs.193400
X12830
33845
interleukin 6 receptor (IL6R),
1
ATATCCAATATTCGCTGTGTCAGCAT

mRNA/cds = (437, 1843)

AGAAGTAACTTACTTAGGTGTGGG

3725
Table 3A
Hs.856
X13274
32691
interferon, gamma (IFNG),
1
TTGTTGACAACTGTGACTGTACCCAA

mRNA/cds = (108, 608)

ATGGAAAGTAACTCATTTGTTAAA

3726
Table 3A
Hs.2299
X13444
29826
CD8 antigen, beta polypeptide 1 (p37)
1
AAGTTTCTCAGCTCCCATTTCTACTCT

(CD881), mRNA/cds = (50, 682)

CCCATGGCTTCATGCTTCTTTCA

3727
Table 3A
Hs.234489
X13794
34314
lactate dehydrogenase B gene exon 1
1
TCTCCATGTTGTCAAAATCATGCCGT

and 2 (EC 1.1.1.27)

TTATAGCTATTTTCACCTCAGTGG

3728
literature
Hs.89137
X13916
34338
low density lipoprotein-related protein
1
GCCCCGTTTTGGGGACGTGAACGTTT

1 (alpha-2-macroglobulin receptor)

TAATAATTTTTGCTGAATTCTTTA

(LRP1), mRNA/cds = (466, 14100)

3729
Table 3A
Hs.82120
X14008
34433
nuclear receptor subfamily 4, group A,
1
AGGTGGGCACAAGTATTACACATCAG

member 2 (NR4A2),

AAAATCCTGACAAAAGGGACACAT

mRNA/cds = (317, 2113)

3730
Table 3A
Hs.77424
X14356
31331
Fc fragment of IgG, high affinity Ia,
1
GTTCAACAACACCAGAACTGTGTGTC

receptor for (CD64) (FCGR1A),

TCATGGTATGTAACTCTTAAAGCA

mRNA/cds = (0, 1124)

3731
Table 3A
Hs.87409
X14787
37464
thrombospondin 1 (THBS1),
1
TTGACCTCCCATTTTTACTATTTGCCA

mRNA/cds = (111, 3623)

ATACCTTTTTCTAGGAATGTGCT

3732
Table 3A
Hs.289088
X15183
32487
heat shock 90kD protein 1, alpha
1
AAAGCTGTTCAAATACTCGAGCCCAG

(HSPCA), mRNA/cds = (60, 2258)

TCTTGTGGATGGAAATGTAGTGCT

3733
Table 3A
Hs.339703
X16277
35137
zv26f06.r1 cDNA, 5′
1
CTTAAGTCTGACGGACCTGTCCTGTC

end/clone =

CAGGCCAGTGCCCAGGGAAGGTGT

IMAGE:754787/clone_end = 5′

3734
Table 3A
Hs.50964
X16354
37197
mRNA for transmembrane
1
TTTCTAACCCTGACACGGACTGTGCA

carcinoembryonic antigen BGPa

TACTTTCCCTCATCCATGCTGTGC

(formerly TM1-CEA)/cds = (72, 1652)

3735
Table 3A
Hs.154672
X16396
35070
methylene tetrahydrofolate
1
CAGCAGCTGCCTGCTTTTCTGTGATG

dehydrogenase (NAD+ dependent),

TATGTATCCTGTTGACTTTTCCAG

methenyltetrahydrofolate

cyclohydrolase (MTHFD2), nuclear

gene encoding mitochondrial protein,

mRNA/cds = (76, 1110)

3736
Table 3A
Hs.14601
X16663
32054
hematopoietic cell-specific Lyn
1
TCCCTGAAGAAATATCTGTGAACCTT

substrate 1 (HCLS1),

CTTTCTGTTCAGTCCTAAAATTCG

mRNA/cds = (42, 1502)

3737
Table 3A
Hs.176663
X16883
31321
leukocyte IgG receptor (Fc-gamma-R)
1
ATGGGAGTAATAAGAGCAGTGGCAG

mRNA, complete cds/cds = (17, 718)

CAGCATCTCTGAACATTTCTCTGGA

3738
Table 3A
Hs.271986
X17033
33906
integrin, alpha 2 (CD49B, alpha 2
1
ACCCATTTCTACTTTTTGCACCTTATT

subunit of VLA-2 receptor) (ITGA2),

TTCTCTGTTCCTGAGCCCCCACA

mRNA/cds = (42, 3587)

3739
Table 3A
Hs.1908
X17042
32432
proteoglycan 1, secretory granule
1
TGTGTTTGCAGAGCTAGTGGATGTGT

(PRG1), mRNA/cds = (24, 500)

TTGTCTACAAGTATGATTGCTGTT

3740
Table 3A
Hs.342863
X17094
31477
Ig48108.x1 cDNA, 3′
1
GGCCCAGCATTGCTGGTTCTATTTAA

end/clone =

TGGACATGAGATAATGTTAGAGGT

IMAGE:2112035/clone_end = 3′

3741
Table 3A
Hs.198951
X51345
34014
jun B proto-oncogene (JUNB),
1
TGAATATAATATATTTGTGTATTTAAC

mRNA/cds = (253, 1296)

AGGGAGGGGAAGAGGGGGCGATC

3742
Table 3A
Hs.3288
X51757
35221
heat shock 70kD protein 6 (HSP708′)
1
TGGCACTTTAACATTGCTTTCACCTAT

(HSPA6), mRNA/cds = (0, 1931)

ATTTTGTGTACTTTGTTACTTGC

3743
Table 3A
Hs.76053
X52104
35219
DEAD/H (Asp—Glu—Ala—Asp/His)
1
AGTAAATGTACAGTGATTTGAAATAC

box polypeptide 5 (RNA helicase, 68kD)

AATAATGAAGGCAATGCATGGCCT

(DDX5), mRNA/cds = (170, 2014)

3744
Table 3A
Hs.323098
X52142
30292
cDNA:FLJ23458 fis, clone
1
CTTAATGTGACCTAGCAATAGGCATA

HIS107327/cds = UNKNOWN

GCTACGTGGCACTATATTCTGGCC

3745
literature
Hs.99987
X52221
31215
ERCC2 gene, exons 1 & 2
1
AGGAGCACCTCACAGATGCCAACCT

(partial)/cds = UNKNOWN

CAACCTGACCGTGGACGAGGGTGTC

3746
Table 3A
Hs.278544
X52882
311380
acetyl-Coenzyme A acetyltransferase
1
CCACGACTTCTGCCCATTCTCTCCAG

2 (acetoacetyl Coenzyme A thiolase)

TGTGTGTAACAGGGTCACAAGAAT

(ACAT2), mRNA/cds = (37, 1230)

3747
Table 3A
Hs.85266
X53587
33950
integrin, beta 4 (ITGB4),
1
GGCCCAAACCTATTTGTAACCAAAGA

mRNA/cds = (126, 5384)

GCTGGGAGCAGCACAAGGACCCAG

3748
Table 3A
Hs.117950
X53793
28383
multifunctional polypeptide similar to
1
GCGAGCAAGCATTTTGAACACATGGA

SAICAR synthetase and AIR

TTTCCTTGAAGCAGGCTGACAAGA

carboxylase (ADE2H1),

mRNA/cds = (24, 1301)

3749
Table 3A
NA
X53795
35832
R2 mRNA for an inducible membrane
1
TCGGATGGGCTGTTTAGATGTTATAT

protein

AATCCACAAAAGGTTCATTGAGCT

3750
Table 3A
Hs.105938
X53961
34415
lactotransferrin (LTF),
1
GGATTGCCCATCCATCTGCTTACAAT

mRNA/cds = (294, 2429)

TCCCTGCTGTCGTCTTAGCAAGAA

3751
Table 3A
Hs.55921
X54326
31957
glutamyl-prolyl-tRNA synthetase
1
AAAATGAAGTCACACAGGACAATTAT

(EPRS), mRNA/cds = (58, 4380)

TCTTATGCCTAAGTTAACAGTGGA

3752
Table 3A
Hs.789
X54489
34625
GRO1 oncogene (melanoma growth
1
GCCTTGTTTAATGGTAGTTTTACAGT

stimulating activity, alpha) (GRO1),

GTTTCTGGCTTAGAACAAAGGGGC

mRNA/cds = (79, 402)

3753
Table 3A
Hs.74085
X54870
35062
DNA segment on chromosome 12
1
AGTGCCTTCCCTGCCTGTGGGGGTC

(unique) 2489 expressed sequence

ATGCTGCCACTTTTAATGGGTCCTC

(D12S2489E), mRNA/cds = (338, 988)

3754
Table 3A
Hs.83758
X54942
29978
CDC28 protein kinase 2 (CKS2),
1
TTCCAGTCAGTTTTTCTCTTAAGTGCC

mRNA/cds = (95, 334)

TGTTTGAGTTTACTGAAACAGTT

3755
Table 3A
Hs.283330
X56733
8924082
hypothetical protein PRO1843
1
TCCAATGCAGTCCCATTCTTTATGGC

(PRO1843), mRNA/cds = (964, 1254)

CTATAGTCTCACTCCCAACTACCC

3756
Table 3A
Hs.312670
X55740
23896
xn42c03.x1 cDNA, 3′
1
TGGTATAAGAAATGACTTTGAACCAC

end/clone =

TTTGCAATTGTAGATTCCCAACAA

IMAGE:2696356/clone_end = 3′

3757
Table 3A
Hs.85112
X57025
33007
IGF-I mRNA for insulin-like growth
1
CCCCTGCTACTTTGAAACCAGAAAAT

factor I/cds = (166, 627)

AATGACTGGCCATTCGTTACATCT

3758
Table 3A
Hs.279920
X57346
23113
tyrosine 3-monooxygenase/tryptophan
1
TGATCTGTCCAGTGTCACTCTGTACC

5-monooxygenase activation protein,

CTCAACATATATCCCTTGTGCGAT

beta polypeptide (YWHAB),

mRNA/cds = (372, 1112)

3759
Table 3A
Hs.74405
X57347
32463
tyrosine 3-monooxygenase/tryptophan
1
AAAAGCCTTGTGAAAATGTTATG

5-monooxygenase activation protein,

CCCCTATGTAACAGCAGAGTAACA

beta polypeptide (YWHAQ),

TAAA

mRNA/cds = (100, 837)

3760
Table 3A
Hs.289110
X57809
33714
rearranged immunoglobulin lambda
1
CCACCACGGGAGACTAGAGCTGCAG

light chain mRNA/cds = (9, 710)

GATCCCGGGGGAGGGGTCTCTCCTC

3761
Table 3A
Hs.289110
X57812
33723
rearranged immunoglobulin lambda
1
CAGTGGAAGTCCCACAGAAGCTACA

light chain mRNA/cds = (9, 710)

GCTGCCAGGTCACGCATGAAGGGAG

3762
Table 3A
Hs.302063
X58529
33480
rearranged immunoglobulin mRNA for
1
CCCACACTGCTTTGCTGTGTATACGC

mu heavy chain enhancer and

TTGTTGCCCTGAAATAAATATGCA

constant region/cds = UNKNOWN

3763
Table 3A
Hs.302063
X58529
33480
rearranged immunoglobulin mRNA for
1
CCCACACTGCTTTGCTGTGTATACGC

mu heavy chain enhancer and

TTGTTGCCCTGAAATAAATATGCA

constant region/cds = UNKNOWN

3764
Table 3A
Hs.155101
X59066
28937

Homo sapiens ATP synthase, H+
1
ACAAATTTCTTGGCTGGATTTGAAGC

transporting, mitochondrial F1 complex,

TTAAACTCCTGTGGATTCACATCA

alpha subunit, isoform 1, cardiac

muscle

3765
Table 3A
Hs.83532
X59405
34508

H. sapiens, gene for Membrane
1
AGAGACCAGTTTTCTCTGGAAGTTG

cofactor protein/cds = UNKNOWN

TTTAAATGACAGAAGCGTATATGA

3766
literature
Hs.861
X60188
31220
ERK1 mRNA for protein
1
CGCCCCTGCCACCTCCCTGACCCGT

serine/threonine kinase/cds = (72, 1211)

CTAATATATAAATATAGAGATGTGT

3767
Table 3A
Hs.81634
X60221
509290
ATP synthase, H+ transporting,
1
GCCAGTCAGATGTTTCTCATCCTTCT

mitochondrial F0 complex, subunit b,

TGCTCTGCCTTTGAGTTGTTCCGT

isoform 1 (ATP5F1),

mRNA/cds = (32, 802)

3768
Table 3A
Hs.44926
X60708
35335
dipeptidylpeptidase IV (CD26,
1
AAATACTGATGTTCCTAGTGAAAGAG

adenosine deaminase complexing

GCAGCTTGAAACTGAGATGTGAAC

protein 2) (DPP4),

mRNA/cds = (75, 2375)

3769
Table 3A
Hs.81226
X60992
29817
CD6 mRNA for T cell glycoprotein
1
AGAAGCTGCACTAGGCCCCGAGTCC

CD6/cds = (120, 1526)

CCATGTGTCTCCTTGAATTGATGAG

3770
Table 3A
Hs.77054
X61123
29508
B-cell translocation gene 1, anti-
1
AAGTCTTTTCCACAAACCACCATCTAT

proliferative (BTG1),

TTTGTGAACTTTGTTAGTCATCT

mRNA/cds = (308, 823)

3771
Table 3A
Hs.76913
X61970
296739
proteasome (prosome, macropain)
1
AAATTTTATTTCCAGCTCCTGTTCCTT

subunit, alpha type, 5 (PSMA5),

GGAAAATCTCCATTGTATGTGCA

mRNA/cds = (21, 746)

3772
Table 3A
Hs.276770
X62466
29645
CDW52 antigen (CAMPATH-1
1
CCTGAAACAGCTGCCACCATCACTCG

antigen) (CDW52),

CAAGAGAATCCCCTCCATCTTTGG

mRNA/cds = (24, 209)

3773
Table 3A
Hs.80684
X82534
32332
high-mobility group (nonhistone
1
TTCTGTGTGTATGGTAGCACAGCAAA

chromosomal) protein 2 (HMG2),

CTTGTAGGAATTAGTATCAATAGT

mRNA/cds = (190, 819)

3774
Table 3A
Hs.172690
X62535
30822
diacylglycerol kinase, alpha (80kD)
1
ACACACATACACACACCCCAAAACAC

(DGKA), mRNA/cds = (103, 2310)

ATACATTGAAAGTGCCTCATCTGA

3775
Table 3A
Hs.77522
X62744
36062
major histocompatibility complex, class
1
GATCTCCTCTTAGGGTAGAAGAAGTC

II, DM alpha (HLA-DMA),

TCTGGGACATCCCTGGGGTGTGTG

mRNA/cds = (45, 830)

3776
Table 3A
Hs.296014
X63563
36121
polymerase (RNA) II (DNA directed)
1
GGCTGCCGCAATAAAACCCAGATTTC

polypeptide B (140kD) (POLR28),

TTTGGTGCGAATGCCTTACGCATG

mRNA/cds = (43, 3567)

3777
Table 3A
Hs.82359
X53717
28741
tumor necrosis factor receptor
1
TCATCATCTGGATTTAGGAATTGCTC

superfamily, member 6 (TNFRSF6),

TTGTCATACCCCCAAGTTTCTAAG

mRNA/cds = (220, 1227)

3778
db mining
Hs.2490
X65019
33792
caspase 1, apoptosis-related cysteine
1
TGCCCACCACTGAAAGAGTGACTTTG

protease (interleukin 1, beta,

ACAAGATGTTTCTACCTCTTCCCA

convertase) (CASP1),

mRNA/cds = (0, 1151)

3779
Table 3A
Hs.75248
X68060
37230
topoisomerase (DNA) II beta (180kD)
1
TTTGATCAGGATTCAGATGTGGACAT

(TOP28), mRNA/cds = (0, 4865)

CTTCCCCTCAGACTTCCCTACTGA

3780
Table 3A
Hs.652
X68550
37269
tumor necrosis factor (ligand)
1
TCTACCTGCAGTCTCCATTGTTTCCA

superfamily, member 5 (hyper-IgM

GAGTGAACTTGTAATTATCTTGTT

syndrome) (TNFSF5),

mRNA/cds = (39, 824)

3781
Table 3A
Hs.116774
X68742
33949
mRNA for integrin, alpha
1
CGGATTGTTGCTGTTAATGCTGCTCA

subunit/cds = UNKNOWN

TTTTAGCACTGTGGAAGATTGGAT

3782
Table 3A
Hs.77502
X68836
36326

Homo sapiens, methionine
1
TAGAGATTGTGAAGAAGAATTTCGAT

adenosyltransferase II, alpha, clone

CTCCGCCCTGGGGTCATTGTCAGG

MGC:4537 IMAGE:3010820,

mRNA, complete cds/cds = (116, 1303)

3783
Table 3A
Hs.192760
X69392
36114
kinesin family member 5A (KIF5A),
1
CTCCTGTTGGGTAAGGGTGTTGAGTG

mRNA/cds = (148, 3246)

TGACTTGTGCTGAAAACCTGGTTC

3784
Table 3A
Hs.83715
X69804
1015499
Sjogren syndrome antigen B
1
AAAAGGAAAACCGAATTAGGTCCACT

(autoantigen La) (SSB),

TCAATGTCCACCTGTGAGAAAGGA

mRNA/cds = (72, 1298)

3785
Table 3A
Hs.309952
X69819
32627
mRNA; cDNA DKFZp434E0516 (from
1
GGAAGAACCGTCCAGAGCTGAGTGA

clone

CGCTGGGATCCGGGATCAAAGTTGG

DKFZp434E0516)/cds = UNKNOWN

3786
Table 3A
Hs.170009
X70340
37069
transforming growth factor, alpha
1
TGTGCATTGTTATTGAGTTGTACTGTA

(TGFA), mRNA/cds = (31, 513)

CCTTATTTGGAAGGATGAAGGAA

3787
Table 3A
Hs.180610
X70944
38457
splicing factor proline/glutamine rich
1
CCCATTTCTTGTTTTTAAAAGACCAAC

(polypyrlmidine tract-binding protein-

AAATCTCAAGCCCTATAAATGGC

associated) (SFPQ),

mRNA/cds = (85, 2208)

3788
Table 3A
Hs.106876
X71490
313011

Homo sapiens, clone MGC:15351
1
AGAAGCATGTCACTTTCATGTTCCTC

IMAGE:4126712, mRNA, complete

CCTAACTCCCTGACCTGAGAACCC

cds/cds = (87, 1142)

3789
Table 3A
Hs.251526
NM_006273
13435401
gene for monocyte chemotactic protein
1
GGATGCTCCTCCCTTCTCTACCTCAT

3 (MCP-3)/cds = (0, 329)

GGGGGTATTGTATAAGTCCTTGCA

3790
Table 3A
Hs.156110
X72475
441418
cDNA:FLJ21321 fis, clone COL02335,
1
GCACCATCTGTCTTCATCTTCCGCCA

highly similar to HSA010442 mRNA for

TCTGATGAGCAGTTGAAATCTGGA

immunoglobulin kappa light

chain/cds = UNKNOWN

3791
Table 3A
Hs.156110
X72475
441418
cDNA:FLJ21321 fis, clone COL02335,
1
GCACCTCTGTCTTCATCTTCCGCCA

highly similar to HSA010442 mRNA for

TCTGATGAGCAGTTGAAATCTGGA

immunoglobulin kappa light

chain/cds = UNKNOWN

3792
Table 3A
Hs.79081
X74008
402777
protein phosphatase 1, catalytic
1
AAAAGAAATCTGTTTCAACAGATGAC

subunit, gamma isoform (PPP1CC),

CGTGTACAATACCGTGTGGTGAAA

mRNA/cds = (154, 1125)

3793
Table 3A
Hs.331328
X74262
397375
intermediate filament protein syncoilin
1
GGCCTGTTACTCTCCATGACTAACTG

(SYNCOILIN), mRNA/cds = (168, 623)

TGTAAGTGCTTAAAATGGAATAAA

3794
Table 3A
Hs.1708
X74801
671526
chaperonin containin TCP1, subunit 3
1
GGCAGCCCCCAGTCCCTTTCTGTCC

(gamma) (CCT3), mRNA/cds = (0, 1634)

CAGCTCAGTTTTCCAAAAGACACTG

3795
Table 3A
Hs.44313
X75042
402648
v-rel avian reticuloendotheliosis viral
1
TCTTGATACCACCTATATAGATGCAG

oncogene homolog (REL),

CATTTTGTATTTGTCTAACTGGGG

mRNA/cds = (177, 2036)

3796
Table 3A
Hs.73965
X75755
455418
splicing factor, arginine/serine-rich 2
1
CGGGCCTTGCATATAAATAACGGAGC

(SFRS2), mRNA/cds = (155, 820)

ATACAGTGACCACATCTAGCTGAT

3797
Table 3A
Hs.74637
X75861
456258
testis enhanced gene transcript
1
CTGTGCTTTTTGCTTGGGATAATGGA

(TEGT), mRNA/cds = (40, 753)

GTTTTTCTTTAGAAACAGTGCCAA

3798
Table 3A
Hs.79362
X75918
415822
p130 mRNA for 130K
1
TTGAGGGGATTAATATGAAAACTTAT

protein/cds = (69, 3488)

GACCTCTTCCTTTAGGAGGGAGTT

3799
Table 3A
Hs.79362
X76061
416030
p130 mRNA for 130K
1
TGTTAAAACCCCTATAGCCACCTTTT

protein/cds = (69, 3488)

GGGAATGTTTTAAATTCTCCAGTT

3800
Table 3A
Hs.83347
X76302
431952
angio-associated, migratory cell
1
TGGCAGGCGTCAACCCCATTTTATTT

protein (AAMP), mRNA/cds = (0, 1358)

GTCCTTATTCCTGTGGAAGCAGTA

3801
Table 3A
Hs.85226
X76488
434305
lipase A, lysosomal acid. cholesterol
1
AATACACCTGCTTCACGTCCCTATGT

esterase (Wolman disease) (LIPA),

TGGGAAGTCCATATTTGTCTGCTT

mRNA/cds = (40, 1239)

3802
Table 3A
Hs.334648
X76770
556782
PAP mRNA/cds = UNKNOWN
1
CAGGAAATGCAGCAACTTCAGGAAAT

GCAGCAACAAAAATACCTACTCCT

3803
Table 3A
Hs.76136
X77584
453963
thioredoxin (TXN),
1
AAACCCAGTTGCCATCTGCGTGACAA

mRNA/cds = (63, 380)

TAAAACATTAATGCTAACACTTTT

3804
Table 3A
Hs.85155
X79067
483524
ERF-1 mRNA 3′
1
TGCTGTATTACTTCTGAAAAGACTGT

end/cds = UNKNOWN

GCAGTGTGTTAGTTGTTGGCTGAA

3805
Table 3A
Hs.153221
X79201
531105
synovial sarcoma translocation,
1
GTGTATGAGAGAGAGAGTGTGTGTTT

chromosome 18 (SS18),

GTGTGTTTCAAGGTCAGAACAGGT

mRNA/cds = (3, 1176)

3806
Table 3A
Hs.179943
X79234
495125
ribosomal protein L11 (RPL11),
1
TGGTTCCAGCAGAAGTATGATGGGAT

mRNA/cds = (0, 538)

CATCCTTCCTGGCAAATAAATTCC

3807
Table 3A
Hs.74576
X79353
695584
GDP dissociation inhibitor 1 (GDI1),
1
TGTCCCCTTCCCCACCCTCTAGTGTA

mRNA/cds = (80, 1423)

TTTCACAGAAAACAAAACCTCCCA

3808
Table 3A
Hs.7957
X79448
2326523
adenosine deaminase, RNA-specific
1
AGTCCAGTTTTATGATTCTGCTTTTAT

(ADAR), transcript variant ADAR-e,

GTGTCCCTTGATAACAGTGACTT

mRNA/cds = (187, 3867)

3809
Table 3A
Hs.249495
X79536
496897
heterogeneous nuclear
1
AAACTCATCTGTCCAAGTTCGTGGCA

ribonucleoprotein A1 (HNRPA1),

GAAAGAACGTCCTTGTGAAGACC

transcript variant 2,

mRNA/cds = (104, 1222)

3810
Table 3A
Hs.151134
X80695
619490
oxidase (cytochrome c) assembly 1-
1
AGAGCACTGGGTAGCCAAGTGATCTT

like (OXA1L), mRNA/cds = (0, 1487)

CCCATTCACAGAGTTAGTAAACCT

3811
Table 3A
Hs.77897
X81789
551449
splicing factor 3a, subunit 3, 60kD
1
CCCCCAGAGACCCCATTTGCCTCTCA

(SF3A3), mRNA/cds = (8, 1513)

ACACTCAGACCTTCAACTGTTTTT

3812
Table 3A
Hs.318501
X82200
899299
stimulated trans-acting factor (50 kDa)
1
CCAGTGACACCCCATATTCATCACAA

(STAF50), mRNA/cds = (122, 1450)

AATTAAAGCAAGAAGTCCATAGTA

3813
Table 3A
Hs.153961
X82206
563882
ARP1 (actin-related protein 1, yeast)
1
TGACACCAAGACCCACCCCAATCCAG

homolog A (centractin alpha)

ACTTCACACAGTATTCTCCCCCAC

(ACTR1A), mRNA/cds = (57, 1187)

3814
Table 3A
Hs.289103
X83300
603028
SMA4 mRNA/cds = (66, 488)
1
GACTGCAAGTCACTCTTAGGGGCTGT

ACTTCCTTAGTACTGGTAGCATTA

3815
Table 3A
Hs.160483
X85116
1161561
epb72 gene exon 1/cds = (61, 927)
1
AACTGAGCATCACGAACCCTGTTTGG

CAGACTGAGGTCACGATGGAGGGG

3816
Table 3A
Hs.24143
X86019
2760482
Wiskott-Aldrich syndrome protein
1
TCCTCCATTGAAGAAGAATGTCAACA

interacting protein (WASPIP),

AGAAAGGAAAAATAGACAAACTGG

mRNA/cds = (108, 1619)

3817
Table 3A
Hs.75410
X87949
1143491
mRNA for BiP
1
AAGTCTCGAATGTAATTGGAATCTTC

protein/cds = (222, 2183)

ACCTCAGAGTGGAGTTGAACTGCT

3818
Table 3A
Hs.2007
X89102
887455
tumor necrosis factor (ligand)
1
CCATCGGTGAAACTAACAGATAAGCA

superfamily member 6 (TNFSF6),

AGAGAGATGTTTTGGGGACTCATT

mRNA/cds = (157, 1002)

3819
Table 3A
Hs.180433
X89602
1150420
rTS beta protein (HSRTSBETA),
1
ACAAAAATAGCTATATCAAGGGCTGG

mRNA/cds = (17, 1267)

CACCTAGACATTAAACTGTACTTT

3820
Table 3A
Hs.13046
X91247
1237037
thioredoxin reductase 1 (TXNRD1),
1
GTCCACCAGTCTCTGAAATTAGAACA

mRNA/cds = (439, 1932)

GTAGGCGGTATGAGATAATCAGGC

3821
Table 3A
Hs.335328
X91348
1418768
predicted non coding cDNA
1
GAAATGTAGCTGGAGTCATCATTTAG

(DGCR5)/cds = UNKNOWN

CAGAGCACGGTGTCCCTGGGTTGG

3822
Table 3A
Hs.2726
X92518
1225979
mRNA for HMGI-C
1
GCCTCTGTGATCCCCATGTGTTTTGA

protein/cds = (848, 1177)

TTCCTGCTCTTTGTTACAGTTCCA

3823
Table 3A
Hs.78335
X94232
1292887
microtubulo-associated protein, RP/EB
1
AAAACAAGAAACAAATGTGCCCACCC

family, member 2 (MAPRE2),

CACTTTCCGCTTAACTGAAAAGCT

mRNA/cds = (112, 1095)

3824
Table 3A
Hs.75841
X94910
3413292
chromosome 12 open reading frame 8
1
GTAAAAAGGCTGTCTGTGATTTTCCA

(C12orfB), mRNA/cds = (11, 796)

GGGTTTGGTGGGGGTAGGGAGGGG

3825
Table 3A
Hs.3416
X97324
1806039
adipose differentiation-related protein
1
CTGACTGAGTCTCAGAATGCTCAGGA

(ADFP), mRNA/cds = (0, 1313)

CCAAGGTGCAGAGATGGACAAGAG

3826
Table 3A
Hs.100555
X98743
1498228
DEAD/H (Asp—Glu—Ala—Asp/His)
1
AGCTTCTTGGGTTCCTAATTCCTGGT

box polypeptide 18 (Myc-regulated)

GTTTAATAATTCTCTCCACGATCA

(DDx18), mRNA/cds = (71, 2083)

3827
Table 3A
Hs.139262
X99699
1869900
XIAP associated factor-1
1
TACTTGCTGTGGTGGTCTTGTGAAAG

(HSXIAPAF1), mRNA/cds = (0, 953)

GTGATGGGTTTTATTCGTTGGGCT

3828
Table 3A
Hs.170121
Y00062
34275
protein tyrosine phosphatase receptor
1
ATTTCCAGTGAGCTTATCATGCTGTC

type, C (PTPRC),

TTTACATGGGGTTTTCAATTTTGC

mRNA/cds = (66, 4000)

3829
Table 3A
Hs.51077
Y00093
35175
integrin, alpha X (antigen CD11C
1
TGCAGCTCACCAGCCCCAGGGGCAG

(p150), alpha polypeptide) (ITGAX),

AAGAGACCCAACCACTTCCTATTTT

mRNA/cds = (58, 3549)

3830
Table 3A
Hs.169476
Y00262
36048

Homo sapiens, glyceraldehyde-3-
1
ACTTACCCAGATGTTGCTTTTGAAAA

phosphate dehydrogenase, clone

GTTGAAATGTGTAATTGTTTTGGA

MGC:10926 IMAGE:368129,

mRNA, complete cds/cds = (2306, 3313)

3831
Table 3A
Hs.76473
Y00285
33054
insulin-like growth factor 2 receptor
1
TGTATATAGACTCTGGTGTTCTATTG

(IGF2R), mRNA/cds = (147, 7622)

CTGAGAAGCAAACCGCCCTGCAGC

3832
Table 3A
Hs.172182
Y00345
35569
poly(A)-binding protein, cytoplasmic 1
1
ATGTCAGTTCTGTTTTAAGTAACAGAA

(PABPC1), mRNA/cds = (502, 2403)

TTGATAACTGAGCAAGGAAACGT

3833
Table 3A
Hs.180414
Y00371
32466
hsc70 gene for 71 kd heat shock
1
TTGGAGCTAAGCTGCCACCTGGTTAA

cognate protein

TTAAGGTCCCAACAGTGAGTTGTG

3834
Table 3A
Hs.233950
Y00503
34038
serine protease inhibitor, Kunitz type 1
1
CTTTGGAGGGTGTCTTCTGGGTAGAG

(SPINT1), mRNA/cds = (175, 1716)

GGATGGGAAGGAAGGGACCCTTAC

3835
Table 3A
Hs.75716
Y00630
35267
serine (or cysteine) proteinase
1
TGCCTTTAATTGTTCTCATAATGAAGA

inhibitor, clade B (ovalbumin), member

ATAAGTAGGTACCCTCCATGCCC

2 (SERPINB2), mRNA/cds = (72, 1319)

3836
Table 3A
Hs.79368
Y07909
1542882
epithelial membrane protein 1 (EMP1),
1
ATTTGCATTACTCTGGTGGATTGTTCT

mRNA/cds = (218, 691)

AGTACTGTATTGGGCTTCTTCGT

3837
Table 3A
Hs.113503
Y08890
2253155

Homo sapiens mRNA for Ran_GTP
1
TTTGGCTTAGTGTTTTCATTGCAAATT

binding protein 5 (RanBP5(Importin5)

ATAATTGCTGTAGAGCCACACAC

gene)/cds = (236, 3529)

3838
Table 3A
Hs.227817
Y09397
1694788
BCL2-related protein A1 (BCL2A1),
1
TTGATGATGTAACTTGACCTTCCAGA

mRNA/cds = (183, 710)

GTTATGGAAATTTTGTCCCCATGT

3839
Table 3A
Hs.43913
Y09631
3925684
PIBF1 gene product (PIBF1),
1
AACAAAAGATGAAGACCTAGTGTTTT

mRNA/cds = (0, 2276)

GGATGGGAAGCACCTGTAGACCAT

3840
Table 3A
Hs.44499
Y09703
4581462
pinin, desmosome associated protein
1
ACATGTGCAAATAAATGTGGCTTAGA

(PNN), mRNA/cds = (30, 2261)

CTTGTGTGACTGCTTAAGACTAAA

3841
Table 3A
Hs.47007
Y10256
1841433
mitogen-activated protein kinase
1
TCTGGGTTGTAGAGAACTCTTTGTAA

kinase kinase 14 (MAP3K14),

GCAATAAAGTTTGGGGTGATGACA

mRNA/cds = (232, 3075)

3842
Table 3A
Hs.7879
Y10313
2708510
interferon-related developmental
1
CGAACCAAAGCTAGAAGCAAATGTCG

regulator 1 (IFRD1),

AGATAAGAGAGCAGATGTTGGAGA

mRNA/cds = (219, 1580)

3843
Table 3A
Hs.51957
Y11251
1848180
splicing factor, arginine/serine-rich 2,
1
CACTCTTCACCTATTGTATGACCAAAT

interacting protein (SFRS2IP),

AAAGGTTATGCTGCTTGTTACGC

mRNA/cds = (1210, 4656)

3844
Table 3A
Hs.129953
Y11289
2808510
Ewing sarcoma breakpoint region 1
1
TGCTAGGTGATGGAGTAGAAATGGAT

(EWSR1), transcript variant EWS,

TCCCTCTGGGAATGGTTTCTTGGT

mRNA/cds = (43, 2013)

3845
Table 3A
Hs.106019
Y13247
2117158
protein phosphatase 1, regulatory
1
TATGAAAACAGTGGATTGGTTGGGTT

subunit 10 (PPP1R10),

TTGTGCAGGGTCTTGGGTTAGAGC

mRNA/cds = (539, 3361)

3846
Table 3A
Hs.16530
Y13710
2326515
small inducible cytokine subfamily A
1
TGCATGGATCAATCAGTGTGATTAGC

(Cys—Cys), member 18, pulmonary and

TTTCTCAGCAGACATTGTGCCATA

activation-regulated (SCYA16),

mRNA/cds = (70, 339)

3847
Table 3A
Hs.17883
Y13936
2315201
protein phosphatase 1G (formerly 2C),
1
CTCATCACCGGTTCTGTGCCTGTGCT

magnesium-dependent, gamma

CTGTTGTGTTGGAGGGAAGGACTG

isoform (PPM1G),

mRNA/cds = (24, 1664)

3848
Table 3A
Hs.195175
Y14039
2653415
mRNA for CASH alpha
1
GCAGCACACTCTGAGAAAGAAACTTA

protein/cds = (481, 1923)

TCCTCTCCTACACATAAGAAACCA

3849
Table 3A
Hs.227913
Y15906
5327056
API5-like (API5L1),
1
TGCAAGACACCTGTTTATCATCTTGTT

mRNA/cds = (132, 1646)

TAAATGTAAATGTCCCCTTATGC

3850
Table 3A
Hs.85951
Y16414
2924334
exportin, tRNA (nuclear export
1
TCAACGCCAATATGTATTCTACAAAA

receptor for tRNAs) (XPOT),

GAGAATGGTTTTAGGCTCCAGTGT

mRNA/cds = (0, 2888)

3851
Table 3A
Hs.271387
Y16645
2916795
mRNA for monocyte chemotactic
1
TGGATCATCAAGGTGAAACACTTTGG

protein-2/cds = (472, 771)

TATTCTTTGGCAATCAGTGCTCCT

3852
Table 3A
Hs.337737
Y17829
4128042
Homer, neuronal immediate early
1
GATACACTGTCTCTCTTCATAGGACT

gene, 1B (SYN47),

GTTTAGGCTCTGCATCAAGATTGC

mRNA/cds = (75, 1139)

3853
Table 3A
Hs.247792
Z00013
33149
germline gene for the leader peptide
1
AAGGCAGGGATCATGACACCTGAGG

and variable region of a kappa

AGTCTAGTTTATGGCTTCAGTTGGA

immunoglobulin (subgroup V kappa I)

3854
Table 3A
Hs.173936
Z17227
393378
mRNA for transmembrane receptor
1
ATGGATGGACTGATCTGAAAATCGAC

protein/cds = (43, 1020)

CTCAACTCAAGGGTGGTCAGCTCA

3855
Table 3A
Hs.211577
Z22551
296163
kinectin 1 (kinesin receptor) (KTN1),
1
TGCTAATGTAATCGGTTTTTGTAATG

mRNA/cds = (83, 3985)

GCGTCACAAATAAAAGGATGCTTA

3856
Table 3A
Hs.82401
Z22578
397938
CD69 antigen (p60, early T-cell
1
TGCAAGACATAGAATAGTGTTGGAAA

activation antigen) (CD69),

ATGTGCAATATGTGATGTGGCAAA

mRNA/cds = (81, 680)

3857
Table 3A
Hs.74078
Z22970
312145
mRNA for M130 antigen cytoplasmic
1
AAGTTTGTGAATGTGACTACTTAGTG

variant 2/cds = (101, 3571)

GTGTATATGAGACTTTCAAGGGAA

3858
Table 3A
Hs.146381
Z23064
3256006
RNA binding motif protein, X
1
CCATTTTGCCTTTCTGACATTTCCTTG

chromosome (RBMX),

GGAATCTGCAAGAACCTCCCCTT

mRNA/cds = (11, 1186)

3859
Table 3A
Hs.225160
Z23090
433597
hypothetical protein FLJ13102
1
CTGTGCCTCCCCCGCCACCTGTGTG

(FLJ13102), mRNA/cds = (80, 1084)

TTCTTTTGATACATTTATCTTCTGT

3860
Table 3A
Hs.4934
Z24724
505034
polyA site DNA/cds = UNKNOWN
1
TGTATATTTATGGTGGGAGGTGGTTG

GGAACTTTTAACAAAATGGGGTGT

3861
Table 3A
Hs.2236
Z29067
479172
nek3 mRNA for protein
1
TCCTTTGGAAACAGAATGAAGCAGAG

kinase/cds = (0, 1379)

GAAACTCTTAATACTTAAAATCGT

3862
Table 3A
Hs.109918
Z35227
609016
ras homolog gene family, member H
1
TTGCCCAGGCCAGTTAGAAAATCCCT

(ARHH), mRNA/cds = (579, 1154)

TGGGGAACTGTGATGAATATTCCA

3863
Table 3A
Hs.198427
Z46378
587201
hexokinase 2 (HK2),
1
CTAGTCATAGAAATACCTCATTCGCC

mRNA/cds = (1490, 4243)

TGTGGGAAGAGAAGGGAAGCCTCT

3864
Table 3A
Hs.171626
Z47087
860989
transcription elongation factor B (SIII),
1
ATGTGGTAAAACCCAGAAAGCATCCA

polypeptide 1-like (TCEB1L),

TCATGAATGCAAGATACTTTCAAT

mRNA/cds = (101, 592)

3865
Table 3A
Hs.180877
Z46950
761715
clone PP781 unknown
1
TGCTTGATTAAGATGCCATAATAGTG

mRNA/cds = (113, 523)

CTGTATTTGCAGTGTGGGCTAAGA

3866
Table 3A
Hs.83465
Z49995
895841
homeo box D1 (HOXD1),
1
TCTTCTGTTTCATCCTGCGGTTCTGG

mRNA/cds = (223, 1209)

AACCAGATTTTGACTTGCGTGTCA

3867
Table 3A
Hs.78683
Z72499
1545951
ubiquitin specific protease 7 (herpes
1
CCTTCAGTTATACTTTCAATGACCTTT

virus-associated) (USP7),

TGTGCATCTGTTAAGGCAAAACA

mRNA/cds = (199, 3507)

3868

Hs.51077
M81695
487829
integrin, alpha X (antigen CD11C
1
ATGCATCTACCGCTCCTTGGGAAATA

(p150), alpha polypeptide) (ITGAX),

ATCTGAAAGGTCTAAAAATAAAAA

mRNA/cds = (58, 3549)

3869
Table 3A
Hs.113029
BF025727
10733439
ribosomal protein S25 (RPS25),
1
CGCAAGAAGCAGGAAGAGGAAAGAG

mRNA/cds = (63, 440)

AAGAAAAGCACAACGGGGAAAGATA

3870
Table 3A
Hs.150675
BF028489
10738201
polymerase (RNA) II (DNA directed)
1
GTAGTGTGTTGCATCCCTCTCACCCT

polypeptide K (7.0kD) (POLR2K),

CTGATCTTCGTCAGTCGTGTCATG

mRNA/cds = (66, 242)

3871
Table 3A
Hs.74170
BF028896
10736608
602708243F1 cDNA, 5′
1
GAGGGAAACCCGGTAATAGGCTGGG

end/clone =

AGTAATCCACACACGTGCTAACATT

IMAGE:4844914/clone_end = 5′

3872
Table 3A
Hs.199061
BF029654
10737366
p300/CBP-associated factor (PCAF),
1
CACACACTGCTACGTGACGTACCACT

mRNA/cds = (458, 2956)

ACTGCCAGCGCAGCACTAGCTCAC

3873
Table 3A
Hs.13268
BF029796
10737508
602634117F1 cDNA, 5′
1
GGATCGTGACACACCGGGTTACACA

end/clone =

CTTTCCACACCGTAATTCCATCAAT

IMAGE:4779149/clone_end = 5′

3874
Table 3A
Hs.149595
BF029894
10737606
601557058F1 cDNA, 5′
1
GGTTGCACCAAGGCTGCCTAGGAGA

end/clone =

AGTGCCTGACTGGACTACCCCGATC

IMAGE:3827172/clone_end = 5′

3875
Table 3A
Hs.118303
BF030930
10738642
601558648F1 cDNA, 5′
1
TCTGCCATCTGTCTATTTCCCAATTTT

end/clone =

CCTTCTGACTGTTCCTTTCTCCT

IMAGE:3828706/clone_end = 5′

3876
Table 3A
Hs.337988
BF033741
10741453

Homo sapiens, clone MGC:17431
1
CTGTGATATTTTGGTCATGGGCTGGT

IMAGE:2984883, mRNA, complete

CTGGTCGGTTTCCCATTTGTCTGG

cds/cds = (1336, 1494)

3877
Table 3A
Hs.144559
BF036688
10744746
601459771F1 cDNA, 5′
1
TACGACATTTGCGAAATTCGCTAAAA

end/clone =

ACAAGGGGGAGTTCACGCGGCCAT

IMAGE:3863248/clone_end = 5′

3878
Table 3A
Hs.39457
BF103848
10886287
602537152F1 cDNA, 5′
1
GCGCAGGTTACCGGAACCCAAGGTC

end/clone =

CTTTGAAATTCACAACTCTCTTTGG

IMAGE:4656037/clone_end = 5′

3879
Table 3A
Hs.279009
BF105172
10887698
matrix Gla protein (MGP),
1
AGCTGTGGAAAGGGCAACCTGTGGT

mRNA/cds = (46, 357)

TTCTCTGTACTGGTGTTTAATGGGG

3880
Table 3A
Hs.95388
BF107010
10889635
602619064F1 cDNA, 5′
1
CACAAACACCCGCCCGAGCAACCAC

end/clone =

AGACACAGGACACGACACCACACAC

IMAGE:4733030/clone_end = 5′

3881
Table 3A
Hs.171595
BF130300
10969340
HIV TAT specific factor 1 (HTATSF1),
1
AAAGGGTTACTTTTCAAAACAGTCTC

mRNA/cds = (57, 2321)

CTTTCGACCGGGGTCAGGGTGGCC

3882
Table 3A
Hs.129872
BF131060
10970089
sperm associated antigen 9 (SPAG9),
1
GGTGGACAGTATAAGGCGGTTAAGAT

mRNA/cds = (110, 2410)

CCGTTGATGGCGAAGGTGAGAATG

3883
Table 3A
Hs.75428
BF131654
10970694
superoxide dismutase 1, soluble
1
GACAGAGCGAGTAGACGGGAGGCGG

(amyotrophic lateral sclerosis 1 (adult))

AGAAGGAAGAGGAGACGAGACGAGG

(SOD1), mRNA/cds = (0, 464)

3884
Table 3A
Hs.9614
BF131656
10970696
nucleophosmin (nucleolar
1
CAAGACACAGAGGCAACGGAGAGAC

phosphoprotein B23, numatrin)

ACGCAGACAAGCAAGGCCACGGAAC

(NPM1), mRNA/cds = (0, 884)

3885
Table 3A
NA
BF184881
11063302
ESTs
1
AGGGATAGGATAATTACAGAGGTACT

GAGACTCCTGGCGTGGGTGACTCT

3886
Table 3A
Hs.160954
BF207290
11100876
602759615F1 cDNA, 5′
1
CCCATCATGAAAAAACGCCTTAGGAG

end/clone =

CCGAAGAAGAAAACCTCGGGAAAA

IMAGE:4895042/clone_end = 5′

3887
Table 3A
Hs.78064
BF214148
11107732
ribosomal protein L27a (RPL27A),
1
GACACAGCGAGAGTCCAGGAACAGG

mRNA/cds = (22, 468)

CAGACAAGCGAGAAAGAGGAGAAGC

3888
Table 3A
Hs.169248
BF214508
11108094
601845758F1 cDNA, 5′
1
GTAGGAGGCGAGAAGGAAGAACAAG

end/clone =

GCACACCGAAGGAGCAAGACCAGAC

IMAGE:4076510/clone_end = 5′

3889
Table 3A
Hs.75968
BF217687
11111273
thymosin, beta 4, X chromosome
1
CAAGAAGCAGAAGCAGCAACCAGAG

(TMSB4X), mRNA/cds = (77, 211)

ACAGAGAGACAAACGCAGAACAACA

3890
Table 3A
Hs.111611
BF219474
11113299
ribosomal protein L27 (RPL27),
1
CAACAAGCAGACGAACAACAAC

mRNA/cds = (17, 427)

AAATATCAACGAGGCGCAGCAGCT

CAAA

3891
Table 3A
Hs.112318
BF237710
11151628
cDNA FLJ14633 fis, clone
1
AACACACAAGAGAAACATAACCACTA

NT2RP2000938/cds = UNKNOWN

AATCACTACAAACACACACAGAAT

3892
Table 3A
Hs.182937
BF242969
11158897
peptidylprolyl isomerase A (cyclophilin
1
AAACGAATTCTTGCACTGAGAGTGTT

A) (PPIA), mRNA/cds = (44, 541)

CACAGCGCCACTTTCCTCCTCCTC

3893
Table 3A
Hs.171774
BF243010
11156938
hypothetical protein (HSPC016),
1
CGAGAAGCAGAAGATGACAGCAGAG

mRNA/cds = (38, 232)

CGAAAGCAGAGAACGAACAGACAAG

3894
Table 3A
Hs.296251
BF243724
11157654
programmed cell death 4 (neoplastic
1
TTGGATTTATTAAAGTCCCTTTGGAA

transformation inhibitor) (PDCD4),

GTCTTCTACCATTACTGTAGACCA

mRNA/cds = (84, 1493)

3895
Table 3A
Hs.109697
BF244603
11158534
601862620F1 cDNA, 5′
1
TCACATACCCTATGCCGACTGAGTGG

end/clone =

AACGAGCCGACTATCACACAGAGC

IMAGE:4080412/clone_end = 5′

3896
Table 3A
Hs.294110
BF245076
11159008
601863910F1 cDNA, 5′
1
CACATGCGCAATAAACCCCGGCGAAG

end/clone =

ACGCCACTCTGCGGCAAAGGACACA

IMAGE:4082235/clone_end = 5′

3897
Table 3A
Hs.182825
BF245224
11159156
ribosomal protein L35 (RPL35),
1
CCGCAGACACGAAAGCACCAACCAC

mRNA/cds = (27, 398)

CGACCGCCACCAGAAGGAACAACAG

3898
Table 3A
Hs.199248
BF245892
11159734
prostagtandin E receptor 4 (subtype
1
GGGCACTTAAATGGTCACCTGTGTAA

EP4) (PTGER4),

CAGTTTGGTGTAACTCCCAGTGAT

mRNA/cds = (388, 1854)

3899
Table 3A
Hs.108124
BF303895
11250572
cDNA:FLJ23088 fis, clone
1
ACAACACGAAAACGAACAAGCA

LNG07026/cds = UNKNOWN

AAGAAAGAAAACGGACACGAGCGA

ACCA

3900
Table 3A
Hs.296251
BF303931
11250608
programmed cell death 4 (neoplastic
1
TTGGATTTATTAAAGTCCCTTTGGAA

transformation inhibitor) (PDCD4),

GTCTTCTACCATTACTGTAGACCA

mRNA/cds = (84, 1493)

3901
Table 3A
NA
BF306204
11253289
cDNA clone IMAGE:4138980 5′
1
CAGCCATGTCCATGACAACCAGAGC

CTGGGAGGAGCTGGATGGCGGCCTG

3902
Table 3A
Hs.5174
BF307213
11254322
ribosomal protein S17 (RPS17),
1
AAACACACAGCAAGAACCACGA

mRNA/cds = (25, 432)

AAAGAGCAACCCAAAATAGGAAAA

GCGG

3903
Table 3A
Hs.84883
BF307871
11255039
mRNA for KIAA0864 protein, partial
1
ACAGCGTGGATATAAGGACCAAGAG

cds/cds = (0, 3856)

ACTAGGGCGCATACTATGATTCGCA

3904
Table 3A
Hs.63906
BF309911
11257388
hypothetical protein MGC14726
1
ATGGACACGAGGACGGAACTGGGGG

(MGC14726), mRNA/cds = (21, 653)

TACTAGAACAACCCTTCTCTGAAAA

3905
Table 3A
Hs.292457
BF310168
11257703

Homo sapiens, clone MGC:16362
1
AGACCAAACGAGAAGGAGAAAAAGC

IMAGE:3927795, mRNA, complete

AAGACCACAAAAGACAACAACAGCG

cds/cds = (498, 635)

3906
Table 3A
NA
BF313856
11261925
601902261F1 5′
1
AAAAAATCGGGCTTTTTCTGGGGGAA

end/clone =

AGGGAAGGGCGGGGAATGCTGGCC

IMAGE:4134998

3907
Table 3A
NA
BF315059
11263244
601899090F1 5′
1
CTACAACAATACAGCACACAGCATAA

end/clone =

GCGCACAGGGCATAGACTAGGCAA

IMAGE:4128334

3908
Table 3A
Hs.99858
BF315159
11263380
ribosomal protein L7a (RPL7a),
1
CAAGAGAGTGGAGACGAGTACGCGA

mRNA/cds = (31, 831)

GAACGCACGACACAGAGCGCAAGAA

3909
Table 3A
Hs.268177
BF339088
11285508
phospholpase C, gamma 1 (formerly
1
TCTGCTGCCCTCTTAAGATCTGACTG

subtype 148) (PLCG1),

CCAAATAAATCATCCTCATGTCCT

mRNA/cds = (76, 3948)

3910
Table 3A
Hs.296317
BF340402
11286776
mRNA for KIAA1789 protein, partial
1
GATGAGAAACAACCACAAGGAAGAG

cds/cds = (3466, 4899)

GGCAGCGCCGGAGACCTACAGAAAG

3911
Table 3A
Hs.116567
BF341330
11287821
602013274F1 cDNA, 5′
1
GCGGGGGCACTGGCTCTTCACATTT

end/clone =

GGTTGCGAGTTGCACACACCACAAC

IMAGE:4149066/clone_end = 5′

3912
Table 3A
Hs.2554
BF341359
11287850
sialyltransferase 1 (beta-galactoside
1
GGGGGAAGCGGAAGGGTTGGATTGG

alpha-2,6-sialytransferase) (SIAT1),

GTGAAAAAAGAATTGTTCGTGTTTA

mRNA/cds = (310, 1530)

3913
Table 3A
Hs.28788
BF341640
11288136
602016073F1 cDNA, 5′
1
ATAATAGAGGAGAGATATTGTAAATA

end/clone =

GAGACTGGCAGCAGTTTCCACAAA

IMAGE:4151706/clone_end = 5′

3914
Table 3A
Hs.33905
BF342246
11289148
602041247F1 cDNA, 5′
1
AGTGGCAGGTGCAATTGTCGGTTCG

end/clone =

ATTTGTGTTCCCAACAGTCTGAAAT

IMAGE:4179250/clone_end = 5′

3915
Table 3A
Hs.127863
BF342439
11289452
601898969F1 cDNA, 5′
1
GAGCCCACGGGGAAGGGAACCCAGC

end/clone =

AACACGGAAATAAGTTGGACCGATC

IMAGE:4128112/clone_end = 5′

3916
Table 3A
Hs.205442
BF377518
11339543
601439689F1 cDNA, 5′
1
ACAACCTGAGAAATAATTCGGTCAAT

end/clone =

ACCAGACTCCAACATTCCTGATCT

IMAGE:3924407/clone_end = 5′

3917
Table 3A
Hs.319825
BF380732
11389857
602021477F1 cDNA, 5′
1
GTCTATTACAAAGTAAAGAGAGTCAA

end/clone =

TTACTCCAGGAGGAGAATTGCAGG

IMAGE:4156915/clone_end = 5′

3918
Table 3A
Hs.5174
BF381953
11363256
ribosomal protein S17 (RPS17),
1
ACCAGACACGGACACACACGAACAC

mRNA/cds = (25, 432)

AAGAAAACACAAAACAAGAGCAACC

3919
Table 3A
Hs.112237
BF525720
11613081
602321076F1 cDNA, 5′
1
CGGTTGGGTCCTCAAAATATGCCTGT

end/clone =

TTGGTTAACAAAAGCGGTTGTGAA

IMAGE:4424130/clone_end = 5′

3920
Table 3A
Hs.136537
BF526066
11613527
602071176F1 cDNA, 5′
1
GATAAAGAAGGGGCGCGGGAAACAG

end/clone =

CGAGGGAAGGACGGGCTGGGAGAAC

IMAGE:4214059/clone_end = 5′

3921
Table 3A
Hs.274472
BF526421
11613784
high-mobility group (nonhistone
1
ATCTCTGGCAATACTGTCTGATTACG

chromosomal) protein 1 (HMG1),

GGGGTGATGCCGACGGTTAAAAAC

mRNA/cds = (52, 699)

3922
Table 3A
Hs.334825
BF530382
11617745
cDNA FLJ14752 fis, clone
1
GAACACAAAAAACCTCTTCTATAACG

NT2RP3003071/cds = (205, 1446)

GGGACACACGCCAAGGGGACAAGT

3923
Table 3A
Hs.255390
BF531016
11616379
602072345F1 cDNA, 5′
1
TTGGGTGCAACAACCAATACACTTAT

end/clone =

ACTTGGAAACCACGGGCCATATTA

IMAGE:4215251/clone_end = 5′

3924
Table 3A
Hs.146426
BF569545
11642925
pro-alpha-1 (V) collagen mRNA,
1
AGGAGGAACAAAAACCGCAGCGTGG

complete cds/cds = (229, 5745)

ATTTCAAATTTCTGGAAGTAAGTCT

3925
Table 3A
Hs.22265
BF571362
11645074
pyruvate dehydrogenase phosphatase
1
AAATTCGCGCACCCTTTGTTTTATTG

(PDP), mRNA/cds = (131, 1855)

CCCCGGTTACAAGGTTTTGAACTG

3926
Table 3A
Hs.301183
BF572855
11646567
molecule possessing ankyrin repeats
1
CGGGCCAGTATGAATGTAGGGTCAA

induced by lipopolysaccharide (MAIL),

GGAACGCCGAGGGTTTCACAAAAGG

homolog of mouse (MAIL),

mRNA/cds = (48, 2204)

3927
Table 3A
Hs.79530
BF663116
11937011
M5-14 protein (LOC51300),
1
CTCAGTGTAGGGCAGAGAGGTCTAA

mRNA/cds = (186, 1043)

CACCAACATAAGGTACTAGCAGTGT

3928
Table 3A
Hs.11356
BF665055
11938950
602119856F1 cDNA, 5′
1
AGAATATATGTATTTTGAAAGGAAAG

end/clone =

GACTTGGGGATTTTTAACAGGGCA

IMAGE:4276860/clone_end = 5′

3929
Table 3A
Hs.3585
BF666961
11940856
602121608F1 cDNA, 5′
1
GAGACTCTCGTTGTCTCCTCTTCTGC

end/clone =

TCTCTTCTCTGTTGGAGGGGAGGA

IMAGE:4278768/clone_end = 5′

3930
Table 3A
Hs.46877
BF667821
11941516
PRO2000 protein (PRO2000),
1
AGGTTGTGGGGAGTATGTTTGGACCA

mRNA/cds = (650, 1738)

AAAATTAAAATATTGTGGGAGGGA

3931
Table 3A
Hs.343615
BF668050
11941945
602621493F1 cDNA, 5′
1
GACCTTACCTGGTGGTTTTGTGGTTT

end/clone =

GTTCTCCCGAAAAATGCGGGGTTT

IMAGE:4755166/clone_end = 5′

3932
Table 3A
Hs.12035
BF668230
11942125
602122419F1 cDNA, 5′
1
CACCCTGGGTTTTAAAGTGTGGGAGA

end/clone =

AAAGCGCCCGGAAGAAGGAAACAA

IMAGE:4279300/clone_end = 5′

3933
Table 3A
Hs.324342
BF688584
11942479
602123634F1 cDNA, 5′
1
GAGGGGACCGGCCATCTGGGCAAGC

end/clone =

AGATATGCTAATTGGGAATTATAGG

IMAGE:4280408/clone_end = 5′

3934
Table 3A
Hs.285729
BF670567
11944559
602013364F1 cDNA 5′
1
ATGACTTGTGAATACCTGAGTTATAC

end/clone =

TTTCCCAACAGATGTGCCTAACAC

IMAGE:4149351/clone_end = 5′

3935
Table 3A
Hs.27590
BF671020
11944915
histone acetyltransferase (MORF),
1
TGATAGCTCACTTAGTTAATTGTTTTG

mRNA/cds = (315, 6536)

AAGCAAATTTTTGGGTTGGATGGG

3936
Table 3A
Hs.99858
BF673951
11947846
ribosomal protein L7a (RPL7A),
1
GACACAGAAGAGAGACAGAAGAGAA

mRNA/cds = (31, 831)

ACGGTCGAGGAGAAGAAGCAGGAGC

3937
Table 3A
Hs.96566
BF673956
11947851
602137338F1 cDNA 5′
1
AAAGACCAGAGACAGGGAGACACGG

end/clone =

CAGACAGAGCGCCCACAAAGAAGAG

IMAGE:4274048/clone_end = 5′

3938
Table 3A
Hs.181357
BF676042
11949937
laminin receptor 1 (87kD, ribosomal
1
CAAGGCGACATGGGAGAGCGAGAAG

protein SA) (LAMR1),

GCTAGGAGGACGACAGACAAGGAAA

mRNA/cds = (85, 972)

3939
Table 3A
Hs.122408
BF677944
11951839
602084766F1 cDNA 5′
1
GAATTTTGGGGAGGTTACTGGTCGG

end/clone =

GGGAAATAACAGGGTTGGACAAACG

IMAGE:4248905/clone_end = 5′

3940
Table 3A
Hs.131887
BF676298
11952193
602415225F1 cDNA 5′
1
CTCCACATATGGGTAACACACTCGGT

end/clone =

CCTTACAAGCACCTAGTCACTTCC

IMAGE:4523725/clone_end = 5′

3941
Table 3A
Hs.205319
BF679831
11953640
602154415F1 cDNA 5′
1
GGGACCAGACTGCTTTCTAAATGCAC

end/clone =

AGCTCTTTCACTATCAGAATGTGT

IMAGE:4295595/clone_end = 5′

3942
Table 3A
Hs.34549
BF680988
11954883
602620683F1 cDNA 5′
1
TGTGGTCACTTGGGAAATAAATTCCA

end/clone =

TCTGGCTTACCCAATGGGTGGTGG

IMAGE:4746422/clone_end = 5′

3943
Table 3A
Hs.10702
BF684382
11969790
hypothetical protein DKFZp761H221
1
CCACAGCCACAACACCAGACAAGCC

(DKFZp761H221),

GACCAACAGACAGATACAGACCACC

mRNA/cds = (776, 1714)

3944
Table 3A
Hs.164675
BF689700
11975108
602186609F1 cDNA 5′
1
ACCACAGCAAGACAACAAGGACGAG

end/clone =

AAAGAGAACAGACAATGAGCAACGA

IMAGE:4298402/clone_end = 5′

3945
Table 3A
Hs.71331
BF691178
11976586
hypothetical protein MGC5350
1
ACTACTGCTTGCGTACCTCTCCGCTT

(MGC5350), mRNA/cds = (189, 995)

TCCCTCTCCTTACTATCGACCATA

3946
Table 3A
Hs.173965
BF691895
11977303
ribosomal protein S6 kinase, 90kD,
1
TCCGTTTATATTAGCACTGTATCCCTT

polypeptide 3 (RPS6KA3),

GTGCCATCCAACATTTGTATGT

mRNA/cds = (0, 2222)

3947
Table 3A
Hs.233936
BF694761
11980263
myosin, light polypeptide, regulatory,
1
CGGGCGCAGGACAGTAGCAGAGAAG

non-sarcomeric (20kD) (MLCB),

AGAGGTGGAGAGCCGGACAACGCAG

mRNA/cds = (114, 629)

3948
Table 3A
Hs.318782
BF696330
11981738
602808489F1 cDNA 5′
1
CTTCAGTCATTATGGGCTCAGTTTCC

end/clone =

TCACTATTGGTTCCTCGCAAGGGA

IMAGE:4940633/clone_end = 5′

3949
Table 3A
Hs.103180
BF698884
11984292
602126455F1 cDNA 5′
1
AAGAGCAACAACGAGGCGAAGAGGA

end/clone =

AGGAGGAGGCAAGACAGAAGAGGAA

IMAGE:4283340/clone_end = 5′

3950
Table 3A
Hs.252723
BF698920
11984328
ribosomal protein L19 (RPL19),
1
GAGGAGCAACGACCAGAGAGACGAA

mRNA/cds = (28, 618)

CTGACATCAACCATAGAAGACGACA

3951
Table 3A
Hs.323662
BF700502
11985910
hypothetical protein MGC14595
1
AAGCATGAAGAAGACCTGGATGAGG

(MGC14595), mRNA/cds = (101, 850)

CTCAGGGAGGTTCCCCCAGTTTAAA

3952
Table 3A
Hs.253550
BF750565
12077241
RC1-BN0410-261000-014-(11 cDNA
1
ATCAGTCAATCAGTCAGCTTCTCAGA

GTAGCAATCCATGTGTCCAGAGGA

3953
Table 3A
Hs.10957
BF793378
12098432
602254823F1 cDNA 5′
1
AAATCCAATCCTTCGGAGAGGGAATG

end/clone =

GGCGGTATTAATTAAGGGAAGTCC

IMAGE:4347076/clone_end = 5′

3954
Table 3A
Hs.293658
BF794089
12099143
602255649F1 cDNA 5′
1
ATGACAAGACAAGCCAGACGAAGAA

end/clone =

GACAAACAAGGGAGACACAGCAGAC

IMAGE:4338732/clone_end = 5′

3955
Table 3A
Hs.206761
BF794256
12099310
602255454F1 cDNA 5′
1
TGCGCCCCAATATTTGTGGAACAGCG

end/clone =

TTTTGTTCGAATAAAACGATCGGT

IMAGE:4338949/clone_end = 5′

3956
Table 3A
Hs.246818
BF796642
12101696
602259646F1 cDNA 5′
1
CTCGAGGTGTAACTCAGGAAGGCCT

end/clone =

AGCGAATCCCGACTCGGATGGTGTC

IMAGE:4343171/clone_end = 5′

3957
Table 3A
Hs.54452
BF797348
12102402
zinc finger protein, subfamily 1A, 1
1
TTCACCTACTCTGTTCTTTTCATCCAT

(lkaros) (ZNFN1A1),

CCCCTGAGTCAGTTGGTTGGAGG

mRNA/cds = (188, 1727)

3958
Table 3A
NA
BF821451
12160669
RT0038 cDNA
1
CTGTTGTCTGGAGTGTGGAGTCTCTT

GTCTGGATTGTGGAGTCTCTTGTC

3959
Table 3A
NA
BF889206
12280465
RC6-TN0073-041200-013-H02
1
CAAGATGATGCTTGCTGTCTTTTTCCT

cDNA/gb = BF889208

CTCGGCTACCCAGAATGGCATTTG

3960
Table 3A
Hs.38664
BF892532
12283991
IL0-MT0152-061100-501-e04
1
AGTACTCATGACTTGAGAGACGTGGA

cDNA

CGGAGCCAGCTTCTACCTTGCTTG

3961
Table 3A
Hs.337534
BF965088
12332283
602268833F1 cDNA 5′
1
GGTCCGACCAATTAATGACTCCATGA

end/clone =

TCGGCCTCGGTTTTCACAAACCTT

IMAGE:4356776/clone_end = 5′

3962
Table 3A
Hs.334691
BF965438
12332653
hypothetical protein FLJ22427
1
AGACAAAGAGAGCATAAATATAGCTC

(FLJ22427), mRNA/cds = (40, 2631)

TACTCATGGGTACCATACCAGTGT

3963
Table 3A
Hs.133864
BF965766
12332981
602276890F1 cDNA 5′
1
TTACATTTGTGGACCATGTTACAGTTA

end/clone =

AAGAAAAATCCTGTTTCAGTCCT

IMAGE:4364495/clone_end = 5′

3964
Table 3A
Hs.279681
BF965960
12333175
heterogeneous nuclear
1
GCAGGTTATCGCAAGATGTCTTAGAG

ribonucleOprotein H3 (2H9) (HNRPH3),

TAGGGTTAAGGTTCTCAGTGACAC

transcript variant 2H9,

mRNA/cds = (118, 1158)

3965
Table 3A
Hs.5324
BF966028
12333243
hypothetical protein (CL25022),
1
ATTTTTAAATGGCTTTACCAAACATTG

mRNA/cds = (157, 1047)

TCAGTACCTTTACGTGTTAGAAG

3966
Table 3A
Hs.179902
BF966049
12333264
transporter-like protein (CTL1),
1
CTTTCCACAGCAATTGTTTTGTACGA

mRNA/cds =0 (0, 1964)

GGGGCCTTACAGCGCGGTCCACTT

3967
Table 3A
Hs.48320
BF966269
12333484
mRNA for ring-IBR-ring domain
1
TTCTACAGCACGATGCCTGGATCTAC

containing protein Dorfin, complete

TGACCTGTCAACCACGAATCTTGA

cds/cds = (317, 2833)

3968
Table 3A
Hs.171802
BF966361
12333576
RST31551 cDNA
1
GAAACAGCAACAAGCAAACAGG

ATCTCAGCATTACCAACAGCCAGC

ACTA

3969
Table 3A
Hs.22790
BF968270
12335485
602269653F1 cDNA 5′
1
TGAGCCTGAACTTTTTTAGCAAATTAT

end/clone =

TATTCTCAGTTTCCATTACCTGT

IMAGE:4357740/clone_end = 5′

3970
Table 3A
NA
BF968628
12335843
cDNA clone IMAGE:4359351 5′
1
CCTTCCAAAGCGGTCACCTGATAGG

GAAGTCTTACGGCTAGGAAGTTACA

3971
Table 3A
Hs.5064
BF968963
12336178
602490910F1 cDNA 5′
1
GAATGGTGGGGAGAAAAAAGGGGGG

end/clone =

CACAGTCATGATCGGCTCTTATAAT

IMAGE:4619835/clone_end = 5′

3972
Table 3A
Hs.24143
BF969990
12337205
Wiskott-Aldrich syndrome protein
1
GTCACATAATCCGGGGACCCAAAGAA

interacting protein (WASPIP),

AGTTCTCCAGAGTGGTTTCACGAG

mRNA/cds = (108, 1619)

3973
Table 3A
Hs.23703
BF970427
12337642
602272760F1 cDNA 5′
1
ACAACAACACATCACGTAACCACAAC

end/clone =

ACGCATAAACAGCAAATCATCCTA

IMAGE:4360767/clone_end = 5′

3974
Table 3A
Hs.102647
BF970875
12338090
602271535F1 cDNA 5′
1
CAGAACACCAACAAGCAGGGACGGA

end/clone =

AGCCGACCGAGCAAACAGCGAAGGG

IMAGE:4359609/clone_end = 5′

3975
Table 3A
Hs.321477
BF970928
12338143
602270204F1 cDNA 5′
1
GTGGACGGCCTGGGAATGTGCCCCC

end/clone =

CGGTGTAACATCGAGCCCACAATGG

IMAGE:4358425/clone_end = 5′

3976
Table 3A
Hs.79101
BF971075
12338290
cyclin G1 (CCNG1),
1
AGGATTAGGAGAGGGTCACAGAACA

mRNA/cds = (187, 1074)

GAAAGCAGATTACACTTGGGATGGA

3977
Table 3A
Hs.33026
BF971984
12339199
mRNA for FLJ00037 protein, partial
1
CTCTGTTTGTCTGGCCGCCTCCGTGA

cds/cds = (3484, 3921)

TCAAACCGTGTCGTCGGCGTGTTC

3978
Table 3A
Hs.146550
BF976590
12343805
DNA sequence from clone RP1-68O2
1
GGCTTGGACATTGCTCTCAAGAAGAT

on chromosome 22 Contains the 5′ end

TAAGAACCCTGGAGGAACACTAGG

of the APOL2 gene for apolipoprotein L

2, the APOL gene for applipoprotein L,

the MYH9 gene for nonmuscle type

myosin heavy chain 9, ESTs, STSs

and GSSs/cds = (0, 5882)

3979
Table 3A
Hs.7905
BF981080
12383892
602310311F1 cDNA 5′
1
TGTACAGCTAAATTTCTCCAAAGCAC

end/clone =

TTTTTCAAAACCAAAAAAGAAAAA

IMAGE:4401411/clone_end = 5′

3980
Table 3A
Hs.182740
BF981263
12384075
ribosomal protein S11 (RPS11),
1
TTTGCACACTGAACACTTACAGATGT

mRNA/cds = (33, 509)

GGCAGATGTGAAATTTGTCATCAA

3981
Table 3A
Hs.289721
BF981634
12384446
cDNA:FLJ22193 fis, clone
1
ACAGAGAGTCACCCGCGAGTACGAA

HRC01108/cds = UNKNOWN

ACAGGCACATTTTTAGAAACTCACA

3982
Table 3A
Hs.83583
BG024761
12410861
actin related protein 2/3 complex,
1
AGGTTCTTACCACCACTTTTGTGCCC

subunit 2 (34 kD) (ARPC2),

ATCTTTCCCTTCGTTCCCAATGTG

mRNA/cds = (84, 986)

3983
Table 3A
Hs.1432
BG026279
12413729
protein kinase C substrate 80K-H
1
CCGGGGTGGCCCTCTCAAATTTGGC

(PRKCSH), mRNA/cds = (138, 1719)

ATGGGGTCCTCTTTCAATGTTGTGG

3984
Table 3A
Hs.279009
BG028577
12417672
matrix Gla protein (MGP),
1
CACGAGCGGCTGGAGGACACCCATT

mRNA/cds = (46, 357)

TTGTGCAGTGCCCGTCCGTCCCTTC

3985
Table 3A
Hs.5122
BG028906
12418001
602293015F1 cDNA 5′
1
GCCCTATGGCGTTGTTAAACACGAGC

end/clone =

GTATGCTAGTAAGTATCATTCATA

IMAGE:4387778/clone_end = 5′

3986
Table 3A
Hs.143554
BG033028
12424903
Pur-beta (PURB) mRNA, complete
1
GGTGTGTCTCGCGGCTGGCCCAGTC

cds/cds = (13, 951)

TATTCTCGGTGTTTATCTTCATCAC

3987
Table 3A
Hs.118787
BG033294
12425446
transforming growth factor, beta-
1
GACAACGGAAACTCTGTCTCTACCAC

induced, 68kD (TGFB1),

CATGTGACAGACGCGTTGATGCGT

mRNA/cds = (47, 2098)

3988
Table 3A
Hs.103902
BG033732
12426494
602301101F1 cDNA 5′
1
CAAGACACAAACAGCACGACTC

end/clone =

ACACAGAGAAAGCAACCATGCCGA

IMAGE:4402465/clone_end = 5′

GGAG

3989
Table 3A
Hs.306155
BG033909
12426670
chorionic somatomammotropin
1
CGCGTCGAACTTCGGGACATTCCCG

hormone 1 (placental lactogen)

TAAACCACAAACAGATAAAGAATTA

(CSH); transcript variant 2,

mRNA/cds = (116, 886)

3990
Table 3A
Hs.332404
BG033953
12426761
CDA02 protein (CDA02),
1
GCGTAAAGTGATCAAAAGGCCCTGAA

mRNA/cds = (2, 1831)

GGGGAAAATGATAAAACCCGTGGT

3991
Table 3A
Hs.12396
BG034192
12427253
602302446F1 cDNA 5′
1
AGAGGAAGCGTGTGAATACAACAATC

end/clone =

TAAAAAGGAGGAGAGGTCGAGCAC

IMAGE:4403868/clone_end = 5′

3992
Table 3A
Hs.125819
BG034799
12428456
putative dimethyldenosine
1
ACACATTCCCCATACCATTTCGTGTT

transferase (HSA9761),

ATTCACATTCCCCGTACCATTTCT

mRNA/cds = (78, 1019)

3993
Table 3A
Hs.16488
BG035120
12428935
calreticul (CALR),
1
TAAAAAGGGGGTGGCGGCTGTAGTA

mRNA/cds = (68, 1321)

AGGAGGAGCGAGTAATGTATAGCAC

3994
Table 3A
Hs.17719
BG035218
12429131
EBP50-PDZ interactor of 64 kD
1
CCATGAGCAGGCGCAACCATAACAG

(EPI64) mRNA/cds = (24, 1550)

TTAGAGACGGCACACAGCACGACAC

3995
Table 3A
Hs.319825
BG036101
12430901
602021477F1 cDNA 5′
1
ACTCACGCAAGAGCAGGGGGACTAT

end/clone =

AACAGAAATAAACAAGTAAATAAAT

IMAGE:4156915/clone_end = 5′

3996
Table 3A
Hs.192965
BG036938
12432665
602287708F1 cDNA 5′
1
TACACAGGCAGCTATGCGGATCATCA

end/clone =

GACGAGCACATATTCTAACAGAGA

IMAGE:4375153/clone_end = 5′

3997
Table 3A
Hs.144924
BG037042
12432874
serine/threonine protein kinase SSTK
1
CGTCGCCGTAGGACGCCTCCGTCGT

(SSTK), mRNA/cds = (122, 943)

CGTCTGGTCTGTCTCCTGCATCGAG

3998
Table 3A
Hs.318893
BG106948
12600794
602291361F1 cDNA 5′
1
AAAGGCAAGAGTCCGGGGTGGCAGA

end/clone =

AGAGTGAAAAATGAAAGAGAGAAGG

IMAGE:4386159/clone_end = 5′

3999
Table 3A
Hs.109007
BG110599
12604105
602342214F1 cDNA 5′
1
TTCTGCCCAGAGTGTATTTGTGAAGA

end/clone =

GTCTCTTATATTATGTTTTGTGGA

IMAGE:4452602/clone_end = 5′

4000
Table 3A
Hs.173737
BG110835
12604341
ras-related C3 botiulinum toxin
1
GTGCGAATGTGGAGTGTTTTACATTG

substrate 1 (rho family, small GTP

ATCTTTGCTAATGAATTAGCATCA

binding protein Rac1) (RAC1),

transcript variant Rac1b,

mRNA/cds = (0, 635)

4001
Table 3A
Hs.323950
BG111212
12604718
zinc finger protein 6 (CMPX1) (ZNF6),
1
CATTACGCATATTGGTAAGACGCAAA

mRNA/cds = (1265, 3361)

ATGAGACAGATCGACACTGGGACG

4002
Table 3A
Hs.37908
BG111773
12605279
601820448F1 cDNA 5′
1
CACAACGGGTCTTAATGACGACGGAA

end/clone =

AGATACATCCATCGGTATGAACGC

IMAGE:4052578/clone_end = 5′

4003
Table 3A
Hs.74313
BG112085
12605591
mRNA for KIAA1265 protein, partial
1
ACCAGCAATCCGCAGCAGAGTCATAA

cds/cds = (68, 2573)

GTGGGGTAGGTGATATGTACTAAC

4004
Table 3A
Hs.320972
BG112503
12606009
602282105F1 cDNA 5′
1
GAAAAAACAAGCTAACAAACAC

end/clone =

ACACGCCCACACCAACATGCCAGA

IMAGE:4369633/clone_end = 5′

ACGC

4005
Table 3A
Hs.7589
BG112505
12606011
602282107F1 cDNA 5′
1
TGAACATGGGTGGGTTTGATCACGAG

end/clone =

GATTCCGCTGAAAAGATTAGAGGG

IMAGE:4369729/clone_end = 5′

4006
Table 3A
NA
BG118529
12612035
cDNA clone IMAGE:4443519 5′
1
CGCGTTCATAACGGCGTCGACTGTTC

TTGTGCTGCTGTTATCTATACTAT

4007
Table 3A
NA
BG121288
12614797
cDNA clone IMAGE:4450407 5′
1
GGGACCAGACTACACGGAATACCAG

AGTTGAAGAAAATTAAGATTTAAGC

4008
Table 3A
Hs.285729
BG163237
12669951
602013384F1 cDNA 5′
1
TATACTGAGAGTGAAGGTCTGGGTGC

end/clone =

CAACTTGAGACAGGTGGTCTAGGA

IMAGE:4149351/clone_end = 5′

4009
Table 3A
Hs.111554
BG164898
12671532
ADP-ribosylation factor-like 7 (ARL7),
1
CCCCTGGTTTTCTCGTTCTGCCTCCT

mRNA/cds = (14, 592)

TTGGACCTGTGTTTGTTTTCTGCT

4010
Table 3A
Hs.193482
BG165998
12672701
cDNA FLJ11903 fis, clone
1
CCCTTAGAATGGTTACTGCCCTTGAA

HEMBB1000030/cds = UNKNOWN

TTAACTTGACACAACTTGGGTTGG

4011
Table 3A
NA
BG166279
12672982
cDNA clone IMAGE:4455496 5′
1
CGAATAATCCCTATTTGATTACCTCA

GAAAGTTTTGTCTTCCGCCAAGG

4012
Table 3A
Hs.87113
BG188139
12674842
602341526F1 cDNA 5′
1
TTGGACCCCAGGGTAAGGCGGATAT

end/clone =

TGGTTGGGACGTTCGGGGAGTGTAT

IMAGE:4449343/clone_end = 5′

4013
Table 3A
Hs.182695
BG170647
12677350
mitochondrial ribosomal protein 63
1
AATTACGTTCGGAGGTATATAAAAAG

(MRP63), mRNA/cds = (215, 523)

GGATCGGCGCAGTGGATAGGGGGT

4014
Table 3A
Hs.204959
BG180098
12886801
hypothetical protein FLJ14886
1
GGAGATCCACAGTGATCTCAGGCCC

(FLJ14888), mRNA/cds = (111, 1169)

TGGACCGGAAAAGGCAGCAAGATCA

4015
Table 3A
NA
BG249224
12759040
cDNA clone IMAGE:4470038 5′
1
AAGACGAGTACACCAAGACCAAAGA

GCGCCAACGAGCACGACCGAGTGAA

4016
Table 3A
Hs.6682
BG254117
12763933
solute carrier family 7, (cationic amino
1
AACGCCGACTAGACGTCACAAAGACT

acid transporter, y+ system) member

TAATAAGAAACACACTGATATCCA

11 (SLC7A11), mRNA/cds = (235, 1740)

4017
Table 3A
NA
BG254292
12764108
cDNA clone IMAGE:4477042 5′
1
CGCAACATTATCCATTTAAACCCCTG

CATAACCCATTACCAAAGCCCTCT

4018
Table 3A
Hs.30724
BG260954
12770770
602372582F1 cDNA 5′
1
GGCACCCCAATCCCCGGCAAAAACA

end/clone =

TTTGTTAACCTCTTGGGAATTTCTT

IMAGE:4480647/clone_end = 5′

4019
Table 3A
Hs.217493
BG282346
13031273
annexin A2 (ANXA2),
1
CTCGTCTGCACCGAGTCTCACAAAT

mRNA/cds = (49, 1068)

TTAGCATCTGGGTCTTGAGCATTA

4020
Table 3A
Hs.71243
BG283002
13032445
602406192F1 cDNA 5′
1
CCCTCCGGGGTCTCTATACCCACAAC

end/clone =

CTTCTATCACTCAATCAGTTGGTA

IMAGE:4518214/clone_end = 5′

4021
Table 3A
Hs.322653
BG283132
13032707
602406784F1 cDNA 5′
1
AACAAGATAGAGAGAAGACGAA

end/clone =

GATCGACACAGACAAACAACCACA

IMAGE:4518957/clone_end = 5′

ACCG

4022
Table 3A
Hs.246818
BG283706
13033918
602259846F1 cDNA 5′
1
TGTTGGGACCCCTCATCTCACGGGTC

end/clone =

ATTTCCACCACTAAACGCCCTTTT

IMAGE:4343171/clone_end = 5′

4023
Table 3A
Hs.151239
BG286500
13039430
602382992F1 cDNA 5′
1
CCCTGAAATCCTAAATTCCGTCACCC

end/clone =

CTCCAACATGACCATAAAAGTCCC

IMAGE:4500527/clone_end = 5′

4024
Table 3A
Hs.323950
BG286649
13039715
zinc finger protein 6 (CMPX1) (ZNF6),
1
GACCACGTTATGTGCCTGACTTCGAG

mRNA/cds = (1265, 3361)

GACACCCTCTCTGGTTTGGTATTT

4025
Table 3A
Hs.278428
BG286817
13040034
progestin induced protein (DD5),
1
TCTCCTTTCAGTTCCTTTGTAGGATTT

mRNA/cds = (33, 8432)

CTGGCCTTGAGGATAGTCTTCA

4026
Table 3A
NA
BG288308
13043014
cDNA clone IMAGE:45127006 5′
1
TCTCATCAACATTTGACTCTCAGAAG

AGCCTCCATTTGCCCTTTCTCTCT

4027
Table 3A
Hs.115467
BG288391
13043387
602388053F1 cDNA 5′
1
GCAGAGCAGACCTTATTACGCACAAT

end/clone =

TGCCGGTAACATGTAACACCAGTT

IMAGE:4517076/clone_end = 5′

4028
Table 3A
Hs.11637
BG288429
13043463
602388093F1 cDNA 5′
1
ATTGGGCATGGTTGGTCCAATGCCTC

end/clone =

ACATGGCCGGGATAACAGGACGCA

IMAGE:4517086/clone_end = 5′

4029
Table 3A
Hs.79101
BG288554
13043326
cyclin G1 (CCNG1),
1
CAAAGGGTGTAATTCCACATTGACAC

mRNA/cds = (187, 1074)

TCCTGTCATGCGGTGGGGCGGGAAC

4030
Table 3A
Hs.44577
BG288837
13044076
602388170F1 cDNA 5′
1
CTAGCTCACTAGTTGTGCCTATATGC

end/clone =

CACACCGGGGGACCCAACAAGGGT

IMAGE:4517129/clone_end = 5′

4031
Table 3A
Hs.173830
BG289048
13044499
602383668F1 cDNA 5′
1
ATACTGTGTGATTTGCCCTTGCTGTC

end/clone =

CAACCCTGTTCTTGCTGCCATTTA

IMAGE:4512712/clone_end = 5′

4032
Table 3A
Hs.169363
BG289347
13045100
GLE1 (yeast homolog)-like, RNA
1
GTGGCCTGAAGTGACCCATTCTATGA

export mediator (GLE1L),

ATTGTTAATTAAGGTGCCAAAAA

mRNA/cds = (87, 2066)

4033
Table 3A
Hs.79914
BG290141
13046637
lumican (LUM), mRNA/cds = (84, 1100)
1
GGGTTTGAGACTTGGGTATGGAAACA

GAACCGGAAATTGTGTGCTCTGGT

4034
Table 3A
Hs.125872
BG290577
13047679
sperm associated antigen 9 (SPAG9),
1
ATTTCTATTATGGAATCCCTGGGGTT

mRNA/cds = (110, 2410)

CAGAATGTAACTTTGTACATGAGA

4035
Table 3A
Hs.95835
BG291649
13049588
RST8356 cDNA
1
GACAGTACACCTCAGGGAAGGGACA

AACAAACACGATAAATCGACACACG

4036
Table 3A
Hs.289088
BG291970
13050316
heat shock 90kD protein 1, alpha
1
TCAGACCCAGTCTTGTGGATGGAAAT

(HSPCA), mRNA/cds = (60, 2258)

GTAGTGCTCGAGTCACATTCTGCT

4037
Table 3A
Hs.322804
BG311130
13112931
ia55a08.yt cDNA, 5′
1
TCCTGAGCCCCACACGCCCGAAGCA

end/clone_end = 5′

ATAAAGAGTCCACTGACTTCCAAAA

4038
Table 3A
Hs.190219
BG326781
13133218
602425659F1 cDNA 5′
1
ACGAATATCGAATCTCCCACGCGGG

end/clone =

GGGTGAGACCCGAATCTGCGGCTGC

IMAGE:4563471/clone_end = 5′

4039
Table 3A
Hs.292457
BG339050
13145488

Homo sapiens, clone MGC:16362
1
AGACACACGAGCAAAACGACGCAGC

IMAGE 3927795, mRNA, complete

AAGAATCAGATAGCATAGCAAACAT

cds/cds = (498, 635)

4040
Table 3A
Hs.170980
BG387694
13281140
cell cycle progression 2 protein
1
GCAGTGGGACGGAACGGGTGAAGCC

(CPR2), mRNA/cds = (126, 1691)

TGATGGCTGATGCGGCACGATCTTG

4041
Table 3A
Hs.268175
BG391695
13285143
cDNA FLJ20673 fis, clone
1
CTTTAAATCTTAGATTGCTCCGCACA

KAIA4464/cds = (104, 1402)

GATAAAGAGAACCAGGATTGGGGC

4042
Table 3A
Hs.301226
BG396292
13289740
mRNA for KIAA1085 protein, partial
1
TTTATTTGGGTACTTTTCCCCAACACA

cds/cds = (0, 1755)

AGTCCTTTTATCCCACCCTTGGG

4043
Table 3A
Hs.58643
BG397564
13291012
602438603F1 cDNA 5′
1
AAAAGATCTCGGAAAATAGCATTTTG

end/clone =

TTAAAACCTTGGGGGGTAAAACCC

IMAGE:4564968/clone_end = 5′

4044
Table 3A
Hs.26670
BG403635
13297083
PAC clone RP3-515N1 from 22q11.2-
1
AACCTTCATGCAAGTGGAGACGGGTA

q22/cds = (0, 791)

GGGGGTTCTATGGGGCATTGGTTG

4045
Table 3A
Hs.292457
BG424974
13331480

Homo sapiens, clone MGC:16362
1
TGTGAAAAGCTGATAAGAAAACCATC

IMAGE:3927795, mRNA, complete

CAGAAAAAGCTCTTCGTTTTACA

cds/cds = (498, 635)

4046
Table 3A
NA
BG427404
13334006
cDNA clone IMAGE:4612518 5′
1
TCATTATAATTCTGTCCTAGGAAATCA

AATTAGAACGCTCCACAAGCCGG

4047
Table 3A
NA
BG432194
13338700
cDNA clone IMAGE:4610035 5′
1
CGCAGAGCTGGGCCTTACAAATGGG

TTCCAAATCGGGCTTCTCACTCAGG

4048
Table 3A
Hs.28491
BG434865
13341371
spermidine/spermine N1-
1
TACAACTGTACCACACTGGGTTACTC

acetyltransferase (SAT),

TAGAAGTCTCTGGTCGGATCCTTC

mRNA/cds = (165, 880)

4049
Table 3A
Hs.281397
BG438232
13344738
hypothetical protein AD034 (AD034),
1
CATAGAGCACAAGAGACACATGGAC

mRNA/cds = (195, 1880)

CGGCACGCGACCCGACCCAAAGCGC

4050
Table 3A
Hs.301226
BG468330
13400600
mRNA for KIAA1085 protein, partial
1
TTTACCTCATTTATTTGGTACTTTCCC

cds/cds = (0, 1755)

CACACAGTCCTTTATCCACCTGG

4051
Table 3A
Hs.334787
BG473226
13405503

Homo sapiens, clone MGC:19556
1
CCATTTTTAGTGGGGGAGAAAACTGT

IMAGE:4304831, mRNA, complete

CACTGTGCTGGCGAAAGAGGTCCA

cds/cds = (1505, 1666)

4052
Table 3A
Hs.292457
BG473813
13406090

Homo sapiens, clone MGC:18362
1
CCGCACCGATTAACGGCCAGAGAAG

IMAGE:3927795, mRNA, complete

CAACAAGCAAATAAAAAGTGGGAAA

cds/cds = (498, 635)

4053
Table 3A
Hs.173737
BG482796
13415077
ras-related C3 bolulinum toxin
1
AACTTAACTCACTGGCGAGAATACAG

substrate 1 (rho family, small GTP

CGTGGGACCCTTCAGCCACTACAA

binding protein Rac1) (RAC1),

transcript variant Rac1b,

mRNA/cds = (0, 635)

4054
Table 3A
Hs.24054
BG489375
13450885
hypothetical protein GL009 (GL009),
1
AGGACTTAACGGGAATACGGGAATAA

mRNA/cds = (77, 628)

CTCCAATTACTTCATCTCTAGGGC

4055
Table 3A
Hs.166254
BG493253
13454765
hypothetical protein DKFZp5661133
1
AAGGAGGTTGCTCACCAGTAGTGCTT

(DKFZP5661133),

GTTACCAAAATGTCACCAGGAGTT

mRNA/cds = (133, 1353)

4056
Table 3A
Hs.29131
BG497765
13459262
nuclear receptor coactivator 2
1
TGAATTAAGTGCATTATCAATTAACCT

(NCOA2), mRNA/cds = (162, 4556)

TATGGTGGTTGGAATAGTGATCA

4057
Table 3A
Hs.172089
BG501063
13482580
mRNA:cDNA DKFZp58612022 (from
1
AAACACACAGGAAAAGGGCAAAGGG

clone DKFZp58812022)/cds =

GGCACCAGGAGAACCGGGAGACAAA

UNKNOWN

4058
Table 3A
NA
BG501895
13463412
cDNA clone IMAGE:4654344 5′
1
CGGAGAAACGGGGCCAAAAGGTTGC

CGAGAGACCCGGCGAAAAGGACAGG

4059
Table 3A
Hs.279009
BG503693
13465210
matrix Gla protein (MGP),
1
ACAAAGCATCAAACAGCAGGGAGCTA

mRNA/cds = (46, 357)

GTGGAGAGGTCTATTGTCCCAGTG

4060
Table 3A
Hs.86437
BG505271
13488788
602411368F1 cDNA 5′
1
GGGTGCATGCCAAGAAAGTATGGTT

end/clone =

GGAATTCCTGGTACACTGAAGTGGA

IMAGE:4540096/clone_end = 5′

4061
Table 3A
Hs.237868
BG505379
13466896
interleukin 7 receptor (IL7R),
1
ATGTTATCTTGGGAATTAGTGTCTTG

mRNA/cds = (22, 1401)

AGCCTCTGTCTGTTACCGTAGTTT

4062
Table 3A
Hs.3280
BG505961
13467478
caspase 6, apoptosis-related cystaine
1
TGACCGAGTAAAAAACATCTATCAAT

protease (CASP6), transcript

TACACAAATGAACAAGAATGTGAG

variant alpha, mRNA/cds = (78, 959)

4063
Table 3A
Hs.293842
BG506472
13467989
601571679F1 cDNA 5′
1
ACAAGAAATGGTTGAGGCGAATATTG

end/clone =

GAAACACATGGGCTTAATGCTGAA

IMAGE:3838675/clone_end = 5′

4064
Table 3A
Hs.111911
BG527060
13518597
602540462F1 cDNA 5′
1
GGTATTGATGCTTGGTTTTTCCTGCC

end/clone =

AGTCCGAAATTCCTGTATTTGTCA

IMAGE:4671519/clone_end = 5′

4065
Table 3A
Hs.12396
BG527658
13519195
602302446F1 cDNA 5′
1
TCATGCTACTTGTCCTGGTTTTGTCAT

end/clone =

TGATACTCTCATAGCCCTTTTGA

IMAGE:4403868/clone_end = 5′

4066
Table 3A
NA
BG531486
13523023
cDNA clone IMAGE:4899409 5′
1
GCCTGGCGGACCGGCAGCCTATATG

ACGGACTTCCTCATTACTTACCACG

4067
Table 3A
Hs.279009
BG532345
13523883
matrix Gla protein (MGP),
1
AAACTGTTTGGAGAATTTAAGCACTC

mRNA/cds = (46, 357)

TCTGATGGGGGACAACTCTATGGA

4068
Table 3A
Hs.129872
BG532470
13524009
sperm associated antigen 9 (SPAG9),
1
TCTTTGTGCAGATACGTTCACCACAT

mRNA/cds = (110, 2410)

AAGTGTGAGCCATTTAAACCTGGT

4069
Table 3A
Hs.343475
BG533994
13525534
601558208T1 cDNA 3′
1
CACCAAAGTGGAGACAAATACATGAT

end/clone =

CTCAAAGATACACAGTACCTACTT

IMAGE:3826392/clone_end = 3′

4070
Table 3A
Hs.74647
BG536394
13527940
T-cell receptor active alpha-chain
1
AATAATTGGTCTTTTAAACAAACACG

mRNA from JM cell line, complete

GAAGTTTGGTGGAATCGGTCATGT

cds/cds = (138, 969)

4071
Table 3A
Hs.343475
BG536841
13528187
601556208T1 cDNA 3′
1
TGTTCGTGCCTTCCTTCTGGGTTCCA

end/clone =

CAAAGGTGGGACCTTACTTATCTA

IMAGE:3826392/clone_end = 3′

4072
Table 3A
Hs.72988
BG537502
13529734
signal transducer and activator of
1
AGGGAAAAACGCAGGGGGTTCAAAA

transcription 2 113kD (STAT2),

ACTCTCTCACTCTATGCAGTGTATA

mRNA/cds = (57, 2612)

4073
Table 3A
NA
BG538731
13530964
cDNA clone IMAGE:4691392 5′
1
AAGCAGCTCAATAGCAGCATAGAGGA

TTAGATTAATGGAACAGCACTGCA

4074
Table 3A
Hs.124675
BG541679
13533912
602571258F1 cDNA 5′
1
ACATATACAAGGACACAGAGGAAAGG

end/clone =

CGGGAACAACGGGAAGAGGTTTTG

IMAGE:4695805/clone_end = 5′

4075
Table 3A
NA
BG542394
13534627
cDNA clone IMAGE:4696046 5′
1
TGTGGCGATTAAGAGAGGTGAAGCAT

AACTGATTTGCAGGATATGGTTTG

4076
Table 3A
Hs.198427
BG547561
13546239
hexokinase 2 (HK2),
1
AAAAGCCAAAAGGTTTCATGTAGATT

mRNA/cds = (1490, 4243)

TTAGTTCACTAAAGGGTGCCCACA

4077
Table 3A
Hs.83077
BG547627
13546292
interleukin 18 (interferon-gamma-
1
GCAGAACTCTAATTGTACGGGGTCAC

inducing factor) (IL18),

AGAGGCGTGATATGGTATCCCAAA

mRNA/cds = (177, 756)

4078
literature
Hs.227656
XM_001289
14732543
xenotropic polytropic murine
1
CTTAACCATACAGAATGATATAACTC

leukemia virus receptor (X3)

CTGTGCAATGAAGGTGATAACAGT

mRNA, complete cds/cds = (165, 2255)

4079
literature
Hs.55468
XM_001939
11426048
H4 histone, family 2
1
CTTCGGAGGCTAGGCCGCCGCTCCA

GCTTTGCACGTTTCGATCCCAAAGG

4080
Table 3A
Hs.170171
XM_002068
14732456
mRNA; cDNA DKFZp434MO813 (from
1
CAAAGTCAAATAACTCCTCATTGTAAA

clone DKFZp434MO813); partial

CAAACTGTGTAACTGCCCAAAGC

cds/cds = (430, 768)

4081
literature
Hs.181097
XM_002135
11428074
tumor necrosis factor (ligand)
1
CCAATCCCGATCCAAATCATAATTTG

superfamily, member 4 (tax-

TTCTTAAGTATACTGGGCAGGTCC

transcriptionally activated glycoprotein

1,34kD) (TNFSF4),

mRNA/cds = (36, 587)

4082
Table 3A
Hs.76913
XM_002158
13839010
proteasome (prosome, macropain)
1
TCCAGCTCCTGTTCCTTGGAAAATCT

subunit, alpha type, 5 (PSMA5),

CCATTGTATGTGCATTTTTTAAAT

mRNA/cds = (21, 746)

4083
Table 3A
Hs.10927
XM_002269
13636009
HSZ78330 cDNA/clone = 2.49-(CEPH)
1
AACTGATGCCTGCTAGTGCTTTCTGA

TTACTCGCATTCTGTTTCTTGCTT

4084
literature
Hs.81424
XM_002513
13646509
ubiquitin-like 1 (sentrin) (UBL1),
1
TCAGGTTGAAGTCAAGATGACAGATA

mRNA/cds = (66, 371)

AGGTGAGAGTAATGACTACTCCAA

4085
Table 3A
Hs.173912
XM_003189
14735115
eukaryotic translation initiation factor
1
TCCTAGGTAGGGTTTAATCCCCAGTA

4A, isoform 2 (EIF4A2),

AAATTGCCATATTGCACATGTCTT

mRNA/cds = (15, 1238)

4086
Table 3A
Hs.63668
XM_003304
14720715
toll-like receptor 2 (TLR2),
1
AGCGGGAAGGATTTTGGGTAAATCTG

mRNA/cds = (129, 2483)

AGAGCTGCGATAAAGTCCTAGGTT

4087
Table 3A
Hs.89714
XM_003507
14731038
small inducible cytokine subfamily B
1
GAGGCCCTAGCATTTCTCCTTGGATA

(Cys-X-Cys), member 5 (epithelial-

GGGGACCAGAGAGAGCTTGGAATG

derived neutrophil-activating peptide

78) (SCYB5), mRNA/cds = (106, 450)

4088
Table 3A
Hs.66052
XM_003593
13646753
CD38 antigen (p45) (CD38),
1
CTCCACAATAAGGTCAATGCCAGAGA

mRNA/cds = (69, 971)

CGGAAGCCTTTTTCCCCAAAGTCT

4089
Table 3A
Hs.251664
XM_004020
11417288
DNA for insulin-like growth factor II
1
CCAATGTTTCTCTTTTGGCCCTATACA

(IGF-2); axon 7 and additional

AAGGCAAGAAGGAAAGACCAAGA

ORF/cds = (0, 233)

4090
Table 3A
Hs.79197
XM_004500
13631147
CD83 antigen (activated B
1
TTTACCTCTGTCTTGGCTTTCATGTTA

lymphocytes, immunoglobulin

TTAAACGTATGCATGTGAAGAAG

superfamily) (CD83),

mRNA/cds = (41, 656)

4091
db mining
Hs.159651
XM_004585
14758499
tumor necrosis factor receptor
1
GGGAAGTTGGTTTATAAGCCTTTGCC

superfamily, member 21 (TNFRSF21),

AGGTGTAACTGTTGTGAAATACCC

mRNA/cds = (0, 1967)

4092
Table 3A
Hs.279903
XM_004611
14740071
Ras homolog enriched in brain 2
1
CCCTCCCTTCAGATTATGTTAACTCT

(RHEB2), mRNA/cds = (23, 577)

GAGTCTGTCCAAATGAGTTCACTT

4093
Table 3A
Hs.302981
XM_004720
14745195
hypothetical protein FLJ11000
1
TTATTCATATATTCCTGTCCAAA

(FLJ11000), mRNA/cds = (223, 780)

GCCACACTGAAAACAGAGGCAGA

GACA

4094
Table 3A
Hs.239138
XM_004839
13629023
pre-B-cell colony-enchancing factor
1
TGCACCTCAAGATTTTAAGGAGATAA

(PBEF), mRNA/cds = (27, 1502)

TGTTTTTAGAGAGAATTTCTGCTT

4095
Table 3A
Hs.79022
XM_005182
14746130
GTP-binding protein overexpressed in
1
TATGGCCTTCAAGCTCAAGTCCAAAT

skeletal muscle (GEM),

CCTGCCATGACCTCTCTGTACTCT

mRNA/cds = (213, 1103)

4096
Table 3A
Hs.234842
XM_005543
13841011
aquaporin 3 (AQP3),
1
TCCATCTGTGCATAAGGAGAGGAAAG

mRNA/cds = (64, 942)

TTCCAGGGTGTGTATGTTTTCAGG

4097
Table 3A
Hs.124029
XM_005693
14737168
inositol polyphosphate-5-phosphatase,
1
GGACCATTCCGGAGCAGCCCCACAT

40kD (INPP5A),

ACCTCACTGTCTCGTCTGTCTATGT

mRNA/cds = (101, 1192)

4098
Table 3A
Hs.326248
XM_005698
13627052
cDNA; FLJ22071 fis, clone
1
TTTGTAAGCGAAGGAGATGGAGGTC

HEP11691/cds = UNKNOWN

GTCTTAAACCAGAGAGCTACTGAAT

4099
Table 3A
Hs.287797
XM_005799
13629831
mRNA for FLJ00043 protein, partial
1
ACCACTGTATGTTTACTTCTCACCATT

cds/cds = (0, 4246)

TGAGTTGCCCATCTTGTTTCACA

4100
Table 3A
Hs.1395
XM_005883
14740090
early growth response 2 (Krox-20
1
AAATCTATTCTAACGCAAAACCACTAA

(Drosophila) homolog) (EGR2),

CTGAAGTTCAGATAATGGATGGT

mRNA/cds = (338, 1768)

4101
Table 3A
Hs.1908
XM_005980
14748566
proteoglycan 1, secretory granule
1
TGTTATAAAAGAGGATTTTCCCACCTT

(PRG1), mRNA/cds = (24, 500)

GACACCAGGCAATGTAGTTAGCA

4102
db mining
Hs.73958
XM_006283
14763523
recombination activating gene 1
1
ACCAGGATGCAATGGATTTATTTGAT

(RAG1), mRNA/cds = (124, 3255)

TCAGGGGACCTGTATTTCCATGTC

4103
Table 3A
Hs.146589
XM_006741
14783662
mRNA for MOP-3, complete
1
AACAGAAACAGCTATGGCAACAGCAT

cds/cds = (0, 4178)

CACCCTCAGAGCATCACCAACTTG

4104
db mining
Hs.99954
XM_006840
14763859
activin A receptor, type IB (ACVR1B),
1
TATTTAACCTGAGTATAGTATTTAACG

transcript variant 1,

AAGCCTAGAAGCACGGCTGTGGG

mRNA/cds = (39, 1556)

4105
Table 3A
Hs.287369
XM_006881
13650909
interleukin 22 (IL22),
1
AACTAACCCCTTTCCCTGCTAGAAA

mRNA/cds = (71, 610)

TAACAATTAGATGCCCCAAAGCGA

4106
literature
Hs.159
XM_006950
13652420
tumor necrosis factor receptor
1
ATAGCAAGCTGAACTGTCCTAAGGCA

superfamily, member 1A (TNFRSF1A),

GGGGCGAGCACGGAACAATGGGGC

mRNA/cds = (255, 1622)

4107
Table 3A
Hs.159492
XM_007156
12737945
sacsin (SACS) gene, complete
1
TGACAGGTTCACTTCTGAGGTTGCTA

cds/cds = (76, 11565)

TGAGGGTGATGGAATGTACTGCCT

4108
Table 3A
Hs.170133
XM_007189
14755876
forkhead box O1A
1
TGTTTAAATGGCTTGGTGTCTTTCTTT

(rhabdomyosarcoma) (FOXO1A),

TCTAATTATGCAGAATAAGCTCT

mRNA/cds = (385, 2352)

4109
Table 3A
Hs.87409
XM_007606
14749307
thrombospondin 1 (THBS1),
1
TTGAAATTGGTGGCTTCATTCTAGAT

mRNA/cds = (111, 3623)

GTAGCTTGTGCAGATGTAGCAGGA

4110
Table 3A
Hs.75415
XM_007650
14785206
cDNA; FLJ22810 fis, clone KAIA2933,
1
ACTTCTTATACATTTGATAAAGTAAGG

highly similar to AB021288 mRNA for

CATGGTTGTGGTTAATCTGGTTT

beta 2-microglobulin/cds = UNKNOWN

4111
Table 3A
Hs.17279
XM_008062
13627121
tyrosylprotein sulfotransferase 1
1
CATGAAGAAGCAAGACGAAAAC

(TPST1), mRNA/cds = (81, 1193)

ACACAGGAGGGAAAATCCTGGGAT

TCTT

4112
Table 3A
Hs.5344
XM_008082
14779810
adaptor-related protein complex 1,
1
GCCTGGCTTGGACCTTGGCATTCCGT

gamma 1 subunit (AP1G1),

TTGAATTCCTTCTAACTGGAACAT

mRNA/cds = (28, 2505)

4113
Table 3A
Hs.75703
XM_008449
13852724
small inducible cytokine A4
1
GTCCACTGTCACTGTTTCTCTGCTGT

(homologous to mouse Mip-1b)

TGCAAATACATGGTAACACATTT

(SCYA4), mRNA/cds = (108, 386)

4114
literature
Hs.79241
XM_008738
13846672
B-cell CLL/lymphoma 2 (BCL2),
1
TTGTGTTGTTGGAAAAAGTCACATTG

nuclear gene encoding mitochondrial

CCATTAAACTTTCCTTGTCTGTCT

protein, transcript variant alpha,

mRNA/cds = (31, 750)

4115
db mining
Hs.9731
XM_008901
11432998
nuclear factor of kappa light
1
CAGTAGCGACAGCGACGGCGGAGAC

polypeptide gene enhancer in B-cells

GAGGGCGTGAGTCAGGAGGAGAGAC

inhibitor, beta (NFKBIB),

mRNA/cds = (0, 1016)

4116
db mining
Hs.69747
XM_009101
11425196
fucosyltransferase 1 (galactoside 2-
1
AGCTGCCACGGGTGAGAGAGCAGGA

alpha-L-fucosyltransferase, Bombay

GGTATGAATTAAAAGTCTACAGCAC

phenotype included) (FUT1),

mRNA/cds = (103, 1200)

4117
db mining
Hs.46328
XM_009103
14760495
mRNA for
1
CTTTCCTCAAAATCTTTAAGCCAGAG

alpha (1,2)fucosyltransferase, complete

GCAGCCTTCCTGCCGGAGTGGACA

cds/cds = (111, 1142)

4118
Table 3A
Hs.84038
XM_009533
14771190
CGI-06 protein (LOC51604),
1
TCTGCCTCACGTGCACTGTGGTGGC

mRNA/cds = (6, 1730)

CGTGTGCTACGGCTCCTTCTACAAT

4119
Table 3A
Hs.296585
XM_009574
14771391
nucleolar protein (KKE/D repeat)
1
CCATAGCCCAAGGTGACATTTCCCAC

(NOP56), mRNA/cds = (21, 1829)

CCTGTGCCGTGTTCCCCAATAAAA

4120
Table 3A
Hs.198298
XM_009641
14770741
cDNA FLJ14219 fis, clone
1
GGGGTATCCAGAATTGGTTGTAAATA

NT2RP3003800, highly similar to

CTTTGCATATTGTCTGATTAAACA

Rattus norvegicus tyrosine protein

kinase pp60-c-src

mRNA/cds = (501, 1256)

4121
Table 3A
Hs.334691
XM_009917
13648023
hypothetical protein FLJ22427
1
GAGGCTTTGCCTTGCCTGCATATTTG

(FLJ22427), mRNA/cds = (40, 2631)

TTTCGCTCTTACTCAGTTTGGGAA

4122
Table 3A
Hs.278027
XM_009929
11417988
LIM domain kinase 2 (LIMK2),
1
GCAAGTGTAGGAGTGGTGGGCCTGA

transcript variant 2b,

ACTGGGCCATTGATCAGACTAAATA

mRNA/cds = (315, 2168)

4123
Table 3A
Hs.32970
XM_010593
14727775
signaling lymphocytic activation
1
TTGCAAAACCCAGAAGCTAAAAAGTC

molecule (SLAM),

AATAAACAGAAAGAATGATTTTGA

mRNA/cds = (133, 1140)

4124
Table 3A
Hs.155595
XM_010897
13837965
neural precursor cell expressed,
1
CCCACACTGCTACACTTCTGATCCCC

developmentally down-regulated 5

TTTGGTTTTACTACCCAAATCTAA

(NEDD5), mRNA/cds = (258, 1343)

4125
Table 3A
NA
XM_011080
14738482
T cell activation, increased late
1
AAAAGAAGCCCTAATAAACCACCCGG

expression

ATAATAACCCTGTCTACCATCTTT

4126
Table 3A
Hs.302014
XM_011062
13626304
interleukin 21 (IL21),
1
GTGAAGATTCCTGAGGATCTAACTTG

mRNA/cds = (46, 534)

CAGTTGGACACTATGTTACATACT

4127
Table 3A
Hs.78687
XM_011714
14749491
neutral sphingomyelinase (N-SMase)
1
AGAAGGATTAGCAGTTCTTAGTAAGT

activation associated factor (NSMAF),

TTACTGTGTATAGGAACGGTTTGT

mRNA/cds = (12, 2765)

4128
literature
Hs.91390
XM_011844
14739654
poly (ADP-ribose) glycohydrolase
1
CGGCTGCCTCTCTTGAGACCATCTGC

(PARG), mRNA/cds = (166, 3096)

CAATCACACAGTAACTATTCGGGT

4129
Table 3A
Hs.76038
XM_011865
14737830
isopentenyl-diphosphate delta
1
CCCAACTGAGGACCACTGTCTACAGA

isomerase (ID11), mRNA/cds = (50, 738)

GTCAGGAAATATTGTAGGGAGAA

4130
Table 3A
Hs.180450
XM_011914
13828205
ribosomal protein S24 (RPS24),
1
CTGGCAAAAAGCCCGAAGGAGT

transcript variant 1,

AAAGGTGCTGCAATGATGTTAGCTG

mRNA/cds = (37, 429)

TGGC

4131
Table 3A
Hs.154938
XM_012059
14771044
hypothetical protein MDS025
1
TGTTTGCTTGAACAGTTGTGTAAATC

(MDS025), mRNA/cds = (5, 769)

ATACAGGATTTTGTGGGTATTGGT

4132
Table 3A
Hs.1051
XM_012328
14750596
granzyme B (granzyme 2, cytotoxic T-
1
GGAGCCAAGTCCAGATTTACACTGG

lumphocyte-associated serine esterase

GAGAGGTGCCAGCAACTGAATAAAT

1) (GZMB), mRNA/cds = (33, 776)

4133
Table 3A
Hs.251526
XM_012649
13833583
gene for monocyte chemotactic protein-
1
GGATGCTCCTCCCTTCTCTACCTCAT

3 (MCP-3)/cds = (0, 329)

GGGGGTATTGTATAAGTCCTTGCA

4134
db mining
Hs.278454
AF285431
12741752
killer cell immunoglobulin-like receptor,
1
TAACTTCAATGTAGTTTTCCATCCTTC

two domains, long cytoplasmic tail, 2

AAATAAACATGTCTGCCCCCATG

(KIR2DL2), mRNA/cds = (14, 1060)

4135
Table 3A
Hs.334437
XM_015180
14778515
hypothetical protein MGC4248
1
GAGTCCTTTTGATTTTTAACTTATTCC

(MGC4248), mRNA/cds = (70, 720)

CCATGTCCCTATACTCGTGTGC

4136
Table 3A
Hs.137555
XM_015921
1760439
putative chemokine receptor, GTP-
1
TGCACGTTCCTCCTGGTTCCTTCGCT

binding protein (HM74),

TGTGTTTCTGTACTTACCAAAAAT

mRNA/cds = (60, 1223)

4137
Table 3A
Hs.164371
XM_016136
13835810
cDNA FLJ1315 fis, clone
1
CAGCTTCAGCTAGGAGTTTGTAAGCA

NT2RP3003842/cds = UNKNOWN

AGGACTTTGTGACACATTTGTCCC

4138
Table 3A
Hs.323463
XM_016481
14721648
mRNA for KIAA1693 protein, partial
1
AATTGAAAAGTACCAAGAAGTG

cds/cds = (0, 2707)

GAAGAAGACCAAGACCCATCATGC

CCCA

4139
Table 3A
Hs.15220
XM_016721
14784971
zinc finger protein 106 (ZFP106),
1
ACTTCCTAGACACTTGTTTCTGAGAC

mRNA/cds = (335, 5986)

AGTTCTTTGCCTTCACTTCCCTGC

4140
Table 3A
Hs.323463
XM_016972
14726508
mRNA for KIAA1693 protein, partial
1
ACAACTGACCTGTCTCCTTCACATAG

cds/cds = (0, 2707)

TCCATATCACCACAAATCACACAA

4141
Table 3A
Hs.180946
XM_018498
14723691
ribosomal protein L5 pseudogene
1
GCTCAGGAGCGGGGCTGCTGAGAGCT

mRNA, complete cds/cds = UNKNOWN

AAACCCAGCAATTTTCTATGATTTT

4142
Literature
Hs.194382
U67093
2072143
ataxia telangiectasia (ATM) gene,
1
AAAGAAAGCCAGTATATTGGTTTGAA

complete cds/cds = (795, 9965)

ATATAGAGATGTGTCCCAATTTCA

4143
Literature
Hs.184167
NM_006276
6857827
splicing factor, arginine/serine-rich 7
1
ACTGGCAGGCTTATTTATCTGTTGCA

(35kD) (SFRS7) mRNA/cds = (105, 490)

CTTGGTTAGCTTTAATTGTTCTGT

4144
Literature
Hs.79037
NM_002156
4504520

Homo sapiens, heat shock 60kD
1
AGCAGCCTTTCTGTGGAGAGTGAGAA

protein 1 (chaperonin), clone

TAATTGTGTACAAAGTAGAGAAGT

MGC:19755 IMAGE:3830225, mRNA,

complete cds/cds = (1705, 3396)

4145
Literature
Hs.206984
U15177
988207
cosmid CRI-JC2015 at D10S289 in
1
CAACTGTGCTGGCCGGGAGGAGAGC

10sp13/cds = (0, 1214)

AGAGACGCAGTCCTGCCCAGTGTAG

4146
Literature
Hs.395
XM_002923
13643499
chamokine (C—C motif) receptor 2
1
CACATGGCTAAAGAAGGTTTCAGAAA

(CCR2), mRNA/cds = (39, 1163)

GAAGTGGGGACAGAGCAGAACTTT

4147
Literature
NA
NC_001807
13959823
mitochondrion, complete genome
1
CCGACATCTGGTTCCTACTTCAGGGT

CATAAAGCCTAAATAGCCCACACG

4148
Literature
Hs.32017
NM_020645
11034818
ASCL3 gene, CEGP 1 gene, C11orf14
1
CTCATTTGTATTCAAGCCTTTAACAG

gene, C11orf15 gene, C11orf16 gene

GAGGGCAAAGAGGTGAGAATGTGT

and C11orf17 gene/cds = (66, 791)

4149
Literature
Hs.74621
U29185
2865216
prion protein (p27-30) (Creutzfeld-
1
GCACTGAATCGTTTCATGTAAGAATC

Jakob disease, Gersimann-Strausler-

CAAAGTGGACACCATTAACAGGTC

Scheinker syndrome, fatal familial

insomnia) (PRMP),

mRNA/cds = (49, 810)

4150
Literature
NA
X04948
36891
T-cell receptor alpha-chain HAP05
1
GCAGACACTGCTTCTTACTTCTGTGC

V(e)3.1/J(a)P

TACGGATGGGAACAGAGATGACAA

4151
Literature
NA
X92768
1054779
mRNA for T-cell receptor alpha (clone
1
GGGGAAACTGGAGGCTTCAAAACTAT

XPBP531)

CTTTGGAGCAGGAACAAGACTATT

4152
Literature
Hs.75064
NM_003192
4507372
tubulin-specific chaperone (TBCC),
1
GGGGAAGGAGGGTGATTATATTGCTT

mRNA/cds = (23, 1063)

TGTAATGGTTTGTGATACTTGAAA

4153
Literature
Hs.99093
8G179517
12686220
chromosome 19, cosmid
1
GTACGAATGGGAGGTCCTCGACACC

R28379/cds = (0, 633)

TGGGGAACTGCGGACTATGCGGCAG

4154
Literature
Hs.77356
NM_003234
4507456
transferrin receptor (p90, CD71)
1
TATCAGACTAGTGACAAGCTCCTGGT

(TFRC), mRNA/cds = (263, 2545)

CTTGAGATGTCTTCTCGTTAAGGAA

4155
Literature
Hs.194638
U89387
2253834
polymerase (RNA) II (DNA directed)
1
TGACCTCCACCAAAGCCCATATAAGG

polypeptide D (POLR2D),

AGCGGAGTTGTTAAGGACTGAAGA

mRNA/cds = (30, 458)

4156
Literature
Hs.15220
NM_022473
14764971
zinc finger protein 106 (ZFP106),
1
TTTCTCCGGACTCATCAGTAAACCTG

mRNA/cds = (335, 5986)

TAGAAGTGTCGCTTTCCAGCCTTT

4157
Literature
Hs.326248
NM_014456
7657448
cDNA; FLJ22071 fis, clone
1
TTTGTAAGCGAAGGAGATGGAGGTC

HEP11691/cds = UNKNOWN

GTCTTAAACCAGAGAGCTACTGAAT

4158
Literature
Hs.182447
BC003394
13097278
heterogeneous nuclear
1
AAAGTTGATACTGTGGGTTATTTTTGT

ribonucleoprotein C (C1/C2) (HNRPC),

GAACAGCCTGATGTTTGGGACCT

transcript variant 1,

mRNA/cds = (191, 1102)

4159
Literature
Hs.31314
X72841
297903
relinoblastoma-binding protein 7
1
AACTTTTACACTTTTTCCTTCCAACAC

(RBBP7), mRNA/cds = (287, 1564)

TTCTTGATTGGCTTTGCAGAAAT

4160
Literature
Hs.177592
NM_001003
4506668
ribosomal protein, large, P1 (RPLP1),
1
ACAGCCAAGACTTAGGTTACAGGGCA

ACGCACTACTGTTCAGCTTTGAAT

4161
Literature
Hs.81361
M65028
337450
heterogeneous nuclear
1
ACGTGTCCTGATTTTGCCACAACCTG

ribonucleoprotein A/B (HNRPAB),

GATATTGAAGCTATCCAAGCTTTT

transcript variant 1,

mRNA/cds = (224, 1219)

4162
Literature
Hs.279939
BC004560
13528726
mitochondrial carrier homolog 1
1
AGCTGTTGATGCTGGTTGGACAGGTT

(MTCH1), nuclear gene encoding

TGAGTCAAATTGTACTTTGCTCCA

mitochondrial protein,

mRNA/cds = (0, 1118)

4163
Literature
Hs.241567
NM_002897
8400725
RNA binding motif, single stranded
1
ATAAGGTGCATAAAACCCTTAAATTC

interacting protein 1 (RBMS1),

ATCTAGTAGCTGTTCCCCCGAACA

transcript variant MSSP-2,

mRNA/cds = (265, 1434)

4164
Literature
NA
BE874440
10323216
NIH_MGC_69 cDNA clone
1
CCAATGACAGCCTACCTATTACCAAG

IMAGE:3891187 5′,

GGCTCCCCTACAACTCTGAACCTT

4165
Literature
Hs.1074
BC005913
13543508
surfactant, pulmonary-associated
1
GACAAACCCTGGAGAAATGGGAGCT

protein C (SFTPC),

TGGGGAGAGGATGGGAGTGGGCAGA

mRNA/cds = (27, 620)

4166
Literature
Hs.56205
BC001880
12804864
insulin induced gene 1 (INSIG1),
1
GTGTCAGTGCCCAAAGGAGGGAGGT

mRNA/cds = (414, 1247)

TGATGGTGCTTAACAAACATGAAGT

4167
Literature
Hs.77356
BC001188
12654696
transferrin receptor (p90, CD71)
1
TCATTGTATAAAAGCTGTTATGTGCAA

(TFRC), mRNA/cds = (263, 2545)

CAGTGTGGAGATTCCTTGTCTGA

4168
Literature
Hs.194638
BC002958
12804200
polymerase (RNA) II (DNA directed)
1
TGACCTCCACCAAAGCCCATATAAGG

polypeptide D (POLR2D),

AGCGGAGTTGTTAAGGACTGAAGA

mRNA/cds = (30, 458)

4169
Literature
Hs.35406
AA057484
1550124
602675161F1 cDNA, 5′
1
TTGGCTTCATTACGAGAGAGAAACAT

end/clone =

AACAGAGGCAGTGATGGTTTCAGA

IMAGE:4797783/clone_end = 5′

4170
Literature
Hs.74451
X04106
35327
calpain 4, small subunit (30K)
1
TTTGTCTATATTCTGCTCCCAGCCTG

(CAPN4), mRNA/cds = (158, 964)

CCAGGCCAGGAGGAAATAAACATG

4171
Literature
Hs.13231
H17596
883836
od15d12.s1
1
AGCACATTGGGAGATACATGATAAAT

cDNA/clone = IMAGE:1368023

TTCTATCTGCAGTTGCTATTTGCA

4172
Literature
Hs.74002
U40396
1117914
mRNA for steroid receptor coactivator
1
GGCCCAGCAGAAGAGCCTCCTTCAG

1e/cds = (201, 4400)

CAGCTACTGACTGAATAACCACTTT

4173
Literature
NA
X17403
59591
CMV HCMVTRL2 = IRL2
1
AATAATAGATTAGCAGAAGGAATAAT

CCGTGCGACCGAGCTTGTGCTTCT

4174
Literature
NA
X17403
59591
CMV HCMVUL27
1
ACATTCAAAAGTTTGAGCGTCTTCAT

GTACGCCGTTTTCGGCCTCACGAG

4175
Literature
NA
X17403
59591
CMV HCMVUL106
1
ACGAACAGAAATCTCAAAAGACGCTG

ACCCGATAAGTACCGTCACGGAGA

4176
Literature
NA
X17403
59591
CMV HCMVTRL7 = IRL7
1
AGGAACCAGCAAGTCAACAAAA

GACTAACAAAGAAAAACCATCTTG

GAAT

4177
Literature
NA
X17403
59591
CMV HCMVUL33
1
CCAACGACACATCCACAAAAATCCCC

CATCGACTCTCACAATCGCATCAT

4178
Literature
NA
X17403
59591
CMV HCMVUL123
1
CCTCTGGAGGCAAGAGCACCCACCC

TATGGTGACTAGAAGCAAGGCTGAC

4179
Literature
NA
X17403
59591
CMV HCMVUL75 Glycoprotein H
1
GATGTCCGTCTACGCGCTATCGGCC

ATCATCGGCATCTATCTGCTCTACC

4180
Literature
NA
X17403
59591
CMV HCMVUS28
1
TTCGTGGGCACCAAGTTTCGCAAGAA

CTACACTGTCTGCTGGCCGAGTTT

4181
Literature
NA
X17403
59591
CMV HCMVUL21
1
GAGATCGACATCGTCATCGACCGAC

CTCCGCAGCAACCCCTACCCAATCC

4182
Literature
NA
X17403
59591
CMV HCMVUL54
1
CTTTGAGCAGGTTCTCAAGGCTGTAA

CTAACGTGCTGTCGCCCGTCTTTC

4183
Literature
NA
X17403
59591
CMV HCMVUL83
1
TCTTCTGGGACGCCAACGACATCTAC

CGCATCTTCGCCGAATTGGAAGGC

4184
Literature
NA
X17403
59591
CMV HCMVUL109
1
AGAGAACAACAAACCACCACGACGA

TGAAACAAAACGCTCAACCAAACA

4185
Literature
NA
X17403
59591
CMV HCMVUL113, spliced to
1
GAGAAAAGATTGTGCGATCTCCCCCT

HCMVUL112

GGTTTCCAGCAGACTCTTGCCAGA

4186
Literature
NA
X17403
59591
CMV HCMVUL122
1
CATCTTCTCCACCAACCAGGGTGGGT

TCATGCTGCCTATCTACGAGACGG

4187
db mining
Hs.164427
AI307795
4002399
tb28c03.x1 cDNA 3′
−1
TCCCATGTTCCCTTTATTTGTCTTTTG

end/clone =

GTTCTGCTTTTTGGGAGATTTTT

IMAGE:2055852/clone_end = 3′

4188
Table 3A
Hs.169168
AA977148
3154594
oq24g08.s1 cDNA 3′
−1
TGGTGCGCTTTTGTGTGCGGTGGAG

end/clone =

GAGTTCCTAACCCTCGGCTTGTTTT

IMAGE:1587326/clone_end = 3′

4189
Table 3A
Hs.117333
AI023714
3238758
mRNA for KIAA1093 protein, partial
−1
GCCGTTGGTTGGCTTAAACTTGGTTT

cds/cds = (179, 5362)

CGTCACTTCGGGCACTTTGGTTTT

4190
Table 3A
NA
AI380955
4190797
lg18b08.x1 cDNA, 3′
−1
CTGGCCTCCCCTGGCTCTTTAAGCTC

end/clone =

CCCTTTGGTTAAAAACTGGGTTTT

IMAGE:2109111

4191
Table 3A
Hs.93870
AA976045
3151837
cDNA; FLJ22664 fis, clone
−1
AAAAGGCCAAGGGTGTTGTTGGGGC

HS108202/cds = UNKNOWN

GTCTGTCTAATGTGGTGGGTCTTTT

4192
Table 3A
Hs.332583
AA788623
2874972
yc77a06.s1 cDNA 3′
−1
GCTGTAAATCTCTGTCTCATCATCCTT

end/clone =

CTCTTTTGTTTCCATAGCCTTTT

IMAGE:21844/clone_end = 3′

4193
Table 3A
Hs.71433
AA131524
1693030
zl31h02.s1 cDNA 3′
−1
GTGTGTGCTGGCTGAGAAGCCACTG

end/clone =

TGAATTGATTCTTCTTCTGAAGTTT

IMAGE:503571/clone_end = 3′

4194
Table 3A
Hs.309127
AI380687
4190540
tg03e04.x1 cDNA 3′
−1
AATAAGGGTGTTGCCCTTTGTTCCCT

end/clone =

CACATAATCGTGAAAGGCTGCTTT

IMAGE:2107710/clone_end = 3′

4195
Table 3A
Hs.102630
AA808085
2877491
602440867F1 cDNA 5′
−1
TTCCTCAGTCCCTGTTCATACCATCT

end/clone =

CTGCACCCACAATCACACTGATTT

IMAGE:4556561/clone_end = 5′

4196
Table 3A
Hs.134473
AI074016
3400660
oy66g02.x1 cDNA 3′
−1
GACCACAGATATGCACTCCTTACATT

end/clone =

AACCTCAGCCTTGATGTATCATTT

IMAGE:1870834/clone_end = 3′

4197
Table 3A
Hs.158653
AI370965
4149718
ta29b11.x1 cDNA 3′
−1
CCCCCTGTTATGAAAAGGGTTAAACT

end/clone =

TGAACCCACCCATTTTAAAAATTT

IMAGE:2045489/clone_end = 3′

4198
Table 3A
Hs.243029
AA424812
2106917
UI-H-B14-aow-c-10-0-UI.s1 cDNA 3′
−1
TTATAGCTACCAGAAGCCACCAGGGC

end/clone =

CTTAGCCCAGCAGTAGAAACCTCT

IMAGE:3086226/clone_end = 3′

4199
Table 3A
Hs.188777
AA432384
2114747
zw76a09.s1 cDNA 3′
−1
GATCAGTAGACACACCCCTCAATGCT

end/clone =

GCGAAGAAAATGAAGGCCACTCTT

IMAGE:782104/clone_end = 3′

4200
Table 3A
Hs.132237
AI031656
3249868
ow48e06.x1 cDNA 3′
−1
AGCAGACAATGGACAACTGTAGTTTT

end/clone =

TGAATTGACTTCTATAGCCATCTT

IMAGE:1650082/clone_end = 3′

4201
db mining
Hs.123445
AA813728
2882413
602623874F1 cDNA 5′
−1
TCCACCACAGTGCATGATAATTCCGA

end/clone =

CAGAACGGCCTTTTATTTGTACCT

IMAGE:4748515/clone_end = 5′

4202
Table 3A
Hs.143049
AI126688
3595202

Homo sapiens, Similar to
−1
TGTTCTCTGAACTGTCTGGATGAACC

DKFZP727C091 protein, clone

GGTCAACGGCACTCATCATACCTT

MGC:10677 IMAGE:3948445, mRNA,

complete cds/cds = (79, 1530)

4203
Table 3A
Hs.108327
AA701667
2704832
damage-specific DNA binding protein
−1
GCTTCACTCTGCTTTCTGTATAAAGG

1 (127kD) (DDB1),

GCAGTCTGTGGTCACGCAAGACTT

mRNA/cds = (109, 3531)

4204
Table 3A
Hs.270264
AA813224
2464262
no19d06.s1 cDNA 3′
−1
AGCAAAGACCAAATTCTCCTTGGGAA

end/clone =

GTGTGGGAGCAGGCTGACATTATT

IMAGE:1101131/clone_end = 3′

4205
Table 3A
Hs.158978
AI380390
4190243
UI-H-B12-ahi-a-03-0-UI.s1 cDNA 3′
−1
GTCCTTTGATAGCAGAACAAGAGGCT

end/clone =

CTGTGATCCTCTGGACCTCAGATT

IMAGE:2726692/clone_end = 3′

4206
Table 3A
Hs.204214
AA826926
2900923
EST389900 cDNA
−1
TCCACGACATGGTACAGCTCTTCACT

TTTTCAGCTTTTTAAATGTCCATT

4207
Table 3A
Hs.326392
AA974839
3150631
son of sevenless (Drosophila)
−1
GACAAGGCAATGCTACTGATCACCTG

homolog 1 (SOS1),

AGGATAATGGTGAAGGACTTTTGT

mRNA/cds = (0, 3998)

4208
Table 3A
Hs.53542
AI084224
3422647
chorea-ecanthocytosis (CHAC)
−1
TCAATAGTTGTGAAATTCTTCTCAGG

mRNA, complete cds/cds = (260, 2784)

CTCCTTAAACCCTCGCTTTGTTGT

4209
Table 3A
Hs.173334
AA284232
1928532
ELL-RELATED RNA POLYMERASE
−1
AGGCTTACGTTTATCCAAAAGCATTT

II, ELONGATION FACTOR (ELL2),

CACCTTGCACATTACTGTTGTTGT

mRNA/cds = (0, 1922)

4210
db mining
Hs.86437
AI300700
3960048
602411368F1 cDNA 5′
−1
ACAAGCATTTAGATCATAACATGGTA

end/clone =

AAGCCTATTACCAGCCAATGTTGT

IMAGE:4540096/clone_end = 5′

4211
db mining
Hs.61558
AI220970
3803173
hz63d07.x1 cDNA 3′
−1
TGTTTTGGCATAGAGCTTTACTTAAAA

end/clone =

TGCTGCTTCATTTTACACATTGT

IMAGE:3212653/clone_end = 3′

4212
Table 3A
Hs.239489
AA639796
2563575
TIA1 cylotoxic granule-associated
−1
TGGAGCTCAATTCTATGCAGTTGTGC

RNA-binding protein (TIA1), transcript

TGATATTTCATTAAGTCACTGTGT

variant 2, mRNA/cds = (185, 1345)

4213
Table 3A
Hs.228795
AI094726
3433702
qa08f05.x1 cDNA 3′
−1
TTTCCCCTTGGCCTGAGTTTTTATAAA

end/clone =

ATTTCCATTAATTGGGGCAGTGT

IMAGE:1688177/clone_end = 3′

4214
db mining
Hs.62699
AA740964
2779556
EST386140 cDNA
−1
TGCAGCTAAATTCGAAGCTTTTGGTC

TATATTGTTAATTGCCATTGCTGT

4215
Table 3A
Hs.124675
AA858297
2948599
ob13b08.s1 cDNA 3′
−1
GGATTTGGAAGATGCTTTCAGAAATA

end/clone =

TGGCATAGGTTTTTGTCGAAATGT

IMAGE:1323543/clone_end = 3′

4216
Table 3A
NA
AI281442
3919675
cDNA clone IMAGE:1967452 3′
−1
AAAGAAAAATTCAGCCTGAACCCTAC

CCTTATAAAACAGGTTAATTGGGT

4217
Table 3A
Hs.228817
AI199388
3751994
qs75e05.x1 cDNA 3′
−1
TGTAAGTCCCATGCCCGAATTTGGAG

end/clone =

ATTTGGGTTTTTCTTTTCAGGGGT

IMAGE:1943936/clone_end = 3′

4218
Table 3A
Hs.291003
AA504269
2240429
hypothetical protein MGC4707
−1
CGGATTCCAAATTACTTAAAGCCTTTA

(MGC4707), mRNA/cds = (72, 1067)

TGGGAACACGGTAGATTGTAGGT

4219
Table 3A
Hs.299416
AA132448
1694015
zo20a03.s1 cDNA 3′
−1
GCCTTCTGGCCTCTGAGGCAAAGGT

end/clone =

CAGTGATACTGATGGGAGGGTAGGT

IMAGE:587404/clone_end = 3′

4220
Table 3A
Hs.6733
AI057025
3330814
phosphoinositide-specific
−1
GCTCAAGATCACCTCTTTGTCATCTT

phospholipase C PLC-epsilon mRNA,

GAACAATGTTTTTCTCTTCTAGGT

complete cds/cds = (235, 7146)

4221
db mining
Hs.177712
AA251806
1886786
zs09c03.s1 cDNA 3′
−1
TGTTTCCACTTCATGGGATATGACTC

end/clone =

CATCACAATGAAAATGGGTCCAGT

IMAGE:684676/clone_end = 3′

4222
Table 3A
Hs.133175
AI51673
3307207
oy77g06.x1 cDNA 3′
−1
TTGTGATTGTAAATCATGTATGTACAA

end/clone =

ATGCCATGAAAATTAAAGCCAGT

IMAGE:1671898/clone_end = 3′

4223
Table 3A
Hs.203041
AI271437
3890604
602417270F1 cDNA, 5′
−1
TTTCCCTTATGCACCTTCCAGTCTTTG

end/clone =

GCAGGACATGATTTATGGACAGT

IMAGE:4538737/clone_end = 5′

4224
Table 3A
Hs.56205
AA846378
2932518
insulin induced gene 1 (INSIG1),
−1
TGCACTCTACCAGATTTGAACATCTA

mRNA/cds = (414, 1247)

GTGAGGTTCACATTCATACTAAGT

4225
Table 3A
NA
AA873734
2969856
Vanin 2
−1
TCAACTGCAGGGAATCTCCTAGGAAG

CGGATAAATCTGGCAATTGGAAGT

4226
Table 3A
NA
AA482019
2209697
cDNA clone IMAGE:746048 3′
−1
ACCACCAGCTATTTGTAATTCCTTCTT

CTAAGGCATAGTGAAAACTTGCT

4227
db mining
Hs.182594
AA806247
2875516
oc21f01.s1 cDNA, 3′
−1
TCGCTTTCTAACTGATTCCATTCCAC

end/clone =

CATGTCAGATACTCCTGGGCTGCT

IMAGE:1341529

4228
Table 3A
Hs.210727
AI075288
3401879
oy69h10.x1 cDNA, 3′
−1
CAGCAATGAGGGGATATTTTTGATGA

end/clone =

GCTGGAATATCCAATTGAACAGCT

IMAGE:1671139/clone_end = 3′

4229
Table 3A
Hs.252300
AI383340
4196121
tc76g05.x1 cDNA, 3′
−1
CCCCCTAAGTTAAAAGCTCTGTCTTT

end/clone =

TTGGGGTTTGCCCTATGTAAAGCT

IMAGE:2070584/clone_end = 3′

4230
Table 3A
Hs.191958
AI347054
4084260
immunoglobulin superfamily receptor
−1
GAAGCCTCTACTCTTGAGTCTCTTTC

translocation associated 2 (IRTA2),

ATTACTGGGGATGTAAATGTTCCT

mRNA/cds = (158, 3091)

4231
Table 3A
Hs.283410
AI253134
3849663
602635144F1 cDNA, 5′
−1
ACACTTGATCTCTTCCTTATTTCTCTC

end/clone =

AGAAAACCTGTAGGATTGTGCCT

IMAGE:4780090/clone_end = 5′

4232
Table 3A
Hs.44189
AI361839
4113460
yz99f01.s1 cDNA, 3′
−1
AGTAGATATTTTGCCGGTGTACTTGG

end/clone =

AATACCTTTCAGAAGCCAAACCCT

IMAGE:291193/clone_end = 3′

4233
Table 3A
Hs.148288
AA908367
3047772
og76c11.s1 cDNA, 3′
−1
AATTCCAATCCTGGTATATAGCACCT

end/clone =

GGTATTATGGGTACCAAAAACCCT

IMAGE:1454228/clone_end = 3′

4234
Table 3A
Hs.143534
AI095189
3434165
602466053F1 cDNA, 5′
−1
ACTGCTCCAAATATCAACCCCATGTA

end/clone =

GGCAGGATGTTTGATCTTGGTACT

IMAGE:4594260/clone_end = 5′

4235
Table 3A
Hs.23349
AI357493
4109114
nab70e03.x1 cDNA, 3′
−1
TGTTGTTGGATACGTACTTAACTGGT

end/clone =

ATGCATCCCATGTCTTTGGGTACT

IMAGE:3273292/clone_end = 3′

4236
db mining
Hs.292235
AI057035
3330824
oy75b11.x1 cDNA, 3′
−1
TTAGGATTGCTCAGTTTCATCAAGGT

end/clone =

TTGAAGGATAGGCAGGCTCTCACT

IMAGE:1671645

4237
Table 3A
Hs.337986
AA101212
1647866

Homo sapiens, clone MGC:17431
−1
GGCCAGTCTCTGTGTGTCTTAATCCC

IMAGE:2984883, mRNA, complete
1
TTGTCCTTCATTAAAAGCAAAACT

cds/cds = (1336, 1494)

4238
Table 3A
Hs.60088
AA004799
1448296
hypothetical protein MGC11314
−1
GCATTCCCGGTCACTCCCTCCCTAAT

(MGC11314), mRNA/cds = (221, 673)

CTGAGCATCACTCAAGCTCTTTAT

4239
db mining
Hs.177376
AA44590
2783354
zb85a06.s1 cDNA, 3′
−1
CTGAATGCCAAGAGCTTCAAGAGTGT

end/clone =

GTGTAAATAAAGCCACACCTTTAT

IMAGE:310354/clone_end = 3′

4240
Table 3A
Hs.163787
AA627122
2540166
nq70g02.s1 cDNA, 3′
−1
CCCGAGGAGGAAGACGAATCGTTAA

end/clone =

ACATCTGAAAGGGTCAGGTGAGTAT

IMAGE:1157714/clone_end = 3′

4241
Table 3A
Hs.332992
AA760848
2809778
nz14f06.s1 cDNA, 3′
−1
CAAACTTGTTCTGAAGACAATTTCCA

end/clone =

AGGTTGTCAGCCATGTCACCATAT

IMAGE:1287779/clone_end = 3′

4242
Table 3A
Hs.129572
AA746320
2786306
ob08f01.s1 cDNA, 3′
−1
TCAGGTTCGTGTTAAACGCTGTATGT

end/clone =

TAACTATGACTGGAATTCTGTGAT

IMAGE:1323097/clone_end = 3′

4243
Table 3A
Hs.233383
AA745714
2785700
RC2-CT0434-310700-013-c08 cDNA
−1
ATGGAGATCCAGAGACGTTGGTTTTC

AAATGGAGCAAACAGCACTGTGAT

4244
Table 3A
Hs.156601
AI146787
3874489
qb83f02.x1 cDNA, 3′
−1
AGCTTTAGGCTGAGGGCATGGAAACT

end/clone =

GTTACGCTTTTCCTTTTATGTGAT

IMAGE:1706715/clone_end = 3′

4245
Table 3A
Hs.273775
AA527312
2269381
ng38a08.s1 cDNA, 3′
−1
TCACTCCAGAATAGAAATTAGAGTAT

end/clone =

AGGTAGGCAGTCCAACCTCTGCAT

IMAGE:936854/clone_end = 3′

4246
Table 3A
Hs.159316
AI380278
4190131
cDNA; FLJ21572 fis, clone
−1
TCAGATGCCACACTTATGAGACCCTC

COL06851/cds = UNKNOWN

ATCCTTCTGCTCACTCTCTTCCAT

4247
Table 3A
Hs.159424
AI380255
4190106
602589478F1 cDNA, 5′
−1
CCCTGCCTTTACCTCTCTACTTGTAG

end/clone =

TGTTCTTTCAGAGCCTGCTCCCAT

IMAGE:4723722/clone_end = 5′

4248
Table 3A
Hs.114931
AA702108
2705221
zi85e01.s1 cDNA, 3′
−1
CAAAACAAGATGTGCCAGGGCCTGG

end/clone =

GGGATGGGATAATTTCAGAGAGAAT

IMAGE:447576/clone_end = 3′

4249
Table 3A
Hs.179779
AI004582
3214092
ribosomal protein L37 (RPL37),
−1
ACCCAAGAGGGCAGCAGTTGTGTCA

mRNA/cds = (28, 321)

TCCAGTTCATCTTAAGAATTTCAAT

4250
Table 3A
Hs.100555
AI352690
4089896
DEAD/H (Asp—Glu—Ala—Asp/His)
−1
GGGGTAGGAAGAGGATGGAATTGAG

box polypeptide 18 (Myc-regulated)

ATGTTTGAGCCTCATTTACATCAAT

(DDX18), mRNA/cds = (71, 2083)

4251
Table 3A
Hs.157213
AI351144
4088350
qt23f10.x1 cDNA, 3′
−1
GCTCTCTGATGCTGGTGGCTGTTCCC

end/clone =

CCAGAATGGAAGCATTGATTAAAT

IMAGE:1948459/clone_end = 3′

4252
Table 3A
Hs.77399
AI337347
4074274
caudal type homeo box transcription
−1
GGGGAGAAGTGATATGGTGAAGGGA

factor 2 (CDX2),

AGTGGGGAGTATTTGAACACAGTTG

mRNA/cds = (360, 1301)

4253
Table 3A
Hs.128630
AI222805
3805008
qp39c07.x1 cDNA, 3′
−1
CACCATGCCTCACTTTTAGCGCAGTG

end/clone =

TGATCCTACACAAATTGCCCTGTG

IMAGE:1925388/clone_end = 3′

4254
Table 3A
Hs.270341
AI270476
3889643
602307338F1 cDNA, 5′
−1
TATGGTTTTTAGGCTATGCAGATATTC

end/clone =

TGTTGGTTTTTGAGACAGCTCTG

IMAGE:4398848/clone_end = 5′

4255
Table 3A
Hs.190229
AA582958
2360318
nn80d08.s1 cDNA, 3′
−1
CCTTCCTTTCTAAGGCATAAGTGCGA

end/clone =

CGTTCGCTGCTGTGCGTGGAACTG

IMAGE:1090191/clone_end = 3′

4256
Table 3A
Hs.170333
AI373163
4153029
qz13a07.x1 cDNA, 3′
−1
GAGAGGAAGGCAGACAGGCAGCCAT

end/clone =

TTTAAGAGAGAAGAGCCAGACAATG

IMAGE:2021364/clone_end = 3′

4257
Table 3A
Hs.158289
AI199223
3751829
qi47c06.x1 cDNA, 3′
−1
GTTATCAAAGGTGGAATCGGAAACAC

end/clone =

CAGGCTCCTAGTGCCACGGAAATG

IMAGE:1859626/clone_end = 3′

4258
Table 3A
Hs.29282
AA748714
2788672
mitogen-activated protein kinase
−1
AAATGTGCCTATTGCTAGAGCTCCTC

kinase kinase 3 (MAP3K3),

CCTCTCAACACCCAGTTTCCTTGG

mRNA/cds = (83, 1963)

4259
Table 3A
Hs.230752
AI025427
3241040
ow27g06.s1 cDNA, 3′
−1
CAATCGTCTTATCTCTACAGAGAGAA

end/clone =

GTGGAAAATTCTTTTTCAAGGGGG

IMAGE:1648090/clone_end = 3′

4260
Table 3A
Hs.131560
AI024984
3240597
ov39d11.x1 cDNA, 3′
−1
CTATGGAAGGCAGTTGGTGGGCAAA

end/clone =

AGTCCGGTTTTTACGCTTTGAGGGG

IMAGE:1839701/clone_end = 3′

4261
Table 3A
Hs.98306
AA418743
2080544
mRNA for KIAA1862 protein, partial
−1
GTCTGATCCTTAGACCGTCTCATCAC

cds/cds = (0, 1874)

AGCAACCCTAACTGCAGAGCAGGG

4262
Table 3A
Hs.337307
AA719537
2732636
zh40g12.s1 cDNA, 3′
−1
AATGGTAAGAAATGCCTTGTGTGGGT

end/clone =

GGCCCTCCAGTCCCCAGTCCAGGG

IMAGE:414598/clone_end = 3′

4263
Table 3A
NA
AA136584
1697794
fetal retina 937202 cDNA clone
−1
AACATATCCAGGGAGGACAAACTCTG

IMAGE:565899 3′

GGCTGGACAATGTATCCACAAGGG

4264
Table 3A
Hs.339990
AI263141
3871344
qw90c01.x1 cDNA, 3′
−1
GCCCATGGTCCTAGAATTAATTCCCC

end/clone =

TAAAAATTTTTGAAATAGGGGCGG

IMAGE:1998338/clone_end = 3′

4265
Table 3A
Hs.309122
AI380449
4190302
tg02f12.x1 cDNA, 3′
−1
GCCAACTGCTTAGAAGCCCAACACAA

end/clone =

CCCATCTGGTCTCTTGAATAAAGG

IMAGE:2107631/clone_end = 3′

4266
Table 3A
Hs.290535
AA719103
2732202
zh33d10.s1 cDNA, 3′
−1
GAGCCCTTAAAATTACTGTATCTCCT

end/clone =

CTAAAGTGTGATTTAATGGCTGCG

IMAGE:413875/clone_end = 3′

4267
Table 3A
Hs.188886
AA576947
2354421
nm82b04.s1 cDNA, 3′
−1
CTTTTGCTGGAGACTCATCGCTTTGG

end/clone =

GAAGTGCATTTGCTTCGTCGTCCG

IMAGE:1074703/clone_end = 3′

4268
Table 3A
Hs.130232
AI089359
3428418
qb05h03.x1 cDNA, 3′
−1
CCCAGTTCACAGTAGAGAGGTGGAG

end/clone =

CTTAGTACTTCCTGCTGCCCATTAG

IMAGE:1695413/clone_end = 3′

4269
Table 3A
Hs.44828
AI384128
4196909
EST389740 cDNA
−1
CTGGGCTGTAGGTACTGCTGGGTCA

CTGTTGCTATAAATGGTCACTGGAG

4270
db mining
Hs.184284
AI434146
4294137
ti36g07.x1 cDNA, 3′
−1
CTTTAGATGTCCCACGTCCCTTCAAG

end/clone =

CACATGAAAGAGCTCACACTGGAG

IMAGE:2132604/clone_end = 3′

4271
Table 3A
Hs.173720
AA534537
2278790
nf80h10.s1 cDNA, 3′
−1
GACTCTGGAACTCGAGCGTGTGGCT

end/clone =

GCTGCGCCGACAGCTGAATCTAGAG

IMAGE:926275/clone_end = 3′

4272
Table 3A
Hs.120891
AA677952
2658474
zi14a06.s1 cDNA, 3′
−1
CCTTAGAGATCGTGACCCTTCCTGCT

end/clone =

TGCCTCCCTGGTGGGCTCTTTCAG

IMAGE:430738/clone_end = 3′

4273
Table 3A
Hs.142838
AI299573
3959158
nucleolar protein interacting with the
−1
AGAGTGAGAAGGCAGTTCCAGTTTTA

FHA domain of pKI-67 (NIFK),

GCACAGATTTGTTTATGTGTTCAG

mRNA/cds = (54, 935)

4274
Table 3A
Hs.8724
AI298509
3958245
serine threonine protein kinase (NDR),
−1
TCTCAAGAGAGAACGCCACAGCAGA

mRNA/cds = (595, 1992)

GAGACCCAATCCGCCTAAGTTGCAG

4275
db mining
Hs.204873
AI086035
3424458
oy70h04.x1 cDNA, 3′
−1
AGGTTTGGGGAGGGGTCCCAGTCTG

end/clone =

CGATCCTTTCTCCCTCTTCGTGCAG

IMAGE:1671223/clone_end = 3′

4276
Table 3A
Hs.323950
AA916990
3056382
zinc finger protein 6 (CMPX1) (ZNF6),
−1
CCTCAGCTTCCAACTCTGATTCCAGG

mRNA/cds = (1265, 3361)

ACAGGATGGAAAACCTTTGGACAG

4277
Table 3A
Hs.144114
AI074020
3400664
oy66g06.x1 cDNA, 3′
−1
AATCCCTTGTACCATGTATACAAATG

end/clone =

AGACAAGTGAGCTTGACATTCAAG

IMAGE:1670842/clone_end = 3′

4278
Table 3A
Hs.235042
AI076222
3405400
oy65b09.x1 cDNA, 3′
−1
GCTACAGCCCGGAACACAAAAGAAG

end/clone =

ACACCCATGCAAATACCATTAAAAG

IMAGE:1670681/clone_end = 3′

4279
Table 3A
Hs.158975
AI380388
4190241
tt96a03.x1 cDNA, 3′
−1
ATTAACCCTTTATTGCCCTAGCCAGT

end/clone =

GGGGTGGGAGGGAGAGATTGTTTC

IMAGE:2107084/clone_end = 3′

4280
Table 3A
NA
AI361642
4113263
qy86d04.x1 cDNA, 3′
−1
GTTATCCTTAGGCCAGGTCTCCCACC

end/clone =

TTTGAGCCGGACAAAACCAGAGTC

IMAGE:2018887

4281
Table 3A
Hs.34549
AI123826
3539592
602620663F1 cDNA, 5′
−1
TGCTGCTACAGTTGCAAAACACTGGA

end/clone =

GCTAGAGAAAATAAAGTACTGATC

IMAGE:4746422/clone_end = 5′

4282
Table 3A
Hs.185062
AI085568
3423991
oy68b05.x1 cDNA, 3′
−1
CGAGAGTCTTGCTGAGCCAGGACTT

end/clone =

GAGTGCCTCGAAGTTTTCAATGATC

IMAGE:1670961/clone_end = 3′

4283
Table 3A
Hs.180201
AA516406
2253788
hypothetical protein FLJ20671
−1
ATCAGGAGAGGGAGATAATTAGTTGC

(FLJ20671), mRNA/cds = (72, 494)

TTCCTCCTTCACACTGTTTGAATC

4284
Table 3A
Hs.54452
AI041828
3281022
zinc finger protein, subfamily 1A, 1
−1
TTGCCCTTTCCTCTCACTGCCTTTTAT

(lkaros) (ZNFN1A1),

AGCCAATATCAATGTCTCTTTGC

mRNA/cds = (168, 1727)

4285
db mining
Hs.206654
AA705316
2715234
EST368531 cDNA
−1
ATCCCTATTGCCAGACACATCATTCT

CTCCATCCAGAAAGCCAACTTTGC

4286
Table 3A
Hs.147040
AI187423
3738061
ql31d04.x1 cDNA, 3′
−1
CTCTCTTCATCTTCTGATTGGGATTGT

end/clone =

GTCCAGTCCTCTGCTTCTTCTGC

IMAGE:1751623/clone_end = 3′

4287
Table 3A
Hs.105230
AA489227
2218829
aa57f07.s1 cDNA, 3′
−1
GAGGGTTCTAGCAACTTAATCCCATT

end/clone =

AGCATGTTAGCTGAAGACTACTGC

IMAGE:825061/clone_end = 3′

4288
db mining
Hs.309108
AI378046
4187899
te67h12.x1 cDNA, 3′
−1
GTCCCAAGGGTCAGTATATTGGAGGA

end/clone =

AAGTAAAGGAGTGAATCAGACTGC

IMAGE:2091815/clone_end = 3′

4289
Table 3A
Hs.209203
AI343473
4080879
tb97a08.x1 cDNA, 3′
−1
CTGGAATTACTAATGTGGAGGTGATC

end/clone =

TGAGAACTGGGAACAAAGTAGGGC

IMAGE:2082262/clone_end = 3′

4290
Table 3A
Hs.158966
AI380236
4190089
tf94b10.x1 cDNA, 3′
−1
TCCAGGGACTGACAAGAGTGAGTGG

end/clone =

TGTCAACCTAAAGAGAAACTCAGGC

IMAGE:2106907/clone_end = 3′

4291
Table 3A
Hs.50477
AA923567
3070876
Rab27a mRNA, complete
−1
CAGAACTCCATAGACAGCCTCACTTT

cds/cds = (245, 910)

GTGCTCGGGGGGCCTGTCCCAAGGC

4292
Table 3A
Hs.133230
AA984890
3163415

Homo sapiens, ribosomal protein S15,
−1
GCACTTCTCCCGGTTCATCCCTCTCA

clone MGC:2295 IMAGE:3507983,

AGTAATGGCTCAGCTAATAAAGGC

mRNA, complete cds/cds = (14, 451)

4293
Table 3A
Hs.165051
AI248204
3843601
qh64h11.x1 cDNA, 3′
−1
TCCATCTCCTTTCTACTGTAGCGGAG

end/clone =

ACTACAAGTCCCAGGATGCCCCGC

IMAGE:1849509/clone_end = 3′

4294
Table 3A
NA
AA663244
2669135
schizo brain S11 cDNA clone
−1
CCACATTCTTGCTGTCCACATCCTGC

IMAGE:971252 3′

TGGGTGAAATTGTGTTGAAGTAGC

4295
Table 3A
NA
AA826572
2898398
cDNA clone IMAGE:1416447 3′
−1
TGACTGTCTTGGTAATTTTCTTCCTTG

TTTTACTTCTGGAAACTGGGAGC

4296
Table 3A
Hs.11637
AI275205
3897479
602388093F1 cDNA, 5′
−1
TGACTTTCAGGAATGTCAGCATTGAC

end/clone =

CTCTCCTTGCCACTGTTACTCAGC

IMAGE:4517086/clone_end = 5′

4297
Table 3A
Hs.21812
AI131018
3601034
AL562895
−1
AAGTTTGTGCAGCACATTCCTGAGTG

cDNA/clone =

TACGATATTGACCTGTAGCCCAGC

CS0DC021YO20-(3-prime)

4298
Table 3A
Hs.21812
AI888714
5593878
AL562895
−1
AAGTTTGTGCAGCACATTCCTGAGTG

cDNA/clone =

TACGATATTGACCTGTAGCCCAGC

CS0DC021YO20-(3-prime)

4299
Table 3A
Hs.59459
AA889552
3016431
ak20d12.s1 cDNA, 3′
−1
ACCAGACTTCAGGAAGAATAAAGGTC

end/clone =

GCCAACTCAATAAAACCACCAAGC

IMAGE:1406519/clone_end = 3′

4300
Table 3A
Hs.230805
AI087055
3425478
oy70c09.x1 cDNA, 3′
−1
ACTTGCCACATAAACAGTTCCATCAT

end/clone =

AAAAACTCTTCCCCTTCTTGTTCC

IMAGE:1671184/clone_end = 3′

4301
Table 3A
Hs.125608
AI380443
4190298
tg02f04.x1 cDNA, 3′
−1
GCTTCCTTGAACCACCCAGAAATCCA

end/clone =

CTCAAATTTGGGGATTGTCATTCC

IMAGE:2107615/clone_end = 3′

4302
Table 3A
Hs.229385
AI354231
4094384
qv12c04.x1 cDNA, 3′
−1
GGGGGTGATGGGTTAATTAAATAAGT

end/clone =

CCATTCCTGGGATTTGAGGGGGCC

IMAGE:1981350/clone_end = 3′

4303
Table 3A
Hs.330928
AI371227
4149980
601659234R1 cDNA, 3′
−1
ATGCCCCTCGTCCTAGAATTAATTCC

end/clone =

CCTAAAAATCTTTGAAATAGGGCC

IMAGE:3895641/clone_end = 3′

4304
db mining
Hs.141153
AI39639
3645611
tx43b11.x1 cDNA, 3′
−1
TCAAACTAAGACCAGGGTTGAAAACT

end/clone =

ATGGCCCAGGGACCACTTCCAGCC

IMAGE:2272317/clone_end = 3′

4305
Table 3A
Hs.134342
AI363001
4114622
mRNA for LanC-like protein 2 (lancl2
−1
GACGCGCACACACCTTGAGTGACAG

gene)/cds = (186, 1538)

CGACCTCTTCTCTACAGGTTTTCCC

4306
Table 3A
Hs.226755
AA909983
3049273
RC1-UT0033-250800-022-h02 cDNA
−1
ATCCAAGCTTTAATTCTGCCATCTCA

GAATGGTGATAAACCATTTCTCCC

4307
Table 3A
Hs.158894
AI378457
4188310
tc79d10.x1 cDNA, 3′
−1
TACTTCATTGCTATTGTAAACCAAAAA

end/clone =

TAAAATTTGAAGCCCCCTGCCCC

IMAGE:2072371/clone_end = 3′

4308
Table 3A
Hs.127327
AI084064
3422487
EST390862 cDNA
−1
CTTCATCACTCAGGAAACAGAAAAGG

CTTCAGAAGGAGCGGCCATGCCCC

4309
Table 3A
Hs.295945
AW081320
6036472
xc30f12.x1 cDNA, 3′
−1
AGAACCCGTATTCATAAAATTTAGAC

end/clone =

CAAAAAGGAAGGAATCGAACCCCC

IMAGE:2585807/clone_end = 3′

4310
Table 3A
Hs.143410
AA825245
2898544
oe59g09.s1 cDNA, 3′
−1
TTTTCTATTTTCATCTGTCATTTTCAC

end/clone =

TGCAGAGCGCACCTCCCGGACCC

IMAGE:1415968/clone_end = 3′

4311
db mining
Hs.228874
AI356505
4108126
qz22b04.x1 cDNA, 3′
−1
AGACTGAAGGGGTTGAAAGACCCGT

end/clone =

AGACGCTCCTTTCCTCTTTTAGACC

IMAGE:2027599/clone_end = 3′

4312
Table 3A
NA
AI364936
4124625
qz23c12.x1 cDNA, 3′
−1
CTCTGCGGCCCTAGAGTTAATCCCAT

end/clone =

CAGCCGAGGTGAGGCACCTGTTAC

IMAGE:2027734

4313
Table 3A
Hs.125892
AI378032
4187885
ta67g08.x1 cDNA, 3′
−1
CCAATTCCGCAGTACAGAGCATTCAG

end/clone =

CAGGTAGTGGTGACCCTGGGTGAC

IMAGE:2091806/clone_end = 3′

4314
Table 3A
Hs.158943
AI379953
4189806
tc81a07.x1 cDNA, 3′
−1
GGCTCCAGCCACCGGCAGCTCTGAA

end/clone =

AGAGTTTGAAGAATTTATTGTTCAC

IMAGE:2072532/clone_end = 3′

4315
Table 3A
Hs.108124
AI362793
4114414
cDNA; FLJ23088 fis, clone
−1
GCTCGCTACCAGAAATCCTACCGATA

LNG07026/cds = UNKNOWN

AGCCCATCGTGACTCAAAACTCAC

4316
db mining
Hs.129332
AA992299
3179055
ol53b06.s1 cDNA, 3′
−1
CACTGGAACACAACCCAGCCATGAAA

end/clone =

AGGAAGAAGCTCTGACTCAGGCAC

IMAGE:1820467/clone_end = 3′

4317
Table 3A
NA
AI318342
4034222
ta73c09.x1 3′
−1
CATCTCATGCGTAGCACTGATCAATG

end/clone =

TGCCCCAGGGTGTGTATTCGCCAC

IMAGE:2049712

4318
Table 3A
Hs.157447
AI028478
3245787
EST388739 cDNA
−1
CAATCAGAGCGCGAGTTACAAGCGC

GGTGGAGTGGGGAAGCGAATGAAAC

4319
Table 3A
Hs.205175
AA885473
2994550
am10c12.s1 cDNA, 3′
−1
GACATTGCACATTTTTGAACCTGTCT

end/clone =

ACAGCAGCCTGGGTTGGTCACAAC

IMAGE:1466422/clone_end = 3′

4320
Table 3A
NA
AI370412
4149165
cDNA, clone
−1
ACACTGGCAGAGTCCAGAAAAGCAG

IMAGE:1987587 3′

CAGAAGAAAAATTCAGAGCAAAAAC

4321
Table 3A
Hs.132594
AI346336
4083542
qp50b04.x1 cDNA, 3′
−1
TTTAACGTGCTTCTGAGACAGCCACC

end/clone =

ACCGAAAGGCACCTTTAGCGGTTA

IMAGE:1926415/clone_end = 3′

4322
Table 3A
Hs.50252
AA984245
3162770
mitochondrial ribosomal protein L32
−1
TCAGCCAACCTGAATCTGGTATCTTT

(MRPL32), mRNA/cds = (46, 612)

ACTTAAACACAGCAGTTGTAGTTA

4323
Table 3A
NA
AA744774
2783538
cDNA clone IMAGE:1283731 3′
−1
AAAAGGAGACGATGTCAGGCAAACA

CTCCTTACCCTGCCATTTCTAGTTA

4324
db mining
Hs.15200
AW190635
6465115
EST379783 cDNA
−1
TCACAATCAGTCTCAGATTCCCAGCA

GCAGAGAGTGAATTGTATGTTGTA

4325
Table 3A
Hs.276766
AI380791
4190844
tg04b12.x1 cDNA, 3′
−1
TAAAGACAATGCTATTTAAGTGCACA

end/clone =

GTTCCAGGGGCGCTTGTGGCTCTA

IMAGE:2107775/clone_end = 3′

4326
Table 3A
NA
AA573427
2347955
cDNA clone IMAGE:1028913 3′
−1
GAAGACCAAGTCTACGCCTGCAAGCT

CTCAGACCGGGAACATCCACTCTA

4327
Table 3A
Hs.127557
AA953396
3117543
on63h10.s1 cDNA, 3′
−1
CTGAAGAGACAGAAAGGGAGACACC

end/clone =

AAAACTTTAATGGCAGTTATTCCTA

IMAGE:1561411/clone_end = 3′

4328
Table 3A
Hs.124391
AA831838
2904937
oc85h08.s1 cDNA, 3′
−1
GCCGCCCCCATGAAGCCCTTTCTTAC

end/clone =

TGTAAGTGCTCAAGAACAAAGATA

IMAGE:1358539/clone_end = 3′

4329
Table 3A
Hs.210943
AI823511
5444182
wh54h10.x1 cDNA, 3′
−1
GCTAGCACGACTCTGCCTTGTTCCTT

end/clone =

TGGAGACAATTGTTATCATCAATA

IMAGE:2384611/clone_end = 3′

4330
Table 3A
NA
AA757952
2805815
zg49e07.s1 cDNA, 3′
−1
ATTGGGAATATAGATCATCAACAGAC

end/clone =

ACAGCCCTGGACGCATAAATTTGA

IMAGE:396708/

4331
Table 3A
Hs.10056
AA576946
2354420
hypothetical protein FLJ14821
−1
ACTAACGTATTTCATCATGGAAGGTC

(FLJ14621), mRNA/cds = (525, 1307)

CTGTGGTGATGGTTTTCCCTGGGA

4332
Table 3A
Hs.132156
AI042377
3281571
ox62c03.x1 cDNA, 3′
−1
AAGTAATAGCTCCCTGTTTGTGCCTT

end/clone =

GTTAGGGCTAGGGATGTTTAAGGA

IMAGE:1660900/clone_end = 3′

4333
Table 3A
Hs.173125
AI052431
3308422
peptidylprolyl isomerase F (cyclophilin
−1
AGCTCCTCCCCTTAGTGACCCCAAGT

F) (PPIF), mRNA/cds = (83, 706)

CTGTTTCCCTCAGCTGCATAAGGA

4334
Table 3A
Hs.122983
AI081246
3418038
oy67b06.x1 cDNA, 3′
−1
CCCTCAAATCTCCCAATCTACTCCAG

end/clone =

GGAAAAGACACTTCAAGTGAGAGA

IMAGE:1670867/clone_end = 3′

4335
db mining
Hs.85923
AA194310
1784006
zq04g12.s1 cDNA, 3′
−1
ACATGCAAACAGTGACTTACTTAGTG

end/clone =

CTTCTGAAAAATTTCTGAGTCAGA

IMAGE:628774/clone_end = 3′

4336
Table 3A
Hs.118659
AI052447
3308438
oz07g04.x1 cDNA, 3′
−1
AATGCCCATTGGTAAGTCAACATTGT

end/clone =

TTTCCCTGAAAGTCCTGAGACAGA

IMAGE:1674678/clone_end = 3′

4337
Table 3A
Hs.231154
AA761571
2818898
oa30h07.s1 cDNA, 3′
−1
CCATGTTTGCTGCTGCTGTTGAGTTT

end/clone =

CTGTGCTTTGGGAGTATAATAAGA

IMAGE:1306525/clone_end = 3′

4338
Table 3A
Hs.57787
AW029440
5888196
602381381F1 cDNA, 5′
−1
TGTGTTTGGTTGGGTGTAATGAGGAA

end/clone =

AATACCTGATAAAATGTCTGAAGA

IMAGE:4498845/clone_end = 5′

4339
Table 3A
Hs.57787
AA588755
2402486
602381381F1 cDNA, 5′
−1
TGGATAAGTGAAGACAGTAATAACAT

end/clone =

TGAAGCAGTGAACCAGTGGAAAGA

IMAGE:4498845/clone_end = 5′

4340
Table 3A
NA
AA974991
3150783
Soares_NFL_T_GBC_S1
−1
AGCACAAAAATGTTGAAGTATTAGGC

cDNA clone IMAGE:1560953 3′

CCAAGCTCCATGTTTGGTTAGTCA

4341
Table 3A
Hs.127514
AI028267
3245576
ow01d06.x1 cDNA, 3′
−1
CGTTTAACAATAATAAAGGTGACTGC

end/clone =

TTCATCTAAGGAATCCGAGCCGCA

IMAGE:1645547/clone_end = 3′

4342
Table 3A
Hs.88130
AI184553
3735191
qd60a05.x1 cDNA, 3′
−1
GGGCATTCCACCGAAATTCTTGGGGA

end/clone =

AATTTAGTAGCCTTCATTTTAGCA

IMAGE:1733840/clone_end = 3′

4343
Table 3A
Hs.158965
AI380220
4190073
tf94a04.x1 cDNA, 3′
−1
TCCATGTTCTGTGCAAGAAGGAGACA

end/clone =

CATTTTCAGTTGAGGTTCCCAGCA

IMAGE:2106894/clone_end = 3′

4344
Table 3A
Hs.235823
AI379474
4189327
602631538F1 cDNA, 5′
−1
AGCTCAACACTGTGGTAGGAAAATAG

end/clone =

CCACTAGAAAGAAAATAAAAAGCA

IMAGE:4776728/clone_end = 5′

4345
db mining
Hs.229560
AI373169
4153035
qz13b11.x1 cDNA, 3′
−1
GCATCTCCAGGGTTTAGCATCAGGAC

end/clone =

AGAGGATTAAGTAAATTCTTTCCA

IMAGE:2021373/clone_end = 3′

4346
Table 3A
Hs.146627
AI141004
3648461
oy68f02.x1 cDNA, 3′
−1
GAGACTACAGAGCCTTAGCCCCTTTA

end/clone =

AAGCCCTTAAAGTTACTACTTCCA

IMAGE:1671003/clone_end = 3′

4347
Table 3A
NA
AA431959
2115667
cDNA clone IMAGE:782188 3′
−1
AGAGCAAGTCTCAGAAATAATGCTGT

ATCTACACTGTCATGTATTTGCCA

4348
db mining
Hs.56156
AA257976
1894471
601463367F1 cDNA, 5′
−1
TGGTTCTCTGATTTGTAATGAGCACC

end/clone =

TGGATATGTCAATTAAAATGCCCA

IMAGE:3866512/clone_end = 5′

4349
Table 3A
Hs.264298
AI380111
4189964
tf98a11.x1 cDNA, 3′
−1
GCAAGACTGTTCAGTATTATGTTAGC

end/clone =

ATTGATATAAAAAGAAGCAGACCA

IMAGE:2107292/clone_end = 3′

4350
Table 3A
Hs.40411
AI266255
3884413
qx69f01.x1 cDNA, 3′
−1
AATGTTCCCAAAGGCCAAATTTGTTG

end/clone =

CCAGGTTTTATACGCAGGTCACCA

IMAGE:2008617/clone_end = 3′

4351
Table 3A
Hs.90753
AI223400
3805603
Tat-interacting protein (30kD) (TIP30),
−1
TGCCTATTGTGATTATCGCTATCACTA

mRNA/cds = (98, 826)

CATCCCCTGACTAAGGGAAACCA

4352
Table 3A
Hs.192427
AI380016
4189869
602296277F1 cDNA, 5′
−1
ACAAAATTCACTGCAGGTCGGTGGAA

end/clone =

TGATAGAATGCATTTTAAATCACA

IMAGE:4390770/clone_end = 5′

4353
Table 3A
NA
AA524720
2265648
cDNA clone IMAGE:937468 3′
−1
GGACGGTTGGCTGAATGGCAACAGT

GATGGAATATTTATATTTAGCCACA

4354
Table 3A
Hs.92909
AA187234
1773460
NREBP mRNA, complete
−1
ACATTGCACATTTAATAGCTGCACCA

cds/cds = (49, 7209)

GACACTAAGAGTTCCTCTCACACA

4355
Table 3A
Hs.158877
AI378113
4187968
tc80c12.x1 cDNA, 3′
−1
CGCTTGTCCTGTGAGTAGCTCGTCAC

end/clone =

CTGAGGCCTTGTCGTGAATATTAA

IMAGE:2072470/clone_end = 3′

4356
Table 3A
Hs.314941
AI039890
3279084
602381893F1 cDNA, 5′
−1
TGGAGCAAACCACAGTTTCATGCCCA

end/clone =

TCGTCCTAGAATTAATTCCCCTAA

IMAGE:4499447/clone_end = 5′

4357
Table 3A
Hs.157813
AI361761
4113382
qz19a07.x1 cDNA, 3′
−1
GGGACAACACAGTGGATTTGAAATCT

end/clone =

GAAGGGGCATTGGTGGTACTGGAA

IMAGE:2021940/clone_end = 3′

4358
Table 3A
Hs.205079
AA742400
2784400
EST388750 cDNA
−1
ACCTCCATATCTTCTCGTACTTGTTCC

TGCTGGTCTCTTAGCTCTCCGAA

4359
Table 3A
Hs.87908
AI381588
4194367
Snf2-related CBP activator protein
−1
CGAGGATGGTTTCCTGATAGCTTTCA

(SRCAP), mRNA/cds = (210, 9125)

AACACCTTTGCCATCTCTTCGCAA

4360
Table 3A
Hs.208854
AI766620
5233129
nab69e11.x1 cDNA, 3′ end
−1
ACTCCTGACAGCTCATCCTGCAAAAT

/clone = IMAGE:3272949/clone_end = 3′

TAAAATCCAAAATTTAAGTCGCAA

4361
Table 3A
Hs.157556
AI356405
4108026
qz26g04.x1 cDNA, 3′ end
−1
GCTGGATCTCTGCCTAAAGTCACGGT

/clone = IMAGE:2028054/clone_end 3′

AGGATGAGAAGTAGAAACGAGCAA

4362
Table 3A
Hs.182594
AA806222
2874997
wd43h11.x1 cDNA, 3′ end
−1
TCAGACCATAGGTGGGTGTTGTTTCT

/clone = IMAGE:2330949/clone_end = 3′

TTTAAGTGTGTGTACTGTGTCCAA

4363
Table 3A
Hs.164168
AA806766
2880855
ob58h11.s1 cDNA, 3′ end
−1
TCATCTATGTAGCTTAATCTCATCGAC

/clone = IMAGE:1335621/clone_end = 3′

GTTTCGGTTCATTTCCTGCACAA

4364
Table 3A
Hs.291129
AA581115
2358887
oe10d02.s1 cDNA
−1
TTCCTTTTCCGCTAATCAAGAGTCCA

/clone = IMAGE:1385475

GGGAGGTGGGAACAGCCTCAACAA

4365
Table 3A
Hs.33757
AI114852
8359997
HA1247 cDNA
−1
CCGGCAGCTGTGTTTAGCCCCTCCA

GATGGAAGTTTCACTTGAATGTAAA

4366
Table 3A
Hs.121709
AA767883
2824475
ai35b09.s1 cDNA, 3′ end
−1
ACAAAGGAATGAAGCTTTATGACAGG

/clone = 1358969/clone_end = 3′

GCACGTGAAATGTTTATAGTGAA

4367
Table 3A
NA
AI335004
4071831
tb21e09.x1 cDNA, 3′ end
−1
ACTAAAGGTCACAACCCATTAACAAC

/clone = IMAGE:2055016/clone_end = 3′

CATGAAATTGGTGTTGGGAAGAAA

4368
Table 3A
Hs.157815
AI361849
4113470
qz19h11.x1 cDNA, 3′ end
−1
TGCTCAGGAACCAAAAAGGATGTCT

/clone = IMAGE:2022021/clone_end = 3′

GCATGGAGGACAAAAAGGCACAAA

4369
Table 3A
Hs.98903
AA913840
3053232
602680377F1 cDNA, 5′ end
−1
TGAGAACCGCGCACCCTACCCATCG

/clone = IMAGE:4813147/clone_end = 5′

GCCACGTGACCAGTCCTTTTTAAAA

4370
Table 3A
Hs.292276
AI184710
3735348
qd64a01.x1 cDNA, 3′ end
−1
GTCTTTGGGTCAGTGTCATCATTCTC

/clone = IMAGE:1734216/clone_end = 3′

TTCAAGTCTGGGGCTTGGGGAAAA

4371
Table 3A
Hs.143314
AI357640
4109261
qy15b06.x1 cDNA, 3′ end
−1
CTCCACACAGGAGAATCTCGGCGATT

/clone = IMAGE:2012051/clone_end = 3′

TACACCCACAGGCTACGCAGAAAA

4372
Table 3A
Hs.259084
AI144328
3666137
hg02g06.x1 cDNA, 3′ end
−1
GCGCTGCTCCCAAAATCTATCTGCTG

/clone = IMAGE:2944474/clone_end 3′

TTTAATAGTTTTTACCTTTCAAA

4373
db mining
Hs.327454
AI378123
4187976
tc80e02.x1 cDNA, 3′ end
−1
GGGTTCAGGGGGTTTTCCCTTTGCCC

/clone IMAGE:2072474/clone_end = 3′

GTTTGGCCCTGGGTTTAATAAAAA

4374
db mining
Hs.132775
AI028477
3245786
ti02c07.x1 cDNA, 3′ end
−1
CCAACTCCTCACAGGGCAGGCTAGC

/clone = IMAGE:2129292/clone_end =

GGGCACCAGGTCGCCGGGGAAGTG

3′

G

4375
db mining
Hs.283392
AI052781
3308772
oy78h07.x1 cDNA, 3′ end
−1
CGGCTGAGAGCCCGGTAGGGCCCAG

/clone = IMAGE:1671997/clone_end =

GGGCCAAGCGCAGGCAGAGGCCGC

3′

G

4376
db mining
Hs.270564
AI361877
4113498
qz25d07.x1 cDNA, 3′ end
−1
CTTGGGGTCCAGGGCACAGCGGTGC

/clone = IMAGE:2027917/clone_end = 3′

CGGGGACACAGCAGTTCCGAGGGTC

4377
db mining
Hs.110059
AA82600
2898912
601763318F1 cDNA, 5′ end
−1
AGTATGGTAATTAGAAAGCATGTTAG

/clone = IMAGE:4026173/clone_end = 5′

AACATGTGGAAAAAGGGGGAAAAA

4378
Table 3A
NA
AI027844
3246543
cDNA clone IMAGE:1671612 3′
−1
CATCAGTCCTCATCAGCTGAAGTGGC

TTCCCAAGGATTTAAATAAATAGT

4379
Table 3A
Hs.229374
AI380491
4190344
602851994F1 cDNA, 5′ end
−1
AGACATTGACTACAGGGTAATTTCTA

/clone = IMAGE:4993678/clone_end = 5′

TGATTATATTATTTAGAAGTATGA

4380
Table 3A
Hs.124344
H12462
877282
MR1-GN0173-071100-009-g10 cDNA
−1
CCAGTGAACTGTTAGCAACAATGCAG

AAGAATCTGCATGTAATAAACTGA

4381
Table 3A
Hs.144119
AI090305
3429384
oy61b01.s1 cDNA, 3′ end
−1
ACTTAAATGCCTTTTAATTTTTGTCGA

/clone = IMAGE:1672201/clone_end = 3′

TGTAATAGTTTAATACCAGTAA

4382
Table 3A
Hs.333513
AI379735
4189588
small inducible cytokine subfamily E.
−1
TTTTTAATTCTAGCTTCTTTTTAAGA

member 1 (endothelial monocycte-

TTATTTGGGTACCTAATAAAGGA

activating) (SCYE1), mRNA

/cds = (49, 987)

4383
Table 3A
Hs.135339
AI051664
3307198
oy77f06.x1 cDNA, 3′ end
−1
CAAAGCCTCCACAGGAGACCCCACC

/clone = IMAGE:1671875/clone_end = 3′

CAGCAGCCCAGCCCCTACCCAGGAG

4384
db mining
Hs.2186
AA182528
1766227

Homo sapiens, eukaryolic translation
1
CGAGTGACATTGGCTGACATCACAGT

elongation factor 1 gamma, clone

TGTCTGAACCTGTTGTGGCTCTAT

MGC:4501 IMAGE:2964623, mRNA,

complete cds/cds = (2278, 3231)

4385
db mining
Hs.101370
AA287260
1932959
AL583391 cDNA
1
TGAATTGCTTCAAAACCTCTTCCATCT

/clone = CS0DL012YA12-(3-prime)

CAGAAGACCAGACCCTGGGAACT

4386
Table 3A
Hs.238514
AA613460
2464498
xy5208.x1 cDNA, 3′ end
1
GCTGAAGTGGCAATAGAGAGAGTCT

/clone = IMAGE:2856808/clone_end = 3′

GCTAGAAAGACGGAAGTCACCATCT

4387
Table 3A
NA
AA665359
2880102
nt89f05.s1 NCI_CGAP_Pr12 cDNA
1
TCTACTGACTATCCTAGAAATCGCTG

clone IMAGE:1205697 similar to

TCGCCTTAATCCAAGCCTACGTTT

SW:ATP6_HUMAN P00846 ATP

SYNTHASE A CH

4388
db mining
Hs.98507
AB011115
3043609
mRNA for KIAA0543 protein, partial
1
GTGTGTGCTTAGCCAAATACAGTAAC

cds/cds = (0, 3338)

TGTGACTGGCCCAGGGATGTTCTC

4389
db mining
Hs.129268
AB037809
7243156
mRNA for KIAA1388 protein, partial
1
GTGAGTCCAATGTATGCTTTAGAAGT

cds/cds = (572, 2371)

AAAGACATTGACCGTCACAGACCA

4390
Table 3A
Hs.296317
AB058692
14017794
mRNA for KIAA1789 protein, partial
1
CTCAAGAAAAGACAGAAGAGAC

cds/cds = (3466, 4899)

AGTGATTTGGGAGAGTCTACTCT

AGGA

4391
Table 3A
Hs.195175
AF005775
2286146
mRNA for CASH alpha protein
1
ACCCTATGCCCATTGTCCTGATCTGA

/cds = (481, 1923)

AATTCTTGGAAATTGTTCCATGT

4392
db mining
Hs.62187
AF022913
2558890
GPI transamidase mRNA complete
1
TTCACAGTCTTCTATTGTTGGACCAC

cds/cds = (17, 1204)

TTACATTGTACCAAATGTTTTCCT

4393
db mining
Hs.248077
AF044592
2852420
lymphocyte-predominant Hodgkin's
1
ATTAAGCCCCCGTAGCCCATCCCGCA

disease case #4 immunoglobulin heavy

AGTTAGATACAGCTATGGTTAAGG

chain gene, variable region

4394
db mining
Hs.248078
AF044595
2852426
lymphocyte-predominant Hodgkin's
1
TTATATTGTAGTGGTGGTATTTGCTTT

disease case #7 immunoglobulin heavy

CCGCCTGTTGGCTACTTCGACCC

chain gene, variable region

4395
Table 3A
Hs.25812
AF058896
3098674
Nijmegen breakage syndrome 1
1
TTGTTCTCTGTCATGCCCACAATCCC

(nibrin) (NBS1), mRNA/cds = (52, 2316)

TTTCTAAGGAAGACTGCCCTACTA

4396
db mining
Hs.300865
AF063725
3142513
clone BCSynL38 immunoglobulin
1
ACTGAGGACGAGGCTGACTACTACT

lambda light chain variable region

GTCAGTCTTATGATAGCACCTATCA

mRNA, partial cds/cds = (0, 116)

4397
db mining
Hs.249208
AF063784
3135618
clone LBLG9 immunogobulin lambda
1
AGATGGAGGATGAAGCTGACTACTAC

light chain variable region gene, partial

TGTTACTCAAGAGACAGCAGTGGT

cds/cds = (0, 289)

4398
db mining
Hs.293441
AF067420
3201899
SNC73 protein (SNC73) mRNA,
1
CATGTCAATGTGTCTGTTGTCATGGC

complete cds/cds = (395, 1549)

GGAGGTGGACGGCACCTGCTACTG

4399
db mining
Hs.293441
AF067420
3201899
SNC73 protein (SNC73) mRNA,
1
GTCAATGTGTCTGTTGTCATGGCGGA

complete cds/cds = (395, 1549)

GGTGGACGGCACCTGCTACTGAGC

4400
db mining
Hs.247721
AF073705
3335589
clone mcg53-54 immunoglobulin
1
TCCAACCTCCAGTTTGAGGATGAGGC

lambda light chain variable region 4a

TGATTATTACTGTGAGACCTGGGA

mRNA, partial cds/cds = (0, 324)

4401
Table 3A
Hs.22380
AF086431
3483776
AL557896 cDNA
1
GACTACAACTGGCAATCCCAACTCCT

/clone = CS0DJ003YD10-(5-prime)

GGGCTAGGGCTTTTTCTACCTTTT

4402
db mining
HS.283882
AF103295
4838126
clone N97 immunoglobulin heavy
1
TATTTCTGTGCGAGAGTTCCCCCTAA

chain variable region mRNA, partial

ACATGGCGGAGGCTTCTTCTACAA

cds/cds = (0, 377)

4403
Table 3A
Hs.167827
AF116909
4768835
clone HH419 unknown mRNA
1
TGGCTAGGAGACCTTGGGCAGTACC

/cds = (189, 593)

TACAGTCTTGCTGTTTCTGTTTCAT

4404
db mining
Hs.149235
AF119843
7770122
PR01085 mRNA, complete cds
1
GTGAGCTGAACAAATACATCATTTAA

/cds = (539, 1582)

ATCTATGCTGCACTTTGAGTTGCT

4405
db mining
Hs.193053
AF121255
6468774
protein translation initiation factor 2C2
1
CCCGTGTGTTTACAGCATTTCCAGGT

(EIF2C2) mRNA, partial cds

CCAGAGAGGTTGGCAGACAAGTGC

/cds = (0, 1133)

4406
db mining
Hs.247909
AF127125
4337068
isolate 459 immunoglobulin lambda
1
AGCTGTGGGATATAAGTAGTGGTCAT

light chain variable region (IGL) gene,

TATGTCTTCGGAGGTGGCACCACT

partial cds/cds = (0, 265)

4407
db mining
Hs.204588
AF150138
5133574
AF150138 cDNA/clone = CBCBOG02
1
GCCCTTTGAGAAAGACTTTGTTCCTG

AACTGCTCCCTTCTCTTTTAGGGT

4408
db mining
Hs.205158
AF150141
5133577
AF150141 cDNA/clone = CBCBQD03
1
GGTCTGGTTCTAGATCAGCCTTTTCA

GTCTGCCCTGGCCTGGTCATTAAT

4409
db mining
Hs.205438
AF150373
5133809
AF150373 cDNA/clone = CBMACE02
1
GAAAAACCTGGCTAGAGCAGAGCAC

AGGATGTAAAAGGGTGGGGGAGAAC

4410
db mining
Hs.283929
AF161340
6841093
HSPC077 mRNA, partial cds
1
GGTTATCTGAGCATAACAGGGACAG

/cds = (0, 396)

GGTGGGCCACAGGATACCTCTGAGG

4411
db mining
Hs.283931
AF181351
6841115
HSPC088 mRNA, partial cds
1
ACAAGCAGGAGCACATCGCTCTTTTA

/cds = (0, 305)

TGAAGCCCTTCAACATTTAACGT

4412
db mining
Hs.326257
AF161360
6841133
602288541T1 cDNA, 3′ end
1
CAGGGACACCACTTATCCTGCTTCCA

/clone = IMAGE:4374059/clone_end = 3′

CTATAGCATGAATCAGTGCTCTCT

4413
db mining
Hs.283934
AF161365
6841143
HSPC102 mRNA, partial cds
1
CATCGCACACGAATTTGAATCATCTG

/cds = (0, 285)

CTCTTTGGAATCGCCTACACCCTG

4414
db mining
Hs.283935
AF161370
6841153
HSPC107 mRNA, partial cds
1
TGTATGTAGGTGTCTGAGCTTCACAA

/cds = (0, 473)

GCCTTTTATAGTCCATTCAGCACT

4415
db mining
Hs.283924
AF168811
5833844
clone case06H1 immunoglobulin
1
CGACGACAACGGTGTATATTATTGTG

heavy chain variable region gene,

CGAAAGATCGGGCAGATTTGACTT

partial cds/cds = (0, 322)

4416
db mining
Hs.177461
AF174394
5802906
apoplotic-related protein PCAR
1
CGGTGAGACTCAGTGAAAGCCATCA

mRNA, partial cds/cds = (0, 439)

GCAAAACTACAGTAATGCGGCACTA

4417
Table 3A
Hs.160422
AF218032
10441993
clone PP902 unknown mRNA
1
AAGTTAAACAAGACTCTGAAAGCCCT

/cds = (693, 1706)

AAATCAACTAGTCCGTCGGCTGCA

4418
db mining
Hs.169992
AF308298
12060848
serologically defined breast cancer
1
CTTGAGTGGTCCTCTTCTGCCTGCTG

antigen NY-BR-84 mRNA, partial cds

CTCATTTGTCTTGGGCAACCATTT

/cds = (0, 721)

4419
db mining
Hs.170580
AI475577
4328822
tc92e07.y1 cDNA 5′ end
1
CCCAGGAATATACAGTACTTCTGTAG

/clone = IMAGE:2073636/clone_end = 5′

TGTCCAGCCATTACTTAGCAAGGG

4420
Table 3A
Hs.145668
AI793342
5341058
fmlc5 cDNA/clone = CR6-21
1
TGCTCTGTCTGCTGGTTTGCATTGTT

TCTGTCTGAGTTAAGAGACTGGCA

4421
Table 3A
Hs.194382
AI904071
6494458
ataxia telangiectasia (ATM) gene,
1
TTCTTTTCTCCGTTAGCCACGCAGCT

complete cds/cds = (795, 9965)

ACCTACTCCCGCTTCCGGTTCAAA

4422
db mining
Hs.333140
AJ225092
3090425
mRNA for single-chain antibody,
1
AAAACTCATCTCAGAAGAGGATCTGA

complete cds (scFv2)/cds = (0, 806)

ATGGGGCCGCACATCACCATCATC

4423
db mining
Hs.272356
AJ275371
7573002
partial IGVH3 gene for immunoglobulin
1
GATGAACAGTCTGAGAGGCGAGGAC

heavy chain V region, case 1, clone 16

ACGGCCTTGTTTAACTGTGCGAGTC

/cds = (0, 236)

4424
db mining
Hs.272357
AJ275374
7573008
>partial IGVH3 gene for
1
TACTACTTGCCAGGTCCAAGAACGGG

immunoglobulin heavy chain V region,

GCGGGTCCTGTTATCATTATTACA

4425
db mining
Hs.272358
AJ275383
7573027
partial IGVH3 gene for immunoglobulin
1
GCTGTGTTTTTCTGTGGGTGAAATAA

heavy chain V region, case 1,

AGGTTTCGGAGCCCGTTTTAGATA

4426
db mining
Hs.272359
AJ275397
7573058
partial IGVH1 gene for immunoglobulin
1
CATTTCTGTGCGAGAGTGAACAGGG

heavy chain V region,

GACCCTAGAGGATTTCGTTGTGGGA

4427
db mining
Hs.272360
AJ275399
7573060
partial IGVL2 gene for immunoglobulin
1
GGACTCCAGGCTGAGGACGAGGCTG

lambda light chain V region

ATTATTAGTGATGCTCATAAACAAG

4428
db mining
Hs.272361
AJ275401
7573064
partial IGVH3 gene for immunoglobulin
1
CTCTTATTGTGCGAGAGACCTCCCGG

heavy chain V region

AACTGCCACTGAAGGTGGAGGCTA

4429
db mining
Hs.272362
AJ275405
7573073
partial IGVL1 gene for immunoglobulin
1
CTCCCTGAGTATCTCGGGCCTCTAGC

lambda light chain V region

CTGAGGACGAGGCTGATTATTATT

4430
db mining
Hs.272364
AJ275413
7573089
partial IGVH3 DP29 gene for
1
AAGAACTCACTGTATCTGCAAATGAA

immunoglobulin heavy chain V region,

CAGCCTGAAAACCGAGGACACGGC

case 1, celll Mo VII 116/cds = (0, 257)

4431
db mining
Hs.272365
AJ275453
7573172
partial IGVH4 gene for immunoglobulin
1
CACGGCTGTGTTTAACTCTGCGACAT

heavy chain V region

GCGGGGGACTATGGTTCGGGGGAA

4432
db mining
Hs.50102
AK002098
7023770
mRNA for rapa-2 (rapa gene)
1
TCAGGGTGATTGAAGGACACATATTG

/cds = (836, 3742)

AAGTACCTAGAATGCCAGAAAGTG

4433
db mining
Hs.270247
AK022039
10433357
cDNA FLJ11977 fis, clone
1
AACAAAACTGTGATTTATATCAAATAA

HEMBB1001254/cds = UNKNOWN

CAATGGCTTGGAGGGGGTATGGA

4434
db mining
Hs.156110
AK024974
10437403
cDNA:FLJ21321 fis, clone COL02335,
1
TTTTCCACAGGGGACCTACCCCTATT

highly similar to HSAD10442 mRNA for

GCGGTCCTCCAGCTCATCTTTCAC

immunoglobulin kappa light chain

/cds = UNKNOWN

4435
db mining
Hs.156110
AK024974
10437403
cDNA:FLJ21321 fis, clone COL02335,
1
TTTTCCACAGGGGACCTACCCCTATT

highly similar to HSA010442 mRNA for

GCGGTCCTCCAGCTCATCTTTCAC

immunoglobulin kappa light chain

/cds = UNKNOWN

4436
db mining
Hs.156110
AK024974
10437403
cDNA:FLJ21321 fis, clone COL02335,
1
TTTTCCACAGGGGACCTACCCCTATT

highly similar to HSA010442 mRNA for

GCGGTCCTCCAGCTCATCTTTCAC

immunoglobulin kappa light chain

/cds = UNKNOWN

4437
db mining
Hs.323884
AK025398
10437905
cDNA:FLJ21745 fis, clone COLF5038
1
TGTGGCTGTACTTAACCTTCTCCAAC

/cds = UNKNOWN

ATACATCCTGCATTACATGAATGG

4438
db mining
Hs.1501
AK025488
10438019
heparan sulfate proteoglycan (HSPG)
1
AAGCCTTTGAAGTGCCTCTGATTCTA

core protein, 3′ end/cds = (0, 1193)

TGTAACTTGTTGCAGACTGGTGTT

4439
db mining
Hs.267697
AK026199
10438971
cDNA:FLJ22546 fis, clone HS100290
1
GCATTGACCTGGAAGGAGAGAAGAT

/cds = UNKNOWN

AGAGAGTGGAGGCTCTGAAGGAGAC

4440
db mining
Hs.287728
AK026793
10439729
cDNA:FLJ23140 fis, clone LNG09065
1
CAGTACAGGGCTGGCAAGCAGTGAT

/cds = UNKNOWN

CTCTCAGGTATATTTATCAATAATT

4441
db mining
Hs.104696
AK026832
10439779
mRNA for KIAA1324 protein, partial
1
CAAACCCTCCTTTCTGCTTGCCTCAA

cds/cds = (0, 1743)

ACCTGCCAAATATACCCACACTTT

4442
db mining
Hs.24684
AK026917
10439889
mRNA for KIAA1376 protein, partial
1
GGTGCTGAATATGTCCTTGTAGGCTC

cds/cds = (143, 1456)

TGTTTTAAGAAAACAATATGTGGG

4443
db mining
Hs.152925
AK027260
10440394
mRNA for KIAA1268 protein, partial
1
AGTGATTTGATTAACTCAGGGCAAGG

cds/cds = (0, 3071)

CTGAATATCAGAGTGTATCGCACT

4444
Table 3A
Hs.301783
AL049935
4884177
mRNA; cDNA DKFZp564O1116 (from
1
GCTTCCACTGGAGGCTTGTATTGACC

clone DKFZp584O1116)

TTGTAACTATATGTTAATCTCGTG

/cds = UNKNOWN

4445
db mining
Hs.18368
AL080186
5262664
mRNA; cDFNA DKFZp564BO769 (from
1
ATGCATGTTTACCAAAATGGCTGTTT

clone DKFZp584B0769); partial cds

ACAGTGCATTCAGTTCTGATATTT

/cds = (0, 900)

4446
Table 3A
Hs.326292
AL134898
6603085
DNA sequence from clone RP5-
1
ACATGACAGGTGTAATTAGTCTGCTG

1167H4 on chromosome 20 Contains

AGCCAGCTTTACCCAATGAAGGGC

ESTs, STSs, GSSs and CpG islands.

Contains a novel gene, the STK15

gene for serine/threonine kinase 15,

the CSTF1 gene for cleavage

stimulation factor subunit 1 (50 kDa), a

novel gene similar to NEDD9 for neural

precursor cell expressed

developmentally-down-regulated

protein 9 (enhancer of filamentation 1,

HEF1) (CRK-associated substrate-

relateed protein, CAS-L) and a 60 S

ribsomal protein, L39 (RPL39)

pseudogene/cds = (44, 622)

4447
Table 3A
Hs.260024
AL136842
6807668
mRNA; cDNA DKEZp434A0530 (from
1
AACAGCAACCAATAACGGATTGTAAA

clone DKFZp434A0530); complete cds

GTGTAAAGGCACAGGTTACTCATG

/cds = (968, 1732)

4448
db mining
Hs.298358
AL137406
6807955
mRNA; cDNA DKFZp434M162 (from
1
CCATGCCAAGGAATGGAATTTCCATC

clone DKFZp434M162)

CTGAGCCAGTTCAGTTAGGTGTCA

/cds = UNKNOWN

4449
db mining
Hs.56265
AL137736
6808315
mRNA; cDNA DKFZp586P2321 (from
1
CTAGAGTTCATCTCTGAGCTGTAAGG

clone DKFZp586P2321)

GTGACCAGGGGGCAGGGGGACGAT

/cds = UNKNOWN

4450
Table 3A
Hs.66151
AL157438
7018513
mRNA; cDNA DKFZp434A115 (from
1
CAAGTAGACACCAGAGTCACTGTTTG

clone DKFZp434A115)

GTTGGTGGGTGATAGTGGGGTCAC

/cds = UNKNOWN

4451
Table 3A
Hs.106875
AL355722
7799110
EST from clone 35214, full insert
1
TGTCACCCTTCCATGACGCCTCCTCT

/cds = UNKNOWN

GTGCATTTGAGTTCACTGTTTATG

4452
db mining
Hs.283849
AL359560
8655615
mRNA; cDNA DKFZp762F0616 (from
1
GGTAACATGAGCTATGGCAGTCGGTT

clone DKFZp762F0616)

GTGAAACCACAGGAAGTGTATGGG

/cds = UNKNOWN

4453
Table 3A
Hs.23964
AL360135
8919158
sin3-associated polypeptide, 18 kD
1
CAAATCGGGCACCACCTCCTTCAGG

(SAP18), mRNA/cds = (573, 1034)

GCGCATGAGACCATATTAATTCTA

4454
Table 3A
Hs.10927
AL385373
9187358
HSZ78330 cDNA/clone = 2.49-(CEPH)
1
CAGAACTGCTTTCCTATGTTTACCCA

GGGGACCTCCTTTCAGATGAACTG

4455
db mining
Hs.171118
AL583913
13093778
DNA sequence from clone RP11-
1
AGCAATAATATCTCTGTTTTCATTTCA

165F24 on chromosome 9. Contains

GAACATTGTGCTGTCTGTCAGCA

the 3′ end of the gene for a novel

protein (similar to Drosophila CG6830

and CG11376, KIAA1058, rat TRG), an

RPL12 (60 S ribosomal protein L12)

pseudogene, ESTs, STSs, GSSs and a

CpG island/cds = (0, 4617)

4456
Table 3A
Hs.11806
AU124763
10949479
7-dehydrocholesterol reductase
1
TTACAACTACATGATGGGCATCGAGT

(DHCR7), mRNA/cds = (194, 1621)

TTAACCCTTGGATCGGGAAGTGGG

4457
db mining
Hs.205435
AV740518
10858099
AV740518 cDNA, 5′ end
1
AATGTTTGAGCTGACCAAGCTTCTGA

/clone = CBDAGC01/clone_end = 5′

GATTCTTAACAGAAAAAGCCATGT

4458
db mining
Hs.204751
AV741208
10858789
AF150335 cDNA/clone = CBLAQF05
1
ACGTCAGCTTAAAACTGGAAAGAAGT

CTTCTGGTGTATACTGAGATTTGA

4459
db mining
Hs.204932
AV743878
10861459
AV743878 cDNA, 5′ end
1
GCCCAAAGGAGTAGCTCTCTGTTGTT

/clone = CBLAOC04/clone_end = 5′

ACTGTTGTGCTCTTCATGGATAAA

4460
db mining
Hs.205159
AV744351
10861932
AF150295 cDNA/clone = CBLADB01
1
GCAAAAAGCCCAAGAGCCTGAATTTA

GACCAATCTATCATCTTCCTCCTC

4461
db mining
Hs.205789
AV758240
10914088
AV756240 cDNA, 5′ end
1
TGGAGATGTGATAACAACTCCTTATC

/clone = BMFAUH12/clone_end = 5′

TCTTTGTTGGCTCATCTGAAGTGT

4462
db mining
Hs.254948
AW291284
6697920
UI-H-BI2-agi-h-10-0-UI.s1 cDNA, 3′
1
CTTGCAGTAAAATGTAGCCCTTCCTC

end/clone = IMAGE:2724714

CTGGTTGTGCAGGAGTGGCCCTCG

/clone_end = 3′

4463
db mining
Hs.250605
AW327360
6797855
dq02e11.x1 cDNA, 5′ end
1
TTTCTTTAGCCCAAGAGTGGAGGCTA

/clone = IMAGE:2846885/clone_end = 5′

AGCTACTTACTTCCAAGCCTGGGT

4464
Table 3A
Hs211194
AW362304
6866954
CM3-CT0275-031199-031-a08 cDNA
1
AGGCAAAGGGAACTTGAAATTAGAAA

ACCCCAGAAACAGTCACAATGGCT

4465
Table 3A
Hs.342300
AW389509
6894188
xm47a06.x1 cDNA, 3′ end
1
AGGGTCCCTTCCATAGTCCTCCTGCA

/clone = IMAGE:2687314/clone_end:3′

TCATTTTCCTCCAACTTGAATAAA

4466
Table 3A
Hs.202402
AW390251
6894910
CM4-ST0182-051099-021-b06 cDNA
1
GCCAACCAGTTCAGAGTGTTCCCAAG

GAATTGCCACCCTTACTCTTCAAA

4467
Table 3A
Hs.192123
AW838827
7932601
CM1-LT0059-280100-e02 cDNA
1
ATCCCAGTCTCAAATTTCTTCATTTGG

AACTGATATGTAGGCCCTCATCG

4468
Table 3A
Hs.194589
AW945338
8123293
AV703056 cDNA, 5′ end
1
TCTCTCACTGTTATCATTTTTGCACAG

/clone = ADBCAMB06/clone end = 5′

GTGGTTTCAGCAGCTTGATGCCA

4469
Table 3A
Hs.83724
BC000957
13111830

Homo sapiens, clone IMAGE:3451448,
1
ATTGTCATTTAGACTTTGAACAGCTCT

mRNA, partial cds/cds = (0, 901)

GGGAAATAGAAGACTAGGGTTGT

4470
db mining
Hs.267690
BC001224
12654762
mRNA for KIAA1228 protein, partial
1
TTTCCTTGTTCCCTCCCATGCCTAGC

cds/cds = (0, 2176)

TGGATTGCAGAGTTAAGTTTATGA

4471
db mining
Hs.76932
BC002332
12803062

Homo sapiens, Similar to hypothetical
1
GGATTCACCGTGGCCGACTCTTTTCC

protein FLJ20419, clone MGC:15417

CTGCTTTGGTTTGTTTGAAATCTA

IMAGE:3942735, mRNA, complete cds

/cds = (208, 918)

4472
Table 3A
Hs.343272
BC002770
12803854

Homo sapiens, clone IMAGE:3816574,
1
CCCTCCACACCATCCTCCCCGATTTA

mRNA, partial cds/cds = (0, 640)

AATATAGTCACTGCTACAAGTAAC

4473
db mining
Hs.81221
BC002792
12803890

Homo sapiens, clone MGC:3963
1
TTCATCATTGCTTGCTTGCCTTCCTC

IMAGE:3621362, mRNA, complete cds

CCTTCTGTCCGCTCTTACTCCCTC

/cds (40, 402)

4474
db mining
Hs.302063
BC002963
12804210
rearranged immunoglobulin mRNA for
1
GCAAACTAACCGTGTCAACGGGGTG

mu heavy chain enhancer and

AGATGTTGCATCTTATAAAATTAGA

constant region/cds = UNKNOWN

4475
db mining
Hs.302063
BC002963
12804210
rearranged immunoglobulin mRNA for
1
GCAAACTAACCGTGTCAACGGGGTG

mu heavy chain enhancer and

AGATGTTGCATCTTATAAAATTAGA

constant region/cds = UNKNOWN

4476
db mining
Hs.302063
BC002963
12804210
rearranged immunoglobulin mRNA for
1
GCAAACTAACCGTGTCAACGGGGTG

mu heavy chain enhancer and

AGATGTTGCATCTTATAAAATTAGA

constant region/cds = UNKNOWN

4477
Table 3A
Hs.334787
BC003063
13937660

Homo sapiens, clone MGC:19556
1
AGTATCTGCTTTCCAGGCTGAAGTGA

IMAGE:4304831, mRNA, complete cds

TTCATTCATTATTCTAGTCCTGCT

/cds = (1505, 1666)

4478
Table 3A
Hs.334573
BC006008
13937718

Homo sapiens, clone IMAGE:4285740,
1
AAGCTGTCTTCTTTGTTGGACAATCA

mRNA/cds = UNKNOWN

GCCAGAATGATAAGCAAACCTGCA

4479
db mining
Hs.300697
BC006402
13623574
mRNA for immunoglobulin lambda
1
CTCTCGCGGTCGCACGAGGATGCTT

heavy chain/cds = (65, 1498)

GGCACGTACCCCCTGTACATACTTC

4480
db mining
Hs.300697
BC006402
13623574
mRNA for immunoglobulin lambda
1
CTCTCGCGGTCGCACGAGGATGCTT

heavy chain/cds = (65, 1498)

GGCACGTACCCCCTGTACATACTTC

4481
db mining
Hs.300697
BC006402
13623574
mRNA for immunoglobulin lambda
1
CTCTCGCGGTCGCACGAGGATGCTT

heavv chain/cds (65, 1498)

GGCACGTACCCCCTGTACATACTTC

4482
Table 3A
Hs.155101
BC007299
13938338
mRNA for KIAA1578 protein, partial
1
CTCCTGTGGATTCACATCAAATACCA

cds/cds = (0, 3608)

GTTCAGTTTTGTCATTGTTCTAGT

4483
db mining
Hs.184778
BC007583
14043190
ribosomal protein L23a (RPL23A),
1
GGCTCCTGATTACGATGCTTTGGATG

mRNA/cds = (23, 493)

TTGCCAACAAAATTGGGATCATCT

4484
db mining
Hs.250528
BC007747
14043522

Homo sapiens, clone IMAGE:4098694,
1
AACGCCAGCATTTTGTTAGAGGAGTT

mRNA, partial cds/cds = (0, 2501)

AGACTTGGAAAAGTTAAGGGAAGA

4485
Table 3A
Hs.44155
BC008629
14250392
mRNA; cDNA DKFZp588G1517 (from
1
ATGGGGACTAAGGGATTAAGAGTGT

clone DKFZp588G1517); partial cds

GAACTAAAAGGTAACATTTTCCACT

/cds = (0, 2755)

4486
Table 3A
Hs.164280
BC008737
14250566

Homo sapiens, Similar to solute carrier
1
ACTGGCGAGTATGTTCTATGTTGGGC

family 25 (mitochondrial carrier,

CTCCTGCTGCAAAACAATAAACAG

adenine nucleotide translocator),

member 5, clone MGC:3042

IMAGE:3342722, mRNA, complete cds

/cds = (88, 984)

4487
Table 3A
Hs.336425
BC009111
14318625

Homo sapiens, clone MGC:17296
1
GCTGATTAACTGTATTCCCCTTTCCC

IMAGE:3460701, mRNA, complete cds

CTATGGCTGCTGGTGTAAATAAAC

/cds = (3250, 3498)

4488
db mining
Hs.287797
BC009469
14495714
mRNA for FLJ0043 protein, partial
1
CCCAGGGTTTCATGTCTGAGGCCCTC

cds/cds = (0, 4248)

ACCAAGTGTGAGTGACAGTATAAA

4489
literature
Hs.287797
BC009469
14495714
mRNA for FLJ00043 protein, partial
1
CCCAGGGTTTCATGTCTGAGGCCCTC

cds/cds = (0, 4248)

ACCAAGTGTGAGTGACAGTATAAA

4490
db mining
Hs.293842
BG506472
13467989
601571679F1 cDNA, 5′ end
1
ACAAGAATGGTTGAGGCGAATATTG

/clone = IMAGE:3838875/clone_end = 5′

GAACCACATGGGCTTAATGCTGAA

4491
db mining
Hs.224344
BG623174
13674545
602646078F1 cDNA, 5′ end
1
ACACCTCTCTATTTTGAAGTCCCTAT

/clone = IMAGE:4769802/clone_end = 5′

GTGCCCTGTAATGTCTCGTTTTAA

4492
db mining
Hs.127128
BI091076
14509406
ok13e12.s1 cDNA, 3′ end
1
GGGAGAGCTCATGTCAGTGAATATAG

/clone = IMAGE:1507726/clone_end = 3′

ATCATTCTGTTGATACCCTTCTTT

4493
db mining
Hs.330212
D20259
501358
HUMGS01233 cDNA, 3′ end
1
TTGAAACTTGTAACTGAGATGCTGTA

/clone = pm1527/clone_end = 3′

GTTTTTTGCCATCTGTAGTGATGT

4494
db mining
Hs.330467
D20413
501509
HUMGS01387 cDNA, 3′ end
1
AAAGGGTTTTATCCACTGTCATTTCAA

/clone = pm1535/clone_end = 3′

TTGGATAACATTTTGTCAAGTTT

4495
db mining
Hs.330223
D20542
501638
HUMGS01517 cDNA, 3′ end
1
TCGGAAAGAAGAAGTGGGAGGATGT

/clone = pm1520/clone_end = 3′

GAATTTTAGTTCTGAGTTTACCAAA

4496
db mining
Hs.330255
D20847
504687
HUMGS01828 cDNA, 3′ end
1
GATCGGGAACTGGCTCCGTTGTGCT

/clone = mp1214/clone_end = 3′

GAGGTCATCTTTGGTCATCAGCCTC

4497
db mining
Hs.141296
D86979
6834000
mRNA for KIAA0226 protein, partial
1
TGGTGCTTGTGCAGCCTGGCAGTTCA

cds/cds = (0, 3033)

TTGTCATCTTTAATAAACTAAGGA

4498
db mining
Hs.303450
H13491
878311
yj15f02.r1 cDNA, 5′ end
1
AGAAGTACAAGATTTCGTTCTTCCTT

/clone = IMAGE:148827/clone_end = 5′

CCATTAAAGTACAATCTCCCTGGG

4499
db mining
Hs.138563
H65914
1024654
601819705F1 cDNA, 5′ end
1
TACAAGTGAAAGCTAAGATGAACACA

/clone = IMAGE:4051657/clone_end = 5′

TTTAAGTTAAATGGCAGCCTTGTT

4500
db mining
Hs.73858
J05158
179935
carboxypeptidase N mRNA, 3′ end
1
AAAAGGATGTGACAGAAGCAGAGAT

/cds = (0, 1810)

GACCAGAAAGCACAGGGGCAGGGTT

4501
db mining
Hs.69771
K01566
187721
B-factor, properdin
1
GGGTTTTCTATAAGGGGTTTCCTGCT

GAACAGGGGCGTGGGATTGAATTA

4502
literature
Hs.278625
K02403
187768
complement component 4B (C4B),
1
CCTGGGACCAGGGCATATTAAAGGC

mRNA/cds = (51, 5285)

TTTTGGCAGCAAAGTGTCAGTGTTG

4503
db mining
Hs.132807
L29376
561725
(clone 3.8-1) MHC class I mRNA
1
TTTGTGGCTTGGGGCTGCCTACTATA

fragment/cds = UNKNOWN

AACTATTGGGGGTTCGTCCATTTT

4504
db mining
Hs.274509
M16768
339399
T-cell receptor aberrantly rearranged
1
TTTACACGCCCTGAAGCAGTCTTCTT

gamma-chain mRNA from cell line

TGCTAGTTGAATTATGTGGTGTGT

HPB-MLT/cds = UNKNOWN

4505
db mining
Hs.247956
M22005
188300
interleukin 2 gene, clone pATlaclL-
1
AATTCCTGAACCGTTGGATCACCTTC

2C/2TT, complete cds, clone pATlaclL-

TGTCAGTCCATCATCTCCACCCTG

2C/2TT/cds = (0, 404)

4506
db mining
Hs.247923
M31949
185254
Ig rearranged mu-chain V-region gene,
1
CTTACGTTGGGACACCTAAATTCGCC

subgroup VH-III, exon 1 and 2

GCGTCTGTAGAAGGCAGATTCGAG

4507
db mining
Hs.247930
M55420
185346
IgE chain, last 2 exons
1
AAAACCGTGTCTGTCCCTTCAACAGA

GTCATCGAGGAGGGGTGGCTGCTA

4508
literature
NA
M73276
177970
Human angiolensin I-converting
1
AAACTGCCGGGTCCCCATCTTCAAAA

enzyme (ACE) gene, 5′ flank

GAGAGGAGGCCCTTTCTCCAGCTT

4509
Table 3A
Hs.154365
M82882
180551
cis-acting sequence/cds = UNKNOWN
1
CAAGAAAGCAACTTGAGCCTTGGGCT

AATCTGGCTGAGTAGTCAGTTATA

4510
Table 3A
Hs.171699
N31778
1152177
yx70d02.r1 cDNA, 5′ end
1
TGTGTTCTTTGAGTTCCCCCTTTACC

/clone = IMAGE:267075/clone_end = 5′

CAAAAGTAATTTGGGGACCAAAGT

4511
db mining
Hs.206035
N39815
1163360
yx93c06.r1 cDNA, 5′ end
1
GGGAAGGCAATCTGATGGGGAAGTT

/clone = IMAGE:269290/clone_end = 5′

GGCAATTTCTGGTTTGGGTGATTTA

4512
db mining
Hs.169401
NM_000041
4557324
apolipoprotein E (APOE), mRNA
1
CCAGCCGTCCTCCTGGGGTGGACCC

/cds = (60, 1013)

TAGTTTAATAAGATTCACCAAGTT

4513
literature
Hs.38069
NM_000066
4557390
complement component 8, beta
1
CATGCAAGGGCAAAAGGCAGTGCCA

polypeptide (C8B), mRNA

TGCAAGCTGTTTAAATAAAGATGT

/cds = (27, 1802)

4514
literature
Hs.317585
NM_000088
14719828
cDNA:FLJ21026 fis, clone CAE06812
1
AGGGGTGGGAGGAAGCAAAAGACTC

/cds = (27, 677)

TGTACCTATTTTGTATGTGTATAAT

4515
db mining
Hs.1472
NM_000173
4504070
glycoprotein Ib (platelet), alpha
1
TCAGGATGTGAGCACTCGTTGTGTCT

polypeptide (GP1BA), mRNA

GGATGTTACAATATGGGTGGTTT

/cds = (42, 1922)

4516
literature
Hs.180532
NM_000175
4504086

Homo sapiens, clone IMAGE:4098234,
1
TGTTCACGTTGTTCACATCCCATGTA

mRNA, partial cds/cds = (0, 904)

GAAAAACAAAGATGCCACGGAGGA

4517
db mining
Hs.290070
NM_000177
4504164
gelsolin (amyloidosis, Finnish type)
1
AGCCCTGCAAAAATTCAGAGTCCTTG

(GSN), mRNA/cds = (14, 2362)

CAAAATTGTCTAAAATGTCAGTGT

4518
literature
Hs.227730
NM_000210
1111111
integrin, alpha 8 (ITGA6), mRNA
1
TGTCATCTCAAGTCAAGTCACTGGTC

/cds = (146, 3387)

TGTTTGCATTTGATACATTTTTGT

4519
db mining
Hs.90598
NM_000247
4557750
MHC class I polypeptide-related
1
GAGTGACCACAGGGATGGCACACAG

sequence A (MICA), mRNA

CTCGGATTTCAGCCTCTGATGTCAG

/cds = (39, 1190)

4520
db mining
Hs.1817
NM_000250
4557758
myeloperoxidase (MPO), nuclear gene
1
GCCTGTTGCCCTTTCTGTACCATTTA

encoding mitochondrial protein, mRNA

TTTGCTCCCAATGTTTATGATAAT

/cds = (177, 414)

4521
db mining
Hs.1817
NM_000200
4567758
myeloperoxidase (MPO), nuclear gene
1
GCCTGTTGCCCTTTCTGTACCATTTA

encoding mitochondrial protein, mRNA

TTTGCTCCCAATGTTTATGATAAT

/cds = (177, 2414)

4522
db mining
Hs.75093
NM_000302
4557836
procollagen-lysine, 2-oxoglutarate 5-
1
TCCTGGATGCCTCTGAAGAGAGGGA

dioxygenase (lysine hydroxylase,

CAGACCGTCAGAAACTGGAGAGTTT

Ehlers-Danios syndrome type VI)

(PLOD), mRNA/cds = (200, 2383)

4523
db mining
Hs.10712
NM_000314
4506248
phosphatase and tensin homolog
1
ACTTAACCATATAAATGTGGAGGCTA

(mutated in multiple advanced cancers

TCAACAAGAATGGGCCTGAAACA

1) (PTEN), mRNA/cds = (1034, 2245)

4524
Table 3A
Hs.83848
NM_000365
4507844
triosephosphate isomerase 1 (TPI1),
1
GTGCCTCTGTGCTGTGTATGTGAACC

mRNA/cds = (34, 783)

ACCCATGTGAGGGAATAAACCTAG

4525
Table 3A
Hs.78943
NM_000388
455366
bleomycin hydrolase (BLMH), mRNA
1
AAACAGACCTAATGCTCCTTGTTCCT

/cds = (78, 1445)

AGAGTAGAGTGGAGGGAGGGTGGC

4526
literature
Hs.285401
NM_000395
4559497
colony stimulating factor 2 receptor,
1
GAGATAGCCTTGCTCCGGCCCCCTT

beta, low-affinity (granulocyte-

GACCTTCAGCAAATCACTTCTCTCC

macrophage) (CSF2RB), mRNA

/cds = (26, 2721)

4527
db mining
Hs.283743
NM_000407
9945387
glycoprotein ib beta mRNA, complete
1
CTGCTGCGTCTCCCTTCCAAACTCTG

cds/cds = (636, 1871)

GTGCTGAATAAACCCTTCTGATCT

4528
db mining
Hs.20019
NM_000410
4504376
hemochromatosis (HFE), mRNA
1
CACTTGGCTGCATAAATGTGGTACAA

/cds = (221, 1267)

CCATTCTGTCTTGAAGGGCAGGTG

4529
literature
Hs.8966
NM_000491
11038661
complement component 1, q
1
CAGCCAATGGACACAGTAGGGCTTG

subcomponent, beta polypeptide

GTGAATGCTGCTGAGTGAATGAGTA

(C1QB), mRNA/cds = (63, 824)

4530
db mining
Hs.278430
NM_000500
14550408
cytochrome P450, subfamily XXIA
1
TGCAGAGGATTGAGGCTTAATTCTGA

(steroid 21-hydroxylase, congenital

GCTGGCCCTTTCCAGCCAATAAAT

adrenal hyperplasia), polypetide 2

(CYP21A2), mRNA/cds = (118, 1605)

4531
db mining
Hs.502
NM_000544
9961245
transporter 2, ATP-binding cassette,
1
TTGACCTTCCACTAGACCATGAGCAC

sub-family B (MDR/TAP) (TAP2),

CTGGGCGGAAAGCCATATATCTTA

transcript variant 1, mRNA

/cds = (96, 2207)

4532
literature
Hs.93210
NM_000562
4557388
complement component 8, alpha
1
ACAAGCAGACACCTGAAACAATCAAC

polypeptide (C8A), mRNA

GCCCAATAAAACAAAGTAGGATGA

/cds = (137, 1891)

4533
db mining
Hs.68876
NM_000564
10835130
interleukin 5 receptor, alpha (IL5RA),
1
TGAGGAAGAAAGCATTTTGCATCAGC

mRNA/cds = (249, 1511)

CTGGAGTGAACCATGAACTTGGAT

4534
literature
Hs.241053
NM_000573
10834973
AL572804 cDNA
1
GGAATAAGGTGTTGCCTGGAATTTCT

/clone = CSODI034YD15-(3-prime)

GGTTTGTAAGGTGGTCACTGTTCT

4535
Table 3A
Hs.89679
NM_000586
10835148
interleukin 2 (IL2), mRNA
1
TGAACAGATGGATTACCTTTTGTCAA

/cds = (47, 517)

AGCATCATCTCAACACTAACTTGA

4536
literature
Hs.78065
NM_000587
4557386
complement component 7 (C7),
1
CCCAGAGTTTTCAGGGAGTACACAG

mRNA/cds = (0, 2531)

GTAGATTAGTTTGAAGCATTGACCT

4537
literature
Hs.960
NM_000590
10834979
interleukin 9 (IL9), mRNA
1
TTCCAGAAAGAAAAGATGAGAGGGAT

/cds = (11, 445)

GAGAGGCAAGATATGAAGATGAAA

4538
literature
Hs.1285
NM_000606
4557392
complement component 8, gamma
1
GGCTGCCCCAGAGGACAGTGGGTGG

polypeptide (C8G), mRNA

AGTGGTACCTACTTATTAAATGTCT

/cds = (61, 669)

4539
literature
Hs.167988
NM_0006151
0834989
neural cell adhesion molecule 1
1
CCGAGCAAAGATCAAAATAAAAAGTG

(NCAM1), mRNA/cds = (201, 2747)

ACACAGCAGCTTCACCAGAGCATT

4540
Table 3A
Hs.17483
NM_000816
10835166
chromosome 12p13 sequence
1
TTTCCTTCAAGCCTAGCCCTTCTCTC

/cds = (194, 1570)

ATTATTTCTCTCTGACCCTCTCCC

4541
db mining
Hs.100007
NM_000635
10835184
regulatory factor X, 2 (influences HLA
1
GGGTCAGTGTTCAAGAAGGAAAGCA

class II expression) (RFX2), mRNA

GTTGTTGAAGCTACAGAAGCCCAGG

/cds = (159, 2330)

4542
db mining
Hs.25954
NM_000640
10834991
interleukin 13 receptor, alpha 2
1
TGAAGACTTTCGATATCAAGAGACAT

(IL13RA2), mRNA/cds = (93, 1235)

GGTATTGACTCAACAGTTTCCAGT

4543
db mining
Hs.1721
NM_000641
10834993
interleukin 11 (IL11), mRNA
1
GGACTGTCATTCAGGGAGGCTAAGG

/cds = (63, 662)

AGAGAGGCTTGCTTGGGATATAGAA

4544
db mining
Hs.78712
NM_000688
4502024
aminolevulinate, delta-, synthase 1
1
TCACTTAACCCCAGGCCATTATCATA

(ALAS1), nuclear gene encoding

TCCAGATGGTCTTCAGAGTTGTCT

mitochondrial protein, mRNA

/cds = (76, 1998)

4545
db mining
Hs.3003
NM_000733
4502670
CD3E antigen, epsilon polypeptide
1
CCACTGGATGGTCATTTGGCATCTCC

(TiT3 complex) (CD3E), mRNA

GTATATGTGCTCTGGCTCCTCAGC

/cds = (54, 677)

4546
Table 3A
Hs.1349
NM_000758
4503076
colony stimulating factor 2 (granulocyte
1
CTGGGCCACACTGACCCTGATACAG

macrophage) (CSF2), mRNA

GCATGGCAGAAGAATGGGAATATTT

/cds = (8, 442)

4547
db mining
Hs.1349
NM_000758
4503078
colony stimulating factor 2 (granulocyte
1
CTGGGCCACACTGACCCTGATACAG

macrophage) (CSF2), mRNA

GCATGGCAGAAGAATGGGAATATTT

/cds = (8, 442)

4548
literature
Hs.86958
NM_000874
4504600
interleukin receptor ifnar2-1 (splice
1
TGATAGCATTGGTCTTGACAAGCACC

variant IFNAR2-1) mRNA, complete

ATAGTGACACTGAAATGGATTGGT

cds/cds = (326, 1321)

4549
literature
Hs.86474
NM_000962
11386140
prostaglandin-endoperoxide synthase
1
CTGAGGATGTAGAGAGAACAGGTGG

1 (prostaglandin G/H synthase and

GCTGTATTCACGCCATTGGTTGGAA

cyclooxygenase) (PTGS1), mRNA

/cds = (5, 1804)

4550
Table 3A
Hs.180450
NM_001026
14918502
ribosomal protein S24 (RPS24),
1
CTGGCAAAAAGCCGAAGGAGTAAAG

transcript variant 1, mRNA

GTGCTGCAATGATGTTAGCTGTGGC

/cds = (37, 429)

4551
Table 3A
Hs.113029
NM_001028
14591916
ribosomal protein S25 (RPS25),
1
TGGTCCAAAGGCAAAGTTCGGGACA

mRNA/cds = (63, 440)

AGCTCAATAACTTAGTCTTGTTTGA

4552
literature
Hs.161305
NM_001057
4507344
tachykinin receptor 2 (TACR2), mRNA
1
CAACAGGTGTCACACTAAGGAGACTT

/cds = (0, 1196)

TGTTCATGGCTGGGGACACAGCCC

4553
literature
Hs.1080
NM_001058
7669544
tachykinin receptor 1 (TACR1),
1
GCATGGAAATTCCCTTCATCTGGAAC

transcript variant long, mRNA

CATCAGAAACACCCTCACACTGGG

/cds = (210, 1433)

4554
literature
Hs.942
NM_001059
7669547
tachykinin receptor 3 (TACR3), mRNA
1
GGCAGCTATGGTCAAATTGAGAAAGG

/cds = (143, 1540).

TAGTGTATAAATGTGACAAAGACA

4555
db mining
Hs.86947
NM_001109
4557252
a disintegrin and metalloproteinase
1
GCTATCTTGTCTGGTTTTCTTGAGAC

domain 8 (ADAMB), mRNA

CTCAGATGTGTGTTCAGCAGGGCT

/cds = (9, 2483)

4556
literature
Hs.1239
NM_001150
4502094
alanyl (membrane) aminopeptidase
1
CCGCCCTGTACCCTCTTTCACCTTTC

(aminopeptidase N, aminopeptidase M,

CCTAAAGACCCTAAATCTGAGGAA

microsomal aminopeptidase, CD13,

p150) (ANPEP), mRNA

/cds = (120, 3023)

4557
db mining
Hs.507
NM_001264
4502758
corneodesmosin (CDSN), mRNA
1
CATATGGGAGAAGGCCAGTGCCCAG

/cds = (14, 1603)

GCATAGGGTTAGCTCAGTTTCCCTC

4558
Table 3A
Hs.74441
NM_001273
4557452
chromodomain helicase DNA binding
1
TTAATACCAGGAACCCAGCGGCTCTA

protein 4 (CHD4), mRNA

GCCACTGAGCGGCTAAATGAAATA

/cds = (89, 5827)

4559
db mining
Hs.5057
NM_001304
8051580
carboxypeptidase D (CPD), mRNA
1
GTGGAGGGGTTTACCACCTTCCTAG

/cds = (15, 4148)

GTCGTTCAACCAGGTTTTGTGAGGA

4560
db mining
Hs.2246
NM_001308
4503010
carboxypeptidase N, polypeptide 1,
1
GCAACCCTTCAGAAAGGCTTTGCTCC

50 kD (CPN1), mRNA/cds = (213, 1589)

TGCTCTCAGATCAGATCAAGCATT

4561
db mining
Hs.336918
NM_001356
4503258
death-associated protein 6 (DAXX),
1
AACATTTGGAGGAAGGTGGGAAGCA

mRNA/cds = (147, 2369)

GATGACTGAGGAAGGGATGGACTAA

4562
Table 3A
Hs.268036
NM_001402
4503470
tRNA isopentenylpyrophosphate
1
TGCCCAGAAAGCTCAGAAGGCTAAT

transferase (IPT), mRNA

GAATAzttATCCCTAATACCTGCCA

/cds = (60, 1040)

4563
Table 3A
Hs.129673
NM_001416
4503528
eukaryotic translation initiation factor
1
AGAGGACTCTTCGAGACATTGAGACC

4A, isoform 1 (EIF4A1), mRNA

TTCTACAACACCTCCATTGAGGAA

/cds = (16, 1236)

4664
Table 3A
Hs.99855
NM_001462
4503780
formyl peptide receptor-like 1 (FPRL1),
1
TGGGGTAAGTGGAGTTGGGAAATAC

mRNA/cds = (772, 1827)

AAGAAGAGAAAGACCAGTGGGGATT

4565
literature
Hs.198252
NM_001504
4504098
G protein-coupled receptor 9 (GPR9),
1
AACTAAAACTTCATCTTCCCCAAGT

mRNA/cds = (68, 1174)

GCGGGGAGTACAAGGCATGGCGTA

4566
db mining
Hs.113207
NM_001505
4504090
G protein-coupled receptor 30
1
AAAACCTTCCCATAAAATGTAAGAAA

(GPR30), mRNA/cds = (691, 1818)

AGCTGATGAGGCTGGTGACGTTCA

4567
db mining
Hs.278589
NM_001518
14670355
general transcription factor II, i
1
TGACATGGTAGCAGAAATAGGCCCTT

(GTF2I), transcript variant 1, mRNA

TTATGTGTTGCTTCTATTTTACCT

/cds = (370, 3368)

4568
db mining
Hs.101840
NM_001531
4504416
major histocompatibility complex, class
1
GCCACAAAATGTTCTTTGTTCTTTGG

I-like sequence (HLALS), mRNA

CTCCAAAAAGACTGTCAGCTTTCA

/cds = (5, 1030)

4569
db mining
Hs.81234
NM_001542
4504626
mRNA for KIAA0466 protein, partial
1
CTGAGGCTCTCCCTTTCTCTGTGATT

cds/cds = (40, 3684)

GGACAGTTGACAGCACCCAAACTC

4570
db mining
Hs.22111
NM_001555
4504624
mRNA for KIAA0364 gene, complete
1
CCCTGTAACTCCTCACTGTACTGATT

cds/cds = (1144, 5127)

TACTGGCGCATGAAATTCTATTAA

4571
Table 3A
Hs285115
NM_001560
4504648
interleukin 13 receptor, alpha 1
1
CTTGAGTAAAATAAATATTGTCTTTTT

(IL13RA1), mRNA/cds = (43, 1326)

GTATGTCAAGCGGGCCGCCACCG

4572
literature
Hs.1211
NM_001811
6138970
acid phosphatase 5, tartrate resistant
1
GGGAGGGAGGGAGGGAAAGCTTCCT

(ACP5), mRNA/cds = (89, 1086)

CCTAAATCAAGCATCTTTCTGTTAC

4573
literature
Hs.10247
NM_001627
4502028
mRNA for MEMD protein
1
TCACAGATGCATATAGACACACATAC

/cds = (0, 1748)

ATAATGGTACTCCCAACTGACAA

4574
db mining
Hs.268571
NM_001645
5174774
intergenic region between apoE and
1
GCTGAGGACTCCCGCCATGTGGCCC

apoCI gene/cds = UNKNOWN

CAGGTGCCACCAATAAAAATCCTAC

4575
db mining
Hs.69771
NM_001710
14550403
B-factor, properdin (BF), mRNA
1
CAAGATGAGGATTTGGGTTTTCTATA

/cds = (129, 2423)

AGGGGTTTCCTGCTGGACAGGGGC

4576
literature
Hs.1281
NM_001735
4502506
complement component 5 (C5),
1
AAACATGGCCTTTGCTTGAAAGAAAA

mRNA/cds = (12, 5042)

TACCAAGGAACAGGAAACTGATCA

4577
literature
Hs.11763
NM_001771
4502650
CD22 antigen (CD22), mRNA
1
GTTTGAGATGGACACACTGGTGTGGA

/cds = (56, 2599)

TTAACCTGCCAGGGAGACAGAGCT

4578
literature
Hs.83731
NM_001772
4502654
CD33 antigen (gp67) (CD33), mRNA
1
GGACCAAAGGCTGATTCTTGGAGATT

/cds = (12, 1106)

TAACTCCCCACAGGCAATGGGTTT

4579
Table 3A
Hs.340325
NM_001774
4502682
yf59e04.s1 cDNA, 3′ end
1
AATATTTGTTTAATCCCCAGTTCGCCT

/clone = IMAGE:26202/clone_end = 3′

GGAGCCCTCCGCCTTCACATTCC

4580
literature
Hs.82685
NM_001777
4502672
CD47 antigen (Rh-related antigen,
1
AAAGTAACTGGTTGTCACCTATGAGA

integrin-associated signal transducer)

CCCTTACGTGATTGTTAGTTAAGT

(CD47), mRNA/cds = (106, 1077)

4581
literature
Hs.264190
NM_001780
4502678
cDNA:FLJ22121 fis, clone HEP18876,
1
CTCAGCCTCCTCATCTGGGGGAGTG

highly similar to AF191298 vacuolar

GAATAGTATCCTCCAGGTTTTTCAA

sorting protein 35 (VPS35) mRNA

/cds = UNKNOWN

4582
literature
Hs.3107
NM_001784
4502690
CD97 antigen (CD97), mRNA
1
GGCAGGAGGTTCTCACTGTTGTGAA

/cds = (70, 2298)

GGTTGTAGACGTTGTGTAATGTGTT

4583
Table 3A
Hs.10029
NM_001814
4503140
cathepsin C (CTSC), mRNA
1
AAGTGGGAATTTTCTGGAAGATGGTC

/cds = (33, 1424)

AGCTATGAAGTAATAGAGTTTGCT

4584
db mining
Hs.11
NM_01815
4502792
carcinoembryonic antigen-related cell
1
GCCTGTGGCCCACCTGGGGTCACTT

adhesion molecule 3 (CEACAM3),

GGAAAGGATCTGAATAAAGGGGACC

mRNA/cds = (54, 692)

4585
db mining
Hs.119140
NM_001970
4503544
eukaryotic translation initiation factor
1
AAATAACTGGCTCCCAGGGTGGCGG

5A (EIF5A), mRNA/cds = (43, 507)

TGGTGGCAGCAGTGATCCTCTGAAC

4586
db mining
Hs.99863
NM_001972
4503548
elastase 2, neutrophil (ELA2), mRNA
1
TGCCCACACCCACACTCTCCAGCATC

/cds = (38, 841)

TGGCACAATAAACATTCTCTGTTT

4587
db mining
Hs.99863
NM_001972
4503548
elastase 2, neutrophil (ELA2), mRNA
1
TGCCCACACCCACACTCTCCAGCATC

/cds = (38, 841)

TGGCACAATAAACATTCTCTGTTT

4588
literature
Hs.193122
NM_002000
4503672
Fc fragment of IgA, receptor for
1
GCACCCACCTTTCTGCACATAAGTTA

(FCAR), mRNA/cds = (39, 902)

TGGTTTTCCATCTTATCTGTCTTC

4589
db mining
Hs.8917
NM_002001
4503674
Fc fragment of IgE, high affinity I,
1
AATTGTCAAACACAGCTTGCAATATA

receptor for, alpha polypeptide

CATAGAAACGTCTGTGCTCAAGGA

(FCER1A), mRNA/cds = (106, 879)

4590
db mining
Hs.77252
NM_002012
4503718
fragile histidine triad gene (FHIT),
1
TCCAGAAACATGACAAGGAGGACTTT

mRNA/cds = (362, 805)

CCTGCCTCTTGGAGATCAGAGGAG

4591
db mining
Hs.108694
NM_002099
8051602
glycophorin A (includes MN blood
1
TCATAGTTAAATTTGGTATTCGTGGG

group) (GYPA), mRNA/cds = (55, 507)

GGAAGAAATGACCATTTCCCTTGT

4592
literature
Hs.342658
NM_002119
4504400
major histocompatibility complex, class
1
ACACACATTCTTGCTCTACCCAAAGC

II, DN alpha (HLA-DNA), mRNA

TCTGCCTGGCAGCACTAAATGCTT

/cds = (76, 828)

4593
literature
Hs.342658
NM_002119
4504400
major histocompatibility complex, class
1
ACACACATTCTTGCTCTACCCAAAGC

II, DN beta (HLA-DNA), mRNA

TCTGGCTGGCAGCACTAAATGCTT

/cds = (76, 828)

4594
db mining
Hs.1802
NM_002120
4504402
major histocompatibility complex, class
1
GCAGTCTCCACAGTCTTCAGAAGACA

II, DO beta (HLA-DOB), mRNA

AATGCTCAGGTAGTCACTGTTTCC

/cds = (56, 877)

4595
db mining
Hs.279930
NM_002124
4504410
major histocompatibility complex, class
1
GCCTCCCGTGCATCTGTACTCACCCT

II, DR beta 3 (HLA-DRB3), mRNA

GTACGACAAACACATTACATTATT

/cds = (35, 835)

4596
db mining
Hs.73885
NM_002127
4504414
HLA-G histocompatibility antigen,
1
TTTCCTGTTCCAGAAAAGGGGCTGGG

class I, G (HLA-G), mRNA

ATGTCTCCGTCTCTGTCTCAATT

/cds = (5, 1021)

4597
db mining
Hs.1521
NM_002180
4504622
immunoglobulin mu binding protein 2
1
CGGCCTTCTCCGGTGTCCTGTACCAA

(IGHMBP2), mRNA/cds = (49, 3030)

CTCTTCTATTTAAGAGAACCTCAG

4598
db mining
Hs.173880
NM_002182
4504660
interleukin 1 receptor accessory
1
GGGACGTTCCATGCCCAGGTTAACAA

protein (IL1RAP), mRNA

AGAACTGTGATATATAGAGTGTCT

/cds = (206, 1918)

4599
literature
Hs.172689
NM_002183
13324709
interleukin 3 receptor, alpha (low
1
ATGGGAGATGCCTGTGTAATTTCGTC

affinity) (IL3RA), mRNA

CGAAGCTGCCAGGAAGAAGAACAG

/cds = (146, 1282)

4600
literature
Hs.12503
NM_002189
4504648
interleukin 15 receptor, alpha
1
CCTCTCCATTGAAGGATTCAGGAAGA

(IL15RA), mRNA/cds = (82, 885)

AGAAAACTCAACTCAGTGCCATTT

4601
literature
Hs.149609
NM_002205
4504750
integrin, alpha 5 (fibronectin receptor,
1
CCTCACCTTGGCACCAGACACCCAG

alpha polypeptide) (ITGA5), mRNA

GACTTATTTAAACTCTGTTGCAAGT

/cds = (23, 3172)

4602
Table 3A
Hs.149846
NM_002213
4504772
integrin, beta 5 (ITGB5), mRNA
1
TGCAATGTGAGTTTCCTCTCCTGTC

/cds = (29, 2419)

CGTGTTTGTTTAGTACTTTTATAA

4603
db mining
Hs.78465
NM_002228
7710122
v-jun avian sarcoma virus 17
1
AGCAGGAATTGGTGGCAGATTTTACA

oncogene homolog (JUN), mRNA

AAGATGTATCCTTCCAATTTGGA

/cds = (974, 1969)

4604
db mining
Hs.169824
NM_002258
4504878
killer cell lactin-like receptor subfamily
1
TGGATCTGCCAAAAAGAACTAACACC

B, member 1 (KLRB1), mRNA

TGTGAGAAATAAAGTGTATCCTGA

/cds = (60, 737)

4605
db mining
Hs.172195
NM_002408
6031183
mannosyl (alpha-1,6-)-glycoprotein,
1
TTCCTGTACTATTGTGTTTTGAGTGTG

beta-1,2-N-

TTTTGGAACCTTCATAGAACACA

acetylglucosaminyltransferase

(MGAT2), mRNA/cds = (489, 1832)

4606
literature
Hs.77367
NM_002416
4505186
monokine induced by gamma
1
TGACCCACTTACCTTGCATCTCACAG

interferon (MIG), mRNA/cds = (39, 416)

GTAGACAGTATATAACTAACAACC

4607
Table 3A
Hs.926
NM_002463
11342663
myxovirus (influenza) resistance 2,
1
TTTCCCTGATTATGATGAGCTTCCATT

homolog of murine (MX2), mRNA

GTTCTGTTAAGTCTTGAAGAGGA

/cds = (104, 2251)

4608
db mining
Hs.173084
NM_002470
11342671
myosin, heavy polypeptide 3, skeletal
1
CACGAGAGTGAAGAGTGAGCCAGCC

muscle, embryonic (MYH3), mRNA

CTTCTGGAGCAGGAGCAGGACAGAA

/cds = (84, 5906)

4609
db mining
Hs.113973
NM_002472
4505300
myosin, heavy polypeptide 6, skeletal
1
AAGAAAGGCACAAAATGTGCTATTTT

muscle, perinatal (MYH8), mRNA

TGGTCACTTGCTTTATGACGTTTA

/cds = (73, 5886)

4610
db mining
Hs.275163
NM_002512
4505408
non-metastatic cells 2, protein
1
GTCCCTGGACACAGCTCTTCATTCCA

(NM23B) expressed in (NME2), nuclear

TTGACTTAGAGGCAACAGGATTGA

gene encoding mitochondrial protein,

mRNA/cds = (72, 530)

4611
Table 3A
Hs.85844
NM_002529
4585711
neurotrophic tyrosine kinase, receptor,
1
GTACCAGCTCTCCAACACGGAGGCA

type 1 (NTRK1), mRNA/cds = (0, 2390)

ATCGACTGCATCACGCAGGGACGTG

4612
db mining
Hs.93728
NM_002586
4505624
pre-B-cell leukemia transcription factor
1
GGGGGCTAGTTCTCTCCTCACTTGTA

2 (PBX2), mRNA/cds = (0, 1292)

AACTTGTGTAGTTTCACAGAAAAA

4613
db mining
Hs.41639
NM_002598
4505854
programmed cell death 2 (PDCD2),
1
ACAGAAGAATTTGTGTGGAAGCAGGA

mRNA/cds = (29, 1063)

TGTAACAGATACACCGTAAGGCA

4614
Table 3A
Hs.181013
NM_002629
4505152
phosphglycerate mutase 1 (brain)
1
CCCTGCCACATGGGTCCAGTGTTCAT

(PGAM1), mRNA/cds = (31, 795)

CTGAGCATAACTGTACTAAATCCT

4615
db mining
Hs.288579
NM_002644
11342673
polymeric immunoglobulin receptor
1
CTTGAAGGAAGAGGGACCAGGGTGG

(PIGR), mRMA/cds = (156, 2450)

GAGAGCTGATTGCAGAAAGGAGAGA

4616
db mining
Hs.261285
NM_002669
4505894
pleiotropic regulator 1 (PRL1,
1
AAACCATTAAAGTATACAGAGAGGAT

Arabidopsis homolog) (PLRG1), mRNA

GACACAGCCACAGAAGAAACTCAT

/cds = (0, 1544)

4617
Table 3A
Hs.79402
NM_002694
14702172
polymerase (RNA) II (DNA directed)
1
AACATGCACAAAGCAGTTAATTAGGC

peptide C (33 kD) (POLR2C),

AGCCTGGAGAAAACCAGAGATCCA

transcript variant gamma, mRNA

/cds = (57, 884)

4618
Table 3A
Hs.77202
NM_002738
4506068
protein kinase C. beta 1 (PRKCB1,
1
ACTTCCAGAAACTCATCAAATGAACA

mRNA/cds = (138, 2151)

GACAATGTCAAAACTACTGTGTCT

4619
literature
Hs.180533
NM_002758
4506098
mitogen-activated protein kinase
1
GCTTTATGGGTTTGGCTTGTTTTTCTT

kinase 3 (MAP2K3), mRNA

GCATGGTTTGGAGCTGATCGCTT

/cds = (337, 1293)

4620
literature
Hs.111825
NM_002758
14589899
mitogen-activated protein kinase
1
TTCTTTCTTGGCCTCAAGTTCAATATG

kinase 6 (MAP2KB), transcript variant

GAGAGGATTGCTTCCCTGAATCC

1, mRNA/cds (340, 1344)

4621
db mining
Hs.241561
NM_002770
4506146
protease, serine, 2 (trysin 2)
1
AACTATGTGGACTGGATTAAGGACAC

(PRSS2), mRNA/cds = (6, 749)

CATAGCTGCCAACAGCTAAAGCCC

4622
db mining
Hs.928
NM_002777
7382457
proteinase 3 (serine proteinase,
1
CCTGACTTCTTCACGCGGGTAGCCCT

neutrophil, Weganer granulomatosis

CTACGTGGACTGGATCCGTTCTAC

autoantigen) (PRTN3), mRNA

/cds = (48, 818)

4623
db mining
Hs.78575
NM_002778
11386146
prosaposin (variant Gaucher disease
1
AGCCAGCAGGACATGAAGTTGCTATT

and variant metachromatic

AAATGGACTTCGTGATTTTTGTTT

leukodystrophy) (PSAP), mRNA

/cds = (38, 1612)

4624
db mining
Hs.250655
NM_002823
4506276
prothymosin, alpha (gene sequence
1
TTTGGCCTGTTTTGATGTATGTGTGA

28) (PTMA), mRNA/cds = (155, 487)

AACAATGTTGTCCAACAATAAACA

4625
db mining
Hs.82547
NM_002888
4506424
retinoic acid receptor responder
1
AACTTGTGCCACAAGAGTTACAATCA

(tazarotene induced) 1 (RARRES1),

AAGTGGTCTCCTTAGACTGAATTC

mRNA/cds = (36, 722)

4626
db mining
Hs.106061
NM_002904
14670267
RD RNA-binding protein (RDBP),
1
AAAGCCTTTAAAAACGGCTGTCAGGT

mRNA/cds = (108, 1250)

TTGATCTCAGTGTAACAACATGGC

4627
db mining
Hs.139228
NM_002914
4506488
replication factor C (activator 1) 2
1
GAAAATGCGCCTTAGGCTGAGCCAA

(40 kD) (RFC2), mRNA

CATGACTGTCCCCCAAACTCCAGTG

/cds = (207, 1271)

4628
db mining
Hs.123638
NM_002918
4506492
regulatory factor X, 1 (influences HLA
1
CCAGCTTCGGTTCCTTCCACCTCATC

class II expression) (RFX1), mRNA

CGGCTGCTCTACGACGAGTACATG

/cds = (93, 3032)

4629
db mining
Hs.166019
NM_002919
4506494
regulatory factor X, 3 (influences HLA
1
AAGATTGGTGCTCCTGATAAAGCAAA

class II expression) (RFX3), mRNA

GGGCTAGGAATACAATGGAAAGGA

/cds = (8, 2131)

4630
db mining
Hs.21273
NM_002920
15011897
transcription factor NYD-sp10 mRNA,
1
TCATTGGTACACATTCTGTATGCTGC

complete cds/cds = (109, 2034)

TGTTTTCAAGTTGGCAAATTAAGC

4631
literature
Hs.73839
NM_002935
4506550
ribonuclease, RNase A family, 3
1
TATCAGCAACTGTCCTCATCAGTCTC

(eosinophil cationic protein) (RNASE3),

CATACCCCTTCAGCTTTCCTGAGC

mRNA/cds = (63, 545)

4632
Table 3A
Hs.74267
NM_002948
4506602
60 S ribosomal protein L15 (EC45)
1
GCAGCTTGGAGAAGGCGCAATACTC

mRNA, complete cds/cds = (34, 648)

CAGCTCCACCGTTACCGCTAATATA

4633
Table 3A
Hs.74267
NM_0020948
4506602
60 S ribosomal protein L15 (EC45)
1
GCAGCTTGGAGAAGGCGCAATACTC

mRNA, complete cds/cds = (34, 648)

CAGCTCCACCGTTACCGCTAATATA

4634
db mining
Hs.74592
NM_002971
4506790
special AT-rich sequence binding
1
CGGAGCCTCAAACAAGCATTATACCT

protein 1 (binds to nuclear

TCTGTGATTATGATTTCCTCTCCT

matrix/scaffold-associating DNA's)

(SATB1), mRNA/cds = (214, 2505)

4635
Table 3A
Hs.89714
NM_002994
4506848
small inducible cytokine subfamily B
1
ATGTTTCTTGGGGAATATGTTAGAGA

(Cys-X-Cys), member 5 (epithelial-

ATTCCCTTACTCTTGATTGTGGGA

derived neutrophil-activating peptide

78) (SCYB5), mRNA/cds = (106, 450)

4636
db mining
Hs.82109
NM_002997
4506858
syndecan 1 (SDC1), mRNA
1
AGAGTGATAGTCTTTTGCTTTTGGCA

/cds = (205, 1137)

AAACTCTACTTAATCCAATGGGTT

4637
db mining
Hs.301698
NM_003033
4506950
BAC 180I23 chromosome 8 map
1
GCCTCTTGCTTGGCGTGATAACCCTG

8q24.3 beta-galactoside alpha 2,3-

TCATCTTCCCAAGCTCATTTATG

sialyltransferase (SIAT4A) gene,

complete sequence

/cds = (12296, 13318)

4638
db mining
Hs.78403
NM_003083
4507102
small nuclear RNA activating complex,
1
TTCAACTGACCAGTCGTGGTTACTCC

polypeptide 2, 45 kD (SNAPC2), mRNA

CTGCTGCCAGGTCCTTCCCCTTCC

/cds = (24, 1028)

4639
literature
Hs.80738
NM_003123
4507180
gene for sialophorin (CD43)
1
GGCTGGCACCTCTCAACGTCTGTGG

/cds = (159, 1361)

ACTGAATGAATAAACCCTCCTCATC

4640
db mining
Hs.81884
NM_003167
4507306
sulfotransferase family, cytosolic, 2A,
1
TGGGAATAACGTCCAAAACACTCTGG

dehydropiandrosterone (DHEA) -

ATCTTATATGGAGAATGACATTGA

preferring, member 1 (SULT2A1),

mRNA/cds = (52, 909)

4641
literature
Hs.7510
NM_003188
4507360
DNA sequence from clone RP1-
1
AGTACTGAACTCAGTTCCATCCGTAA

154G14 on chromosome 6q15-18.3,

AATATGTAAAGGTAAGTGGCAGCT

Contains the 3′ end of the MAP3K7

gene for mitogen-activated protein

kinase kinase kinase 7 (TGF-beta

activated kinase 1, TAK1), ESTs, STSs

and GSSs/cds = (0, 1700)

4642
db mining
Hs.250841
NM_003290
4507850
tropomyosin 4 (TPM4), mRNA
1
GCCCAACTTCATTTCCATACTTCAGG

/cds = (50, 796)

GAACAGCAAATTGAGGATTTACTT

4643
Table 3A
Hs.178551
NM_003316
10835036
ribosomal protein L8 (RPL8), mRNA
1
CCGTTGAATGAGTGTGTTTTGTACAT

/cds = (43, 816)

AACTTCAGATACTTGTGAACATGC

4644
Table 3A
Hs.4248
NM_003371
4507870
vav 2 oncogene (VAV2), mRNA
1
TTTCTTGGGAGAGTCACTCCAGCCCT

/cds = (5, 2641)

GAAGTCTGTCTCTAGCTCCTCTGT

4645
Table 3A
Hs.89414
NM_003467
4503174
chemokine (C-X-C motif), receptor 4
1
TCAGGAGTGGGTTGATTTCAGCACCT

(fusin) (CXCR4), mRNA

ACAGTGTACAGTCTTGTATTAAGT

/cds = (88, 1146)

4646
Table 3A
Hs.100293
NM_003605
6006036
O-linked N-acetylglucosamine
1
TTAGGAGTGATTACTAATTATCAAGG

(GlcNAc) transferase (UDP-N-

GCACAGTTGTGGTACTGTCATTGA

acetylglucosamine:polypeptide-N-

acetylglucosaminyl transferase) (OGT),

mRNA/cds = (2039, 4801)

4647
db mining
Hs.24640
NM_003612
4504236
serna domain, immunoglobulin domain
1
CGGACGGAAGGACGGAAAAAGCTCT

(Ig), and GP1 membrane anchor,

ATTTTTATGTTAGGCTTATTTCATG

(sernaphorin) 7A (SEMA7A, mRNA

/cds = (17, 2017)

4648
db mining
Hs.131814
NM_003747
4507612
TRF1-interacting ankyrin-related ADP-
1
AGTCCCTGACAGCCTAGAAATAAGCT

ribose polymerase mRNA, partial cds

GTTTGTCTTCTATAAAGCATTGCT

/cds = (0, 3264)

4649
db mining
Hs.321231
NM_003779
13929468
UDP-Gal:betaGlcNAc beta 1,4-
1
GCATTTTCTGCCTATGCTGGAATAGC

galactosyltransferase, polypeptide 3

TCCCTCTTCTGGTCCTGGCTCAGG

(84GALT3), mRNA/cds = (262, 1443)

4650
Table 3A
Hs.151481
NM_003797
14523051
embryonic ectoderm development
1
AGTAAGGGCACGTAGAGCATTTAGAG

(EED), mRNA/cds = (34, 1317)

TTGTCTTTCAGCATTCAATCAGGC

4651
Table 3A
Hs.103755
NM_003821
4506536
receptor-interacting serine-threonine
1
TGGGTCTTCAGCCTTACCCGGAAATA

kinase 2 (RIPK2), mRNA/cds = (0, 1622)

CTTGTGGTTTCTAGATCACCATCT

4652
db mining
Hs.184376
NM_003825
4507096

Homo sapiens, synaptosomai-
1
ACAAGGCTGACACCAACAGAGATCGT

associated protein, 23 kD, clone

ATTGATATTGCCAATGCCAGAGCA

MGC:5155 IMAGE:3481227, mRNA,

complete cds/cds = (73, 708)

4653
db mining
Hs.158315
NM_003853
4504656
interleukin 18 receptar accessory
1
AGCTACTTCTGCCTTATGGCTAGGGA

protein (IL18RAP), mRNA

ACTGTCATGTCTACCATGTATTGT

/cds = (463, 2282)

4654
db mining
Hs.102865
NM_003854
4504682
interleukin 1 receptor-like 2 (IL1RL2),
1
TGACTTGTTTTGCTCCATGTCTCCTC

mRNA/cds = (134, 1822)

ATTCCTACACCTATTTTCTGCTGC

4655
db mining
Hs.159301
NM_003855
4504654
interleukin 18 receptor 1 (IL18R1),
1
CTGTGAAACCGTCAGTTCGGAAGGCT

mRNA/cds = (24, 1649)

GGTTAGAACATGTGGGAGCAACAT

4656
db mining
Hs.35947
NM_003925
4505120
methyl-CpG binding domain protein 4
1
GCCTAGTGTGTGTGCTTTCTTAATGT

(MBD4), mRNA/cds = (176, 1918)

GTGTGCCAATGGTGGATCTTTGCT

4657
db mining
Hs.287832
NM_003953
4506356
myelin protein zero-like 1 (MPZL1),
1
ACCAAACTGGACTCTCGTGCAGAAAA

mRNA/cds = (132, 941)

TGTAGCCCATTACCACATGTAGCC

4658
Table 3A
Hs.108371
NM_003973
4506600
E2F transcription factor 4, p107/p130-
1
GCACCTGCTCCAAAGGCATCTGGCA

binding (E2F4), mRNA/cds = (62, 1303)

AGAAAGCATAAGTGGCAATCATAA

4659
Table 3A
Hs.155101
NM_004046
4757809
mRNA for KIAA1578 protein, partial
1
CTCCTGTGGATTCACATCAAATACCA

cds/cds = (0, 3608)

GTTCAGTTTTGTCATTGTTCTAGT

4660
Table 3A
Hs.238990
NM_004064
4757961

Homo sapiens, Similar to cyclin-
1
GCCAACAGAACAGAAGAAAATGTTTC

dependent kinase inhibitor 18 (p27,

AGACGGTTCCCCAATGCCGGTTC

Kip1), clone MGC:5304

IMAGE:3458141, mRNA, complete cds

/cds = (377, 973)

4661
Table 3A
Hs.239760
NM_004077
4758075

Homo sapiens, clone MGC:19593
1
CTCTAGAAAGGCCCAAGTCCATGAGC

IMAGE:3542491, mRNA, complete cds

ACAGAGGGTCTGATGAAGTTTGTG

/cds = (118, 1518)

4662
db mining
Hs.272537
NM_004088
4758185
deoxynucleotidyltransferase, terminal
1
AGACCAAGAGGATATTCCTCAAAGCA

(DNTT), mRNA/cds = (0, 1532)

GAAAGTGAAGAAGAAATTTTTGCG

4663
db mining
Hs.75450
NM_004089
4758197
mRNA for GILZ, complete cds
1
TGGAGAAGTTCCAGTCCTGTCTGAGC

/cds = (233, 637)

CCTGAAGAGCCAGCTCCCGAATCC

4664
db mining
Hs.32981
NM_004186
4759089
serna domain, immunoglobulin domain
1
GAAGTAGACTTTCTGTCCTCACACCG

(Ig), short basic domain, secreted,

AAGAACCCGAGTGAGCAGGAGGGA

(sernaphorin) 3F (SEMA3F), mRNA

/cds = (78, 2435)

4665
db mining
Hs.444
NM_004197
4759179
serine/threonine kinase 19 (STK19),
1
GTGGGATTTCTGGGGAGGCTGGTGA

transcript variant 2, mRNA

AGGAGGGCAGGGTTCTTTTCTCTAC

/cds = (128, 1234)

4666
db mining
Hs.74115
NM_004258
4758589
immunoglobulin superfamily, member
1
CTATAGCTTCATGACCGTAACATGTG

2 (IGSF2), mRNA/cds = (21, 3086)

ACCTGTGTGCTGGCAGGACGACTC

4667
db mining
Hs.25887
NM_004263
4759093
mRNA; cDNA DKFZp761O15121
1
ATGATCCCCATGTTGCAATATGGAGT

(from clone DKFZp761O15121);

CTCTGCCCTGAGATCTTCCCCATC

complete cds/cds = (111, 2423)

4668
Table 3A
Hs.184211
NM_004279
4758733
peptidase (mitochondrial processing)
1
TGGTCAGTCTTTGTTCTCTGAGAAAT

beta (PMPCB), mRNA/cds = (13, 1482)

TATGTTGGAAGCAGCATACTTTCA

4669
db mining
Hs.18142
NM_004313
4757779
arrestin, beta 2 (ARRB2), mRNA
1
CCCCAAGATACACACTGGACCCTCTC

/cds = (53, 1282)

TTGCTGAATGTGGGCATTAATTTT

4670
literature
Hs.54457
NM_044356
4757943
CD81 antigen (target of
1
TTCTAACACGTCGCCTTCAACTGTAA

antiproliferative antibody 1) (CD81),

TCACAACATCCTGACTCCGTCATT

mRNA/cds = (238, 948)

4671
db mining
Hs.42853
NM_004381
14577922
cAMP responsive element binding
1
TTTTTCATTTTGGAGCTAGTTACTGG

protein-like 1 (CREBL1), mRNA

GAGTAAGGGAGGGTGGGGTGGGGG

/cds = (33, 2144)

4672
db mining
Hs.318546
NM_004390
475895
cDNA:FLJ22499 fis, clone
1
GGGACTGTCTTTTCTGTATTCGCTGT

HRC11250, highly similar to HSCATHH

TCAATAAACATTGAGTGAGCACCT

mRNA for cathepsin H (EC 3.4.22.16)

/cds = UNKNOWN

4673
literature
Hs.318546
NM_004390
4758095
cDNA:FLJ22499 fis, clone
1
GGGACTGTCTTTTCTGTATTCGCTGT

HRC11250, highly similar to HSCATHH

TCAATAAACATTGAGTGAGCACCT

mRNA for cathepsin H (EC 3.4.22.16)

/cds = UNKNOWN

4674
Table 3A
Hs.124024
NM_004416
4758201
deltex (Drosophila) homolog 1 (DTX1),
1
AGAGAAGACTCATCTTCACTATCGGC

mRNA/cds = (503, 2365)

ACGTCCAACACCACGGGCGAGTCG

4675
Table 3A
Hs.74088
NM_004430
4758251
early growth response 3 (EGR3),
1
AAACCGAAATATTGAAATGGTGTAAT

mRNA/cds = (357, 1520)

GTTGTACCATTTGCACTGTGAGCA

4676
db mining
Hs.278611
NM_004482
9945386
UDP-N-acetyl-alpha-D-
1
AGGTGGGGGAAAATGAATTTTGTATG

galactosamine:polypeptide N-

CTGAATTTCTAAGCGCCTATTGTT

acetylgalactosaminyltransferase 3

(GalNAc-T3) (GALNT3), mRNA

/cds = (0, 1901)

4677
db mining
Hs.73734
NM_004488
4758459
glycoprotein V (platelet) (GP5), mRNA
1
GTGGATGTGGAGCAGGAGAGCTGGA

/cds = (270, 1952)

TCGTGGCATTTGTTTCTGGGTTCTG

4678
db mining
Hs.182447
NM_004500
14110430
heterogeneous nuclear
1
AAAGTTGATACTGTGGGATTTTTGTG

ribonucleoprotein C (C1/C2) (HNRPC),

AACAGCCTGATGTTTGGGACCTTT

transcript variant 1, mRNA

/cds = (191, 1102)

4679
db mining
Hs.111085
NM_004505
4758563
ubiquitin specific protease 6 (Tre-2
1
TGTGGTTGCCTCTATGTGCTGTTTTT

oncogene) (USP6), mRNA

CCTCATACAAGTAAACACAGAAAG

/cds = (1696, 4056)

4680
Table 3A
Hs.76038
NM_004508
4758583
isopentenyl-diphospate delta
1
CCCAACTGAGGACCACTGTCTACAGA

isomerase (IDI1), mRNA/cds = (50, 736)

GTCAGGAAATATTGTAGGGAGAAA

4681
db mining
Hs.296281
NM_004514
4758599
interleukin enhancer binding factor 1
1
TGTTTGTTTCTTTGTGTTGACTTTGTC

(ILF1), mRNA/cds = (197, 2164)

CCTGGCAAAATTTTCCACTCTGA

4682
db mining
Hs.172674
NM_004555
4758803
nuclear factor of activated T-cells,
1
AGGTGACCTGGTTACTTAGCTAGGAT

cytoplasmic, calcineurin-dependent 3

TGGTGATTTGTACTGCTTTATGGT

(NFATC3), mRNA/cds = (210, 3416)

4683
Table 3A
Hs.78920
NM_004581
4759015
Rab geranylgeranyltransferase, alpha
1
CCCTACCCTTGCCCTTTAACTTATTG

subunit (RABGGTA), mRNA

GGACTGAATAAAGAATGGAGAGGC

/cds = (274, 1977)

4684
db mining
Hs.90957
NM_004620
4759253
TNF receptor-associated factor 6
1
GGGCTTTTGCTCTGGTGTATTTTATT

(TRAF6), mRNA/cds = (221, 1789)

GTCAGAAAGTCCAGACTCAAGAGT

4685
db mining
Hs.25333
NM_0044833
4758597
interleukin 1 receptor, type II (IL1R2),
1
TGGTCTGACTGTGCTATGGCCTCATC

mRNA/cds = (61, 1257)

ATCAAGACTTTCAATCCTATCCCA

4686
db mining
Hs.82222
NM_004636
4759091
serna domain, immunoglobulin domain
1
GGGCGAGGCAGGCCGACTGTACTAA

(Ig), short basic domain, secreted,

AGTAACGCAATAAACGCATTATCAG

(sernaphorin) 3B (SEMA3B), mRNA

/cds = (235, 2484)

4687
db mining
Hs.332229
NM_004669
4758005
zh68e05.s1 cDNA, 3′ end
1
GTACGCCGCTACCTGGACAGCGCGA

/clone = IMAGE:417248/clone_end = 3′

TGCAGGAGAAAGAGTTCAAATACAC

4688
Table 3A
Hs.77324
NM_004730
4759033
eukaryotic translation termination
1
TGCAGAGAGATACTAAGCAGCAAAAT

factor 1 (ETF1), mRNA

CTTGGTGTTGTGATGTACAGAAAT

/cds = (135, 1446)

4689
Table 3A
Hs.326159
NM_004735
4758689
leucine rich repeat (in FLII) interacting
1
GGATAACAAGTAATGTCTGAAAGCA

protein 1 (LRRFIP1), mRNA

TGAGGGGCTTTATTTGCCTTTACC

/cds = (178, 2532)

4690
db mining
Hs.107526
NM_004776
13929470
UDP-Gal:betaGlcNAc beta 1,4-
1
TGAGCTTGCTCTTACGTTTTAAGAGG

galactosyltransferase, polypeptide 5

TGCCAGGGGTACATTTTTGCACTG

(B4GALT5), mRNA/cds = (112, 1278)

4691
Table 3A
Hs.49587
NM_004811
4758669
leupaxin (LPXN), mRNA
1
ACTGGACAACTTTGAGTACTGACATC

/cds = (93, 1253)

ATTGATAAATAAACTGGCTTGTGG

4692
db mining
Hs.24395
NM_004887
4757869
NJAC protein (NJAC) mRNA,
1
CGCAGGGTCTACGAAGAATAGGGTG

complete cds/cds = (7, 306)

AAAAACCTCAGAAGGGAAAACTCCA

4693
Table 3A
Hs.145696
NM_004902
4757925
splicing facfor (CC1.3) (CC1.3), mRNA
1
AGGTTTTGTCTGGTTGCATATAATCTT

/cds = (149, 1723)

TGCTCTTTTTAAGCTCTGTGAGC

4694
db mining
Hs.129738
NM_004977
4826787
potassium voltage-gated channel,
1
CCTTGCAGACCCCACCCCCTGCCTG

Shaw-related subfamily, member 3

CTCTCTTTCCCTACAACTAGGTCAG

(KCNC3), mRNA/cds = (295, 2568)

4695
db mining
Hs.279946
NM_004990
14043021
methionine-tRNA synthease (MARS),
1
GCCCCTAAAGGCAAGAAGAAAA

mRNA/cds = (23, 2725)

AGTAAAAGACCTTGGCTCATAGAA

AGTC

4696
db mining
Hs.927
NM_004997
4826841
myosin-binding protein H (MYBPH),
1
GGAGTTGCACTCTGGGTGGGAAGCA

mRNA/cds = (28, 1458)

CTCAATAAAGATGCGTGGTGTTAA

4697
Table 3A
Hs.180610
NM_005066
4826997
splicing factor proline/glutamine rich
1
AGCTTTTGAAAAGTGGAAAGGTCATT

(polyprimidine tract-binding protein-

TTGTTGCATTTCCCCATTTCTTGT

associated) (SFPQ), mRNA

/cds = (85, 2208)

4698
literature
Hs.100001
NM_005074
4827009
solute carrier family 17 (sodium
1
ACCTCCTTATTGAAGGGAAGAGGGAC

phosphate), member 1 (SLC17A1),

CAGCACATGAGGCTGAGGCTGAGG

mRNA/cds = (12, 1415)

4699
db mining
Hs.81737
NM_005155
6325470
inactive palmitoyl-protein thioesterase-
1
GGTATCTCCCACACAGCCTGGCACTC

2i (PPT2) mRNA, complete cds

CAACCGTACCCTTTATGAGACCTG

/cds = (568, 1473)

4700
db mining
Hs.179735
NM_005167
4885066
ras homolog gene family, member C
1
AAGGATGGTCACACACCAGCACTTTA

(ARHC), mRNA/cds = (76, 657)

TACACTTCTGGCTCACAGGAAAGT

4701
literature
Hs.113222
NM_005201
13929430
chemokine (C-C motif) receptor 8
1
ATCATCCTGCCAGCAGCACTCCTCCC

(CCR8), mRNA/cds = (120, 1187)

GTTCCTCCAGCGTAGACTACATTT

4702
db mining
Hs.181128
NM_005229
11496880
DNA sequence from PAC 212G6 on
1
AGTGCTACACTCGTCTCCACTGTTTG

chromosome Xp11.3-p11.4, Contains

TTTTACTTCCCCAAAATGGACCTT

synapsin 1, brain protein 4.1, properdin,

tyrosine kinase (ELK1) oncogene,

ESTs, STS, GSS/cds = (9150, 10436)

4703
Table 3A
Hs.248109
NM_005238
4885218
v-ets avian erythroblatosis virus E26
1
ACGCTACTATTACGACAAAAACATCA

oncogene homolog 1 (ETS1), mRNA

TCCACAAGACAGCGGGGAACGCT

/cds = (278, 1603)

4704
Table 3A
Hs.85146
NM_005239
4865220
chromosome 21 derived BAC
1
TTTGAGAGGGTAGGAGGGTGGGAAG

containing erythroblastosis virus

GAAACAACCATGTCATTTCAGAAGT

oncogene homolog 2 protein (ets-2)

gene, complete cds/cds = (290, 1699)

4705
db mining
Hs.129953
NM_005243
4885224
Ewing sarcoma breakpoint region 1
1
CATGCTCAGTATCATTGTGGAGAACC

(EWSR1), transcript variant EWS,

AAGAGGGCCTCTTAACTGTAACAA

mRNA/cds = (43, 2013)

4706
db mining
Hs.289098
NM_005265
4885270
kidney gamma-glutamyl
1
GACCGGCTTCCCCTGTGAGCAGCAG

transpeptidase type II mRNA, 3′ end

AGCAGCAGAATAAATGAGGCCACTG

/cds = (0, 598)

4707
Table 3A
Hs.181307
NM_005324
4885384
H3 histone, family 3A (H3F3A), mRNA
1
GAAGATACCCACCTGTGTGCCATCCA

/cds = (374, 784)

CGCTAAGAGAGTCACCATCATGCC

4708
Table 3A
Hs.79334
NM_005384
4885516
nuclear factor, interleukin 3 regulated
1
GTTATCACTCTGCCTGTGTATAGTCA

(NFIL3), mRNA/cds = (213, 1601)

GATAGTCCATGCGAAGGCTGTATA

4709
db mining
Hs.297939
NM_005385
6631099
cathepsin B (CTSB), mRNA
1
ACTGACAGAGTGAACTACAGAAATAG

/cds = (177, 1196)

CTTTTCTTCCTAAGGGGATTGTT

4710
db mining
Hs.78824
NM_005424
4885630
tyrosine kinase with immunoglobulin
1
TAAGCCAGCACTCACACCACTAACAT

and epidermal growth factor homology

GCCCTGTTCAGCTACTCCCACTCC

domains (TIE), mRNA/cds = (38, 3452)

4711
Table 3A
Hs.181195
NM_005494
4885494

Homo sapiens, MRJ gene for a
1
GGATGTTTTCTAGTTGTGCATGAATG

member of the DNAJ protein family,

CTGGCAACTTAGTAAGTTTTGACA

clone MGC:1152 IMAGE:3346070,

mRNA, complete cds/cds = (163, 1143)

4712
db mining
Hs.153299
NM_015510
5031670
DOM-3 (C. elegans) homolog Z
1
CCCAAATAGTAATGCTTTAGAGGGAG

(DOM3Z), transcript variant 2, mRNA

GCAGTCATATCTCTGTGTGCAGAT

/cds = (129, 1319)

4713
db mining
Hs.77961
NM_005514
5031742
major histocompatibility complex, class
1
ATGTGTAGGAGGAAGAGTTCAGGTG

I, B (HLA-B), mRNA/cds = (0, 1088)

GAAAAGGAGGGAGCTACTCTCAGGC

4714
literature
Hs.279853
NM_005516
5031744
HSPC018 protein (HSPC018), mRNA
1
CCCCTTCCTCACACTGACCTGTGTTC

/cds = (148, 651)

CTTCCCTGTTCTCTTTTCTATTAA

4715
db mining
Hs.60288
NM_005527
5031788
heat shock 70 kD protein-like 1
1
AAACTCTACCAAGGAGGATGCACTGG

(HSPA1L), mRNA/cds = (0, 1925)

GCCTGCCTGCGGAACAGGGTATGT

4716
db mining
Hs.171776
NM_005536
8393607
inositol(myo)-1(or 4)-
1
CCCTTGGCACGTAAACAGACTACTAG

monophosphatase 1 (IMPA1), mRNA

ACTTATTGTAGGTTCGTTTGAGCT

/cds = (98, 931)

4717
db mining
Hs.102171
NM_005545
5031808
immunoglobulin superfamily containing
1
CAAAGGCCAGCCAGCTTGGGAGCAG

leucine-rich repeat (ISLR), mRNA

CAGAGAAATAAACAGCATTTCTGAT

/cds = (98,1384)

4718
literature
Hs.150101
NM_005561
7669500
lysosomal-associated membrane
1
GTGAGATCGGTGCGTTCTCCTGATGT

protein 1 (LAMP1), mRNA

TTTGCCGTGGCTTGGGGATTGTAC

/cds = (190, 1440)

4719
db mining
Hs.154970
NM_005653
5032174
transcription factor CP2 (TFCP2),
1
GAACTTTCAGGAAGAAGCATGTTTTA

mRNA/cds = (508, 1860)

TTCTGGACACAATGAAAGAAACCA

4720
Table 3A
Hs.82173
NM_005655
5032176
TGFB inducible early growth response
1
TTGGGTGTAGATTTCTGACATCAAAA

(TIEG), mRNA cds = (123, 1565)

CTTGGACCCTTGAAAACAAAAGT

4721
db mining
Hs.200600
NM_005698
5032076
secretory carrier membrane protein 3
1
CAACCCAGCTTCCCTCTGCTGTGCCA

(SCAMP3), mRNA/cds = (96, 1139)

CGGCTGTTGCTTCGGTTATTTAAA

4722
db mining
Hs.157144
NM_005819
5032130
syntaxin 6 (STXB), mRNA/cds = (0,
1
ATAGCCATCCTCTTTGCAGTCCTGTT

767)

GGTTGTGCTCATCCTCTTCCTAGT

4723
db mining
Hs.17704
NM_005844
5031730
PERB11 family member in MHC class

ACATGAGCTTCTACCTCCAGATGTGC

I region (HCGIX), mRNA/cds = (37, 270)

CAGGGTGCATCTCAATAAACTTGG

4724
db mining
Hs.135194
NM_005849
5031672
immunoglobulin superfamily, member
1
ACTGAAAAGACAACTGGCTACA

6 (IGSF6), mRNA/cds = (44, 769)

AAGAAGGATGTCAGAATGTAAGGA

AACT

4725
db mining
Hs.4953
NM_005895
5174440
golgi autoantigen, golgin subfamily a, 3
1
AAGTTGTGGCTGTTCTTGGGAAAGGG

(GOLGA3), mRNA/cds = (269, 4861)

GTCACCGTGTCTGACAAAGTGTAA

4726
db mining
Hs.211580
NM_005931
5174564
MHC class I polypeptide-related
1
CCCCTCGCCCCGTCACACCGTTATG

sequence B (MICB), mRNA

CATTACTCTGTGTCTACTATTATGT

/cds = (5, 1156)

4727
Table 3A
Hs.68583
NM_005932
5174566
mitochondrial intermediate peptidase
1
GCTGTGAGAGCTTGTTTCTGATTGTT

(MIPEP), nuclear gene encoding

TCATTGTTCGCTTCTGTAATTCTG

mitochondrial protein, mRNA

/cds = (74, 2215)

4728
Table 3A
Hs.54452
NM_006060
5174500
zinc finger protein, subfamily 1A, 1
1
ACCAACACTGTCCCAAGGTGAAATGA

(Ikaros) (ZNFN1A1), mRNA

AGCAACAGAGAGGAAATTGTACAT

/cds = (168, 1727)

4729
db mining
Hs.292276
NM_006068
5174720
qd64a01.x1 cDNA, 3′ end
1
TGCTCAGTTTTTCAGCTCCTCTCCAC

/clone = IMAGE:1734216/clone_end = 3′

TCTGCTTTCCCAAATGGATTCTGT

4730
db mining
Hs.131342
NM_006072
5174670
small inducible cytokine subfamily A
1
ATATTCACTACCAAAAGAGGCAAGAA

(Cys—Cys), member 26 (SCYA26),

AGTCTGTACCCATCCAAGGAAAAA

mRNA/cds = (0, 284)

4731
db mining
Hs.2414
NM_006080
5174672
serna domain, immunoglobulin domain
1
GCTGCATTACCTCTAGAAACCTCAAA

(Ig), short basic domain, secreted,

CAAGTAGAAACTTGCCTAGACAAT

(sernaphorin) 3A (SEMA3A), mRNA

/cds = (15, 2330)

MHC binding factor, beta (MHCBFB),
1
TCCAAGTCGAAATCGCTGCTGAGGCT

4732
db mining
Hs.2654
NM_006081
5174562
mRNA/cds = (90, 1286)

GAGATGAAGAAAGAAAAGTCCAAA

4733
literature
Hs.125359
NM_006288
5454117

Homo sapiens, clone MGC:846
1
CATCTCCTCCCAGAACGTCACAGTGC

IMAGE:3507917, mRNA, complete cds

TCAGAGACAAACTGGTCAAGTGTG

/cds = (60, 545)

4734
db mining
Hs.23168
NM_006313
14149626
ubiquitin specific protease 15
1
TTTGTCTGCACTTGAGTTCACTTGAG

(USP15), mRNA/cds = (9, 2867)

TTTACATTTGAAATGTGCATGTTT

4735
db mining
Hs.171921
NM_006379
5454047
serna domain, immunoglobulin domain
1
AGTTCCCTTTATTTCACATAAGCCCAA

(Ig), short basic domain, secreted,

ACTGATAGACAGTAACGGTGTTT

(sernaphorin) 3C (SEMA3C), mRNA

/cds = (562, 2817)

4736
db mining
Hs.240534
NM_006411
5453717
1-acylglycerol-3-phosphate O-
1
GGAGAGGGTGGGACCCAGTTTTGCG

acyltransferase 1 (lysophosphatidic

TGGTTGGTTTTTATTAATTATCTGG

acid acyltrasferase, alpha)

4737
db mining
Hs.181368
NM_006445
5453983
U5 snRNP-specific protein (220 kD),
1
CCTCTTTCCCTCTGTCTGTGCCTGTG

ortholog at S. cerevisiae Prp8p (PRP8),

TTGTTGACCTCCTGATGGCTTGTC

mRNA/cds = (41, 7048)

4738
db mining
Hs.239506
NM_006561
5729815
mab-21 (C. elegans)-like 1
1
CTGATTCTTCTGTCCTCATTGTGAAC

(MAB21L1), mRNA/cds = (818, 1897)

ATAACCGTGTAGTTGAAACAGTCA

4739
db mining
Hs.34526
NM_006564
5730105
G protein-coupled receptor (TYMSTR),
1
TTTCCAATGTCTGCCACACAAACGTA

mRNA/cds = (81, 1109)

TGTAAATGTATATACCCACACACA

4740
db mining
Hs.86998
NM_006599
572944
nuclear factor of activated T-cells 5,
1
TCCTGAGAAACAACACATTTTTCCCC

tonicity-resonsive (NFAT5), mRNA

ATGAACGGTGCTGTTCTGAAGTCT

/cds = (318, 4913)

4741
db mining
Hs.167751
NM_006604
5730012
ret finger protein-like 3 (RFPL3),
1
TATTGCCACCATCCAACTCATTGAGT

mRNA/cds = (292, 1158)

CTTATGGTTCACATCTTGTTTCCT

4742
db mining
Hs.157427
NM_006605
5730010
ret finger protein-like 2 (RFPL2),
1
AGTCCTATGGTTCACATCTTGTTTCCT

mRNA/cds = (292, 1158)

ATAGAAATGTCCTGTATTCTGGG

4743
db mining
Hs.74861
NM_006713
5729967
activated RNA polymerase II
1
AAACCAGGAAGAAAAGGTATTTCTTT

transcription cofactor 4 (PC4), mRNA

AAATCCAGAACAATGGAGCCAGCT

/cds = (0, 383)

4744
db mining
Hs.75063
NM_006734
5803032
DNA sequence from clone 67K17 on
1
AAGCAGTTGGACTTTCACAGCAGCAA

chromosome 6q24.1-24.3, Contains

GGAATTATCTTCAAGCACAGAGGA

the HIVEP2 (Schnurri-2) gene for HIV

type 1 Enhancer-binding Protein 2, and

a possible pseudogene in an intron of

this gene. Contains STSs and GSSs

and an AAAT repeat polymorphism

/cds = (545, 7885)

4745
db mining
Hs.56328
NM_006737
5803051
killer cell immunoglobuin-like receptor,
1
CTTCAGTGTAGCTCTCTCCTCTTCAA

three domains, long cytoplasmic tail, 2

ATAAACATGTCTGCCCTCATGGTT

(KIR3DL2), mRNA/cds = (2, 1369)

4746
db mining
Hs.82210
NM_006766
5803097
zinc finger protein 220 (ZNF220),
1
TTCTCTCGTGCAACCAGTTTGCCCAT

mRNA/cds = (393, 6407)

TCTCTTCCTATTACTTGCTCCAGG

4747
db mining
Hs.57692
NM_006781
11321623
chromosome 6 open reading frame 10
1
TGCTCTTCAGAAGTTTCACCCTTTTTA

(C6orf10), mRNA/cds = (238, 1942)

ATCTCTCAGCCACAAACCTCAGT

4748
db mining
Hs.84865
NM_006790
5803105
titin immunoglobulin domain protein
1
ACGTTTACTGGTACTGCTTTCTAAATA

(myotilin) (TTID), mRNA

CTGTTTTACCCGTTTTCTCTTGT

/cds = (280, 1776)

4749
db mining
Hs.170027
NM_006880
6031173
mouse double minute 2, homolog of;
1
GACAACCAATTCAAATGATTGTGCTA

p53-binding protein (MDM2), transcript

ACTTATTTCCCCTAGTTGACCTGT

variant MDM2, mRNA/cds = (311, 1786)

4750
literature
Hs.27954
NM_006889
5901919
CD86 antigen (CD28 antigen ligand 2,
1
GGCCAAGCCCAGCTTAATGGCTCAT

B7-2 antigen) (CD86), mRNA

GACCTGGAAATAAAATTTAGGACCA

/cds = (147, 1118)

4751
Table 3A
Hs.173737
NM_006908
9845510
ras-related C3 botulinum toxin
1
CTCAAGACAGTGTTTGACGAAGCGAT

substrate 1 (rho family, small GTP

CCGAGCAGTCCTCTGCCCGCCTCC

binding protein Rac1) (RAC1),

transcript variant RaC1b, mRNA

/cds = (0, 635)

4752
db mining
Hs.218354
NM_006913
5902053
ring finger protein 5 (RNF5), mRNA
1
CTTTTTCACCACCGTCTTCAATGCCC

/cds = (0, 542)

ATGAGCCTTTCCGCCGGGGTACAG

4753
db mining
Hs.153299
NM_006929
13787218
DOM-3 (C. elegans) homolog Z
1
ACATCGTATTTGCGGCCAGCCTCTAC

(DOM3Z), transcript variant 2, mRNA

ACCCAGTGAATGCCCCATGTAAA

/cds = (129, 1319)

4754
literature
Hs.278721
NM_006979
5901935
HLA class II region expressed gene
1
TATTCCTTTTATATCACTGTGTTTGAA

KE4 (HKE4), mRNA/cds = (326, 1615)

TCGAGGGGGAGGGGTGGTAACCG

4755
Table 3A
Hs.97437
NM_007018
5901923
centrosomal protein 1 (CEP1), mRNA
1
ATGGGAATAGTTGCATATGGGAATTT

/cds = (472, 3456)

AAACCAACATGTGGCTGAGCCTTT

4756
db mining
Hs.41716
NM_007036
13259505
endothelial cell-specific molecule 1
1
GGCCTTTGAATGTAAAGCTGCATAAG

(ESM1), mRNA/cds = (68, 622)

CTGTTAGGTTTTGTTTTAAAAGGA

4757
db mining
Hs.155150
NM_007042
5902065
ribonuclease P (14 kD) (RPP14),
1
CAGTTTGGCCTTATGCTTTATGCAGA

mRNA/cds = (169, 543)

CTTGAGTGTATGCAGGATTTCATT

4758
db mining
Hs.81743
NM_007053
5901909
natural killer cell receptor,
1
CAGACCAAGAGCACCACAGACT

immunoglobulin superfamily member

ACAACTGCCCAGCTTCATCTAAAT

(BY55), mRNA/cds = (215, 760)

ACTT

4759
db mining
Hs.43543
NM_007056
5902129
suppressor of white apricot homolog 2
1
GTGGGTAAGGGGCTCAAGCTGTGAT

(SWAP2), mRNA/cds = (143, 2122)

GCTGCTGGTTTTATCTCTAGTGAAA

4760
db mining
Hs.247979
NM_007128
9507238
pre-B lymphocyte gene 1 (VPREB1),
1
ACCCTCCCAGGTTCCTGCTGAGATAT

mRNA/cds = (0, 437)

TTCTCACAATCAGACAAGAGCCAG

4761
literature
Hs.41682
NM_007334
7669498
killer cell lectin-like receptor subfamily
1
GGGCAGAGAAGGTGGAGAGTAAAGA

D, member 1 (KLRD1), transcript

CCCAACATTACTAACAATGATACAG

variant 1, mRNA/cds = (260, 799)

4762
Tabe 3A
Hs.173334
NM_012081
6912353
ELL-RELATED RNA POLYMERASE
1
GGCTCACATCAAAAGGCTAATAGGTG

II, ELONGATION FACTOR (ELL2),

AATTTGACCAACAGCAAGCAGAGT

mRNA/cds = (0, 1922)

4763
db mining
Hs.268555
NM_012255
6912743
5′-3′ exoribonuclease 2 (XRN2),
1
AACACATTTGAGGAATAGGAGGTCCG

mRNA/cds = (68, 2920)

GGTTTTCCATAATGGGTAAAATGG

4764
db mining
Hs.258612
NM_012312
6912471
killer cell immunoglobulin-like receptor,
1
GCTGTTCCACCTCCCTTCAGACTATC

two domains, short cytoplasmic tail, 4

TTTCAGCCTTCTGCCAGCAGTAA

(KIR2DS4), mRNA/cds = (46, 960)

4765
db mining
Hs.212414
NM_012431
6912649
serna domain, immunoglobulin domain
1
ACTATAAGTCATTTTGAGTGTTGGTG

(Ig), short basic domain, secreted,

TTAAGCATGAAACAAACAGCAGCT

(sernaphorin) 3E (SEMA3E), mRNA

/cds = (466, 2793)

4766
Table 3A
Hs.144519
NM_012468
10947106
T-cell leukemia/lymphoma 6 (TCL6),
1
GCTATTCACAGTTCTGGGGAACAACC

transcript variant TCL6a2, mRNA

AAAGGAGGAGGAGGACAAAGGGAA

/cds = (1767, 2192)

4767
db mining
Hs.334729
NM_013230
7019342
cDNA FLJ20161 fis, clone COL09252,
1
AAGCTACTGTGTGTGTGAATGAACAC

highly similar to L33930 CD24 signal

TCTTGCTTTATTCCAGAATGCTGT

transducer mRNA/cds = UNKNOWN

4768
db mining
Hs.278911
NM_013278
7019434
interleukin 17C (IL17C), mRNA
1
CTATCCACAGAAGCTGGCCTTCGCC

/cds = (0, 593)

GAGTGCCTGTGCAGAGGCTGTATCG

4769
db mining
Hs.71979
NM_013371
7019574
interleukin 19 (IL19), mRNA
1
GTCATATAGTCCATGTCTGTGATGTG

/cds = (47, 580)

AGCCAAGTGATATCCTGTAGTACA

4770
db mining
Hs.247362
NM_013974
7524353
dimethylarginine
1
TCCACTGGGTGAATCCTCCCTCTCAG

dimethylaminohydrolase 2 (DDAH2),

AACCAATAAAATAGAATTGACCTT

mRNA/cds = (276, 1133)

4771
Table 3A
Hs.8360
NM_014039
7662640
PTDO12 protein (PTD012), mRNA
1
GAGTTTCTCTATCGCATTGGTCAACC

/cds = (473, 1087)

AAAAGAGACGCATTCCATTGGGCG

4772
Table 3A
Hs.6975
NM_014086
7662589
AF001542 cDNA
1
TTCTCTGCATCTAGGCCATCATACTG

/clone = alpha_est218/52C1

CCAGGCTGGTTATGACTCAGAAGA

4773
db mining
Hs.278944
NM_014148
7661751
HSPC048 protein (HSPC048), mRNA
1
TGCGAAATTGTGGACTGTTGGACTGT

/cds = (87, 419)

GATTCTAAGTGGGGGAAATAGGCT

4774
db mining
Hs.278946
NM_014152
7661759
HSPC054 protein (HSPC054), mRNA
1
GAACCTTTCTGAAACCAGTGGCAGCC

/cds = (107, 397)

CAAGTTAGAGCCCAGCATTAAGTC

4775
db mining
Hs.278948
NM_014163
7661781
HSPC073 protein (HSPC073), mRNA
1
CCAGAATCTTCTATTCCCACTTCCCA

/cds = (278, 649)

TTTCTCAAATCATTTGACCTGTCG

4776
db mining
Hs.130101
NM_014227
14140235
solute carrier family 5 (neutral amino
1
CCTCCTGGCTGTGGTGGTCTTTATTC

acid transporters, system A), member 4

ACGGCTACTATGCCTGAACTCTAT

(SLC5A4), mRNA/cds = (18, 1995)

4777
db mining
Hs.205736
NM_014260
7657161
HLA class II region expressed gene
1
GAAATTAAGCGATACGAATCCCAGCT

KE2 (HKE2), mRNA/cds = (0, 389)

TCGGGATCTTGAGCGGCAGTCAGA

4778
db mining
Hs.241385
NM_014271
7657231
interleukin 1 receptor accessory
1
TCACAGTGACCACTACAGAGTACTAA

protein-like 1 (IL1RAPL1), mRNA

GAAGAGAAGATCAAGGGCATGAAA

/cds = (510, 2600)

4779
Table 3A
Hs.211973
NM_014285
7657527

Homo sapiens, Similar to homolog of
1
TCTTAAAGCCAGAAATAATGGAGGAG

yeast RRP4 (ribosomal RNA

ATTGTGATGGAAACACGCCAGAGG

processing 4), 3′-5′-exoribonuclease,

clone MGC:2403 IMAGE:2821702,

mRNA, complete cds/cds = (11, 892)

4780
db mining
Hs.129751
NM_014339
7657229
interleukin 17 receptor (IL17R), mRNA
1
CTTTTCTTTGTGCAGCGGTCTGGTTA

/cds = (32, 2632)

TCGTCTATCCCCAGGGGAATCCAC

4781
db mining
Hs.296429
NM_014348
7657468
similar to rat integral membrane
1
CCACGTTGGGGTCACTACTGGAGTG

glycoprotein, POM121 (POM121L1),

GATGGAGGCCCTTCACATTTCTGGG

mRNA/cds = (0, 1286)

4782
db mining
Hs.21814
NM_014432
7657690
interleukin 20 receptor, alpha
1
TGACCTTTCGTGATTATCCGCAAATG

(IL20RA), mRNA/cds = (236, 1897)

CAAACAGTTTCAGATCTAATGGTT

4783
db mining
Hs.110040
NM_014443
7657227
interleukin 17B (IL17B), mRNA
1
CAGTCATGGAGACCATCGCTGTGGG

/cds = (41, 583)

CTGCACCTGCATCTTCTGAATCACC

4784
db mining
Hs.76698
NM_014445
7657551
mRNA; cDNA DKFZp434L, 1621 (from
1
AGGTTTCTTCATGAGTCATTCCAAGT

clone DKFZp434L1621); complete cds

TTTCTAGTCCATACCACAGTGCCT

/cds = (315, 515)

4785
db mining
Hs.326248
NM_014456
7657448
cDNA:FLJ22071 fis, clone HEP11691
1
GAGGTCGTCTTAAACCAGAGAGCTAC

/cds = UNKNOWN

TGAATATAAGAACTCTTGCAGTCT

4786
db mining
Hs.278441
NM_014634
7661861
KIAA0015 gene product KIAA0015),
1
GCAGTCTCCCAAGGACCCACCATGC

mRNA/cds = (106, 1470)

AGAAGTGTCAATAAACCACAAGTTC

4787
db mining
Hs.19056
NM_014824
7662295
KIAA0769 gene product (KIAA0769),
1
GGAGGGAGCCTCTGTGCAGAATGTGC

mRNA/cds = (239, 2293)

TTTCTTTACAGTGGCTGTAAAAAGT

4788
db mining
Hs.11711
NM_014844
7662057
mRNA for KIAA0297 gene, partial cds
1
GATGCTTTTAAAGTTGTAGCTTCGTG

/cds = (0, 3815)

CTTTGTACAGTTTTCTTTCTGGTT

4789
db mining
Hs.7724
NM_014963
7662409
KIAA0963 protein (KIAA0963), mRNA
1
AATATATGCAATTCTCCCTCCCCCAG

/cds = (215, 4315)

CCCTTCCCTGACCCCTAAGTTATT

4790
Table 3A
Hs.31989
NM_015449
14149687
DKFZP586G1722 protein
1
AATCTGCCAGGCTATGTGACAGTAGG

(DKFZP586G1722), mRNA

AAGGAATGGTTTCCCCTAACAAGC

/cds = (210, 869)

4791
db mining
Hs.30488
NM_015453
14149489
DKFZP434F091 protein
1
AGCACATACATTGATAGATGGGGTGT

(DKFZP434F091), mRNA

GGGACCAACAAACCAAATTAAAAG

/cds = (334, 1857)

4792
Table 3A
Hs.104640
NM_015898
7705374
HIV-1 inducer of short transcripts
1
CAACGGCCAGGAGAAGCACTTTAAG

binding protein (FBI1), mRNA

GACGAGGACGAGGACGAGGACGTGG

/cds = (0, 1754)

4793
db mining
Hs.278428
NM_015902
13435357
progestin induced protein (DD5),
1
TTGTGGAAACTGTTTCAGCAAAGGTT

mRNA/cds = (33, 8432)

CTTGTATAGAGGGAATAGGGAATT

4794
db mining
Hs.279583
NM_016025
7705788

Homo sapiens, Similar to CGI-81
1
GGGGGAAGGAAGGCTTCAGACTTGG

protein, clone MGC:705

GGGAAGGGGAGATTATTGCAAATTG

IMAGE:3350598, mRNA, complete cds

/cds = (248, 1099)

4795
db mining
Hs.179817
NM_016026
7705790
CGI-82 protein (LOC51109), mRNA
1
CTATGGAGGAATTGAGGGCAAGCAC

/cds = (40, 996)

CCAGGACTGATGAGGTCTTAACAA

4796
db mining
Hs.236494
NM_016131
7705848
RAB10, member RAS oncogene
1
ACACCAAACAGTTAAGTCCATTCTCT

family (RAB10), mRNA/cds = (90, 692)

GGTACTAGCTACAAATTCGGTTTC

4797
db mining
Hs.115515
NM_016184
7705337
C-type (calcium dependent,
1
TGCACACAGGGAGAGAACATGAGTC

carbohydrate-recognition domain)

TCTCTTSSTTTTTSTCTGGTTGCTA

lectin, superfamily member 6

(CLECSF6), mRNA/cds = (241, 954)

4798
Table 3A
Hs.7905
NM_016224
7706705
SH3 and PX domain-containing protein
1
TTCAATGGAAAATGAGGGGTTTCTCC

SH3PX1 (SH3PX1), mRNA

CCACTGATATTTTACATAGAGTCA

/cds = (43, 1830)

4799
db mining
Hs.66
NM_016232
11136631
interleukin 1 receptor-like 1 (IL1RL1),
1
GACCACATTGCCAATAAAAGzgTCCCT

mRNA/cds = (0, 1670)

GAATTCCAAATTCTGGAAGCACGT

4800
db mining
Hs.180403
NM_016271
7706722
STRIN protein (STRIN), mRNA
1
AGGCCCAAATCACAGAATAAGGACT

/cds = (221, 958)

AAGAGTGGATTTGCTGACATTCCA

4801
Table 3A
Hs.3059
NM_016451
7705388
coatomer protein complex, subunit
1
GCTGTCCTCAAAGTATATAATGTTTCA

beta (COPB), mRNA/cds = (178, 3039)

TGTACCAAGACCCTTTTCACAGT

4802
Table 3A
Hs.321245
NM_016530
7706562
cDNA FLJ10249 fis, clone
1
AAGGGTATTTGGTCTGGTTCATATGG

HEMBB1000725, highly similar to

TCAAATATTACTGCCTTGGTAGCA

Rattus norvegicus GTPase Rab8b

mRNA/cds = UNKNOWN

4803
db mining
Hs.115897
NM_016580
14589925
protocadherin 12 (PCDH12), mRNA
1
GGGGTGCCAGGAAATGCTCTCTGAC

/cds = (1211, 4765)

CTATCAATAAAGGAAAAGCAGTGAT

4804
db mining
Hs.98309
NM_018584
7706701
SGRF protein, interleukin 23 p19
1
TGGGAAGGGAAATTTGGGGATTATTT

subunit (SGRF), mRNA/cds = (143, 712)

ATCCTCCTGGGGACAGTTTGGGGA

4805
Table 3A
Hs.273385
NM_016592
7706588
guanine nucleotide binding protein (G
1
GCCACAAAAGTTCCCTCTCACTTTCA

protein), alpha stimulating activity

GTAAAAATAAATAAAACAGCAGCA

polypeptide 1 (GNAS1), mRNA

/cds = (68, 1252)

4806
db mining
Hs.241567
NM_016838
1111111
RNA binding motif, single stranded
1
ATAAGGTGCATAAAACCCTTAAATTC

interacting protein 1 (RBMS1),

ATCTAGTAGCTGTTCCCCCGAACA

transcript variant MSSP-2, mRNA

/cds = (265, 1434)

4807
db mining
Hs.272354
NM_01741611
225606
interleukin 1 receptor accessory
1
GATACCCAGGAATTTCACAGGAACAG

protein-like 2 (IL1RAPL2), mRNA

TTCTTTGCTGCCTTTATCCTCCAA

/cds = (758, 2816)

4808
db mining
Hs.105956
NM_017436
8392829
globotriaosylceramide/CD77 synthase;
1
CCCACCCTGCCGCCCGCATTATAAAC

Gb3/CD77 synthase; alpha1,4-

ACAGGAGAATAATCAATAGAATAA

galactosyltransferase; 4-N-

acetylglucosaminyltransferase

(A14GALT), mRNA/cds = (133, 1194)

4809
db mining
Hs.283690
NM_017548
6923709
clone H41 unknown mRNA
1
AAACCAGGCCCTTAAACTTCAGCTAG

/cds = (323, 1099)

ACAACCAATATGCTGTGCTTGAAA

4810
db mining
Hs.14512
NM_017583
8923748
DIPB protein (HSA249128), mRNA
1
CCAGATCCACAGCAGGCACATATCTC

/cds = (177, 1211)

TCCAAGGGATGACCAGTTTTATGC

4811
Table 3A
Hs.288036
NM_017646
8923064
tRNA isopentenylpyrophosphate
1
GGACTTGAAGACCAAAGACTTTGAAA

transferase (IPT), mRNA

TTTGCGAGCTGCTCATGTGTGAGT

/cds = (60, 1040)

4812
Table 3A
Hs.106650
NM_017866
8923499

Homo sapiens, Similar to hypothetical
1
GAAACGGCATAAAGATGAGAAATGAG

protein FLJ20533, clone MGC:3448

CCTATTTGTTAGTGTTCGTGCCTA

IMAGE:3831570, mRNA, complete cds

/cds = (380, 865)

4813
Table 3A
Hs.272134
NM_018067
8922367
AL544307 cDNA
1
CCTGCCCTCGCCTGGAATCAGTGTTA

/clone = CS0DI019YG13-(5-prime)

CTGCATCTGATTAAATGTCTCCAG

4814
Table 3A
Hs 7187
NM_018187
8922608
mRNA for KIAA1757 protein, partial
1
AATGAGTTGTGTTGAAGCCTCCGTCT

cds/cds = (347, 4576)

CCCATCCTTGCCTGTAGCCCGTAG

4815
db mining
Hs.85752
NM_018461
8923923
mRNA for KIAA1541 protein, partial
1
CAGAGTTGACGGACACTGCTCCCAAA

cds/cds = (908, 2341)

AGGTCATTACTCAGAATAATGTA

4816
db mining
Hs.272373
NM_018724
11036633
interleukin 20 (L20), mRNA
1
GAACCTCAGGCAGCAGTTGTGAAGG

/cds = (0, 530)

CTTTGGGGGAACTAGACATTCTTCT

4817
db mining
Hs.110309
NM_018950
9665231
major histocompatibility complex, class
1
GGACTGAGAAGCAAGATATCAATGTA

I, F (HLA-F), mRNA/cds = (0, 1088)

GCAGAATTGCACTTGTGCCTCACG

4818
Table 3A
Hs.225674
NM_018963
11321643
mRNA for WDR9 protein (WDR9
1
CAATGGTTGCACCTTATGACCTTGAG

gene), form B/cds = (79, 6888)

GGAAAGCCAGTTCATTTAAGAGGA

4819
db mining
Hs.278430
NM_019105
14719824
cytochrome P450, subfamily XXIA
1
GGGGGAGGGGAGGGGTTCGTACAG

(steroid 21-hydroxylase, congenital

GAGCAATAAAGGAGAAACTGAGGTAC

adrenal hyperplasia), polypetide 2

(CYP212), mRNA/cds = (118, 1805)

4820
db mining
Hs.278430
NM_019105
14719824
cytochrome P450, subfamily XXIA
1
GGGGGAGGGGAGGGGTTCGTACAG

(steroid 21-hydroxylase, congenital

GAGCAATAAAGGAGAAACTGAGGTAC

adrenal hyperplasia), polypeptide 2

(CYP21A2), mRNA/cds = (118, 1605)

4821
db mining
Hs.159679
NM_019598
9665235
kallikrein 12 (KLK12), mRNA
1
ACTTCTTGGAACTTTAACTCCTGCCA

/cds = UNKNOWN

GCCCTTCTAAGACCCACGAGCGGGG

4822
db mining
Hs.247808
NM_019602
9824966
butyrophilin-like 2 (MHC class II
1
TGTTCCATCAGCATCCCCTTTTTGGG

associated) (BTNL2), mRNA

CGAGGAGAAAATCGCAACTTTTTC

/cds = (0, 1387)

4823
db mining
Hs.36989
NM_019616
10518502
coagulation factor VII (serum
1
CAGACTATTCCCCACCTGCTTCCCAG

prothrombin conversion accelerator)

CTTCACAATAAACGGCTGCGTCTC

(F7), transcript variant 1, mRNA

/cds = (51, 1451)

4824
db mining
Hs.36989
NM_019616
10518502
coagulation factor VII (serum
1
CAGACTATTCCCCACCTGCTTCCCAG

prothrombin conversion accelerator)

CTTCACAATAAACGGCTGCGTCTC

(F7), transcript variant 1, mRNA

/cds = (51, 1451)

4825
db mining
Hs.289095
NM_020056
11095446
major histocompatibility complex, class
1
GTCTGTGGGCCTCATGGGCATTGTG

II, DQ alpha 2 (HLA-DQA2), mRNA

GTGGGCACTGTCTTCATCATCCAAG

/cds = (0, 767)

4826
db mining
Hs.296552
NM_020070
13399297
DNA sequence from clone CTA-246H3
1
CTCCAAACAGAGCAACAACAAG

on chromosome 22 Contains the gene

TACGCGGCCAGCAGCTACCTGAGC

for IGLL1 (immunoglobulin lambda-like

CTGA

polypeptide 1, pre-B-cell specific), a

pseudogene similar to LRP5

(Lipoprotein Receptor Related

Protein), ESTs, Genomic markers

(D22S414, D22S925, D22S926), CA

repeats, STSs, GSSs and a CpG Island

/cds = (0, 438)

4827
Table 3A
Hs.94395
NM_020324
10947128
ATP-binding cassette, sub-family D
1
CCAAAGTCCTCACTCAGACCAGTGCC

(ALD), member 4 (ABCD4), transcript

CCTCCAGTTCAGTTGTCTATGTAT

variant 5, mRNA/cds = (51, 1544)

4828
db mining
Hs.105509
NM_020428
9966908
cDNA FLJ14613 fls, clone
1
TGTCTTCCACCCTCAAGAAACTCTTG

NT2RP1001113, highly similar to CTL2

AACAAGACCAACAAGAAGGCAGCG

gene/cds = UNKNOWN

4829
literature
Hs.248158
NM_020530
10092620
oncostatin M (OSM), mRNA
1
GCAGGACCAGACCCTCCAGGAAAGG

/cds = (0, 758)

CAAGAGACTCATGACCAGGGGACAG

4830
db mining
Hs.105052
NM_020979
10280625
adaptor protein with pleckstrin
1
GGTGGGACACGCCAAGCTCTTCAGT

homology and src homolog 2 domains

GAAGACACGATGTTATTAAAAGCCT

(APS), mRNA/cds = (127, 2025)

4831
literature
Hs.1510
NM_021068
10835102
interferon, alpha 4 (IFNA4), mRNA
1
AGCTTGGTGTATACCTTGCAGGCACT

/cds = (140, 709)

AGTCCTTTACAGATGACAATGCTG

4832
db mining
Hs.76293
NM_021103
1063894
thymosin, beta 10 (TMSB10), mRNA
1
AGGAAGAGCCACCTGCAAGATGGAC

/cds = (65, 199)

ACGAGCCACAAGCTGCACTGTGAAC

4833
db mining
Hs.3254
NM_021134
10863930
mitochondrial ribosomal protein L23
1
GGGTGCAGCATGGCTCTAACAAGAG

(MRPL23), mRNA/cds = (54, 515)

AAGAGATCACAGAAACGTGAGGATC

4834
Table 3A
Hs.7137
NM_121188
10863994
clones 23667 and 23775 zinc finger
1
TACATTCTCCCTTTAGCAACCTGAGT

protein (LOC57862), mRNA

AAGAGACTCTCTGCCACTGGGCTG

/cds = (182, 1618)

4835
db mining
Hs.11090
NM_021201
11139298
high affinity immunoglobulin epsilon
1
AACTCTTGGCCTCAGAGGAAGGAAAA

receptor beta subunit (CFFM4), mRNA

GCAACTCAACACTCATGGTCAAGT

/cds = (148, 868)

4836
db mining
Hs.241587
NM_021246
10864054
megakaryocyte-enhanced gene
1
AGGGAACAAGGGAGCAAGGGAACAA

transcript 1 protein (MEGT1), mRNA

GGGACATCTGAACATCTAATGTGAG

/cds = (3, 1151)

4837
db mining
Hs.110915
NM_021258
10864066
interleukin 22 receptor (IL22R), mRNA
1
GTGGCCCCTGGACGGGTACAATAAC

/cds = (23, 1747)

ACACTGTACTGATGTCACAACTTTG

4838
db mining
Hs.210546
NM_021798
11141868
interleukin 21 receptor (IL21R), mRNA
1
CCCCTACCCTGCCCCAATTCAATCCT

/cds = (68, 1684)

GCCAATAAATCCTGTCTTATTTGT

4839
Table 3A
Hs.302014
NM_021803
11141874
interleukin 21 (IL21), mRNA
1
ACACGGAAGTGAAGATTCCTGAGGAT

/cds = (46, 534)

CTAACTTGCAGTTGGACACTATGT

4840
db mining
Hs.82887
NM_021959
11388174
protein phosphatase 1, regulatory
1
CGGTCCTTTTGCCATACACAGTTACA

(inhibitor) subunit 11 (PPP1R11),

GAGATCAGTCAAATCCATACCACC

mRNA/cds = (199, 579)

4841
db mining
Hs.79372
NM_021970
11415051
retinoid X receptor, beta (RXRB),
1
ATACCTGTGAGGACTGGTTGTCTCTC

mRNA/cds = (179, 1780)

TTCGGTGCCCTTGAGTCTCTGAAT

4842
db mining
Hs.293934
NM_021983
11875206
major histocompatibility complex, class
1
TCATCTACTTCAGGAATCAGAAAGGA

II, DR beta 4 (HLA-DRB4), mRNA

CACTCTGGACTTCAGCCAACAGGT

/cds = (58, 948)

4843
Table 3A
Hs.96560
NM_022086
11545798

Homo sapiens, Similar to hypothetical
1
TGCTTCTTGAAATGGATTTAACAACA

protein FLJ11656, clone MGC:5247,

GCCAGGAGCTTCCTGTCAGTAACC

mRNA, complete cds/cds = (149, 271)

4844
db mining
Hs.288316
NM_022107
11545816
chromosome 6 open reading frame 9
1
CCCTCCCCACTGCTGCTGAGTCTGTC

(C6orf9), mRNA/cds = (373, 855)

TGATGTTTTGGTTGTGTGAATAAA

4845
db mining
Hs.99134
NM_022110
11545622
DIR1 protein (NG7), mRNA
1
AGGAGGAACTGGGGAAGGTGGTCAT

/cds = (268, 879)

TCAGGGGAAGAACCAGGATGCAGGG

4846
Table 3A
Hs.24633
NM_022136
11545870
SAM domain, SH3 domain and
1
TGGGAAAGTGTGAGTTAATATTGGAC

nuclear localisation signals, 1

ACATTTTATCCTGATCCACAGTGG

(SAMSN1), mRNA/cds = (82, 1203)

4847
literature
Hs.247885
NM_022304
1111111
histamine receptor H2 (HRH2), mRNA
1
TTAAAAGGAGCACATTAAAATTCTCA

/cds = (525, 1604)

GAGGACTTGGCAAGGGCCGCACAG

4848
db mining
Hs.271815
NM_022352
11641262
caspase recruitment domain protein 9
1
GCACACGCCATCTGTGTAACTTCAGG

(LOC84170), mRNA/cds = (146, 1246)

ATCTGTTCTGTTTCACCATGTAAC

4849
db mining
Hs.294030
NM_022447
13937360
topoisomerase-related function protein
1
TTTTTCCCAGCTCGCCACAGAATGGA

4-2 (TRF4-2), mRNA/cds = (338, 869)

TCATGAAGACTGACAACTGCAAAA

4850
Table 3A
Hs.15220
NM_022473
11968022
zinc finger protein 106 (ZFP106),
1
AAGAGAAATATATGCCCTAGAGCTGC

mRNA/cds = (335, 5966)

TCCAGCACCCTTGGTTTCTGATTT

4851
db mining
Hs.28921
NM_022482
11968149
DNA sequence from clone RP3-
1
ACAGACAGACTCGATGCCCACACAG

322G13 on chromosome 20p11.21-

CTTCACTCTTTGAGCAACATGGAAT

12.3 Contains the gene for NTF2-

related export protein (NXT1), a gene

for a novel zinc finger protein with three

isoforms, two isoforms for the 3′ part of

a novel gene, a gene for a novel

protein similar to mouse and bovine

beta-soluble NSF attachment protein

(SNAP-beta), a novel gene similar to

cystalin, another novel gene similar to

cystalin 8 (CST8) with two isoforms,

ESTs, STSs, GSSs and CPG islands

/cds = (0, 2135)

4852
Table 3A
Hs.161786
NM_022570
13384603
C-type (calcium dependent,
1
GCACGGTGTGTTGCCACGATTTGACC

carbohydrate-recognition domain)

CTCAACTTCTAGCAGTATATCAGT

lectin, superfamily member 12

(CLECSF12), mRNA/cds = (71, 676)

4853
db mining
Hs.302036
NM_022789
12232484
interleukin 17E (IL17E), mRNA
1
AGTGTAGTTACTAGTCTTTTGACATG

/cds = (258, 791)

GATGATTCTGAGGAGGAAGCTGTT

4854
Table 3A
Hs.302981
NM_024033
13162284
hypothetical protein FLJ11000
1
TCACTGCCATACAGGTTTTCCAATAC

(FLJ11000), mRNA/cds = (223, 780)

ACAAGTGCTAGAAAATACACACAA

4855
db mining
Hs.267194
NM_024039
13128993
hypothetical protein MGC2488
1
TTGCTTGCCCTCCATGTCTTCCTAAA

(MGC2488), mRNA/cds = (553, 1170)

GAGCAGAACTTGGAGTTTCTCCTT

4856
Table 3A
Hs.250723
NM_024104
13129111
hypothetical protein MGC2747
1
AGAATGAGCCTGAATGTTGGTGGTTT

(MGC2747), mRNA/cds = (92, 247)

TTGAAATCCTGACTTGGAGGTAA

4857
db mining
Hs.71746
NM_024663
13375916
hypothetical protein FLJ11583
1
CCTCGGCCCTGACAAACGGGGATCT

(FLJ11583), mRNA/cds = (371, 1606)

TTTACCTCACTTTGCACTGATTAAT

4858
db mining
Hs.94810
NM_024681
13489098
hypothetical protein FLJ12242
1
TGGCTTGGCCTTCTCTTTGGTGATCC

(FLJ12242), mRNA/cds = (185, 1057)

CACCCCCAGCCATTTGCATTGCTG

4859
Table 3A
Hs.180799
NM_024835
13376244
C3HC4-type zinc-finger protein (LZK1),
1
AATGTTTCTCTTCCTGTGAGACTTACT

mRNA/cds = (47, 2140)

AAAGCAACTTAGTGGCAAAAAGT

4860
db mining
Hs.183171
NM_024838
13376250
hypothetical protein FLJ22002
1
AGTACTTGAGTAGTCTCAATAGGAGT

(FLJ22002), mRNA/cds = (115, 783)

GTATTTGTAGACAGCAGTTTCCCT

4861
db mining
Hs.212839
NM_024879
13376250
mRNA for KIAA1714 protein, partial
1
ACCCTAGATGAGCTGTCCTGCTCCAG

cds/cds = (0, 3175)

TAACATTCTTTTTCTAAAATCATT

4862
db mining
Hs.125034
NM_025085
13376839
mRNA for putative N-acetyltransferase
1
AACTAGAAGATGTACTTCGACAGCAT

/cds = (208, 2808)

CCATTTTACTTCAAGGCAGCAAGA

4863
db mining
Hs.3365937
NM_025222
13489105
mRNA; cDNA DKFZp434C0814 (from
1
ATTTGAGTTCCTGTGTGTCCAAAACT

clone DKFZp434C0814)

GAGGCACCATGTTCTTTGAAAACA

/cds = UNKNOWN

4864
Table 3A
Hs.336937
NM_025222
13489105
mRNA; cDNA DKFZp434C0814 (from
1
ATTTGAGTTCCTGTGTGTCCAAACT

clone DKFZp434C0814)

GAGGCACCATGTTCTTTGAAAACA

/cds = UNKNOWN

4865
Table 3A
Hs.338937
NM_025222
13489105
mRNA; cDNA DKFZp434C0814 (from
1
ATTTGAGTTCCTGTGTGTCCAAAACT

clone DKFZp434C08104)

GAGGCACCATGTTCTTTGAAAACA

/cds = UNKNOWN

4866
db mining
Hs.247879
NM_025280
13376871
G6B protein (G6B), mRNA
1
GTCCACAGCGGACCCTGCTGATGCC

/cds = (0, 725)

TCCACCATCTATGCAGTTGTAGTTT

4867
db mining
Hs.241586
NM_025261
13376873
G6C protein (G6C), mRNA
1
CAGGCTCCCATATGTACCCCATCCCC

/cds = (54, 431)

CATACTCACCTCTTTCCATTTTGA

4868
db mining
Hs.118354
NM_025263
13376877
CAT56 protein (CAT56), mRNA
1
GTTGTATTGGCAAGAGGGAGGGGTG

/cds = (284, 1025)

AGAGCTGTTGGAGAACTGAGAATGA

4869
db mining
Hs.301920
NM_030651
13449284
chromosome 6 open reading frame 31
1
GTACCATCCTCACCGTAGTCATCATC

(C6orf31), mRNA/cds = (0, 602)

ATCGCCGCGCAGCACCACGAGAAC

4870
Table 3A
Hs.196270
NM_030780
13540550
folate transporter/carrier (LOC81034),
1
ATTTATCGTAAACATCCACGAGTGCT

mRNA/cds = (128, 1075)

GTTGCACTACCATCTATTTGTTGT

4871
db mining
Hs.107149
NM_030934
13569898
novel protein similar to archaeal, yeast
1
ATCGCTGAATATGTTGATCAGTGATG

and worn N2,N2-dimethylguanosine

AGTTGGGCTTAATGCAAAGATCCT

tRNA methyltransferase (C1ORF25),

mRNA/cds = (194, 2395)

4872
literature
Hs.225946
NM_031200
14043041
chemokine (C—C motif) receptor 9
1
AGGCTATTTACTTCCATGCTTCTCCTT

(CCR9), transcript variant A, mRNA

TTCTTACTCTATAGTGGCAACAT

/cds = (157, 1268)

4873
db mining
Hs.25063
NM_031268
13775167
PRO0461 protein (PRO0461), mRNA
1
GGGACCCCCACCCAGTGAGTCAACA

/cds = (779, 970)

TAGGCTCATGTCAAGTTTGAAAATA

4874
Table 3A
Hs.301183
NM_031419
13899228
molecule possessing ankyrin repeats
1
TGGTGTGATATGAACCAGTCCATTCA

induced by lipopolysaccharide (MAIL),

CATTGGAAAAACTGATGGTTTTAA

homolog of mouse (MAIL), mRNA

/cds = (48, 2204)

4875
db mining
Hs.283801
NM_032009
14196461
protocadherin gamma subfamily A, 2
1
TTTTTATCAGCGCCTCAATCTCTACTC

(PCDHGA2), transcript variant 1,

GAAGAAGAAAGAGAAGAAACGTT

mRNA/cds = (185, 2983)

4876
Table 3A
Hs.301104
NM_032236
14149943
602313002F1 cDNA, 5′ end
1
CGCTGTCGCCTTAATCCAAGCCTACG

/clone = IMAGE:4422480/clone_end = 5′

TTTTCACACTTCTAGTAAGCCTCT

4877
Table 3A
Hs.193669
NM_032270
14150008
hypothetical protein DKFZp586J1119
1
CTGTCGGGCTCTGAAGCGAGCTGGT

(DKFZp586J1119), mRNA

TTAGTTGTAGAAGATGCTCTGTTTG

/cds = (27, 2153)

4878
db mining
Hs.323682
NM_032334
14150117
hypothelical protein MGC14595
1
AGAAGCAGAATGCAGAAGGAGAATG

(MGC14595), mRNA/cds = (101, 850)

AATCCTTTGGATACTTTCAAGGACA

4879
db mining
Hs.106823
NM_032335
14150119
mRNA for KIAA1823 protein, partial
1
TCTGGCACAGTCCAGCTCACAACAAC

cds/cds = (52, 1185)

ATCAAGAGCAGAATTTGGAGACTT

4880
db mining
Hs.334639
NM_032389
14150222
SH3 domain-containing protein 6511
1
GGGACTTGACTTTCTTTCTGGACTGT

(LOC51165), mRNA/cds = (215, 1489)

TTGTATTGAAACAAGTGGTGTCA

4881
db mining
Hs.248367
NM_032445
14192940
MEGF11 protein (MEGF11), mRNA
1
AGCCTAAACATGTATACTGTGCATTTT

/cds = (159, 3068)

ATGGGTGACTTTGAAAGATCTGT

4882
db mining
Hs.69233
NM_032494
14210505
zinc finger protein (LOC64524), mRNA
1
AGACTGGTGATTTGGAGTAGTTTACA

/cds = (92, 967)

AGATTCCTCATTCAGAGTGCCCTC

4883
db mining
Hs.28514
NM_032597
14211930
testes development-related NYD-SP21
1
TTGCCTCCTCCAATCTGTGTTCTCAA

(NYD-SP21), mRNA/cds = (76, 2115)

CTGTGGTTGCCACCTCATTAACTT

4884
Table 3A
Hs.10056
NM_032811
14249499
hypothetical potein FLJ14621
1
TGGAACATACCACATGTAGAAAGGTT

(FLJ14621), mRNA/cds = (525, 1307)

GAACTGGTTTTTCAGCTATAATGC

4885
Table 3A
Hs.334788
NM_032815
14249507
hypothetical protein FLJ14639
1
TCACTTAGCCTTTCTGGTTTCCCTTC

(FLJ14639), mRNA/cds = (273, 689)

CTGTGCATTGCCCATTTTCTCATG

4886
Table 3A
Hs.11360
NM_032839
14249551
hypothetical protein FLJ14784
1
AGCCAAGAGGTATATCGATGATGGAA

(FLJ14784), mRNA/cds = (133, 1569)

ATTAGCCACATGTACACTACATTT

4887
db mining
Hs.29206
NM_032895
14249657
hypothetical protein MGC14376
1
CTTCACCGCCCTACTTCCACCTCCGC

(MGC14376), mRNA/cds = (184, 255)

CCAGCCTGTAATGTTTATATAAGC

4888
Table 3A
Hs.154172
R64548
836427
602575012F1 cDNA, 5′ end
1
CTTTCAGAGCCAGTTTGTCCAAGGCC

/clone = IMAGE:4703258/clone_end = 5′

AGCATCCCGTCTGGGAGATGCACC

4889
db mining
Hs.159388
S74639
807023
AL560682 cDNA
1
GCCGTATATTACTGTGCGAGAGGGC

/clone = CS0DL004YM19-(5-prime)

CGGAGTGGTTACTCGGTATGGACGT

4890
Table 3A
Hs.172762
T75153
691915
16b3 cDNA
1
AGGCAAAAGCGCCTCACGCATTCTTG

TTCCTTGTTTGCTTCTTCGGTTT

4891
Table 3A
Hs.294092
T93822
726995
EST375308 cDNA
1
TTAGAAAGAAAAGTCTTTTATTAGTAC

TGTGTAGGGAAGGCTAAAGAAAT

4892
db mining
Hs.301385
U19885
642583
602462113F1 cDNA, 5′ end
1
ACTGTGCGAAACGTACTGTATTACGA

/clone = IMAGE:4575051/clone_end = 5′

TTTTTGGAGTGGCCGAAGTAGTCC

4893
db mining
Hs.318720
U33547
3320135

Homo sapiens, clone MGC:12387
1
CAGACCCTGGTGATGCTGGAAACAG

IMAGE:3933019, mRNA, complete cds

TTCCTCGGAGTGGAGAGGTTTACAC

/cds = (63, 863)

4894
db mining
Hs.267811
U62624
1575443
mRNA for HLA-C alpha chain
1
GTCCAGCAACAGTGCCCAGGGCTCT

(Cw*1701)/cds = (0, 1118)

GATGAGTCTCTCATCGCTTGTAAAG

4895
db mining
Hs.247987
U80113
1791068
immunoglobulin heavy chain variable
1
GTGTATTACTGTGCGAGAGCCTTCCG

region (V4-31) gene, partial cds

CCATCCCGGAGTACGTCCAATATG

/cds = (0, 356)

4896
db mining
Hs.289036
U80180
1791202
immnoglobulin heavy chain variable
1
CCCGTCCCTCAAGAGTCGAGTCACC

region (VH4) mRNA, VH4-59 allele,

ATATCAGTAGACAAGTCCAAGAACC

partial cds/cds = (0, 353)

4897
db mining
Hs.247898
U96393
2078365
partial mRNA for Ig lambda light chain
1
GGCTCCAGGCTCAGGATGAGGCTGA

variable region, clone MB91 (331 bp)

TTATTACTGCTGCTCATATACAAGC

/cds = (0, 330)

4898
db mining
Hs.914
X00457
36405

Homo sapiens, Similar to major
1
CCCTCACTGTCACCTTCCCGAGAATA

histocompatibility complex, class II, DR

CCCTAAGACCAATAATACTTCAG

alpha, clone MGC:14114

IMAGE:4309471, mRNA, complete cds

/cds = (40, 822)

4899
db mining
Hs.296552
X03529
33351
DNA sequence from clone CTA-246H3
1
TGAATGACTTCTATCTGGGAATCTTG

on chromosome 22 Contains the gene

ACGGTGACCTGGAAGGCAGATGGT

for IGLL1 (immunoglobulin lamba-like

polypeptide 1, pre-B-cell specific), a

pseudogene similar to LRP5

(Lipoprotein Receptor Related

Protein.), ESTs, Genomic markers

(D22S414, D22S925, D22S926), CA

repeats, STSs, GSSs and a CpG island

/cds = (0, 438)

4900
literature
Hs.287797
X07979
31441
mRNA for FLJ00043 protein, partial
1
ACCACTGTATGTTTACTTCTCACCATT

cds/cds = (0, 4248)

TGAGTTGCCCATCTTGTTTCACA

4901
db mining
Hs.247804
X51887
37616
V108 gene encoding an
1
AGAACAGAGATGATTACACCTACGAA

immunoglobulin kappa orphon

GTCTGAGTTATGGTGTGAGTTGGA

4902
db mining
Hs.81220
X58397
33615
CLL-12 transcript of unrearranged
1
TTCATCATTGCTTGCTTGCCTTCCTC

immunoglobulin V(H)5 gene

CCTCCTGTCCGCTCTCACTCACTC

/cds = (39, 425)

4903
Table 3A
Hs.275959
X60656
31134
eukaryotic translation elongation factor
1
TGGATGTGGCTGCTTTCAACAAGATC

1 beta 2 (EEF1B2), mRNA

TAAAATCCATCCTGGATCATGGCA

/cds = (235, 912)

4904
db mining
Hs.90093
X67643
2244651
mRNA for heat shock protein apg-2,
1
TGAAGAACGACCAAAATTATTTGAAG

complete cds/cds = (278, 2800)

AACTAGGGAAACAGATCCAACAGT

4905
db mining
Hs.300697
Y14737
2765424
mRNA for immunoglobulin lambda
1
GTCTACATACTTCCCAGGCACCCAGC

heavy chain/cds = (65, 1498)

ATGGAAATAAAGCACCCACCACTG

4906
db mining
Hs.300697
Y14737
2785424
mRNA for immunoglobulin lambda
1
ATACTTCCCAGGCACCCAGCATGGAA

heavy chain/cds = (65, 1498)

ATAAAGGACCCACCACTGCCCTGG

4907
db mining
Hs.181125
Y14738
2785426

Homo sapiens, clone MGC:12849
1
CCCAAGGCATCAAGCCCTTCTCCCTG

IMAGE:4308973, mRNA, complete cds

CACTCAATAAACCCTCAATAAATA

/cds = (24, 725)

4908
Table 3A
Hs.283770
Z00008
33142
germline gene for the leader peptide
1
AAGGCAGAGATCTTGACACCTAAGGA

and variable region of a kapppa

GTCTAGTTTAGGGCTTTGGTTGGA

immunoglobulin (subgroup V kappa I)

4909
db mining
Hs.37089
Z00010
33146
germ line pseudogene for
1
GTTGACATTAGAAGCAGGATTCTCTG

immunoglobulin kappa tight chain

GTACTCCCTCAGAAAATAGAATGC

leader peptide and variable region

(subgroup V kapppa I)

4910
db mining
Hs.148661
Z00022
33158
qg78c05.x1 cDNA 3′ end
1
TTGGAGCGTTTTTGTGTTTGAGATATT

/clone = IMAGE:1841288/clone_end = 3′

AGCTCAGGTCAATTCCAAAGAGT

4911
Table 1
Hs.181297
AA010282
1471308
tc35a11.x1 cDNA, 3′ end
1
GGTTGTGTCTCTGGTTTCCCCTTTTC

/clone = IMAGE:2066588/clone_end = 3′

CCCGTGGTTTTAATTTTTAAGAAC

4912
Table 1
Hs.189468
AA069335
1576904
tm30a06.x1 cDNA, 3′ end
1
ACCATAGCAGACAGGGTCAGATGGA

/clone = IMAGE:2158068/clone_end = 3′

ATATTAGCGGTTTAGGTGAAGAACC

4913
Table 1
Hs.13659
AA115345
1670525
mRNA; cDNA DKFZp586F2423 (from
1
ATCCACATTCTTACCTTTGGTAGTCA

clone DKFZp586F2423)

GGTTTGGCTACTTTGCAGCTCGCC

/cds = UNKNOWN

4914
Table 1
Hs.182278
AA203528
1799239

Homo sapiens, calmodulin 2
1
TCTGTTACCACCTCTAAAATATTGGG

(phosphorylase kinase, delta), clone

GTGGAATAAAGCTGGGTTCTTGCA

MGC:1447 IMAGE:3504793, mRNA,

complete cds/cds = (93, 542)

4915
Table 1
Hs.100651
AA251184
1886149
golgi SNAP receptor complex member
1
AAGGATGAAGGACTGATGGAGGGCA

2 (GOSR2), mRNA/cds = (0, 838)

GAGGAACTGGAGGCAGCAGGCACAA

4916
Table 1
NA
AA252909
1885512
zr76a03.r1 Soares_NhHMPu_S1
1
AGATGTCTGTATAAACAACCTTTGGG

cDNA clone IMAGE:669292 5′, mRNA

TAGCAGGTGGTCAGTTAGGCAGGA

sequence

4917
Table 1
Hs.194480
AA258979
1894266
EST389427 cDNA
1
TGCTTGTCTTTTAAACACCTTCACAGA

TATCATTTGCACCTTGCCAAAGG

4918
Table 1
Hs.5241
AA280051
1921589
fatty acid binding protein 1, liver
1
GGGTAGGCAGCTTGCACCCAGTTCT

(FABP1), mRNA/cds = (42, 425)

CCTTTATCTCAACTTATTGTCCTGG

4919
Table 2
Hs.23128
AA282304
1925220

Homo sapiens, Similar to RIKEN
1
ACTTGGAACAGAAGAACTTCGGCAAC

cDNA 4931428D14 gene, clone

GAGAACACTATCTCAAGCAGAAGA

MGC:15407 IMAGE:4309813, mRNA,

complete cds/cds = (123, 1151)

4920
Table 1
NA
AA282774
1925825
zt14g01.r1 NCI_CGAP_GC81 cDNA
1
GCGGTGTCCCTGAGTGAGGGCAAAG

clone IMAGE:713136 5′, mRNA

TTGTAATAACACTTGTTCTCTCCTT

sequence

4921
Table 1
Hs.89072
AA283081
1926050
hypothetical protein MGC4618
1
ACGGCGTTCTGAAATTTAGCACACTG

(MGC4618), mRNA/cds = (107, 1821)

GGAAGTCCACATGGTTCATCTGAA

4922
Table 1
Hs.291448
AA290921
1938772
EST368168 cDNA
1
AATGAGATCACAGATGGTGACACTGA

GCGGAAGGATGCAGTACCTCGGAG

4923
Table 1
Hs.211866
AA290993
193898
wh99f02.x1 cDNA, 3′ end
1
GGCTAGTGGTGTTCAGAGAAATACCA

/clone = IMAGE:2388891/clone_end = 3′

AAACGTGTTTTTATCATTGCTGGT

4924
Table 1
NA
AA319163
1971490
EST21341 Adrenal gland tumor cDNA
1
AGCTGCCTCAGGAGGTTCTTAACATA

5′ end, mRNA sequence

TAGGAATGTAATTATCAGATTCAA

4925
Table 1
Hs.260238
AA332553
1984806
hypothetical protein FLJ10842
1
AGGAAACCAAGCCCTCACAGGAAAG

(FLJ10842), mRNA/cds = (39, 1307)

AAAGCCTGATTCAAGAAAACAAAGT

4926
Table 1
Hs.343557
AA401648
2058830
601500320F1 cDNA, 5′ end
1
GCTGGGGCTGAGAGAGGGTCTGGGT

/clone = IMAGE:3902237/clone_end = 5′

TATCTCCTTCTGATCTTCAAAACAA

4927
Table 1
Hs.186674
AA402069
2056860
qf56f06.x1 cDNA, 3′ end
1
TCATGGACACAAACTTTGGAGTATAA

/clone = IMAGE:1754051/clone_end = 3′

GCGACATCCCTTAAGCAACAGGCT

4928
Table 1
Hs.301985
AA412436
2071006
602435787F1 cDNA, 5′ end
1
GCCATTTTCCCTCCAGAAACAAAACC

/clone = IMAGE:4553684/clone_end = 5′

AAGATAATTTATCCTGAACACGGT

4929
Table 1
Hs.9691
AA418765
2080566
cDNA; FLJ23249 fis, clone COL04196
1
TGTTTGTACCACTAGCATTCTTATGTC

/cds = UNKNOWN

TGTACTTGAACGTGTAGTTAGCA

4930
Table 1
Hs.24143
AA426506
2106769
Wiskoff-Aldrich syndrome protein
1
AGGACCATAGGGAAGAGCCAGCCTT

interacting protein (WASPIP), mRNA

GCCTTTTCTTATATGATTTTGTTTA

/cds = (108, 1619)

4931
Table 1
Hs.89519
AA429783
2112974
KIAA1046 protein (KIAA1046), mRNA
1
CCTGGGTTGCCTTGTAATGAAAAGGG

/cds = (577, 1782)

AGATCGAGCCATTGTACCACCTTA

4932
Table 1
NA
AA457757
2180477
aa92c03.r1 Stratagene fatal retina
1
AGCTGTTTAATTGAATTGGAATCGTT

937202 cDNA clone IMAGE:836756 5′,

CCACTTGGAACCCAAGTTTGGAAA

mRNA sequence

4933
Table 1
Hs.82772
AA480876
2185996
collagen, type X1, alpha 1 (COL11A1),
1
TCGTTCTACGTTATCTCATCTCCTTGT

mRNA/cds = (161, 5581)

TTTCAGTGTGCTTCAATAATGCA

4934
Table 1
Hs.13809
AA476568
2204779
mRNA for KIAA1525 protein, partial
1
TGTTTTTGCTTCCTCAGAAACTTTTTA

cds/cds = (0, 2922)

TTGCATCTGCCATCCTTCATTGG

4935
Table 1
NA
AL047171
5936355
DKFZp586F2018_r1 588 (synonym:
1
TGCACTTACTCATTAGTTTTTAGTTTG

hute1) cDNA clone DKFZp586F2018

AACTCTCCTGCGAGGTCTAATGT

5′, mRNA sequence

4936
Table 1
Hs.77868
AL513780
12777274
ORF (LOC51035), mRNA
1
TGGTTCTTCTGATGAGCAAGGGAACA

/cds = (135, 1031)

ACACTGAGAATGAGGAGGAGGAGT

4937
Table 2
Hs.30120
AL533737
12797230
cDNA/clone = CS0DF00ZYH09-(5-
1
AAGCAAGAGATTGTAAACCGGGTACA

prime)

GATCCAAGAGATGAGAGAGGACCC

4938
Table 1
Hs.285401
AL540399
12870508
colony stimulating factor 2 receptor,
1
CGTCTACTGCGGAAAAGTCAGGGGA

beta, low affinity (granulocyte-

AACTGCCAAACAAAGGAAAATGCCC

macrophage) (CSF2RB), mRNA

/cds = (26, 2721)

4939
Table 1
NA
AV689330
10291193
AV689330 GKC cDNA clone
1
GTGTTTGACTTCACTGCTGCGAAATG

GKCDJE03 5′, mRNA sequence

ACTGTCTCCTGGCTAGTAGGATCT

4940
Table 1
Hs.90960
AV710415
10729044
602563938F1 cDNA, 5′ end
1
ATGTGGGAGGGGCATGGCAGCTATG

/clone = IMAGE:4688769/clone_end =5′

AAGGACCTCCTACCTCTGGTTTCTG

4941
Table 1
Hs.237868
AV716565
10813717
interleukin 7 receptor (IL7R), mRNA
1
CCAGCCTTTGCCTCTTCCTTCAATGT

/cds = (22, 1401)

GGTTTCCATGGGAATTTGCTTCAG

4942
Table 1
Hs.127160
AV719938
10817090
AV659177 cDNA, 3′ end
1
ACCTTGTAAGTGCCTAAGAAATGAGA

/clone = GLCFUC08/clone_end = 3′

CTACAAGCTCCATTTCAGCAGGAC

4943
Table 2
Hs.21536
AV720964
10818136
yf69a03.s1 cDNA, 3′ end
1
GCCGAGATCTGCTCAGACTACATGG

/clone = IMAGE:27414/clone_end = 3′

CTTCCACTATAGGGTTCTACAGTGT

4944
Table 1
Hs.22003
AV730135
10839556
solute carrier family 6
1
ATGTCTATAAATGGTGTCATAACTAG

(neurotransmitter transporter, GABA),

AGCACGGGCGTTATGTAAGTTTCT

member 1 (SLC6A1), mRNA

/cds = (234, 2033)

4945
Table 1
Hs.339696
AV755367
10913215
ribosomal protein S12 (RPS12),
1
TGAGTCGTATTACAATTCACTGGCCG

mRNA/cds = (80, 478)

TCGTTTTACAACGTCGTGACTGGG

4946
Table 1
Hs.301553
AW021037
5874567
karyopherin alpha 6 (importin alpha 7)
1
ACATAGGCGAAGAAAACATGGCATTG

(KPNA8), mRNA/cds = (55, 1685)

AGTGTGCTGAGTCCAGACAAATGT

4947
Table 2
NA
AW402007
6920693
UI-HF-BK0-aao-g-02-0-UI.r1
1
GTGCAGTCCATCAGATCCAAGCCTGT

NIH_MGC_38 cDNA clone

CTCTTGAGGAACAACCGCGCAGAC

IMAGE:3054530 5′, mRNA sequence

4948
Table 1
NA
AW499658
7111531
UI-HF-BR0p-ajj-c-07-0-UI.r1
1
TGGTGGCAAATCTGATTTTTGGAAAC

NIH_MGC_52 cDNA clone

GAGTATTGGAGGACTATAAAACAA

IMAGE:3074677 5′, mRNA sequene

4949
Table 1
NA
AW499828
7111870
UI-HF-BN0-ake-c-06-0-UI.r1
1
ACATTTCTTGTTGGCACTACAGCAAC

NIH_MGC_50 cDNA clone

CACATACAGTACAGACAACCTCCA

IMAGE:3076619 5′, mRNA sequence

4950
Table 1
Hs.145668
AW500534
7113240
fmfc5 cDNA/clone = CR6-21
1
CCTGGCACATGTTGTCTGGAGTCTGG

CACACTGGTTATCAATAGCACATT

4951
Table 1
Hs.120996
AW504293
7141960
serine/threonine kinase 17b (epoptosis-
1
CTGTGGTCTGTTATATGAGAGAGATC

inducing) (STK17B), mRNA

CTTTAACTAGAGCAAAGAGGGAGT

/cds = (281, 1379)

4952
Table 1
Hs.194589
AW945536
8123293
AV703056 cDNA, 5′ end
1
TCTCTCACTGTTATCATTTTTGCACAG

/clone = ADBCMB06/clone_end = 5′

GTGGTTTCAGCAGCTTGATGCCA

4953
Table 1
NA
BE177661
8656813
RC1-HT0598-020300-011-h02
1
AATCACAGCAGTAACTCCCAGTAGGA

HT0598 cDNA, mRNA sequence

AAGATTCTCAAAGGAATAGTTCTT

4954
Table 2
NA
BE253336
9123402
601117146F1 NIH_MGC_16 cDNA
1
CCTGGCCTTCAAGAAGTCGTAGTGG

clone IMAGE:3357826 5′, mRNA

CTATTTTCTTTGGACAAAGTAAGA

sequence

4955
Table 1
Hs.343565
BE540808
9769453
601510248F1 cDNA, 5′ end
1
ATAGACAGACGGAGGTCCTGATATCC

/clone = IMAGE:3912034/clone end =5′

ATGGGCCAACGGCTTGGATTATTC

4956
Table 2
NA
BE569141
9812861
601338954F2 NIH_MGC_53 cDNA
1
GATATTGGTAGTAAAGGGGTTACCTG

clone IMAGE:3881180 5′, mRNA

TGAACTTCCAAAATTCCTTGGGGC

sequence

4957
Table 1
Hs.271272
BE737348
10151340
DKFZp434K1715_rt cDNA, 5′ end
1
GGTGGAGAATCAAAACGACCCCGCA

/clone = DKFZp434K1715/clone_end = 5′

AATAAACATGGCGATTTGGCTTGGG

4958
Table 2
Hs.20225
BE792125
10213323
tuftelin-interacting protein (TIP39),
1
GATATCAGACAGCATCGTCTCTGCGA

mRNA/cds = (283, 2776)

GCACAAAGATCTGTTTGCTGAGCA

4959
Table 1
Hs.31314
BE872245
10321021
retinoblastoma-binding protein 7
1
ACATTTTATAAGGCATTTGTGTTAGCC

(RBBP7), mRNA/cds = (287, 1584)

ACTCAGTCATCTTTGGGTGCTGC

4960
Table 2
NA
BE884898
10333674
601506831F1 NIH_MGC_71 cDNA
1
ATCTGGAGTGGGACCCTTCAAACCAT

clone IMAGE:3908551 5′, mRNA

GTCTGTGCTTATGCGGGAACAAT

sequence

4961
Table 1
Hs.250824
BE887846
10343176
cDNA:FLJ23435 fis, clone HRC12631
1
AATTAACGGCCATCACACCCACGACT

/cds = UNKNOWN

GACGGTGATCAAACAAATTCACAG

4962
Table 1
NA
BE898691
10361375
601440131F1 NIH_MGC_71 cDNA
1
GACAGTACTCCTAAGACCCCTGTGTG

clone IMAGE:3925062 5′, mRNA

TGTCCCGATGAGATCATGACTGGG

sequence

4963
Table 1
Hs.337986
BF033741
10741453

Homo sapiens, clone MGC:17431
1
CTGTGATATTTTGGTCATGGGCTGGT

IMAGE:2984883, mRNA, complete 1ds

CTGGTCGGTTTCCCATTTGTCTGG

/cds = (1336, 1494)

4964
Table 1
Hs.268177
BF339088
11285508
phospholipase C, gamma 1 (formerly
1
CTCATAGCATAGCCAGCATTCAGCAC

subtype 148) (PLCG1), mRNA

ACACAAACCTACTGCCCACATTTG

/cds = (76, 3948)

4965
Table 1
Hs.2554
BF341359
11287850
sialytransferase 1 (beta-galactoside
1
CACATTTGAAGGCCAAAGGGAA

alpa-2,6-sialytransferase) (SIAT1),

AACGGGGGAAGCGGAAGGGTTGGA

mRNA/cds = (310, 1530)

TTGG

4966
Table 1
Hs.334825
BF530382
11617745
cDNA FLJ14752 fis, clone
1
TACGACCACTGAGAAACGGGCCACC

NT2RP3003071/cds = (205, 1446)

CGGCACACGGATCTTGGAACACAAA

4967
Table 1
Hs.79530
BF683110
11937011
M5-14 protein (LOC51300), mRNA
1
CTCAGTGTAGGGCAGAGAGGTCTAA

/cds = (186, 1043)

CACCAACATAAGGTACTAGCAGTGT

4968
Table 1
Hs46677
BF667621
11941516
PRO2000 protein (PRO2000), mRNA
1
AGGTTGTGGGGAGTATGTTTGGACCA

/cds = (650, 1738)

AAAATTAAAATATTGTGGGAGGGA

4969
Table 1
Hs.27590
BF671020
11944915
histone acetyltransferase (MORF),
1
TGATAGCTCACTTAGTTAATTGTTTTG

mRNA/cds = (315, 6538)

AAGCAAATTTTGGGTTGGATGGG

4970
Table 1
Hs.71331
BF691178
11976586
hypothetical protein MGC5350
1
ACTACTGCTTGCGTACCTCTCCGCTT

(MGC5350), mRNA/cds = (189, 995)

TCCCTCTCCTTACTATCGACCATA

4971
Table 1
Hs.337534
BF985068
12332283
602268833F1 cDNA, 5′ end
1
GGTCCGACCAATTAATGACTCCATGA

/clone = IMAGE:4356776/clone_end = 5′

TCGGCCTCGGTTTTCACAAACCTT

4972
Table 1
Hs.334691
BF965438
12332653
hypothetical protein FLJ22427
1
AGACAAAGAGAGCATAAATATAGCTC

(FLJ22427), mRNA/cds = (40, 2631)

TACTCATGGGTACCATACCAGTGT

4973
Table 1
Hs.279681
BF985960
12333175
heterogeneous nuclear
1
GCAGGTTATCGCAAGATGTCTTAGAG

ribonucleoprotein H3 (2H9) (HNRPH3),

TAGGGTTACGGTTCTCAGTGACAC

transcript variant 2H9, mRNA

/cds = (118, 1158)

4974
Table 1
Hs.5324
BF966028
12333243
hypothetical protein (CL25022), mRNA
1
AAATGGCTTTACCAAACATTGTCAGT

/cds = (157, 1047)

ACCTTTACGTGTTAGAAGGCATTT

4975
Table 1
Hs.179902
BF966049
12333264
transporter-like protein (CTL1), mRNA
1
CTTTCCACAGCAATTGTTTTGTACGA

/cds = (0, 1964)

GGGGCCTTACAGCGCGGTCCACTT

4976
Table 1
Hs.109441
BF969847
12337062
cDNA FLJ14235 fis, clone
1
CCCTACTTGATTAAAGATTGAGGTGG

NT2RP4000187/cds = (82, 2172)

AATTCTAGATGTGGTCATTCGTGT

4977
Table 2
Hs.289721
BF981634
12384446
cDNA:FLJ22193 fis, clone HRC01108
1
ACAGAGAGTCACCCGCGAGTACGAA

/cds = UNKNOWN

ACAGGCACATTTTTAGAAACTCACA

4978
Table 1
Hs.125819
BG034799
12428456
putative dimethyladenosine
1
AGAAATGGTACGGGGAATGTGAATAA

transfease (HSA9761), mRNA

CACGAAATGGTATGGGGAAATGTG

/cds = (76, 1019)

4979
Table 1
Hs.34908
BG111773
12605279
6018204481F1 cDNA, 5′ end
1
CACAACGGGTCTTAATGACGACGGAA

/clone = IMAGE:4052578/clone_end = 5′

AGATACATCCATCGGTATGAACGC

4980
Table 1
NA
1BG118529
2612035
602348464F1 NIH_MGC_90 cDNA
1
TGTTCTTGTGCTGCTGTTATCTATACT

clone IMAGE:4443519 5′, mRNA

ATTTTTGTTCGTGCCTTCTGACT

sequence

4981
Table 1
Hs.285729
BG163237
12669951
602013364F1 cDNA, 5′ end
1
GTCTGGGTGCCAACTTGAGACAGGT

/clone = IMAGE:4149351/clone_end = 5′

GGTCTAGGAAATTGCGGTAAGAGCG

4982
Table 2
Hs.111554
BG164898
12671532
ADP-ribosylation factor-like 7 (ARL7),
1
CCCCTGGTTTTCTCGTTCTGCCTCCT

mRNA/cds = (14, 592)

TTGGACCTGTGTTTGTTTTCTGCT

4983
Table 1
Hs.193482
BG165998
12672701
cDNA FLJ11903 fis, clone
1
CCCTTAGAATGGTTACTGCCCTTGAA

HEMBB1000030/cds = UNKNOWN

TTAACTTGACACAACTTGGGTTGG

4984
Table 1
Hs.83731
BG179257
12685889
CD33 antigen (gp67) (CD33), mRNA
1
AGGCTGATTCTTGGAGATTTAACACC

/cds = (12, 1108)

CCACAGGCAATGGGTTTATAGACA

4985
Table 1
Hs.278426
BG286817
13040034
progestin induced protein (DD5),
1
TCTCCTTTCAGTTCCTTTGTAGGATTT

mRNA/cds = (33, 8432)

CTGGGCTTGAAGGATAGTCTTCA

4986
Table 1
Hs.173830
BG289048
13044499
602383666F1 cDNA, 5′ end
1
ATACTGTGTGATTTGCCCTTGCTGTC

/clone = IMAGE:4512712/clone_end = 5′

GAACCCTGTTCTTGCTGCCATTTA

4987
Table 1
Hs.129872
BG290577
13047679
sperm associated antigen 9 (SPAG9),
1
AGAATGTCCCACTTGCTGTCTCTTAG

mRNA/cds = (110, 2410)

AGGCTGAGCTTCATTTCTATGAGC

4988
Table 1
Hs.170980
BG387694
13281140
cell cycle progression 2 protein
1
CAACCTCTGGAGAGTGCCTACTGTTA

(CPR2), mRNA/cds = (126, 1691)

GAAGCTGAAGGGATGTCAAAGTCA

4989
Table 1
Hs.266175
BG391695
13285143
cDNA FLJ20673 fis, clone KAJA4464
1
CTTTAAATCTTAGATTGCTCCGCACA

/cds = (104, 1402)

GATAAAGAGAACCAGGATTGGGGC

4990
Table 1
Hs.58643
BG397564
13291012
602438603F1 cDNA, 5′ end
1
GCCTCAGTACAGAGGGGGCTCTGGA

/clone = IMAGE:4564968/clone_end = 5′

AGTGTTTGTTGACTGAATAACGGA

4991
Table 1
Hs.24054
BG489375
13450885
hypothetical protein GL009 (GL009),
1
AGGACTTAACGGGAATACGGGAATAA

mRNA/cds = (77, 628)

CTCCAATTACTTCATCTCTAGGGC

4992
Table 1
Hs.29131
BG497765
13459282
nuclear receptor coactivator 2
1
TGCCTAAGAGCAAAGCATCCTCTGCG

(NCOA2), mRNA/cds = (182, 4556)

ACAAAAGAAAATTACTGTAGTGGC

4993
Table 2
Hs.172089
BG501063
13462580
mRNA; cDNA DKFZp586I2022 (from
1
AAACACACAGGAAAAGGGCAAGGG

clone DKFZp586I2022)

GGCACCAGGAGAACCGGGAGACAAA

/cds = UNKNOWN

4994
Table 1
NA
BG501895
13463412
602548201F1 NIH_MGC_61 cDNA
1
GACATGGAGCCCCCGGAAAAGCGGG

clone IMAGE:4654344 5′, mRNA

TCTGGACACCAAGTCGATGTGTGAG

sequence

4995
Table 1
Hs.3280
BG505961
13467478
caspaso 6, apoptosis-related cysteine
1
ACAGAATCAGATTTTGCAGGTGTCCA

protease (CASP6), transcript variant

ACCTATAGTGGCTAAGAATTATGT

alpha, mRNA/cds = (78, 959)

4996
Table 1
Hs.279009
BG532345
13523883
matrix Gla protein (MGP), mRNA
1
AAACTGTTTGGAGAATTTAAGCACTC

/cds = (46, 357)

TCTGATGGGGGACAACTCTATGGA

4997
Table 1
Hs.74647
BG536394
13527940
T-cell receptor active alpha-chain
1
AATAATTGGTCTTTTAAACAAACACG

mRNA from JM cell line, complete cds

GAAGTTTGGTGGAATCGGTCATGT

/cds = (136, 969)

4998
Table 1
NA
BG542394
13534627
602571761F1 NIH_MGC_77 cDNA
1
TGTGGCGATTAAGAGAGGTGAAGCAT

clone IMAGE:4696046 5′, mRNA

AACTGATTTGCAGGATATGGTTTG

sequence

4999
Table 1
Hs.83077
BG547627
13546292
interleukin 18 (interferon-gamma-
1
GCAGAACTCTAATTGTACGGGGTCAC

inducing factor) (IL18), mRNA

AGAGGCGTGATATGGTATCCCAAA

/cds = (177, 758)

5000
Table 1
Hs.301497
BG566035
13573688
arginine-tRNA-protein transferase 1-1p
1
TGGAGATCCTTCTACTTGGCTGCTGT

(ATE1) mRNA, alternatively spliced

ATTCATGCATTATGTTGGTTTGAG

product, partial cds/cds = (0, 1544)

5001
Table 1
Hs.343475
BG566964
13574617
601556208T1 cDNA, 3′ end
1
ATTTGTACCAAATCTTTGGGATTCATT

/clone = IMAGE:3826392/clone_end = 3′

GGCAAATAATTTCAGTGTGGTGT

5002
Table 1
Hs.11050
BG571068
13578721
mRNA; cDNA DKFZp4340118 (from
1
GGTTTTAGCAGTTCTTTAGCCCGTGG

clone DKFZp434C0118); partial cds

TATTTCAGTGTTGGGTTTCATAGC

/cds = (0, 1644)

5003
Table 1
Hs.194110
BG571747
13579400
hypothetical protein PRO2730
1
GGGAGCCATAAGAACGACTCCAAAAA

(PR02730), mRNA/cds = (183, 596)

GAGCCCCAAGGAGGACAAGGGGG

5004
Table 1
Hs.306155
BG572371
13580024
chorionic somatornammotropin
1
TCAGGGTCTTGGATACTCAAGAGAAA

hormone 1 (placental lactogen)

GGAGACTTGTGGTTAATGTTTGGA

(CSH1), transcript variant 2, mRNA

/cds = (116, 886)

5005
Table 1
Hs.301756
BG573202
1358055

Homo sapiens, clone MGC:17544
1
TCCTTAGCACACGAAAAAGCCCCTTC

IMAGE:3482146, mRNA complete cds

CCCTGGATTCATGTTTCTTATTTC

/cds = (258, 894)

5006
Table 1
Hs.79101
BG575739
13583392
cyclin G1 (CCNG1), mRNA
1
AAGCAAGTAGACACCTTCATAACTAT

/cds = (187, 1074)

GAATGAAGCTGCTGAAGTAGTGTT

5007
Table 1
Hs.172780
BG611117
13682488
602343016F1 cDNA, 5′ end
1
TCCATTAAAGATCGCAAATGTTGAGG

/clone = IMAGE:4453466/clone_end = 5′

TCCTGTAGCCTGAAAACTCTCTGC

5008
Table 1
Hs.5064
BG614405
13885776
602490910F1 cDNA, 5′ end
1
CTGATTCAAACAGGTTCCAACGTAA

/clone = IMAGE:4619835/clone_end = 5′

ACGTTCACACTTCCACCATTTCCT

5009
Table 1
Hs.86437
BG815272
13666643
602411368F1 cDNA, 5′ end
1
TGATGTTGGTATGCTTGCCCTGTTAC

/clone = IMAGE:4540098/clone_end = 5′

TTATAGACAGTCTTTGTCATAGGC

5010
Table 1
Hs.111911
BG617515
13668888
602540482F1 cDNA, 5′ end
1
GGTCTTTGTCCCAGTAGAGTTCATAG

/clone = IMAGE:4671519/clone_end = 5′

TCTATTTAGTGTGCATGTTTTTCC

5111
Table 1
Hs.326392
BG618351
13669722
son of sevenless (Drosophila)
1
TTGTGTCCAAAAGTGTTAACGAAGAC

homolog 1 (SOS1), mRNA

TACTTAACCCAATGATTGGCGCGA

/cds = (0, 3998)

5012
Table 1
NA
BG622313
13673684
602646981F1 NIH_MGC_79 cDNA
1
ATGCGTGGATATTGAGAACTTAGGTG

clone IMAGE:4768413 5′, mRNA

TCTAATGGGGAGGATTATTGCTGT

sequence

5013
Table 1
Hs.173334
BG674441
13905837
ELL-RELATED RNA POLYMERASE
1
AAGCATTTCCATTTCAACGAGTTTGT

II, ELONGATION FACTOR (ELL2),

CAGCTTTATTAATGTTGGGCAAAA

mRNA/cds = (0, 1922)

5014
Table 1
Hs.343615
BG675211
13906607
602621493F1 cDNA, 5′ end
1
AAACCTACCACTTTAAGAAGACAGCG

/clone = IMAGE:4755166/clone_end = 5′

ATGGGTAATTCTTTATTGGCAGGT

5015
Table 1
Hs.250905
BG675766
13907162
hypothetical protein (LOC51234),
1
ATTCAGCATTAGTTTCTCACATCTTCC

mRNA/cds = (0, 551)

CCCAGGTATCCCCAACAGAATTA

5016
Table 1
NA
BG676788
13908185
602623378F1 NCI_CGAP_Skn4
1
ACACCTCTCTTAGGGCTCCATCAAAC

cDNA clone IMAGE:4748322 5′, mRNA

AGAACTTTTAGACTGAGTAACGCT

sequence

5017
Table 1
Hs.21812
BG676903
13908300
AL562895 cDNA
1
AAGTTTGTGCAGCACATTCCTGAGTG

/clone = CS0DC021YO20-(3-prime)

TACGATATTGACCTGTAGCCCAGC

5018
Table 2
Hs.171802
BG678827
13910224
RST31551 cDNA
1
ACCATGAACAGTGTGTTGCTTCAGAC

TATTACAAAGAGAATGGGGCAGGT

5019
Table 1
Hs.12396
BG679427
13910824
602302446F1 cDNA, 5′ end
1
TTTTTGAAAAGTATGTTTGGTAGAAAT

/clone = IMAGE:4403866/clone_end = 5′

TAGTTGTATGCCCTCAGGACGGT

5020
Table 1
Hs.4248
BG679662
13911059
vav 2 oncogene (VAV2), mRNA
1
GAAATTAGTGTGAACATGTGGGAAGC

/cds = (5, 2641)

CCGATGCATGTGGGTCAGGGATCT

5021
Table 1
Hs.182937
BG681320
13912717
peptidylpropyl isomerase A (cyclophilin
1
TCCCTGGGTGATACCATTCAATGTCT

A) (PPIA), mRNA/cds = (44, 541)

TAATGTACTTGTGGCTCAGACCTG

5022
Table 1
NA
BG682704
13914101
602629666F1 NCI_CGAP_Skn4
1
CAGACAGCACAGCCTGAGGGTAGCA

cDNA clone IMAGE:4754273 5′, mRNA

GCAGCCACCCATGTTCAGGTAAGTC

sequence

5023
Table 2
Hs.250465
BG707615
13984138
mRNA; cDNA DKFZp434E2023 (from
1
GCCATGAGGTGGAGGACGTGGACCT

clone DKFZp434E2023)

GGAGCTGTTCAACATCTCGGTGCAG

/cds = UNKNOWN

5024
Table 1
Hs.235883
BG708357
13985818
602628774F1 cDNA, 5′ end
1
TCTGCACCCAAACAAATACCTTTTGA

/clone = IMAGE:4753483/clone_end = 5′

GATTTCTTATAGGCATTCCTCTCG

5025
Table 1
Hs.119960
BG709079
13987060
mRNA; cDNA DKFZp727G051 (from
1
GAAGCTCTGCCGCAGCGCCAGGCAC

clone DKFZp727G051); partial cds

TTCCTACACCACTACTACGTCCACG

/cds = (0, 1423)

5026
Table 1
Hs.87908
BG709315
13987530
Snf2-related CBP activator protein
1
CAGCTCGGACCACCGCCACCTCCCT

(SRCAP), mRNA/cds = (210, 9125)

TTTTATTTACAGATCACCCAGTAAG

5027
Table 1
Hs.10056
BG720359
13999546
hypothetical protein FLJ14621
1
GGTCCCCTCCTGGAGACTCCCTCAC

(FLJ14621), mRNA/cds = (525, 1307)

AAAATCTTTCCCCAAGCTGTTCCCC

5028
Table 1
Hs.6986
BG723274
14002461
glucose transporter pseudogene
1
TGAATGGGCGTTTATCTTAATGACCA

/cds = UNKNOWN

GTTATTGACCAAAGTGTACTCAGA

5029
Table 1
Hs.181392
BG740787
14051440
major histocompatibility complex, class
1
AGCCTATTCCTATTCTCTAGCCTATTC

I, E (HLA-E), mRNA/cds = (7, 1083)

CTTACCACCTGTAATCTTGACCA

5030
Table 2
Hs.86543
BG743518
14054171
602495247F1 cDNA, 5′ end
1
GCAATGGGCGGCCAACTATGAACCC

/clone = IMAGE:4609330/clone_end = 5′

TACGTGGTGGTGGCACGAGACTGTC

5031
Table 1
Hs.77202
BG743900
14054553
protein kinase C, beta 1 (PRKCB1),
1
GCCTGGAGCTTGGCTTTGTATCCAAG

mRNA/cds = (138, 2151)

TGTATGGTTGCTTTGTCTAAGAGG

5032
Table 2
Hs.95835
BG747882
14058515
RST8356 cDNA
1
AGGGAGACTCTCAGCCTTCAGCTTCC

TAATTCTGTGTCTGTGACTTTCG

5033
Table 1
Hs.204959
BG758589
14069222
hypothetical protein FLJ14886
1
AGCCTACAAGCCACCTCGCCACTGT

(FLJ14888), mRNA/cds = (111, 1169)

GAACTTGTCGTCACTCTTGGATGTC

5034
Table 2
Hs.37617
BG760189
14070842
602144947F1 cDNA, 5′ end
1
CCTGCTCACAGACCAGGAACTCTACA

/clone = IMAGE:4308683/clone_end = 5′

AGCTGGACCCTGACCGGCAGTACC

5035
Table 1
Hs.182447
BG766957
14077610
heterogeneous nuclear
1
AGCAGTTCCACAGTGTTTCACACTAC

ribonucleoprotein C (C1/C2) (HNRPC),

AGGATTTAAATATTTTGCTCCAGA

transcript variant 1, mRNA

/cds = (191, 1102)

5036
Table 2
Hs.301226
BG768471
14079124
mRNA for KIAA1085 protein, partial
1
CCTTTATCCACCTGGATTTTAGGGAC

cds/cds = (0, 1755)

AACACTGAAAACGAATAAGTCCA

5037
Table 2
Hs.301226
BG768471
14079124
mRNA for KIAA1085 protein, partial
1
CCTTTATCCACCTGGATTTTAGGGAC

cds/cds = (0, 1755)

AAACACTGAAAACGAATAAGTCCA

5038
Table 1
Hs.124675
BG772661
14083314
ob13b08.s1 cDNA, 3′ end
1
CAGAGAACGAAGTCAAGTGCAGCG

/clone = IMAGE:1323543/clone_end = 3′

AGTTGGGTGGAAGCTGATAGAGCAA

5039
Table 2
Hs.301228
BG775621
14045938
mRNA for KIAA1085 protein, partial
1
CCACAAACCATTCAGATCAGGCACTT

cds/cds = (0, 1755)

GCTGACCCTGGTTCTTAAGGACAC

5040
Table 1
Hs.180450
BG820627
14168214
ribosomal protein S24 (RPS24),
1
AAGAAACTATGTAGCATAGTGTCTTA

transcript variant 1, mRNA

ACACCTCAGTAAAGTAAGCTGGCC

/cds = (37, 429)

5041
Table 1
Hs.1432
BG913430
14293906
protein kinase C substrate 80K-H
1
AGCAGGAGACAGCTTCCTGATCTAGA

(PRKCSH), mRNA/cds = (136, 1719)

TGTACAATTAGAGTTTAGGTTGGA

5042
Table 1
Hs.247474
BG913498
14293974
hypothetical protein FLJ21032
1
TGGAACTAGTCACAATTGAAGTTCTT

(FLJ21032), mRNA/cds = (235, 1005)

CATCCAGTAGGTGTTAACAGTGT

5043
Table 1
Hs.72988
BI086609
14504939
signal transducer and activator of
1
CCCACACAAGTGCGCCACATAAATCT

transcription 2, 113 kD (STAT2), mRNA

GCGAGACTCCACGACAACACAGGG

/cds = (57, 2612)

5044
Table 1
Hs.288036
BI086741
14505071
tRNA isopentenylpyrophosphate
1
GCAAACAAGTTCTAAAGTTGTGGAGA

transferase (IPT), mRNA

AAAAGTGATGTGGTCAAGAGTTGA

/cds = (60, 1040)

5045
Table 1
Hs.131887
BI090806
14509136
602415255F1 cDNA, 5′ end
1
GCCAGAAAGAGAAACGTAAAAA

/clone = IMAGE:4523725/clone_end =

CAGATAGAGATTCTGCCTGTGCTT

5′

TGGT

5046
Table 1
Hs.287797
BI091791
14510121
mRNA for FLJ00043 protein, partial
1
GAGAGTTGCTGGTGTAAAATACGTTT

cds/cds = (0, 4248)

GAAATAGTTGATCTACAAAGGCCA

5047
Table 1
Hs.146381
BI092128
14510458
RNA binding motif protein, X
1
GGTTAACGCTTCTGTGAGGACCTTCT

chromosome (RBMX), mRNA

GGCTCTTGAGATACCCTAAATATT

/cds = (11, 1186)

5048
Table 1
Hs.75249
BI092568
14510898
mRNA for KIAA0069 gene, partial cds
1
ACTTTCATTGGTAAATAAGCCTGTCTT

/cds = (0, 680)

CCTATCTGGATTTTTGGTGTGCA

5049
Table 1
Hs.73965
BI093470
14511800
splicing factor, arginine/serine-rich 2
1
CAGTTATTTAAAGGCTGACAACTGCC

(SFRS2), mRNA/cds = (155, 820)

TTCCAGACCCGCGCTGTATTAATA

5050
Table 1
Hs.104679
BI094249
14512579

Homo sapiens, clone MGC:18216
1
TGGTGGGTACAGAAACATTGTCACAG

IMAGE:4156235, mRNA, complete cds

GGATCCTGGAACAGAGGAAGAGTT

/cds = (2206, 2373)

5051
Table 1
Hs.7905
BI193299
14648319
SH3 and PX domain-containing protein
1
TTCTGACCTAATAATTACGGGAAATG

SH3PX1 (SH3PX1), mRNA

GAAAGTCTGGGCCAGCATCAATAA

/cds = (43, 1830)

5052
Table 1
Hs.217493
BI195901
14650921
annaxin A2 (ANXA2), mRNA
1
TGGGTCGGCAAAGCTATTATAACTTT

/cds = (49, 1068)

GAATGCTAACGGCATGTTTGACCT

5053
Table 1
Hs.33026
BI198202
14653223
mRNA for FLJ00037 protein, partial
1
GCTGTGTCCTTTCTGGCACAATCGGG

cds/cds = (384, 3921)

GATTCCATTCTTTAGACACTGGAA

5054
Table 1
Hs.179661
BI222978
14676422

Homo sapiens, tubulin, beta 5, clone
1
TTGACAAAGATGACATCGCCCCAAGA

MGC:4029 IMAGE:3617988, mRNA,

GCCAAAAATAAATGGGAATTGAAA

complete cds/cds = (1705, 3039)

5055
Table 1
Hs.23158
BI224666
14678110
600943902F1 cDNA, 5′ end
1
GTAAAGATCAGAATACCAAGGCCAGC

/clone = IMAGE:2966352/clone_end = 5′

TAAGGCAACGACTCCCTCCCCAAA

5056
Table 1
Hs.218387
H03298
866231
tc88c11.x1 cDNA, 3′ end
1
ATACGGGACAATAAAATCTGCCTTTT

/clone = IMAGE:2073236/clone_end = 3′

GCTCTGGAGGGAGATACTACCTCT

5057
Table 1
Hs.178703
H56344
1004988
AV716627 cDNA, 5′ end
1
ATGCTGGTGTCATGTGACATTTGTTG

/clone = DCBBCH05/clone_end = 5′

AGTCTCGGGCATGTTCACGGTGGG

5058
Table 1
NA
H57221
1010053
yr08e08.r1 Soares fetal liver spleen
1
GGAAATTGTGCCAAAACCATGGAAAA

1NFLS cDNA clone IMAGE:204710 5′,

TATTACTGTGTGTGGGGTGTCTGT

mRNA sequence

5059
Table 1
Hs.74002
H81660
1059749
mRNA for steroid receptor coactivator
1
TTTGTGTGTGAAATATAACATTGATTG

1e/cds = (201, 4400)

AATTGCAGTTACATTTGGTTAGT

5060
Table 1
Hs.5122
N31700
1152099
602293015F1 cDNA, 5′ end
1
AACATTCTACATAGCACAGGAGCTTA

/clone = IMAGE:4387778/clone_end = 5′

AGAGTGGCATTATCTTCTCGCCTT

5061
Table 1
NA
R11456
764191
yf46a09.r1 Soares fetal liver spleen
1
TAAGGTTAGGCAATAACTTAGGGGTA

1NFLS cDNA clone IMAGE:129880 5′

TATTCTCTTCCTGCATCCCAGTGC

similar to gb|M87943|HUMAALU4

5062
Table 1
Hs.208603
R64054
835933
7f01d11.x1 cDNA, 3′ end
1
TAAGGTGTTTGCTGGGGGATGTTGTG

/clone = IMAGE:3293397/clone_end = 3′

TGTATTAGGGGAGTGTTTCCCTTG

5063
Table 1
NA
R85137
943543
yo41c07.r1 Soares adult brain
1
AAAACATTGCCAGACCATTTAGTCCT

N2b4HB55Y cDNA clone

CTTGGAAGGGCCTCTCCGGTGGGG

IMAGE:180492 5′, mRNA sequence

5064
Table 1
NA
T80378
698887
yd05c01.r1 Soares infant brain 1NIB
1
CGGGGGAATAGGAGGAAAAACATGG

cDNA clone IMAGE:24693 5′, mRNA

CATGGAACAACCAACATAAAAGGT

sequence

5065
Table 1
NA
T80854
703539
yd22a08.r1 Soares fetal liver spleen
1
ACTGGTGTTGGTGCTTTTGTCTGTCA

1NFLS cDNA clone IMAGE:108950 5′,

TACCATAGTATTTTCAAAACTTCA

mRNA sequence

5066
Table 1
Hs.44189
W00466
1271875
yz99f01.s1 cDNA, 3′ end
1
CCTTGAGAAACACCCATCTCCACTTC

/clone = IMAGE:291193/clone_end = 3′

CTAGACAAACCAATGAACATTAGT

5067
Table 1
Hs.306117
W18552
1290934
capicua protein (CIC) mRNA,
1
AACTGTGAGGCAAATAAAATGCTTCT

complete cds/cds = (40, 4868)

CAAACTGTGTGGCTCTTATGGGGT

5068
Table 1
Hs.17778
W19201
1295429
neuroplin 2 (NRP2), mRNA
1
CTAAGTCATTGCAGGAACGGGGCTG

/cds = (0, 2780)

TGTTCTCTGCTGGGACAAAACAGGA

5969
Table 1
Hs.340717
W25088
1302933
we58c01.x1 cDNA, 3′ end
1
GCCGTTCTTTATAGAACAATTCCTTTC

/clone = IMAGE:2345280/clone_end = 3′

TCTTCTCTTGAATGTGGCAGTCA

5070
Table 1
Hs.8294
W80882
1391906
KIAA0196 gene product (KIAA0196),
1
AGCCTACCTCCCTACCCCAAGCTGTC

mRNA/cds = (273, 3752)

TGTTGAGAGCAGTGCTGACCCCAG

5071
Table 1
Hs.133543
AA251316
1886279
EST378950 cDNA
−1
TTTCATAAACCCACTCCTTCCTCTTCA

CCCACTTGCAATCCGCATGCTTC

5072
Table 3A
Hs.96487
AA524555
2265483
7q23106.s1 cDNA, 3′ end
−1
CAAGTTGGTTTAGTTATGTAACAACC

/clone = IMAGE:3899226/clone_end = 3′

TGACATGATGGAGGAAAACAACCT

5073
Table 3A
NA
AA628833
2541220
af37g04.s1
−1
GACTCGTTACGCCGTAGTTTGTCCTA

Soares_total_fetus_Nb2HF8_9w cDNA

TCTTGTTTATCAAATGAATTTCGT

clone IMAGE:1033878 3′, mRNA

sequence

5074
db mining
NA
AA701193
2704358
zj80c03.s1
−1
AGCCGCCCAGCTACTTAATCCCTCAG

Soarses_fetal_liver_spleen_1NFLS_S1

TAACATCTATCTAAATCTCCCATG

cDNA clone IMAGE:461188 3′ similar

to gb:M11124 HLA C

5075
Table 3A
Hs.307486
AA729508
2750867
nx54a03.s1 cDNA
−1
TGGCCTGTGCTTTTACCACACCGTCA

/clone = IMAGE:1266028

AACCCTTGATCATTTCTGTAAACA

5076
Table 3A
Hs.104157
AA765569
2816807
EST380899 cDNA
−1
ACATTCTCATAGTCCAGGGGCTCAAC

AACTTTGGCCTTTTCCAGCACCAC

5077
db mining
Hs.220649
AA774984
2834318
QV1-GN0320-051200-552-b08 cDNA
−1
TCAGCAGTTGTGCCTTTTCTCACAGA

TCCAGCCGTCCTTCTCGCTGTCAC

5078
db mining
Hs.192078
AA884466
2993996
te30h04.x1 cDNA, 3′ end
−1
TGCAAGCAATAAAATCTTGCTTTAATC

/clone = IMAGE:2087479/clone_end = 3′

AGTAACCACTGTCTGACAGGACA

5079
db mining
Hs.194249
AA907080
3042540
HOA43-1-G6.R cDNA
−1
GGTCGTAGAGAAGACAGCAAGGGAG

GGGATAAAACCCAGGAGGACTTAA

5080
Table 3A
Hs.143254
AA961072
3127626
EST388440 cDNA
−1
GGCTCACGATGACAACCGCCTACGG

AAAAACTCTAATTCCTAAACATCTA

5081
db mining
Hs.163271
AF343666
13591717
translocation associated fusion protein
−1
GACAAGCCAGGTCAGCCCAGATTGC

IRTA/IGA1 (IRTA1/IGHA1) mRNA,

CAAAGCAGCACTTGCCTACACCAGC

complete cds/cds = (136, 402)

5082
Table 3A
Hs.46476
AI018105
3232624
EST386846 cDNA
−1
GGTTCCCTTGAAGCAGTGCCAACCTA

AATCTACCTCAGGTAAGTAGTTAG

5083
Table 3A
Hs.238954
AI031624
3249836
602637935F1 cDNA, 5′ end
−1
GCTGACAGTATGGAGGCTAAAGGTG

/clone = IMAGE:4765448/clone_end = 5′

TGGAGGAACCAGGAGGAGATGAGTA

5084
db mining
Hs.133261
AI052754
3308745
oy78e01.x1 cDNA, 3′ end
−1
CAAGTGTGCCGGGCAAGTTTGGGAA

/clone = IMAGE:1671960/clone_end = 3′

GGTGAAGCAATCTGTGACTTAAATA

5085
db mining
Hs.292803
AI056470
3330336
oy77d03.x1 cDNA, 3′ end
−1
GAGCTACTCAAGGGGAAAAAAGGGC

/clone = IMAGE:1671845/clone_end = 3′

ATATAGTATGCTCTGGTAGTAAAAGT

5086
db mining
Hs.6733
AI057025
3330814
phosphoinosilide-specific
−1
GCTCAAGATCACCTCTTTGTCATCTT

phospholipase C PLC-epsilon mRNA,

GAACAATGTTTTTCTCTTCTAGGT

complete cds/cds = (235, 7146)

5087
db mining
Hs.133930
AI073993
3400637
oy66d03.x1 cDNA, 3′ end
−1
TGGTGATAATAGAGATTGTTTCTGCC

/clone = IMAGE:1670789/clone_end = 3′

CTGGGGGTAGTTCAAGGATAACAC

5088
db mining
Hs.133949
AI074528
3401172
oy79d05.x1 cDNA, 3′ end
−1
CTTCAGGTTTGGCCCAGCCCCTCCTT

/clone = IMAGE:1672041/clone_end = 3′

GAAGACTCCTTCCATCCAGTCAAG

5089
db mining
Hs.134018
AI076071
3405249
oy80b11.x1 cDNA, 3′ end
−1
CCCAAGTGAAGTCAAAGTTACTGTGT

/clone = IMAGE:1672125/clone_end = 3′

GGTTGATAGGGAACATGGCTGGAT

5090
db mining
NA
AI081253
3418045
oy67c02.x1 NCI_CGAP_CLL1 cDNA
−1
ACCCGCAGACCAGATGGTTGAAAGG

clone IMAGE:1670882 3′ similar to

AAAAATTAAAGCCTTCTTGGGGATT

gb:X64707 BREAST BASIC

CONSERVED PR

5091
db mining
Hs.134590
AI081258
3418050
oy67c11.x1 cDNA, 3′ end
−1
GGAGTTAGATCAACCTTATGGGGAAG

/clone = IMAGE:1870900/clone_end = 3′

GGAAAGGCAGGGCTTGTGACAATT

5092
Table 3A
Hs.105621
AI084553
3422976
HNC29-1-B1.R cDNA
−1
GATGGCTGCTTGGTTGCTAAACCCAG

ACAGGGTCCTTCCAGTGCATCTGC

5093
db mining
Hs.230775
AI085588
3424011
oy68d10.x1 cDNA, 3′ end
−1
CATTTGTGGGTGGAGGGTTTTGAATG

/clone = IMAGE:1670995/clone_end = 3′

TCCTCTTTCCATGTCAGGCAAAGG

5094
db mining
Hs.146591
AI086023
3424446
oy70f10.x1 cDNA, 3′ end
−1
TTCTATGAAGGTTTCCCTGGACAAGA

/clone = IMAGE:1671211/clone_end = 3′

AACTGCCAGAGAGCCCTTAGCTCA

5095
Table 3A
Hs.23158
AI097125
3446707
600943902F1 cDNA, 5′ end
−1
TGCTGAATGTACCTGAGTGTATGTAT

/clone = IMAGE:2968352/clone_end = 5′

TTAAAAGGACTCACATGGGCATCA

5096
db mining
Hs.150708
AI122689
3538455
oy79f03.x1 cDNA, 3′ end
−1
TCTCAACCCTAATATTCATTGTTCCAT

/clone = IMAGE:1672061/clone_end = 3′

GAGCATTGTCAGGTTTTGGATGG

5097
db mining
Hs.326995
AI144314
3668123
oy64f01.x1 cDNA, 3′ end
−1
ACAAGTGGAAGAGGAAGACAGAAGA

/clone = IMAGE:1672537/clone_end = 3′

ATGGGTCAGGGAGATGCAAGGATGG

5098
db mining
NA
AI144317
3666126
oy84f04.x1 NCI_CGAP_CLL1 cDNA
−1
TCCTTAGGGAAAAGAAGATTTTCAAA

clone IMAGE:1872543 3′ similar to

CCCTTCGTTAGTTTCGGTAGGGCC

gb:X64707 BREAST BASIC

CONSERVED PR

5099
db mining
NA
AI187859
3739068
qe7h05.x1 Soares_testis_NHT cDNA
−1
ACGCAATTTGTTCACATACATACACAT

clone IMAGE:1738329 3′, mRNA

GCAAATCCCAAAAGAAGGTTTTA

sequence

5100
Table 3A
Hs.121210
AI204611
3757217
EST384285 cDNA
−1
CCCAGCCCTCTATGTACCCGTGTCCC

AGCCAGCAATAAATGCCATCTTGG

5101
db mining
Hs.144814
AI220630
3802833
RST44972 cDNA
−1
AGCCTGGAATTCTAAGCAGCAGTTTC

ACAATCTGTAATTGCACGTTTCTG

5102
db mining
Hs.126580
AI222355
3804558
602691805F1 cDNA, 5′ end
−1
TGGTTACTCATGTCCTCAAAGACGAC

/clone = IMAGE:4824264/clone_end = 5′

TCATGATGCTGGATATGAAGAACT

5103
Table 3A
Hs.36475
AI243620
3839017
EST372075 cDNA
−1
AGGCAAAAGTCATTTCTTCCCTATATT

TTGTCATGCTTATCTCCTGTCTC

5104
db mining
NA
AI283168
3871371
qh49e10.x1 Soares_NFL_T_GBC_S1
−1
GTATGAAGGCAAGAAAATTTCAGGGG

cDNA clone IMAGE:1848042 3′, mRNA

AAAACAAGTGGTTATTTTCTGGCC

sequence

5105
Table 3A
Hs.158501
AI290845
3933819
7q71b07.x1 cDNA, 3′ end
−1
GATACCCTCTTCCTAAGACTCATCGC

/clone = IMAGE:3703644/clone_end = 3′

GTCTCTTCCAGCCTCCTCGCCCCA

5106
db mining
Hs.150175
AI301070
3960416
qo16d04.x1 cDNA, 3′ end
−1
TCTGTATGCTGTGGTCTCATCAGGAA

/clone = IMAGE:1908679/clone_end = 3′

CCTTTTCTCTGCACTGCATTTTTCC

5107
db mining
NA
AI356349
4107970
qz26d12.x1 NCI_CGAP_CLL1 cDNA
−1
AGAGCTGGTTCCAGAAGGTTCGGAT

clone IMAGE:2028023 3′ similar to

GAGTCCTGAATGTTTATGTAGGGCA

contains MER7.b2 MER7 repetitive et

5108
db mining
Hs.157560
AI356388
4108009
qz26e07.x1 cDNA, 3′ end
1
TCCTTAGTCTCCTTCAATTTCCACACA

/clone = IMAGE:2028036/clone_end = 3′

CTGAACATGACATTTTACCCTTT

5109
db mining
NA
AI356470
4108091
qz27b11.x1 NCI_CGAP_CLL1 cDNA
−1
TTTTCTGTTTTCTGTTTTAAGAAAATC

clone IMAGE:2028093 3′, mRNA

TGGAACCGCAAGGCCGTCCCTTT

sequence

5110
db mining
Hs.157808
AI381701
4113322
qz18e09.x1 cDNA, 3′ end
−1
CCAAAGCCTTTGTTGTTTGGTGGCGA

/clone = IMAGE:2021896/clone_end = 3′

GGCCCCTTTTTGAATGGGGTTTTT

5111
db mining
Hs.327396
AI381729
4113350
qz24a08.x1 cDNA, 3′ end
−1
TGCCGCCCCCAGGATTCTTTTAAGAA

/clone = IMAGE:2027798/clone_end = 3′

TAAAAAGAAATGAGTGTGGACATG

5112
db mining
Hs.157811
AI361733
4113354
qz24b02.x1 cDNA, 3′ end
−1
CCTACGATATCCTTTTCAAATAGGGG

/clone = IMAGE:2027787/clone_end = 3′

TGGGTCCAGCCCCCTTGTGCCCTG

5113
db mining
Hs.270193
AI361773
4113394
qz19c05.x1 cDNA, 3′ end
−1
CTGGGAGAAAGGTACTTTGGGTTAGT

/clone = IMAGE:2021960/clone_end = 3′

GGTAGGGATAGGGATGAACGGGAA

5114
db mining
NA
AI364677
4124366
qz05h09.x1 NCI_CGAP_CLL1 cDNA
−1
AGCATAATCCTAATGAGGAACTTTGT

clone IMAGE:2020673 3′, mRNA

CTGAAGTCTGAGGCTGAGTTACTT

sequence

5115
db mining
Hs.327411
AI364926
4124615
qz23b07.x1 cDNA, 3′ end
−1
TTTTGGAACCCTTAGCCCTGTGCAAA

/clone IMAGE:2027701/clone_end = 3′

TCAAAGGATGTGAGGGGAAAAAGG

5116
db mining
Hs.157279
AI364931
4124620
qz23c04.x1 cDNA, 3′ end
−1
ATTTCCCCTACGGATGGGACCAAGAA

/clone = IMAGE:2027718/clone_end = 3′

ACTGATGAGAACGGCCAAGTGTTT

5117
db mining
Hs.157280
AI364944
4124633
qz23d11.x1 cDNA, 3′ end
−1
AACACCCGAAACCGTCTTCTGTGGCA

/clone = IMAGE:2027733/clone_end = 3′

TTTGTCAGTTGAAAAAGAACACCT

5118
db mining
Hs.283433
AI365377
4125066
qz08a02.x1 cDNA, 3′ end
−1
CCAGTGGCTGGGATGGTGACAGTGA

/clone = IMAGE:2020874/clone_end = 3′

CATCCACAGTAAACAGATGAAATGT

5119
db mining
Hs.304043
AI365414
4125103
7e97a03.x1 cDNA, 3′ end
−1
GGATTTCAGAAACAGTTGCAGATATT

/clone = IMAGE:3293068/clone_end = 3′

ATTGATTAGCTAGTTGGCAGTGGG

5120
db mining
Hs.80426
AI385418
4125107
brain and reproductive organ-
−1
CTTGTTCCCAGGCCAGCCCCACACA

expressed (TNFRSF1A modulator)

GTAGGCAGTCATTAAGTTTGGTGA

(BRE), mRNA/cds = (146, 1297)

5121
db mining
Hs.157310
AI365460
4125149
qz09e06.x1 cDNA, 3′ end
−1
TTTTCCTTCAACTCTTGCGACTTTCTT

/clone = IMAGE:2021026/clone_end = 3′

GGTCTGCCTGTGTGGTTTTAATA

5122
db mining
Hs.157311
AI365473
4125162
qz09f09.x1 cDNA, 3′ end
−1
TTCTGTTAATAGCAAACATTGCCTTTG

/clone = IMAGE:2021033/clone_end = 3′

AGTGCTACTACTAAACCTGAGGC

5123
db mining
NA
AI367021
4136766
qz23h06.x1 NCI_CGAP_CLL1 cDNA
−1
TCTAGGGATCTGCCCGGCTCAAAATC

clone IMAGE:2027771 3′ similar to

CCAGGCCGTTAGGCTAAGTTGTTC

contains MSR1.t1 MSR1 repetitive el

5124
db mining
Hs.296281
AI368512
4147265
interleukin enhancer binding factor 1
−1
CGGACAAGGGCTGGCAGGTAAATGC

(ILF1), mRNA/cds = (197, 2164)

CTTCAGTTTGTTGTTAAATAGAGGC

5125
db mining
Hs.327453
AI378055
4187908
tc79e11.x1 cDNA, 3′ end
−1
AGCCTTAGCCCCTTTAAAGCACTTAA

/clone-IMAGE:2072396/clone_end = 3′

AGTTACTACTTCCAAATGTGATTT

5126
db mining
NA
AI378091
4187944
tc80a09.x1 NCI_CGAP_CLL1 cDNA
−1
ACCTTGTCATTAACAGCTCACTTTGAT

clone IMAGE:2072440 3′, mRNA

TGAACATCTACTCTGTGGCGGTT

sequence

5127
db mining
Hs.158876
AI378095
4187948
tc80b01.x1 cDNA, 3′ end
−1
TGGAACGGCTATTTGCCGGTTTAAAA

/clone = IMAGE:2072425/clone_end = 3′

ACCAAAAACCCCGGTTTTTCCCAAA

5128
db mining
Hs.283438
AI378109
4187962
7f19bo3.x1 cDNA, 3′ end
−1
GTAAGGCAGACGAGAGAGGCGGAGG

/clone = IMAGE:3295085/clone_end = 3′

TCTCACAGTGAACCACAGGATCTGG

5129
db mining
Hs.158956
AI380117
4189970
tf98bo7.x1 cDNA, 3′ end
−1
TTGCCTGCCATGCCCTTATAAGTGCC

/clone = IMAGE:2107285/clone_end = 3′

CTTTAATGTCATAGCATGTAAAGG

5130
db mining
Hs.158967
AI380252
4190105
tf94d05.x1 cDNA, 3′ end
−1
GGGTTTGTGTCCCCATTTAGAATCTG

/clone = IMAGE:2106921/clone_end = 3′

ATGAAACGGTGGGCTTTCCTTCTT

5131
db mining
Hs.158969
AI380263
4190136
tf99g02.x1 cDNA, 3′ end
−1
CAGAGCCTCCAGAATTATGTGAACTT

/clone = IMAGE:2107442/clone_end = 3′

GTCTCAAAACATTCTCTAAATGGC

5132
db mining
Hs.158971
AI380329
4190182
tf94g05.x1 cDNA, 3′ end
−1
GAAAGGACCCGAGGGTTTGTATTTAA

/clone = IMAGE:2106968/clone_end = ′3′

AAAGCCTCCCCTGGGCCTCAAAAA

5133
db mining
Hs.309122
AI380449
4190302
tg02f12.x1 cDNA, 3′ end
−1
GCCAACTGCTTAGAAGCCCAACACAA

/clone = IMAGE:2107631/clone_end = 3′

CCCATCTGGTCTCTTGAATAAAGG

5134
db mining
Hs.302447
AI380514
4190367
tg01e02.x1 cDNA, 3′ end
−1
TGTCTAGAACAGACTGAGAGTGACAC

/clone = IMAGE:2107514/clone_end = 3′

GCATATTTGATTGTGAGGACAGTT

5135
db mining
Hs.231261
AI380594
4190447
tf95h06.x1 cDNA, 3′ end
−1
GTTTGGCCCCCAAAGTGTTTAGGAGA

/clone = IMAGE:2107067/clone_end = 3′

GCTTTCTCCCTAGATCGCCCTGTG

5136
db mining
Hs.158988
AI380719
4190572
tg03h03.x1 cDNA, 3′ end
−1
CCAGGAGGGCCAGAATTTGAAAATTC

/clone = IMAGE:2107733/clone_end = 3′

CTTGGGGTTGTTCTTTTTCCAAAA

5137
db mining
Hs.159000
AI381037
4190890
tg20h01.x1 cDNA, 3′ end
−1
CAGTTTGAGCAAAAGCCTTTGAAATC

/clone = IMAGE:2109381/clone_end = 3′

CAAGACTTTTCCCCTTGGGGTGCT

5138
db mining
Hs.159025
AI381601
4194382
td05g03.x1 cDNA, 3′ end
−1
CCAGTTGGTTTTTGGACTCCAAAGCC

/clone = IMAGE:2074804/clone_end = 3′

CAGGACCCTTCCAATCCTGCTTG

5139
db mining
NA
AI382670
4195451
qz05f05.x1 NCI_CGAP_CLL1 cDNA
−1
AGGCCCTTTTTCAAAGAAAAACC

clone IMAGE:2020641 3′, mRNA

CCTTTGGGGAAAAAGGGAAAGGGC

sequence

AAAA

5140
db mining
Hs.192078
AI383475
4196256
tc30h04.x1 cDNA, 3′ end
−1
TTTTGCTTGCTGTCGGGAGAATAAAG

/clone = IMAGE:2087479/clone_end = 3′

CAGGGAACCTTTATGTAGTGAAAA

5141
db mining
Hs.327467
AI383510
4196291
td03c10.x1 cDNA, 3′ end
−1
GGGTTTGGCCCGATTATATTAGGTTG

/clone = IMAGE:2074578/clone_end = 3′

GGTGGGGGAAAAATTTTATGGGGG

5142
db mining
Hs.105125
AI383774
4196555
602639120F1 cDNA, 5′ end
−1
GTGAACTGGATCTTGAGGCCGTGCT

/clone IMAGE:4762804/clone_end = 5′

GGAAACCGGAAGGTACACTGCTTGG

5143
db mining
NA
AI383803
4196584
tc98f01.x1 NCI_CGAP_CLLI cDNA
−1
CAAAACTTGAGATAAGGTTAAAACTG

clone IMAGE:2074201 3′ similar to

TGCCCAGAGGAAAACTGGTAGTCT

gb:J03626 URIDINE 5′-

MONOPHOSPHATE

5144
db mining
NA
AI384024
4196805
td05b02.x1 NCI_CGAP_CLL1 cDNA
−1
TGCAGCCAGATTGTTCCAAGGTTGCC

clone IMAGE:2074731 3′ similar to

AATTACCTAGTGGGTAAATTTCCC

contains Alu repetitive element; con

5145
Table 3A
Hs.107622
AI391443
4217447
tf96e06.x1 cDNA, 3′ end
−1
AGTGCTTATCATGAAATGTGCTTCAC

/clone = IMAGE:2107138/clone_end = 3′

TGGTTCAGCTCTGTTGTTTCCTTA

5146
db mining
Hs.160956
AI391451
4217455
tf96f03.x1 cDNA, 3′ end
−1
GTTATTTGGGAGACAAATGGACGGG

/clone = IMAGE:2107133/clone_end = 3′

CAGGAAGATTGATGCTCCGCTGTTC

5147
Table 3A
Hs.160959
AI391500
4217504
602086202F1 cDNA, 5′ end
−1
AGCTGAAGGGCTTCAACTTTGCTTGG

/clone = IMAGE:4250424/clone_end = 5′

ATTTTTAATATTTTCCTTGCATA

5148
Table 3A
NA
AI392705
4222252
tg23b03.x1 NCI_CGAP_CLL1 cDNA
−1
TGCAGGCTCATTGTGCTCCTTCTTCT

clone IMAGE:2109581 3′, mRNA

GGGTTTCAATTGGATTTCAGTCCT

sequence

5149
db mining
Hs.160978
AI392745
4222292
tg08b05.x1 cDNA, 3′ end
−1
ATCTCTAATGAAGCCTAGGATCAGAT

/clone = IMAGE:2108145/clone_end = 3′

TTGTGGCATACCAACAGCACATGT

5150
db mining
Hs.160981
AI392793
4222340
tg04g01.x1 cDNA, 3′ end
−1
CCACAAGGGTTAGTTTGGGCCTTAAA

/clone = IMAGE:2107824/clone_end = 3′

ACTGCCAAGGAGTTTCCAAGGATT

5151
db mining
Hs.160982
AI392799
4222346
tg04g09.x1 cDNA, 3′ end
−1
CGCTTTATTCCCACGAAACCTAGGAC

/clone = IMAGE:2107840/clone_end = 3′

AGTGGCCATCAAACCGAGCGCTTT

5152
Table 3A
Hs.189031
AI392805
4222352
tg04h03.x1 cDNA, 3′ end
−1
CCTGTTGTGGCTGGCTGCATAATAAT

/clone = IMAGE:2107829/clone_end = 3′

TTCCAGGAGGCTTTCGGAAATGTT

5153
Table 3A
Hs.221014
AI392814
4222361
MR2-HT1162-180101-007-d08 cDNA
−1
CGGTCCAGTCGGCTGCTTCCATTCCC

TGAAGAAGAGGCCCTAAAGTTAAA

5154
Table 3A
Hs.168287
AI392830
4222377
tg10b09.x1 cDNA, 3′ end
−1
TTAGCCTCAAAGGGGTGGGAAAAG

/clone = IMAGE:2108345/clone_end = 3′

CCCATACCTCCTGGGCCAGTCCTAG

5155
db mining
Hs.276774
AI392845
4222392
tg10d01.x1 cDNA, 3′ end
−1
CCTTAGAATTAAGTTGAATTTTCCTGC

/clone = IMAGE:2108353/clone_end = 3′

CTTGCTAAGCAAGACTTCCTGCA

5156
Table 3A
Hs.159855
AI392893
4222440
tg05d07.x1 cDNA, 3′ end
−1
CAGCCACGGCCCCTCGCGTCTTCGC

/clone = IMAGE:2107885/clone_end = 3′

GGCACGTTAAATTAATGCGGAAAAC

5157
db mining
Hs.327469
AI392990
4222537
tg22f02.x1 cDNA, 3′ end
−1
TTTTACCCAAATTTTAAAGGCCGGAT

/clone = IMAGE:2109531/clone_end = 3′

AAAAGGGTTTTTGTTTGGAAGGGA

5158
db mining
Hs.230848
AI392999
4222546
tg22f11.x1 cDNA, 3′ end
−1
GGAGGTTAGGGCCTGAAGCTCAAAG

/clone = IMAGE:2109549/clone_end = 3′

CTCCCCCTTTTTAATAGTTTTTCCC

5159
db mining
NA
AI393006
4222553
tg22g06.x1 cDNA, 3′ end
−1
CCCCTTTGGGCCCCCCGGGTTTTCC

/clone = IMAGE:2109562/clone_end = 3′

CTTTTTGGTTTCGGGTTGTTTTTTG

5160
db mining
Hs.228891
AI393017
4222564
tg22h05.x1 cDNA, 3′ end
−1
ACGTGGGCCTTTGGACCCCTTATAAG

/clone = IMAGE:2109561/clone_end = 3′

ATGGTCATAAGACCCCAAAACTGA

5161
db mining
Hs.159706
AI393038
4222585
tg25b07.x1 cDNA, 3′ end
−1
ATGGCTATAAGGCCAAAAAAAGT

/clone = IMAGE:2109781/clone_end =

TTGGCGGCATGGGGGATTTTTTGC

3′

TCTT

5162
Table 3A
Hs.160273
AI393041
4222588
tg25b10.x1 cDNA, 3′ end
−1
AGAGACGGCCACCTGAGACCAATTA

/clone = IMAGE:2109787/clone_end = 3′

GAATATCCACACCAGTGGAAGAGAG

5163
Table 3A
Hs.126265
AI393205
4222752

Homo sapiens, Similar to RIKEN
−1
GCCTCCCCAACCCCTGGCCTCAATTT

cDNA 0610006H10 gene, clone

CCCTTTCTATAAAATGGAAGATGT

MGC:9740 IMAGE:3853707, mRNA,

complete cds/cds = (171, 1130)

5164
db mining
Hs.159718
AI393217
4222764
tg14c09.x1 cDNA, 3′ end
−1
ACACCCAGCCAAAGAAAAGCATACCT

/clone = IMAGE:2108752/clone_end = 3′

GAATCCAAGAGAGTATTTACACTG

5165
db mining
Hs.240635
AI393223
4222770
tg14d03.x1 cDNA, 3′ end
−1
CTCAGAGAAGAACAGTGTAGAA

/clone = IMAGE:2108741/clone_end =

ACCCGCGCTGTGTGAAGCGAGGTT

3′

GGGC

5166
Table 3A
Hs.160401
AI393906
4223453
tg05f08.x1 cDNA, 3′ end
−1
ACTTTCCATTGTTGAGCTGGGGAGTT

/clone = IMAGE:2107911/clone_end = 3′

GGATTTTGTCCATTTGTTTTTATG

5167
Table 3A
Hs.340891
AI393908
4223455
wt30d11.x1 cDNA, 3′ end
−1
TCCCAGTGATGATTCGCTCCCTTTGT

/clone = IMAGE:2391765/clone_end = 3′

TAATTACTCAGTGTTTCTTGTTTT

5168
Table 3A
Hs.274851
AI393960
4223507
tg11d04.x1 cDNA, 3′ end
−1
TGCGTGCTGCTAATACTTAGGTACCC

/clone = IMAGE:2108455/clone_end = 3′

ATAATAGGTCTTTACACTCAGTTT

5169
Table 3A
Hs.160405
AI393962
4223509
tg11d08.x1 cDNA, 3′ end
−1
CCTGACCTTGAGGCATTTTTGATTGT

/clone = IMAGE:2108463/clone_end = 3′

GCAGTTACCTAGGGTATGCTTGTG

5170
Table 3A
Hs.76239
AI393970
4223517
hypothetical protein FLJ20608
−1
GAGGACTGGGACCGTGATTCCACTA

(FLJ20608), mRNA/cds = (81, 680)

ACCGGAAACCGTCGCCTTTCGGGCC

5171
Table 3A
Hs.160408
AI393992
4223539
tg06c05.x1 cDNA, 3′ end
−1
GGGGAAGTCAAGGAGACACACACGC

/clone = IMAGE:2107976/clone_end = 3′

TCTTTCAACAGAATCAGCTCTTAAT

5172
Table 3A
Hs.244666
AI394001
4223548
tg06d04.x1 cDNA, 3′ end
−1
AACTAGATCCTGCCTTAGAAAACCTT

/clone = IMAGE:2107975/clone_end = 3′

TTGCCATGAATGACAAATTCATGT

5173
db mining
Hs.160410
AI394009
4223556
tg11e02.x1 cDNA, 3′ end
−1
TGTCAGCATCTGGAATAGTGTAAGTA

/clone = IMAGE:2108474/clone_end = 3′

TGCAGTGGAGGAAATCTCATCCTT

5174
db mining
Hs.160423
AI394303
4223850
tg09g11.x1 cDNA, 3′ end
−1
TTAACAGGACCTCTGGGCCACCAAG

/clone = IMAGE:2108324/clone_end = 3′

GAGAAAGGGCTGGGGAAGCCAACAG

5175
Table 3A
Hs.159678
AI394671
4224218
tg24a07.x1 cDNA, 3′ end
−1
GTTCTGTGATAGTTTGTTTCCCCTCAT

/clone = IMAGE:2109684/clone_end = 3′

CTCCCTCACCTCTGCCTGGGTTG

5176
db mining
Hs.228337
AI394690
4224237
tg24c06.x1 cDNA, 3′ end
−1
GGCCCCTCCTTTTGCTGGAGAGTTT

/clone = IMAGE:2109706/clone_end = 3′

TTATAAACTGGAGCCCGATTTCAT

5177
db mining
Hs.159682
AI394730
4224277
tg24g04.x1 cDNA, 3′ end
−1
GGGCTTTTTCTTCCCCTAATCAGGGT

/clone = IMAGE:2109750/clone_end = 3′

GACCTGGGCCTTTTGGGCAGGATC

5178
db mining
Hs.159683
AI394733
4224280
tg24g09.x1 cDNA, 3′ end
−1
AAGGAGGGGAGTGAATGATATTGCT

/clone = IMAGE:2109760/clone_end = 3′

GTCATTTCTCAGCAAATCATAGTGA

5179
db mining
Hs.177146
AI399977
4243064
tg92e06.x1 cDNA, 3′ end
−1
TAAATTCTCTGTGGGAAAAAGCCTG

/clone = IMAGE:2116258/clone_end = 3′

CCAATAAAATGGGGGTTTTTGGGC

5180
Table 3A
Hs.225567
AI400714
4243801
tg93g12.x1 cDNA, 3′ end
−1
ACAGACTAAGCTGGTTTGGTGGATTC

/clone = IMAGE:2116390/clone_end = 3′

ATCTTTCACTTATGAAGAAAGCAG

5181
db mining
NA
AI400725
4243812
tg93h12.x1 NCI_CGAP_CLL1 cDNA
−1
CCCAAAGCCTGGGGGGTTTGGCCCA

clone IMAGE:2116391 3′ similar to

AACCTTCCCCCTGGTTTTTATAAAA

contains TAR1.t1 MER22 repetitive e

5182
db mining
Hs.224409
AI400798
4243883
IL3-ET0114-011100-330-F11 cDNA
−1
ACTGCTTTCAAGAAAGTGGGACCAGT

GGCATTGTAGCCACCATAATCACT

5183
db mining
Hs.174778
AI400826
4243913
th10g11.x1 cDNA, 3′ end
−1
GCCCTTGGCAAATGATTTGAGACCCC

/clone = IMAGE:2117924/clone_end = 3′ end

TTTTGAAAACCATGTAGGATGAAT

5184
db mining
Hs.270294
AI401001
4244088
tm29d11.x1 cDNA, 3′ end
−1
CACACAGCAGTGGCTTGGGGATGAG

/clone = IMAGE:2158005/clone_end = 3′

GAAGGAAGGGAGAATCTCAACGGAG

5185
db mining
Hs.224178
AI401179
4244286
tg26g11.x1 cDNA, 3′ end
−1
TTTTTCTGTGAGTTAGGGGCATGGAG

/clone = IMAGE:2109956/clone_end = 3′

GCGGCAGTGTTGGGAGCTGGAGCC

5186
db mining
Hs.175338
AI401184
4244271
7o18b08.x1 cDNA, 3′ end
−1
AGTTGGCTCTAGTTTAAAGATATAAAT

/clone = IMAGE:3574239/clone_end = 3′

ACGTACCTCACTTAAACCCCATGT

5187
db mining
Hs.327913
AI401303
4244390
tg92d01.x1 cDNA, 3′ end
−1
CTTCAGGCCCAAGTTCAACGGGTTAA

/clone = IMAGE:2116225/clone_end = 3′

AGAGGTCCGCTCCCAAATTATTCT

5188
db mining
Hs.159693
AI417000
4260504
th02f02.x1 cDNA, 3′ end
−1
GTCCCAGTAGCCCCATTTCAGGGCTT

/clone = IMAGE:2117115/clone_end = 3′

GCTAGTTACATGGGTTTGTGTTTA

5189
Table 3A
Hs.79968
AI419082
4265013
splicing factor 30, survival of motor
−1
GGATGTGTGATGTTTATATGGGAGAA

neuron-related (SPF30), mRNA

CAAAAAGCTGATGTATAGCCCTGT

/cds = (0, 716)

5190
Table 3A
Hs.131067
AI421806
4267737
yf85b05.s1 cDNA, 3′ end
−1
CAATTTCCACCTCTAAGGGGGTCGG

/clone = IMAGE:231057/clone_end = 3′

GAAAGGCACGCTGAGGGTGAATATG

5191
Table 3A
Hs.159103
AI431873
4306229
tc97d09.x1 cDNA, 3′ end
−1
GCTTTCAAATGAATTTCAGGGCTTTC

/clone = IMAGE:2074097/clone_end = 3′

TTTGAAGCAGTCTTGTAAAGTTGT

5192
Table 3A
Hs.254006
AI432340
4309500
tg54e06.x1 cDNA, 3′ end
−1
TCCTTTCTGGATACCAGGAATCACTT

/clone = IMAGE:2112610/clone_end = 3′

AAAAATCTGTGTATAATGCCCCCA

5193
db mining
Hs.283442
AI435240
4301796
ti02a80.x1 cDNA, 3′ end
−1
AAACAGGGAACGACAGGAAAAAGAT

/clone = IMAGE:2129270/clone_end = 3′

GACCGTGATACACTCTGCTAAAAGC

5194
db mining
Hs.327548
AI435268
4301992
ti02d10.x1 cDNA, 3′ end
−1
CCCCCCCGGCTTCCCCCTTTTTTCCC

/clone = IMAGE:2129299/clone_end = 3′

CGCCCGTTTTTTTGGGGGAATGGG

5195
Table 3A
NA
AI436418
4281540
ti01h02.x1 NCI_CGAP_CLL1 cDNA
−1
GGCCATGCCGGGCCAGCCCCACCTG

clone IMAGE:2129235 3′ similar to

AAGCTCAGTGAAAGCTGATTAAAAA

SW:SYB2_HUMAN P19065

SYNAPTOBREVIN

5196
Table 3A
Hs.165703
AI438561
4282683
ti03b03.x1 cDNA, 3′ end
−1
CGCAGGACTCTAAAGATCCAAGCTCA

/clone = IMAGE:2129357/clone_end = 3′

CAAAACACTCCAAATCCACCTCGA

5197
Table 3A
Hs.111377
AI436587
4282890
AL562032 cDNA
−1
AACTTTACTTCTGTTCTTGGCAGGAC

/clone = CS0DL003YA06-(3-prime)

ATGGAGAGAGGGAGGGATTCCAAA

5198
db mining
Hs.283443
AI436589
4282906
7f34g01.x1 cDNA, 3′ end
−1
GGGTGATAATTGAGGGTGCCGCTGG

/clone = IMAGE:3296592/clone_end = 3′

GAAGGTCCGAGAATGGGTTTTCATG

5199
Table 3A
Hs.257066
AI438957
4300957
UI-H-BI3-aka-h-10-0-UI.s1 cDNA, 3′
−1
GTTCATTGCTGTTCAGAGTGTTGCTG

end/clone = IMAGE:2733930

CTGTGGTGCTATAAATGCTCCCAG

/clone_end = 3′

5200
db mining
Hs.165701
AI438979
4301111
tc89d11.x1 cDNA, 3′ end
−1
TATTCCACCAGTGAGCTACACTCCCG

/clone = IMAGE:2073333/clone_end = 3′

GCCCCTTTAGTGTTGTTTGTAAAC

5201
db mining
Hs.165702
AI438980
4301118
tc89d12.x1 cDNA 3′ end
−1
CCGTGTTGTGGCAAAATGGTCCCTG

/clone = IMAGE:2073335/clone_end = 3′

GAGTTTTTGACCCTGTGTTTAAAGA

5202
db mining
Hs.327566
AI439020
4301397
tc89e05.x1 cDNA, 3′ end
−1
TTTTTTGGGGCCGAAAACCCCCAATG

/clone = IMAGE:2073344/clone_end = 3′

AGGGGGATTAAAGCTGTTTTCCCC

5203
db mining
Hs.327567
AI439044
4301565
tc89h03.x1 cDNA 3′ end
−1
GGGGTTGTCCTTTTCCCACCCTGATG

/clone = IMAGE:2073365/clone_end = 3′

GGGAATTTATGGATGGGTTTCCTT

5204
db mining
Hs.165704
AI439060
4301677
tc84f07.x1 cDNA, 3′ end
−1
AAATGAGTGACCAAAACACTTCTGTA

/clone = IMAGE:2072869/clone_end = 3′

CCACTTCTGTGAGCTGAGGTCCAG

5205
Table 3A
Hs.165681
AI439580
4305318
QV3-DT0043-211299-044-d03 cDNA
−1
AGGAACCTAAAGAAACTGCCAAGTGT

AGATAAGCATTGAGTATGTTACCC

5206
db mining
NA
AI439601
4305465
tc85d10.x1 NCI_CGAP_CLL1 cDNA
−1
GGTTGTCCAGTTTTCGGTTTTTAACG

clone IMAGE:2072947 3′, mRNA

CCCCCCATAGGGGATTTGGCCCCC

sequence

5207
Table 3A
Hs.192463
AI439633
4305688
7q86c05.x1 cDNA, 3′ end
−1
GTTTTGGAATCAGGAATGATTTTTCTA

/clone = IMAGE:3705201/clone_end = 3′

AGCCTGACATCAGATGTCTGACA

5208
db mining
Hs.165732
AI439643
4305758
tc91e06.x1 cDNA, 3′ end
−1
GAAATTCTCCCCTTTTCCCCTCTCCTT

/clone = IMAGE:2073538/clone_end = 3′

CCCTTCTGCTGACCTGTTCTCAG

5209
Table 3A
Hs.255490
AI439645
4305772
tc91e08.x1 cDNA, 3′ end
−1
CACAGAGGGAGTGTGCAGGGCCAGA

/clone = IMAGE:2073542/clone_end = 3′

TTTCATCCTGGGGCCACGCTGAAAT

5210
Table 3A
Hs.9614
AI440234
4281195
Nucleophosmin (probe bad, mutations,
−1
TGATAGGACATAGTAGTACGGGTGGT

wrong clone used) (nucleolar

CAGACATGAAAATGGTGGGGAGCC

phosphoprotein B23, nurnatrin)

5211
Table 3A
Hs.309279
AI440337
4282020
tc88b03.x1 cDNA, 3′ end
−1
CAATACCTACCCCCAGTGGCAGCCG

/clone = IMAGE:2073197/clone_end = 3′

CCTGCTCCTCATGACCCAAGTAAGT

5212
Table 3A
Hs.89104
AI440491
4300600
602590917F1 cDNA, 5′ end
−1
TGTTTTAACAACTCTTCTCAACATTTT

/clone = IMAGE:4717348/clone_end = 5′

GTCCAGGTTATTCCCTGTAACCA

5213
Table 3A
Hs.59844
AI440512
4300747
tc83f09.x1 cDNA, 3′ end
−1
TAAGTGTCAGGTTTGTGGGGAAGGTT

/clone = IMAGE:2072777/clone_end = 3′

ATTCTTGCCTTGTGTATTTTGTCC

5214
Table 3A
Hs.327610
AI452611
4286566
tj27g07.x1 cDNA, 3′ end
−1
CAAACCCCTATCCCCCATTCTCCTCC

/clone = IMAGE:2142760/clone_end = 3′

TATCCCTCAACCCCGACATCATTA

5215
Table 3A
Hs.121973
AI458739
4311318
602428025F1 cDNA, 5′ end
−1
CCTGCAACAGCTAAGGCCAAGCCAA

/clone = IMAGE:4547239/clone_end = 5′

ACTTACCGTGGACTCAAACACTTTG

5216
Table 3A
Hs.86437
AI469584
4331674
602411368F1 cDNA, 5′ end
−1
TGAATTTGGAGTCCCTGGCACATAAA

/clone = IMAGE:4540098/clone_end = 5′

TCTACCTTCAAATCAGAGGTCCTT

5217
Table 3A
Hs.149095
AI471868
4333956
ti67d04.x1 cDNA, 3′ end
−1
TCCCACCCCTTTTCTACTGAATTTGT

/clone = IMAGE:2137063/clone_end = 3′

GGGGATCCTATAATAAAAGTGAAT

5218
Table 3A
Hs.303682
AI472078
4334168
tj85h03.x1 cDNA, 3′ end
−1
ACTACCAGAGCCCTAGGACTTCTGAG

/clone = IMAGE:2148341/clone_end = 3′

CACATTTAGAAAATACCAGAGGCA

5219
db mining
Hs.170772
AI472328
4334416
tj87c09.x1 cDNA, 3′ end
−1
CATGTCAGAGTTCTTAACAGAAAGCA

/clone = IMAGE:2148496/clone_end = 3′

AAGGTTTCCAACAGCACTTGCATT

5220
Table 3A
Hs.78746
AI474074
4327119
cAMP-specific phosphodiesterase 8A
−1
ATGAAATCTCATGGGGCCAAACTGCA

(PDE8A) mRNA, partial cds

CATCAGCTACTGCTACCTTCTTGC

/cds = (0, 2141)

5221
db mining
NA
AI475527
4328572
tc85g07.x1 NCI_CGAP_CLL1 cDNA
−1
CCCTGTGGCAACTTGTGGGTACGGTT

clone IMAGE:2072988 3′, mRNA

TAACTGGACCACGCTGAGCTTCTG

sequence

5222
db mining
Hs.292501
AI75611
4328656
7f03g08.x1 cDNA, 3′ end
−1
AGAAATAGTGTTTCTCGGAAGCTCAG

/clone = IMAGE:3293630/clone_end = 3′

TTTGGAGCTGACTGCACACGTTGC

5223
Table 3A
Hs.300759
AI475653
4328698
ribosomal protein L36 (RPL36), mRNA
−1
GTTGCTGGCTGCCCTCCCCTGCACT

/cds = (145, 482)

CTCCCTGAAATAAAGAACAGCTTGG

5224
db mining
Hs.300759
AI475653
4328698
ribosomal protein L36 (RPL36), mRNA
−1
GTTGCTGGCTGCCCTCCCCTGCACT

/cds = (145, 482)

CTCCCTGAAATAAAGAACAGCTTGG

5225
Table 3A
NA
AI475668
4326711
tc93c06.x1 NCI_CGAP_CLL1 cDNA
−1
ACGTGTCAGACACAATCCTGAGCCTT

clone IMAGE:207310 3′, mRNA

CTACAAGTGTTCCCTCTTACTCCT

sequence

5226
db mining
NA
AI475678
4328723
tc93d10.x1 NCI_CGAP_CLL1 cDNA
−1
AAGCCCTGTTTACCCAGGTTTTTCTT

clone IMAGE:2073715 3′ similar to

AAGGCGAGAAGGTTTAGGGTGGTG

gb:M92287 G1/S-SPECIFIC CYCLIN

D3 (

5227
Table 3A
Hs.105678
AI475680
4328725
tc93d12.x1 cDNA, 3′ end
−1
GAGAAAGCTCCCAGTCTGTCTTTCCC

/clone = IMAGE:2073719/clone_end = 3′

AACATCCCTTCAGTTTCAATAAGC

5228
db mining
Hs.170338
AI475882
4328727
tc93e03.x1 cDNA, 3′ end
−1
TTCAGGTGAGTGTGCCTGGAGGTGG

/clone = IMAGE:2073724/clone_end = 3′

AGAACTATGGTTTTGATAACTTGGC

5229
Table 3A
Hs.236030
AI475694
4328739
SWI/SNF related, matrix associated,
−1
AAGGTGCCATGTATTGAAAGTGTGCG

actin dependent regulator of chromatin,

TCAAAGAACATAAATATCAGTGGA

subfamily c. member 2 (SMARCC2),

mRNA/cds = (22, 3663)

5230
db mining
NA
AI475735
4328780
tc86g02.x1 NCI_CGAP_CLL1 cDNA
−1
TGTAATTATTTTCTGTATGTTCAAGAA

clone IMAGE:2073074 3′, mRNA

GGTAAAGGAAAGGACAGCTATGGGA

sequence

5231
db mining
Hs.327640
AI475806
4328851
tc94g03.x1 cDNA, 3′ end
−1
ATTTATTTGGGGTTGGTCCCCCCTTT

/clone = IMAGE:2073844/clone_end = 3′

GGGCCCCCCGGGTTTTCCCTTTTTT

5232
db mining
Hs.170586
AI475815
4328860
tc94h02.x1 cDNA, 3′ end
−1
AACCATAAAAGGCCCGTTTGGTTAGT

/clone = IMAGE:2073843/clone_end = 3′

TTTCCCTGTTTCCTGGTTTGGGCT

5233
Table 3A
Hs.105052
AI475827
4328872
adaptor protein with pleckstrin
−1
TTATGGGGTAACTCACTTTGGGCGGC

homolog and src homology 2 domains

ACGAAGAACTCCAGGCGGAAGCGT

(APS), mRNA/cds = (127, 2025)

5234
db mining
Hs.258864
AI475833
4328878
tc87b01.x1 cDNA, 3′ end
−1
TCTCTCCCCATCCCAAGTCATCCAGC

/clone = IMAGE:2073097/clone_end = 3′

CCTTTTTCCTACCCTCAATAAACC

5235
Table 3A
Hs.170587
AI475884
4328929
tc95c12.x1 cDNA, 3′ end
−1
CCCCCTGATGGACTTCAAATATGTCT

/clone = IMAGE:2073910/clone_end = 3′

CATCAACTACAGTATTAAATGCCA

5236
Table 3A
Hs.170588
AI475905
4328950
tc95f06.x1 cDNA, 3′ end
−1
CGAGAATGCCTAGGGAAACCAGCTA

/clone = IMAGE:2073923/clone_end = 3′

CGCTTACAAGCCAGCTACGCAGCCC

5237
db mining
Hs.170589
AI475909
4328954
tc95f10.x1 cDNA, 3′ end
−1
GGAAACATTGGCCTGGGGGTGTCCC

/clone = IMAGE:2073931/clone_end = 3′

CCAAAAGGGGGCCGTTTTTAAAGGG

5238
db mining
NA
AI475926
4328971
tc95h10.x1 NCI_CGAP_CLL1 cDNA
−1
TGGGTTGACATTGTTCGCACGGGGT

clone IMAGE:2073955 3′ similar to

GTTTCTTATATTAAAAAGACTCACT

gb:M59849 FIBRILLARIN (HUMAN):,

mRN

5239
Table 3A
NA
AI478558
4371782
tm53e03.x1 NCI_CGAP_Kid11 cDNA
−1
CTTTCCACAAAATAATCGATAACCTTG

clone IMAGE:2161852 3′, mRNA

GGGGATTGTTTTATGGCTTGACA

sequence

5240
db mining
NA
AI479016
4372184
tm29h05.x1 NCI_CGAP_CLL1 cDNA
−1
CCGCCTTGGGGAGACAGGTCTTGAT

clone IMAGE:2158041 3′ similar to

TGTCTTTTTCCCAGTGAACATTGTT

gb:X58141_ma1 ERYTHROCYTE

ADDUCIN

5241
Table 3A
Hs.170784
AI479022
4372190
tm30a05.x1 cDNA, 3′ end
−1
TCCCAGACTTTCAGGAAAGTAACTGT

/clone = IMAGE:2158064/clone_end = 3′

AGCACTGTTAATATCACAACAACA

5242
db mining
Hs.187200
AI479029
4372197
tm30b08.x1 cDNA, 3′ end
−1
TTTTAGCTGGGAGTGGGGGGACTAT

/clone = IMAGE:2158067/clone_end = 3′

GGGGAATAACTTTCCTTCATTTAAT

5243
Table 3A
Hs.337139
AI479075
4372243
tm30h01.x1 cDNA, 3′ end
−1
ACATGTGTGTGTTTTCCATGAGGCAC

/clone = IMAGE:2158129/clone_end = 3′

TGCTTTTTATGCATTTCCCTCCCC

5244
db mining
NA
AI479094
4372262
tm31b02.x1 NCI_CGAP_CLL1 cDNA
−1
CTGTATTTGAAGTCAGCAGGGCTCAG

clone IMAGE:2158155 3′ similar to

CAGGATTTGACCGACAGTTACCTC

contains TAR1.t1 MER22 repetitive e

5245
db mining
Hs.185498
AI479659
4372827
tm32h04.x1 cDNA, 3′ end
−1
TGGTTTATAGATGCACTTCCTTTCATA

/clone = IMAGE:2158327/clone_end = 3′

GGCAGTCCCTGGCACTTTCTTGC

5246
Table 3A
Hs.170909
AI492034
4393037
tg06f12.x1 cDNA, 3′ end
−1
AGGAGCTGGTATTATTGGAGGGTATT

/clone = IMAGE:2108015/clone_end = 3′

ATAGATCCAGTGTATTGTGACTGT

5247
db mining
NA
AI492041
4393044
tg06g08.x1 NCI_CGAP_CLL1 cDNA
−1
GCAGTAGTGCTAAGGCGTCTTTTGTA

clone IMAGE:2108030 3′ similar to

GGCTTTAGATTTTGTCGTTATGGC

gb:L23320 ACTIVATOR 1 140 KD

SUBUNI

5248
Table 3A
Hs.119923
AI492068
4393069
tg12b03.x1 cDNA, 3′ end
−1
GCTTGTCAGAACAGAAGATATTTCCA

/clone = IMAGE:2108525/clone_end = 3′

CCCTGCCTAGTAGATGTGTTTCAG

5249
db mining
Hs.327698
AI492127
4393130
tg07d04.x1 cDNA, 3′ end
−1
CCCCCGTTTTAGGTTAGGGCCTTGG

/clone = IMAGE:2108071/clone_end = 3′

GCAGGGGTTTGCCCCCTGTTACCCC

5250
db mining
Hs.170912
AI492164
4393167
tg12h01.x1 cDNA, 3′ end
−1
TTGGTTTTATTTATCCAAAACTGAGCC

/clone = IMAGE:2108593/clone_end = 3′

TTCTCATAGGCTTTACACCCGGA

5251
Table 3A
Hs.341634
AI492181
4393184
wt85e01.x1 cDNA, 3′ end
−1
GGCAGGCTCTAGCCACCCTGTCGGT

/clone = IMAGE:2514264/clone_end = 3′

TCCCAATAAGCCATTTATTGAATAA

5252
Table 3A
Hs.276903
AI492640
4393643
qz18a06.x1 cDNA, 3′ end
−1
TTTTTGACCAGTCTACATTTCGTATCT

/clone = IMAGE:2021842/clone_end = 3′

GTGGGATCTGCATTTGTGAATTC

5253
db mining
Hs.170933
AI492648
4393651
qz18b06.x1 cDNA, 3′ end
−1
TCTGGACAATGTTGATGCTAACCTTG

/clone = IMAGE:2021843/clone_end = 3′

ATGATATCCATCCCTATTACTGGG

5254
db mining
NA
AI492653
4393656
qz18c02.x1 NCI_CGAP_CLL1 cDNA
−1
AGGACATGAAGGTCTGAAAAAG

clone IMAGE:2021858 3′ similar to

AAACAGGAAAATACAGACATCCCC

contains Alu repetitive element;, m

GCTT

5255
Table 3A
Hs.170331
AI492865
4393888
th78a05.x1 cDNA, 3′ end
−1
AAGTCAAGGAACCCTCTCGGGTCTCT

/clone = IMAGE:2124752/clone_end = 3′

GAGATCCAGGCCAACAGTAACAG

5256
db mining
Hs.327702
AI193426
4394429
tg91a07.x1 cDNA, 3′ end
−1
AGGGGGCTTTAAAATTTAAAAATTGC

/clone = IMAGE:2116116/clone_end = 3′

CTTTTGTTTTAAAAAAGGCCCATGT

5257
Table 3A
Hs.276907
AI493726
4394729
qz12f08.x1 cDNA, 3′ end
−1
CCCCCTCCCACCCAAAGAAAAAGAAA

/clone = IMAGE:2021319/clone_end = 3′

TGGTAACTACCTGGACAAAACATT

5258
db mining
Hs.342652
AI493740
4394743
yi60c05.r1 cDNA, 5′ end
−1
CCCTTGGCTCTTATTGTTCTTGCTGG

/clone = IMAGE:143824/clone_end = 5′

TGTGGTATGTTCCCGGCTGAAAAA

5259
db mining
NA
AI494343
4395346
qz14a10.x1 cDNA, 3′ end
−1
TTCCCCTTTTTTCCCCCTTTTTTAAAA

/clone = IMAGE:2021466/clone_end = 3′

AGCCCCTTTTTTAAATGGGGCGC

5260
db mining
Hs.283456
AI494542
4395545
7f12b08.x1 cDNA, 3′ end
−1
AAGGACAGCTTGCTTGCTGATGAACA

/clone = IMAGE:3294423/clone_end = 3′

CTTCCACAGTCTTTTGAGCTAAGT

5261
Table 3A
Hs.171009
AI494612
4395615
RST42450 cDNA
−1
ACATGAGAATTAACCATGTCCAGTAG

TTAAGTTCATTTTCCTACAGTGTGC

5262
Table 3A
Hs.342008
AI498316
4390298
UI-H-BI1-aeq-b-02-UI.s1 cDNA, 3′
−1
GCCAGAATGGTACAGAGTGGAGGGT

end/clone = IMAGE:2720186

GTTCTGCTAATGACTTCAGAGAAGT

/clone_end = 3′

5263
Table 3A
Hs.169541
AI523598
4437733
th08g11.x1 cDNA, 3′ end
−1
GCACAACTTCTGGGAATCTAGTGGCT

/clone = IMAGE:2117732/clone_end = 3′

GTATGTTAAGCATCGGTAAAAGA

5264
db mining
Hs.171098
AI523617
4437752
tg95b03.x1 cDNA, 3′ end
−1
AAAAAGGCCCCTTGTTTGTTGGTTTT

/clone = IMAGE:2116493/clone_end = 3′

TGGCCCGTTGGGGAAAATGCCTGT

5265
db mining
Hs.264120
AI523641
4437776
601436078F1 cDNA, 5′ end
−1
TTTAGGAGCTGACCATACATGATGAG

/clone = IMAGE:3921187/clone_end = 5′

TGATACAGCCTGTACTTTGCTCAT

5266
Table 3A
Hs.309484
AI523766
4437901
tg94f07.x1 cDNA, 3′ end
−1
GGTTTCCCACGAACGGGAGGCTGCT

/clone = IMAGE:2116453/clone_end = 3′

GAAGAGTCAAAGCCTGGGCAGACTC

5267
db mining
NA
AI523780
4437915
tg94h09.x1 NCI_CGAP_CLL1 cDNA
−1
CAGGTCATGAGTATTCCAAGCTCAGG

clone IMAGE:2116481 3′ similar to

TGGTGAGTCCTCCTCACCGGGATG

gb:M15059 LOW AFFINITY

IMMUNOGLOBUL

5268
db mining
Hs.171108
AI523790
4437925
tg96b01.x1 cDNA, 3′ end
−1
AAAGGGAAACTGGCTCTGGCACCAC

/clone = IMAGE:2116585/clone_end = 3′

CTACTGGAGACCAAACTTCACCAAA

5269
Table 3A
Hs.194054
AI523854
4437989
HA0669 cDNA
−1
GACAAAATAGTTACCTATGCTTTCCTT

CTGGCACCCCGAATGTACGCAGG

5270
Table 3A
Hs.228926
AI523873
4438008
tg97c12.x1 cDNA, 3′ end
−1
ATCTGACCTGAGGGAGATCACAATG

/clone = IMAGE:2116726/clone_end = 3′

CCTTCTGTATTGGGTGGTAATGAT

5271
db mining
Hs.207993
AI523884
4438019
tg97e12.x1 cDNA, 3′ end
−1
TCCGTTGTAACACATCTAATGTGAAC

/clone = IMAGE:2116750/clone_end = 3′

GCATTATAAACATGGACCTGTACT

5272
db mining
NA
AI523904
4438039
tg97h03.x1 NCI_CGAP_CLL1 cDNA
−1
ACATAACTATTCCGTTGATGAATAGC

clone IMAGE:2116757 3′ similar to

ATCAGGACTTAAATGGTGACCTTGT

SW:MKK2_HUMAN P49137 MAP

KINASE-ACT

5273
db mining
Hs.337129
AI523973
4438108
tg98h03.x1 cDNA, 3′ end
−1
AACGGGTTTGGGTTTGGGGGGGTTT

/clone = IMAGE:2116853/clone_end = 3′

GTTCTTTTTATTGAATCCATTTAAGT

5274
db mining
Hs.340482
AI523988
4438123
tg99b05.x1 cDNA, 3′ end
−1
TATAGGAGATGGGATACTCATTCCCG

/clone = IMAGE:2116881/clone_end = 3′

CTGCTATTGATAAGGTCGGAGGCG

5275
db mining
Hs.283457
AI523989
4438124
7f27b07.x1 cDNA, 3′ end
−1
CAGAACGTCCTCAAGGACACACTCCT

/clone = IMAGE:3295861/clone_end = 3′

CCCTCGGGCCTCACTCTGGAGCAC

5276
db mining
Hs.229405
AI524004
4438139
tg99d01.x1 cDNA, 3′ end
−1
CTGGACATGTTGTTTCCATGTTCAGT

/clone = IMAGE:2116897/clone_end = 3′

CCCTTCCCGGTTTTTGGGTGTTTT

5277
db mining
Hs.283458
AI524006
4438141
tg99d05.x1 cDNA, 3′ end
−1
AAAGTAGCCATCCTGAGTCTCCAGGG

/clone = IMAGE:2116905/clone_end = 3′

TGATGAGCGGACTTGGGTGTGGAT

5278
db mining
Hs.327719
Al524013
4438148
tg99e03.x1 cDNA, 3′ end
−1
CCTTCCATCTCATCGGTGGCCTCTCA

/clone = IMAGE:2116924/clone_end = 3′

CTGTGGCTCACTGTTTAACACATG

5279
Table 3A
Hs.252359
AI524022
4438157
tg99f02.x1 cDNA, 3′ end
−1
TGTTCAAGGTCACATAGTTTAGGTAA

/clone = IMAGE:2116923/clone_end = 3′

GAAGCTCAAACCTGAGTTTTAGGT

5280
Table 3A
Hs.192524
AI524039
4438174
tg99h02.x1 cDNA, 3′ end
−1
CACCTGATTCCCCCTCTTGCCCACAG

/clone = IMAGE:2116947/clone_end = 3′

GACTCTGCTGTTGTTTTCATTCTG

5281
db mining
Hs.283459
AI524048
4438181
th01a01.x1 cDNA, 3′ end
−1
TCTCGTGAGGTGATGTGGTGCTGCA

/clone = IMAGE:2116968/clone_end = 3′

GACTTAAGCTATCTGCCTTGAAGAT

5282
db mining
Hs.171119
AI524139
4438274
th09f04.x1 cDNA, 3′ end
−1
AACAAGCCTGGAATAATGCCCCCAAA

/clone = IMAGE:2117791/clone_end = 3′

GATTGAGTGGAAATCGCCCCTTTTT

5283
db mining
NA
AI524156
4438291
th09h01.x1 NCI_CGAP_CLL1 cDNA
−1
GAGGACCAGATGGCCCAGGAGGAAG

clone IMAGE:2117809 3′ similar to

TGGATGCTTTCTTGGTAGGGAATGG

contains Alu repetitive element; con

5284
Table 3A
Hs.171122
AI524202
4438337
th10d11.x1 cDNA, 3′ end
−1
CCTCCTGCTAGAAGACAGATTTCTTC

/clone = IMAGE:2117877/clone_end = 3′

CTTGGCTGACAGGCTGAATTAAGC

5285
db mining
Hs.171123
AI524214
4438349
th11b04.x1 cDNA, 3′ end
−1
AATTTCCAAAAACAAAACAAAA

/clone = IMAGE:2117935/clone_end =

CAAGCAGGTTTCATGGAGCCCGAG

3′

TCCA

5286
db mining
Hs.171124
AI524233
4438368
th11d04.x1 cDNA, 3′ end
−1
CCTTTATGCAAGTTGTAAGGGGTTGA

/clone = IMAGE:2117959/clone_end = 3′

CCAGTAAAGAGGAAGTTTTGCCCC

5287
Table 3A
Hs.174193
AI524263
4438398
th11g07.x1 cDNA, 3′ end
−1
AGTATTAGCTACAAACAAGCCTTGTT

/clone = IMAGE:2118012/clone_end = 3′

TCCTCTTGGCTGTCAGGCACTGCT

5288
db mining
Hs.230874
AI524266
4438401
th11g12.x1 cDNA, 3′ end
−1
AAGCCCCAGTAAGGTGTTCAGGACT

/clone = IMAGE:2118022/clone_end = 3′

GGTAAACGACTGTCCTCAAGTAAGG

5289
Table 3A
Hs.12315
AI524824
4438759
hypothetical protein FJ11608
−1
TGGTTCAGGTAGTAAATGCTTTTGGT

(FLJ11608), mRNA/cds = (561, 1184)

CACATCAGAACTCTAGATCTGGGG

5290
db mining
Hs.327722
AI524626
4438761
td11c03.x1 cDNA, 3′ end
−1
GCCTGGGCTGTTTTTGCTATATGTAA

/clone = IMAGE:2075332/clone_end = 3′

ATAAAGCCCTTGGGTCTTTATTTT

5291
db mining
Hs.231512
AI524700
4438835
th12c05.x1 cDNA, 3′ end
−1
GGAGGTTAGGAAGCCCTTTTAAAGTA

/clone = IMAGE:2118058/clone_end = 3′

CAAACCCCCGGCATGGGGAATTTT

5292
db mining
Hs.171140
AI524720
4438855
th12e10.x1 cDNA, 3′ end
−1
AACGGGAGTGATCGGGAAGTGAACA

/clone = IMAGE:2118090/clone_end = 3′

GTTTCATCATCTGCTGCTGCTATTC

5293
db mining
Hs.292520
AI524724
4438859
th12f03.x1 cDNA, 3′ end
−1
CTGGTATGTTGCTTTGTAGGGGAAAA

/clone = IMAGE:21118077/clone_end = 3′

ACTAATTTTGTTGGGTCAGGGACA

5294
db mining
Hs.283462
AI538419
4452554
td06a02.x1 cDNA, 3′ end
−1
CCGGACAAGCCATTTGATGTTCTAGT

/clone = IMAGE:2074826/clone_end = 3′

TTGCAATTACTCCACGCAAAGTGG

5295
db mining
Hs.231292
AI538420
4452555
td06a03.x1 cDNA, 3′ end
−1
TTTGGGCATCAACTTCAACAACTACT

/clone = IMAGE:2074828/clone_end = 3′

ACCAGGACGCCTGAGGGTGCTTTT

5296
db mining
Hs.171216
AI538445
4452580
td06d02.x1 cDNA, 3′ end
−1
TCGAAGAAAGTACCTGTAAATGTAGA

/clone = IMAGE:2074851/clone_end = 3′

GTAATTGCGAAGCTGTCAGGAATA

5297
Table 3A
Hs.203784
AI538474
4452609
td06h08.x1 cDNA, 3′ end
−1
TCCTAGACCCTGCATTGTGAAATGGG

/clone = IMAGE:2074911/clone_end = 3′

GCTTGAATTTTAGTTCTGAATTTT

5298
Table 3A
Hs.306024
AI538546
4452681
FK506-binding protein 3 (25 kD)
−1
CTAAAGCAGTGTCTGACCTGGATTTG

(FKBP3), mRNA/cds = (23, 697)

CTGCCAATTTGTAAGCTTTCATGA

5299
Table 3A
Hs.192534
AI538554
4452689
EST384032 cDNA
−1
GGAGCTGAGCAGGGATGCAAAACCA

TCCAGTCTGTAAGATTCACAGAGAC

5300
db mining
Hs.171260
AI540044
4457417
td08e06.x1 cDNA, 3′ end
−1
AAACGGTGTTTGAGCTGCTTTGGGAA

/clone = IMAGE:2075074/clone_end = 3′

AACCCATGTTGCAGATTTTCAGGT

5301
db mining
Hs.283463
AI540109
4457482
7f10e03.x1 cDNA, 3′ end
−1
CAGAGCTGTGTTTCCTCAACAAGTGT

/clone = IMAGE:3294268/clone_end = 3′

GCGAGCGGTCGTGTGCGCCATGAG

5302
Table 3A
Hs.171261
AI540125
4457498
MR1-BN0212-280600-001 cDNA
−1
AAATCGCTTCTGTATTGTTAATAGCAA

TATATGACCTCTGCTGTCCTCCT

5303
db mining
NA
AI540130
4457503
td09g11.x1 NCI_CGAP_CLL1 cDNA
−1
GAAGGATAATTTCGAACCCTTGCAT

clone IMAGE:2075204 3′ similar to

AGTTTCGGTATGGGCCGTGCCAAC

gb:X64707 BREAST BASIC

CONSERVED PR

5304
Table 3A
Hs.171264
AI540161
4457534
td10c10.x1 cDNA, 3′ end
−1
CCCTCTTGAACTGCACTGCCTAAGAA

/clone = IMAGE:2075250/clone_end = 3′

ATGTTGGTTGCATGGAGACATATT

5305
Table 3A
Hs.222188
AI540165
4457538
td10d05.x1 cDNA, 3′ end
−1
TCTGCCTTATTTGGCTTGGAAGAGAA

/clone = IMAGE:2075241/clone_end = 3′

ACCGATAAACACTCCCGTGCTAGT

5306
Table 3A
Hs.170935
AI540204
4457577
MYE6493a cDNA
−1
AAACAGCAGAAAAGTAATTTCTGGTG

AACTGATGAGAATTCCCTATTGCA

5307
db mining
Hs327797
AI540784
4458157
tc87e06.x1 cDNA, 3′ end
−1
AGGTTGTTTTGGAAAAATTATTTGTTT

/clone = IMAGE:2073158/clone_end = 3′

TGTCCTAAGGGGTCCTGCCCACC

5308
db mining
Hs.327798
AI540789
4458162
tc87f03.x1 cDNA, 3′ end
−1
CCTCCGGAACGTTTTTAAAAAGGAAA

/clone = IMAGE:2073149/clone_end = 3′

AAGCCCGGGTTTTCCCTTGGGAAAAA

5309
Table 3A
Hs.170577
AI540813
4458186
602574255F1 cDNA, 5′ end
−1
CAGACCTGTGGGCTGATTCCAGACT

/clone = IMAGE:4702644/clone_end = 5′

GAGAGTTGAAGTTTTGTGTGCATCA

5310
Table 3A
Hs.173182
AI554733
4487096
tn27f08.x1 cDNA, 3′ end
−1
ACCAAGTTTGAATTTGTCAAATCCCA

/clone = IMAGE:2168871/clone_end = 3′

AGTCAATCCAGGATGTTCATTTCT

5311
Table 3A
Hs.282963
AI557431
4489794
602583968F1 cDNA, 5′ end
−1
AGTGATCTGCCTTTCAGCAACTGTCT

/clone = IMAGE:4711721/clone_end = 5′

TATTTTGGTTCTTTGAAACTGTGA

5312
db mining
Hs.104679
AI559444
4509649

Homo sapiens, clone MGC:18216
−1
TTTGAATGGCTGAAGCTAAGGCAACG

IMAGE:4156235, mRNA, complete cds

TTAGTTTCTCCTTACTCTGCTTTT

/cds = (2206, 2373)

5313
db mining
Hs.118392
AI560581
4510902
RST42486 cDNA
−1
ACCTTTGTGATTCTGTCTAGTGAAAAT

GGGACATTTTTAATAGTGCCAGA

5314
Table 3A
NA
AI560651
4510992
tq60f01.x1 NCI_CGAP_Ut1 cDNA
−1
GAACTTGCCCCTAAACTGGGTTAAT

clone IMAGE:2213209 3′ similar to

GGACCCTGTTGAGTTTTCTGGACA

gb:M36072 60 S RIBOSOMAL

PROTEIN L7A

5315
db mining
Hs.327874
AI568374
4531748
th13e03.x1 cDNA, 3′ end
−1
TAAATTGGGCAAAGTTTTTTATGGAAT

/clone = IMAGE:211118172/clone_—

TTCCGGGGCAAGGTTTTGGGGGC

end =3′

5316
Table 3A
Hs.340517
AI568459
4531833
tn39e07.x1 cDNA, 3′ end
−1
AAATCTCATTTGCAAGTTCTCCCATTA

/clone = IMAGE:2170020/clone_end = 3′

AGCAAGGGAGTAGTTTACTAGGA

5317
Table 3A
Hs.143951
AI568622
4531996
tn41e10.x1 cDNA, 3′ end
−1
AAGAAAGGCCCATAACAGATGGCAAA

/clone = IMAGE:2170218/clone_end = 3′

ATAGAGGATTGGTGAGGGATATGC

5318
db mining
Hs.75969
AI568695
4532069
proline-rich protein with nuclear
−1
AAAACCATTCCAGCTTAATGCCTTTAA

targeting signal (B4-2), mRNA

TTTTAATGCCAACAAAATTGGGG

/cds = (113, 1096)

5319
Table 3A
NA
AI568725
4532009
th15a01.x1 NCI_CGAP_CLL1 cDNA
−1
TGCAACCTTCTTAAAATGTGGGCTAC

clone IMAGE:2118312 3′, mRNA

TGGAGATCATGCCACTGCACTCCA

sequence

5320
Table 3A
Hs.159014
AI568751
4532125
th15d09.x1 cDNA, 3′ end
−1
AGCTCAGATGGGTCCCCAAAAGAGG

/clone = IMAGE:2118353/clone_end = 3′

CATAGGAAAGCGCGACCTCACTGCC

5321
db mining
Hs.174242
AI568753
4532127
tn15e04.x1 cDNA, 3′ end
−1
CAAATAAAAAGGCTGGGGCCAAAGG

/clone = IMAGE:2118366/clone_end = 3′

TGGGCACCAAAAGTCCTCCTATGTG

5322
Table 3A
NA
AI568755
4532129
th15f03.x1 NCI_CGAP_CLL1 cDNA
−1
TGCAGCTCCCATTTCCTGAGCGTCTA

clone IMAGE:2118365 3′, mRNA

CCAGGTACTAGGAGAACTCTTACA

sequence

5323
db mining
Hs.327876
AI568771
4532145
th15h04.x1 cDNA, 3′ end
−1
ATTATCCTTTTCCCCAGGAAGCCCTC

/clone = IMAGE:2118391/clone_end = 3′

GGCCCCCAAAAAGGGAAACAGTTT

5324
db mining
Hs.179070
AI568773
4532147
th15h09.x1 cDNA, 3′ end
−1
CATGAGCCCAGGGGTTTCATGACAAA

/clone = IMAGE:2118401/clone_end = 3′

CATTACTAGCATGTTCAACTGCCC

5325
Table 3A
NA
AI569898
4533272
tr57c12.x1 NCI_CGAP_Pan1 cDNA
−1
GCCCGGTTTATGGAAAAACCAGGAC

clone IMAGE:2222422 3′ similar to

CAGTTTATGTTTGGGGTTTTGGGAA

gbD16234 PROBABLE PROTEIN

DISULFID

5326
Table 3A
Hs.92448
AI570295
4533669
EST390664 cDNA
−1
GCTTGGTACTGTCATAGTGATTACAA

ATTTCATGGAATGCGAAGAGCAAC

5327
Table 3A
Hs.5637
AI570531
4533905
602998983F1 cDNA, 5′ end
−1
TTTTCTCCCCTCTCTTCCCCTTCCAC

/clone = IMAGE:5141013/clone_end = 5′

GAACTGCAATACCAGTAACCTTGG

5328
Table 3A
Hs.14623
AI571519
4534893
interferon, gamma-inducible protein 30
−1
AGCCCAGATACACAAAATTCCACCC

(IF130), mRNA/cds = (40, 951)

CATGATCAAGAATCCTGCTCCACT

5329
db mining
Hs.8882
AI572757
4536131
tu43c07.x1 cDNA, 3′ end
−1
CATGTGTTGACTCTGTAATGGATTTAT

/clone = IMAGE:2253804/clone_end = 3′

GTAGCCCACTTCAGTCTGCAAAT

5330
Table 3A
Hs.230430
AI579979
4564355
tq45a01.x1 cDNA, 3′ end
−1
AGGGGTGTCCCTTTTCCCCTTCATGT

/clone = IMAGE:2211720/clone_end = 3′

AAAATTCTAACTGGGGCTACCAGT

5331
Table 3A
NA
AI581199
4565575
ti94h10.x1 NCI_CGAP_Co14 cDNA
−1
TCTACTGACTATCCTAGAAATCGCTG

clone IMAGE:2154787 3′ similar to

TCGCCTTAATCCCAAGCCTACGTTT

SW:ATP6_HUMAN P00846 ATP

SYNTHASE A

5332
Table 3A
Hs.327922
AI581383
4565759
to71c02.x1 cDNA, 3′ end
−1
TGAAGAAACTGCCCTTTCTGTGATGT

/clone = IMAGE:2183714/clone_end = 3′

TTTTGAATACTACCCAACAGCCAA

5333
Table 3A
Hs.229918
AI581732
4567629
ar74f03.x1 cDNA, 3′ end
−1
CTTCCTAGCCCTAAGTTTGGCCTTTG

/clone = IMAGE:2128349/clone_end = 3′

GGTGGCTCCAAAAAGGATTAGGTT

5334
Table 3A
Hs.292553
AI582954
4566851
tr98e07.x1 cDNA, 3′ end
−1
TCCCCCTCGTTTTGTAGGGTTTGTAC

/clone = IMAGE:2227140/clone_end = 3′

ATAATAAAACAATGGGGTGGGGCC

5335
Table 3A
Hs.340925
AI590337
4599385
wh96a06.x1 cDNA, 3′ end
−1
TGTTAAGTGTGAGGTTTTCTGAACCC

/clone = IMAGE:2388562/clone_end = 3′

TTAGCAGAAGGACTTTTAATGTTT

5336
Table 3A
Hs.101617
AI597917
4606976
601513709F1 cDNA, 5′ end
−1
AGTTCCACTGCTGTTCCTCTTACCTT

/clone = IMAGE:3914786/clone_end = 5′

GATTAATGCCTATGCATGTACTT

5337
db mining
Hs.13646
AI611245
4620412
601287348F1 cDNA, 5′ end
−1
AGTTCTGTTGTGTAATCTGGTGCTGG

/clone = IMAGE:3621754/clone_end = 5′

TTCCCTGGGCATATGTATTCTGTG

5338
Table 3A
NA
AI619574
4628700
ty50c09.x1 NCI_CGAP_Ut2 cDNA
−1
CCCCCTTGCTTGGTTTTAAGTAGGTA

clone IMAGE:2282512 3′ similar to

TGGAATGTTATTATAGGCCATAGT

gb:M23613 NUCLEOLAR

PHOSPHOPROTEIN B

5339
db mining
Hs.340564
AI625119
4650050
is47b12.x1 cDNA, 3′ end
−1
TCAGTGTAAACCATAATTAGGCCGTGA

/clone = IMAGE:2231711/clone_end = 3′

GTTTTTGCTCTTACTCCCAGGTTT

5340
Table 3A
Hs.188385
AI625368
4650299
ts37c10.x1 cDNA, 3′ end
−1
TGTAAACTTGTTTTAACAACTCTTTTC

/clone = IMAGE:2230770/clone_end = 3′

AACATTTTGGCCGGGGTATTCCC

5341
Table 3A
Hs.278554
AI627495
4664295
chromobox homolog 3 (Drosophila
−1
TGCTGAAAGTGGTCCCAAAGGGGTA

HP1 gamma) (CBX3), mRNA

CTAGTTTTTAAGCTCCCAACTCCCC

/cds = (111, 662)

5342
Table 3A
Hs.171262
AI628993
4665693
ty95h02.x1 cDNA, 3′ end
−1
TTCCCAGTTGCCACAGACCGTTTATA

/clone = IMAGE:2286867/clone_end = 3′

TGAAGAAATGCTAAAGAAGTTCCC

5343
Table 3A
NA
AI628930
4665730
ty40d03.x1 NCI_CGAP_Ut2 cDNA
−1
TCTACTGACTATCCTAGAAATCGCTG

clone IMAGE:2281541 3′ similiar to

TCGCCTTAATCCAAGCCTACGTTT

SW:ATP6_HUMAN P00846 ATP

SYNTHASE A

5344
db mining
Hs.264154
AI630176
4681506
ad06a03.r1 cDNA/clone = ad06a03-
−1
AGTTCTAAAGCCGGGAATTCCTAAGG

(random)

ATATACTAAATGAGATTATGTGTGG

5345
Table 3A
Hs.340604
AI631850
4683180
wa36h07.x1 cDNA, 3′ end
−1
GCCTGGGGGAGGAGAAGTCCCTTCC

/clone = IMAGE:2300221/clone_end = 3′

CATTCCAGCTCGATCAATCTTGCTG

5346
Table 3A
Hs.256729
AI634652
4685982
wx27c05.x1 cDNA, 3′ end
−1
GGAGTAGAGAGAGTCTTGCTACATGC

/clone = IMAGE:2544872/clone_end = 3′

GGGAACTAGAATTACATCACTGCG

5347
Table 3A
Hs.319825
AI634972
4686302
602021477F1 cDNA, 5′ end
−1
AAGAAGTTTCATTGATATCCACTGGT

/clone = IMAGE:4156915/clone_end = 5′

CACATCATACCTGTCTATAGGGCA

5348
Table 3A
Hs.176920
AI638800
4691034
tt32e01.x1 cDNA, 3′ end
−1
TGCTTCAAGCACAGGATTTATGGAAT

/clone = IMAGE:2242488/clone_end = 3′

AGTTGGCAAATTAAACAACATGCT

5349
Table 3A
Hs.197028
AI650871
4734850
602643870F1 cDNA, 5′ end
−1
CGGCAGCCTTATGGAATGAGTTTCTT

/clone = IMAGE:4774817/clone_end = 5′

GTCATGAATGTTGTCCCCAAAGCT

5350
Table 3A
Hs.4283
AI651212
4735191
602621616F1 cDNA, 5′ end
−1
ACAGTTACTTTGGAGCTGCTAGACTG

/clone = IMAGE:4755315/clone_end = 5′

GTTTTCTGTGTTGGTAAATTGCCT

5351
db mining
Hs.203064
AI651922
4735901
hy16b12.x1 cDNA, 3′ end
−1
TGTGAAGAATCCCTACCATTAATACC

/clone = IMAGE:3191471/clone_end = 3′

CTGGGTGGGATAAATAAAAATGGG

5352
Table 3A
Hs.195378
AI653766
4737745
ty01b06.x1 cDNA, 3′ end
−1
CCCAAAATTTGTTTAAAGTTCCGACTT

/clone = IMAGE:2277779/clone_end = 3′

CCAAAAGGGGCCAATAAAAAGGG

5353
db mining
Hs.111941
AI660405
4763975
qd92a04.x1 cDNA, 3′ end
−1
CACCGCCTCTGCCTCCGCCTCTTCCA

/clone = IMAGE:1736910/clone_end = 3′

CTGGAGAGCCCGAGGTCAAAAGGTC

5354
Table 3A
Hs.200442
AI669591
4834365
tw34b09.x1 cDNA, 3′ end
−1
CCCTCACCTAGCAGTACTACCACAAT

/clone = IMAGE:2261561/clone_end = 3′

AATGCTATCATGGTGCCAGGGAAT

5355
Table 3A
Hs.101150
AI672433
4852164

Homo sapiens, clone IMAGE:4054156,
−1
TCTCCTTCCCCATTGGGCCGCCTTTA

mRNA, partial cds/cds = (0, 526)

TCAATTGCCTGTTTTGTTTTGTTT

5356
Table 3A
Hs.341178
AI676004
4888186
xa30a04.x1 cDNA, 3′ end
−1
TTTTTATCTTTCTTGGTGGGGGTGTG

/clone = IMAGE:2568270/clone_end = 3′

GTGGTGGTGAAGAGGACCTAAAAA

5357
Table 3A
Hs.324507
AI676099
4888261
hypothetical protein FLJ20986
−1
CGCCAGAGGTCAGAACATGTCTATTT

(FLJ20986), mRNA/cds = (182, 2056)

TGAATTGGATCGTTACAAATGAGC

5358
Table 3A
Hs.178784
AI681868
4892050
602587746F1 cDNA, 5′ end
−1
GCAGGCACTGACATTTTTGAGCAAAG

/clone = IMAGE:4716442/clone_end = 5′

ACGTGATGTTATGAGATAAATATC

5359
Table 3A
Hs.90744
AI684022
4895316
proteasome (prosome, macropain)
−1
TTCTGACACGATTACACAACGAGGCT

265 subunit, non-ATPase, 11

TTAATGCCATTTGGGTAGGTGAGC

(PSMD11), mRNA/cds = (0, 1268)

5360
db mining
Hs.328323
AI684369
4695663
tc96e09.x1 cDNA, 3′ end
−1
TTTTAAAGGGGAGGGGCCGGGGTTT

/clone = IMAGE:2074024/clone_end = 3′

GGTCCCCGGTCCCAAAGGTAAAAGTT

5361
Table 3A
Hs.58774
AI684437
4895731

Homo sapiens, Similar to zinc finger
−1
GAGTGAGAAGAGGCTTTTAAGGACCA

protein 175, clone MGC:12651

TGTGAAGAGGCTTTTAAACACTTT

IMAGE:4301632, mRNA, complete cds

/cds = (367, 522)

5362
db mining
Hs.182817
AI684847
4896141
602290551F1 cDNA, 5′ end
−1
GGGTTGGGATAAACTGCTTAGATGTT

/clone = IMAGE:4385293/clone_end = 5′

TGCCTACTTGTCCAGTGAAATTAC

5363
Table 3A
NA
AI688560
4899854
wd39f08.x1 Soarses_NFL_T_GBC_S1
−1
ACTGAAAAGTTGAAAGACTTTTGCAG

cDNA clone IMAGE:2330535 3′, mRNA

TGAACATTTATATAACTCCCCGCT

sequence

5364
Table 3A
Hs.201789
AI693179
4970519
MR1-CI0181-081100-001-a01 cDNA
−1
ATTCATAGGTAGTGCCCAGAGAGAGT

ACAAGCTCTGACTCATATGGCAGT

5365
literature
Hs.202407
AI697497
49805397
we14b06.x1 cDNA, 3′ end
−1
ACATGTTACCTGGAGTAGCTGTGTCA

/clone = IMAGE:2341043/clone_end = 3′

ACAGATTAATATGGAATGCTACTA

5366
Table 3A
Hs.177708
AI697756
4985658
602369210F1 cDNA, 5′ end
−1
TGGTTCCTGTGCTCACCATAGGGCTG

/clone = IMAGE:4477370/clone_end = 5′

GTGTACATTGGGCCATTAATAAAC

5367
Table 3A
Hs.206854
AI700738
4988836
EST388531 cDNA
−1
ACAGATCCCTATTGCCAGACACATCA

TTCTCTCCATCCAGAAAGCAAACA

5368
Table 3A
Hs.80887
AI701165
4989065
v-yes-1 Yamaguchi sarcoma viral
−1
TCTGGGAAAGACATTTTTAAGCTGCT

related oncogene homolog (LYN),

GACTTCACCTGCAAAATCTAACAG

mRNA/cds = (297, 1835)

5369
Table 3A
Hs.102793
AI707589
4997365
RST17769 cDNA
−1
AGTCACGATAAACCTGGTCACCTGAA

AATTGAATTGAGCCACTTCCTTG

5370
Table 3A
Hs.30933
AI707809
4997585
as28g09.x1 cDNA, 3′ end
−1
AAACTGGCGGCCCAACAAAACAGTG

/clone = IMAGE:2318560/clone_end = 3′

GGTTAAATGGGTCCCTGGGTGACAT

5371
Table 3A
Hs.107369
AI707896
4997672
as34a10.x1 cDNA, 3′ end
−1
AGTGTTTCCTCCACATCTAAAGAAAG

/clone = IMAGE:2319066/clone_end = 3′

CCCATTTTGAAACTGGATACTGCA

5372
Table 3A
Hs.176430
AI708327
4998103
at04c02.x1 cDNA, 3′ end
−1
CCCAGGTGGCCCCTCTCCATCAGAT

/clone = IMAGE:2354114/clone_end = 3′

GTTATTGCTCTTCCCCATTTATTTA

5373
Table 3A
Hs.300710
AI709236
4999012
RC-MT0059-200600-021-g05 cDNA
−1
AAGATGCCTAAGCGTTAACCAGGTGA

AACAGGGGTGGGAGAGAGAAAGAA

5374
Table 3A
Hs.297184
AI720536
5037792
601502712F1 cDNA, 5′ end
−1
GTCATACACCTATCCCCCATTTTCCT

/clone = IMAGE:3904539/clone_end = 5′

CCTATCCCTCAACCCGGACATCAT

5375
Table 3A
Hs.313929
AI733018
5054131
oh60h01.x5 cDNA, 3′ end
−1
GCAGGTGGCAGAATGGGGTGCATGA

/clone = IMAGE:1471441/clone_end = 3′

AGGTTTCTGAAAATTAACACTGCTT

5376
Table 3A
Hs.310333
AI735206
5056730
at07f03.x1 cDNA, 3′ end
−1
ACAGAGAGGCAGCATTTGTTTTCCAG

/clone = IMAGE:2354429/clone_end = 3′

TTAAAATTTGACCTCACTGTGATT

5377
Table 3A
Hs.277201
AI740667
5108955
wg07b07.x1 cDNA, 3′ end
−1
CCCCCTTTTGTTGTGGTTTTATATTGG

/clone = IMAGE:2364373/clone_end = 3′

AACCCCCTTTTTCTTTGGAACTA

5378
Table 3A
Hs.204656
AI741246
5109534
wg26g09.x1 = 1 cDNA, 3′ end
−1
CTGACCCCTTCCTCACCCCTGCCAAC

/clone = IMAGE:2366272/clone_end = 3′

AGTGGTGGCATATATCACAAATGG

5379
Table 3A
Hs.299883
AI742850
5111138
hypothetical protein FLJ23399
−1
TGTTTTACCTCACTGTTGGACATACAT

(FLJ23399), mRNA/cds = (282, 1789)

TCCAAGCTTTTCAACTCTAGGAG

5380
Table 3A
Hs.6187
AI745230
5113518
wg10e05.x1 cDNA, 3′ end
−1
CAGAACATGCCCAAAGAAGCCTATAT

/clone = IMAGE:2364704/clone_end = 3′

CTTGCTGCTGGGAAATGTAAAGCA

5381
Table 3A
Hs.293842
AI748827
5127091
601571679F1 cDNA, 5′ end
−1
CAAACACCGGCAGTTGAAAGGAAAA

/clone = IMAGE:3838675/clone_end = 5′

GGACGGGGAATGTGATGGAAAAGAG

5382
Table 3A
NA
AI749435
5127699
at24b03.x1 Barstead aorta HPLRB6
−1
CCCCCTCCCTGCCCCGGTGAGCTTT

cDNA clone IMAGE:2356015 3′ similar

GGGGAACCCAAAAATTAGATTTTGC

to gb:X55715 40S RIBOSOMAL PRO

5383
Table 3A
Hs.204929
AI749444
5127708
at24c03.x1 cDNA, 3′ end
−1
CCCAAATCCAAGGACCAATGCTGTTG

/clone = IMAGE:2356036/clone_end = 3′

TAAACAAGGGGTAAAGGGCCTAAA

5384
Table 3A
Hs.205071
AI760018
5175685
wh83b02.x1 cDNA, 3′ end
−1
ACTCCACCAAGACTGTGAACTCCACC

/clone = IMAGE:2387307/clone_end = 3′

GGGGTAGGAAGCATATTTTACTCA

5385
Table 3A
Hs.160951
AI760020
5175687
wh83b05.x1 cDNA, 3′ end
−1
GAGAACTCGTTTCAAGGAACTCGATG

/clone = IMAGE:2367313/clone_end = 3′

TTTCCGGGGACCAAGCCCGCCCAG

5386
Table 3A
Hs.340921
AI760026
5175693
wh83c05.x1 cDNA, 3′ end
−1
CCAGCGAATTTCCAGCTTTTGAAACT

/clone = IMAGE:2367336/clone_end = 3′

CAGATTTCCTTTTGCGACCCAGGT

5387
Table 3A
Hs.26873
AI760224
5175891
wh62g06.x1 cDNA, 3′ end
−1
GATGCGCGGCAAGAATGTACCTGTA

/clone = IMAGE:2385370/clone_end = 3′

GATGTGTACATACCACAGTGCTGTA

5388
Table 3A
Hs.14373
AI760353
5176020
yx26h11.r1 cDNA, 5′ end
−1
TTTATCTCAGAATCTTGATGAACTCTG

/clone = IMAGE:282917/clone_end = 5′

AAATGACCCCTGATGGGGGCATG

5389
db mining
Hs.204598
AI760374
5176041
wh87d12.x1 cDNA, 3′ end
−1
GGCCCCCTGTCCTTACCTGTTTTCGG

/clone = IMAGE:2387735/clone_end =3′

CCCCCTTAATTTTTTAACCCCGGG

5390
db mining
Hs.283496
AI760389
5176056
wh87f08.x1 cDNA, 3′ end
−1
GTCACAGTGTAGACACATGGTGCTTC

/clone = IMAGE:2387751/clone_end = 3′

CATAGTGAGTAGAATATCCATTGT

5391
db mining
Hs.340927
AI760556
5176223
wi10d09.x1 cDNA, 3′ end
−1
GTGGCCTGGCCTGGCTCTCACAGAC

/clone = IMAGE:2389841/clone_end = 3′

CCAAGGCTTCCGTGTAGAATATGTC

5392
db mining
Hs.205803
AI760674
5176341
wh96b04.x1 cDNA, 3′ end
−1
GGATTGTGGCAGGAACTGTTTCCCCT

/clone = IMAGE:2388559/clone_end = 3′

CCCAGCCTTAAATTTTTCTGTGTT

5393
db mining
Hs.283497
AI760699
5176366
7f34c12.x1 cDNA, 3′ end
−1
AAACCCACACCTCAGTGAATTTAAAA

/clone = IMAGE:3296566/clone_end = 3′

GAGTAGATGTTTTAAAAGACCGGA

5394
db mining
Hs.264654
AI760835
5176502
wh96f11.x1 cDNA, 3′ end
−1
TGCCATTTGGTATTTTTTCCTGAAACA

/clone = IMAGE:2388621/clone_end = 3′

TTACATAATAAGAATGCAGCATGC

5395
Table 3A
NA
AI760901
5176568
wi09h06.x1 NCI_CGAP_CLL1 cDNA
−1
GCCTGAAACCATCCTGCCTTCTAGGA

clone IMAGE:2389787 3′, mRNA

AGACAGCAATTCTGGAAGAGCAAG

sequence

5396
db mining
Hs.230931
AI760991
5176658
wh97b11.x1 cDNA, 3′ end
−1
GGTGGTTCCCCAGCCCTTTTCCCTGG

/clone = IMAGE:2388669/clone_end = 3′

CCCTGGGTTGGAAAATTTGTTTTC

5397
db mining
Hs.328494
AI761029
5178898
wi10d06.x1 cDNA, 3′ end
−1
AAAACCTTTCGCCCGGCTTAAATTT

/clone = IMAGE:2389835/clone_end = 3′

ACCGGGGTTTGGTTTTATTTGGTTT

5398
Table 3A
Hs.98531
AI761058
5176725
wi69b03.x1 cDNA, 3′ end
−1
CTCCTTGGTGTCATGCAACTGAGGAA

/clone = IMAGE:2398541/clone_end = 3′

CCTAATTGGCTGGGTGGGTTGTTC

5399
Table 3A
Hs.205452
AI761141
5178808
wh97g08.x1 cDNA, 3′ end
−1
GTTTGTAAAAGAACCTGCCACATTTG

/clone = IMAGE:2388734/clone_end = 3′

TTGAAAAGTTAGAGCCATCACAGC

5400
Table 3A
NA
AI761144
5176811
wh97h01.x1 NCI_CGAP_CLL1 cDNA
−1
CTCTTGGCTGCTGGCCTTTTGTTCTT

clone IMAGE:2388721 3′, mRNA

GTCATGGCTCATTAGCTCCCTAAA

sequence

5401
db mining
Hs.328495
AI761468
5177135
wh98e07.x1 cDNA, 3′ end
−1
CCAGGGGTTTTTAAATTTTCTGAAGTT

/clone = IMAGE:2388804/clone_end = 3′

TTTGGGGCCATTTTGGTTGTTGG

5402
Table 3A
Hs.80887
AI761622
5177289
v-yes-1 Yamaguchi sarcoma viral
−1
CCCCGCTTGCCTTTTATTTCAGAACC

related oncogene homolog (LYN),

CCAAGTATTACCCAATATGTTACA

mRNA/cds = (297, 1835)

5403
Table 3A
Hs.289834
AI761924
5177591
wg68h03.x1 cDNA, 3′ end
−1
GCCGAAGCTCACAGAGGCTAAGTTA

/clone = IMAGE:2370293/clone_end = 3′

CACGCTTAGGTGTTCTTATTCCTAC

5404
Table 3A
Hs.204610
AI762023
5177690
wh89f04.x1 cDNA, 3′ end
−1
AACCAGGTTTATGATGCTGTAATAAA

/clone = IMAGE:2387935/clone_end = 3′

CCATGGCATTAAAGAGGGCAAGAG

5405
db mining
NA
AI762158
5177823
wh90e05.x1 NCI_CGAP_CLLI cDNA
−1
GGGTTAAGGAGGGCCGCTCCAAAAT

/clone = IMAGE:2388032 3′ similar to

TTTCCTTTTTCCCAGGAAGCCCTTG

gb:X64707 BREAST BASIC

CONSERVED PR

5406
db mining
Hs.204771
AI762177
5177844
wh90g09.x1 cDNA, 3′ end
−1
ATGCTGTGAGTGGTACACATGGCTGA

/clone = IMAGE:2388064/clone_end = 3′

GGTTATGATCTGTTAAAATATGTA

5407
Table 3A
Hs.205327
AI782557
5178224
wh92f07.x1 cDNA, 3′ end
−1
TTCATTAATTCCTCAACCCAATACTGT

/clone = IMAGE:2388229/clone_end = 3′

CTGGCTTCCACCAACAGGAGCGG

5408
db mining
Hs.328503
AI762707
5178374
wh93d08.x1 cDNA 3′ end
−1
TGGTTTCTATTTTAAAAACCTGGGTTA

/clone = IMAGE:2388299/clone_end = 3′

GGCCAAGGTTTGGGGTTCGCCCT

5409
db mining
Hs.204477
AI762719
5178386
wh93e10.x1 cDNA, 3′ end
−1
CAACATTGCCTACCAGTTGCAGTTCA

/clone = IMAGE:2388330/clone_end = 3′

TTAGCCCCGTCCGCCCCAGCATTG

5410
db mining
Hs205815
AI762739
5178406
wh93g11.x1 cDNA, 3′ end
−1
CCTTTGGGGTGGGGGCTTTTTCCTTT

/clone = IMAGE:2388356/clone_end = 3′

TTGGCCGGTTCAATTAAGGTTTTT

5411
Table 3A
NA
AI762741
5178408
wh93h02.x1 NCI_CGAP_CLL1 cDNA
−1
CCCACTCCGGCTGTTTTAGAAGTTTT

clone IMAGE:2388339 3′, mRNA

CCCGAATCCGTGATCCCTTTACAA

sequence

5412
db mining
NA
AI762797
5178464
wi04c12.x1 NCI_CGAP_CLL1 cDNA
−1
AATGGGCAAATTTTACCCAAAACTTA

clone IMAGE:2389270 3′ similar to

AGCTTGCCTATTCCGTTTGAGGCA

TR:Q61655 Q61655 EUKARYOTIC

TRANSLA

5413
Table 3A
Hs.333513
AI762870
5178537
wi63c07.x1 cDNA, 3′ end
−1
GAAGGAGAGGCACACACAAATACAC

/clone = IMAGE:2397996/

ACACTCACACAAAACTCAACAACCA

5414
db mining
Hs.204480
AI762931
5178598
wh94e08.x1 cDNA, 3′ end
−1
GGATACCCCCTTTATCCCGAGGGAAT

/clone = IMAGE:2388422/clone_end = 3′

TTTTACCCTTTGGATGCCTTTAAA

5415
db mining
Hs.289836
AI762955
5178622
wh94g12.x1 cDNA, 3′ end
−1
CAAATTACAAACCTAAAAATACAGAA

/clone = IMAGE:2388454/clone_end = 3′

CATCAGCGGAGAAGACAGGAGAGC

5416
db mining
Hs.277238
AI763079
5178748
wh95a12.x1 cDNA, 3′ end
−1
CTCCTCCCTTGGGTGGGACCTGGGT

/clone = IMAGE:2388476/clone_end = 3′

TGGGGGTTTGATAGAAAAATTAACC

5417
Table 3A
Hs.173904
AI763121
5178788
wi06d12.x1 cDNA, 3′ end
−1
GGTTAAACTAGATCCCTGCAAGGCCA

/clone = IMAGE:2389463/clone_end = 3′

TCACCTCCATTCCAAGTTGTTACT

5418
Table 3A
Hs.190453
AI763208
5178873
wh95e09.x1 cDNA, 3′ end
−1
AGTGGGTTATTTTAGATCTTTTCCTG

/clone = IMAGE:2388520/clone_end = 3′

GGGTTCAGGTCACATAGCTTAACT

5419
db mining
Hs.283500
AI763225
5178892
UI-H-BW1-anj-a-06-0-UI.s1 cDNA, 3′
−1
TGTTTGGGTATATTGTTTGGGTTTTG

end/clone = IMAGE:3082282

GGCACTAGGATGGGTGACTCAGGG

/clone_end = 3′

5420
Table 3A
Hs.130059
AI763262
5178929
wi66c04.x1 cDNA, 3′ end
−1
GCCAGTGAATCTAGTTTTGGCTATTC

/clone = IMAGE:2398278/clone_end = 3′

TGTATTTTGTCCAGTTTTTCCCAT

5421
db mining
Hs.328504
AI763414
5179081
wh92a11.x1 cDNA, 3′ end
−1
AACCATTTTCCCCCGGGAACCCGTTT

/clone = IMAGE:2388168/clone_end = 3′

TGCCTGGTTTCGGATTTTTTACCC

5422
Table 3A
Hs.36137
AI765153
5231662
hepalocyte nuclear factor 3, gamma
−1
CCGGGAAGCGGGGTACTGGCTGTGT

(HNF3G), mRNA/cds = (0, 1043)

TTAATCATTAAAGGTACCGTGTCCG

5423
db mining
Hs.340947
AI766625
5233134
wi01f06.x1 cDNA, 3′ end
−1
TTTTTCCCCCTCCCAAATTCACTGCAT

/clone = IMAGE:2388995/clone_end = 3′

TACAGTTTTTGAAACAGAACGGG

5424
Table 3A
NA
AI766638
5233147
wi02a10.x1 NCI_CGAP_CLL1 cDNA
−1
TACGAGAAGTCAGGAAGTTTTGAAAT

clone IMAGE:2389050 3′, mRNA

GGCAGTGACAGGAGACGGGGGAAG

sequence

5425
db mining
Hs.210276
AI766658
5233165
wi02d04.x1 cDNA, 3′ end
−1
AAGGGCAGGCAAATCAATTAAAATTA

/clone = IMAGE:2389063/clone_end = 3′

GCCGTAACAACAACCTCGGGGGTG

5426
Table 3A
Hs.223935
AI766706
5233215
wl0g211.x1 cDNA, 3′ end
−1
AGTACACGGCCCTCAAAAGTTATATG

/clone = IMAGE:2389124/clone_end = 3′

TGCTGAATGTAACCTACTTAGCGA

5427
Table 3A
Hs.89104
AI766963
5233472
602590917F1 cDNA, 5′ end
−1
TTGTTTTAACAACTCTTCTCAACATTT

/clone = IMAGE:4717348/clone_end = 5′

TGTCCAGGTTATTCACTGTAACCA

5428
Table 3A
Hs.209511
AI768880
5235389
wh71e04.x1 cDNA, 3′ end
−1
CTTCTCCACCTCGGCCAGGTATAGG

/clone = IMAGE:2386206/clone_end = 3′

GCCAGCTTCTCGTCTCTGGGATCCG

5429
Table 3A
Hs.203594
AI796317
5381780
uncharacterized gastric protein ZA43P
−1
GCCAGGTCATTGTATAGGGAGTAAGA

mRNA, partial cds/cds = (0, 134)

TGAAGGTGAATTTGCAGCTAGTTG

5430
Table 3A
Hs.230939
AI796419
5361882
wj17f02.x1 cDNA, 3′ end
−1
TGTGTTTTGTTTTTCTGGTCCCAGGG

/clone = IMAGE:2403099/clone_end = 3′

CACCGTTTGTTTTGTGAACTCCTC

5431
db mining
Hs.291079
AI797561
5363033
602437732F1 cDNA, 5′ end
−1
CATGGCTCTAAAATTTGGAATTAACTT

/clone = IMAGE:4555638/clone_end = 5′

CTCTTGCCTTAAGAGCTGCTTGT

5432
Table 3A
Hs.159577
AI797788
5383260
wh78b11.x1 cDNA, 3′ end
−1
GCTGGTGGGAAGTTGAGCCATGTTTA

/clone = IMAGE:2386845/clone_end = 3′

TCTCTAGTGGAATCCTTACCTTGT

5433
db mining
Hs.207473
AI797813
5363370
wh79c04.x1 cDNA, 3′ end
−1
CATGTTTACACAAATTCCTTCAAAGC

/clone = IMAGE:2386950/clone end = 3′

CCCTTAAACATGGGGCCGGGCCCC

5434
db mining
Hs.171110
AI797652
5363409
7e88g03.x1 cDNA, 3′ end
−1
ACCCTAATAGCTAGGCTGGGTATATT

/clone = IMAGE:3292276/clone_end = 3

TTCAAAGTGTAGCGAAACCCCACG

5435
db mining
NA
AI797901
5363296
wh78f12.x1 NCI_CGAP_CLL1 cDNA
−1
CAGTTGGCCTCCTACAATTGGGAATT

clone IMAGE:2386895 3′ similar to

CTACCAAGCTCCAAGTTGACCTGG

contains Alu repetitive element;. m

5436
db mining
Hs.226571
AI797916
5363311
DKFZp434G048_s1 cDNA, 3′ end
−1
GGATTCCCGACAAAGGCTTGATGTGT

/clone = DKFZp434G048/clone_end = 3′

ACTTGAAGTGAGCAAAGGGTTTTG

5437
db mining
Hs.223520
AI797988
5363460
wh80a02.x1 cDNA, 3′ end
−1
GGGTGGGAGACAGGCTAATCCTTTC

/clone = IMAGE:2387018/clone_end = 3′

CCCTTGTTTTCCACGTCTTTATGAC

5438
db mining
Hs.207062
AI798027
5363499
wh80e09.x1 cDNA, 3′ end
−1
ACAACCTTCTTAATATATTAGAGACCC

/clone = IMAGE:2387080/clone_end = 3′

GCAGGAAACATTTAGTGGTGAAAC

5439
db mining
Hs.341012
AI798028
5363500
wh80f11.x1 cDNA, 3′ end
−1
GTACATGTTTGTGTGCTAAATTGCTC

/clone = IMAGE:2387085/clone_end = 3′

ATTTGGCAGTGATAGATTGAAAAAC

5440
db mining
Hs.229494
AI798100
5363583
wh81d01.x1 cDNA, 3′ end
−1
GGGGGTCAAAGAGGGTACAAATGTA

/clone = IMAGE:2387137/clone_end = 3′

TGGGGGTATATTGAATGCTAAACAT

5441
db mining
Hs.328535
AI798101
536384
wh81d02.x1 cDNA, 3′ end
−1
GGGAGCCCGTTTTAGAAGGAAGGGC

/clone = IMAGE:2387139/clone_end = 3′

AAAAGTAGGGTTTTTAACCCAAACG

5442
db mining
Hs.210307
AI798114
5363576
wh81c01.x1 cDNA, 3′ end
−1
TCCGTCCCATTCCCCCGGAAAACAAG

/clone = IMAGE:2387138/clone_end = 3′

GTTTTGAATTGGCCCGTAAAAGGG

5443
Table 3A
Hs.209609
AI798144
5363816
wh81g12.x1 cDNA, 3′ end
−1
ACGTCCTTATACAATGCACTGTTTGA

/clone = IMAGE:2387208/clone_end = 3′

TTTTTAACAATACCTGAAGGGCT

5444
Table 3A
Hs.158989
AI799909
5365381
602666595F1 cDNA, 5′ end
−1
AC TCAATACTCGGGAAAGGCTTCACA

/clone = IMAGE:4806358/clone_end = 5′

TTTCTGGGACTCAGCATTATCCAA

5445
Table 3A
Hs.135167
AI802181
5367664
AV712376 cDNA, 5′ end
−1
TTGAGAGGCAACACTTAAACACTAGG

/clone = DCAAND12/clone_end = 5′

GCTACTGTGGCATCTATGTAGACA

5446
Table 3A
Hs.195175
AI802547
5368019
mRNA for CASH alpha protein
−1
AGCCCTTTCTTGTTGCTGTATGTTTA

/cds = (481, 1923)

GATGCTTTCCAATCTTTTGTTACT

5447
Table 3A
Hs.25648
AI803065
5368537
tumor necrosis factor receptor
−1
GGGGTATGGTTTAGTAATATCCACCA

superfamily, member 5 (TNFRSF5),

GACCTTCCGATCCAGCAGTTTGGT

mRNA/cds = (47, 880)

5446
Table 3A
Hs.301209
AI804629
5370101
myeloid/lymphoid or mixed-lineage
−1
AACAACAACAGCAAAATCCCCTTAGT

leukemia (trithorax (Drosophila)

GCGTAACTTGAAATTCCCTTCGGC

homolog); translocated to, 10

(MLLT10), mRNA/cds = (183, 3266)

5449
db mining
Hs.209261
AI805106
5391760
tc90g10.x1 cDNA, 3′ end
−1
TTGTAAGTGGGTGCATAAGAAGATCT

/clone = IMAGE:2073474/clone_end = 3′

CTTCAATTAAATGCCCCCGCTGGT

5450
Table 3A
Hs.187698
AI805111
5391765
cytomegatovirus partial fusion receptor
−1
ATAATTAAGAAATCAGCCGTGTGCTT

mRNA, partial cds/cds = (0, 1037)

CTCACGTTTGGGCTCCGAGACGTG

5451
Table 3A
Hs.167206
AI805131
5391785
602727149F1 cDNA, 5′ end
−1
GTCAGTCTCCTCACCTGCCTCTGCTC

/clone = IMAGE:4868348/clone_end = 5′

CTCGCTTAGCCCATTGATTGCATC

5452
db mining
NA
AI805144
5391798
td11g08.x1 NCI_CGAP_CLL1 cDNA
−1
GGGAAGAAGCCCGTGCCCCCACCCA

clone IMAGE:2075390 3′ similar to

ATAAATGTTGGTTTTGGCCCTGATG

gb:L24038_ma1 A-RAF PROTO-

ONCOGENE

5453
db mining
NA
AI805257
5391750
tc90f09.x1 NCI_CGAP_CLL1 cDNA
−1
CAGAACTTCTGGCGAAGGCCATGTAA

clone IMAGE:2073449 3′, mRNA

GAACTACTCCAAGGAGGAAGAGGC

sequence

5454
Table 3A
NA
AI807278
5393844
wf38h03.x1 Soares_NFL_T_GBC_S1
−1
CTCTACCATAAGGCACTATCAGAGAC

cDNA clone IMAGE:2357909 3′ ,mRNA

TGCTACTGGAGTGTATATTTGGTT

sequence

5455
db mining
NA
AI808039
5394527
wf52h02.x1 Soares_NFL_T_GBC_S1
−1
ACTGCTACAGCTTAACCATTGTTCCA

cDNA clone IMAGE:2359251 3′ similar

AGCTAATTAAATTACCTTTGGGGA

to TR:Q62845 Q62845 NEURAL CELL

5456
Table 3A
Hs.87912
AI808931
5395497
EST379776 cDNA
−1
CAATTGTGATTTGGAAGGTTTAACTG

GGTCTGCCCAGATGTTTACGAATA

5457
db mining
Hs.209989
AI809181
5395747
wh75d05.x1 cDNA, 3′ end
−1
TCCAAGCAAAAGTTATGCAATAAGAC

/clone = IMAGE:2386569/clone_end = 3′

AGAATATAAAGTCTCCGAGAGCCT

5458
db mining
Hs.230485
AI809184
5395750
wh75d08.x1 cDNA, 3′ end
−1
GGGTGGGGTGGGGTGAGAGTGTGTG

/clone = IMAGE:2386575/clone_end = 3′

GAGTAAGGACCTTCAGAATTAATAT

5459
db mining
Hs.292761
AI809305
5395871
wh75g11.x1 cDNA, 3′ end
−1
TGCAGTTCTTATTTTCTTTTGCCTGTG

/clone = IMAGE:2386628/clone_end = 3′

ATAATTGCAAATCCGTCAATAGAA

5460
Table 3A
Hs.210385
AI809310
5395876
wh75h08.x1 cDNA, 3′ end
−1
TGCAAGTTTCTGAGACTGTGAAAAGT

/clone = IMAGE:2386623/clone_end = 3′

GTTTTGCTTCTTTTGTTACCCAAT

5461
db mining
Hs.90463
AI809378
5395944
wa27e12.x1 cDNA, 3′ end
−1
TCCCAGCGAATGTGAATCATTTAGTG

/clone = IMAGE:2299342/clone_end = 3′

TGCTACTCAAAATTAGGTGTCCAC

5462
Table 3A
Hs.257466
AI809475
5398041
UI-H-BI3-aid-e-08-0-UI.s1 cDNA, 3′
−1
TAAGATGTAGGGGCCACCGGCCAGC

end/clone = IMAGE:2736471

AGTACCCAGGAATGACCACTATCAG

/clone_end = 3′

5463
db mining
Hs.208153
AI809564
5396130
wh76e01.x1 cDNA, 3′ end
−1
ATAAATGAAAGCATACCAAGTGCTGT

/clone = IMAGE:2386680/clone_end = 3′

CCATTCCATAGGTACAACTATGGA

5464
db mining
Hs.310486
AI809746
5396312
7e96g11.x1 cDNA, 3′ end
−1
CTGGTATTCTGAGGTCAGATGTAGGC

/clone = IMAGE:3293060/clone_end = 3′

TGTTGCTCGCTCCGGCTGGGTCTC

5465
Table 3A
Hs.277293
AI811065
5397631
tr03f05.x1 cDNA, 3′ end
−1
CCATCGGGGGTATTGGGGTTTTGGG

/clone = IMAGE:2217249/clone_end = 3′

CTGAATTTACTTGATTATTGGAAAA

5466
Table 3A
Hs.86693
AI817153
5436320
EST380760 cDNA
−1
GCCAGATTGTGGCAGGTAAAGAGAC

AATGTAATTTGCACTCCCTATGATA

5467
Table 3A
Hs.230492
AI818596
5437675
wk74d04.x1 cDNA, 3′ end
−1
TTTAAAAAGGAGGGAGGATTTCTGGG

/clone = IMAGE:2421127/clone_end = 3′

TTAAAACTTTTATTTGGCCCCCAT

5468
Table 3A
Hs.229990
AI818777
5437856
wl11f10.x1 cDNA, 3′ end
−1
TAAAACCCAAGACTTCAGATTCAGCC

/clone = IMAGE:2424819/clone_end = 3′

GAATTGTGGTGTTTCACAAGGCCG

5469
Table 3A
NA
AI818951
5438030
wj89e12.x1 NCI_CGAP_Lym12 cDNA
−1
CTAAGCATGGGGAAGGGGGCAGAGT

clone IMAGE:2410030 3′ similar to

GAGGACTGTGCCATTGATTAAAGTG

WP:C11H1.7 CE18492; contains Alu r

5470
Table 3A
Hs.51039
AI823541
5444212
KIAA0078 gene product (KIAA0076),
−1
GTACAGAAACATATTCCATGCTTTGA

mRNA/cds = (86, 5182)

AATAAAGGGAAGTGCTCTCCTGTT

5471
Table 3A
Hs.211535
AI823649
5444320
wi85g03.x1 cDNA, 3′ end
−1
GAAGCCTTTTCTTTTCTGTTCACCCTC

/clone = IMAGE:2400148/clone_end = 3′

ACCAAGAGCACAACTTAAATAGG

5472
Table 3A
Hs.304477
AI824522
5445193
tx71d03.x1 cDNA, 3′ end
−1
ACCGATCGTTTTTAGGATAATATGCA

/clone = IMAGE:2275013/clone_end = 3′

TGTTTCAAGTGGTATTGAAACCCCC

5473
db mining
Hs.270624
AI825098
5445859
7b65e05.x1 cDNA, 3′ end
−1
TGAGGGACAGGCTGCCTAAAGTCTAA

/clone = IMAGE:3233120/clone_end = 3′

TTGGAGAGTTAACCTAATGTCTGT

5474
Table 3A
Hs.117906
AI825845
5446316
wb75b09.x1 cDNA, 3′ end
−1
CACCATCGTGGCTCTGAGAACTGAC

/clone = IMAGE:2311481/clone_end = 3′

GCCGTGAATGTTGACCTGAGTGCCG

5475
Table 3A
Hs.229993
AI827451
5448122
wt17d11.x1 cDNA, 3′ end
−1
GGGGAGAGACCACCCTAGACATTTG

/clone = IMAGE:2425173/clone_end = 3′

CATTTTTGTAAGTTAGCCAGCCAAT

5476
Table 3A
Hs.181400
AI827911
5448669
602650370T1 cDNA, 3′ end
−1
TGGATAAATCTGAGCAACTTTCTTCTT

/clone = IMAGE:4761353/clone_end = 3′

TGTGCTCCAGGAACCTACGCACT

5477
Table 3A
Hs.342617
AI827950
5448708
ha15h10.x1 cDNA, 3′ end
−1
TGTGGGTTTTGATTGACATACTGTTG

/clone = IMAGE:2873827/clone_end = 3′

TTCATGCTGAAGTTTGAGTGTCGT

5478
Table 3A
Hs.132238
AI829569
5450240
wf28e02.x1 cDNA, 3′ end
−1
GGTGTGCAGTCCGCCTGAAAGCCTT

/clone = IMAGE:2356922/clone_end = 3 ′

CCCTTTAGCTATTAGGAATTGAGTC

5479
db mining
Hs.289878
AI831819
5452490
wh84f12.x1 cDNA, 3′ end
−1
ACATTGGAAAGAAACCCTACAACTGT

/clone = IMAGE:2387471/clone_end = 3′

AATGAATATGAAAAGAATTGTCTAAAA

5480
Table 3A
Hs.341177
AI832038
5452709
wj99e02.x1 cDNA, 3′ end
−1
AAAACCGTTTTCCCCATACATAAAGA

/clone = IMAGE:2410970/clone_end = 3′

ACAGGGGTACTCCCGCCCTGATGG

5481
Table 3A
Hs.210995
AI832182
5452853
td13h11.x1 cDNA, 3′ end
−1
TTTGGTGAAGTGAAAGAGAGAAGTTG

/clone = IMAGE:2075589/clone_end = 3′

CTCTAAAAGGTTGGAAACCAGCCC

5482
Table 3A
Hs.249031
AI832183
5452854
wh80g09.x1 cDNA 3′ end
−1
TGGACTGTTGTAATGTTTTGCGTTAT

/clone = IMAGE:2387104/clone_end = 3′

CAAATGAAAACTGCCAAATGAGA

5483
Table 3A
Hs.63908
AI85871
5512387
hypothetical protein MGC14726
−1
GCTTTGAGTTTTGGGATGGTCACATG

(MGC14726), mRNA/cds = (21, 653)

ACACAATCCAGCACTTGAACCTGA

5484
Table 3A
Hs.252259
AI859076
5512692
ribosomal protein S3 (RPS3), mRNA
−1
AGAGCCATTCCCACAAAGTAAATGTG

/cds = (22, 753)

CAGTGCCCATGTTTCTTGTGTTTA

5485
Table 3A
NA
AI860120
5513736
wh39e01.x1 NCI_CGAP_Kid11 cDNA
−1
GACTCTGAGAGAGAGCGACGGCCAT

clone IMAGE:2383128 3′, mRNA

CATAGAACAGCGAAGGCAGTCGATC

sequence

5486
db mining
Hs.156811
AI862332
5526439
hz33g10.x1 cDNA, 3′ end
−1
ATCGATGAGAAGAGTCTGCAAAACAC

/clone = IMAGE:3209826/clone_end = 3′

TTCATCCTCAGGACGTGCTGTCCT

5487
db mining
Hs.304508
AI882595
5526702
wh99g01.x1 cDNA, 3′ end
−1
ATATATTAAACCACAGGTATTAGAGA

/clone = IMAGE2388912/clone_end = 3′

CATGAATTGCACCCAACACAAGCT

5488
Table 3A
NA
AI862623
5526730
wh99h10.x1 NCI_CGAP_CLL1 cDNA
−1
ATTCATTCGGGTCTTCCTTTCTTCCG

clone IMAGE:2388931 3′, mRNA

CCCCCTTCCTTCCATTGGCACCTC

sequence

5489
Table 3A
Hs.181426
AI86542
5529523
EST367815 cDNA
−1
TCAGTTTTGTGGAATCTGGTGTTTGC

ACTATAGGTTAAGAGTTGCCATTT

5490
Table 3A
Hs.341208
AI855603
5529710
wk47g03.x1 cDNA, 3′ end
−1
TGTGTGGTGGGGGTGCTTTTGAGGTT

/clone = IMAGE:2418580/clone_end = 3′

GGAGGAAAGTAGAGACAGCGAAAC

5491
Table 3A
Hs.9788
AI866194
5530301
hypothetical protein MGC10924 similar
−1
TGTGCTTTTTGCCCAAGTGGTAATTC

to Nedd4 WW-binding protein 5

ATCTTGGTTTGCTATGTTAAAACT

(MGC10924), mRNA/cds = (104, 769)

5492
Table 3A
Hs.224760
AI224760
5548156
wm49b01.x1 cDNA, 3′ end
−1
CTTTGGGGACCTAAACCCCAGGTGG

/clone = IMAGE:2439241/clone_end = 3′

TCTCTTGGTGTTAATAATGCTGGAA

5493
Table 3A
NA
AI880542
5554591
at80h05.x1 Barstead colon HPLRB7
−1
AAATCGCGGTCGCCTTAATCCAAGCC

cDNA clone IMAGE:2378381 3′ similar

TAGGTTTTCACACTTTTAGTAAGC

to SW:ATP6_HUMAN P00846 ATP SY

5494
Table 3A
Hs.220850
AI880607
5554856
ym91d11.r1 cDNA, 5′ end
−1
TGGGGCACTTTGAAAACTTCACAGGC

/clone = IMAGE:166293/clone_end = 5′

CCACTGCTGCTTGCTGAAATAAAA

5495
Table 3A
Hs.89414
AI884548
5589712
chemokine (C-X-C motif), receptor 4
−1
GACATTCATCTGTTTCCACTGAGTCT

(fusin) (CXCR4), mRNA

GAGTCTTCAAGTTTTCACTCCAGC

/cds = (88, 1146)

5496
Table 3A
Hs.23096
AI884871
5589335
602254146F1 cDNA, 5′ end
−1
TGGCGAGGATAAATAGAGGCATTGTT

/clone = IMAGE:4345626/clone_end = 5′

TTTGCTACTTTGCATATCATTGGC

5497
db mining
Hs.34650
AI885574
5590738
602286784T1 cDNA, 3′ end
−1
TGGCTCTCCTCTTTGTAATATACAGG

/clone = IMAGE:4375724 clone_end = 3′

GTGAACTCTTTACTGATACACACA

5498
Table 3A
Hs.121572
AL886313
5591477
EST387650 cDNA
−1
CCAGTGTCCTGCATGGGTGCTAGGC

TGAATTATTTGTAATTGTGCTTAGG

5499
Table 3A
Hs.213385
AI912585
5632440
we11d07.x1 cDNA, 3′ end
−1
ACCGTCTTTTGTGATTCCCTGGAAAC

/clone = IMAGE:2340781/clone_end = 3′

CCTTAATTCAATAGTCCTGACTGA

5500
Table 3A
Hs.228486
AI917348
5637203
ts83d10.x1 cDNA, 3′ end
−1
AGCCCTGGGTAGCCAAGTGATTTTCC

/clone = IMAGE:2237875/clone_end = 3′

CATTCCCAAAGTTAGTAAACCTTT

5501
Table 3A
Hs.179391
AI917642
5637497
wi52d11.x1 cDNA, 3′ end
−1
GCAGGAAAGATGGGGTGGTGGACTG

/clone = IMAGE:2393877/clone_end = 3′

TTTTTGCCTACTTTTTGTTTTTGAA

5502
Table 3A
Hs.337286
AI922889
5858853
wn64g11.x1 cDNA, 3′ end
−1
CCCCCTGAAACTGGCATTTTGTAAAT

/clone = IMAGE:2450276/clone_end = 3′

GTGGTTTGACTATTTTTGTATGTT

5503
Table 3A
Hs.212553
AI922921
5658885
wn81c05.x1 cDNA, 3′ end
−1
ACCTGGAGAATTCCCTAAGGCCAAAG

/clone = IMAGE:2452232/clone_end = 3′

CAAGGTAACAGGGACTTCAGTTTT

5504
Table 3A
Hs.58643
AI926251
5662139
602438603F1 cDNA, 5′ end
−1
GCCTCAGTACAAAGGGGGCTTTGGA

/clone = IMAGE:4564968/clone_end = 5′

AGTGTTTGTTGGCTGAATAAAGGAA

5505
Table 3A
Hs.40328
AI927454
5663418
nab63b04.x1 CDNA, 3′ end
−1
ACCCATGCCAATTGAAGAACGTGTTA

/clone = IMAGE:3272383/clone_end = 3′

AAGATGAGGAGGAGAGATGTACCA

5506
db mining
Hs.154368
AI934956
5673826
ng40b06.s1 cDNA, 3′ end
1
GCACATTCCTTCCTTATATCCTGGAA

/clone = IMAGE:937235/clone_end = 3′

GCACCCAGATATTCTTCATGTCCC

5507
Table 3A
Hs.101370
AI936516
5675386
AL583391 cDNA
1
TTAAGTCATCTGCTGAGCAGTGTGCT

/clone = CS0DL012YA12-(3-prime)

GTGTCAACCTCCTCCTAGGTAACC

5508
Table 3A
Hs.180446
A1948513
5740623
importin beta subunit mRNA, complete
−1
CAGGGTATCAGATATTGTGCCTTTTG

cds/cds = (337, 2967)

GTGCCAGGTTCAAAGTCAAGTGCC

5509
Table 3A
Hs.71245
AI954490
5746809
zl17f11.r1 cDNA, 5′ end
−1
TGGTAATAGTGTTTGACTCCAGGGAA

/clone = IMAGE:502221/clone_end = 5′

GAACAGATGGGTGCCAGAGTGAAA

5510
Table 3A
Hs.118820
AI955314
5747624

Homo sapiens, clone IMAGE:3357862,
−1
TCAAGTATACCATTTAAAATATTTCAT

mRNA, partial cds/cds = (0, 325)

CAGGCAGAGCCCTGACCAGGAAA

5511
db mining
NA
AI961962
5754664
wt40g09.x1 NCI_CGAP_Pan1 cDNA
−1
CTTTTCCGGTTGCCCGAGGATGCTTG

clone IMAGE:2509984 3′ similar to

GGAAGGAACCCGTCTCCCTTCTTC

gb:M87789 IG GAMMA-1 CHAIN C

REGION

5512
Table 3A
Hs341528
AI962127
5754840
wx77f07.x1 cDNA, 3′ end
−1
TCCCCAAACCCCCTTAAAGGTTTTTA

/clone = IMAGE:2549701/clone_end = 3′

AATTGTTTCAAATCTGGGCAAGTT

5513
Table 3A
Hs.37121
AI968387
5765205
phospholipase C, beta 3
−1
GACTCGGAGAGCCAGGAGGAGAACA

(phosphatidylinositol-specific) (PLCB3),

CGCAGCTCTGAACTGGCTGAGCGAG

mRNA/cds = (0, 3704)

5514
db mining
Hs.13034
AI969716
5766534
hv63f09.s1 CDNA, 3′ end
−1
CTGTTGTGAATCATTTGTGTCCTTTTC

/clone = IMAGE:3178121/clone_end = 3′

AACTGTCTTTCAGAGGAAAGGTA

5515
Table 3A
Hs.193247
AI978581
5803611
hypothetical protein DKFZp434A171
−1
AAGAAGCAACCACAGCTAATTTTAGA

(DKFZp434A171), mRNA

ACATGCACTCTGACAGAAAAGACA

/cds = (113, 2584)

5516
Table 3A
Hs.153
AI984074
5811293
ribosomal protein L7 (RPL7), mRNA
−1
GCTTTTGAGGACCTTTCTGGAGGAAA

/cds = (10, 756)

GGAAAAGCCTGTTTTGGGGAGTCT

5517
Table 3A
Hs.7557
AL042081
5421426
FK506-binding protein 5 (FKBP5),
−1
AGGCTGCATATGGATTGCCAAGTCAG

mRNA/cds = (153, 1526)

CATATGAGGAATTAAAGACATTGT

5518
Table 3A
Hs.133262
AL044498
5432716
DKFZp434I082_s1 cDNA, 3′ end
−1
AAGACTAGAGCTACACTAGGCCACTA

/clone = DKFZp434I082/clone_end = 3′

TCTTATTACACGACAGCACAACAT

5519
Table 3A
Hs.39911
AL138429
6855110
mRNA for FLJ00089 protein, partial
−1
TTAAGAACCCCAAAGATTAAAGGAAA

cds/cds = (82, 1111)

CAATGTTAAGGGCTTTTGTGAGGA

5520
Table 3A
Hs.89986
AL515381
12778874
cDNA/clone = CL0BB0172H06-(3-
−1
CGGAAGTCGAAATCAAATCTATGCTT

prime)

TTAATTGAAACCGTGCCTGAAACG

5521
Table 3A
Hs.9096
AL520535
12784028
hypothetical protein FLJ20473
−1
TCTTCACCAGGTTCAAGCTCCGTGGG

(FLJ20473), mRNA/cds = (57, 1472)

CCACACTGCTGCTGTGCCAAGAAG

5522
Table 3A
Hs.13144
AL521097
12784590
HSPC160 protein (HSPC160), mRNA
−1
GATACACTGTCCAGCCCAGGTCCAG

/cds = (53, 514)

GCCCTAGGTTCTTTACTCTAGCTAC

5523
Table 3A
Hs.118142
AL522477
12785970
AL522477 cDNA
−1
TGGAATTTACTAAATTGTGAAATTAAC

/clone = CS0DB008YK14-(3-prime)

GTAACCGAAGCAACAACCGGCAA

5524
Table 3A
Hs.295112
AL528020
12791513
KIAA0616 gene product (KIAA0618),
−1
GCGGGAGGCTGGGACTTTCCATTAC

mRNA/cds = (1041, 4040)

AATAGAGACTTCATTCCTGTTGAG

5525
Table 3A
Hs.26670
AL540260
12870241
AL540260 cDNA
−1
ACTCAGGTGGTGCTGGTGTTAGTGAT

/clone = CS0DF032YF03-(3-prime)

GCTGGAGAAGAGAATATTACTGGT

5526
Table 3A
Hs.285013
AL543900
12876379
putative HLA class II associated
−1
CAGGTTGCTTTCGTGTCCCTCTTCTG

protein I (PHAP1), mRNA

GTTGCTTTAGAAGTGACGTGTAAT

/cds = (148, 897)

5527
Table 3A
Hs.183232
AL581892
12909772
hypothetical protein FLJ22638
−1
AAACACAGCCCACCCCATTTCAGACC

(FLJ22638), mRNA/cds = (12, 476)

GCCTTCCTGAGGAGAAAATGACAG

5528
Table 3A
Hs.21812
AL582895
12911771
AL562895 cDNA
−1
GCTAACTGGATAAAGTTTGTGCAGAC

/clone = CS0DC021YO20-(3-prime)

ATTCCTGAGTGTACGATATTGACC

5529
Table 3A
Hs.21812
AL582895
12911771
AL562895 cDNA
−1
GCTAACTGGATAAAGTTTGTGCAGAC

/clone = CS0DC021YO20-(3-prime)

ATTCCTGAGTGTACGATATTGACC

5530
Table 3A
Hs.181165
AL565738
12917408
eukaryotic translation elongation factor
−1
AGCTGGCTTCACTGCTCAGGTGATTA

1 alpha 1 (EEF1A1), mRNA

TCCTGAACCACCAGGCCAAATAAG

/cds = (53, 1441)

5531
Table 3A
Hs.77393
AL567986
12921892
famesyl diphosphate synthase
−1
AGTCAGGACTGTCTAGGTCAGGGAA

(famesyl pyrophosphate synthetase,

GCCAAGATGTCTGAAGAGAGAGGAA

dimethylallyltransferase,

geranyltranstransferase) (FDPS),

mRNA/cds = (114, 1373)

5532
Table 3A
Hs.13256
AL570416
12928702
AL570416 cDNA
−1
ATTCAACCAGTAATGGTACCTGAGGA

/clone = CS0DI020Y05-(3-prime)

ATTGAAATGGGTATTTGTTTCTGT

5533
Table 3A
Hs.180546
AL571386
12928631
AL571388 cDNA
−1
AGTGGAGAGGCCCTGTTAGTTTACTT

/clone = CS0DI009YL09-(3-prime)

TTCATATTGAGTGATGCATGAGGT

5534
Table 3A
Hs.21732
AL573787
12933363
AL573787 cDNA
−1
GCATTCTATTTAAAAAGGGAGTGGGG

/clone = CS0DI055YM17-(3-prime)

AGCAAATGAAAATTAAATGTGGGG

5535
Table 3A
Hs.23294
AL574514
12934790
hypothetical protein FLJ14393
−1
TCACCAGGAAAACATGCTTGTGAATT

(FLJ14393), mRNA/cds = (60, 1454)

GTGCAGTAAAAGGTGGTAATGACT

5536
Table 3A
Hs.181392
AL575666
12937052
major histocompatibility complex, class
−1
CCTTTTCTCTCCCATGACCCTTTAACA

I, E (HLA-E), mRNA/cds = (7, 1083)

GCATCTGCTTCATTCCCCTCACC

5537
Table 3A
Hs.85258
AL575755
12937231
CD8 antigen, alpha polypeptide (p32)
−1
CTGAGAGCCCAAACTGCTGTCCCAAA

(CD8A), mRNA/cds = (65, 772)

CATGCACTTCCTTGCTTAAGGTAT

5538
Table 3A
Hs.169610
AL576149
12938006
mRNA for transmembrane
−1
TGAGTGAACAAAGCTGTGAAACATTC

glycoprotein (CD44 gene)

TGCGTTTATGCAACTTCCTTGCCT

/cds = (178, 2406)

5539
Table 3A
Hs.174905
AL577970
12941605
mRNA for KIAA0033 gene, partial cds
−1
CAAGAAGACAAGCATCTGTGGTGCG

/cds = (0, 1008)

GAGGCAAGCAGGCTAACTAGGAGTT

5540
Table 3A
Hs.5057
AL578975
12943566
AL578975 cDNA
−1
TTGGCCCAGTGTGATTGATTGCTTTA

/clone = CS0DK012YN01-(3-prime)

TCTTTGGTACTTTTACTTGAATGG

5541
Table 3A
Hs.279555
AL582047
12949649
AL582047 cDNA
−1
CATCCAGCACTAATTTTCATGCATTTA

/clone = CS0DL003YD01-(3-prime)

TGAAAGGATGCCTGAGGACCCTT

5542
Table 3A
Hs.198296
AL582354
12950255
SWI/SNF related, matrix associated,
−1
AGCCTGAGGCAAATAAAATTCCAGTA

actin dependent regulator of chromatin,

ATTTCGAAGAATGGGTGTTGGCAA

subfamily a, member 2 (SMARCA2),

mRNA/cds = (297, 5015)

5543
Table 3A
Hs.101370
AL583391
12952309
AL583391 cDNA
−1
AGGACCTTGACAAGCCGTTTGAGATG

/clone = CS0DL012YA12-(3-prime)

GAATGTAGGCCCTGATGTTATGCT

5544
Table 3A
Hs.101370
AL583391
12952309
AL583391 cDNA
−1
AGGACCTTGACAAGCCGTTTGAGATG

/clone = CS0DL012YA12-(3-prime)

GAATGTAGGCCCTGATGTTATGCT

5545
Table 3A
Hs.7187
AU158636
11020157
mRNA for KIAA1757 protein, partial
−1
AGTGGAGTGTTTACACCTTGCTGTAA

cds/cds = (347, 4576)

CATTTGAACTTTCACAAGAGATGT

5546
Table 3A
Hs.86671
AV648638
9869652
602079785F2 cDNA, 5′ end
−1
ATATCATATTATTTGATGCCATTAGGC

/clone = IMAGE:4254068/clone_end = 5′

GGCCTGGATCACCAATTCTAAGT

5547
Table 3A
Hs.343475
AV648670
9869684
601556208T1 cDNA, 3′ end
−1
GCCACCAGACAGAAGGACCAGAGTT

/clone = IMAGE:3826392/clone_end = 3′

TCTGATTATAAACAATGATGCTGGG

5548
Table 3A
Hs.2730
AV650434
9871446
heterogeneous nuclear
−1
TGTTGGTGAGCAATGTGCAGAGGCA

ribonucleoprotein L (HNRPL), mRNA

GAGCCGCTGAAGTATGGTTCCTGAG

/cds = (28, 1704)

5549
Table 3A
Hs.312582
AV651615
9872629
601439711F1 cDNA, 5′ end
−1
GGCTGCTGTTGACTGAAATTCCTATC

/clone = IMAGE:3924482/clone_end = 5′

CTCAAATTACTCTAGACTGAAGCT

5550
Table 3A
Hs.5897
AV653169
9874183
cDNA FLJ13388 fis, clone
−1
CTTTTTAGTAGGCAAAGGTTCTTCTTC

PLACE10011681/cds = UNKNOWN

CTCCTCTTTTGGTGCAGGGACGC

5551
Table 3A
NA
AV664188
9875202
AV654188 GLC cDNA clone
−1
GCGTGTATGTGGGATGCCATAGGTG

GLCDTC01 3′, mRNA sequence

TGACTGTAGAGTCATTCTTCCTTCC

5552
Table 3A
Hs.38218
AV659358
9880372
602569369F1 cDNA, 5′ end
−1
TGTAAGTTGACTTTCAAAAGTCTCTG

/clone = IMAGE:4693744/clone_end = 5′

GAAACACTGGACTTTAGCTGGTCC

5553
Table 3A
Hs.133333
AV661783
9882797
AV661783 cDNA, 3′ end
−1
GAAGCGTGGCAGAGAACTATGGATC

/clone = GLCGXE12/clone_end = 3′

AGGCAGCCCCTCTCATCTTTACCAT

5554
Table 3A
Hs.85844
AV700210
10302181
neurotropic tyrosine kinase, receptor,
−1
TTGGTCCAAACTCTGGAGCCTTGTGG

type 1 (NTRK1), mRNA/cds = (0, 2390)

GAGAACATAGGGCATAACGTGTTT

5555
Table 3A
Hs.285173
AV700298
10302269
602632207F1 cDNA, 5′ end
−1
CCCTTCTTAGTAAAGAGACATCTTCT

/clone = IMAGE:4777537/clone_end = 5′

ACAGTAACCACAGAGAAGAAGTGG

5556
Table 3A
Hs.238730
AV700542
10302513
hypothetical protein MGC10823
−1
TGGACATAACCTGGGTCAGAAGAGAA

(MGC10823), mRNA/cds = (63, 1235)

ACTTTTGAAGCTACACGAACAAGC

5557
Table 3A
Hs.284674
AV700636
10302607
AV700636 cDNA, 3′ end
−1
CGGCTCAAATAAACCTTTACCGGATT

/clone = GKBAGH12/clone_end = 3′

TTTGGGGTTATGCCCACACCCTTG

5558
Table 3A
Hs.240077
AW002624
5849540
wu60d10.x1 cDNA, 3′ end
−1
GGACCACTAGTACTCCAGAACCATAA

/clone = IMAGE:2524435/clone_end = 3′

TATAACTAGACATGCCTGGAATGC

5559
Table 3A
Hs.301704
AW002985
5849991
eomesodermin (Xenopus laevis)
−1
AACAAGCCATGTTTGCCCTAGTCCAG

homolog (EOMES), mRNA

GATTGCCTCACTTGAGACTTGCTA

/cds = (0, 206O)

5660
Table 3A
NA
AW004905
5853768
wz82d03.x1 NCI_CGAP_Gas4 cDNA
−1
TCTACTGACTATCCTAGAAATCGCTG

clone IMAGE:2565317 3′ similar to

TCGCCTTAATCCAAGCCTACGTTT

SW:ATP6_HUMAN P00848 ATP

SYNTHASE A

5561
Table 3A
Hs.173280
AW005378
5854154
ws94a12.x1 cDNA, 3′ end
−1
GAGAAACTTCCGTGCATGAAGGTTTC

/clone = IMAGE:2505598/clone_end = 3′

CTCCTTGACTCGGCAGCAGCGGCC

5562
Table 3A
Hs.233560
AW006045
5854823
wz81b09.x1 cDNA, 3′ end
−1
CCAAGTAGGTTTTAACTCTGGTATGG

/clone = IMAGE:2565209/clone_end = 3′

TCTCGTGTTTTCATTTGTTGTGCA

5563
Table 3A
Hs.159643
AW006352
5855130
wt04d12.x1 cDNA, 3′ end
−1
GTTCCCACGGAGCTGACTTCTCCGG

/clone = IMAGE:2506487/clone_end = 3′

GGTGCCTGTGCCCTACATTAAACCC

5564
Table 3A
Hs.231987
AW006867
5855845
602320903F1 cDNA, 5′ end
−1
CCGTAACTCCGACAACGCAGAACTT

/clone = IMAGE:4424065/clone_end = 5′

CTTGAGGCTTTCTTCTTCTAAGGA

5565
db mining
Hs.157118
AW009081
5857859
ws76g10.x1 cDNA, 3′ end
−1
TCTGGACCCTGCTTGGGTTCACAGCA

/clone = IMAGE:2503938/clone_end = 3′

TTGGTGGAGGTAAGTAGTATTCTC

5566
Table 3A
Hs.134272
AW009671
5858449
ws85g09.x1 CDNA, 3′ end
−1
GAAGAGGAAGCTCATCCGAAGTCTTC

/clone = IMAGE:2504800/clone_end = 3′

CGACAGAGTGAGCCGTCATGCCCG

5567
db mining
Hs.131887
AW009730
5858508
602415255F1 cDNA, 5′ end
−1
AGTGTGTATTCTTGATGTTTATTGGCT

/clone = IMAGE:4523725/clone_end = 5′

CATGTGGACAGAAATGTACAGGG

5568
Table 3A
Hs.232000
AW016002
5864759
UI-H-B10p-abh-h-06-0-UI.s1 cDNA, 3′
−1
AGATGAGGCTGCTCTGAAGATTCAGT

end/clone = IMAGE:2712035

AATTAGGATGGACAGTCAGCTACT

/clone_end = 3′

5569
Table 3A
Hs.233261
AW026667
5880120
wv15d09.x1 cDNA, 3′ end
−1
TGGGCTTTGGGGTTCAGTTTGTTACC

/clone = IMAGE:2529617/clone_end = 3′

TTTGGAGACTTATTTAATGAAACC

5570
Table 3A
Hs.101340
AW026713
5880166
EST380762 dnNA
−1
CAGTGGTTCCTGAGAGAATCTTAGTT

CAAAGGACTGCCCCCGCCAACCCC

5571
Table 3A
NA
AW027160
5885916
wt72b08.x1 Soares_thymus_NHFTh
−1
ACCGCCAAAGCCAATCATCCACTTTC

cDNA clone IMAGE:2512983 3′ similar

AGTACTTACCTAACCAATCTCCCA

to contains Alu repetitive eleme

5572
Table 3A
Hs.233564
AW027530
5888286
wv74c06.x1 cDNA, 3′ end
−1
CAGGATGTTATTGACAGGGTGGCCTT

/clone = IMAGE:2535274/clone_end = 3′

TGTGATTCCTCCGGTGGTGGCAGC

5573
Table 3A
Hs.311783
AW043857
5904386
wy61g04.x1 cDNA, 3′ end
−1
GCCATTTCATTTGCTGTGTGGTTAGA

/clone = IMAGE:2554998/clone_end = 3′

CTTCCAGGAGGCTGTTTAGCTCTA

5574
Table 3A
Hs.277672
AW050975
5913245
wz25f04.x1 cDNA, 3′ end
−1
CCTTTGTGAAAAGTCACCTGTGACTG

/clone = IMAGE:2559103/clone_end = 3′

TCAGGGGTATGCTATGGGCCTTTT

5575
db mining
Hs.279068
AW063114
8887051
TN0103 cDNA, 3′ end/clone_end = 3′
−1
GATCCACTTTGGGGTTCGGCGGCAG

ATTATTCCGCTGGTAGAGCCGGATG

5576
db mining
Hs.279082
AW063120
8887169
TN0257 cDNA, 3′ end/clone_end = 3′
−1
AATAAGGGACTCATTCATTATGCAGC

AAATGTTCTTTGTTATTGGCTTGC

5577
db mining
Hs.279083
AW063153
8887202
TN0788 cDNA, 3′ end/clone_end = 3′
−1
CTTCATGGTCTCCAGCCAGGACTCCA

TCAGCGCCACGGCTTCATCCGAAC

5578
db mining
Hs.279127
AW063155
8887204
DP1003 cDNA, 3′ end/clone_end = 3′
−1
TTGATGCTCATCATCTGCTCGAGGTG

ATTGATGCCAGGTTGACGCACCAT

5579
db mining
Hs.279104
AW063156
8887205
TN0974 cDNA, 3′ end/clone_end = 3′
−1
TCCTTTGGATAAGGTCCAAAACCTGT

AACACATGACCCTCAGAGCCCTTT

5580
db mining
Hs.279085
AW063158
8887207
TN0311 cDNA, 3′ end/clone_end = 3′
−1
CCCGGCGACTTCACCACCCGCTATCT

GGGCACCAAAGACTATATCTAGAT

5581
db mining
Hs.279086
AW063159
8887208
TN0312 cDNA, 3′ end/clone_end = 3′
−1
CGCAATAGTCCTCGACAAGTCGCCAA

CCCTCCCACTTCGGTGGATCAGCT

5582
db mining
Hs.279092
AW063191
8887240
TN0359 cDNA, 3′ end/clone_end = 3′
−1
CGTCGGGTACCTCGCCGATAAAATC

GCTGATGGCCTGGTCGATCCTGAAG

5583
db mining
Hs.279093
AW063196
8887245
TN0380 cDNA, 3′ end/clone_end = 3′
−1
ATCTTATCCCTCTGTTACTCAATGTGA

GTGCATACTTTACATTGCCTACT

5584
db mining
Hs.279102
AW063210
8887259
TN0377 cDNA, 3′ end/clone_end = 3′
−1
GGTCCTTGAAGATGACGCGGATGAT

CGAGGTCTCTGCGCCGTAGGCGATG

5585
db mining
Hs279067
AW063230
8887055
TN0107 cDNA, 3′ end/clone_end = 3′
−1
ATGATGAAGCTGCTGTCCAACGCCTT

CGTCTGCCAGTTTCTGCTGGTGTG

5586
db mining
Hs.279069
AW063239
8887064
TN0018 cDNA, 3′ end/clone_end = 3′
−1
TCCTTGCCAGAGCCTTCGGGTTCTAC

GATTTGATCGACGACGCTGGTGTC

5587
db mining
Hs.279070
AW063242
8887067
TN0138 cDNA, 3′ end/clone_end = 3′
−1
TCGAACATGGGCAGCTCCGTTTCAAG

ATGGCTCAAGACTAGCGGATTGGG

5588
db mining
Hs.279071
AW663246
8887071
TN0358 cDNA, 3′ end/clone_end = 3′
−1
AGTGATAGAGACCAAAGACTGCTTTT

TAATTTTGTGGGGGAGGGGGTGGA

5589
db mining
Hs.279072
AW063252
8887077
TN0149 cDNA, 3′ end/clone_end = 3′
−1
CGGGTCACTCATGTTGGCTACTAACC

CTTTTCGTGCGCCGGGCATTCTAG

5590
db mining
Hs.279087
AW063267
8887092
TN0331 cDNA, 3′ end/clone_end = 3′
−1
CTTGTCCTTGATCGCTTCCTTCTCTG

CAAGGGAGAGCTTCTGGACCTTCA

5591
db mining
Hs.279073
AW063271
8887096
TN0158 cDNA, 3′ end/clone_end = 3′
−1
CTTGTTTGACATCAGCGCCATCTCGA

CAGCGTATTCCGCTATGACTGTTT

5592
db mining
Hs.279074
AW063274
8887099
TN0792 cDNA, 3′ end/clone_end = 3′
−1
CACGAAGCCTTCGATCAGTTGCAGCA

CGCGGCCAGAGCGGTCGATAGAAC

5593
db mining
Hs.279122
AW063299
8887124
TN0185 cDNA, 3′ end/clone_end = 3′
−1
CATTTTGCCATCTGCGAGCATCTGGG

TATTGACATGATCCCCAGTGGAGC

5594
db mining
Hs.279076
AW063319
8887144
TN0230 cDNA, 3′ end/clone_end = 3′
−1
CACCAAGCTGGTCAACATCCAGGCG

AATGGCTATTACGTGGATGAGATCA

5595
db mining
Hs.279078
AW063325
8887150
TN0238 cDNA, 3′ end/clone_end = 3′
−1
TTGCTGATACGGCCTTTGATCATGTT

TTCAACGATGTTTTCCGGCTTGCC

5596
db mining
Hs.279079
AW063327
8887152
TN0238 cDNA, 3′ end/clone_end = 3′
−1
CCTCGACAAACTAAATGTTGATTTGA

ATTGGCCTGTTATCATCTTGATCAC

5597
db mining
Hs.302423
AW063352
8887269
TN0725 cDNA, 3′ end/clone_end = 3′
−1
GTTTCAGATCGGGCCGCTCCCGCCG

GGTACCTATAGCGGAATCGAATTTC

5598
db mining
Hs.279095
AW063358
8887295
TN0979 cDNA, 3′ end/clone_end = 3′
−1
GAAAACAGAAATGATGCTCGGCACAT

TCTCGTCCAGCACCTCGGCAACGG

5599
db mining
Hs.279096
AW063371
8887308
TN0746 cDNA, 3′ end/clone_end = 3′
−1
AACTGTATTCGATCACCGTGGCGCTG

ATGGTGTCAGCAGTCGCCTTGTTC

5600
db mining
Hs.279097
AW063372
8887309
TN1085 cDNA, 3′ end/clone_end = 3′
−1
AGTTGACATATAACCCACTTTACATAC

ATTCCAAAATTGCGAGTAGTGAGT

5601
db mining
Hs.279075
AW063428
8887365
TN0121 cDNA, 3′ end/clone_end = 3′
−1
ATATCGTACCGAGAAACTAGTGCGGA

TATCTGACCAGGTATGGCGGTTGG

5602
db mining
Hs.279099
AW063436
8887373
TN0922 cDNA, 3′ end/clone_end = 3′
−1
GTGGATGACCTGATCCAGGTCGGCC

TGATCGGCCTGACTGATGAGCTGTC

5603
db mining
Hs.279100
AW063458
8887395
TN0949 cDNA, 3′ end/clone_end = 3′
−1
ATGATGACCAGATGCTCTGGCACCGT

GTCGAGTTCGAGGATGCCGACATT

5604
db mining
Hs.279103
AW063469
8887406
TN0961 cDNA, 3′ end/clone_end = 3′
−1
GATCTGGGACGCATGGCCGAAGCTG

AAAAGCTGGCTGTAGAAGACCTCGA

5605
db mining
Hs.279101
AW063474
8887411
TN0354 cDNA, 3′ end/clone_end = 3′
−1
AACATGGCAATATTTATTGGTCCTAAT

ACTGTCACTGGCAAGGTTGGTGT

5606
db mining
Hs.279821
AW063497
8887434
TN0113 cDNA, 3′ end/clone_end = 3′
−1
GAGGCAGAGGTGTAGCGAGTCCAGG

CTCTCTTCGAACGTTGCACCCGACG

5607
db mining
Hs.279105
AW063509
8887446
TN1012 cDNA, 3′ end/clone_end = 3′
−1
GTCCCACACGTTCGGCCCTGACTCT

GCTGTGTTCGACGAGGACAATCTCG

5608
db mining
Hs.279089
AW063534
8887471
TN1054 cDNA, 3′ end/clone_end = 3′
−1
CATGACGTTGTGCTCGACACCCCAAC

AGATCACGTAATCAGCCTGGTGGA

5609
db mining
Hs.279080
AW083546
8887483
TN0243 cDNA, 3′ end/clone_end = 3′
−1
TAGGCTATAGAGATGTGAGGGATTAT

TATTAGTCACACCTCTAGTCATGCC

5610
db mining
Hs.279108
AW063552
8887489
TN1055 cDNA, 3′ end/clone_end = 3′
−1
GGCTGCCGGATGTGTAGGTCTTCCC

ATGTTGTGAAGTAACGGTGCTCCAC

5611
db mining
Hs.279109
AW063556
8887493
TN1059 cDNA, 3′ end/clone_end = 3′
−1
TGCCCTGTATAGTGTTGTAAAAATTA

GAATGTTTCACCCAAACCATCTGG

5612
db mining
Hs.279110
AW063561
8887498
TN1066 cDNA, 3′ end/clone_end = 3′
−1
GTCTTTCGAATCGCTCTTTAGCTCGT

GCGGGCTGTTGTCCCACTTGTTGG

5613
db mining
Hs.279090
AW063572
8887509
TN1079 cDNA, 3′ end/clone_end = 3′
−1
CTATGCGCTGCGCTACAAGCTGGAC

CTGTATTCGGACTTCAGCTACTACC

5614
db mining
Hs.279111
AW063598
8887535
DP0133 cDNA, 3′ end/clone_end = 3′
−1
TTCGAAGCGACGCTGCGTGCGCTGC

TCGTCCAATTGCAGCATGGATAAGG

5615
db mining
Hs.302424
AW063600
8887537
DP0925 cDNA, 3′ end/clone_end = 3′
−1
CCTTCCGCTGTCCCTTCAGTAGCTGT

TTCTGTTCCCTGACGCCCACTTCT

5616
db mining
Hs.279124
AW063609
8887546
DP0922 cDNA, 3′ end/clone_end = 3′
−1
CAATGCAGCGGCTGATGCAGATCAC

CCACGAGATGCAGGACGAAGGCGAG

5617
db mining
Hs.279113
AW063830
8887567
DP0154 cDNA, 3′ end/clone_end = 3′
−1
TCATTCAGTCTGAGTAGGAGGAAAGA

GGACAGGTTGTTGGAGAGTTGGTT

5618
db mining
Hs.279114
AW063635
8887572
DP0774 cDNA, 3′ end/clone_end = 3′
−1
TAATTGCCGCTGAAGCAGAATCCTC

GAAATGCGTCACCTTCGGATTGAC

5619
db mining
Hs.279125
AW063652
8887589
DP0189 cDNA, 3′ end/clone_end = 3′
−1
AAATGTGGTGACAAAGTACCAGCAAG

AACTGGACTGTGTTTCTGGAGCCT

5620
db mining
Hs.279116
AW063878
8887615
DP0229 cDNA, 3′ end/clone_end = 3′
−1
GTTCATCGTCTCGCGTCGCAAGAAGT

AAGGGCTAGGCCATGACTCGTTCG

5621
db mining
Hs.279117
AW063709
8887648
DP0338 cDNA, 3′ end/clone_end = 3′
−1
CTCTTGGCAGCCCTGCTCTCGTGGG

TCAGCATCGTCGCGTGCTCCGGTGG

5622
db mining
Hs.279118
AW063718
8887655
DP0314 cDNA, 3′ end/clone_end = 3′
−1
GTGCTCGCTGAGCTGGTCCAGAAAT

CCGTCGACTGAGGCGATGGCGGCTG

5623
db mining
Hs.279119
AW063746
8887683
DP0347 cDNA, 3′ end/clone_end = 3′
−1
CATGAACAAGGGCCGGATCATCCTG

ATGCCCAACACACTGGACTTCGGTG

5624
db mining
Hs.279123
AW063778
8887715
DP0954 cDNA, 3′ end/clone_end = 3′
−1
CACCCGTTGTAGGCGACGAGCGTGA

ACGAAAACGTGTCGGACGGCTTGTA

5625
db mining
Hs.279121
AW063780
8887717
DP0388 cDNA, 3′ end/clone_end = 3′
−1
CATATGCGGCTGTGCCATAGCCGGA

TGTTCTTCGTGCGTGCCTACCCCCG

5626
db mining
Hs.279123
AW063833
8887770
DP0758 cDNA, 3′ end/clone_end = 3′
−1
TTCTTTCCGTCGCGCATCGGAATGCG

AAACTCGTACTTCGTGTAGAACTC

5627
db mining
Hs.279138
AW063909
8887846
SP0953 cDNA, 3′ end/clone_end = 3′
−1
GCCAGGGGCTTTATCACTTCCATGGC

CGCAGCGATGACCAGGTCAAGCTG

5628
db mining
Hs.279126
AW063951
8887888
DP0988 cDNA, 3′ end/clone_end = 3′
−1
CGCCGACCAAGCTTACCGACTTCTCG

CCGATCTACTGCGACGAAGAAGGC

5629
db mining
Hs.279174
AW063977
8887914
DP1019 cDNA, 3′ end/clone_end = 3′
−1
GGTAGTGACGTGCTGAATGACGGTG

CCGTCCATCATCGGGTCGGAGTAAG

5630
db mining
Hs.279128
AW064020
8887957
DP1073 cDNA, 3′ end/clone_end = 3′
−1
TTCAGGACTCGTTTCACGTAGGCAAC

GCTGTCTAAGTTCCCAAGGGATT

5631
db mining
Hs.279130
AW064046
8887983
SP0153 cDNA, 3′ end/clone_end = 3′
−1
CTCTTTACCCGGAAACAGGTTGGGGA

GATGACACGCAGAAAATCATACGC

5632
db mining
Hs.279084
AW064052
8887989
SP0159 cDNA, 3′ end/clone_end = 3′
−1
CTTTGGATATATCGAGAAAGGCCAGG

GCCTGAACAAGGAAAGCTTCCAGG

5633
db mining
Hs.279825
AW064053
8887990
SP0992 cDNA, 3′ end/clone_end = 3′
−1
AAGGCTGGTCAAGAATCTTGAGACG

GAATTGCACAGTCTCGGCGTGATCC

5634
db mining
Hs.279131
AW064060
8887997
SP0636 cDNA, 3′ end/clone_end = 3′
−1
GATCGATTCGGGGGTGACATCGGCG

CTGAGCACCATCACCGGAACATAAG

5635
db mining
Hs.279135
AW064084
8888021
SP0612 cDNA, 3′ end/clone_end = 3′
−1
CTGAGATCACCCTGAACACCGACAAG

GACGAGATCGCAGTCTGCAACCTG

5636
db mining
Hs.279136
AW064098
8888035
SP0575 cDNA, 3′ end/clone_end = 3′
−1
CTGAAGGCTTTGGCGACAACCAGGT

CTATCCGTTTGAATTGGCGAGAAC

5637
db mining
Hs.302426
AW064100
8888037
SP0684 cDNA, 3′ end/clone_end = 3′
−1
TCTTGTGCCAGCACGTCTTGCTGATA

GCCGATGAATCGCGTCCCTTTGTC

5638
db mining
Hs.279175
AW064121
8888058
SP0554 cDNA, 3′ end/clone_end = 3′
−1
GAACTCCTCAAGGAAATAGTCCACCG

CCTGCTGCTTGGACGCTGCCAGTT

5639
db mining
Hs.279139
AW064129
8888068
SP0696 cDNA, 3′ end/clone_end = 3′
−1
GTGACCTCGGGGTCCCCCTTGGTGA

GGGTGCCGGTCTTGTCGAAGACGAC

5640
db mining
Hs.279140
AW064138
8888073
SP0570 cDNA, 3′ end/clone_end = 3′
−1
GTGTTCGGGCTTCATGTCGCCAACAC

CATCGGCACTGGCATCATCGATCC

5641
db mining
Hs.279106
AW064157
8888094
TN1014 cDNA, 3′ end/clone_end = 3′
−1
AGGTTGATTTCCACTTCCTCGGGAGG

TTTCGCCACCTCTTCGCCTTTGAG

5642
db mining
Hs.279141
AW064160
8888097
SP0594 cDNA, 3′ end/clone_end = 3′
−1
GTTAGCTTCCACGCTTTATCTCCTGC

TCTGAGTGTGTACCCGCGCTGCTC

5643
db mining
Hs.279142
AW064161
8888098
SP0595 cDNA, 3′ end/clone_end = 3′
−1
TTAAAGTGGTAAGGGAGGTTTCTACT

CCTGGGGAAACATTAAGTACCTT

5644
db mining
Hs.279143
AW064166
8888103
SP0605 cDNA, 3′ end/clone_end = 3′
−1
CTTTCTCCGACTTCGAGATCTGCCCG

TGGTCGAGATCGTGGTAGATGATG

5645
db mining
Hs.279144
AW064175
8888112
SP0615 cDNA, 3′ end/clone_end = 3′
−1
AACTGGATAGAGCACGAGCCTTCTAA

GCTTGGAGTTGCAGGTTCGAATCC

5646
db mining
Hs.279824
AW064185
8888122
SP0630 cDNA, 3′ end/clone_end = 3′
−1
GAAGATCGGCGCAACGAAGACCGCT

TCCACTTCATCAACTGGACCAAGAA

5647
Table 3A
NA
AW064187
8888124
(One single EST, artifact ?) SP0632
−1
TGCTTCTGTGACAGATTAGCTTACAT

KRIBB Human CD4 intrathymic T-cell

CTTACCACCTCACCGAGAAGAGCT

cDNA library cDNA 3′, mRNA

sequence

5648
db mining
Hs.279146
AW064189
8888128
SP0634 cDNA, 3′ end/clone_end = 3′
−1
AGCTCAAGAGCTTCCGCGACGTACC

CAGCAAAGTAACGCTCGACGAATGC

5649
db mining
Hs.279145
AW064194
8888131
SP0633 cDNA, 3′ end/clone_end = 3′
−1
ATCGAAGACGTGATGCTGAACCTTTG

GGCGAAGGCCGAGAAGGAAGGCAA

5650
db mining
Hs.279147
AW064201
8888138
SP0650 cDNA, 3′ end/clone_end = 3′
−1
CGATACCCTCACTAGACCTCGGATCG

AATAAATCAGAGCGATCACATCG

5651
db mining
Hs.279132
AW064208
8888145
SP0658 cDNA, 3′ end/clone_end = 3′
−1
GGGGATACACACCCCACAAGCCTTC

CTGCGGCTTCATCACGGTTACCACC

5652
db mining
Hs.279148
AW064218
8888155
SP0732 cDNA, 3′ end/clone_end = 3′
−1
GATCTTGGTGAGAAGCTCGGTCATGT

AGAAGACCTCGCCCTGGGACACTA

5653
db mining
Hs.279826
AW064223
8888160
SP0676 cDNA, 3′ end/clone_end = 3′
−1
ATTTTATCGCCAGCTACGTCGGCATT

GGTCAGGACGACCTGAAGGGGAAT

5654
db mining
Hs.279149
AW064250
8888187
SP1013 cDNA, 3′ end/clone_end = 3′
−1
TGATGCGGAGAGCGAGGTAGATCCC

GGCGGAGTTTTCGTCGATGGGAAAG

5655
db mining
Hs.279150
AW064255
8888192
SP0105 cDNA, 3′ end/clone_end = 3′
−1
GTACACTTCCTGGATCTGATCCACGA

GGTAACGAGCGAGAGTGGTGATAC

5656
db mining
Hs.279134
AW064258
8888195
SP0717 cDNA, 3′ end/clone_end = 3′
−1
GTGACTTCATGCTCGGGGTTGAGCTT

GGCGTCCACCACCTTTTCCCACTC

5657
db mining
Hs.279151
AW064272
8888209
SP0130 cDNA, 3′ end/clone_end = 3′
−1
CCGGTGTCCTTGATCAGCTTCAGCAG

TGGCTTGACGTAGATGCGGGTCGG

5658
db mining
Hs.302427
AW064275
8888212
SP1065 cDNA, 3′ end/clone_end = 3′
−1
CATCAGTGTTTCTCCTGCTGGGACTG

TTGCATGTGGTGCATCACGGTTTG

5659
db mining
Hs.279153
AW064284
8888221
SP0755 cDNA, 3′ end/clone_end = 3′
−1
GCGAGGCGAAACATAGCTTCCATTGT

GTCTTTTCTCCTTATGCGTCTTGC

5660
db mining
Hs.279156
AW064319
8888256
SP1055 cDNA, 3′ end/clone_end = 3′
−1
AATGAGACCCGCCGTCCCTGGAGAT

GAAGATGTCGTCCGACTCCGTCCAC

5661
db mining
Hs.279157
AW064320
8888257
SP0145 cDNA, 3′ end/clone_end = 3′
−1
CGGATGTTGTCGTTCCAGAACGAAG

GATCGGCCTCTTGGGCCTGGATTTC

5662
db mining
Hs.279164
AW064343
8888280
SP0916 cDNA, 3′ end/clone_end = 3′
−1
GGCACCGACTTGGGCCTGAGAGAGG

CGCAGGTCATCAATATAGAATCGGG

5663
db mining
Hs.279159
AW064348
8888285
SP1044 cDNA, 3′ end/clone_end = 3′
−1
CCATGCTGAACTTGGCCAGGTCCTTG

ACGGCGGTGTTTTCCGACAGCACC

5664
db mining
Hs.279161
AW064375
8888312
SP0115 cDNA, 3′ end/clone_end = 3′
−1
CGCGATGATCTCGTCCTTCGGCATG

GCGATGCGCTATTCCTTCGACATGG

5665
db nining
Hs.279182
AW064377
8888314
SP1066 cDNA, 3′ end/clone_end = 3′
−1
GCCCATTGACCGTATCGCGTCATCTT

GCTGGCATTTCTAAGAAAATACCG

5666
db mining
Hs.279163
AW064378
8888315
SP0966 cDNA, 3′ end/clone_end = 3′
−1
TGAACAGGGAAAAGCCAGGAAGAT

CTCCGGTTCCACGTCCAATTTGTAC

5667
db mining
Hs.279168
AW064424
8888361
SP1056 cDNA, 3′ end/clone_end = 3′
−1
CAAGAATGACGGAAAAATCCGTGAGC

ACAAGGCAAAGGCTTGCCGTGTGG

5668
db mining
Hs.279165
AW064433
8888370
SP1030 cDNA, 3′ end/clone_end = 3′
−1
GACTTGATCACAACCCGATCCGTAAC

GACGTATTGGAGCCACTCGAACAA

5669
db mining
Hs.279166
AW064445
8888382
SP1042 cDNA, 3′ end/clone_end = 3′
−1
CTTCTCGCCGTAACTTTTCCGCCGAG

CACGCTACGCACGTAGGTGTTGTG

5670
db mining
Hs.279823
AW064450
8888387
SP1048 cDNA, 3′ end/clone_end = 3′
−1
TCGACTACGACTTCAACTTCCCCAAA

CGGTGGGAGAAGCGAGCTTGAGGC

5671
db mining
Hs.279167
AW064452
8888389
SP1069 cDNA, 3′ end/clone_end = 3′
−1
AAGTTGATCAGATCACGGGCCACGC

CTGCAACCAGAGGCTTGTCATCGTC

5672
db mining
Hs.279169
AW064468
8888405
SP1067 cDNA, 3′ end/clone_end = 3′
−1
TGATCTGATTGTGAGGAGAGTGGAGA

AGGTGGTATAGAAGCTGAAAGGGT

5673
db mining
Hs.279155
AW064473
8888410
SP1072 cDNA, 3′ end/clone_end = 3′
−1
CTTCATGCTCGAGAAGAAAATGCTCC

GTGCCTCCGACGACGCCACCATCG

5674
db mining
Hs.279170
AW064478
8888415
SP1080 cDNA, 3′ end/clone_end = 3′
−1
CAGATGGTCACGAGACGCTTGTCCG

TGATGTCTTCCGTCAGCGTGCAGAG

5675
db mining
Hs.279171
AW064479
8888416
SP0147 cDNA, 3′ end/clone_end = 3′
−1
TGATGGATTTGGAAAGTGTTATTCTG

TTTGACTTCTCCCTGCTCTGCTCA

5676
db mining
Hs.279158
AW064487
8888424
SP1087 cDNA, 3′ end/clone_end = 3′
−1
TTGAACGGGTATAGCCACCAAGGCAT

TGGCTGCAAAGTCGGGCAAAACTT

5677
db mining
Hs.330544
AW064490
8888427
SP1090 cDNA, 3′ end/clone_end = 3′
−1
ACTGTGTATTGATGAGTATCTGATGC

CTATAACATCTGTAGGAGGCTACA

5678
db mining
Hs.279160
AW067725
8888472
SP0110 cDNA, 3′ end/clone_end = 3′
−1
GTACGAAGGTGGCGATGATGCGTTC

GATCACCTCGGGGATTTCCTCGGCG

5679
db mining
Hs.279129
AW067742
8888489
SP0150 cDNA, 3′ end/clone_end = 3′
−1
CGACCTTCGGCGTTTCCGCTTCGGAA

CCCGTGAAGGCGTTCTTCACTTTG

5680
db mining
Hs.279133
AW067752
8888499
SP0141 cDNA, 3′ end/clone_end = 3′
−1
ATTCGCTGGCAACATAATTACCAGAC

TCACATCGAACGAAGCTCGGTTCC

5681
db mining
Hs.279154
AW067760
8888507
SP0122 cDNA, 3′ end/clone_end = 3′
−1
TGTTCGTTGCCATCCTTGTCGAGGAA

CATCTCGCTTTCCAGTTCCCCCTG

5682
Table 3A
Hs.89433
AW071894
8026892
ATP-binding cassette, sub-family C
−1
TTTGGGGGATCCTTTTGTAATGACTT

(CFTR/MRP), member 1 (ABCC1),

ACACTGGAAATGCGAACATTTGCA

transcript variant 1, mRNA

/cds = (196, 4791)

5683
Table 3A
Hs.299581
AW073707
6028705
xb01h03.x1 cDNA, 3′ end
−1
GGACAAGGGGCACCCGGATTATATTT

/clone = IMAGE:2575061/clone_end = 3′

CCCACCAATCCTAATCCTAAACCC

5684
db mining
Hs.243286
AW075809
6030807
xa85g05.x1 cDNA, 3′ end
−1
TGGAGCTTATTTTGGAGAACTGTCAC

/clone = IMAGE:2573624/clone_end = 3′

CATTTTATCCCAGTTGGCAATTTT

5685
db mining
Hs.277714
AW075814
6030812
xa85h03.x1 cDNA, 3′ end
−1
ATTATGGGTAAGGCTTGGGCTTGTTC

/clone = IMAGE:2573821/clone_end = 3′

CCACATGTTAACCAAATGGCCTCA

5686
db mining
Hs.244048
AW075894
6030892
xa81c04.x1 cDNA, 3′ end
−1
GGGAGGGCCAAAGAAATCTTTTTCCC

/clone = IMAGE:2573190/clone_end = 3′

GTTTCAATTATGTTCCCCAAAAA

5687
db mining
Hs.329433
AW075905
6030903
xa81d05.x1 cDNA, 3′ end
−1
TTACCCCAAATGCTTTTGCCCCGGTGG

/clone = IMAGE:2573193/clone_end = 3′

CCCAGTTTGTAAATTGGTTTGATT

5688
db mining
Hs.329434
AW075921
6030919
xa81f04.x1 cDNA, 3′ end
−1
CCCCCCTTGGCAGGTTAATTGGTGTT

/clone = IMAGE:2573215/clone_end = 3′

TAAGGAACCCTCCAGGGTGGGGGG

5689
db mining
NA
AW075929
6030927
xa81g05.x1 NCI_CGAP_CML1 cDNA
−1
CCCCCCAGTTTTAATGTTAGGGGGAA

clone IMAGE:2673240 3′, mRNA

GGGATTTAACCCCTTATTTAAAAAA

sequence

5690
db mining
Hs.265834
AW075948
6030946
xa82b03.x1 cDNA, 3′ end
−1
CTATCACCCTTGATATGAAATTCCAG

/clone = IMAGE:2573281/clone_end = 3′

AATTTTCTGTGATACCACATGGCC

5691
db mining
Hs.277716
AW075986
6030984
xa82f05.x1 cDNA, 3′ end
−1
ACTCCGGGCCTTAATGGATTTGGCCT

/clone = IMAGE:2573313/clone_end = 3′

GTCCTCAAGAATGGTAATTATGAA

5692
db mining
Hs.241982
AW076004
6031002
xa82h04.x1 cDNA, 3′ end
−1
ACGTGGTTTCAGTCCTTAGCACCGTG

/clone = IMAGE:2573335/clone_end = 3′

GTATTGACATGACATCAGTTGCAA

5893
db mining
Hs.257711
AW076027
6031025
he31c12.x1 cDNA, 3′ end
−1
CACAACTTGCTGTTCACGTCTTTGGG

/clone = IMAGE:2920630/clone_end = 3′

GTGTTTTCCATTCCTAATAGATGG

5694
db mining
Hs.277717
AW076038
6031036
xa83d08.x1 cDNA, 3′ end
−1
AACCCGTCCTCCATTATAATTACCTT

/clone = IMAGE:2573391/clone_end = 3′

TCAAAGGGCAAGTCAAAAGTTGT

5695
db mining
Hs.241983
AW076068
6031068
xa84e02.x1 cDNA, 3′ end
−1
AAACAGCACAACATGAGTGTTTCCTA

/clone = IMAGE:2573450/clone_end = 3′

CCACATCAATTTTAATGAAGACAC

5696
db mining
Hs.277718
AW076075
6031073
xa84a10.x1 cDNA, 3′ end
−1
CGGAATCGGGTTTCCATTGGACCCCA

/clone = IMAGE:2573466/clone_end = 3′

AAAATTTCCCTTTGGGCTTCATGA

5697
db mining
Hs.242605
AW076083
6031081
xa84b10.x1 cDNA, 3′ end
−1
TGAGGATAGAAGCAGCCTTTTATATT

/clone = IMAGE:2573467/clone_end = 3′

TTTGTGTGGTAAAGCAAATTGGCA

5698
db mining
Hs.329436
AW076127
6031125
xa84g01.x1 cDNA, 3′ end
−1
GGGGCAAATTTCAAGGGACCTCCCC

/clone = IMAGE:2573520/clone_end = 3′

AAAGGGGGTGTTTTCCCTGGATGGG

5699
Table 3A
Hs.244816
AW078847
6033999
xb18g07.x1 cDNA, 3′ end
−1
AAACAGGAAGGGGGTTTGGGCCCTT

/clone = IMAGE:2576700/clone_end = 3′

TGATCAACTGGAACCTTTGGATCAAG

5700
Table 3A
Hs.245616
AW080951
6036103
xc28c10.x1 cDNA, 3′ end
−1
ACTCTTTGTCTTTTTAAGACCCCTAAT

/clone = IMAGE:2585588/clone_end = 3′

AGCCCTTTGTAACTTGATGGCTT

5701
Table 3A
Hs.176498
AW081098
6036250
xc29a12.x1 cDNA, 3′ end
−1
CCGGCTGCCTCCATCCCAGAAGAGT

/clone = IMAGE:2585662/clone_end = 3′

GCGCAGAGAATTAAATCTAGATATT

5702
Table 3A
NA
AW081232
6036384
xc22e08.x1 NCI_CGAP_Co19 cDNA
−1
GGGATGTAATACATATTTTTCCAAATA

clone IMAGE:2585030 3′ similar to

AAATGCCTCATGGGCTTTGGGGC

SW:RSIA_HUMAN P39027 40S

RIBOSOMAL

5703
Table 3A
Hs.295945
AW081320
6036472
xc30f12.x1 cDNA, 3′ end
−1
AGAACCCGTATTCATAAAATTTAGAC

/clone = IMAGE:2585807/clone_end = 3′

CAAAAAGGAAGGAATCGAACCCCC

5704
Table 3A
Hs.120219
AW081455
6036607
xc31c07.x1 cDNA, 3′ end
−1
AGTTAGTATACAGCCAGAACAGCCAA

/clone = IMAGE:2585868/clone_end = 3′

GCCTCAATTCTTGTACCTTGTGTC

5705
Table 3A
Hs.277738
AW082714
6037888
xb61f07.x1 cDNA, 3′ end
−1
CCCTGATCCTCTGTAGGGAACTTCCT

/clone = IMAGE:2580805/clone_end = 3′

TTTCTCTAATCCTAGATCTTTTCA

5706
db mining
NA
AW088500
6044305
xd10a04.x1 NCI_CGAP_Or23 cDNA
−1
GAGGCATCAGAGGTTCAGGAGAGTT

clone IMAGE:2593326 3′ similar to

ACAGGCAGCAGGTGCGGTATAATAT

SW:BAT3_HUMAN P48379 LARGE

PROLINE-

5707
Table 3A
Hs.243457
AW102836
6073449
xd38h12.x1 cDNA, 3′ end
−1
TTTGTTTCTTTGGGCCTGATTTGTATC

/clone = IMAGE:2596103/clone_end = 3′

TCTGGAAGGCATTAATTCTTGAA

5708
Table 3A
Hs.341908
AW117189
6085773
xd83f08.x1 cDNA, 3′ end
−1
GCTTTGCCTCTCGGAGGAGTCAAAG

/clone = IMAGE:2604231/clone_end = 3′

GGGCAGTAACTGTATGGGGTGAGAG

5709
Table 3A
Hs.3642
AW130007
6131612
RAB1, member RAS oncogene family
−1
GCTCCCGAATATTGTAATTTGTTGCC

(RAB1), mRNA/cds = (50, 667)

CCCTATGTACCCAACCCCCTGAAA

5710
Table 3A
Hs.248367
AW131768
6133375
MEGF11 protein (MEGF11), mRNA
−1
AGGAAGTATGAGAGTTCTGAAACCCT

/cds = (159, 3068)

TGATAGAAACTGGAAGCCTGCCAT

5711
Table 3A
Hs.203606
AW131782
6133389
PM0-UT0103-300101-002-f12 cDNA
−1
GACATAGGGTTGCAGTAGTGAGTGG

GCATCTGTTCTCAGAAGGCAGTGCC

5712
Table 3A
Hs.335449
AW136717
6140850
UI-H-BI1-adm-a-03-0-UI.s1 cDNA, 3′
−1
TTCTGGCCTTGTTCACCTAGAAACGC

end/clone = IMAGE:2717092

TATTTCCTGTGTTATGGTTCTGGC

/clone_end = 3′

5713
Table 3A
Hs.8121
AW137104
6141237
Notch (Drosophila) homolog 2
−1
GCTCTGGGAAAGAGACAGGGAAGTC

(NOTCH2), mRNA/cds = (12, 7427)

TGGAATGGAAAAGAACACGATGAGA

5714
Table 3A
Hs.12035
AW137149
6141282
602122419F1 cDNA, 5′ end
−1
GGGTTACATTTGAGTCTCTGTACCTG

/clone = IMAGE:4279300/clone_end = 5′

CTTGGAAGAAATAAAAATACGTGT

5715
Table 3A
Hs.342003
AW138461
6142779
UI-H-BI1-edg-e-06-0-UI.s1 cDNA, 3′
−1
CTGGGAATATGAAGCGAACGCCACA

end/clone = IMAGE:2716882

CACTAGAACGCGCCCTGGGAGCTGG

/clone_end = 3′

5716
Table 3A
Hs.245138
AW139918
6144636
UI-H-BI1-aee-d-05-0-UI.s1 cDNA, 3′
−1
GCTGCTTTTGCCCATCCAGGTTTCCA

end/clone = IMAGE:2719138

CATCCTAATCTTTGCTTTTCTTGT

/clone_end = 3′

5717
Table 3A
Hs.276718
AW148618
6196514
601473284T1 cDNA, 3′ end
−1
TGTAAATGTGGTTTGACTATTTCTGTA

/clone = IMAGE:3876165/clone_end = 3′

TGTCCCCATCTATTGATGAGGGT

5718
Table 3A
Hs.89104
AW148765
6196661
602590917F1 cDNA, 5′ end
−1
TTGTTTTAACAACTCTTCTCAACATTT

/clone = IMAGE:4717348/clone_end = 5′

TGTCCAGGTTATTCACTGTAACCA

5719
Table 3A
Hs.248857
AW150084
6198076
xg36f03.x1 cDNA, 3′ end
−1
ACATAAACTGTCCCTTTAGGAAGAAG

/clone = IMAGE:2629661/clone_end = 3′

CCCAATGCCCGATTTTGCCCTTTA

5720
Table 3A
NA
AW150085
6196077
xg36f04.x1 NCI_CGAP_UI1 cDNA
−1
GGACAAGTGGCATCGGTACTATATTT

clone IMAGE:2829663 3′ similar to

CCCACCAATCCTAATCCTAATCCC

gb:X65018 PULMONARY

SURFACTANT-ASSOC

5721
Table 3A
Hs.265838
AW150944
6198842
xg42e09.x1 cDNA, 3′ end/clone =
−1
TATGTCCCTTTTTCTCCTCCCTTCCCC

IMAGE: 2630248/clone_end = 3′

ATTCCCTGGCATCATATTGGGAC

5722
Table 3A
Hs.301104
AW151854
6199839
602313002F1 cDNA, 5′ end/
−1
CGCTGTCGCCTTAATCCAAGCCTACG

clone = IMAGE: 4422480/

TTTTCACACTTCTAGTAAGCCTCT

clone_end = 5′

5723
Table 3A
Hs.337727
AW161820
6300853
au70h03.x1 cDNA, 3′ end/clone =
−1
TGTGGGCTTGGTATAAACCCTACTTT

IMAGE: 2781653/clone_end = 3′

GTGATTTGCTAAAGCACAGGATGT

5724
Table 3A
Hs.299967
AW166001
6397526
xf43e11.x1 cDNA, 3′ end/clone =
−1
CCGCCTGAAACGGGCATTTTGTAAAT

IMAGE: 2620844/clone_end = 3′

GGGGTTTGACTATTTTTGTATGTC

5725
Table 3A
Hs.81248
AW166442
6397967
CUG triplet repeat, RNA-binding
−1
ACTGGCAAATGAAGCATACTGGCTTG

protein 1 (CUGBP1), mRNA/cds =

CAGGGACCTTCTGATTCAAGTACA

(137, 1585)

5726
Table 3A
Hs.169738
AW172306
6438254
xj37a08x1 cDNA, 3′ end/clone =
−1
GAATTCGATTTGAGATCTGAGGGCAG

IMAGE: 2659382/clone_end = 3′

ACCCGAACCAGGAAAGCAACTCAG

5727
Table 3A
Hs.8991
AW172850
6438798
adaptor-related protein complex 1,
−1
AATGCACCAGGCTGCCACCTGCACC

gamma 2 subunit (AP1G2),

AGTGGTTGCTACATGGGATAAGAAA

mRNA/cds = (45, 2402)

5728
Table 3A
Hs.143525
AW173163
6439111
xj84b08x1 cDNA, 3′ end/clone =
−1
TATGATAGGATTCTCCACAGTGGCTT

IMAGE = 2663895/clone_end =

CCGACTCAGGCTCCAATGGACCAA

3′

5729
Table 3A
Hs.38664
AW188135
6462571
IL0-MT0152-061100-501-e04
−1
TGCTGTATGGGCAGGTTGTCTTATTA

cDNA

TGTGATCAACAGATGTCCAGGAAC

5730
Table 3A
NA
AW188398
6462834
xj98c03.x1 NCI_CGAP_Co18
−1
ACCTCCAAGAACATCTGCCTTTGTTG

cDNA clone IMAGE: 2665252 3′,

AACGTGTTTATTACCTGTCCACTC

mRNA sequence

5731
Table 3A
Hs.252989
AW191929
6470628
xl77c10.x1 cDNA, 3′ end/clone =
−1
CCTTTTGCCCCTTAGCCCTTGGATAA

IMAGE: 2680722/clone_end = 3′

TCCGGCTGGGAATGGGGGTGAGGG

5732
Table 3A
Hs.203755
AW194379
6473179
xm08h07.x1 cDNA, 3′ end/clone =
−1
CCCAAATAAGCTCTGTACTTCGGTTA

IMAGE: 2683645/clone_end = 3′

CCTATGTACCTGTTACCACTTTCA

5733
Table 3A
Hs.253151
AW195119
6474139
xn66b07.x1 cDNA, 3′ end/clone =
−1
GCCACATGTCCTATTCTCACACAGGT

IMAGE: 2699413/clone_end = 3′

GCTTTAATTTCAGCCCAGTCTCTA

5734
db mining
Hs.253154
AW195169
6474211
xn66h03.x1 cDNA, 3′ end/clone =
−1
CTTGAAGGGGCTTTGTTGGGTTTTTG

IMAGE: 2699477/clone_end = 3′

GGGTTTTGGGTGGGACTCCCAAAG

5735
db mining
Hs.330019
AW195270
6474330
xn67c04.x1 cDNA, 3′ end/clone =
−1
GGGGTTTTAAAAATTTTCCCGATTTGA

IMAGE: 2699528/clone_end = 3′

AAATTAATTTTCCGTTGCCCCCCGG

5736
db mining
Hs.253167
AW195284
6474352
xn67d09.x1 cDNA, 3′ end/clone =
−1
CCCCCTGGGGTTTTTGGGAATGAGG

IMAGE: 2699537/clone_end = 3′

TAAGGCTTTGAATTTGGTTTGATAT

5737
db mining
Hs.253168
AW195300
6474388
xn67112.x1 cDNA, 3′ end/clone =
−1
ACATGCTTAGAGCTGGAGGCTTGAAA

IMAGE: 2699567/clone_end = 3′

CCATAATCCCAATTAAGTGCTGTC

5738
db mining
Hs.253169
AW195313
6474381
xn67h05.x1 cDNA, 3′ end/clone =
−1
TGTTTGTCCAGGAAAAGGAAGAGGG

IMAGE: 2699577/clone_end = 3′

GGAAATTAAAACCTTTCCGGTTAGT

5739
Table 3A
Hs.253384
AW204029
6503501
UI-H-BI1-aen-d-02-0-UI.s1 cDNA,
−1
GCACTGCTCCGTCTAGCTGTATGACC

3′ end/clone = IMAGE: 2719899/

TTTGTTATGTTTCTTTTCTTCCGT

clone_end = 3′

5740
Table 3A
Hs.253502
AW205824
6505098
UI-H-BI1-afr-e-01-0-UI.s1 cDNA,
−1
CTTCAATCTGGGCTGGGCACTCCAC

3′ end/clone = IMAGE: 2722657/

GCACATAATCGTCACTCTCGGAGGA

clone_end = 3′

5741
Table 3A
Hs.330058
AW206977
6506473
UI-H-BI1-afs-h-11-0-UI.s1 cDNA,
−1
GCGGGAAGTGAAAGCGGAGGCTGGG

3′ end/clone = IMAGE: 2723180/

ACAAGGGGAACTTACTGCTCAAAAA

clone_end = 3′

5742
Table 3A
Hs.157315
AW207701
6507197
UI-H-BI2-age-e-03-0-UI.s1 cDNA,
−1
AGTGGTGTGGTGGCAATAGGAAAAG

3′ end/clone = IMAGE: 2724172

AAAAGATCAGGATGAGAAATTGCTT

clone_end = 3′

5743
db mining
NA
AW236188
6568575
xn70e07.x1 NCI_CGAP_CML 1
−1
CCAAGGGCCTTTTGGGGTTGTTTCCT

cDNA clone IMAGE: 2699844 3′,

ATAACTTCAGTATTGTAAATTAGT

mRNA sequence

5744
db mining
NA
AW238203
6568592
xn70h07.x1 NCI_CGAP_CML 1
−1
CATAAAGGGGCATTCCCCTAGCCGG

cDNA clone IMAGE: 2699869 3′,

TCCGGCCTTTTTCCAGTCCATCCTG

mRNA sequence

5745
db mining
Hs.330063
AW236208
6568597
xn71a06.x1 cDNA, 3′ end/clone =
−1
AGGTTTAAGAAATTTCCCCTAAATCTT

IMAGE: 2699890/clone_end = 3′

GTTTGGTTGGTTGGGATGAAAAGT

5746
db mining
Hs.253747
AW238262
6568641
xn71g08.x1 cDNA, 3′ end/clone =
−1
AATTGATCCCATTCTTGCTGAAGTAG

IMAGE: 2699966/clone_end = 3′

ACAGTGCCCTCAAGTGGAATTAAA

5747
db mining
Hs.253748
AW236271
6568880
xn72b03.x1 cDNA, 3′ end/clone =
−1
CTCCAATGCTGTTATCCCGGCTGGGT

IMAGE: 2699981/clone_end = 3′

CCTCACACTCCCCCAACAATCCCA

5748
db mining
NA
AW236345
6568734
xn73c12.x1 NCI_CGAP_CML 1
−1
AGAATGCGCTATTTCCCTCAAAGCCC

cDNA clone IMAGE: 2700118 3′

TGGCTGTAATAAAGAAGCCGATTT

similar to contains element MER21

repetitive e

5749
Table 3A
Hs.253820
AW237483
6569872
xm72e01.x1 cDNA, 3′ end/clone =
−1
CTGAGGTCAGTGTGGTTTGGTGGAA

IMAGE: 2689752/clone_end = 3′

GGATTATGATATTTACAAGCTGAGT

5750
Table 3A
Hs.342342
AW243795
6577635
xo56f02.x1 cDNA, 3′ end/clone =
−1
GGTCAATGTTTTGAAATTTGTGGAGC

IMAGE: 2707995/clone_end = 3′

AAACCCCAGTTTTATGCCCTTGGT

5751
Table 3A
Hs.250591
AW262077
6638893
xp19e09.x1 cDNA, 3′ end/clone =
−1
AGTTGGAAATTTAGAAATGTCCACT

IMAGE: 2740840/clone_end = 3′

GTAGGACGTGGAATATGGCGTCGA

5752
db mining
Hs.250591
AW262272
6639088
xp19e09.x1 cDNA, 3′ end/clone =
−1
TTCACGTCCTAAAGTGTGGTAGACGC

IMAGE: 2740840/clone_end = 3′

GCCCGCGAATTTAGTAGTAGTAGG

5753
Table 3A
Hs.277994
AW262728
6639544
xq94a12.x1 cDNA, 3′ end/clone =
−1
GGACAAGTGGCATCCGTATTATATTT

IMAGE: 2758270/clone_end = 3′

CCCACCATTCCTATTCTTAATCCC

5754
db mining
Hs.61345
AW262891
6639707
mRNA for KIAA1154 protein,
−1
GGTCTGCCTCAGTCTTCTACTCATCA

partial cds/cds = (0, 676)

GCACCACACTGTCAAAATGTTGGA

5755
Table 3A
Hs.5662
AW264291
6641033
guanine nucleotide binding protein
−1
AGATGAATTGAAGCAAAAGTTTTCA

(G protein), beta polypeptide 2-

GTACCAGCAGCAAGGCAGACCCCC

like 1 (GNB2L1), mRNA/cds =

(95, 1048)

5756
Table 3A
Hs.122656
AW274156
6681186
hypothetical protein MGC14425
−1
TCACCTCCACCTCTGAGGGAGCAAC

(MGC14425), mRNA/cds = (318,

GAATACAAAGGTAGACCCCCAAAAG

686)

5757
Table 3A
Hs.250600
AW291304
6697940
UI-H-BI2-agk-a-02-0-UI.s1 cDNA,
−1
CCCCAGCCAGCACTTCCCTTTTCTGC

3′ end/clone = IMAGE: 2724386/

GAGGGTTTTCTGTTTCTTTGATTA

clone_end = 3′

5758
Table 3A
Hs.47325
AW291458
6698021
UI-H-BI2-agh-c-02-0-UI.s1 cDNA,
−1
AGAAAATTTGAACCCTACCCTTCTCC

3′ end/clone = IMAGE: 2724099/

CATCCCACTTCTTACTCCATCCCG

clone_end = 3′

5759
Table 3A
Hs.170381
AW291507
6698143
UI-H-BI2-aga-g-11-0-UI.s1 cDNA,
−1
CTGTGGCATCATTCACACCACCAGCA

3′ end/clone = IMAGE: 2723900/

GAGTCCCTTCCAAGAGGGGTCTGG

clone_end = 3′

5760
db mining
Hs.255118
AW292757
6699393
UI-H-BW0-aij-b-12-0-UI.s1
−1
CCGTGTTAAAACCAAAGTTTGGGATT

cDNA, 3′ end/clone = IMAGE:

TTTCGGGTATTCATTGGAAGTCAC

2729423/clone_end = 3′

5761
Table 3A
Hs.255119
AW292772
6699408
UI-H-BW0-aij-d-03-0-UI.s1
−1
CGAGAGCCTGGAAGCTTTGCACACTA

cDNA, 3′ end/clone = IMAGE:

CTGCCTGGAAGATCTGATTCTTTG

2729501/clone_end = 3′

5762
db mining
Hs.255123
AW292814
6699450
UI-H-BW0-aij-h-02-0-UI.s1
−1
TGTTTTAAAAGTGGGTTTATTTCAACC

cDNA, 3′ end/clone = IMAGE:

GCTTCACTCCCGGTTGGTGACCG

2729691/clone_end = 3′

5763
db mining
Hs.255129
AW292855
6699491
UI-H-BW0-aif-d-03-0-UI.s1
−1
TCTTCTCTCAGTCTTCAGCAAGTAGC

cDNA, 3′ end/clone = IMAGE:

TTCTTTCAGAACTGCCTCCTCCCG

2729117/clone_end = 3′

5764
db mining
Hs.255544
AW292873
6899509
UI-H-BW1-ame-e-09-0-UI.s1
−1
GTTTTCTGCATCCCAAATGTCCTGGG

cDNA, 3′ end/clone = IMAGE:

GCATGTGTCCCTTCCTTGCTGACC

3069784/clone_end = 3′

5765
db mining
Hs.265134
AW292900
6699536
UI-H-BW0-aig-a-05-0-UI.s1
−1
TGTTATGATTCTCTCAATTTCATAAAG

cDNA, 3′ end/clone = IMAGE:

CTCTTCTGGCAGAGGAGACAGAT

2729000/clone_end = 3′

5766
db mining
Hs.255135
AW292902
6699538
UI-H-BW0-aig-a-07-0-UI.s1
−1
AAATGGATTACAATTTCCCTGACATTT

cDNA, 3′ end/clone = IMAGE:

GGGCATAAAACATCTGCCATCCT

2729004/clone_end = 3′

5767
db mining
Hs.256139
AW292928
6699584
UI-H-BW0-aig-d-11-0-UI.s1
−1
TCCTCCTTCCAGAGACCTTTGCTTTA

cDNA, 3′ end/clone = IMAGE:

CTGCCATTTTTTCTGTGGGCTTTT

2729156/clone_end = 3′

5768
db mining
Hs.255140
AW292941
6699577
UI-H-BW0-aig-f-10-0-UI.s1
−1
AGGCATAGCAGTAGAATCTGTCAAAA

cDNA, 3′ end/clone = IMAGE:

AGGAGGCATGGAATGAAATGAACC

2729250/clone_end = 3′

5769
db mining
Hs.255142
AW292960
6699598
UI-H-BW0-aih-a-02-0-UI.s1
−1
CTGACCCTCTCGCCCCTCCACCTGTG

cDNA, 3′ end/clone = IMAGE:

CTTCTGCCCTAGGATAACGCTGGG

2728995/clone_end = 3′

5770
db mining
Hs.147728
AW292969
6699625
RST12623 cDNA
−1
GACCCAAAGAAAAGATCAAGAC

CGCATGTAGCAAATGTAGCAAGGA

GGCA

5771
db mining
Hs.255152
AW293001
6699637
UI-H-BW0-aih-d-12-0-UI.s1
−1
CTAATTTCCCACTAAAAGGTCCAGAA

cDNA, 3′ end/clone = IMAGE:

AAATTGATGCCACCTGTAGTTTGG

2729159/clone_end = 3′

5772
db mining
NA
AW293017
6699653
UI-H-BW0-aih-f-06-0-UI.s1
−1
GTAAAGTTCCAAGCGAGTGGAAGGTA

NCI_CGAP_Sub6 cDNA clone

AATCACGACTGTGGCACCGGAGCC

IMAGE: 2729243 3′, mRNA

sequence

5773
db mining
NA
AW293143
6699779
UI-H-BW0-aii-a-03-0-UI.s1
−1
GAAACTGAATGACCATGGAATGCTGA

NCI_CGAP_Sub6 cDNA clone

AATTCCAAAAGAAAAACGTCGCGC

IMAGE: 2729356 3′, mRNA

sequence

5774
db mining
Hs.255172
AW293158
6699794
UI-H-BW0-aii-b-07-0-UI.s1
−1
TCTCTCAGGTCGTCTTCAGAGTCCAT

cDNA, 3′ end/clone = IMAGE:

TCCCTTTGTCTTGATCTTTTCTCT

2729412/clone_end = 3′

5775
Table 3A
Hs.166975
AW293159
6699795
splicing factor, arginine/serine-rich
−1
CTCCCATCATTCCCTCCCGAAAGCCA

5 (SFRS5), mRNA/cds = (218,

TTTTGTTCAGTTGCTCATCCACGC

541)

5776
db mining
Hs.255174
AW293172
6699808
UI-H-BW0-aii-c-10-0-UI.s1
−1
GCCCTGCCCCCTACCCTTGCCCTTTA

cDNA, 3′ end/clone = IMAGE:

AATTTTTGGGACTGAATAAAGAAT

2729466/clone_end = 3′

5777
Table 3A
Hs.255178
AW293267
6899829
UI-H-BW0-aii-e-10-0-UI.s1
−1
TGCAGGATAACTTGCTCATGAAAGGA

cDNA, 3′ end/clone = IMAGE:

AATGCCAGATTAAACCCCTTGCCA

2729582/clone_end = 3′

5778
Table 3A
Hs.75354
AW293424
6700060
mRNA for KIAA0219 gene, partial
−1
GCCTTCCCTTCGTTCCTTTCCAGGCA

cds/cds = (0, 7239)

ATAATGACATCATTAGTGATGCAA

5779
Table 3A
Hs.255200
AW293428
6700062
UI-H-BI2-ahm-b-02-0-UI.s1
−1
CGCCACGGCTCCAATCCCTATATGAG

cDNA, 3′ end/clone = IMAGE:

TGAGCAGTAGAATCACATAGGAAT

2727122/clone_end = 3′

5780
Table 3A
Hs.10041
AW293461
6700097
602713308F1 cDNA, 5′ end/
−1
CCTAGAATCAGACTTTAAGCACAAGC

clone = IMAGE: 4853618/

AGGGAGGGAAAGCACTTGAGCAGT

clone_end = 5′

5781
db mining
Hs.291317
AW293859
6700495
nx40e10.s1 cDNA, 3′ end/clone =
−1
GCACATGCAAAAACTCAGATGTGCAA

IMAGE: 1258602/clone_end = 3′

ATAACTGTTCCCTATTAACTACAA

5782
Table 3A
Hs.255249
AW293895
6700531
UI-H-BW0-ain-f-10-0-UI.s1
−1
GGTGCTCAAACTGTATTTTCTCCCTC

cDNA, 3′ end/clone = IMAGE:

CCTCCCTCCTTCTTTCTTTCCAGA

2729995/clone_end = 3′

5783
db mining
Hs.255251
AW293922
6700558
UI-H-BW0-aik-a-04-0-UI.s1
−1
TTCTTCCACGGGATTTCTAATTCATTA

cDNA, 3′ end/clone = IMAGE:

AATAGGACCTCCACACCAGACCT

2729382/clone_end = 3′

5784
db mining
Hs.255253
AW293949
6700585
UI-H-BW0-aik-c-10-0-UI.s1
−1
TATCCAGCCTGACTTCTTCATGCTGT

cDNA, 3′ end/clone = IMAGE:

ACTAGCCTTCCAATCCTTAACTAA

2729490/clone_end = 3′

5785
do mining
Hs.255254
AW293950
6700588
UI-H-BW0-aik-c-11-0-UI.s1
−1
TGGACATTGGGGGTCAAACCCTTTTG

cDNA, 3′ end/clone = IMAGE:

TTTAAATTTTCCCTTTCCCAGGGC

2729492/clone_end = 3′

5786
Table 3A
Hs.255255
AW293955
670000591
UI-H-BW0-alk-d-05-0-UI.s1
−1
GCTGTGCCACGGTCAGGTGGCTTCC

cDNA, 3′ end/clone = IMAGE:

AATCTGTACTCAATTGTTACTGTAC

2729526/clone_end = 3′

5787
Table 3A
Hs.190904
AW294363
670000729
UI-H-BI2-ahg-b-05-0-UI.s1
−1
TCAGAGATGCTGATGTCATATAAGTA

cDNA, 3′ end/clone = IMAGE:

GTTTCCCTGTCTGGCCTTGGATGT

2726720/clone_end = 3′

5788
db mining
Hs.255330
AW294818
6701254
UI-H-BW0-ail-a-05-0-UI.s1
−1
GTATGACTGATGATAGCTGCGAATGA

cDNA, 3′ end/clone = IMAGE:

GGAGGAGGGAAGGGAAGGCTGGAG

2729385/clone_end = 3′

5789
db mining
Hs.255333
AW294644
6701280
UI-H-BW0-ail-c-11-0-UI.s1
−1
CCATTGCCCCGGTGTTTTGGTTTAAT

cDNA, 3′ end/clone = IMAGE:

TTTCCCAGGCTTATTTTAAAGGCC

2729493/clone_end = 3′

5790
Table 3A
Hs.255687
AW294654
6701290
UI-H-BW0-ail-d-10-0-UI.s1
−1
AGGAAATTAAACATGAGCATGACATG

cDNA, 3′ end/clone = IMAGE:

ACCCCAACTCTCAAGAAATCCCCA

2729539/clone_end = 3′

5791
Table 3A
Hs.255336
AW294081
6701317
UI-H-BW0-ail-g-10-0-UI.s1
−1
ATCAGGTCCCCTACAAAATTAGCTAC

cDNA, 3′ end/clone = IMAGE:

TTTGGCCTTTCCTACAAAATTAGC

2729683/clone_end = 3′

5792
db mining
Hs.255337
AW294692
6701328
UI-H-BW0-ail-h-11-0-UI.s1
−1
TCATTCGTTTGCTTTCTCTGACTGACA

cDNA, 3′ end/clone = IMAGE:

GGCAGTAATGACTTCAATAAGCT

2729733/clone_end = 3′

5793
Table 3A
Hs.255339
AW294695
6701331
UI-H-BW0-aim-e-02-0-UI.s1
−1
AGGGCCTGCTTCAGAGTTTGTTTCCT

cDNA, 3′ end/clone = IMAGE:

AAATAAAACAATGGCTCTCCCCGT

2729738/clone_end = 3′

5794
db mining
Hs.255341
AW294697
67001333
UI-H-BW0-aim-a-04-0-UI.s1
−1
CCCCCAACTTACATGGAAAAGGGATG

cDNA, 3′ end/clone = IMAGE:

GTTGCATTTCTGTGTCATATGCAT

2729742/clone_end = 3′

5795
db mining
Hs.342539
AW294717
67001353
UI-H-BW0-ajl-g-03-0-UI.s1
−1
GCAGAGGGAAGAGGAAATGCTTTGA

cDNA, 3′ end/clone = IMAGE:

AGCCTTGCTAGTTATTTAATTAGTT

2732333/clone_end = 3′

5796
db mining
Hs.255347
AW294739
67001375
UI-H-BW0-aim-f-07-0-UI.s1
−1
GACATAGTTGCAAAACACAATACTTA

cDNA, 3′ end/clone = IMAGE:

ATACTTTTTCTGGAGGAGGGGGCC

2729988/clone_end = 3′

5797
db mining
Hs.255354
AW294769
67001405
UI-H-BW0-ail-g-02-0-UI.s1
−1
ACCCCTTTTCTTAATTTCTCAGGAGAA

cDNA, 3′ end/clone = IMAGE:

TGGCAGCTCCTTCTTTTGTCGTC

2729667/clone_end = 3′

5798
db mining
NA
AW294812
6701448
UI-H-BI2-ahi-d-06-0-UI.s1
−1
CCTCCGGTGTCTTCGGAAGCACTGAA

NCI_CGAP_Sub4 cDNA clone

GGGACATCTGGGGACCCTCACCTG

IMAGE: 2726842 3′, mRNA

sequence

5799
db mining
Hs.255388
AW295071
6701707
UI-H-BW0-ait-c-03-0-UI.s1
−1
ACTCTTTGACCAATAAATCACTGGAA

cDNA, 3′ end/clone = IMAGE:

TAGAGGTTCCAGCATATTCTGAGA

2730245/clone_end = 3′

5800
Table 3A
Hs.255389
AW295088
6701724
UI-H-BW0-ait-d-09-0-UI.s1
−1
ATGCTTACACCCTGGATGAATAAAGT

cDNA, 3′ end/clone = IMAGE:

CTTTATTTACACCTCCACCTCCCC

2730305/clone_end = 3′

5801
db mining
Hs.255157
AW295376
6702012
UI-H-BI2-ahv-f-03-0-UI.s1 cDNA,
−1
CTCTTCACAGGTCATAAGCCCCTCTG

3′ end/clone = IMAGE: 2728085/

AGCGGCGACAGTCCTCGCATCCAG

clone_end = 3′

5802
db mining
Hs.330175
AW295597
6702233
UI-H-BW0-aip-a-10-0-UI.s1
−1
CAGCTCGACCTCAGTCCCCTTCAGAA

cDNA, 3′ end/clone = IMAGE:

ATAAGATGGCGGCTGCGCTGACAG

2729779/clone_end = 3′

5803
Table 3A
Hs.255446
AW295610
6702246
UI-H-BW0-alp-c-03-0-UI.s1
−1
TTTCAACGTGTACCTTTCCTGGGAAA

cDNA, 3′ end/clone = IMAGE:

CCATCTCAATAAACACATTTTGGT

2729861/clone_end = 3′

5804
db mining
Hs.255448
AW295616
6702252
UI-H-BW0-alp-c-09-0-UI.s1
−1
GCTGGACACATGGGTTAAGAGGAGG

cDNA, 3′ end/clone = IMAGE:

AAAAGTAGGAAAGGAGGAGGGGAGA

2729873/clone_end = 3′

5805
db mining
Hs.255449
AW295629
6702288
UI-H-BW1-amu-a-09-0-UI.s1
−1
GGCTGGGACCAGGGTTTTTCAAGCC

cDNA, 3′ end/clone = IMAGE:

ACCTTTTCCTGTCTCAGTTCAGAGA

3071128/clone_end = 3′

5806
Table 3A
Hs.255454
AW295664
6702300
UI-H-BW0-aip-g-12-0-UI.s1
−1
CCCACTTTCACACATGACTCACACGA

cDNA, 3′ end/clone = IMAGE:

CTGAAGGAAAGAAAGGGCATCCTT

2730071/clone_end = 3′

5807
db mining
Hs.255465
AW295689
6702305
UI-H-BW0-aip-h-06-0-UI.s1
−1
AAGAAATTAAGGAAGGCAAGAG

cDNA, 3′ end/clone = IMAGE:

GGTAGGTGTTGGCCCATGGAAGTT

2730107/clone_end = 3′

TCCC

5808
db mining
Hs.255457
AW295888
6702324
UI-H-BW0-aiw-b-02-0-UI.s1
−1
CTGGCAAATATTGCGGAAGATGTACT

cDNA, 3′ end/clone = IMAGE:

GAAATGTAATTGAAATGTAGCTGC

2730578/clone_end = 3′

5809
db mining
Hs.255459
AW295711
6702347
UI-H-BW0-aiw-d-03-0-UI.s1
−1
AGCATAAGAGATACGAAGCTGATGGT

cDNA, 3′ end/clone = IMAGE:

AATTAACTTGTACCCCTTGAAGTG

2730676/clone_end = 3′

5810
db mining
Hs.255462
AW295724
6702360
UI-H-BW0-aiw-e-08-0-UI.s1
−1
AGTGTCAGACAATTAGATACTCTTTC

cDNA, 3′ end/clone = IMAGE:

CTGTCTTCAGGAGCCCATCTGGAA

2730734/clone_end = 3′

5811
db mining
Hs.255484
AW295731
6702367
UI-H-BW0-aiw-f-05-0-UI.s1
−1
GAAGTGTAAACATGCCAACAGGGTTT

cDNA, 3′ end/clone = IMAGE:

ATATTTAGGTTCCAAGAGTTGCCA

2730776/clone_end = 3′

5812
Table 3A
Hs.158814
AW295985
6702531
KIAA0377 gene product
−1
CTTCCCAAACTCCATTGTCTCATTCTC

(KIAA0377), mRNA/cds = (126,

ACTGCTTATGTTATTGCTCTTAT

4346)

5813
Table 3A
Hs.255492
AW295005
6702641
UI-H-BW0-aiu-b-01-0-UI.s1
−1
CCCACACAGCAGAGAAGTATCAGAAA

cDNA, 3′ end/clone = IMAGE:

ACATAGAAACATGTGAAAATGCGC

2730552/clone_end = 3′

5814
db mining
Hs.255495
AW296020
6702656
UI-H-BW0-aiu-c-07-0-UI.s1
−1
AGGTTCAATTCATTTTCCTGAGATGTT

cDNA, 3′ end/clone = IMAGE:

TGGTTTATAAGATTTGAGGATGGT

2730612/clone_end = 3′

5815
db mining
Hs.255497
AW296044
6702680
UI-H-BW0-aiu-e-10-0-UI.s1
−1
ATACTTACATGTGCTTGGATCCTGGG

cDNA, 3′ end/clone = IMAGE:

TGGGAGGCTTGGTTAGAAGTCACG

2730714/clone_end = 3′

5816
db mining
Hs.255498
AW296054
6702690
UI-H-BW0-aiu-f-10-0-UI.s1
−1
TGGGTCAGCGTGTTCAATTTTAAATA

cDNA, 3′ end/clone = IMAGE:

GGAATACACTAGCCTTACAACGGA

2730762/clone_end = 3′

5817
db mining
Hs.255499
AW296058
6702694
UI-H-BW0-aiu-g-02-0-UI.s1
−1
TGTTCATCTTGATGTAATAGAGAAGG

cDNA, 3′ end/clone = IMAGE:

AAAGAGAGAGCATCCCTTTTCAGT

2730794/clone_end = 3′

5818
Table 3A
Hs.255501
AW296063
6702699
UI-H-BW0-aiu-g-08-0-UI.s1
−1
ACCAGTAACACAATGACGGCAAGCAC

cDNA, 3′ end/clone = IMAGE:

AGAGAAGGAAAAAGTCAGATCCCC

2730806/clone_end = 3′

5819
db mining
Hs.255502
AW296066
6702702
UI-H-BW0-aiu-g-11-0-UI.s1
−1
ACTTGGAGCTAGAGAGCCACCCATCA

cDNA, 3′ end/clone = IMAGE:

TATGGAGGAGAAGTGGTCACTCTA

2730812/clone_end = 3′

5820
db mining
Hs.34871
AW298352
6702988
zinc finger homeobox 1B
−1
TGCATGTGTGTTGTGTACTTGTCTGT

(ZFHX1B), mRNA/cds = (444,

TCTGTAAGATTGTCGGTGTTACAC

4088)

5821
db mining
Hs.255543
AW298373
6703009
UI-H-BW0-aio-c-10-0-UI.s1
−1
TTCCTGGCAGTAAAGAAAAGAA

cDNA, 3′ end/clone = IMAGE:

AGAAGATGTGAGTTATGAAGCATT

2729874/clone_end = 3′

GACT

5822
db mining
Hs.255548
AW298398
6703034
UI-H-BW0-aio-f-01-0-UI.s1
−1
AAATAGGAATATAATCTGTCCACATC

cDNA, 3′ end/clone = IMAGE:

AAAGAATGGGAAGTCGAAGTGTACA

2730000/clone_end = 3′

5823
db mining
Hs.255549
AW296404
6703040
UI-H-BW0-aio-f-08-0-UI.s1
−1
GTTCCAAATGTTTTCCGCTAATAGTTT

cDNA, 3′ end/clone = IMAGE:

GTCCTAAAGCCTTTGCCATTCCT

2730014/clone_end = 3′

5824
db mining
Hs.255552
AW298446
6703082
UI-H-BW0-aiq-b-07-0-UI.s1
−1
ACAGAGAAGGCTTATTTACGTTGGGA

cDNA, 3′ end/clone = IMAGE:

ATTACATTAAGGAAAAGTGGTGAC

2730160/clone_end = 3′

5825
Table 3A
Hs.255554
AW296490
6703126
UI-H-BW0-aiq-f-08-0-UI.s1
−1
CCTTCCTCCTATATCCTGCCTTGAAT

cDNA, 3′ end/clone = IMAGE:

AGGGATGTGATACCTTGAGCCATG

2730374/clone_end = 3′

5826
db mining
Hs.255558
AW298504
6703140
UI-H-BW0-aiq-g-12-0-UI.s1
−1
ATATTTGGGTCTCTGTTTAAGATTTCA

cDNA, 3′ end/clone = IMAGE:

TTGCCGTGGTAGGGAGAGTTCCA

2730430/clone_end = 3′

5827
db mining
Hs.255556
AW298511
6703147
UI-H-BW0-aiq-h-08-0-UI.s1
−1
TGGATGCCATGATGACACCAATAAGC

cDNA, 3′ end/clone = IMAGE:

AACCCACAGATTAGGGGAAATACT

2730470/clone_end = 3′

5828
Table 3A
Hs.255559
AW296532
6703168
UI-H-BW0-aiv-b-07-0-UI.s1
−1
GGGGCTGGGAGCCACCAAAAGGGCC

cDNA, 3′ end/clone = IMAGE:

TGCTCTTCGGAGAAATGCTGAATTC

2730565/clone_end = 3′

5829
Table 3A
Hs.255560
AW296545
6703181
UI-H-BW0-aiv-c-11-0-UI.s1
−1
AGGCATCTTGAAAGTTCCATAAAGAC

cDNA, 3′ end/clone = IMAGE:

AGAAGTAAGGGTCATTCAGTCATT

2730621/clone_end = 3′

5830
db mining
Hs.255561
AW296567
6703203
UI-H-BW0-aiv-f-04-0-UI.s1
−1
AGCTAAAGCCACGGAACTCAATGAGA

cDNA, 3′ end/clone = IMAGE:

TTTATGCATGGAAGGAAACAGGTT

2730751/clone_end = 3′

5831
db mining
Hs.255569
AW296695
6703331
UI-H-BW0-aix-c-06-0-UI.s1
−1
TGTTCTCTCTCGAACTCTGGAGCACA

cDNA, 3′ end/clone = IMAGE:

TCAGCTCTCTCTGCATAAACTGTT

2730635/clone_end = 3′

5832
db mining
Hs.255572
AW296727
6703363
UI-H-BW0-aix-f-09-0-UI.s1
−1
ATCTGGAGGATGGCAGTTTGAGAATT

cDNA, 3′ end/clone = IMAGE:

AGGACTAAGCCCGTCTCCCCTTTG

2730785/clone_end = 3′

5833
Table 3A
Hs.255573
AW296730
6703386
UI-H-BW0-aix-f-12-0-UI.s1
−1
CATTAGCTCTCTAAACATTTGGCCTA

cDNA, 3′ end/clone = IMAGE:

AGGGATTCATAGGTGAAGCCTTTA

2730791/clone_end = 3′

5834
db mining
Hs.255575
AW296758
6703394
UI-H-BW0-ajb-a-10-0-UI.s1
−1
GGTAGGATTTATCCTTTTTCTTCATGTG

cDNA, 3′ end/clone = IMAGE:

CAACTGTATAAACTGGCAAAGCA

2730931/clone_end = 3′

5835
db mining
Hs.255577
AW296773
6703409
UI-H-BW0-ajb-c-04-0-UI.s1
−1
AGTCTTATGGGACAGAGCAGCTCTCC

cDNA, 3′ end/clone = IMAGE:

AGTCTAGGATGGTAGAAGATTCTT

2731015/clone_end = 3′

5836
Table 3A
Hs.255579
AW296797
6703433
UI-H-BW0-ajb-e-07-0-UI.s1
−1
GAGTCTGTACCCCTTTCTAATAAACT

cDNA, 3′ end/clone = IMAGE:

GCTCTGGACACAATGAACCCTGAA

2731117/clone_end = 3′

5837
db mining
Hs.255550
AW296802
6733438
UI-H-BW0-ajb-f-02-0-UI.s1
−1
CCATCGGCAAGCCTTGGTGGGTTCAT

cDNA, 3′ end/clone = IMAGE:

ATTCAGTGGCATTAGGGATTAAGG

2731155/clone_end = 3′

5838
db mining
Hs.255590
AW296914
6703550
UI-H-BW0-ajc-e-12-0-UI.s1
−1
CCATTTCTTCTGGATCCTCTCCTAGTT

cDNA, 3′ end/clone = IMAGE:

GTCTTTGTGTGGACGCACAAGCG

2731294/clone_end = 3′

5839
db mining
Hs.255591
AW296947
6703583
UI-H-BW0-ajc-e-05-0-UI.s1
−1
GATCCTTTGCTGACACTGGTTTCTCT

cDNA, 3′ end/clone = IMAGE:

CTTATTTTGCCCCGCCAATAAAAA

2731472/clone_end = 3′

5840
db mining
Hs.255598
AW297024
6703660
UI-H-BW0-ajf-e-04-0-UI.s1
−1
TCTGTCTGAAACTTCTTTTCTCTCTGA

cDNA, 3′ end/clone = IMAGE:

GAATTAAATTTTCCAATGGACCGT

2731495/clone_end = 3′

5841
db mining
Hs.255600
AW297026
6703662
UI-H-BW0-ajf-e-06-0-UI.s1
−1
GATCTGTGTTTTCCTCCCAAAAGAAG

cDNA, 3′ end/clone = IMAGE:

ATCATCTTTCCAGAAAAAGAGGAT

2731499/clone_end = 3′

5842
db mining
Hs.255601
AW297030
6703666
UI-H-BW0-ajf-e-10-0-UI.s1
−1
TTCCATATGTCACTGTATCTGCCTGG

cDNA, 3′ end/clone = IMAGE:

CATTACCCCTTCTTAAAACACACA

2731507/clone_end = 3′

5843
db mining
Hs.288403
AW297038
6703672
AV757131 cDNA, 5′ end/clone =
−1
GCTCACTACCACTTCTTCAAATCCAG

BMFAKG04/clone_end = 5′

CTAAAAGCATCACGGCCTCAATGA

5844
db mining
Hs.255614
AW291182
6703808
HNC68-1F10.R cDNA
−1
GTCTGGTTGTTAGCTTTCCCGATCCT

CCACACATTGGAAACCTAAGCATA

5845
db mining
Hs.255615
AW297175
6703811
UI-H-BW0-ajd-c-04-0-UI.s1
−1
GGGCAATGGAGCCACAGACTCTCTA

cDNA, 3′ end/clone = IMAGE:

ACTTCAAGAGGTGTTTCATAGGTGT

2731375/clone_end = 3′

5846
db mining
Hs.255618
AW297199
6703835
UI-H-BW0-ajd-e-07-0-UI.s1
−1
AGCTGAGGTCAGACAAACCACAACAT

cDNA, 3′ end/clone = IMAGE:

ATATGCAGATTTATCAGCAATAAA

2731477/clone_end = 3′

5847
db mining
Hs.255617
AW297201
6703637
7k38c02.x1 cDNA, 3′ end/clone =
−1
CCTGCCAGGGTTGTTCGGAAGTCGC

IMAGE: 3477507/clone_end = 3′

AGGTCCGAAAATCTCCTCCGCATAC

5848
db mining
Hs.255621
AW297220
6703656
UI-H-BW0-ajd-g-09-0-UI.s1
−1
CTTCTCTGAAATGGTACGCCTATACT

cDNA, 3′ end/clone = IMAGE:

TGCATTTCTGAGAAGCCAAACAAA

2731577/clone_end = 3′

5849
db mining
Hs.255622
AW297233
6703869
UI-H-BW0-aji-a-03-0-UI.s1
−1
AGTTTTCTGGCTAAGTCACCTCTTAA

cDNA, 3′ end/clone = IMAGE:

GGAGATCCCTGTAAAATTCACCCT

2731684/clone_end = 3′

5850
db mining
NA
AW297255
6703891
UI-H-BI2-ahi-d-06-0-UI.s1
−1
CAGATTAAAAACCCCATCCCGGCCCT

NCI_CGAP_Sub6 cDNA clone

CACCGAGGTGTTACAACTCTGTCC

IMAGE: 2731782 3′, mRNA

sequence

5851
db mining
Hs.48820
AW297262
6703998
TAFII105 mRNA, partial/cds = (0,
−1
AGCAAATTACTCTGCCTGGAAATAAA

2405)

ATTCTGTCACTTCAAGCATCTCCT

5852
db mining
Hs.255628
AW297265
6703901
UI-H-BW0-aji-d-02-0-UI.s1
−1
TCCAGGCACTGTATAGGTGGCGAGG

cDNA, 3′ end/clone = IMAGE:

ACACAATGATAGGCAAAGTAGTACA

2731826/clone_end = 3′

5853
db mining
Hs.255630
AW297294
6703930
UI-H-BW0-aji-f-09-0-UI.s1
−1
ACACACCCAAACCTCACACAGTGAAA

cDNA, 3′ end/clone = IMAGE:

GGCCACTTTCCTCACACAGTGAAA

2731936/clone_end = 3′

5854
db mining
Hs.255632
AW297313
6703949
7k46h07.x1 cDNA, 3′ end/clone =
−1
TTGCTTCAGACTTTTAACAACAATCCT

IMAGE: 3478525/clone_end = 3′

AGAAGCCAGAAAACAATGAAGAAA

5855
db mining
Hs.255633
AW297317
6703953
UI-H-BW0-aji-h-12-0-UI.s1
−1
TTCTGTCAGGGCTTCAAAAGAGACTT

cDNA, 3′ end/clone = IMAGE:

CCATAGTTTTGGGAACTGGAGTCA

2732038/clone_end = 3′

5856
db mining
Hs.255634
AW297318
6703954
UI-H-BW0-air-a-01-0-UI.s1
−1
GATATATTGAAGGTCAGAGGCAGAGC

cDNA, 3′ end/clone = IMAGE:

TAAACAGGTGATGCCACTGGGTCT

2730121/clone_end = 3′

5857
db mining
Hs.215635
AW297328
6703964
UI-H-BW0-air-a-11-0-UI.s1
−1
AGGCTCTTGTTGAGTATTCCTTTGATT

cDNA, 3′ end/clone = IMAGE:

CCTGCTTCTGTCTTTTTAAATCA

2730141/clone_end = 3′

5858
Table 3A
Hs.255637
AW297339
6703975
UI-H-BW0-air-c-03-0-UI.s1
−1
ACACACCAAAAGAAATACAAGAGTCT

cDNA, 3′ end/clone = IMAGE:

TTTTCTGCCCTTGGGGAATCTGCA

2730221/clone_end = 3′

5859
db mining
NA
AW297356
6703992
UI-H-BW0-air-d-08-0-UI.s1
−1
ACACCCAGCACCCACAGGGAAGAAA

NCI_CGAP_Sub6 cDNA clone

TAATTCCACAGAGCTAAGTATTCCA

IMAGE: 2730279 3′, mRNA

sequence

5860
db mining
Hs.330185
AW297367
6104003
UI-H-BW0-air-f-01-0-UI.s1
−1
TGTGCCTGTGTGCTCCAGCCTCTTCC

cDNA, 3′ end/clone = IMAGE:

TATGTGTGTAACTTCAATAAAACC

2730361/clone_end = 3′

5861
db mining
Hs.255644
AW297374
6704010
UI-H-BW0-air-f-08-0-UI.s1
−1
ACCGAGTGTTACCGCAAGAGGTGTAA

cDNA, 3′ end/clone = IMAGE:

AAATCGAGGTTCATCTTTGCACAC

2730375/clone_end = 3′

5862
db mining
Hs.255645
AW297384
6704020
UI-H-BW0-air-g-08-0-UI.s1
−1
TCCTGATTCTCAAAGTACCCCCTTCC

cDNA, 3′ end/clone = IMAGE:

CTACAACTCTAACATGCTTTGTCT

2730423/clone_end = 3′

5863
db mining
Hs.255646
AW297390
6704026
UI-H-BW0-air-h-05-0-UI.s1
−1
CCATGATTTTTCCAATGGACAAGCAC

cDNA, 3′ end/clone = IMAGE:

TATTAACATGGGACTGTATTTCCT

2730485/clone_end = 3′

5864
Table 3A
Hs.255647
AW297400
6704038
UI-H-BW0-ais-a-05-0-UI.s1
−1
AATAGAACTGATAGCCCATGATGATT

cDNA, 3′ end/clone = IMAGE:

GGCTGGCAGGGTTAAGGAAGTGGG

2730152/clone_end = 3′

5865
db mining
Hs.255648
AW297401
6704037
UI-H-BW0-ais-a-08-0-UI.s1
−1
TCCCAGGAGAGTCACATTTCTTTTTC

cDNA, 3′ end/clone = IMAGE:

ACTAAATAAGGAGGGGAAGAAAAA

2730154/clone_end = 3′

5866
db mining
Hs.255649
AW297407
6704043
UI-H-BW0-ais-b-02-0-UI.s1
−1
GGGTTACCTCACTTTCTAGGTTCCCA

cDNA, 3′ end/clone = IMAGE:

AGATTCCCAAGTTAAGGAAGCTTT

2730194/clone_end = 3′

5867
db mining
Hs.255650
AW297411
6704047
UI-H-BW0-ais-b-07-0-UI.s1
−1
AAAGCGTCCAGTCCCCCTAACTCAAA

cDNA, 3′ end/clone = IMAGE:

CACAGAAACATAACAATTTTACAA

2730204/clone_end = 3′

5868
db mining
Hs.255653
AW297426
6704062
UI-H-BW0-ais-c-12-0-UI.s1
−1
CCCAGGGCTCCTCCACCTGAAAGAAT

cDNA, 3′ end/clone = IMAGE:

TGTCAGGGTTTCAGATCAGCTAAA

2730262/clone_end = 3′

5869
db mining
Hs.256657
AW297443
6704079
UI-H-BW0-ais-e-09-0-UI.s1
−1
TGGCCTCCACCCATTAAACTGTCTTT

cDNA, 3′ end/clone = IMAGE:

GCCTAAGACAAATAATTCCCAGGA

2730352/clone_end = 3′

5870
Table 3A
Hs.255661
AW297522
6704158
UI-H-BW0-aja-e-02-0-UI.s1
−1
TGTACTCCTGATGCCTGAAAATCGTT

cDNA, 3′ end/clone = IMAGE:

AAGTGAAGACTTATCACATTACCG

2731108/clone_end = 3′

5871
db mining
Hs.255665
AW297581
6704217
UI-H-BW0-ajg-b-08-0-UI.s1
−1
ATCCTTCAGATTGAGCTGGGTGTCAG

cDNA, 3′ end/clone = IMAGE:

CATTCAATTCCACAAGCCTACCTG

2731718/clone_end = 3′

5872
db mining
Hs.255686
AW297590
6704226
RST6539 cDNA
−1
TGGATAAGCAATATGTTGGACTAGTA

TGAAAATGGCATTCCCAGCAGTGA

5873
db mining
Hs.256672
AW297628
6704262
UI-H-BW0-ajg-f-12-0-UI.s1
−1
TCACTAGCAGAATATAGTGGGCATGA

cDNA, 3′ end/clone = IMAGE:

CCAGTATCCTAGTAGAGCTGACCC

2731918/clone_end = 3′

5874
db mining
Hs.255673
AW297030
6704272
UI-H-BW0-ajg-h-03-0-UI.s1
−1
AGTTTCTTTCTTACAATGCGGGTCTG

cDNA, 3′ end/clone = IMAGE:

AAATCCAGGGTTTCCACACCAGGG

2731996/clone_end = 3′

5875
db mining
Hs.255674
AW297849
6704285
UI-H-BW0-ajh-a-05-0-UI.s1
−1
CCAAATACTTAGTGTAGTTGACTTGT

cDNA, 3′ end/clone = IMAGE:

CTTGGGTTGCACTGTAAGGCAGAG

2731665/clone_end = 3′

5876
db mining
Hs.255675
AW297651
6704267
UI-H-BW0-ajh-a-07-0-UI.s1
−1
CAAGAGTTTCCATGCGTCCAGTGATG

cDNA, 3′ end/clone = IMAGE:

ACCGGAATTAATCATGTATGGTGT

2731669/clone_end = 3′

5877
db mining
Hs.255677
AW297664
6704300
UI-H-BW0-ajh-b-11-0-UI.s1
−1
GTTTCTAACCCATAAGTGCCTCATAC

cDNA, 3′ end/clone = IMAGE:

ATACATTGCTAGTCTAAAGAGCTTT

2731725/clone_end = 3′

5878
db mining
Hs.255679
AW297692
6704328
UI-H-BW0-ajh-e-05-0-UI.s1
−1
ACCGGCTAATTTTGTAACTGGCTTGT

cDNA, 3′ end/clone = IMAGE:

TTGTAAAATAAATCCTTCCTGTGT

2731857/clone_end = 3′

5879
db mining
Hs.255881
AW297694
6704330
UI-H-BW0-ajh-e-07-0-UI.s1
−1
TGGTGGGACTATGTGTTATTCTTGTA

cDNA, 3′ end/clone = IMAGE:

TACTTGCAGTGGGTAGATGTCACT

2731881/clone_end = 3′

5880
db mining
Hs.255682
AW297698
6704334
UI-H-BW0-ajh-e-11-0-UI.s1
−1
ACTTCCCTACCTCACAGGTTAGGATT

cDNA, 3′ end/clone = IMAGE:

CAAAGTGTGTATTCCCCCATTGTG

2731869/clone_end = 3′

5881
db mining
Hs.255688
AW297728
6704364
UI-H-BW0-aiy-a-01-0-UI.s1
−1
GGGTGCTTTACAGGATTCTTGGAAAT

cDNA, 3′ end/clone = IMAGE:

GTGTAGTGGATGCTGGCTCTAGGG

2730888/clone_end = 3′

5882
db mining
Hs.255688
AW297749
6704385
UI-H-BW0-aiy-c-03-0-UI.s1
−1
ACAGAAGCAGGGGGTCAGAAAGTTT

cDNA, 3′ end/clone = IMAGE:

CATAAAGGAGGTGTCTTGGAACAAA

2730988/clone_end = 3′

5883
db mining
Hs.342530
AW297758
6704392
UI-H-BW0-aiy-d-01-0-UI.s1
−1
CTATTGTGTGGGTTGCCTTGTCCTAC

cDNA, 3′ end/clone = IMAGE:

TCAACTTCAAATATTCACCACCCC

2731032/clone_end = 3′

5884
db mining
Hs.255691
AW297780
6704416
UI-H-BW0-aiy-e-11-0-UI.s1
−1
CAGGTGTGCTTACTGGCAGGAACCG

cDNA, 3′ end/clone = IMAGE:

AGGGGATAAATAAAGATCACTGGAA

2731100/clone_end = 3′

5885
db mining
Hs.255692
AW297761
6704417
UI-H-BW0-aiy-e-12-0-UI.s1
−1
ACCAGCCTTATGTGTGTGGGTATTCA

cDNA, 3′ end/clone = IMAGE:

ATACTCTGCACATTATATACTGTA

2731102/clone_end = 3′

5886
db mining
Hs.255693
AW297785
6794421
UI-H-BW0-aiy-f-04-0-UI.s1
−1
GGGCATTTGTTACCCCCTCCTCACCA

cDNA, 3′ end/clone = IMAGE:

CCATCCCCATTAAAGGCTTCGGGG

2731134/clone_end = 3′

5887
Table 3A
Hs.255695
AW297613
6704438
UI-H-BW0-aiy-g-09-0-UI.s1
−1
CTGTATCTACAACTCCTGACTTCAGA

cDNA, 3′ end/clone = IMAGE:

TTTTTGCTTTCTTCAAAACAGCCT

2731192/clone_end = 3′

5888
Table 3A
Hs.255697
AW297627
6704452
UI-H-BW0-aiy-h-11-0-UI.s1
−1
AGCAAGACTTAACCACTAATTACTATT

cDNA, 3′ end/clone = IMAGE:

ATCTGACCCAGGACTCCGCC

2731244/clone_end = 3′

5889
db mining
Hs.255698
AW297843
6704488
UI-H-BW0-aoa-c-05-0-UI.s1
−1
TGGATAGTTGCTCAATGTAGCAGTGA

cDNA, 3′ end/clone = IMAGE:

TGTTCTTGGGATTGCCAGCAGAGC

3083913/clone_end = 3′

5890
db mining
Hs.326317
AW297929
6704565
yg18e06.s1 cDNA, 3′ end/clone =
−1
CCAACAGATTCGTGCTTACCCTGAGG

IMAGE: 32551/clone_end = 3′

TGAAGCCTCGTTTGAGAACCAAAT

5891
db mining
Hs.255705
AW297949
6704565
UI-H-BW0-ajn-d-11-0-UI.s1
−1
CAACCTTCTTGTTGAATTGATTTACTA

cDNA, 3′ end/clone = IMAGE:

CTCATCAGGGTCATGCACAAGCA

2732229/clone_end = 3′

5892
db mining
Hs.255706
AW297951
6704587
UI-H-BW0-ejn-e-01-0-UI.s1
−1
ACATTCAAACTGCCAGAATATGACTG

cDNA, 3′ end/clone = IMAGE:

TAAAACAGCGAAGTGTTCTCTTGC

2732257/clone_end = 3′

5893
db mining
Hs.255708
AW297970
6704600
UI-H-BW0-ajn-f-10-0-UI.s1
−1
TCTTCCTGGGAATGTGATGTGTTTTT

cDNA, 3′ end/clone = IMAGE:

CACTGGTTCTAATTCTGTCTTCCT

2732323/clone_end = 3′

5894
db mining
Hs.255710
AW297974
6704610
UI-H-BW0-ajn-g-02-0-UI.s1
−1
ACTTATTAATTCTCACCTCAGCCTCA

cDNA, 3′ end/clone = IMAGE:

GGGATGTATGTAGGGAAGGAGCAT

2732355/clone_end = 3′

5895
db mining
Hs.255713
AW297994
6704830
UI-H-BW0-ajn-h-11-0-UI.s1
−1
ACATTCCTGTCATTAGTGAATAAGAA

cDNA, 3′ end/clone = IMAGE:

GCTGAGGTGTGACTAAGAAGACAA

2732421/clone_end = 3′

5896
db mining
Hs.255717
AW298042
6704678
UI-H-BW0-ajp-e-07-0-UI.s1
−1
CCTCCTTGATAAAATCAAGAACAGGT

cDNA, 3′ end/clone = IMAGE:

TAGATTAAAGCAGTAAATCCTAGACT

2732629/clone_end = 3′

5697
db mining
Hs.330189
AW298048
6704684
UI-H-BW0-ejp-f-01-0-UI.s1
−1
TCCTGGCCTTTGTGGGTTTTTAATTC

cDNA, 3′ end/clone = IMAGE:

CCTTTACCTTTTCCCTTTTTGGAT

2732665/clone_end = 3′

5898
db mining
Hs.255721
AW298073
6704709
UI-H-BW0-ajp-h-05-0-UI.s1
−1
ACTGCTGCAACTACAATTCTCAGATA

cDNA, 3′ end/clone = IMAGE:

GTCCCATTTGTTTAAATCACGCAT

2732769/clone_end = 3′

5899
db mining
Hs.342533
AW296095
6704731
UI-H-BW0-ajs-b-12-0-UI.s1
−1
CCTTCCCTCTTGCCTGTAGGTTCTGT

cDNA, 3′ end/clone = IMAGE:

GGCTATAAACAAATCATAACTTTT

2732878/clone_end = 3′

5900
db mining
Hs.255725
AW298100
6704742
UI-H-BW0-ajs-c-07-0-UI.s1
−1
TTAAATGCTTCCCTGGCTCTCCCTGG

cDNA, 3′ end/clone = IMAGE:

GTTTCAGTTTCTATCCATGCCCTG

2732916/clone_end = 3′

5901
db mining
Hs.255726
AW298110
6704746
UI-H-BW0-ajs-c-11-0-UI.s1
−1
TTGTTCTCCTCCCAAGTCTCTGGTTC

cDNA, 3′ end/clone = IMAGE:

TATTTGGCTTTTTCAGCTCTGTGC

2732924/clone_end = 3′

5902
db mining
Hs.255727
AW298123
6704759
UI-H-BW0-ajs-e-01-0-UI.s1
−1
GCATTTCAGGGACACAAATGGGT

cDNA, 3′ end/clone = IMAGE:

CCATGGCAGAGACCAGTAATGCCA

2733000/clone_end = 3′

GATA

5903
db mining
Hs.255736
AW298201
6704837
UI-H-BW0-ajt-d-08-0-UI.s1
−1
TTTTATCCCCGCTTTAACTTTGTTTGC

cDNA, 3′ end/clone = IMAGE:

TTGGTACTTTTCTTGTGGTTACA

2732967/clone_end = 3′

5904
db mining
NA
AW298208
6704844
UI-H-BW0-ajl-e-05-0-UI.s1
−1
CACGCACCCAACTCCCCACTGCTCCT

NCI_CGAP_Sub6 cDNA clone

CTCCATCCAGATGTTCGTCCAGAG

IMAGE: 2733009 3′, mRNA

sequence

5905
db mining
Hs.255740
AW298234
6704870
UI-H-BW0-ajt-g-09-0-UI.s1
−1
TTTGAGGGCAATTTAATGGTTAAGTG

cDNA, 3′ end/clone = IMAGE:

TAGGAAAATCCACTCTTACAGTGT

2733113/clone_end = 3′

5906
db mining
Hs.330191
AW298238
6704874
UI-H-BW0-ajt-h-04-0-UI.s1
−1
GGCCTTTTGATTTTCCATTGGGGTCC

cDNA, 3′ end/clone = IMAGE:

CCCGCTTTCCCATTTTTGGTTTTT

2733151/clone_end = 3′

5907
db mining
Hs.255743
AW298239
6704875
UI-H-BW0-ajt-h-05-0-UI.s1
−1
GACAGTTTGGGGAAGGGATTGAAGG

cDNA, 3′ end/clone = IMAGE:

TCTGCGTCAAAGAGAACAGAAAACC

2733153/clone_end = 3′

5908
db mining
NA
AW298271
6704994
UI-H-BW0-ajk-d-01-0-UI.s1
−1
AGGGGCCTTTTACCGGTTTGTTTTCC

cDNA, 3′ end/clone = IMAGE:

CTTAAATTTTTAAAGGAATTGAAT

2732184/clone_end = 3′

5909
db mining
Hs.183669
AW298312
6705035
mRNA for KIAA1271 protein,
−1
TCCTCTTTCTTGTCACTGTGAAGCGA

partial cds/cds = (72, 1700)

TGAATAAACCTGGGTGTAGATCCA

5910
db mining
Hs.302681
AW298348
6704908
7j80e10.x1 cDNA, 3′ end/clone =
−1
CCTAGAAATTATTATACAGGGATAAAT

IMAGE: 3392778/clone_end = 3′

GAGGCACTGAAGGTGGGAGAACC

5911
db mining
Hs.255746
AW298349
6704909
UI-H-BW0-ajj-c-10-0-UI.s1
−1
ACGACAAACTGCACAGTAAATATCAC

cDNA, 3′ end/clone = IMAGE:

AAACACGGAAATACCACAGTGTCT

2731795/clone_end = 3′

5912
db mining
Hs.255747
AW298355
6704915
UI-H-BW0-ajj-d-06-0-UI.s1
−1
ACCATGACTTGGCAAAGAGTTTCAAG

cDNA, 3′ end/clone = IMAGE:

AGAGGGCATAATCAAAAGTAACCA

2731835/clone_end = 3′

5913
db mining
Hs.255749
AW298388
6704948
UI-H-BW0-ajj-g-08-0-UI.s1
−1
GATTAATCAAGGGAAGAGCTTCAAGC

cDNA, 3′ end/clone = IMAGE:

AGAGCTCCTTAGGTTTTTCAAAAA

2731983/clone_end = 3′

5914
Table 3A
Hs.313413
AW298430
6705068
802721745F1 cDNA, 5′ end/
−1
GCTCAGGGGACAGCTATTCTTTTTCA

clone = IMAGE: 4848506/

AGAGCTCCTTAGGTTTTTCAAAA

clone_end = 5′

5915
db mining
Hs.255762
AW298437
6705073
UI-H-BW0-ajl-d-08-0-UI.s1
−1
TGAGAGCTTTCCTTCCTCCTACGATC

cDNA, 3′ end/clone = IMAGE:

CAACCTGTCAAACATTTCCTACA

2732199/clone_end = 3′

5916
db mining
Hs.255763
AW298445
6705081
UI-H-BW0-ajl-e-07-0-UI.s1
−1
TGTGCCAACGCATGATTTCTTTGAGT

cDNA, 3′ end/clone = IMAGE:

AAATTTCTAAACGTCACAGAAGTT

2732245/clone_end = 3′

5917
db mining
Hs.255764
AW298447
6705083
UI-H-BW0-ajl-e-09-0-UI.s1
−1
AGTCAACATGGAGCAAGTGAGCTAAG

cDNA, 3′ end/clone = IMAGE:

GAAGTAATGGAAACTGTTTGGAGA

2732249/clone_end = 3′

5918
db mining
Hs.255766
AW298482
6705118
UI-H-BW0-ajl-h-11-0-UI.s1
−1
AGCTCAGGTCTTCCCTCATCTGTTAG

cDNA, 3′ end/clone = IMAGE:

TTTCCTGGAGTCTGTTCTCATACT

2732397/clone_end = 3′

5919
db mining
Hs.255767
AW298489
6705125
UI-H-BW0-ajm-a-08-0-UI.s1
−1
AAACATACTCCTCTTCACCAGCACTC

cDNA, 3′ end/clone = IMAGE:

AGACATTTGTATCCAGAGAAAGCT

2732078/clone_end = 3′

5920
db mining
Hs.255768
AW298490
6705128
UI-H-BW0-ajm-a-09-0-UI.s1
−1
AGTCTGCAATTGTTTAAGCCTGTGA

cDNA, 3′ end/clone = IMAGE:

TCTTTCTTTTCCCAGTTAAGAGTT

2732080/clone_end = 3′

5921
db mining
Hs.255769
AW298494
6705130
UI-H-BW0-ajm-b-01-0-UI.s1
−1
TGTCCTCTCAACCCTACTTGTGGTTT

cDNA, 3′ end/clone = IMAGE:

TACACTGTTAATTACACTATTTGC

2732112/clone_end = 3′

5922
db mining
Hs.132781
AW298502
6705138
class I cytokine receptor (WSX-1),
−1
GTGTGTGTATGGTTGTTGGGCGTAG

mRNA/cds = (138, 2048)

GACAGGTTTCGGGGATGCGCGGTAC

5923
db mining
Hs.255770
AW298503
6705139
UI-H-BW0-ajm-b-12-0-UI.s1
−1
CTGTGCTTGACTATTGAAAACTTAGA

cDNA, 3′ end/clone = IMAGE:

ATTGGGATGCCAAAGTTACTTCCT

2732134/clone_end = 3′

5924
db mining
Hs.255772
AW298510
6705146
UI-H-BW0-ajm-c-11-0-UI.s1
−1
GGTTGTATCAAAAGAACTCCACATCC

cDNA, 3′ end/clone = IMAGE:

ATATTGAATAAACTCCCACTAGCC

2732180/clone_end = 3′

5925
db mining
Hs.255777
AW298559
6705195
UI-H-BW0-ajm-n-04-0-UI.s1
−1
GGCTGCCCAGATCTCGTGGGAAGAA

cDNA, 3′ end/clone = IMAGE:

GACCACAGGAGGACTCGGCTCAATG

2732406/clone_end = 3′

5926
db mining
Hs.255779
AW298607
6705243
UI-H-BW0-ajr-d-12-0-UI.s1
−1
TGGAAAAATGATAGCAGCCAACTTGA

cDNA, 3′ end/clone = IMAGE:

CAGAAGAACCCAGCATACACATTC

2732615/clone_end = 3′

5927
db mining
Hs.255762
AW298616
6705252
UI-H-BW0-ajr-e-10-0-UI.s1
−1
TTGGTTTTGGGGATTGGGAAGTCTTA

cDNA, 3′ end/clone = IMAGE:

AGCCAAATTGTCCCCGGTCTCCCC

2732659/clone_end = 3′

5928
db mining
Hs.255783
AW298627
6705263
UI-H-BW0-ajr-f-10-0-UI.s1
−1
GCCCTATATCTAGTGAGCAGGTTGTG

cDNA, 3′ end/clone = IMAGE:

GCAATCAGGAAGGGATTGATATTT

2732707/clone_end = 3′

5929
db mining
Hs.255784
AW298832
6705268
UI-H-BW0-ajr-g-04-0-UI.s1
−1
TGCACGCAATGCTTGAAGTGTTCCCA

cDNA, 3′ end/clone = IMAGE:

GGTATTTAGTTTCAGGTAAATTTT

2732743/clone_end = 3′

5930
db mining
Hs.255785
AW298647
6705283
UI-H-BW0-ajr-h-09-0-UI.s1
−1
CTGTAGGTATGAGCTGCCAGGATCCA

cDNA, 3′ end/clone = IMAGE:

GGTGTGACTCGGGTATTTCTAGGG

2732801/clone_end = 3′

5931
db mining
Hs.255788
AW298875
6705311
UI-H-BW0-ajo-c-03-0-UI.s1
−1
TCCCATTTGGGGGGTGGGCTGTTAA

cDNA, 3′ end/clone = IMAGE:

ATTTTGACTCCCTGTTTTAAACCC

2732524/clone_end = 3′

5932
db mining
Hs.255794
AW298720
6705358
UI-H-BW0-ajo-g-07-0-UI.s1
−1
CCACTTGCATCTCTTCTGGGGGTTCT

cDNA, 3′ end/clone = IMAGE:

TTCCTTTCTTTCCTGTTCTAAGGC

2732724/clone_end = 3′

5933
db mining
Hs.255797
AW298752
6705388
UI-H-BW0-ajq-b-08-0-UI.s1
−1
TGGGTAATCAACACTCAACCATCAAC

cDNA, 3′ end/clone = IMAGE:

AAACACTCTCTATTCCAGGCACTG

2732506/clone_end = 3′

5934
db mining
Hs.255799
AW298806
6705442
RC4-MT0235-061200-011-a11
−1
AGGAGAAATAATTAGAGTGGCACACT

AGCATGATGGTAAACATTCTGTCA

5935
Table 3A
Hs.157396
AW300500
6710177
xs66c06.x1 cDNA, 3′ end/clone =
−1
AGGAGTTCAAGAAGCAGAGATTTCCA

IMAGE: 2774602/clone_end = 3′

GGTCCATGCACCAAAGCTCATGTG

5936
Table 3A
Hs.262789
AW300888
6710545
xk07d09.x1 cDNA, 3′ end/clone =
−1
CTTGTCCTCTCCTGATCCAGGGCTCC

IMAGE: 2666033/clone_end = 3′

AGTGCCCATGTCCAGTGCCTTGGT

5937
db mining
Hs.255880
AW337887
6834513
he12d07.x1 cDNA, 3′ end/clone =
−1
GCATCTCCCCGCTGTCAGCCTCAGC

IMAGE: 2918797/clone_end = 3′

CCTCTCCTACCAAAATCTCTTTCGA

5938
Table 3A
Hs.328348
AW338115
6834741
tp39g05.x1 cDNA, 3′ end/clone =
−1
GGCGTTTCCCATTGACCAGTTTGACC

IMAGE: 2190200/clone_end = 3′

CTGGTTTGAATAAAGAGAAGTGCG

5939
db mining
Hs.255920
AW339530
6836156
he13d09.x1 cDNA, 3′ end/clone =
−1
AGCCCATTGAAAACCTTGGCAAAATG

IMAGE: 2918897/clone_end = 3′

TCAGACCTTAAGACTTTCCACTAT

5940
Table 3A
Hs.255927
AW339851
6836277
he15g04.x1 cDNA, 3′ end/clone =
−1
TCAGAGACAACGGAAGCTGAAAAATA

IMAGE: 2919126/clone_end = 3′

AGAGCTGAGAAAGGAAGAACTTTT

5941
Table 3A
Hs.207995
AW340421
6837047
hc96h02.x1 cDNA, 3′ end/clone =
−1
ATATACATACAAATCTAAGCTCCAAG

IMAGE: 2907891/clone_end = 3′

AAGCCTAAGAAAACCCCTTAGGGG

5942
Table 3A
Hs.256031
AW341086
6837631
xz92h04.x1 cDNA, 3′ end/clone =
−1
GGGCAATTTACATCGGGACTCGTTTC

IMAGE: 2871703/clone_end = 3′

ATCTCTAGACCTTCACTTACCTGA

5943
Table 3A
Hs.283867
AW341449
6838075
arginyl aminopeptidase (amino-
−1
AGCTCTGGAGTGCCCCTCCCTCCAAA

peptidase B) (RNPEP), mRNA/

TAAAGTATTTTAAGCGAACACTGA

cds = (9, 1982)

5944
Table 3A
Hs.337986
AW440517
6975823

Homo sapiens, clone MGC: 17431
−1
GCCAGTCTCTATGTGTCTTAATCCCT

IMAGE: 2984883, mRNA,

TGTCCTTCATTAAAAGCAAAACTA

complete cds/cds = (1338, 1494)

5945
db mining
Hs.256958
AW440813
6976044
he03b05.x1 cDNA, 3′ end/clone =
−1
CCCTCAGGCATAGAAATTGAATCTGA

IMAGE: 2917905/clone_end = 3′

AATGGCTGATGAATAAGCAAAGGC

5946
db mining
Hs.313573
AW440817
6976048
he03c02.x1 cDNA, 3′ end/clone =
−1
CAGCCCTGCCTGAGTTTTTGACACCT

IMAGE: 2917922/clone_end = 3′

GCATCCCTCCCTGCCTCACCTCAC

5947
Table 3A
Hs.256981
AW440866
6976172
he05f02.x1 cDNA, 3′ end/clone =
−1
AGAGCAGGAGAAATCCTACTGCATTA

IMAGE: 2918139/clone_end = 3′

TTAATCTGAAAGCACAAGGACAGC

5948
Table 3A
Hs.173730
AW440869
6976175
Mediterranean faver (MEFV),
−1
CTGTCTTGGTTTGTATGGGAAAATCT

mRNA/cds = (41, 2386)

GCGGGTTGTGGAATATTAGGTTCT

5949
Table 3A
Hs.118448
AW440985
6976271
HNC35-1-D12.R cDNA
−1
TGGGATTATAGGGGGAGACAGGAGT

TGTGGAATTACAGGAGAGGTTCACT

5950
db mining
Hs.118446
AW440985
6976271
HNC35-1-D12.R cDNA
−1
TGGGATTATAGGGGGAGACAGGAGT

TGTGGAATTACAGGAGAGGTTCACT

5951
Table 3A
Hs.256971
AW440974
6976280
he08e12.x1 cDNA, 3′ end/clone =
−1
CTGAGAAAAGGAGTGTCTCTCTTCTG

IMAGE: 2918254/clone_end = 3′

CTCCCAAACTTCCAGTAGCTTCCA

5952
Table 3A
Hs.342632
AW444482
6988244
UI-H-BI3-akb-e-05-0-UI.s1 cDNA,
−1
TCGAGGTTCTTCCCAAGAAAAGCCCA

3′ end/clone = IMAGE:

ATCTTATAAACTGTTACTTCCCCT

2733777/clone_end = 3′

5953
Table 3A
Hs.250
AW444632
6988394
xanthene dehydrogenase (XDH),
−1
TGCAATGAGGCAGTGGGGTAAGGTT

mRNA/cds = (81, 4082)

AAATCCTCTAACCGTCTTTGAATCA

5954
Table 3A
Hs.335815
AW444812
6986574
UI-H-BI3-ajy-d-11-0-UI.s1 cDNA,
−1
TGGCAACTTCAACTCCTTGATGGCGA

3′ end/clone = IMAGE:

TAATCTCTGGTATGAATATGAGCC

2733380/clone_end = 3′

5955
Table 3A
Hs.99665
AW444899
6986661
UI-H-BI3-ajz-d-07-0-UI.s1 cDNA,
−1
TTGTGCTCCTGATACGACGTTGCCAC

3′ end/clone = IMAGE:

AGTTAATCCGTTCTGATCTCTGCT

2733373/clone_end = 3′

5956
Table 3A
Hs.257283
AW450350
6991126
UI-H-BI3-akn-c-01-0-UI.s1 cDNA,
−1
CAAGCCTAACTTTCCAACACTCCCGC

3′ end/clone = IMAGE:

GACGCAACCCCTTCCCCTTTCCTC

2734825/clone_end = 3′

5957
Table 3A
Hs.313715
AW450835
6991611
UI-H-BI3-alf-f-06-0-UI.s1 cDNA,
−1
CACGGTTAGAGTCACCAAACCTGTAT

3′ end/clone = IMAGE:

TTCAGGGGACATCTTTCCAGCTCC

2736539/clone_end = 3′

5958
Table 3A
Hs.199014
AW250874
6991850
601499703F cDNA, 5′ end/clone =
−
CCAAAGGCTCACTACCCCTGTGCGTT

IMAGE: 3901440/clone_end = 5′

GTCCAGCACACAGACACTATGTGC

5959
Table 3A
Hs.342873
AW451293
6992069
RC3-HT0230-130100-014-g06
−1
TGCTTGGGAAATTTGGTTTGTAAACC

cDNA

TAAAATAGCCCTTATTTCTGGGGA

5960
Table 3A
Hs.101370
AW452023
6992799
AL583391 cDNA/clone =
−1
CATCTGCTGAGCAGTGTGCTGTGTCA

CS0DL012YA12-(3-prime)

ACCTCCTCCTAGGTCTCCTCTATG

5961
Table 3A
Hs.342735
AW452096
6992953
UI-H-BI3-alo-d-02-0-UI.s1 cDNA,
−1
CTTTCTGCCTGAAGCTGCCCCCATGA

3′ end/clone = IMAGE:

CTCCCTTCTTTGTGCAAAAGCATG

3069196/clone_end = 3′

5962
Table 3A
NA
AW452487
6993243
UI-H-BI3-als-e-09-0-UI.s1
−1
GAAATGAGTTGGTGTCTTCACAGAAT

NCI_CGAP_Sub5 cDNA clone

GAGGATCCCCAGAGCCATCTTGCC

IMAGE: 3068632 3′, mRNA

sequence

5963
Table 3A
Hs.257579
AW452513
6993289
UI-H-BW1-ame-b-03-0-UI.s1
−1
GTCTCCCTCCCACTCTCTGCCTTACC

cDNA, 3′ end/clone = IMAGE:

TGGTATCTATGACTCGACTGAAAT

3069628/clone_end = 3′

5964
db mining
Hs.257581
AW452528
6993304
UI-H-BW1-ame-c-07-0-UI.s1
−1
TGCGAGAGGAAGCAGAGACCACCT

cDNA, 3′ end/clone = IMAGE:

GAAACTCGGGTGCATTAAGTCCTTG

3069684/clone_end = 3′

5965
db mining
Hs.257582
AW452545
6993321
UI-H-BW1-ame-d-12-0-UI.s1
−1
TTAGCCACTGCTATTCTAGGTTCCTT

cDNA, 3′ end/clone = IMAGE:

GATGGAGCCCCACTCCCACGCCTA

3069742/clone_end = 3′

5966
db mining
Hs.257630
AW452932
6993708
UI-H-BW1-amd-c-07-0-UI.s1
−1
ACCACCCAGAGGTTGCTGGCTTCCTT

cDNA, 3′ end/clone = IMAGE:

AATAAAGCTAACTTTCCTTTCACC

3069325/clone_end = 3′

5967
db mining
Hs.257632
AW452953
6993729
UI-H-BW1-amd-e-04-0-UI.s1
−1
AGGGGAGCCAGTGGTTTTTGGTCAT

cDNA, 3′ end/clone = IMAGE:

GGGAAGTGTTCTCATAAAATTCATT

3069415/clone_end = 3′

5968
db mining
Hs.257633
AW452960
6993736
UI-H-BW1-amd-e-11-0-UI.s1
−1
GCACCAGACTTCTGAACAGGCTGGG

cDNA, 3′ end/clone = IMAGE:

AGAGTGAGGCATAAACACATGAAAT

3069429/clone_end = 3′

5969
db mining
Hs.257638
AW452985
6993761
UI-H-BW1-amd-g-12-0-UI.s1
−1
ACACAGTACTTTGTTGAGATGTTGGC

cDNA, 3′ end/clone = IMAGE:

TTCTTGGTTTATGGCATGAATTCT

3069527/clone_end = 3′

5970
Table 3A
Hs.257640
AW453021
6993797
UI-H-BW1-ama-c-02-0-UI.s1
−1
ACTTATCTTTTGCCACCCATGTTCCT

cDNA, 3′ end/clone = IMAGE:

GGATGCCTTGCCTTCCTCTTTCAT

3069290/clone_end = 3′

5971
db mining
Hs.257644
AW453034
6993810
UI-H-BW1-ama-d-03-0-UI.s1
−1
AAACAGGAAGCCTCTCATGAATTTGA

cDNA, 3′ end/clone = IMAGE:

CCAAGGAGCTACATTCGTTCTCTA

3069340/clone_end = 3′

5972
db mining
Hs.257645
AW453039
6993815
UI-H-BW1-ama-d-08-0-UI.s1
−1
TGAGGAAGAGGAGATTTATTAAGCCC

cDNA, 3′ end/clone = IMAGE:

CTTCTTTTAGGCTAGGAGGTTTCC

3069350/clone_end = 3′

5973
Table 3A
Hs.257648
AW453044
6993820
UI-H-BW1-ama-e-01-0-UI.s1
−1
GGACACTGGCTTTTGTGCAGCTCTTC

cDNA, 3′ end/clone = IMAGE:

ATCACAGAGTCTGTTGAGCTACAA

3069384/clone_end = 3′

5974
db mining
Hs.257647
AW453055
6993831
UI-H-BW1-ama-e-12-0-UI.s1
−1
ACAGTGATTTTCAACCAAGGGGCTTT

cDNA, 3′ end/clone = IMAGE:

TTCAAACTACATTCCTTAGCTCCC

3069408/clone_end = 3′

5975
Table 3A
Hs.257667
AW467193
7037299
he07a04.x1 cDNA, 3′ end/clone =
−1
GGTGGTGGCTACAAGGGTGATTGCC

2918288/clone_end = 3′

TTATGATAATTGACCGTGTCATAAT

5976
db mining
Hs.257688
AW487208
703314
he07c09.x1 cDNA, 3′ end/clone =
−1
AGCTGGGAGGCCATTACTTTTTGTCT

2918320/clone_end = 3′

GAGTCTTCTGGAGTTCTAGCAAAA

5977
db mining
Hs.255877
AW467312
703418
he09b01.x1 cDNA, 3′ end/clone =
−1
AGTTGCATTAAACTGAGCTTAGATGT

2918473/clone_end = 3′

GTAAGTTTGCTAACGGATGGGTTT

5978
db mining
Hs.257677
AW467338
7037444
he09e07.x1 cDNA, 3′ end/clone =
−1
CCTCTAAGGCATTTATTTACTGACAA

2918532/clone_end = 3′

CATAAAATCTTGAACCCCAGGTCA

5979
db mining
Hs.257679
AW467385
7037491
he10d12.x1 cDNA, 3′ end/clone =
−1
TCACCTCCATCAACTTACTAGCACAT

2918815/clone_end = 3′

AAAGGGTGGGATTTCATGTGTTGA

5980
Table 3A
Hs.257880
AW487400
7037506
he10f11.x1 cDNA, 3′ end/clone =
−1
CTGGCAAAGGCATGGGTACAACCTG

IMAGE: 2918637/clone_end = 3′

CTCTGTGATCTACCTTCTGAACCAC

5981
db mining
NA
AW487421
7037527
he17b02.x1 NCI_CGAP_CML 1
−1
ACACCTGTGGTATATTTGTATCATTCA

cDNA clone IMAGE: 2919243 3′

GTCTGGTTTCTCACCCTTCCTAA

similar to contians Alu repetitive

element; con

5982
Table 3A
NA
AW487437
7037543
he17d05.x1 NCI_CGAP_CML 1
−1
AACCCTCGTAAGGTTTCATCTTCCTT

cDNA clone IMAGE: 2919273 3′

GATTGCAAAATGAGTTTGTGTGAA

mRNA sequence

5983
db mining
NA
AW467445
7037551
he17e08.x1 NCI_CGAP_CML 1
−1
CCCGCTTCACCTTCCCTAAATAACTC

cDNA clone IMAGE: 2919302 3′

GTTTGCAGGCTAATTCCATCAAAT

similar to contains element MSR1

repetitive el

5984
db mining
NA
AW487448
7037554
he17l02.x1 NCI_CGAP_CML 1
−1
ATTTTGCTCATTACCTGTCAGGAGAA

cDNA clone IMAGE: 2919291 3′

AACCCTCCTTCCCCAGTCTCCACT

similar to contians Alu repetitive

element; con

5985
Table 3A
Hs.257687
AW467501
7037607
he19e06.x1 cDNA, 3′ end/clone =
−1
ACCTACTGAATCTCCAGATTGCCAAG

IMAGE: 2919490/clone_end = 3′

TGAAACACAATGGTTGCCTCTTCA

5986
db mining
Hs.257688
AW467571
7037677
he21l02.x1 cDNA, 3′ end/clone =
−1
TGCGAAAGCTAATTCCCTAGTATGAA

IMAGE: 2919675/clone_end = 3′

TAAACTTCAGACCTTGCTCTCCTT

5987
db mining
Hs.257690
AW467582
7037688
602497524F1 cDNA, 5′ end/
−1
AGCCTGAGGTGGGTGAAGAAAATAC

clone = IMAGE: 4611316/

CTGCTTTATACTGTTCTGGAAACTC

clone_end = 5′

5988
db mining
Hs.266387
AW467607
7037713
he22c05.x1 cDNA, 3′ end/clone =
−1
CTTTTCCCCTTCATGGTAGTTGCTGC

IMAGE: 2919752/clone_end = 3′

TTAAGTTTCTCTAACATGCCTGCA

5989
Table 3A
Hs.257695
AW467746
7037776
he23d05.x1 cDNA, 3′ end/clone =
−1
TGAATGTGCAGATGCAGAACCCATTG

IMAGE: 2919849/clone_end = 3′

ATATGGAGGGCTGAGTGTCTGAAA

5990
Table 3A
Hs.257705
AW467863
7037969
he27c04.x1 cDNA, 3′ end/clone =
−1
TGTACTACTTATTTATGTGTAAACCAT

IMAGE: 2920230/clone_end = 3′

ACACAGGGCTAGAAAGGAAGGGAT

5991
Table 3A
Hs.257706
AW467884
7037970
he27c05.x1 cDNA, 3′ end/clone =
−1
TGTAGAATTGCGGAGTAGAAAGACCC

IMAGE: 2920232/clone_end = 3′

TTGAAAGATCATTTGTCCTGTGGT

5992
Table 3A
Hs.257709
AW467992
7038098
he30b01.x1 cDNA, 3′ end/clone =
−1
GCTCAAGTTCCCAGCACCTGGGGAA

IMAGE: 2920489/clone_end = 3′

TTCTAAGCCTGAGGAAGACAAGGTG

5993
db mining
Hs.257713
AW468139
7038245
he32g11.x1 cDNA, 3′ end/clone =
−1
TGTTTTTATGTCCTGAGCAAGCAAATT

IMAGE: 2920772/clone_end = 3′

GCTGCAATTAAAATCACCAATTT

5994
Table 3A
Hs.257716
AW468207
7038313
he34e12.x1 cDNA, 3′ end/clone =
−1
AGGCCTGATATTGAAAGCTTTTGATA

IMAGE: 2920894/clone_end = 3′

CTGAGATCCTATTAATCTCAGATGA

5995
db mining
Hs.257719
AW468316
7038422
he38a05.x1 cDNA, 3′ end/clone =
−1
TGTTAGTTTGCTTTTGAAATTCTTTGG

IMAGE: 2921072/clone_end = 3′

AGGGTACTCTTCAGGGCTTCACA

5996
db mining
Hs.278060
AW488430
7038538
he37h10.x1 cDNA, 3′ end/clone =
−1
TAGTGATTATCTCCAGGAATCAAGTA

IMAGE: 2921251/clone_end = 3′

CAAACTTTGAAAAAAGACTGGAGGT

5997
Table 3A
Hs.257727
AW488431
7038537
he37h11.x1 cDNA, 3′ end/clone =
−1
TTGTCCCAAGGGCTCAGACTGAAAG

IMAGE: 2921253/clone_end = 3′

AATGCAATGTGAGAGGTATGCCAC

5998
db mining
Hs.330268
AW468459
7038565
he38d05.x1 cDNA, 3′ end/clone =
−1
TCTGTGAAAATCTTTCTGCAAATGTCT

IMAGE: 2921289/clone_end = 3′

TTGCTTGCTTGTACTCACGTTTT

5999
db mining
Hs.257738
AW468559
7038665
he41a07.x1 cDNA, 3′ end/clone =
−1
TGTCTTTAACGCACAGATGTTACTTC

IMAGE: 2921556/clone_end = 3′

AGCACCACAAGGACTGTTGATGGA

6000
Table 3A
Hs.257743
AW488621
7038727
he42e03.x1 cDNA, 3′ end/clone =
−1
CAGTCAGATGTTGGAATTGGGGGTA

IMAGE: 2921692/clone_end = 3′

GAGGGATTATAGAGTTGTGTGTGCT

6001
Table 3A
Hs.122116
AW469546
7039652
hd19e09.x1 cDNA, 3′ end/clone =
−1
AAAGGAGGGACTATGGCATCAAACA

IMAGE: 2909992/clone_end = 3′

GCCTCTTCAGCACAGTGACACCATG

6002
Table 3A
Hs.80618
AW510795
7148873
hypothetical protein (FLJ20015),
−1
ACCCAGTTTGTGCATAGTTCATGATC

mRNA/cds = (31, 522)

CTCTATAAAACCAGCTTTTGTGGA

6003
Table 3A
Hs.193869
AW512498
7150576
hypothelical protein
−1
CTGTCGGGCTCTGAAGCGAGCTGGT

DKFZp588J1119

TTAGTTGTAGAAGATGCTCTGTTTG

(DKFZp588J1119), mRNA/cds =

(27, 2153)

6004
Table 3A
Hs.42915
AW572538
7237271
ARP2 (actin-related protein 2,
−1
TGGAATGGACTCTTAAAACAATGAAA

yeast) homolog (ACTR2), mRNA/

GAGCATTTATCGTTTGTCCCTTGA

cds = (74, 1258)

6005
Table 3A
Hs.342858
AW572930
7237663
hf17f07.x1 cDNA, 3′ end/clone =
−1
TCACTACCTTCAATTGTTTACAAGGT

IMAGE: 2932165/clone_end = 3′

GGATATGGGCAGGCAACAGATACT

6006
Table 3A
Hs.325991
AW573211
7237944
602679187F1 cDNA, 5′ end/
−1
CTAGGCCGGATGGGCCAGAGAAGGA

clone = IMAGE: 4812093/

GAACCATGGCAGGAGCCGGAAGCAG

clone_end = 5′

6007
db mining
Hs.258933
AW589231
7276337
he27g09.x1 cDNA, 3′ end/clone =
−1
AAATGTTGAGCAACTGTTCAAAT

IMAGE: 2920288/clone_end = 3′

AACAGCACTAATTGTGTGTTCATT

GGCT

6008
Table 3A
Hs.304925
AW592876
7280068
hg04d05.x1 cDNA, 3′ end/clone =
−1
CTGGCACATCCAGGTTTTAGAGCAGG

IMAGE: 2944617/clone_end = 3′

CAGCCTGAGATTTCAAAAATGAGG

6009
Table 3A
Hs.298654
AW614181
7319367
hg77d03.x1 cDNA, 3′ end/clone =
−1
GGAGCGGAATACAGTAAAAGCACTG

IMAGE: 2951621/clone_end = 3′

GACTGACCTAAGAGTTTGTTTCTGC

6010
Table 3A
Hs.259842
AW614193
7319379
cDNA FLJ11025 fis, clone
−1
ACACCATTTCAGCGTTGGATCACAGA

PLACE 1003968, moderately

CAGCTCTTCCTTTATATCCCAGCA

similar to 5′-AMP-ACTIVATED

PROTEIN KINASE, GAMMA-1

SUBUNIT/cds = (159, 1145)

6011
Table 3A
Hs.342967
AW629176
7375966
802819939F1 cDNA, 5′ end/
−1
CCACCTTGCTGCCTTTTGAAACACTC

clone = IMAGE: 4745649/

AGGAAATATAGTTGGCTAAAACTG

clone_end = 5′

6012
Table 3A
Hs.140720
AW629485
7376275
FRAT2 mRNA, complete cds/
−1
CACTTCGCAACGGAGTGTTTGAAATT

cds = (129, 830)

GTGGTGGTCCTGATTTATAGGATT

6013
db mining
Hs.175437
AW771958
7704007
hn88h09.x1 cDNA, 3′ end/clone =
−1
GCTTTGGCAGATGGATTAACCTTGTT

IMAGE: 3032897/clone_end = 3′

CTTTTGGAGCCAGATCAATATCTA

6014
Table 3A
Hs.151393
AW778854
7793457
glutamate-cysteine ligase catalytic
−1
AGAATGCCTGGTTTTCGTTTGCAATT

subunit (GCLC), mRNA/cds = (92,

TGCTTGTGTAAATCAGGTTGTAAA

2005)

6015
Table 3A
Hs.109441
AW780057
7794660
cDNA FLJ14235 fis, clone
−1
TTCTGAACATTTTAGTCAAGCTACAAC

NT2RP4000167/cds = (62, 2172)

AGGTTTGGAAAACCTCTGTGGGG

6016
Table 3A
Hs.343475
AW873028
8007081
601556208T1 cDNA, 3′ end/
−1
TGCAAGTGGATGGTTTGGTATCACTG

clone = IMAGE: 3826392/

TAAATAAAAAGAGGGCCTGGGAAA

clone_end = 3′

6017
Table 3A
Hs.166338
AW873324
8007377
hl92e07.x1 cDNA, 3′ end/clone =
−1
GTGGCTTTTCTGTTGACGCCAAAGGT

IMAGE: 3009396/clone_end = 3′

TACTCCCTCTGCCTCACCATAAAA

6018
Table 3A
Hs.90960
AW873326
8007379
602563938F1 cDNA, 5′ end/
−1
ACCTCCTACGTCTGTTTTCTGGCTGT

clone = IMAGE: 4688769/

GGTGACTTGGGATTTTTAACCTTA

clone_end = 5′

6019
Table 3A
Hs.120243
BE044364
8361417
gamma-parvin (PARVG), mRNA/
−1
ATCGTTGGATTATCTTTGAACCCCCT

cds = (0, 995)

TGTGTGGATCATTTTGAGCCGCCT

6020
db mining
Hs.157489
BE047166
8364219
602462536F1 cDNA, 5′ end/
−1
AGCTCCAAAGTGGTTTGATGACCACA

clone = IMAGE: 4575393/

GGCTAAAATTCATAGTCTTAAAAT

clone_end = 5′

6021
Table 3A
Hs.82316
BE049439
8366494
interferon-induced, hepatitus C-
−1
TCAGAAAGGAGAAAACACAGAC

associated microtubular aggregate

CAAAGAGAAGTATCTAAGACCAAA

protein (44kD) (MTAP44),

GGGA

mRNA/cds = (0, 1334)

6022
Table 3A
Hs.121587
BE217848
8905166
602637362F1 cDNA, 5′ end/
−1
GCATCACGATTTGTCTACATAAGTCC

clone = IMAGE: 4765191/

AGTTCATCTCGCGTTTGTTTTGGC

clone_end = 5′

6023
Table 3A
Hs.5734
BE218938
8906256
meningloma expressed antigen 5
−1
ATACAGGGTTCCATCCAGAAAGCATT

(hyaluronidase) (MGEA5), mRNA/

CAGTCAGAGCAAGTTAAAGTCAGT

cds = (395, 3145)

6024
Table 3A
Hs.203772
BE220869
8908187
FSHD region gene 1 (RFG1),
−1
AAGTGCCAGATTTTGATAATCACCAG

mRNA/cds = (191, 967)

CCTCTCATTCAACTCCTATGTTGC

6025
Table 3A
Hs.73931
BE220959
8908277
major histocompatibility complex,
−1
ACCCTTGGTCACTGGTGTTTCAAACA

class II, DQ beta 1 (HLA-DQB1),

TTCTGGCAAGTCACATCAATCAAG

mRNA/cds = (57, 842)

6026
Table 3A
Hs.128675
BE222032
8909271
hr61g11.x1 cDNA, 3′ end/clone =
−1
AGCTCTGGAGCCTTTGCTTCCTCAAA

IMAGE: 3133028/clone_end = 3′

TACGAGCGGGAACTGCGTTGAGCG

6027
Table 3A
Hs.167988
BE222301
8909619
neural cell adhesion molecule 1
−1
AAGTTGTCCTGTGCTAAAGCAAGCGT

(NCAM1), mRNA/cds = (201,

GGGATGATCCTACCTACCTCTAGG

2747)

6028
Table 3A
Hs.79914
BE222392
8909710
lumican (LUM), mRNA/cds =
−1
ATTTGGACAGATGCAGAAGGAACTGT

(84, 1100)

TAGTGAGTCAAGACAAACACATCT

6029
Table 3A
Hs.99237
BE326857
9200633
hr65h06.x1 cDNA, 3′ end/clone =
−1
CCCCTACCCCTGGAAAGTAATATACT

IMAGE: 3133403/clone_end = 3′

GAAGTCTCATCATACTGTTTTGGG

6030
Table 3A
Hs.83623
BE328818
9202594
nuclear receptor subfamily 1,
−1
TGTTTCGTAAATTAAATAGGTCTGGC

group I, member 3 (NR1I3),

CCAGAAGACCCACTCAATTGCCTT

mRNA/cds = (272, 1318)

6031
Table 3A
Hs.27774
BE348809
9260662
602386841F1 cDNA, 5′ end/
−1
AGCTAGTGATGTTTTGTCCAAAGGAA

clone = IMAGE: 4515730/

GATTCTGACAACAGCTTCAGCAGA

clone_end = 5′

6032
Table 3A
NA
BE348955
9260808
hs91h01.x1 NCI_CGAP_Kid13
−1
ACACAGACATATTGACCGCACACAAC

cDNA clone IMAGE: 3144625 3′,

ACTGAAATGGACTGACTTGAGAAA

mRNA sequence

6033
Table 3A
Hs.56156
BE349148
9261067
601463367F1 cDNA, 5′ end/
−1
TGGTTCTCTGATTTGTAATGAGCACC

clone = IMAGE: 3866512/

TGGATATGTCAATTAAAATGCCCA

clone_end = 5′

6034
Table 3A
Hs.315050
BE351010
9262791
hl22g04.x1 cDNA, 3′ end/clone =
−1
GGTCCATGTCACCGTGAGTACACCC

IMAGE: 3147510/clone_end = 3′

CTATGATTGGTTTGTTGTCAAGAAG

6035
Table 3A
Hs.5027
BE379724
9325089
601159415T1 cDNA, 3′ end/
−1
TGCTAGTTCAGGTCCTCCAGGCATTG

clone = IMAGE: 3511107/

ATTTGTACAGTTAAACTCCGAGTG

clone_end = 3′

6036
Table 3A
Hs.86437
BE464239
9510014
602411368F1 cDNA, 5′ end/
−1
ACAAGCATTTAGATCATAACATGGTA

clone = IMAGE: 4540096/

AAGCCTATTACCAGCCAATGTTGT

clone_end = 5′

6037
Table 3A
Hs.127426
BE466500
9512198

Homo sapiens, Similar to homeo
−1
GGCCTACTGACCAAATTGTTGTGTTG

box A9 clone MGC: 19648

AGATGATATTTAACTTTTTGCCAA

IMAGE: 2987818, mRNA,

complete cds/cds = (62, 880)

6038
Table 3A
Hs.21812
BE467470
9513245
AL562895 cDNA/clone =
−1
AAGTTTGTGCAGCACATTCCTGAGTG

CS0DC021YO20-(3-prime)

TACGATATTGACCTGTAGCCCAGC

6039
Table 3A
Hs.122575
BE502248
9704854
endotheilial differentation,
−1
CGATAGAATTGAAGCAGTCCACGGG

lysophosphatidic acid G-protein-

GAGGGGATGATACAAGGAGTAAACC

coupled receptor, 4 (EDG4),

mRNA/cds = (6, 1061)

6040
Table 3A
Hs.279522
BE502919
9705327
hz81b08.x1 cDNA, 3′ end/clone =
−1
ATAGACTCCAAAGAGGCGTTAAGCAC

IMAGE: 3214359/clone_end = 3′

CTGGTTTTCCTTTGGCTCAGAAAA

6041
Table 3A
Hs.197766
BE502992
9705400
clone 23932 mRNA sequence/
−1
CTCAAACGAAATTGGGCAGGCCATTT

cds = UNKNOWN

GCGTGGTTTCTCTGGATAAGTTCC

6042
Table 3A
Hs.61426
BE550944
9792636
602329933F1 cDNA, 5′ end/
−1
GCACATGACAGTAAGCGAGGTTTTGG

clone = IMAGE: 4431248/

GTAAATATAGATGAGGATGCCTAT

clone_end = 5′

6043
Table 3A
Hs.201792
BE551203
9792895
7b55h12.x1 cDNA, 3′ end/clone =
−1
TCCCAGAGTAACTGACAGTATCAAAT

IMAGE: 3232199/clone_end = 3′

AGCAAGAGAGTTAGGATGAGGACT

6044
Table 3A
Hs.122655
BE551867
9793559
hypothetical protein MGC14425
−1
ACACAGGAACCGCTTACCCACCAGCT

(MGC14425), mRNA/cds = (318,

CTGCCCGCGTCTCTACCGCCATAG

686)

6045
Table 3A
Hs.282091
BE552131
9793823
hw29b05.x1 cDNA, 3′ end/clone =
−1
TTCTTCCAAGAGAATAACCCTATTAAA

IMAGE: 3184305/clone_end = 3′

GGCTAAAAATGGAAGCTCCCAGT

6046
Table 3A
Hs.146381
BE613237
9894834
RNA binding motif protein, X
−1
ACTGACCTAGCAGATGTGTGGAAAAG

chromosome (RBMX), mRNA/

GAATCAGATCTTGATTCTTCTGGG

cds = (11, 1186)

6047
Table 3A
Hs.4310
BE614297
9895894
eukaryotic translation initiation
−1
ACAACTCAAGTGAAAAGATGTCTCCA

factor 1A (EIF1A), mRNA/cds =

GTTTCTGAAGATAACGCACGCTGA

(207, 641)

6048
Table 3A
Hs.198802
BE621611
9892551
601493754T1 cDNA, 3′ end/
−1
CGCCGACTCGTTGAAAGTTTTGTTGT

clone = IMAGE: 3895836/

GTAGTTGGTTTTCGTTGAGTTCTT

clone_end = 3′

6049
Table 3A
Hs.324481
BE646433
9970744
EEST 380617 cDNA
−1
CACCCACCTGGTAGGAAGGTCAATCT

TATGCTCAGAAGTCCCACCCACCA

6050
db mining
Hs.283165
BE646441
9970752
7e86h06.x1 cDNA, 3′ end/clone =
−1
CAACTCCTTAAAGGGTTGAAGGTTGT

IMAGE: 3292091/clone_end = 3′

GACAATAACTGAGGGAACTGATGT

6051
Table 3A
Hs.341573
BE6466470
9970781
tc38c11.x1 cDNA, 3′ end/clone =
−1
AAAACACTCCACCTAAAAGCAG

IMAGE: 2066900/clone_end = 3′

GAAAGATGGCAATTCTAAATAGCA

GCTA

6052
db mining
Hs.283166
BE646492
9970803
7e87g01.x1 cDNA, 3′ end/clone =
−1
GGAGGTTTTGATCGTGACTTTATTTT

IMAGE: 3292178/clone_end = 3′

GAGATATTGTATCTTTGTTAGTATTGC

6053
Table 3A
Hs.187872
BE646499
9970810
7e87h02.x1 cDNA, 3′ end/clone =
−1
TTGTAAGGTTCCGGGGAACTGACTCA

IMAGE: 3292179/clone_end = 3′

ACATGGTTCTCCAACTCGAGGTTG

6054
db mining
Hs.283167
BE646510
9970821
7e88b08.x1 cDNA, 3′ end/clone =
−1
TGTGAGTGTTATAGGTTACAGTGGAT

IMAGE: 3292215/clone_end = 3′

TCCAAACTAGCCACAAGTGAAGCA

6055
db mining
Hs.283168
BE646569
9970880
7e89c01.x1 cDNA, 3′ end/clone =
−1
TCAGCCAGGAGGAAAAGCACTCTGAT

IMAGE: 3292320/clone_end = 3′

TATGAATTGAGCAGAAGGAAACAA

6056
db mining
Hs.283169
BE646617
9970928
7e91b07.x1 cDNA, 3′ end/clone =
−1
GTTCCCACTCGTTCTTGCCGGAGAAA

IMAGE: 3292501/clone_end = 3′

CCTGCCTTTTCAAGCATAATTCAA

6057
db mining
Hs.225200
BE46840
9970951
7e91f08.x1 cDNA, 3′ end/clone =
−1
GGGTCCAAGATTATTGATTAATTTGG

IMAGE: 3292551/clone_end = 3′

GCACCGCGAGAGCTCGAGTCCCCC

6058
Table 3A
Hs.129192
BE670584
10031125
7e36h08.x1 cDNA, 3′ end/clone =
−1
GACCACCTGTAAAGCAAGTCCTTTCA

IMAGE: 3284607/clone_end = 3′

AGTTTCACTGCACATCCCAAACCA

6059
Table 3A
Hs.75703
BE670804
10031345
small inducible cytokine A4
−1
TGGTCCACTGTCACTGTTTCTCTGCT

(homologous to mouse Mip-1b)

GTTGCAAATACATGGATAACACAT

(SCYA4), mRNA/cds = (108, 386)

6060
Table 3A
Hs.195374
BE671815
10032445
7a47c12.x1 cDNA, 3′ end/clone =
−1
AGACTCTGGAAAAGGAGGGTCGGAG

IMAGE: 3221878/clone_end = 3′

TATTAAACTGGCTGGGAATGAGAGG

6061
Table 3A
NA
BE672733
10033274
7b75g07.x1 NCI_CGAP_Lu24
−1
TGAGAGCACACCATAAATTCACAGCA

cDNA clone IMAGE: 3234108 3′

GGAATAAACGAAGACACACGAGCA

similar to TR: O99231 O99231

CYTOCHROME OXIDASE

6062
Table 3A
Hs.77542
BE673364
10033905
602629438F1 cDNA, 5′ end/
−1
ACATTCTCTCATTTTGCTGAAGCTGAT

clone = IMAGE: 4754432/

TTGATTGGGTGTCTGTTTCTCGC

clone_end = 5′

6063
Table 3A
Hs.66357
BE673759
10034300
7d69d02.x1 cDNA, 3′ end/clone =
−1
TGAGAAGGTAAAGTAGAAAGGGAAG

IMAGE: 3278211/clone_end = 3′

ATGATGAGTGAACAATAAGCCTTGT

6064
db mining
Hs.283248
BE674662
10035284
7e93g03.x1 cDNA, 3′ end/clone =
−1
ACATTATTCCATGGGAATAAGTCATC

IMAGE: 3292758/clone_end = 3′

AGTGCAAAGGACTGTAAGGAGTGC

6065
Table 3A
Hs.88845
BE674685
10035307
AV733781 cDNA, 5′ end/
−1
CGCCGCTCCTGGAGACCTGATAACTT

clone = cdAASF08/clone_end = 5′

AGGCTTGAAATAATTGACTTGTCT

6066
Table 3A
Hs.171120
BE674709
10035331
7e94105.x1 cDNA, 3′ end/clone =
−1
TGTATGTGCAATATGCTTATGGGTAA

IMAGE: 3292833/clone_end = 3′

TTATGGGCAAGAGAAATGGAAACA

6067
db mining
Hs.283249
BE674713
10035335
7e94g02.x1 cDNA, 3′ end/clone =
−1
ACCCCTTGGTAAAGCAGTTGTAAGAA

IMAGE: 3292850/clone_end = 3′

TTAAACAAGAGGAATTGCTCTTTC

6068
Table 3A
Hs.167208
BE674762
10035230
7e98d05.x1 cDNA, 3′ end/clone =
−1
AAATCAGGCCCCTTGCGCCATTCACA

IMAGE: 3293193/clone_end = 3′

AAAATCCTTGTGAGATGACTCAAG

6069
db mining
Hs.283247
BE674807
10035275
7e93d11.x1 cDNA, 3′ end/clone =
−1
AGGGCAGAGGTCCTTTGGGAGGGTA

IMAGE: 3292725/clone_end = 3′

AGCTCACAAAAACTCAGGGAGGCAG

6070
Table 3A
Hs.174010
BE674902
10035443
7e97a04.x1 cDNA, 3′ end/clone =
−1
TCATCTCCGCCAAGGTTCCCACTAGG

IMAGE: 3293070/clone_end = 3′

CAGGAAAGGATTTTTATCTAAAGT

6071
Table 3A
Hs.174144
BE674951
10035492
7e97g10.x1 cDNA, 3′ end/clone =
−1
CCACCCAAGTCGGAATCCGAGTGAA

IMAGE: 3293154/clone_end = 3′

ATAAATAGCATCGCCCGCCAACTAC

6072
Table 3A
Hs.190065
BE874984
10035505
7f11b09.x1 cDNA, 3′ end/clone =
−1
AGGCACACGATTGTCACCATTTCTCC

IMAGE: 3294329/clone_end = 3′

CTTTACAAGCTGTATAATCAGTAA

6073
Table 3A
Hs.211826
BE875092
10035633
7f02d07.x1 cDNA, 3′ end/clone =
−1
GCAACGTCTGAATGTAGTAATGTGAC

IMAGE: 3293485/clone_end = 3′

TCAGAGCTTCAAAGTAAGCATTCG

6074
db mining
Hs.330706
BE675125
10035668
IL3-UT0114-301100-357-H02
−1
GCCACCCCATCTGGGAGGCCCAGCA

cDNA

TCCAATTCAGTCGCCTTCAATGATT

6075
db mining
Hs.283251
BE875180
10035721
7f03h06.x1 cDNA, 3′ end/clone =
−1
TGATAGACTGGATGCTGCTATGGTAA

IMAGE: 3293827/clone_end = 3′

TCTGCCTCAGGAAAATGCCGGACT

6076
db mining
Hs.339281
BE675338
10035879
HNC29-1-D4.R cDNA
−1
TGGAGCCAAGAAGCCACTGACTCAA

GAGGATTTCAAGCGAGAGCTGCTTG

6077
db mining
Hs.283253
BE675379
10035920
7f08b02.x1 cDNA, 3′ end/clone =
−1
CAACTTTTGTAACAGGGGACTTAGCC

IMAGE: 3294027/clone_end = 3′

GGGGGCAGGAGGGGTTCTTGAGAC

6078
db mining
Hs.283254
BE675403
10035944
7f08d10.x1 cDNA, 3′ end/clone =
−1
ACTTGAAGGCACATCTTCCTTTTGGT

IMAGE: 3294067/clone_end = 3′

TGTTTTCCATCTTCAAATTAAACT

6079
db mining
Hs.283255
BE675434
10035975
7f09a10.x1 cDNA, 3′ end/clone =
−1
TAAAAACTGACATGACATGAGATGGT

IMAGE: 3294138/clone_end = 3′

TTAAGTGTCAAACATAAGGGTCTTT

6080
db mining
Hs.283256
BE675531
10036072
7f10h08.x1 cDNA, 3′ end/clone =
−1
ACTGACATAAGCCCACTTCAGGTGTT

IMAGE: 3294303/clone_end = 3′

TGGAAGACACTAAAGAGAATCAGA

6081
db mining
Hs.315345
BE675610
10038151
7f12g09.x1 cDNA, 3′ end/clone =
−1
GCAGCTTTTTGCTGGCGGGGGTCTA

IMAGE: 3294496/clone_end = 3′

AATAAAGTAGCTTCCCCAAAAGAAA

6082
db mining
Hs.180637
BE875718
10036259
7f14h04.x1 cDNA, 3′ end/clone =
−1
ACCTGGTTATCTCGCAATGACCTAGC

IMAGE: 3294679/clone_end = 3′

TAACACAAATGCAACATCAGCCGG

6083
db mining
Hs.283258
BE675792
10036333
7f18b02.x1 cDNA, 3′ end/clone =
−1
TGATCAAAATGAAGATGCTCCAACCG

IMAGE: 3294795/clone_end = 3′

TATAAATGGCAGATGAAATAGACT

6084
db mining
Hs.283259
BE675819
10036360
7f17d10.x1 cDNA, 3′ end/clone =
−1
GCAGGAGAGAAATACCTTCTAATGGG

IMAGE: 3294931/clone_end = 3′

TGTGGACACTGGAGGAACTGTTAC

6085
db mining
Hs.283261
BE675957
10036498
7f19b06.x1 cDNA, 3′ end/clone =
−1
AGGGCACTGTTTGTTCCTTTAATATG

IMAGE: 3295091/clone_end = 3′

GAGAAATATCGCAAATAACTGGGA

6086
db mining
NA
BE676019
10036560
7f20c12.x1 NCI_CGAP_CLL1
−1
TTGGCCTATGTTAATTTCTATTCTCAG

cDNA clone IMAGE: 3295222 3′

TTCTTCTGTGCCCTTCCTCCTCT

similar to contains Alu repetitive

element; m

6087
Table 3A
Hs.170584
BE676049
10036590
7f21a03.x1 cDNA, 3′ end/clone =
−1
GAACGTAAGCCCGACGCTAGGCAGT

IMAGE: 3295276/clone_end = 3′

GCTGTTAGAAAGTGATTTGGAAGAG

6088
Table 3A
Hs.181015
BE676054
1003695
signal transducer and activator of
−1
ATCCCATTCTCCCTCTCAAGGCAGGG

transcription 6, interleukin-4

GTCATAGATCCTAAGCCATAAAAT

induced (STAT6), mRNA/cds =

(165, 2708)

6089
db mining
Hs.283263
BE676154
10036695
7f24a12.x1 cDNA, 3′ end/clone =
−1
TGCTGTAAAATGGCAGCTCCATAGGA

IMAGE: 3295582/clone_end = 3′

ACCTATTTTCCATAGGAACCTGCA

6090
db mining
Hs.283264
BE676173
10036714
7f24c12.x1 cDNA, 3′ end/clone =
−1
ACTGGAGAAAGGTGTCTTCCTGTCCT

IMAGE: 3295606/clone_end = 3′

TTCAGGGGCTCCTGCGGGGAATTC

6091
Table 3A
Hs.134648
BE676210
10036751
7f25c05.x1 cDNA, 3′ end/clone =
−1
ATTATATTTGTCCCTATCAGAATCCTC

IMAGE: 3295688/clone_end = 3′

GAATCCCTAGCAGCCAGTCCCTG

6092
db mining
Hs.283266
BE676275
10036816
7f26d04.x1 cDNA, 3′ end/clone =
−1
TGCTCACTGTCTTCTGGAAGAGACAA

IMAGE: 3295783/clone_end = 3′

GCACTTTCTTGAAATTCCTAAGCA

6093
Table 3A
Hs.158714
BE676408
10036949
7f29b11.x1 cDNA, 3′ end/clone =
−1
CAATCGGATCATTCTTCTCAACTTGG

IMAGE: 3296061/clone_end = 3′

GCGGCTCTTTCCTCCCTTCCTTCC

6094
Table 3A
Hs.220929
BE676472
10037003
cDNA FLJ14369 firs, clone
−1
TGCTTTGGGCAGTAGCTGAAGCCGA

HEMBA 1001174, highly similar

AGTATGAACAGTCCATTTTGTTTCT

to ADP-RIBOSYLATION

FACTOR-LIKE PROTEIN 5/cds =

(207, 746)

6095
db mining
Hs.283268
BE676474
10037005
7f30c08.x1 cDNA, 3′ end/clone =
−1
CACAGTTGAGTAGGAGGTCATGAAGA

IMAGE: 3296174/clone_end = 3′

AGAAGAGATGATACCTGCCTTACC

6096
db mining
Hs.283269
BE676528
10037069
7f31d12.x1 cDNA, 3′ end/clone =
−1
TTTGTGTAGCAAATGTTCATTAATTGC

IMAGE: 3296279/clone_end = 3′

CTACTTTGTGCCAAATTCAGGCC

6097
Table 3A
Hs.123254
BE676541
10037082
AL572805 cDNA/clone =
−1
TCCAGCATTGTATTGTCTATTGACAC

CS0DI034YHI06-(3-prime)

ACAAAGTTTGAAAATAAAGGGGCA

6098
db mining
Hs.283505
BE676548
10037089
wh79f01.x1 cDNA, 3′ end/clone =
−1
CACCCACCAGACCGAGGATTCCAAAA

IMAGE: 2386969/clone_end = 3′

GGGGGCGAAGGCGGAGAGCAAAGG

6099
db mining
Hs.283270
BE676813
10037154
7f33a08.x1 cDNA, 3′ end/clone =
−1
TGGACTCTGTTTTCAAGAGGAAGAAA

IMAGE: 3296438/clone_end = 3′

CAACTGACAAATAAGTTGATGTCA

6100
db mining
Hs.283271
BE676614
10037155
7f33a10.x1 cDNA, 3′ end/clone =
−1
ATGTTGAAACTGGTTTTAACTTGTAAT

IMAGE: 3298442/clone_end = 3′

GGTGTGGCTGATGTTACCCGACC

6101
db mining
Hs.283272
BE676667
10037208
7f34a07.x1 cDNA, 3′ end/clone =
−1
ACACAGATTTGAAGTCTACTGTTCTA

IMAGE: 3296532/clone_end = 3′

AATGGCCTCTACTTCCTGCTGTCA

6102
db mining
Hs.102165
BE676737
10037278
7f37g03.x1 cDNA, 3′ end/clone =
−1
GGAACTTCTGCTTCCACTTACGATGA

IMAGE: 3296884/clone_end = 3′

AGGAACTTGTACTCAATCCATCCA

6103
db mining
Hs.283276
BE676772
10037313
7f35d05.x1 cDNA, 3′ end/clone =
−1
GAAGCCTTCCTGTGGTCATAACAAGT

IMAGE: 3298849/clone_end = 3′

CTCACACACCCCAAGGACTGATCT

6104
db mining
Hs.86761
BE738569
10152561
601572850F1 cDNA, 5′ end/
−1
GAGTCCAGCCTTTGAACCTGGCGCT

clone = IMAGE: 3839581/

GAATCCTGACTTTACTGCTTATTCA

clone_end = 5′

6105
Table 3A
Hs.293842
BE748883
10162655
601571679F1 cDNA, 5′ end/
−1
AAACTCATACATGCAGAAAATTTG

clone = IMAGE: 3838675/

TCTTTGCTCGAAATGGTAATGCC

clone_end = 5′

AAAA

6106
Table 3A
Hs.293842
BE748663
10162655
601571879F1 cDNA, 5′ end/
−1
AAACTCATACATGCAGAAAATTGTCTT

clone = IMAGE: 3838875/

TGCTCGAAATGGTAATGCCAAAA

clone_end = 3′

6107
Table 3A
Hs.270293
BE857296
10371182
7g27b01.x1 cDNA, 3′ end/clone =
−1
ACAAAAGTCATGGCTGTGAGGCTATC

IMAGE: 3307657/clone_end = 3′

ATTACCCTTTTACCAAAGTTGGAA

6108
Table 3A
Hs.155935
BE858152
10373065
complement component 3a
−1
AGTTCTATTTCTATCCCAAACTAAGCT

receptor 1 (C3AR1), mRNA/cds =

ATGTGAAATAAGAGAAGCTACTTTGT

(0, 1448)

6109
Table 3A
Hs.294348
BE961923
11764299
601655335R1 cDNA, 3′ end/
−1
ATCCCGATGGTGCCCACCGCTATTAA

clone = IMAGE: 3845768/

AGGTTCGTTGTTCCACGATTAAA

clone_end = 3′

6110
Table 3A
Hs.5181
BE962588
11765836
proliferation-associated 2G4,
−1
ATGTCTCCATACCCATTACAATCTCC

38kD (PA2G4), mRNA/cds =

AGCATTCCCCCTCAAACCTAAAAA

(97, 1281)

6111
Table 3A
Hs.314941
BE962883
11766238
602381893F1 cDNA, 5′ end/
−1
GCCCGTATTTACCCTATAGCACCCCC

clone = IMAGE: 4499447/

TCTACCCCCTTTAGAGCCCAAAA

clone_end = 5′

6112
Table 3A
Hs.301110
BE963194
11766612
601656811R1 cDNA, 3′ end/
−1
ACATTTTCCTCCGCATAAGCCTGCGT

clone = IMAGE: 3865731/

CAGATTAAAACACTGAACTGACAA

clone_end = 3′

6113
Table 3A
Hs.330887
BE963374
11788792
601857137R1 cDNA, 3′ end/
−1
CCAAGCTGGTTTCAAGCCAACCCCAT

clone = IMAGE: 3866193/

GGCCTCCATGACTTTTTCCAAAAC

clone_end = 3′

6114
Table 3A
Hs.334926
BE963551
11755970

Homo sapiens, clone MCG: 8857
−1
TGATCAGGTGAACCGGAAGTCTCCAA

IMAGE: 3868266, mRNA,

TTTCTGAATGGATTATGTTTCTAA

complete cds/cds = (62, 133)

6115
Table 3A
Hs.316047
BE963666
11767085
601656685R1 cDNA, 3′ end/
−1
TGAGTACGTGACACTTGTTGTAGAAT

clone = IMAGE: 3865820/

AGTGGTGTTGAGCTATATTCTTGT

clone_end = 3′

6116
Table 3A
Hs.294578
BE963811
11767228
601657482R1 cDNA, 3′ end/
−1
GTGACCCTTGGCACCCGCTAGAAGTT

clone = IMAGE: 3875846/

TATGGCCGAGCTTTACCAATTAAA

clone_end = 3′

6117
Table 3A
Hs.302585
BE964028
11767358
601657601R1 cDNA, 3′ end/
−1
TGAACTCCAACTTTGACCAACCCATG

clone = IMAGE: 3875617/

AGACCCCTGTTATCCAAACTTTCT

clone_end = 3′

6118
db mining
Hs.210628
BE964051
11767519
601472729T1 cDNA, 3′ end/
−1
CCCTCTACTATTTGGCTCCATAACTTA

clone = IMAGE: 3875791/

GGACCTGCCTTTCCCGGTTCCAG

clone_end = 3′

6119
Table 3A
Hs.330588
BE964134
11767602
601151626F1 cDNA, 5′ end/
−1
CCCGTATTTACCCTATAGCACCCCCT

clone = IMAGE: 3507774/

CTACCCCCTTTAGAGCCCCAAAA

clone_end = 5′

6120
Table 3A
Hs.252259
BE964149
11767617
ribosomal protein S3 (RPS3),
−1
CCAACTTTCAGAACAGAAGGGTGGG

mRNA/cds = (22, 753)

AAACCAGAACCGCCTGCCATGCCCC

6121
Table 3A
Hs.184052
BE964596
11768078
PP1201 protein (PP1201), mRNA/
−1
GCGCCAGAAATCCAATCCAGCCCAA

cds = (75, 1010)

GGATATAGTTAGGATTAATTACTTA

6122
Table 3A
Hs.288754
BE965319
11769559
601859229R1 cDNA, 3′ end/
−1
CTGAGTTTTGGGTTTTCCACACGGG

clone = IMAGE: 3895783/

CCAAGATACCCGGCCTCTGCTGAG

clone_end = 3′

6123
Table 3A
Hs.297190
BE965554
11770044
601659486R1 cDNA, 3′ end/
−1
ATATCATTTCCACTTAGTATTATACCC

clone = IMAGE: 3896204/

ACACCCACCCAAGAACAGGGTTT

clone_end = 3′

6124
Table 3A
Hs.108327
BF001438
10701713
damage-specific DNA binding
−1
ACAGCATGAGAAACTGTTAGTACGCA

protein 1 (127kD) (DDB1),

TACCTCAGTTCAAACCTTTAGGGA

mRNA/cds = (109, 3531)

6125
Table 3A
Hs.161075
BF001821
10702098
7g93g02.x1 cDNA, 3′ end/clone =
−1
GCTTGCCCTAGCAGAGTCATACGGAA

IMAGE: 3314068/clone_end = 3′

TAATGGAAAACTCAACTTGTGTTC

6126
Table 3A
NA
BF056055
10809951
7k07h12.x1 NCI_CGAP_GC6
−1
CACAATGCTGCCTCCTCTGTGGATGA

cDNA clone IMAGE: 3443950 3′

CTGATGGCAAGAGTCTGAATTGAA

similar to contains element L1

repetitive eleme

6127
Table 3A
Hs.221695
BF058398
10812294
7k30d01.x1 cDNA, 3′ end/clone =
−1
CCTCTCACTCTCAGACTCCAAGGGCC

IMAGE: 3476785/clone_end = 3′

AAGAAAAACTACGGACAGGAAGCC

6128
db mining
Hs.255664
BF058429
10812325
7k30g11.x1 cDNA, 3′ end/clone =
−1
GAGAGGAGGGGTCTCAGACGTTGGG

IMAGE: 3476949/clone_end = 3′

GGACACACTGCTGGGTGGGTGATTT

6129
Table 3A
Hs.43857
BF058599
10812495
mRNA for KIAA1247 protein,
−1
TAAGAAATCCCAATTTTCAGGAGTGG

partial cds/cds = (285, 2942)

TGGTGTCAATAAACGCTCTGTGGC

6130
Table 3A
Hs.144583
BF059133
108113029

Homo sapiens, clone IMAGE:
−1
CGGCAGGGTGGCCTGTAACAATTTCA

3462401, mRNA, partial cds/cds =

GTTTTCGCAGAACATTCAGGTATT

(0, 153)

6131
db mining
Hs.257697
BF060727
10819637
AL533532 cDNA/clone =
−1
GGGGCTCCCTTCCCGGCTTTGTTTTC

CS0DN004YJ14-(5-prime)

TCTGGGAGATTTTATTTTACCTAA

6132
Table 3A
Hs.193237
BF062295
10821193
7k76b11.x1 cDNA, 3′ end/clone =
−1
GAAAGTGGAGGGAGTGGACGGGGAG

IMAGE: 3481293/clone_end = 3′

GAGACTAGCCAGAGAGGCTCATTAG

6133
Table 3A
Hs.174215
BF062628
10821538
7h62h05.x1 cDNA, 3′ end/clone =
−1
CTTCTCCCCTCTTGCCCTCTGTGGTC

IMAGE: 3320601/clone_end = 3′

TGTTTAAAACGAAAAGGTCGGAT

6134
db mining
Hs.159013
BF063875
10822585
hh82b10.x1 cDNA, 3′ end/clone =
−1
GGACTTCTGAAATAGAGCTGGCTCCC

IMAGE: 2969275/clone_end = 3′

TGGGGTGACAATGTATATATGCAA

6135
Table 3A
Hs.125887
BF109873
10939563
hypothetical protein FLJ14464
−1
CTGGGTGTCGTGGAAGATGACGAAG

(FLJ14484), mRNA/cds = (69,

ATGCTGGGCTGGCAGATGCAGTCCA

3146)

6136
Table 3A
Hs.288443
BF110312
10940002
7n38d08.x1 cDNA, 3′ end/clone =
−1
ACCAGGGCTTAAAACCTCAATTTATG

IMAGE: 3566854/clone_end = 3′

TTCATGACAGTGGGGATTTTTCTT

6137
Table 3A
Hs.250905
BF116224
10985700
hypothetical protein (LOC51234),
−1
ATTCTCCAACCACAAACAGCACTTCT

mRNA/cds = (0, 551)

AAACTAACTTTACTTTCTGCCCA

6138
Table 3A
Hs.318215
BF183507
11061818
60180999R1 cDNA, 3′ end/clone =
−1
GATATAGTCTCCATACCCCATTACCA

IMAGE: 4040470/clone_end = 3′

TCTCCCAGCCATTCCCCCTCCAAC

6139
Table 3A
Hs.96568
BF194880
11081165
602137338F1 cDNA, 5′ end/
−1
TGATACTTTGGTTCTCTTTCCTGCTCA

clone = IMAGE: 4274048/

GGTCCCTTCATTTGTACTTTGGA

clone_end = 5′

6140
Table 3A
Hs.232257
BF195579
11082611
RST2302 cDNA
−1
TAATACTGGAGGGGCTTGAAGAAGG

CTGTCGTGTTTTGTCACCTGCTTTG

6141
Table 3A
Hs.3353
BF197153
11085769
beta-1,3-glucuronyltransferase 1
−1
GTCTTTCCCGTCTTTCTTCCTCACCTA

(glucuronosyltransferase P)

TGTAATTTCAGTAGTCTCTCAGC

(B3GAT1), mRNA/cds = (175,

1179)

6142
Table 3A
NA
BF197762
11087169
7p91f02.x1 NCI_CGAP_Skn1
−1
AGGAAGAGCCTGCACCTGTGGTGGA

cDNA clone IMAGE: 3653139 3′,

ACAATCAGGGAAAAGGAAGTCAAAA

mRNA sequence

6143
Table 3A
Hs.50785
BF221780
11128957
SEC22, vesicle trafficking protein
−1
TTGGAGCTTCTATAGGAGTGGAGAG

(S. cerevisiae)-like 1 (SEC22L1),

GGGCAGCTCATTGTTGAGAGTTGC

mRNA/cds = (119, 766)

6144
Table 3A
Hs.250811
BF432643
11444806
v-ral simian leukemia viral
−1
TGATCTGACTGGAAAACAATCCTGTA

oncogene homolog B (ras related;

TCCCCTCCCAAAGAATCATGGGCT

GTP binding protein) (RALB),

mRNA/cds = (170, 790)

6145
Table 3A
Hs.296356
BF433058
11445221
mRNA; cDNA DKFZp434M162
−1
TCATCCCTTAAACACTCTGTGATGGG

(from clone DKFZp434M162)/

ATCTTCAGGATCATCTTTTGAAGT

cds = UNKNOWN

6146
Table 3A
Hs.76611
BF433353
11445518
601435773F1 cDNA, 5′ end/
−1
TGCGTTTGGTTTAGGAATGTGCTTTT

clone = IMAGE: 3920582/

GTACTTCCACTTGAATAAAGGTGT

clone_end = 5′

6147
Table 3A
Hs.178703
BF433657
11445848
AV716627 cDNA, 5′ end/clone =
−1
TGCTCAGGGCACATGCACACAGACAT

DCBBCH05/clone_end = 5′

TTATCTCTGCACTCACATTTTGTG

6148
Table 3A
Hs.222833
BF435098
11447388
7p05g01.x1 cDNA, 3′ end/clone =
−1
GGTTATTGCTGACACGCTGTCCTCTG

IMAGE: 3645097/clone_end = 3′

GCGACCTGTCGCTGGAGAGGTTGG

6149
Table 3A
Hs.293478
BF435821
11447923
hypothetical protein FKSG44
−1
CGTTTTCTGAGCATCCGTTGTGCCTT

(FKSG44), mRNA/cds = (126,

AACATTTTCTGCTTGTCCTTTGGG

1520)

6150
db mining
Hs.257641
BF436704
11448943
7p07d12.x1 cDNA, 3′ end/clone =
−1
CTTCTGAATGCCCGAGTCTTCTCTTT

IMAGE: 3644999/clone_end = 3′

TGTGCTCACAAATGCCACCCAATC

6151
Table 3A
Hs.160980
BF437585
11449991
7p74d12.x1 cDNA, 3′ end/clone =
−1
TGCTTACAAGGGTGATTGACCTTGCC

IMAGE: 3651526/clone_end = 3′

TTACTCTTTATGTAAATTATGGCA

6152
db mining
Hs.258513
BF437915
11450432
AF150421 cDNA/clone =
−1
CTGGCGTATTACCATTTTGATAGCCT

CBNBCG12

CTCTTCAGGCTAGATAAGCTGGGG

6153
Table 3A
Hs.128594
BF445163
11510224
nad21d12.x1 cDNA, 3′ end/clone =
−1
CCCTGTATTATTGAAATGTCAGCATA

IMAGE: 3368191/clone_end = 3′

ATGACTGGAAGGTGAAATTGGTCC

6154
Table 3A
Hs.174104
BF445405
11510543
601438710F1 cDNA, 5′ end/
−1
ACTGCTGTTGCATGAATAGATGATAC

clone = IMAGE: 3923643/

AAAGCAAGTGATGAGGTTGGTATG

clone_end = 5′

6155
Table 3A
Hs.143389
BF446017
11511155
7p18a11.x1 cDNA, 3′ end/clone =
−1
TGGAAGAACAAATTCAGACATCATCA

IMAGE: 3646004/clone_end = 3′

GTAAGTCTTTAGGGACACAGGGAA

6156
Table 3A
Hs.295726
BF447885
11513023
integrin, alpha V (vitronactin
−1
AGTGAAAACTGGTACAGTGTTCTGCT

receptor, alpha polypeptide,

TGATTTACAACATGTAACTTGTGA

antigen CD51) (ITGAV), mRNA/

cds = (41, 3187)

6157
Table 3A
Hs.179528
BF475501
11548328
upregulated by 1,25-dihydroxy-
−1
GCCAGAAAGTGTGGGCTGAAGATGG

vitamin D-3 (VDUP1), mRNA/

TTGGTTTCATGTTTTTGTATTATGT

cds = (221, 1396)

6158
Table 3A
Hs.181311
BF478236
11549065
asparaginyl-tRNA synthetase
−1
TGTCCTCTGAACCTGAGTGAAGAAAT

(NARS), mRNA/cds = (73, 1719)

ATACTCTGTCCTTTGTACCTGCGT

6159
Table 3A
Hs.179703
BF5077849
11591147
tripartite motif protein 14
−1
CCATTTCCACTACATGCCTTTCCTAC

(TRIM14), mRNA/cds = (10,

CTTCCCTTCACAACCAATCAAGTG

1230)

6160
Table 3A
Hs.159873
BF508053
11591351
UI-H-BI4-apx-b-11-0-UI.s1
−1
ACACTTCCCTGAATGTTGAAGAAGAT

cDNA, 3′ end/clone = IMAGE:

ATGCTATCCATGCAATCCTTGTCG

3088845/clone_end = 3′

6161
Table 3A
Hs.158999
BF508694
11591992
UI-H-BI4-aop-f-09-0-UI.s1
−1
ACTTGTGTTTGAACCACTTCTGCTTC

cDNA, 3′ end/clone = IMAGE:

CTCTTTAACCTGAGATGCACACGT

3085601/clone_end = 3′

6162
Table 3A
Hs.77542
BF508702
11592000
602629438F1 cDNA, 5′ end/
−1
ACATTCTCTCATTTTGCTGAAGCTGAT

clone = IMAGE: 4754432/

TTGATTGGGTGTCTGTTTCTCGC

clone_end = 5′

6163
Table 3A
Hs.127311
BF508731
11592029
AU185774 cDNA/clone =
−1
TGACAGAATGAACTGGAAATGAAATC

B02302-013

CCACAGTTATGATCGTAGTAGAGT

6164
Table 3A
Hs.144265
BF509758
11593056
UI-H-BI4-apg-d-04-0-UI.s1
−1
AAGTACAGATGCCATCCCGGTGCTGT

cDNA, 3′ end/clone = IMAGE:

GATCTTCCAGCCATTCTCCATTTC

3087390/clone_end = 3′

6165
Table 3A
Hs.256931
BF510393
11593891
zb02d05.s1 cDNA, 3′ end/
−1
ACTGCCAATCTGATTTAAAATTCTCCA

clone = IMAGE: 300873/

AGCTTAATTCTGTGCAACAAACA

clone_end = 3′

6166
Table 3A
Hs.276341
BF510670
11593968
UI-H-BI4-aof-b-08-0-UI.s1
−1
GCCTGTTGTTCTGTTTATCGCCCTAT

cDNA, 3′ end/clone = IMAGE:

TTTACAAAACTGATTCTGACCTGG

3084615/clone_end = 3′

6167
Table 3A
Hs.248689
BF512500
11597602
UI-H-BI3-alw-h-10-0-UI.s1
−1
AACTGGCATTGCTAAGCCCCAGAAAA

cDNA, 3′ end/clone = IMAGE:

ATGTATTTAGTGGAACAGATGAAA

3069162/clone_end = 3′

6168
Table 3A
Hs.136375
BF513274
11598453
602544150F1 cDNA, 5′ end/
−1
ACACTAGGTCCTTTTATACCTGTGCC

clone = IMAGE: 4668332/

TTTACGTTCGTTTTCCTGATTGCA

clone_end = 5′

6169
Table 3A
Hs.300870
BF513602
11598781
mRNA; cDNA DKFZp547M072
−1
AATACAGATTCATTTTATTTAAGCGTC

(from clone DKFZp547M072)/

CGTGGCACCGACAGGGACCCCAG

cds = UNKNOWN

6170
Table 3A
Hs.255340
BF514247
11599426
UI-H-BW1-ani-h-09-0-UI.s1
−1
AGTTCATCCCCTTTCAGAAGCTGTTT

cDNA, 3′ end/clone = IMAGE:

GCTCTTGGCTCATTAAACCTGTGA

3082601/clone_end = 3′

6171
Table 3A
Hs.283022
BF514341
11599520
triggering recaptor expressed on
−1
GCCTCTTTTCCTGTATCACACAAGGG

myeloid cells 1 (TREM1), mRNA/

TCAGGGATGGTGGAGTAAAAGCTC

cds = (47, 751)

6172
Table 3A
Hs.83734
BF515538
11600717
syntaxin 4A (placental) (STX4A),
−1
TGTTAGGTGGCCTCTGCATACCTATG

mRNA/cds = (66, 959)

GGAACTCAGTGATGTAATGCAAAG

6173
Table 3A
Hs.146065
BF591040
11683364
AL580165 cDNA/clone =
−1
CTGGGGCCGTAGCAAAAATCATGAAA

CS0DJ005YB18-(3-prime)

AACACTTCAACGTGTCCTTTCAAT

6174
Table 3A
Hs.30941
BF592138
11684462
calcium channel, voltage-
−1
TGCCAAGTCAGCAGATTTGCTTTATG

dependent, beta 2 subunit

AATTACAGGGACTAGAAATGCCCA

(CACNB2), mRNA/cds = (501,

2318)

6175
Table 3A
Hs.695
BF890338
11975746
cystalin B (stefin B) (CSTB),
−1
TTGCATGTCTCTTCCTAAATTTCATTG

mRNA/cds = (96, 392)

TGTTGATTTCTAATCCTTCCCGT

6176
Table 3A
Hs.142838
BF732404
12057407
nuclear protein interacting with
−1
AGAGTGAGAAGGCAGTTCCAGTTTTA

the FHA domain of pIG-87

GCACAGATTTGTTTATGTGTTCAG

(NIFK), mRNA/cds = (54, 935)

6177
Table 3A
Hs.296317
BF938959
12356279
mRNA for KIAA1789 protein,
−1
GAAGTGACACTGACTGTATCTACCCTC

partial cds/cds = (3466, 4899)

TCCTTTTTCTTCATCAGGTGTTCCT

6178
Table 3A
Hs.182937
BF939014
12356334
peptidylpropyl isomerase A
−1
TCCCTGGGTGATACCATTCAATGTCT

(cyclophilin A) (PPIA), mRNA/

TAATGTACTTGTGGCTCAGACCTG

cds = (44, 541)

6179
Table 3A
Hs.28138
BF940103
12357423
hypothetical protein MGC14158
−1
AATTCCAAAGGAGTGATGTTGGAATA

(MGC14156), mRNA/cds = (82,

GTCCCTCTAAGGGAGAGAAATGCA

426)

6180
Table 3A
Hs.133372
BF940291
12357611
AF150127 cDNA/cds =
−1
AGCCCCTCCACCCCACCCAGTACTTT

CBCBGA01

TACAATGTGTTATTAAAGACCCCT

6181
Table 3A
Hs.304900
BF980139
12347354
602288147F1 cDNA, 5′ end/
−1
CCATCCTTGAGAAATGTGGGCACCAA

clone = IMAGE: 4373983/

GTCCATAATCTCCATAAATCCAAT

clone_end = 5′

6182
Table 3A
Hs.303214
BG0546649
12511436
7045b01.x1 cDNA, 3′ end/
−1
CGTTGCATTTTCACATTTGTGTGGCA

clone = IMAGE: 3576912/

GGACAAGCATGGGGCAAGAGGGAC

clone_end = 5′

6183
Table 3A
Hs.8258
BG054966
12512220
cDNA FLJ14737 fls, clone
−1
TATGAGTTTATGCGTTTTCCCAGCCC

NT2RP3002273, weakly similar to

TCCGAATCACTGACTGGGGCGTTT

SCD8 PROTEIN/cds = (77, 1468)

6184
Table 3A
Hs.179661
BG056668
12521375

Homo sapiens, tubulin, beta 5,
−1
TTGAAAAGATGACATCGCCCCAAGAG

clone MGC: 4029 IMAGE:

CCAAAAATAAATGGGAATTGAAAA

3817988, mRNA, complete cds/

cds = (1705, 3039)

6185
Table 3A
Hs.56205
BG057282
12522612
insulin induced gene 1 (INSIG1),
−1
TGCACTCTACCAGATTTGAACATCTA

mRNA/cds = (414, 1247)

GTGAGGTTCACATTCATACTAAGT

6186
Table 3A
Hs.3709
BG057892
12523835
low molecular mass ubiquinone-
−1
TGGTGATATCTGCTTAGATTTCCCTG

binding protein (9.5kD) (QP-C),

TATCTTTGCTGCCCTCCTTCAAGT

mRNA/cds = (77, 358)

6187
Table 3A
Hs.5122
BG058599
12525258
602293015F1 cDNA, 5′ end/
−1
AGTTGGAGCTATCTGTGCAGCAGTTT

clone = IMAGE: 4387778/

CTCTACAGTTGTGCATAAATGTTT

clone_end = 5′

6188
Table 3A
Hs.89104
BG058739
12525527
602590917F1 cDNA, 5′ end/
−1
CGTGGGAGGATGACAAAGAAGCATG

clone = IMAGE: 4717348/

AGTCACCCTGCTGGATAAACTTAGA

clone_end = 5′

6189
Table 3A
Hs.166962
BG149747
12661777
phosphatidylinositol glycan,
−1
GTGGTTTGGTCAGCATACACACTTCT

class F (PIGF), mRNA/cds = (67,

CATTTCATTTGATGTACACAGCCA

726)

6190
Table 3A
Hs.100293
BG149988
12662016
O-linked N-acetylglucosamine
−1
ACCTGGGATTTCATTTCTGCTGAAAG

(GlcNAc) transferase (UDP-N-

AAATAGGAAGAACAGGACTCACTT

acetylglucosamine: polypeptide-N-

acetylglucosaminyl transferase)

(OGT), mRNA/cds = (2039,

4801)

6191
Table 3A
Hs.198427
BG150273
12662303
hexokinase 2 (HK2), mRNA/
−1
GGGTGTGATGAATAGCGAATCATCTC

cds = (1490, 4243)

AAATCCTTGAGCACTCAGTCTAGT

6192
Table 3A
Hs.313810
BG150461
12662491
7k01d08.x1 cDNA, 3′ end/
−1
AGCTTTCACCACCTCGCAGTTGTAGA

clone = IMAGE: 3443006/

GATAGTCCCCGAAATATTATTCCA

clone_end = 3′

6193
Table 3A
Hs.184456
BG230563
12725596
hypothetical protein (LOC51249),
−1
GTGTGAAGTGACAGCCTTGTGTGTGA

mRNA/cds = (0, 611)

TGTTTTCTGCCTTCCCCAAGTTTG

6194
Table 3A
Hs.89104
GB231557
12726664
602590917F1 cDNA, 5′ end/
−1
TTGTTTTAACAACTCTTCTCAACATTT

clone = IMAGE: 4717348/

TGTCCAGGTTATTCACTGTAACCA

clone_end = 5′

6195
Table 3A
Hs.152925
BG231805
12726934
mRNA for KIAA1268 protein,
−1
TAAGTGGATTGGCAGACTCCTTGTTG

partial cds/cds = (0, 3071)

CTTAAGAGTGGCTTTCTAGGCAGG

6196
Table 3A
Hs.89104
BG231961
12727100
602590917F1 cDNA, 5′ end/
−1
TTGTTTTAACAACTCTTCTCAACATTT

clone = IMAGE: 4717348/

TGTCCAGGTTATTCACTGTAACCA

clone_end = 5′

6197
Table 3A
Hs.337986
BG235942
12749789

Homo sapiens,

−1
GCCAGTCTCTATGTGTCTTAATCCCT

clone MGC: 17431 IMAGE:

TGTCCTTCATTAAAAGCAAAACTA

2984883, mRNA, complete cds/

cds = (1336, 1494)

6198
Table 3A
Hs.3353
BG236015
12749882
beta-1,3-glucuronyltransferase 1
−1
GTCTTTCCCGTCTTTCTTCCTCACCTA

(glucuronosyltransferase P)

TGTAATTTCAGTAGTCTCTCAGC

(B3GAT1), mRNA/cds = (175,

1179)

6199
Table 3A
Hs.75703
BG238084
12749931
small inducible cytokine A4
−1
GGTCCACTCTCACTCTTTCTCTGCTG

(homologous to mouse Mip-1b)

TTGCAAATACATGGATAACACCGT

(SCYA4), mRNA/cds = (108, 386)

6200
db mining
Hs.5146
D19756
500072
HUMGS00712 cDNA, 3′ end/
−1
CATTCAGTATTTATTGGGAAGACTTG

clone = mm0970/clone_end = 3′

TCAAGCACCATGATAAGTGGTGGA

6201
db mining
Hs.237971
D19770
500086
hypothetical protein MGC5627
−1
AGAGGGGGAAGGACTTACATGACAT

(MGC5627), mRNA/cds = (72,

CCTACTGGGAATTTGCTAGAAACCA

584)

6202
db mining
Hs.30709
D20225
501322
HUMGS01199 cDNA, 3′ end/
−1
CTGGTGAAGCTGACTCCCCAGGTAAA

clone = pm0880/clone_end = 3′

GAGATATCAGCTCTGCTTCAGACT

6203
db mining
Hs.30731
D20378
501474
HUMGS01352 cDNA, 3′ end/
−1
TTGCTTCTTCCTGCTTTATAGAGTTCC

clone = pm2943/clone_end = 3′

CGTAAAATACCCTTCACCCTGGC

6204
db mining
NA
D20425
501521
HUMGS01399 Human
−1
TCTGACCTCCGTGACGTTTATTACCA

promyelocyte cDNA clone pm1261

GCTGATGTCCCGTACACTGATTTCA

3′, mRNA sequence

6205
db mining
Hs.229071
D20458
501554
HUMGS01432 cDNA, 3′ end/
−1
GGGAAGGGTCAGCAACGATTTCTCA

clone = pm1542/clone_end = 3′

CCAAATCACTACACAGACACAAAGG

6206
db mining
Hs.330221
D20465
501581
HUMGS01439 cDNA, 3′ end/
−1
ACCACTAAATGGTTACACTACACCAA

clone = pm2194/clone_end = 3′

GACACTAAAATGGCAGGGAGCCCT

6207
db mining
Hs.92440
D20522
501618
HUMGS01497 cDNA, 3′ end/
−1
AAATTCAAATCACCCTTGATACCCAC

clone = pm1507/clone_end = 3′

TTCTTTCTCCCACCCAAATCTGAT

6208
db mining
Hs.90165
D20538
501634
HUMGS01513 cDNA, 3′ end/
−1
ACCATATCGTGCAAAATGTAATATGG

clone = pm1504/clone_end = 3′

AATTTCCAAACATCAATGAAGGGAT

6209
db mining
Hs.90171
D20572
501668
HUMGS01547 cDNA, 3′ end/
−1
AATAAGTACCGTATATAAACACTTCTC

clone = pm1503/clone_end = 3′

TTTCTCTCCTCCACAATGGCACG

6210
db mining
Hs.30766
D20726
504546
HUMGS01703 cDNA, 3′ end/
−1
AGCATCACTCTTAGAAGAAGCAACTC

clone = mp0664/clone_end = 3′

CTTCCCTTGATTCTGTGTATTTGG

6211
db mining
Hs.5816
D20846
504688
HUMGS01827 cDNA, 3′ end/
−1
TCAACCCAGAATCTATAATGTATGAA

clone = mp0825/clone_end = 3′

ATAAATTAATAGAGAACCCAACAGAT

C

6212
db mining
Hs.30793
D20888
504708
HUMGS01869 cDNA, 3′ end/
−1
AAGGTCTCCATCTAACAGGTAGAGCA

clone = mp0838/clone_end = 3′

GTTGGTGCAGATGAGATGAGCCTG

6213
Table 3A
Hs.292590
D59502
960608
602628588F1 cDNA, 5′ end/
−1
GGTGATGATACCACCTCCAATGAACA

clone = IMAGE: 4751396/

GGGAAGCAAGTTCATCAGTCAACA

clone_end = 5′

6214
Table 3A
Hs.119274
F13765
758015
RAS p21 protein activator (GTPase
−1
AGCTGTTGGGGCTGCACTGAGCTGC

activating protein) 3 (Ins(1,3,4,5)-

AATTTTTAACATGGATTTATAACTT

P4-binding protein) (GAP1|P48P),

mRNA/cds = (46, 2550)

6215
db mining
Hs.238797
H07915
872737
602081681F1 cDNA, 5′ end/
−1
AAGGAATTTGTTTTCCCTATCCTAACT

clone = IMAGE: 4245999/

CAGTAACAGAGGGTTTACTCCGA

clone_end = 5′

6216
db mining
Hs.11307
H09541
874363
RST29274 cDNA
−1
CGCACACATTTTCTGTATGGACAAAT

CCTGGATTGGCTTCGTTATTTGGT

6217
Table 3A
Hs.187908
H69141
1030426
EST375312 cDNA
−1
GGTAATGAAACAATCATCCAGTTAAC

AATCAGCAAGGTTCTTCAGAGCCT

6218
Table 3A
Hs.117005
H71236
1043052
sialic acid binding lg-like lectin 5
−1
TGGAAGAGTGGACTGAAGAAAG

(SIGLEC5), mRNA/cds = (142,

AACTTATACTCTCCCTCCTCTAAAA

1797)

TTGA

6219
Table 3A
NA
H78395
1056484
yu12f03.x1 Soares fetal liver
−1
TCCTGGGCTATTGGCTTTATGATATC

spleen 1NFLS cDNA clone

TTTTGAGAAACAGGATTTTCACTT

IMAGE: 233597 3′ similar to

contains Alu repet

6220
Table 3A
Hs.38864
H80108
1058197
IL0-MT0152-061100-501-e04
−1
ACCTTTTAAGGATGTCTTATTTCCACC

cDNA

CCAACTCTCCACTCCATTTTAGT

6221
Table 3A
NA
H92914
1099242
yl94g03.s1
−1
GAACCTTCAAAACTGTCACTTTGAGT

Soares_pineal_gland_N3HPG

TCCAGAAGAGTCCTTCAGCATCTT

cDNA clone IMAGE: 231988 3′,

mRNA sequence

6222
Table 3A
Hs.2210
L40410
703109
thyroid receptor interactor (TRIP3)
−1
GTATTTGGGCTTCTCCAAGCAGATCA

mRNA, 3′ end of cds/cds = (0,

CGCAGACGACGGTGCTACATTTGA

458)

6223
Table 3A
Hs.2200
L40557
705359
perforin 1 (performing protein)
−1
CAAGCATACTGGTTCTTTCCAAGCTC

(PRF1), mRNA/cds = (0, 1667)

ACTGTTCTCACCACACGGCCCCAC

6224
Table 3A
Hs.198726
M24069
181483
vasoactive intestinal peptide
−1
TCCATATCCATTTCTGACGTTGAACC

receptor 1 (VIPR1), mRNA/cds =

ATTTGACAGTGCCAAGGACTTTGG

(56, 1543)

6225
Table 3A
Hs.132911
N20190
1125145
MR2-OT0079-290500-007-b03
−1
AAGCCTGTTTTTCACTCTAAAAATTCA

cDNA

AGAGGACACGCTAAGAACGATCA

6226
Table 3A
Hs.323950
N23307
1137457
zinc finger protein 6 (CMPX1)
−1
CCTCAGCTTCCAACTCTGATTCCAGG

(ZNF8), mRNA/cds = (1265,

ACAGGATGGAAAACCTTTGGACAG

3361)

6227
db mining
Hs.32250
N30152
1148872
yx81l03.s1 cDNA, 3′ end/clone =
−1
AGTTGTGTTTGCTACTTTAGAAGC

IMAGE: 268157/clone_end = 3′

AGTTGTGTTTGCTACTTTAGAAGC

6228
Table 3A
Hs.44512
N33584
1153983
yv21f11.s1 cDNA, 3′ end/clone =
−1
AACTCACGACAATTGCTACAAAACAC

IMAGE: 243405/clone_end = 3′

CAGGGAGGGGGCTTTTTGTGTTTTT

6229
Table 3A
Hs.3353
N36787
1157929
beta-1,3-glucuronyltransferase 1
−1
GTCTTTCCCGTCTTTCTTCCTCACCTA

(glucuronosyltransferase P)

TGTAATTTCAGTAGTCTCTCAGC

(B3GAT1), mRNA/cds = (175,

1179)

6230
Table 3A
Hs.38218
N39230
1162437
602569369F1 cDNA, 5′ end/
−1
GCCCTGGTATGTATGCCTTTCTCTCC

clone = IMAGE: 4693744/

TACTGTCTAATAGCACCTCGTAAA

clone_end = 5′

6231
Table 3A
Hs.236456
N49836
1191002
602287746T1 cDNA, 3′ end/
−1
AAGAAACCGTGGAAGATACTGGTTTA

clone = IMAGE: 4375067/

TTTCAAATGAGCAGAGTATGTTGT

clone_end = 3′

6232
Table 3A
Hs.114453
N58052
1201942
601880526F1 cDNA, 5′ end/
−1
CCACCTCTTCTGACATGAATGTAGCA

clone = IMAGE: 4109119/

TAAGTTAGCAATCGGTTCTTCCAA

clone_end = 5′

6233
Table 3A
Hs.334731
N58136
1202026

Homo sapiens, clone IMAGE:
−1
AGGTTCCCTTTCAAATAAAGATAAAG

3448308, mRNA, partial cds/cds =

(0, 2353)

6234
Table 3A
Hs.205565
N72600
1229704
za46f08.r1 cDNA, 5′ end/
−1
GGCTGGCCTCATTTTGAAAAGTTAGT

clone = IMAGE: 295623/

ACAATTTTCTTCAGTGCTAACTTG

clone_end = 5′

6235
Table 3A
Hs.256931
N80578
1243279
zb02d05.s1 cDNA, 3′ end/
−1
ACTCCAGAACGTCAGAAATGGTGTAG

clone = IMAGE: 300873/

CAGAATGAATTCTGTTATAAGGAA

clone_end = 3′

6236
Table 3A
Hs.303018
N94511
1266820
zb80g04.s1 cDNA, 3′ end/
−1
CTGTTCGAAAGTTGGAGACTGCCTGT

clone = IMAGE: 309942/

ACCCAGGTTGATAGTCAATTGTTT

clone_end = 3′

6237
db mining
Hs.118964
NM_017660
8923093
hypothetical protein FLJ20085
−1
CCACCTTGAGCGCCTTCTTCTGGTTG

(FLJ20085), mRNA/cds = (82,

GTTGTCATGCAGTTCTCACACATG

655)

6238
Table 3A
Hs.11594
R12665
765741
yl40a04.s1 cDNA, 3′ end/
−1
ACCCTTCCCCTTTTTCATATCCTTTCT

clone = IMAGE: 129294/

TCAAAAATCTAAATGATGTGCCT

clone_end = 3′

6239
db mining
Hs.108082
R40823
821181
602068988F1 cDNA, 5′ end/
−1
AGTTCCAGGAGGTGGTTTTAAATATT

clone = IMAGE: 4067972/

GGATGAAAACTTACAGGCTGTTTT

clone_end = 5′

6240
db mining
Hs.94881
R50838
812740
602387588F1 cDNA, 5′ end/
−1
ACAATACATTTACAAAGCCATCTTTAC

clone = IMAGE: 4516388/

ATGCATTAAACGAGGGCTACAAC

clone_end = 3′

6241
Table 3A
Hs.94881
R50838
812740
602387588F1 cDNA, 5′ end/
−1
ACAATACATTTACAAAGCCATCTTTAC

clone = IMAGE: 4518388/

ATGCATTAAACGAGGGCTACAAC

clone_end = 5′

6242
RG house-
Hs.92004
R52541
814443
HSU55987 cDNA/clone = 39883
−1
GGCCTGAAGAAGGAGATAAGTGTTC

keeping

CATTCGGCAACATAAGAGAAGTTAA

genes

6243
RG house-
Hs.26766
R60313
831008
602270716F1 cDNA, 5′ end/
−1
TCCATCCCAAAGGAGAGCTACTGTAC

keeping

clone = IMAGE: 4359027/

TGACTGTACTTGTGGAATGCAGCG

genes

clone_end = 5′

6244
db mining
Hs.330530
T25714
583034
ESTDIR309 cDNA, 3′ end/
−1
ACCCACCACTCTCAGGACCACCTGAA

clone = CDDIRX9/clone_end =

GGCAGAATAAACCGGATCCTGTTG

3′

6245
db mining
NA
T25727
583047
ESTDIRX51 CD34 +
−1
AAATTGTGTGAGAAGGCTGATAAACG

DIRECTIONAL cDNA clone

TCTGTGGTTTCTCCCTGTGCTATT

CDDIRX51 3′, mRNA sequence

6246
db mining
Hs.7569
T26893
587784
ESTDIR485 cDNA, 3′ end/
−1
GCTGGGCTTCTGCAAAATTATAAAGT

clone = CDDIR465/clone_end =

TGCTTTATTAAATTCATACATGCGG

3′

6247
db mining
Hs.172822
T26903
587794
ESTDIR551 cDNA, 3′ end/
−1
AGCTGATTCATTCATTCTATGTGTGC

clone = CDDIR551/clone_end =

CACTAAATAAAGAGATTGAGCAAGT

3′

6248
Table 3A
Hs.185675
T98171
747516
QV2-EN0098-010201-603-a05
−1
CTTGAAGCTGTGTTGGTGGCCTGTGA

cDNA

CCTTCCAATGCAATCTAGACTGTG

6249
Table 3A
Hs.58066
W72392
1382348
602389077F1 cDNA, 5′ end/
−1
CTCATACACTTCTCAGCCTCAGCACC

clone = IMAGE: 4517875/

TAACCCTCACACAACACTCCAGTA

clone_end = 5′

6250
Table 3A
NA
W86427
1400194
zh81c11.s1
−1
TGAGTATTGTTGTGGGGGCGGGTAT

Soares_fetal_liv-

GTCTGTATATAAATCTGTGCAGCCA

er_spleen_1NFLS_S1 cDNA

clone IMAGE: 416564 3′,

mRNA sequence

6251
Table 1
NA
AA136584
1697794
zn95b02.s1 Stratagene fetal retinal
−1
AACATATCCAGGGGAGGACAAAC

937202 cDNA clone IMAGE:

TCTGGGCTGGACAATGTATCCACA

565899 3′, mRNA sequence

AGGG

6252
Table 1
NA
AA431959
2115667
zw77a03.s1 Soares_testis_NHT
−1
AGAGCAAGTCTCAGAAATAATGCTGT

cDNA clone IMAGE: 782188 3′,

ATCTACACTGTCATGTATTTGCCA

mRNA sequence

6253
Table 1
NA
AA482019
2209697
zu98e04.s1 NCI_CGAP_GCB1
−1
ACCACCAGCTATTTGTAATTCCTTCTT

cDNA clone IMAGE: 746046 3′,

CTAAGGCATAGTGAAAACTTGCT

mRNA sequence

6254
Table 1
NA
AA524720
2265848
ng42e03.s1 NCI_CGAP_Co3
−1
GGACGGTTGGCTGAATGGCAACAGT

cDNA clone IMAGE: 937468 3′,

GATGGAATATTTATATTTAGCCACA

mRNA sequence

6255
Table 1
Hs.57787
AA588755
2402488
602381381F1 cDNA, 5′ end/
−1
AGGTTGTTATCAGGTGGCACAAATTA

clone = IMAGE: 4498845/

AATCCATCTTGAAGACTTCACACA

clone_end = 5′

6256
Table 1
NA
AA628833
2541220
af37g04.s1
−1
GACTCGTTACGCCGTAGTTTGTCCTA

Soares_total_fetus_Nb2HF8_9w

TCTTGTTTATCAAATGAATTTCGT

cDNA clone IMAGE: 1033878 3′,

mRNA sequence

6257
Table 2
Hs.180669
AA633203
2556817
OS-4 protein (OS-4) mRNA,
−1
AGAGCTATGGGTGCTACAGGCTTGTC

complete cds/cds = (305, 1158)

TTTCTAAGTGACATATTCTTATCT

6258
Table 1
Hs.239489
AA639796
2563575
TIA1 cytotoxic granule-associated
−1
ACCCTTATAAACCAGAGCCCAGGAAA

RNA-binding protein (TIA1),

GACAGCTCGAGTGTATAATTCTCT

transcript variant 2, mRNA/cds =

(185, 1345)

6259
Table 1
Hs.29282
AA748714
2788872
mitogen-activated protein kinase
−1
AGCTCCTCCCTCTCAACACCCAGTTT

kinase kinase 3 (MAP3K3),

CCTTGGGAGTTGTCATTAAAGGAA

mRNA/cds = (83, 1983)

6260
Table 1
Hs.111554
AA806222
2874972
ADP-ribosylation factor-like 7
−1
GCTGTAATTCTCTGTCTCATCATCCTT

(ARL7), mRNA/cds = (14, 592)

CTCTTTTGTTTCCATAGCCTTTT

6261
Table 1
NA
AA806766
2875516
ob91d04.s1 NCI_CGAP_GCB1
−1
TCGCTTTCTAACTGATTCCATTCCAC

cDNA clone IMAGE: 1338727 3′,

CATGTCAGATACTCCTGGGCTGCT

mRNA sequence

6262
Table 1
Hs.226755
AA909983
3049273
RC1-UT0033-250800-022-h02
−1
ATCCAAGGTTTAATTCTGCCATCTCA

cDNA

GAATGGTGATAAACCATTTCTCCC

6263
Table 1
Hs.50252
AA984245
3162770
milochondrial ribosomal protein
−1
TCAGCCAACCTGAATCTGGTATCTTT

L32 (MRPL32), mRNA/cds = (46,

ACTTAAACACAGCAGTTGTAGTTA

612)

6264
Table 1
Hs.53542
AI084224
3422647
chorea-acanthocylosis (CHAC)
−1
TCAATAGTTGTGAAATTCTTCTCAGG

mRNA, complete cds/cds = (260,

CTCCTTAAACCCTCGCTTTGTTGT

9784)

6265
Table 1
Hs.135167
AI091533
3430592
AV712376 cDNA, 5′ end/
−1
AGAGGCAACACTTAAACACTAGGGCT

clone = DCAAND12/clone_end =

ACTGTGGCATCTATGTAGACAGGA

5′

6266
Table 1
Hs.11637
AI275205
3897479
602388093F1 cDNA, 5′ end/
−1
TGACTTTCAGGAATGTCAGCATTGAC

clone = IMAGE: 4517086/

CTCTCCTTGCCACTGTTACTCAGC

clone_end = 5′

6267
Table 1
Hs.8724
AI298509
3958245
serine threonine protein kinase
−1
TCTCAAGAGAGAACGCCACAGCAGA

(NDR), mRNA/cds = (595, 1992)

GAGACCCAATCCGCCTAAGTTGCAG

6268
Table 1
Hs.142838
AI299573
3959158
nucleolar protein interacting with
−1
AGAGTGAGAAGGCAGTTCCAGTTTTA

the FHA domain of pKi-67

GCACAGATTTGTTTATGTGTTCAG

(NIFK), mRNA/cds = (54, 935)

6269
Table 1
Hs.100555
AI352690
4089896
DEAD/H (Asp—Glu—Ala—Asp/
−1
GGGGTAGGAAGAGGATGGAATTGAG

His) box polypeptide 18 (Myc-

ATGTTTGAGCCTCATTTACATCAAT

regulated) (DDX18), mRNA/cds =

(71, 2083)

6270
Table 1
Hs.108124
AI362793
4114414
cDNA: FLJ23088 fls, clone
−1
GCTCGCTACCAGAAATCCTACCGATA

LNG07026/cds = UNKNOWN

AGCCCATCGTGACTCAAAACTCAC

6271
Table 1
Hs.134342
AI363001
4114622
mRNA for LanC-like protein 2
−1
GACGCGCACACACCTTGAGTGACAG

(lancl2 gene)/cds = (186, 1538)

CGACCTCTTCTCTACAGGTTTTCCC

6272
Table 1
Hs.192427
AI380016
4189889
602298277F1 cDNA, 5′ end/
−1
ACTTCCCCTTTAGGTATCCCTGGAGT

clone = IMAGE: 4390770/

AATAATGACAACAAAATTCACTGC

clone_end = 5′

6273
Table 2
Hs.158978
AI380390
4190243
UI-H-BI2-ahi-a-03-0-UI.s1
−1
GTCCTTTGATAGCAGAACAAGAGGCT

cDNA, 3′ end/clone = IMAGE:

CTGTGATCCTCTGGACCTCAGATT

2726892/clone_end = 3′

6274
Table 1
NA
AI392705
422252
tg23b03.x1 NCI_CGAP_CLL1
−1
TGCAGGCTCATTGTGCTCCTTCTTCT

cDNA clone IMAGE: 2109581 3′,

GGGTTTCAATTGGATTTCAGTCCT

mRNA sequence

6275
Table 1
Hs.76239
AI393970
4223517
hypothetical protein FLJ20608
−1
GAGGACTGGGACCGTGATTCCACTA

(FLJ20608), mRNA/cds = (81,

ACCGGAAACCGTCGCCTTTCGGGCC

880)

6276
Table 1
Hs.79988
AI419082
4265013
splicing factor 30, survival of
−1
GGATGTGTGATGTTTATATGGGAGAA

motor neuron-related (SPF30),

CAAAAAGCTGATGTATAGCCCTGT

mRNA/cds = (0, 716)

6277
Table 1
Hs.121973
AI458739
4311318
602428025F1 cDNA, 5′ end/
−1
CCTGCAACAGCTAAGGCCAAGCCAA

clone = IMAGE: 4547239/

ACTTACCGTGGACTCAAACACTTTG

clone_end = 5′

6278
Table 1
Hs.342008
AI498318
4390298
UI-H-BI1-aeq-b-02-0-UI.s1
−1
GCCAGAATGGTACAGAGTGGAGGGT

cDNA, 3′ end/clone = IMAGE:

GTTCTGCTAATGACTTCAGAGAAGT

2720186/clone_end = 3′

6279
Table 1
Hs.194054
AI523854
4437989
HA0669 cDNA
−1
GACAAAATAGTTACCTATGCTTTCCTT

CTGGCACCCCGAATGTACGCAGG

6280
Table 1
Hs.14623
AI571519
4534893
interferon, gamma-inducible
−1
AAGCCCAGATACACAAAATTCCACCC

protein 30 (IFI30), mRNA/cds =

CATGATCAAGAATCCTGCTCCACT

(40, 951)

6281
Table 1
Hs.278554
AI627495
4664295
chromobox homolog 3 (Drosophila
−1
TGCTGAAAGTGGTCCCAAAGGGGTA

HP1 gamma) (CBX3), mRNA/

CTAGTTTTTAAGCTCCCAACTCCCC

cds = (111, 682)

6282
Table 1
Hs.17132
AI633798
4885128
602326676F1 cDNA, 5′ end/
−1
GCAACTGTTTTCTAGGACATGTTTAC

clone = IMAGE: 4427970/

TAGAACTACTTTAAGTATGCTGTGC

clone_end = 5′

6283
Table 1
Hs.4283
AI651212
4735191
602621616F1 cDNA, 5′ end/
−1
ACAGTTACTTTGGAGCTGCTAGACTG

clone = IMAGE: 4755315/

GTTTTCTGTGTTGGTAAATTGCCT

clone_end = 5′

6284
Table 1
Hs.324507
AI678099
4888281
hypothetical protein FLJ20986
−1
CGCCAGAGGTCAGAACATGTCTATTT

(FLJ20988), mRNA/cds = (182,

TGAATTGGATCGTTACAAATGAGC

2056)

6285
Table 1
Hs.90744
AI684022
4895316
proteasome (prosome, macropain)
−1
TTCTGACACGATTACACAACGAGGCT

26S subunit, non-ATPase, 11

TTAATGCCATTTGGGTAGGTGAGC

(PMSD11), mRNA/cds = (0, 1268)

6286
Table 1
NA
AI688560
4899854
wd39f08.x1
−1
ACTGAAAAGTTGAAAGACTTTTGCAG

Soares_NFL_T_GBC_S1 cDNA

TGAACATTTATATAACTCCCCCGCT

clone IMAGE: 2330535 3′, mRNA

sequence

6287
Table 1
Hs.177708
AI697756
4985658
602369210F1 cDNA, 5′ end/
−1
TGGTTCCTGTGCTCACCATAGGGCTG

clone = IMAGE: 4477370/

GTGTACATTGGGCCATTAATAAAC

clone_end = 5′

6288
Table 1
Hs.80887
AI701165
4989065
v-yes-1 Yamaguchi saricoma
−1
TCTGGGAAAGACATTTTTAAGCTGCT

viral related oncogene homolog

GACTTCACCTGCAAAATCTAACAG

(LYN), mRNA/cds = (297, 1835)

6289
Table 1
Hs.299883
AI742850
5111138
hypothetical protein FLJ23399
−1
TGTTTTACCCTCACTGTTGGACAT

(FLJ23399), mRNA/cds = (282,

ACATTCCAAGCTTTTCAACTCTA

1769)

GGAG

6290
Table 1
Hs.14373
AI760353
5176020
yx26h11.r1 cDNA, 5′ end/
−1
TTATCTCAGAATCTTGATGAACTCTG

clone = IMAGE: 262917/

AAATGACCCCTGATGGGGGCATG

clone_end = 5′

6291
Table 1
Hs.36137
AI785153
6231662
hepalocyte nuclear factor 3,
−1
CCGGGAAGCGGGGTACTGGCTGTGT

gamma (HNF3G), mRNA/cds =

TTAATCATTAAAGGTACCGTGTCCG

(0, 1043)

6292
Table 1
Hs.195175
AI802547
5368019
mRNA for CASH alpha protein/
−1
AGCCCTTTCTTGTTGCTGTATGTTTA

cds = (481, 1923)

GATGCTTTCCAATCTTTTGTTACT

6293
Table 1
Hs.24848
AI803065
5288537
tumor necrosis factor receptor
−1
GGGGTATGGTTTAGTAATATCCACCA

superfamily, member 5

GACCTTCCGATCCAGCAGTTTGGT

(TNFRSF5), mRNA/cds = (47,

880)

6294
Table 1
NA
AI807278
5393844
wf38h03.x1
−1
CTCTACCATAAGGCACTATCAGAGAC

Soares_NFL_T_GBC_S1 cDNA

TGCTACTGGAGTGTATATTTGGTT

clone IMAGE: 2357909 3′, mRNA

sequence

6295
Table 1
Hs.220850
AI880607
5554656
ym91d11.r1 cDNA, 5′ end/
−1
TGGGGCACTTTGAAAACTTCACAGGC

clone = IMAGE: 166293/

CCACTGCTGCTTGCTGAAATAAAA

clone_end = 5′

6296
Table 1
Hs.23098
AI884671
5589835
602254138F1 cDNA, 5′ end/
−1
TGGCGAGGATAAATAGAGGCATTGTT

clone = IMAGE: 4346626/

TTTGCTACTTTGCATATCATTGGC

clone_end = 5′

6297
Table 1
Hs.179391
AI917642
5637497
wi52d11.x1 cDNA, 3′ end/
−1
GCAGGAAAGATGGGGTGGTGGACTG

clone = IMAGE: 2393877/

TTTTTGCCTACTTTTTGTTTTTGAA

clone_end = 3′

6298
Table 1
Hs.180446
AI948513
5740823
importin beta subunit mRNA,
−1
CAGGGTATCAGATATTGTGCCTTTTG

complete cds/cds = (337, 2987)

GTGCCAGGTTCAAAGTCAAGTGCC

6299
Table 1
Hs.7557
AL042081
5421426
FK508-binding protein 5 (FKBP5),
−1
AGGCTGCATATGGATTGCCAAGTCAG

mRNA/cds = (153, 1526)

CATATGAGGAATTAAAGACATTGT

6300
Table 1
Hs.39911
AL138429
6855110
mRNA for FLJ00089 protein,
−1
TTAAGAACCCCAAAGATTAAAGGAAA

partial cds/cds = (62, 1111)

CAATGTTAAGGGCTTTTGTGAGGA

6301
Table 1
Hs.13144
AL521097
12784590
HSPC160 protein (HSPC160),
−1
GATACACTGTCCAGCCCAGGTCCAG

mRNA/cds = (53, 514)

GCCCTAGGTTCTTTACTCTAGCTAC

6302
Table 1
Hs.26670
AL540260
12870241
AL540260 cDNA/clone =
−1
ACTCAGGTGGTGCTGGTGTTAGTGAT

CS0DF032YF03-(3-prime)

GCTGGAGAAGAGAATATTACTGGT

6303
Table 1
Hs.183232
AL561892
12909772
hypothetical protein FLJ22638
−1
AAACACAGCCCACCCCATTTCAGACC

(FLJ22638), mRNA/cds = (12,

GCCTTCCTGAGGAGAAAATGACAG

476)

6304
Table 1
Hs.5057
AL578975
12943566
AL578976 cDNA/clone =
−1
TTGGCCCAGTGTGATTGATTGCTTTA

CS0DK012YN01-(3-prime)

TCTTTGGTACTTTTACTTGAATGG

6305
Table 1
Hs.198296
AL582354
12950255
SWI/SNF related, matrix
−1
AGCCTGAGGCAAATAAAATTCCAGTA

associated, actin dependent

ATTTCGAAGAATGGGTGTTGGCAA

regulator of chromatin, subfamily

a, member 2 (SMARCA2),

mRNA/cds = (297, 5015)

6306
Table 1
Hs.101370
AL583391
12952309
AL583391 cDNA/clone =
−1
AGGACCTTGACAAGCCGTTTGAGATG

CS0DL012YA12-(3-prime)

GAATGTAGGCCCTGATGTTATGCT

6307
Table 1
Hs.38218
AV659358
9880372
602589369F1 cDNA, 5′ end/
−1
TGTAAGTTGACTTTCAAAAGTCTCTG

clone = IMAGE: 4893744/

GAAACACTGGACTTTAGCTGGTCC

clone_end = 5′

6308
Table 1
Hs.301704
AW002985
5849991
eomesodermin (Xanopus laevis)
−1
AACAAGCCATGTTTGCCCTAGTCCAG

homolog (EOMES), mRNA/cds =

(0, 2060)

6309
Table 1
NA
AW027160
5885918
wf72b08.x1
−1
ACCGCCAAAGCCAATCATCCACTTTC

Soares_thymus_NHFTh cDNA

AGTACTTACCTAACCAATCTCCCA

clone IMAGE: 2512983 3′ similar

to contains Alu repetitive eleme

6310
Table 1
Hs.89433
AW071894
6026892
ATP-binding cassette, sub-family
−1
TTTGGGGGATCCTTTTGTAATGACTT

C (CFTR/MRP), member 1

ACACTGGAAATGCGAACATTTGCA

(ABCC1), transcript variant 1,

mRNA/cds = (196, 4791)

6311
Table 1
Hs.335449
AW136717
6140850
UI-H-BI1-adm-a-03-0-UI.s1
−1
TTCTGGCCTTGTTCACCTAGAAACGC

cDNA, 3′ end/clone = IMAGE:

TATTTCCTGTGTTATGGTTCTGGC

2717092/clone_end = 3′

6312
Table 1
Hs.12035
AW137149
8141282
602122419F1 cDNA, 5′ end/
−1
GGGTTACATTTGAGTCTCTGTACCTG

clone = IMAGE: 4279300/

CTTGGAAGAAATAAAAATACGTGT

clone_end = 5′

6313
Table 1
Hs.337727
AW161820
6300853
au70h03.x1 cDNA, 3′ end/
−1
TGTGGGCTTGGTATAAACCCTACTTT

clone = IMAGE: 2781653/

GTGATTTGCTAAAGCACAGGATGT

clone_end = 3′

6314
Table 1
Hs.81248
AW166442
6397987
CUG triplet repeat, RNA-binding
−1
ACTGGCAAATGAAGCATACTGGCTTG

protein 1 (CUGBP1), mRNA/cds =

CAGGGACCTTCTGATTCAAGTACA

(137, 1585)

6315
Table 1
Hs.166975
AW293159
6699795
splicing factor, arginine/serine-rich
−1
CTCCCATCATTCCCTCCCGAAAGCCA

5 (SFRS5), mRNA/cds = (218,

TTTTGTTCAGTTGCTCATCCACGC

541)

6316
Table 1
Hs.328348
AW338115
6834741
lp39g05.x1 cDNA, 3′ end/
−1
GGCGTTTCCCATTGACCAGTTTGACC

clone = IMAGE: 2190200/

CTGGTTTGAATAAAGAGAAGTGCG

clone_end = 3′

6317
Table 1
Hs.337988
AW440517
8975823

Homo sapiens, clone MGC: 17431
−1
GCCAGTCTCTATGTGTCTTAATCCCT

IMAGE: 2984883, mRNA,

TGTCCTTCATTAAAAGCAAAACTA

complete cds/cds = (1336, 1494)

6318
Table 1
Hs.250
AW444632
8986394
xanthene dehydrogenase (XDH),
−1
TGCAATGAGGCAGTGGGGTAAGGTT

mRNA/cds = (81, 4082)

AAATCCTCTAACCGTCTTTGAATCA

6319
Table 2
Hs.335815
AW444812
8986574
UI-H-BI3-ajy-d-11-0-UI.s1
−1
TGGCAACTTCAACTCCTTGATGGCGA

cDNA, 3′ end/clone = IMAGE:

TAATCTCTGGTATGAATATGAGCC

2733380/clone_end = 3′

6320
Table 1
Hs.342873
AW451293
6992069
RC3-HT0230-130100-014-g06
−1
TGCTTGGGAAATTTGGTTTGTAAACC

cDNA

TAAAATAGCCCTTATTTCTGGGGA

6321
Table 1
Hs.342735
AW452096
6992953
UI-H-BI3-alo-d-02-0-UI.s1
−1
CTTTCTGCCTGAAGCTGCCCCCATGA

cDNA, 3′ end/clone = IMAGE:

CTCCCTTCTTTGTGCAAAAGCATG

3068186/clone_end = 3′

6322
Table 1
Hs.80618
AW510795
7148873
hypothetical protein (FLJ20015),
−1
ACCCAGTTTGTGCATAGTTCATGATC

mRNA/cds = (31, 522)

CTCTATAAAACCAGCTTTTGTGGA

6323
Table 1
Hs.259842
AW614193
7319379
cDNA FLJ11025 fls, clone
−1
ACACCATTTCAGCGTTGGATCACAGA

PLACE 1003968, moderately

CAGCTCTTCCTTTATATCCCAGCA

similar to 5′-AMP-ACTIVATED

PROTEIN KINASE, GAMMA-1

SUBUNIT/cds = (159, 1145)

6324
Table 1
Hs.334437
AW778778
7793371
hypothetical protein MGC4248
−1
TGGCATAATGTTGGATTGAATCTACA

(MGC4248), mRNA/cds = (70,

TTTTGGCAGAAGTTAAACATTCCC

720)

6325
Table 1
Hs.151393
AW778854
7793457
glutamate-cysteine ligase, catalytic
−1
AGAATGCCTGGTTTTCGTTTGCAATT

subunit (GCLC), mRNA/cds = (92,

TGCTTGTGTAAATCAGGTTGTAAA

2005)

6326
Table 1
Hs.120243
BE044384
8361417
gamma-parvin (PARVG), mRNA/
−1
ATCGTTGGATTATCTTTGAACCCCCT

cds = (0, 995)

TGTGTGGATCATTTTGAGCCGCCT

6327
Table 1
Hs.5734
BE218938
8908256
meningloma expressed antigen 5
−1
ATACAGGGTTCCATCCAGAAAGCATT

(hyaluronidase) (MGEA5), mRNA/

CAGTCAGAGCAAGTTAAAGTCAGT

cds = (395, 3145)

6328
Table 1
Hs.167988
BE222301
8909619
neural cell adhesion molecule 1
−1
AAGTTGTCCTGTGCTAAAGCAAGCGT

(NCAM1), mRNA/cds = (201,

GGGATGATCCTACCTACCTCTAGG

2747)

6329
Table 1
Hs.27774
BE348809
9260662
602386841F1 cDNA, 5′ end/
−1
AGCTAGTGATGTTTTGTCCAAAGGAA

clone = IMAGE: 4515730/

GATTCTGACAACAGCTTCAGCAGA

clone_end = 5′

6330
Table 1
NA
BE348955
9260808
hs91h01.x1 NCI_CGAP_Kid13
−1
ACACAGACATATTGACCGCACACAAC

cDNA clone IMAGE: 3144625 3′,

ACTGAAATGGACTGACTTGAGAAA

mRNA sequence

6331
Table 1
Hs.56156
BE349148
9261087
601463367F1 cDNA, 5′ end/
−1
TGGTTCTCTGATTTGTAATGAGCACC

clone = IMAGE: 3868512/

TGGATATGTCAATTAAAATGCCCA

clone_end = 5′

6332
Table 1
Hs.127428
BE466500
9512198

Homo sapiens, Similar to homeo
−1
GGCCTACTGACCAAATTGTTGTGTTG

box A9 clone MGC: 19648

AGATGATATTTAACTTTTTGCCAA

IMAGE: 2987818, mRNA,

complete cds/cds = (62, 880)

6333
Table 1
Hs.122575
BE502248
9704854
endotheilial differentation,
−1
CGATAGAATTGAAGCAGTCCACGGG

lysophosphatidic acid G-protein-

GAGGGGATGATACAAGGAGTAAACC

coupled receptor, 4 (EDG4),

mRNA/cds = (6, 1061)

6334
Table 1
Hs.197766
BE502992
9705400
clone 23932 mRNA sequence/
−1
CTCAAACGAAATTGGGCAGGCCATTT

cds = UNKNOWN

GCGTGGTTTCTCTGGATAAGTTCC

6335
Table 1
Hs.61426
BE550944
9792636
602329933F1 cDNA, 5′ end/
−1
GCACATGACAGTAAGCGAGGTTTTGG

clone = IMAGE: 4431248/

GTAAATATAGATGAGGATGCCTAT

clone_end = 5′

6336
Table 1
Hs.122655
BE551867
9793559
hypothetical protein MGC14425
−1
ACACAGGAACCGCTTACCCACCAGCT

(MGC14425), mRNA/cds = (318,

CTGCCCGCGTCTCTACCGCCATAG

686)

6337
Table 1
Hs.4310
BE614297
9895894
eukaryotic translation initiation
−1
ACAACTCAAGTGAAAAGATGTCTCCA

factor 1A (EIF1A), mRNA/cds =

GTTTCTGAAGATAACGCACGCTGA

(207, 641)

6338
Table 1
Hs.341573
BE6466470
9970781
tc38c11.x1 cDNA, 3′ end/clone =
−1
AAAACACTCCACCTAAAAGCAG

IMAGE: 2066900/clone_end = 3′

GAAAGATGGCAATTCTAAATAGCA

GCTA

6339
Table 1
Hs.88845
BE674685
10035307
AV733781 cDNA, 5′ end/
−1
CGCCGCTCCTGGAGACCTGATAACTT

clone = cdAASF08/clone_end = 5′

AGGCTTGAAATAATTGACTTGTCT

6340
Table 1
Hs.181015
BE676054
1003695
signal transducer and activator of
−1
ATCCCATTCTCCCTCTCAAGGCAGGG

transcription 6, interleukin-4

GTCATAGATCCTAAGCCATAAAAT

induced (STAT6), mRNA/cds =

(165, 2708)

6341
Table 1
Hs.108327
BF001438
10701713
damage-specific DNA binding
−1
ACAGCATGAGAAACTGTTAGTACGCA

protein 1 (127kD) (DDB1),

TACCTCAGTTCAAACCTTTAGGGA

mRNA/cds = (109, 3531)

6342
Table 1
NA
BF056055
10809951
7k07h12.x1 NCI_CGAP_GC6
−1
CACAATGCTGCCTCCTCTGTGGATGA

cDNA clone IMAGE: 3443950 3′

CTGATGGCAAGAGTCTGAATTGAA

similar to contains element L1

repetitive eleme

6343
Table 1
Hs.43857
BF058599
10812495
mRNA for KIAA1247 protein,
−1
TAAGAAATCCCAATTTTCAGGAGTGG

partial cds/cds = (285, 2942)

TGGTGTCAATAAACGCTCTGTGGC

6344
Table 1
Hs.144583
BF059133
108113029

Homo sapiens, clone IMAGE:
−1
CGGCAGGGTGGCCTGTAACAATTTCA

3462401, mRNA, partial cds/cds =

GTTTTCGCAGAACATTCAGGTATT

(0, 153)

6345
Table 1
Hs.144519
BF061421
10820331
T-cell leukemia/lymphoma 6
−1
GCTGGAGGGAGAGGCACTGGGGAAT

(TCL6), transcript variant TCL6a2,

TTTTCCTGGTGAATACTGAAGTTAC

mRNA/cds = (1767, 2192)

6346
Table 1
Hs.96568
BF194880
11081165
602137338F1 cDNA, 5′ end/
−1
TGATACTTTGGTTCTCTTTCCTGCTCA

clone = IMAGE: 4274048/

GGTCCCTTCATTTGTACTTTGGA

clone_end = 5′

6347
Table 1
Hs.111583
BF197608
11088855
602365742F1 cDNA, 5′ end/
−1
ACTGCCAGTGAAGACTGTAAAGACAG

clone = IMAGE: 4473923/

AACACACTATTTTGGAGGGAGGAT

clone_end = 5′

6348
Table 2
NA
BF197762
11087169
7p91f02.x1 NCI_—CGAP_Skn1
−1
AGGAAGAGCCTGCACCTGTGGTGGA

cDNA clone IMAGE: 3653139 3′,

ACAATCAGGGAAAAGGAAGTCAAAA

mRNA sequence

6349
Table 2
Hs.50785
BF221780
11128957
SEC22, vesicle trafficking protein
−1
TTTGGAGCTTCTATAGGAGTGGAGAG

(S. cerevisiae)-like 1 (SEC22L1),

GGGCAGCTCATTGTTGAGAGTTGC

mRNA/cds = (119, 766)

6350
Table 1
Hs.250811
BF432643
11444806
v-ral simian leukemia viral
−1
TGATCTGACTGGAAAACAATCCTGTA

oncogene homolog B (ras related;

TCCCCTCCCAAAGAATCATGGGCT

GTP binding protein) (RALB),

mRNA/cds = (170, 790)

6351
Table 1
Hs.293478
BF435821
11447923
hypothetical protein FKSG44
−1
CGTTTTCTGAGCATCCGTTGTGCCTT

(FKSG44), mRNA/cds = (126,

AACATTTTCTGCTTGTCCTTTGGG

1520)

6352
Table 1
Hs.174104
BF445405
11510543
601438710F1 cDNA, 5′ end/
−1
ACTGCTGTTGCATGAATAGATGATAC

clone = IMAGE: 3923643/

AAAGCAAGTGATGAGGTTGGTATG

clone_end = 5′

6353
Table 1
Hs.295726
BF447885
11513023
integrin, alpha V (vitronactin
−1
AGTGAAAACTGGTACAGTGTTCTGCT

receptor, alpha polypeptide,

TGATTTACAACATGTAACTTGTGA

antigen CD51) (ITGAV), mRNA/

cds = (41, 3187)

6354
Table 1
Hs.181311
BF478236
11549065
asparaginyl-tRNA synthetase
−1
TGTCCTCTGAACCTGAGTGAAGAAAT

(NARS), mRNA/cds = (73, 1719)

ATACTCTGTCCTTTGTACCTGCGT

6355
Table 1
Hs.179703
BF5077849
11591147
tripartite motif protein 14
−1
CCATTTCCACTACATGCCTTTCCTAC

(TRIM14), mRNA/cds = (10,

CTTCCCTTCACAACCAATCAAGTG

1230)

6356
Table 1
Hs.300870
BF513602
11598781
mRNA; cDNA DKFZp547M072
−1
AATACAGATTCATTTTATTTAAGCGTC

(from clone DKFZp547M072)/

CGTGGCACCGACAGGGACCCCAG

cds = UNKNOWN

6357
Table 1
Hs.283022
BF514341
11599520
triggering recaptor expressed on
−1
GCCTCTTTTCCTGTATCACACAAGGG

myeloid cells 1 (TREM1), mRNA/

TCAGGGATGGTGGAGTAAAAGCTC

cds = (47, 751)

6358
Table 1
Hs.146065
BF591040
11683364
AL580165 cDNA/clone =
−1
CTGGGGCCGTAGCAAAAATCATGAAA

CS0DJ005YB18-(3-prime)

AACACTTCAACGTGTCCTTTCAAT

6359
Table 1
Hs.170577
BF725383
12041294
602574255F1 cDNA, 5′ end/
−1
CAGACCTGTGGGCTGATTCCAGACT

clone = IMAGE: 4702644/

GAGAGTTGAAGTTTTGTGTGCATCA

clone_end = 5′

6360
Table 1
Hs.104640
BF726114
12042025
HIV-1 inducer of short transcripts
−1
AAGGCAACCAACCACATTAGAAGTCT

binding protein (FBI1), mRNA/

TGGCACTTTGTAACGGAACGGGTA

cds = (0, 1754)

6361
Table 1
Hs.296317
BF938959
12356279
mRNA for KIAA1789 protein,
−1
GAAGTGACACTGACTGTATCTACCCTC

partial cds/cds = (3466, 4899)

TCCTTTTTCTTCATCAGGTGTTCCT

6362
Table 1
Hs.28138
BF940103
12357423
hypothetical protein MGC14158
−1
AATTCCAAAGGAGTGATGTTGGAATA

(MGC14156), mRNA/cds = (82,

GTCCCTCTAAGGGAGAGAAATGCA

426)

6363
Table 1
Hs.133372
BF940291
12357611
AF150127 cDNA/cds =
−1
AGCCCCTCCACCCCACCCAGTACTTT

CBCBGA01

TACAATGTGTTATTAAAGACCCCT

6364
Table 1
Hs.304900
BF980139
12347354
602288147F1 cDNA, 5′ end/
−1
CCATCCTTGAGAAATGTGGGCACCAA

clone = IMAGE: 4373983/

GTCCATAATCTCCATAAATCCAAT

clone_end = 5′

6365
Table 1
Hs.8258
BG054966
12512220
cDNA FLJ14737 fls, clone
−1
TATGAGTTTATGCGTTTTCCCAGCCC

NT2RP3002273, weakly similar to

TCCGAATCACTGACTGGGGCGTTT

SCD8 PROTEIN/cds = (77, 1488)

6366
Table 1
Hs.5122
BG058599
12525258
602293015F1 cDNA, 5′ end/
−1
AGTTGGAGCTATCTGTGCAGCAGTTT

clone = IMAGE: 4387778/

CTCTACAGTTGTGCATAAATGTTT

clone_end = 5′

6367
Table 2
Hs.89104
BG058739
12525527
602590917F1 cDNA, 5′ end/
−1
CGTGGGAGGATGACAAAGAAGCATG

clone = IMAGE: 4717348/

AGTCACCCTGCTGGATAAACTTAGA

clone_end = 5′

6368
Table 1
Hs.166962
BG149747
12661777
phosphatidylinositol glycan,
−1
GTGGTTTGGTCAGCATACACACTTCT

class F (PIGF), mRNA/cds = (67,

CATTTCATTTGATGTACACAGCCA

726)

6369
Table 1
Hs.184456
BG230583
12725596
hypothetical protein (LOC51249),
−1
GTGTGAAGTGACAGCCTTGTGTGTGA

mRNA/cds = (0, 611)

TGTTTTCTGCCTTCCCCAAGTTTG

6370
Table 1
Hs.3353
BG236015
12749882
beta-1,3-glucuronyltransferase 1
−1
GTCTTTCCCGTCTTTCTTCCTCACCTA

(glucuronosyltransferase P)

TGTAATTTCAGTAGTCTCTCAGC

(B3GAT1), mRNA/cds = (175,

1179)

6371
Table 1
Hs.83623
BG654774
13792183
nuclear receptor subfamily 1,
−1
TGTTTCGTAAATTAAATAGGTCTGGC

group I, member 3 (NR113),

CCAGAAGACCCACTCAATTGCCTT

mRNA/cds = (272, 1318)

6372
Table 1
Hs.109007
BG655723
13793132
602342214F1 cDNA, 5′ end/
−1
GTGGAAATCAGCACACAACCACAATG

clone = IMAGE: 4452602/

ACATTTAAGCACAGGATCATTATT

clone_end = 5′

6373
Table 1
Hs.14453
BG744911
14055584
interferon consensus sequence
−1
AGAATGGCAGACCTGTTTGCTGAAGT

binding protein 1 (ICSBP1),

GTTCATAAGATAACAATAGGCTTG

mRNA/cds = (47, 1327)

6374
Table 1
Hs.2730
BI084548
14502878
heterogeneous nuclear ribonucleo-
−1
TGGGATTTTGTTTTTAAGTCATTTGGT

protein L (HNRPL), mRNA/cds =

TTGGGGAGGACCTTGTTTATTTT

(28, 1704)

6375
Table 1
Hs.296356
BI085832
14504182
mRNA; cDNA DKFZp434M162
−1
TGGACAAACTGACAGGGACTGCTTTG

(from clone DKFZp434M162)/

AAAGACAGGTACTCAGTTGAGTAT

cds = UNKNOWN

6376
Table 1
Hs.132911
N20190
1125145
MR2-OT0079-290500-007-b03
−1
AAGCCTGTTTTTCACTCTAAAAATTCA

cDNA

AGAGGACACGCTAAGAACGATCA

6377
Table 1
Hs.334731
N58136
1202026

Homo sapiens, clone IMAGE:
−1
AGGTTCCCTTTCAAATAAAGATAAAG

3448306, mRNA, partial cds/cds =

AATTTGACTTGGGACACTGCCAGA

(0, 2353)

6378
Table 1
Hs.303018
N94511
1266820
zb80g04.s1 cDNA, 3′ end/
−1
CTGTTCGAAAGTTGGAGACTGCCTGT

clone = IMAGE: 309942/

ACCCAGGTTGATAGTCAATTGTTT

clone_end = 3′

6379
Table 1
NA
W68708
1377588
zd35h04.s1
−1
AGCAGAGTTAAGTTTAAATTTCCATTC

Soares_fetal_heart_NbHH19W

TCACTAGTTTGTGACCTTTGCCA

cDNA clone IMAGE: 342679 3′,

mRNA sequence

6380
Table 1
NA
W88427
1400194
zh81c11.s1
−1
TGAGTATTGTTGTGGGGGCGGGTAT

Soares_fetal_liv-

GTCTGTATATAAATCTGTGCAGCCA

er_spleen_1NFLS_S1 cDNA

clone IMAGE: 416564 3′, mRNA

sequence

6381
Table 3A
NA

36G5
1
CCCTTGCAGATACATGAGACAGGCA

GGGGCTGGAGTCTTGTTCCATCCTG

6382
Table 3A
NA

38F11
1
GAGTAGTTGTCTTTCCTGGCACTAAC

GTTGAGCTCGTGTACGCACTGAAG

6383
Table 1
NA

37G7
1
GAGTCCAATCTACACTCTAGTAGTGA

AGACAGAAGAGTTGGCATACGAGT

6384
Table 1
NA

37G8
1
GGCTGAACTTACTCATTAAGCCACAT

AACTTCGAGTCAAGTTCCAGTCCA

6385
Table 3A
Hs.197345

thyroid autoantigen 70kD (Ku
1
GCTCTCAAGCCTCCTCCAATAAAGCT

antigen) (G22P1), mRNA/cds =

CTATCGGGAAACAAATGAACCAGT

(17, 1846)

6386
Table 1
NA

40E4
1
AGGAATGCACACATTGCTCCAGGATC

ACTGTGAGGATTAAAGGAGATGGT

6387
Table 3A
NA

41E9
1
AGTAACGGAACAGTTCCCAGTACTCC

TGGTTCCTAGGTGAGCAGGTGATG

6388
Table 3A
Hs.169476

Homo sapiens, glyceraldehyde-3-
1
GGTGTGAACCATGAGAAGTTCGACAA

phosphate dehydrogenase, clone

CAGCCTCAAGATCATCAGCAATGA

MGC: 10926 IMAGE: 3628129,

mRNA, complete cds/cds = (2306,

3313)

6389
Table 3A
NA

47E5
1
GGAGGTGTATAGGCTGGGATTTGAAA

AGGAAAATAATCAGCGTGGTGCCA

6390
Table 2
NA

47D11
1
CCTAGACACCTGCATCAGTCAAGGTC

ATGGATATTGGGAAGACAGACAGC

6391
Table 1
NA

50A11
1
TCCAGCAGATATAGGAAGCAGTGTAT

CTAAACAGACAAATAAAAAGGCCT

6392
Table 3A
Hs.132906

DNA sequence from clone RP11-
1
ATCTAGTGTACGAGACTTGGAGTCAG

404F10 on chromosome 1q23.1-

GCAGTGAGACTGGTGGGGCACGGG

24.1. Contains the 5′ end of the

SLAM gene for signaling

lymphocytic activation molecule a

SET (SET translocation (myeloid

leukemia-associated)) protein

pseudogene, the CD48 gene for

CD48 antigen (B-cell membrane

protein), the gene for a novel

LY9 (lymphocyte antigen 9) like

protein and the 5′ end of the LY9

gene. Contains ESTs, STSs and

GSSs/cds = (41, 1048)

6393
Table 1
NA

52B9
1
TGGTTTAATGGAAAATGCTCTGGAAA

ATTCTTTTGCAACAGTTCATCGCT

6394
Table 1
NA

53B1
1
CACTAAAAGAGTGGGGAGGTGCAGC

ACCTGGCTGGGGAACAAGAATATGG

6395
Table 1
NA

53E3
1
AAACGAATCACGTGCCTCGAAAGGG

ACATATATTGTTCCTTTAAGCATTT

6396
Table 1
NA

53E10
1
AAGGGTTCAATTTCTTCTTTGGAAGG

TGATGGTAAGGGTGTGGCTCCAGA

6397
Table 2
NA

53G7
1
TGGACAATTCCAAGTCCAAGAGGACT

GTCTACTTTCGACCTTGTGTGATT

6398
Table 1
NA

54F4
1
TTGTGTTAACCTGTTGTCCACGCTAA

GATACAAACTTCCCGGAGGAAAGT

6399
Table 1
NA

54G9
1
TGTCACAGTGTTCTATTATTTGCCCG

GTTCTTAAAGTGAGAGCATCCTGA

6400
Table 1
NA

59G1
1
ACAATGATATTGATGAGGCACCCAGT

CTTTTCATTTACTCTGAGTGAAGT

6401
Table 1
Hs.48320

mRNA for ring-IBR-ring domain
1
AGATCGAGATCTTCAGTCCTCTGCTT

containing protein Dorfin,

CATCTGTGAGCTTGCCTTCAGTCA

complete cds/cds = (317, 2833)

6402
Table 1
NA

60G8
1
GGCCAGAGACCCTAAGCTGCTTAATA

CATTTATACCACATCCTTCTCAGC

6403
Table 2
NA

62C9
1
CCCTTGGAATTACTTGTTCAACTTCTT

TCTTTCCCACTAGACGGGGACTT

6404
Table 3A
NA

62F11
1
CTTTGTAGATGCAGAGAGAAGCTATA

AGAAACCCCAGTACTTGCCGGGCG

6405
Table 1
NA

63E1
1
ACTGCCACATCTGACTTTACAGAATA

ACCAATGTAAGTTAAAATAGAGAAAC

AG

6406
Table 2
NA

65B1
1
AGTCTTGCGAGTCAACTCAGACTCAA

ATGTAGAACTGGGAAGGACAGTGC

6407
Table 2
NA

65d10
1
AGCACTGTGCAGATGGCTTTAGAAGA

TTCAGAACAGAAGCACAATCTGTT

6408
Table 2
NA

65D11
1
AGCACTGTGCAGATGGCTTTGGAAGA

TTCAGAACAGAAGCACAATCTGTT

6409
Table 2
NA

65D12
1
CTATGGAGTCTTGGAGGACACTGGA

GTCACCATGCTAACACTGTGCAGAT

6410
Table 1
NA

68C9
1
CCCTGTCACCCTTCGTGGCCAGTGC

CAGACAGTAACTAGTGGATGCTAAA

6411
Table 1
NA

69F8
1
GAGAGAATAGGGTAGAGAGACCGGG

ACTTGGGTAGAGATGACCGGGATTC

6412
Table 1
NA

69H11
1
AGTGGAAGCTAGGAGAAATATCGAAT

GTGTTAGGGACTTTGAAGTTACCA

6413
Table 3A
NA

70B6
1
CTGCATCTCTCTTTACTACCAGTGATT

ACAAAGTGGGGTTTGGTGGGAGT

6414
Table 3A
Hs.17109

integral membrane protein 2A
1
TCTCTGACTTCTTATTACCAAGGACA

(ITM2A), mRNA/cds = (139, 930)

CTCTATCTGTTGCCTCTTACTCTT

6415
Table 2
NA

72D4
1
CAGTTCCCAGATGTGCGTGTTGTGGT

CCCCAAGTATCACCTTCCAATTTC

6416
Table 3A
Hs.234279

microtubule-associated protein,
1
AACGACCCTGTATTGCAGAAGATTGT

RP/EB family, member 1

AGACATTCTGTATGCCACAGATGA

(MAPRE1), mRNA/cds = (64,

870)

6417
Table 2
NA

72D8
1
GGGTCCCGAGCCCTTCAAGAGCTAG

ATTTACTCAAGTTTGTTCCCTTGCC

6418
Table 1
NA

73C4
1
CACTGAAGCCAAACCACAGAAGACTT

TTGAGAATGAGGAGACAAATGAGT

6419
Table 1
NA

73H4
1
AGGTGAAAATTACTCTTCAGAAGATA

GCAGAGTGGATAATGGCCCATCGA

6420
Table 2
NA

73A7
1
TGCAGTGAGACTACATTTCTGTCTAA

AGAAGATGTGTGAGTTCCGTCCTT

6421
Table 3A
Hs.174228

small inducible cytokine subfamily
1
TCCAGCCAGCCAGCTCATTTCACTTT

C, member 2 (SCYC2), mRNA/

ACACCCTCATGGACTGGGATTATA

cds = (0, 344)

6422
Table 3A
Hs.3945

CGI-107 protein (LOC51012),
1
TTTCATACATTGGAACTCCACCTGAC

mRNA/cds = (84, 719)

TTTGGACCAACCCCAGAACAGAGC

6423
Table 1
NA

75A2
1
AGCACCGGAATACAAAAATGATACTA

TGCTGCCCTCCTAGATCTCAGGGA

6424
Table 3A
Hs.249495

heterogeneous nuclear ribonucleo-
1
TGCCCATACACATGAGTATTTGTCTA

protein A1 (HNRPA1), transcript

AAACATGTCTTCTTTGTAGCAGCT

variant 2, mRNA/cds = (104,

1222)

6425
Table 2
NA

75B12
1
GCAAATCTAAACTGCAGGAAAATTTT

TGCACCCGAAGTATTCAGATCCCT

6426
Table 2
Hs.205442

601439689F1 cDNA, 5′ end/
−1
GGCCCAGTGCTAATGTAACCAATGAT

clone = IMAGE: 3924407/

GCCATGTCGATATTGGAAACCATA

clone_end = 5′

6427
Table 3A
NA

101G7
1
GGGGAAGAACAAGATAATCTAGTGAC

CTCACCACAGTCTATGCCCAGGCC

6428
Table 3A
Hs.179565

minichromosome maintenance
1
AATTCAACTGAAGGCGAGGAATGTTG

deficient (S. cerevisiae) 3

GTGATGAAGCTGAGATCAGGACTC

(MCM3), mRNA/cds = (44, 2470)

6429
Table 1
Hs.119640

hBKLF for basic kruppel like
1
CACCTATATCGAAAGTTTGGGCTCAT

factor (LOC51274), mRNA/

CTCCCATTGGTGGCAAAGACCTCC

cds = (55, 1092)

6430
Table 3A
Hs.215595

guanine nucleotide binding protein
1
TGGTGGAAAAGTGTGTCTGTCTGACA

(G protein), beta polypeptide 1

ATTACACTCAAGTTTACCTCTGGT

(GNB1), mRNA/cds = (280,

1302)

6431
Table 1
NA

105A10
1
ACGATAATACTGTTGGTTACTGCCAT

AAATATTGGAAGCTAATGTAAAATGC

A

6432
Table 1
NA

107G11
1
TTCTCTTATAAAGGACAGCAAGTTTAA

AATGGAGCAAGGAGCATTGGAAA

6433
Table 1
NA

107H8
1
TGGCCAAAGAATAGAAGCTCTAGACC

TTCCTTATTTCTATCGTGAAAACA

6434
Table 3A
Hs.64239

DNA sequence from clone RP5-
1
ACATGACCTGTGCAGTGTGTGGCTGT

1174N9 on chromosome 1p34.1-

GAATTCTGTTGGCTTTGTATGAAA

35.3. Contains the gene for a novel

protein with IBR domain, a

(pseudo?) gene for a novel

protein similar to MT1E

(metallothionein 1E (functional)),

ESTs, STSs, GSSs and two

putative CpG islands/cds = (0,

2195)

6435
Table 1
NA

109H9
1
TGACATAACTACCATCCCTGCAACTA

ATGAACCCACCCTCACAGCTTCCT

6436
Table 3A
Hs.80261

enhancer of filamentation 1 (cas-
1
GAATGACATAAACCCCCTCCGGTCTG

like docking; Crk-associated

AGGTCCGGCCTTCCAGCTTGTCTC

substrate related) (HEF1), mRNA/

cds = (163, 2667)

6437
Table 3A
Hs.1422

Gardner-Rasheed feline sarcoma
1
GCCTTTCTCACTCCATCCCCACCCAA

viral (v-fgr) oncogene homolog

AGTGCTCAGACCTTGTCTAGTTAT

(FGR), mRNA/cds = (147, 1736)

6438
Table 3A
Hs.333114

AV713318 cDNA, 5′ end/clone =
1
TCGTTTTACAACGTCGTGACTGGGAA

DCAAAC09/clone_end = 5′

AACCCTGGCGTTACCCAACTTAAT

6439
Table 1
NA

129A12
1
TGTTTTGTTTTCTGAAACGAAATCCTG

CTCTGTTGGCCCAGCTAGAACGC

6440
Table 1
NA

129F10
1
CAGAAGCTGGATGACGTTGCTCCATC

TTCACTCTGTTAATGAGACATGAT

6441
Table 3A
NA

137D4
1
CACATCTTCCATTCAGCCCTACCATG

AAAACCGTACCTCGGGCGCGACCA

6442
Table 1
NA

142F9
1
AATTTGCTTTAAATTGAGTTTCCTTGC

CATTGCACACTCCTATCTTTCTG

6443
Table 3A
Hs.250655

prothymosin, alpha (gene sequence
1
CAGATGACACGCGCTCTCCACCACC

28) (PTMA), mRNA/cds = (155,

CAACCCAAACCATGAGAATTTGCAA

487)

6444
Table 3A
Hs.249495

heterogeneous nuclear ribonucleo-
1
CCCATGCTGTTGATTGCTAAATGTAA

protein A1 (HNRPA1), transcript

CAGTCTGATCGTGACGCTGAATAA

variant 2, mRNA/cds = (104,

1222)

6445
Table 1
NA

149G2
1
GACACAGACAGACCAAGCTATAGTCA

GACCTGGTTACACACATACACACA

6446
Table 1
NA

149A11
1
TGGCAAAGATCACTGAAATTTAGGAC

ACCAAAGCTAAAACCCCAAATGCT

6447
Table 3A
NA

151F11
1
GCTTGTGCTCGAGACCGCTTGCTATA

GAAACGCTGAGCTGCTGGTTTATG

6448
Table 1
NA

162E8
1
CTGGTTAAAAGCCCCATTACTGACCT

TCGCCGCCACCACGCCTATCACTA

6449
Table 3A
Hs.334330

calmodulin 3 (phosphonylase
1
GCATCCACCTCCTTCTCTGTCTCATG

kinase, delta) (CALM3), mRNA/

TGTGCTCTTCTTCTTTCTACAGTA

cds = (123, 581)

6450
Table 1
NA

170F7
1
TTAAATCTATCAAGAATTCATCCAAAT

TGGTACCCTGCCGGGCCGCCTCG

6451
Table 2
NA

170F9
1
AGTGCTGTATTGACTTTGCTCGGCAG

TAGATGAAGCTATTCTGAACCCAA

6452
Table 3A
NA

177A3
1
TGCTGGACAAAGACAATGAGATGATT

ATTGGTGGTGGGATGGCTGTTACC

6453
Table 1
NA

331A3
1
GTGGAAAAGTCACTACCAGGCTGGC

AGGGAATGGGGCAATCTATTCATAC

6454
Table 1
NA

331A5
1
AAGGGACAGGGAGCGGGCACAAAAT

AAAACTTAGTTTGGTAGAAATTATA

6455
Table 3A
NA

146C3
1
TCAAAGCACTGGAGATGAGAGCCAG

GATGGACCCGAAAAGAATTTTACAG

6456
Table 1
NA

146D8
1
CAGGAACATGGCTGCAGCATATAAAA

AGAATTGAATTCCATACTTTTGTTAAC

CCT

6457
Table 3A
Hs.153

ribosomal protein L7 (RPL7),
1
TTGCCATAACCACGCTTGTAGATTAG

mRNA/cds = (10, 756)

TTCATTTACTGACTTCAGATTGGG

6458
Table 1
NA

158G6
1
TTACAGGCAACCGGAGCATCCAATCA

CCTTTCTCTAAGAGAGTACCTCGG

6459
Table 1
NA

158H6
1
AAAAGCATCTTCGAGAGGGACTGTCA

ATTCTCGACTATTTTCCAACCCGC

6460
Table 3A
Hs.119598

ribosomal protein L3 (RPL3),
1
AAGAAGGAGCTTAATGCCAGGAACA

mRNA/cds = (6, 1217)

GATTTTGCAGTTGGTGGGGTCTCAA

6461
Table 1
NA

158E9
1
AGAGACACCTAAATTACAGATTTGTG

AGCTGAGAGCTGGAGTTTTTCATT

6462
Table 3A
Hs.326249

ribosomal protein L22 (RPL22),
1
AACAGCAAAGAGAGTTACGAATTACG

mRNA/cds = (51, 437)

TTACTTCCAGATTAACCAGGACGA

6463
Table 3A
Hs.297753

vimentin (VIM), mRNA/cds =
1
AGCGCAAGATAGATTTGGAATAGGAA

(122, 1522)

TAAGCTCTAGTTCTTAACAACCGA

6464
Table 3A
NA

155H10
1
GCATGGACAAGATGCCAAGGCCCGG

ATGCTTTAGGATGAAGTTCTTATCT

6465
Table 3A
Hs.108124

cDNA: FLJ23088 fls, clone
1
CCTCCAGTCACCATACACAGGTTACC

LNG07026/cds = UNKNOWN

AGTGTCGAACTTGATGAAATCAGT

6466
Table 1
NA

159F8
1
CCAAACATCTGGACTTGTGACTGTAA

AAGGGGAGGAGGTAGCCAATGATT

6467
Table 3A
NA

166F3
1
TTATGGTGGTCGGGGTGGGTGGTAG

TTCAATGGGAGGTATGGGATTTATT

6468
Table 1
NA

166F6
1
AGCTGTCTGGCTCAAAGATCTACATT

CTGAAGTTGGCTGGAAATGTCTTG

6469
Table 1
Hs.8121

Notch (Drosophila) homolog 2
1
CTGGTTCCTACCAGTGCCAGTGCCTT

(NOTCH2), mRNA/cds = (12,

CAGGGCTTCACAGGCCAGTACCTC

7427)

6470
Table 2
Hs.25130

cDNA FLJ14923 fls, clone
1
TGACACAGACTGTTTCAATCTTGGAG

PLACE1008244, weakly similar to

CAGCGACTGACTTTGACAGAAGAT

VEGETATIBLE INCOMPATI-

BILITY PROTEIN HET-E-1/cds =

UNKNOWN

6471
Table 1
NA

188A9
1
TGCTATTTAAAGCACCATGATAAATAT

GAGGCCACTTGGAAATCCATCCA

6472
Table 1
NA

171F11
1
GCAGGCGATGCTCTATAATCTAAAAT

GTATCTCTCTTTCCCTAAGCTGAA

6473
Table 3A
NA

171G11
1
AAGTAAGACCACCTGTGAACTTGATC

ATTATCTGGCGCACATAGGAAGAT

6474
Table 1
NA

175D1
1
GCTGGGGCTGGGAATTGCGTGGGCT

AATGTGTCATTTGACTTAAGAAACT

6475
Table 1
NA

182H1
1
TTTGGGAAGAACCGATTGCTAAATTA

TGCCTAATTCATGTCAGAAGAGGG

6476
Table 3A
NA

184B5
1
AAGCAGTATACCATTTATATAGCAAA

CAGCCAGTGGCCAGTTCACTGTAT

6477
Table 3A
NA

184D2
1
CTGCCCTTTGGTAGTGAGAGGACCA

CGCCAATGATGCTTTTAAGTAACCT

6478
Table 1
NA

184H1
1
CATTTCTTCATCTCTAAGGCACACTT

GCTACCCCTCTTTGCTGACCCCAG

6479
Table 1
NA

46D1
1
GCCTGCGTGTCTGTCTCAGTGTTTCC

TGGTCCTCCTCTAAGTACTCTAAA

6480
Table 1
NA

98C1
1
AATCCTAGACATGTGCTTGTCATTGC

TCCCATGAAGGTAGTTTTCAAACA

6481
Table 1
NA

98C3
1
ACCAATAGAGAAGAAGCTCTAGAAGA

CAAAATCCCAAACCTTGGCACAAA

6482
Table 2
Hs.205442

601439689F1 cDNA, 5′ end/
1
GGCTTCAACAGAAACATCAAATGCCA

clone = IMAGE: 3924407/

AGACCAGTGAGAGAGCGTCAAAAA

clone_end = 5′

6483
Table 1
NA

98H4
1
GCAAGCCCACTAAAATAAACATCTAA

CCAGCATCTTTCCCCCATTATAGG

6484
Table 1
Hs.169363

GLE1 (yeast homolog)-like, RNA
1
ATGGATCTGTTCCTCTGTGCTAAATG

export mediator (GLE1L), mRNA/

TCTTGTGGCAGGGTGTGTTTGTGG

cds = (87, 2068)

6485
Table 3A
NA

113F12
1
GCCGTAATGTCTCGGGATCTCTAATA

ATAGAGGAGGTGAGTTGTGGTGTC

6486
Table 1
Hs.30212

thyroid receptor interacting protein
1
AGGCACTCCTCAACCAGTGTTCACTG

15 (TRIP15), mRNA/cds = (15,

AATTCAACTGCTGAAATTGTAACA

1346)

6487
Table 3A
NA

173A10
1
AGAGAGGGTTTTAAGGGAGGGCTTG

TGAATACTTGGGAGAATACGGAAGG

6488
Table 3A
Hs.334853

hypothetical protein FLJ23544
1
ATGAATTTGAAGACATGGTGGCTGAA

(FLJ23544), mRNA/cds = (125,

AAGCGGCTCATCCCAGATGGCTGT

517)

6489
Table 3A
Hs.20252

DNA sequence from clone RP4-
1
TTCCACAGATAGGTAAGCCAGGCGC

646B12 on chromosome 1q42.11-

GGCAAGATGAGACTGTATTCAGTTA

42.3. Contains an FTH1 (femitin,

heavy polypeptide 1) (FTHL6)

pseudogene, the gene for a novel

Ras family protein, ESTs, STSs,

GSSs and a putative CpG islands/

cds = (0, 776)

6490
Table 1
NA

174D1
1
TCTTGTCCTAGTCATTGTGGCAACCC

CATCTGACACCTTGTGTAGTACCT

6491
Table 1
NA

45B9
1
TTCTGGCAAGCTCTTGTCATGGTGTT

CGACACTTCCTTCTGTCTTCTTGG

6492
Table 1
NA

45H8
1
TTTCAACATGGCTAGATCCATCAGAA

ACTGAAGGCGGGGGAGAAAGCTCTC

6493
Table 1
NA

111H6
1
GGTACTCAAAGGAAATTACTCTTTCT

CTGGAACCCTGGCAGAAAGTTTTA

6494
Table 1
NA

111E12
1
ATCCTTCCTACCTTTTATTATGAAAGT

TTTGGTACCTGGCCCGGCGAGCG

6495
Table 1
NA

111H11
1
ATTAAGGTTTTTAACATCTACTTTGGG

TGATGGAGCCTTCAATGAAGTCA

6496
Table 1
NA

112H3
1
GAAAGACTACGAATTTCGCTGGGAG

GTAATAGGGAAGCCTTCCACATAAA

6497
Table 1
NA

112E9
1
AAATGAGGTCAGCAATAACCTTGATT

CGGTCCTCCACTGGCAACATTTTA

6498
Table 1
NA

114G3
1
CTTCTCTCCCTGTAACCAGGCAGTGT

GTGGGCGGGGCTCAGAACATATCT

6499
Table 1
NA

117H6
1
GTTGCCCTGATCTGGAAATCCTGTTG

CTTCTTCTGGGATGAAGGAACCTC

6500
Table 1
NA

165E7
1
TAAGATAACCCACAGGCACTTCCTGT

CATAAAGCCAACGACACAGACCAG

6501
Table 1
NA

165E11
1
ATGGGAACAGGATGTTAAATACACAC

ATACATACGCACACAAGCGTTGGG

6502
Table 1
NA

165F7
1
CCTCTGCTATCACTAGAGAATGTAGA

GAATGGAAATGGCTGCCTTTATGC

6503
Table 1
NA

176A6
1
GATACAGATGTGATTATTCAGCCTCA

AGGGGACTTCTCCATTGCGTAACG

6504
Table 1
NA

176G2
1
TTATTGTTACCAATTAGAATCAGCAAT

TCAACTGTGCGGTGATTTGGCCT

6505
Table 1
NA

176E10
1
TCATCACTTGGGTTAACTAAAGGTTT

GCGTATCACACAATTACACTACAA

6506
Table 3A
NA

176F11
1
TTCATAGTCAAACAAAAGGTAAGATC

ATGCATATACCCACGGCAACAAGG

6507
Table 1
Hs.232400

heterogeneous nuclear ribonucleo-
1
CCCACCCCCTTCCCCTCCATGTGAAG

protein A2/B1 (HNRPA2B1),

ATTTGGGTGCTTAACATATCATTT

transcript variant B1, mRNA/

cds = (169, 1230)

6508
Table 1
NA

71F2
1
GGGAGACATGCTGATTCCACTCAAAG

ATCTCATAATAAACAGCTTTGGCC

6509
Table 1
Hs.172028

a disintegrin and metalloproteinase
1
AAATAAATTTGGAATGGGACATTGTG

domain 10 (ADAM10), mRNA/

CTGTTTCACCTTCAATGCTGTTA

cds = (469, 2715)

6510
Table 1
Hs.180610

splicing factor proline/glutamine
1
AGAACAGTCTTGGGTTCAGGGGTGT

rich (polypyrimidine tract-binding

GATGCCAGAATGTATTTTCGTACCT

protein-associated) (SFPQ),

mRNA/cds = (85, 2208)

6511
Table 1
NA

124G4
1
AAGGCGAAGTCAATCCCATCTCCCTG

AACCCAACTGCCAGTAGGTAGTTC

6512
Table 1
NA

123C8
1
AGTTAAACTGTTGGTGAGGTAGTGTG

TCAGGTACTCTGTATATTAGCTCT

6513
Table 1
NA

124F9
1
ACTGGATAAACAGAACGGATCAAAGA

TAAAAGTATTCTTGTTGCCTGGGC

6514
Table 3A
NA

127A12
1
GTCCCTTAGGGGAGGGAGAGTTGTC

CTCTTTGCCCACAGTCTACCCTCAG

6515
Table 1
Hs.50180

601652275F1 cDNA, 5′ end/
1
ACTGGACTACTGAACTTTAGAATACT

clone = IMAGE: 3935610/

GTCCTAAGGAAATAGGTCTGGGCA

clone_end = 5′

6516
Table 1
NA

161E8
1
CAAACAACAAAAGTGGCCTCCATCGC

TGTGAGCCTCTCAAGGGACAGGGC

6517
Table 1
NA

186E8
1
AAGGTGGCTGGCTTTTATGATACAGT

GGTGGTAATGTAGCCCTTTTTGGT

6518
Table 2
NA

191F6
1
TGCTCAATTGCCATACATGCACTATA

GGCCGGGATAGAAAATCGTCAGCT

6519
Table 3A
NA

193G3
1
TTCAAGGATGTGACTGATATCTGGTG

TGGTTTATTTTGTTTGTTTTGGGG

6520
Table 1
NA

194C2
1
AGCTTTGGAAATTTGAACAAGGTGGG

GACAAAATCAGGCAATAACAGACT

6521
db mining
NA

458C6
1
CACTTCCTGAGTGTTTCCTGAGAACA

AAGGATCAGAGCTTCGGCTGTGAG

6522
Table 1
NA

458E4
1
TTTTCCTTTTCGCTGACTTTCCCACTC

ACTGTCTGTCTCTCATTTTCTCT

6523
Table 1
NA

458G10
1
GCATGGGAATTGGCTGTCATCACTCA

TAGCACGGTGTATAAACTCAAGGA

6524
Table 1
NA

459B3
1
GTCCACTCAAGTTACCTGGCTGTCTA

TCTTTTGGCTGACCCCTGAAGCGA

6525
Table 1
NA

459D2
1
CTAAGTAAGCAAAGAGGCAGAGGGG

AGGAGGGGAGTGTTTGGTACTGTCC

6526
Table 1
NA

459E6
1
TGGTGCGGTGTTCATGATTATTATGC

AGGGTGGAAGTTCAGTATTTGGTC

6527
Table 3A
Hs.20830

DNA sequence from cosmid
1
AGCACATTTGTGCAGAAAGGTTTTGC

ICK0721Q on chromosome 6.

AGGTATCTGAGGCACTGCTCACCT

Contains a 60S Ribosomal Protein

L35A LIKE pseudogene, a gene

coding for a 60S Ribosomal

Protein L12 LIKE protein in an

intron of the HSET gene coding

for a Kinesin related protein,

the PHF1 (PHF2) gene coding

for alternative splice products

PHD finger proteins 1 and 2, the

gene coding for five different

alternatively spliced mRNAs

coding for a protein similar to

CYTA (CYCY) and identical to a

polypeptide coded for by a known

patented cDNA, and the first

two exons of the gene coding for

the homolog of the rat synaptic

ras GTPase-activating protein

p135 SynGAP. Contains three

predicted CpG islands, ESTs and

an STS/cds = (163, 2184)

6528
Table 3A
NA

460D5
1
AGAACAACACGGGATTGAAGTGGGA

AGAGATGGGACCCTCATTGGATCTG

6529
Table 1
NA

480B9
1
GGAACAATAGACCTCTTCACTAGCTC

CCTGCTGTTTGATGGTTTGGTTGG

6530
Table 3A
NA

461A4
1
AGAGGATGACTTTGAGGTAAATGTTT

ACGATGCACGGTTTTAGGCGATGT

6531
Table 1
NA

461G8
1
GTGTCCTGGGGAGTGAGGAGAGGTG

GAGTAGACTCTGAGAGGAGTGAAAA

6532
Table 1
NA

461D9
1
AGATCATGTCTGGATTGTGTTTCCTA

TTACCTAGAGACGAACACAGATCT

6533
Table 3A
Hs.80788

chloride channel 7 (CLCN7),
1
GTGTCCCAGGACGAGCGGGAGTGCA

mRNA/cds = (38, 2455)

CCATGGACCTCTCCGAGTTCATGAA

6534
Table 1
NA

481H7
1
TGTATGGCTTATAGCCAGAGATGAAA

CAGAACCCAAGTTAATATTGCCAG

6535
Table 1
Hs.333513

small inducible cytokine subfamily
1
AGGTTTCAGAATCTGGGCCTTACCTT

E, member 1 (endothelial

TACAGGTTCAACAAAAGAATGGCA

monocyle-activating) (SCYE1),

mRNA/cds = (49, 987)

6536
Table 1
NA

483A5
1
AAGATGAGGCGTAGCTCATGTACAAA

TGCAGCATTCTCATAAGTGCTTTA

6537
Table 1
NA

483B2
1
AGATAGTGGTATTTGGGTGCTGGGCT

TGTCTGAACTGAGGAGGTGGGTGC

6538
Table 1
NA

483C5
1
CCTTGCACCAGAGACGACTGACATAT

ATAGATGGGAGTCACTCATGCGCT

6539
Table 3A
Hs.40919

hypothetical protein FLJ14511
1
GGTGTAGCGTGAAGATCTGGACAGC

(FLJ14511), mRNA/cds = (22,

GCACTACGACCCGGGCCACTGTTTC

1272)

6540
Table 1
NA

463H5
1
AGAAGCAAACCTGTGAAGCTACTATC

GTTTATCATCAGTGTGAATGCACT

6541
Table 1
NA

463A7
1
TAGTGATACAATTTGGGGTGCCAGAG

GTTGGGGGTAAGGAATTTTGAAGC

6542
Table 1
NA

463B10
1
GTGTGGCCTAAGGAACACCTCTTGTG

GGGAGTAAGAGCCCAGCCCTTCCTC

6543
Table 1
NA

463C7
1
AGATGCGGGCGCAAGCTTATGTCCT

GTTATGAGGGTTTAAATTAGATTGG

6544
Table 1
NA

463F10
1
TCATAACGCCCTTCAAAACATTGAAT

AAAATCAGTGCAAAACATTGAGCA

6545
Table 1
NA

464C2
1
TGAGAAAGGAGTTAGCAGAATATTAA

CATACCGAGAAGCTGTTGTTAGCA

6546
Table 1
NA

464C5
1
CTGGAGACTCAGGTCGCTTAAGTGG

AGGGGACGGGCACAGCCATTCCTCC

6547
Table 1
NA

464C10
1
AAAGACCTGCCACTTATTTTTGGCTC

TCATCTGTACTCTTAAGTGTGTGT

6548
Table 1
NA

464D8
1
AGACACAGCTGCAGAAAACTTATTCT

TTTCAAGCATGCACAGTCACAAAA

6549
Table 1
Hs.221695

7k30d01.x1 cDNA, 3′ end/
1
CATTCAACAACACAAACCGAGCACCT

clone = IMAGE: 3476765/

ACTGTGTGCCACGCCACAGACAAG

clone_end = 3′

6550
Table 1
NA

464E7
1
CCTAGGAAACACAGGTCAAAGA

AACACAGTCCAACATGTATTCAGA

ATTC

6551
Table 1
NA

464H12
1
AAACGCAATCTATTTTAGGTTTGAGAT

TAGAAGCTGAGGCCAAGGACTCA

6552
Table 2
NA

465B3
1
TCCTCCAGATGCATGGTCCGTGAAGA

AATTTAATAGCAAAGACGAGAAGA

6553
Table 1
NA

465G2
1
GGCTCTCATGCTTATGCCACACATCC

TTGATTCTGCTTAGGAGTCTCTGG

6554
Table 1
NA

465H5
1
AAGCCTGAGCTAACAAGAGCTGAGG

ACAGTAGCTTATTCCTCTTTATGGG

6555
Table 1
NA

465A12
1
TGGATGATGGGATTGGATAAGCATGT

GGACTGGATTGTGTTACAAACTCT

6556
Table 1
NA

465F7
1
TGCTGTTTCTAGGATTAACACGAAAT

CATCACTTTGCCATATTTTGAGCT

6557
Table 1
NA

465G8
1
GGCTCAGCACAAAAGAGAATTCGTAG

CACTTTCATGTGAAAGCAGACCCA

6558
Table 1
NA

465H10
1
GATATTAAGGTACTTTCAGTACAAATC

TGGTGCTGTGAGTGGGCTCATCC

6559
Table 3A
Hs.136309

DNA sequence from clone RP4-
1
TCCAGTTTCTCATAAACAAATTCTTCT

612B15 on chromosome 1p22.2-

ATCCTGGCATTTGGATTTGGGTT

31.1. Contains the (possibly

pseudo) gene for a novel protein

similar to 60S ribosomal protein

L17 (RPL17), the gene for CGI-61,

endophilin B1 and KIAA0491,

ESTs, STSs, GSSs and two CpG

islands/cds = (1011, 1406)

6560
Table 1
NA

515C12
1
TCATGGTCATAGCTGTAACCTGTGTG

AAATAGTAATCAGATCAAAAAGCG

6561
Table 1
NA

515H10
1
ATATGTACCTGGAGGGCGGACGATC

GAAATTACTAGTGAATTAGCGGCAG

6562
Table 1
NA

55G3
1
TGCGAGTGTAATTTCTGTAAGGAGGG

TATGGGATAATTAATAGCACGCCT

6563
Table 1
NA

55F9
1
GCCCCCAGCATTCAATTCATTTTGTA

CCCTTAGTTTAAAGAACTTCTCCC

6564
Table 3A
NA

99E7
1
AACTTTGCTTTCTGAAGGTTTTGGTG

TACCTCGGGCGCGAACACGCTAAT

6565
Table 1
Hs.319825

602021477F1 cDNA, 5′ end/
1
ATTGACTCCACTTTGTGCCAAGCTCT

clone = IMAGE: 4156915/

GCGGGTAGGCATATTTCATATCTT

clone_end = 5′

6566
Table 1
Hs.17481

mRNA; cDNA DKFZp434G2415
1
CAGTGGAGAAGCTGCACTGTCTCCG

(from clone DKFZp434G2415)/

GGCTTGTGTGATCCGATCTCTGTAC

cds = UNKNOWN

6567
Table 1
NA

116C9
1
AGCTTTGAAAGTAATGTCTAACCCTG

CTGTCAGTTTATCACAAGTGCATT

6568
Table 1
NA

128F5
1
AGCTTAATTGAATTGGAGGAGCACCG

AACAGGCAGTTTCCTGAGCAGTGG

6569
Table 1
NA

135F10
1
GCTCTCACTGATCTCTCTTCTCTATCT

CTTTCTGCAGTTATACCAGCACT

6570
Table 1
NA

189F3
1
TGAGAAGAGCTGTGAAGGCAGAGGC

GGGGCAAGTGCAAAGGTCCTGACTT

6571
Table 1
NA

189A8
1
AACTCCCTGTTCAGTTCAGTTGCTAA

TGATCTCAAGCTCTTCCCTGATTA

6572
Table 1
NA

195H12
1
CAGCCTAATGCCTAACCACACAGATA

CCATTGGTGGGCGACGTGACCCAG

6573
Table 1
Hs.292457

Homo sapiens, clone MGC: 16362
1
CACCATCTTTTGCTCGGATACTAGCC

IMAGE: 3927795, mRNA,

CGCAATACCCACTCACCTACCACC

complete cds/cds = (498, 835)

6574
Table 3A
NA

466C4
1
AGGGTCTCCACCTTACAGAAGTACAT

GAACAACCAGAGATAGCAGGGCTG

6575
Table 1
NA

466D1
1
ACCAGGAAAAGTAAAAATCATAGTTG

GTGTCTCTCGGGTTTCTCACCTTC

6576
Table 1
NA

466G2
1
ATGTATGAGAGAGATTCGAGATGAGT

TAAAGGAGGGGAAGGGAGGGGTGGT

6577
Table 1
NA

466H5
1
CATGAGTATTGGCACTGGGGTTCAAG

TTCCAGGGCAGAGCAGGATAAGAG

6578
Table 1
NA

466B7
1
CTCCTGGGGCTGGAGTCCTGGTCTG

CCTTCTGGGGACAGAGATTAGGTCG

6579
Table 2
NA

466B10
1
TGGAACTTCAGTCAAAAACATCTGTA

CTTTGTACAGGACAAAGATTTGGC

6580
Table 1
NA

466C9
1
ATAGAACTTGTTTTACCCTATGAG

CCTTGCCTTGTATTTATTCACTG

TGGC

6581
Table 1
Hs.7187

mRNA for KIAA1757 protein,
1
ACATCTCTTGTGAAAGTTCAAATGTTA

partial cds/cds = (347, 4576)

CAGCAAGGTGTAAACACTCCACT

6582
Table 1
NA

121F1
1
GGGTGAATTAATCGGGAGATGGGTA

GTCAGGGCAAATGATGGGTGGGTTT

6583
Table 1
NA

121A11
1
TGCAATTGTGGAGACAAATTGTTAGA

GTTTAAATCCTGGCTCTGTTCCCT

6584
Table 3A
NA

121F8
1
GGACCTATGTCCTCAAGACATGGAAA

CTACTAGTTCTGTCGTGCCAGGAG

6585
Table 1
NA

178B2
1
AATTAAGGATGCCCTACCGACATCTA

TCAGCATACCTGGAACAGGTTCGA

6586
Table 3A
NA

178B5
1
CGGCCAACCCAGGAGGGCAGGTGTT

TTGGGCATCTGGTTTATAGTACCTC

6587
Table 1
NA

178F5
1
GCTGGGGTGAAAACTTGAAGACTCA

GACCTCAGTGGAAACAGATGAATGT

6588
Table 1
NA

178C12
1
CCCCAGGCTCTGTGACGCTTGAAATT

CTAATTAGCGCAGAAAAGGGCTAA

6589
Table 1
NA

462A11
1
CCTGACTACGTGTTTTCCCCACAGAC

ATCACACTGGTTCACCTCGTTGAA

6590
Table 1
Hs.13231

od15d12.s1 cDNA/clone =
1
AATGGAAAGACACTTCTGTATACACT

IMAGE: 1368023

GGAAATCTCAGGAAATTTCTTTTTTCC

6591
Table 1
NA

462D9
1
GACAGTACAGTACCCTAAGAGCACTG

AGGAGGGCCAGGGGACGTGAACTC

6592
Table 1
NA

462E8
1
TTTCCTTGGAGATTTCAGGCATCTTA

GGCCGGAAGGGACCTCGAAGGTGG

6593
Table 1
NA

462F9
1
CTCCGCTTCTTTCACTCATTCGTTTAG

TGTTTCTTTAAGCTTTGCCTTGT

6594
Table 1
NA

462F11
1
TCCACATTTTGATCATGCATTTATGAA

AGCCCTGGGTTTGTTATTGAGAA

6595
Table 1
NA

462G12
1
GCTATCTTCTGCTGAATCAGCGTAAT

GCTGATATACACCCTATTTTCTGT

6596
Table 1
NA

462H9
1
AAAAGAAAAGTTTTTCAACCCAGGGA

ATTTATAGTGGGTGTCAGTCGAGA

6597
Table 1
NA

472B1
1
AGGAGACGATGTAGGGGGAAGTGTG

TTAGATTGTAATGGAGGGGTTTGGA

6598
Table 1
NA

472C1
1
GCTCTTTCCCAGACCCAGCCGCCAG

GTTCTCTGTAGAAGAAAATAAATGC

6599
Table 1
NA

472E6
1
AAGGAGGAATGGGAATCTCAAGCTCA

AGGGCACTCTCACTAATTGTGGGT

6600
Table 1
NA

472F4
1
AAATAGCCACCTTCTCCCCATTTTCT

GTCAGAACACACACTTTATATCCA

6601
Table 1
NA

472G2
1
TTTGGTAAAAGAGATTGGAGGGGACA

CCAGGGAAACCAGGATTTTCTGGC

6602
Table 1
NA

472D7
1
AAGTGCTAAGGCATTCTCTAAACTAT

CTTTCCAGCTCCGGGCGACAATGG

6603
Table 1
NA

472G12
1
CCACTCTCTAAGTCAAGCGAGTCCTT

CCTGCATACCTGTACTGGGTGCTG

6604
Table 1
Hs.75354

mRNA for KIAA0219 gene, partial
1
GGACTTTGCAGGCTTCATTCCCTGTC

cds/cds = (0, 7239)

TGTGTCTTTTCCTTCTGGTGTGTT

6605
Table 2
NA

64G9
1
ATTTGCTGGCCAATCCTGCTGACTAT

GAATCTTTGGGGGCACTGAGTTAC

6606
Table 1
NA

467E5
1
CTGGGGTACTGGGGAAAAGGAACTG

GTATTGAGATTTTATATTTGGGGCG

6607
Table 1
NA

467A8
1
TTGAGTAAGGCTCAGAGTTGCAGATG

AGGTGCAGAGAACATCCTGTGACT

6608
Table 1
NA

467C9
1
GGTCACAGAGAGAAATGGTAGCTGA

AGAAGCAGGGCACGAGGGCTCTAAC

6609
Table 3A
NA

467F8
1
TTTCCGGTATATTCGTGTGGGTTGAC

TTTTTGTGTGTGTGGTTGTGGTGG

6610
Table 1
NA

468E6
1
GGATCTCTTGCTCCTCTCACCTGTGT

GACAGACTACTAACAGCCCAACTG

6611
Table 1
NA

468B9
1
ACAGTGTGGGACAGAAGAGTGCTCA

GTGATTAAATGCCTGATAATAGATT

6612
Table 1
NA

468E10
1
CTCTCTCGCAATTTACAACCGCTTTC

AGTACCATTCACCGTCACTCCTCT

6613
Table 1
NA

468F10
1
CTTTGGGGAGTGGAGTTGTTGTAGAT

GGGGAGAGAATCAGAACAAGGAGA

6614
Table 1
NA

468F11
1
CCTTACTGCTTACGGTCATCGGTCAT

CAGCCCAACCCGCTTGGTTAGGTG

6615
Table 1
NA

468G12
1
AGAGTATAATTTCCCCAGTGTGGAGT

GGTTAGTGTTGCTAAAGAAGAGGT

6616
Table 1
NA

468H11
1
CTGTGTCGTGTCTGCACTCACCTGG

TCATGTGTTCTGTTGTGCGGTAGT

6617
Table 1
NA

469B6
1
AGGGGCAGAGAAGAATCCACACTCA

CAAGAGATGACCAGGAGTAAAACTG

6618
Table 1
NA

469D2
1
CCCAGCAGAGGCCAACAAGCAGCCA

TACCCAAACTTCAGCCAAAATAAAA

6619
Table 1
NA

469A10
1
TGTGCAAATACGGCAGAGAAGAAGTG

CATGAGAAAGTGCTTTATAAGCTGT

6620
Table 1
NA

469E12
1
CCAGCTTTTCCTTTGATGTTAGTTAG

CAGTAAGTCACAGGTTTGAGCCCC

6621
Table 1
NA

469F8
1
GGCACGCATCCTCATTCCTGCATGCT

CTTAGAATATCTATCAATGATCAT

6622
Table 1
NA

469G8
1
ACTTCTATACTCAGTGCGCTGTGGGT

AACCAAGCAAGCAGGTTTGTTGTC

6623
Table 1
NA

470B2
1
GCGGGATGGTGGGAAGACAGACACT

GCCTTAGAGCATGAATAATTGAAGA

6624
Table 1
Hs.118174

tetratricopeptide repeat domain 3
1
AGGTAGACTATTTAGCTGGAAGCATC

(TTC3), mRNA/cds = (2082,

CAAACAGGGGATTTTAAAAATACTCA

7460)

6625
Table 1
NA

470C3
1
AAAATGTAGGTTAAAACTCTCACTTAA

GAAGGAGAAGATCTGAGTAAACCCA

6626
Table 1
NA

470D5
1
ACCTGAACAATGAATGAAGAAAGGAA

GACTTGGTTCTTCTAGCTCTGGAC

6627
Table 1
NA

470E1
1
CATGGCTCACAAGCTCTAACACTCCC

CTCCCTCCAGATCCTAAGAAGAAG

6628
Table 1
NA

470E5
1
TCTGAGCTTCACTTCAAGAACTGGTA

GTCCAAAAGAACTGGTTCGTTCAG

6629
Table 1
NA

470F3
1
ACTTCACTCACTTTTTAGCCTGTTCAT

ATGAGCTTGTCAGTGCTTTTGTT

6630
Table 1
NA

470G6
1
TGAGGAGGATGGGAGGCGCACAGGC

AATTTAGCTAGATATAGAAAGAGAA

6631
Table 1
NA

470B8
1
AGCTGATTTGGATTCTTGCGGTTTGC

ATCGGTCTAATTTATCAAGTGTGT

6632
Table 1
NA

470G10
1
TCCATCCTTGGAAGCTTGACAAGCAT

TCACACTACTGGCTCACCTACTAT

6633
Table 1
NA

471D6
1
TAGCACTGTAGCCAGAGTCCCTGCTT

GTACCAGGAAGCTGGGTGGTGGTT

6634
Table 1
NA

471F1
1
TGGATAGCAGAATTACGTGTTTTGT

GGATTGGGGAGGGAGGGGAGGAAA

6635
Table 1
NA

471F4
1
GCACTCCTGGAACCTTCTCACTAATT

CGGGGACCAGTTTTGTGAATGTTG

6636
Table 1
NA

471F6
1
TTGCTGCGGATGACCTGACTGAGCC

CTGGGAGACTGTGCTATAATCTCTC

6637
Table 1
NA

471E9
1
AGAAGGAGGATCTGTTCTAAACATCT

GCGAGGGGAGGACAAAGCATTGAA

6638
Table 1
NA

471E11
1
CTGCATCTGAGTGAAGATGAACCTT

TCTTTCCCAGCCCTGAGAGAGGGA

6639
Table 1
NA

471H11
1
GTCTAGCTGGCAGGTGATGGATGAAT

GGATGAGCTGGCAGACCAACAGAA

6640
Table 1
NA

473E4
1
TGCATGGAAATGTTTCGAGTACGGGG

AAAATAAGGGAGCCAAAACTGTGT

6641
Table 1
NA

473F3
1
TTTTAAGGTGTGACTCAATTTACAGG

CATTCTGTATTTTTGCGATTTGGT

6642
Table 1
NA

473E11
1
ACCTTTGGGAGAAAGTCTTACAACTA

CATGAAATGCAGATTTATGGACTC

6643
Table 1
NA

476C1
1
GAAGGGACAGAACAATCAACTGTGA

GAGATGGGAAGAAAACTCAAATGGA

6644
Table 1
NA

476D3
1
CTAGTTTGGGGACTTTCATTGGGCAC

GTGAATCCAGGAGGGCTGAATTTT

6645
Table 1
NA

476F5
1
GGCCCAGATTGTAGACAGCATAAAAA

TAATTTTGGGCTTTTCCTGTTAAA

6646
Table 1
NA

476G3
1
CTGGGCTTCTTGTGTGAGAAGCACC

GCAGCCAAGAACAACCAGTGCAACT

6647
Table 2
NA

476G4
1
GAAGGGGGATTCGGTGATGGGGGAA

GCCAAGGGACAAGGGAAAAAGGAAA

6648
Table 1
NA

476A10
1
AACCCAACCATGAAAAAGAAGA

AGCTCTGGACTACGGCCAGGCGTG

GGAG

6649
Table 1
NA

476G8
1
TGGCTATTTGAGTTTTCTCTTACATGA

AATGCCTGGCAACGTACACTGGC

6650
Table 1
NA

476H10
1
TGAACTCTGATTTCCGCCGAAACTAG

GAGGAAACACCCAAAAGAAGACGG

6651
Table 2
NA

477E1
1
TTTGCTGGGACTAAAATCAAAACTGC

ACTGCAGAGCAGGTGAGGGTTCAT

6652
Table 1
NA

477E6
1
TGGAGAGTGTGTGTATTACCATTTTTT

TACATTGCATCACATTTTACCATCTAT

ATCT

6653
Table 2
NA

477A11
1
TTTGAAGCCCCTCATAGAGAAGAGAC

TGTACCATAAGAGAAGCCCACTCA

6654
Table 1
NA

477D9
1
AACTCTCAGTCCATGAGCTTGATTAC

TCCATTGTACCATTTGGAAGCCCA

6655
Table 1
NA

477D10
1
GTGGGTAGCCATTAAGTGGTCTGGC

ACAGAAAGGGACAAGTAGCTTCAAG

6656
Table 2
NA

480A3
1
CTGGTGCTGAGTGGAGTCACAGTAA

GGCTGTAGATGGAGCGCCCTGGGAA

6657
Table 1
NA

480B5
1
TTTTGATGTGACCAGTCGTGCATGGC

GGGGGACAGGAGCTTAGGGGGAAT

6658
Table 1
NA

480D2
1
ATTATGCATGTCGAGGGGACAACTTT

TATTAAACAGGAGGGGTGTGTCTT

6659
Table 1
NA

480E2
1
TGGTCATGTTTCCCTCTTTACTCCAC

GACAGTTTCATTATTGTAACCAGG

6660
Table 1
NA

480E3
1
TTCTGTTGGTTATATGAATGGCAGTT

ATTGTCTCCCAGTGTGTGGGTTCT

6661
Table 1
NA

480F3
1
AGTCCTGGCAACTTTACCTGGGAATT

GTCTGTAATCTTTAAGCAGTGGCG

6662
Table 1
NA

480G4
1
AGGACTTATCTAGCTTTCACAGATTC

AGAGTGCGTTTCAAACATCATTGT

6663
Table 1
NA

480C8
1
TTTAACAGGCTTATCTAGGACATAGG

CCCAAGAGGGGAGGAGGAGGAAGGC

6664
Table 1
NA

480D9
1
CTCCAGGCCGAACGAGCCTCCACTC

TGGATTAAGATCTGTCATCTTGACA

6665
Table 1
NA

480E7
1
GCAGGACTTGTGGCAGGACTCAACG

GGAGAGAAAGAGGCTGAAACATAAA

6666
Table 1
NA

480E11
1
AAGAACATCCCAACTTTTCCGGTAGG

CAAGTGTCAAGTCACCTGGACAAT

6667
Table 1
NA

480F8
1
TCTGTGGCTTGTTGTGGGACCCCTGC

GCCCTTTAAATTAGGGCATATTTTA

6668
Table 1
NA

487F11
1
GCGCTAAAAACCTGGTGATTAAATGA

CAAACAGAACGTGAGAAGAGATTT

6669
Table 3A
NA

499G1
1
TCCTGCACACAACAAATAAAGACAAG

AATAAAGGGCCACCCATCAGTAGC

6670
Table 1
NA

518F10
1
ATGTTGTTCAAATTAAACATCATACCA

CATGGGGGCAGCTACCAATTTTT

6671
Table 3A
NA

524A12
1
TAATATGAAAAGCTGGAAAAGAATTA

AGGGGTTGAGGAGACGTGCCGGGT

6672
Table 1
NA

526B9
1
GTTACCCTGACGAATGCAGTCCTCGT

GTGGAATGTCTATGCCCTCTTGAG

6673
Table 1
NA

583B5
1
ACACCAGCAGTCATAGGGGAAAGGG

GAATACAGTTAATTGGGTATTTGTT

6674
Table 1
NA

583D6
1
ACTCCCTCCCATCTCTGGTCTTTAGT

TGGAAGCAAGCTTTCGGACAACGG

6675
Table 1
NA

583G8
1
TCCAACAAGGGTTACGGCAGAATTTA

TGCGAAAGTCTTCTTTGGGCTAAA

6676
Table 3A
NA

584A1
1
TTGTTCTGCTCAGGCCAAGGATTGTT

GTGTGCTCTGTATTTGCTGCTTTG

6677
Table 1
NA

584D3
1
GGCCCGGCATGTCTTCGTTTTGTCAG

TCCTCATCCAATCCATCTTCATAT

6678
Table 3A
NA

DNA sequence from clone RP4-
1
GTGGGTTTTTAGACACCTGCAGCAAG

620E11 on chromosome 20q11.2-

AAGAAATACTGACTGACTAGGCAT

12 Contains l

6679
Table 3A
NA

591H9
1
TTTTAAAGAAAAATCTATTATCTTGGA

GCATGGATGGGGGAATGCGAAGG

6680
Table 3A
Hs.6179

DNA sequence from clone RP3-
1
CAGAAGAAACATGGCAAACTGCTCTG

434P1 on chromosome 22 Contains

TGCTTTCAAACCAAAGTGTTCCCC

the KCNJ4 gene for inwardly

rectifying potassium channel J4

(hippocampal inward rectifier,

HIR, HRK1, HIRK2, KIR2.3), the

KDELR3 gene for KDEL

(Lys—Asp—Glu—Leu)

endoplasmic reticulum protein

retention receptor 3, the DDX17

gene for DEAD/H

(Asp—Glu—Ala—Asp/His)

box polypeptide 17 (72kD), ESTs,

STSs, GSSs and slx putative CpG

islands/cds = (307, 2259)

6681
Table 1
Hs.44577

602388170F1 cDNA, 5′ end/
1
GTTACTTAAGATCAGTATGTGTGGTG

clone = IMAGE: 4517129/

CATATGTGATTTCGACCATTCAGT

clone_end = 5′

6682
Table 3A
Hs.108124

cDNA: FLJ23088 fls, clone
1
GAGAATTTCCGTCTGATCTATGACAC

LNG07026/cds = UNKNOWN

CAAGGGTCGCTTTGCTGTACCTCG

6683
Table 1
NA

119F12
1
CTGGGTTAATACTCACCAACTTTGAG

AAGGTTGGTCTCTGCTCTTCTGTA

6684
Table 1
NA

119G10
1
GGAAAGACAGGTGAGTGTGCCACAA

CTACCTAACACATCAGCAAATCTGG

6685
Table 1
NA

485A8
1
GTCACTTTAGCGAGCGGGAAAACAAT

GGCGGAAAGGGAAAACCTGGAAAG

6686
Table 1
NA

485D5
1
CGATAAGCTGTGGTGTTGGGAGTGA

GAGATGTTACTTTGCGAATGTTCAA

6687
Table 1
NA

489H9
1
AAAGGCTAGGTTTGCGAAAGCCCTTC

TAAAACTATGCTTTGGTGGTTACT

6688
Table 2
NA

494B11
1
CTGACCCTGCGGGGCGGAAGATAAA

ACAAAAACGAGAAGAACAAGCAAGA

6689
Table 1
NA

478E5
1
AAGATTGTAAAAATACATTTTAGGCTC

AAGAGTTCCAGGGGTTTCAGAGC

6690
Table 1
NA

478G6
1
TGCAAGCTGGCACCTTCACGTTTATT

TTTAAAGGGCTTCACATCAAAGAT

6691
Table 3A
NA

478H3
1
AAACAAAGAAGGAAAATGAAGAGGG

GGAAAAGATGAACATCAGGCTGGGT

6692
Table 1
NA

478C7
1
TCCAAAGGATGTTCTGGTGTTGCAGC

ATGATTTCTGGTGTTAGTCTTTCT

6693
Table 1
NA

478G8
1
TTTGTGGGTGCGTGAGAGGGGATTTA

TACTCCTTGAGCCATATTTTGTGA

6694
Table 1
NA

478H7
1
GGGTTCACAGCATGGGTGGAGGTAA

GTAGTATTCTCATTGGTTGGTTAGT

6695
Table 3A
NA

479B4
1
GACAGTGAGAAGAATATGGAGTAGA

GTCCTTTTGGTCTTTGAGGCGGTCA

6696
Table 1
NA

479D2
1
AACAGCTGAAGAACAAGAAGGTGAG

CTCTGAATGCGTCAGGTGGTCATTC

6697
Table 1
NA

479G2
1
GGCTGACCAGTACAGGCTTGGGAAT

TTTATGGTTGGGTGGTTTCTACCAA

6698
Table 1
NA

479G3
1
GGGGGAGCTATATTACTGATTAAAAC

CACCATTTCTTCACCCAACTTATG

6699
Table 1
NA

479G5
1
AAGTCTTGTATTATGAGGTACTGGGG

CTCTGGGGGATATTGAGATGAGAA

6700
Table 1
NA

479G6
1
AGTCCTGCTGAATCATTGGTTTATAG

AAGACTATCTGGAGGGCCTGATAG

6701
Table 1
NA

479H4
1
GGAGCTTCCAGTCTAATAGAAAAGAT

GCACTTACGAATAGACTTTGGGTA

6702
Table 1
NA

479H5
1
TCTGTGCTCTGTGGACCCGTCACCCT

GAGCTCCTCAGTTGCTGAACCATC

6703
Table 1
NA

479H6
1
TGCTGGCATGTGGATAGACTTTAGCA

AATGGTAGTCATCTTCTAATTTCT

6704
Table 1
NA

479G12
1
AATGGGAATCTTAAGGCCTCTCTGGA

AAGGGTGTGAGGGGGTCGAGGGGG

6705
Table 1
NA

479H12
1
TGCATATTGTCACTGACTGGCTAGGG

TCTCTAAATTTATGAAACCTTACA

6706
Table 1
NA

482A5
1
GTCAGCAACTAAAAAGGGAGATATAT

CTTAGAGAGACTGGAATAAGCAACTC

6707
Table 3A
NA

483G5
1
GGAAGGACTCAAACTGGCCATAAAG

GCAATACGGCATGTTCATTACACCA

6708
Table 1
NA

488C4
1
TTTGTTGACTATGAAATAGTGGTCCT

GGTTTTAACTCTTTGGGGTTCCCT

6709
Table 1
NA

490F10
1
AATTATATTTTAGGCTGATGTGGGTG

GTCTGTAATGCTCTCATTTACCCAC

6710
Table 1
NA

493C2
1
CTGTGTTTCTGTATGGTATTGCATTTG

TCCCGGCCTGTTGGGTTTGGTGG

6711
Table 1
NA

58G4
1
TTCATGCTCATTAGGACATTGAACAA

ATGGCAGAGTAAGAAAGTTTGGCC

6712
Table 3A
Hs.169370

DNA sequence from PAC 66H14
1
GGGAATGGACTCATATGCAAGATTGC

on chromosome 6q21-22. Contains

TGACTTCGGATTGGCCCGATTGAT

FYN (P59-FYN, SYN, SLK) gene

coding for two isoforms. Contains

ESTs and STSs/cds = (12, 1706)

6713
Table 1
NA

598H2
1
CAACACATGGGACGGGAAGGAAATC

CTTCCGTGTGATTTTGTTAAAAATA

6714
Table 3A
NA
AA077131
1836605
7B08E10 Chromosome 7 Fetal
1
CAGCCACCTCCTCAGGTCAGACAAG

Brain cDNA Library cDNA clone

CCCAGCACCCCAAATACCACTATCTG

7B08E10, mRNA sequence

6715
Table 3A
NA
AA501725
2236692
ng18e12.s1 NCI_CGAP_Lip2
1
GGCTTCCCTATTACCTCCCAGCGAAA

cDNA clone IMAGE: 929806

TTCGTAGTCTTTCTCTATGGAGTT

similar to contains Alu repetitive

element; mRNA

6716
Table 3A
NA
AA501934
2236901
nh56a10.s1 NCI_CGAP_Pr6
1
TGCTGATGTGTTAGGTAGTTGTGGCA

cDNA clone IMAGE: 956346,

CACTCACCTGTCTTTCCTAAATGC

mRNA sequence

6717
Table 3A
NA
AA579400
2357584
nf33d05.s1 NCI_CGAP_‘3Pr1
1
TTCATGCTCAGCAAAACAACGTTTTA

cDNA clone IMAGE: 915561

GGATGGTGAGAGAAGACAAAGTAA

similar to contains Alu

repetitive element contains

6718
Table 3A
NA
AF249845
8099620
isolate Slddi 10 hypervariable
1
TATTAACCACTCACGGGAGCTCTCCA

region I, mitochondrial sequence

TGCATTTGGTATTTTCGTCTGGGG

6719
db mining
Hs.277051
AI630242
4681572
ad07c09.y1 cDNA/clone =
1
TTACCTGCTTTGCATGCTCTCCATCG

ad07c09-(random)

TCAAAGTCTTCTGGAAACTTAGGC

6720
db mining
Hs.277052
AI630342
4681672
ad08g11.y1 cDNA/clone =
1
CCCCACCCCAACACATACAAACGTTT

ad08g11-(random)

CCCACCAATCCTTGAACTGCAAAA

6721
db mining
NA
AI732228
5053341
nf19e05.x5 NCI_CGAP_Pr1
1
TTCAAGGTCCCAATACCCAACTAACT

cDNA clone IMAGE: 914240

CGAAGGAAGAAATGGAAATCTATT

similar to contains Alu repetitive

element, mRNA s

6722
Table 3A
Hs.197803
AW379049
6883708
mRNA for KIAA0180 gene, partial
1
TGCACAGAACTCTTACTTACATGTCT

cds/cds = (0, 2413)

CATCGAAACTCCAGAACACCGTCG

6723
Table 3A
Hs.232000
AW380881
6885540
UI-H-BI0p-abh-h-06-0-UI.s1
1
TGCATGTATCCCGGTAATTCAAATCC

cDNA, 3′ end/clone = IMAGE:

AATTTCACAGCCACTGCTGAATAT

2712035/clone_end = 3′

6724
Table 3A
Hs.325568
AW384988
6889647
602386081F1 cDNA, 5′ end/
1
TACAGGAAAATGAAACTAGACGGGTG

clone = IMAGE: 4514972/

GGGGACACTAGAATGAAAACCAGT

clone_end = 5′

6725
Table 3A
NA
AW836389
7930363
PM0-LT0030-101299-001-f08
1
AGTTTCTGCTTTCAGTGACTGAGGCT

LT0030 cDNA, mRNA sequence

TTGCTTTAACCTGGTGACTCCCAA

6726
Table 3A
NA
AW837717
7931691
CM2-LT0042-281299-062-e11
1
TCCCACTTCAAGTTAAGCACCAAAGC

LT0042 cDNA, mRNA sequence

AATCACTAATTCTGGAGCACAGGA

6727
Table 3A
NA
AW837808
7931782
CM1-LT0042-100300-140-105
1
CATGGATGGGGGCAGTGGTGTTTCT

LT0042 cDNA, mRNA sequence

AGTGTGTGAGGAAGCAGAGCAGATG

6728
Table 3A
NA
AW842489
7936472
PM4-CN0032-050200-002-c11
1
TCACCACAGATGGGAAGATCGTTTCC

CN0032 cDNA, mRNA sequence

TGAAAACAGTCTATAAATCACAGA

6729
Table 3A
NA
AW846656
7942373
QV3-CT0195-011099-001-c09
1
CAGACGCTCCAGTGCTGCCGAGGTT

CT0195 cDNA, mRNA sequence

AGTGTGTTTATTAGACCTGAAATGA

6730
Table 3A
NA
AW856490
7952183
PM4-CT0290-271099-001-c04
1
CCCTTTAGGCCTCTTGCCCGAACAGT

CT0290 cDNA, mRNA sequence

GAACACTAATAGATATCCTAAGCT

6731
Table 3A
NA
AW891344
8055549
PM2-NT0079-030500-001-a04
1
ATGGGGATCATGTTTTATTTTTCTCTA

NT0079 cDNA, mRNA sequence

TATAATGGGCCAGTGTGTTCCCA

6732
Table 3A
NA
BE061115
8405765
QV0-BT0041-011199-039-f09
1
AGCTGTAGACCATAAGCCACCTTCAG

BT0041 cDNA, mRNA sequence

GTAGTGGTTTGGGAAATCAAGCAA

6733
Table 3A
NA
BE086076
8476469
PM2-BT0672-130400-008-h09
1
TGTACTTATGCTTGTCTTCTCTACCTG

BT0672 cDNA, mRNA sequence

TGTACTTATGCTTGTCTTCTCTACCTG

6734
Table 3A
NA
BE091932
8482364
IL2-BT0733-130400-068-C11
1
GGAGGGTGTGGGAAGCAAGAGAAGA

BT0733 cDNA, mRNA sequence

ACATTCTGTTAGGGGCAGAGAAGAA

6735
Table 3A
Hs.173334
BE160822
8823543
ELL-RELATED RNA POLY-
1
GCATCTCCAGCTTTCATAGTTACCCA

MERASE II, ELONGATION

ACTTGTAAACCAGAAGATGTGCTG

FACTOR (ELL2), mRNA/cds =

(0, 1922)

6736
Table 3A
NA
BE163106
8625827
QV3-HT0457-060400-148-h10
1
GGCCAGTGCCAGACGGTAGCTAGTT

HT0457 cDNA, mRNA sequence

GGATGCTAAAGGTAGAATTTAGATA

6737
Table 3A
Hs.301497
BE168334
8631159
arginine-tRNA-protein transferase
1
GGCATTGTAGGGTTGACACCAGC

1-1p (ATE1) mRNA, alternatively

AAAGACTCAGAGTGACTTGAGCAT

spliced product, partial cds/cds =

TGGA

(0, 1544)

6738
Table 3A
Hs.172780
BE176373
869102
602343016F1 cDNA, 5′ end/
1
AGCCCATTTGGATATGGCCCATCTTT

clone = IMAGE: 4453468/

ACCTAATGGCTACTATAGTGAGGT

clone_end = 5′

6739
Table 3A
NA
BE177661
8656813
RC1-HT0598-020300-011-h02
1
AATCACAGCAGTAACTCCCAGTAGGA

HT0598 cDNA, mRNA sequence

AAGATTCTCAAAGGAATAGTTCTT

6740
Table 3A
NA
BE178880
8658032
PM1-HT0609-060300-001-g03
1
AATGGTCAGGCACAGGTAGAATCAAA

HT0609 cDNA, mRNA sequence

GTCCTGTATGTATGTTCACACAGA

6741
Table 3A
NA
BE247056
9098807
TCBAP1D6404 Pediatric pre-B
1
TACCTGAAGGTGTAGAGAGTGCCCG

cell acute lymphoblastic leukemia

CATCCAGCAAGGCCAACAGCTCCAC

Baylor-HGSC project = TCBA

cDNA clone T

6742
Table 3A
Hs.11050
BE763412
10193336
mRNA; cDNA DKFZp434C0118
1
CTGTGTTTTTCCCAAAGCAACAATTTC

(from clone DKFZp434C0118);

AAACAAAGTGAGAGCCACTGACA

partial cds/cds = (0, 1644)

6743
Table 3A
NA
BF330908
11301656
RC3-BT0333-310800-115-f11
1
GACTCCGAGCTCAAGTCAGTCTGTAC

BT0333 cDNA, mRNA sequence

CCCCAACCCCTAACCCACTGCATC

6744
Table 3A
NA
BF357523
11316597
CM2-HT0945-150900-379-g06
1
TGTAACTGACTTTATGTATCACTCAAG

HT0945 cDNA, mRNA sequence

TCTTGCCTTTACTGAGTGCCTGA

6745
Table 3A
NA
BF364413
11326438
RC6-NN1068-070600-011-B01
1
TCTCTCTAACCAAAACTGTAATCTTCA

NN1088 cDNA, mRNA sequence

GGACCAGCAAACTCAGCCCAAGG

6746
Table 3A
NA
BF373638
11335663
MR0-FT0176-040900-202-g09
1
AACTCTTGGTTAAATGGGTTAATAGA

FT0176 cDNA, mRNA sequence

GGATTGGAACACTTTGTTTGCTGT

6747
Table 3A
NA
BF740663
12067339
QV1-HB0031-071200-562-h04
1
AGAAGCAAACCTGTGAAGCTACTATC

HB0031 cDNA, mRNA sequence

GTTTATCATCAGTGTGAATGCACT

6748
Table 3A
NA
BF749089
12075765
MR2-BN0388-051000-014-b04
1
GGACTAACTTCCACCTCCTCTGCTAC

BN0386 cDNA, mRNA sequence

TTCCAGCTGCTTCTAATCACACTT

6749
Table 3A
NA
BF758480
12106360
MR4-CT0539-141100-003-d05
1
AGTCTTCCACCCAGCATAGGTATCAC

CT0539 cDNA, mRNA sequence

ACAACCAGCTCTGTTTTACTCCTG

6750
Table 3A
NA
BF773126
12121026
CM3-IT0048-151200-568-f08
1
TTAGCTGGTACATTGTTCAGAGTTTA

IT0048 cDNA, mRNA sequence

CTGGGAGCCGGTAAGATAGTCACC

6751
Table 3A
NA
BF773393
12121293
CM2-IT0039-191200-638-h02
1
AGCGTGATGCTTCCTCATGTCGGTGA

IT0039 cDNA, mRNA sequence

TTTTCTGTTGAGACATCTTCAAGC

6752
Table 3A
NA
NF805164
12134153
QV1-CI0173-061100-456-f03
1
CAGGGTTAACAAAAGTATGGAATTCA

CI0173 cDNA, mRNA sequence

ATTCTTTTTATATGCTGCAGCCATGTT

CCT

6753
Table 3A
NA
BF818594
12156027
MR3-CI0184-201200-009-a04
1
TGTAATTGATTTCCGCATAAACGGTC

CI0184 cDNA, mRNA sequence

ATTACTGGCACCTATGGCAGCACC

6754
Table 3A
NA
BF827734
12171909
RC8-HN0025-041200-002-F08
1
GTGATCCACTTGGAGCTGCTACTGGT

HN0025 cDNA, mRNA sequence

CCCATTGAGTCCTATAGTACTTCA

6755
Table 3A
NA
BF645167
12201450
RC5-HT1035-271200-012-F08
1
TGCCATGAAATCTCTATTAATTCTCAG

HT1035 cDNA, mRNA sequence

AAAGATCAAAGGAGGTCCCGTGT

6756
Table 3A
NA
BF869167
12259297
IL5-ET0119-181000-181-b11
1
CCCACCTGGCAAATCCTCAAGTGTGA

ET0119 cDNA, mRNA sequence

CCCTAGTCATCTTTCTCCTTTTGG

6757
Table 3A
NA
BF875575
12265705
QV3-ET0100-111100-391-c02
1
GCTAAACAGAAAAGAACCTGAAGTAC

ET0100 cDNA, mRNA sequence

AGTTCCCGTCTTCAAAGAAGATGC

6758
Table 3A
NA
BF877979
12268109
MR0-ET0109-171100-001-b02
1
ATCCTCCTCCCCTGGGATGGCATAGA

ET0109 cDNA, mRNA sequence

AGAGACTTTAAAACCAAATGAGCC

6759
Table 3A
NA
BF897042
12288501
IL2-MT0179-271100-254-C11
1
GTCAGTAAGCTCTGCCTGCCAAGAAG

MT0179 cDNA, mRNA sequence

ACACAGTGAGAGGTGTCCACAGTC

6760
Table 3A
NA
BF898285
12289744
QV1-MT0229-281100-508-e11
1
GTTTCCACTTAGTTACTTCTTCCTACC

MT0229 cDNA, mRNA sequence

TGCTGTGAAGCTCTGCACCCTGC

6761
Table 3A
NA
BF899484
12290923
IL5-MT0211-011200-317-f03
1
AGAGTAATCCACATCCCAGGGACAGT

MT0211 cDNA, mRNA sequence

CACAATGACCTACGGCTTTAGCTG

6762
Table 3A
NA
BF904425
12295884
CM1-MT0245-211200-662-d02
1
GCAGGGCTACACCAAGTCCATTGATA

MT0245 cDNA, mRNA sequence

TTTGGTCTGTAGGCTGCATTCTGG

6763
Table 3A
NA
BF906114
12297573
IL3-MT0267-281200-425-A05
1
TCTTCTCTAAAATGCCCTCCTCTCCTT

MT0267 cDNA, mRNA sequence

CCTTTTTCCAGACCTGGTTTAAA

6764
Table 3A
NA
BF926187
12323197
CM2-NT0193-301100-562-c07
1
TCGCCATTTGGTAGTTCCACAGTGAC

NT0193 cDNA, mRNA sequence

TGCTCTTCTATTTTACGAAGCCAC

6765
Table 3A
NA
BF928844
12326772
QV3-NT0216-061200-517-g03
1
GTAGATTACTATGAGACCAGCAGCCT

NT0218 cDNA, mRNA sequence

CTGCTCCCAGCCAGCTGTGGTGTG

6766
Table 3A
NA
BG006820
12450388
RC4-GN0227-271100-011-d03
1
TTTCCTTTTCGCTGACTTTCTCACTCA

GN0227 cDNA, mRNA sequence

CTGTCTGTCTCTCATTTTCTCCA

6767
Table 3A
NA
F11941
708260
HSC33F051 normalized infant
1
TGGTAAGTTTCTGGCAGTGTGGAGAC

brain cDNA cDNA clone c-33f05,

AGGGGAATAATCTCAACAGTAGGT

mRNA sequence

6768
Table 3A
NA
U46388
1236904
HSU46388 Human pancreatic
1
CCATGGTGGTGCTTGACTTTGCTTTG

cancer cell line Patu 8988t cDNA

GGGCTTAATCCTAGTATCATTTGG

clone xs425, mRNA sequence

6769
Table 3A
NA
U75805
1938265
HSU75805 Human cDNA clone
1
TCAGTGGGTGTTGGTTGTCCATTAGT

f48, mRNA sequence

TGAGACTTAGTTGTTGCTCTGGGA

6770
Table 3A
NA
W27858
1307658
36f10 Human retina cDNA
1
GGCTGGACAGCAGATGATTCAAATCT

randomly primed sublibrary

CAATACTACATGCCCATTCTGTGG

cDNA, mRNA sequence

6771
Table 3A
NA

38G5
−1
CAGGATGGAACAAGACTCCAGCCCC

TGCCTGTCTCATGTATCTGCAAGGG

6772
Table 3A
NA

38F11
−1
CTTCAGTGCGTACACGAGCTCAACGT

TAGTGCCAGGAAAGACAACTACTC

6773
Table 1
NA

37G7
−1
ACTCGTATGCCAACTCTTCTGTCTTC

ACTACTAGAGTGTAGATTGGACTC

6774
Table 1
NA

37G8
−1
TGGACTGGAACTTGACTCGAAGTTAT

GTGGCTTAATGAGTAAGTTCAGCC

6775
Table 3A
Hs.197345

thyroid autoantigen 70kD (Ku
−1
ACTGGTTCATTTGTTTCCCGATAGAG

antigen) (G22P1), mRNA/cds =

CTTTATTGGAGGAGGCTTGAGAGC

(17, 1846)

6776
Table 1
NA

40E4
−1
ACCATCTCCTTTAATCCTCACAGTGA

TCCTGGAGCAATGTGTGCATTCCT

6777
Table 3A
NA

41E9
−1
CATCACCTGCTCACCTAGGAACCAGG

AGTACTGGGAACTGTTCCGTTACT

6778
Table 3A
Hs.169476

Homo sapiens, glyceraldehyde-3-
−1
TCATTGCTGATGATCTTGAGGCTGTT

phosphate dehydrogenase, clone

GTCGAACTTCTCATGGTTCACACC

MGC: 10926 IMAGE: 3628129,

mRNA, complete cds/cds = (2306,

3313)

6779
Table 3A
NA

47E5
−1
TGGCACCACGCTGATTATTTTCCTTTT

CAAATCCCAGCCTATACACCTCC

6780
Table 2
NA

46D11
−1
GCTGTCTGTCTTCCCAATATCCATGA

CCTTGACTGATGCAGGTGTCTAGG

6781
Table 1
NA

50A11
−1
AGGCCTTTTTATTTGTCTGTTTAGATA

CACTGCTTCCTATATCTGCTGGA

6782
Table 3A
Hs.132906

DNA sequence from clone RP11-
−1
CCCGTGCCCCACCAGTCTCACTGCC

404F10 on chromosome 1q23.1-

TGACTCCAAGTCTCGTACACTAGAT

24.1. Contains the 5′ end of the

SLAM gene for signaling

lymphocytic activation molecule a

SET (SET translocation (myeloid

leukemia-associated)) protein

pseudogene, the CD48 gene for

CD48 antigen (B-cell membrane

protein), the gene for a novel

LY9 (lymphocyte antigen 9) like

protein and the 5′ end of the LY9

gene. Contains ESTs, STSs and

GSSs/cds = (41, 1048)

6783
Table 1
NA

52B9
−1
AGCGATGAACTGTTGCAAAAGAATTT

TCCAGAGCATTTTCCATTAAACCA

6784
Table 1
NA

53B1
−1
CCATATTCTTGTTCCCCAGCCAGGTG

CTGCACCTCCCCACTCTTTTTAGTG

6785
Table 1
NA

53E3
−1
AAATGCTTAAAGGAACAATATATGTC

CCTTTTCGAGGCACGTGATTCGTTT

6786
Table 1
NA

53E10
−1
TCTGGAGCCACACCCTTACCATCACC

TTCCAAAGAAGAAATTGAACCCTT

6787
Table 2
NA

53G7
−1
AATCACACAAGGTCGAAAGTAGACAG

TCCTCTTGGACTTGGAATTGTCCA

6788
Table 1
NA

54F4
−1
ACTTTCCTCCGGGAAGTTTGTATCTT

AGCGTGGACAACAGGTTAACACAA

6789
Table 1
NA

54G9
−1
TCAGGATGCTCTCACTTTAAGAACCG

GGCAAATAATAGAACACTGTGACA

6790
Table 1
NA

59G1
−1
ACTTCACTCAGAGTAAATGAAAAGAC

TGGGTGCCTCATCAATATCATTGT

6791
Table 1
Hs.48320

mRNA for ring-IBR-ring domain
−1
TGACTGAAGGCAAGCTCACAGATGAA

containing protein Dorfin,

GCAGAGGACTGAAGATCTCGATCT

complete cds/cds = (317, 2833)

6792
Table 1
NA

60G8
−1
GCTGAGAAGGATGTGGTATAAATGTA

TTAAGCAGCTTAGGGTCTCTGGCC

6793
Table 2
NA

62C9
−1
AAGTCCCCGTCTAGTGGGAAAGAAA

GAAGTTGAACAAGTAATTCCAAGGG

6794
Table 3A
NA

62F11
−1
CGCCCGGCAAGTACTGGGGTTTCTTA

TAGCTTCTCTCTGCATCTACAAAG

6795
Table 1
NA

63E1
−1
CTGTTTCTCTATTTTAACTTACATTGG

TTATTCTGTAAAGTCAGATGTGGCAG

6796
Table 2
NA

65B1
−1
GCACTGTCCTTCCCAGTTCTACATTT

GAGTCTGAGTTGACTCGCAAGACT

6797
Table 2
NA

65D10
−1
AACAGATTGTGCTTCTGTTCTGAATC

TTCTAAAGCCATCTGCACAGTGCT

6798
Table 2
NA

65D11
−1
AACAGATTGTGCTTCTGTTCTGAATC

TTCCAAAGCCATCTGCACAGTGCT

6799
Table 2
NA

65D12
−1
ATCTGCACAGTGTTAGCATGGTGACT

CCAGTGTCCTCCAAGACTCCATAG

6800
Table 1
NA

68C9
−1
TTTAGCATCCACTAGTTACTGTCTGG

CACTGGCCACGAAGGGTGACAGGG

6801
Table 1
NA

69F8
−1
GAATCCCGGTCATCTCTACCCAAGTC

CCGGTCTCTCTACCCTATTCTCTC

6802
Table 1
NA

69H11
−1
TGGTAACTTCAAAGTCCCTAACACAT

TCGATATTTCTCCTAGCTTCCACT

6803
Table 3A
NA

70B6
−1
ACTCCCACCAAACCCCACTTTGTAAT

CACTGGTAGTAAAGAGAGATGCAG

6804
Table 3A
Hs.17109

integral membrane protein 2A
−1
AAGAGTAAGAGGCAACAGATAGAGT

(ITM2A), mRNA/cds = (139, 930)

GTCCTTGGTAATAAGAAGTCAGAGA

6805
Table 2
NA

72D4
−1
GAAATTGGAAGGTGATACTTGGGGAC

CACAACACGCACATCTGGGAACTG

6806
Table 3A
Hs.234279

microtubule-associated protein,
−1
TCATCTGTGGCATACAGAATGTCTAC

RP/EB family, member 1

AATCTTCTGCAATACAGGGTCGTT

(MAPRE1), mRNA/cds = (64,

870)

6807
Table 2
NA

72D8
−1
GGCAAGGGAACAAACTTGAGTAAATC

TAGCTCTTGAAGGGCTCGGGACCC

6808
Table 1
NA

73C4
−1
ACTCATTTGTCTCCTCATTCTCAAAAG

TCTTCTGTGGTTTGGCTTCAGTG

6809
Table 1
NA

73H4
−1
TCGATGGGCCATTATCCACTCTGCTA

TCTTCTGAAGAGTAATTTTCACCT

6810
Table 2
NA

73A7
−1
AAGGACGGAACTCACACATCTTCTTT

AGACAGAAATGTAGTCTCACTGCA

6811
Table 3A
Hs.174228

small inducible cytokine subfamily
−1
TATAATCCCAGTCCATGAGGGTGTAA

C, member 2 (SCYC2), mRNA/

AGTGAAATGAGCTGGCTGGCTGGA

cds = (0, 344)

6812
Table 3A
Hs.3945

CGI-107 protein (LOC51012),
−1
GCTCTGTTCTGGGGTTGGTCCAAAGT

mRNA/cds = (84, 719)

CAGGTGGAGTTCCAATGTATGAAA

6813
Table 1
NA

75A2
−1
TCCCTGAGATCTAGGAGGGCAGCAT

AGTATCATTTTTGTATTCCGGTGCT

6814
Table 3A
Hs.249495

heterogeneous nuclear ribonucleo-
−1
AGCTGCTACAAAGAAGACATGTTTTA

protein A1 (HNRPA1), transcript

GACAAATACTCATGTGTATGGGCA

variant 2, mRNA/cds = (104,

1222)

6815
Table 2
NA

75B12
−1
AGGGATCTGAATACTTCGGGTGCAAA

AATTTTCCTGCAGTTTAGATTTGC

6816
Table 2
Hs.205442

601439689F1 cDNA, 5′ end/
−1
TATGGTTTCCAATATCGACATGGCAT

clone = IMAGE: 3924407/

CATTGGTTACATTAGCACTGGGCC

clone_end = 5′

6817
Table 3A
NA

101G7
−1
GGCCTGGGCATAGACTGTGGTGAGG

TCACTAGATTATCTTGTTCTTCCCC

6818
Table 3A
Hs.179565

minichromosome maintenance
−1
GAGTCCTGATCTCAGCTTCATCACCA

deficient (S. cerevisiae) 3

ACATTCCTCGCCTTCAGTTGAATT

(MCM3), mRNA/cds = (44, 2470)

6819
Table 1
Hs.119640

hBKLF for basic kruppel like
−1
GGAGGTCTTTGCCACCAATGGGAGA

factor (LOC51274), mRNA/

TGAGCCCAAACTTTCGATATAGGTG

cds = (55, 1092)

6820
Table 3A
Hs.215595

guanine nucleotide binding protein
−1
ACCAGAGGTAAACTTGAGTGTAATTG

(G protein), beta polypeptide 1

TCAGACAGACACACTTTTCCACCA

(GNB1), mRNA/cds = (280,

1302)

6821
Table 1
NA

105A10
−1
TGCATTTTACATTAGCTTCCAATATTT

ATGGCAGTAACCAACAGTATTATCGT

6822
Table 1
NA

107G11
−1
TTTCCAATGCTCCTTGCTCCATTTTAA

ACTTGCTGTCCTTTATAAGAGAA

6823
Table 1
NA

107H8
−1
TGTTTTCACGATAGAAATAAGGAAGG

TCTAGAGCTTCTATTCTTTGGCCA

6824
Table 3A
Hs.64239

DNA sequence from clone RP5-
−1
TTTCATACAAAGCCAACAGAATTCAC

1174N9 on chromosome 1p34.1-

AGCCACACACTGCACAGGTCATGT

35.3. Contains the gene for a novel

protein with IBR domain, a

(pseudo?) gene for a novel

protein similar to MT1E

(metallothionein 1E (functional)),

ESTs, STSs, GSSs and two

putative CpG islands/cds = (0,

2195)

6825
Table 1
NA

109H9
−1
AGGAAGCTGTGAGGGTGGGTTCATT

AGTTGCAGGGATGGTAGTTATGTCA

6826
Table 3A
Hs.80261

enhancer of filamentation 1 (cas-
−1
GAGACAAGCTGGAAGGCCGGACCTC

like docking; Crk-associated

AGACCGGAGGGGTTTATGTCATTC

substrate related) (HEF1), mRNA/

cds = (163, 2667)

6827
Table 3A
Hs.1422

Gardner-Rasheed feline sarcoma
−1
ATAACTAGACAAGGTCTGAGCACTTT

viral (v-fgr) oncogene homolog

GGGTGGGGATGGAGTGAGAAAGGC

(FGR), mRNA/cds = (147, 1736)

6828
Table 3A
Hs.333114

AV713318 cDNA, 5′ end/clone =
−1
ATTAAGTTGGGTAACGCCAGGGTTTT

DCAAAC09/clone_end = 5′

CCCAGTCACGACGTTGTAAAACGA

6829
Table 1
NA

129A12
−1
GCGTTCTAGCTGGGCCAACAGAGCA

GGATTTCGTTTCAGAAAACAAAACA

6830
Table 1
NA

129F10
−1
ATCATGTCTCATTAACAGAGTGAAGA

TGGAGCAACGTCATCCAGCTTCTG

6831
Table 3A
NA

137D4
−1
TGGTCGCGCCCGAGGTACGGTTTTC

ATGGTAGGGCTGAATGGAAGATGTG

6832
Table 1
NA

142F9
−1
CAGAAAGATAGGAGTGTGCAATGGC

AAGGAAACTCAATTTAAAGCAAATT

6833
Table 3A
Hs.250655

prothymosin, alpha (gene sequence
−1
TTGCAAATTCTCATGGTTTGGGTTGG

28)

GTGGTGGAGAGCGCGTGTCATCTG

6834
Table 3A
Hs.249495

heterogeneous nuclear ribonucleo-
−1
TTATTCAGCGTCACGATCAGACTGTT

protein A1 (HNRPA1), transcript

ACATTTAGCAATCAACAGCATGGG

variant 2, mRNA/cds = (104,

1222)

6835
Table 1
NA

149G2
−1
TGTGTGTATGTGTGTAACCAGGTCTG

ACTATAGCTTGGTCTGTCTGTGTC

6836
Table 1
NA

149A11
−1
AGCATTTGGGGTTTTAGCTTTGGTGT

CCTAAATTTCAGTGATCTTTGCCA

6837
Table 3A
NA

151F11
−1
CATAAACCAGCAGCTCAGCGTTTCTA

TAGCAAGCGGTCTCGAGCACAAGC

6838
Table 1
NA

162E8
−1
TAGTGATAGGCGTGGTGGCGGCGAA

GGTCAGTAATGGGGCTTTTAACCAG

6839
Table 3A
Hs.334330

calmodulin 3 (phosphonylase
−1
TACTGTAGAAAGAAGAAGAGCACACA

kinase, delta) (CALM3), mRNA/

TGAGACAGAGAAGGAGGTGGATGC

cds = (123, 581)

6840
Table 1
NA

170F7
−1
CGAGGCGGCCCGGCAGGGTACCAAT

TTGGATGAATTCTTGATAGATTTAA

6841
Table 2
NA

170F9
−1
TTGGGTTCAGAATAGCTTCATCTACT

GCCGAGCAAAGTCAATACAGCACT

6842
Table 3A
NA

177A3
−1
GGTAACAGCCATCCCACCACCAATAA

TCATCTCATTGTCTTTGTCCAGCA

6843
Table 1
NA

331A3
−1
GTATGAATAGATTGCCCCATTCCCTG

CCAGCCTGGTAGTGACTTTTCCAC

6844
Table 1
NA

331A5
−1
TATAATTTCTACCAAACTAAGTTTTAT

TTTGTGCCCGCTCCCTGTCCCTT

6845
Table 3A
NA

146C3
−1
CTGTAAAATTCTTTTCGGGTCCATCC

TGGCTCTCATCTCCAGTGCTTTGA

6846
Table 1
NA

146D8
−1
AGGGTTAACAAAAGTATGGAATTCAA

TTCTTTTTATATGCTGCAGCCATGTTC

CTG

6847
Table 3A
Hs.153

ribosomal protein L7 (RPL7),
−1
CCCAATCTGAAGTCAGTAAATGAACT

mRNA/cds = (10, 756)

AATCTACAAGCGTGGTTATGGCAA

6848
Table 1
NA

158G6
−1
CCGAGGTACTCTCTTAGAGAAAGGTG

ATTGGATGCTCCGGTTGCCTGTAA

6849
Table 1
NA

158H6
−1
GCGGGTTGGAAAATAGTCGAGAATTG

ACAGTCCCTCTCGAAGATGCTTTT

6850
Table 3A
Hs.119598

ribosomal protein L3 (RPL3),
−1
TTGAGACCCCACCAACTGCAAAATCT

mRNA/cds = (6, 1217)

GTTCCTGGCATTAAGCTCCTTCTT

6851
Table 3A
NA

158G11
−1
AATGAAAAACTCCAGCTCTCAGCTCA

CAAATCTGTAATTTAGGTGTCTCT

6852
Table 3A
Hs.326249

ribosomal protein L22 (RPL22),
−1
TCGTCCTGGTTAATCTGGAAGTAACG

mRNA/cds = (51, 437)

TAATTCGTAACTCTCTTTGCTGTT

6853
Table 3A
Hs.297753

vimentin (VIM), mRNA/cds =
−1
TCGGTTGTTAAGAACTAGAGCTTATT

(122, 1522)

CCTATTCCAAATCTATCTTGCGCT

6854
Table 3A
NA

155H10
−1
AGATAAGAACTTCATCCTAAAGCATC

CGGGCCTTGGCATCTTGTCCATGC

6855
Table 3A
Hs.108124

cDNA: FLJ23088 fls, clone
−1
ACTGATTTCATCAAGTTCGACACTGG

LNG07026/cds = UNKNOWN

TAACCTGTGTATGGTGACTGGAGG

6856
Table 1
NA

159F8
−1
AATCATTGGCTACCTCCTCCCCTTTT

ACAGTCACAAGTCCAGATGTTTGG

6857
Table 3A
NA

166F3
−1
AATAAATCCCATACCTCCCATTGAAC

TACCACCCACCCCGACCACCATAA

6858
Table 1
NA

166F6
−1
CAAGACATTTCCAGCCAACTTCAGAA

TGTAGATCTTTGAGCCAGACAGCT

6859
Table 1
Hs.8121

Notch (Drosophila) homolog 2
−1
GAGGTACTGGCCTGTGAAGCCCTGA

(NOTCH2), mRNA/cds = (12,

AGGCACTGGCACTGGTAGGAACCAG

7427)

6860
Table 2
Hs.25130

cDNA FLJ14923 fls, clone
−1
ATCTTCTGTCAAAGTCAGTCGCTGCT

PLACE1008244, weakly similar to

CCAAGATTGAAACAGTCTGTGTCA

VEGETATIBLE INCOMPATI-

BILITY PROTEIN HET-E-1/cds =

UNKNOWN

6861
Table 1
NA

188A9
−1
TGGATGGATTTCCAAGTGGCCTCATA

TTTATCATGGTGCTTTAAATAGCA

6862
Table 1
NA

171F11
−1
TTCAGCTTAGGGAAAGAGAGATACAT

TTTAGATTATAGAGCATCGCCTGC

6863
Table 3A
NA

171G11
−1
ATCTTCCTATGTGCGCCAGATAATGA

TCAAGTTCACAGGTGGTCTTACTT

6864
Table 1
NA

175D1
−1
AGTTTCTTAAGTCAAATGACACATTAG

CCCACGCAATTCCCAGCCCCAGC

6865
Table 1
NA

182H1
−1
CCCTCTTCTGACATGAATTAGGCATA

ATTTAGCAATCGGTTCTTCCCAAA

6866
Table 3A
NA

184B5
−1
ATACAGTGAACTGGCCACTGGCTGTT

TGCTATATAAATGGTATACTGCTT

6867
Table 3A
NA

184D2
−1
AGGTTACTTAAAAGCATCATTGGCGT

GGTCCTCTCACTACCAAAGGGCAG

6868
Table 1
NA

184H1
−1
CTGGGGTCAGCAAAGAGGGGTAGCA

AGTGTGCCTTAGAGATGAAGAAATG

6869
Table 1
NA

46D1
−1
TTTAGAGTACTTAGAGGAGGACCAGG

AAACACTGAGACAGACACGCAGGC

6870
Table 1
NA

98C1
−1
TGTTTGAAAACTACCTTCATGGGAGC

AATGACAAGCACATGCTAGGATT

6871
Table 1
NA

98C3
−1
TTTGTGCCAAGGTTTGGGATTTTGTC

TTCTAGAGCTTCTTCTCTATTGGT

6872
Table 2
Hs.205442

601439689F1 cDNA, 5′ end/
−1
TTTTGACGCTCTCTCACTGGTCTTG

clone = IMAGE: 3924407/

GCATTTGATGTTTCTGTTGAAGCC

clone_end = 5′

6873
Table 1
NA

98H4
−1
CCTATAATGGGGGAAAGATGCTGGTT

AGATGTTTATTTTAGTGGGCTTGC

6874
Table 1
Hs.169363

GLE1 (yeast homolog)-like, RNA
−1
CCACAAACACACCCTGCCACAAGACA

export mediator (GLE1L), mRNA/

TTTAGCACAGAGGAACAGATCCAT

cds = (87, 2068)

6875
Table 3A
NA

113F12
−1
GACACCACAACTCACCTCCTCTATTA

TTAGAGATCCCGAGACATTACGGC

6876
Table 1
Hs.30212

thyroid receptor interacting protein
−1
TGTTACAATTTCAGCAGTTGAATTCA

15 (TRIP15), mRNA/cds = (15,

GTGAACACTGGTTGAGGAGTGCCT

1346)

6877
Table 3A
NA

173A10
−1
CCTTCCGTATTCTCCCAAGTATTCAC

AAGCCCTCCCTTAAAACCCTCTCT

6878
Table 3A
Hs.334853

hypothetical protein FLJ23544
−1
ACAGCCATCTGGGATGAGCCGCTTTT

(FLJ23544), mRNA/cds = (125,

CAGCCACCATGTCTTCAAATTCAT

517)

6879
Table 3A
Hs.20252

DNA sequence from clone RP4-
−1
TAACTGAATACAGTCTCATCTTGCCG

646B12 on chromosome 1q42.11-

CGCCTGGCTTACCTATCTGTGGAA

42.3. Contains an FTH1 (femitin,

heavy polypeptide 1) (FTHL6)

pseudogene, the gene for a novel

Ras family protein, ESTs, STSs,

GSSs and a putative CpG islands/

cds = (0, 776)

6880
Table 1
NA

174D1
−1
AGGTACTACACAAGGTGTCAGATGG

GGTTGCCACAATGACTAGGACAAGA

6881
Table 1
NA

45B9
−1
CCAAGAAGACAGAAGGAAGTGTCGA

ACACCATGACAAGAGCTTGCCAGAA

6882
Table 1
NA

45H8
−1
GAGAGCTTTCTCCCCGCCTTCAGTTT

CTGATGGATCTAGCCATGTTGAAA

6883
Table 1
NA

111H6
−1
TAAAACTTTCTGCCAGGGTTCCAGAG

AAAGAGTAATTTCCTTTGAGTACC

6884
Table 1
NA

111E12
−1
CGCTCGCCGGGCCAGGTACCAAAAC

TTTCATAATAAAAGGTAGGAAGGAT

6885
Table 1
NA

111H11
−1
TGACTTCATTGAAGGCTCCATCACCC

AAAGTAGATGTTAAAAACCTTAAT

6886
Table 1
NA

112H3
−1
TTTATGTGGAAGGCTTCCCTATTACC

TCCCAGCGAAATTCGTAGTCTTTC

6887
Table 1
NA

112E9
−1
TAAAATGTTGCCAGTGGAGGACCGAA

TCAAGGTTATTGCTGACCTCATTT

6888
Table 1
NA

114G3
−1
AGATATGTTCTGAGCCCCGCCCACAC

ACTGCCTGGTTACAGGGAGAGAAG

6889
Table 1
NA

117H6
−1
GAGGTTCCTTCATCCCAGAAGAAGCA

ACAGGATTTCCAGATCAGGGCAAC

6890
Table 1
NA

165E7
−1
CTGGTCTGTGTCGTTGGCTTTATGAC

AGGAAGTGCCTGTGGGTTATCTTA

6891
Table 1
NA

165E11
−1
CCCAACGCTTGTGTGCGTATGTATGT

GTGTATTTAACATCCTGTTCCCAT

6892
Table 1
NA

165F7
−1
GCATAAAGGCAGCCATTTCCATTCTC

TACATTCTCTAGTGATAGCAGAGG

6893
Table 1
NA

176A6
−1
CGTTACGCAATGGAGAAGTCCCCTTG

AGGCTGAATAATCACATCTGTATC

6894
Table 1
NA

176G2
−1
AGGCCAAATCACCGCACAGTTGAATT

GCTGATTCTAATTGGTAACAATAA

6895
Table 1
NA

176E10
−1
TTGTAGTGTAATTGTGTGATACGCAA

ACCTTTAGTTAACCCAAGTGATGA

6896
Table 3A
NA

176F11
−1
CCTTGTTGCCGTGGGTATATGCATGA

TCTTACCTTTTGTTTGACTATGAA

6897
Table 1
Hs.232400

heterogeneous nuclear ribonucleo-
−1
AAATGATATGTTAAGCACCCAAATCTT

protein A2/B1 (HNRPA2B1),

CACATGGAGGGGAAGGGGGTGGG

transcript variant B1, mRNA/

cds = (169, 1230)

6898
Table 1
NA

71F2
−1
GGCCAAAGCTGTTTATTATGAGATCT

TTGAGTGGAATCAGCATGTCTCCC

6899
Table 1
Hs.172028

a disintegrin and metalloproteinase
−1
TTAACAGCATTGAAGGTGAAACAGCA

domain 10 (ADAM10), mRNA/

CAATGTCCCATTCCAAATTTATTT

cds = (469, 2715)

6900
Table 1
Hs.180610

splicing factor proline/glutamine
−1
AGGTACGAAAATACATTCTGGCATCA

rich (polypyrimidine tract-binding

CACCCTGAACCCAAGACTGTTCT

protein-associated) (SFPQ),

mRNA/cds = (85, 2208)

6901
Table 1
NA

124G4
−1
GAACTACCTACTGGCAGTTGGGTTCA

GGGAGATGGGATTGACTTCGCCTT

6902
Table 1
NA

123C8
−1
AGAGCTAATATACAGAGTACCTGACA

CACTACCTCACCAACAGTTTAACT

6903
Table 1
NA

124F9
−1
GCCCAGGCAACAAGAATACTTTTATC

TTTGATCCGTTCTGTTTATCCAGT

6904
Table 3A
NA

127A12
−1
CTGAGGGTAGACTGTGGGCAAAGAG

GACAACTCTCCCTCCCCTAAGGGAC

6905
Table 1
Hs.50180

601652275F1 cDNA, 5′ end/
−1
TGCCCAGACCTATTTCCTTAGGACAG

clone = IMAGE: 3935610/

TATTCTAAAGTTCAGTAGTCCAGT

clone_end = 5′

6906
Table 1
NA

161E8
−1
GCCCTGTCCCTTGAGAGGCTCACAG

CGATGGAGGCCACTTTTGTTGTTTG

6907
Table 1
NA

186E8
−1
ACCAAAAAGGGCTACATTACCACCAC

TGTATCATAAAAGCCAGCCACCTT

6908
Table 2
NA

191F6
−1
AGCTGACCATTTTCTATCCCGGCCTA

TAGTGCATGTATGGCAATTGAGCA

6909
Table 3A
NA

193G3
−1
CCCCAAAACAAACAAAATAAACCACA

CCAGATATCAGTCACATCCTTGAA

6910
Table 1
NA

194C2
−1
AGTCTGTTATTGCCTGATTTTGTCCC

CACCTTGTTCAAATTTCCAAAGCT

6911
db mining
NA

458C6
−1
CTCACAGCCGAAGCTCTGATCCTTTG

TTCTCAGGAAACACTCAGGAAGTG

6912
Table 1
NA

458E4
−1
AGAGAAAATGAGAGACAGACAGTGA

GTGGGAAAGTCAGCGAAAAGGAAAA

6913
Table 1
NA

458G10
−1
TCCTTGAGTTTATACACCGTGCTATG

AGTGATGACAGCCAATTCCCATGC

6914
Table 1
NA

459B3
−1
TCGCTTCAGGGGTCAGCCAAAAGATA

GACAGCCAGGTAACTTGAGTGGAC

6915
Table 1
NA

459D2
−1
GGACAGTACCAAACACTCCCCTCCTC

CCCTCTGCCTCTTTGCTTACTTAG

6916
Table 1
NA

459E6
−1
GACCAAATACTGAACTTCCACCCTGC

ATAATAATCATGAACACCGCACCA

6917
Table 3A
Hs.20830

DNA sequence from cosmid
−1
AGGTGAGCAGTGCCTCAGATACCTG

ICK0721Q on chromosome 6.

CAAAACCTTTCTGCACAAATGTGCT

Contains a 60S Ribosomal Protein

L35A LIKE pseudogene, a gene

coding for a 60S Ribosomal

Protein L12 LIKE protein in an

intron of the HSET gene coding

for a Kinesin related protein,

the PHF1 (PHF2) gene coding

for alternative splice products

PHD finger proteins 1 and 2, the

gene coding for five different

alternatively spliced mRNAs

coding for a protein similar to

CYTA (CYCY) and identical to a

polypeptide coded for by a known

patented cDNA, and the first

two exons of the gene coding for

the homolog of the rat synaptic

ras GTPase-activating protein

p135 SynGAP. Contains three

predicted CpG islands, ESTs and

an STS/cds = (163, 2184)

6918
Table 3A
NA

460D5
−1
CAGATCCAATGAGGGTCCCATCTCTT

CCCACTTCAATCCCGTGTTGTTCT

6919
Table 1
NA

480B9
−1
CCAACCAAACCATCAAACAGCAGGGA

GCTAGTGAAGAGGTCTATTGTTCC

6920
Table 3A
NA

461A4
−1
ACATCGCCTAAAACCGTGCATCGTAA

ACATTTACCCTCAAAGTCATCCTCT

6921
Table 1
NA

461G8
−1
TTTTCACTCCTCTCAGAGTCTACTCC

ACCTCTCCTCACTCCCCAGGACAC

6922
Table 1
NA

461D9
−1
AGATCTGTGTTCGTCTCTAGGTAATA

GGAAACACAATCCAGACATGATCT

6923
Table 3A
Hs.80788

chloride channel 7 (CLCN7),
−1
TTCATGAACTCGGAGAGGTCCATGGT

mRNA/cds = (38, 2455)

GCACTCCCGCTCGTCCTGGGACAC

6924
Table 1
NA

481H7
−1
CTGGCAATATTAACTTGGGTTCTGTT

TCATCTCTGGCTATAAGCCATACA

6925
Table 1
Hs.333513

small inducible cytokine subfamily
−1
TGCCATTCTTTTGTTGAACCTGTAAA

E, member 1 (endothelial

GGTAAGGCCCAGATTCTGAAACCT

monocyle-activating) (SCYE1),

mRNA/cds = (49, 987)

6926
Table 1
NA

483A5
−1
TAAAGCACTTATGAGAATGCTGCATT

TGTACATGAGCTACGCCTCATCTT

6927
Table 1
NA

483B2
−1
GCACCCACCTCCTCAGTTCAGACAAG

CCCAGCACCCAAATACCACTATCT

6928
Table 1
NA

483C5
−1
AGCGCATGAGTGACTCCCATCTATAT

ATGTCAGTCGTCTCTGGTGCAAGG

6929
Table 3A
Hs.40919

hypothetical protein FLJ14511
−1
GAAACAGTGGCCCGGGTCGTAGTGC

(FLJ14511), mRNA/cds = (22,

GCTGTCCAGATCTTCACGCTACACC

1272)

6930
Table 1
NA

463H5
−1
AGTGCATTCACACTGATGATAAACGA

TAGTAGCTTCACAGGTTTGCTTCT

6931
Table 1
NA

463A7
−1
GCTTCAAAATTCCTTACCCCCAACCT

CTGGCACCCCAAATTGTATCACTA

6932
Table 1
NA

463B10
−1
GAGGAAGGGCTGGCTCTTACTCCCC

ACAAGAGGTGTTCCTTAGGCCACAC

6933
Table 1
NA

463C7
−1
CCAATCTAATTTAAACCCTCATAACAG

GACATAAGCTTGCGCCCGCATCT

6934
Table 1
NA

463F10
−1
TGCTCAATGTTTTGCACTGATTTTATT

CAATGTTTTGAAGGGCGTTATGA

6935
Table 1
NA

464C2
−1
TGCTAACAACAGCTTCTCGGTATGTT

AATATTCTGCTAACTCCTTTCTCA

6936
Table 1
NA

464C5
−1
GGAGGAATGGCTGTGCCCGTCCCCT

CCACTTAAGCGACCTGAGTCTCCAG

6937
Table 1
NA

464C10
−1
ACACACACTTAAGAGTACAGTGAGA

GCCAAAAATAAGTGGCAGGTCTTT

6938
Table 1
NA

464D8
−1
TTTTGTGACTGTGCATGCTTGAAAAG

AATAAGTTTTCTGCAGCTGTGTCT

6939
Table 1
Hs.221695

7k30d01.x1 cDNA, 3′ end/
−1
CTTGTCTGTGGCGTGGCACACAGTA

clone = IMAGE: 3476765/

GGTGCTCGGTTTGTGTTGTTGAATG

clone_end = 3′

6940
Table 1
NA

464E7
−1
GAATTCTGAATACATGTTGGACTGTG

TTTCTTTGACCTGTGTTTCCTAGG

6941
Table 1
NA

464H12
−1
TGAGTCCTTGGCCTCAGCTTCTAATC

TCAAACCTAAAATAGATTGCGTTT

6942
Table 2
NA

465B3
−1
TCTTCTCGTCTTTGCTATTAAATTTCT

TCACGGACCATGCATCTGGAGGA

6943
Table 1
NA

465G2
−1
CCAGAGACTCCTAAGCAGAATCAAGG

ATGTGTGGCATAAGCATGAGAGCC

6944
Table 1
NA

465H5
−1
CCCATAAAGAGGAATAAGCTACTGTC

CTCAGCTCTTGTTAGCTCAGGCTT

6945
Table 1
NA

465A12
−1
AGAGTTTGTAACACAATCCAGTCCAC

ATGCTTATCCAATCCCATCATCCA

6946
Table 1
NA

465F7
−1
AGCTCAAAATATGGCAAAGTGATGAT

TTCGTGTTAATCCTAGAAACAGCA

6947
Table 1
NA

465G8
−1
TGGGTCTGCTTTCACATGAAAGTGCT

ACGAATTCTCTTTTGTGCTGAGCC

6948
Table 1
NA

465H10
−1
GGATGAGCCCACTCACAGCACCAGA

TTTGTACTGAAAGTACCTTAATATC

6949
Table 3A
Hs.136309

DNA sequence from clone RP4-
−1
AACCCAAATCCAAATGCCAGGATAGA

612B15 on chromosome 1p22.2-

AGAATTTGTTTATGAGAAACTGGA

31.1. Contains the (possibly

pseudo) gene for a novel protein

similar to 60S ribosomal protein

L17 (RPL17), the gene for CGI-61,

endophilin B1 and KIAA0491,

ESTs, STSs, GSSs and two CpG

islands/cds = (1011, 1406)

6950
Table 1
NA

515C12
−1
CGCTTTTTGATCTGATTACTATTTCAC

ACAGGTTACAGCTATGACCATGA

6951
Table 1
NA

515H10
−1
CTGCCGCTAATTCACTAGTAATTTCG

ATCGTCCGCCCTCCAGGTACATAT

6952
Table 1
NA

55G3
−1
AGGCGTGCTATTAATTATCCCATACC

CTCCTTACAGAAATTACACTCGCA

6953
Table 1
NA

55F9
−1
GGGAGAAGTTCTTTAAACTAAGGGTA

CAAAATGAATTGAATGCTGGGGGC

6954
Table 3A
NA

99E7
−1
ATTAGCGTGTTCGCGCCCGAGGTAC

ACCAAAACCTTCAGAAAGCAAAGTT

6955
Table 1
Hs.319825

103C4
−1
AAGATATGAAATATGCCTACCGGCAG

AGCTTGGCACAAAGTGGAGTCAAT

6956
Table 1
Hs.17481

mRNA; cDNA DKFZp434G2415
−1
GTACAGAGATCGGATCACACAAGCC

(from clone DKFZp434G2415)/

CGGAGACAGTGCAGCTTCTCCACTG

cds = UNKNOWN

6957
Table 1
NA

116C9
−1
AATGCACTTGTGATAAACTGACAGCA

GGGTTAGACATTACTTTCAAAGCT

6958
Table 1
NA

128F5
−1
CCACTGCTCAGGAAACTGCCTGTTCG

GTGCTCCTCCAATTCAATTAAGCT

6959
Table 1
NA

135F10
−1
AGTGCTGGTATAACTGCAGAAAGAGA

TAGAGAAGAGAGATCAGTGAGAGC

6960
Table 1
NA

189F3
−1
AAGTCAGGACCTTTGCACTTGCCCCG

CCTCTGCCTTCACAGCTCTTCTCA

6961
Table 1
NA

189A8
−1
TAATCAGGGAAGAGCTTGAGATCATT

AGCAACTGAACTGAACAGGGAGTT

6962
Table 1
NA

195H12
−1
CTGGGTCACGTCGCCCACCAATGGT

ATCTGTGTGGTTAGGCATTAGGCTG

6963
Table 1
Hs.292457

Homo sapiens, clone MGC: 16362
−1
GGTGGTAGGTGAGTGGGTATTGCGG

IMAGE: 3927795, mRNA,

GCTAGTATCCGAGCAAAAGATGGTG

complete cds/cds = (498, 835)

6964
Table 3A
NA

466C4
−1
CAGCCCTGCTATCTCTGGTTGTTCAT

GTACTTCTGTAAGGTGGAGACCCT

6965
Table 1
NA

466D1
−1
GAAGGTGAGAAACCCGAGAGACACC

AACTATGATTTTTACTTTTCCTGGT

6966
Table 1
NA

466G2
−1
ACCACCCCTCCCTTCCCTCCTTTAAC

TCATCTCGAATCTCTCTCATACAT

6967
Table 1
NA

466H5
−1
CTCTTATCCTGCTCTGCCCTGGAACT

TGAACCCCAGTGCCAATACTCATG

6968
Table 1
NA

466B7
−1
CGACCTAATCTCTGTCCCCAGAAGGC

AGACCAGGACTCCAGCCCCCAGGAG

6969
Table 2
NA

466B10
−1
GCCAAATCTTTGTCCTGTACAAAGTA

CAGATGTTTTTGACTGAAGTTCCA

6970
Table 1
NA

466C9
−1
GCCACAGTGAATAAATACAAGGCAAG

GCTCATAGGTAAAACAAGTTCTAT

6971
Table 1
Hs.7187

mRNA for KIAA1757 protein,
−1
AGTGGAGTGTTTACACCTTGCTGTAA

partial cds/cds = (347, 4576)

CATTTGAACTTTCACAAGAGATGT

6972
Table 1
NA

121F1
−1
AAACCCACCCATCATTTGCCCTGACT

ACCCATCTCCCGATTAATTCACCC

6973
Table 1
NA

121A11
−1
AGGGAACAGAGCCAGGATTTAAACTC

TAACAATTTGTCTCCACAATTGCA

6974
Table 3A
NA

121F8
−1
CTCCTGGCACGACAGAACTAGTAGTT

TCCATGTCTTGAGGACATAGGTCC

6975
Table 1
NA

178B2
−1
TCGAACCTGTTCCAGGTATGCTGATA

GATGTCGGTAGGGCATCCTTAATT

6976
Table 3A
NA

178B5
−1
GAGGTACTATAAACCAGATGCCCAAA

ACACCTGCCCTCCTGGGTTGGCCCG

6977
Table 1
NA

178F5
−1
ACATTCATCTGTTTCCACTGAGGTCT

GAGTCTTCAAGTTTTCACCCCAGC

6978
Table 1
NA

178C12
−1
TTAGCCCTTTTCTGCGCTAATTAGAAT

TTCAAGCGTCACAGAGCCTGGGG

6979
Table 1
NA

462A11
−1
TTCAACGAGGTGAACCAGTGTGATGT

CTGTGGGGAAAACACGTAGTCAGG

6980
Table 1
Hs.13231

od15d12.s1 cDNA/clone =
−1
GGAAAAAAGAAATTTCCTGAGATTTC

IMAGE: 1368023

CAGTGTATACAGAAGTGTCTTTCCAT

6981
Table 1
NA

462D9
−1
GAGTTCACGTGGGGTGGCCCTCCTC

AGTGCTCTTAGGGTACTGTACTGTC

6982
Table 1
NA

462E8
−1
CCACCTTCGAGGTCCCTTCCGGCCTA

AGATGCCTGAAATCTCCAAGGAAA

6983
Table 1
NA

462F9
−1
ACAAGGCAAAGCTTAAAGAAACACTA

AACGAATGAGTGAAAGAAGCGGAG

6984
Table 1
NA

462F11
−1
TTCTCAATAACAAACCCAGGGCTTTC

ATAAATGCATGATCAAAATGTGGA

6985
Table 1
NA

462G12
−1
ACAGAAAATAGGGTGTATATCAGCAT

TACGCTGATTCAGCAGAAGATAGC

6986
Table 1
NA

462H9
−1
TCTCGACTGACACCCACTATAAATTC

CCTGGGTTGAAAAACTTTTCTTTT

6987
Table 1
NA

472B1
−1
TCCAAACCCCTCCATTACAATCTAAC

ACACTTCCCCCTACATCGTCTCCT

6988
Table 1
NA

472C1
−1
GCATTTATTTTCTTCTACAGAGAACCT

GGCGGCTGGGTCTGGGAAAGAGC

6989
Table 1
NA

472E6
−1
ACCCACAATTAGTGAGAGTGCCCTTG

AGCTTGAGATTCCCATTCCTCCTT

6990
Table 1
NA

472F4
−1
TGGATATAAAGTGTGTGTTCTGACAG

AAAATGGGGAGAAGGTGGCTATTT

6991
Table 1
NA

472G2
−1
GCCAGAAAATCCTGGTTTCCCTGGTG

TCCCCTCCAATCTCTTTTACCAAA

6992
Table 1
NA

472D7
−1
CCATTGTCGCCCGGAGCTGGAAAGA

TAGTTTAGAGAATGCCTTAGCACTT

6993
Table 1
NA

472G12
−1
CAGCACCCAGTACAGGTATGCAGGA

AGGACTCGCTTGACTTAGAGAGTGG

6994
Table 1
Hs.75354

mRNA for KIAA0219 gene, partial
−1
AACACACCAGAAGGAAAAGACA

cds/cds = (0, 7239)

CAGACAGGGAATGAAGCCTGCAAA

GTCC

6995
Table 2
NA

64G9
−1
GTAACTCAGTGCCCCCAAAGATTCAT

AGTCAGCAGGATTGGCCAGCAAAT

6996
Table 1
NA

467E5
−1
CGCCCCAAATATAAAATCTCAATACC

AGTTCCTTTTCCCCAGTACCCCAG

6997
Table 1
NA

467A8
−1
AGTCACAGGATGTTCTCTGCACCTCA

TCTGCAACTCTGAGCCTTACTCAA

6998
Table 1
NA

467C9
−1
GTTAGAGCCCTCGTGCCCTGCTTCTT

CAGCTACCATTTCTCTCTGTGACC

6999
Table 3A
NA

467F8
−1
CCACCACAACCACACACACAAA

AAGTCAACCCACACGAATATACCG

GAAA

7000
Table 1
NA

468E6
−1
CAGTTGGCTGTTAGTAGTCTGCAC

ACAGGTGAGAGGAGCAAGAGATCC

7001
Table 1
NA

468B9
−1
AATCTATTATCAGGCATTTAATCACTG

AGCACTCTTCTGTCCCACACTGT

7002
Table 1
NA

468E10
−1
AGAGGAGTGACGGTGAATGGTACTG

AAAGCGGTTGTAAATTGCGAGAGAG

7003
Table 1
NA

468F10
−1
TCTCCTTGTTCTGATTCTCTCCCCATC

TACAACAACTCCACTCCCCAAAG

7004
Table 1
NA

468F11
−1
CACCTAACCAAGCGGGTTGGGCTGA

TGACCGATGACCGTAAGCAGTAAGG

7005
Table 1
NA

468G12
−1
ACCTCTTCTTTAGCAACACTAACCAC

TCCACACTGGGGAAATTATACTCT

7006
Table 1
NA

468H11
−1
ACTACCGCACAACAGAACACATGACC

AGGTGAGTGCAGACACGACATCAG

7007
Table 1
NA

469B6
−1
CAGTTTTACTCCTGGTCATCTCTTGT

GAGTGTGGATTCTTCTCTGCCCCT

7008
Table 1
NA

469D2
−1
TTTTATTTTGGCTGAAGTTTGGGTATG

GCTGCTTGTTGGCCTCTGCTGGG

7009
Table 1
NA

469A10
−1
ACAGCTTATAAAGCACTTTCTCATGC

ACTTCTTCTCGCCGTATTTGCACA

7010
Table 1
NA

469E12
−1
GGGGCTCAAACCTGTGACTTACTGCT

AACTAACATCAAAGGAAAAGCTGG

7011
Table 1
NA

469F8
−1
ATGATCATTGATAGATATTCTAAGAG

CATGCAGGAATGAGGATGCGTGCC

7012
Table 1
NA

469G8
−1
GACAACAAACCTGCTTGCTTGGTTAC

CCACAGCGCACTGAGTATAGAAGT

7013
Table 1
NA

470B2
−1
TCTTCAATTATTCATGCTCTAAGGCA

GTGTCTGTCTTCCCACCATCCCGC

7014
Table 1
Hs.118174

tetratricopeptide repeat domain 3
−1
TGAGTATTTTTAAAATCCCCTGTTTGG

(TTC3), mRNA/cds = (2082,

ATGCTTCCAGCTAAATAGTCTACCT

7460)

7015
Table 1
NA

470C3
−1
TGGGTTTACTCAGATCTTCTCCTTCTT

AAGTGAGAGTTTTAACCTACATTTT

7016
Table 1
NA

470D5
−1
GTCCAGAGCTAGAAGAACCAAGTCTT

CCTTTCTTCATTCATTGTTCAGGT

7017
Table 1
NA

470E1
−1
CTTCTTCTTAGGATCTGGAGGGAGGG

GAGTGTTAGAGCTTGTGAGCCATG

7018
Table 1
NA

470E5
−1
CTGAACGAACCAGTTCTTTTGGACTA

CCAGTTCTTGAAGTGAAGCTCAGA

7019
Table 1
NA

470F3
−1
AACAAAAGCACTGACAAGCTCATATG

AACAGGCTAAAAAGTGAGTGAAGT

7020
Table 1
NA

470G6
−1
TTCTCTTTCTATATCTAGCTAAATTGC

CTGTGCGCCTCCCATCCTCCTCA

7021
Table 1
NA

470B8
−1
ACACACTTGATAAATTAGACCGATGC

AAACCGCAAGAATCCAAATCAGCT

7022
Table 1
NA

470G10
−1
ATAGTAGGTGAGCCAGTAGTGTGAAT

GCTTGTCAAGCTTCCAAGGATGGA

7023
Table 1
NA

471D6
−1
AACCACCACCCAGCTTCCTGGTACAA

GCAGGGACTCTGGCTACAGTGCTA

7024
Table 1
NA

471F1
−1
TTTCCTCCCCTCCCTCCCCAATCCAC

AAAACACGTAATCTGACTATCCA

7025
Table 1
NA

471F4
−1
CAACATTCACAAAACTGGTCCCCGAA

TTAGTGAGAAGGTTCCAGGAGTGC

7026
Table 1
NA

471F6
−1
GAGAGATTATAGCACAGTCTCCCAGG

GCTCAGTCAGGTCATCCGCAGCAA

7027
Table 1
NA

471E9
−1
TTCAATGCTTTGTCCTCCCCTCGCAG

ATGTTTAGAACAGATCCTCCTTCT

7028
Table 1
NA

471E11
−1
TCCCTCTCTCAGGGCTGGGAAAGAAA

GGTTCATCTTCACTCAGATGCAAG

7029
Table 1
NA

471H11
−1
TTCTGTTGGTCTGCCAGCTCATCCAT

TCATCCATCACCTGCCAGCTAGAC

7030
Table 1
NA

473E4
−1
ACACAGTTTTGGCTCCCTTATTTTCC

CCGTACTCGAAACATTTCCATGCA

7031
Table 1
NA

473F3
−1
ACCAAATCGCAAAAATACAGAATGCC

TGTAAATTGAGTCACACCTTAAAA

7032
Table 1
NA

473E11
−1
GAGTCCATAAATCTGCATTTCATGTA

GTTGTAAGACTTTCTCCCAAAGGT

7033
Table 1
NA

476C1
−1
TCCATTTGAGTTTTCTTCCCATCTCTC

ACAGTTGATTGTTCTGTCCCTTC

7034
Table 1
NA

476D3
−1
AAAATTCAGCCCTCCTGGATTCACGT

GCCCCAATGAAAGTCCCCAAACTAG

7035
Table 1
NA

476F5
−1
TTTAACAGGAAAAGCCCAAAATTATTT

TTATGCTGTCTACAATCTGGGCC

7036
Table 1
NA

476G3
−1
AGTTGCACTGGTTGTTCTTGGCTGCG

GTGCTTCTCACACAAGAAGCCCAG

7037
Table 2
NA

476G4
−1
TTTCCTTTTTCCCTTGTCCCTTGGCTT

CCCCCATCACCGAATCCCCCTTC

7038
Table 1
NA

476A10
−1
CTCCCACGCCTGGCCGTAGTCCAGA

GCTTCTTCTTTTTCATGGTTGGGTT

7039
Table 1
NA

476G8
−1
GCCAGTGTACGTTGCCAGGCATTTCA

TGTAAGAGAAAACTCAAATAGCCA

7040
Table 1
NA

476H10
−1
CCGTCTTCTTTTGGGTGTTTCCTCCT

AGTTTCGGCGGAAATCAGAGTTCA

7041
Table 2
NA

477E1
−1
ATGAACCCTCACCTGCTCTGCAGTGC

AGTTTTGATTTTAGTCCCAGCAAA

7042
Table 1
NA

477E6
−1
AGATATAGATGGTAAAATGTGATGCA

ATGTAAAAAATGGTAATACACACAC

TCTCCA

7043
Table 2
NA

477A11
−1
TGAGTGGGCTTCTCTTATGGTACAGT

CTCTTCTCTATGAGGGGCTTCAAA

7044
Table 1
NA

477D9
−1
TGGGCTTCCAAATGGTACAATGGAGT

AATCAAGCTCATGGACTGAGAGTT

7045
Table 1
NA

477D10
−1
CTTGAAGCTACTTGTCCCTTTCTGTG

CCAGACCACTTAATGGCTACCCAC

7046
Table 2
NA

480A3
−1
TTCCCAGGGCGCTCCATCTACAGCCT

TACTGTGACTCCACTCAGCACCAG

7047
Table 1
NA

480B5
−1
ATTCCCCCTAAGCTCCTGTCCCCCGC

CATGCACGACTGGTCACATCAAAA

7048
Table 1
NA

480D2
−1
AAGACACACCCCTCCTGTTTAATAAA

AGTTGTCCCCTCGACATGCATAAT

7049
Table 1
NA

480E2
−1
CCTGGTTACAATAATGAAACTGTCGT

GGAGTAAAGAGGGAAACATGACCA

7050
Table 1
NA

480E3
−1
AGAACCCACACACTGGGAGACAATAA

CTGCCATTCATATAACCAACAGAA

7051
Table 1
NA

480F3
−1
CGCCACTGCTTAAAGATTACAGACAA

TTCCCAGGTAAAGTTGCCAGGACT

7052
Table 1
NA

480G4
−1
ACAATGATGTTTGAAACGCACTCTGA

ATCTGTGAAAGCTAGATAAGTCCT

7053
Table 1
NA

480C8
−1
GCCTTCCTCCTCCTCCCTCTTGGGCC

TATGTCCTAGATAAGCCTGTTAAA

7054
Table 1
NA

480D9
−1
TGTCAAGATGACAGATCTTAATCCAG

AGTGGAGGCTCGTTCGGCCTGGAG

7055
Table 1
NA

480E7
−1
TTTATGTTTCAGCCTCTTTCTCTCCCG

TTGAGTCCTGCCACAAGTCCTGC

7056
Table 1
NA

480E11
−1
ATTGTCCAGGTGACTTGACACTTGCC

TACCGGAAAAGTTGGGATGTTCTT

7057
Table 1
NA

480F8
−1
TAAAATATGCCCTAATTTAAAGGGCG

CAGGGTCCCACAACAAGCCACAGA

7058
Table 1
NA

487F11
−1
AAATCTCTTCTCACGTTCTGTTTGTCA

TTTAATCACCAGGTTTTTAGCGC

7059
Table 3A
NA

499G1
−1
GCTACTGATGGGTGGCCCTTTATTCT

TGTCTTTATTTGTTGTGTGCAGGA

7060
Table 1
NA

518F10
−1
AAAAATTGGTAGCTGCCCCCATGTGG

TATGATGTTTAATTTGAACAACAT

7061
Table 3A
NA

524A12
−1
ACCCGGCACGTCTCCTCAACCCCTTA

ATTCTTTTCCAGCTTTTCATATTA

7062
Table 1
NA

526B9
−1
CTCAAGAGGGCATAGACATTCCACAC

GAGGACTGCATTCGTCAGGGTAAC

7063
Table 1
NA

583B5
−1
AACAAATACCCAATTAACTGTATTCCC

CTTTCCCCTATGACTGCTGGTGT

7064
Table 1
NA

583D6
−1
CCGTTGTCCGAAAGCTTGCTTCCAAC

TAAAGACCAGAGATGGGAGGGAGT

7065
Table 1
NA

583G8
−1
TTTAGCCCAAAGAAGACTTTCGCATA

AATTCTGCCGTAACCCTTGTTGGA

7066
Table 3A
NA

584A1
−1
CAAAGCAGCAAATACAGAGCAC

ACAACAATCCTTGGCCTGAGCAGA

ACAA

7067
Table 1
NA

584D3
−1
ATATGAAGATGGATTGGATGAGGACT

GACAAAACGAAGACATGCCGGGCC

7068
Table 3A
NA

DNA sequence from clone RP4-
−1
ATGCCTAGTCAGTCAGTATTTCTTCTT

620E11 on chromosome 20q11.2-

GCTGCAGGTGTCTAAAAACCCAC

12 Contains l

7069
Table 3A
NA

591H9
−1
CCTTCGCATTCCCCCATCCATGCTCC

AAGATAATAGATTTTTCTTTAAAA

7070
Table 3A
Hs.6179

DNA sequence from clone RP3-
−1
GGGGAACACTTTGGTTTGAAAGCACA

434P1 on chromosome 22 Contains

GAGCAGTTTGCCATGTTTCTTCTG

the KCNJ4 gene for inwardly

rectifying potassium channel J4

(hippocampal inward rectifier,

HIR, HRK1, HIRK2, KIR2.3), the

KDELR3 gene for KDEL

(Lys—Asp—Glu—Leu)

endoplasmic reticulum protein

retention receptor 3, the DDX17

gene for DEAD/H

(Asp—Glu—Ala—Asp/His)

box polypeptide 17 (72kD), ESTs,

STSs, GSSs and slx putative CpG

islands/cds = (307, 2259)

7071
Table 1
Hs.44577

602388170F1 cDNA, 5′ end/
−1
ACTGAATGGTCGAAATCACATATGCA

clone = IMAGE: 4517129/

CCACACATACTGATCTTAAGTAAC

clone_end = 5′

7072
Table 3A
Hs.108124

cDNA: FLJ23088 fls, clone
−1
CGAGGTACAGCAAAGCGACCCTTGG

LNG07026/cds = UNKNOWN

TGTCATAGATCAGACGGAAATTCTC

7073
Table 1
NA

119F12
−1
TACAGAAGAGCAGAGACCAACCTTCT

CAAAGTTGGTGAGTATTAACCCAG

7074
Table 1
NA

119G10
−1
CCAGATTTGCTGATGTGTTAGGTAGT

TGTGGCACACTCACCTGTCTTTCC

7075
Table 1
NA

485A8
−1
CTTTCCAGGTTTTCCCTTTCCGCCAT

TGTTTTCCCGCTCGCTAAAGTGAC

7076
Table 1
NA

485D5
−1
TTGAACATTCGCAAAGTAACATCTCT

CACTCCCAACACCACAGCTTATCG

7077
Table 1
NA

489H9
−1
AGTAACCACCCAAAGCATAGTTT

TAGAAGGGCTTTCGCAAACCTAGC

CTTT

7078
Table 2
NA

494B11
−1
TCTTGCTTGTTCTTCTCGTTTTTGTTT

TATCTTCCGCCCGGCAGGGTCAG

7079
Table 1
NA

478E5
−1
GCTCTGAAACCCCTGGAACTCTTGAG

CCTAAAATGTATTTTTACAATCTT

7080
Table 1
NA

478G6
−1
ATCTTTGATGTGAAGCCCTTTAAAAAT

AAACGTGAAGGTGCCAGCTTGCA

7081
Table 3A
NA

478H3
−1
ACCCAGCCTGATGTTCATCTTTTCCC

CCTCTTCATTTTCCTTCTTTGTTT

7082
Table 1
NA

478C7
−1
AGAAAGACTAACACCAGAAATCATGC

TGCAACACCAGAACATCCTTTGGA

7083
Table 1
NA

478G8
−1
TCACAAAATATGGCTCAAGGAGTATA

AATCCCCTCTCACGCACCCACAAA

7084
Table 1
NA

478H7
−1
ACTAACCAACCAATGAGAATACTACT

TACCTCCACCCATGCTGTGAACCC

7085
Table 3A
NA

479B4
−1
TGACCGCCTCAAAGACCAAAAGGACT

CTACTCCATATTCTTCTCACTGTC

7086
Table 1
NA

479D2
−1
GAATGACCACCTGACGCATTCAGAGC

TCACCTTCTTGTTCTTCAGCTGTT

7087
Table 1
NA

479G2
−1
TTGGTAGAAACCACCCAACCATAAAA

TTCCCAAGCCTGTACTGGTCAGCC

7088
Table 1
NA

479G3
−1
CATAAGTTGGGTGAAGAAATGGTGGT

TTTAATCAGTAATATAGCTCCCCC

7089
Table 1
NA

479G5
−1
TTCTCATCTCAATATCCCCCAGAGCC

CCAGTACCTCATAATACAAGACTT

7090
Table 1
NA

479G6
−1
CTATCAGGCCCTCCAGATAGTCTTCT

ATAAACCAATGATTCAGCAGGACT

7091
Table 1
NA

479H4
−1
TACCCAAAGTCTATTCGTAAGTGCAT

CTTTTCTATTAGACTGGAAGCTCC

7092
Table 1
NA

479H5
−1
GATGGTTCAGCAACTGAGGAGCTCA

GGGTGACGGGTCCACAGAGCACAGA

7093
Table 1
NA

479H6
−1
AGAAATTAGAAGATGACTACCATTTG

CTAAAGTCTATCCACATGCCAGCA

7094
Table 1
NA

479G12
−1
CCCCCTCGACCCCCTCACACCCTTTC

CAGAGAGGCCTTAAGATTCCCATT

7095
Table 1
NA

479H12
−1
TGTAAGGTTTCATAAATTTAGAGACC

CTAGCCCAGTCAGTGACAATATGCA

7096
Table 1
NA

482A5
−1
GAGTTGCTTATTCCAGTCTCTCTAAG

ATATATCTCCCTTTTTAGTTGCTGAC

7097
Table 3A
NA

483G5
−1
TGGTGTAATGAACATGCCGTATTGCC

TTTATGGCCAGTTTGAGTCCTTCC

7098
Table 1
NA

488C4
−1
AGGGAACCCCAAAGAGTTAAAA

CCAGGACCACTATTTCATAGTCAA

CAAA

7099
Table 1
NA

490F10
−1
GTGGTAAATGAGAGCATTACAGACCA

CCCACATCAGCCTAAAATATAATT

7100
Table 1
NA

493C2
−1
CCACCAAACCCAACAGGCCGGGACA

AATGCAATACCATACAGAAACACAG

7101
Table 1
NA

58G4
−1
GGCCAAACTTTCTTACTCTGCCATTT

GTTCAATGTCCTAATGAGCCATGAA

7102
Table 3A
Hs.169370

DNA sequence from PAC 66H14
−1
ATCAATCGGGCCAATCCGAAGTCAGC

on chromosome 6q21-22. Contains

AATCTTGCATATGAGTCCATTCCC

FYN (P59-FYN, SYN, SLK) gene

coding for two isoforms. Contains

ESTs and STSs/cds = (12, 1706)

7103
Table 1
NA

598H2
−1
TATTTTTAACAAAATCACACGGAAGG

ATTTCCTTCCCGTCCCATGTGTTG

7104
Table 3A
NA
AA077131
1836605
7B08E10 Chromosome 7 Fetal
−1
CAGATAGTGGTATTTGGGTGCTGGG

Brain cDNA Library cDNA clone

CTTGTCTGACCTGAGGAGGTGGCTG

7B08E10, mRNA sequence

7105
Table 3A
NA
AA501725
2236692
ng18e12.s1 NCI_CGAP_Lip2
−1
AACTCCATAGAGAAAGACTACGAATT

cDNA clone IMAGE: 929806

TCGCTGGGAGGTAATAGGGAAGCC

similar to contains Alu repetitive

element; mRNA

7106
Table 3A
NA
AA501934
2236901
nh56a10.s1 NCI_CGAP_Pr6
−1
GCATTTAGGAAAGACAGGTGAGTGTG

cDNA clone IMAGE: 956346,

CCACAACTACCTAACACATCAGCA

mRNA sequence

7107
Table 3A
NA
AA579400
2357584
nf33d05.s1 NCI_CGAP_‘3Pr1
−1
TTACTTTGTCTTCTCTCACCATCCTAA

cDNA clone IMAGE: 915561

AACGTTGTTTTGCTGAGCATGAA

similar to contains Alu

repetitive element contains

7108
Table 3A
NA
AF249845
8099620
isolate Slddi 10 hypervariable
−1
CCCCAGACGAAAATACCAAATGCATG

region I, mitochondrial sequence

GAGAGCTCCCGTGAGTGGTTAATA

7109
db mining
Hs.277051
AI630242
4681572
ad07c09.y1 cDNA/clone =
−1
GCCTAAGTTTCCAGAAGACTTTGACG

ad07c09-(random)

ATGGAGAGCATGCAAAGCAGGTAA

7110
db mining
Hs.277052
AI630342
4681672
ad08g11.y1 cDNA/clone =
−1
TTTTGCAGTTCAAGGATTGGTGGGAA

ad08g11-(random)

ACGTTTGTATGTGTTGGGGTGGGG

7111
db mining
NA
AI732228
5053341
nf19e05.x5 NCI_CGAP_Pr1
−1
AATAGATTTCCATTTCTTCCTTCGAGT

cDNA clone IMAGE: 914240

TAGTTGGGTATTGGGACCTTGAA

similar to contains Alu repetitive

element, mRNA s

7112
Table 3A
Hs.197803
AW379049
6883708
RC3-HT0230-201199-013-c12
−1
CGACGGTGTTCTGGAGTTTCGATGAG

HT0230 cDNA, mRNA sequence

ACATGTAAGTAAGAGTTCTGTGCA

7113
Table 3A
Hs.232000
AW380881
6885540
UI-H-BI0p-abh-h-06-0-UI.s1
−1
ATATTCAGCAGTGGCTGTGAAATTGG

cDNA, 3′ end/clone = IMAGE:

ATTTGAATTACCGGGATACATGCA

2712035/clone_end = 3′

7114
Table 3A
Hs.325568
AW384988
6889647
602386081F1 cDNA, 5′ end/
−1
ACTGGTTTTCATTCTAGTGTCCCCCA

clone = IMAGE: 4514972/

CCCGTCTAGTTTCATTTTCCTGTA

clone_end = 5′

7115
Table 3A
NA
AW836389
7930363
PM0-LT0030-101299-001-f08
−1
TTGGGAGTCACCAGGTTAAAGCAAAG

LT0030 cDNA, mRNA sequence

CCTCAGTCACTGAAAGCAGAAACT

7116
Table 3A
NA
AW837717
7931691
CM2-LT0042-281299-062-e11
−1
TCCTGTGCTCCAGAATTAGTGATTGC

LT0042 cDNA, mRNA sequence

TTTGGTGCTTAACTTGAAGTGGGA

7117
Table 3A
NA
AW837808
7931782
CM1-LT0042-100300-140-105
−1
CATCTGCTCTGCTTCCTCACACACTA

LT0042 cDNA, mRNA sequence

GAAACACCACTGCCCCCATCCATG

7118
Table 3A
NA
AW842489
7936472
PM4-CN0032-050200-002-c11
−1
TCTGTGATTTATAGACTGTTTTCAGGA

CN0032 cDNA, mRNA sequence

AACGATCTTCCCATCTGTGGTGA

7119
Table 3A
NA
AW846656
7942373
QV3-CT0195-011099-001-c09
−1
TCATTTCAGGTCTAATAAACACACTAA

CT0195 cDNA, mRNA sequence

CCTCGGCAGCACTGGAGCGTCTG

7120
Table 3A
NA
AW856490
7952183
PM4-CT0290-271099-001-c04
−1
AGCTTAGGATATCTATTAGTGTTCACT

CT0290 cDNA, mRNA sequence

GTTCGGGCAAGAGGCCTAAAGGG

7121
Table 3A
NA
AW891344
8055549
PM2-NT0079-030500-001-a04
−1
TGGGAACACACTGGCCCATTATATAG

NT0079 cDNA, mRNA sequence

AGAAAAATAAAACATGATCCCCAT

7122
Table 3A
NA
BE061115
8405765
QV0-BT0041-011199-039-f09
−1
TTGCTTGATTTCCCAAACCACTACCT

BT0041 cDNA, mRNA sequence

GAAGGTGGCTTATGGTCTACAGCT

7123
Table 3A
NA
BE086076
8476469
PM2-BT0672-130400-008-h09
−1
TTCCACCACTTCAAGACTGGGGGCA

BT0672 cDNA, mRNA sequence

GGTAGAGAAGACAAGCATAAGTACA

7124
Table 3A
NA
BE091932
8482364
IL2-BT0733-130400-068-C11
−1
TTCTTCTCTGCCCCTAACAGAATGTT

BT0733 cDNA, mRNA sequence

CTTCTCTTGCTTCCCACACCCTCC

7125
Table 3A
Hs.173334
BE160822
8823543
ELL-RELATED RNA POLY-
−1
CAGCACATCTTCTGGTTTACAAGTTG

MERASE II, ELONGATION

GGTAACTATGAAAGCTGGAGATGC

FACTOR (ELL2), mRNA/cds =

(0, 1922)

7126
Table 3A
NA
BE163106
8625827
QV3-HT0457-060400-148-h10
−1
TATCTAAATTCTACCTTTAGCATCCAA

HT0457 cDNA, mRNA sequence

CTAGCTACCGTCTGGCACTGGCC

7127
Table 3A
Hs.301497
BE168334
8631159
arginine-tRNA-protein transferase
−1
TCCAATGCTCAAGTCACTCTGAGTCT

1-1p (ATE1) mRNA, alternatively

TTGCTGGTGTCAACCTACAATGCC

spliced product, partial cds/cds =

(0, 1544)

7128
Table 3A
Hs.172780
BE176373
869102
602343016F1 cDNA, 5′ end/
−1
ACCTCACTATAGTAGCCATTAGGTAA

clone = IMAGE: 4453468/

AGATGGGCCATATCCAAATGGGCT

clone_end = 5′

7129
Table 3A
NA
BE177661
8656813
RC1-HT0598-020300-011-h02
−1
AAGAACTATTCCTTTGAGAATCTTTCC

HT0598 cDNA, mRNA sequence

TACTGGGAGTTACTGCTGTGATT

7130
Table 3A
NA
BE178880
8658032
PM1-HT0609-060300-001-g03
−1
TCTGTGTGAACATACATACAGGACTT

HT0609 cDNA, mRNA sequence

TGATTCTACCTGTGCCTGACCATT

7131
Table 3A
NA
BE247056
9098807
TCBAP1D6404 Pediatric pre-B
−1
GTGGAGCTGTTGGCCCTTGCTGGATG

cell acute lymphoblastic leukemia

CGGGCACTCTCTACACCTTCAGGTA

Baylor-HGSC project = TCBA

cDNA clone T

7132
Table 3A
Hs.11050
BE763412
10193336
mRNA; cDNA DKFZp434C0118
−1
TGTCAGTGGCTCTCACTTTGTTTGAA

(from clone DKFZp434C0118);

ATTGTTGCTTTGGGAAAAACACAG

partial cds/cds = (0, 1644)

7133
Table 3A
NA
BF330908
11301656
RC3-BT0333-310800-115-f11
−1
GATGCAGTGGGTTAGGGGTTGGGGG

BT0333 cDNA, mRNA sequence

TACAGACTGACTTGAGCTCGGAGTC

7134
Table 3A
NA
BF357523
11316597
CM2-HT0945-150900-379-g06
−1
TCAGGCACTCAGTAAAGGCAAGACTT

HT0945 cDNA, mRNA sequence

GAGTGATACATAAAGTCAGTTACA

7135
Table 3A
NA
BF3644413
11326438
RC6-NN1068-070600-011-B01
−1
CCTTGGGCTGAGTTTGCTGGTCCTGA

NN1088 cDNA, mRNA sequence

AGATTACAGTTTTGGTTAGAGAGA

7136
Table 3A
NA
BF373638
11335663
MR0-FT0176-040900-202-g09
−1
ACAGCAAACAAAAGTGTTCCAAT

FT0176 cDNA, mRNA sequence

CCTCTATTAACCCATTTAACCAAG

AGTT

7137
Table 3A
NA
BF740663
12067339
QV1-HB0031-071200-562-h04
−1
AGTGCATTCACACTGATGATAAACGA

HB0031 cDNA, mRNA sequence

TAGTAGCTTCACAGGTTTGCTTCT

7138
Table 3A
NA
BF749089
12075765
MR2-BN0388-051000-014-b04
−1
AAGTGTGATTAGAAAGCAGCTGG

BN0386 cDNA, mRNA sequence

AAGTAGCAGAGGAGGTGGAAGTTA

GTCC

7139
Table 3A
NA
BF758480
12106360
MR4-CT0539-141100-003-d05
−1
CAGGAGTAAAACAGAGCTGGTTGTGT

CT0539 cDNA, mRNA sequence

GATACCTATGCTGGGTGGAAGACT

7140
Table 3A
NA
BF773126
12121026
CM3-IT0048-151200-568-f08
−1
GGTGACTATCTTACCGGCTCCCAGTA

IT0048 cDNA, mRNA sequence

AACTCTGAACAATGTACCAGCTAA

7141
Table 3A
NA
BF773393
12121293
CM2-IT0039-191200-638-h02
−1
GCTTGAAGATGTCTCAACAGAAAATC

IT0039 cDNA, mRNA sequence

ACCGACATGAGGAAGCATCACGCT

7142
Table 3A
NA
NF805164
12134153
QV1-CI0173-061100-456-f03
−1
AGGAACATGGCTGCAGCATATAAAAA

CI0173 cDNA, mRNA sequence

GAATTGAATTCCATACTTTTGTTAACC

CTG

7143
Table 3A
NA
BF818594
12156027
MR3-CI0184-201200-009-a04
−1
GGTGCTGCCATAGGTGCCAGTAATG

CI0184 cDNA, mRNA sequence

ACCGTTTATGCGGAAATCAATTACA

7144
Table 3A
NA
BF827734
12171909
RC8-HN0025-041200-002-F08
−1
TGAAGTACTATAGGACTCAATGGGAC

HN0025 cDNA, mRNA sequence

CAGTAGCAGCTCCAAGTGGATCAC

7145
Table 3A
NA
BF645167
12201450
RC5-HT1035-271200-012-F08
−1
ACACGGGACCTCCTTTGATCTTTCTG

HT1035 cDNA, mRNA sequence

AGAATTAATAGAGATTTCATGGCA

7146
Table 3A
NA
BF869167
12259297
IL5-ET0119-181000-181-b11
−1
CCAAAAGGAGAAAGATGACTAGGGT

ET0119 cDNA, mRNA sequence

CACACTTGAGGATTTGCCAGGTGGG

7147
Table 3A
NA
BF875575
12265705
QV3-ET0100-111100-391-c02
−1
GCATCTTCTTTGAAGACGGGAACTGT

ET0100 cDNA, mRNA sequence

ACTTCAGGTTCTTTTCTGTTTAGC

7148
Table 3A
NA
BF877979
12268109
MR0-ET0109-171100-001-b02
−1
GGCTCATTTGGTTTTAAAGTCTCTTCT

ET0109 cDNA, mRNA sequence

ATGCCATCCCAGGGGAGGAGGAT

7149
Table 3A
NA
BF897042
12288501
IL2-MT0179-271100-254-C11
−1
GACTGTGGACACCTCTCACTGTGTCT

MT0179 cDNA, mRNA sequence

TCTTGGCAGGCAGAGCTTACTGAC

7150
Table 3A
NA
BF898285
12289744
QV1-MT0229-281100-508-e11
−1
GCAGGGTGCAGAGCTTCACAGCAGG

MT0229 cDNA, mRNA sequence

TAGGAAGAAGTAACTAAGTGGAAAC

7151
Table 3A
NA
BF899484
12290923
IL5-MT0211-011200-317-f03
−1
CAGCTAAAGCCGTAGGTCATTGTGAC

MT0211 cDNA, mRNA sequence

TGTCCCTGGGATGTGGATTACTCT

7152
Table 3A
NA
BF904425
12295884
CM1-MT0245-211200-662-d02
−1
CCAGAATGCAGCCTACAGACCAAATA

MT0245 cDNA, mRNA sequence

TCAATGGACTTGGTGTAGCCCTGC

7153
Table 3A
NA
BF906114
12297573
IL3-MT0267-261200-425-A05
−1
TTTAAACCAGGTCTGGAAAAGGAAG

MT0267 cDNA, mRNA sequence

GAGAGGAGGGCATTTTAGAGAAGA

7154
Table 3A
NA
BF926187
12323197
CM2-NT0193-301100-562-c07
−1
GTGGCTTCGTAAAATAGAAGAGCAGT

NT0193 cDNA, mRNA sequence

CACTGTGGAACTACCAAATGGCGA

7155
Table 3A
NA
BF928844
12326772
QV3-NT0216-061200-517-g03
−1
CACACCACAGCTGGCTGGGAGCAGA

NT0216 cDNA, mRNA sequence

GGCTGCTGGTCTCATAGTAATCTAC

7156
Table 3A
NA
BG006820
12450388
RC4-GN0227-271100-011-d03
−1
TGGAGAAATGAGAGACAGACAGTG

GN0227 cDNA, mRNA sequence

AGTGAGAAAGTCAGCGAAAAGGAAA

7157
Table 3A
NA
F11941
707260
HSC33F051 normalized infant
−1
ACCTACTGTTGAGATTATTCCCCTGT

brain cDNA cDNA clone c-33f05,

CTCCACACTGCCAGAAACTTACCA

mRNA sequence

7158
Table 3A
NA
U46388
1236904
HSU46388 Human pancreatic
−1
CCAAATGATACTAGGATTAAGCCCCA

cancer cell line Patu 8988t cDNA

AAGCAAAGTCAAGCACCACCATGG

clone xs425, mRNA sequence

7159
Table 3A
NA
U75805
1938265
HSU75805 Human cDNA clone
−1
TCCCAGAGCAACAACTAAGTCTCAAC

f48, mRNA sequence

TAATGGACAACCAACACCCACTGA

7160
Table 3A
NA
W27858
1307658
36f10 Human retina cDNA
−1
CCACAGAATGGGCATGTAGTATTGAG

randomly primed sublibrary

ATTTGAATCATCTGCTGTCCAGCC

cDNA, mRNA sequence

7161
db mining
Hs.681
nm_004146
10764846
NADH dehydrogenase
1
ACCTCATCCGGCTGCTCAAGTGCAAG

(ubiquinone) 1 beta subcomplex, 7

CGTGACAGCTTCCCCAACTTCCTG

(18kD, B18) (NDUFB7), mRNA/

cds = (22, 435)

7162
db mining
Hs.943
NM_004221
4758811
natural killer cell transcript 4
1
GACCTGGTGCTGTCGCCCTGGCATC

(NK4), mRNA/cds = (59, 763)

TTAATAAAACCTGCTTATACTTCCC

7163
db mining
Hs.1063
NM_003093
4507126
small nuclear ribonucleoprotein
1
GCATAAGGAAGACTTGCTCCCCTGTC

polypeptide C (SNRPC), mRNA/

CTATGAAAGAGAATAGTTTTGGAG

cds = (15, 494)

7164
db mining
Hs.1321
NM_000505
9981354
coagulation factor XII (Hageman
1
GGGACTCATCTTTCCCTCCTTGGTGA

factor) (F12), mRNA/cds = (49,

TTCCGCAGTGAGAGAGTGGCTGGG

1896)

7165
db mining
Hs.288856
NM_003903
14110370
prefoldin 5 (PFDN5), mRNA/cds =
1
AGACTGGATCGCACACCTTTGCAACA

(423, 926)

GATGTGTTCTGATTCTCTGAACCT

7166
db mining
Hs.1975
NM_030794
13540575
hypothetical protein FLJ21007
1
AAGCAAATACCTTTTACAAGTGAAAG

(FLJ21007), mRNA/cds = (257,

GAAGAATTTTTCTTCTGCCGTCAA

2212)

7167
db mining
Hs.3804
NM_014045
13027587
DKFZP564C1940 protein
1
GCAACAAATGCTTCTATTCCATAGCT

(DKFZP564C1940), mRNA/cds =

ACGGCATTGCTCAGTAAGTTGAGG

(565, 1260)

7168
db mining
Hs.3832
NM_032493
14210503
clathrin-associated protein AP47
1
TCCGTGTAGAGGTTACAGCCTTTTAT

(AP47), mRNA/cds = (76, 1347)

GCTGTTGAGCTCCCAGGTACCAAA

7169
db mining
Hs.4113
NM_006821
5729723
S-adenosylhomocysteine
1
GCCCACTTGGATTTATAGTATAGCCC

hydrolase-like 1 (AHCYL1),

TTCCTCGACTCCCACCAGACTTGC

mRNA/cds = (47, 1549)

7170
db mining
Hs.83848
NM_000991
13904865
triosephosphate isomerase 1
1
AAGAGCTCCTGAGCCCCCTGCCCCC

(TPI1), mRNA/cds = (34, 783)

AGAGCAATAAAGTCAGCTGGCTTTC

7171
db mining
Hs.5076
AK025781
10438401
cDNA: FLJ22128 fls, clone
1
GCTCAACATGGAAAGAAGGTACAGAA

HEP19543/cds = UNKNOWN

AGTGATGTGTTCAAAACATTAGCA

7172
db mining
Hs.5298
NM_015999
7705760
CGI-45 protein (LOC51094),
1
TTATATACCCTGGTCCCATCTTTCTAG

mRNA/cds = (182, 1294)

GGCCTGGATCTGCTTATAGAGCA

7173
db mining
Hs.5473
AW953785
8143488
602659798F1 cDNA, 5′ end/
1
GTTTACTCCGTCCCTATCACTGGTGT

clone = IMAGE: 4802950/

GGCTGTGGGCAAACCACTTATTGC

clone_end = 5′

7174
db mining
Hs.5831
NM_003254
4507508
tissue inhibitor of
1
GAACTGAAGCCTGCACAGTGTCCAC

metalloproteinase 1 (erythroid

CCTGTTCCCACTCCCATCTTTCTTC

potentiating activity, collagenase

inhibitor) TIMP1), mRNA/cds =

(62, 685)

7175
db mining
Hs.5890
BF698885
11984293
hypothetical protein FLJ23306
1
GAAGACCAAGAGAGACAACAGACGC

(FLJ23306), mRNA/cds = (562,

AGCAAACAGCCGAAGCACCAGACAA

930)

7176
db mining
Hs.6211
NM_015846
7710138
methyl-CpG binding domain
1
AATTCAGAAAATTGTTGGGAGGACAG

protein 1 (MBD1), transcript

CCCTTTTGTGAACCTTGTTTGGGG

variant 1, mRNA/cds = (139,

1956)

7177
db mining
Hs.6285
AL080220
5262711
mRNA; cDNA DKFZp586P0123
1
TTTACCCAGCTCTGAAGGTCATTGTT

(from clone DKFZp586P0123);

CTTGCCTGTGTTTGAATAAAATCA

partial cds/cds = (0, 1067)

7178
db mining
Hs.6441
AL110197
5817115
mRNA; cDNA DKFZp586J021
1
GTCTCTGATGCTTTGTATCATTCTTGA

(from clone DKFZp586J021)/

GCAATCGCTCGGTCCGTGGACAA

cds = UNKNOWN

7179
db mining
Hs.6459
NM_024531
13375681
hypothetical protein FLJ11856
1
GGTAAGCCCCTGAGCCTGGGACCTA

(FLJ11856), mRNA/cds = (239,

CATGTGGTTTGCGTAATAAAACATT

1576)

7180
db mining
Hs.6618
AL524742
12768235
AL524742 cDNA/clone =
1
TCTGGCTCTGACCGGTTGATGGCCTT

CS0DC008YI07-(5-prime)

GAGCGAATGAAATCATGAAATTGA

7181
db mining
Hs.6650
NM_007259
6005775
vacuolar protein sorting 45B
1
TGCCCTACATAGCAATTTTCTGTGGC

(yeast homolog) (VPS45B),

ACTGAGAAACCATGTATGACCACA

mRNA/cds = (33, 1745)

7182
db mining
Hs.6763
NM_015310
7662395
KIAA0942 protein (KIAA0942),
1
GCAGTGTACTGTGTGCAATACCAAGG

mRNA/cds = (52, 1658)

GCATAGCTCCCTGTAATTTGGGAA

7183
db mining
Hs.6780
NM_007284
6005845
protein tyrosine kinase B-like
1
CTGAGACTAGGGTCCCAGCACAGCC

(AB-related protein) (PTK9L),

CAGAACCTTTGGCCACAAGAAGTG

mRNA/cds = (104, 1153)

7184
db mining
Hs.6817
NM_025200
13376793
putative oncogene protein
1
TCGCCTTCCATGGTTTTTAAATGCAG

hlc14-06-p (HLC14-08-P), mRNA/

TAAATAACATTTCTGGATGAGACT

cds = (51, 635)

7185
db mining
Hs.7709
U79457
4205083

Homo sapiens, Similar to WW
1
GCTTTACCCCCGCAGGACATACACAG

domain binding protein 1 clone

GAGCCTTTGATCTCATTAAAGAGA

MGC: 15305 IMAGE: 4309279

mRNA, complete cds/cds = (162,

971)

7186
db mining
Hs.7740
AF288741
14209837
oxysterol binding protein 2
1
GGAATGTACCTCTCCCCAACACTGTT

(OSBP2) mRNA, complete cds/

TTGTTAGCGAGCACCTTTTGACCA

cds = (112, 2748)

7187
db mining
Hs.8108
NM_‘3021080
10835268
disabled (Drosophila) homolog 1
1
ACTCGCTCAGAAGAGGGAACTAAGC

(DAB1), mRNA/cds = (785, 2426)

ATTTTTGGCAACCAATGGGCAGATA

7188
db mining
Hs.8109
NM_022743
12232400
hypothetical protein FLJ21080
1
AGCTGTGTGAACCTCTCTTATTGGAA

(FLJ21080), mRNA/cds = (127,

ATTCTGTTCCGTGTTTGTGTAGGT

1236)

7189
db mining
Hs.8207
NM_020198
9910241
GK001 protein (GK001), mRNA/
1
AGTCCCATACATTTGGACCATGGCAG

cds = (184, 1635)

CTAATTTTGTAACTTAAGCATTCA

7190
db mining
Hs.226627
BC007375
13938462
leptin receptor short form (db)
1
CTGCCCCCTTCCTGGACTTCGTGCCT

mRNA, complete cds/cds = (0, 2890

TACTGAGTCTCTAAGACTTTTTCT

TABLE 8

SEQ

ID
Origin
Unigene
Locus
GI
Nominal Description
Strand
Probe Sequence

7191
db mining
Hs.8768
NM_018243
8922711
hypothetical protein FLJ10849
1
GGATAACATTTCTCATGAACCCACTG

(FLJ10849), mRNA/cds = (93, 1382)

CCCCTCTGCSTTTTCCTCACTGGT

7192
db mining
Hs.8834
NM_006315
5454011
ring finger protein 3 (RNF3), mRNA/
1
CGCTTAAGAACATTGCCTCTGGGTGT

cds = (114, 857)

CATGTGGACCAGACTTTCTGAATAG

7193
db mining
Hs.9683
NM_006260
5453979
protein-kinase, interferon-inducible
1
GGGTTCAATCCCTTCAGCTCAGGCG

double stranded RNA dependent

GACCATTTAGATTTAAATTCCACTT

inhibitor (PRKRI), mRNA/

cds = (690, 2204)

7194
db mining
Hs.9825
NM_016062
7706342
CGI-128 protein (LOC51647), mRNA/
1
GCTCCTGCCAGGGCTGTTACCGTTGT

cds = (35, 526)

TTTCTTGAATCACTCACAATGAGA

7195
db mining
Hs.10590
AL031685
9368423
DNA sequence from clone RP5-
1
AATCTGGCGAAACCTTCGTTTGAGGG

963K23 on chromosome 20q13.11-

ACTGATGTGAGTGTATGTCCACCT

13.2 Contains a KRT18 (Keratin type 1,

Cylosketetal 18 (Cytokeratin 18,

CK18, CYK18), pseudogene, a gene for

a novel protein, the gene for

spermatogenesis associated protein

PD1 (KIAA0757) and the 3′ end of the

gene for KIAA0939 (novel

Sodium/hydrogen exchanger family

member). Contains ESTs, STSs, GSSs

and four putative CpG islands/

cds = (2, 688)

7196
db mining
Hs.11485
NM_004832
4758483
glutathions-S transferase like:
1
GACTATGGGCTCTGAAGGGGGCAGG

glutathione transferase omega

AGTCAGCAATAAAGCTATGTCTGAT

(GSTTLp28), mRNA/cds = (9, 734)

7197
db mining
Hs.11538
NM_005720
5031600
actin related protein 2/3 complex,
1
AGGGAGGGGACAGATGGGGAGCTTT

subunit 1A (41 kD) (ARPC18), mRNA/

TCTTACCTATTCAACGAATACGTGC

cds = (80, 1198)

7198
db mining
Hs.12707
AK023168
10434970
cDNA FLJ13106 fis, clone
1
ACCTTCTGAAAGCTCACAGTACACAT

NT2RP3002455, highly similar to

TAGTATGTATAACTGGCTTTACCA

mRNA for KIAA0678 protein/

cds = UNKNOWN

7199
db mining
Hs.12785
AL031685
9368423
DNA sequence from clone RP5-
1
TTTAAGGGAGTCAGGAATAGATGTAT

963K23 on chromosome 20q1311-

GAACAGTCGTGTCACTGGATGCCT

13.2 Contains a KRT18 (Keratin type 1,

Cytoskeletal 18 (Cytokeratin 18,

CK18, CYK18)) pseudogene, a gene for

a novel protein, the gene for

spermatogenesis associated protein

PD1 (KIAA0757) and the 3′ end of the

gene for KIAA0939 (novel

Sodium/hydrogen exchanger family

member). Contains ESTs, STSs, GSSs

and four putative CpG islands/

cds = (0, 1313)

7200
db mining
Hs.13323
NM_022752
12232416
hypothetical protein FLJ22059
1
CCCACCTTCCACCTCTTAGCACTGGT

(FLJ22059), mRNA/cds = (783, 1967)

GACCCCAAAAATGAAACCATCAAT

7201
db mining
Hs.13659
AL080209
5262698
Hypothetical protein DKFZp586F2423
1
AGACCAGCAGTGTTTAAATCTAAATA

CGTTGTGAGTCTGTTATCTGTCCT

7202
db mining
Hs.14089
NM_013379
7019510
dipeptidyl peptidase 7 (DPP7), mRNA/
1
ACCTCGACCTCAGAGCCTCCCACCC

cds = (0, 1478)

AGAAGATCCTGCTTCCGTGGTTGAG

7203
db mining
Hs.16488
NM_004343
5921996
calreticulin (CALR), mRNA/
1
GGGCAGTGGGTCCCACATTGGCTCA

cds = (88, 1321)

CACTGAGAATGTAAGAACTACAAAC

7204
db mining
Hs.16580
NM_018303
8922829
hypothetical protein FLJ11026
1
TGGCCTTAAGTTTTCTAATTCAAGCG

(FLJ11026), mRNA/cds = (31, 2355)

GGTTTTTGGAAAAATTTATGGTCT

7205
db mining
Hs.109438
AB028950
5689390
clone 24775 mRNA sequence/
1
TGCAGAGTTATAAGCCCCAAACAGGT

cds = UNKNOWN

CATGCTCCAATAAAAATGATTCTA

7206
db mining
Hs.18588
NM_014826
7662135
KIAA0451 gene product (KIAA0451),
1
CCAAACAATGATGTGGATTCTTTTGC

mRNA/cds = (1482, 2219)

ACAGAAATATTTAAGGTGGGATGG

7207
db mining
Hs.19575
NM_015941
7708261
CGI-11 protein (LOC51606), mRNA/
1
ACAAAAGTCAACTGTTGTCTCTTTTCA

cds = (233, 1684)

AACCAAATTGGGAGAATTGTTGC

7208
db mining
Hs.20529
AK025464
10437985
cDNA, FLJ21811 fis, clone HEP01037/
1
GCTGGGGACTCTAGCCTCTGTGTTCA

cds = UNKNOWN

TAAAGACATTAAGAAGTGGATGGA

7209
db mining
Hs.20725
NM_020963
14211539
Mov10 (Moloney leukemia virus 10,
1
GGAGAATGACACATCAAGCTGCTAAC

mouse) homolog (MOV10), mRNA/

AATTGGGGGAAGGGGAAGGAAGAA

cds = (70, 3081)

7210
db mining
Hs.343590
AB011104
3043587
601471579f1 cDNA, 5′ end/
1
ACCTGGGTTTAATACAGCTCACATCA

clone = IMAGE:3874747/clone_end =

CTGAATGTTACACATGAGTTTAAA

5′

7211
db mining
Hs.23449
NM_018842
10047119
insulin receptor tyrosine kinase
1
CTTAAGGACGCCTTTGCCTGGCCCCT

substrate (LOC55971), mRNA/

TTATTACAGCCCAACACGGTAGGC

cds = (333, 1553)

7212
db mining
Hs.23990
NM_017838
8923443
nucleolar protein family A, member 2
1
TCCATCAGTGCCATTTCCTGTAGAAC

(H/ACA small nucleolar RNPs)

TAAAGGCTGTTCCAAGAATGTGGG

(NOLA2), mRNA/cds = (66, 547)

7213
db mining
Hs.24024
NM_015376
7662333
KIAA0846 protein (KIAA0846),
1
ATCTGTAAAGCACTCAGAAGGCAGCC

mRNA/cds = (272, 2341)

ATCCCTAGATGTTGGTTTCATGTA

7214
db mining
Hs.334842
BC008330
14249901
tubulin, alpha, uiquitous (K-ALPHA-
1
TGGTTAGATTGTTTTCACTTGGTGAT

1), mRNA/cds = (67, 1422)

CATGTCTTTTCCATGTGTACCTGT

7215
db mining
Hs.24641
AK022982
10434687
cDNA FLJ12920 fis, clone
1
CATGTCCCTTGAAACATGATAGTTAC

NT2RP2004594/cds = (96, 2144)

ATACACAGTTTTCTCTCCACACAT

7216
db mining
Hs.321105
NM_016462
7661683
cDNA: FLJ21737 fis, clone COLF3396/
1
AGGTTTCACATGAACCTGTTCTAGGC

cds = UNKNOWN

TGTGGACATTGGTGTGGAGAGGTT

7217
db mining
Hs.26802
NM_021158
11056039
protein kinase domains containing
1
GACACTTGGGGTCCACAATCCCAGG

protein similar to phosphoprotein

TCCATACTCTAGGTTTTGGATACCA

C8FW (LOC57761), mRNA/

cds = (294, 1370)

7218
db mining
Hs.26892
NM_018456
8922098
uncharacterized bone marrow protein
1
AGAAATGATTTGCAGCTGAGTGAATC

BM040 (BM040), mRNA/

AGGAAGTGACAGTGATGACTGAAG

cds = (257, 749)

7219
db mining
Hs.27076
NM_003729
4506588
RNA 3′-terminal phosphate cyclase
1
TCCTGAGAGATGGACAATGAAATATC

(RPC), mRNA/cds = (170, 1270)

AGTTGGTGGATATGTGTGATAGCT

7220
db mining
Hs.27445
NM_018209
7706428
unknown (LOC51693), mRNA/
1
CTTTCAGGGCAGGCAGCTGTGCATG

cds = (58, 480)

TTCTCTCAACTAAAGGTCTTGTGAG

7221
db mining
Hs.27633
NM_015456
7661663
DKFZP586B0519 protein
1
GCTGGACACACGGTGAGATTTTCTCG

(DKFZP586B0519), mRNA/

TATGTAAATAAAAGGCAATTTGGT

cds = (75, 1199)

7222
db mining
Hs.28310
BG260891
12770707
602372491F1 cDNA, 5′ end/
1
CTCAACGAAAGGCTCACACTAACAGG

clone = IMAGE:4480510/clone_end =

GGAGGATTACAGCACCACAATACT

5′

7223
db mining
Hs.28914
NM_000485
4502170
adenine phosphoribosyltransferase
1
CCACACTGAACCCAATTACACACAGC

(APRT), mRNA/cds = (71, 613)

GGGAGAACGCAGTAAACAGCTTTC

7224
db mining
Hs.29893
AL133426
6562628
mRNA full length insert cDNA clone
1
AGGCCCTGGAAAATTTTGTGCTTCCA

EUROIMAGE 146397/

ACGTGGCCTTCAATTCTTGCTTTT

cds = UNKNOWN

7225
db mining
Hs.30120
BF970068
12337281
802272333F1 cDAN, 5′ end/
1
TATTAAGCTTGCCCAGGCTCCTGTTC

clone = IMAGE:4360233/clone_end =

ATGAAGGTTCCCCCAGCGGTGGCC

5′

7226
db mining
Hs.30250
AF055376
3335147
short form transcription factor C-MAF
1
GCTATACCACTGACTGTATTGAAAAC

(c-mal) mRNA, complete cds/

CAAAGTATTAAGAGGGGAAACGCC

cds = (807, 1926)

7227
db mining
Hs.30443
AL138599
13276598
mRNA: cDNA DKFZp564G1816 (from
1
TCGGGGTCAGTTAAGCCTCAGTATTC

clone DKFZp5864G1816); complete

TTAGCTTTTGTTGATTTTGGCACT

cds/cds = (137, 3091)

7228
db mining
Hs.31137
NM_006504
5729992
protein tyrosine phosphatase, receptor
1
ATGGTGCAAACCCTGGAACAGTATGA

type, E (PTPRE), mRNA/

ATTCTGCTACAAAGTGGTACAAGA

cds = (51, 2153)

7229
db mining
Hs.34114
NM_000702
4502270
ATPase, Na+/K+ transporting, alpha 2
1
AGAAGCAGCGAGTGCATGGGCTAAT

(+)polypeptide (ATP1A2), mRNA/

TATCATCAATCTTTATGTATTTGTT

cds = (104, 3166)

7230
db mining
Hs.35254
NM_020119
9910221
hypothetical protein FLB6421
1
GGAAATGTTGCTGTGGGGGATTCATT

(FLB6421), mRNA/cds = (310, 792)

GTAACTCTCCTTGTGAACTGCTCA

7231
db mining
Hs.38735
BG149337
12661367
nad26g06.x1 cDNA, 3 end/
1
ATGCCAAATTCCTGACACGTGGCGTT

clone = IMAGE:3365730/clone_end =

TGAAAATACCATGGAACGTTTCCA

3′

7232
db mining
Hs.41322
AI655467
4739446
tt13b01.x1 cDNA 3′ end/
1
ACATTCTGACTCCATCTGCGGCCTCA

clone = IMAGE:2240617/clone_end =

TTAAGGTGATAGAAACATACTAGG

3′

7233
db mining
Hs.42346
AY013295
11693027
calcineurin-binding protein calsarcin-1
1
ATGATAATGTTGGCATCTGTGATAAA

mRNA, complete cds/cds = (131, 925)

CTATCAATGAGGCTCCCATCATGC

7234
db mining
Hs.42699
AW956580
8146278
EST368865 cDNA
1
AGAGTCACATGTAGAAAAGCCTCCAG

TATTAAGCTCCTGAATTCATTCCT

7235
db mining
Hs.44131
AB023191
4669591
mRNA for KIAA0974 protein, partial
1
ATGGCAACAATGCTGACAGCAAGCA

cds/cds = (0, 1697)

GTAGATCCTCTGATTCCAATTACCA

7236
db mining
Hs.44441
BE295812
9179366
601176827F1 cDNA, 5′ end/
1
GGGAACCCTCATTAATTAGACAAGAA

clone = IMAGE:3532039/clone_end =

CACCAAGGCTATGACCACAGCAGC

5′

7237
db mining
Hs.46919
AY007155
9956067
clone CDABP0095 mRNA sequence/
1
GGCTCACCAGAGTACCCAGAAGAAT

cds = UNKNOWN

CAGTATGGAATTAGAGGACAGTGGC

7238
db mining
Hs.56009
NM_006187
5453823
2′-5′-oligoadenylate synthetase 3 (100
1
ATTCCAGGCCCTCAGTCTTTGGCAAT

kD) (OAS3), mRNA/cds = (34, 3297)

GGCCACCCTGGTGTTGGCATATTG

7239
db mining
Hs.57843
W63785
1371386
zd30g09.s1 cDNA, 3′ end/
1
GCATACATAAAGGCAAAGAATGACAA

clone = IMAGE:342208/clone_end = 3′

AAGGCTTAATCCACCTAGAAGACA

7240
db mining
Hs.58373
BF339746
11286202
602034942F1 cDNA, 5′ end/
1
ATATAGTGGGAGACAAAACACAGGAG

clone = IMAGE:4182851/clone_end =

GCGGGGGATATCATGTAGCAGAGC

5′

7241
db mining
Hs.59238
NM_032139
14149802
hypothetical protien DKFZp434L0718
1
TCTAATGTGCCTTGGATATGTGCCAA

(DKFZP434L0718), mRNA/

ATGATGGAMAGAAACAGTAAACT

cds = (133, 3285)

7242
db mining
Hs.62406
NM_024660
13375912
hypothetical protein FLJ22573
1
GCTTGGCTCATCTGGGGTTTGCTGG

(FLJ22573), mRNA/cds = (99, 1166)

GCTTAACACCCAATAAAGAACTTTG

7243
db mining
Hs.63042
NM_018457
8922158
DKFZp564J157 protein
1
CTGCGGTTTTGGAACCTTACCTCTCC

(DKFZP564J157), mRNA/

TCCTTAGCCCAATATGCTGTCTTG

cds = (77, 523)

7244
db mining
Hs.65648
NM_005105
4826971
RNA binding motif protein 8A
1
TCCAGGCCATTTTGCAGGGACTCTGA

(RBM8A), mRNA/cds = (12, 536)

AGTGACCTTTAGTAGTAATAGTCT

7245
db mining
Hs.339868
NM_003974
4503356
oh47h10s1 cDNA, 3′ end/
1
TGGCAGCCAGGAACTGAGTATGACA

clone = IMAGE:1469827/clone_end =

ATGTTGTACTAAAGAAAGGCCCAAA

3′

7246
db mining
Hs.75056
NM_003938
4501976
adaptor-related protein complex 3,
1
AGAGAGAGACATATCACGCTGCTGTC

delta 1 subunit (AP3D1), mRNA/

ATGATTTTGTGTCAAGATGATCCA

cds = (209, 3547)

7247
db mining
Hs.75082
NM_001665
4502218
ras homolog gene family, member G
1
CTTCTGGGGACCTTTCCTACCCCCAT

(rho G) (ARHG), mRNA/cds =

CAGCATCAATAAAACCTCCTGTCT

(129, 704)

7248
db mining
Hs.75309
NM_001961
4503482
eukaryctic translation elongation factor
1
TAGATGATTTCTAGCAGGCAGGAAGT

2 (EEF2), mRNA/cds = (0, 2576)

CCTGTGCGGTGTCACCATGAGCAC

7249
db mining
Hs.75725
NM_003584
4507356
transgelin 2 (TAGLN2), mRNA/
1
CCATGGTCTGGGGCTTGAGGAAGAT

cds = (73, 672)

GAGTTTGTTGATTTAAATAAAGAAT

7250
db mining
Hs.75770
NM_000321
4506434
retinoblastoma 1 (including
1
AGGTCAAGGGCTTACTATTTCTGGGT

osteosarcoma) (RB1), mRNA/

CTTTTGCTACTAAGTTCACATTAG

cds = (138, 2924)

7251
db mining
Hs.75790
NM_002642
4505794
phosphalidylinositol glycan, class C
1
TTTCTGGGGACCTCTTGAATTACATG

(PIGC), mRNA/cds = (293, 1186)

CTGTAACATATGAAGTGATGTGGT

7252
db mining
Hs.76057
NM_000403
9945333
galactose-4-epimerase, UDP-(GALE),
1
TGGCACAAAACCTCCTCCTCCCAGGC

mRNA/cds = (76, 1122)

ACTCATTTATATTGCTCTGAAAGA

7253
db mining
Hs.76662
NM_032327
14150105
hypothetical protein MGC2993
1
TGAGGTCACTGCCACTTCTCACATGC

(MGC2993), mRNA/cds = (158, 1048)

TGCTTAAGGGAGCACAAATAAAGG

7254
db mining
Hs.77266
NM_002826
13325074
quiescin Q6 (QSCN6), mRNA/
1
CACGCTACCCCCTGCCTTGGGAGGT

cds = (75, 2318)

GTGTGGAATAAATTATTTTTGTTAA

7255
db mining
Hs.77290
NM_006755
5803186
transaldolase 1 (TALDO1), mRNA/
1
AATGCAGAGAATGGAAAGTAGCGCAT

cds = (50, 1063)

CCCTGAGGCTGGACTCCAGATCTG

7256
db mining
Hs.77805
NM_001696
4502316
ATPase, H+ transporting, lysosomal
1
GTGGCACACCACTCCTTCCAGCAGTA

(vacuolar proton pump) 31 kD

GTCGCTTTACTGTTACCTGTTTAG

(ATP6E), mRNA/cds = (75, 755)

7257
db mining
Hs.78592
NM_001414
4503502
eukaryotic translation initiation factor
1
AGCAACAGTATTCTGCATGGTTCACT

2b, subunit 1 (alpha, 26 kD) (EIF281),

GCTTAAGAAAATGCCTTCTGGAAT

mRNA/cds = (10, 927)

7258
db mining
Hs.78605
BC006159
13544048

Homo sapiens, clone IMAGE:3635549,
1
AAACATGTCCCTGGAGAGTAGCCTGC

mRNA, partial cds/cds = (0, 891)

TCCCACACTGTCACTGGATGTCAT

7259
db mining
Hs.78890
AF171938
5852969
NUMB isoform 1 (NUMB) mRNA,
1
CAGTTGCAGCCTCTTGACCTCGGATA

complete cds/cds = (270, 2225)

ACAATAAGAGAGCTCATCTCATTT

7260
db mining
Hs.79150
NM_006430
5453604
chaperonin containing TCP1, subunit 4
1
TGGGCTTGGTCTTCCAGTTGGCATTT

(delta) (CCT4), mRNA/cds = (0, 1619)

GCCTGAAGTTGTATTGAAACAATT

7261
db mining
Hs.79259
NM_016404
7705476
hypothetical protein (HSPC152),
1
TTCTGCCGTGTGTATCCCCAACCCTT

mRNA/cds = (35, 412)

GACCCAATGACACCAAACACAGTG

7262
db mining
Hs.79358
NM_006762
5803055
Lysosomal-associated multispanning
1
TGTGTGCGACAGGGAGGAAGTTTCA

membrane protein-5 (LAPTM5),

ATAAAGCAACAACAAGCTTCAAGGA

mRNA/cds = (75, 863)

7263
db mining
Hs.79572
NM_001909
4503142
cathepsin D (lysosomal aspartyl
1
CTCCCCTTGGGCGGCTGAGAGCCCC

protease) (CTSD), mRNA/

AGCTGACATGGAAATACAGTTGTTG

cds = (2, 1240)

7264
db mining
Hs.81337
NM_009587
6806889
lectin, galactoside-binding, soluble, 9
1
CTCCACCACCTGACCAGAGTGTTCTC

(galectin 9) (LGALS9), transcript

TTCAGAGGACTGGCTCCTTTCCCA

variant long, mRNA/cds = (56, 1123)

7265
db mining
Hs.82030
NM_004184
7710155
tryptophanyl-tRNA synthetase
1
CTCTGCCCTCCTGTCACCCAGTAGAG

(WARS), mRNA/cds = (187, 1502)

TAAATAAACTTCCTTGGCTCCTAA

7266
db mining
Hs.82396
NM_016816
8051620
2′,5′-oligoadenylate synthetase 1 (40-
1
AAATTCCAGCCTTGACTTTCTTCTGT

48 kD) (OAS1), transcript variant E18,

GGACCTGATGGGAGGGTAATGTCT

mRNA/cds = (33, 1235)

7267
db mining
Hs.82933
BC008739
14250568

Homo sapiens, protein x 013, clone
1
CTGTAGGCCAGGGTGGAATGAAGTC

MGC:3073 IMAGE:3346340, mRNA,

AGCTCCTTTTTATAGTTGAAATACA

complete cds/cds = (101, 325)

7268
db mining
Hs.83753
NM_003091
4507124
small nuclear ribonucleoprotein
1
TTGGCGGGCCATCCCAACAGGTGAT

polypeptides B and B1 (SNRPB),

GACCCCACAAGGAAGAGGTACTGTT

mRNA/cds = (0, 695)

7269
db mining
Hs.85838
NM_004207
4759111
solute carrier family 16
1
GGAAGATGGAAATAAACCTGCGTGTG

(monocarboxylic acid transporters),

GGTGGAGTGTTCTCGTGCCGAATT

member 3 (SLC18A3), mRNA/

cds = (62, 1459)

7270
db mining
Hs.306586
NM_013341
9558756
clone HQ0688/cds = UNKNOWN
1
AGTGAGGACAATGTGGGTTGCTCCTT

TTTGAATCTACAGATAATGCATGT

7271
db mining
Hs.89497
NM_005573
5031876
lamin B1 (LMNB1), mRNA
1
GAGGGTGGGGGAGGGAGGTGGAGG

GAGGGAAGGGTTTCTCTATTAAAATG

7272
db mining
Hs.89525
NM_004494
4758515
heptoma-derived growth factor (high-
1
TGCTGACTGTAGCTTTGGAAGTTTAG

mobility group protein 1-like) (HDGF),

CTCTGAGAACCGTAGATGATTTCA

mRNA/cds = (315, 1037)

7273
db mining
Hs.92208
NM_003815
11497001
a disintegrin and metalloproteinase
1
GATTGAGGAAGGTCCGCACAGCCTG

domain 15 (metargidin) (ADAM15),

TCTCTGCTCAGTTGCAATAAACGTG

mRNA/cds = (7, 2451)

7274
db mining
Hs.103527
NM_003975
4503632
SH2 domain protein 2A (SH2D2A),
1
GATTCTTGTCTGGCTAATAAATCATCA

mRNA/cds = (88, 1255)

CCAACTGCCTTCTGCTACAGGGA

7275
db mining
Hs.104679
BF347382
11294957

Homo sapiens, clone MGC:18216
1
AGATTCTTAGGGCACGTTTGTTCCCC

IMAGE:4156235, mRNA, complete

TTGGAGGGTTTTCCACACGGAGTC

cds/cds = (2208, 2373)

7276
db mining
Hs.105749
AB011125
3043629
mRNA for KIAA0553 protein, partial
1
GCCATACTCTGGCTGCCTCTTTGCCT

cds/cds = (0, 3289)

TCCTAGGGGCATTTTCTTTAACTT

7277
db mining
Hs.105751
AL138761
8573811
DNA sequence from clone RO11-
1
TGCCTCTTATCTACTTGAGAGCAACA

16H23 on chromosome 10. Contains

TGTCTTTTCAATCATGGGATTGAC

the gene KIAA0204 (HSLK) for a

protein kinase, the COL17A1 gene for

collagen type XVII alpha 1 (BP180),

ESTs and GSSs/cds = (0, 3557)

7278
db mining
Hs.324406
AK026741
10439662
ribosonal protein L41 (RPL41), mRNA/
1
TGGACCTGTGACATTCTGGACTATTT

cds = (83, 180)

CTGTGTTTATTTGTGGGCGAGTGT

7279
db mining
Hs.108371
NM_001950
12669914
E2F transcription factor 4, p107/p130-
1
TGAAGGTGTCTGTGACCTCTTTGATG

binding (E2F4), mRNA/cds =

TGCCTGTTCTCAACCTCTGACTGA

(62, 1303)

7280
db mining
Hs.109760
NM_002491
4505360
NADH dehydrogenase (ubiquinone) 1
1
CCTGGAGTCCCTGAATAAAGATAAGA

beta subcomplex, 3 (12 kD, B12)

AGCATCACTGAAGATAATACCTGG

(NDUFB3), mRNA/cds = (252, 548)

7281
db mining
Hs.109857
AF151783
14248494
MEG3 (MEG3) mRNA, complete cds/
1
TTGTCCCGAAGATTTGCGCCTTTAGT

cds = (52, 2253)

7282
db mining
Hs.306417
NM_014714
7662193
cDNA FLJ10935 fis, clone
1
CTGCTAGGTCTGCCCACCGGCCAC

OVARC1000661/cds = (250, 938)

CAACACTCCTGTAATTCCAATAAAG

7283
db mining
Hs.114199
BG621594
13672965
602617003F1 cDNA, 5′ end/
1
TTAAAATACTGTCATTGGTTGGGAGG

clone = IMAGE:4730858/clone_end =

GGATTGCATTAAATGATTAGTCCA

5′

7284
db mining
Hs.118786
BF131637
10970677
601820457F1 cDNA, 5′ end/
1
CTCACACACGCAGGCGACAGTCAGA

clone = IMAGE:4052246/clone_end =

ACAAACAGGAACAAAGCTACAACAC

5′

7285
db mining
Hs.122559
NM_024872
13376307
hypothetical protein FLJ22570
1
TGAATAGTGTGCAGACTCACAGATAA

(FLJ22570), mRNA/cds = (0, 1490)

TAAAGCTCAGAGCAGCTCCCGGCA

7286
db mining
Hs.123373
AW963279
8153115
602853825F1 cDNA, 5′ end/
1
CCCAGTGCTTCACGGAGTTAAAGGAA

clone = IMAGE:4994982/clone_end =

AGATCTGCTGGTAGTGTTTAGTCT

5′

7287
db mining
Hs.125078
AF090094
4063829
clone IMAGE 172979/
1
CGAGCCGACCATGTCTTCATTTGCTT

cds = UNKNOWN

CCACAAGAACCGCGAGGACAGAGC

7288
db mining
Hs.130740
AK000315
7020316
cDNA FLJ20308 fis, clone HEP07264/
1
TTTTCCCCCTTTAGTCTCCTGGCTTTT

cds = (90, 1226)

TCCTTTCCCTTCCCTTCTCCACT

7289
db mining
Hs.132955
AL132665
6137021
mRNA; cDNA DKFZp566E034 (from
1
AACCCGTTGTGGAGATTATTGGAATT

clone DKFZp586E034); complete cds/

AACTGAGCCAAAGTGATTATGCAT

cds = UNKNOWN

7290
db mining
Hs.133230
BC000085
12652672

Homo sapiens, ribosomal protein S15,
1
GCCCCCGATCCTACACCCTGAGCCT

clone MGC:2295 IMAGE:3507983,

CAGAGCACTGCTACTTTTTAAAATA

mRNA, complete cds/cds = (14, 451)

7291
db mining
Hs.142677
AK024108
10436406
cDNA FLJ14046 fis, clone
1
AAGCGTCTCATGGAGTTCGGACTGGT

HEMBA1006461/cds = UNKNOWN

TGGGGTGATAATATTTGTTTCTTT

7292
db mining
Hs.146170
NM_022842
12383093
hypothetical protein FLJ22969
1
AAGCCAGGCTTTGGGATACAAGTTCT

(FLJ22969), mRNA/cds = (274, 2223)

TTCCTCTTCATTTGATGCCGTGCA

7293
db mining
Hs.148550
Z82215
3135984
DNA sequence from clone RP1-68O2
1
AGCTGTCACCACTACAGTAAGCTGGT

on chromosome 22 Contains the 5′ end

TTACAGATGTTTTCCACTGAGCAT

of the APOL2 gene for apolipoprotein L

2, the APOL gene for apolipoprotein L,

the MYH9 gene for nonmuscle type

myosin heavy chain 9, ESTs, STSs

and GSSs/cds = (0, 5882)

7294
db mining
Hs.149846
NM_002213
4504772
integrin, beta 5 (ITGB5), mRNA/
1
TGAAGGTACATCGTTTGCAAATGTGA

cds = (29, 2419)

GTTTCCTCTCCTGTCCGTGTTTGT

7295
db mining
Hs.151738
NM_004994
4828835
matrix metalloproteinase 9 (gelatinase
1
GGATACAAACTGGTATTCTGTTCTGG

B, 92 kD gelatinase, 92 kD type IV

AGGAAAGGGAGGAGTGGAGGTGGG

collaenase) (MMP9), mRNA/

cds = (19, 2142)

7296
db mining
Hs.336451
NM_024519
13375657
Nucleoside disphosphate kinase type 6
1
CTGCCGCTGCCCAGCCACATCCCTT

(inhibito of p53-induced apoptosis-

GGTTTTGTATTTTATTTACAGAGTT

alpha)

7297
db mining
Hs.154276
NM_001186
4502352
BTB and CNC homology 1, basic
1
TGCAGTAGACGATACAGGTTGCATGT

leucine zipper transcription factor 1

GGACACTCAGTCACATTAACAACT

(BACH1), mRNA/cds = (118, 2328)

7298
db mining
Hs.155975
NM_005608
5032004
protein tyrosine phosphatase, receptor
1
CCCCAACCACAGGCATCAGGCAACC

type, C-associated protein

ATTTGAAATAAAACTCCTTCAGCCT

(PTPRCAP), mRNA/cds = (63, 683)

7299
db mining
Hs.159410
NM_014484
7657338
molybdopterin synthase sulfurylase
1
GTACTGAGGTGACTGGTATAGTCTGA

(MOCS3), mRNA/cds = (2, 1384)

TGAGAAAGATGTGGATTGCCATAA

7300
db mining
Hs.160999
AV648418
9869432
AV648418 cDNA, 3′ end/
1
CACTTGTTCAATCATGGAACTTTCTA

clone = GLCBJC04/clone_end = 3′

GAACGCTGCCACTCTTCAAAGGCT

7301
db mining
Hs.164036
NM_002078
4504060
glucosamine (N-acetyl)-8-sulfatase
1
TCATCACAGTGTGGTAAGGTTGCAAA

(Sanfilippo disease IIID) (GNS),

TTCAAAACATGTCACCCAAGCTCT

mRNA/cds = (87, 1745)

7302
db mining
Hs.164478
NM_022461
11988002
hypothetical protein FLJ21939 similar
1
ACAACCTGATCATTGAAGCCAACTTT

to 5-azacytidine induced gene 2

GTCCCAGCACATTCCTTAAGTCCT

(FLJ21939), mRNA/cds = (379, 1557)

7303
db mining
Hs.169615
NM_023080
12751496
hypothetical protein FLJ20989
1
ACTTGATTAGGCTCCGGTTTTCCTTT

(FLJ20989), mRNA/cds = (52, 741)

GGCTTCTGCTTTTCAGTGAATGGC

7304
db mining
Hs.171811
AK023758
10435787
cDNA FLJ13696 fis, clone
1
TTGCAGACAAATTCCTCTGAGCTTAG

PLACE2000140/cds = UNKNOWN

CTAGGAGTTCATTATGCTTCCTGT

7305
db mining
Hs.171992
NM_002843
4506314
protein tyrosine phosphatase, receptor
1
ACAGTAGCTTAGCATCAGAGGTTTGC

type, J (PTPRJ), mRNA/

TTCCTCAGTAACATTTCTGTTCTC

cds = (349, 4362)

7306
db mining
Hs.173373
AB023148
4589505
mRNA for KIAA0931 protein, partial
1
ATGTGAGCCAGAGCATGTTGCAGCAA

cds/cds = (0, 2204)

ATCTATTGTTTGTAAAAATAACAA

7307
db mining
Hs.173638
NM_030756
13540470
transcription factor 7-like 2 (T-cell
1
TTTGTGCCATGTGGCTACATTAGTTG

specific, HMG-box) (TCF7L2), mRNA/

ATGTTTATCGAGTTCATTGGTCAA

cds = (307, 2097)

7308
db mining
Hs.177534
NM_007207
13518225
dual specificity phosphatase 10
1
AGCCCAACCATTAAAAATTTAATACAA

(DUSP10), mRNA/cds = (142, 1590)

CTTGGTTTCTCCCCCTTTTTCCT

7309
db mining
Hs.177592
NM_001003
4506668
602791378F1 cDNA, 5′ end/
1
GCAAAGAAAGAAGAATCCGAGGAGT

clone = IMAGE:4896908/clone_end =

CTGATGATGACATGGGCTTTGGTCT

5′

7310
db mining
Hs.179661
BC008791
14250651

Homo sapiens, tubulin, beta5, clone
1
TTGAAAAGATGACATCGCCCCAAGAG

MGC:4029 IMGAE:3817988, mRNA,

CCAAAAATAAATGGGAATTGAAAA

complete cds/cds = (1705, 3039)

7311
db mining
Hs.179988
NM_005803
6552331
flotilin 1 (FLOT1), mRNA/
1
TTTTCCTGACCAAGACTGAGGGATGG

cds = (164, 1447)

GCTGGAGGTTTTCAACTTTGCCTAC

7312
db mining
Hs.180859
NM_016139
7705850
16.7 Kd protein (LOC51142), mRNA/
1
TCTGGGACTGGGCAAATGTTTGTGTG

cds = (81, 536)

GCCTCCTTAAACTAGCTGTTATGT

7313
db mining
Hs.181301
AK024855
10437263
cDNA; FLJ21202 fis, clone COL00293/
1
AACCTAAACGTATTTCACTAACTCTG

cds = UNKNOWN

GCTCCTTCTCCATAAAGCACATTT

7314
db mining
Hs.181311
NM_004539
7262387
asparaginyl-tRNA synthetase (NARS),
1
CCACCAAATGCATGTCATGTATTCTC

mRNA/cds = (73, 1719)

AATAGGCTGTATTCCCAGCAGTCA

7315
db mining
Hs.181391
AL390158
9388848
mRNA; cDNA DKFZp781G2113 (from
1
TGTACAGGTAGCTAACTTTGTAAACG

clone DKFZp781G2113)/cds = (0, 564)

CTCTGTATTCCCTCTGCCCCCATG

7316
db mining
Hs.182281
NM_016407
7705482
hypothetical protein (HSPC164),
1
TCTCATCATTTCGAAGATAGCAGAGT

mRNA/cds = (70, 990)

CATAGTTGGGCACCCAGTGATTGG

7317
db mining
Hs.183180
NM_016476
13324711
anaphase promoting complex subunit
1
CAACAAGGTGGAAACAAGGGGTGGA

11 (yeast APC11 homolog)

GCTGCGTTTGTTTTGCCATCACTAT

(ANAPC11), mRNA/cds = (0, 398)

7318
db mining
Hs.183593
NM_006965
5902161
zinc finger protein 24 (KOX 17)
1
GAGCATTCCTCAGGGGAGGTCACCT

(ZNF24), mRNA/cds = (164, 1270)

GTGAGGTTCCCAGAACTGTAGTTTT

7319
db mining
Hs.184029
AL137509
6808164

Homo sapiens, clone MGC:2764
1
TGCAGGTGTTGACAAGATCCGCCATC

IMAGE:2958229, mRNA, complete

TGTAATGTCCTTGGCACAATAAAA

cds/cds = (70, 1785)

7320
db mining
Hs.187652
AA833892
2907491
od84g04.s1 cDNA/
1
AAGAGTCTGACTTCTCACTAGGAGCA

clone = IMAGE:1372758

TGTCTGTTGTACTTACTTCAAACA

7321
db mining
Hs.188751
BG111636
12605142
60228268F1 cDNA, 5′ end/
1
CAAACACCAAACCAAGATAACACCGG

clone = IMAGE:4369892/clone_end =

AACGATAAACAGCAGAAACAGAGA

5′

7322
db mining
Hs.193392
U46120
1164779
expressed unknown mRNA/
1
TGGGTTTGTCCAGTTCAGGCTAGATG

cds = UNKNOWN

TGCATCATGGCAGGAAGAAAGAAG

7323
db mining
Hs.195453
NM_001030
4506710
ribosomal protein S27
1
AAGGATGTTCCTTCAGGAGGAAGCA

(metallopanstimulin 1) (RPS27),

GCACTAAAAGCACTCTGAGTCAAGA

mRNA/cds = (35, 289)

7324
db mining
Hs.196914
D86978
1504025
mRNA for KIAA0223 gene, partial cds/
1
CGGAAGCCACCGTGTGGTTCTTTCAC

cds = (0, 3498)

AGGCACGTTTATTTTGCTGAAATA

7325
db mining
Hs.198281
NM_002654
4505838
pyruvate kinase, muscle (PKM2),
1
CCTCCACTCAGCTGTCCTGCAGCCAA

mRNA/cds = (109, 1704)

CACTCCACCCTCCACCTTCCATTT

7326
db mining
Hs.200317
AB037825
7243188
mRNA for KIAA1404 protein, partial
1
TCCCTCCTTCCAGTGTTCCTTAGAAC

cds/cds = (64, 5841)

AGACATTTAGGTATCTCAGGTCCT

7327
db mining
Hs.202613
BG284262
13035032
802407238F1 cDNA, 5′ end/
1
CAGCCGCAGCATCTAAACGAACAACA

clone = IMAGE:4519449/clone_end =

GAGGAGAACGACGAGGACAGAGTT

5′

7328
db mining
Hs.210778
AL136679
12052881
mRNA; cDNA DKFZp584C1278 (from
1
TCACTGGATTTCTGTGTCTTCACTAG

clone DKFZp584C1278); complete cds/

AACACCATTGTCATCTCATATTGA

cds = (104, 1690)

7329
db mining
Hs.211594
NM_006503
5729990
proteasome (prosome, macropain)
1
GCTTCTCTCGCACCCCCAGCACCTCT

28S subunit, ATPase, 4 (PSMC4),

GTCCCAAAACCTCATTCCCTTTTT

mRNA/cds = (12, 1268)

7330
db mining
Hs.226307
NM_004900
4758159
phorbolin (similar to apolipoprotein B
1
AGCTGCTCACAGACACCAGCACAGC

mRNA editing protein) (DJ742C19.2),

AATGTGCTCCTGATCAAGTAGATTT

mRNA/cds = (79, 651)

7331
db mining
Hs.326048
NM_008319
5453905
cDNA FLJ14188 fis, clone
1
ATGCTCATGTGGTGTCCCCACCGCC

NT2RP2005726/cds = UNKNOWN

CACTTGTTTGATGTCACTGACTGTC

7332
db mining
Hs.227835
NM_014972
14149656
KIAA1049 protein (KIAA1049),
1
GCTGAGTGTGTCGCTCCCTGGTCCA

mRNA/cds = (96, 2126)

CTGTTTCTCCTATAAATGTAAATGG

7333
db mining
Hs.231967
NM_014423
7656878
ALL 1 fused gene from 5q31
1
TGCAGCACATTGATAAGATGGTTTCC

(AF5Q31), mRNA/cds = (337, 3828)

GTGAGCTATGATAAGATTGAAATT

7334
db mining
Hs.232400
NM_031243
14043071
heterogeneous nuclear
1
ATAAATATGCAGTGATATGGCAGAAG

ribonucleoprotein A2/B1 (HNRPA2B1),

ACACCAGAGCAGATGCAGAGAGCC

transcript variant B1, mRNA/

cds = (169, 1230)

7335
db mining
Hs.236131
NM_022740
13430859
homeodomain-interacting protein
1
TTGAACCGGGGAGTGGGAGGACGTA

kinase 2 (HIPK2), mRNA/

GAGCAGAGAAGAGAACATTTTTAAA

cds = (108, 3704)

7338
db mining
Hs.343558
AF090896
6690168
clone HQ0131 PRO0131 mRNA,
1
TTTGCTCATTCTAAACTCAAGCTTTTA

partial cds/cds = (0, 233)

AGCCTCACAGGATTTACAGGGGT

7337
db mining
Hs.238936
BG538032
13530264
602563534F1 cDNA, 5′ end/
1
GCCATAGGCTTACATGGGGCATACTC

clone = IMAGE:4688193/clone_end =

5′

7338
db mining
Hs.241412
NM_030882
13582089
apolipoprotein L, 2 (APOL2), mRNA/
1
GGTCTCTCGCTCTGTCTTTCCAGCAT

cds = (477, 1490)

CCACTCTCCCTTGTCCTTCTGGGG

7339
db mining
Hs.241471
AL133642
6599293
mRNA; cDNA DKFZp58BG1721 (from
1
TCAGCACCAAGTCATGTTTAAAAGAC

clone DKFZp586G1721); partial cds/

CAGAGAGACAAGCATTTTGCCAAG

cds = (0, 669)

7340
db mining
Hs.245188
NM_000362
9257248
tissue inhibitor of metalloproteinase 3
1
CGAACCCTGTCTAGAAGGAATGTATT

(Sorsby fundus dystrophy,

TGTTGCTAAATTTCGTAGCACTGT

pseudoinflammatory) (TIMP3), mRNA/

cds = (1183, 1818)

7341
db mining
Hs.249170
NM_012476
7110734
ventral anterior homeobox 2 (VAX2),
1
CAAATGGCCTTGGTCCCGCAGCTTGT

mRNA/cds = (32, 904)

GTGCGTGAGTGCAGTGTGAGTGTG

7342
db mining
Hs.258551
NM_012100
6912247
aspartyl aminopeptidase (DNPEP),
1
CTCTTGGAAAGACTTCTCTCCCATCC

mRNA/cds = (151, 1578)

CTTTGCACCTGAGAGGGGAAGTTC

7343
db mining
Hs.259412
BG772376
14083029
602722490F1 cDNA, 5′ end/
1
GGCGCGGTGACCCACTTATGGGACT

clone = IMAGE:4839143/clone_end =

TGGCCTTTCTTTGTTGTTTGTTTAA

5′

7344
db mining
Hs.259577
AW665292
7457838
hj02c11.x1 cDNA, 3′ end/
1
ACCCAGTTCATGATTACTTCTACTCTT

clone = IMAGE:2980628/clone_end =

AACACTCAATCCCCCTAATTAAACC

3′

7345
db mining
Hs.259679
AW956608
8146291
EST388878 cDNA
1
TTCGATAAACAGCGTTGACTTGCTTG

TACCACTTAAGAGTTGTGAGTGCT

7346
db mining
Hs.265827
NM_022873
13259549
interferon, alpha-inducible protein
1
TCCAGAACTTTGTCTATCACTCTCCC

(clone IFI-6-16) (G1P3), transcript

CAACAACCTAGATGTGAAAACAGA

variant 3, mRNA/cds = (107, 523)

7347
db mining
Hs.265891
AK001503
7022798
cDNA FLJ10641 fis, clone
1
GGGATCTTTCAAATGGATAGTGAGTT

NT2RP2005748/cds = UNKNOWN

GCCTTTTCCTATAGGTGACAATCA

7348
db mining
Hs.266456
AW768893
7700715
hk65e11.x1 cDNA, 3′ end/
1
AGAGCAAGCATTACAGAAAATAGGTC

clone = IMAGE:3001580/clone_end =

TGGAAGACAGGAAAAGGACAAAGA

3′

7349
db mining
Hs.267368
NM_017842
8923451
hypothetical protein FLJ20489
1
ATGTGTCCTGCCCCTCAGCTCTTTGC

(FLJ20489), mRNA/cds = (482, 1201)

CTTATCTGTGTCACTGTCACTTTA

7350
db mining
Hs.267812
NM_003794
4507144
sorting nexin 4 (SNX4), mRNA/
1
TCCTGTGAATTGAATTTCTCTTCAATC

cds = (0, 1352)

AAAGTGCCCCAAACAGAAGCACA

7351
db mining
Hs.272027
NM_012177
6912365
F-box only protein 5 (FBXO5), mRAN/
1
AGGTCCCCTGCCTGGTACAAAGAAAA

cds = (61, 1404)

GCAAAAAGAATTTACGAAGATTGT

7352
ob mining
Hs.272534
AL080068
5262475
mRNA; cDNA DKFZp584J082 (from
1
GCCAGAAGCATAATTTACCAGAGACG

clone DKFZp564J082)/

AGAACAGGGTGTGGGAGAGAGGAA

cds = UNKNOWN

7353
db mining
Hs.273415
NM_000034
4557304
aldolase A, fructose-bisphosphate
1
TCTTTCTTCCCTCGTGACAGTGGTG

(ALDOA), mRNA/cds = (187, 1261)

GTGGTGTCGTCTGTGAATGCTAAG

7354
db mining
Hs.273830
AK022804
10434416
cDNA FLJ12742 fis, clone
1
CAGTCAAACATTTTACCTTGTGCCTT

NT2RP2000844/cds = UNKNOWN

GGGTCACTCTGTGCCTTTTCTCCA

7355
db mining
Hs.274287
AK001508
7022805
cDNA FLJ10648 fis, clone
1
ACAGGAAACGGGCTTTCTCTGAATTG

NT2RP2005773, highly similar to

GTAAATGGGAAAGAAGTGAGCAAC

pyrroline 5-carboxylate reductase

isoform mRNA/cds = UNKNOWN

7356
db mining
Hs.275163
NM_002512
4505408
non-metastalic cells 2, protein
1
GTCCCTGGACACAGCTCTTCATTCCA

(NM23B) expressedin (NME2), nuclear

TTGACTTAGAGGCAACAGGATTGA

gene encoding mitochondrial protein,

mRNA/cds = (72, 530)

7357
db mining
Hs.276818
AI435118
4300940
th95e09.x1 cDNA, 3′ end/
1
ACCCTCGCCACAAGATTCTGCAATCT

clone = IMAGE:2126440/clone_end =

CCTAAAGTACAGATGAGAAAGGAA

3′

7358
db mining
Hs.278582
AF135794
4574743
AKT3 proein kinase mRNA, complete
1
TGCCAAGGGGTTAATGAAACAAATAG

cds/cds = (0, 1439)

CTGTTGACGTTTGCTCATTTAAGA

7359
db mining
Hs.279535
AK027035
10440049
cDNA; FLJ23382 fis, clone HEP16349/
1
CAGTGGCACACCTTAACCAGTCACTA

cds = UNKNOWN

ATTTTCACTGTTGTGAAAGTGATT

7360
db mining
Hs.283007
NM_006227
5453913
phospholipid transfer protein (PLTP),
1
CCCAGTGCCACAGAGAAGACGGGAT

mRNA/cds = (87, 1588)

TTGAAGCTGTACCCAAATTTAATTCC

7361
db mining
Hs.283585
NM_005438
4885242
FOS-like antigen-1 (FOSL1), mRNA/
1
TGAGCCCTACTCCCTGCAGATGCCAC

cds = (34, 849)

CCTAGCCAATGTCTCCTCCCCTTC

7362
db mining
Hs.284296
AK026646
10439543
cDNA; FLJ22993 fis, clone KAT11914/
1
GCAGGGAGGGGAGGATAAGTGGGAT

cds = UNKNOWN

CTACCAATTGATTCTGGCAAAACAA

7363
db mining
Hs.284892
AF246229
10419514
AF246229 cDNA/clone = RB82
1
GGCCACTACCTTTGTTGGAAACAAAG

CATAAGGGAGTGAAAGTGTCTAAA

7364
db mining
Hs.284893
AF246230
10419515
AF246230 cDNA/clone = RB16
1
GCTGGCCCGATCTCTCCCCACAGTT

GCAAGAAGCATTTTCAAAGAATAGT

7365
db mining
Hs.285280
AK024885
10437298
cDNA; FLJ21232 fis, clone COL00752/
1
ATTGGGATGAAACTACTTTAGCAAAG

cds = UNKNOWN

TCCACAGATCAGAAACCAGACGGT

7366
db mining
Hs.288038
NM_006625
12056474
TLS-associated serine-arginine protein
1
AGGAGACTGGGTCCTATAATTAGATT

1 (TASR1), mRNA/cds = (72, 623)

ATTTTGAGGCAGACAGAGAGCTGT

7367
db mining
Hs.288283
AK026008
10438707
cDNA; FLJ22355 fis, clone HRC06344/
1
AGCCTGCAAGGTTAGGACTTGAAGA

cds = UNKNOWN

GGGAAGGTATTTAATAACTGGGCGA

7368
db mining
Hs.289043
AL138719
12052956
mRNA; cDNA DKFZp566G0346 (from
1
TTAGTGCAGTTGGAATGAATGTGTAT

clone DKFZp566G0346); complete cds/

AGGTCAGAGGTCTTCGTGTTCACA

cds = (278, 790)

7369
db mining
Hs.289087
AK024468
10440449
mRNA for FLJ00061 protein, partial
1
TCACCTCTCAGTTGAAAGATTTCTTCT

cds/cds = (0, 522)

TTGAAAGGTCAAGACCGTGAACT

7370
db mining
Hs.290494
BF475245
11544422
EST 003 cDNA, 5′ end/clone_end = 5′
1
AGTCTGGATGTAAGGCCTGCCTCAAA

GAGACACTAATGGGAGGGAACAAA

7371
db mining
Hs.290874
BE730505
10144599
601562627F1 cDNA, 5′end/
1
AAAGGAAGAAGCACGATGCAAACAG

clone = IMAGE:3832302/clone_end =

AAACAACACGACACAGAGTGAGCGA

5′

7372
db mining
Hs.332403
NM_024113
13129129
hypothetical protein MGC4707
1
ACTCCTTCAAGTCTTGACCCCTTTGT

(MGC4707), mRNA/cds = (72, 1067)

GTCTAATAGCTAAACAAACATGTG

7373
db mining
Hs.292998
AW972292
8162138
EST384381 cDNA
1
AACAATAGGAATAAGGTTACTTCAGC

CTTAAGGGGCTTATCATACTGCTG

7374
db mining
Hs.293984
NM_032323
14150097
hypothetical protein MGC13102
1
GACAGGGAAATCTGCCTACCAAGAG

(MGC13102), mRNA/cds = (161, 1345)

GGGTGTGTGTGTCTTTGTGCCCACA

7375
db mining
Hs.295362
AK027385
14041993
cDNA FLJ14459 fis, clone
1
AACAAGTCCATGACTCCCAAGGGTTT

HEMBB1002409/cds = UNKNOWN

AAGGACCAATGGTTCAGTGAGACA

7376
db mining
Hs.297964
BF836049
12187621
RC1-HT0975-161100-011-g07 cDNA
1
ACACTCATACTCATATGTACGTGCTC

AGICGAACGGACTGCAGTCCGTTC

7377
db mining
Hs.299329
AK000770
7021066
cDNA FLJ20763 fis, clone COL09911/
1
TACTGCTATGGAATGAGACCACCACT

cds = UNKNOWN

TCTCCTGTTGTCCTTCCCAGCTTC

7378
db mining
Hs.300631
AK022958
10434651
cDNA FLJ12896 fis, clone
1
TGCCAAGTGAGGACAAACTGCTAGG

NT2RP2004194, weakly similar to

CTGTATCCCATAATTTCAGGATGAG

Rattus norvegicus Golgi SNARE GS15

mRNA/cds = UNKNOWN

7379
db mining
Hs.301417
M80899
178282
novel protein AHNAK mRNA, partial
1
AAACCGACCGCCTGTAGGCTCCTGG

sequence/cds = (0, 3835)

AACTATACAGATAGGTAAAGAGTTC

7380
db mining
Hs.301612
NM_005253
4885244
FOS-like antigen 2 (FOSL2), mRNA/
1
GACCAATCATCAGACTCCTTGAACTC

cds = (3, 983)

CCCCACTCTGCTGGCTCTGTAACC

7381
db mining
Hs.301636
NM_000287
4505728
peroxisomal biogenesis factor 6
1
AGAGATCCAGGGCAAGTGGATTGA

(PEX6), mRNA/cds = (70, 3012)

GACAGCAGCAACAGCTCAAGAGATA

7382
db mining
Hs.337774
NM_004723
4758871
rho/rac guanine nucleotide exchange
1
ATGTCCCTTTCTCCTCTCCCCTCTTC

factor (GEF) 2 (ARHGEF2), mRNA/

CTCTTACTGCTGTTCTCCCTTTCT

cds = (112, 2988)

7383
db mining
Hs.318568
BF475243
11544420
EST 001 cDNA, 5′ end/clone_end = 5′
1
ACATCCATAGAACAATACATCAAAGT

TGTTGAAGTGTTGCAGGGGAGGGC

7384
db mining
Hs.318569
BF475244
11544421
EST 002 cDNA, 5′ end/clone_end = 5′
1
AGCACTTACTGTCAGGCATTCAGAAT

GTGAGCAATGACAATAATTTACCT

7385
db mining
Hs.321709
NM_002560
4505548
purinergic receptor P2X, ligand-gated
1
AATCTGATTGAGTCTCCACTCCACAA

ion channel, 4 (P2RX4), mRNA/

GCACTCAGGGTTCCCCAGCAGCTC

cds = (27, 1193)

7386
db mining
Hs.322478
D38491
559327
mRNA for KIAA0117 gene, partial cds/
1
AACCCAAGAAAAGAGTTGCTCTTACT

cds = (0, 883)

ATCTACTGCTGACTCTTGAACTTT

7387
db mining
Hs.323114
AK023846
10435906
cDNA FLJ13784 fis, clone
1
TTCGTAGGTGGGCTTTTCCTATCAGA

PLACE400593/cds = UNKNOWN

GCTTGGCTCATAACCAAATAAAGT

7388
db mining
Hs.323949
NM_002231
13259537
kangai 1 (suppression of
1
AGGTGGGCTGGACTTCTACCTGCCC

lumorigenicity 6, prostate; CD82

TCAAGGGTGTGTATATTGTATAGGG

antigen (R2 leukocyte antigen, antigen

detected by monoclonal and antibody

IA4)) (KAI1), mRNA/cds = (181, 984)

7389
db mining
Hs.324507
NM_024524
13375667
hypothetical protein FLJ02986
1
TGTGTCAGAATGGCACTAGTTCAGTT

(FLJ20986), mRNA/cds = (182, 2056)

TATGTCCCTTCTGATATAGTAGCT

7390
db mining
Hs.326447
BC004857
13436058

Homo sapiens, clone IMAGE:3690478,
1
CTATCAGCCCCAAGTGGAGCAGAAC

mRNA, partial cds/cds = (0, 71)

AGAGGGATTTGGGAGGAATGTCCTC

7391
db mining
Hs.333558
BG577468
13592532
gu.seq cDNA
1
TGCTAAGGAGAGGGGCCATGAAGAG

TTTTGTTGAGAACATCGTGTCTGAG

7392
db mining
Hs.334303
BG642392
13777102
gu.seq395250 cDNA
1
AGTCAGAACTTCAAGTCCCCATTAAA

GGGGCTGGAAAATACAAGTACAGT

7393
db mining
Hs.334804
NM_000558
6715603
hemoglobin, alpha 1 (HBA1), mRNA/
1
CTCCCCTTCCTGCACCCGTACCCCC

cds = (37, 485)

GTGGTCTTTGAATAAAGTCTGAGTG

7394
db mining
Hs.334853
NM_032241
14149953
hypothetical protein FLJ23544
1
CAGATGGTTGTGGGGTCAAGTACATC

(FLJ23544), mRNA/cds = (125, 517)

CCCAGTCGTGGCCCTTTGGACAAG

7395
db mining
Hs.250655
NM_032695
14249283
Prothymosin, alpha (gene sequence
1
TTTTGGCCTGTTTGATGTATGTGTGA

28)

AACAATGTTGTCCAACAATAAACA

7396
db mining
Hs.336689
AA493477
2223318
ESTs
1
AGCCTAGGTGACAGAGCAAGACTCC

ATTTCAAAAACAAAACAAAACAAAA

7397
db mining
Hs.180450
BF791433
1206487
ribosomal protein S24 (RPS24),
1
ACACTGAGAATACACGACATACACGC

transcipt variant 1, mRNA/

ACGCACAAGACAACAACAGACAGC

cds = (37, 429)

7398
Table 3A
NA
AA077131
1836605
7B08E10 Chromosome 7 Fetal Brain
1
CAGCCACCTCCTCAGGTCAGACAAG

cDNA Library cDNA clone 7B08E10,

CCCAGCACCCAAATACCACTATCTG

mRNA sequence

7399
Table 3A
NA
AA501725
2236692
ng18e12.s1 NCI_CGAP_Lip2 cDNA
1
GGCTTCCCTATTACCTCCCAGCGAAA

clone IMAGE:929806 similar to

TTCGTAGTCTTTCTCTATGGAGTT

contains Alu repetitive element; mRNA

7400
Table 3A
NA
AA501934
2236901
nh56a10.s1 NCI_CGAp_Pr8 cDNa
1
TGCTGATGTGTTAGGTAGTTGTGGCA

clone IMAGE:956348, mRNA

CACTCACCTGTCTTTCCTAAATGC

sequence

7401
Table 3A
NA
AA579400
2357584
nf33d05.s1 NCI_CGAP_Pr1 cDNA
1
TTCATGCTCAGCAAAACAACGTTTTA

clone IMAGE:915561 similar to

GGATGGTGAGAGAAGACAAAGTAA

contains Alu repetitive

element; contains

7402
Table 3A
NA
AF249845
8099620
isolate Siddi 10 hypervariable region 1,
1
TATTAACCACTCACGGGAGCTCTCCA

mitochondrial sequence

TGCATTTGGTATTTTCGTCTGGGG

7403
db mining
Hs.277051
AI630242
4681572
ad07c09.y1 cDNA/clone = ad07c09-
1
TTACCTGCTTTGCATGCTCTCCATCG

(random)

TCAAAGTCTTCTGGAAACTTAGGC

7404
db mining
Hs.277052
AI630342
4681672
ad08g11.y1 cDNA/clone = ad08g11-
1
CCCCACCCCAACACATACAACGTTT

(random)

CCCACCAATCCTTGAACTGCAAAA

7405
db mining
NA
AI732228
5053341
nf19e05.x5 NCI_CGAP_Pr1 cDNA
1
TTCAAGGTCCCAATACCCAACTAACT

clone IMAGE:914240 similar to

CGAAGGAAGAAATGGAAATCTATT

contains Alu repetitive element;

mRNAs

7406
Table 3A
Hs.197803
AW379049
6883708
mRNA for KIAA0160 gene, partial cds/
1
TGCACAGAACTCTTACTTACATGTCT

cds = (0, 2413)

CATCGAAACTCCAGAACACCCGTCG

7407
Table 3A
Hs.232000
AW380881
6885540
UI-H-B10p-abh-h-06-0-UI.s1 cDNA, 3′
1
TGCATGTATCCCGGTAATTCAAATCC

end/clone = IMAGE:2712035/

AATTTCACAGCCACTGCTGAATAT

clone_end = 3′

7408
Table 3A
Hs.325568
AW384988
6889647
602386081F1 cDNA, 5′ end/
1
TACAGGAAAATGAAACTAGACGGGTG

clone = IMAGE:4514972/clone_end =

GGGGACACTAGAATGAAAACCAGT

5′

7409
Table 3A
NA
AW836389
7930383
PM0-LT0030-101299-001-f08 LT0030
1
AGTTTCTGCTTTCAGTGACTGAGGCT

cDNA, mRNA sequence

TTGCTTTAACCTGGTGACTCCCAA

7410
Table 3A
NA
AW837717
7931691
CM2-LT0042-281299-062-e11 LT0042
1
TCCCACTTCAAGTTAAGCACCAAAGC

cDNA, mRNA sequence

AATCACTAATTCTGGAGCACAGGA

7411
Table 3A
NA
AW837808
7931782
CM1-LT0042-100300-140-f05 LT0042
1
CATGGATGGGGGCAGTGGTGTTTCT

cDNA, mRNA sequence

AGTGTGTGAGGAAGCAGAGCAGATG

7412
Table 3A
NA
AW842489
7938472
PM4-CN0032-050200-002-c11
1
TCACCACAGATGGGAAGATCGTTTCC

CN0032 cDNA, mRNA sequence

TGAAAACAGTCTATAAATCACAGA

7413
Table 3A
NA
AW846856
7942373
QV3-CT0195-011099-001-c09
1
CAGACGCTCCAGTGCTGCCGAGGTT

CT0195 cDNA, mRNA sequence

AGTGTGTTTATTAGACCTGAAATGA

7414
Table 3A
NA
AW856490
7952183
PM4-CT0290-271099-001-c04
1
CCCTTTAGGCCTCTTGCCCGAACAGT

CT0290 cDNA, mRNA sequence

GAACACTAATAGATATCCTAAGCT

7415
Table 3A
NA
AW891344
8055549
PM2-NT0079-030500-001-a04
1
ATGGGGATCATGTTTTATTTTTCTCTA

NT0079 cDNA, mRNA sequence

TATAATGGGCCAGTGTGTTCCCA

7416
Table 3A
NA
BE061115
8405765
QV0-BT0041-011199-039-f09 BT0041
1
AGCTGTAGACCATAAGCCACCTTCAG

cDNA, mRNA sequence

GTAGTGGTTTGGGAAATCAAGCAA

7417
Table 3A
NA
BE086076
8476469
PM2-BT0672-130400-006-h09
1
TGTACTTATGCTTGTCTTCTCTACCTG

BT0672 cDNA, mRNA sequence

CCCCCAGTCTTGAAGTGGTGGAA

7418
Table 3A
NA
BE091932
8482384
IL-2BT0733-130400-068-C11 BT0733
1
GGAGGGTGTGGGAAGCAAGAGAAGA

cDNA, mRNA sequence

ACATTCTGTTAGGGGCAGAGAAGAA

7419
Table 3A
Hs.173334
BE160822
8623543
ELL-RELATED RNA POLYMERASE
1
GCATCTCCAGCTTTCATAGTTACCCA

II, ELONGATION FACTOR (ELL2),

ACTTGTAAACCAGAAGATGTGCTG

mRNA/cds = (0, 1922)

7420
Table 3A
NA
BE163106
8625827
QV3-HT0457-060400-146-h10
1
GGCCAGTGCCAGACGGTAGCTAGTT

HT0457 cDNA, mRNA sequence

GGATGCTAAAGGTAGAATTTAGATA

7421
Table 3A
Hs.301497
BE168334
8631159
arginine-tRNA-protein transferase 1-1p
1
GGCATTGTAGGTTGACACCAGCAAAG

(ATE1) mRNA, alternatively spliced

ACTCAGAGTGACTTGAGCATTGGA

product, partial cds/cds = (0, 1544)

7422
Table 3A
Hs.172780
BE176373
8639102
602343016F1 cDNA, 5′ end/
1
AGCCCATTTGGATATGGCCCATCTTT

clone = IMAGE:4453468/clone_end =

ACCTAATGGCTACTATAGTGAGGT

5′

7423
Table 3A
NA
BE177661
8658813
RC1-HT0598-020300-011-h02
1
AATCACAGCAGTAACTCCCAGTAGGA

HT0598 cDNA, mRNA sequence

AAGATTCTCAAAGGAATAGTTCTT

7424
Table 3A
NA
BE178880
8658032
PM1-HT0509-060300-001-g03
1
AATGGTCAGGCACAGGTAGAATCAAA

HT0609 cDNA, mRNA sequence

GTCCTGTATGTATGTTCACACAGA

7425
Table 3A
NA
BE247056
9098807
TCBAP1D6404 Pediatric pre-B cell
1
TACCTGAAGGTGTAGAGAGTGCCCG

acute lymphoblastic leukemia Baylor-

CATCCAGCAAGGCCAACAGCTCCAC

HGSC project = TCBA cDNA clone T

7426
Table 3A
Hs.11050
BE763412
10193336
mRNA; cDNA DKFZp434C0118 (from
1
CTGTGTTTTTCCCAAAGCAACAATTTC

clone DKFZp434C0118); partial cds/

AAACAATGAGAGCCACTGACA

cds = (0, 1644)

7427
Table 3A
NA
BF330908
11301656
RC3-BT0333-310800-115-f11 BT0333
1
GACTCCGAGCTCAAGTCAGTCTGTAC

cDNA, mRNA sequence

CCCCAACCCCTAACCCACTGCATC

7428
Table 3A
NA
bf357523
11316597
CM2-HT0945-150900-379-g08
1
TGTAACTGACTTTATGTATCACTCAAG

HT0945 cDNA, mRNA sequence

TCTTGCCTTTACTGAGTGCCTGA

7429
Table 3A
NA
BF364413
11326438
RC6-NN1068-070600-011-B01
1
TCTCTCTAACCAAAACTGTAATCTTCA

NN1068 cDNA, mRNA sequence

GGACCAGCAAACTCAGCCCAAGG

7430
Table 3A
NA
BF373638
11335663
MR0-FT0176-040900-202-g09 FT0176
1
AACTCTTGGTTAAATGGGTTAATAGA

cDNA, mRNA sequence

GGATTGGAACACTTTGTTTGCTGT

7431
Table 3A
NA
BF740663
12067339
QV1-HB0031-071200-582-h04
1
AGAAGCAAACCTGTGAAGCTACTATC

HB0031 cDNA, mRNA sequence

GTTTATCATCAGTGTGAATGCACT

7432
Table 3A
NA
BF749089
12075765
MR2-BN0386-051000-014-b04
1
GGACTAACTTCCACCTCCTCTGCTAC

BN0386 cDNA, mRNA sequence

TTCCAGCTGCTTCTAATCACACTT

7433
Table 3A
NA
BF758480
12106380
MR4-CT0539-141100-003-d05
1
AGTCTTCCACCCAGACAYAGGTA

CT0539 cDNA, mRNA sequence

TCACACACCAGCTCTGTTTTACT

CCTG

7434
Table 3A
NA
BF773126
12121026
CM3-IT0048-151200-568-f08 IT0048
1
TTAGCTGGTACATTGTTCAGAGTTTA

cDNA, mRNA sequence

CTGGGAGCCGGTAAGATAGTCACC

7435
Table 3A
NA
BF773393
12121293
CM2-IT0039-191200-638-h02 IT0039
1
AGCGTGATGCTTCCTCATGTCGGTGA

cDNA, mRNA sequence

TTTTCTGTTGAGACATCTTCAAGC

7436
Table 3A
NA
BF805164
12134153
QV1-C10173-061100-456-f03 CI0173
1
ACAAAAGTATGGAATTCAATTCTTTTT

cDNA, mRNA sequence

ATATGCTGCAGCCATGTTCCTGCCCT

AGA

7437
Table 3A
NA
BF818594
12156027
MR3-CI0184-201200-009-e04 CI0184
1
TGTAATTGATTTCCGCATAAACGGTC

cDNA, mRNA sequence

ATTACTGGCACCTATGGCAGCACC

7438
Table 3A
NA
BF827734
12171909
RC5-HN0025-041200-022-F08
1
GTGATCCACTTGGAGCTGCTACTGGT

HN0025 cDNA, mRNA sequence

CCCATTGAGTCCTATAGTACTTCA

7439
Table 3A
NA
BF845167
12201450
RC5-HT1035-271200-012-F08
1
TGCCATGAAATCTCTATTAATTCTCAG

HT1035 cDNA, mRNA sequence

AAAGATCAAAGGAGGTCCCGTGT

7740
Table 3A
NA
BF869167
12259297
IL5-ET0119-181000-181-b11 ET0119
1
CCCACCTGGCAAATCCTCAAGTGTGA

cDNA, mRNA sequence

CCCTAGTCATCTTTCTCCTTTTGG

7441
Table 3A
NA
BF875575
12255705
QV3-ET0100-111100-391-c02 ET0100
1
GCTAAACAGAAAAGAACCTGAAGTAC

cDNA, mRNA sequence

AGTTCCCGTCTTCAAAGAAGATGC

7442
Table 3A
NA
BF877979
12268109
MR0-ET0109-171100-001-b02
1
ATCCTCCTCCCCTGGGATGGCATAGA

ET0109 cDNA, mRNA sequence

AGAGACTTTAAAACCAAATGAGCC

7443
Table 3A
NA
BF897042
12288501
IL2-MT0179-271100-254-C11 MT0179
1
GTCAGTAAAGCTCTGCCTGCCAA

cDNA, mRNA sequence

GAAGACACAGTGAGAGGTGTCCAC

AGTC

7444
Table 3A
NA
BF898285
12289744
QV1-MT0229-281100-508-e11
1
GTTTCCACTTAGTTACTTCTTCCTACC

MT0229 cDNA, mRNA sequence

TGCTGTGAAGCTCTGCACCCTGC

7445
Table 3A
NA
BF899464
12290923
IL5-MT0211-011200-317-f03 MT0211
1
AGAGTAATCCACATCCCAGGGACAGT

cDNA, mRNA sequence

CACAATGACCTACGGCTTTAGCTG

7446
Table 3A
Hs.324473
BF904425
12295884
40 kDa protein kinase related to rat
1
GCAGGGCTACACCAAGTCCATTGATA

ERK2/cds = (134, 1180)

TTTGGTCTGTAGGCTGCATTCTGG

7447
Table 3A
NA
BF906114
12297573
IL3-MT0267-281200-425-A05 MT0267
1
TCTTCTCTAAAATGCCCTCCTCTCCTT

cDNA, mRNA sequence

CCTTTTTCCAGACCTGGTTTAAA

7448
Table 3A
Hs.104679
BF926187
12323197

Homo sapiens, clone MGC-18218
1
TCGCCATTTGGTAGTTCCACAGTGAC

IMAGE:4156235, mRNA, complete

TGCTCTTTCTATTTTACGAAGCCAC

cds/cds = (2206, 2373)

7449
Table 3A
Hs.75703
BF928844
12326772
small inductible cytokine A4
1
GTAATTACTATGAGACCAGCAGCCT

(homologous to mouse Mip-1b)

CTGCTCCCAGCCAGCTGTGGTGTG

(SCYA4), mRNA/cds = (108, 386)

7450
Table 3A
NA
BG006820
12450386
RC4-GN0227-271100-011-d03
1
TTTCCTTTTCGCTGACTTTCTCACTCA

GN0227 cDNA, mRNA sequence

CTGTCTGTCTCTCATTTTCTCCA

7451
Table 3A
NA
F11941
706260
HSC33F051 normalized infant brain
1
TGGTAAGTTTCTGGCAGTGTGGAGAC

cDNA cDNA clone c-33f05, mRNA

AGGGGAATAATCTCAACAGTAGGT

sequence

7452
Table 3A
NA
U46388
1235904
HSU46388 Human pancreatic cancer
1
CCATGGTGGTGCTTGACTTTGCTTTG

cell line Patu 8988t cDNA clone xs425,

GGGCTTAATCCTAGTATCATTTGG

mRNA sequence

7453
Table 3A
NA
U75805
1938265
HSU75805 Human cDNA clone f46,
1
TCAGTGGGTGTTGGTTGTCCATTAGT

mRNA sequence

TGAGACTTAGTTGTTGCTCTGGGA

7454
Table 3A
NA
W27656
1307658
36f10 Human retina cDNA randomly
1
GGCTGGACAGCAGATGATTCAAATCT

primed sublibrary cDNA, mRNA

CAATACTACATGCCCATTCTGTGG

sequence

7455
literature
NA
X17403
59591
Human cytomegalovirus strain AD169
1
AATAATAGATTAGCAGAAGGAATAAT

complete genome

CCGTGCGACCGAGCTTGTGCTTCT

7456
literature
NA
X17404
59591
Human cytomegalovirus strain AD169
1
TTTTGCGAACTTTTAGGAACCAGCAA

complete genome

GTCAACAAAAGACTAACAAAGAAA

7457
literature
Hs.2799
X17405
59591
Cartilage linking protein 1
1
GAGATCGACATCGTCATCGACCGAC

CTCCGCAGCAACCCCTACCCAATCC

7458
literature
Hs.2159
X17406
59591
mRNA for cartilege specific
1
ACATTCAAAAGTTTGAGCGTCTTCAT

proteoglycan

GTACGCCGTTTTCGGCCTCACGAG

7459
literature
NA
X17407
59591
Human cytomegalovirus strain AD169
1
CCAACGACACATCCACAAAAATCCCC

complete genome

CATCGACTCTCACAATCGCATCAT

7460
literature
NA
X17408
59591
Human cytomegalovirus strain AD169
1
CTTTGAGCAGGTTCTCAAGGCTGTAA

complete genome

CTAACGTGCTGTCGCCCGTCTTTC

7461
literature
NA
X17409
59591
Human cytomegalovirus strain AD169
1
GATGTCCGTCTACGCGCTATCGGCC

complete genome

ATCATCGGCATCTATCTGCTCTACC

7462
literature
NA
X17410
59591
Human cytomegalovirus strain AD169
1
TCTTCTGGGACGCCAACGACATCTAC

complete genome

CGCATCTTCGCCGAATTGGAAGGC

7463
literature
NA
X17411
59591
Human cytomegalovirus strain AD169
1
ACGAACAGAAATCTCAAAAGACGCTG

complete genome

ACCCGATAAGTACCGTCACGGAGA

7464
literature
NA
X17412
59591
Human cytomegalovirus strain AD169
1
AGAGAACAACAAACCACCACGACGA

complete genome

TGAAACAAACGCTCAACCAAACA

7465
literature
NA
X17413
59591
Human cytomegalovirus strain AD169
1
CTGCATCGTCGTCGTCCTCCTCCTCT

complete genome

CGGAGATCGCGACGGAGAAACAAC

7466
literature
NA
X17414
59591
Human cytomegalovirus strain AD169
1
CTGAGCCTGGCCATCGAGGCAGCCA

complete genome

TCCAGGACCTGAGGAACAAGTCTCA

7467
literature
NA
X17415
59591
Human cytomegalovirus strain AD169
1
CCTCTGGAGGCAAGAGCACCCACCC

complete genome

TATGGTGACTAGAAGCAAHHCTGAC

7468
literature
NA
X17416
59591
Human cytomegalovirus strain AD169
1
TTCGTGGGCACCAAGTTTCGCAAGAA

complete genome

CTACACTGTCTGCTGGCCGAGTTT

7469
literature
NA
J01917
209811
Adenovirus type 2, complete genome
1
CTGTGGAATGTATCGAGGACTTGCTT

AACGAGTCTGGGCAACCTTTGGAC

7470
literature
NA
J01918
209811
Adenovirus type 2, complete genome
1
GCTGGCCTGCACCCGCGCTGAGTTT

GGCTCTAGCGATGAAGATACAGATT

7471
literature
NA
J01919
209811
Adenovirus type 2, complete genome
1
GGGGCGGTTAGGCTGTCCTCCTTCT

CGACTGACTCCATGATCTTTTTCTG

7472
literature
NA
J01920
209811
Adenovirus type 2, complete genome
1
TGTTTGCCTTATTATTATGTGGCTTAT

TTGTTGCCTAAAGCGCAGACGC

7473
literature
Hs.250596
J01921
209811
xy45f10.x1 cDNA, 3′ end/
1
ACGGTGATCAATATAAGCTATGTGGT

clone = IMAGE:2856139/clone_end =

GGTGGGGCTATACTACTGAATGAA

3′

7474
literature
NA
J01922
209811
Adenovirus type 2, complete genome
1
TTTCTGCCCTGAAGGCTTCCTCCCCT

CCCAATGCGGTTTAAAACATAAAT

7475
literature
NA
J01923
209811
Adenovirus type 2, complete genome
1
GGCTTATGCCCATGTATCTGAACATC

CAGAGTCACCTTTACCACGTCCTG

7476
literature
NA
J01924
209811
Adenovirus type 2, complete genome
1
CTACTGCCGTACAGCGAAAGCCGCC

CCAACCCGCGAAACGAGGAGATATG

7477
Table 3A
NA
AA077131
1836605
7B08E10 Chromosome 7 Fetal Brain
−1
CAGATAGTGGTATTTGGGTGCTGGG

cDNA Library cDNA clone 7B08E10,

CTTGTCTGACCTGAGGAGGTGGCTG

mRNA sequence

7478
Table 3A
NA
AA501725
2236692
ng18e12.s1 NCI_CGAP_Lip2 cDNA
−1
AACTCCATAGAGAAAGACTACGAATT

clone IMAGE:929808 similar to

TCGCTGGGAGGTAATAGGGAAGCC

contains Alu repetitive element; mRNA

7479
Table 3A
NA
AA501934
226901
nh56a10.s1 NCI_CGAP_Pr8 cDNA
−1
GCATTTAGGAAAGACAGGTGAGTGTG

clone IMAGE:958346, mRNA

CCACAACTACCTAACACATCAGCA

sequence

7480
Table 3A
NA
AA579400
2357584
nf33d05.s1 NCI_CGAP_Pr1 cDNA
−1
TTACTTTGTCTTCTCTCACCATCCTAA

clone IMAGE:91581 similar to

contains Alu repetitive

element:contains

7481
Table 3A
NA
AF249845
8099620
isolate Siddi 10 hypervariable region 1,
−1
CCCCAGACGAAAATACCAAATGCATG

mitochondrial sequence

GAGAGCTCCCGTGAGTGGTTAATA

7482
db mining
Hs.277051
AI630242
4881572
ad07c09.y1 cDNA/clone = ad07c09-
−1
GCCTAAGTTTCCAGAAGACTTTGACG

(random)

ATGGAGAGCATGCAAAGCAGGTAA

7483
db mining
Hs.277052
AI830342
4681672
ad08g11.y1 cDNA/clone = ad08g11-
−1
TTTTGCAGTTCAAGGATTGGTGGGAA

(random)

ACGTTTGTATGTGTTGGGGTGGGG

7484
db mining
NA
AI732228
5053341
nf19e05.x5 NCI_CGAP_Pr1 cDNA
−1
AATAGATTTCCATTTCTTCCTTCGAGT

clone IMAGE:91420 similar to

TAGTTGGGTATTGGGACCTTGAA

contains Alu repetitive element; mRNA

s

7485
Table 3A
Hs.197803
AW379049
6883708
mRNA for KIAA0160 gene, partial cds/
−1
CGACGGTGTTCTGGAGTTTCGATGAG

CDS = (0, 2413)

ACATGTAAGTAAGAGTTCTGTGCA

7486
Table 3A
Hs.232000
AW380881
6885540
UI-H-B10p-abh-h-06-UI.s1 cDNA 3′
−1
ATATTCAGCAGTGGCTGTGAAATTGG

end/clone = IMAGE:2712035/

ATTTGAATTACCGGGATACATGCA

clone_end = 3′

7487
Table 3A
Hs.325588
AW384988
6889647
602386081F1 cDNA 5′ end/
−1
ACTGGTTTTCATTCTAGTGTCCCCCA

clone = IMAGE:4514972/clone_end =

CCCGTCTAGTTTCATTTTCCTGTA

5′

7488
Table 3A
NA
AW836389
7930363
PM0-LT0030-101299-001-f08 LT0030
−1
TTGGGAGTCACCAGGTTAAAGCAAAG

cDNA, mRNA sequence

7489
Table 3A
NA
AW837717
7931691
CM2-LT0042-2612990-062-e11
−1
TCCTGTGCTCCAGAATTAGTGATTGC

LT0042 cDNA, mRNA sequence

TTTGGTGCTTAACTTGAAGTGGGA

7490
Table 3A
NA
AW837608
7931782
CM1-LT0042-100300-140-f05 LT0042
−1
CATCTGCTCTGCTTCCTCACACACTA

cDNA, mRNA sequence

GAAACACCACTGCCCCCATCCATG

7491
Table 3A
NA
AW842489
7936472
PM4-CN0032-050200-002-c11
−1
TCTGTGATTTATAGACTGTTTTCAGGA

CN0032 cDNA, mRNA sequence

AACGATCTTCCCATCTGTGGTGA

7492
Table 3A
NA
AW848856
7942373
QV3-CT0195-011099-001-c09
−1
TCATTTCAGGTCTAATAAACACACTAA

CT0195 cDNA, mRNA sequence

CCTCGGCAGCACTGGAGCGTCTG

7493
Table 3A
NA
AW856490
7952183
PM4-CT0290-271099-001-c04
−1
AGCTTAGGATATCTATTAGTGTTCACT

CT0290 cDNA, mRNA sequence

GTTCGGGCAAGAGGCCTAAAGGG

7494
Table 3A
NA
AW891344
8055549
PM2-NT0079-030500-001-a04
−1
TGGGAACACACTGGCCCATTATATAG

NT0079 cDNA, mRNA sequence

AGAAAAATAAAACATGATCCCCAT

7495
Table 3A
NA
BE061115
8405785
QV0-BT0041-011199-039-f09 BT0041
−1
TTGCTTGATTTCCCAAACCACTACCT

cDNA, mRNA sequence

GAAGGTGGCTTATGGTCTACAGCT

7496
Table 3A
NA
BE086076
8476469
PM2-BT0672-130400-008-h09
−1
TTCCACCACTTCAAGACTGGGGGCA

BT0672 cDNA, mRNA sequence

GGTAGAGAAGACAAGCATAAGTACA

7497
Table 3A
NA
BE091932
8482384
IL2-BT0733-130400-068-C11 BT0733
−1
TTCTTCTCTGCCCCTAACAGAATGTT

cDNA, mRNA sequence

CTTCTCTTGCTTCCCACACCCTCC

7498
Table 3A
Hs.173334
BE160822
8623543
ELL-RELATED RNA POLYMERASE
−1
CAGCACATCTTCTGGTTTACAAGTTG

II, ELONGATION FACTOR (ELL2),

GGTAACTATGAAAGCTGGAGATGC

mRNA/cds = (0, 1922)

7499
Table 3A
NA
BE163106
8825827
QV3-HT0457-050400-146-h10
−1
TATCTAAATTCTACCTTTAGCATCCAA

HT0457 cDNA, mRNA sequence

CTAGCTACCGTCTGGCACTGGCC

7500
Table 3A
Hs.301497
BE168334
8631159
arginine-tRNA-protein transferase 1-1p
−1
TCCAATGCTCAAGTCACTCTGAGTCT

(ATE1) mRNA, alternatively spliced,

TTGCTGGTGTCAACCTACAATGCC

product, partial cds/cds = (0, 1544)

7501
Table 3A
Hs.172780
BE176373
8839102
602343016F1 cDNA, 5′ end/
−1
ACCTCACTATAGTAGCCATTAGGTAA

clone = IMAGE:4453466/clone_end =

AGATGGGCCATATCCAAATGGGCT

5′

7502
Table 3A
NA
BE177681
8656813
RC1-HT0598-020300-011-h02
−1
AAGAACTATTCCTTTGAGAATCTTTCC

HT0598 cDNA, mRNA sequence

TACTGGGAGTTACTGCTGTGATT

7503
Table 3A
NA
BE178880
8658032
PM1-HT0609-060300-001-g03
−1
TCTGTGTGAACATACATACAGGACTT

HT0609 cDNA, mRNA sequence

TGATTCTACCTGTGCCTGACCATT

7504
Table 3A
Hs.88543
BE247056
9098807
602495247F1 cDNA, 5′ end/
−1
GTGGAGCTGTTGGCCTTGCTGGATG

clone = IMAGE:4609330/clone_end =

CGGGCACTCTCTACACCTTCAGGTA

5′

7505
Table 3A
Hs.11050
BE763412
10193336
mRNA; cDNA KDFZp434C0118 (from
−1
TGTCAGTGGCTCTCACTTTGTTTGAA

clone DKFZp434C0228); partial cds/

ATTGTTGCTTTGGGAAAAACACAG

cds = (0, 1644)

7506
Table 3A
NA
BF330908
11301656
RC3-BT0333-310800-115-f11 BT0333
−1
GATGCAGTGGGTTAGGGGTTGGGGG

cDNA, mRNA sequence

TACAGACTGACTTGAGCTCGGAGTC

7507
Table 3A
NA
BF357523
11316597
CM2-HT0945-150900-379-g06
−1
TCAGGCACTCAGTAAAGGCAAGACTT

HT0945 cDNA, mRNA sequence

GAGTGATACATAAAGTCAGTTACA

7508
Table 3A
NA
BF384413
11326438
RC6-NN1068-070600-011-B01
−1
CCTTGGGCTGAGTTTGCTGGTCCTGA

NN1068 cDNA, mRNA sequence

AGATTACAGTTTTGGTTAGAGAGA

7509
Table 3A
NA
BF373838
11335663
MR0-FT0176-040900-202-g09 FT0173
−1
ACAGCAAACAAAGTGTTCCAATCCTC

cDNA, mRNA sequence

TATTAACCCATTTAACCAAGAGTT

7510
Table 3A
NA
BF740663
12067339
QV1-HB0031-071200-582-h04
−1
AGTGCATTCACACTGATGATAAACGA

HB0031 cDNA, mRNA sequence

TAGTAGCTTCACAGGTTTGCTTCT

7511
Table 3A
NA
BF749089
12075765
MR2-BN0388-051000-014-b04
−1
AAGTGTGATTAGAAGCAGCTGGAAGT

BN0386 cDNA, mRNA sequence

AGCAGAGGAGGTGGAAGTTAGTCC

7512
Table 3A
NA
BF756480
12108380
MR4-CT0539-141100-003-d05
−1
CAGGAGTAAAACAGAGCTGGTTGTGT

CT0539 cDNA, mRNA sequence

GATACCTATGCTGGGTGGAAGACT

7513
Table 3A
NA
BF773126
12121026
CM3-IT0048-151200-568-f08 IT0048
−1
GGTGACTATCTTACCGGCTCCCAGTA

cDNA, mRNA sequence

AACTCTGAACAATGTACCAGCTAA

7514
Table 3A
NA
BF773393
12121293
CM2-IT0039-191200-638-h02 IT0039
−1
GCTTGAAGATGTCTCAACAGAAAATC

cDNA, mRNA sequence

ACCGACATGAGGAAGCATCACGCT

7515
Table 3A
NA
BF805184
12134153
QV1-CI0173-061100-456-f03 CI0173
−1
TCTAGGGCAGGAACATGGCTGCAGC

cDNA, mRNA sequence

ATATAAAAAGAATTGAATTCCATACTT

TTGT

7516
Table 3A
NA
BF818594
12156027
MR3-CI0184-201200-009-a04 CI0184
−1
GGTGCTGCCATAGGTGCCAGTAATG

cDNA, mRNA sequence

ACCGTTTATGCGGAAATCAATTACA

7517
Table 3A
NA
BF8277734
12171909
RC6-HN0025-041200-022-F08
−1
TGAAGTACTATAGGACTCAATGGGAC

HN0025 cDNA, mRNA sequence

CAGTAGCAGCTCCAAGTGGATCAC

7518
Table 3A
NA
BF845167
12201450
RC5-HT1035-271200-012-F08
−1
ACACGGGACCTCCTTTGATCTTTCTG

HT1035 cDNA, mRNA sequence

AGAATTAATAGAGATTTCATGGCA

7519
Table 3A
NA
BF869167
12259297
IL5-ET0119-181000-181-b11 ET0119
−1
CCAAAAGGAGAAAGATGACTAGGGT

cDNA, mRNA sequence

CACACTTGAGGATTTGCCAGGTGGG

7520
Table 3A
NA
BF875575
12265705
QV3-ET0100-111100-391-c02 ET0100
−1
GCATCTTCTTTGAAGACGGGAACTGT

cDNA, mRNA sequence

ACTTCAGGTTCTTTTCTGTTTAGC

7521
Table 3A
NA
BF877979
12268109
MR0-ET0109-171100-001-b02
−1
GGCTCATTTGGTTTTAAAGTCTCTTCT

ET0109 cDNA, mRNA sequence

ATGCCATCCCAGGGGAGGAGGAT

7522
Table 3A
NA
BF897042
12288501
IL2-MT0179-271100-254-C11
−1
GACTGTGGACACCTCTCACTGTGTCT

MT0179 cDNA, mRNA sequence

TCTTGGCAGGCAGAGCTTACTGAC

7523
Table 3A
NA
BF898285
12289744
QV1-MT0229-28100-508-e11
−1
GCAGGGTGCAGAGCTTCACAGCAGG

MT0229 cDNA, mRNA sequence

TAGGAAGAAGTAACTAAGTGGAAAC

7524
Table 3A
NA
BF899464
12290923
IL5-MT0211-011200-317-f03 MT0211
−1
CAGCTAAAGCCGTAGGTCATTGTGAC

cDNA, mRNA sequence

TGTCCCTGGGATGTGGATTACTCT

7525
Table 3A
Hs.324473
BF904425
12295884
40 kDa protein kinase related to rat
−1
CCAGAATGCAGCCTACAGACCAAATA

ERK2/cds = (134, 1180)

TCAATGGACTTGGTGTAGCCCTGC

7526
Table 3A
NA
BF906114
12297573
IL3-MT0267-281200-425-A05 MT0267
−1
TTTAAACCAGGTCTGGAAAAAGGAG

cDNA, mRNA sequence

GAGAGGAGGGCATTTTAGAGAAGA

7527
Table 3A
Hs.104679
BF926187
12323197

Homo sapiens, clone MGC:18216
−1
GTGGCTTCGTAAAATAGAAGAGCAGT

IMAGE:4156235, mRNA, complete

CACTGTGGAACTACCAAATGGCGA

cds/cds = (2208, 2373)

7528
Table 3A
Hs.75703
BF928644
12326772
small inducible cytokine A4
−1
CACACCACAGCTGGCTGGGAGCAGA

(homologous to mouse Mip-1b)

GGCTGCTGGTCTCATAGTAATCTAC

(SCYA4), mRNA/cds = (108, 386)

7529
Table 3A
NA
BG006820
12450386
RC4-GN0227-271100-001-d03
−1
TGGAGAAAATGAGAGACAGACAGTG

GN0227 cDNA, mRNA sequence

AGTGAGAAAGTCAGCGAAAAGGAAA

7530
Table 3A
NA
F11941
706260
HSC33F051 normalized infant brain
−1
ACCTACTGTTGAGATTATTCCCCTGT

cDNA cDNA clone c-33f05, mRNA

CTCCACACTGCCAGAAACTTACCA

sequence

7531
Table 3A
NA
U46388
1236904
HSU46388 Human pancreatic cancer
−1
CCAAATGATACTAGGATTAAGCCCCA

cell line Palu 89881 cDNA clone xs425,

AAGCAAAGTCAAGCACCACCATGG

mRNA sequence

7532
Table 3A
NA
U75805
1938265
HSU75805 Human cDNA clone f48,
−1
TCCCAGAGCAACAACTAAGTCTCAAC

mRNA sequence

TAATGGACAACCAACACCCACTGA

7533
Table 3A
NA
W27658
1307658
38f10 Human retina cDNA randomly
−1
CCACAGAATGGGCATGTAGTATTGAG

primed sublibrary cDNA, mRNA

ATTTGAATCATCTGCTGCCAGCC

sequence

7534
literature
Hs.99962
BC005929
13543541
proteoglycan 2, bone marrow (natural
1
TACTGGCGTCGAGCCCACTGCCTCA

killer cell activator, eosinophil granule

GAAGACTTCCTTTCATCTGTTCCTA

major basic protein) (PRG2), mRNA/

cds = (857, 1525)

7535
literature
Hs.46295
X14348
31182
eosinophil peroxidase (EPX), mRNA/
1
GTTTCAAGGGACATCTTCAGAGCCAA

cds = (0, 2147)

CATCTACCCTCGGGGCTTTGTGAA

7536
literature
Hs.1256
J05225
179078
arylsulfatase B (ARSB), mRNA/
1
CTACAGTTCTACCATAAACACTCAGT

cds = (559, 2160)

CCCCGTGTACTTCCCTGCACAGGA

7537
literature
Hs.728
M28129
556208
ribonucleae, RNase A family, 2 (liver,
1
TAGTTGCATGTGACAACAGAGATCAA

eosinophil-derived neurotoxin)

CGACGAGACCCTCCACAGTATCCG

(RNASE2), mRNA/cds = (71, 556)

7538
literature
Hs.889
NM_001828
6325464
Charol-Leyden crystal protein (CLC),
1
TTGACCATAGAATCAAGCCTGAGGCT

mRNA/cds = (33, 461)

GTGAAGATGGTGCAAGTGTGGAGA

7539
literature
Hs.135626
M69138
180539
chymase 1, mast cell (CMA1), mRNA/
1
CTGCTGTCTTCACCCGAATCTCCCAT

cds = (0, 743)

TACCGGCCCTGGATCAACCAGATC

7540
literature
Hs.334455
NM_003293
13699841
tryptase, alpha (TPS1), mRNA/
1
GTCACTGGAGGACCAACCCCTGCTG

cds = (17, 844)

7541
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
CATGCCATGCATATTTCAACTGGGCT

genome

GTCTATTTTTGACACCAGCTTATT

7542
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
GAGAAGCACCTCAACCTGGAGACAAT

genome

TCTACTGTTCAAACAGCAGCAGCA

7543
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
ACTTGTCAGGGCCATTCTCTCTCCGG

genome

GCACTGGGTCACTAGGACTGTTTT

7544
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
GACAGCGTCCTAGAAACCCTGGCGA

genome

CCATTGCCTCCAGCGGGATAGAGTG

7545
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
CATCCTCTGGAGCCTGACCTGTGATC

genome

GTCGCATCATAGACCGCCAGTAGA

7546
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
GCCTCCACACGACATCACACCATATA

genome

CCGCAAGGAATATCAGGGATGCTG

7547
literature
Hs.279852
BC004555
13528716
G protein-coupled receptor (G2A),
1
ACAGCCATCCTCCCCTTGAGAGTCAT

mRNA/cds = (900, 2042)

CAGAAAAATACATTAGGAAAATGT

7548
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
ACCTTCGTCTTCTGAGTCTCATGCCT

genome

CAAAACCTAGTTTGATAGACAGGA

7549
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
AGATGGCTACCCTTCTGATTATGATC

genome

CTTTCGTAGAAAATGCTCAAATCT

7550
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
ATGCATCGCCGACAAGTCTTGAATTA

genome

GGATTGTCGAAATTAGACAAAGAA

7551
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
CGGGTGTGTTCAATCATCGACGGTGA

genome

CAATCCTATCTCCATCTATAATCC

7552
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
GAAGAGCGAAATGCAATCTTCTGCTT

genome

CTTCAGTAGAGACTTTACAGTCTT

7553
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
GCACATCCATCGCCCAAAGTGAAGTC

genome

TGCAAGGATGCCATTTATTGGTTG

7554
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
TCTCGGTTTACCTTTTTGCTGTTGTG

genome

GTTCTTTGTTCTTGCTGGTTTGCT

7555
literature
NA
NC_001345
9625578
Human herpesvirus 4, complete
1
TCTGAATACTCTACAAAACGCTCCTT

genome

GTCTGCTCTTAAAACCATCTGTGT

7556
literature
NA
NC_001345
9625578
Human herpesvirus 6, complete
1
TGAAGCTGACACCTGTGAAACTAACT

genome

TAAACGCATGTTCTTCTGACTCAG

7557
literature
NA
NC_001345
9625578
Human herpesvirus 6, complete
1
TTCTGTTTTGGGCCAGGAACCGTTCT

genome

ATAAATTGTTTTATTGACTACACG

7558
literature
NA
NC_001345
9625578
Human herpesvirus 6, complete
1
TAACACCGTCCAAGAAATTTTGCCGT

genome

TGTGTCCCCATACTTCTCTAGGGC

7559
literature
NA
NC_001345
9625578
Human herpesvirus 6, complete
1
AGAAGAAGGATCAGATGGAGAGTTG

genome

AAAACTTTAGCTGGTAAGTACATGA

7560
literature
NA
NC_001345
9625578
Human herpesvirus 6, complete
1
CCGATACCGGCAAGATCTGTCGTCTG

genome

GCAAACTCGTTTTCCACCTTATGG

7561
literature
NA
NC_001664
9628290
Human herpesvirus 6, complete
1
CTGTGGGTCCCTCCCCCTCATCTGTT

genome

ATTCCCTTCCCCTCTGCCACCGAT

7562
db mining
Hs.159568
AI382620
4195401
qz04e10.x1 cDNa, 3′ end/
1
ACTACATTTTAATTAAAGATTAATGGG

clone = IMAGE:2020554/clone_end =

CATATTAGAAGTTTCTCAAAGTTAGG

3′

CT

7563
db mining
Hs.129055
NM_002540
4505490

Homo sapiens. Similar to outer dense
1
AAAAGGAGTGAGCTATCATCAGTGCT

fiber of sperm tails 2, clone MGC:9034

GTGAAATAAAAGTCTGGTGTGCCA

IMAGE:3874501, mRNA, complete

cds/cds = (656, 2947)

7564
db mining
Hs.12329
AB014597
3327207
mRNA for KIAA0697 protein, partial
1
AAAGCCACCACTGTTCCCAGTCAGCA

cds/cds = (0, 2906)

TATACAAGCTCTTAATATTCTGTT

7565
db mining
Hs.119177
NM_001659
4502202
ADP-ribosylation factor 3 (ARF3),
1
AAATGTGGGATAACGCGATGACTGTG

mRNA/cds = (311, 856)

ACCCTGGTTGGAAATTAAACTTGT

7566
db mining
Hs.12379
BC003376
13097227

Homo sapiens, ELAV (embryonic
1
AACACAGAAACATTTGAGCATTGTAT

lethal, abnormal vision, Drosphila)-like

TTCTCGCATCCCTTCTCGTGAGCG

1 (Hu antigen R), clone MGC:5084

IMAGE:2901220, mRNA, complete

cds/cds = (142, 1122)

7567
db mining
Hs.319886
AL589290
13243062
DKFZp451F1715_r1 cDNA, 5′ end/
1
AACCTATCAAAGCCTAGCCTAAGGGC

clone = DKFZp451F1715/clone_end =

TGCCATCTCTGTCTAAATTCTAGT

5′

7568
db mining
Hs.315597
NM_015960
7705727
cDNA FLJ10280 fis, clone
1
AACTGCATGGTATGAATTCAGAGTGT

HEMBB1001288, highly similar to

GACTTAAGGGTCAATTCAAAGCAG

CGI-32 protein mRNA/cds =

UNKNOWN

7569
db mining
Hs.110457
AF071594
3249714
MMSET type I (WHSC1) mRNA,
1
ACAGACTTTGTTAATGTAGGAAATCT

complete cds/cds = (29, 1972)

CTCCAAGTGGAAACGTGCTAACTT

7570
db mining
Hs.144904
NM_006311
5454137
nuclear receptor co-repressor 1
1
ACAGGCAATTCAGTGGACTATAATAA

(NCOR1), mRNA/cds = (240, 7562)

TAGTGGAGGGTTGAGATGTAGAGT

7571
db mining
Hs.118064
NM_022731
12232386
similar to rel nuclear ubiquitous casein
1
ACAGGTCACAGTGGATTTCTTTTCAA

kinase 2 (NUCKS), mRNA/

ACTGACAATGTTTAGGTTTTAAGC

cds = (68, 557)

7572
db mining
Hs.337616
NM_000753
4502924
phosphodiesterase 3B, cGMP-
1
ACCTCAAGCAGATGAGATTCAGGTAA

inhibited (PDE3B), mRNA/

TTGAAGAGGCAGATGAAGAGGAAT

cds = (0, 3338)

7573
db mining
Hs.152049
AW962287
8152099
EST374360 cDNA
1
ACCTTCTACACCACTGGAAAATAACA

TGGAGGTTTAGAGCCGTGCAAAAT

7574
db mining
Hs.115325
NM_03929
4506374
RAB7, member RAS oncogene family-
1
ACTAAACTCTGAGGCCTGAAGTTCTG

like 1 (RAB7L1), mRNA/cds =

TGATAGACCTTAAATAAGTGTCCT

(40, 851)

7575
db mining
Hs.119178
AK024468
10440445
mRNA for FLJ00059 protein, partial
1
ACTGGGGTGGTGATGTTTTCGTTCTG

cds/cds = (2624, 4057)

TTTTATTTTTCTAACTCTGCTGAC

7576
db mining
Hs.183898
NM_000269
4557796
ribosomal protein L29 (RPL29),
1
ACTTCATCATAATTTGGAGGGAAGCT

mRNA/cds = (29, 508)

CTTGGAGCTGTGAGTTCTCCCTGT

7577
db mining
Hs.15787
AB023166
4589541
mRNA for KIAA0949 protein, partial
1
AGAACGAGGAAGAGAACACAAGGAA

cds/cds = (0, 2822)

TGATTCAAGATCCACCTTGAGAGGA

7578
db mining
Hs.108104
NM_003347
4507788
ubiquitin-conjugating enzyme E2L3
1
AGAGAATAGGCTTTCTAAGATGCTGC

(UBE2L3), mRNA/cds = (15, 479)

GATCCCGTTCTGCTGCCCGTAATA

7579
db mining
Hs.163593
NM_000980
11415025
ribosomal protein L18a (RPL18A),
1
AGCACAAGCCACGCTTCACCACCAA

mRNA/cds = (19, 549)

GAGGCCCAACACCTTCTTCTAGGTG

7580
db mining
Hs.121044
L39061
632997
transcription factor SL1 mRNA, partial
1
AGGCCAATCACTGCTGACTAAGAATT

cds/cds = (0, 1670)

CATTATATTGGCTTAGTACACAGA

7581
db mining
Hs.309348
NM_032472
14277125
Ic93c11.x1 cDNA 3′ end/
1
AGGGAAGATTTCTGTATACTTGCTGG

clone = IMAGE:2073716/clone_end =

AGAGGAGGAATGTGTATAGTTACT

3′

7582
db mining
Hs.16493
AK027866
14042851
cDNA FLJ14960 fis, clone
1
AGTTTTAATACCTTAAGCTTTTTCAAG

PLACE4000192, weakly similar to

ACCTAACTGCAGCCGCTTTGGGA

ZINC FINGER PROTEIN 142/

cds = (114, 3659)

7583
db mining
Hs.1342
NM_001882
4502982
cytochrome c oxidase subunit Vb
1
ATGTGCTGTAAAGTTTCTTCTTTCCAG

(COX5B), nuclear gene encoding

TAAAGACTAGCCATTGCATTGGC

mitochondrial protein, mRNA/

cds = (21, 410)

7584
db mining
Hs.111076
NM_005918
5174540
malate dehydrogenase 2, NAD
1
ATTGTGGGTGGCTCTGTGGGCGAT

(mitochondrial) (MDH2), nuclear gene

CAATAAAAGCCGTCCTTGATTTTAT

encoding mitochondrial protein, mRNA/

cds = (86, 1102)

7585
db mining
Hs.107476
NM_006476
5453560
ATP synthase, H+ transporting,
1
ATTTGAGTGTTGTTGGACCATGTGTG

mitochondrial F1F0, subunit g

ATCAGACTGCTATCTGAATAAAAT

(ATP5JG), mRNA/cds = (73, 384)

7586
db mining
Hs.146354
NM_005809
5902725
peroxiredoxin 2 (PRDX2), mRNA/
1
CAAGCCCACCCAGCCGCACACAGGC

cds = (89, 685)

CTAGAGGTAACCAATAAAGTATTAG

7587
db mining
Hs.12124
NM_018127
11875212
elaC (E. coli) homolog 2 (ELAC2),
1
CACCAGAGACAAGCAGAGTAACAGG

mRNA/cds = (0, 2480)

ATCAGTGGGTCTAAGTGTCCGAGAC

7588
db mining
Hs.154023
AB011145
3043669
mRNA for KIAA0573 protein, partial
1
CAGGAGGTAGGGATCTGGCTGAGAG

cds/cds = (0, 1356)

GGAATAATCTGAGCAAAGGTATGAA

7589
db mining
Hs.109051
NM_031288
13775197
SH3BGRL3-like protein (SH3BGRL3),
1
CAGTCCCTCTCCCAGGAGGACCCTA

mRNA/cds = (71, 352)

GAGGCAATTAAATGATGTCCTGTTC

7590
db mining
Hs.125307
AA836204
2910523
od22g11.s1 cDNA/
1
CATGAGAAGTATCTGCAATAACCCA

clone = IMAGE:1368740

AGTCAACATTTAGGTTTGTGTACA

7591
db mining
Hs.16803
NM_018032
8922296
LUC7 (S. cerevisiae)-like (LUC7L),
1
CATGTTGAGTAGGAATAAATAAATCT

mRNA/cds = (71, 1048)

GATGCTGCCTCCTGAGGCTGCGGG

7592
db mining
Hs.148580
NM_001975
5803010
enolase 2, (gamma, neuronal)
1
CCACCACCTCTGTGGCATTGAAATGA

(ENO2), mRNA/cds = (222, 1526)

GCACCTCCATTAAAGTCTGAATCA

7593
db mining
Hs14169
AK027567
1402333
cDNA FLJ14681 fis, clone
1
CCATGCCGCCTCGTTGGATTGTCGG

NT2RP2002710, weakly similar to

AATGTAGACAGAAATGTACTGTTCT

SH3-BINDING PROTEIN 3BP-1/

cds = (70, 2481)

7594
db mining
Hs.118625
NM_000188
4504390
hexokinase 1 (HK1), nuclear gene
1
CCCACCGCTTTGTGAGCCGTGTCGTA

encoding mitochondrial protein, mRNA/

TGACCTAGTAAACTTTGTACCAAT

cds = (81, 2834)

7595
db mining
Hs.144505
NM_015653
13124762
DKFZP566F0546 protein
1
CCCACGGGAGACTATTTCACACAATT

(DKFZP566F0546), mRNA/

TAATACAGGAAGTCGATAATGAGG

cds = (377, 1308)

7596
db mining
Hs.155751
NM_004889
4757811
ATP synthase, H+ transporting,
1
CCCTCCGTGAGGAACACAACTCAAT

mitochondrial F0 complex, subunit 1,

CGTTGCTGAATCCTTTCATATCCT

isoform 2 (ATP5J2), mRNA/

cds = (27, 311)

7597
db mining
Hs.10267
NM_015367
7662505
ML1 protein (ML1), nuclear gene
1
CCGTGTCTTTCCAGCCCTAAAGGAAG

encoding mitochondrial protein, mRNA/

GGCAGACCCGTGTCTTTCCATGCC

cds = (71, 1231)

7598
db mining
Hs.14632
BC008013
14124973

Homo sapiens. Similar to CG12113
1
CCTGAAGCACTTCACCTGGAATTGAT

gene product, clone IMAGE:3532726,

GTGTAGGCTTAAGGAGTATGTGAC

mRNA, partial cds/cds = (0, 2372)

7599
db mining
Hs.125156
NM_001488
4503956
transcriptional adaptor 2 (ADA2, yeast,
1
CGCAGGCAAGAGCACTCATCAAGATA

homolog)-like (TADAZL), mRNA/

GATGTGAACAAAACCCGGAAAATC

cds = (0, 1091)

7600
db mining
Hs.159545
NM_013308
7019400
platelet activating receptor homolog
1
CGCTCAAAGGTCACTGAGACTTTTGC

(H963), mRNA/cds = (219, 1178)

CTCACCTAAAGAGACCAAGGCTCA

7601
db mining
Hs.152936
NM_004068
4757993
adaptor-related protein complex 2, mu
1
CGGCCTCAGTCCCTACTCTGCTTTGG

1 subunit (AP2M1), mRNA/

GATAGTGTGAGCTTCATTTTGTAC

cds = (135, 1442)

7602
db mining
Hs.110857
NM_016310
7706498
polymerase (RNA) III (DNA directed)
1
CTAGTGTGTGCTTGCCTTGTCCCTCG

polypeptide K (12.3 kDa) (POLR3K),

GGGTAGATGCTTAGCTGGCAGTAT

mRNA/cds = (39, 365)

7603
db mining
Hs.118666
NM_025207
13376805
hypothetical protein PP591 (PP591),
1
CTTTCAGATTCCCTCTGGTCTCCGTC

mRNA/cds = (820, 1704)

CGAAACGTCTACCTCTTCCCAGGC

7604
db mining
Hs.16390
AK024453
10440419
mRNA for FLJ0045 protein, partial
1
GAAATTCACAGGCCAGGGCACATCTT

cds/cds = (106, 924)

TTATTTATTTCATTATGTTGGCCA

7605
db mining
Hs.109302
AA808018
2877424
nv64d09.s1 cDNA, 3′ end/
1
GACTCCCTCAACACCCAAAACTCTA

clone = IMAGE:1234577/clone_end =

3′

7606
db mining
Hs.111126
NM_004339
11038870
pituitary tumor-transforming 1
1
GAGCAGCCACAAAACTGTAACCTCAA

interacting protein (PTTG1iP), mRNA/

GGAAACCATAAAGCTTGGAGTGCC

cds = (210, 752)

7607
db mining
Hs.127376
NM_021645
11063982
KIAA0266 gene product (KIAA0266),
1
GCAGCAAACAGAGGGTCAGTCACAG

mRNA/cds = (733, 3033)

GATGTTCTGACACACCATTGTAACT

7608
db mining
Hs.108196
NM_016095
7706366
HSPC037 protein (LOC51659), mRNA/
1
GCCAACAATGCTGACCGGTGCTTATC

cds = (78, 635)

CTCTAAGCCCTGATCCACAATAAA

7609
db mining
Hs.117487
AF040965
2792365
unknown protein IT 12 mRNA, partial
1
GCCAGTGTAATTTCTGTCAACCACGG

cds/cds = (0, 2622)

ACGTTTGCCTTCATGTGTAGAATT

7610
db mining
Hs.107882
NM_018171
8922576
hypothetical protein FLJ10659
1
GCCCAAGCACTAGTAGAGATGCGCG

(FLJ10659), mRNA/cds = (38, 1000)

ATACAGGTCTAGTTTCGGTAACTGT

7611
db mining
Hs.147585
NM_024785
13376147
hypothetical protein FLJ22746
1
GGCCAGATTTTGACTCCCAGATTCCT

(FLJ22746), mRNA/cds = (266, 1072)

TTACAAAACGCACTCATTCATTCA

7612
db mining
Hs.153357
NM_001084
4505890
procollagen-lysine, 2-oxoglutarate 5-
1
GGGACTCCCCGCGTGATAAATTATTA

dioxygenase 3 (PLOD3), mRNA/

ATGTTCCGCAGTCTCACTCTGAAT

cds = (216, 2432)

7613
db mining
Hs.148495
NM_002810
5292160
proteasome (prosome, macropain)
1
GGGACTGCATGGGAAGCACGGAATA

26S Subunit, non-ATPase, 4 (ODMD4),

TAGGGTTAGATGTGTGTTATCTGTA

mRNA/cds = (62, 1195)

7614
db mining
Hs.13144
NM_014182
7661819
HSPC160 protein (HSPC160), mRNA/
1
GGGGTTCGTGTCTTTGGCATCAACAA

cds = (53, 514)

ATACTGAGGGATGGGTTTTGGGAC

7615
db mining
Hs.1189
NM_001949
12669913
E2F transcription factor (E2F3)
1
GGGTGACCTGTTCTCTAGCTGTGATC

mRNA, complete cds/cds = (66, 1463)

TTACCACTTCAAATGGGTGTAATT

7616
db mining
Hs.12284
BC001699
12804564

Homo sapiens, clone IMAGE:2989556,
1
GGTGTGAACGGGCTGACTTGGTGAA

mRNA, partial cds/cds = (0, 370)

TTGGGCAACTCCTTATAGTGTTGTG

7617
db mining
Hs.158380
AI381581
4194362
td05e04.x1 cDNA, 3′ end/
1
GTACCACTTGAATGATTTCAGTCAATT

clone = IMAGE:2074782/clone_end =

TTGAACCCCTTTGGAAAGAGGTG

3′

7618
db mining
Hs.1390
BC000268
12653014

Homo sapiens, proteasome (prosome,
1
GTGAAACCCCGTCTCTGCTAAAAATA

macropain) subunit, beta type, 2, clone

CAAAAATTAGCTGGGCGTGGTGGC

MGC:1664 IMAGE:3352313, mRNA,

complete cds/cds = (58, 683)

7619
db mining
Hs.115808
NM_002287
11231175
leukocyte-associated tg-like receptor 1
1
GTTCTCTGGGTTGTGCTTTACTCCAC

(LAIR1), transcript variant a, mRNA/

GCATCAATAAATAATTTTGAAGGC

cds = (57, 920)

7620
db mining
Hs.119960
AL117477
5911950
mRNA; cDNA DKFZp727G051 (from
1
TACTGCCAACTGACCTTATAACCCTC

clone DKFZp727G051); partial cds/

TGCACCTTCAAAAAGATTCATGGT

cds = (0, 1423)

7621
db mining
Hs.154073
NM_005827
5032212
UDP-galactose transporter related
1
TCAAACAGTGACATCTCTTGGGAAAA

(UGTREL1), mRNA/cds = (87, 1055)

TGGACTTAATAGGAATATGGGACT

7622
db mining
Hs.11747
NM_017798
8923363
hypothetical protein FLJ20391
1
TCACTTCCTCTGAACTGTTACTGCCT

(FLJ20391), mRNA/cds = (9, 602)

GAATGGAGTCCTGGACGACATTGG

7623
db mining
Hs.10881
AB011113
3043605
mRNA for KIAA0541 protein, partial
1
TCCACTTAATAGACTCTATGTGTGCT

cds/cds = (0, 3484)

GAATGTTCCTGTGTACATATGTGT

7624
db mining
Hs.153850
AK024476
10440465
mRNA for FLJ00069 protein, partial
1
TCCCGCAGAGTGCAGAGACAGGAAG

cds/cds = (2657, 4396)

CTGGAGATGTCTTTATAAAGTCACA

7625
db mining
Hs.247870
AL035694
4678462
DNA sequence from clone 33L1 on
1
TCTAGGACCCTAGGAAGCTTAACTCT

chromosome 6q14.1-15. Contains the

GTCATCATCTCAAGTATCTGCACA

gene for novel T-box (Brachyury)

family protein. Contains ESTs, STSs,

GSSs and two putative CpG islands/

cds-(0, 1505)

7626
db mining
Hs.324648
NM_003128
4507194
cDNA FLJ13700 fis, clone
1
TCTTCCGCCATCTCCTCTGATAAACA

PLACE2000216, highly similar to

CGAGGTGTCTGCCAGCACCCAGAG

SPECTRIN BETA CHAIN, BRAIN/

cds = UNKNOWN

7627
db mining
Hs.118722
NM_004480
4758407
fucosyltransferase 8 (alpha (1, 6)
1
TGATATGTTGATCAGCCTTATGTGGA

fucosyltransferase) (FUT8), mRNA/

AGAACTGTGATAAAAAGAGGAGCT

cds = (716, 2443)

7628
db mining
NA
AL134726
6602913
DKFZp547A1290_r1 cDNA, 5′ end/
1
TGCAGTATTTTTCAAACTTCTGGTCG

clone = DKFZp547A1290/clone_end =

5′

7629
db mining
Hs.166887
NM_003915
4503012
copine I (CPNE1), mRNA/
1
TGCTGCTCTTGATCCCACCTTTGCTC

cds = (156, 1769)

CTGACAACCCTCATTCAATAAAGA

7630
db mining
Hs.146324
AK023182
10434993
cDNA FLJ13120 fis, clone
1
TGGTTTGTTCATGGATGTATTCTAAG

NT2RP3002882, highly similar to CGI-

AGCTGAGAACAGGGCCTGGACACA

145 protein mRNA/cds = (176, 961)

7631
db mining
Hs.12438
AK026309
10439130
cDNA; FLJ22656 fis, clone HS107655/
1
TGTTCTGAATGTTGGTAGACCCTTCA

cds = UNKNOWN

TAGCTTTGTTACAATGAAACCTTG

7632
db mining
Hs.15164
NM_006333
5453582
nuclear DNA-binding protein (C1D),
1
TGTTGATGGATGAATTTTGGCATGAT

mRNA/cds = (117, 542)

GACTGTACTCTCAATAAAGGCTGA

7633
db mining
Hs.130743
AA642459
2567877
ns30d01.s1 cDNA, 3′ end/
1
TTCATCCTGTGAGTGCTGGGGAGGA

clone = IMAGE:1185121/clone_end =

3′

7634
db mining
Hs.16492
NM_015497
13794264
DKFZP546G2022 protein
1
TTCATTTTCCTGGGAAGTCAAGGTTA

(DKFZP564G2022), mRNA/

CATCTTGCAGAGGTTGTTTTGAG

cds = (42, 1709)

7635
db mining
Hs.122552
NM_016266
7705291
G-2 and S-phase expressed 1
1
TTCTAAGCCCGAACCAAATCCTTTGCC

(GTSE1), mRNA/cds = (70, 2232)

TTGAAAGAACAGCCCTAAAGTGGT

7636
db mining
Hs.312510
AI74807
6361196
HA2528 cDNA
1
TTTGTTTGTTTGTTTCAGATAGGGTCT

CCCTCTGTCACCCAGGCTGCAGT

7637
db mining
Hs.108258
NM_012090
10048480
actin cross-linking factor (ACF7),
1
TTTTGTAAATCACGGACACCTCAATTA

transcript varient 1, mRNA/

GCAAGAACTGAGGGGAGGGCTTT

cds = (51, 16343)

7638
db mining
Hs.111092
NM_024724
13376033
hypothetical protein FLJ22332
1
CGGTGTGGAAAATGTTGTCCTTTGAG

(FLJ2232), mRNA/cds = (275, 1255)

TGGCAAGAATTAGAAAAATCTTCA

7639
db mining
Hs.114311
NM_003504
4502712
CDC45 (cell division cycle 45,
1
CTGAAAGCTGAGGATCGGAGCAAGT

S. cerevisiae, homolog)-like (CDC45L),

TTCTGGACGCACTTATTTCCCTCCT

mRNA/cds = (24, 1724)

7640
db mining
Hs.11081
NM_02541
13376853
UBX domain-containing gene 1
1
GTTGGCCTCAGCCCTGTGGGTCTGT

(UBXD1), mRNA/cds = (96, 1421)

CTCATGCTCTCCCTGTTCCTCTCCC

7641
db mining
Hs.100217
NM_005892
5174400
formin-like (FMNL), mRNA/
1
TAGCCATACTTAGCCTCAGCAGGAGC

cds = (39, 1430)

CTGGCCTGTAACTTATAAAGTGCA

7642
db mining
Hs.12258
AL137728
6808258
mRNA, cDNA DKFZp434B0920 (from
1
TGAGGGCTGTGCTGACCTTTGAGAG

clone DKFZp4348B0920)/

GATTTGAAATTGCTTCATATTGTGA

cds = UNKNOWN

7643
db mining
Hs.155462
NM_005915
7427518
minichromosome maintenance
1
TGTGTAAGAAAAGGCCATTACTTTT

deficient (mis5, S. pombe) 6 (MCM6),

AAGGTATGTGCTGTCCTATTGAGC

mRNA/cds = (61, 2526)

7644
db mining
Hs.165998
NM_015640
7661625
PAI-1 mRNA-binding protein (PAI-
1
TTGTTGGTAGGCACATCGTGTCAAGT

RBP1), mRNA/cds = (85, 1248)

GAAGTAGTTTTATAGGTATGGGTT

7645
db mining
Hs.164207
NM_024805
13376184
hypothetical protein FLJ21172
1
TTTCTAGCTTTTCCGTGTATCTAAACA

(FLJ21172), mRNA/cds = (138, 1169)

CAATTTGCTACACAAGTCACTGT

7646
db mining
Hs.150275
D87682
1663899
mRNA for KIAA0241 gene, partial cds/
1
ACTGTGGCACATGTTTTGATCAGAAA

cds = (0, 1568)

GGTAGTTCTCTTTGCTCTGGTAGT

7647
db mining
Hs.11039
NM_024102
13129109
hypothetical protein MGC2722
1
CATCTTCTGCCCTGGTCCCCTTTCTC

(MGC2722), mRNA/cds = (69, 1097)

TTGATGTGGAAAGTCTGAATGCAG

7648
db mining
Hs.102708
NM_015396
7661561
DKFZP434A043 protein
1
CGCTCTAATACTGCATTCTGTTTCTC

(DKFZP434A043), mRNA/

CTTTTGTGCCCTGATTGTAATCCA

cds = (697, 1425)

7649
db mining
Hs.109646
NM_002493
4505364
NADH dehydrogenase (ubiquinone) 1
1
CTGGAGACTGGAGAAGTAATTCCACC

beta subcomplex, 6 (17kD, B17)

AATGAAAGATTTCCTGATCAACA

(NDUFB8), mRNA/cds = (68, 454)

7650
db mining
Hs.142307
AL137273
6807710
mRNA; cDNA DKFZp43410714 (from
1
TCAGTGTTTCGTTATTCCATATCAGTG

clone DKFZp43410714)/cds = (0.412)

GCTTTTACTGTCAAAGATTGTGT

7651
db mining
Hs.16297
NM_005694
5031844
COX17 (yeast) homolog, cytochrome c
1
TGCATGAGAGCCCTAGGATTTAAAAT

oxidase assembly protein (COX17),

ATGAAATGGTGGTCTGCTGTGTGA

mRNA/cds = (86, 277)

7652
db mining
Hs.11184
NM_017811
8923387
hypothetical protein FLJ20419
1
TGTGCTAAGCCTGATGAAATGTGCTC

(FLJ20419), mRNA/cds = (191, 907)

CTTCAATCTCCATGAAACCATCGT

7653
db mining
Hs.12013
NM_002940
4506558
ATP-binding cassette, sub-family E
1
AAATGATCTCCCTTTATTACCCTCCCA

(OABP), member 1 (ABCE1), mRNA/

AAGGTTACCAGCGTTTGAATTTA

cds = (117, 1918)

7654
db mining
Hs.155485
NM_005339
12545382
huntingtin interacting protein 2 (HIP2),
1
ACACACTAATGTAACCATTTTATGAAG

mRNA/cds = (77, 679)

GTTGAAGTGGATTTATGCAGGCA

7655
db mining
Hs.154573
AW955094
8144777
EST367164 cDNA
1
ATCAGGAGAATGTCAAAGAAGTCCTT

TATGTGGATTGCCCGAGCTTCTCT

7656
db mining
Hs.142157
AF080255
5733121
iodestar protein mRNA, complete cds/
1
ATTGTGCCACTGTTTTCCAGCCTGGG

cds = (30, 3518)

CAATACAGTGAGACCCTGTCTCAA

7657
db mining
Hs.1191
AK025679
10438273
cDNA; FLJ22026 fis, clone HEP08537/
1
CGTCAAAGTCAATCCCAAAACAGATA

cds = UNKNOWN

AGCCCTATGAGGATGTCAGCATCA

7658
db mining
Hs.13340
NM_003642
4504340
histone acetyltransferase 1 (HAT1),
1
ACGACTTGCTCAAGAGTAAAGATTAT

mRNA/cds = (38, 1295)

ACTGCTCTGTACAGGAAGCTTGCA

7659
db mining
Hs.108110
NM_014034
7681591
DKFZP547E2110 protein
1
TGTTGAGGAAAGGAAAAGGGCATTTG

(DKFZP547E2110), mRNA/

TCTAAACATGGATTCTGAGTTGTA

cds = (192, 806)

7660
db mining
Hs.123295
AA833793
2908561
od61g07.s1 cDNA/
1
GTGGATGAGTAGGGAGTGGGCGAGA

clone = IMAGE:1372476

CAGGGACGAGATGAGCAGGGTCAAG

7661
db mining
Hs.126565
AB020688
420210
mRNA for KIAA0861 protein, partial
1
GGTGTTCGTGTTAGTGCCAAGATTGC

cds/cds = (0, 2948)

TTCGTTGTAGAGAGAGTTCGTTCC

7662
db mining
Hs.155174
AB007892
2887434
KIAA0432 mRNA, complete cds/
1
ACTAGAGTCCAGGTAATAGTAGTGGA

cds = (0, 2251)

GATATGTGGAGAGACATGATAGGT

7663
db mining
Hs.116445
AA648776
2575205
ns24d11.s1 cDNA, 3′ end/
1
TTCCTGTGTGAGATTTCTCGCCATTC

clone = IMAGE:1184565/clone_end =

CTCAATTCAACAAATATGCCTTTT

3′

7664
db mining
Hs.124933
AA825303
2898805
oc67e04.s1 cDNA, 3′ end/
1
TATACTTTGATCCCTCAGCAAGTTGT

clone = IMAGE:1354782/clone_end =

CCTCACTGTTGTGTGAACCTGTTT

3′

7665
db mining
Hs.313267
AW295641
6702277
UI-H-BW0-aip-e-12-0-UI.s1 cDNA, 3′
1
TTTCCTGAATACTTTATGACAACTGAG

end/clone = IMAGE:2729975/

TTTGCCGGGTAGAGTGGCCGTTT

clone_end = 3′

7666
db mining
Hs.313203
AW293882
6700518
UI-H-BW0-ain-e-07-0-UI.s1 cDNA, 3′
1
AAACTAGAATTCCGGTTTCCCAAGGT

end/clone = IMAGE:2729941/

GGCTTATGACAACCAGAATCCTTT

clone_end = 3′

7667
db mining
Hs.105488
AA521017
2261560
aa70f05.s1 cDNA, 3′ end/
1
GGCTTCCCGCCTGTGCAGTCATTTGT

clone = IMAGE:826305/clone_end =

ATGTGTTTTATATATTGGAGTGTT

3′

7668
db mining
Hs.125802
AA06833
2876049
oc29b10.s1 cDNA, 3′ end/
1
ACAAAATATAAGGGTGTGACTTTGGAT

clone = IMAGE:1351099/clone_end =

CCTGACTCAAACCAACCAGCTGTT

3′

7669
db mining
Hs.313274
AW295745
6702381
UI-H-BW0-aiw-g-10-UI.s1 cDNA, 3′
1
TCAAAATCCGTTACTCTTTCCACAACA

end/clone = IMAGE:2730834/

ATTGAGGGTAATGGTGTTCAGTT

clone_end = 3′

7670
db mining
Hs.320376
BF512113
11597325
UI-H-BW1-ami-h-04-0-UI.s1 cDNA, 3′
1
GCCATTCCGGGCTTCTCTATTTGAAAA

end/clone = IMAGE:3070302/

CAGTTACCATATTCCCCCTCAGTT

clone_end = 3′

7671
db mining
Hs.315341
BE675056
10035597
7f02/10.x1 cDNA, 3′ end/
1
ATTTGGTAGAGACGGGGTTTCACCTT

clone = IMAGE:3293419/clone_end =

ATTGCCCAGGCCATCATGTATCTT

3′

7672
db mining
Hs.320407
BF512394
11597660
UI-H-BW1-amc-f-01-0-UI.s1 cDNA, 3′
1
TGTCATTTGCCCTTTCCCCCATATAT

end/clone = IMAGE:3069456/

GTAGAATTGGGTCTTTTTCAACTT

clone_end = 3′

7673
db mining
Hs.313347
AW297156
6703802
UI-H-BW0-ajd-b-05-0-UI.s1 cDNA, 3′
1
AACAGGGAGAGACTACACACAA

end/clone = IMAGE:2731329/

GCCAACCTCAATCTCATCTTTATGC

clone_end = 3′

CATT

7674
db mining
Hs.123298
AA809468
2878874
ob85a10.s1 cDNA, 3′ end/
1
TCTTCTTTTTGATGTGAATTACTCTTG

clone = IMAGE:1338138/clone_end =

AAATGCCGGAGAAGGGACAAATT

3′

7675
db mining
Hs.320416
BF512570
11597749
UI-H-BW1-amf-e-12-0-UI.s1 cDNA, 3′
1
AGATAGAGTCATATTCTATTTAGCTTG

end/clone = IMAGE:3069791/

GGACATGGCAGGTACTCAGTTGT

clone_end = 3′

7676
db mining
Hs.309262
AI440532
4300887
CM4-NT0290-150101-684-e05 cDNA
1
AGCCTTTTTGGGAGTGAGGGTTTATA

TGATGTCTGATTCTGTAATACTGT

7677
db mining
Hs.313338
AW297010
6703646
UI-H-BW0-ejf-d-01-0-UI.s1 cDNA, 3′
1
GCAGCCCTGAGCCTGGAATAGATACT

end/clone = IMAGE:2731441/

TTTTGGTCTTTTGGTTGTAGATGT

clone_end = 3′

7678
db mining
Hs.315325
BE646400
9970711
7e66c01.x1 cDNA, 3′ end/
1
CCCTCCCTATCTTTTTATGGGTAATTT

clone = IMAGE:3292032/clone_end =

GATTATACACGGTGCTTGAATGT

3′

7679
db mining
Hs.313172
AW293016
6699652
UI-H-BW0-aih-f-04-0-UI.s1 cDNA, 3′
1
TATGTCTTCTTACCCCAGCACCCCTA

end/clone = IMAGE:2729239/

ATTTAAAATACAGATCCCTGAGGT

clone_end = 3′

7680
db mining
Hs.313361
AW297413
5704049
UI-H-BW0-ais-b-09-0-UI.s1 cDNA, 3′
1
AAAACCTTGACAGTTCATTTCACCAA

end/clone = IMAGE:2730208/

GCACCTATCAGGTATTTGGCAGGT

clone_end = 3′

7681
db mining
Hs.313365
AW297482
6704118
UI-H-BW0-aja-a-05-0-UI.s1 cDNA, 3′
1
AGTGCCCATGCTGTTTCAGATGCTCT

end/clone = IMAGE:2730920/

TCTAGCTCCTGGAGATACATCAGT

clone_end = 3′

7682
db mining
Hs.313558
AW297377
6704013
UI-H-BW0-eir-f-11-0-UI.s1 cDNA, 3′
1
TGAGCTTCTGCTAGTAATTCCTTCAG

end/clone = IMAGE:2730381/

GGGATTTCCTCCATGGCCGTAAGT

clone_end = 3′

7683
db mining
Hs.320474
BF513180
11598359
UI-H-BW1-amj-d-06-0-UI.s1 cDNA, 3′
1
GAGGGTGTCTGCTAATGATTTCCGAA

end/clone = IMAGE:3070115/

AAGTTCTTCAAAACACTCCGAAGT

clone_end = 3′

7684
db mining
Hs.313382
AW297707
6704343
UI-H-BW0-ajh-f-10-0-UI.s1 cDNA, 3′
1
ACCAGTGTCATGAGTTTTGACAAGAG

end/clone = IMAGE:2731915/

ACAAAAGGAAAGGGTGGGAGAAGT

clone_end = 3′

7685
db mining
Hs.125779
AA810831
2880442
oa78d09.s1 cDNA, 3′ end/
1
GCTGGTTGTTGCCTTTCAAGACAGCC

clone = IMAGE:1318193/clone_end =

AACTACCATTTATTCAACAGAAGT

3′

7686
db mining
Hs.313389
AW297882
6704507
UI-H-BW0-aju-e-07-0-UI.s1 cDNA, 3′
1
AGTCTGTCTATTCTCTTCTCTTTAGCT

end/clone = IMAGE:2733038/

CTGTCTGTTGCTCAAATTCAAGT

clone_end = 3′

7687
db mining
Hs.313391
AW297905
6704541
UI-H-BW0-eju-h-11-0-UI.s1 cDNA, 3′
1
GCCAAGGTGAGTCAAAACACTGCTCT

end/clone = IMAGE:2733188/

TCAGAAAGCAATTATTTGAAAAGT

clone_end = 3′

7688
db mining
Hs.309446
AI492055
4393058
tg12a01.x1 cDNA, 3′ end
1
CATTGTCCCTCCCGCTGTGCTCTCAG

clone = IMAGE:2108520/clone_end =

GCAATAAATGATTTGATTATTTCT

3′

7689
db mining
Hs.313311
AW296433
6703069
UI-H-BWD-aiq-a-05-0-UI.s1 cDNA, 3′
1
GGTCAGAAACAGGCCCACAGAGACT

end/clone = IMAGE:2730128/

CTGGAGGGTTCTTCCTTTGTGTTCT

clone_end = 3′

7690
db mining
Hs.319887
BF507608
11590906
UI-H-BW1-ana-e-05-0-UI.s1 cDNA, 3′
1
TTCAACTGCTTTGGCACTGCCATGGG

end/clone = IMAGE:3071720/

TACCTGAGGATAAGAGAGATGTCT

clone_end = 3′

7691
db mining
Hs.225237
AW293790
6700426
UI-H-B12-ahp-e-06-0-UI.s1 cDNA, 3′
1
GGGTTGACTAAATGCACATGGGCTTA

end/clone = IMAGE:2727635/

TCTTTACCTCTTCCAGAAATGTCT

clone_end = 3′

7692
db mining
Hs.313383
AW297459
6704095
UI-H-BW0-ais-g-03-0-UI.s1 cDNA, 3′
1
TGCATGACCAGAAACACTGCCTGATA

end/clone = IMAGE:2730436/

CAGTAAGCAGAGGTAGCTGTCTCT

clone_end = 3′

7693
db mining
Hs.320367
BF512169
11597272
UI-H-BW1-ami-c-10-0-UI.s1 cDNA, 3′
1
ACCTGCCAGCCAGCCCACAACTATAA

end/clone = IMAGE:3070074/

ACTGTGTGACACCCAAATTTATCT

clone_end = 3′

7694
db mining
Hs.320440
BF512733
15597912
UI-H-BW1-amm-d-04-0-UI.s1 cDNA,
1
GGTTTCTGAGGTGATTCTAATATGCA

3′ end/clone = IMAGE:3070494/

GTCATGGTTAAGAACCTGTGATCT

clone_end = 3′

7695
db mining
Hs.313374
AW297607
6704243
UI-H-BW0-ajg-e-04-0-UI.s1 cDNA, 3′
1
AAGCCTTGGACCAGCTTCCCGTTTCT

end/clone = IMAGE:2731854/

CTCTTGTCTCCTGCCAAAAGATCT

clone_end = 3′

7696
db mining
Hs.313355
AW297325
6703961
UI-H-BW0-air-a-08-0-UI.s1 cDNA, 3′
1
ACCCAAAGGATGGTGTCTCCTGTCCC

end/clone = IMAGE:2730135/

AGTTGAAAAGGTTTCTACCTAGCT

clone_end = 3′

7697
db mining
Hs.320420
BF512599
11597778
UI-H-BW1-anf-h-07-0-UI.s1 cDNA,
1
TGGTTGAATACGCAGGAACACCCACA

3′ end/clone = IMAGE:3069925/

GTACCCAGGGACTAATAAATAGCT

clone_end = 3′

7698
db mining
Hs.118899
AA243283
1874126
zs13g11.s1 cDNA, 3′ end/
1
TTAGGGCAGTGGAGAATCAGGGTGT

clone = IMAGE:685124/clone_end =

ATCTAATAAATTCCTTCATGGAGCT

3′

7699
db mining
Hs.105226
AA489212
2218814
aa57d11.s1 cDNA, 3′ end/
1
GCAGATGTCTGCGTCATGGTTTATTA

clone = IMAGE:825045/clone_end =

CTCCTGTGTTCGTTTCAAGGAGCT

3′

7700
db mining
Hs.297505
BF514865
11600044
UI-H-BW1-anj-f-12-0-UI.s1 cDNA, 3′
1
TGTCTGTATTTGGAGTCCAGTAGTAC

end/clone = IMAGE:3082534/

ACTGAAAATAATCCCGTAAAAGCT

clone_end = 3′

7701
db mining
Hs.320492
BF513340
11598519
UI-H-BW1-amk-b-10-0-UI.s1 cDNA, 3′
1
CTCCCTTCCCACCATACACACACTCC

end/clone = IMAGE:3070050/

CAGCTCATTTTGATTCCTTTTCCT

clone_end = 3′

7702
db mining
Hs.304837
AW292802
6699438
UI-H-BW0-aij-f-12-0-UI.s1 cDNA, 3′
1
GGTGAAATTGACTGGGTTCCTCTCCC

end/clone = IMAGE:2729615/

ACCTCTCTTTCCGTAGCAATTCCT

clone_end = 3′

7703
db mining
Hs.24656
BF507762
11591060
KIAA0907 protein (KIAA0907),
1
ACTAATTCCCGTGTCTGGCCCTGAAC

mRNA/cds = (26, 1720)

ATGAAGATATAATGGACGATCCCT

7704
db mining
Hs.320460
BF512975
11598154
UI-H-BW1-amh-b-06-0-UI.s1 cDNA, 3′
1
TTAAAGGCTCAAACCTACCTCAGACA

end/clone = IMAGE:3069559

CTGCTCTACCCATCCCCATCCCCT

clone_end = 3′

7705
db mining
Hs.313384
AW297745
6704381
UI-H-BW0-aiy-b-10-0-UI.s1 cDNA, 3′
1
CCCTTTGTGAGAAGAAGCAGGTTTCC

end/clone = IMAGE:2730954/

TTTCCTATGGATTGATGTGACCCT

clone_end = 3′

7706
db mining
Hs.105105
AA419402
2079198
zu99a12.s1 cDNA, 3′ end/
1
TTCTACCCATCACACAGATTCTTCCA

clone = IMAGE:746110/clone_end =

CTTAATAAAATCCATCACCTACCT

3′

7707
db mining
Hs.123180
AA805419
2874169
oc13g03.s1 cDNA, 3′ end/
1
TCATTACTGTTGTGAAGGCTCTTCAA

clone = IMAGE:1340788/clone_end =

GAGAGAAAGATGAAGCTGAAACCT

3′

7708
db mining
Hs.297396
BF515183
11600450
UI-H-BW1-ani-c-01-0-UI.s1 cDNA, 3′
1
GCTGTCCGTGAAAGCACTCTCAAGTC

end/clone = IMAGE:30827728/

AGGAACTGAACTAAGAACTTTACT

clone_end = 3′

7709
db mining
Hs.334992
AI084211
3422634
RST20881 cDNA
1
CTCCTGTAATCCCAGCACTGGAGCTT

GCAGTGAGCCAAGATCATGCCACT

7710
db mining
Hs.313273
AW295743
6702379
UI-H-BW0-aiw-g-08-0-UI.s1 cDNA, 3′
1
TTGGTCACCACACCTGGGTGTCTGAA

end/clone = IMAGE:2730830/

TGTCTTGTCCTTCTAAAGGTAACT

clone_end = 3′

7711
db mining
Hs.319891
BF507631
11590929
UI-H-BW1-and-h-01-0-UI.s2 cDNA, 3′
1
GCAACAATTCTTTGGAAAGTGACTCT

end/clone = IMAGE:3071856

CTAGGGTGCGGAGAATGGTGTGAT

clone_end = 3′

7712
db mining
Hs.320422
BF512614
11597793
UI-H-BW1-amg-a-12-0-UI.s1 cDNA, 3′
1
TCATCTCTGTAGGTCTTCCTAATCCTA

end/clone = IMAGE:3069822

TGCGGAGCCAAATATAGACGGAT

clone_end = 3′

7713
db mining
Hs.319872
BF507414
11590721
UI-H-BW1-amz-a-11-0-UI.s2 cDNA, 3′
1
CTTTGTATTTCAAAGAAAGTAGCCCC

end/clone = IMAGE:3071517/

TTGGCTCTGATATTAGTTGCAGAT

clone_end = 3′

7714
db mining
Hs.264120
AI523841
4437776
601435078F1 cDNA, 5′ end/
1
TTTAGGAGCTGACCATACATGATGAG

clone = IMAGE:3921187/clone_end =

TGATACAGCCTGTACTTTGCTCAT

5′

7715
db mining
Hs.105284
AA491263
2220436
aa49d04.s1 cDNA, 3′ end/
1
ACTGGGATGAGATGAGATTCAAGGCA

clone = IMAGE:824283/clone_end =

CTTTTGGAGGGTGTAGCTAGCCAT

3′

7716
db mining
Hs.124376
AA831043
2904142
oc58h02.s1 cDNA, 3′ end/
1
AGGCTGTTGCTGCACGGGCTTTTCAA

clone = IMAGE:1353939/clone_end =

AAGCGACTCATTATGAAGAAGAAT

3′

7717
db mining
Hs.309144
AI384035
4196816
td05c02.x1 cDNA, 3′ end/
1
GCACTCCAGCCTGGGCAACAAGAGC

clone = IMAGE:2074754/clone_end =

GAAACTCTGCCTCCAATAAATAAAT

3′

7718
db mining
Hs.301325
BF514004
11599183
UI-H-BW1-amv-e-04-0-UI.s1 cDNA, 3′
1
CGGGCGGTGGCGGCTGCCTGGGAG

end/clone = IMAGE:3071311/

AAGATGAATCTTTCATGAGTGATTTG

clone_end = 3′

7719
db mining
Hs.319904
BF507742
11591040
UI-H-BW1-anc-f-02-0-UI.s2 cDNA, 3′
1
GATGGAACTCAAGGTGCTTTACGCTT

end/clone = IMAGE:3072122/

TCCTCAGTCTTACCAGGAGGCTTG

clone_end = 3′

7720
db mining
Hs.320092
AI392740
4222287
tg23f02.x1 cDNA, 3′ end/
1
ACCAACCCTATGGACAACTTGATCTT

clone = IMAGE:2109267/clone_end =

GAACTTCTAGCTTTCAGACCTGTG

3′

7721
db mining
Hs.313371
AW297578
6704214
UI-H-BW0-aig-b-03-UI.s1 cDNA, 3′
1
AATGTAGCTGACATTGGAGCCACCGC

end/clone = IMAGE:2731708/

CCATAGAAGAAGGCTAAAACTGTG

clone_end = 3′

7722
db mining
Hs.320444
BF512784
11597963
UI-H-BW1-amm-h-10-0-UI.s1 cDNA,
1
CTTCACTGACGATCTGAGACACTAGG

3′ end/clone = IMAGE:3070698/

CAGGTTGGAAAGGGTGGAGTGGTG

clone_end = 3′

7723
db mining
Hs.320473
BF513155
11598334
UI-H-BW1-amj-b-03-0-UI.s1 cDNA, 3′
1
GCCCCTGGTGGTTGGAAAAGTGTTCT

end/clone = IMAGE:3070013/

GAATCCAATAAAAGGAAAGCGGTG

clone_end = 3′

7724
db mining
Hs.320419
BF512597
11597776
UI-H-BW1-amf-h-05-0-UI.s1 cDNA, 3′
1
CAACAGTGGCAAGAGTAGCCAGCCC

end/clone = IMAGE:3089921/

ATAGGACGGAATGAAAATCAAGGTG

clone_end = 3′

7725
db mining
Hs.320365
BF512157
11597260
UI-H-BW1-ami-b-20-0-UI.s1 cDNA, 3′
1
CATCCTTAGATGCCAGTCTTCACTTT

end/clone = IMAGE:3070026/

GGGTATTTTCCTGCCTCCTCAGTG

clone_end = 3′

7726
db mining
Hs.299471
BF513893
1599072
UI-H-BW1-aq-d-02-0-UI.s1 cDNA, 3′
1
ACCAACAGTACCGTTATTGCCACCAC

end/clone = IMAGE:3070874/

AAGTAAACCAGTCCCTCACTTCTG

clone_end = 3′

7727
db mining
Hs.313368
AW297544
6704180
UI-H-BW0-aja-g-01-0-UI.s1 cDNA, 3′
1
AGGCTAAATCAGAGCTTTCCTCCCCA

end/clone = IMAGE:2731200/

GATAAAGGAAATTTTCCCTCCCTG

clone_end = 3′

7728
db mining
Hs.105170
AA481410
2210962
zv02g12.s1 cDNA, 3′ end/
1
AACTTCCAGAGGCAGGAGATTAGACA

clone = IMAGE:746374/clone_end =

GGGATGACAGTTAAGGGGTTACTG

3′

7729
db mining
Hs.313251
AW295130
6701766
UI-H-BW0-alt-h-08-0-UI.s1 cDNA, 3′
1
ACCTCTTCGTTGTATTTTACCTTTCAC

end/clone = IMAGE:2730495/

TTACAAACAAGCTCATGCCACTG

clone_end = 3′

7730
db mining
Hs.297392
BF514201
11599380
UI-H-BW1-ani-d-05-0-UI.s1 cDNA, 3′
1
GATCAAAACAAGGTCCTTGACTTTTT

end/clone = IMAGE:3082401/

GCAGGGGCAGCCTGGCAATCAATG

clone_end = 3′

7731
db mining
Hs.122417
AA761212
2810142
nz20c03.s1 cDNA, 3′ end/
1
CCTAAATGTTGTCCCTCAGAGATGCA

clone = IMAGE:1288324/clone_end =

CAGATGTATATGGGTAAGGAAATG

3′

7732
db mining
Hs.297469
BF512785
11597964
UI-H-BW1-amm-h-11-0-UI.s1 cDNA,
1
CCAACCATAGTCATGAAGCTGCTTCT

3′ end/clone = IMAGE = 3070700/

GTTCCCAATGCAATCCCATTGTGG

clone_end = 3′

7733
db mining
Hs.313275
AW295750
6702386
UI-H-BW0-aiw-h-03-0-UI.s1 cDNA, 3′
1
GCTTTTCAATGCTTCCGAAACTGAGT

end/clone = IMAGE:2730868/

GCTAACAGGGGCAATTAGTGCTGG

clone_end = 3′

7734
db mining
Hs.313173
AW293031
6899667
UI-H-BW0-aih-g-10-0-UI.s1 cDNA, 3′
1
AGTTCTTGTAACAGTTAAAACTTTCTT

end/clone = IMAGE:2729299/

GCCAGCTCTCAGGTTATCACTGG

clone_end = 3′

7735
db mining
Hs.320386
BF512295
11597474
UI-H-BW0-amb-e-03-0-UI.s1 cDNA, 3′
1
GTGTGTAAATGAGTGTCAGATCTTTT

end/clone = IMAGE:3069389/

CTTGAAAACAGGTTTGGATTGGGG

clone_end = 3′

7736
db mining
Hs.320429
BF512664
11597843
UI-H-BW1-amg-f-03-0-UI.s1 cDNA, 3′
1
AGGGTCCACAAGGAGAATATTTTCTT

end/clone = IMAGE:3069844/

AAAGTAACTCCCTGATTTGCGGGG

clone_end = 3′

7737
db mining
Hs.123352
AA811133
2880744
oa98b10.s1 cDNA, 3′ end/
1
GCTCCCCTATGCCTGTGTAGCAGAAT

clone = IMAGE:1320283/clone_end =

CTAAAAGATAATCATGTGAACGGG

3′

7738
db mining
Hs.320389
BF512323
11597502
UI-H-BW1-amb-g-09-0-UI.s1 cDNA, 3′
1
TTGTCTTGTTTCTTTTATCTCCCCTAT

end/clone = IMAGE:3069497/

GTTTCATCTTAGTGCAGGCAGGG

clone_end = 3′

7739
db mining
Hs.120563
AA741118
2779708
nz04f08.s1 cDNA, 3′ end/
1
ACAGTTGCCTTTGAGATTCCTGTATTT

clone = IMAGE:1286823/clone_end =

CTGCATGAATAAATCCATAAGGG

3′

7740
db mining
Hs.320373
BF512098
11597310
UI-H-BW1-ami-f-12-0-UI.s1 cDNA, 3′
1
GTCCTTGGAAGGTAACACTTGTGATT

end/clone = IMAGE:3070222/

GGAACCACTCTTCAAGCTGAACGG

clone_end = 3′

7741
db mining
Hs.320490
BF513327
11598508
UI-H-BW1-amk-a-07-0-UI.s1 cDNA, 3′
1
ATTCATTCATTCATTCAACAAGCACTT

end/clone = IMAGE:3069996

AAAAACAATGCCTGTGTGCCAGG

clone_end = 3′

7742
db mining
Hs.313290
AW296074
6702710
UI-H-BW0-aiu-h-07-0-UI.s1 cDNA, 3′
1
CACACCCAGCCCCATTCACAAAGGAC

end/clone = IMAGE:2730852/

TATAAAATCTACACCCCAGTCACG

clone_end = 3′

7743
db mining
Hs.320390
BF512330
11597509
UI-H-BW1-amb-h-05-0-UL.s1 cDNA,
1
GGCATAGTAGTGCTAAACAGAGGTG

3′ end/clone = IMAGE:3069537/

GAAGTAGTGAAGGGAGTTTTGAACG

clone_end = 3′

7744
db mining
Hs.297397
BF507606
11590904
UI-H-BW1-ana-e-02-0-UI.s2 cDNA,
1
CTAGTCCTGCCCCCACCTCCCCAAGT

3′ end/clone = IMAGE:3071714/

ATTACCCCTCCTAAGTCCTGCTAG

clone_end = 3′

7745
db mining
Hs.309256
AI373161
4153027
qz13a01.x1 cDNA, 3′ end/
1
AGATAAGCAGGATAAACAAGACAGGT

clone = IMAGE:2021352/clone_end =

TGGATTGTGATCAGCTCTATGGAG

3′

7746
db mining
Hs.343303
BF13322
11598501
UI-H-BW1-amk-a-02-0-UI.s1 cDNA,
1
GATGGCTAGGACAAGATGATTTACAA

3′ end/clone = IMAGE:3069986/

GAGCGTGGCGGGAGGGACGGCGAG

clone_end = 3′

7747
db mining
Hs.301870
BF507614
11590912
UI-H-BW1-ana-f-03-0-UI.s2 cDNA,
1
CCGTGTCTGGAATTGTGTGTCTTACTT

3′ end/clone = IMAGE:3071764/

CTAAAGGTGCACATACTTCATAAG

clone_end = 3′

7748
db mining
Hs.300479
AW452510
6993286
UI-H-BW1-ame-a-12-0-UI.s1 cDNA,
1
GTATCTCTGCACCTCACTACTACCCT

3′ end/clone = IMAGE:3069598/

TCACTCCTTGGAGACCTGGGCAAG

clone_end = 3′

7749
db mining
Hs.320387
BF512301
11597480
UI-H-BW1-amb-e-09-0-UI.s1 cDNA,
1
AACACACCACCAAACATTCTTCCCAT

3′ end/clone = IMAGE:3069401/

CCTTCTTCACCAACCAGCTACAAG

clone_end = 3′

7750
db mining
Hs.122854
AA292626
1940611
zs57h08.r1 cDNA, 5′ end/
1
ACAATTGGAGTTGGGGCTGTCACCAC

clone = IMAGE:701631/clone_end =

CTGAAGTGTGTCAACCACAGAAAG

5′

7751
db mining
Hs.300488
AW453029
6993805
UI-H-BW1-ama-c-10-0-UI.s1 cDNA,
1
TTAGGGCAAAAGTCCTAGTGGCGGC

3′ end/clone = IMAGE:3069306/

AGCTTTCTTGTCTAGACCCTGGTTC

clone_end = 3′

7752
db mining
Hs.335081
AI380942
4190801
tg18c08.x1 cDNA, 3′ end/
1
AGTGATGCTTGCCTTTTCGCTTTCCT

clone = IMAGE:2109134/clone_end =

AAAGATGTCATTTGAAAACAAGTC

3′

7753
db mining
Hs.313822
AW452916
6993692
UI-H-BW1-amd-b-02-0-UI.s1 cDNA,
1
CCCAGCTTCATTAATGTGAATGGTGG

3′ end/clone = IMAGE:3069267/

CAGACACCTCTAGCTATAGAGCTC

clone_end = 3′

7754
db mining
Hs.309486
AI523959
4438094
tg98f09.x1 cDNA, 3′ end/
1
GAGCCAAGATTGGGCCACTGCACTC

clone = IMAGE:2115841/clone_end =

CAGCCTGGGTGACAGAGTGAGACTC

3′

7755
db mining
Hs.303926
AI084223
3422646
oy72g05.x1 cDNA, 3′ end/
1
GAGCCGAGATTGCATCACTGCACTCC

clone = IMAGE:1571416/clone_end =

AGCCTGGTCAACAGAGCGAGACTC

3′

7756
db mining
Hs.313170
AW292942
6699578
UI-H-BW0-aig-f-11-0-UI.s1 cDNA,
1
TTCAGTCATGCAGCAACATCCGCTTA

3′ end/clone = IMAGE:2729252/

ATGCCTCCTAAGTGCAGAACACTC

clone_end = 3′

7757
db mining
Hs.313795
AW452553
6993329
UI-H-BW1-ame-e-11-0-UI.s1 cDNA,
1
GGTCCTCTTCTCTCTACTCTCCCTAG

3′ end/clone = IMAGE:3069788/

TAACTAACCACCAAAGCCTAAATC

clone_end = 3′

7758
db mining
Hs.319883
BF507567
11590865
UI-H-BW1-amr-h-08-0-UI.s1 cDNA,
1
TTGTTTGTTTGTTTATTTATTTATTTG

3′ end/clone = IMAGE:3071079/

AGGCAGCGTCTTGCTCTGTTGC

clone_end = 3′

7759
db mining
Hs.320476
BF513187
11598365
UI-H-BW1-amj-e-02-0-UI.s1 cDNA,
1
TGCCATCTTTACATCTAATCAAGAGG

3′ end/clone = IMAGE:3070155/

TAGAGCTTCCCCTGGTGTTCCTGC

clone_end = 3′

7760
db mining
Hs.313828
AW453000
6993776
UI-H-BW1-ama-a-05-0-UI.s1 cDNA,
1
TGCTCTGCTCTTCCCAAATCAAGGAA

3′ end/clone = IMAGE:3069200/

TGTAGATCTTGCTAACAGAACTGC

clone_end = 3′

7761
db mining
Hs.120251
AA731388
2753542
nz86f07.s1 cDNA, 3′ end/
1
TGGCACCAACTTACACTTCCAGAAGA

clone = IMAGE:1302373/clone_end =

GAGTGGTTCAGGAAATTACTATGC

3′

7762
db mining
Hs.313392
AW297908
6704544
UI-H-BW0-ajn-a-04-0-UI.s1 cDNA,
1
AACTTTGGGAAGTGAGACTCTGTCTT

3′ end/clone = IMAGE:2732071/

GGGTTTTTGATAATAAATGTGGGC

clone_end = 3′

7763
db mining
Hs.343320
BF512697
11597876
UI-H-BW1-amm-a-02-0-UI.s1 cDNA,
1
CCGAGAAAGTACGGCTGGAGCGGAC

3′ end/clone = IMAGE:3070348/

TGGGGAGACGGAAATATTGAGTCGC

clone_end = 3′

7764
db mining
Hs.304178
AI540182
4457555
td10f04.x1 cDNA, 3′ end/
1
CGAAGAAAGAATTGGATGCAGAATTG

clone = IMAGE:2075263/clone_end =

TTGCCTAACCTGGGTGACAAGAGC

3′

7765
db mining
Hs.320425
BF512629
11597808
UI-H-BW1-amg-c-03-0-UI.s1 cDNA,
1
AGTGCCTGTGATTCCACCCCCTTACC

3′ end/clone = IMAGE:3069700/

TCCCACTCAAGTGACAATGTAAGC

clone_end = 3′

7766
db mining
Hs.313236
AW294711
6701347
UI-H-BW0-aim-b-12-0-UI.s1 cDNA,
1
AGAAAGTTAGGAGTCGGCAACCTTAA

3′ end/clone = IMAGE:2729806/

GGAGGAGTTTCCTATCATCTCTCC

clone_end = 3′

7767
db mining
Hs.313379
AW297666
6704302
UI-H-BW0-ajh-c-02-0-UI.s1 cDNA,
1
TGTCACAAAGATGAAGCAAGGTGGCT

3′ end/clone = IMAGE:2731755/

CAGGGAACGTGCTCAGAAACCTCC

clone_end = 3′

7768
db mining
Hs.123341
AA810927
2880538
oa77d07.s1 cDNA, 3′ end/
1
GCAAAGTGAAAGTTTTCCCTTTGGCC

clone = IMAGE:1318285/clone_end =

CTAAAATATGAAAGCAAAGCATCC

3′

7769
db mining
Hs.313208
AW293991
6700627
UI-H-BW0-aik-h-08-0-UI.s1 cDNA,
1
CCCTGTCCATCTTTTCCTGTTCCTATC

3′ end/clone = IMAGE:2729726/

CAGCCTTCCCTCTCCTTTTTGCC

clone_end = 3′

7770
db mining
Hs.123344
AA811024
2880635
ca82g05.s1 cDNA, 3′ end/
1
CCACGGAGGGCTCCCCATCTAAAGG

clone = IMAGE:1318808/clone_end =

GAGTTTAATAAACAAAGGAATGGCC

3′

7771
db mining
Hs.320450
BF512839
11598018
UI-H-BW1-amu-e-10-0-UI.s1 cDNA,
1
CAATTGGTACATTCTCGGCAAACCCT

3′ end/clone = IMAGE:3071322/

TGCCCACAATTTCCTCAGGAAGCC

clone_end = 3′

7772
db mining
Hs.313359
AW297549
6704185
UI-H-BW0-aja-g-08-0-UI.s1 cDNA,
1
AGGGTGTCCCTGTGATTTTTAAATTC

3′ end/clone = IMAGE:2731214/

ACTATCTAGCTGTCCCTATCCCCC

clone_end = 3′

7773
db mining
Hs.297527
BF515924
11501103
UI-H-BW1-aoa-e-01-0-UI.s1 cDNA,
1
CTTATATTATGTTTTCTCTGTGACAAG

3′ end/clone = IMAGE:3084001/

CACCTCACCTCCCAACCCACCCC

clone_end = 3′

7774
db mining
Hs.297513
BF515498
11600677
UI-H-BW1-ann-g-04-0-UI.s1 cDNA,
1
GAGAATTCAAATTAAATGCAGAGTCC

3′ end/clone = IMAGE:3082950/

TAGGCCCACCCTGGCATACCACCC

clone_end = 3′

7775
db mining
Hs.105218
AA488881
2218483
aa55f06.s1 cDNA, 3′ end/
1
ACAACCAATGCCTCACACTTAAGCTC

clone = IMAGE:824867/clone_end =

CTAGAAGTCACTAGGGACCAGACC

3′

7776
db mining
Hs.309447
AI492062
4393085
tg12a11.x1 cDNA, 3′ end/
1
GCCCTCACCAGAATTCAATCATGCTG

clone = IMAGE:2108540/clone_end =

GCACCTTATCTTGGACTTTCAACC

3′

7777
db mining
Hs.309483
AI523758
4437893
tg94e10.x1 cDNA, 3′ end/
1
AGGGTAAGAGTTCCAGACCTGACTG

clone = IMAGE:2116458/clone_end =

GACAATAAAGTGAGACTGTCTCTAC

3′

7778
db mining
Hs.343333
BF515310
11600412
UI-H-BW1-ank-g-09-0-UI.s1 cDNA,
1
CTCCGTCTGCCGCCTCCGTAGCCAC

3′ end/clone = IMAGE:3082577/

AGCGACTTTGGAAGTGATATTTGAC

clone_end = 3′

7779
db mining
Hs.309687
AI401187
4244274
tg26h10.x1 cDNA, 3′ end/
1
CCCTGGAGAAGGAGGGTGATTTATTT

clone = IMAGE:2109955/clone_end =

TCAACTTTCTGATTTACCACCGAC

3′

7780
db mining
Hs.314730
AI523958
4438093
tg98f08.x1 cDNA, 3′ end/
1
GATTGTTTGAGCCTGGGAGTTCCACA

clone = IMAGE:2116839/clone_end =

CCAGCCTGGGCTACATAGGGAGAC

3′

7781
db mining
Hs.313337
AW297006
6703842
UI-H-BW0-ajf-c-09-0-UI.s1 cDNA,
1
CTGCTCTAGACTGAGCACAGCCACTG

3′ end/clone = IMAGE:2731409/

ACAGGTGACCTTCAGAATCCTCAC

clone_end = 3′

7782
db mining
Hs.116455
AA649141
2575570
ns32g12.s1 cDNA, 3′ end/
1
ACCCCTGCTTTACTGTGACAGACATA

clone = IMAGE:1185382/clone_end =

TAGTTTGTCATACATAAAACCCAC

3′

7783
db mining
Hs.123313
AA810089
2879495
od12f12.s1 cDNA, 3′ end/
1
ACCTAACAGAAATTTGGATTCGGGTT

clone = IMAGE:1367758/clone_end =

GTCTAAATACACCCTGGTGGGTTA

3′

7784
db mining
Hs.319668
BF507353
11590660
UI-H-BW1-amx-c-04-0-UI.s1 cDNA,
1
GCCTTTCCCACCAACAGTTTATGTGA

3′ end/clone = IMAGE:3071239/

TTCCCTGCCCTACCCTTACCATTA

clone_end = 3′

7785
db mining
Hs.123342
AA811005
2880618
oa73g11.s1 cDNA, 3′ end/
1
TCCCATTGCATGTCCCGTATATTGAA

clone = IMAGE:1317956/clone_end =

AGCTGCCTCTACTTCTCTCTGGTA

3′

7786
db mining
Hs.313288
AW296061
6702697
UI-H-BW0-aiu-g-06-0-UI.s1 cDNA,
1
GGCAGGGGATGAACCAGATAATTTTCC

3′ end/clone = IMAGE:2730802/

AGCCCTTCTTGGTAGCTCTTCGTA

clone_end = 3′

7787
db mining
Hs.308998
AI358553
4108174
qz27h12.x1 cDNA, 3+ end/
1
GCTTAGGAGTTTGGGACCAGCCTGG

clone = IMAGE:2028167/clone_end =

GTAACATAGTGAAACCCTGTCTCTA

3′

7788
db mining
Hs.313328
AW296796
6703432
UI-H-BW0-ajb-e-06-0-UI.s1 cDNA,
1
TTGCAGCTATTTTCAAGTTGTAAGAAA

3′ end/clone = IMAGE:2731115/

TGAACTTGCAACACATAGGGCTA

clone_end = 3′

7789
db mining
Hs.320462
BF512988
11598185
UI-H-BW1-amh-c-06-0-UI.s1 cDNA,
1
TCTCTTGCCACAGGGATTTCCTCCAA

3′ end/clone = IMAGE:3069707/

GCTGGAATCACCATTTCCTTCCTA

clone_end = 3′

7790
db mining
Hs.297514
BF516300
11601479
UI-H-BW1-anz-e-06-0-UI.s1 cDNA,
1
CCCACCCACCAGTAGGTTGTGATTCA

3′ end/clone = IMAGE:3084010/

ACTGAACCATTTCAGGAGCACCTA

clone_end = 3′

7791
db mining
Hs.124358
AA803650
2903749
oc52g02.s1 cDNA, 3′ end/
1
GAACCCAGCTAAGCCACACCCAGATT

clone = IMAGE:135362/clone_end =

CTGACCCAGGGATACTCTGAAATA

3′

7792
db mining
Hs.313345
AW297163
6703789
UI-H-BW0-ajd-a-04-0-UI.s1 cDNA,
1
GTGTGTGCTGGCGTGCCTTATAGGT

3′ end/clone = IMAGE:2731279/

GTGCGTGTTTCCCTGTCAGTTTTGA

clone_end = 3′

7793
db mining
Hs.320484
BF513248
11598425
UI-H-BW1-amo-b-06-0-UI.s1 cDNA,
1
AGGAAAACTCAGAAATAATTTCTGCC

3′ end/clone = IMAGE:3070426/

CCCTGGATTCTCTAAGATTTGTGA

clone_end = 3′

7794
db mining
Hs.105130
AA482030
2209708
zu98g04.s1 cDNA, 3′ end/
1
GTGGAAAGAATCCTACAACGAACACT

clone = IMAGE:746070/clone_end =

ATTAAAGTCTGCACCTAGATCTGA

3′

7795
db mining
Hs.104176
AA214530
1813155
zr92a06.s1 cDNA, 3′ end/
1
GGCCTAGGTTCCAGCATTCAGTCATC

clone = IMAGE:683122/clone_end =

AAGTCTTGTTACAGAAATAAATGA

3′

7796
db mining
Hs.121118
AA721101
2737236
nz67a0.s1 cDNA, 3 end/
1
CCCCATTTGGAGTCTAGTCAAAACAG

clone = IMAGE:1300488/clone_end =

CAGCTTCTTTGAGTTACCATTGGA

3′

7797
db mining
Hs.313313
AW296455
6703091
UI-H-BW0-aiq-c-05-0-UI.s1 cDNA,
1
AAGGCTTGTAACTGTAGGCCCTTGTA

3′ end/clone = IMAGE:2730224/

CTACACTGTGCTATACCTGGTAGA

clone_end = 3′

7798
db mining
Hs.335116
AI524072
4438207
th01d07.x1 cDNA, 3′ end/
1
CACTTTGGGAGGCAGAGGTGAGCAG

clone = IMAGE:2117005/clone_end =

ATCACTTGAGGCCAGGAGTTTGAGA

3′

7799
db mining
Hs.309130
AI382229
4195010
td04d04.x1 cDNA, 3′ end/
1
GGATCACTTGAAGCCAGCAGTTTGAG

clone = IMAGE:2074663/clone_end =

ACCAGCCTGGGCAATAAAATGAGA

3′

7800
db mining
Hs.297504
BF514819
11599998
UI-H-BW1-anj-b-10-0-UI.s1 cDNA,
1
TCAGTTGTGATGGGATTTCTTGATGG

3′ end/clone = IMAGE:3082338/

ATGAGATGTGTCGTGTGACAGAGA

clone_end = 3′

7801
db mining
Hs.297473
BF513074
11598253
UI-H-BW1-amn-c-03-0-UI.s1 cDNA,
1
CCTCCTAGAACTGGAACCAAGACTGC

3′ end/clone = IMAGE:3070445/

TCCATCAGAGTTAAAGGTGTAAGA

clone_end = 3′

7802
db mining
Hs.313168
AW292924
6699560
UI-H-BW0-aig-d-05-0-UI.s1 cDNA,
1
GCTCACCCTTGCACCTCCTTCCCAAA

3′ end/clone = IMAGE:2729144/

TCTGCTGTCACATTTTCTCAAAGA

clone_end = 3′

7803
db mining
Hs.319885
BF507583
11590881
UI-H-BW1-ana-b-03-0-UI.s2 cDNA,
1
TTCCTGTCTCCATGTTGTGGTCAAGA

3′ end/clone = IMAGE:3071572/

TTGCCATTTGCTTCCTGAGTTTCA

clone_end = 3′

7804
db mining
Hs.320411
BF512514
11597693
UI-H-BW1-amc-h-10-0-UI.s1 cDNA,
1
CTGGTTCTAGTGCAGTCTCCTCACTT

3′ end/clone = IMAGE:3069570/

TCCTGGTGTTTGGTTTATCTTTTCA

clone_end = 3′

7805
db mining
Hs.116501
AA651832
2583484
ns40b05.s1 cDNA, 3′ end/
1
TGACATGATTACCTGACTGATGTTTC

clone-IMAGE:1188065/clone_end =

TCCTCCATTAGACTGAATGCTTCA

3′

7806
db mining
Hs.320438
BF512719
11597898
UI-H-BW1-amm-c-01-0-UI.s1 cDNA,
1
TGGCAAAAAGCCTAACACTGACTCAT

3′ end/clone = IMAGE:3070440/

CCCATTCTATCAGCACAAACTTCA

clone_end = 3′

7807
db mining
Hs.319888
BF507612
11590910
UI-H-BW1-ana-e-12-0-UI.s2 cDNA,
1
GTTTACAAGGGATACTAGTTCCTGGA

3′ end/clone = IMAGE:3071734/

GGGACGAAGGAGGCTCTGTTTGCA

clone_end = 3′

7808
db mining
Hs.250726
AW298545
6705181
UI-H-BW0-ajm-g-01-0-UI.s1 cDNA,
1
TCCTCAACTCGGAGATTCCTGTATGG

3′ end/clone = IMAGE:2732352/

AGAGAATCAATTTCATATATTTGCA

clone_end = 3′

7809
db mining
Hs.120738
AA749236
2789194
nx99c09.s1 cDNA, 3′ end/
1
ACATTTCTTAGGTGTGTGTAGTGG

clone = IMAGE:1270384/clone_end =

TGAAGGAAAATAGTGGAAGATGTC

3′

TGCA

7810
db mining
Hs.320404
BF512350
11597616
UI-H-BW1-amc-b-01-0-UI.s1 cDNA,
1
TCAGGAGGCTTGAAAAGACTCAAGGT

3′ end/clone = IMAGE:3069264/

TTCTACACTATGGGAAATAAGGCA

clone_end = 3′

7811
db mining
Hs.319880
BF507510
11590808
UI-H-BW1-amr-c-04-0-UI.s1 cDNA,
1
GTTTTCACTTGTCATACTAACTATTGT

3′ end/clone = IMAGE:3070831/

TTTTCTCCCCCATGCCAAGAGCA

clone_end = 3′

7812
db mining
Hs.320371
BF512091
11597303
UI-H-BW1-ami-f-05-0-UI.s1 cDNA,
1
AGCCAAGGGAGCATATTATTCTCTTA

3′ end/clone = IMAGE:3070208/

TTTTAAACCTCTCCGTAGGCAGCA

clone_end = 3′

7813
db mining
Hs.307837
AI052783
3308774
oy78h09.x1 cDNA, e′ end/
1
AGAAGGACCCCTGGTTGAGAACCAC

clone = IMAGE:1872001/clone_end =

GGTTGTATAGAAAGGAATTGAAGCA

3′

7814
db mining
Hs.124383
AA831706
2904805
oc85b04.s1 cDNA, 3′ end/
1
TTGACTGCCATAGCCAAGAGTTAATA

clone = IMAGE:1356463/clone_end =

TAGTTGCGTTTTCTTAAGGAAGCA

3′

7815
db mining
Hs.123304
AA809672
2879078
nz99b08.s1 cDNA, 3′ end/
1
CTTACTGTGTCTTTTAGGTTTTGT

clone = IMAGE:1303575/clone_end =

TGCTTTCTGTCTGTATGCTATGT

3′

TCCA

7816
db mining
Hs.123368
AA811539
2881150
ob45d08.s1 cDNA, 3′ end/
1
TGCAGTTAGGAGTGTGGACACTCTGC

clone = IMAGE:1334319/clone_end =

CCATCTCCATTGAATTAAATTCCA

3′

7817
db mining
Hs.313178
AW293164
6699800
UI-H-BW0-aii-c-01-0-UI.s1 cDNA,
1
ACTTGGGTTCTATCCCCACGATAACT

3′ end/clone = IMAGE:2729448/

TGTTATGTATATGCCAATATCCCA

clone_end = 3′

7818
db mining
Hs.313171
AW292976
8699812
UI-H-BW0-aih-b-08-0-UI.s1 cDNA,
1
AGCTAGAAAATGTCCCTTTTTCTTCTT

3′ end/clone:IMAGE:2729055

TGGAGGTCTTTAACCAAGGCCCA

clone_end = 3′

7819
db mining
Hs.343308
BF508886
11592184
UI-H-B14-aos-a-03-0-UI.s1 cDNA,
1
ATCACCAATCTTATTTAGCACTGTGG

3′ end/clone = IMAGE:3085732/

ATGCCGTTTTGCAAATGTCACCCA

clone_end = 3′

7820
db mining
Hs.320468
BF513104
11598283
UI-H-BW1-amn-e-10-0-UI.s1 cDNA,
1
TGACTTAAGGTTGGAATATCTCCTAC

3′ end/clone = IMAGE:3070555/

TACTCCCCTGTCCTCCTTGGACCA

clone_end = 3′

7821
db mining
Hs.120585
AA743221
2782727
ny21c06.s1 cDNA, 3′ end/
1
TGTGGTTTGCAATGGTTTACTGATGA

clone = IMAGE:1272394/clone_end =

GACAGCAAAAATGAGACAGGACCA

3′

7822
db mining
Hs.297468
BF513126
11598305
UI-H-BW1-amn-g-09-0-UI.s1 cDNA,
1
TGGCGAGCCAGTCTCTGGATGGGAT

3′ end/clone = IMAGE:3070649/

TCTGATCAACAGAAGTTCTCATACA

clone_end = 3′

7823
db mining
Hs.313205
AW293932
67000568
UI-H-BW0-aik-b-02-0-UI.s1 cDNA,
1
TGCCCATCCTTTGCTGTTTTTCTCTTT

3′ end/clone = IMAGE:2729426/

CAGTCATGGCCTATTTGGAGACA

clone_end = 3′

7824
db mining
Hs.343329
BF515646
11500825
UI-H-BW1-anu-d-06-0-UI.s1 cDNA,
1
CTCAACCTTGGCCCTAAACTAACAGT

3′ end/clone = IMAGE:3083555/

GACAGGGAGTTCCCCAGCCTCAC

clone_end = 3′

7825
db mining
Hs.319906
BF507755
11591053
UI-H-BW1-anc-g-07-UI.s2 cDNA,
1
TCCTGACCGTTGACAGAGAGCTTTTA

3′ end/clone = IMAGE:3072180/

CAGAAGTCTTAGGCAGTACACACA

clone_end = 3′

7826
db mining
Hs.320465
BF513053
11598232
UI-H-BW1-amn-a-05-0-UI.s1 cDNA,
1
AGTGTGTGGCACCCAGGATCACTG

3′ end/clone = IMAGE:3070355/

TATGAGAATTTTCCTGAACAACAACA

clone_end = 3′

7827
db mining
Hs.320430
BF512667
11597846
UI-H-BW1-amg-f-08-0-UI.s1 cDNA,
1
GCTGTAAGTCCCTTCCTTACTCATCT

3′ end/clone = IMAGE:3069850/

TCCCTCTCAAATACAACAACAACA

clone_end = 3′

7828
db mining
Hs.120718
AA748539
2788497
ny05h12.s1 cDNA, 3′ end/
1
GCCAGTTGGCACCATTTATGAAACAC

3′ end/clone = IMAGE:1270919/clone_end =

ACCACCTTGTAACCACTGAATTAA

3′

7829
db mining
Hs.320472
BF513154
11598333
UI-H-BW1-amj-b-02-0-UL.s1 cDNA,
1
TCAACCTAGCACAGTGCCTGGCTGAT

3′ end/clone = IMAGE:3070011/

AGGTGTTGAATATTTCCACTCTAA

clone_end = 3′

7830
db mining
Hs.319899
BF507695
11590993
UI-H-BW1-anb-h-05-0-UI.s2 cDNA,
1
GCAACCCTCTGCCCCTGCAAAGAGAT

3′ end/clone = IMAGE:3071885/

ATTGTGACAAAGATATTCACTGAA

clone_end = 3′

7631
db mining
Hs.124932
AA825273
2898575
oc67a02.s1 cDNA, 3′ end/
1
TAACATTCCTGGCACAGTCCCTGGCA

clone = IMAGE:1354730/clone_end =

TAGGGTAGATAATAAATGGTGGAA

3′

7832
db mining
Hs.313354
AW297308
6703944
UI-H-BW0-aji-h-03-0-UI.s1 cDNA,
1
TCTCTAACCATCAAGGAAGGTCAAGG

3′ end/clone = IMAGE:2732020/

GCCATGTATCTCTTTTAGGGAGAA

clone_end = 3′

7833
db mining
Hs.127178
AA938725
3096753
oc10g07.s1 cDNA, 3′ end/
1
TTCCACAAACTCAGGTGTGCAAGAAA

clone = IMAGE:1340508/clone_end =

CAATGCATTACTTTATTTTCAGAA

3′

7834
db mining
Hs.320445
BF512786
11597965
UI-H-BW1-amm-h-12-0-UI.s1 cDNA,
1
CAGGAGTTTGAGACCAGCCTGGGCA

3′ end/clone = IMAGE:3070702/

ACATAGTAAGTCTCCATCTCTTCAA

clone_end = 3′

7835
db mining
Hs.319902
BF507708
11591006
UI-H-BW1-and-b-02-UI.s2 cDNA,
1
TCCCTAGTCCTGGAGACTCGGGAACT

3′ end/clone = IMAGE:3071930/

AAAACAATCAATTCCCCTGAGCAA

clone_end = 3′

7836
db mining
Hs.104348
AA251338
1886301
zs08a06.s1 cDNA, 3′ end/
1
TCCTCTTCATTGGAGACCCCTCCCTG

clone = IMAGE:684562/clone_end =

TCACAGCACAATGTGGGTAATAAA

3′

7837
db mining
Hs.320442
BF512761
11597940
UI-H-BW1-amm-f-08-0-UI.s1 cDNA,
1
CAGAACAAGGCCCACAGTGTGAAAG

3′ end/clone = IMAGE:3070598/

GTGCTGCTGAACAAAGATAAATAAA

clone_end = 3′

7838
db mining
Hs.320470
BF513152
11598331
UI-H-BW1-amj-a-12-0-UI.s1 cDNA,
1
GAGTCAGCAACAGTGGTCCTCTTGCC

3′ end/clone = IMAGE:3069983/

TTGGTTGATGCTTTTGAACTGAAA

clone_end = 3′

7839
db mining
Hs.300359
BF516423
11601602
UI-H-BW1-aob-h-05-0-UI.s1 cDNA,
1
TAAGGATGTATCCCTATGGGCAGGAA

3′ end/clone = IMAGE:3084512/

ACCCAATTCTAAGAAACTTACAAA

clone_end = 3′

7840
db mining
Hs.309152
AI392970
4222517
tg22d05.s1 cDNA, 3′ end/
1
GCCACTGCACTCCAGCCTGGGCAAC

clone = IMAGE:2109513/clone_end =

AGAGCGAGACCTTGACTCTTTAAAA

3′

7841
db mining
Hs.122448
AA761767
2810697
nz31e08.s1 cDNA, 3′ end/
1
CACAACACCCAAAAGGCTGCATTGCA

clone = IMAGE:1289414/clone_end =

TAACATGTATTTGTTGAATGAAAA

3′

7842
db mining
Hs.319874
BF507452
11590750
UI-H-BW1-amz-e-06-0-UI.s2 cDNA,
1
GGGGTCCTTGCTCACAGAGCTCCCA

3′ end/clone = IMAGE:3071699/

AGATGGTGGTGGGCCACTTCCAAAA

clone_end = 3′

7843
db mining
Hs.104177
AA214542
1813167
zr92b09.s1 cDNA, 3′ end/
1
TCCCTCTATAGGTAAAAGACCTGTTT

clone = IMAGE:683129/clone_end =

GTCTGAAATGTGTGGAACCTGTCT

3′

7844
db mining
Hs.104182
AA521405
2261948
aa68c0.s1 cDNA, 3′ end/
1
GCTGCCGTGTCTTTTGGCATTTTCAG

clone = IMAGE:826090/clone_end =

CATGACTATATGTTTTTGTAATGT

3′

7845
db mining
Hs.255522
AW296182
6702818
UI-H-B12-aia-c-01-0-UI.s1 cDNA,
1
CCGAAGGCCCGTGTGGCGCTTCTCC

3′ end/clone = IMAGE:2728680/

TATTCTGTAGAGTGGTAGTTTGTTT

clone_end = 3′

7846
db mining
Hs.124926
AA765668
2816906
ca04f02.s1 cDNA, 3′ end/
1
AAAGAGGTAAACGCAAGTTCTCTCTT

clone = IMAGE:1303995/clone_end =

GTAGGTCGGGCTACAGGTGACTTT

3′

7847
db mining
Hs.320388
BF512314
11597493
UI-H-BW1-amb-f-11-0-UI.s1 cDNA,
1
TGGTTCTCAGCCTGGGTGAACAGAG

3′ end/clone = IMAGE:3069453/

AAGGGGTCTAATTTGGTCTTTTGTT

clone_end = 3′

7848
db mining
Hs.123161
AA807319
2876895
oc38b01.s1 cDNA, 3′ end/
1
TGTTCTTGGCACCCTGCACTGTCAGG

clone = IMAGE:1351945/clone_end =

CTATATCATTTCTGTTTGTTTCTT

3′

7849
db mining
Hs.120608
AA743877
2783228
ny25b04.s1 cDNA, 3′ end/
1
TCTCATTTTCTTTTCCTAGCTGTGATG

clone = IMAGE:1272751/clone_end =

CAAAGTGTCAGTGGTCCCATCTT

3′

7850
db mining
Hs.120554
AA741010
2779602
ny99a10.s1 cDNA, 3′ end/
1
TGTCCAACCTTCCTTTTGCTACAAAC

clone = IMAGE:1286394/clone_end =

AAAGAATGCCTAGGGATTCAACTT

3′

7851
db mining
Hs.330148
BE676227
10036768
xm80f05.x1 cDNA, 3′ end/
1
CAAGTGGCCTTGGTGTTTAAATCTTG

clone = IMAGE:2690529/clone_end =

CCCTAAATTGTAACTCACATGATT

3′

7852
db mining
Hs.120259
AA731522
2753678
nw59h09.s1 cDNA, 3′ end/
1
ACCAACCAGTGGTGTGCTGGAGCTG

clone = IMAGE:1250945/clone_end =

TCTCATACTATCTTGAGAGTCCATT

3′

7853
db mining
Hs.124333
AA829233
2902332
od05a10.s1 cDNA, 3′ end/
1
AGCACTTGCTTTGTTCCAGACATTGT

clone = IMAGE:1358298/clone_end =

CCTTAGCTCCTTTCTTGTGTAATT

3′

7854
db mining
Hs.124281
AA825840
2899152
od59d02.s1 cDNA, 3′ end/
1
TGCAGCAAAAATTGAATTTCATAGGC

clone = IMAGE:132227/clone_end =

CATTCAGTGTTCTCTGCGATAATT

3′

7855
db mining
Hs.120716
AA748500
2788458
ny01h10.s1 cDNA, 3′ end/
1
CCAGGAATGGAAATACGCCAACCCA

clone = IMAGE:1270531/clone_end =

GGTTAGGCACCTCTATTGCAGAATT

3′

7856
db mining
Hs.320428
BF512663
11597842
UI-H-BW1-amg-f-02-0-UI.s1 cDNA,
1
AGGAAATTGGTTGAAGTCGTTTTTCT

3′ end/clone = IMAGE:3089642/

CTTGTTAGTCTCATGTTAAGCTGT

clone_end = 3′

7857
db mining
Hs.123593
AA814828
2884424
ob73d07.s1 cDNA, 3′ end/
1
TCGCCTGGGGAGATTTAAAATCTAA

clone = IMAGE:1337005/clone_end =

GTCGCTGGAAGTCCCTTTGTATGT

3′

7858
db mining
Hs.120214
AA730985
2752189
nw67a04.s1 cDNA, 3′ end/
1
ACCTGTAGGAAGGGTTTGTGAATATT

clone = IMAGE:1251630/clone_end =

CTGTTGCTCTGAATTATTAGCGGT

3′

7859
db mining
Hs.123365
AA811469
2881080
ob83c11.s1 cDNA, 3′ end/
1
TGAGAGGATCTTGAGACATTCTTGTG

clone = IMAGE:1337972/clone_end =

TTATTTGCCCTCTATGTTTTAGGT

3′

7860
db mining
Hs.127156
AA938155
3096266
oc10a09.s1 cDNA, 3′ end/
1
TCCCAAGCATGAGACAAGTACCACCA

clone = IMAGE:130440/clone_end =

GTGGTTCAGGAGATGATTTTAGGT

3′

7861
db mining
Hs.320488
BF513278
11598455
UI-H-BW1-amo-e-01-0-UI.s1 cDNA,
1
ACAAGACAGCAGCCTTCCCGAAATGT

3′ end/clone = IMAGE:3070560/

CACTACTAAGAATTATTCAGAGGT

clone_end = 3′

7862
db mining
Hs.343330
BF514718
11599897
UI-H-BW1 = ans-a-12-0-UI.s1 cDNA,
1
GCTGCCCAAACTTCCATTTATTTACC

3′ end/clone = IMAGE:3083063/

CTCCAAACATCACTTCCTTCCTCT

clone_end = 3′

7863
db mining
Hs.123584
AA814349
2883945
nz06h06.s1 cDNA, 3′ end/
1
ACATTTGCCAATGCACTTGATGTAAA

clone = IMAGE:1287035/clone_end =

GTTGTTGAGGATGTTGACTCTCCT

3′

7864
db mining
Hs.123376
AA811751
2881362
nb80e12.s1 cDNA, 3′ end/
1
TCCCCCTTCCTAACACCAATTTGGGA

clone = IMAGE:1337710/clone_end =

ACATCACTACTTGTATATTATCCT

3′

7865
db mining
Hs.122860
AA766374
2817612
oa36b03.s1 cDNA, 3′ end/
1
TCAAGACCCTTAGAGTAAGTTAACTC

clone = IMAGE:1307021/clone_end =

CCAAGGAAATGTAGTTAGTTCCCT

3′

7866
db mining
Hs.105268
AA490812
2219985
aa49e05.s1 cDNA, 3′ end/
1
AACCCACAATCCAACTCCCTTGATGA

clone = IMAGE:824288/clone_end =

GGATGATCATTAACAACAATCACT

3′

7867
db mining
Hs.297485
BF512677
11597856
UI-H-BW-amg-g-04-0-UI.s1 cDNA,
1
TTTGAAGCCTCTGGTACTTCCCCTTC

3′ end/clone = IMAGE:3069894/

CCAAACCAGTCACAGGAAACACT

clone_end = 3′

7868
db mining
Hs.127167
AA938326
3096437
oc11c08.s1 cDNA, 3′ end/
1
TTGGAGGTTAACAGTATTCCTTTGAG

clone = IMAGE:1340558/clone_end =

TGGTGTGATTAAAGGTGCTTTTAT

3′

7869
db mining
Hs.123361
AA811359
2880970
ob82a07.s1 cDNA, 3′ end/
1
CCACCTCCAGAACTGCCTATCTAAC

clone = IMAGE:1337844/clone_end =

TCATCTGTGGTGATGGAATGCTAT

3′

7870
db mining
Hs.105282
AA491247
2220420
aa49b01.s1 cDNA, 3′ end/
1
AGTGGCTCTCTGCTGTTAGCATGGTT

clone = IMAGE:824233/clone_end =

ACTAATCTTTTGGTTACTTTTCAT

3′

7871
db mining
Hs.320385
BF512292
11597471
UI-H-BW-amb-d-12-0-UI.s1 cDNA,
1
TGACCTCAGTGTCTACTTCAGCAGAA

3′ end/clone = IMAGE:3089359/

CCTGTGGGTATATGCCTACCTCAT

clone_end = 3′

7872
db mining
Hs.105506
AA521196
2261739
aa74c04.s1 cDNA, 3′ end/
1
AAGGAGAACTGTCAACTGAATCTCAA

clone = IMAGE:826662/clone_end =

ATGCAGTCAAATGAAGAGAGGCAT

3′

7873
db mining
Hs.124928
AA765759
2816997
ao07h05.s1 cDNA, 3′ end/
1
TTCAAGTCATTATAGGTTTGGGCATA

clone = IMAGE:1304313/clone_end =

CAGGGTTAACCTTGTGATGTACAT

3′

7874
db mining
Hs.320488
BF513286
11598465
UI-H-BW1-amo-e-11-0-UI.s1 cDNA,
1
AGCAGAACAACATGTGTTTGACACTT

3′ end/clone = IMAGE:3070580/

TTCCTTCTCTGTAATGAGGTACAT

clone_end = 3′

7875
db mining
Hs.122891
AA767601
2818816
ao45h09.s1 cDNA, 3′ end/
1
TGCCTGTGTGGGTCAAAGGAATCATC

clone = IMAGE:1307969/clone_end =

TATGCTAATGTATTTGAGCCAAAT

3′

7876
db mining
Hs.116435
AA848285
2574714
ns20d12.s1 cDNA, 3′ end/
1
ACCGAAAGCAGCATTTTCAATGTTTA

clone = IMAGE:1184183/clone_end =

ATTAAATCGATGCAGGAAATTGTG

3′

7877
db mining
Hs.300303
AW292760
6699396
UI-H-BW0-aij-c-03-0-UI.s1 cDNA,
1
GTCCCTGGCCCTTCACTCTTCGTCCA

3′ end/clone = IMAGE:2729453/

GGCTCTCTGACCTCTTTCCCTCTG

clone_end = 3′

7878
db mining
Hs.123154
AA688058
2674964
nv58c04.s1 cDNA, 3′ end/
1
TGTCCGCTGTTTTACCTCACTGCTCC

clone = IMAGE:1233990/clone_end =

TGTTTATGCCCTTAACTTCTGCTG

3′

7879
db mining
Hs.320489
BF513296
11598475
UI-H-BW1-amo-f-11-0-UI.s1 cDNa,
1
GCACAAGACCTCACTTGGAACAAGTA

3′ end/clone = IMAGE:3070628/

CCAGGCAGAAGAGAGCATTACCTG

clone_end = 3′

7880
db mining
Hs.124353
AA830448
2903547
oc51d05.s1 cDNA, 3′ end/
1
TTTCATATCTTGGCAGTTGGATGCGG

clone = IMAGE:1353225/clone_end =

TAAGAGCCACAGAGAAACCACCTG

3′

7881
db mining
Hs.122824
AA765319
2616557
ao01f11.s1 cDNA, 3′ end/
1
AGGACCCTTTTCCCATATTTCTGGCT

clone = IMAGE:1303725/clone_end =

ATATACAAGGATATCCAGACACTG

3′

7882
db mining
Hs.124317
AA827178
2901175
ob53g04.s1 cDNA, 3′ end/
1
ACCAGGCCTAGAATTTAGGTTCTAGG

clone = IMAGE:1335126/clone_end =

TGTAAACTATTGGCCTATCAGATG

3′

7883
db mining
Hs.300373
AW297820
6704445
UI-H-BW0-aiy-h-04-0-UI.s1 cDNA,
1
GTGCATTTTAGCAACAGACTTCCAGG

3′ end/clone = IMAGE:2731230/

TTTCCAGCGCGGGCCAGGAAGGGG

clone_end = 3′

7884
db mining
Hs.320464
BF513050
11598229
UI-H-BW1-amn-a-03-0-UI.s1 cDNA,
1
CTGTCATGCACCACCTCATCCCCTCC

3′ end/clone = IMAGE:3070349/

TTCAGGGCCAGGGACAGTCCCTAG

clone_end = 3′

7885
db mining
Hs.313366
AW297537
6704173
UI-H-BW0-aja-f-05-0-UI.s1 cDNA,
1
AGAGGAGGAGGGGGTAGAATGAATT

3′ end/clone = IMAGE:2731160/

TCATTTAAAGCTCAACCTAGTTCAG

clone_end = 3′

7886
db mining
Hs.320427
BF512648
11597827
UI-H-BW1-amg-d-19-0-UI.s1 cDNA,
1
CAGTCTCCCAGCTTTCTTGGCCTCCT

3′ end/clone = IMAGE:3069762/

CTGCCAACTGGATGCAAGGCTCAG

clone_end = 3′

7887
db mining
Hs.252840
AW015143
5883960
UI-H-B10p-abb-e-07-0-UI.s1 cDNA,
1
TGGAGAGAAGGTTCGGGAAGACGAG

3′ end/clone = IMAGE:2711149/

GGGGCTGGGAGGTTTGGAAAGACAG

clone_end = 3′

7888
db mining
Hs.313161
AW292801
6699437
UI-H-BW0-aij-f-11-0-UI.s1 cDNA,
1
CTGAAATGGGGGAAGGTGGGTTATG

end/clone = IMAGE:2729613/

ACAAAGTTCATGGAGAGGCCTGAAG

clone_end = 3′

7889
db mining
Hs.309124
AI380478
4190331
tf95a09.x1 cDNA, 3′ end/
1
TAAAGCGGTACGGGATTCCGCACCC

clone = IMAGE:2107000/clone_end =

TACTCCAGCAAGAAAGAGCCTGAAG

3′

7890
db mining
Hs.120562
AA741096
2779688
ny99g07.s1 cDNA, 3′ end/
1
AGCATTCATTCCTCCAAACACACTCC

clone = IMAGE:1286460/clone_end =

CAGGGTTAGGTCTCTTACCTCTGC

3′

7891
db mining
Hs.105530
AA521450
2261993
aa69d11.s1 cDNA, 3′ end/
1
GGTGTTGAATATTTATACGGATTGGC

clone = IMAGE:826197/clone_end =

ATCATAAGATACCGCGATACCTGC

3′

7892
db mining
Hs.123194
AA805997
2874747
oc18g05.s1 cDNA, 3′ end/
1
ACCTTAGTCTAACTGCCTTCTGTAAA

clone = IMAGE:1341272/clone_end =

GTGGGTTGCTATAGTCTTTAAGCC

3′

7893
db mining
Hs.122833
AA765597
2816835
ao08a10.s1 cDNA, 3′ end/
1
TGAGGTTTGGATGGTGGCAGGTAAAA

clone = IMAGE:1304346/clone_end =

CAGAAAGGCAAGATGTCATCTGAC

3′

7894
db mining
Hs.313827
AW452984
5993760
UI-H-BW1-amd-g-11-UI.s1 cDNA,
1
TGGAGCTGCTACATAATTATTTCAGG

3′ end/clone = IMAGE:3069525/

TCTCAAAGCTTCCAAGAAGTGGAC

clone_end = 3′

7895
db mining
Hs.122383
AA789140
2849260
aa66g10.s1 cDNA, 3′ end/
1
AGACGGAACCTGAGATGTTGGATGTT

clone = IMAGE:825954/clone_end =

GTTGATCTTAGCAAACAGACTTTA

3′

7896
db mining
Hs.120226
AA731687
2752576
nw58f05.s1 cDNA, 3′ end/
1
AGATCTGTAATCTTTGGCAAATGGAA

clone = IMAGE:1250817/clone_end =

CTCACCTGCAACGATACCTACTTA

3′

7897
db mining
Hs.120288
AA731998
2753949
nw61b04.s1 cDNA, 3′ end/
1
GAGGACTTCCATTCCCCATTTCCCGC

clone = IMAGE:1251055/clone_end =

ATACCTGCTGTTCTGTCTGAATTA

3′

7898
db mining
Hs.123168
AA804519
2873850
ns28a11.s1 cDNA, 3′ end/
1
AGCTCACACCTGTTCCTTCATGGGTC

clone = IMAGE:1184924/clone_end =

AGTTCCTTTCATTTTCACTTTTGA

3′

7899
db mining
Hs.124369
AA830835
2903934
oc54b06.s1 cDNA, 3′ end/
1
AGCTGCTGCTTCTCTTTCAGTTGCAA

clone = IMAGE:135491/clone_end =

ATGCAAACCTGTTATAATCTTTGA

3′

7900
db mining
Hs.122482
AA767335
2818350
nz65h02.s1 cDNA, 3′ end/
1
TCAATATCTGTGTGTCTTTTCATGAGT

clone = IMAGE:1300371/clone_end =

GGCTGTTACTTGTGAAGAATTGA

3′

7901
db mining
Hs.313287
AW296059
6702695
UI.H.BW0-aiu-g-03-0-UI.s1 cDNA,
1
TGAGTGGACTGAGGAATGAATAGAAA

3′ end/clone = IMAGE:2730796/

ACGTGGATATATGTAGAAAGCTGA

clone_end = 3′

7902
db mining
Hs.120705
AA748015
2787973
nx87c05.s1 cDNA, 3′ end/
1
ACCAGCCCCTGGGAATGTTATGAGCA

clone = IMAGE:1269224/clone_end =

AATGATACTCCATGAGTAAAATGA

3′

7903
db mining
Hs.320495
BF513385
11598564
UI-H-BW1 = amk-f-10-0-UI.s1 cDNa,
1
TCGTGTGAGTGTGAGAGACATGTTCA

3′ end/clone = IMAGE:3070242/

TTGTGAAAAGATACTCCTAGTGGA

clone_end = 3′

7904
db mining
Hs.121104
AA721020
2737155
nx89f11.s1 cDNA, 3′ end/
1
TTTGTCAAATGCCTGTTCACCATCTG

clone = IMAGE:1269453/clone_end =

TGGAAGTCATTATATGATTCAGGA

3′

7905
db mining
Hs.124297
AA827809
2900172
od08c04.s1 cDNA, 3′ end/
1
ACACTTTTCTTCTAAGGAGAGCTTTCT

clone = IMAGE:1387334/clone_end =

TAGGCATTTCAAAGAACTTTCGA

3′

7906
db mining
Hs.320372
BF512096
11597308
UI-H-BW1-ami-f-10-0-UI.s1 cDNA,
1
ACCAAATGAGTACCATCTGTTGAACA

3′ end/clone = IMAGE:3070218/

CAGGGTGGCGATCCAAGTGTTTCA

clone_end = 3′

7907
HUVEC
Hs.92381
AB007956
3413930
mRNA, chromosome 1
1
ACCTGACTTCCACGATAAAATGGAGA

cDNA

transcript KIAA0487/cds =

TGAGTGCAGGGGTGAGTGTATAGT

UNKNOWN

7908
HUVEC
Hs.24950
AB008109
2554613
regulator of G-protein signalling 5
1
TGCAGATTTATACTCCTGACGTGTCT

cDNA

(RGS5), mRNA/cds = (81, 626)

CATTCACAGCTAAATAATAGGCCA

7909
HUVEC
Hs.306193
AB011087
3043553
hypothetical protein (LQFBS-1),
1
ACCCTCGCCCTTTCCCTCCGGTTCAG

cDNA

mRNA/cds = (0, 743)

TACCTATTGTTTCTCCTTTCAAAT

7910
HUVEC
Hs.154919
AB014525
3327063
mRNA for KIAA0625 protein, partial
1
AAGAGGAAATGGCAGAATTAAAAGCA

cDNA

cds/cds = (0, 2377)

GAAACAAGAAGATGGACATGGATT

7911
HUVEC
Hs.153026
AB014540
3327093
mRNA for KIAA0640 protein, partial
1
AAGAGTGTTTGAGTGCTTGTCATCAG

cDNA

cds/cds = (0, 1812)

GTGTTTTCCTTAATAAGTAGGGAT

7912
HUVEC
Hs.24439
AB014546
3327105
ring finger protein (C3HC4 type) 8
1
CTGCTGTCCACTTTCCTTCAGGCTCT

cDNA

(RNF8), mRNA/cds = (112, 1569)

GTGAATACTTCAACCTGCTGTGAT

7913
HUVEC
Hs.155829
AB014576
3327185
mRNA for KIAA0676 protein, partial
1
TTCCTTGGATTCATTTCACTTGGCTA

cDNA

cds/cds = (0, 3789)

GAAATTACACTGTGCTCAATGCCT

7914
HUVEC
Hs.93675
AB022718
4204189
decidual protein induced by
1
AGGTCTCTGCCACCTCCTTCTCTGTG

cDNA

progesterone (DEPP), mRNA/

AGCTGTCAGTCAGGTTATTCTCT

cds = (218, 856)

7915
HUVEC
Hs.104305
AB023143
4589483
death effector filament-forming Ced-4-
1
GAATAGGAGGGACATGGAACCATTTG

cDNA

like apoptosis protein (DEFCAP),

CCTCTGGCTGTGTCACAGGGTGAG

transcript variant B, mRNA/

cds = (522, 4811)

7916
HUVEC
Hs.103329
AB023187
14133228
KIAA0970 protein (KIAA0970),
1
CCTGTTTAAGAAAGTGAAATGTTATG

cDNA

mRNA/cds = (334, 2667)

GTCTCCCCTCTTCCAATGAGCTTA

7917
HUVEC
Hs.155182
AB017848
5689408
KIAA1036 protein (KIAA1036),
1
TTTCACTTTCACACTTCATCTCATTCC

cDNA

mRNA/cds = (385, 1482)

TGTTGTCACTTTCCCCGAAACGA

7918
HUVEC
Hs.129218
AB028997
5689484
DNA sequence from clone RP11-
1
TCTGGATCAATAGCTTCCCCTCTAGG

cDNA

154E8 on chromosome 10. Contains

GTCTACTGATGAGTCAAATCTAAA

the gene KIAA1074, the 3′ end of the

YME1L1 gene for YME1 (S.

cerevisiae)-like 1, ESTs, STSs, GSSs

and a CpG island/cds = (166, 5298)

7919
HUVEC
Hs.8383
AB032255
6663499
bromodomain adjacent to zinc finger
1
TTTATCTACTGTGTGTTGTGGTGGCC

cDNA

domain, 2B (BAZ2B), mRNA/

TGTTGGAGGCAAATAGATCAGATT

cds = (366, 6284)

7920
HUVEC
Hs.15165
AB037755
7243048
novel retinal pigment epithellal gene
1
GACATTTTTGTAGGATGCCTGACGAG

cDNA

(NORPEG), mRNA/cds = (111, 3053)

GTGTAGCCTTTTATCTTGTTTCCG

7921
HUVEC
Hs.82113
AB049113
10257384
dUTP pyrophosphatase (OUT), mRNA/
1
CCCAGTTTGTGGAAGCACAGGCAAG

cDNA

cds = (29, 523)

AGTGTTCTTTTCTGGTGATTCTCCA

7922
HUVEC
Hs.8180
AF000652
2795862
syndecan binding protein (syntenin)
1
TGTTCCTTTTCCTGACTCCTCCTTGC

cDNA

(SDCBP), mRNA/cds = (148, 1044)

AAACAAAATGATAGTTGACACTTT

7923
HUVEC
Hs.147918
AF000982
2580549
DEAD/H (Asp-Glu-Ala-Asp/His) box
1
GTGACTTGTACATTCAGCAATAGCAT

cDNA

polypeptide 3 (DDX3), transcript

TTGAGCAAGTTTTATCAGCAAGCA

variant 2, mRNA/cds = (856, 2844)

7924
HUVEC
Hs.75056
AF002163
2290769
adaptor-related protein complex 3,
1
TTGCTATCGACATTCCCGTATAAAGA

cDNA

delta 1 subunit (AP3D1), mRNA/

GAGAGACATATCACGCTGCTGTCA

cds = (209, 3547)

7925
HUVEC
Hs.42915
AF006082
2282029
ARP2 (actin-related protein 2, yeast)
1
CCRFCCAGTGTCAGAAAATCCTATTT

cDNA

homolog (ACTR2), mRNA/

ATGAATCCTGTCGGTATTCCTTGG

cds = (74, 1258)

7926
HUVEC
Hs.11538
AF006084
2282033
actin related protein 2/3 complex,
1
AGGGAGGGGACAGATGGGGAGCTTT

cDNA

subunit 1A (41 kD) (ARPC1B), mRNA/

TCTTACCTATTCAAGGAATACGTGC

CDS = (80, 1198)

7927
HUVEC
Hs.6895
AF006086
2282037
actin related protein 2/3 complex,
1
TCAAGAATTTGGGTGGGAGAAAAGAA

cDNA

subunit 3 (21 kD) (ARPC3), mRNA/

AGTGGGTTATCAAAGGGTGATTTGA

cds = (25, 561)

7928
HUVEC
Hs.286027
AF010313
6468761
etoposide-induced mRNA (PIG8),
1
TGTGATTAGGTTGTTTTCCTGTCATTT

cDNA

mRNA/cds = (72, 1151)

TTGAGAGACTAAAATTGTGGGGG

7929
HUVEC
Hs.79150
AF026291
2559007
chaperonin containing TCP1, subunit 4
1
TGGGCTTGGTCTTCCAGTTGGCATTT

cDNA

(delta) (CCT4), mRNA/cds = (0, 1619)

GCCTGAAGTTGTATTGAAACAATT

7930
HUVEC
Hs.81452
AF030555
3158350
fatty-acid-Coenzyme A ligase, long-
1
AACAAGATGAGAACAGATAAAGATTG

cDNA

chain 4 (FACL4), transcript variant 2,

TGTGGTGTTTTGGATTTGGAGAGA

mRNA/cds = (506, 2641)

7931
HUVEC
Hs.139851
AF035752
2665791
caveolin 2 (CAV2), mRNA/
1
TGTAGCTCCCACAAGGTAAACTTCAT

cDNA

cds = (20, 508)

TGGTAAGATTGCACTGTTCTGATT

7932
HUVEC
Hs.194709
AF037364
14030860
paraneoplastic antigen MA1 (PNMA1),
1
TCACTCCCCCATTTCACTTCTTTGTCA

cDNA

mRNA/cds = (664, 1725)

GAGAATAGTTCTTGTTCATACTG

7933
HUVEC
Hs.79516
AF039656
2773159
brain acid-soluble protein 1 (BASP1),
1
TGGGAGTGACAAACATTCTCTCATCC

mRNA/cds = (52, 735)

TACTTAGCCTACCTAGATTTCTCA

7934
HUVEC
Hs.29417
AF039942
4730926
HCF-binding transcription factor
1
AATGGAAGGATTAGTATGGCCTATTT

cDNA

Zhangfei (ZF), mRNA/cds =

TTAAAGCTGCTTTGTTAGGTTCCT

(457, 1275)

7935
HUVEC
Hs.26232
AF044414
6136293
mannosidase, alpha, class 2C,
1
CCCCAGCCTAAAGCAGGGATCAGTC

cDNA

member 1 (MAN2C1), mRNA/

TTTTCTTGTGGAATAAATCCTTGGA

cds = (56, 3244)

7936
HUVEC
Hs.3776
AF062072
3668065
zinc finger protein 216 (ZNF216),
1
TGTGGTAATGCCTGTTTTCATCTGTA

cDNA

mRNA/cds = (288, 929)

AATAGTTAAGTATGTACACGAGGC

7937
HUVEC
Hs.74034
AF070648
3283922
clone 24651 mRNA sequence/
1
AGATGCTTAGTCCCTCATGCAAATCA

cDNA

cds = UNKNOWN

ATTACTGGTCCAAAAGATTGCTGA

7938
HUVEC
Hs.274230
AF074331
5052074
PAPS synthetase-2 (PAPSS2) mRNA,
1
AAAACTGCTCTTCTGCTCTAGTACCA

cDNA

complete cds/cds = (63, 1907)

TGCTTAGTGCAAATGATTATTTCT

7939
HUVEC
Hs.12540
AF081281
3415122
lysophospholipase (LYPLA1), mRNA/
1
AGCTATTAGGATCTTCAACCCAGGTA

cDNA

cds = (35, 727)

ACAGGAATAATTCTGTGGTTTCAT

7940
HUVEC
Hs.159629
AF092131
5138911
myosin IXB (MYO9B), mRNA/
1
TCCTGCGTCTATCCATGTGGAATGCT

cDNA

cds = (0, 6068)

GGACAATAAAGCGAGTGCTGCCCA

7941
HUVEC
Hs.273385
AF105253
7532779
guanine nucleotide binding protein (G
1
GCCACAAAAGTTCCCTCTCACTTTCA

cDNA

protein), alpha stimulating activity

GTAAAAATAAATAAAACAGCAGCA

polypeptide 1 (GNAS1), mRNA/

cds = (68, 1252)

7942
HUVEC
Hs.2934
AF107045
5006419
ribonucleotide reductase M1
1
ACTGCTTTGACTGGTGGGTCTCTAGA

cDNA

polypeptide (RRM1), mRNA/

AGCAAAACTGAGTGATAACTCATG

cds = (187, 2565)

7943
HUVEC
Hs.158237
AF112345
6650627
integrin alpha 10 subunit (ITGA10)
1
GGCATTGTCTCTGTTTCCCAGTGGGG

cDNA

mRNA, complete cds/cds = (76, 3579)

TGGACAGTATATCAGATGGTCAGA

7944
HUVEC
Hs.183698
AF116627
7959755
ribosomal protein L29 (RPL29),
1
CCCTGGGCTACCATCTGCATGGGGC

cDNA

mRNA/cds = (29, 508)

TGGGGTCCTCCTGTGCTATTTTGTAC

7945
HUVEC
Hs.2186
AF119852
7770136

Homo sapiens, eukaryctic translation
1
TCAAGTGAACATCTCTTGCCATCACC

cDNA

elongation factor 1 gamma, clone

TAGCTGCCTGCACCTGCCCTTCAG

MGC:4501 IMAGE:2964623, mRNA,

complete cds/cds = (2278, 3231)

7946
HUVEC
Hs.22900
AF134891
7381111
nuclear factor (erythroid-derived 2)-like
1
TCTTGGCAGCCATCCTTTTTAAGAGT

cDNA

3 (NFE2L3), mRNA/cds = (492, 1694)

AAGTTGGTTACTTCAAAAAGAGCA

7947
HUVEC
Hs.108258
AF141968
6273777
actin cross-linking factor (ACF7),
1
AGCTAAAGAGAGGGAACCTCATCTAA

cDNA

transcript variant 1, mRNA/

GTAACATTTGCACATGATACAGCA

cds = (51, 16343)

7948
HUVEC
Hs.11158
AF151072
7106885
hypothetical protein (LOC51255),
1
GCTGAGTGCTGGCCCTCTGCGTCTT

cDNA

mRNA/cds = (0, 461)

CCTTATTAACCTTGAATCCTCATTA

7949
HUVEC
Hs.179573
AF193556
6907041
collagen, type 1, alpha 2 (COL1A2),
1
TGAATGATCAGAACTGACATTTAATTC

cDNA

mRNA/cds = (139, 4239)

ATGTTTGTCTCGCCATGCTTCTT

7950
HUVEC
Hs.41135
AF205940
8547214
endomucin-2 (LOC51705), mRNA/
1
TCCGGGCCAAGAATTTTTATCCATGA

cDNA

cds = (78, 863)

AGACTTTCCTACTTTTCTCGGTGT

7951
HUVEC
Hs.142908
AF219119
7158848
E2F-like protein (LOC51270), mRNA/
1
GCAGAGTTCATTGTTGCCCCTTAACA

cDNA

cds = (278, 979)

GTTTTTCCTGAGTTTACTGAAGAA

7952
HUVEC
Hs.154721
AF261088
9802307
aconitase 1, soluble (ACO1), mRNA/
1
TTATCAAGCAGAGACCTTTGTTGGGA

cDNA

cds = (107, 2776)

GGCGGTTTGGGAGAACACATTTCT

7953
HUVEC
Hs.78288
AF261089
8802309
calpain 2, (m/ll) large subunit
1
GGGTATGCTGCCTCTGTAAATTCATG

cDNA

(CAPN2), mRNA/cds = (142, 2244)

TATTCAAAGGAAAAGACACCTTGC

7954
HUVEC
Hs.152707
AJ001259
2769253
glioblastoma amplified sequence
1
TTGTCTGCCCCACAATCAAGAATGTA

cDNA

(GBAS), mRNA/cds = (8, 868)

TGTGTAAAGTGTGAATAAATCTCA

7955
HUVEC
Hs.5097
AJ002308
2959871
synaplogyrin 2 (SYNGR2), mRNA/
1
ATGCCCGGCCTGGGATGCTGTTTGG

cDNA

cds = (29, 703)

AGACGGAATAAATGTTTTCTCATTC

7956
HUVEC
Hs.143323
AJ243706
6572290
mRNA for RB-binding protein
1
AGCAGTTTGTGATATAGCAGAGGTTT

cDNA

(rbbo2h1a gene)/cds = (757, 5802)

AAATGTACCCTCCCCTTTTATGCA

7957
HUVEC
Hs.1197
NM_002157
4504522
Heat shock 10 kD protein 1 (chaperonin
1
TGATGCTGCCCATTCCACTGAAGTTC

cDNA

10)

TGAAATCTTTCGTCATGTAAATAA

7958
HUVEC
Hs.79037
BC010112
14603308

Homo sapiens, heat shock 60 kD
1
AGCAGCCTTTCTGTGGAGAGTGAGAA

cDNA

protein 1 (chaperonin), clone

TAATTGTGTACAAAGTAGAGAAGT

MGC:19755 IMAGE:3630225, mRNA,

complete cds/cds = (1705, 3396)

7959
HUVEC
Hs.279860
AJ400717
7573518
tumor protein, translationally-controlled
1
CATCTGAAGTGTGGAGCCTTACCCAT

cDNA

1 (TPT1), mRNA/cds = (94, 612)

TTCATCACCTACAACGGAAGTAGT

7960
HUVEC
Hs.165563
AK024508
10440535
DNA sequence form clone RP4-
1
GCCAGGCTGGTTCCGCATGGTGATC

cDNA

591C20 on chromosome 20. Contains

TCCGTCTTGTATGTCTGAATGTTGG

ESTs, STSs, GSSs and CpG islands.

Contains a novel gene for a protein

similar to NG26, the TPD52L2 gene for

two isoforms of tumor protein D52-like

protein 2, a gene for a novel DnaJ

domain protein similar to mouse and

bovine cysteine string protein with two

isoforms, a gene for a novel

phosphoribulokinase with three

isoforms, the KIAA1196 gene and the

5′ part of the TOM gene for a putative

mitochondrial outer membrane protein

import receptor similar to yeast pre-

mRNA splicing factors Prp1/Zer1 and

Prp6/cds = (0, 503)

7961
HUVEC
Hs.91146
AL050147
4884153
protein kinase D2 mRNA, complete
1
CTATTTCCAAGGCCCCTCCCTGTTTC

cDNA

cds/cds = (39, 2675)

CCCAGCAATTAAAACGGACTCATC

7962
HUVEC
Hs.66762
AL050367
4914600
mRNA, cDNA DKFZp584A026 (from
1
AAAGTGCCAGAATGACTCTTCTGTGC

cDNA

clone DKFZp564A026)/

ATTCTTCTTAAAGAGCTGCTTGGT

cds = UNKNOWN

7963
HUVEC
Hs.165998
AL080119
5262550
PAI-1 mRNA-binding protein (PAI-
1
TTGTTGGTAGGCACATCGTGTCAAGT

cDNA

RBP1), mRNA/cds = (85, 1248)

GAAGTAGTTTTATAGGTATGGGTT

7964
HUVEC
Hs.111801
AL096723
5419856
mRNA; cDNA DKFZp564H2023 (from
1
AGTCCTGTATCATCCATACTTGTACTA

cDNA

clone DKFZp584H2023)/

CCTTGTCCTATGAAGCTCTGAGA

cds = UNKNOWN

7965
HUVEC
Hs.89434
AL110225
5817161
drebrin 1 (DBN1), mRNA/
1
TTGGCCGCTTCCCTACCCACAGGGC

cDNA

cds = (97, 2046)

CTGACTTTTACAGCTTTTCTCTTTT

7966
HUVEC
Hs.7527
AL110239
5817182
small fragment nuclease
1
TATGACACAGCAGCTCCTTTGTAAGT

cDNA

(DKFZP588E144), mRNA/

ACCAGGTCATGTCCATCCCTTGGT

cds = (77, 790)

7967
HUVEC
Hs.187991
AL110269
5817043
DKFZP564A122 protein
1
TTGGTGAGTTGCCAAAGAAGCAATAC

cDNA

(DKFZP564A122), mRNA/

AGCATATCTGCTTTTGCCTTCTGT

cds = (2570, 2908)

7968
HUVEC
Hs.25882
AL117665
5912262
mRNA; cDNA DKFZp586M1824 (from
1
TGCATAGATGACCTTTGGATTATTGG

cDNA

clone DKFZp586M1824); partial cds/

ACTCTGACTATTGGGACCCTAAAT

cds = (0, 3671)

7969
HUVEC
Hs.17428
AL133010
6453416
RBP1-like protein (BCAA), transcript
1
TGGACGCCCTAAGAAACAGAGA

cDNA

variant 2, mRNA/cds = (468, 4143)

AAACAGAAATAACAACCAGGAACT

GCTT

7970
HUVEC
Hs.278242
AL137300
6807762

Homo sapiens, clone MGC:3214
1
CAATAGCTTGTGGGTCTGTGAAGACT

cDNA

IMAGE:3502820, mRNA complete cds/

GCGGTGTTTGAGTTTCTCACACCC

cds = (2066, 3421)

7971
HUVEC
Hs.7378
AL137663
6807784
mRNA; cDNA DKFZp434G227 (from
1
TGCACTGTACTCTCTTCATAGGATTG

cDNA

clone DKFZp434G227)/

TAAAGGTGTTCTAATCCAATTGCA

cds = UNKNOWN

7972
HUVEC
Hs.61289
AL157424
7018453
mRNA; cDNA DKFZp761E1512 (from
1
TGAAGTCATTTCATTGGGAAGGAAAG

cDNA

clone DKFZp761E1512)/

CTGCCAAAGATTATTGGGGGACTAG

cds = UNKNOWN

7973
HUVEC
Hs.240013
AL390148
9388882
mRNA; cDNA DKFZp547A166 (from
1
TTTCATCTGGCCCACCCTCCTTAGAC

cDNA

clone DKFZp547A166)/

TCTCCTCCCTTCAAGAGTTGGAGC

cds = UNKNOWN

7974
HUVEC
Hs.22629
AW887820
8049833
602281231F1 cDNA, 5′ end/
1
GTGTAGAATTCGGATCCAGTCATCTC

cDNA

clone = IMAGE:4368943/clone_end =

ACAGAACTTTCCACTAGGGTGCCA

5′

7975
HUVEC
Hs.333414
BE562833
9806553
hypothetical protein MGC14151
1
CGGACCCCAGTTTCTTGTACCAAGGG

cDNA

(MGC14151), mRNA/cds = (108, 485)

GGAAACATGCGGGGACCCCAATGG

7976
HUVEC
NA
BE612847
9894444
601452239F1 NH_MGC_68 cDNA
1
TAAAGATGTCCGGGTACACTTCGCCA

cDNA

clone IMAGE:3856304 5′, mRNA

AGGGTTAGCGTCTTTGGGCATTTC

sequence

7977
HUVEC
Hs.86412
BE876332
10325018
chromosome 9 open reading frame 5
1
AACACAACACTAAAACCGAACA

cDNA

(C9orf5), mRNA/cds = (32, 2767)

CACACGTACTAACACACCCACGAC

CCAA

7978
HUVEC
Hs.285814
BE906689
10400012
sprouly (Drosophila) homolog 4
1
CCTTCTGGTTCTGCTTTTGACCAGA

cDNA

(SPRY4), mRNA/cds = (205, 525)

TTTTTGTGCCCCTCTGTTACTGTG

7979
HUVEC
Hs.113029
BF025727
10733439
ribosomal protein S25 (RPS25),
1
GATATACGAAACACACCACTGGACGA

cDNA

mRNA/cds = (63, 440)

TGCGAAAAACGAGACGACATAAGC

7980
HUVEC
Hs.263339
BF107006
10889631
602377929F1 cDNA, 5′ end/
1
TGGACAGGCATGAAAGGTTACAAATG

cDNA

clone = IMAGE:4508646/clone_end =

GGAGAAAACTCACACACGTTATGT

5′

7981
HUVEC
Hs.182426
BF204683
11098269
601887521F1 cDNA, 5′ end/
1
GCAGGAGAGCGAGAGAGGAGAAGAA

cDNA

clone = IMAGE:4110052/clone_end =

GAGGCAGGAGGGAGAAAGAGCGTAC

5′

7982
HUVEC
Hs.75968
BF217687
11111273
thymosin, beta 4, X chromosome
1
CAAGAAGCAGAAGCAGCAACCAGAG

cDNA

(TMSB4X), mRNA/cds = (77, 211)

ACAGAGAGACAAACGCAGAACAACA

7983
HUVEC
Hs.112318
BF237710
11151828
cDNA FLJ4633 fis, clone
1
AGAGGAAAGAATAGGACCAGTGCCG

cDNA

NT2RP2000938/cds = UNKNOWN

AGGTATAGGGAGGAGGGCATACTAA

7984
HUVEC
Hs.293981
BF247088
11162147

Homo sapiens, clone MGC:16393
1
TCGGAGTAAGGGCGATTGTCTCGTTA

cDNA

IMAGE:3939021, mRNA, complete

GGTAATACATCATCTTCGTGCATA

cds/cds = (506, 1900)

7985
HUVEC
Hs.157850
BF303931
11250608

Homo sapiens, clone MGC:15545
1
AGACAAGACGAGCAACGACAACCAC

cDNA

IMAGE:3050745, mRNA, complete

AGCAGCTCCATACACTCTGCCTCTC

cds/cds = (1045, 1623)

7986
HUVEC
Hs.217493
D00017
219909
annexin A2 (ANXA2), mRNA/
1
AGTGAAGTCTATGATGTGAAACACTT

cDNA

cds = (49, 1068)

TGCCTCCTGTGTACTGTGTCATAA

7987
HUVEC
Hs.76549
D00099
219941
mRNA for Na, K-ATPase alpha-
1
TCACAAGACAGTCATCAGAACCAGTA

cDNA

subunit, complete cds/cds = (318, 3389)

AATATCCGTCTGCCAGTTCGATCA

7988
HUVEC
Hs.330716
D10522
219893
cDNA FLJ4368 fis, clone
1
AAACTCCTGCTTAAGGTGTTCTAATTT

cDNA

HEMBA 1001122/cds = UNKNOWN

TCTGTGAGCACACTAAAAGCGAA

7989
HUVEC
Hs.75929
D21255
575578
mRNA for O8-cadherin-2, complete
1
CGTGCCAGATATAACTGTCTTGTTTC

cDNA

cds/cds = (476, 2557)

AGTGAGAGACGCCCTATTTCTATG

7990
HUVEC
Hs.178710
D21260
434760
clathrin, heavy polypeptide (Hc)
1
TCCCTGAGGCTTGTGTATGTTGGATA

cDNA

(CLTC), mRNA/cds = (172, 5199)

TTGTGGTGTTTTAGATCACTGAGT

7991
HUVEC
Hs.334822
D23660
432358

Homo sapiens. Similar to ribosomal
1
CAGAGAAGAAACCTACTACAGAGGA

cDNA

protein L4, clone MGC:2968

GAAGAAGCCTGCTGCATAAACTCTT

IMAGE:3139805, mRNA, complete

cds/cds = (1616, 2617)

7992
HUVEC
Hs.262823
D28500
7678803
hypothetical protein FLJ10326
1
TCAGAACATAGATATGTATTCAGCTT

cDNA

(FLJ10326), mRNA/cds = (2, 2296)

GTCTTCAAATACGGCCAAGCAGAA

7993
HUVEC
Hs.151761
D43947
603948
KIAA0100 gene product (KIAA0100),
1
TTGGGGTCAAGTGAAAGGGTAGGGG

cDNA

mRNA/cds = (329, 6607)

GATAGTCCTGATCAAGTGTGATAAA

7994
HUVEC
Hs.699
D50525
1167502
peptidylprolyl isomerase B (cyclophilin
1
CAGCAAATCCATCTGAACTGTGGAGG

cDNA

B) (PPIB), mRNA/cds = (21, 671)

AGAAGCTCTCTTTACTGAGGGTGC

7995
HUVEC
Hs.278607
D50911
6633996
mRNA; cDNA DKFZp434N0735 (from
1
CCTTCTCTTCATGTGTGTAAATCTGTA

cDNA

clone DKFZp434N0735); partial cds/

ATATACCATTCTCTGTGGCCTGT

cds = (0, 1577)

7996
HUVEC
Hs.57729
D50922
1469188
Ketch-like ECH associated protein 1
1
GGATGGCACTTCCCCACCGGGATGGA

cDNA

(KIAA0132), mRNA/cds = (112, 1986)

CAGTTATTTTGTTGATAAGTAACCC

7997
HUVEC
Hs.240770
D59253
1060898

Homo sapiens, nuclear cap binding
1
TGAGTCAGTGTCTTTACTGAGCTGGA

cDNA

protein subunit 2, 20 kD, clone

AGCCTCTGAAAGTTATTAAAGGCA

MGC:4991 IMAGE:3458927, mRNA,

complete cds/cds = (26, 496)

7998
HUVEC
Hs.155595
D83878
981447
neural precursor cell expressed,
1
CCCACACTGCTACACTTCTGATCCCC

cDNA

developmentally down-regulated 5

TTTGGTTTTACTACCCAAATCTAA

(NEDD5), mRNA/cds = (258, 1343)

7999
HUVEC
Hs.80712
D86957
1503987
septin 2 (SEP2) mRNA, partial cds/
1
GTGGCTTGCTAGTCTGTTACGTTAAC

cDNA

cds = (0, 1527)

ATGCTTTTCTAAAATTGCTTCACG

8000
HUVEC
Hs.75822
D86970
1504013
mRNA for KIAA0216 gene, complete
1
TTGTACTCACTGGGCTGTGCTCTCCC

cDNA

cds/cds = (484, 5229)

CTGTTTACCCGATGTATGGAAATA

8001
HUVEC
Hs.170311
D89678
3128539
heterogeneous nuclear
1
TTTATGATTAGGTGACGAGTTGACAT

cDNA

ribonucleoprotein D-like (HNRPDL),

TGAGATTGTCCTTTTCCCCTGATC

transcript variant 1, mRNA/

cds = (580, 1842)

8002
HUVEC
Hs.83213
J02874
178348
fatty acid binding protein 4, adipocyte
1
TTGTTGTTTTCCCTGATTTAGCAAGCA

cDNA

(FABP4), mRNA/cds = (47, 445)

AGTAATTTTCTCCCAAGCTGATT

8003
HUVEC
Hs.177766
J03473
337423
ADP-ribosyltransferase (NAD+; poly
1
TTAGAAACAAAAAGAGCTTTCCTTCT

cDNA

(ADP-ribose) polymerase) (ADPRT),

CCAGGAATACTGAACATGGGAGCT

mRNA/cds = (159, 3203)

8004
HUVEC
Hs.155560
L10284
186522
calnexin (CANX), mRNA/
1
CCATTGTTGTCAAATGCCCAGTGTCC

cDNA

cds = (89, 1887)

ATCAGATGTGTTCCTCCATTTTCT

8005
HUVEC
Hs.75693
L13977
431320
prolylcarboxypeptidase
1
GATGTCTGGTGCCCAATCCCAGGAA

cDNA

(anglotensinase C) (PRCP), mRNA/

GTGAGAGCCATTTCTTTTGTACTGG

cds = (29, 1519)

8006
HUVEC
Hs.539
L31610
1220380
ribosomal protein S29 (RPS29),
1
AGTTGGACTAAATGCTCTTCCTTCAG

cDNA

mRNA/cds = (30, 200)

AGGATTATCCGGGGCATCTACTCA

8007
HUVEC
Hs.1742
L33075
536843
IQ motif containing GTPase activating
1
TGAATTTACTTCCTCCCAAGAGTTTG

cDNA

protein 1 (IQGAP1), mRNA/

GACTGCCCGTCAGATTGTTTCTGC

cds = (467, 5440)

8008
HUVEC
Hs.180446
L38951
893287
Importin beta subunit mRNA, complete
1
AAACACATACACACAAAACAGC

cDNA

cds/cds = (337, 2967)

AAACTTCAGGTAACTATTTTGGAT

TGCA

8009
HUVEC
Hs.79572
M11233
181179
cathepsin D (lysosomal aspartyl
1
CTGAGGATGAGCTGGAAGGAGTGAG

cDNA

protease) (CTSD), mRNA/

AGGGGACAAAACCCACCTTGTTGGA

cds = (2 1240)

8010
HUVEC
Hs.273415
M11580
178350
aldolase A, fructose-bisphosphate
1
TCTTTCTTCCCTCGTGACAGTGGTGT

cDNA

(ALDOA), mRNA/cds = (167, 1261)

GTGGTGTCGTCTGTGAATGCTAAG

8011
HUVEC
Hs.254105
M14328
182113
anolase 1, (alpha) (ENO1), mRNA/
1
GCTAGATCCCCGGTGGTTTTGTGCTC

cDNA

cds = (94, 1398)

AAAATAAAAAGCCTCAGTGACCCA

8012
HUVEC
Hs.237519
M20867
183059
yz35c09.s1 cDnA, 3′ end/
1
GCATGGCTTAACCTGGTGATAAAAGC

cDNA

clone = IMAGE:285040/clone_end =

AGTTATTAAAAGTCTACGTTTTCC

3′

8013
HUVEC
Hs.1239
M22324
178535
alanyl (membrane) aminopeptidase
1
CCGCCCTGTACCCTCTTTCACCTTTC

cDNA

(aminopeptidase N, aminopeptidase M,

CCTAAAGACCCTAAATCTGAGGAA

microsomal aminopeptidase, CD13,

p150) (ANPEP), mRNA/

cds = (120, 3023)

8014
HUVEC
Hs.118126
M22960
190282
protective protein for beta-
1
GGACAGCCCACAGGGAGGTGGTGGA

cDNA

galactosidase (galactoslaidosis)

CGGACTGTAATTGATAGATTGATTA

(PPGB), mRNA/cds = (6, 1448)

8015
HUVEC
Hs.198281
M26252
338826
pyruvate kinase, muscle (PKM2),
1
ATTGAAGCCGACTCTGGCCCTGGCC

cDNA

mRNA/cds = (109, 1704)

CTTACTTGCTTCTCTAGCTCTCTAG

8016
HUVEC
Hs.2050
M31166
339991
pentaxin-related gene, rapidly induced
1
ACTAGACTTTATGCCATGGTGCTTTC

cDNA

by IL-1 beta (PTX3), mRNA/

AGTTTAATGCTGTGTCTCTGTCAG

cds = (87, 1212)

8017
HUVEC
Hs.99853
M59849
182591
fibrillarin (FBL), mRNA/cds =
1
GAGCCATATGAAAGAGACCATGCCGT

cDNA

(59, 1024)

GGTCGTGGGAGTGTACAGGCCACC

8018
HUVEC
Hs.283473
M64098
183891
hypothetical protein PRO2900
1
ATAACAGACTCCAGCTCCTGGTCCAC

cDNA

(PRO2900), mRNA/cds = (271, 501)

CCGGCATGTCAGTCAGCACTCTGG

8019
HUVEC
Hs.211573
M85289
184426
heparan sulfate proleoglycan 2
1
CTGGCCTCTGTGTCCTAGAAGGGAC

cDNA

(perlecan) (HSPG2), mRNA/

CCTCCTGTGGTCTTTGTCTTGATTT

cds = (40, 13221)

8020
HUVEC
Hs.75103
M86400
189952
tyrosine 3-monooxygenase/tryptophen
1
CCCAAAGCTCACTTTACAAAATATTTC

cDNA

5-monooxygenase activation protein,

CTCAGTACTTTGCAGAAAACACC

zeta polypeptide (YWHAZ), mRNA/

cds = (84, 821)

8021
HUVEC
Hs.59271
M98982
338262
U2(RNU2) small nuclear RNA auxillary
1
ATGTCTGCTAGAAAGTGTTGTAGTTG

cDNA

factor 1 (non-standard symbol)

ATTGACCAAACCAGTTCATAAGGG

cDNA

(U2AF1), mRNA/cds = (38, 760)

8022
HUVEC
Hs.110802
NM_000552
9257255
von Willebrand factor (VWF), mRNA/
1
CTCTGCATGTTCTGCTCTTGTGCCCT

cDNA

cds = (310, 8751)

TCTGAGCCCACAATAAAGGCTGAG

8023
HUVEC
Hs.274466
NM_001403
4503472
eukaryotic translation elongation factor
1
TGCATCGTAAAACCTTTCAGAAGGAA

cDNA

1 alpha 1-like 14 (EEF1A1L14),

AGGAGAATGTTTTGTGGACACGTT

mRNA/cds = (620, 1816)

8024
HUVEC
Hs.279518
NM_001642
4502146
amyloid beta (A4) precursor-like
1
AGCCCTATTCATGTCTCTACCCACTA

cDNA

protein 2 (APLP2), mRNA/

TGCACAGATTAAACTTCACCTACA

cds = (72, 2363)

8025
HUVEC
Hs.76224
NM_004105
9865261
EGF-containing fibulin-like
1
AGTGACAGTGAACTTAAGCAAATTAC

cDNA

extracellular matrix protein 1

CCTCCTACCCAATTCTATGGAATA

(EFEMP1), transcript variant 1, mRNA/

cds = (149, 1630)

8026
HUVEC
Hs.19545
NM_012193
6912383
frizzled (Drosophila) homolog 4
1
ACACATGCCCTGAATGAATTGCTAAA

cDNA

(FZD4), mRNA/cds = (306, 1919)

TTTCAAAGGAAATGGACCCTGCTT

8027
HUVEC
Hs.87125
NM_014600
7657055
EH-domain containing 3 (EHD3),
1
GCCACTGAACCAATCACTTTGTATGC

cDNA

mRNA/cds = (285, 1892)

TATGCTCCTACTGTGATGGAAAAC

8028
HUVEC
Hs.119503
NM_016091
7705432
HSPC025 (HSPC025), mRNA/
1
AGGACCGAAGTGTTTCAAGTGGATCT

cDNA

cds = (33, 1727)

CAGTAAAGGATCTTTGGAGCCAGA

8029
HUVEC
Hs.7905
NM_016224
7706705
SH3 and PX domain-containing protein
1
TTCAATGGAAAATGAGGGGTTTCTCC

cDNA

SH3PX1 (SH3PX1), mRNA/

CCACTGATATTTTACATAGAGTCA

cds = (43, 1830)

8030
HUVEC
Hs.283722
NM_020151
9910251
GTT1 protein (GTT1), mRNA/
1
GCTCCATGTTCTGACTTAGGGCAATT

cDNA

cds = (553, 1440)

TGATTCTGCACTTGGGGTCTGTCT

8031
HUVEC
Hs.286233
NM_020414
14251213
sperm autoantigenic protein 17
1
GCAGCAGCTTAATTTTTCTGTATTGC

cDNA

(SPA17), mRNA/cds = (1210, 1685)

AGTGTTTATAGGCTTCTTGTGTGT

8032
HUVEC
Hs.272822
S56985
298485
RuvB (E. coli homolog)-like 1
1
ACCTCCCACTTTGTCTGTACATACTG

cDNA

(RUBVL1), mRNA/cds = (76, 1446)

GCCTCTGTGATTACATAGATCAGC

8033
HUVEC
Hs.279518
S60099
300168
amyloid beta (A4) precursor-like
1
AGCCCTATTCATGTCTCTACCCACTA

cDNA

protein 2 (APLP2), mRNA/

TGCACAGATTAAACTTCACCTACA

cds = (72, 2383)

8034
HUVEC
Hs.194662
S80582
1245968
calporin 3, acidic (CNN3), mRNA/
1
ACATGGAAGACTAAACTCATGCTTAT

cDNA

cds = (83, 1072)

TGCTAAATGTGGTCTTTGCCAACT

8035
HUVEC
Hs.76869
U08021
494988
nicotinamide N-methyltransferase
1
AGACCCCTGTGATGCCTGTGACCTCA

cDNA

(NNMT), mRNA/cds = (117, 911)

ATTAAAGCAATTCCTTTGACCTGT

8036
HUVEC
Hs.89657
U13991
582076
TATA box binding protein (TBP)-
1
CGCACTACTTCACCTGAGCCACCCAA

cDNA

associated factor, RNA polymerase II,

CCTAAATGTACTTATCTGTCCCCA

h, 30 kD (TAF2H), mRNA/

cds = (17, 673)

8037
HUVEC
Hs.1516
U20982
695253
insulin-like growth factor binding
1
CTGTAGACTCAGTGCCAGCCCAC

cDNA

protein 4 (IGFBP4) gene promoter and

AGCTTCAGAGATTGTGCTCACATG

complete

GTAT

8038
HUVEC
Hs.183648
U22816
930342
protein tyrosine phosphate, receptor
1
TGACAAAGGATTTTACGTTTATAAAAT

cDNA

type, I polypeptide (PTPRF), interacting

TATGACAGAAGCCATGTGCCCCG

protein (liprin), alpha 1 (PPFIA1),

mRNA/cds = (229, 3837)

8039
HUVEC
Hs.83383
U25182
799380
thioredoxin peroxidase (antioxidant
1
GTCTGCCCTGCTGGCTGGAAACCTG

cDNA

enzyme) (ADE372), mRNA/

GTAGTGAAACAATAATCCCAGATCC

cds = (43, 828)

8040
HUVEC
Hs.75888
U30255
984324
phosphogluconate dehydrogenase
1
CTCGTCATACAATGCCTGATGGGCTC

cDNA

(PGD), mRNA/cds = (6, 1457)

CTGCTACCCTCCACGTCTCCACAG

8041
HUVEC
Hs.169478
U34995
1497857

Homo sapiens, glyceraldehyde-3-
1
CTAGGGAGCCGCACCTTATCATGTAC

cDNA

phosphate dehydrogenase, clone

CATCAATAAAGTACCCTGTGCTCA

MCG:10926 IMAGE:3828129, mRNA,

complete cds/cds = (2308, 3313)

8042
HUVEC
Hs.192023
U39067
1718194
eukaryolic translation initiation factor 3,
1
TCCGTATCCATTACTTCGACCCACAG

cDNA

subunit 2 (beta, 36 kD) (EIF3S2),

TACTTTGAATTTGAGTTTGAGGCT

mRNA/cds = (17, 994)

8043
HUVEC
Hs.155637
U47077
13570016
DNA-dependent protein kinase
1
CCAGTCCTCCACACCCAAACTGTTTC

cDNA

catalytic subunit (DNA-PKcs) mRNA,

TGATTGGCTTTTAGCTTTTTGTTG

complete cds/cds = (57, 12443)

8044
HUVEC
Hs.285313
U51869
2745959
core promoter element binding protein
1
CTGTTGTCTCTCTGAGGCTGCCAGTT

cDNA

(COPEB), mRNA/cds = (117, 968)

GTTGTGTGTTACCGATGCCAGAAG

8045
HUVEC
Hs.184270
U56637
1336098
capping protein (actin filament) muscle
1
AATATAGTCAAGCAAGTTTGTTCCAG

cDNA

Z-line, alpha 1 (CAPZA1), mRNA/

GTGACCCATTGAGCTGTGTATGCA

cds = (0, 860)

8046
HUVEC
Hs.75064
U61234
1465773
tubulin-specific chaperone c (TBCC),
1
TTTGCTATTTTCGTCATGCCTTTGAGA

cDNA

mRNA/cds = (23, 1063)

CTGAGTCTTACTCCGTCCCCCAG

8047
HUVEC
Hs.183684
U73824
1857236
eukaryotic translation initiation factor 4
1
TTGTGGGTGTGAAACAAATGGTGAGA

cDNA

gamma, 2 (EIF4G2), mRNA/

ATTTGAATTGGTCCCTCCTATTAT

cds = (306, 3029)

8048
HUVEC
Hs.165283
U89278
1877500
early development regulator 2
1
CAGGAAGGAGGTAGGCACCTTTCTG

cDNA

(homolog of polyhomeotic 2) (EDR2),

AGCTTATTCTATTCCCCACCCACAC

mRNA/cds = (8, 1309)

8049
HUVEC
Hs.334703
W29012
1308969

Homo sapiens, clone IMAGE:3875338,
1
GGGAGCCATCCCTCTCTACCAAGGT

cDNA

mRNA, partial cds/cds = (0, 930)

GGCAATGATGGAGGGAACTTGCATG

8050
HUVEC
Hs.287820
X02761
31396
mRNA for fibronectin (FN precursor)/
1
TGGCCCGCAATACTGTAGGAACAAG

cDNA

cds = (0, 6987)

CATGATCTTGTTACTGTGATATTTT

8051
HUVEC
Hs.14378
X04098
28338
actin, gamma 1 (ACTG1), mRNA/
1
GGTTTTCTACTGTTATGTGAGAACATT

cDNA

cds = (74, 1201)

AGGCCCCAGCAACACGTCATTGT

8052
HUVEC
Hs.290070
X04412
35447
gelsolin (amyloidosis, Finnish type)
1
AGCCCTGCAAAAATTCAGAGTCCTTG

cDNA

(GSN), mRNA/cds = (14, 2362)

CAAAATTGTCTAAAATGTCAGTGT

8053
HUVEC
Hs.79088
X06323
34753
mitochondrial ribosomal protein L3
1
TGGGGACTATAGTGCAACCTATTTGG

cDNA

(MRPL3), mRNA/cds = (78, 1122)

GTAAAGAAACCATTTGCTAAAATG

8054
HUVEC
Hs.287797
X07979
31441
mRNA for FLJ00043 protein, partial
1
ACCACTGTATGTTTACTTCTCACCATT

cDNA

cds/cds = (0, 4248)

TGAGTTGCCCATCTTGTTTCACA

8055
HUVEC
Hs.87409
X14787
37464
thrombospandin 1 (THBS1), mRNA/
1
TTGACCTCCCATTTTTACTATTTGCCA

cDNA

cds/cds = (111, 3623)

ATACCTTTTTCTAGGAATGTGCT

8056
HUVEC
Hs.82202
X53777
34198
ribosomal protein L17 (RPL17),
1
GAGGAGGTTGCCCAGAAGAAAAAGA

cDNA

mRNA/cds = (286, 840)

TATCCCAGAAGAAACTGAAGAAACA

8057
HUVEC
Hs.233936
X54304
34755
myosin, light polypeptide, regulatory,
1
AACCTACCAGCCCTTCTCCCCCAATA

cDNA

non-sarcomeric (20 kD) (MLCB),

ACTGTGGGTCTATACAGAGTCAAT

mRNA/cds = (114, 629)

8058
HUVEC
Hs.74405
X57347
32463
tyrosine 3-monooxygenase/tryptophan
1
AGAGAGTTGGACCACTATTGTGTGTT

cDNA

5-monooxygenase activation protein,

GCTAATCATTGACTGTAGTCCCAA

theta polypeptide (YWHAQ), mRNA/

cds = (100, 837)

8059
HUVEC
Hs.77813
X59960
402620
sphingomyelin phosphodiesterase 1,
1
CCCTGTACTGCTGCTGCGACCTGATG

cDNA

acid lysosomal (acid

CTGCCAGTCTGTTAAAATAAAGAT

sphingomyelinase) (SMPD1), mRNA/

cds = (0, 1889)

8060
HUVEC
Hs.172690
X62535
30822
diacylglycerol kinase, alpha (80 kD)
1
ACACACATACACACACACCCCAAA

cDNA

(DGKA), mRNA/cds = (103, 2310)

ACACATACATTGAAAGTGCCTCAT

CTGA

8061
HUVEC
Hs.272822
X63527
36127
RuvB (E. coli homolog)-like 1
1
ACCTCCCACTTTGTCTGTACATACTG

cDNA

(RUVBL1), mRNA/cds = (78, 1446)

GCCTCTGTGATTACATAGATCAGC

8062
HUVEC
Hs.119529
X67698
37476
epididymal secretory protein (19.5 kD)
1
AACAACATTAACTTGTGGCCTCTTTCT

cDNA

(HE1), mRNA/cds = (10, 465)

ACACCTGGAAATTTACTCTTGAA

8063
HUVEC
Hs.211579
X68264
433891
MUC18 gene exons 1&2/
1
TCTCTGCTCAATCTCTGCTTGGCTCC

cDNA

cds = (26, 1966)

AAGGACCTGGGATCTCCTGGTACG

8064
HUVEC
Hs.75061
X70326
38434
macrophage myrisloylated alanine-rich
1
TGTCTTACTCAAGTTCAAACCTCCAG

cDNA

C kinase substrate (MACMARCKS),

CCTGTGAATCAACTGTGTCTCTTT

mRNA/cds = (13, 800)

8065
HUVEC
Hs.31314
X72841
297903
retinoblastoma-binding protein 7
1
AACTTTTACACTTTTTCCTTCCAACAC

cDNA

(RBBP7), mRNA/cds = (287, 1564)

TTCTTGATTGGCTTTGCAGAAAT

8066
HUVEC
Hs.79088
X78869
469884
reticulocalbin, 2, EF-hand calcium
1
TGGTGAGTGGAATTTGACATTGTCCA

cDNA

binding domain (RCN2), mRNA/

AACCTTTTTCATTTTTGAGTGATT

cds = (66, 1019)

8067
HUVEC
Hs.7957
X79448
2326523
adenosine deaminase, RNA-specific
1
GAGTGAGGAAGACCCCCAAGCATAG

cDNA

(ADAR), transcript variant ADAR-a,

ACTCGGGTACTGTGATGATGGCTGC

mRNA/cds = (187, 3867)

8068
HUVEC
Hs.76206
X79981
599833
cadherin 5, type 2, VE-cadherin
1
TGGCAAAGCCCCTCACACTGCAAGG

cDNA

(vascular epithelium) (CDH5), mRNA/

GATTGTAGATAACACTGACTTGTTT

cds = (120, 2474)

8069
HUVEC
Hs.172182
Y00345
35569
poly(A)-binding protein, cytoplasmic 1
1
GGAAAGGAAACTTTGAACCTTATGTA

cDNA

(PABPC1), mRNA/cds = (502, 2403)

CCGAGCAAATGCCAGGTCTAGCAA

8070
HUVEC
Hs.180414
Y00371
32466
hsc70 gene for 71 kd heat shock
1
AGTTAAGATTATTCAGAAGGTCGGGG

cDNA

cognate protein

ATTGGAGCTAAGCTGCCACCTGGT

8071
HUVEC
Hs.75216
Y00815
34266
protein tyrosine phosphatase, receptor
1
TTACCTTGTGGATGCTAGTGCTGTAG

cDNA

type F (PTPRF), mRNA/

AGTTCACTGTTGTACACAGTCTGT

cds = (370, 6083)

8072
HUVEC
Hs.65114
Y07604
1945761
keratin 18 (KRT18), mRNA/
1
GGGGTCTTCACATTATCATAACCTCT

cDNA

cds = (51, 1343)

CCTCTAAAGGGGAGGCATTAAAAT

8073
HUVEC
Hs.113503
Y08890
2253155

Homo sapiens mRNA for Ran_GTP
1
TTTCCTTGTGCAATTCAGACTTAAGC

cDNA

binding protein 5 (RanBP5(importin5)

ATCGAGTTTTTACCATCTTCCACT

gene)/cds = (236, 3529)

8074
HUVEC
Hs.44499
Y09703
4581462
pinin, desmosome associated protein
1
ACATGTGCAAATAAATGTGGCTTAGA

cDNA

(PNN), mRNA/cds = (30, 2261)

CTTGTGTGACTGCTTAAGACTAAA

8075
HUVEC
Hs.8867
Y11307
2791897
cysteine-rich, angiogenic inducer, 61
1
AAATGTAGCTTTTGGGGAGGGAGGG

cDNA

(CYR61), mRNA/cds = (80, 1225)

GAAATGTAATACTGGAATAATTTGT

8076
HUVEC
Hs.90061
Y12711
6759555
progesterone receptor membrane
1
ACCCACTGCAAAAGTAGTAGTCAAGT

cDNA

component 1 (PGRMC1), mRNA/

GTCTAGGTCTTTGATATTGCTCTT

cds = (78, 665)

8077
HUVEC
Hs.101033
Y14391
6562622
Pseudoautosomal GTP-binding protein
1
GCCTGCTGTGAACTGCTTTCCCTCGG

cDNA

like (PGPL), mRNA/cds = (329, 1540)

AATGTTTCCGTAACAGGACATTAA

8078
HUVEC
Hs.24322
Y15286
2584788
ATPase, H+ transporting, lysosomal
1
GAAGAGCCATCTCAACAGAATCGCAC

cDNA

(vacuolar proton pump) 9 kD (ATP6H),

CAAACTATACTTTCAGGATGAATT

mRNA/cds = (82, 307)

8079
HUVEC
Hs.291904
Z31696
479156
accessory proteins BAP31/BAP29
1
AGGAGGGTGGGTGGAACAGGTGGAC

cDNA

(DXS1357E), mRNA/cds = (136, 878)

TGGAGTTTCTCTTGAGGGCAATAAA

8080
HUVEC
Hs.180877
Z48950
761715
clone PP781 unknown mRNA/
1
TGCTTGATTAAGATGCCATAATAGTG

cDNA

cds = (113, 523)

CTGTATTTGCAGTGTGGGCTAAGA

8081
HUVEC
Hs.289101
Z49835
860985
glucose regulated protein, 58 kD
1
TTGGGGGAAATGTTGTGGGGGTGGG

cDNA

(GRP58), mRNA/cds = (0, 1517)

GTTGAGTTGGGGGTATTTTCTAATT

8082
HUVEC
Hs.10340
AK000452
7020548
hypothetical protein FLJ20445
1
AGCATGGTAAACCTGGGTTTTTGTTCA

cDNA

(FLJ20445), mRNA/cds = (334, 1170)

TATTTTCTCCAGACAGAAATGCAA

8083
HUVEC
Hs.194676
AK001313
7022490
tumor necrosis factor receptor
1
GGTCTCTTTGACTAATCACCAAAAAG

cDNA

superfamily, member 6b, decoy

CAACCAACTTAGCCAGTTTTATTT

(TNFRSF6B), transcript variant 2,

mRNA/cds = (827, 4488)

8084
HUVEC
Hs.808
AK001364
7022577
heteroganeous nuclear
1
GCCCTTGATGCTGGAGTCACATCTGT

cDNA

ribonucleoprotein F (HNRPF), mRNA/

TGATAGCTGGAGAACTTTAGTTTC

cds = (323, 1570)

8085
HUVEC
Hs.15978
AK002211
7023952
cDNA FLJ11349 fis, clone
1
GCCGATTCCAAGCGAGGGATTTAATC

cDNA

PLACE4000650, weakly similar to

CTTACATTTTTGCCCATTTGGCTC

TUBERIN/cds = UNKNOWN

8086
HUVEC
Hs.29692
AK021498
10432693
cDNA FLJ11436 fis, clone
1
TTCCCTGGACAGTTTGATGTGCTTAT

cDNA

HEMBA1001213/cds = UNKNOWN

GGTTGAGATTTATAATCTGCTTGT

8087
HUVEC
Hs.109672
AK023900
10435975

Homo sapiens. Similar to
1
GGCGGTGACTGCCCCAGACTTGGTT

cDNA

sialytransferase 7 ((alpha-N-

TTGTAATGATTTGTACAGGAATAAA

acetylneuraminyl 2,3-betagalactosyl-

1,3)-N-acetyl galactosaminide alpha-

2,6-slaytransferase) F, clone

MGC:14252 IMAGE:4128833, mRNA,

complete cds/cds = (128, 1129)

8088
HUVEC
Hs.25635
AK024039
10436304
cDNA FLJ13977 fis, clone
1
TGACCATTTGGAGGGGCGGGGCCTC

cDNA

Y79AA1001603, weakly similar to

CTAGAAGAACCTTCTTAGACAATGG

POLYPEPTIDE N-

ACETYLGALACTOSAMINYL-

TRANSFERASE (EC 2.4.1.41)/cds =

(418, 1791)

8089
HUVEC
Hs.288967
AK024167
10438481
cDNA FLJ14105 fis, clone
1
CAGTCCTCACACCAGCCAAGGTCACA

cDNA

MAMMA1001202/cds = UNKNOWN

GGCAAGAGCAAGAAGAGAAACTGA

8090
HUVEC
Hs.25001
AK024230
10436557
cDNA FLJ14168 fis, clone
1
CCTCAGTGATGGAATATCATGAATGT

cDNA

NT2RP2001440, highly similar to

GAGTCATTATGTAGCTGTCGTACA

mRNA for 14-3-3gamma/

cds = UNKNOWN

8091
HUVEC
Hs.6101
AK025006
10437439
hypothetical protein MGC3716
1
ACACACAACTTCAGCTTTGCATCACG

cDNA

(MGC3178), mRNA/cds = (81, 1055)

AGTCTTGTATTCCAAGAAAATCAA

8092
HUVEC
Hs.322680
AK025200
10437664
cDNA; FLJ21547 fis, clone COL08206/
1
GGAATTTCGCACCAGAGGACCCACC

cDNA

cds = UNKNOWN

ACGTCCTCGCTTCGACATCTTGAAC

8093
HUVEC
Hs.288061
AK025375
10437878
actin, beta (ACTB), mRNA/
1
GGAGGCAGCCAGGGCTTACCTGTAC

cDNA

cds = (73, 1200)

ACTGACTTGAGACCAGTTGAATAAA

8094
HUVEC
Hs.288869
AK025842
10438480
nuclear receptor subfamily 2, group F,
1
CAGAGAAAGAAAAGGCAAAAGACTG

cDNA

member 2 (NR2F2), mRNA/

GTTTGTTTGCTTAATTTCCTTCTGT

cds = (342, 1588)

8095
HUVEC
Hs.251653
AK026594
10439481
tubulin beta, 2 (TUBB2), mRNA/
1
GAAAGCAGGGAAGCAGTGTGAACTC

cDNA

cds = (0, 1337)

TTTATTCACTCCCAGCCTGTCCTGT

8096
HUVEC
Hs.334842
AK026632
10439528
tubulin, alpha, ubiquitous (K-ALPHA-
1
TGGTTAGATTGTTTTCACTTGGTGAT

cDNA

1), mRNA/cds = (67, 1422)

CATGTCTTTTCCATGTGTACCTGT

8097
HUVEC
Hs.288036
AK026650
10439548
tRNA isopentenylpyrophosphate
1
TGCATCGTAAAACCTTCAGAAGGAAA

cDNA

transferase (IPT), mRNA/

GGAGAATGTTTTGTGGACCACTTT

cds = (60, 1040)

8098
HUVEC
Hs.324406
AK026741
10439662
ribosomal protein L41 (RPL41),
1
TGGACCTGTGACATTCTGGACTATTT

cDNA

mRNA/cds = (83, 160)

CTGTGTTTATTTGTGGCCGAGTGT

8099
HUVEC
Hs.274388
AK026775
10439706
MSTP032 protein (MSTP032), mRNA/
1
TGCAACTAGCAACTCATCTTCGGAAG

cDNA

cds = (68, 319)

ACACAGCCAGGAGAATGAAGTAGA

8100
HUVEC
Hs.289071
AK027187
10440255
cDNA; FLJ22245 fis, clone HRC02612/
1
GACTTCCTCTCTGCGAGCTTCTACT

cDNA

cds = UNKNOWN

TCTAAGTCTGAATCCAGTCAGAAA

8101
HUVEC
Hs.334788
BG385658
13278634
hypothetical protein FLJ14639
1
GTTTCTCTTTGGTTTTCCAGATTTTCT

cDNA

(FLJ14639), mRNA/cds = (273, 689)

TTAGAACGGTGACTGACCCTCCT

8102
HUVEC
NA
NC_002090
9507429
many cloning vectors, kanamycin
1
CTGAGCAATAACTAGCATAACCCCTT

cDNA

resistance, gene

GGGGCCTCTAAACGGGTCTTGAGG

8103
HUVEC
NA
IJ07360
478289
Human DXS1178 locus dinucleotide
1
TGCCCATTTCACATTGCTCATTACTCA

cDNA

repeat polymorphism sequence

TGCAAATTTCTTCTTGCTAACCT

8104
HUVEC
Hs.230165
AA449779
316529
zx09e02.s1 cDNA, 3′ end/
1
ACCCACCATTGGTAAAATATTCAGGG

cDNA

clone = IMAGE:785978/clone_end =

GAACTTGGTTTAAAAGTTTATGCT

3′

8105
HUVEC
NA
AI000459
3191013
c107c08.s1 NCI_CGAP_GC3 cDNA
1
GTCAAATAAGGTTGTTCTTTCCTTGAA

cDNA

clone IMAGE:1914158 3′ similar to

GGACAGCACCCATGCCACAGCAC

gb:700361 60S RIBOSOMAL

PROTEIN (HUM

8106
HUVEC
Hs.172922
AI06204
3230540
ot83f03.s1 cDNA, 3′ end/
1
CTGGAAAAACATCACATGGTTGAGTC

cDNA

clone = IMAGE:1823389/clone_end =

AAGGATGAAAAGTCAAACTACCT

3′

8107
HUVEC
Hs.96457
AI081571
3418383
ox59h10.s1 cDNA, 3′ end/
1
ATCCATCCAATAAACACAGCAACACC

cDNA

clone = IMAGE:1660675/clone_end =

CTATGCTACTGACCAAGCAAAGCT

3′

8108
HUVEC
NA
AI082318
3419110
ox72c08.x1 Soares_NhHMPu_S1
1
TAGTTAGAGTCCAAGACATGGTTCCT

cDNA

cDNA clone IMAGE:1661870 3′

CCCCCTTTGTCTGTACATCCTGGC

similar to gb:X63527 60S

RIBOSOMAL PROTEIN

8109
HUVEC
Hs.145222
AI187426
3738064
qf31d08.x1 cDNA, 3′ end/
1
CAGCCTGCCTGCTTGCCATTTTTCTT

cDNA

clone = IMAGE:1751631/clone_end =

CCCCTTCCATTTTTCTAACCTCAG

3′

8110
HUVEC
Hs.273194
AI285483
3923716
ty56b02.x1 cDNA, 3′ end/
1
ACTTCCTCCCCCTCCCCCTAGCATTA

cDNA

clone = IMAGE:2283051/clone_end =

CTTATATGATATGTTTCCATACCC

3′

8111
HUVEC
Hs.238797
AI307808
4002412
602081661F1 cDNA, 5′ end/
1
AAGGAATTTGTTTTCCCTATCCTAACT

cDNA

clone = IMAGE:4245999/clone_end =

CAGTAACAGAGGGTTTACTCCGA

3′

8112
HUVEC
Hs.135872
AW028193
5886949
wv61h08.x1 cDNA, 3′ end/
1
TTTGCATCCCGAGTTTTGTATTCCAA

cDNA

clone = IMAGE:2534079/clone_end =

GAAAATCAAAGGGGGCCAATTTGT

3′

8113
HUVEC
Hs.244816
AW078847
603399
xb18g07.x1 cDNA, 3′ end/
1
AAACAGGAAGGGGGTTTGGGCCCTT

cDNA

clone = IMAGE:2576700/clone_end =

TGATCAACTGGAACCTTTGGATCAAG

3′

8114
HUVEC
Hs.249863
AW162315
6301348
au66d07.x1 cDNA, 3′ end/
1
AAAAACGGTTTATGGGGGTAGGGAAA

cDNA

clone = IMAGE:2781229/clone_end =

CAGGCCGAAAAGAACGTGGAGAAA

3′

8115
HUVEC
Hs.329930
AW170757
6402282
xj4207.x1 cDNA, 3′ end/
1
GGGGACTCAGGCCCCCGCTGGGGGT

cDNA

clone = IMAGE:2658180/clone_end =

CCCACATAGGGTTTTTATCCAAAAA

3′

8116
HUVEC
Hs.23349
AW237511
6569900
nab70e03.x1 cDNA, 3′ end/
1
TGTTGTTGGATACGTACTTAACTGGT

cDNA

clone = IMAGE:3273292/clone_end =

ATGCATCCCATGTCTTTGGGTACT

3′

8117
HUVEC
NA
BE672733
10033274
7b75g07.x1 NCI_CGAP_Lu24 cDNA
1
TGAGAGCACACCATAAATTCACAGCA

cDNA

clone IMAGE:3234108 3′ similar to

GGAATAAACGAAGACACACGAGCA

TR:O99231 O99231 CYTOCHROME

OXIDASE

8118
HUVEC
Hs.288443
BF110312
10940002
7n36d08.x1 cDNA, 3′ end
1
ACCAGGGCTTAAAACCTCAATTTATG

cDNA

clone = IMAGE:3566654/clone_end =

TTCATGACAGTGGGGATTTTTCTT

3′

8119
HUVEC
Hs.111301
J03210
180670
matrix metalloproteinase 2 (gelatinase
1
AGCCATAGAAGGTGTTCAGGTATTGC

cDNA

A, 72 kD gelatinase, 72 kD type IV

ACTGCCAACTCTTTGTCCGTTTTG

collagenase) (MMP2), mRNA/

cds = (289, 2271)

8120
HUVEC
Hs.82085
M14083
189566
serine (or cysteine) proteinase
1
CCATGCCCTTGTCATCAATCTTGAAT

cDNA

inhibitor, clade E (nexin, plasminogen

CCCATAGCTGCTTGAATCTGCTGC

activator inhibitor type 1), member 1

(SERPINE1), mRNA/cds = (75, 1283)

8121
HUVEC
Hs.80120
Y10343
2292903
UDP-N-acetyl-alpha-D-
1
TTAAGAATGTGGCAGAAATGTATGCT

cDNA

galactosamine:polypeptide N-

GAGGTAGCCCAGTCAATCCTTATT

acetylgalactosaminyltransferase 1

(FalNAc-T1) (GALNT1), mRNA/

cds = (31, 1710)

8122
HUVEC
Hs.10340
AK000452
7020548
hypothetical protein FLJ20445
1
ATCAGTAGCAAAACAAACCCAGCAAC

cDNA

(FLJ20445), mRNA/cds = (334, 1170)

TTCTGTCCAGCATCTGCTGTAGGG

8123
HUVEC
Hs.73742
AK001313
7022490
cDNA FLJ10451 fis, clone
1
CCCATCTAACTAGCACACGAACCTTC

cDNA

NT2RP1000959, highly similar to

CACGAGGACGCCTGGCGAGAGAAG

acidic ribosomal phosphoprotein PD

mRNA/cds = UNKNOWN

8124
HUVEC
Hs.808
AK001364
7022577
heterogeneous nuclear
1
GAACTTGGCAGTTGTAGCAGAGGCA

cDNA

ribonucleoprotein F (HNRPF), mRNA/

GTTGAGGCTTGTTGACCATCACCAT

cds = (323, 1570)

8125
HUVEC
Hs.15978
AK002211
7023952
cDNA FLJ11349 fis, clone
1
CGCTCTCTCCTGCACAGCACCACCAC

cDNA

PLACE4000650, weakly similar to

CAACAGTCTGGATGATTTTAGGCA

TUBERIN/cds = UNKNOWN

8126
HUVEC
Hs.29692
AK021498
10432693
cDNA FLJ11436 fis, clone
1
TTTTGGGAAGAAAACCCTATGCATCT

cDNA

HEMBA1001213/cds = UNKNOWN

GAAATACAATTGGCAATGGAAGCT

8127
HUVEC
Hs.109672
AK023900
10435975

Homo sapiens. Similar to
1
CTCTTTGTTGCTACTCATTTCTCTCCG

cDNA

sialytransferase 7 ((alpha-N-

GCGTCTGCTGAGGGGTAGGTGTC

acetylneuraminyl 2,3-betagalactosyl-

1,3)-N-acetyl galactosaminide alpha-

2,6-sialytransferase) F, clone

MGC:14252 IMAGE:4128833, mRNA,

complete cds/cds = (126, 1129)

8128
HUVEC
Hs.25835
AK024039
10436304
cDNA FLJ13977 fis, clone
1
CACCTTCCTCTTGGTTACCCAGAAGA

cDNA

Y79AA1001603, weakly similar to

ACAGCAGCACCGTGATCCAGAGCA

POLYPEPTIDE N-

ACETYLGALACTOSAMINYL-

TRANSFERASE (EC 2.4.1.41)/cds =

(418, 1791)

8129
HUVEC
Hs.288967
AK024167
10436481
cDNA FLJ14105 fis, clone
1
CTGTACATCTGCATCCCAGCAAAGAG

cDNA

MAMMA1001202/cds = UNKNOWN

CAGCAGGGACAGGAGGGAGGAGAG

8130
HUVEC
Hs.25001
AK024230
10438557
cDNA FLJ14168 fis, clone
1
CACAGACAGAAGGTTTCGTTCCTCAT

cDNA

NT2RP2001440, highly similar to

TCGACAGTGGCTCATTCAGCTCTG

mRNA for 14-3-3gamma/

cds = UNKNOWN

8131
HUVEC
Hs.6101
AK025006
10437439
hypothetical protein MGC3178
1
TCAAGATTGGCAATTCACTGTGCCCA

cDNA

(MGC3178), mRNA/cds = (81, 1055)

TTAAACCACTCAGTAGCTCAGCCT

8132
HUVEC
Hs.322680
AK025200
10437664
cDNA; FLJ21547 fis, clone COL08206/
1
AGTTGTCCTGAGAGTTTTACACTTGT

cDNA

cds = UNKNOWN

GAGAAAATACTGGCAGCTTTGATT

8133
HUVEC
Hs.288061
AK025375
10437878
actin, beta (ACTB), mRNA/
1
CACATAGGAATCCTTCTGACCCATGC

cDNA

cds = (73, 1200)

CCACCATACACGCCCTGGTGCCTGG

8134
HUVEC
Hs.288869
AK025842
10438480
nuclear receptor subfamily 2, group F,
1
AACAGGAACCTTTATCTCTTTGTGAG

cDNA

member 2 (NR2F2), mRNA/

GCGATTTGCATTCTCCACACAGGC

cds = (342, 1586)

8135
HUVEC
Hs.251653
AK026594
10439481
tubulin, beta, 2 (TUBB2), mRNA/
1
GTACTTGCCGCCGGTGGCCTCATTG

cDNA

cds = (0, 1337)

AGTACACGTTGATGCGTTCCAGCT

8136
HUVEC
Hs.278242
AK026632
10439528

Homo sapiens, clone MGC:3214
1
ATAGTGGCTAGGGATTAGGAGGCGA

cDNA

IMAGE:3502620, mRNA, complete

AGGCGACAGGAGCAGACACCGGGTC

cds/cds = (2066, 3421)

8137
HUVEC
Hs.181165
AK026850
10439548
eukaryotic translation elongation factor
1
CATTTTGGCTTTTAGGGGTAGTTTTC

cDNA

1 alpha 1 (EEF1A1), mRNA/

ACGACACCTGTGTTCTGGCGGCAA

cds = (53, 1441)

8138
HUVEC
Hs.108124
AK026741
10439662
cDNA; FLJ23088 fis, clone LNG07026/
1
CCCTGGTTCAGGAATTAAGGGGACA

cDNA

cds = UNKNOWN

GACTTGAATAAGAAACAAAACAAAA

8139
HUVEC
Hs.274368
AK026775
10439706
MSTP032 protein (MSTP032), mRNA/
1
ACAGTAGAGAATTTGAGTACACAGGG

cDNA

cds = (88, 319)

TATGGAGAGTAGGGCACAAAATGT

8140
HUVEC
Hs.241507
AK027187
10440255
cDNA; FLJ23534 fis, clone LNG06974,
1
GAACAGCCTCGTCTTTCCCCGAATGC

cDNA

highly similar to HUMRPS6A

CAGGCAGGATGACGATGAACGTGG

ribosomal protein S6 mRNA/cds =

UNKNOWN

8141
HUVEC
Hs.334788
BG392671
13286119
hypothetical protein FLJ14639
1
GACCTCCAGAATTTCCTCATCGCTGT

cDNA

(FLJ14639), mRNA/cds = (273, 689)

CGGTGACCAAGTCCACAGACACTA

8142
HUVEC
NA
NC_002090
9507429
many cloning vectors, kanamycin
1
TCTTGCCATCCTATGGAACTGCCTCG

cDNA

resistance, gene

GTGAGTTTTCTCCTTCATTACAGA

8143
HUVEC
NA
U07360
476289
Human DXS1178 locus dinucleotide
1
TGTTACTCCTTCAAGCCCCTGAATCA

cDNA

repeat polymorphism sequence

CTATAGCCACGACTCTCCAACTGA

TABLE 9

Viral genomes were used to design oligonucleotides for

the microarrays. The accession numbers for the viral genomes

used are given, along with the gene name and location of the

region used for oligonucleotide design.

Virus
Gene Name
Genome Location

Adenovirus,
E1a
1226 . . . 1542

type 2
E1b_1
3270 . . . 3503

Accession
E2a_2
complement(24089 . . . 25885)

#J01917
E3-1
27609 . . . 29792

E4 (last exon
complement(33193 . . . 32802)

at 3′-end)

IX
3576 . . . 4034

Iva2
complement(4081 . . . 5417)

DNA Polymerase
complement(5187 . . . 5418)

Cytomega-
HCMVTRL2
1893 . . . 2240

lovirus
(IRL2)

(CMV)
HCMVTRL7
complement(6595 . . . 6843)

Accession
(IRL7)

#X17403
HCMVUL21
complement(26497 . . . 27024)

HCMVUL27
complement(32831 . . . 34657)

HCMVUL33
43251 . . . 44423

HCMVUL54
complement(76903 . . . 80631)

HCMVUL75
complement(107901 . . . 110132)

HCMVUL83
complement(119352 . . . 121037)

HCMVUL106
complement(154947 . . . 155324)

HCMVUL109
complement(157514 . . . 157810)

HCMVUL113
161503 . . . 162800

HCMVUL122
complement(169364 . . . 170599)

HCMVUL123
complement(171006 . . . 172225)

(last exon at 3′-end)

HCMVUS28
219200 . . . 220171

Epstein-
Exon in EBNA-1 RNA
67477 . . . 67649

Barr virus
Exon in EBNA-1 RNA
98364 . . . 98730

(EBV)
BRLF1
complement(103366 . . . 105183)

Accession
BZLF1 (first of
complement(102655 . . . 103155)

#
3 exons)

NC_001345
BMLF1
complement(82743 . . . 84059)

BALF2
complement(161384 . . . 164770)

Human
U16/U17
complement(26259 . . . 27349)

Herpesvirus
U89
complement(133091 . . . 135610)

6 (HHV6)
U90
complement(135664 . . . 135948)

Accession
U86
complement(125989 . . . 128136)

#
U83
123528 . . . 123821

NC_001664
U22
complement(33739 . . . 34347)

DR2 (DR2L)
791 . . . 2653

DR7 (DR7L)
5629 . . . 6720

U95
142941 . . . 146306

U94
complement(141394 . . . 142866)

U39
complement(59588 . . . 62080)

U42
complement(69054 . . . 70598)

U81
complement(121810 . . . 122577)

U91
136485 . . . 136829

TABLE 10A

Lupus gene expression markers

SEQ

Oligo/

ID

SEQ ID
Source
Unigene
Acc
GI
(Acc)
Name
Strand
SAM FDR
CART

41
cDNA
Hs.166120
NM_004031
4809287
8845
interferon regulatory factor 7 (IRF7)
1
1.1
NA

T-cells

328
Tabel 3A
NA
NA
NA
8846
53G7
1
NA
surrogate

668
Table 3A
Hs.169895
NM_004223
4759281
8847
ubiquitin-conjugating enzyme E2L 6
1
1.6
NA

855
Table 3A
Hs.135187
NM_030930
13569892
8848
unc93 (C. elegans) homolog B
1
1.1
NA

981
Table 3A
Hs.17448
AK023680
10435678
8849
cDNA FLJ13618 fis
1
1.6
NA

1001
Table 3A
Hs.85155
NM_004926
15812179
8850
zinc finger protein 36, C3H type-like 1
1
NA
Model II

(5 gene)

3rd Splitter

1003
Table 3A
Hs.24115
AK024240
10436567
8851
cDNA FLJ14178 fis
1
NA
Model II

(5 gene)

Secondary

Splitter

1025
Table 3A
Hs.12293
NM_024556
13375720
8852
hypothetical protein FLJ21103
1
NA
Model II

(3 gene)

Secondary

Splitter

1035
Table 3A
Hs.166254
NM_030938
20070348
8853
VMP1 ortholog of rat vacuole protein 1
1
NA
surrogate

1227
Table 3A
Hs.322456
NM_032039
14042969
8854
hypothetical protein DKFZp761D0211
1
NA
surrogate

1341
Table 3A
Hs.181165
AV756188
10914036
8855
eukaryotic translation elongation factor
1
1.6
NA

1390
Table 3A
Hs.238990
NM_004064
17978497
8856
EST IMAGE:3458141,
1
1.1
NA

Similar to p27, Kip1,

1436
Table 3A
Hs.288061
NM_001101
5016088
8857
actin, beta (ACTB)
1
NA
Model I

(3 gene)

Secondary

Splitter

1535
Table 3A
Hs.356755
BE868389
10317165
8858
tripartite motif protein 14 (TRIM14)
1
1.6
NA

1750
Table 3A
Hs.198253
NM_002122
18426974
8859
HLA-DQA1
1
1.1
NA

2102
Table 3A
Hs.301921
NM_001295
4502630
8860
chemokine (C-C motif)
1
1.6
NA

receptor 1 (CCR1)

2331
Table 3A
Hs.172182
NM_002568
4505574
8861
poly(A)-binding protein, cytoplasmic 1
1
1.6
NA

2386
Table 3A
Hs.63489
NM_002831
18104988
8862
protein tyrosine phosphatase, PTPN6
1
1.6
NA

2412
Table 3A
Hs.79411
NM_002946
4506584
8863
replication protein A2
1
1.1
Model I

(2 gene)

Primary

Splitter

2560
literature
Hs.1524
NM_003811
4507608
8864
TNF (ligand) superfamily,
1
1.6
NA

member 9 (TNFSF9)

2648
Table 3A
Hs.38125
NM_080424
17986253
8865
SP110 nuclear body protein
1
1.6
Model I

(2 gene)

Primary

Splitter

2895
Table 3A
Hs.18420
NM_006289
16753232
8866
talin 1 (TLN1)
1
1.1
NA

3249
Table 3A
Hs.7104
NM_015995
7706289
8867
cDNA DKFZp761P06121
1
NA
surrogate

3305
Table 3A
Hs.183125
NM_016523
7705573
8868
killer cell lectin-like receptor
1
1.6
NA

subfamily F

3541
literature
Hs.170222
R14692
768965
8869
Na+/H+ exchanger NHE-1 isoform
1
1.6
NA

3692
Table 3A
Hs.173334
W47229
1331869
8870
ELL-RELATED RNA
1
1.1
NA

POLYMERASE II

3701
Table 3A
Hs.1103
NM_000660
10863872
8871
transforming growth factor,
1
1.6
NA

beta 1 (TGFB1)

3741
Table 3A
Hs.198951
NM_002229
4504808
8872
jun B proto-oncogene (JUNB)
1
1.1
NA

3825
Table 3A
Hs.3416
NM_001122
4557260
8873
adipose differentiation-related
1
1.1
NA

protein (ADFP)

3827
Table 3A
Hs.139262
NM_017523
8923794
8874
XIAP associated factor-1
1
2.67
NA

(HSXIAPAF1)

3832
Table 3A
Hs.172182
NM_002568
4505574
8875
poly(A)-binding protein, cytoplasmic 1
1
1.6
NA

4149
Literature
Hs.74621
NM_000311
4506112
8876
prion protein (p27-30) (PRNP)
1
1.6
NA

4400
db mining
NA
AF073705
3335589
8877
immunoglobulin lambda light chain
1
1.1
NA

variable region 4a

4601
literature
Hs.149609
NM_002205
4504750
8878
Integrin, alpha 5 (fibronectin receptor)
1
1.6
NA

4604
db mining
Hs.169824
NM_002258
4504878
8879
killer cell lectin-like receptor
1
1.1
NA

subfamily B, member 1

4631
literature
Hs.73839
NM_002935
4506550
8880
ribonuclease, RNase A family, 3
1
1.1
NA

4637
db mining
Hs.301698
NM_003033
4506950
8881
beta-galactoside alpha-2,3-
1
NA
NA

sialyltransferase (SIAT4A)

5067
Table 3B
Hs.356291
W16552
1290934
8882
capicua protein (CIC) mRNA
1
0
Model II

(1 gene)

Primary

Splitter

5074
db mining
NA
AA701193
2704358
8883
EST Soares_fetal_liver_spleen
−1
1.6
NA

IMAGE: 461188 3′

5468
Table 3A
Hs.229990
AI818777
5437856
8884
EST IMAGE: 2424619
−1
1.6
NA

5531
Table 3A
Hs.77393
AL567986
12921892
8885
famesyl diphosphate synthase
−1
1.6
NA

5607
db mining
Hs.279105
AW063509
8887446
8886
TN1012 cDNA
−1
1.6
NA

6382
Table 3A
Hs.179665
NM_078467
17978494
8887
cyclin-dependent kinase
1
1.6
NA

inhibitor 1A (p21, Cip1)

6956
Table 3B
NA
BM852711
19209110
8888
ESTT (Negative stand probe
1
1.1
NA

to Hs.17481)

7238
db mining
Hs.56009
NM_006187
5453823
8889
2′-5′-oligoadenylate synthetase 3
1
1.1
NA

7330
db mining
Hs.226307
NM_004900
4758159
8890
phorbolin
1
0.25
NA

7641
db mining
Hs.100217
NM_005892
5174400
8891
formin-like (FMNL)
1
1.6
NA

8015
HUVEC
Hs.198281
NM_002654
4505838
8892
pyruvate kinase, muscle (PKM2)
1
1.6
NA

cDNA

8095
HUVEC
Hs.251653
NM_006088
20127490
8893
tubulin, beta, 2 (TUBB2)
1
1.6
NA

cDNA

TABLE 10B

PCR Primers for lupus marker genes

SEQ ID
PRIMER SET 1
Tm
SEQ ID
Primer Set 2
Tm
SEQ ID

41
FORWARD GAAGAGCCTGGTCCTGGTGA
62.74
8894
TGACGACATCGAGTGCTTCC
62.41
8895

REVERSE AGAGGCTGAGGCTGCTGCTA
62.82
8896
CAGCTCTAGGTGGGCTGCTC
62.56
8897

328
FORWARD GCCCAAGGGTGAAAACTGTG
62.77
8898
TGGGTCTGCTGCTGTCTGTC
62.67
8899

REVERSE TCCGTCGTTGACTTGTGTCC
62.15
8900
AGGACGGGGATGGACGTATC
63.32
8901

668
FORWARD TACATTCCCCAGAGCCAAGG
62.28
8902
GCCTGCTTGCAGGAAATGAA
63.63
8903

REVERSE GCCTGCAAGGTGACCTGTCT
62.79
8904
CTCCCACCCATATGCTCCAC
62.63
8905

855
FORWARD TACATTCCCCAGAGCCAAGG
62.28
8906
GCCTGCTTGCAGGAAATGAA
63.63
8907

REVERSE GCCTGCAAGGTGACCTGTCT
62.79
8908
CTCCCACCCATATGCTCCAC
62.63
8909

981
FORWARD CCGTAATCTTAAAGAGAAAATCTTTGGA
62.24
8910
CCCGTAATCTTAAAGAGAAAATCTTTGG
63.41
8911

REVERSE TCACTCAGAAATGGAACTTTTACCTG
61.95
8912
TCACTCAGAAATGGAACTTTTACCTGT
62.55
8913

1001
FORWARD TGGATTCCAGGTCTGGAGTTTT
62.09
8914
CACGTGCCCATCTCAAGACA
63.3
8915

REVERSE CGACGGTAGTGACCAGCAAG
61.84
8916
ATGTGTGTGTGCCAGTTCTGTTT
61.82
8917

1003
FORWARD GCCTCTCAACTGAGCAGTAAAGGT
62.42
8918
GCAGTAAAGGTAAGGAGAGCTCAATC
62.1
8919

REVERSE TGAAGTCTCAAGTGGGCATGA
61.79
8920
TGAAGTCTCAAGTGGGCATGA
61.79
8921

1025
FORWARD AACCCACTCCCCAGGCTAGA
63.2
8922
GCCGCCTGTTCAAGTTCAAG
63.16
8923

REVERSE ATCCAGACCCCGAGTCCTTC
62.71
8924
CACATTGGTGTGCTGTGTGG
62.16
8925

1035
FORWARD ATGGCAGCCTTGCCTAATCC
63.58
8926
TGCATGAGAGAGCCACTACCA
61.95
8927

REVERSE TATGCAGCAGCCCAGTTTCA
62.83
8928
AGGTAGGCCAATCCCAGAGG
62.62
8929

1227
FORWARD ACCTCTGTGCCTTGCTGCTC
63.06
8930
ATCCCAAGGAACTGGCTGTG
62.4
8931

REVERSE ATCAGGCTGCTTTGGCTACG
62.72
8932
GCCTCTTCAGGGACAGAGCA
63.01
8933

1341
FORWARD AAGGATTGATCGCCGTTTTG
62.22
8934
CTGAACCATCCAGGCCAAAT
62.17
8935

REVERSE TGGGCCTGACAAGAACCATT
62.76
8936
ACGGCGATCAATCCTTTCCT
63.1
8937

1390
FORWARD TGGCATGTTTTGTGCATTTGT
62.27
8938
AAGCCAAAGTGGCATGTTTTG
62.27
8939

REVERSE CTTGGCTCAGTATGCAACCTTTT
61.81
8940
GGCTCAGTATGCAACCTTTTAAGC
62.48
8941

1436
FORWARD GCCGAGGACTTTGATTGCAC
63.04
8942
GAACGGTGAAGGTGACAGCA
62.29
8943

REVERSE GAAGTGGGGTGGCTTTTAGGA
62.55
8944
AATCAAAGTCCTCGGCCACA
62.89
8945

1535
FORWARD TCCACACCATGGGCAGAAC
63.02
8946
CAGGGCCTGGGTTTGAATAA
62.08
8947

REVERSE GGCCCTGCAATTATTCAAACC
62.69
8948
TTGATTGCTGAATGGGAGAGG
62.41
8949

1750
FORWARD CCCTTGGTGTCTGGAAGCAC
63.01
8950
TTAGGTAGCTGGGCGGCTTA
62.06
8951

REVERSE GTCTGTGCCTTGGGGTTGTC
62.89
8952
GGTGCTTCCAGACACCAAGG
63.01
8953

2102
FORWARD AGGAAGCAGGGTTGGTTTCC
62.63
8954
CCCAGAGCCAATCAGTAGCC
62.07
8955

REVERSE CCAAGATGGCAGTCGGAACT
62.53
8956
TGTTCCCCAGGATTCCAAGA
62.71
8957

2331
FORWARD GGCTGCCCAGAAAGCAGTTA
62.7
8958
AAAGAGGCTGCCCAGAAAGC
63.13
8959

REVERSE TTCTTCGGTGAAGCACAAGTTTC
62.83
8960
TGAAGCACAAGTTTCTTTTCATGG
62.63
8961

2386
FORWARD AAGTGAGCGGTGCTGTCCTC
62.92
8962
AGCGGTCAGCAGACAAGGAG
63.04
8963

REVERSE TGGGGCACTCCTAGGTTCAG
62.51
8964
AATGCTTCCACAGGGTCAGG
62.4
8965

2412
FORWARD TGGCCTCTGCCTGTTTTCAT
63.02
8966
AGGACCAGGGCGTTATAGGC
62.56
8967

REVERSE CGTCATGGCAAGTGTGTCAA
61.78
8968
ATGCCACACAACCAAAGTCG
61.81
8969

2560
FORWARD GGGTCCCTGCTGCTTTCTCT
63.11
8970
GGCGTCCATCTTCACACTGA
62.27
8971

REVERSE TCCAACTTGGGGAAGGAGTG
62.36
8972
ACCCGGAAGAGTCCCAAGAC
62.72
8973

2648
FORWARD AGCATCCCCACCTCAGGATT
63.08
8974
TTACGGTGAGCCCTTTCAGG
62.43
8975

REVERSE GTGTCTGGGTTTGGGTCCTG
62.74
8976
GCATGTCTCGCACAAACCAT
62.09
8977

2895
FORWARD CCAAGTGCCTTCATGCCCTA
63.37
8978
TCTGCCTTCAGAGCTTCGAGA
62.79
8979

REVERSE CGGCAGATTCAGATCGAGGT
62.65
8980
CAGCCCAGAAGGCTTTGGTA
62.56
8981

3249
FORWARD CTGGCAGGACTGCAACAAGA
62.55
8982
GCTCCCTCAGCGACTACAGC
62.58
8983

REVERSE CAGATGGGGCAGCTGAACTT
62.66
8984
AGGAAAGGCCAGGGACTCAC
62.85
8985

3305
FORWARD TCCCTCCATCATCGACACTG
62.09
8986
GTCTAGCCTCAGAGTAACCCCTGTT
62.42
8987

REVERSE TTGGCATAAAATAAGCGACGAA
61.72
8988
TTGGCATAAAATAAGCGACGAA
61.72
8989

3541
FORWARD CTGCTGACCCACCAAGGTCT
62.64
8990
GAGCAGGGGTGGTTTCTACG
61.96
8991

REVERSE CCCGCAGCTCTGAGTAAGGA
62.9
8992
TCCTTCCCCTAGCAGCTTCC
62.98
8993

3692
FORWARD TGGTTGCCTTAAGGTGTTTGC
62.27
8994
ACATTAAATCCGCCCTGCAA
62.58
8995

REVERSE GCCACAGTATGCTTCCCATTG
62.7
8996
TGCTCTAATCAAGTGGGAAGCAG
62.93
8997

3701
FORWARD TTGACTTCCGCAAGGACCTC
62.65
8998
GCCTTTCCTGCTTCTCATGG
62.19
8999

REVERSE TCCAGGCTCCAAATGTAGGG
62.28
9000
CTCCGTGGAGCTGAAGCAAT
62.79
9001

3741
FORWARD TCCACCTCGACGTTTACAAGC
62.48
9002
CCTGCCCCTTTACGGACAC
62.76
9003

REVERSE CCCTCTTCCCCTCCCTGTTA
62.59
9004
GCCGGAGTCCAGTGTGGT
62.21
9005

3825
FORWARD ACCCTCCTGTCCAACATCCA
62.73
9006
TGTTAACAACACGCCCCTCA
62.45
9007

REVERSE CAGCATTGCGGAACACTGAG
62.95
9008
TGTCCATCTCTGCACCTTGG
62.26
9009

3827
FORWARD TTTTGATGTCAGAGCCCAAGC
62.57
9010
TCAGTGTGGCATCCTGCTTC
62.41
9011

REVERSE GAAGCAGGATGCCACACTGA
62.41
9012
TGAAGCTAACCACCGGCATT
62.81
9013

3832
FORWARD TGGCATGTTGTTGGAGATTGA
62.43
9014
GGCTGCCCAGAAAGCAGTTA
62.7
9015

REVERSE TGGGCAGCCTCTTTAGCTTG
62.81
9016
TTCTTCGGTGAAGCACAAGTTTC
62.83
9017

4149
FORWARD AAACCCTTTTGCGTGGTCCT
63
9018
TTAATATGTGGGAAACCCTTTTGC
62.25
9019

REVERSE CCTGTTAATGGTGTCCACTTTGG
62.7
9020
CCTGTTAATGGTGTCCACTTTGG
62.7
9021

4400
FORWARD ACATCATCGCATGGCATCAG
63.06
9022
ACAACAAGGGGAGCGGAGTT
63.23
9023

REVERSE AACTCCGCTCCCCTTGTTGT
63.23
9024
TCAGCCTCATCCTCAAACTGG
62.65
9025

4601
FORWARD CAGCTCCAAGGGGAATCAGA
62.61
9026
AGCCAGGAATTTCCCAGGAC
62.62
9027

REVERSE CTGGATCTGCCTGGATTGGT
62.38
9028
ACAGTGGGCTCCCCTTTCTC
62.85
9029

4604
FORWARD GGCAGCAACTCCGAGAGAAA
62.91
9030
TGCAGTGTGGACATTCAACAGA
62.71
9031

REVERSE GCAGGCTGGATTCTTTGGTG
63.02
9032
TCTCGGAGTTGCTGCCAATA
61.85
9033

4631
FORWARD CTCACAGGAGCCACAGCTCA
62.79
9034
CCACGGTATCCTGTGGTTCC
62.51
9035

REVERSE CACCCATAAGCCCCAACAGA
63.12
9036
TGATTGAGGAGCTTGGCAGA
62.03
9037

4637
FORWARD ATGCTGCCCTTCTTTTGCAC
62.59
9038
GGCAAGCTTGGGAATGAATG
62.78
9039

REVERSE GGAGCCTCTGGTGGCTCATA
62.65
9040
TGCTGGAGGTAATCGCCACT
63.04
9041

5067
FORWARD TCGACATGGTGAGGTAGAGCA
61.81
9042
TTTGGTGACAGTGAGCTTGAGG
62.69
9043

REVERSE TGTTCTGGCAGCACCTCAAG
62.55
9044
TGGATGGCCGTTTAGAGAGAA
61.99
9045

5074
FORWARD GGCTTAACCCAGGCATCCTC
63.1
9046
TGTCTGGAAGCCACAACTGG
62.27
9047

REVERSE GAGGCCTGCTTCCAGTTGTG
63.27
9048
GGGTTTTCTGTGGCCCTCTT
62.63
9049

5468
FORWARD CCCACTTCCCCATGTTTGTC
62.5
9050
TAAAACAGCCCAGCGCTCAC
63.65
9051

REVERSE CGGCAGATCCCTGAAATGAC
62.88
9052
GCTGGAAACCTGGCAGTGAT
62.55
9053

5531
FORWARD CCATGGGGTCTTGCCCTAC
62.62
9054
TGCTCCTTCTCGCCATCAAT
63.14
9055

REVERSE AGGCTGGACCATCAGTCAGG
62.62
9056
AGGAAGCAGCCAGGAAGATG
61.82
9057

5607
FORWARD AAACTCGGCATGTCCTCCAG
62.53
9058
CGGTCAGATCGTTGCGTAGA
62.33
9059

REVERSE CAAGGATGAGGACGGTGCTT
62.53
9060
TGGGCTTAGCCTTGATCCAC
62.43
9061

6382
FORWARD TGGGGCTGGGAGTAGTTGTC
62.4
9062
CATCCCTCCCCAGTTCATTG
62.6
9063

REVERSE GGAAGGTGTTTGGGGTCAGA
62.25
9064
GTGGCATGCCCTGTCCATA
62.91
9065

6956
FORWARD TCTTGGAGATTCGAGCAGCA
62.17
9066
AGGCAGCAGTGCAAGTGACA
63.23
9067

REVERSE CTGCGACCAGAGTCAGTGGA
62.65
9068
TGGCTATTGCTGGCCTCCTA
63.03
9069

7238
FORWARD CTCTGCCAAGTTGTCCAGCA
62.55
9070
GGACCCCAAACTCCACCTCT
62.59
9071

REVERSE AGGTACCCAACTGCGACCTG
62.43
9072
TGGACAACTTGGCAGAGCAG
62.55
9073

7330
FORWARD CCTGGGTTGAGCAGCAGAAT
62.66
9074
CAGCCCTGGGATGGACTAGA
62.5
9075

REVERSE AGCACATTGCTTTGCTGGTG
62.36
9076
AGGCCCATCCTTCAGTTTCC
62.62
9077

7641
FORWARD CAGGCTGAGGCTCAAGGAAG
62.53
9078
CCTCCGACCTCTCGCTGTAG
62.41
9079

REVERSE CCAAGAGGAGGATGCACCAG
63.11
9080
GCTGAGGACCACCTTCCTTG
62.15
9081

8015
FORWARD CCCTGGCCCTTACTTGCTTC
63.22
9082
GCAAGAGGGTGACAGCTTCC
62.3
9083

REVERSE GGTGGAGGGTGGAGTGTTTG
62.74
9084
GCTGTTTCTTGACCCCAAGC
62.09
9085

TABLE 10 C

Surrogates for lupus gene expression markers

SEQ

Hierarchical

(Oligo)

Clustering

ID
Acc
Name
CART Surogates
Surrogates

41
NM_004031
interferon regulatory factor 7 (IRF7)

328
unknown
53G7

668
AF061736
ubiquitin-conjugating enzyme E2L 6

855
AJ271326
unc93 (C. elegans) homolog B

171

981
AK023680
cDNA FLJ13618 fis

1001
NM_004926
zinc finger protein 36, C3H type-like 1
1015, 1019, 1036, 1037, 1013,
2401, 209, 8004, 578

1003
AK024240
cDNA FLJ14178 fis
10, 100, 1005, 1004, 1001
6074

1025
AK024756
hypothetical protein FLJ21103
103, 1041, 1042, 1046, 1003

1035
NM_030938
VMP1 ortholog of rat vacuole protein 1

1227
NM_032039
hypothetical protein DKFZp761D0211

1341
AV756188
eukaryotic translation elongation factor

1390
AY004255
EST IMAGE:3458141, Similar to p27, Kip1,

1436
NM_001101
actin, beta (ACTB)
5067, 7330, 3692,
1052

1635
BE868389
tripartite motif protein 14 (TRIM14)

1750
M11124
HLA-DQA1

1770, 1769

2102
NM_001295
chemokine (C-C motif) receptor 1 (CCR1)

2331
NM_002568
poly(A)-binding protein, cytoplasmic 1

3832

2386
NM_002831
protein tyrosine phosphatase, PTPN6

2412
NM_002946
replication protein A2
855, 7330, 2331, 2895,
3741, 3692

2560
NM_003811
TNF (ligand) superfamily, member 9 (TNFSF9)

2648
NM_080424
SP110 nuclear body protein
2412, 855, 7330, 2331, 2895,
3328, 824, 2969, 371,

8016, 7238, 3827, 4

2895
NM_006289
talin 1 (TLN1)

8095, 2386

3249
NM_015995
cDNA DKFZp761P06121

3305
NM_016523
killer cell lectin-like receptor subfamily F

3541
R14692
Na⁺/H⁺ exchanger NHE-1 isoform

3692
W47229
ELL-RELATED RNA POLYMERASE II

3701
X02812
transforming growth factor, beta 1 (TGFB1)

3741
X51345
jun B proto-oncogene (JUNB)

3825
X97324
adipose differentiation-related protein (ADFP)

3827
X99699
XIAP associated factor-1 (HSXIAPAF1)

3832
Y00345
poly(A)-binding protein, cytoplasmic 1

2331

4149
NM_000311
prion protein (p27-30) (PRNP)

4444

4400
AF073705
immunoglobulin lambda light chain variable region 4a

4601
NM_002205
integrin, alpha 5 (fibronectin receptor)

4604
NM_002258
killer cell lectin-like receptor subfamily B, member 1

1991

4631
NM_002935
ribonuclease, RNase A family, 3

4637
NM_003033
beta-galactoside alpha-2,3-sialyltransferase (SIAT4A)

5067
W16552
capicua protein (CIC) mRNA
328, 2412, 1227, 3249, 2331,
7242

5074
AA701193
EST Soares_fetal_liver_spleen IMAGE:461188 3′

5468
AI818777
EST IMAGE:2424619

5531
AL567986
farnesyl diphosphate synthase

5607
AW063509
TN1012 cDNA

6382
NM_078467
cyclin-dependent kinase inhibitor 1A (p21, Cip1)

6956
BM852711
ESTT (Negative stand probe to Hs.17481)

5278

7238
NM_006187
2′-5′-oligoadenylate synthetase 3

3328, 824, 2969, 371,

8016, 1785, 3827, 41

7330
NM_004900
phorbolin

7641
NM_005892
formin-like (FMNL)

8015
M26252
pyruvate kinase, muscle (PKM2)

8095
AK026594
tubulin, beta, 2 (TUBB2)

TABLE 11

Kits for discovery of, or application of diagnostic gene sets

A. Contents of kit for discovery of diagnostic

gene sets using microarrays

1.
Sterile, endotoxin and RNAse free blood collection tubes

2.
Alcohol swabs, tourniquet, blood collection set

3.
-PBS (phosphate buffer saline; needed when method of example 8 is

used to derived mononuclear RNA)

4.
Cell lysis buffer

5.
RNA isolation kit

6.
Substrates for labeling of RNA (may vary for various expression

profiling techniques)

For fluorescence microarray expression profiling:

Reverse transcriptase and 10x RT buffer

T7(dT)24 primer (primer with T7 promoter at 5′ end)

DTT

Deoxynucleotides 100 mM each

RNAse inhibitor

2^ndstrand cDNA buffer

DNA polymerase

Rnase H

T7 RNA polymerase

Ribonucleotides

In Vitro transcription buffer

Cy3 and Cy5 labeled ribonucleotides

7.
Microarrays containing candidate gene libraries

8.
Cover slips for slides

9.
Hybridization chambers

10.
Software package for identification of diagnostic gene set from data

Contains statistical methods.

Allows alteration in desired sensitivity and specificity of

gene set.

Software facilitates access to and data analysis by

centrally located database server.

11.
Password and account number to access central database server.

12.
Kit User Manual

B. Contents of kit for application of diagnostic

gene sets using microarrays

1.
Sterile, endotoxin and RNAse free blood collection tubes

2.
Alcohol swabs, tourniquet, blood collection set

3.
-PBS (phosphate buffer saline; needed when method of example 7 is

used to derived mononuclear RNA)

4.
Cell lysis buffer

5.
RNA isolation kit

6.
Substrates for labeling of RNA (may vary for various expression

profiling techniques)

For fluorescence microarray expression profiling:

Reverse transcriptase and 10x RT buffer

T7(dT)24 primer (primer with T7 promoter at 5′ end)

DTT

Deoxynucleotides 100 mM each

RNAse inhibitor

2^ndstrand cDNA buffer

DNA polymerase

Rnase H

T7 RNA polymerase

Ribonucleotides

In Vitro transcription buffer

Cy3 and Cy5 labeled ribonucleotides

7.
Microarrays containing candidate gene libraries

8.
Cover slips for slides

9.
Hybridization chambers

10.
Software package for identification of diagnostic geng set from data

Contains statistical methods.

Allows alteration in desired sensitivity and specificity of

gene set.

Software facilitates access to and data analysis by centrally

located database server.

11.
Password and account number to access central database server.

12.
Kit User Manual

C. Contents of kit for application of diagnostic gene sets

using Real-time RT-PCR

1.
Sterile, endotoxin and RNAse free blood collection tubes

2.
Alcohol swabs, tourniquet, blood collection set

3.
-PBS (phosphate buffer saline; needed when method of example 7

is used to derived mononuclear RNA)

4.
Cell lysis buffer

5.
RNA isolation kit

6.
Substrates for real time RT-PCR (may vary for various real-time PCR techniques:

poly dT primers, random hexamer primers

Reverse Transcriptase and RT buffer

DTT

Deoxynucleotides 100 mM

RNase H

primer pairs for diagnostic and control gene set

10x PCR reaction buffer

Taq DNA polymerase

Fluorescent probes for diagnostic and control gene set

(alternatively, fluorescent dye that binds to only double stranded DNA)

reaction tubes with or without barcode for sample tracking

96-well plates with barcode for sample identification, one

barcode for entire set, or individual barcode per reaction

tube in plate

7.
Software package for identification of diagnostic gene set from data

Contains statistical methods.

Allows alteration in desired sensitivity and specificity of gene

set.

Software facilitates access to and data analysis by centrally

located database server

8.
Password and account number to access central database server.

9.
Kit User Manual

Number	Name	Date	Kind
4190535	Luderer et al.	Feb 1980	A
4350593	Kessler	Sep 1982	A
4358535	Falkow et al.	Nov 1982	A
4582789	Sheldon, III et al.	Apr 1986	A
4683195	Mullis et al.	Jul 1987	A
4683202	Mullis	Jul 1987	A
4751001	Saunders	Jun 1988	A
4762780	Spector et al.	Aug 1988	A
4789630	Bloch et al.	Dec 1988	A
4800159	Mullis et al.	Jan 1989	A
4818418	Saunders	Apr 1989	A
4843155	Chomczynski	Jun 1989	A
4889818	Gelfand et al.	Dec 1989	A
4908318	Lerner	Mar 1990	A
4946952	Kiefer	Aug 1990	A
4965188	Mullis et al.	Oct 1990	A
5053134	Luderer et al.	Oct 1991	A
5063162	Kiefer	Nov 1991	A
5066584	Gyllensten et al.	Nov 1991	A
5075216	Innis et al.	Dec 1991	A
5079352	Gelfand et al.	Jan 1992	A
5091310	Innis	Feb 1992	A
5142033	Innis	Aug 1992	A
5143854	Pirrung et al.	Sep 1992	A
5210015	Gelfand et al.	May 1993	A
5212071	Fearon et al.	May 1993	A
5215882	Bahl et al.	Jun 1993	A
5219727	Wang et al.	Jun 1993	A
5264351	Harley	Nov 1993	A
5278043	Bannwarth et al.	Jan 1994	A
5310652	Gelfand et al.	May 1994	A
5314809	Erlich et al.	May 1994	A
5322770	Gelfand	Jun 1994	A
5340720	Stetler	Aug 1994	A
5352600	Gelfand et al.	Oct 1994	A
5374553	Gelfand et al.	Dec 1994	A
5385824	Hoet et al.	Jan 1995	A
5389512	Sninsky et al.	Feb 1995	A
5393672	Ness et al.	Feb 1995	A
5405774	Abramson et al.	Apr 1995	A
5407800	Gelfand et al.	Apr 1995	A
5411876	Bloch et al.	May 1995	A
5418149	Gelfand et al.	May 1995	A
5420029	Gelfand et al.	May 1995	A
5445940	Brenner et al.	Aug 1995	A
5455170	Abramson et al.	Oct 1995	A
5459037	Sutcliffe et al.	Oct 1995	A
5466591	Abramson et al.	Nov 1995	A
5468613	Erlich et al.	Nov 1995	A
5476774	Wang et al.	Dec 1995	A
5487970	Rowley et al.	Jan 1996	A
5487972	Gelfand et al.	Jan 1996	A
5491063	Fisher et al.	Feb 1996	A
5491086	Gelfand et al.	Feb 1996	A
5501963	Burckhardt	Mar 1996	A
5512462	Cheng	Apr 1996	A
5514556	Shearer et al.	May 1996	A
5538848	Livak et al.	Jul 1996	A
5561058	Gelfand et al.	Oct 1996	A
5565339	Bloch et al.	Oct 1996	A
5569583	Greenberg et al.	Oct 1996	A
5571673	Picone	Nov 1996	A
5573906	Bannworth et al.	Nov 1996	A
5604099	Erlich et al.	Feb 1997	A
5618703	Gelfand et al.	Apr 1997	A
5618711	Gelfand et al.	Apr 1997	A
5624833	Gelfand et al.	Apr 1997	A
5635365	Ansari et al.	Jun 1997	A
5641864	Gelfand	Jun 1997	A
5658744	Ochoa et al.	Aug 1997	A
5665551	Gelfand et al.	Sep 1997	A
5674738	Abramson et al.	Oct 1997	A
5677152	Birch et al.	Oct 1997	A
5693517	Gelfand et al.	Dec 1997	A
5707807	Kato	Jan 1998	A
5716787	Dunn et al.	Feb 1998	A
5721351	Levinson	Feb 1998	A
5766585	Evans et al.	Jun 1998	A
5773258	Birch et al.	Jun 1998	A
5789224	Gelfand et al.	Aug 1998	A
5795762	Abramson et al.	Aug 1998	A
5804375	Gelfand et al.	Sep 1998	A
5807522	Brown et al.	Sep 1998	A
5811284	Chang et al.	Sep 1998	A
5837832	Chee et al.	Nov 1998	A
5939270	Haunsø et al.	Aug 1999	A
5939292	Gelfand et al.	Aug 1999	A
5958342	Gamble et al.	Sep 1999	A
5958688	Eberwine et al.	Sep 1999	A
5965366	Ochoa et al.	Oct 1999	A
5968799	Gelfand et al.	Oct 1999	A
5973137	Heath	Oct 1999	A
5981481	Fearon et al.	Nov 1999	A
5994056	Higuchi	Nov 1999	A
5994076	Chenchik et al.	Nov 1999	A
6001611	Will	Dec 1999	A
6004755	Wang	Dec 1999	A
6010853	Kanteti et al.	Jan 2000	A
6020186	Henco et al.	Feb 2000	A
6033860	Lockhart et al.	Mar 2000	A
6040138	Lockhart et al.	Mar 2000	A
6040166	Erlich et al.	Mar 2000	A
6045996	Cronin et al.	Apr 2000	A
6048695	Bradley et al.	Apr 2000	A
6048709	Falb	Apr 2000	A
6060240	Kamb et al.	May 2000	A
6066322	Levinson	May 2000	A
6066498	Levinson	May 2000	A
6084083	Levinson	Jul 2000	A
6087112	Dale	Jul 2000	A
6087477	Falb et al.	Jul 2000	A
6090556	Kato	Jul 2000	A
6099823	Falb	Aug 2000	A
6124433	Falb et al.	Sep 2000	A
6127155	Gelfand et al.	Oct 2000	A
6146828	Lapidus et al.	Nov 2000	A
6150121	Hamawy et al.	Nov 2000	A
6156887	Levinson	Dec 2000	A
6162604	Jacob	Dec 2000	A
6168933	Kaser et al.	Jan 2001	B1
6171785	Higuchi	Jan 2001	B1
6177254	Rattner et al.	Jan 2001	B1
6187534	Strom et al.	Feb 2001	B1
6190857	Ralph et al.	Feb 2001	B1
6190872	Slotman	Feb 2001	B1
6194158	Kroes et al.	Feb 2001	B1
6197563	Erlich et al.	Mar 2001	B1
6204371	Levinson	Mar 2001	B1
6214979	Gelfand et al.	Apr 2001	B1
6218122	Friend et al.	Apr 2001	B1
6225084	Falb et al.	May 2001	B1
6225093	Grant et al.	May 2001	B1
6228628	Gelfand et al.	May 2001	B1
6242185	Kaser et al.	Jun 2001	B1
6245334	Seilhammer et al.	Jun 2001	B1
6245526	Yue et al.	Jun 2001	B1
6245527	Busfield et al.	Jun 2001	B1
6248527	Chen et al.	Jun 2001	B1
6248528	Chen et al.	Jun 2001	B1
6251597	Shyjan	Jun 2001	B1
6262244	Houchins et al.	Jul 2001	B1
6280941	Tsao et al.	Aug 2001	B1
6303321	Tracey et al.	Oct 2001	B1
6306602	Sillekens et al.	Oct 2001	B1
6365352	Yerramilli et al.	Apr 2002	B1
6403304	Stashenko et al.	Jun 2002	B1
6410319	Raubitschek et al.	Jun 2002	B1
20020042386	Rosen et al.	Apr 2002	A1
20020128436	Strom et al.	Sep 2002	A1
20020132235	Avihingsanon et al.	Sep 2002	A1

Number	Date	Country
0 217 992	Apr 1987	EP
1 077 254	Feb 2001	EP
1 162 276	Dec 2001	EP
WO 9118626	Dec 1991	WO
WO 9517506	Jun 1995	WO
WO 9639536	Dec 1996	WO
WO 9730065	Aug 1997	WO
WO 9824935	Jun 1998	WO
WO 9910536	Mar 1999	WO
WO 9911782	Mar 1999	WO
WO 9915700	Apr 1999	WO
WO 9952541	Oct 1999	WO
WO 9957130	Nov 1999	WO
WO 0004191	Jan 2000	WO
WO 0012753	Mar 2000	WO
WO 0023573	Apr 2000	WO
WO 0046372	Aug 2000	WO
WO 0052209	Sep 2000	WO
WO 0055375	Sep 2000	WO
WO 0063372	Oct 2000	WO
WO 0073498	Dec 2000	WO
WO 0078808	Dec 2000	WO
WO 0120004	Mar 2001	WO
WO 0123426	Apr 2001	WO
WO 0123564	Apr 2001	WO
WO 0129269	Apr 2001	WO
WO 0132927	May 2001	WO
WO 0140302	Jun 2001	WO
WO 0147944	Jul 2001	WO
WO 0154733	Aug 2001	WO
WO 0155164	Aug 2001	WO
WO 0155201	Aug 2001	WO
WO 0155203	Aug 2001	WO
WO 0155205	Aug 2001	WO
WO 0155328	Aug 2001	WO
WO 0155368	Aug 2001	WO
WO 0160860	Aug 2001	WO
WO 0171005	Sep 2001	WO
WO 0181916	Nov 2001	WO
WO 0186003	Nov 2001	WO
WO 0200677	Jan 2002	WO
WO 0200928	Jan 2002	WO
WO 0228999	Apr 2002	WO

	Number	Date	Country
Parent	10006290	Oct 2001	US
Child	10131827		US

Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Term Extension

Abstract

Description

Claims

RELATED APPLICATIONS

US Referenced Citations (150)

Foreign Referenced Citations (43)

Related Publications (1)

Provisional Applications (1)

Continuation in Parts (1)